Psyllid ID: psy1840
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
ID ![]() | Alignment graph ![]() | Length ![]() |
Definition ![]() |
RBH(Q2H) ![]() |
RBH(H2Q) ![]() |
Q cover ![]() |
H cover ![]() |
Identity ![]() |
E-value ![]() |
| Query | 423 | 2.2.26 [Sep-21-2011] | |||||||
| Q07553 | 1163 | Guanylate cyclase 32E OS= | yes | N/A | 0.460 | 0.167 | 0.586 | 3e-60 | |
| P11528 | 986 | Resact receptor OS=Arbaci | N/A | N/A | 0.423 | 0.181 | 0.465 | 2e-38 | |
| P16065 | 1125 | Speract receptor OS=Stron | no | N/A | 0.453 | 0.170 | 0.425 | 1e-36 | |
| P55202 | 1050 | Atrial natriuretic peptid | N/A | N/A | 0.423 | 0.170 | 0.427 | 1e-33 | |
| P18910 | 1057 | Atrial natriuretic peptid | yes | N/A | 0.420 | 0.168 | 0.432 | 1e-33 | |
| P18293 | 1057 | Atrial natriuretic peptid | yes | N/A | 0.420 | 0.168 | 0.432 | 3e-33 | |
| P16066 | 1061 | Atrial natriuretic peptid | yes | N/A | 0.420 | 0.167 | 0.427 | 9e-33 | |
| P46197 | 1047 | Atrial natriuretic peptid | no | N/A | 0.423 | 0.170 | 0.410 | 2e-30 | |
| O19179 | 1109 | Retinal guanylyl cyclase | no | N/A | 0.420 | 0.160 | 0.406 | 3e-30 | |
| P20594 | 1047 | Atrial natriuretic peptid | no | N/A | 0.423 | 0.170 | 0.410 | 3e-30 |
| >sp|Q07553|GCY3E_DROME Guanylate cyclase 32E OS=Drosophila melanogaster GN=Gyc32E PE=1 SV=4 | Back alignment and function desciption |
|---|
Score = 232 bits (592), Expect = 3e-60, Method: Compositional matrix adjust.
Identities = 119/203 (58%), Positives = 140/203 (68%), Gaps = 8/203 (3%)
Query: 35 GMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKA 94
GMI+LHDSEIISHGNLRSSNCLIDSRWV QI+DFGLH KAGQ+E + +R L A
Sbjct: 638 GMIYLHDSEIISHGNLRSSNCLIDSRWVCQISDFGLHELKAGQEEPNKSELELKRALCMA 697
Query: 95 PELLRQPHLP-RGTQKGDVYSFGLVLYEVIGRQGPWGHLRMTDEEIITSVT-----QGSG 148
PELLR + P RG+QKGDVYSFG++LYE+IGR+GPWG + EEII V Q
Sbjct: 698 PELLRDAYRPGRGSQKGDVYSFGILLYEMIGRKGPWGDTAYSKEEIIQFVKCPEMLQHGV 757
Query: 149 LRPDT--SSLDCAPSIIACMRTCWEEDPELRPDLRFVHHKLKEMNAGLKANIFDNMLAIM 206
RP + LD I C+ CW+EDPE+RPD+R V LKE+ AGLK NIFDNML+IM
Sbjct: 758 FRPALTHTHLDIPDYIRKCLCQCWDEDPEVRPDIRLVRMHLKELQAGLKPNIFDNMLSIM 817
Query: 207 EKYAFNLEGEWTDWTASLRRRPK 229
EKYA+NLEG + T L K
Sbjct: 818 EKYAYNLEGLVQERTNLLYEEKK 840
|
Drosophila melanogaster (taxid: 7227) EC: 4EC: .EC: 6EC: .EC: 1EC: .EC: 2 |
| >sp|P11528|GCY_ARBPU Resact receptor OS=Arbacia punctulata PE=1 SV=1 | Back alignment and function description |
|---|
Score = 160 bits (404), Expect = 2e-38, Method: Compositional matrix adjust.
Identities = 88/189 (46%), Positives = 122/189 (64%), Gaps = 10/189 (5%)
Query: 35 GMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDET---GQERKLRRRKL 91
G+++LH SEI SHG+L+SSNC++D+RWVLQI D+GLH F+ GQ E G+ KL RKL
Sbjct: 676 GLVYLHSSEIKSHGHLKSSNCVVDNRWVLQITDYGLHEFRKGQKEDVDLGEHAKL-ARKL 734
Query: 92 YKAPELLRQ--PHLPRGTQKGDVYSFGLVLYEVIGRQGPWGHLRMTDEEIITSVTQGS-- 147
+ APE LR+ P GT KGD+YSF ++L E+ RQ P+ + +II V++G
Sbjct: 735 WTAPEHLREGKSMHPGGTPKGDIYSFSIILTEMYSRQEPFHENDLELADIIARVSKGEVP 794
Query: 148 GLRPDTSSLD-CAPS-IIACMRTCWEEDPELRPDLRFVHHKLKEMNAGLKANIFDNMLAI 205
RP ++++ AP ++ +R CW EDP RP++ V L + GLK NI DNM+AI
Sbjct: 795 PYRPVLNAVNEAAPDCVLTAIRACWVEDPMERPNIIEVRTMLAPLQKGLKPNILDNMIAI 854
Query: 206 MEKYAFNLE 214
ME+Y NLE
Sbjct: 855 MERYTNNLE 863
|
Implicated as a cell-surface receptor on spermatozoa for 'resact' a chemotactic peptide, and on various other cells as a receptor for atrial natriuretic peptide. Arbacia punctulata (taxid: 7641) EC: 4 EC: . EC: 6 EC: . EC: 1 EC: . EC: 2 |
| >sp|P16065|GCY_STRPU Speract receptor OS=Strongylocentrotus purpuratus PE=2 SV=1 | Back alignment and function description |
|---|
Score = 154 bits (389), Expect = 1e-36, Method: Compositional matrix adjust.
Identities = 86/202 (42%), Positives = 125/202 (61%), Gaps = 10/202 (4%)
Query: 35 GMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDET---GQERKLRRRKL 91
G+++LH SEI SHG+L+SSNC++D+RWVLQI D+GL+ FK GQ + G KL R+L
Sbjct: 679 GIVYLHSSEIKSHGHLKSSNCVVDNRWVLQITDYGLNEFKKGQKQDVDLGDHAKL-ARQL 737
Query: 92 YKAPELLRQP-HLP-RGTQKGDVYSFGLVLYEVIGRQGPWGHLRMTDEEIITSVTQGS-- 147
+ +PE LRQ +P G+ +GD+YSF ++L E+ RQ P+ M +II V G
Sbjct: 738 WTSPEHLRQEGSMPTAGSPQGDIYSFAIILTELYSRQEPFHENEMDLADIIGRVKSGEVP 797
Query: 148 GLRPDTSSLDCAP--SIIACMRTCWEEDPELRPDLRFVHHKLKEMNAGLKANIFDNMLAI 205
RP ++++ A +++ +R CW EDP RP++ V L + GLK NI DNM+AI
Sbjct: 798 PYRPILNAVNAAAPDCVLSAIRACWPEDPADRPNIMAVRTMLAPLQKGLKPNILDNMIAI 857
Query: 206 MEKYAFNLEGEWTDWTASLRRR 227
ME+Y NLE + T L++
Sbjct: 858 MERYTNNLEELVDERTQELQKE 879
|
Implicated as a cell-surface receptor on spermatozoa for 'speract' a chemotactic peptide, and on various other cells as a receptor for atrial natriuretic peptide. Strongylocentrotus purpuratus (taxid: 7668) EC: 4 EC: . EC: 6 EC: . EC: 1 EC: . EC: 2 |
| >sp|P55202|ANPRB_ANGJA Atrial natriuretic peptide receptor 2 OS=Anguilla japonica GN=npr2 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 144 bits (363), Expect = 1e-33, Method: Compositional matrix adjust.
Identities = 79/185 (42%), Positives = 114/185 (61%), Gaps = 6/185 (3%)
Query: 35 GMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKA 94
GM LH+S I SHGNL+SSNC++DSR+VL+I D+GL +F++ E L +KL+ A
Sbjct: 634 GMNFLHNSYIGSHGNLKSSNCVVDSRFVLKITDYGLASFRSSC-ENEDSHALYAKKLWTA 692
Query: 95 PELL-RQPHLPRGTQKGDVYSFGLVLYEVIGRQGPW--GHLRMTDEEIITSVTQGSG--L 149
PELL H P+GTQKGDVYSFG++L E+ R GP+ + ++ +EI+ V G
Sbjct: 693 PELLIYDRHPPQGTQKGDVYSFGIILQEIALRNGPFYVDGMDLSPKEIVQKVRNGQKPYF 752
Query: 150 RPDTSSLDCAPSIIACMRTCWEEDPELRPDLRFVHHKLKEMNAGLKANIFDNMLAIMEKY 209
RP T + + + M CW EDP RPD ++ + ++N +I +N+L+ ME+Y
Sbjct: 753 RPTTDTSCHSEELSILMEGCWAEDPADRPDFSYIKIFVMKLNKEGSTSILNNLLSRMEQY 812
Query: 210 AFNLE 214
A NLE
Sbjct: 813 ANNLE 817
|
Receptor for the C-type natriuretic peptide NPPC/CNP hormone. Has guanylate cyclase activity upon binding of its ligand. May play a role in the regulation of skeletal growth. Anguilla japonica (taxid: 7937) EC: 4 EC: . EC: 6 EC: . EC: 1 EC: . EC: 2 |
| >sp|P18910|ANPRA_RAT Atrial natriuretic peptide receptor 1 OS=Rattus norvegicus GN=Npr1 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 144 bits (363), Expect = 1e-33, Method: Compositional matrix adjust.
Identities = 80/185 (43%), Positives = 113/185 (61%), Gaps = 7/185 (3%)
Query: 35 GMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKA 94
GM+ LH+ I SHGNL+SSNC++D R+VL+I D+GL +F+ + E G L +KL+ A
Sbjct: 642 GMLFLHNGAICSHGNLKSSNCVVDGRFVLKITDYGLESFRDPEPEQGH--TLFAKKLWTA 699
Query: 95 PELLRQPHLP-RGTQKGDVYSFGLVLYEVIGRQGPW--GHLRMTDEEIITSVTQGSG--L 149
PELLR P RG+Q GDVYSFG++L E+ R G + L ++ +EII VT+G
Sbjct: 700 PELLRMASPPARGSQAGDVYSFGIILQEIALRSGVFYVEGLDLSPKEIIERVTRGEQPPF 759
Query: 150 RPDTSSLDCAPSIIACMRTCWEEDPELRPDLRFVHHKLKEMNAGLKANIFDNMLAIMEKY 209
RP + M+ CW EDP+ RP + + L++ N +NI DN+L+ ME+Y
Sbjct: 760 RPSMDLQSHLEELGQLMQRCWAEDPQERPPFQQIRLALRKFNKENSSNILDNLLSRMEQY 819
Query: 210 AFNLE 214
A NLE
Sbjct: 820 ANNLE 824
|
Receptor for the atrial natriuretic peptide NPPA/ANP and the brain natriuretic peptide NPPB/BNP which are potent vasoactive hormones playing a key role in cardiovascular homeostasis. Has guanylate cyclase activity upon binding of the ligand. Rattus norvegicus (taxid: 10116) EC: 4 EC: . EC: 6 EC: . EC: 1 EC: . EC: 2 |
| >sp|P18293|ANPRA_MOUSE Atrial natriuretic peptide receptor 1 OS=Mus musculus GN=Npr1 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 143 bits (360), Expect = 3e-33, Method: Compositional matrix adjust.
Identities = 80/185 (43%), Positives = 113/185 (61%), Gaps = 7/185 (3%)
Query: 35 GMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKA 94
GM+ LH+ I SHGNL+SSNC++D R+VL+I D+GL +F+ + E G L +KL+ A
Sbjct: 642 GMLFLHNGAIGSHGNLKSSNCVVDGRFVLKITDYGLESFRDPEPEQGH--TLFAKKLWTA 699
Query: 95 PELLRQPHLP-RGTQKGDVYSFGLVLYEVIGRQGPW--GHLRMTDEEIITSVTQGSG--L 149
PELLR P RG+Q GDVYSFG++L E+ R G + L ++ +EII VT+G
Sbjct: 700 PELLRMASPPARGSQAGDVYSFGIILQEIALRSGVFYVEGLDLSPKEIIERVTRGEQPPF 759
Query: 150 RPDTSSLDCAPSIIACMRTCWEEDPELRPDLRFVHHKLKEMNAGLKANIFDNMLAIMEKY 209
RP + M+ CW EDP+ RP + + L++ N +NI DN+L+ ME+Y
Sbjct: 760 RPSMDLQSHLEELGQLMQRCWAEDPQERPPFQQIRLALRKFNKENSSNILDNLLSRMEQY 819
Query: 210 AFNLE 214
A NLE
Sbjct: 820 ANNLE 824
|
Receptor for the atrial natriuretic peptide NPPA/ANP and the brain natriuretic peptide NPPB/BNP which are potent vasoactive hormones playing a key role in cardiovascular homeostasis. Has guanylate cyclase activity upon binding of the ligand. Mus musculus (taxid: 10090) EC: 4 EC: . EC: 6 EC: . EC: 1 EC: . EC: 2 |
| >sp|P16066|ANPRA_HUMAN Atrial natriuretic peptide receptor 1 OS=Homo sapiens GN=NPR1 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 141 bits (356), Expect = 9e-33, Method: Compositional matrix adjust.
Identities = 79/185 (42%), Positives = 113/185 (61%), Gaps = 7/185 (3%)
Query: 35 GMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKA 94
GM+ LH+ I SHGNL+SSNC++D R+VL+I D+GL +F+ E G + +KL+ A
Sbjct: 646 GMLFLHNGAICSHGNLKSSNCVVDGRFVLKITDYGLESFRDLDPEQGH--TVYAKKLWTA 703
Query: 95 PELLRQPHLP-RGTQKGDVYSFGLVLYEVIGRQGPW--GHLRMTDEEIITSVTQGSG--L 149
PELLR P RG+Q GDVYSFG++L E+ R G + L ++ +EII VT+G
Sbjct: 704 PELLRMASPPVRGSQAGDVYSFGIILQEIALRSGVFHVEGLDLSPKEIIERVTRGEQPPF 763
Query: 150 RPDTSSLDCAPSIIACMRTCWEEDPELRPDLRFVHHKLKEMNAGLKANIFDNMLAIMEKY 209
RP + + M+ CW EDP+ RP + + L++ N +NI DN+L+ ME+Y
Sbjct: 764 RPSLALQSHLEELGLLMQRCWAEDPQERPPFQQIRLTLRKFNRENSSNILDNLLSRMEQY 823
Query: 210 AFNLE 214
A NLE
Sbjct: 824 ANNLE 828
|
Receptor for the atrial natriuretic peptide NPPA/ANP and the brain natriuretic peptide NPPB/BNP which are potent vasoactive hormones playing a key role in cardiovascular homeostasis. Has guanylate cyclase activity upon binding of the ligand. Homo sapiens (taxid: 9606) EC: 4 EC: . EC: 6 EC: . EC: 1 EC: . EC: 2 |
| >sp|P46197|ANPRB_BOVIN Atrial natriuretic peptide receptor 2 OS=Bos taurus GN=NPR2 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 133 bits (335), Expect = 2e-30, Method: Compositional matrix adjust.
Identities = 76/185 (41%), Positives = 106/185 (57%), Gaps = 6/185 (3%)
Query: 35 GMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKA 94
GM LH+S I SHG+L+SSNC++DSR+VL+I D+GL +F++ E L +KL+ A
Sbjct: 630 GMAFLHNSIIASHGSLKSSNCVVDSRFVLKITDYGLASFRS-TAEPDDSHALYAKKLWTA 688
Query: 95 PELLRQPHLP-RGTQKGDVYSFGLVLYEVIGRQGPW--GHLRMTDEEIITSVTQGS--GL 149
PELL LP G QK DVYSFG++L E+ R GP+ L ++ +EI+ V G
Sbjct: 689 PELLSGNPLPTTGMQKADVYSFGIILQEIALRSGPFYLEGLDLSPKEIVQKVRNGQRPYF 748
Query: 150 RPDTSSLDCAPSIIACMRTCWEEDPELRPDLRFVHHKLKEMNAGLKANIFDNMLAIMEKY 209
RP ++ M CW +DP RPD + ++ N +I DN+L ME+Y
Sbjct: 749 RPSIDRTQLNEELVLLMERCWAQDPAERPDFGQIKGFIRRFNKEGGTSILDNLLLRMEQY 808
Query: 210 AFNLE 214
A NLE
Sbjct: 809 ANNLE 813
|
Receptor for the C-type natriuretic peptide NPPC/CNP hormone. Has guanylate cyclase activity upon binding of its ligand. May play a role in the regulation of skeletal growth. Bos taurus (taxid: 9913) EC: 4 EC: . EC: 6 EC: . EC: 1 EC: . EC: 2 |
| >sp|O19179|GUC2D_CANFA Retinal guanylyl cyclase 1 OS=Canis familiaris GN=GUCY2D PE=2 SV=1 | Back alignment and function description |
|---|
Score = 133 bits (335), Expect = 3e-30, Method: Compositional matrix adjust.
Identities = 74/182 (40%), Positives = 106/182 (58%), Gaps = 4/182 (2%)
Query: 35 GMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKA 94
GM +LH + +HG L+S NC++D R+VL++ D G HA E +L+ A
Sbjct: 657 GMRYLHHRGV-AHGRLKSRNCVVDGRFVLKVTDHG-HARLMEAQRVLLEPPSAEDQLWTA 714
Query: 95 PELLRQPHLPR-GTQKGDVYSFGLVLYEVIGRQGPWGHLRMTDEEIITSVTQGSGLRPDT 153
PELLR P L R GT GDV+S G+++ EV+ R P+ L +T EE++ V L +
Sbjct: 715 PELLRDPALERRGTLPGDVFSLGIIMQEVVCRSAPYAMLELTPEEVVERVRSPPPLCRPS 774
Query: 154 SSLDCAP-SIIACMRTCWEEDPELRPDLRFVHHKLKEMNAGLKANIFDNMLAIMEKYAFN 212
S+D AP I M+ CW E P+LRP L + + K +N G K NI D+ML ++E+Y+ N
Sbjct: 775 VSMDQAPVECIQLMKQCWAEHPDLRPSLGHIFDQFKSINKGRKTNIIDSMLRMLEQYSSN 834
Query: 213 LE 214
LE
Sbjct: 835 LE 836
|
Canis familiaris (taxid: 9615) EC: 4 EC: . EC: 6 EC: . EC: 1 EC: . EC: 2 |
| >sp|P20594|ANPRB_HUMAN Atrial natriuretic peptide receptor 2 OS=Homo sapiens GN=NPR2 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 133 bits (334), Expect = 3e-30, Method: Compositional matrix adjust.
Identities = 76/185 (41%), Positives = 106/185 (57%), Gaps = 6/185 (3%)
Query: 35 GMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKA 94
GM LH+S I SHG+L+SSNC++DSR+VL+I D+GL +F++ E L +KL+ A
Sbjct: 630 GMAFLHNSIISSHGSLKSSNCVVDSRFVLKITDYGLASFRS-TAEPDDSHALYAKKLWTA 688
Query: 95 PELLRQPHLP-RGTQKGDVYSFGLVLYEVIGRQGPW--GHLRMTDEEIITSVTQGS--GL 149
PELL LP G QK DVYSFG++L E+ R GP+ L ++ +EI+ V G
Sbjct: 689 PELLSGNPLPTTGMQKADVYSFGIILQEIALRSGPFYLEGLDLSPKEIVQKVRNGQRPYF 748
Query: 150 RPDTSSLDCAPSIIACMRTCWEEDPELRPDLRFVHHKLKEMNAGLKANIFDNMLAIMEKY 209
RP ++ M CW +DP RPD + ++ N +I DN+L ME+Y
Sbjct: 749 RPSIDRTQLNEELVLLMERCWAQDPAERPDFGQIKGFIRRFNKEGGTSILDNLLLRMEQY 808
Query: 210 AFNLE 214
A NLE
Sbjct: 809 ANNLE 813
|
Receptor for the C-type natriuretic peptide NPPC/CNP hormone. Has guanylate cyclase activity upon binding of its ligand. May play a role in the regulation of skeletal growth. Homo sapiens (taxid: 9606) EC: 4 EC: . EC: 6 EC: . EC: 1 EC: . EC: 2 |
Close Homologs in the Non-Redundant Database Detected by BLAST 
Original result of BLAST against Nonredundant Database
GI ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Q cover ![]() |
H cover ![]() |
Identity ![]() |
E-value ![]() |
| Query | 423 | ||||||
| 195030426 | 1148 | GH10964 [Drosophila grimshawi] gi|193904 | 0.460 | 0.169 | 0.606 | 1e-62 | |
| 270011251 | 2331 | hypothetical protein TcasGA2_TC002175 [T | 0.460 | 0.083 | 0.611 | 1e-62 | |
| 189239742 | 2106 | PREDICTED: similar to atrial natriuretic | 0.460 | 0.092 | 0.611 | 1e-62 | |
| 195385138 | 1161 | GJ14934 [Drosophila virilis] gi|19414772 | 0.460 | 0.167 | 0.597 | 4e-61 | |
| 242024284 | 1053 | Guanylate cyclase 32E precursor, putativ | 0.458 | 0.184 | 0.592 | 8e-61 | |
| 170046339 | 1299 | atrial natriuretic peptide receptor [Cul | 0.460 | 0.150 | 0.592 | 3e-60 | |
| 157109534 | 987 | atrial natriuretic peptide receptor [Aed | 0.460 | 0.197 | 0.582 | 5e-60 | |
| 391343898 | 1104 | PREDICTED: guanylate cyclase 32E-like [M | 0.449 | 0.172 | 0.57 | 1e-59 | |
| 158299465 | 1025 | AGAP008848-PA [Anopheles gambiae str. PE | 0.460 | 0.190 | 0.587 | 2e-59 | |
| 195434068 | 1108 | GK15240 [Drosophila willistoni] gi|19416 | 0.460 | 0.175 | 0.586 | 5e-59 |
| >gi|195030426|ref|XP_001988069.1| GH10964 [Drosophila grimshawi] gi|193904069|gb|EDW02936.1| GH10964 [Drosophila grimshawi] | Back alignment and taxonomy information |
|---|
Score = 246 bits (629), Expect = 1e-62, Method: Compositional matrix adjust.
Identities = 122/201 (60%), Positives = 143/201 (71%), Gaps = 6/201 (2%)
Query: 35 GMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKA 94
G+I+LHDSEIISHGNLRSSNCLIDSRWV QIADFGLH KAGQDE + +R L A
Sbjct: 629 GLIYLHDSEIISHGNLRSSNCLIDSRWVCQIADFGLHELKAGQDEPNKAELEVKRALSMA 688
Query: 95 PELLRQPHLP-RGTQKGDVYSFGLVLYEVIGRQGPWGHLRMTDEEIITSVT-----QGSG 148
PELLR P+ P RG+QKGD+YSFG++LYE+IGR+GPWG T+EEII V Q
Sbjct: 689 PELLRDPYRPARGSQKGDIYSFGILLYEMIGRKGPWGETAYTNEEIIKFVISPDLLQHGV 748
Query: 149 LRPDTSSLDCAPSIIACMRTCWEEDPELRPDLRFVHHKLKEMNAGLKANIFDNMLAIMEK 208
RP + LD I +C+R CW+ED E+RPD+R V LKE+ AGLK NIFDNMLAIMEK
Sbjct: 749 FRPALTYLDIPNYIRSCLRLCWDEDAEVRPDIRLVRMHLKELQAGLKPNIFDNMLAIMEK 808
Query: 209 YAFNLEGEWTDWTASLRRRPK 229
YA+NLEG + T L K
Sbjct: 809 YAYNLEGLVQERTNLLYEEKK 829
|
Source: Drosophila grimshawi Species: Drosophila grimshawi Genus: Drosophila Family: Drosophilidae Order: Diptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
| >gi|270011251|gb|EFA07699.1| hypothetical protein TcasGA2_TC002175 [Tribolium castaneum] | Back alignment and taxonomy information |
|---|
Score = 246 bits (629), Expect = 1e-62, Method: Compositional matrix adjust.
Identities = 121/198 (61%), Positives = 143/198 (72%), Gaps = 3/198 (1%)
Query: 35 GMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKA 94
GMI+LHDS+IISHGNLRSSNCLIDSRWV+QI DFGLH FKA + + K +R L++A
Sbjct: 1814 GMIYLHDSDIISHGNLRSSNCLIDSRWVVQITDFGLHEFKACPEGAETQSKKLKRSLWRA 1873
Query: 95 PELLRQPHLP-RGTQKGDVYSFGLVLYEVIGRQGPWGHLRMTDEEIITSVTQGSG--LRP 151
PELLR P P RGTQKGDVYSFG+VLYE+IGR+GPWG + EI+ V + LRP
Sbjct: 1874 PELLRDPSPPARGTQKGDVYSFGIVLYEIIGRRGPWGDTNIEPSEILRQVIEVKEVPLRP 1933
Query: 152 DTSSLDCAPSIIACMRTCWEEDPELRPDLRFVHHKLKEMNAGLKANIFDNMLAIMEKYAF 211
+L A II CM+ CW E+P+ RPD+RFV +LKEM AGLK NIFDNMLAIMEKYA+
Sbjct: 1934 PLENLGAADYIIKCMKACWHEEPDQRPDIRFVRVRLKEMQAGLKPNIFDNMLAIMEKYAY 1993
Query: 212 NLEGEWTDWTASLRRRPK 229
NLEG + T L K
Sbjct: 1994 NLEGLVQERTNQLTEEKK 2011
|
Source: Tribolium castaneum Species: Tribolium castaneum Genus: Tribolium Family: Tenebrionidae Order: Coleoptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
| >gi|189239742|ref|XP_001809661.1| PREDICTED: similar to atrial natriuretic peptide receptor [Tribolium castaneum] | Back alignment and taxonomy information |
|---|
Score = 246 bits (629), Expect = 1e-62, Method: Compositional matrix adjust.
Identities = 121/198 (61%), Positives = 143/198 (72%), Gaps = 3/198 (1%)
Query: 35 GMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKA 94
GMI+LHDS+IISHGNLRSSNCLIDSRWV+QI DFGLH FKA + + K +R L++A
Sbjct: 1656 GMIYLHDSDIISHGNLRSSNCLIDSRWVVQITDFGLHEFKACPEGAETQSKKLKRSLWRA 1715
Query: 95 PELLRQPHLP-RGTQKGDVYSFGLVLYEVIGRQGPWGHLRMTDEEIITSVTQGSG--LRP 151
PELLR P P RGTQKGDVYSFG+VLYE+IGR+GPWG + EI+ V + LRP
Sbjct: 1716 PELLRDPSPPARGTQKGDVYSFGIVLYEIIGRRGPWGDTNIEPSEILRQVIEVKEVPLRP 1775
Query: 152 DTSSLDCAPSIIACMRTCWEEDPELRPDLRFVHHKLKEMNAGLKANIFDNMLAIMEKYAF 211
+L A II CM+ CW E+P+ RPD+RFV +LKEM AGLK NIFDNMLAIMEKYA+
Sbjct: 1776 PLENLGAADYIIKCMKACWHEEPDQRPDIRFVRVRLKEMQAGLKPNIFDNMLAIMEKYAY 1835
Query: 212 NLEGEWTDWTASLRRRPK 229
NLEG + T L K
Sbjct: 1836 NLEGLVQERTNQLTEEKK 1853
|
Source: Tribolium castaneum Species: Tribolium castaneum Genus: Tribolium Family: Tenebrionidae Order: Coleoptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
| >gi|195385138|ref|XP_002051265.1| GJ14934 [Drosophila virilis] gi|194147722|gb|EDW63420.1| GJ14934 [Drosophila virilis] | Back alignment and taxonomy information |
|---|
Score = 241 bits (616), Expect = 4e-61, Method: Compositional matrix adjust.
Identities = 120/201 (59%), Positives = 141/201 (70%), Gaps = 6/201 (2%)
Query: 35 GMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKA 94
G+I+LHDSEIISHGNLRSSNCLIDSRWV QI+DFGLH KAGQDE + +R L A
Sbjct: 632 GLIYLHDSEIISHGNLRSSNCLIDSRWVCQISDFGLHELKAGQDEPNKTELELKRALCMA 691
Query: 95 PELLRQPHLP-RGTQKGDVYSFGLVLYEVIGRQGPWGHLRMTDEEIITSVT-----QGSG 148
PELLR P RG+QKGD+YSFG++LYE+IGR+GPWG T EEII V Q
Sbjct: 692 PELLRNSFRPARGSQKGDIYSFGILLYEMIGRKGPWGETAYTKEEIIKFVKSPDLLQHGV 751
Query: 149 LRPDTSSLDCAPSIIACMRTCWEEDPELRPDLRFVHHKLKEMNAGLKANIFDNMLAIMEK 208
RP ++L+ I C+R CW+EDPE+RPD+R V LKE+ AGLK NIFDNMLAIMEK
Sbjct: 752 FRPALNTLNIPNYIRNCLRLCWDEDPEVRPDIRLVRMHLKELQAGLKPNIFDNMLAIMEK 811
Query: 209 YAFNLEGEWTDWTASLRRRPK 229
YA+NLEG + T L K
Sbjct: 812 YAYNLEGLVQERTNLLYEEKK 832
|
Source: Drosophila virilis Species: Drosophila virilis Genus: Drosophila Family: Drosophilidae Order: Diptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
| >gi|242024284|ref|XP_002432558.1| Guanylate cyclase 32E precursor, putative [Pediculus humanus corporis] gi|212518018|gb|EEB19820.1| Guanylate cyclase 32E precursor, putative [Pediculus humanus corporis] | Back alignment and taxonomy information |
|---|
Score = 240 bits (613), Expect = 8e-61, Method: Compositional matrix adjust.
Identities = 118/199 (59%), Positives = 149/199 (74%), Gaps = 5/199 (2%)
Query: 35 GMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKA 94
G+I+LHDS+IISHG L+SSNCLIDSRWVL ++DFGLH FKAGQ+E ++++ + L+ A
Sbjct: 643 GLIYLHDSDIISHGRLKSSNCLIDSRWVLLLSDFGLHEFKAGQEERKKDKEEKNL-LWTA 701
Query: 95 PELLRQPH-LPRGTQKGDVYSFGLVLYEVIGRQGPWGHLRMTDEEIITSVT---QGSGLR 150
PELLR P+ PRGTQKGDVYSFG++LYE+IG+ GPWG++ +T EIIT V G R
Sbjct: 702 PELLRNPNCFPRGTQKGDVYSFGILLYEIIGKHGPWGNIPLTPSEIITKVKSYQNGKPFR 761
Query: 151 PDTSSLDCAPSIIACMRTCWEEDPELRPDLRFVHHKLKEMNAGLKANIFDNMLAIMEKYA 210
P T ++D ++ CM +CW+EDPE RPD+R+V KLKEM AGLK NIFDNMLAIMEKYA
Sbjct: 762 PQTQNIDAEKYVLKCMESCWDEDPEQRPDIRYVRVKLKEMQAGLKPNIFDNMLAIMEKYA 821
Query: 211 FNLEGEWTDWTASLRRRPK 229
NLE ++ T L K
Sbjct: 822 SNLEALVSERTDQLTEEKK 840
|
Source: Pediculus humanus corporis Species: Pediculus humanus Genus: Pediculus Family: Pediculidae Order: Phthiraptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
| >gi|170046339|ref|XP_001850726.1| atrial natriuretic peptide receptor [Culex quinquefasciatus] gi|167869147|gb|EDS32530.1| atrial natriuretic peptide receptor [Culex quinquefasciatus] | Back alignment and taxonomy information |
|---|
Score = 238 bits (608), Expect = 3e-60, Method: Compositional matrix adjust.
Identities = 118/199 (59%), Positives = 144/199 (72%), Gaps = 4/199 (2%)
Query: 35 GMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKA 94
G+I+LHDS+I SHG+LR S LIDSRWV QIADFGLH FK+ Q+E + + RR L+KA
Sbjct: 734 GLIYLHDSDIGSHGSLRPSKVLIDSRWVAQIADFGLHEFKSSQEEPAKFERELRRSLWKA 793
Query: 95 PELLRQPHLP-RGTQKGDVYSFGLVLYEVIGRQGPWGHLRMTDEEIITSVT--QGSGL-R 150
PE+LR P+ P +GTQKGDVYSFGL+LYE+IGR+GPWG + M+ +EII V Q G+ R
Sbjct: 794 PEILRNPNTPSKGTQKGDVYSFGLILYEIIGRKGPWGGIGMSRQEIIARVISPQNYGIFR 853
Query: 151 PDTSSLDCAPSIIACMRTCWEEDPELRPDLRFVHHKLKEMNAGLKANIFDNMLAIMEKYA 210
P LD +I C++ CW EDPE RPD+R V KLK M AGLK+NIFDNMLAIMEKYA
Sbjct: 854 PPLCGLDAPDYVIQCLQACWAEDPEDRPDIRLVRVKLKPMQAGLKSNIFDNMLAIMEKYA 913
Query: 211 FNLEGEWTDWTASLRRRPK 229
+NLEG + T L K
Sbjct: 914 YNLEGIVQERTNQLTEEKK 932
|
Source: Culex quinquefasciatus Species: Culex quinquefasciatus Genus: Culex Family: Culicidae Order: Diptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
| >gi|157109534|ref|XP_001650712.1| atrial natriuretic peptide receptor [Aedes aegypti] gi|108878976|gb|EAT43201.1| AAEL005330-PA, partial [Aedes aegypti] | Back alignment and taxonomy information |
|---|
Score = 238 bits (607), Expect = 5e-60, Method: Compositional matrix adjust.
Identities = 116/199 (58%), Positives = 144/199 (72%), Gaps = 4/199 (2%)
Query: 35 GMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKA 94
G+I+LHDS++ SHGNLRSS LIDSRWV QI+DFGLH FK+GQDE + K R L+KA
Sbjct: 581 GLIYLHDSDVGSHGNLRSSKILIDSRWVAQISDFGLHEFKSGQDEPNKFEKELHRSLWKA 640
Query: 95 PELLRQPHLP-RGTQKGDVYSFGLVLYEVIGRQGPWGHLRMTDEEIITSVT--QGSGL-R 150
PE+LR P+ P RGTQKGDVYSFG+VLYE++G +GPWG + + +EII V Q G+ R
Sbjct: 641 PEILRNPNTPSRGTQKGDVYSFGIVLYEIVGMKGPWGEINLNYQEIIARVISPQNYGIFR 700
Query: 151 PDTSSLDCAPSIIACMRTCWEEDPELRPDLRFVHHKLKEMNAGLKANIFDNMLAIMEKYA 210
P L+ + +I C++ CWEE+P+ RPD+R V KLK M AGLK NIFDNMLAIMEKYA
Sbjct: 701 PPLRGLEASDYVIQCLQACWEEEPDDRPDIRLVRVKLKPMQAGLKPNIFDNMLAIMEKYA 760
Query: 211 FNLEGEWTDWTASLRRRPK 229
+NLEG + T L K
Sbjct: 761 YNLEGIVQERTNQLTEEKK 779
|
Source: Aedes aegypti Species: Aedes aegypti Genus: Aedes Family: Culicidae Order: Diptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
| >gi|391343898|ref|XP_003746242.1| PREDICTED: guanylate cyclase 32E-like [Metaseiulus occidentalis] | Back alignment and taxonomy information |
|---|
Score = 236 bits (603), Expect = 1e-59, Method: Compositional matrix adjust.
Identities = 114/200 (57%), Positives = 141/200 (70%), Gaps = 10/200 (5%)
Query: 35 GMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKA 94
GMI++HDSEI+SHGNL+SSNCL+DSRWVLQ+ADFGLH FK GQ L ++A
Sbjct: 626 GMIYIHDSEIVSHGNLKSSNCLVDSRWVLQVADFGLHEFKCGQSLPNTSPLL-----WRA 680
Query: 95 PELLRQPHLP-RGTQKGDVYSFGLVLYEVIGRQGPWGHLRMTDEEIITSVTQGSGL---- 149
PELLR P P RGTQKGD+YSFG+VLYE+IGR GPWG + + II S+ +
Sbjct: 681 PELLRHPSPPARGTQKGDIYSFGIVLYEIIGRAGPWGPEALPTKYIIDSLIDPPDIQNPP 740
Query: 150 RPDTSSLDCAPSIIACMRTCWEEDPELRPDLRFVHHKLKEMNAGLKANIFDNMLAIMEKY 209
RP LDCA ++ C+R CW+E+PE+RPD RFV+ +L+EM AGLK NIFDNM+AIMEKY
Sbjct: 741 RPPLEVLDCADYVVRCLRECWDENPEIRPDFRFVNVRLREMQAGLKPNIFDNMIAIMEKY 800
Query: 210 AFNLEGEWTDWTASLRRRPK 229
A+NLE + T L K
Sbjct: 801 AYNLESLVQERTYQLLEEKK 820
|
Source: Metaseiulus occidentalis Species: Metaseiulus occidentalis Genus: Metaseiulus Family: Phytoseiidae Order: Mesostigmata Class: Arachnida Phylum: Arthropoda Superkingdom: Eukaryota |
| >gi|158299465|ref|XP_319590.4| AGAP008848-PA [Anopheles gambiae str. PEST] gi|157013532|gb|EAA14802.5| AGAP008848-PA [Anopheles gambiae str. PEST] | Back alignment and taxonomy information |
|---|
Score = 236 bits (601), Expect = 2e-59, Method: Compositional matrix adjust.
Identities = 117/199 (58%), Positives = 142/199 (71%), Gaps = 4/199 (2%)
Query: 35 GMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKA 94
G+I+LHDS++ SHGNLRSS LIDSRWV QIADFGLH FK+ Q+E + K RR L+KA
Sbjct: 608 GLIYLHDSDVGSHGNLRSSKILIDSRWVAQIADFGLHEFKSCQEEPSKFEKELRRSLWKA 667
Query: 95 PELLRQPHL-PRGTQKGDVYSFGLVLYEVIGRQGPWGHLRMTDEEIITSVT---QGSGLR 150
PELLR P+ P+GTQKGDVYSFG+VLYE+IGR+GPWG L M+ ++I+ V + R
Sbjct: 668 PELLRDPNCPPKGTQKGDVYSFGIVLYEIIGRKGPWGDLNMSWQDIVARVMSPEEYGIFR 727
Query: 151 PDTSSLDCAPSIIACMRTCWEEDPELRPDLRFVHHKLKEMNAGLKANIFDNMLAIMEKYA 210
P +D +I + +CWEEDPE RPD+R V KLK M AGLK NIFDNMLAIMEKYA
Sbjct: 728 PSLRGIDAPEYVIQLLHSCWEEDPEDRPDIRLVRVKLKPMQAGLKPNIFDNMLAIMEKYA 787
Query: 211 FNLEGEWTDWTASLRRRPK 229
+NLEG + T L K
Sbjct: 788 YNLEGIVQERTNQLSEEKK 806
|
Source: Anopheles gambiae str. PEST Species: Anopheles gambiae Genus: Anopheles Family: Culicidae Order: Diptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
| >gi|195434068|ref|XP_002065025.1| GK15240 [Drosophila willistoni] gi|194161110|gb|EDW76011.1| GK15240 [Drosophila willistoni] | Back alignment and taxonomy information |
|---|
Score = 234 bits (598), Expect = 5e-59, Method: Compositional matrix adjust.
Identities = 119/203 (58%), Positives = 142/203 (69%), Gaps = 8/203 (3%)
Query: 35 GMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKA 94
GMI+LHDSEIISHGNLRSSNCLIDSRWV QI+DFGLH K+G++E + +R L A
Sbjct: 596 GMIYLHDSEIISHGNLRSSNCLIDSRWVCQISDFGLHELKSGEEEPNKTELELKRALCMA 655
Query: 95 PELLRQPHLP-RGTQKGDVYSFGLVLYEVIGRQGPWGHLRMTDEEIITSVT-----QGSG 148
PELLR + P RG+QKGDVYSFG++LYE+IGR+GPWG + EEII V Q
Sbjct: 656 PELLRDSYRPARGSQKGDVYSFGILLYEMIGRKGPWGDTTYSKEEIIKFVKCPELLQHGI 715
Query: 149 LRPDT--SSLDCAPSIIACMRTCWEEDPELRPDLRFVHHKLKEMNAGLKANIFDNMLAIM 206
RP + L+ I C+R CWEEDPE+RPD+R V +LKE+ AGLK NIFDNMLAIM
Sbjct: 716 FRPALTHTHLNIPDYIRQCLRQCWEEDPEIRPDIRLVRMRLKELQAGLKPNIFDNMLAIM 775
Query: 207 EKYAFNLEGEWTDWTASLRRRPK 229
EKYA+NLEG + T L K
Sbjct: 776 EKYAYNLEGLVQERTNLLYEEKK 798
|
Source: Drosophila willistoni Species: Drosophila willistoni Genus: Drosophila Family: Drosophilidae Order: Diptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST 
Original result of BLAST against Gene Ontology (AMIGO)
ID ![]() |
Alignment graph ![]() |
Length ![]() |
Definition ![]() |
Q cover ![]() |
H cover ![]() |
Identity ![]() |
E-value ![]() |
| Query | 423 | ||||||
| FB|FBgn0010197 | 1163 | Gyc32E "Guanyl cyclase at 32E" | 0.427 | 0.155 | 0.613 | 7e-75 | |
| FB|FBgn0261360 | 1525 | CG42637 [Drosophila melanogast | 0.444 | 0.123 | 0.43 | 1.1e-60 | |
| FB|FBgn0261688 | 1525 | Gyc76C "Guanylyl cyclase at 76 | 0.444 | 0.123 | 0.43 | 1.1e-60 | |
| FB|FBgn0036368 | 1272 | CG10738 [Drosophila melanogast | 0.460 | 0.153 | 0.456 | 1.2e-59 | |
| UNIPROTKB|G3N2S3 | 421 | NPR2 "Guanylate cyclase" [Bos | 0.423 | 0.425 | 0.410 | 1.6e-54 | |
| UNIPROTKB|E1BN71 | 1064 | NPR1 "Guanylate cyclase" [Bos | 0.418 | 0.166 | 0.435 | 1.9e-52 | |
| RGD|3195 | 1057 | Npr1 "natriuretic peptide rece | 0.420 | 0.168 | 0.432 | 5e-52 | |
| MGI|MGI:97371 | 1057 | Npr1 "natriuretic peptide rece | 0.420 | 0.168 | 0.432 | 1.1e-51 | |
| UNIPROTKB|P16066 | 1061 | NPR1 "Atrial natriuretic pepti | 0.418 | 0.166 | 0.430 | 1.4e-51 | |
| UNIPROTKB|F1PMP1 | 1060 | NPR1 "Guanylate cyclase" [Cani | 0.418 | 0.166 | 0.430 | 2.2e-51 |
| FB|FBgn0010197 Gyc32E "Guanyl cyclase at 32E" [Drosophila melanogaster (taxid:7227)] | Back alignment and assigned GO terms |
|---|
Score = 569 (205.4 bits), Expect = 7.0e-75, Sum P(2) = 7.0e-75
Identities = 116/189 (61%), Positives = 136/189 (71%)
Query: 35 GMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKA 94
GMI+LHDSEIISHGNLRSSNCLIDSRWV QI+DFGLH KAGQ+E + +R L A
Sbjct: 638 GMIYLHDSEIISHGNLRSSNCLIDSRWVCQISDFGLHELKAGQEEPNKSELELKRALCMA 697
Query: 95 PELLRQPHLP-RGTQKGDVYSFGLVLYEVIGRQGPWGHLRMTDEEIITSVT-----QGSG 148
PELLR + P RG+QKGDVYSFG++LYE+IGR+GPWG + EEII V Q
Sbjct: 698 PELLRDAYRPGRGSQKGDVYSFGILLYEMIGRKGPWGDTAYSKEEIIQFVKCPEMLQHGV 757
Query: 149 LRPDTSS--LDCAPSIIACMRTCWEEDPELRPDLRFVHHKLKEMNAGLKANIFDNMLAIM 206
RP + LD I C+ CW+EDPE+RPD+R V LKE+ AGLK NIFDNML+IM
Sbjct: 758 FRPALTHTHLDIPDYIRKCLCQCWDEDPEVRPDIRLVRMHLKELQAGLKPNIFDNMLSIM 817
Query: 207 EKYAFNLEG 215
EKYA+NLEG
Sbjct: 818 EKYAYNLEG 826
|
|
| FB|FBgn0261360 CG42637 [Drosophila melanogaster (taxid:7227)] | Back alignment and assigned GO terms |
|---|
Score = 444 (161.4 bits), Expect = 1.1e-60, Sum P(3) = 1.1e-60
Identities = 86/200 (43%), Positives = 131/200 (65%)
Query: 35 GMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFK-AGQDETGQERKLRRRKLYK 93
GMI++H+S+++ HGNL+SSNC++ SRW+LQ+ DFGLH + ++E+ E + R +L++
Sbjct: 661 GMIYIHNSQLVYHGNLKSSNCVVTSRWMLQVTDFGLHELRQCAENESIGEHQHYRNQLWR 720
Query: 94 APELLRQPHLPRGTQKGDVYSFGLVLYEVIGRQGPWGHLRMTDEEIITSVTQ----GSG- 148
APELLR H+ G+QKGDVY+F +++YE+ R+GP+G + +EI+ V + G
Sbjct: 721 APELLRN-HI-HGSQKGDVYAFAIIMYEIFSRKGPFGQINFEPKEIVDYVKKLPLKGEDP 778
Query: 149 LRPDTSSL----DCAPSIIACMRTCWEEDPELRPDLRFVHHKLKEMNAGLKANIFDNMLA 204
RP+ S+ C ++AC+R CW EDPE RP+ + ++LK+M G NI D M+
Sbjct: 779 FRPEVESIIEAESCPDYVLACIRDCWAEDPEERPEFSVIRNRLKKMRGGKTKNIMDQMME 838
Query: 205 IMEKYAFNLEGEWTDWTASL 224
+MEKYA NLE T+ T L
Sbjct: 839 MMEKYANNLEDIVTERTRLL 858
|
|
| FB|FBgn0261688 Gyc76C "Guanylyl cyclase at 76C" [Drosophila melanogaster (taxid:7227)] | Back alignment and assigned GO terms |
|---|
Score = 444 (161.4 bits), Expect = 1.1e-60, Sum P(3) = 1.1e-60
Identities = 86/200 (43%), Positives = 131/200 (65%)
Query: 35 GMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFK-AGQDETGQERKLRRRKLYK 93
GMI++H+S+++ HGNL+SSNC++ SRW+LQ+ DFGLH + ++E+ E + R +L++
Sbjct: 661 GMIYIHNSQLVYHGNLKSSNCVVTSRWMLQVTDFGLHELRQCAENESIGEHQHYRNQLWR 720
Query: 94 APELLRQPHLPRGTQKGDVYSFGLVLYEVIGRQGPWGHLRMTDEEIITSVTQ----GSG- 148
APELLR H+ G+QKGDVY+F +++YE+ R+GP+G + +EI+ V + G
Sbjct: 721 APELLRN-HI-HGSQKGDVYAFAIIMYEIFSRKGPFGQINFEPKEIVDYVKKLPLKGEDP 778
Query: 149 LRPDTSSL----DCAPSIIACMRTCWEEDPELRPDLRFVHHKLKEMNAGLKANIFDNMLA 204
RP+ S+ C ++AC+R CW EDPE RP+ + ++LK+M G NI D M+
Sbjct: 779 FRPEVESIIEAESCPDYVLACIRDCWAEDPEERPEFSVIRNRLKKMRGGKTKNIMDQMME 838
Query: 205 IMEKYAFNLEGEWTDWTASL 224
+MEKYA NLE T+ T L
Sbjct: 839 MMEKYANNLEDIVTERTRLL 858
|
|
| FB|FBgn0036368 CG10738 [Drosophila melanogaster (taxid:7227)] | Back alignment and assigned GO terms |
|---|
Score = 435 (158.2 bits), Expect = 1.2e-59, Sum P(2) = 1.2e-59
Identities = 94/206 (45%), Positives = 129/206 (62%)
Query: 35 GMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRK---- 90
G+I+LHDS I HG L +SNCL+DSRWV+++ DFGL AFK G +++ + + K
Sbjct: 706 GVIYLHDSPIRFHGALCTSNCLVDSRWVVKLTDFGLFAFKQGIEDSSTDMQHMSAKCLKL 765
Query: 91 LYKAPELLRQ-PH-LPRGTQKGDVYSFGLVLYEVIGRQGPWGHLRMTDEEIITSVTQGSG 148
LY+APELLRQ P L GTQ+GD YSFG++LYE+ R+GP+G +T + + V Q
Sbjct: 766 LYRAPELLRQGPSSLVMGTQRGDAYSFGILLYEMHVRRGPFGETGLTPMQCLQKVLQPQD 825
Query: 149 L----RPDTSSLDCAPSIIA-CMRTCWEEDPELRPDLRFVHHKLKEMNAGLKANIFDNML 203
RP L+ A ++ C+R CW E PE RPD + + KL+ + G++ NIFDNM+
Sbjct: 826 YLNPYRPSLQPLETAFDCVSECLRECWAERPEDRPDFKTIRTKLRPLRKGMRPNIFDNMM 885
Query: 204 AIMEKYAFNLEGEWTDWTASLRRRPK 229
A+MEKYA NLE D T L+ K
Sbjct: 886 AMMEKYANNLEALVDDRTDQLQEEKK 911
|
|
| UNIPROTKB|G3N2S3 NPR2 "Guanylate cyclase" [Bos taurus (taxid:9913)] | Back alignment and assigned GO terms |
|---|
Score = 336 (123.3 bits), Expect = 1.6e-54, Sum P(3) = 1.6e-54
Identities = 76/185 (41%), Positives = 106/185 (57%)
Query: 35 GMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKA 94
GM LH+S I SHG+L+SSNC++DSR+VL+I D+GL +F++ E L +KL+ A
Sbjct: 4 GMAFLHNSIIASHGSLKSSNCVVDSRFVLKITDYGLASFRSTA-EPDDSHALYAKKLWTA 62
Query: 95 PELLRQPHLPR-GTQKGDVYSFGLVLYEVIGRQGPW--GHLRMTDEEIITSVTQGSG--L 149
PELL LP G QK DVYSFG++L E+ R GP+ L ++ +EI+ V G
Sbjct: 63 PELLSGNPLPTTGMQKADVYSFGIILQEIALRSGPFYLEGLDLSPKEIVQKVRNGQRPYF 122
Query: 150 RPDTSSLDCAPSIIACMRTCWEEDPELRPDLRFVHHKLKEMNAGLKANIFDNMLAIMEKY 209
RP ++ M CW +DP RPD + ++ N +I DN+L ME+Y
Sbjct: 123 RPSIDRTQLNEELVLLMERCWAQDPAERPDFGQIKGFIRRFNKEGGTSILDNLLLRMEQY 182
Query: 210 AFNLE 214
A NLE
Sbjct: 183 ANNLE 187
|
|
| UNIPROTKB|E1BN71 NPR1 "Guanylate cyclase" [Bos taurus (taxid:9913)] | Back alignment and assigned GO terms |
|---|
Score = 365 (133.5 bits), Expect = 1.9e-52, Sum P(2) = 1.9e-52
Identities = 81/186 (43%), Positives = 115/186 (61%)
Query: 35 GMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKA 94
GM+ LH+ I SHGNL+SSNC++D R+VL+I D+GL +F+ + E G L +KL+ A
Sbjct: 649 GMLFLHNGAICSHGNLKSSNCVVDGRFVLKITDYGLESFRDPEPEQGHT--LYAKKLWTA 706
Query: 95 PELLRQPHLP-RGTQKGDVYSFGLVLYEVIGRQGPWGH---LRMTDEEIITSVTQGSG-- 148
PELLR P RG+Q GDVYSFG++L E+ R G + H L ++ +EII VT+G
Sbjct: 707 PELLRMASPPARGSQAGDVYSFGIILQEIALRSGAF-HVEGLDLSPKEIIERVTRGEQPP 765
Query: 149 LRPDTSSLDCAPSIIACMRTCWEEDPELRPDLRFVHHKLKEMNAGLKANIFDNMLAIMEK 208
RP + + M+ CW EDP+ RP + + L++ N +NI DN+L+ ME+
Sbjct: 766 FRPSLALQSHLEELGQLMQRCWAEDPQERPPFQQIRLMLRKFNRENSSNILDNLLSRMEQ 825
Query: 209 YAFNLE 214
YA NLE
Sbjct: 826 YANNLE 831
|
|
| RGD|3195 Npr1 "natriuretic peptide receptor A/guanylate cyclase A (atrionatriuretic peptide receptor A)" [Rattus norvegicus (taxid:10116)] | Back alignment and assigned GO terms |
|---|
Score = 361 (132.1 bits), Expect = 5.0e-52, Sum P(2) = 5.0e-52
Identities = 80/185 (43%), Positives = 113/185 (61%)
Query: 35 GMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKA 94
GM+ LH+ I SHGNL+SSNC++D R+VL+I D+GL +F+ + E G L +KL+ A
Sbjct: 642 GMLFLHNGAICSHGNLKSSNCVVDGRFVLKITDYGLESFRDPEPEQGHT--LFAKKLWTA 699
Query: 95 PELLRQPHLP-RGTQKGDVYSFGLVLYEVIGRQGPW--GHLRMTDEEIITSVTQGSG--L 149
PELLR P RG+Q GDVYSFG++L E+ R G + L ++ +EII VT+G
Sbjct: 700 PELLRMASPPARGSQAGDVYSFGIILQEIALRSGVFYVEGLDLSPKEIIERVTRGEQPPF 759
Query: 150 RPDTSSLDCAPSIIACMRTCWEEDPELRPDLRFVHHKLKEMNAGLKANIFDNMLAIMEKY 209
RP + M+ CW EDP+ RP + + L++ N +NI DN+L+ ME+Y
Sbjct: 760 RPSMDLQSHLEELGQLMQRCWAEDPQERPPFQQIRLALRKFNKENSSNILDNLLSRMEQY 819
Query: 210 AFNLE 214
A NLE
Sbjct: 820 ANNLE 824
|
|
| MGI|MGI:97371 Npr1 "natriuretic peptide receptor 1" [Mus musculus (taxid:10090)] | Back alignment and assigned GO terms |
|---|
Score = 358 (131.1 bits), Expect = 1.1e-51, Sum P(2) = 1.1e-51
Identities = 80/185 (43%), Positives = 113/185 (61%)
Query: 35 GMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKA 94
GM+ LH+ I SHGNL+SSNC++D R+VL+I D+GL +F+ + E G L +KL+ A
Sbjct: 642 GMLFLHNGAIGSHGNLKSSNCVVDGRFVLKITDYGLESFRDPEPEQGHT--LFAKKLWTA 699
Query: 95 PELLRQPHLP-RGTQKGDVYSFGLVLYEVIGRQGPW--GHLRMTDEEIITSVTQGSG--L 149
PELLR P RG+Q GDVYSFG++L E+ R G + L ++ +EII VT+G
Sbjct: 700 PELLRMASPPARGSQAGDVYSFGIILQEIALRSGVFYVEGLDLSPKEIIERVTRGEQPPF 759
Query: 150 RPDTSSLDCAPSIIACMRTCWEEDPELRPDLRFVHHKLKEMNAGLKANIFDNMLAIMEKY 209
RP + M+ CW EDP+ RP + + L++ N +NI DN+L+ ME+Y
Sbjct: 760 RPSMDLQSHLEELGQLMQRCWAEDPQERPPFQQIRLALRKFNKENSSNILDNLLSRMEQY 819
Query: 210 AFNLE 214
A NLE
Sbjct: 820 ANNLE 824
|
|
| UNIPROTKB|P16066 NPR1 "Atrial natriuretic peptide receptor 1" [Homo sapiens (taxid:9606)] | Back alignment and assigned GO terms |
|---|
Score = 357 (130.7 bits), Expect = 1.4e-51, Sum P(2) = 1.4e-51
Identities = 80/186 (43%), Positives = 114/186 (61%)
Query: 35 GMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKA 94
GM+ LH+ I SHGNL+SSNC++D R+VL+I D+GL +F+ E G + +KL+ A
Sbjct: 646 GMLFLHNGAICSHGNLKSSNCVVDGRFVLKITDYGLESFRDLDPEQGHT--VYAKKLWTA 703
Query: 95 PELLRQPHLP-RGTQKGDVYSFGLVLYEVIGRQGPWGH---LRMTDEEIITSVTQGSG-- 148
PELLR P RG+Q GDVYSFG++L E+ R G + H L ++ +EII VT+G
Sbjct: 704 PELLRMASPPVRGSQAGDVYSFGIILQEIALRSGVF-HVEGLDLSPKEIIERVTRGEQPP 762
Query: 149 LRPDTSSLDCAPSIIACMRTCWEEDPELRPDLRFVHHKLKEMNAGLKANIFDNMLAIMEK 208
RP + + M+ CW EDP+ RP + + L++ N +NI DN+L+ ME+
Sbjct: 763 FRPSLALQSHLEELGLLMQRCWAEDPQERPPFQQIRLTLRKFNRENSSNILDNLLSRMEQ 822
Query: 209 YAFNLE 214
YA NLE
Sbjct: 823 YANNLE 828
|
|
| UNIPROTKB|F1PMP1 NPR1 "Guanylate cyclase" [Canis lupus familiaris (taxid:9615)] | Back alignment and assigned GO terms |
|---|
Score = 361 (132.1 bits), Expect = 2.2e-51, Sum P(2) = 2.2e-51
Identities = 80/186 (43%), Positives = 115/186 (61%)
Query: 35 GMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKA 94
GM+ LH+ I SHGNL+SSNC++D R+VL+I DFGL +F+ + E G L +KL+ A
Sbjct: 645 GMLFLHNGAICSHGNLKSSNCVVDGRFVLKITDFGLESFRDPEPEQGHI--LYAKKLWTA 702
Query: 95 PELLRQPHLP-RGTQKGDVYSFGLVLYEVIGRQGPWGH---LRMTDEEIITSVTQGSG-- 148
PELLR P RG+Q GDVYSFG++L E+ R G + H L ++ +EI+ VT+G
Sbjct: 703 PELLRMASPPARGSQAGDVYSFGIILQEIALRSGVF-HVEGLDLSPKEIVERVTRGEQPP 761
Query: 149 LRPDTSSLDCAPSIIACMRTCWEEDPELRPDLRFVHHKLKEMNAGLKANIFDNMLAIMEK 208
RP + + M+ CW E+P+ RP + + L++ N +NI DN+L+ ME+
Sbjct: 762 FRPSLALQSHLEELGQLMQRCWAEEPQERPPFQQIRLMLRKFNRESSSNILDNLLSRMEQ 821
Query: 209 YAFNLE 214
YA NLE
Sbjct: 822 YANNLE 827
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries 
Original result of BLAST against SWISS-PROT
ID ![]() | Name ![]() | Annotated EC number ![]() | Identity ![]() | Query coverage ![]() | Hit coverage ![]() | RBH(Q2H) ![]() | RBH(H2Q) ![]() |
| Q07553 | GCY3E_DROME | 4, ., 6, ., 1, ., 2 | 0.5862 | 0.4609 | 0.1676 | yes | N/A |
Prediction of Functionally Associated Proteins
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST 
Original result of RPS-BLAST against CDD database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() |
| Query | 423 | |||
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 1e-21 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 4e-21 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 2e-20 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 5e-20 | |
| smart00044 | 194 | smart00044, CYCc, Adenylyl- / guanylyl cyclase, ca | 1e-16 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 7e-16 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 4e-15 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 4e-15 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 5e-15 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 3e-14 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 5e-14 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 5e-14 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 1e-13 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 4e-13 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 5e-13 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 5e-13 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 8e-13 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 8e-13 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 1e-12 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 2e-12 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 2e-12 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 3e-12 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 4e-12 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 5e-12 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 7e-12 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 9e-12 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 1e-11 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 2e-11 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 2e-11 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 2e-11 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 3e-11 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 4e-11 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 4e-11 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 5e-11 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 5e-11 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 6e-11 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 6e-11 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 6e-11 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 8e-11 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 8e-11 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 1e-10 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 2e-10 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 2e-10 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 2e-10 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 3e-10 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 4e-10 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 4e-10 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 5e-10 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 9e-10 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 1e-09 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 1e-09 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 1e-09 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 2e-09 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 2e-09 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 4e-09 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 6e-09 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 1e-08 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 1e-08 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 1e-08 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 1e-08 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 1e-08 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 2e-08 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 2e-08 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 2e-08 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 4e-08 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 6e-08 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 6e-08 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 7e-08 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 8e-08 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 1e-07 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 1e-07 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 2e-07 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 2e-07 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 3e-07 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 3e-07 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 4e-07 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 4e-07 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 4e-07 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 7e-07 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 8e-07 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 9e-07 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 1e-06 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 1e-06 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 1e-06 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 2e-06 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 2e-06 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 2e-06 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 3e-06 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 4e-06 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 4e-06 | |
| pfam00211 | 184 | pfam00211, Guanylate_cyc, Adenylate and Guanylate | 5e-06 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 5e-06 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 7e-06 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 7e-06 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 1e-05 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 1e-05 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 2e-05 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 2e-05 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 2e-05 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 2e-05 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 3e-05 | |
| PHA02882 | 294 | PHA02882, PHA02882, putative serine/threonine kina | 3e-05 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 4e-05 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 6e-05 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 6e-05 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 7e-05 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 8e-05 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 8e-05 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 8e-05 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 9e-05 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 1e-04 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 1e-04 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 1e-04 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 1e-04 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 1e-04 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 2e-04 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 2e-04 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 3e-04 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 4e-04 | |
| pfam07701 | 209 | pfam07701, HNOBA, Heme NO binding associated | 4e-04 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 4e-04 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 4e-04 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 4e-04 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 5e-04 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 5e-04 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 5e-04 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 5e-04 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 6e-04 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 6e-04 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 7e-04 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 7e-04 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 8e-04 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 8e-04 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 0.001 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 0.001 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 0.001 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 0.001 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 0.001 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 0.001 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 0.002 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 0.002 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 0.002 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 0.003 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 0.003 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 0.003 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 0.003 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 0.004 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 0.004 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 0.004 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 0.004 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 93.3 bits (233), Expect = 1e-21
Identities = 48/156 (30%), Positives = 75/156 (48%), Gaps = 14/156 (8%)
Query: 35 GMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKA 94
GM +L + H +L + NCL+ V++I+DFGL D + + + A
Sbjct: 114 GMEYLESKNFV-HRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRGGGKLPIKWMA 172
Query: 95 PELLRQPHLPRGTQKGDVYSFGLVLYEVI--GRQGPWGHLRMTDEEIITSVTQGSGL-RP 151
PE L+ T K DV+SFG++L+E+ G Q P+ M++EE++ + G L RP
Sbjct: 173 PESLKDGKF---TSKSDVWSFGVLLWEIFTLGEQ-PYP--GMSNEEVLELLEDGYRLPRP 226
Query: 152 DTSSLDCAPSIIACMRTCWEEDPELRPDLRFVHHKL 187
+ +C + M CW DPE RP + L
Sbjct: 227 E----NCPDELYELMLQCWAYDPEDRPTFSELVEDL 258
|
Length = 258 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 91.8 bits (229), Expect = 4e-21
Identities = 47/159 (29%), Positives = 80/159 (50%), Gaps = 18/159 (11%)
Query: 35 GMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGL--HAFKAGQDETGQERKLRRRKLY 92
GM +L + + H +L + NCL+ V++I+DFGL + KL R +
Sbjct: 117 GMEYLASKKFV-HRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIRWM- 174
Query: 93 KAPELLRQPHLPRGTQKGDVYSFGLVLYEVI--GRQGPWGHLRMTDEEIITSVTQGSGL- 149
APE L+ T K DV+SFG++L+E+ G P+ +++EE++ + +G L
Sbjct: 175 -APESLKDGIF---TSKSDVWSFGVLLWEIFTLGAT-PYP--GLSNEEVLEYLRKGYRLP 227
Query: 150 RPDTSSLDCAPSIIACMRTCWEEDPELRPDLRFVHHKLK 188
+P+ C + M +CW+ DPE RP + +L+
Sbjct: 228 KPE----YCPDELYELMLSCWQLDPEDRPTFSELVERLE 262
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 89.5 bits (223), Expect = 2e-20
Identities = 53/169 (31%), Positives = 77/169 (45%), Gaps = 41/169 (24%)
Query: 35 GMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYK- 93
GM +L I H +L + NCL+ V++I+DFGL R L Y+
Sbjct: 114 GMEYLESKNFI-HRDLAARNCLVGENLVVKISDFGL------------SRDLYDDDYYRK 160
Query: 94 ----------APELLRQPHLPRG--TQKGDVYSFGLVLYEVI--GRQGPWGHLRMTDEEI 139
APE L+ G T K DV+SFG++L+E+ G Q P+ M++EE+
Sbjct: 161 RGGKLPIRWMAPESLK-----EGKFTSKSDVWSFGVLLWEIFTLGEQ-PYPG--MSNEEV 212
Query: 140 ITSVTQGSGL-RPDTSSLDCAPSIIACMRTCWEEDPELRPDLRFVHHKL 187
+ + G L +P +C P + M CW EDPE RP + L
Sbjct: 213 LEYLKNGYRLPQPP----NCPPELYDLMLQCWAEDPEDRPTFSELVEIL 257
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 88.4 bits (220), Expect = 5e-20
Identities = 52/169 (30%), Positives = 76/169 (44%), Gaps = 41/169 (24%)
Query: 35 GMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYK- 93
GM +L I H +L + NCL+ V++I+DFGL R L YK
Sbjct: 115 GMEYLESKNFI-HRDLAARNCLVGENLVVKISDFGL------------SRDLYDDDYYKV 161
Query: 94 ----------APELLRQPHLPRG--TQKGDVYSFGLVLYEVI--GRQGPWGHLRMTDEEI 139
APE L+ G T K DV+SFG++L+E+ G + G M++ E+
Sbjct: 162 KGGKLPIRWMAPESLK-----EGKFTSKSDVWSFGVLLWEIFTLGEEPYPG---MSNAEV 213
Query: 140 ITSVTQGSGL-RPDTSSLDCAPSIIACMRTCWEEDPELRPDLRFVHHKL 187
+ + +G L +P +C P + M CW EDPE RP + L
Sbjct: 214 LEYLKKGYRLPKPP----NCPPELYKLMLQCWAEDPEDRPTFSELVEIL 258
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|214485 smart00044, CYCc, Adenylyl- / guanylyl cyclase, catalytic domain | Back alignment and domain information |
|---|
Score = 77.7 bits (192), Expect = 1e-16
Identities = 35/54 (64%), Positives = 41/54 (75%), Gaps = 1/54 (1%)
Query: 308 EKKKTDALLHRMLPRSVSESLKRG-DFVEPESFDSVTIYFSDIVGFTQLSAEST 360
EKKKTD LL ++LP SV+E LKRG V ES+D+VTI FSDIVGFT L + ST
Sbjct: 2 EKKKTDRLLDQLLPASVAEQLKRGGSPVPAESYDNVTILFSDIVGFTSLCSTST 55
|
Present in two copies in mammalian adenylyl cyclases. Eubacterial homologues are known. Two residues (Asn, Arg) are thought to be involved in catalysis. These cyclases have important roles in a diverse range of cellular processes. Length = 194 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 76.6 bits (189), Expect = 7e-16
Identities = 52/158 (32%), Positives = 76/158 (48%), Gaps = 19/158 (12%)
Query: 35 GMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDE--TGQERKLRRRKLY 92
GM +L I H +L + N L+ V +IADFGL A DE + K + +
Sbjct: 115 GMAYLESRNYI-HRDLAARNILVGENLVCKIADFGL-ARLIEDDEYTAREGAKFPIK--W 170
Query: 93 KAPELLRQPHLPRGTQKGDVYSFGLVLYEVI--GRQGPWGHLRMTDEEIITSVTQGSGL- 149
APE R T K DV+SFG++L E++ GR G MT+ E++ V +G +
Sbjct: 171 TAPEAAN---YGRFTIKSDVWSFGILLTEIVTYGRVPYPG---MTNREVLEQVERGYRMP 224
Query: 150 RPDTSSLDCAPSIIACMRTCWEEDPELRPDLRFVHHKL 187
RP +C + M CW++DPE RP ++ L
Sbjct: 225 RPP----NCPEELYDLMLQCWDKDPEERPTFEYLQSFL 258
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 74.6 bits (184), Expect = 4e-15
Identities = 39/149 (26%), Positives = 65/149 (43%), Gaps = 14/149 (9%)
Query: 35 GMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRR--KLY 92
G+ +LH S I H +L+ N L+D V++IADFGL A + Y
Sbjct: 110 GLEYLH-SNGIIHRDLKPENILLDENGVVKIADFGL----AKKLLKSSSSLTTFVGTPWY 164
Query: 93 KAPELLR--QPHLPRGTQKGDVYSFGLVLYEVIGRQGPW-GHLRMTDEEIITSVTQGSGL 149
APE+L + K DV+S G++LYE++ + P+ G + ++I +
Sbjct: 165 MAPEVLLGGNGY----GPKVDVWSLGVILYELLTGKPPFSGENILDQLQLIRRILGPPLE 220
Query: 150 RPDTSSLDCAPSIIACMRTCWEEDPELRP 178
+ + ++ C +DP RP
Sbjct: 221 FDEPKWSSGSEEAKDLIKKCLNKDPSKRP 249
|
Length = 260 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 74.4 bits (183), Expect = 4e-15
Identities = 44/155 (28%), Positives = 70/155 (45%), Gaps = 14/155 (9%)
Query: 35 GMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKA 94
GM +L + I H +L + N L+ V ++ADFGL ++K+ + + A
Sbjct: 116 GMAYLEEQNSI-HRDLAARNILVGEDLVCKVADFGLARLIKEDVYLSSDKKIPYK--WTA 172
Query: 95 PELLRQPHLPRGTQKGDVYSFGLVLYEVIGR-QGPWGHLRMTDEEIITSVTQGSGL-RPD 152
PE + K DV+SFG++LYE+ Q P+ M + E+ +T G + P
Sbjct: 173 PEAASHGTF---STKSDVWSFGILLYEMFTYGQVPYPG--MNNHEVYDQITAGYRMPCP- 226
Query: 153 TSSLDCAPSIIACMRTCWEEDPELRPDLRFVHHKL 187
C I M CW +PE RP + + +L
Sbjct: 227 ---AKCPQEIYKIMLECWAAEPEDRPSFKALREEL 258
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 74.9 bits (184), Expect = 5e-15
Identities = 57/199 (28%), Positives = 87/199 (43%), Gaps = 36/199 (18%)
Query: 3 RSVRETEAITPNPLSPFNIPIG-SISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRW 61
S NPL P + I+ A GM +L + + + H +L + NCL+
Sbjct: 112 HSTSSARKCGLNPL-PLSCTEQLCIAKQVAA--GMAYLSERKFV-HRDLATRNCLVGENM 167
Query: 62 VLQIADFGLHAFKAGQDETGQERKLRRRKLYKAPE--LLRQPHLP-------RGTQKGDV 112
V++IADFGL R + YKA E + +P R T + DV
Sbjct: 168 VVKIADFGL------------SRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDV 215
Query: 113 YSFGLVLYEVI--GRQGPWGHLRMTDEEIITSVTQGSGLR-PDTSSLDCAPSIIACMRTC 169
+++G+VL+E+ G Q +G M EE+I V G+ L PD +C + MR C
Sbjct: 216 WAYGVVLWEIFSYGMQPYYG---MAHEEVIYYVRDGNVLSCPD----NCPLELYNLMRLC 268
Query: 170 WEEDPELRPDLRFVHHKLK 188
W + P RP ++ L+
Sbjct: 269 WSKLPSDRPSFASINRILQ 287
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 71.1 bits (175), Expect = 3e-14
Identities = 37/154 (24%), Positives = 63/154 (40%), Gaps = 43/154 (27%)
Query: 35 GMIHLHDSEIISHGNLRSSNCLIDSR-WVLQIADFGLHAFKAGQDETGQERKLRRRKLYK 93
G+ +LH + II H +L+ N L+DS +++ADFGL K + + + Y
Sbjct: 104 GLEYLHSNGII-HRDLKPENILLDSDNGKVKLADFGL--SKLLTSDKSLLKTIVGTPAYM 160
Query: 94 APELLRQPHLPRGTQKGDVYSFGLVLYEVIGRQGPWGHLRMTDEEIITSVTQGSGLRPDT 153
APE+L ++K D++S G++LYE+
Sbjct: 161 APEVLLG--KGYYSEKSDIWSLGVILYEL------------------------------- 187
Query: 154 SSLDCAPSIIACMRTCWEEDPELRPDLRFVHHKL 187
P + +R ++DPE RP + + L
Sbjct: 188 ------PELKDLIRKMLQKDPEKRPSAKEILEHL 215
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 71.6 bits (175), Expect = 5e-14
Identities = 52/179 (29%), Positives = 87/179 (48%), Gaps = 19/179 (10%)
Query: 15 PLSPFNIPIGSISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFK 74
+ +++ + + GM++L + H +L + NCL+ V++I DFG+
Sbjct: 115 APGQLTLG-QMLAIASQIASGMVYLASLHFV-HRDLATRNCLVGQGLVVKIGDFGMSRDI 172
Query: 75 AGQD--ETGQERKLRRRKLYKAPELLRQPHLPRGTQKGDVYSFGLVLYEVI--GRQGPWG 130
D G L R + L R + T + D++SFG+VL+E+ G+Q PW
Sbjct: 173 YSTDYYRVGGRTMLPIRWMPPESILYR-----KFTTESDIWSFGVVLWEIFTYGKQ-PWY 226
Query: 131 HLRMTDEEIITSVTQGSGL-RPDTSSLDCAPSIIACMRTCWEEDPELRPDLRFVHHKLK 188
L T E I +TQG L RP T C P + A M+ CW+ +P+ R ++ +H +L+
Sbjct: 227 QLSNT--EAIECITQGRELERPRT----CPPEVYAIMQGCWQREPQQRMVIKDIHSRLQ 279
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 71.3 bits (175), Expect = 5e-14
Identities = 46/156 (29%), Positives = 82/156 (52%), Gaps = 19/156 (12%)
Query: 35 GMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKA 94
GM +L + + H +L + N L+ V +++DFGL A +A Q + + ++ + A
Sbjct: 114 GMEYLEEKNFV-HRDLAARNVLVSEDLVAKVSDFGL-AKEASQGQDSGKLPVK----WTA 167
Query: 95 PELLRQPHLPRGTQKGDVYSFGLVLYEV--IGRQGPWGHLRMTDEEIITSVTQGSGLR-P 151
PE LR + + K DV+SFG++L+E+ GR P+ R+ ++++ V +G + P
Sbjct: 168 PEALR---EKKFSTKSDVWSFGILLWEIYSFGRV-PYP--RIPLKDVVPHVEKGYRMEAP 221
Query: 152 DTSSLDCAPSIIACMRTCWEEDPELRPDLRFVHHKL 187
+ C P + M+ CWE DP RP + + +L
Sbjct: 222 EG----CPPEVYKVMKDCWELDPAKRPTFKQLREQL 253
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 70.0 bits (171), Expect = 1e-13
Identities = 46/158 (29%), Positives = 79/158 (50%), Gaps = 19/158 (12%)
Query: 35 GMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGL-HAFKAGQDETGQERKLRRRKLYK 93
GM +L +S+ + H +L + N L+ V +++DFGL G D + K +
Sbjct: 112 GMEYL-ESKKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMGVDNSKLPVK------WT 164
Query: 94 APELLRQPHLPRGTQKGDVYSFGLVLYEVI--GRQGPWGHLRMTDEEIITSVTQGSGLRP 151
APE L+ + K DV+S+G++L+EV GR P+ +M+ +E+ V +G + P
Sbjct: 165 APEALKHKKF---SSKSDVWSYGVLLWEVFSYGRA-PYP--KMSLKEVKECVEKGYRMEP 218
Query: 152 DTSSLDCAPSIIACMRTCWEEDPELRPDLRFVHHKLKE 189
C + M +CWE +P+ RP + KL++
Sbjct: 219 PE---GCPADVYVLMTSCWETEPKKRPSFHKLREKLEK 253
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 68.6 bits (168), Expect = 4e-13
Identities = 43/146 (29%), Positives = 71/146 (48%), Gaps = 13/146 (8%)
Query: 35 GMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKA 94
M +L + I H +L + NCL+ V++++DFGL + T + K +
Sbjct: 112 AMEYLESNGFI-HRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQGTKFPVK-WAP 169
Query: 95 PELLRQPHLPRGTQKGDVYSFGLVLYEVI-GRQGPWGHLRMTDEEIITSVTQGSGL-RPD 152
PE+ R + K DV+SFG++++EV + P+ R ++ E++ SV+ G L RP
Sbjct: 170 PEVFDYS---RFSSKSDVWSFGVLMWEVFSEGKMPYE--RFSNSEVVESVSAGYRLYRPK 224
Query: 153 TSSLDCAPSIIACMRTCWEEDPELRP 178
+ M +CW E PE RP
Sbjct: 225 L----APTEVYTIMYSCWHEKPEDRP 246
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 68.4 bits (167), Expect = 5e-13
Identities = 46/150 (30%), Positives = 79/150 (52%), Gaps = 21/150 (14%)
Query: 35 GMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDET---GQERKLRRRKL 91
GM +L + I H +L + NCL+D + ++++DFGL + + T G + +R
Sbjct: 112 GMAYLESKQFI-HRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSSVGSKFPVR---- 166
Query: 92 YKAPELLRQPHLPRGTQKGDVYSFGLVLYEV--IGRQGPWGHLRMTDEEIITSVTQGSGL 149
+ PE+L + + K DV++FG++++EV +G+ P+ R + E + V+QG L
Sbjct: 167 WSPPEVL---LYSKFSSKSDVWAFGVLMWEVYSLGKM-PYE--RFNNSETVEKVSQGLRL 220
Query: 150 -RPDTSSLDCAPSIIACMRTCWEEDPELRP 178
RP +S + A M +CW E E RP
Sbjct: 221 YRPHLAS----EKVYAIMYSCWHEKAEERP 246
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 5e-13
Identities = 45/166 (27%), Positives = 82/166 (49%), Gaps = 11/166 (6%)
Query: 25 SISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQER 84
I + + GM ++ I H +LR++N L+ + +IADFGL + T +E
Sbjct: 105 LIDFSAQIAEGMAYIERKNYI-HRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREG 163
Query: 85 KLRRRKLYKAPELLRQPHLPRGTQKGDVYSFGLVLYEVIGRQGPWGHLRMTDEEIITSVT 144
K + APE + T K DV+SFG++LYE++ G + M++ ++++++
Sbjct: 164 AKFPIK-WTAPEAINFGSF---TIKSDVWSFGILLYEIV-TYGKIPYPGMSNSDVMSALQ 218
Query: 145 QGSGL-RPDTSSLDCAPSIIACMRTCWEEDPELRPDLRFVHHKLKE 189
+G + R + C + M+TCW+E E RP ++ L +
Sbjct: 219 RGYRMPRMEN----CPDELYDIMKTCWKEKAEERPTFDYLQSVLDD 260
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 8e-13
Identities = 47/164 (28%), Positives = 81/164 (49%), Gaps = 12/164 (7%)
Query: 26 ISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAG--QDETGQE 83
I + A+ GM +L I H +L + NCL+ + VL+I+DFG+ + TG
Sbjct: 97 IQMVENAAAGMEYLESKHCI-HRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGM 155
Query: 84 RKLRRRKLYKAPELLRQPHLPRGTQKGDVYSFGLVLYEVIGRQGPWGHLRMTDEEIITSV 143
+++ + + APE L + R + + DV+SFG++L+E G + +++++ ++
Sbjct: 156 KQIPVK--WTAPEAL---NYGRYSSESDVWSFGILLWEAFS-LGAVPYANLSNQQTREAI 209
Query: 144 TQGSGLRPDTSSLDCAPSIIACMRTCWEEDPELRPDLRFVHHKL 187
QG L C ++ M CWE DP RP VH +L
Sbjct: 210 EQGVRLPCPE---LCPDAVYRLMERCWEYDPGQRPSFSTVHQEL 250
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 67.9 bits (166), Expect = 8e-13
Identities = 51/161 (31%), Positives = 84/161 (52%), Gaps = 20/161 (12%)
Query: 35 GMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQD--ETGQERKLRRRKLY 92
GM++L S+ H +L + NCL+ V++I DFG+ D G L R +
Sbjct: 134 GMVYL-ASQHFVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDYYRVGGHTMLPIR--W 190
Query: 93 KAPE--LLRQPHLPRGTQKGDVYSFGLVLYEVI--GRQGPWGHLRMTDEEIITSVTQGSG 148
PE + R + T + DV+SFG+VL+E+ G+Q PW L ++EE+I +TQG
Sbjct: 191 MPPESIMYR-----KFTTESDVWSFGVVLWEIFTYGKQ-PWYGL--SNEEVIECITQGRL 242
Query: 149 LRPDTSSLDCAPSIIACMRTCWEEDPELRPDLRFVHHKLKE 189
L+ C + M CW+ DP+ R +++ +H +L++
Sbjct: 243 LQRPR---TCPSEVYDIMLGCWKRDPQQRINIKDIHERLQK 280
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 67.4 bits (164), Expect = 1e-12
Identities = 46/163 (28%), Positives = 82/163 (50%), Gaps = 18/163 (11%)
Query: 33 SVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLH--AFKAGQDETGQERKLRRRK 90
+ GM++L + H +L + NCL+ +++I DFG+ + G L R
Sbjct: 130 AAGMVYLASQHFV-HRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIR- 187
Query: 91 LYKAPELLRQPHLPRGTQKGDVYSFGLVLYEVI--GRQGPWGHLRMTDEEIITSVTQGSG 148
+ PE + T + DV+S G+VL+E+ G+Q PW ++++ E+I +TQG
Sbjct: 188 -WMPPESIMYRKF---TTESDVWSLGVVLWEIFTYGKQ-PW--YQLSNNEVIECITQGRV 240
Query: 149 L-RPDTSSLDCAPSIIACMRTCWEEDPELRPDLRFVHHKLKEM 190
L RP T C + M CW+ +P +R +++ +H L+ +
Sbjct: 241 LQRPRT----CPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNL 279
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 66.8 bits (163), Expect = 2e-12
Identities = 51/158 (32%), Positives = 79/158 (50%), Gaps = 15/158 (9%)
Query: 35 GMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKA 94
GM + I H +LR++N L+ +IADFGL + T +E K + A
Sbjct: 114 GMAFIERKNYI-HRDLRAANILVSETLCCKIADFGLARLIEDNEYTAREGAKFPIK-WTA 171
Query: 95 PELLRQPHLPRGTQKGDVYSFGLVLYEVI--GRQGPWGHLRMTDEEIITSVTQGSGL-RP 151
PE + T K DV+SFG++L E++ GR G MT+ E+I ++ +G + RP
Sbjct: 172 PEAINYGTF---TIKSDVWSFGILLTEIVTYGRIPYPG---MTNPEVIQNLERGYRMPRP 225
Query: 152 DTSSLDCAPSIIACMRTCWEEDPELRPDLRFVHHKLKE 189
D +C + MR CW+E PE RP ++ L++
Sbjct: 226 D----NCPEELYELMRLCWKEKPEERPTFEYLRSVLED 259
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 66.6 bits (163), Expect = 2e-12
Identities = 47/152 (30%), Positives = 77/152 (50%), Gaps = 24/152 (15%)
Query: 35 GMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQD--ETGQERKLRRRKL- 91
GM +L + + H +L + NC++ ++I DFG+ +D ET RK + L
Sbjct: 131 GMAYLAAKKFV-HRDLAARNCMVAEDLTVKIGDFGM-----TRDIYETDYYRKGGKGLLP 184
Query: 92 --YKAPELLRQPHLPRGTQKGDVYSFGLVLYEV--IGRQGPWGHLRMTDEEIITSVTQGS 147
+ APE L+ T K DV+SFG+VL+E+ + Q P+ L ++EE++ V G
Sbjct: 185 VRWMAPESLKDGVF---TTKSDVWSFGVVLWEMATLAEQ-PYQGL--SNEEVLKFVIDGG 238
Query: 148 GLRPDTSSLDCAPSIIA-CMRTCWEEDPELRP 178
L + P + MR CW+ +P++RP
Sbjct: 239 HLDLP----ENCPDKLLELMRMCWQYNPKMRP 266
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 66.2 bits (162), Expect = 3e-12
Identities = 45/159 (28%), Positives = 75/159 (47%), Gaps = 13/159 (8%)
Query: 33 SVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGL-HAFKAGQDETGQERKLRRRKL 91
++GM +L + H +L + N L+ +R +I+DFG+ A AG D R
Sbjct: 105 AMGMAYLESKHFV-HRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGRWPLK 163
Query: 92 YKAPELLRQPHLPRGTQKGDVYSFGLVLYEVIGR-QGPWGHLRMTDEEIITSVTQGSGL- 149
+ APE + + + + K DV+S+G+ L+E P+G M E+I + G L
Sbjct: 164 WYAPECI---NYGKFSSKSDVWSYGVTLWEAFSYGAKPYG--EMKGAEVIAMLESGERLP 218
Query: 150 RPDTSSLDCAPSIIACMRTCWEEDPELRPDLRFVHHKLK 188
RP+ +C I + M +CW+ PE RP + +
Sbjct: 219 RPE----ECPQEIYSIMLSCWKYRPEDRPTFSELESTFR 253
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 65.6 bits (160), Expect = 4e-12
Identities = 46/160 (28%), Positives = 78/160 (48%), Gaps = 14/160 (8%)
Query: 32 ASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKL 91
A+ GM +L I H +L + NCL+ VL+I+DFG+ + G T + L++ +
Sbjct: 102 AAAGMEYLESKNCI-HRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSD-GLKQIPI 159
Query: 92 -YKAPELLRQPHLPRGTQKGDVYSFGLVLYEVI-GRQGPWGHLRMTDEEIITSVTQGSGL 149
+ APE L R T + DV+S+G++L+E P+ M++++ + G +
Sbjct: 160 KWTAPEALN---YGRYTSESDVWSYGILLWETFSLGDTPYPG--MSNQQTRERIESGYRM 214
Query: 150 -RPDTSSLDCAPSIIACMRTCWEEDPELRPDLRFVHHKLK 188
P C I M CW DPE RP ++++L+
Sbjct: 215 PAPQL----CPEEIYRLMLQCWAYDPENRPSFSEIYNELQ 250
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 65.4 bits (160), Expect = 5e-12
Identities = 44/158 (27%), Positives = 78/158 (49%), Gaps = 12/158 (7%)
Query: 35 GMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKA 94
GM +L + + H +L + N L++S V +++DFGL + T + + + A
Sbjct: 118 GMKYLSEMNYV-HRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKIPIRWTA 176
Query: 95 PELLRQPHLPRGTQKGDVYSFGLVLYEVI--GRQGPWGHLRMTDEEIITSVTQGSGLRPD 152
PE + T DV+SFG+V++EV+ G + W M+++++I +V G L P
Sbjct: 177 PEAIAYRKF---TSASDVWSFGIVMWEVMSYGERPYWD---MSNQDVIKAVEDGYRLPP- 229
Query: 153 TSSLDCAPSIIACMRTCWEEDPELRPDLRFVHHKLKEM 190
+DC ++ M CW++D RP + L +M
Sbjct: 230 --PMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKM 265
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 64.9 bits (158), Expect = 7e-12
Identities = 41/145 (28%), Positives = 77/145 (53%), Gaps = 11/145 (7%)
Query: 35 GMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKA 94
GM +L + I H +L + NCL+ S V++++DFG+ + DE + +
Sbjct: 112 GMEYLERNSFI-HRDLAARNCLVSSTGVVKVSDFGMTRYVL-DDEYTSSSGAKFPVKWSP 169
Query: 95 PELLRQPHLPRGTQKGDVYSFGLVLYEVIGRQGPWGHLRMTDEEIITSVTQGSGL-RPDT 153
PE+ + + + K DV+SFG++++EV +G + ++ E++ +++G L RP
Sbjct: 170 PEVF---NFSKYSSKSDVWSFGVLMWEVF-TEGKMPFEKKSNYEVVEMISRGFRLYRPKL 225
Query: 154 SSLDCAPSIIACMRTCWEEDPELRP 178
+S+ ++ M +CW E PE RP
Sbjct: 226 ASM----TVYEVMYSCWHEKPEGRP 246
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 65.1 bits (159), Expect = 9e-12
Identities = 41/159 (25%), Positives = 70/159 (44%), Gaps = 23/159 (14%)
Query: 35 GMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKL-YK 93
GM +L I H +L + N L++S +++I+DFGL + ++ + +
Sbjct: 121 GMDYLGSQRYI-HRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWY 179
Query: 94 APELLRQPHLPRGTQKGDVYSFGLVLYEV-------------IGRQGPWGHLRMTDEEII 140
APE LR + + DV+SFG+ LYE+ R +M ++
Sbjct: 180 APECLRT---SKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLL 236
Query: 141 TSVTQGSGL-RPDTSSLDCAPSIIACMRTCWEEDPELRP 178
+ +G L RP + C + M+ CWE +P+ RP
Sbjct: 237 ELLKEGERLPRPPS----CPDEVYDLMKLCWEAEPQDRP 271
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 64.8 bits (158), Expect = 1e-11
Identities = 50/167 (29%), Positives = 78/167 (46%), Gaps = 17/167 (10%)
Query: 28 VNTTASV--GMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGL-HAFKAGQDETGQER 84
++ A V GM +L I H +L + N L+ + ++ADFGL K E +
Sbjct: 106 IDMAAQVASGMAYLEAQNYI-HRDLAARNVLVGENNICKVADFGLARVIKEDIYEAREGA 164
Query: 85 KLRRRKLYKAPELLRQPHLPRGTQKGDVYSFGLVLYEVI--GRQGPWGHLRMTDEEIITS 142
K + + APE R + K DV+SFG++L E++ GR G MT+ E++
Sbjct: 165 KFPIK--WTAPEAA---LYNRFSIKSDVWSFGILLTEIVTYGRMPYPG---MTNAEVLQQ 216
Query: 143 VTQGSGLRPDTSSLDCAPSIIACMRTCWEEDPELRPDLRFVHHKLKE 189
V QG + C + M CW+EDP+ RP + KL++
Sbjct: 217 VDQGYRMPCPPG---CPKELYDIMLDCWKEDPDDRPTFETLQWKLED 260
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 63.8 bits (155), Expect = 2e-11
Identities = 43/157 (27%), Positives = 81/157 (51%), Gaps = 17/157 (10%)
Query: 35 GMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAF---KAGQDETGQERKLRRRKL 91
GM +L S +I H +L + NCL+ V++++DFG+ F TG + ++
Sbjct: 112 GMAYLESSNVI-HRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSSTGTKFPVK---- 166
Query: 92 YKAPELLRQPHLPRGTQKGDVYSFGLVLYEVIGRQGPWGHLRMTDEEIITSVTQGSGL-R 150
+ +PE+ + + K DV+SFG++++EV +G + ++ E++ ++ G L +
Sbjct: 167 WSSPEVFS---FSKYSSKSDVWSFGVLMWEVFS-EGKTPYENRSNSEVVETINAGFRLYK 222
Query: 151 PDTSSLDCAPSIIACMRTCWEEDPELRPDLRFVHHKL 187
P + S+ M+ CW+E PE RP + H+L
Sbjct: 223 PRL----ASQSVYELMQHCWKERPEDRPSFSLLLHQL 255
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 63.7 bits (155), Expect = 2e-11
Identities = 46/164 (28%), Positives = 75/164 (45%), Gaps = 15/164 (9%)
Query: 30 TTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRR 89
T S M +L I H +L + NCL+ ++++ADFGL G T
Sbjct: 111 TQISSAMEYLEKKNFI-HRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPI 169
Query: 90 KLYKAPELLRQPHLPRGTQKGDVYSFGLVLYEVIGRQG--PWGHLRMTDEEIITSVTQGS 147
K + APE L + K DV++FG++L+E I G P+ + ++ + + +G
Sbjct: 170 K-WTAPESLAYNKF---SIKSDVWAFGVLLWE-IATYGMSPYPGIDLSQ--VYELLEKGY 222
Query: 148 GL-RPDTSSLDCAPSIIACMRTCWEEDPELRPDLRFVHHKLKEM 190
+ RP+ C P + MR CW+ +P RP +H + M
Sbjct: 223 RMERPE----GCPPKVYELMRACWQWNPSDRPSFAEIHQAFETM 262
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 63.9 bits (156), Expect = 2e-11
Identities = 50/174 (28%), Positives = 76/174 (43%), Gaps = 38/174 (21%)
Query: 35 GMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYK- 93
GM +L + H +L + NCL+ + ++IADFG+ R L Y+
Sbjct: 142 GMRYLESLNFV-HRDLATRNCLVGKNYTIKIADFGM------------SRNLYSSDYYRV 188
Query: 94 ---APELLR-----QPHLPRGTQKGDVYSFGLVLYEV--IGRQGPWGHLRMTDEEII--- 140
AP +R L + T K DV++FG+ L+E+ + R+ P+ HL TD+++I
Sbjct: 189 QGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHL--TDQQVIENA 246
Query: 141 TSVTQGSGL-----RPDTSSLDCAPSIIACMRTCWEEDPELRPDLRFVHHKLKE 189
+ G RP C I M CW D E RP R +H L+
Sbjct: 247 GHFFRDDGRQIYLPRPPN----CPKDIYELMLECWRRDEEDRPTFREIHLFLQR 296
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 3e-11
Identities = 45/159 (28%), Positives = 80/159 (50%), Gaps = 19/159 (11%)
Query: 35 GMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKA 94
M +L + + H +L + N L+ V +++DFGL + +TG KL + + A
Sbjct: 114 AMEYLEANNFV-HRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTG---KLPVK--WTA 167
Query: 95 PELLRQPHLPRGTQKGDVYSFGLVLYEV--IGRQGPWGHLRMTDEEIITSVTQGSGL-RP 151
PE LR+ + + K DV+SFG++L+E+ GR P+ R+ ++++ V +G + P
Sbjct: 168 PEALREK---KFSTKSDVWSFGILLWEIYSFGRV-PYP--RIPLKDVVPRVEKGYKMDAP 221
Query: 152 DTSSLDCAPSIIACMRTCWEEDPELRPDLRFVHHKLKEM 190
D C P + M+ CW D RP + +L+ +
Sbjct: 222 D----GCPPVVYDVMKQCWHLDAATRPSFLQLREQLEHI 256
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 62.9 bits (154), Expect = 4e-11
Identities = 37/153 (24%), Positives = 66/153 (43%), Gaps = 21/153 (13%)
Query: 35 GMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKL--- 91
+ +LH I+ H +L+ N L+D +++ADFGL A Q + G+ +
Sbjct: 109 ALEYLHSKGIV-HRDLKPENILLDEDGHVKLADFGL----ARQLDPGE----KLTTFVGT 159
Query: 92 --YKAPE-LLRQPHLPRGTQKGDVYSFGLVLYEVIGRQGPWGHLRMTDEEIITSVTQGSG 148
Y APE LL + + + D++S G++LYE++ + P+ E+ + +
Sbjct: 160 PEYMAPEVLLGKGY----GKAVDIWSLGVILYELLTGKPPFPG-DDQLLELFKKIGKPK- 213
Query: 149 LRPDTSSLDCAPSIIACMRTCWEEDPELRPDLR 181
D +P +R +DPE R
Sbjct: 214 PPFPPPEWDISPEAKDLIRKLLVKDPEKRLTAE 246
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 62.6 bits (153), Expect = 4e-11
Identities = 35/147 (23%), Positives = 66/147 (44%), Gaps = 13/147 (8%)
Query: 35 GMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKA 94
G+ +LH + I+ H +++ +N L+DS V+++ADFG + +R + A
Sbjct: 113 GLAYLHSNGIV-HRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMA 171
Query: 95 PELLRQ-PHLPRGTQKGDVYSFGLVLYEVIGRQGPWGHLRMTDEEI--ITSVTQGSGLRP 151
PE++R + + D++S G + E+ + PW L + I S + + P
Sbjct: 172 PEVIRGEEY----GRAADIWSLGCTVIEMATGKPPWSELGNPMAALYKIGSSGEPPEI-P 226
Query: 152 DTSSLDCAPSIIACMRTCWEEDPELRP 178
+ + +R C DP+ RP
Sbjct: 227 E----HLSEEAKDFLRKCLRRDPKKRP 249
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 5e-11
Identities = 48/157 (30%), Positives = 78/157 (49%), Gaps = 9/157 (5%)
Query: 33 SVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLY 92
+ GM ++ I H +LRS+N L+ V +IADFGL + T ++ K +
Sbjct: 112 AAGMAYIERMNYI-HRDLRSANILVGDGLVCKIADFGLARLIEDNEYTARQGAKFPIK-W 169
Query: 93 KAPELLRQPHLPRGTQKGDVYSFGLVLYEVIGRQGPWGHLRMTDEEIITSVTQGSGLRPD 152
APE R T K DV+SFG++L E++ + G + M + E++ V +G +
Sbjct: 170 TAPE---AALYGRFTIKSDVWSFGILLTELVTK-GRVPYPGMNNREVLEQVERGYRM--- 222
Query: 153 TSSLDCAPSIIACMRTCWEEDPELRPDLRFVHHKLKE 189
DC S+ M CW++DPE RP ++ L++
Sbjct: 223 PCPQDCPISLHELMLQCWKKDPEERPTFEYLQSFLED 259
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 62.6 bits (152), Expect = 5e-11
Identities = 49/164 (29%), Positives = 79/164 (48%), Gaps = 21/164 (12%)
Query: 35 GMIHLHDSEIISHGNLRSSNCLI-----DSRWVLQIADFGL--HAFKAGQDETGQERKLR 87
G ++L I H +L + NCL+ D+ V++I DFGL +K+ E L
Sbjct: 118 GCVYLEQMHFI-HRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLP 176
Query: 88 RRKLYKAPELLRQPHLPRGTQKGDVYSFGLVLYEVI--GRQGPWGHLRMTDEEIITSVTQ 145
R + APE L T + DV+SFG++++E++ G+Q P+ L ++E++ VT
Sbjct: 177 VR--WMAPESLLDGKF---TTQSDVWSFGVLMWEILTLGQQ-PYPAL--NNQEVLQHVTA 228
Query: 146 GSGLRPDTSSLDCAPSIIACMRTCWEEDPELRPDLRFVHHKLKE 189
G L+ +C I M CW +DP RP + L+
Sbjct: 229 GGRLQKPE---NCPDKIYQLMTNCWAQDPSERPTFDRIQEILQN 269
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 62.6 bits (152), Expect = 6e-11
Identities = 50/176 (28%), Positives = 74/176 (42%), Gaps = 33/176 (18%)
Query: 35 GMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRK---- 90
GM +LH I H +L + N L+D+ +++I DFGL A G E R
Sbjct: 119 GMAYLHSQHYI-HRDLAARNVLLDNDRLVKIGDFGL----AKAVPEGHEYYRVREDGDSP 173
Query: 91 -LYKAPELLRQPHLPRGTQKGDVYSFGLVLYEVIGRQGPWGHLRMTDEEIITSVTQG--- 146
+ A E L++ + DV+SFG+ LYE++ EE+I QG
Sbjct: 174 VFWYAVECLKENKFSYAS---DVWSFGVTLYELLTHCDSKQSPPKKFEEMI-GPKQGQMT 229
Query: 147 ---------SGLR---PDTSSLDCAPSIIACMRTCWEEDPELRPDLRFVHHKLKEM 190
G+R P +C + M+ CWE + + RP R + LKEM
Sbjct: 230 VVRLIELLERGMRLPCPK----NCPQEVYILMKNCWETEAKFRPTFRSLIPILKEM 281
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 62.4 bits (151), Expect = 6e-11
Identities = 47/161 (29%), Positives = 84/161 (52%), Gaps = 20/161 (12%)
Query: 35 GMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKL--- 91
GM +L+ ++ + H +L + NC++ + ++I DFG+ ET RK + L
Sbjct: 131 GMAYLNANKFV-HRDLAARNCMVAEDFTVKIGDFGM---TRDIYETDYYRKGGKGLLPVR 186
Query: 92 YKAPELLRQPHLPRGTQKGDVYSFGLVLYEV--IGRQGPWGHLRMTDEEIITSVTQGSGL 149
+ +PE L+ T DV+SFG+VL+E+ + Q G M++E+++ V +G L
Sbjct: 187 WMSPESLKDGVF---TTYSDVWSFGVVLWEIATLAEQPYQG---MSNEQVLRFVMEGGLL 240
Query: 150 -RPDTSSLDCAPSIIACMRTCWEEDPELRPDLRFVHHKLKE 189
+PD +C + MR CW+ +P++RP + +KE
Sbjct: 241 DKPD----NCPDMLFELMRMCWQYNPKMRPSFLEIISSIKE 277
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 62.0 bits (150), Expect = 6e-11
Identities = 45/155 (29%), Positives = 75/155 (48%), Gaps = 9/155 (5%)
Query: 35 GMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKA 94
GM + I H +LR++N L+ + V +IADFGL + T +E K + A
Sbjct: 114 GMAFIEQRNYI-HRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIK-WTA 171
Query: 95 PELLRQPHLPRGTQKGDVYSFGLVLYEVIGRQGPWGHLRMTDEEIITSVTQGSGLRPDTS 154
PE + T K DV+SFG++L E++ G + M++ E+I ++ +G + P
Sbjct: 172 PEAINFGSF---TIKSDVWSFGILLMEIVT-YGRIPYPGMSNPEVIRALERGYRM-PRPE 226
Query: 155 SLDCAPSIIACMRTCWEEDPELRPDLRFVHHKLKE 189
+ C + M CW+ PE RP ++ L +
Sbjct: 227 N--CPEELYNIMMRCWKNRPEERPTFEYIQSVLDD 259
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 61.6 bits (150), Expect = 8e-11
Identities = 48/160 (30%), Positives = 70/160 (43%), Gaps = 16/160 (10%)
Query: 35 GMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGL-HAFKAGQDETGQERKLRRRKLYK 93
GM +L I H +L + N L+ S ++I DFGL A +D E L+ +
Sbjct: 109 GMRYLESKRFI-HRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFAWC 167
Query: 94 APELLRQPHLPRGTQKGDVYSFGLVLYEVI--GRQGPWGHLRMTDEEIITSV-TQGSGL- 149
APE LR + DV+ FG+ L+E+ G + PW L +I+ + +G L
Sbjct: 168 APESLR--TR-TFSHASDVWMFGVTLWEMFTYGEE-PWAGLS--GSQILKKIDKEGERLE 221
Query: 150 RPDTSSLDCAPSIIACMRTCWEEDPELRPDLRFVHHKLKE 189
RP+ C I M CW +P RP + L E
Sbjct: 222 RPE----ACPQDIYNVMLQCWAHNPADRPTFAALREFLPE 257
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 61.9 bits (150), Expect = 8e-11
Identities = 41/158 (25%), Positives = 76/158 (48%), Gaps = 11/158 (6%)
Query: 33 SVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKL- 91
S+GM +L + H +L + N L+ ++ +I+DFGL D + R + L
Sbjct: 105 SMGMKYLEGKNFV-HRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKWPLK 163
Query: 92 YKAPELLRQPHLPRGTQKGDVYSFGLVLYEVIGR-QGPWGHLRMTDEEIITSVTQGSGLR 150
+ APE + + + + + DV+S+G+ ++E Q P+ +M E+++ + QG L
Sbjct: 164 WYAPECI---NFRKFSSRSDVWSYGITMWEAFSYGQKPYK--KMKGPEVMSFIEQGKRLD 218
Query: 151 PDTSSLDCAPSIIACMRTCWEEDPELRPDLRFVHHKLK 188
C P + A M+ CW E RP+ V +++
Sbjct: 219 CPAE---CPPEMYALMKDCWIYKWEDRPNFAKVEERMR 253
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 61.5 bits (149), Expect = 1e-10
Identities = 42/151 (27%), Positives = 77/151 (50%), Gaps = 21/151 (13%)
Query: 35 GMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAF-----KAGQDETGQERKLRRR 89
GM +L D + H +L + N L++S V +++DFGL +A G + +R
Sbjct: 118 GMKYLSDMGYV-HRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIR-- 174
Query: 90 KLYKAPELLRQPHLPRGTQKGDVYSFGLVLYEVI--GRQGPWGHLRMTDEEIITSVTQGS 147
+ APE + + T DV+S+G+V++EV+ G + W M+++++I ++ +G
Sbjct: 175 --WTAPEAIA---YRKFTSASDVWSYGIVMWEVMSYGERPYW---EMSNQDVIKAIEEGY 226
Query: 148 GLRPDTSSLDCAPSIIACMRTCWEEDPELRP 178
L +DC ++ M CW++D RP
Sbjct: 227 RLPA---PMDCPAALHQLMLDCWQKDRNERP 254
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 2e-10
Identities = 44/170 (25%), Positives = 85/170 (50%), Gaps = 18/170 (10%)
Query: 26 ISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLH--AFKAGQDETGQE 83
+ + + + GM++L + H +L + NCL+ + +++I DFG+ + G
Sbjct: 126 LHIASQIASGMVYLASQHFV-HRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGH 184
Query: 84 RKLRRRKLYKAPELLRQPHLPRGTQKGDVYSFGLVLYEVI--GRQGPWGHLRMTDEEIIT 141
L R + PE + T + DV+SFG++L+E+ G+Q PW ++++ E+I
Sbjct: 185 TMLPIR--WMPPESIMYRKF---TTESDVWSFGVILWEIFTYGKQ-PW--FQLSNTEVIE 236
Query: 142 SVTQGSGL-RPDTSSLDCAPSIIACMRTCWEEDPELRPDLRFVHHKLKEM 190
+TQG L RP C + M CW+ +P+ R +++ ++ L +
Sbjct: 237 CITQGRVLERPRV----CPKEVYDIMLGCWQREPQQRLNIKEIYKILHAL 282
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 60.9 bits (148), Expect = 2e-10
Identities = 46/180 (25%), Positives = 76/180 (42%), Gaps = 42/180 (23%)
Query: 26 ISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERK 85
+ + + GM +L S H +L + NCL+ ++I+DFGL
Sbjct: 127 LHIAIQIAAGMEYL-SSHHFVHRDLAARNCLVGEGLTVKISDFGL--------------- 170
Query: 86 LRRRKLYKAPELLRQPH---LP------------RGTQKGDVYSFGLVLYEVI--GRQGP 128
R +Y A + R LP + T + D++SFG+VL+E+ G Q
Sbjct: 171 --SRDIYSA-DYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPY 227
Query: 129 WGHLRMTDEEIITSVTQGSGLRPDTSSLDCAPSIIACMRTCWEEDPELRPDLRFVHHKLK 188
+G +++E+I + L DC + A M CW E P RP + +H +L+
Sbjct: 228 YGF---SNQEVIEMIRSRQLL---PCPEDCPARVYALMIECWNEIPARRPRFKDIHTRLR 281
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 2e-10
Identities = 45/161 (27%), Positives = 77/161 (47%), Gaps = 17/161 (10%)
Query: 33 SVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKA-GQDETGQERKLRRR-- 89
S+GM +L ++ + H +L + N L+ ++ +I+DFGL KA G DE + K +
Sbjct: 105 SMGMKYLEETNFV-HRDLAARNVLLVTQHYAKISDFGLS--KALGADENYYKAKTHGKWP 161
Query: 90 -KLYKAPELLRQPHLPRGTQKGDVYSFGLVLYEVIGR-QGPWGHLRMTDEEIITSVTQGS 147
K Y APE + + + + K DV+SFG++++E Q P+ M E+ + G
Sbjct: 162 VKWY-APECM---NYYKFSSKSDVWSFGVLMWEAFSYGQKPY--KGMKGNEVTQMIESGE 215
Query: 148 GLRPDTSSLDCAPSIIACMRTCWEEDPELRPDLRFVHHKLK 188
+ C P + M+ CW + RP V +L+
Sbjct: 216 RM---ECPQRCPPEMYDLMKLCWTYGVDERPGFAVVELRLR 253
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 60.3 bits (146), Expect = 3e-10
Identities = 55/193 (28%), Positives = 95/193 (49%), Gaps = 20/193 (10%)
Query: 3 RSVRETEAITPNPLSPFNIPIGSISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWV 62
RS R+ E +TP+P + + ++ G++HLH + I H +L NCL+ +
Sbjct: 87 RSCRKAELMTPDPTT-----LQRMACEIAL--GLLHLHKNNFI-HSDLALRNCLLTADLT 138
Query: 63 LQIADFGLHAFKAGQDETGQERKLRRRKLYKAPELLRQPH----LPRGTQKGDVYSFGLV 118
++I D+GL K +D +L + APEL+ + H + T++ +V+S G+
Sbjct: 139 VKIGDYGLSHNKYKEDYYVTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVT 198
Query: 119 LYEV--IGRQGPWGHLRMTDEEIITSVTQGSGLRPDTSSLDCAPS--IIACMRTCWEEDP 174
++E+ +G Q P+ HL +DE+++T + L+ L S M+ CW + P
Sbjct: 199 IWELFELGSQ-PYRHL--SDEQVLTYTVREQQLKLPKPRLKLPLSDRWYEVMQFCWLQ-P 254
Query: 175 ELRPDLRFVHHKL 187
E RP VH L
Sbjct: 255 EQRPSAEEVHLLL 267
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 59.7 bits (144), Expect = 4e-10
Identities = 42/143 (29%), Positives = 72/143 (50%), Gaps = 8/143 (5%)
Query: 47 HGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKAPELLRQPHLPRG 106
H +LR++N L+ V +IADFGL + T ++ K + APE R
Sbjct: 125 HRDLRAANILVGDNLVCKIADFGLARLIEDNEYTARQGAKFPIK-WTAPE---AALYGRF 180
Query: 107 TQKGDVYSFGLVLYEVIGRQGPWGHLRMTDEEIITSVTQGSGLRPDTSSLDCAPSIIACM 166
T K DV+SFG++L E++ + G + M + E++ V +G + C S+ M
Sbjct: 181 TIKSDVWSFGILLTELVTK-GRVPYPGMVNREVLEQVERGYRM---PCPQGCPESLHELM 236
Query: 167 RTCWEEDPELRPDLRFVHHKLKE 189
+ CW++DP+ RP ++ L++
Sbjct: 237 KLCWKKDPDERPTFEYIQSFLED 259
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 4e-10
Identities = 47/163 (28%), Positives = 85/163 (52%), Gaps = 24/163 (14%)
Query: 35 GMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQD--ETGQERKLRRRKL- 91
GM +L+ + + H +L + NC++ + ++I DFG+ +D ET RK + L
Sbjct: 131 GMAYLNAKKFV-HRDLAARNCMVAHDFTVKIGDFGM-----TRDIYETDYYRKGGKGLLP 184
Query: 92 --YKAPELLRQPHLPRGTQKGDVYSFGLVLYEV--IGRQGPWGHLRMTDEEIITSVTQGS 147
+ APE L+ T D++SFG+VL+E+ + Q G +++E+++ V G
Sbjct: 185 VRWMAPESLKDGVF---TTSSDMWSFGVVLWEITSLAEQPYQG---LSNEQVLKFVMDGG 238
Query: 148 GL-RPDTSSLDCAPSIIACMRTCWEEDPELRPDLRFVHHKLKE 189
L +PD +C + MR CW+ +P++RP + + LK+
Sbjct: 239 YLDQPD----NCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKD 277
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 59.4 bits (144), Expect = 5e-10
Identities = 47/182 (25%), Positives = 86/182 (47%), Gaps = 20/182 (10%)
Query: 1 MRRSVRETEAITPNPLSPFNIPIGSISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSR 60
+R + + E + P PLS +++ T ++GM HL ++ + H +L + NCL+ S+
Sbjct: 99 LRATKSKDEKLKPPPLSTKQK----VALCTQIALGMDHLSNARFV-HRDLAARNCLVSSQ 153
Query: 61 WVLQIADFGLHAFKAGQDETGQERKLRRRKL----YKAPELLRQPHLPRGTQKGDVYSFG 116
++++ L +D E R L + APE +++ + K DV+SFG
Sbjct: 154 REVKVSLLSL-----SKDVYNSEYYKLRNALIPLRWLAPEAVQEDDF---STKSDVWSFG 205
Query: 117 LVLYEVIGRQGPWGHLRMTDEEIITSVTQGSGLRPDTSSLDCAPSIIACMRTCWEEDPEL 176
++++EV QG ++DEE++ + G P C + M CW +P+
Sbjct: 206 VLMWEVF-TQGELPFYGLSDEEVLNRLQAGKLELPVPEG--CPSRLYKLMTRCWAVNPKD 262
Query: 177 RP 178
RP
Sbjct: 263 RP 264
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 58.6 bits (142), Expect = 9e-10
Identities = 43/155 (27%), Positives = 76/155 (49%), Gaps = 22/155 (14%)
Query: 35 GMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGL------HAFKAGQDETGQERKLRR 88
GM +L + + H +L + NC++D + +++ADFGL + + + TG + ++
Sbjct: 110 GMEYLASKKFV-HRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVK- 167
Query: 89 RKLYKAPELLRQPHLPRGTQKGDVYSFGLVLYEVIGRQG-PWGHLRMTDEEIITSVTQGS 147
+ A E L+ + T K DV+SFG++L+E++ R P+ + D I + QG
Sbjct: 168 ---WMALESLQT---QKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFD--ITVYLLQGR 219
Query: 148 GLR-PDTSSLDCAPSIIACMRTCWEEDPELRPDLR 181
L P+ C + M +CW PE+RP
Sbjct: 220 RLLQPEY----CPDPLYEVMLSCWHPKPEMRPTFS 250
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 1e-09
Identities = 43/159 (27%), Positives = 78/159 (49%), Gaps = 15/159 (9%)
Query: 32 ASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKL 91
A+ GM +L I H +L + NCL+ VL+I+DFG+ + Q++ G +++
Sbjct: 102 AAAGMAYLESKNCI-HRDLAARNCLVGENNVLKISDFGM----SRQEDDGIYSSSGLKQI 156
Query: 92 ---YKAPELLRQPHLPRGTQKGDVYSFGLVLYEVIGRQGPWGHLRMTDEEIITSVTQGSG 148
+ APE L + R + + DV+S+G++L+E G + MT+++ V +G
Sbjct: 157 PIKWTAPEAL---NYGRYSSESDVWSYGILLWETFS-LGVCPYPGMTNQQAREQVEKGYR 212
Query: 149 LRPDTSSLDCAPSIIACMRTCWEEDPELRPDLRFVHHKL 187
+ + C + M+ CW+ PE RP + +L
Sbjct: 213 M---SCPQKCPDDVYKVMQRCWDYKPENRPKFSELQKEL 248
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 1e-09
Identities = 44/158 (27%), Positives = 78/158 (49%), Gaps = 23/158 (14%)
Query: 33 SVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAF-----KAGQDETGQERKLR 87
+ GM +L D + H +L + N L++S +++DFGL + +G + +R
Sbjct: 117 AAGMKYLSDMNYV-HRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIR 175
Query: 88 RRKLYKAPELLRQPHLPRGTQKGDVYSFGLVLYEVI--GRQGPWGHLRMTDEEIITSVTQ 145
+ APE + T DV+SFG+V++EV+ G + W M++ E++ ++
Sbjct: 176 ----WTAPEAIAYRKF---TSASDVWSFGIVMWEVMSFGERPYW---DMSNHEVMKAIND 225
Query: 146 GSGLRPDTSSLDCAPSIIACMRTCWEEDPELRPDLRFV 183
G L + +DC ++ M CW++D RP RFV
Sbjct: 226 GFRL---PAPMDCPSAVYQLMLQCWQQDRARRP--RFV 258
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 1e-09
Identities = 50/180 (27%), Positives = 82/180 (45%), Gaps = 14/180 (7%)
Query: 32 ASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKL 91
+ GM +L + + I H +L + N L+ +IADFGL G++ ++ R
Sbjct: 128 VATGMQYLSEKQFI-HRDLAARNVLVGENLASKIADFGL---SRGEEVYVKKTMGRLPVR 183
Query: 92 YKAPELLRQPHLPRGTQKGDVYSFGLVLYEVIGRQGPWGHLRMTDEEIITSVTQGSGLRP 151
+ A E L T K DV+SFG++L+E++ G + MT E+ + QG +
Sbjct: 184 WMAIESLNYSVY---TTKSDVWSFGVLLWEIVSLGGT-PYCGMTCAELYEKLPQGYRME- 238
Query: 152 DTSSLDCAPSIIACMRTCWEEDPELRPDLRFVHHKLKEMNAGLKANIFDNMLAIMEKYAF 211
+C + MR CW + P RP + +L M KA + NM A+ E + +
Sbjct: 239 --KPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLEARKAYV--NM-ALFENFTY 293
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 58.0 bits (140), Expect = 2e-09
Identities = 44/153 (28%), Positives = 78/153 (50%), Gaps = 23/153 (15%)
Query: 35 GMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAF--KAGQDET-----GQERKLR 87
GM +L + + H +L + N L++S V +++DFGL F D T G + +R
Sbjct: 118 GMKYLSEMNYV-HRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIR 176
Query: 88 RRKLYKAPELLRQPHLPRGTQKGDVYSFGLVLYEVI--GRQGPWGHLRMTDEEIITSVTQ 145
+ APE + + T DV+S+G+V++EV+ G + W M+++++I ++ Q
Sbjct: 177 ----WTAPEAIA---YRKFTSASDVWSYGIVMWEVMSYGERPYWD---MSNQDVINAIEQ 226
Query: 146 GSGLRPDTSSLDCAPSIIACMRTCWEEDPELRP 178
L P +DC ++ M CW++D RP
Sbjct: 227 DYRLPP---PMDCPTALHQLMLDCWQKDRNARP 256
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 2e-09
Identities = 45/161 (27%), Positives = 76/161 (47%), Gaps = 10/161 (6%)
Query: 30 TTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRR 89
T + GM +L I H +L + NC+++ + +ADFGL D Q R +
Sbjct: 119 TDIASGMEYLSSKSFI-HRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMP 177
Query: 90 KLYKAPELLRQPHLPRGTQKGDVYSFGLVLYEVIGR-QGPWGHLRMTDEEIITSVTQGSG 148
+ A E L T K DV+SFG+ ++E+ R Q P+ + + EI + QG+
Sbjct: 178 VKWIAIESLADRVY---TTKSDVWSFGVTMWEIATRGQTPYPGVE--NSEIYDYLRQGNR 232
Query: 149 LRPDTSSLDCAPSIIACMRTCWEEDPELRPDLRFVHHKLKE 189
L+ LD + + M +CW +P+ RP + +L++
Sbjct: 233 LKQPPDCLDG---LYSLMSSCWLLNPKDRPSFETLRCELEK 270
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 56.9 bits (137), Expect = 4e-09
Identities = 49/182 (26%), Positives = 86/182 (47%), Gaps = 20/182 (10%)
Query: 20 NIPIGSIS----VNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGL-HAFK 74
NIP SI+ + + GM +L + H +L + NCL+ + + ++IADFG+
Sbjct: 122 NIPSVSIANLLYMAVQIASGMKYLASLNFV-HRDLATRNCLVGNHYTIKIADFGMSRNLY 180
Query: 75 AGQDETGQERKLRRRKLYKAPELLRQPHLPRGTQKGDVYSFGLVLYEV--IGRQGPWGHL 132
+G Q R + + +L L + T DV++FG+ L+E+ + ++ P+ L
Sbjct: 181 SGDYYRIQGRAVLPIRWMAWESIL----LGKFTTASDVWAFGVTLWEMFTLCKEQPYSLL 236
Query: 133 RMTDEEIITSV-----TQGSGLRPDTSSLDCAPSIIACMRTCWEEDPELRPDLRFVHHKL 187
+DE++I + QG + + L C + M CW D + RP +HH L
Sbjct: 237 --SDEQVIENTGEFFRNQGRQIYLSQTPL-CPSPVFKLMMRCWSRDIKDRPTFNKIHHFL 293
Query: 188 KE 189
+E
Sbjct: 294 RE 295
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 56.5 bits (136), Expect = 6e-09
Identities = 44/160 (27%), Positives = 83/160 (51%), Gaps = 12/160 (7%)
Query: 33 SVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLY 92
S GM +L + +++ H +L + N L+ ++I+DFGL +D + K R +
Sbjct: 137 SRGMQYLAEMKLV-HRDLAARNVLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKW 195
Query: 93 KAPELLRQPHLPRGTQKGDVYSFGLVLYEVIGRQG-PWGHLRMTDEEIITSVTQGSGL-R 150
A E L H+ T + DV+SFG++L+E++ G P+ + E + + G + R
Sbjct: 196 MAIESLFD-HIY--TTQSDVWSFGVLLWEIVTLGGNPYPGI--APERLFNLLKTGYRMER 250
Query: 151 PDTSSLDCAPSIIACMRTCWEEDPELRPDLRFVHHKLKEM 190
P+ +C+ + M TCW+++P+ RP + +L++M
Sbjct: 251 PE----NCSEEMYNLMLTCWKQEPDKRPTFADISKELEKM 286
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 1e-08
Identities = 47/156 (30%), Positives = 72/156 (46%), Gaps = 11/156 (7%)
Query: 35 GMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKA 94
GM +L + I H +L + N L+ +V +IADFGL GQ+ ++ R + A
Sbjct: 136 GMDYLSQKQFI-HRDLAARNILVGENYVAKIADFGL---SRGQEVYVKKTMGRLPVRWMA 191
Query: 95 PELLRQPHLPRGTQKGDVYSFGLVLYEVIGRQGPWGHLRMTDEEIITSVTQGSGLRPDTS 154
E L + T DV+S+G++L+E++ G + MT E+ + QG L
Sbjct: 192 IESL---NYSVYTTNSDVWSYGVLLWEIVSLGGT-PYCGMTCAELYEKLPQGYRLE---K 244
Query: 155 SLDCAPSIIACMRTCWEEDPELRPDLRFVHHKLKEM 190
L+C + MR CW E P RP + L M
Sbjct: 245 PLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRM 280
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 55.3 bits (133), Expect = 1e-08
Identities = 45/163 (27%), Positives = 72/163 (44%), Gaps = 25/163 (15%)
Query: 35 GMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGL-HAFKAGQDETGQERKLRRRKLYK 93
GM +L + + H +L + N L++S ++I DFGL A + ++ + L +
Sbjct: 121 GMDYLGSRQYV-HRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWY 179
Query: 94 APELLRQPHLPRGTQKGDVYSFGLVLYEVI--------------GRQGPWGHLRMTDEEI 139
APE L Q + DV+SFG+ LYE++ GP H +MT +
Sbjct: 180 APECLIQSKFYIAS---DVWSFGVTLYELLTYCDSESSPMTLFLKMIGP-THGQMTVTRL 235
Query: 140 ITSVTQGSGL-RPDTSSLDCAPSIIACMRTCWEEDPELRPDLR 181
+ + +G L RP +C + MR CWE P R +
Sbjct: 236 VRVLEEGKRLPRPP----NCPEEVYQLMRKCWEFQPSKRTTFQ 274
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 55.2 bits (133), Expect = 1e-08
Identities = 36/150 (24%), Positives = 71/150 (47%), Gaps = 14/150 (9%)
Query: 35 GMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKA 94
G+ +LH I+ H +L++ N L+D+ + +I+DFG+ + Q ++ + A
Sbjct: 120 GLAYLHSKGIL-HRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSVFWMA 178
Query: 95 PELLRQPHLPRG-TQKGDVYSFGLVLYEVIGRQGPWGHLRMTDEEI-----ITSVTQGSG 148
PE++ +G + K D++S G V+ E+ + PW +E I + +
Sbjct: 179 PEVIHSYS--QGYSAKVDIWSLGCVVLEMFAGRRPWS----DEEAIAAMFKLGNKRSAPP 232
Query: 149 LRPDTSSLDCAPSIIACMRTCWEEDPELRP 178
+ PD S +P + + C+ +P+ RP
Sbjct: 233 IPPDVSMN-LSPVALDFLNACFTINPDNRP 261
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 56.0 bits (135), Expect = 1e-08
Identities = 47/169 (27%), Positives = 78/169 (46%), Gaps = 39/169 (23%)
Query: 26 ISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERK 85
IS + + GM L + I H +L + N L+ V++I DFGL
Sbjct: 176 ISYSFQVARGMEFLASRKCI-HRDLAARNILLSENNVVKICDFGL--------------- 219
Query: 86 LRRRKLYKAPELLRQ--PHLPRG------------TQKGDVYSFGLVLYEVIGRQG-PWG 130
R +YK P+ +R+ LP T + DV+SFG++L+E+ P+
Sbjct: 220 --ARDIYKDPDYVRKGDARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYP 277
Query: 131 HLRMTDEEIITSVTQGSGLR-PDTSSLDCAPSIIACMRTCWEEDPELRP 178
+++ DEE + +G+ +R P+ ++ P I + M CW +PE RP
Sbjct: 278 GVQI-DEEFCRRLKEGTRMRAPEYAT----PEIYSIMLDCWHNNPEDRP 321
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 55.5 bits (134), Expect = 1e-08
Identities = 44/167 (26%), Positives = 75/167 (44%), Gaps = 18/167 (10%)
Query: 33 SVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLH--AFKAGQDETG--QERKLRR 88
+ GM +LH +I H ++ + NC+ID ++I D L F G + R ++
Sbjct: 127 ACGMSYLHKRGVI-HKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGDNENRPVK- 184
Query: 89 RKLYKAPELLRQPHLPRGTQKGDVYSFGLVLYEVIG-RQGPWGHLRMTDEEIITSVTQGS 147
+ A E L + DV+SFG++L+E++ Q P ++ + E+ + G
Sbjct: 185 ---WMALESLVNKEY---SSASDVWSFGVLLWELMTLGQTP--YVEIDPFEMAAYLKDGY 236
Query: 148 GLRPDTSSLDCAPSIIACMRTCWEEDPELRPDLRFVHHKLKEMNAGL 194
L ++C + A M CW DPE RP + L + +A L
Sbjct: 237 RL---AQPINCPDELFAVMACCWALDPEERPSFSQLVQCLTDFHAQL 280
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 55.1 bits (132), Expect = 2e-08
Identities = 42/143 (29%), Positives = 71/143 (49%), Gaps = 8/143 (5%)
Query: 47 HGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKAPELLRQPHLPRG 106
H +LR++N L+ V ++ADFGL + T ++ K + APE R
Sbjct: 125 HRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIK-WTAPE---AALYGRF 180
Query: 107 TQKGDVYSFGLVLYEVIGRQGPWGHLRMTDEEIITSVTQGSGLRPDTSSLDCAPSIIACM 166
T K DV+SFG++L E + +G + M + E++ V +G + P +C S+ M
Sbjct: 181 TIKSDVWSFGILLTE-LTTKGRVPYPGMVNREVLDQVERGYRM-PCPP--ECPESLHDLM 236
Query: 167 RTCWEEDPELRPDLRFVHHKLKE 189
CW ++PE RP ++ L++
Sbjct: 237 CQCWRKEPEERPTFEYLQAFLED 259
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 54.7 bits (132), Expect = 2e-08
Identities = 43/174 (24%), Positives = 73/174 (41%), Gaps = 21/174 (12%)
Query: 19 FNIPIGSISVNTTASV------GMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHA 72
+ P G + A+V G+ +LH + I H ++++ N L+ ++IADFG+ A
Sbjct: 92 SSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQI-HRDIKAGNILLGEDGSVKIADFGVSA 150
Query: 73 FKAGQDETGQERKLRRRK------LYKAPELLRQPHLPRG-TQKGDVYSFGLVLYEVIGR 125
A G +R + RK + APE++ Q H G K D++SFG+ E+
Sbjct: 151 SLA----DGGDRTRKVRKTFVGTPCWMAPEVMEQVH---GYDFKADIWSFGITAIELATG 203
Query: 126 QGPWGHLRMTDEEIITSVTQGSGLRPDTSSLDCAPSIIACMRTCWEEDPELRPD 179
P+ ++T L + S + C ++DP RP
Sbjct: 204 AAPYSKYPPMKVLMLTLQNDPPSLETGADYKKYSKSFRKMISLCLQKDPSKRPT 257
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 54.5 bits (131), Expect = 2e-08
Identities = 45/175 (25%), Positives = 81/175 (46%), Gaps = 15/175 (8%)
Query: 18 PFNIPIGS-ISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHA--FK 74
PF +P+ + + + GM +L I H +L + NC+++ + +ADFGL +
Sbjct: 107 PFTLPLQTLVRFMIDIASGMEYLSSKNFI-HRDLAARNCMLNENMTVCVADFGLSKKIYS 165
Query: 75 AGQDETGQERKLRRRKLYKAPELLRQPHLPRGTQKGDVYSFGLVLYEVIGR-QGPWGHLR 133
G KL + L A E L T DV++FG+ ++E++ R Q P+ +
Sbjct: 166 GDYYRQGCASKLPVKWL--ALESLADNVY---TTHSDVWAFGVTMWEIMTRGQTPYAGVE 220
Query: 134 MTDEEIITSVTQGSGLRPDTSSLDCAPSIIACMRTCWEEDPELRPDLRFVHHKLK 188
+ EI + +G+ L+ DC + M CW +P+ RP + + +L+
Sbjct: 221 --NSEIYNYLIKGNRLK---QPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLE 270
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 4e-08
Identities = 40/155 (25%), Positives = 70/155 (45%), Gaps = 8/155 (5%)
Query: 38 HLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKAPEL 97
H+H ++ H +++ +N I + V+++ D GL F + + T L Y +PE
Sbjct: 121 HMHSRRVM-HRDIKPANVFITATGVVKLGDLGLGRFFSSK--TTAAHSLVGTPYYMSPER 177
Query: 98 LRQPHLPRGTQKGDVYSFGLVLYEVIGRQGPWGHLRMTDEEIITSVTQGSGLRPDTSSLD 157
+ H K D++S G +LYE+ Q P+ +M + + Q P S
Sbjct: 178 I---HENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCD--YPPLPSDH 232
Query: 158 CAPSIIACMRTCWEEDPELRPDLRFVHHKLKEMNA 192
+ + + C DPE RPD+ +V+ K M+A
Sbjct: 233 YSEELRQLVNMCINPDPEKRPDITYVYDVAKRMHA 267
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 53.6 bits (129), Expect = 6e-08
Identities = 44/169 (26%), Positives = 69/169 (40%), Gaps = 24/169 (14%)
Query: 35 GMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLY-K 93
GM +L + H +L + N L++S ++I DFGL E + R+ ++
Sbjct: 120 GMEYLGSKRYV-HRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGESPIFWY 178
Query: 94 APELLRQPHLPRGTQKGDVYSFGLVLYEV-----IGRQGPWGHLRMTDEE---------I 139
APE L + + DV+SFG+VLYE+ P +RM + +
Sbjct: 179 APESLTESKFSVAS---DVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHL 235
Query: 140 ITSVTQGSGL-RPDTSSLDCAPSIIACMRTCWEEDPELRPDLRFVHHKL 187
I + L P C I A M+ CW DP RP + ++
Sbjct: 236 IELLKNNGRLPAPP----GCPAEIYAIMKECWNNDPSQRPSFSELALQV 280
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 6e-08
Identities = 44/158 (27%), Positives = 75/158 (47%), Gaps = 12/158 (7%)
Query: 33 SVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLY 92
+ GM +L S H +L + N LI + ++I+D GL D + K +
Sbjct: 134 AAGMEYL-SSHFFVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKSLLPIRW 192
Query: 93 KAPELLRQPHLPRGTQKGDVYSFGLVLYEVI--GRQGPWGHLRMTDEEIITSVTQGSGLR 150
PE + + + D++SFG+VL+E+ G Q +G +++E+I V + L
Sbjct: 193 MPPEAIM---YGKFSSDSDIWSFGVVLWEIFSFGLQPYYG---FSNQEVIEMVRKRQLL- 245
Query: 151 PDTSSLDCAPSIIACMRTCWEEDPELRPDLRFVHHKLK 188
S DC P + + M CW+E P RP + +H +L+
Sbjct: 246 --PCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLR 281
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 53.0 bits (127), Expect = 7e-08
Identities = 42/167 (25%), Positives = 73/167 (43%), Gaps = 31/167 (18%)
Query: 35 GMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKL-------- 86
GM +L + + H L + L++S V +I+ F QE K
Sbjct: 119 GMKYLSEMGYV-HKGLAAHKVLVNSDLVCKISGFR----------RLQEDKSEAIYTTMS 167
Query: 87 -RRRKLYKAPELLRQPHLPRGTQKGDVYSFGLVLYEVI--GRQGPWGHLRMTDEEIITSV 143
+ L+ APE ++ H + DV+SFG+V++EV+ G + W M+ +++I +V
Sbjct: 168 GKSPVLWAAPEAIQYHHF---SSASDVWSFGIVMWEVMSYGERPYWD---MSGQDVIKAV 221
Query: 144 TQGSGLRPDTSSLDCAPSIIACMRTCWEEDPELRPDLRFVHHKLKEM 190
G L +C + M CW+++ RP +H L +M
Sbjct: 222 EDGFRLPA---PRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSKM 265
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 53.0 bits (127), Expect = 8e-08
Identities = 45/180 (25%), Positives = 79/180 (43%), Gaps = 32/180 (17%)
Query: 26 ISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERK 85
I + T + GM +L + H +L + NCL+ + ++IADFG+ R
Sbjct: 133 IFMATQIASGMKYLSSLNFV-HRDLATRNCLVGKNYTIKIADFGM------------SRN 179
Query: 86 LRRRKLYKAPELLRQP---------HLPRGTQKGDVYSFGLVLYEVIG--RQGPWGHLRM 134
L Y+ P L + T DV++FG+ L+E++ ++ P+ L
Sbjct: 180 LYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQL-- 237
Query: 135 TDEEIITSV-----TQGSGLRPDTSSLDCAPSIIACMRTCWEEDPELRPDLRFVHHKLKE 189
+DE++I + QG + +L C S+ M +CW + + RP + +H L E
Sbjct: 238 SDEQVIENTGEFFRDQGRQVYLPKPAL-CPDSLYKLMLSCWRRNAKERPSFQEIHATLLE 296
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 52.4 bits (125), Expect = 1e-07
Identities = 47/161 (29%), Positives = 73/161 (45%), Gaps = 11/161 (6%)
Query: 30 TTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRR 89
+ GM +L + I H +L + N L+ +V +IADFGL GQ+ ++ R
Sbjct: 119 ADVARGMDYLSQKQFI-HRDLAARNILVGENYVAKIADFGL---SRGQEVYVKKTMGRLP 174
Query: 90 KLYKAPELLRQPHLPRGTQKGDVYSFGLVLYEVIGRQGPWGHLRMTDEEIITSVTQGSGL 149
+ A E L + T DV+S+G++L+E++ G + MT E+ + QG L
Sbjct: 175 VRWMAIESL---NYSVYTTNSDVWSYGVLLWEIVSLGGT-PYCGMTCAELYEKLPQGYRL 230
Query: 150 RPDTSSLDCAPSIIACMRTCWEEDPELRPDLRFVHHKLKEM 190
L+C + MR CW E P RP + L M
Sbjct: 231 E---KPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRM 268
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 52.2 bits (125), Expect = 1e-07
Identities = 49/163 (30%), Positives = 77/163 (47%), Gaps = 18/163 (11%)
Query: 25 SISVNTTASV--GMIHLHDSEIISHGNLRSSNCLIDSR-WVLQIADFG----LHAFKAGQ 77
++ +N T + G+ +LH+++II H +++ +N LIDS L+IADFG L A G
Sbjct: 103 AVIINYTEQLLRGLSYLHENQII-HRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGA 161
Query: 78 DE-TGQERKLRRRKLYKAPELLRQPHLPRGTQKGDVYSFGLVLYEVIGRQGPWGHLRMTD 136
E GQ L + APE+LR R DV+S G V+ E+ + PW + ++
Sbjct: 162 GEFQGQ---LLGTIAFMAPEVLRGEQYGRSC---DVWSVGCVIIEMATAKPPWNAEKHSN 215
Query: 137 E-EIITSVTQGSGLRPDTSSLDCAPSIIACMRTCWEEDPELRP 178
+I + + L +P + C E PE RP
Sbjct: 216 HLALIFKIASATTAPSIPEHL--SPGLRDVTLRCLELQPEDRP 256
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 52.0 bits (125), Expect = 2e-07
Identities = 38/163 (23%), Positives = 76/163 (46%), Gaps = 22/163 (13%)
Query: 35 GMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGL-HAFKAGQDE---TGQERKLRRRK 90
GM +L + ++ H +L + N L+ + ++I DFGL + E G + ++
Sbjct: 121 GMSYLEEKRLV-HRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIK--- 176
Query: 91 LYKAPELLRQPHLPRGTQKGDVYSFGLVLYEVI--GRQGPWGHLRMTDEEIITSVTQGSG 148
+ A E + T K DV+S+G+ ++E++ G + P+ + EI + +G
Sbjct: 177 -WMALESI---LHRIYTHKSDVWSYGVTVWELMTFGAK-PYEGIPAV--EIPDLLEKGER 229
Query: 149 L-RPDTSSLDCAPSIIACMRTCWEEDPELRPDLRFVHHKLKEM 190
L +P ++D + + CW D E RP + + ++ +M
Sbjct: 230 LPQPPICTID----VYMVLVKCWMIDAESRPTFKELINEFSKM 268
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 2e-07
Identities = 44/160 (27%), Positives = 72/160 (45%), Gaps = 39/160 (24%)
Query: 35 GMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKA 94
GM L + I H +L + N L+ V++I DFGL R +YK
Sbjct: 191 GMEFLASRKCI-HRDLAARNILLSENNVVKICDFGL-----------------ARDIYKD 232
Query: 95 PELLRQ--PHLPRG------------TQKGDVYSFGLVLYEVIGR-QGPWGHLRMTDEEI 139
P+ +R+ LP T + DV+SFG++L+E+ P+ +++ DEE
Sbjct: 233 PDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKI-DEEF 291
Query: 140 ITSVTQGSGLR-PDTSSLDCAPSIIACMRTCWEEDPELRP 178
+ +G+ +R PD ++ P + M CW +P RP
Sbjct: 292 CRRLKEGTRMRAPDYTT----PEMYQTMLDCWHGEPSQRP 327
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 51.5 bits (123), Expect = 3e-07
Identities = 47/175 (26%), Positives = 77/175 (44%), Gaps = 22/175 (12%)
Query: 26 ISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGL-HAFKAGQDETGQER 84
+ V + GM +L + H +L + NCL+ ++IADFG+ AG Q R
Sbjct: 141 LHVALQIASGMKYLSSLNFV-HRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGR 199
Query: 85 KLRRRKLYKAPELLRQPHLPRGTQKGDVYSFGLVLYEVIG--RQGPWGHLRMTDEEIITS 142
+ + +L + + T DV++FG+ L+E++ ++ P+G L TDE++I +
Sbjct: 200 AVLPIRWMAWECIL----MGKFTTASDVWAFGVTLWEILMLCKEQPYGEL--TDEQVIEN 253
Query: 143 V-----TQGSGL---RPDTSSLDCAPSIIACMRTCWEEDPELRPDLRFVHHKLKE 189
QG + RP C + M CW D RP +H L E
Sbjct: 254 AGEFFRDQGRQVYLFRPPP----CPQGLYELMLQCWSRDCRERPSFSDIHAFLTE 304
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 51.6 bits (124), Expect = 3e-07
Identities = 45/151 (29%), Positives = 69/151 (45%), Gaps = 16/151 (10%)
Query: 35 GMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKL--- 91
GM L + I H +L + N L+ V++IADFGL D RK +L
Sbjct: 144 GMEFLASKKCI-HRDLAARNVLVTEDHVMKIADFGLARDIHHID---YYRKTTNGRLPVK 199
Query: 92 YKAPELLRQPHLPRGTQKGDVYSFGLVLYEVIGRQG-PWGHLRMTDEEIITSVTQGSGLR 150
+ APE L T + DV+SFG++L+E+ G P+ + + EE+ + +G +
Sbjct: 200 WMAPEALFDRVY---THQSDVWSFGVLLWEIFTLGGSPYPGIPV--EELFKLLKEGYRME 254
Query: 151 PDTSSLDCAPSIIACMRTCWEEDPELRPDLR 181
+C + MR CW E P RP +
Sbjct: 255 K---PQNCTQELYHLMRDCWHEVPSQRPTFK 282
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 4e-07
Identities = 50/189 (26%), Positives = 87/189 (46%), Gaps = 43/189 (22%)
Query: 6 RETEAITPNPLSPFNIPIGSISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQI 65
+ET+ + +PL+ ++ S V + GM L + I H +L + N L+ V++I
Sbjct: 161 QETDDLWKSPLTMEDLICYSFQV----ARGMEFLASRKCI-HRDLAARNILLSENNVVKI 215
Query: 66 ADFGLHAFKAGQDETGQERKLRRRKLYKAPELLRQ--PHLPRG------------TQKGD 111
DFGL R +YK P+ +R+ LP T + D
Sbjct: 216 CDFGL-----------------ARDIYKDPDYVRKGSARLPLKWMAPESIFDKVYTTQSD 258
Query: 112 VYSFGLVLYEVIGR-QGPWGHLRMTDEEIITSVTQGSGLR-PDTSSLDCAPSIIACMRTC 169
V+SFG++L+E+ P+ +++ +EE + G+ +R P+ ++ P I M C
Sbjct: 259 VWSFGVLLWEIFSLGASPYPGVQI-NEEFCQRLKDGTRMRAPENAT----PEIYRIMLAC 313
Query: 170 WEEDPELRP 178
W+ DP+ RP
Sbjct: 314 WQGDPKERP 322
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 50.8 bits (122), Expect = 4e-07
Identities = 40/165 (24%), Positives = 67/165 (40%), Gaps = 20/165 (12%)
Query: 22 PIGSISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAF---KAGQD 78
+G I+V G+ +LH+ I H +++ SN L++SR +++ DFG+ +
Sbjct: 101 ILGKIAVAVLK--GLTYLHEKHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLAKT 158
Query: 79 ETGQERKLRRRKLYKAPELLRQPHLPRGTQKGDVYSFGLVLYEV-IGR--QGPWGHLRMT 135
G Y APE ++ + K D++S GL L E+ GR P
Sbjct: 159 FVGT-------SSYMAPERIQGNDY---SVKSDIWSLGLSLIELATGRFPYPPENDPPDG 208
Query: 136 DEEIITSVTQGSGLRPDTSSLDCAPSIIACMRTCWEEDPELRPDL 180
E++ + P S +P + C +DP RP
Sbjct: 209 IFELLQYIVNEPP--PRLPSGKFSPDFQDFVNLCLIKDPRERPSY 251
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 50.7 bits (121), Expect = 4e-07
Identities = 50/195 (25%), Positives = 85/195 (43%), Gaps = 24/195 (12%)
Query: 3 RSVRETEAITPNPLSPFNIPIGSISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWV 62
RS R A + S G++ LH ++ I H +L NC + +
Sbjct: 87 RSNRGMVAQMAQKDVLQRMACEVAS-------GLLWLHQADFI-HSDLALRNCQLTADLS 138
Query: 63 LQIADFGLHAFKAGQD--ETGQERKLRRRKLYKAPELLRQPH---LPRG-TQKGDVYSFG 116
++I D+GL + +D T + R + APEL+ LP+ T+K +++S G
Sbjct: 139 VKIGDYGLALEQYPEDYYITKDCHAVPLR--WLAPELVEIRGQDLLPKDQTKKSNIWSLG 196
Query: 117 LVLYEV--IGRQGPWGHLRMTDEEIITSVTQGSGLRPDTSSLDC--APSIIACMRTCWEE 172
+ ++E+ Q P+ L +DE+++ V + ++ LD + M+ CW
Sbjct: 197 VTMWELFTAADQ-PYPDL--SDEQVLKQVVREQDIKLPKPQLDLKYSDRWYEVMQFCW-L 252
Query: 173 DPELRPDLRFVHHKL 187
DPE RP VH L
Sbjct: 253 DPETRPTAEEVHELL 267
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 7e-07
Identities = 43/147 (29%), Positives = 67/147 (45%), Gaps = 8/147 (5%)
Query: 35 GMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKA 94
GM +L + I H +L + N L+ V++IADFGL D + R + A
Sbjct: 146 GMEYLASQKCI-HRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMA 204
Query: 95 PELLRQPHLPRGTQKGDVYSFGLVLYEVIGRQGPWGHLRMTDEEIITSVTQGSGLRPDTS 154
PE L T + DV+SFG++L+E+ G + + EE+ + +G R D
Sbjct: 205 PEALFDRVY---THQSDVWSFGVLLWEIF-TLGGSPYPGIPVEELFKLLKEGH--RMDKP 258
Query: 155 SLDCAPSIIACMRTCWEEDPELRPDLR 181
+ +C + MR CW P RP +
Sbjct: 259 A-NCTHELYMIMRECWHAVPSQRPTFK 284
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 49.7 bits (119), Expect = 8e-07
Identities = 43/161 (26%), Positives = 74/161 (45%), Gaps = 14/161 (8%)
Query: 35 GMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKA 94
+ H+H S+ I H +++ +N I + V+++ D GL F + +T L Y +
Sbjct: 118 ALEHMH-SKRIMHRDIKPANVFITATGVVKLGDLGLGRFFS--SKTTAAHSLVGTPYYMS 174
Query: 95 PELLRQPHLPRGTQ-KGDVYSFGLVLYEVIGRQGPWGHLRMTDEEIITSVTQG--SGLRP 151
PE + + G K D++S G +LYE+ Q P+ +M + + + L
Sbjct: 175 PERIHE----NGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEKCDYPPLPA 230
Query: 152 DTSSLDCAPSIIACMRTCWEEDPELRPDLRFVHHKLKEMNA 192
D S + + C+ DPE RPD+ +V KEM+A
Sbjct: 231 DHYSEELRDLVSRCINP----DPEKRPDISYVLQVAKEMHA 267
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 49.6 bits (118), Expect = 9e-07
Identities = 38/154 (24%), Positives = 70/154 (45%), Gaps = 8/154 (5%)
Query: 38 HLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKAPEL 97
H+H ++ H +++ +N I + V+++ D GL F + +T L Y +PE
Sbjct: 121 HMHSRRVM-HRDIKPANVFITATGVVKLGDLGLGRFFS--SKTTAAHSLVGTPYYMSPER 177
Query: 98 LRQPHLPRGTQKGDVYSFGLVLYEVIGRQGPWGHLRMTDEEIITSVTQGSGLRPDTSSLD 157
+ H K D++S G +LYE+ Q P+ +M + + Q P +
Sbjct: 178 I---HENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQCD--YPPLPTEH 232
Query: 158 CAPSIIACMRTCWEEDPELRPDLRFVHHKLKEMN 191
+ + + C DP+ RPD+ +VH K+M+
Sbjct: 233 YSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQMH 266
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 49.6 bits (118), Expect = 1e-06
Identities = 49/172 (28%), Positives = 76/172 (44%), Gaps = 16/172 (9%)
Query: 17 SPFNIPIGSISVNTTASV------GMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGL 70
+P +P +S S GM +L + I H +L + N L+ V++IADFGL
Sbjct: 128 NPTQVPEEQLSFKDLVSCAYQVARGMEYLASKKCI-HRDLAARNVLVTEDNVMKIADFGL 186
Query: 71 HAFKAGQDETGQERKLRRRKLYKAPELLRQPHLPRGTQKGDVYSFGLVLYEVIGRQG-PW 129
D + R + APE L T + DV+SFG++L+E+ G P+
Sbjct: 187 ARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIY---THQSDVWSFGVLLWEIFTLGGSPY 243
Query: 130 GHLRMTDEEIITSVTQGSGLRPDTSSLDCAPSIIACMRTCWEEDPELRPDLR 181
+ + EE+ + +G R D S +C + MR CW P RP +
Sbjct: 244 PGVPV--EELFKLLKEGH--RMDKPS-NCTNELYMMMRDCWHAVPSQRPTFK 290
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 1e-06
Identities = 47/167 (28%), Positives = 75/167 (44%), Gaps = 10/167 (5%)
Query: 35 GMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKA 94
GM +L I H +L + N L+ V++IADFGL D + R + A
Sbjct: 146 GMEYLESRRCI-HRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMA 204
Query: 95 PELLRQPHLPRGTQKGDVYSFGLVLYEVIGRQG-PWGHLRMTDEEIITSVTQGSGLRPDT 153
PE L T + DV+SFG++++E+ G P+ + + EE+ + +G R D
Sbjct: 205 PEALFDRVY---THQSDVWSFGILMWEIFTLGGSPYPGIPV--EELFKLLREGH--RMDK 257
Query: 154 SSLDCAPSIIACMRTCWEEDPELRPDLRFVHHKLKEMNAGLKANIFD 200
S +C + MR CW P RP + + L ++ A + D
Sbjct: 258 PS-NCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVLAAVSEEYLD 303
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 49.4 bits (118), Expect = 1e-06
Identities = 42/140 (30%), Positives = 63/140 (45%), Gaps = 20/140 (14%)
Query: 47 HGNLRSSNCLIDSRW---VLQIADFGLHAFKAGQDETGQE--RKLRRRKL---YKAPELL 98
H ++ + NCL+ + V +IADFG+ +D RK R L + PE
Sbjct: 139 HRDIAARNCLLTCKGPGRVAKIADFGM-----ARDIYRASYYRKGGRAMLPIKWMPPEAF 193
Query: 99 RQPHLPRGTQKGDVYSFGLVLYEVIGRQGPWGHLRMTDEEIITSVTQGSGLRPDTSSLDC 158
T K DV+SFG++L+E+ G + T++E++ VT G L P C
Sbjct: 194 LDGIF---TSKTDVWSFGVLLWEIFSL-GYMPYPGRTNQEVMEFVTGGGRLDPPKG---C 246
Query: 159 APSIIACMRTCWEEDPELRP 178
+ M CW+ PE RP
Sbjct: 247 PGPVYRIMTDCWQHTPEDRP 266
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 48.7 bits (117), Expect = 2e-06
Identities = 35/146 (23%), Positives = 65/146 (44%), Gaps = 14/146 (9%)
Query: 35 GMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRR-RKLYK 93
G+ +LH + II H +++++N L+ S +++ DFGL + Q + R +
Sbjct: 110 GLEYLHSNGII-HRDIKAANILLTSDGEVKLIDFGL----SAQLSDTKARNTMVGTPYWM 164
Query: 94 APELLRQ-PHLPRGTQKGDVYSFGLVLYEVIGRQGPWGHLRMTDEEIITSVTQGSGLRPD 152
APE++ P+ K D++S G+ E+ + P+ L + GLR
Sbjct: 165 APEVINGKPY----DYKADIWSLGITAIELAEGKPPYSELPPMKALFKIATNGPPGLRNP 220
Query: 153 TSSLDCAPSIIACMRTCWEEDPELRP 178
D + + C +++PE RP
Sbjct: 221 EKWSDEFKDFL---KKCLQKNPEKRP 243
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 48.7 bits (116), Expect = 2e-06
Identities = 38/148 (25%), Positives = 72/148 (48%), Gaps = 13/148 (8%)
Query: 35 GMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFG----LHAFKAGQDETGQERKLRRRK 90
G+ +LH+ II H +++ +N L+D++ ++I+DFG L A G L+
Sbjct: 118 GLNYLHNRGII-HRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSV 176
Query: 91 LYKAPELLRQPHLPRGTQKGDVYSFGLVLYEVIGRQGPWGHLRMTDEEIITSVTQGSGLR 150
+ APE+++Q T+K D++S G ++ E++ + P+ T + I + G
Sbjct: 177 FWMAPEVVKQTSY---TRKADIWSLGCLVVEMLTGKHPFP--DCTQLQAIFKI--GENAS 229
Query: 151 PDTSSLDCAPSIIACMRTCWEEDPELRP 178
P+ S + + I + +E D RP
Sbjct: 230 PEIPS-NISSEAIDFLEKTFEIDHNKRP 256
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 49.4 bits (118), Expect = 2e-06
Identities = 33/106 (31%), Positives = 54/106 (50%), Gaps = 10/106 (9%)
Query: 35 GMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKA 94
G+ +LH + I+ H +++ N L++S VL+I DFGL A DE+ + + Y+A
Sbjct: 115 GLKYLHSAGIL-HRDIKPGNLLVNSNCVLKICDFGL-ARVEEPDESKHMTQEVVTQYYRA 172
Query: 95 PELLRQPHLPRGTQKGDVYSFGLVLYEVIGR------QGPWGHLRM 134
PE+L T D++S G + E++GR Q P L +
Sbjct: 173 PEILMGS--RHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDL 216
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 3e-06
Identities = 44/157 (28%), Positives = 72/157 (45%), Gaps = 10/157 (6%)
Query: 26 ISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERK 85
+S + GM +L + I H +L + N L+ V++IADFGL D +
Sbjct: 140 VSCTYQVARGMEYLASQKCI-HRDLAARNVLVTENNVMKIADFGLARDVNNIDYYKKTTN 198
Query: 86 LRRRKLYKAPELLRQPHLPRGTQKGDVYSFGLVLYEVIGRQG-PWGHLRMTDEEIITSVT 144
R + APE L T + DV+SFG++++E+ G P+ + + EE+ +
Sbjct: 199 GRLPVKWMAPEALFDRVY---THQSDVWSFGVLMWEIFTLGGSPYPGIPV--EELFKLLK 253
Query: 145 QGSGLRPDTSSLDCAPSIIACMRTCWEEDPELRPDLR 181
+G R D + +C + MR CW P RP +
Sbjct: 254 EGH--RMDKPA-NCTNELYMMMRDCWHAIPSHRPTFK 287
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 47.9 bits (114), Expect = 4e-06
Identities = 41/161 (25%), Positives = 70/161 (43%), Gaps = 42/161 (26%)
Query: 35 GMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKA 94
GM +L + I H +L + NC++ + +ADFGL +K+Y
Sbjct: 125 GMEYLSNRNFI-HRDLAARNCMLREDMTVCVADFGL-----------------SKKIYSG 166
Query: 95 PELLRQPHLPRG---------------TQKGDVYSFGLVLYEVIGR-QGPWGHLRMTDEE 138
+ RQ + + T K DV++FG+ ++E+ R Q P+ + + E
Sbjct: 167 -DYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVE--NHE 223
Query: 139 IITSVTQGSGLR-PDTSSLDCAPSIIACMRTCWEEDPELRP 178
I + G+ L+ P+ DC + M +CW DP+ RP
Sbjct: 224 IYDYLRHGNRLKQPE----DCLDELYDLMYSCWRADPKDRP 260
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 47.7 bits (114), Expect = 4e-06
Identities = 29/95 (30%), Positives = 49/95 (51%), Gaps = 14/95 (14%)
Query: 35 GMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGL-HAFKAGQDETGQERKLRRRKLYK 93
G+ ++H + I+ H +L+ +N LI + VL+IADFGL F + + R Y+
Sbjct: 111 GVAYMHANGIM-HRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQVATRW--YR 167
Query: 94 APELLRQPHLPRGTQK----GDVYSFGLVLYEVIG 124
APELL G +K D+++ G + E++
Sbjct: 168 APELL------YGARKYDPGVDLWAVGCIFAELLN 196
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|201086 pfam00211, Guanylate_cyc, Adenylate and Guanylate cyclase catalytic domain | Back alignment and domain information |
|---|
Score = 46.5 bits (111), Expect = 5e-06
Identities = 15/28 (53%), Positives = 21/28 (75%)
Query: 334 VEPESFDSVTIYFSDIVGFTQLSAESTE 361
V +S+D+VTI F+DIVGFT LS+ +
Sbjct: 1 VYAQSYDNVTILFADIVGFTALSSRHSP 28
|
Length = 184 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 47.5 bits (113), Expect = 5e-06
Identities = 42/148 (28%), Positives = 66/148 (44%), Gaps = 20/148 (13%)
Query: 38 HLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRK---LYKA 94
+LH + I H +L +N ++ + I DFGL K E KL LY
Sbjct: 128 YLHKEKRIVHRDLTPNNIMLGEDDKVTITDFGLAKQK------QPESKLTSVVGTILYSC 181
Query: 95 PELLRQPHLPRGTQKGDVYSFGLVLYEVIGRQGPWGHLRMTDEEIITSVTQG--SGLRPD 152
PE+++ + P G +K DV++FG +LY++ Q P+ M + T + + L
Sbjct: 182 PEIVK--NEPYG-EKADVWAFGCILYQMCTLQPPFYSTNML--SLATKIVEAVYEPLPEG 236
Query: 153 TSSLDCAPSIIACMRTCWEEDPELRPDL 180
S D I +C+ D E RPD+
Sbjct: 237 MYSEDVTDVITSCLTP----DAEARPDI 260
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 47.8 bits (112), Expect = 7e-06
Identities = 28/100 (28%), Positives = 46/100 (46%), Gaps = 6/100 (6%)
Query: 35 GMIHLHDSEIISHGNLRSSNCLIDS-RWVLQIADFGLHAFKAGQDETGQERKLRRRKL-- 91
+ +LH II H +++ N L+D V+++ DFGL T L +
Sbjct: 113 ALEYLHSKGII-HRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGT 171
Query: 92 --YKAPELLRQPHLPRGTQKGDVYSFGLVLYEVIGRQGPW 129
Y APE+L L + D++S G+ LYE++ P+
Sbjct: 172 PGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPF 211
|
Length = 384 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 47.0 bits (112), Expect = 7e-06
Identities = 39/164 (23%), Positives = 70/164 (42%), Gaps = 26/164 (15%)
Query: 32 ASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLH------AFKAGQDETGQERK 85
G+ +L+ + NL S + L+ + L+I GL FK
Sbjct: 131 CCKGLYNLYKYTNKPYKNLTSVSFLVTENYKLKIICHGLEKILSSPPFKNVNF------- 183
Query: 86 LRRRKLYKAPELLRQPHLPRGTQKGDVYSFGLVLYEVIGRQGPWGHLRMTDEEIITS-VT 144
+Y + ++L T K D+YS G+VL+E+ + P+ + +T +EI +
Sbjct: 184 ----MVYFSYKMLNDIFSEY-TIKDDIYSLGVVLWEIFTGKIPFEN--LTTKEIYDLIIN 236
Query: 145 QGSGLRPDTSSLDCAPSIIACMRT-CWEEDPELRPDLRFVHHKL 187
+ + L+ LDC P I C+ C D RP+++ + + L
Sbjct: 237 KNNSLKLP---LDC-PLEIKCIVEACTSHDSIKRPNIKEILYNL 276
|
Length = 283 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 46.9 bits (112), Expect = 1e-05
Identities = 30/94 (31%), Positives = 50/94 (53%), Gaps = 7/94 (7%)
Query: 35 GMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRR---RKL 91
G+ ++H + +I H +L+ SN L++ L+I DFG+ A T + + +
Sbjct: 119 GLKYIHSANVI-HRDLKPSNLLVNEDCELRIGDFGM-ARGLSSSPTEHKYFMTEYVATRW 176
Query: 92 YKAPELLRQPHLPRGTQKGDVYSFGLVLYEVIGR 125
Y+APELL LP T D++S G + E++GR
Sbjct: 177 YRAPELLLS--LPEYTTAIDMWSVGCIFAEMLGR 208
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 45.9 bits (109), Expect = 1e-05
Identities = 37/148 (25%), Positives = 65/148 (43%), Gaps = 18/148 (12%)
Query: 35 GMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKA 94
G+ +LHD + H +++ +N L+D+ V+++ADFG+ + + + A
Sbjct: 114 GLEYLHDRNTV-HRDIKGANILVDTNGVVKLADFGMAKQVVEFSFA---KSFKGSPYWMA 169
Query: 95 PELLRQPHLPRGTQKGDVYSFGLVLYEVIGRQGPWGHLRMTDEEIITSVTQGSG----LR 150
PE++ Q G D++S G + E+ + PW L E + G
Sbjct: 170 PEVIAQQG-GYGLA-ADIWSLGCTVLEMATGKPPWSQL----EGVAAVFKIGRSKELPPI 223
Query: 151 PDTSSLDCAPSIIACMRTCWEEDPELRP 178
PD S + I+ C++ DP LRP
Sbjct: 224 PDHLSDEAKDFILKCLQ----RDPSLRP 247
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 45.8 bits (109), Expect = 2e-05
Identities = 30/100 (30%), Positives = 51/100 (51%), Gaps = 12/100 (12%)
Query: 35 GMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGL--HAFKAGQDETGQERKLRRR--- 89
G+ +LH++ I+ H +++++N LID++ +L+IADFGL + G R+
Sbjct: 127 GINYLHENHIL-HRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKGGGGGGTRKYTN 185
Query: 90 ----KLYKAPELLRQPHLPRGTQKGDVYSFGLVLYEVIGR 125
+ Y+ PELL R T D++ G V E+ R
Sbjct: 186 LVVTRWYRPPELLL--GERRYTTAVDIWGIGCVFAEMFTR 223
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 45.7 bits (108), Expect = 2e-05
Identities = 39/158 (24%), Positives = 75/158 (47%), Gaps = 12/158 (7%)
Query: 35 GMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKA 94
GM +L + ++ H NL + N L+ S ++QIADFG+ D+ + + + A
Sbjct: 121 GMYYLEEHRMV-HRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMA 179
Query: 95 PELLRQPHLPRGTQKGDVYSFGLVLYEVIGRQG-PWGHLRMTDEEIITSVTQGSGL-RPD 152
E + R T + DV+S+G+ ++E++ P+ +R E+ + +G L +P
Sbjct: 180 LESI---LFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRP--HEVPDLLEKGERLAQPQ 234
Query: 153 TSSLDCAPSIIACMRTCWEEDPELRPDLRFVHHKLKEM 190
++D + M CW D +RP + + ++ M
Sbjct: 235 ICTID----VYMVMVKCWMIDENVRPTFKELANEFTRM 268
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 45.7 bits (109), Expect = 2e-05
Identities = 38/153 (24%), Positives = 68/153 (44%), Gaps = 25/153 (16%)
Query: 35 GMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKL--- 91
G+ +LH +I H +++S N L+ +++ADFG A Q + K +R +
Sbjct: 128 GLEYLHSQNVI-HRDIKSDNILLSKDGSVKLADFGF----AAQ---LTKEKSKRNSVVGT 179
Query: 92 --YKAPEL-LRQPHLPRGTQKGDVYSFGLVLYEVIGRQGPWGHLRMTDEEIITSVTQGSG 148
+ APE+ R+ + K D++S G++ E+ + P +LR + +T G
Sbjct: 180 PYWMAPEVIKRKDY----GPKVDIWSLGIMCIEMAEGEPP--YLREPPLRALFLITT-KG 232
Query: 149 LRP--DTSSLDCAPSIIACMRTCWEEDPELRPD 179
+ P + P + C +DPE RP
Sbjct: 233 IPPLKNPEKWS--PEFKDFLNKCLVKDPEKRPS 263
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 45.8 bits (108), Expect = 2e-05
Identities = 42/146 (28%), Positives = 70/146 (47%), Gaps = 10/146 (6%)
Query: 47 HGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKL-YKAPELLRQPHLPR 105
H +L + N LI +++I DFGL A +D + L + APE +
Sbjct: 262 HRDLAARNVLICEGKLVKICDFGL-ARDIMRDSNYISKGSTFLPLKWMAPESIFNNLY-- 318
Query: 106 GTQKGDVYSFGLVLYEVIGRQG-PWGHLRMTDEEIITSVTQGSGLRPDTSSLDCAPSIIA 164
T DV+SFG++L+E+ G P+ L M +E+ ++ +G + + D I
Sbjct: 319 -TTLSDVWSFGILLWEIFTLGGTPYPELPM-NEQFYNAIKRGYRMAKPAHASD---EIYE 373
Query: 165 CMRTCWEEDPELRPDLRFVHHKLKEM 190
M+ CWEE E+RPD + H + ++
Sbjct: 374 IMQKCWEEKFEIRPDFSQLVHLVGDL 399
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 45.2 bits (107), Expect = 3e-05
Identities = 31/96 (32%), Positives = 50/96 (52%), Gaps = 8/96 (8%)
Query: 35 GMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHA-FKAGQDETGQERKLRRRKLYK 93
G+ HLH II + +L+ N L+D+ ++I+D GL K GQ +T + +
Sbjct: 109 GLEHLHQRRII-YRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKT---KGYAGTPGFM 164
Query: 94 APELLRQPHLPRGTQKGDVYSFGLVLYEVIGRQGPW 129
APELL+ D ++ G+ LYE+I +GP+
Sbjct: 165 APELLQGEEYDFSV---DYFALGVTLYEMIAARGPF 197
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|165211 PHA02882, PHA02882, putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Score = 45.3 bits (107), Expect = 3e-05
Identities = 30/111 (27%), Positives = 54/111 (48%), Gaps = 9/111 (8%)
Query: 23 IGSISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGL--HAFKAGQ--D 78
I +I + ++ IH H ISHG+++ N ++D I D+G+ H G+ +
Sbjct: 128 IKNIMKDMLTTLEYIHEHG---ISHGDIKPENIMVDGNNRGYIIDYGIASHFIIHGKHIE 184
Query: 79 ETGQERKLRRRKLYKAPELLRQPHLPRGTQKGDVYSFGLVLYEVIGRQGPW 129
+ +++ L R LY A L + T++GD+ S G + + G + PW
Sbjct: 185 YSKEQKDLHRGTLYYAG--LDAHNGACVTRRGDLESLGYCMLKWAGIKLPW 233
|
Length = 294 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 44.4 bits (105), Expect = 4e-05
Identities = 38/153 (24%), Positives = 67/153 (43%), Gaps = 21/153 (13%)
Query: 32 ASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKL 91
+G+ HLH +I+ H +++S N +D+ ++I D G+ K D T +
Sbjct: 110 ILLGLAHLHSKKIL-HRDIKSLNLFLDAYDNVKIGDLGVA--KLLSDNTNFANTIVGTPY 166
Query: 92 YKAPELLR-QPHLPRGTQKGDVYSFGLVLYEVIGRQGPWGHLRMTDEE----IITSVTQG 146
Y +PEL +P+ +K DV++ G+VLYE + P+ D +I + +G
Sbjct: 167 YLSPELCEDKPY----NEKSDVWALGVVLYECCTGKHPF------DANNQGALILKIIRG 216
Query: 147 SGLRPDTSSLDCAPSIIACMRTCWEEDPELRPD 179
S + + + C +D RPD
Sbjct: 217 ---VFPPVSQMYSQQLAQLIDQCLTKDYRQRPD 246
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 44.0 bits (105), Expect = 6e-05
Identities = 26/91 (28%), Positives = 42/91 (46%), Gaps = 20/91 (21%)
Query: 38 HLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHA-FKAGQDETGQ-----ERKLRRRKL 91
+LH II + +L+ N L+D+ +++ DFGL + T E
Sbjct: 108 YLHSLGII-YRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNTFCGTPE-------- 158
Query: 92 YKAPE-LLRQPHLPRGTQKGDVYSFGLVLYE 121
Y APE LL + + + D +S G++LYE
Sbjct: 159 YLAPEVLLGKGY----GKAVDWWSLGVLLYE 185
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 44.1 bits (105), Expect = 6e-05
Identities = 23/75 (30%), Positives = 36/75 (48%), Gaps = 24/75 (32%)
Query: 35 GMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKL--- 91
G+ +LH + I+ H +++ SN LI++ VL++ADFGL R +R
Sbjct: 112 GLQYLHSNGIL-HRDIKGSNILINNDGVLKLADFGL------------ARPYTKRNSADY 158
Query: 92 --------YKAPELL 98
Y+ PELL
Sbjct: 159 TNRVITLWYRPPELL 173
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 44.3 bits (105), Expect = 7e-05
Identities = 32/90 (35%), Positives = 50/90 (55%), Gaps = 9/90 (10%)
Query: 35 GMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKA 94
G+ HLH + II H +L+ SN ++ S L+I DFGL A AG + R Y+A
Sbjct: 130 GIKHLHSAGII-HRDLKPSNIVVKSDCTLKILDFGL-ARTAGTSFMMTPYVVTR--YYRA 185
Query: 95 PELLRQPHLPRGTQKG-DVYSFGLVLYEVI 123
PE++ L G ++ D++S G ++ E+I
Sbjct: 186 PEVI----LGMGYKENVDIWSVGCIMGEMI 211
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 43.6 bits (104), Expect = 8e-05
Identities = 33/149 (22%), Positives = 65/149 (43%), Gaps = 23/149 (15%)
Query: 38 HLHDSEIISHGNLRSSNCLIDSRWVLQIADFGL-----HAFKAGQDETGQERKLRRRKLY 92
+LH +I+ H +++ N + S ++++ DFG+ + G Y
Sbjct: 118 YLHSRKIL-HRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLAKTVVGT-------PYY 169
Query: 93 KAPELLR-QPHLPRGTQKGDVYSFGLVLYEVIGRQGPWGHLRMTDEEIITSVTQGSGLRP 151
+PEL + +P+ K D++S G VLYE+ + P+ + E+ + +G P
Sbjct: 170 LSPELCQNKPY----NYKSDIWSLGCVLYELCTLKHPFEGENL--LELALKILKGQ-YPP 222
Query: 152 DTSSLDCAPSIIACMRTCWEEDPELRPDL 180
S + + + ++DPE RP +
Sbjct: 223 IPSQYS--SELRNLVSSLLQKDPEERPSI 249
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 43.9 bits (104), Expect = 8e-05
Identities = 27/95 (28%), Positives = 45/95 (47%), Gaps = 11/95 (11%)
Query: 35 GMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKA 94
G+ H I+ H +L+ N LI++ VL++ADFGL + R Y+A
Sbjct: 110 GLAFCHSHGIL-HRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTHYVVTR--WYRA 166
Query: 95 PELL---RQPHLPRGTQKGDVYSFGLVLYEVIGRQ 126
PELL + + D++S G + E++ R+
Sbjct: 167 PELLLGDKGY-----STPVDIWSVGCIFAELLSRR 196
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 43.5 bits (103), Expect = 8e-05
Identities = 41/153 (26%), Positives = 67/153 (43%), Gaps = 17/153 (11%)
Query: 34 VGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFG--LHAFKAGQDETGQERKLRRRKL 91
G+ +LH I+ H +++ +N +D V+++ DFG + + + L
Sbjct: 110 EGLAYLHSHGIV-HRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPA 168
Query: 92 YKAPELLRQPHLPRGTQKG-----DVYSFGLVLYEVIGRQGPWGHLRMTDEEIITSVTQG 146
Y APE++ G KG D++S G V+ E+ + PW L D E G
Sbjct: 169 YMAPEVIT-----GGKGKGHGRAADIWSLGCVVLEMATGKRPWSEL---DNEFQIMFHVG 220
Query: 147 SGLRPDT-SSLDCAPSIIACMRTCWEEDPELRP 178
+G +P SL +P + C E DP+ RP
Sbjct: 221 AGHKPPIPDSLQLSPEGKDFLDRCLESDPKKRP 253
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 43.6 bits (103), Expect = 9e-05
Identities = 38/138 (27%), Positives = 69/138 (50%), Gaps = 20/138 (14%)
Query: 47 HGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKL---YKAPELLRQPHL 103
H ++ + N L+ S +++ DFGL + +DE+ K + KL + APE + +
Sbjct: 130 HRDIAARNVLVSSPDCVKLGDFGLS--RYLEDES--YYKASKGKLPIKWMAPESI---NF 182
Query: 104 PRGTQKGDVYSFGLVLYEVI--GRQGPWGHLRMTDEEIITSVTQGSGL-RPDTSSLDCAP 160
R T DV+ FG+ ++E++ G + P+ + + ++I + G L P +C P
Sbjct: 183 RRFTSASDVWMFGVCMWEILMLGVK-PFQGV--KNNDVIGRIENGERLPMPP----NCPP 235
Query: 161 SIIACMRTCWEEDPELRP 178
++ + M CW DP RP
Sbjct: 236 TLYSLMTKCWAYDPSKRP 253
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 43.3 bits (103), Expect = 1e-04
Identities = 30/125 (24%), Positives = 51/125 (40%), Gaps = 28/125 (22%)
Query: 23 IGSISVNTT----ASVGMI--HLHDSEIISHGNLRSSNCLIDSRWVLQIADFG------- 69
GS+ T A + + +LH II H +L+ N L+D ++I DFG
Sbjct: 96 YGSLDEKCTRFYAAEILLALEYLHSKGII-HRDLKPENILLDKDMHIKITDFGTAKVLDP 154
Query: 70 ----LHAFKAGQDETGQERKLRRRK-------LYKAPELLRQPHLPRGTQKGDVYSFGLV 118
+ Q K RRR Y +PELL + + D+++ G +
Sbjct: 155 NSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPA---GKSSDLWALGCI 211
Query: 119 LYEVI 123
+Y+++
Sbjct: 212 IYQML 216
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 43.5 bits (102), Expect = 1e-04
Identities = 43/172 (25%), Positives = 79/172 (45%), Gaps = 18/172 (10%)
Query: 22 PIGSISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGL--HAFKAGQDE 79
P + + T + GM L ++ H +L + N L+ + ++I+D GL + A +
Sbjct: 123 PADFVHIVTQIAAGMEFLSSHHVV-HKDLATRNVLVFDKLNVKISDLGLFREVYAADYYK 181
Query: 80 TGQERKLRRRKLYKAPELLRQPHLPRGTQKGDVYSFGLVLYEVI--GRQGPWGHLRMTDE 137
L R + +PE + + + D++S+G+VL+EV G Q G+ +++
Sbjct: 182 LMGNSLLPIR--WMSPEAIM---YGKFSIDSDIWSYGVVLWEVFSYGLQPYCGY---SNQ 233
Query: 138 EIITSVTQGSGLR-PDTSSLDCAPSIIACMRTCWEEDPELRPDLRFVHHKLK 188
++I + L PD DC + M CW E P RP + +H +L+
Sbjct: 234 DVIEMIRNRQVLPCPD----DCPAWVYTLMLECWNEFPSRRPRFKDIHSRLR 281
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 43.1 bits (102), Expect = 1e-04
Identities = 29/92 (31%), Positives = 52/92 (56%), Gaps = 5/92 (5%)
Query: 35 GMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKA 94
G+ ++H + ++ H +L+ SN L+++ L+I DFGL + + + E + R Y+A
Sbjct: 120 GLKYIHSANVL-HRDLKPSNLLLNANCDLKICDFGLARTTSEKGDFMTEYVVTRW--YRA 176
Query: 95 PELLRQPHLPRGTQKGDVYSFGLVLYEVIGRQ 126
PELL + T DV+S G + E++GR+
Sbjct: 177 PELLL--NCSEYTTAIDVWSVGCIFAELLGRK 206
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 43.0 bits (102), Expect = 1e-04
Identities = 43/156 (27%), Positives = 65/156 (41%), Gaps = 34/156 (21%)
Query: 39 LHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQER--KLRRRKL----Y 92
LH + II H +L+ N LIDS L++ DFGL + + K +R + Y
Sbjct: 109 LHSNGII-HRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDY 167
Query: 93 KAPE-LLRQPHLPRGTQKGDVYSFGLVLYEVIGRQGPWGHLRMTDEEIITSVTQGSGLRP 151
APE +L Q H ++ D +S G +LYE + P+ T EEI ++ G
Sbjct: 168 IAPEVILGQGH----SKTVDWWSLGCILYEFLVGIPPFH--GETPEEIFQNILNG----- 216
Query: 152 DTSSLDCAPSIIACMRTCWEEDPELRPDLRFVHHKL 187
+ W ED E+ + + KL
Sbjct: 217 ---------------KIEWPEDVEVSDEAIDLISKL 237
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 43.7 bits (103), Expect = 1e-04
Identities = 40/144 (27%), Positives = 71/144 (49%), Gaps = 15/144 (10%)
Query: 38 HLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAG--QDETGQERKLRRRKLYKAP 95
H+H +I H +++S+N L+ S ++++ DFG A D+ G R Y AP
Sbjct: 158 HVHSKHMI-HRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVG--RTFCGTPYYVAP 214
Query: 96 ELLRQ-PHLPRGTQKGDVYSFGLVLYEVIGRQGPWGHLRMTDEEIITSVTQGSGLRPDTS 154
E+ R+ P+ ++K D++S G++LYE++ + P+ M EE++ G R D
Sbjct: 215 EIWRRKPY----SKKADMFSLGVLLYELLTLKRPFDGENM--EEVMHKTLAG---RYDPL 265
Query: 155 SLDCAPSIIACMRTCWEEDPELRP 178
+P + + DP+ RP
Sbjct: 266 PPSISPEMQEIVTALLSSDPKRRP 289
|
Length = 496 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 42.8 bits (101), Expect = 2e-04
Identities = 29/96 (30%), Positives = 53/96 (55%), Gaps = 9/96 (9%)
Query: 35 GMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGL-HAFKAGQDE-TGQERKLRRRKLY 92
G+ ++H + ++ H +L+ N L+++ L+I DFGL F E G + + Y
Sbjct: 117 GLKYIHSANVL-HRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEYVATRWY 175
Query: 93 KAPELL--RQPHLPRGTQKGDVYSFGLVLYEVIGRQ 126
+APE++ Q + T+ DV+S G +L E++GR+
Sbjct: 176 RAPEIMLSFQSY----TKAIDVWSVGCILAELLGRK 207
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 42.7 bits (100), Expect = 2e-04
Identities = 28/92 (30%), Positives = 49/92 (53%), Gaps = 8/92 (8%)
Query: 35 GMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKA 94
G+ +L + I H +++ SN L++SR +++ DFG+ +GQ + Y +
Sbjct: 115 GLAYLREKHQIMHRDVKPSNILVNSRGEIKLCDFGV----SGQLIDSMANSFVGTRSYMS 170
Query: 95 PELLRQPHLPRGTQKGDVYSFGLVLYEV-IGR 125
PE L+ H + + D++S GL L E+ IGR
Sbjct: 171 PERLQGTHY---SVQSDIWSMGLSLVELAIGR 199
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 42.3 bits (99), Expect = 3e-04
Identities = 30/104 (28%), Positives = 54/104 (51%), Gaps = 10/104 (9%)
Query: 23 IGSISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQ 82
+G +S+ G+ +L + I H +++ SN L++SR +++ DFG+ +GQ
Sbjct: 105 LGKVSIAVIK--GLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGV----SGQLIDSM 158
Query: 83 ERKLRRRKLYKAPELLRQPHLPRGTQKGDVYSFGLVLYEV-IGR 125
+ Y +PE L+ H + + D++S GL L E+ IGR
Sbjct: 159 ANSFVGTRSYMSPERLQGTHY---SVQSDIWSMGLSLVEMAIGR 199
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 42.0 bits (98), Expect = 4e-04
Identities = 38/158 (24%), Positives = 74/158 (46%), Gaps = 12/158 (7%)
Query: 35 GMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKA 94
GM++L + ++ H +L + N L+ S ++I DFGL G ++ + + A
Sbjct: 121 GMMYLEERRLV-HRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMA 179
Query: 95 PELLRQPHLPRGTQKGDVYSFGLVLYEVIGRQG-PWGHLRMTDEEIITSVTQGSGL-RPD 152
E + H + T + DV+S+G+ ++E++ G P+ + EI + +G L +P
Sbjct: 180 LECI---HYRKFTHQSDVWSYGVTIWELMTFGGKPYDGI--PTREIPDLLEKGERLPQPP 234
Query: 153 TSSLDCAPSIIACMRTCWEEDPELRPDLRFVHHKLKEM 190
++D + M CW D + RP + + + M
Sbjct: 235 ICTID----VYMVMVKCWMIDADSRPKFKELAAEFSRM 268
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|219526 pfam07701, HNOBA, Heme NO binding associated | Back alignment and domain information |
|---|
Score = 41.1 bits (97), Expect = 4e-04
Identities = 16/30 (53%), Positives = 22/30 (73%)
Query: 299 QERTNQLTQEKKKTDALLHRMLPRSVSESL 328
+E +L +EKKKTD LL+ MLP+SV+ L
Sbjct: 180 EEAHRELEEEKKKTDDLLYSMLPKSVANRL 209
|
The HNOBA domain is found associated with the HNOB domain and pfam00211 in soluble cyclases and signalling proteins. The HNOB domain is predicted to function as a heme-dependent sensor for gaseous ligands, and transduce diverse downstream signals, in both bacteria and animals. Length = 209 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 41.7 bits (98), Expect = 4e-04
Identities = 27/91 (29%), Positives = 41/91 (45%), Gaps = 12/91 (13%)
Query: 34 VGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQE-RKLRRRKLY 92
+G+ LH II H +++ N LID L++ DFGL G E +K Y
Sbjct: 108 LGVEDLHQRGII-HRDIKPENLLIDQTGHLKLTDFGL-------SRNGLENKKFVGTPDY 159
Query: 93 KAPELLRQPHLPRGTQKGDVYSFGLVLYEVI 123
APE + + D +S G V++E +
Sbjct: 160 LAPETILGVG---DDKMSDWWSLGCVIFEFL 187
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 41.8 bits (99), Expect = 4e-04
Identities = 31/89 (34%), Positives = 51/89 (57%), Gaps = 5/89 (5%)
Query: 35 GMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKA 94
G+ HLHD+ I+ H +L++SN L+++R +L+I DFGL A + G +L Y+A
Sbjct: 118 GVAHLHDNWIL-HRDLKTSNLLLNNRGILKICDFGL-AREYG-SPLKPYTQLVVTLWYRA 174
Query: 95 PELLRQPHLPRGTQKGDVYSFGLVLYEVI 123
PELL + D++S G + E++
Sbjct: 175 PELLLGA--KEYSTAIDMWSVGCIFAELL 201
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 41.7 bits (99), Expect = 4e-04
Identities = 33/99 (33%), Positives = 50/99 (50%), Gaps = 18/99 (18%)
Query: 35 GMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQE--------RKL 86
G+ +LH + +I H +L+ SN L++S L+I DFGL A DE + R
Sbjct: 115 GLKYLHSANVI-HRDLKPSNILVNSNCDLKICDFGL-ARGVDPDEDEKGFLTEYVVTR-- 170
Query: 87 RRRKLYKAPELLRQPHLPRGTQKGDVYSFGLVLYEVIGR 125
Y+APELL R T+ D++S G + E++ R
Sbjct: 171 ----WYRAPELLLSSS--RYTKAIDIWSVGCIFAELLTR 203
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 41.6 bits (98), Expect = 5e-04
Identities = 39/165 (23%), Positives = 72/165 (43%), Gaps = 18/165 (10%)
Query: 23 IGSISVNTTASVGMIH-LHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETG 81
+G ++V A V +H L + + H +++ SN L+D+ +++ DFG+
Sbjct: 116 LGKMTV---AIVKALHYLKEKHGVIHRDVKPSNILLDASGNVKLCDFGISGRLV------ 166
Query: 82 QERKLRRRK----LYKAPELLR-QPHLPRGTQKGDVYSFGLVLYEVIGRQGPWGHLRMTD 136
+ K + R Y APE + P+ + DV+S G+ L E+ Q P+ T+
Sbjct: 167 -DSKAKTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPY-KNCKTE 224
Query: 137 EEIITSVTQGSGLRPDTSSLDCAPSIIACMRTCWEEDPELRPDLR 181
E++T + Q + +P + + C +D RP R
Sbjct: 225 FEVLTKILQEEPPSLP-PNEGFSPDFCSFVDLCLTKDHRKRPKYR 268
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 41.3 bits (97), Expect = 5e-04
Identities = 39/159 (24%), Positives = 73/159 (45%), Gaps = 13/159 (8%)
Query: 35 GMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKL-YK 93
GM L I H +L + N L+ +++I DFGL A D + R + +
Sbjct: 153 GMAFLASKNCI-HRDLAARNVLLTHGKIVKICDFGL-ARDIMNDSNYVVKGNARLPVKWM 210
Query: 94 APELLRQPHLPRGTQKGDVYSFGLVLYEVIGRQG-PWGHLRMTDEEIITSVTQGSGL-RP 151
APE + T + DV+S+G++L+E+ P+ + + D + + +G + +P
Sbjct: 211 APESIFNCVY---TFESDVWSYGILLWEIFSLGSNPYPGMPV-DSKFYKLIKEGYRMAQP 266
Query: 152 DTSSLDCAPSIIACMRTCWEEDPELRPDLRFVHHKLKEM 190
+ + + I M+TCW+ DP RP + + + +
Sbjct: 267 EHAPAE----IYDIMKTCWDADPLKRPTFKQIVQLIGKQ 301
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 41.7 bits (98), Expect = 5e-04
Identities = 31/114 (27%), Positives = 58/114 (50%), Gaps = 10/114 (8%)
Query: 33 SVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLY 92
++G+ LH II + +L+ N ++D+ ++IADFG+ K R Y
Sbjct: 111 AIGLFFLHSKGII-YRDLKLDNVMLDAEGHIKIADFGM--CKENIFGGKTTRTFCGTPDY 167
Query: 93 KAPEL-LRQPHLPRGTQKGDVYSFGLVLYEVIGRQGPWGHLRMTDEEIITSVTQ 145
APE+ QP+ + D ++FG++LYE++ Q P+ ++E+ S+ +
Sbjct: 168 IAPEIIAYQPY----GKSVDWWAFGVLLYEMLAGQPPFDG--EDEDELFQSIME 215
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 41.5 bits (97), Expect = 5e-04
Identities = 31/97 (31%), Positives = 53/97 (54%), Gaps = 6/97 (6%)
Query: 33 SVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLY 92
SVG+ LH II + +L+ N ++DS ++IADFG+ K + R Y
Sbjct: 111 SVGLFFLHRRGII-YRDLKLDNVMLDSEGHIKIADFGM--CKEHMVDGVTTRTFCGTPDY 167
Query: 93 KAPELLRQPHLPRGTQKGDVYSFGLVLYEVIGRQGPW 129
APE++ + P G + D +++G++LYE++ Q P+
Sbjct: 168 IAPEII--AYQPYG-KSVDWWAYGVLLYEMLAGQPPF 201
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 41.0 bits (96), Expect = 6e-04
Identities = 28/96 (29%), Positives = 49/96 (51%), Gaps = 9/96 (9%)
Query: 35 GMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKL-YK 93
G+ LH E I + +L+ N L+D ++I+D GL A + G+ + R + Y
Sbjct: 114 GLEDLH-RERIVYRDLKPENILLDDYGHIRISDLGL----AVEIPEGETIRGRVGTVGYM 168
Query: 94 APELLRQPHLPRGTQKGDVYSFGLVLYEVIGRQGPW 129
APE+++ R T D + G ++YE+I + P+
Sbjct: 169 APEVVKN---ERYTFSPDWWGLGCLIYEMIEGKSPF 201
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 40.9 bits (96), Expect = 6e-04
Identities = 28/96 (29%), Positives = 46/96 (47%), Gaps = 9/96 (9%)
Query: 35 GMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHA-FKAGQDETGQERKLRRRKLYK 93
G+ HLH I+ + +L+ N L+D ++I+D GL K G+ G+ Y
Sbjct: 107 GLEHLHQRRIV-YRDLKPENVLLDDHGNVRISDLGLAVELKGGKKIKGRAGTPG----YM 161
Query: 94 APELLRQPHLPRGTQKGDVYSFGLVLYEVIGRQGPW 129
APE+L+ D ++ G LYE+I + P+
Sbjct: 162 APEVLQGE---VYDFSVDWFALGCTLYEMIAGRSPF 194
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 40.8 bits (95), Expect = 7e-04
Identities = 42/161 (26%), Positives = 71/161 (44%), Gaps = 18/161 (11%)
Query: 35 GMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDET-----GQERKLRRR 89
GM +L + ++ H +L + N L+ S ++I DFGL A DET G + ++
Sbjct: 121 GMSYLEEVRLV-HRDLAARNVLVKSPNHVKITDFGL-ARLLDIDETEYHADGGKVPIKWM 178
Query: 90 KLYKAPELLRQPHLPRGTQKGDVYSFGLVLYEVIGRQGPWGHLRMTDEEIITSVTQGSGL 149
L +L + R T + DV+S+G+ ++E++ G + + EI + +G L
Sbjct: 179 AL---ESILHR----RFTHQSDVWSYGVTVWELM-TFGAKPYDGIPAREIPDLLEKGERL 230
Query: 150 RPDTSSLDCAPSIIACMRTCWEEDPELRPDLRFVHHKLKEM 190
C + M CW D E RP R + + M
Sbjct: 231 ---PQPPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRM 268
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 41.0 bits (97), Expect = 7e-04
Identities = 27/72 (37%), Positives = 38/72 (52%), Gaps = 19/72 (26%)
Query: 35 GMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKL--- 91
G+ +LH + I+ H +L+ +N LI S VL++ADFGL A G RK+
Sbjct: 114 GLEYLHSNWIL-HRDLKPNNLLIASDGVLKLADFGL-ARSFGSP---------NRKMTHQ 162
Query: 92 -----YKAPELL 98
Y+APELL
Sbjct: 163 VVTRWYRAPELL 174
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 40.9 bits (96), Expect = 8e-04
Identities = 29/92 (31%), Positives = 49/92 (53%), Gaps = 8/92 (8%)
Query: 35 GMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKA 94
G+ +L + I H +++ SN L++SR +++ DFG+ +GQ + Y +
Sbjct: 111 GLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGV----SGQLIDSMANSFVGTRSYMS 166
Query: 95 PELLRQPHLPRGTQKGDVYSFGLVLYEV-IGR 125
PE L+ H T + D++S GL L E+ IGR
Sbjct: 167 PERLQGTHY---TVQSDIWSLGLSLVEMAIGR 195
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 40.8 bits (95), Expect = 8e-04
Identities = 31/96 (32%), Positives = 49/96 (51%), Gaps = 9/96 (9%)
Query: 35 GMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKL-YK 93
G+ LH I+ + +L+ N L+D ++I+D GL A GQ K R + Y
Sbjct: 114 GLEDLHQERIV-YRDLKPENILLDDHGHIRISDLGL----AVHVPEGQTIKGRVGTVGYM 168
Query: 94 APELLRQPHLPRGTQKGDVYSFGLVLYEVIGRQGPW 129
APE+++ R T D ++ G +LYE+I Q P+
Sbjct: 169 APEVVKNE---RYTFSPDWWALGCLLYEMIAGQSPF 201
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 40.8 bits (96), Expect = 0.001
Identities = 21/68 (30%), Positives = 40/68 (58%), Gaps = 7/68 (10%)
Query: 35 GMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGL-HAFKAGQDETGQERKLRRRKL-- 91
G+ ++H ++I+ H +++++N LI +L++ADFGL AF + + + R +
Sbjct: 131 GLYYIHRNKIL-HRDMKAANILITKDGILKLADFGLARAFS--LSKNSKPNRYTNRVVTL 187
Query: 92 -YKAPELL 98
Y+ PELL
Sbjct: 188 WYRPPELL 195
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 40.5 bits (95), Expect = 0.001
Identities = 33/152 (21%), Positives = 69/152 (45%), Gaps = 33/152 (21%)
Query: 38 HLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKAPEL 97
++H + I+ H ++++ N + ++++ DFG+ K E + Y +PEL
Sbjct: 116 YIHKAGIL-HRDIKTLNIFLTKAGLIKLGDFGIS--KILGSEYSMAETVVGTPYYMSPEL 172
Query: 98 LRQPHLPRGTQ---KGDVYSFGLVLYEVIGRQGPWGHLRMTDE-----EIITSVTQGS-- 147
+ G + K D+++ G VLYE++ L+ T + ++ + QG+
Sbjct: 173 CQ------GVKYNFKSDIWALGCVLYELLT-------LKRTFDATNPLNLVVKIVQGNYT 219
Query: 148 -GLRPDTSSLDCAPSIIACMRTCWEEDPELRP 178
+ +S L I+ + + ++DPE RP
Sbjct: 220 PVVSVYSSEL------ISLVHSLLQQDPEKRP 245
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 40.6 bits (95), Expect = 0.001
Identities = 38/162 (23%), Positives = 71/162 (43%), Gaps = 11/162 (6%)
Query: 33 SVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLY 92
+ G+ H+H + H +L NC + S +++ D+G+ + +D E +
Sbjct: 109 AAGVTHMHKHNFL-HSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKCVPLRW 167
Query: 93 KAPELLRQPH----LPRGTQKGDVYSFGLVLYEVIGRQG-PWGHLRMTDEEIITSVTQGS 147
APEL+ + H T+ +V++ G+ L+E+ P+ HL +D E++ V +
Sbjct: 168 LAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHL--SDREVLNHVIKDQ 225
Query: 148 GLRPDTSSLDCAPS--IIACMRTCWEEDPELRPDLRFVHHKL 187
++ L+ S ++ CW PE R VH L
Sbjct: 226 QVKLFKPQLELPYSERWYEVLQFCWLS-PEKRATAEEVHRLL 266
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 40.8 bits (95), Expect = 0.001
Identities = 32/90 (35%), Positives = 50/90 (55%), Gaps = 9/90 (10%)
Query: 35 GMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKA 94
G+ HLH + II H +L+ SN ++ S L+I DFGL A AG + R Y+A
Sbjct: 138 GIKHLHSAGII-HRDLKPSNIVVKSDCTLKILDFGL-ARTAGTSFMMTPYVVTR--YYRA 193
Query: 95 PELLRQPHLPRGTQKG-DVYSFGLVLYEVI 123
PE++ L G ++ D++S G ++ E+I
Sbjct: 194 PEVI----LGMGYKENVDIWSVGCIMGEMI 219
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 40.4 bits (94), Expect = 0.001
Identities = 29/98 (29%), Positives = 53/98 (54%), Gaps = 8/98 (8%)
Query: 33 SVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLY 92
++G+ LH II + +L+ N ++DS ++IADFG+ K + + Y
Sbjct: 111 AIGLFFLHSKGII-YRDLKLDNVMLDSEGHIKIADFGM--CKENMWDGVTTKTFCGTPDY 167
Query: 93 KAPELLR-QPHLPRGTQKGDVYSFGLVLYEVIGRQGPW 129
APE++ QP+ + D ++FG++LYE++ Q P+
Sbjct: 168 IAPEIIAYQPY----GKSVDWWAFGVLLYEMLAGQAPF 201
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 40.1 bits (94), Expect = 0.001
Identities = 29/102 (28%), Positives = 48/102 (47%), Gaps = 17/102 (16%)
Query: 35 GMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDE-----TGQERKLRRR 89
G+ LH + H +L +N I+S+ + +IADFGL A + G + E RR
Sbjct: 131 GLNVLHKWYFM-HRDLSPANIFINSKGICKIADFGL-ARRYGYPPYSDTLSKDETMQRRE 188
Query: 90 KL--------YKAPELLRQPHLPRGTQKGDVYSFGLVLYEVI 123
++ Y+APELL + D++S G + E++
Sbjct: 189 EMTSKVVTLWYRAPELLMGAE--KYHFAVDMWSVGCIFAELL 228
|
Length = 335 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 39.7 bits (92), Expect = 0.002
Identities = 35/161 (21%), Positives = 73/161 (45%), Gaps = 16/161 (9%)
Query: 35 GMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQ--DETGQERKLRRRKLY 92
G+ +LH + I H +++++N L+ +++ADFG+ AGQ D + +
Sbjct: 113 GLDYLHSEKKI-HRDIKAANVLLSEHGEVKLADFGV----AGQLTDTQIKRNTFVGTPFW 167
Query: 93 KAPELLRQPHLPRGTQKGDVYSFGLVLYEVIGRQGPWGHLRMTDEEIITSVTQGSGLRPD 152
APE+++Q K D++S G+ E+ + P H + +++ + + + P
Sbjct: 168 MAPEVIKQSAY---DSKADIWSLGITAIELAKGEPP--HSELHPMKVLFLIPKNN---PP 219
Query: 153 TSSLDCAPSIIACMRTCWEEDPELRPDLR-FVHHKLKEMNA 192
T + + + + C ++P RP + + HK A
Sbjct: 220 TLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKHKFIVRFA 260
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 39.7 bits (93), Expect = 0.002
Identities = 49/182 (26%), Positives = 81/182 (44%), Gaps = 26/182 (14%)
Query: 18 PFNIPIGSISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQ 77
P I +G I+V T ++ +L + I H +++ SN L+D +++ DFG+ +GQ
Sbjct: 105 PEEI-LGKIAVATVKALN--YLKEELKIIHRDVKPSNILLDRNGNIKLCDFGI----SGQ 157
Query: 78 --DETGQERKLRRRKLYKAPELLRQPHLPRGTQ-KGDVYSFGLVLYEVIGRQGP---WGH 131
D + R R Y APE + P G + DV+S G+ LYEV + P W
Sbjct: 158 LVDSIAKTRDAGCRP-YMAPERI-DPSARDGYDVRSDVWSLGITLYEVATGKFPYPKW-- 213
Query: 132 LRMTDEEIITSVTQGSG--LRPDTSSLDCAPSIIACMRTCWEEDPELRPDLRFVHHKLKE 189
+ + +T V +G L + +PS + + C +D RP + +L E
Sbjct: 214 --NSVFDQLTQVVKGDPPILSNS-EEREFSPSFVNFINLCLIKDESKRPK----YKELLE 266
Query: 190 MN 191
Sbjct: 267 HP 268
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 39.2 bits (92), Expect = 0.002
Identities = 22/89 (24%), Positives = 46/89 (51%), Gaps = 10/89 (11%)
Query: 35 GMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQ--DETGQERKLRRRKLY 92
G+ +LH ++ I H ++++ N L++ ++ADFG+ +GQ D + + +
Sbjct: 111 GLEYLHSNKKI-HRDIKAGNILLNEEGQAKLADFGV----SGQLTDTMAKRNTVIGTPFW 165
Query: 93 KAPELLRQPHLPRGTQKGDVYSFGLVLYE 121
APE++++ K D++S G+ E
Sbjct: 166 MAPEVIQE---IGYNNKADIWSLGITAIE 191
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 39.0 bits (91), Expect = 0.003
Identities = 26/101 (25%), Positives = 48/101 (47%), Gaps = 9/101 (8%)
Query: 35 GMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQD---ETGQERKLRRRKL 91
G+ +LH + I+ H +++ +N L DS +++ DFG A K Q + +
Sbjct: 116 GVEYLHSNMIV-HRDIKGANILRDSAGNVKLGDFG--ASKRLQTICSSGTGMKSVTGTPY 172
Query: 92 YKAPELLRQPHLPRGTQKGDVYSFGLVLYEVIGRQGPWGHL 132
+ +PE++ R K DV+S G + E++ + PW
Sbjct: 173 WMSPEVISGEGYGR---KADVWSVGCTVVEMLTEKPPWAEF 210
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 39.3 bits (91), Expect = 0.003
Identities = 31/90 (34%), Positives = 50/90 (55%), Gaps = 9/90 (10%)
Query: 35 GMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKA 94
G+ HLH + II H +L+ SN ++ S L+I DFGL A AG + R Y+A
Sbjct: 131 GIKHLHSAGII-HRDLKPSNIVVKSDCTLKILDFGL-ARTAGTSFMMTPYVVTR--YYRA 186
Query: 95 PELLRQPHLPRGTQKG-DVYSFGLVLYEVI 123
PE++ L G ++ D++S G ++ E++
Sbjct: 187 PEVI----LGMGYKENVDIWSVGCIMGEMV 212
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 38.8 bits (90), Expect = 0.003
Identities = 27/99 (27%), Positives = 50/99 (50%), Gaps = 9/99 (9%)
Query: 33 SVGMIHLHDSEIISHGNLRSSNCLIDSR-WVLQIADFGLHAFKAGQDETGQERKLRRRKL 91
S+G+ H+HD +I+ H +++S N + V ++ DFG+ + D
Sbjct: 111 SLGLKHIHDRKIL-HRDIKSQNIFLSKNGMVAKLGDFGIA--RQLNDSMELAYTCVGTPY 167
Query: 92 YKAPELLR-QPHLPRGTQKGDVYSFGLVLYEVIGRQGPW 129
Y +PE+ + +P+ K D++S G VLYE+ + P+
Sbjct: 168 YLSPEICQNRPY----NNKTDIWSLGCVLYELCTLKHPF 202
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 38.6 bits (90), Expect = 0.003
Identities = 37/149 (24%), Positives = 70/149 (46%), Gaps = 23/149 (15%)
Query: 35 GMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAG---QDETGQERKLRRRKL 91
G+ LH+ +I+ H +L+S+N L+ + +++I D G+ + + G
Sbjct: 115 GLQALHEQKIL-HRDLKSANILLVANDLVKIGDLGISKVLKKNMAKTQIGT-------PH 166
Query: 92 YKAPELLR-QPHLPRGTQKGDVYSFGLVLYEVIGRQGPWGHLRMTDEEIITSVTQGSGLR 150
Y APE+ + +P+ + K D++S G +LYE+ P+ M +++ V +G
Sbjct: 167 YMAPEVWKGRPY----SYKSDIWSLGCLLYEMATFAPPFEARSM--QDLRYKVQRGKYPP 220
Query: 151 -PDTSSLDCAPSIIACMRTCWEEDPELRP 178
P S D I + ++ P+LRP
Sbjct: 221 IPPIYSQDLQNFIRSMLQV----KPKLRP 245
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 38.6 bits (90), Expect = 0.004
Identities = 36/151 (23%), Positives = 67/151 (44%), Gaps = 16/151 (10%)
Query: 35 GMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKA 94
G+ +LH +II H +++ SN L+ + +++ DFG+ +G+ Y A
Sbjct: 117 GLSYLHSRKII-HRDIKPSNILLTRKGQVKLCDFGV----SGELVNSLAGTFTGTSFYMA 171
Query: 95 PELLR-QPHLPRGTQKGDVYSFGLVLYEVIGRQGPW---GHLRMTDEEIITSVTQGSGLR 150
PE ++ +P+ + DV+S GL L EV + P+ G + E+++ +
Sbjct: 172 PERIQGKPY----SITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMPNPE 227
Query: 151 -PDTSSLDC--APSIIACMRTCWEEDPELRP 178
D + ++ C E+DP RP
Sbjct: 228 LKDEPGNGIKWSEEFKDFIKQCLEKDPTRRP 258
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 38.6 bits (90), Expect = 0.004
Identities = 27/107 (25%), Positives = 53/107 (49%), Gaps = 9/107 (8%)
Query: 23 IGSISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQ 82
+G I+V G+ +L++ I H +++ SN L++SR +++ DFG+ +G+
Sbjct: 105 LGKIAVAVVE--GLTYLYNVHRIMHRDIKPSNILVNSRGQIKLCDFGV----SGELINSI 158
Query: 83 ERKLRRRKLYKAPELLRQPHLPRGTQKGDVYSFGLVLYEVIGRQGPW 129
Y +PE ++ T K DV+S G+ + E+ + P+
Sbjct: 159 ADTFVGTSTYMSPERIQGGKY---TVKSDVWSLGISIIELALGKFPF 202
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 38.2 bits (90), Expect = 0.004
Identities = 31/94 (32%), Positives = 45/94 (47%), Gaps = 15/94 (15%)
Query: 35 GMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGL-HAFKAGQDETGQERKLRRRKL-- 91
G+ + H I+ H +L+ N LI+ VL++ADFGL AF R +
Sbjct: 110 GLAYCHSHRIL-HRDLKPQNILINRDGVLKLADFGLARAF------GIPLRTYTHEVVTL 162
Query: 92 -YKAPE-LLRQPHLPRGTQKGDVYSFGLVLYEVI 123
Y+APE LL H T D++S G + E+I
Sbjct: 163 WYRAPEILLGSKHY--STAV-DIWSVGCIFAEMI 193
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 38.6 bits (90), Expect = 0.004
Identities = 28/92 (30%), Positives = 49/92 (53%), Gaps = 8/92 (8%)
Query: 33 SVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLY 92
++ + HLH II + +L+ N L+D +++ DFGL K D + Y
Sbjct: 108 ALALDHLHSLGII-YRDLKPENILLDEEGHIKLTDFGLS--KESIDHEKKAYSFCGTVEY 164
Query: 93 KAPELL-RQPHLPRGTQKGDVYSFGLVLYEVI 123
APE++ R+ H TQ D +SFG++++E++
Sbjct: 165 MAPEVVNRRGH----TQSADWWSFGVLMFEML 192
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
Conserved Domains Detected by HHsearch 
Original result of HHsearch against CDD database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Probability ![]() |
| Query | 423 | |||
| KOG1023|consensus | 484 | 100.0 | ||
| KOG4171|consensus | 671 | 100.0 | ||
| KOG0192|consensus | 362 | 99.98 | ||
| KOG0197|consensus | 468 | 99.97 | ||
| KOG0581|consensus | 364 | 99.97 | ||
| KOG0193|consensus | 678 | 99.97 | ||
| KOG0591|consensus | 375 | 99.96 | ||
| KOG0575|consensus | 592 | 99.96 | ||
| KOG4721|consensus | 904 | 99.96 | ||
| KOG0615|consensus | 475 | 99.96 | ||
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 99.96 | |
| KOG1026|consensus | 774 | 99.95 | ||
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 99.95 | |
| KOG0582|consensus | 516 | 99.95 | ||
| KOG0198|consensus | 313 | 99.95 | ||
| PHA02988 | 283 | hypothetical protein; Provisional | 99.95 | |
| KOG0592|consensus | 604 | 99.95 | ||
| KOG1095|consensus | 1025 | 99.95 | ||
| KOG0598|consensus | 357 | 99.95 | ||
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 99.95 | |
| KOG0201|consensus | 467 | 99.94 | ||
| KOG0578|consensus | 550 | 99.94 | ||
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 99.94 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 99.94 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 99.94 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 99.94 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 99.94 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 99.94 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 99.94 | |
| KOG0583|consensus | 370 | 99.94 | ||
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 99.94 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 99.94 | |
| KOG0983|consensus | 391 | 99.94 | ||
| KOG0588|consensus | 786 | 99.94 | ||
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 99.94 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 99.93 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 99.93 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 99.93 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 99.93 | |
| KOG0661|consensus | 538 | 99.93 | ||
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 99.93 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 99.93 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 99.93 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 99.93 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 99.93 | |
| KOG0599|consensus | 411 | 99.93 | ||
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 99.93 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 99.93 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 99.93 | |
| KOG0585|consensus | 576 | 99.93 | ||
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 99.93 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 99.93 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 99.93 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 99.93 | |
| KOG0593|consensus | 396 | 99.93 | ||
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 99.93 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 99.93 | |
| KOG0595|consensus | 429 | 99.93 | ||
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 99.93 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 99.93 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 99.93 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 99.93 | |
| KOG1187|consensus | 361 | 99.93 | ||
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 99.93 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 99.93 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 99.93 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 99.93 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 99.93 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 99.93 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 99.93 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 99.93 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 99.93 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 99.93 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 99.93 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 99.93 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 99.93 | |
| KOG4278|consensus | 1157 | 99.92 | ||
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 99.92 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 99.92 | |
| KOG0033|consensus | 355 | 99.92 | ||
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 99.92 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 99.92 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 99.92 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 99.92 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 99.92 | |
| KOG2345|consensus | 302 | 99.92 | ||
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 99.92 | |
| KOG0660|consensus | 359 | 99.92 | ||
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 99.92 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 99.92 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 99.92 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 99.92 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 99.92 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 99.92 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 99.92 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 99.92 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 99.92 | |
| KOG0196|consensus | 996 | 99.92 | ||
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 99.92 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 99.92 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 99.92 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 99.92 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 99.92 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 99.92 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 99.92 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 99.92 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 99.92 | |
| KOG0616|consensus | 355 | 99.92 | ||
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 99.92 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 99.92 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 99.92 | |
| KOG0194|consensus | 474 | 99.92 | ||
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 99.92 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 99.92 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 99.92 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 99.92 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 99.92 | |
| KOG4257|consensus | 974 | 99.92 | ||
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 99.92 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 99.92 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 99.92 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 99.92 | |
| KOG0200|consensus | 609 | 99.92 | ||
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 99.92 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 99.92 | |
| KOG1024|consensus | 563 | 99.92 | ||
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 99.92 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 99.92 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 99.92 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 99.92 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 99.92 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 99.92 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 99.92 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 99.92 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 99.92 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 99.92 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 99.92 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 99.92 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 99.92 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 99.92 | |
| KOG0694|consensus | 694 | 99.92 | ||
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 99.92 | |
| KOG0597|consensus | 808 | 99.92 | ||
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 99.92 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 99.92 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 99.92 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 99.92 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 99.92 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 99.92 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 99.92 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 99.92 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 99.92 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 99.92 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 99.92 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 99.91 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 99.91 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 99.91 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 99.91 | |
| KOG0596|consensus | 677 | 99.91 | ||
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 99.91 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 99.91 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 99.91 | |
| KOG0600|consensus | 560 | 99.91 | ||
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 99.91 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 99.91 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 99.91 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 99.91 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 99.91 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 99.91 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 99.91 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 99.91 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 99.91 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 99.91 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 99.91 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 99.91 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 99.91 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 99.91 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 99.91 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 99.91 | |
| PTZ00284 | 467 | protein kinase; Provisional | 99.91 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 99.91 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 99.91 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 99.91 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.91 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 99.91 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 99.91 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 99.91 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 99.91 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 99.91 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 99.91 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 99.91 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 99.91 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 99.91 | |
| KOG0589|consensus | 426 | 99.91 | ||
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 99.91 | |
| KOG1094|consensus | 807 | 99.91 | ||
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 99.91 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 99.91 | |
| KOG0658|consensus | 364 | 99.91 | ||
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 99.91 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 99.91 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 99.91 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 99.91 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 99.91 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 99.91 | |
| KOG0199|consensus | 1039 | 99.91 | ||
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 99.91 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 99.91 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 99.91 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 99.91 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 99.91 | |
| KOG0594|consensus | 323 | 99.91 | ||
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 99.91 | |
| KOG0659|consensus | 318 | 99.91 | ||
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 99.91 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 99.91 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 99.91 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 99.9 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 99.9 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 99.9 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 99.9 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 99.9 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 99.9 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 99.9 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 99.9 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 99.9 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 99.9 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 99.9 | |
| KOG0579|consensus | 1187 | 99.9 | ||
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 99.9 | |
| KOG1035|consensus | 1351 | 99.9 | ||
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 99.9 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 99.9 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 99.9 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 99.9 | |
| KOG0603|consensus | 612 | 99.9 | ||
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 99.9 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 99.9 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 99.9 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 99.9 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 99.9 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 99.9 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 99.9 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 99.9 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 99.9 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 99.9 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 99.9 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 99.9 | |
| KOG0577|consensus | 948 | 99.9 | ||
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 99.9 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 99.9 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 99.9 | |
| KOG1989|consensus | 738 | 99.9 | ||
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 99.9 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 99.9 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 99.9 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 99.9 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 99.9 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 99.9 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 99.9 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 99.9 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 99.9 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 99.9 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 99.9 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 99.9 | |
| KOG0611|consensus | 668 | 99.9 | ||
| KOG0605|consensus | 550 | 99.9 | ||
| KOG4279|consensus | 1226 | 99.9 | ||
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 99.9 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 99.9 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 99.9 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 99.89 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 99.89 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 99.89 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 99.89 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 99.89 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 99.89 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 99.89 | |
| KOG0604|consensus | 400 | 99.89 | ||
| KOG4645|consensus | 1509 | 99.89 | ||
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 99.89 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 99.89 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 99.89 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 99.89 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 99.89 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 99.89 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 99.89 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 99.89 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 99.89 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 99.89 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 99.89 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 99.89 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 99.89 | |
| KOG0032|consensus | 382 | 99.89 | ||
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 99.89 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 99.89 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 99.89 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 99.89 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 99.89 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 99.89 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 99.89 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 99.89 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 99.89 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 99.89 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 99.89 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 99.88 | |
| KOG0584|consensus | 632 | 99.88 | ||
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 99.88 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 99.88 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 99.88 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 99.88 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 99.88 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 99.88 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 99.88 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 99.88 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 99.88 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 99.88 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 99.88 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 99.88 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 99.88 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 99.88 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 99.88 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 99.88 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 99.88 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 99.88 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 99.88 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 99.88 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 99.88 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 99.88 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 99.88 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 99.88 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 99.88 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 99.88 | |
| KOG0667|consensus | 586 | 99.88 | ||
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 99.88 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 99.88 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 99.88 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 99.88 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 99.88 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 99.87 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 99.87 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 99.87 | |
| KOG0663|consensus | 419 | 99.87 | ||
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 99.87 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 99.87 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 99.87 | |
| KOG1027|consensus | 903 | 99.87 | ||
| KOG0580|consensus | 281 | 99.87 | ||
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 99.87 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 99.87 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 99.87 | |
| KOG0986|consensus | 591 | 99.87 | ||
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.87 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 99.87 | |
| KOG1025|consensus | 1177 | 99.87 | ||
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 99.87 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 99.87 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 99.87 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 99.87 | |
| KOG4717|consensus | 864 | 99.87 | ||
| KOG1006|consensus | 361 | 99.87 | ||
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 99.86 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 99.86 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 99.86 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 99.86 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 99.86 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 99.86 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 99.86 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 99.86 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 99.86 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.86 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.85 | |
| KOG0614|consensus | 732 | 99.85 | ||
| KOG2052|consensus | 513 | 99.85 | ||
| KOG3653|consensus | 534 | 99.85 | ||
| KOG0690|consensus | 516 | 99.85 | ||
| KOG0574|consensus | 502 | 99.85 | ||
| KOG0696|consensus | 683 | 99.84 | ||
| KOG0984|consensus | 282 | 99.84 | ||
| KOG0610|consensus | 459 | 99.84 | ||
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 99.84 | |
| KOG0666|consensus | 438 | 99.83 | ||
| KOG0671|consensus | 415 | 99.83 | ||
| KOG0669|consensus | 376 | 99.83 | ||
| KOG0664|consensus | 449 | 99.82 | ||
| KOG4236|consensus | 888 | 99.81 | ||
| KOG1151|consensus | 775 | 99.8 | ||
| KOG0586|consensus | 596 | 99.8 | ||
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 99.8 | |
| KOG0612|consensus | 1317 | 99.8 | ||
| KOG0607|consensus | 463 | 99.8 | ||
| KOG0665|consensus | 369 | 99.79 | ||
| KOG0695|consensus | 593 | 99.79 | ||
| KOG4250|consensus | 732 | 99.76 | ||
| KOG0587|consensus | 953 | 99.76 | ||
| KOG0668|consensus | 338 | 99.75 | ||
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.74 | |
| KOG0608|consensus | 1034 | 99.73 | ||
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.71 | |
| KOG0662|consensus | 292 | 99.7 | ||
| KOG0670|consensus | 752 | 99.7 | ||
| KOG1345|consensus | 378 | 99.69 | ||
| KOG0195|consensus | 448 | 99.68 | ||
| KOG0590|consensus | 601 | 99.68 | ||
| KOG0576|consensus | 829 | 99.63 | ||
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.62 | |
| KOG1152|consensus | 772 | 99.59 | ||
| KOG1240|consensus | 1431 | 99.59 | ||
| KOG3618|consensus | 1318 | 99.59 | ||
| KOG3619|consensus | 867 | 99.56 | ||
| KOG0606|consensus | 1205 | 99.55 | ||
| KOG4158|consensus | 598 | 99.54 | ||
| KOG1290|consensus | 590 | 99.53 | ||
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.52 | |
| KOG1033|consensus | 516 | 99.52 | ||
| KOG1164|consensus | 322 | 99.51 | ||
| KOG1167|consensus | 418 | 99.5 | ||
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.49 | |
| KOG0603|consensus | 612 | 99.46 | ||
| smart00044 | 194 | CYCc Adenylyl- / guanylyl cyclase, catalytic domai | 99.35 | |
| KOG1163|consensus | 341 | 99.19 | ||
| KOG1165|consensus | 449 | 99.19 | ||
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.14 | |
| KOG0590|consensus | 601 | 99.05 | ||
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.0 | |
| KOG1166|consensus | 974 | 98.91 | ||
| KOG2137|consensus | 700 | 98.79 | ||
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 98.79 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 98.78 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 98.76 | |
| PF00211 | 184 | Guanylate_cyc: Adenylate and Guanylate cyclase cat | 98.71 | |
| KOG3618|consensus | 1318 | 98.7 | ||
| COG2114 | 227 | CyaA Adenylate cyclase, family 3 (some proteins co | 98.62 | |
| KOG1266|consensus | 458 | 98.61 | ||
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.61 | |
| KOG3619|consensus | 867 | 98.5 | ||
| KOG0606|consensus | 1205 | 98.49 | ||
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 98.47 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 98.45 | |
| smart00090 | 237 | RIO RIO-like kinase. | 98.45 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 98.3 | |
| KOG0601|consensus | 524 | 98.28 | ||
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 98.28 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 98.25 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 98.25 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 98.19 | |
| cd07302 | 177 | CHD cyclase homology domain. Catalytic domains of | 98.04 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 97.88 | |
| PF07701 | 219 | HNOBA: Heme NO binding associated; InterPro: IPR01 | 97.81 | |
| KOG1243|consensus | 690 | 97.72 | ||
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 97.7 | |
| KOG0601|consensus | 524 | 97.7 | ||
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 97.63 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 97.62 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 97.51 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 97.37 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 97.3 | |
| KOG3087|consensus | 229 | 97.22 | ||
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 96.94 | |
| KOG3741|consensus | 655 | 96.85 | ||
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 96.62 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 96.26 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 96.16 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 94.8 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 94.26 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 93.25 | |
| KOG1035|consensus | 1351 | 92.87 | ||
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 91.11 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 90.69 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 89.81 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 89.34 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 88.86 | |
| PRK10271 | 188 | thiK thiamine kinase; Provisional | 88.5 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 88.45 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 88.4 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 88.33 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 87.8 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 87.18 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 87.04 | |
| KOG0576|consensus | 829 | 86.98 | ||
| COG5072 | 488 | ALK1 Serine/threonine kinase of the haspin family | 85.7 | |
| KOG1826|consensus | 2724 | 84.91 | ||
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 84.73 | |
| PF01633 | 211 | Choline_kinase: Choline/ethanolamine kinase; Inter | 83.41 | |
| smart00587 | 196 | CHK ZnF_C4 abd HLH domain containing kinases domai | 83.36 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 82.35 | |
| COG0510 | 269 | ycfN Thiamine kinase and related kinases [Coenzyme | 82.31 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 82.31 | |
| TIGR02904 | 309 | spore_ysxE spore coat protein YsxE. Members of thi | 82.29 | |
| PF07387 | 308 | Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099 | 82.23 |
| >KOG1023|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-59 Score=466.78 Aligned_cols=316 Identities=43% Similarity=0.654 Sum_probs=273.7
Q ss_pred HHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCccEEEeccCCcccccCCCcccccccccCCccccCCccccCCCCC
Q psy1840 25 SISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKAPELLRQPHLP 104 (423)
Q Consensus 25 ~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~ 104 (423)
+.+++.+|+.||.|||.+.+.+||.|++.||++|.+|.+||+|||+.....................|.|||.+++....
T Consensus 50 ~~s~~rdi~~Gl~ylh~s~i~~hg~l~s~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~ 129 (484)
T KOG1023|consen 50 ILSFIRDISKGLAYLHNSPIGYHGALKSSNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQ 129 (484)
T ss_pred HHHHHHHHHHHHHHHhcCcceeeeeeccccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccc
Confidence 78999999999999999998789999999999999999999999998766431111111223345679999999985321
Q ss_pred C----CCCccchHHHHHHHHHHHhCCCCCCCC--CCChHHHHHHHhc-C-CCCCCCCCCC-CchHHHHHHHHHhhhcCCC
Q psy1840 105 R----GTQKGDVYSFGLVLYEVIGRQGPWGHL--RMTDEEIITSVTQ-G-SGLRPDTSSL-DCAPSIIACMRTCWEEDPE 175 (423)
Q Consensus 105 ~----~s~ksDVyS~Giil~elltg~~Pf~~~--~~~~~~i~~~i~~-~-~~~~p~~~~~-~~~~~l~~Li~~C~~~dP~ 175 (423)
. .++++||||||++++|+++++.||... ...+.+++..+.. + .+.+|..... ..++.+..++++||.++|+
T Consensus 130 ~~~~~~~~~gdiYs~~ii~~ei~~r~~~~~~~~~~~~~~eii~~~~~~~~~~~rP~i~~~~e~~~~l~~l~~~cw~e~P~ 209 (484)
T KOG1023|consen 130 SLESALTQKGDIYSFGIIMYEILFRSGPFDLRNLVEDPDEIILRVKKGGSNPFRPSIELLNELPPELLLLVARCWEEIPE 209 (484)
T ss_pred cccccccccCCeehHHHHHHHHHhccCccccccccCChHHHHHHHHhcCCCCcCcchhhhhhcchHHHHHHHHhcccChh
Confidence 2 588999999999999999999999763 4445678888877 3 3467776643 5677899999999999999
Q ss_pred CCCCHHHHHHHHHHHhhhc--CCChHHHHHHHHHHhhhcccccchhhHHhhccCCCCCCCCchhhHHHHHHHHHhhhhhh
Q psy1840 176 LRPDLRFVHHKLKEMNAGL--KANIFDNMLAIMEKYAFNLEGEWTDWTASLRRRPKMGPCSRAASRILVFWLFGLLDKIC 253 (423)
Q Consensus 176 ~RPt~~~I~~~L~~i~~~~--~~~~~d~~~~~~e~~~~~lE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 253 (423)
+||++.+|...++.+.... +.+++|+++.+|++|+++||+
T Consensus 210 ~rPs~~~i~~~~~~~~~~~~~~~nl~D~m~~~le~Y~~nLe~-------------------------------------- 251 (484)
T KOG1023|consen 210 KRPSIEQIRSKLLTINKGGSSKGNLMDSLFRMLESYADNLEK-------------------------------------- 251 (484)
T ss_pred hCccHHHHHhhhhhhcccccccchhHHHHHHHHHHHHhhhHH--------------------------------------
Confidence 9999999999999999875 469999999999999999999
Q ss_pred heeeeechhhhhhhhhhhccccccchhhhhhcccccccccchhhHHHHHHHHHHHHHHHHHHHHhhCcHHHHHHHhCCCC
Q psy1840 254 TIFVFLSETKAENWALHQGRIQDFGFWAFWFTGQNLHHFRVPGLVQERTNQLTQEKKKTDALLHRMLPRSVSESLKRGDF 333 (423)
Q Consensus 254 ~~~~~~~~~~~~n~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~~~~~l~~e~~~~~~ll~~~lp~~ia~~l~~g~~ 333 (423)
.|+|++++|+.|++|+|.||++|||++||++||.|+.
T Consensus 252 -------------------------------------------~v~eRt~~l~~e~~k~d~LL~~mLP~~VA~~lk~G~~ 288 (484)
T KOG1023|consen 252 -------------------------------------------LVDERTAELEEEKKKTDTLLGQMLPKSVAESLKLGKT 288 (484)
T ss_pred -------------------------------------------HHHHHHHHHHHHHHHHHHHHHHhcCHHHhhHhhcCCc
Confidence 9999999999999999999999999999999999999
Q ss_pred CCCccccceeEEEeeccccccccccCCHhHHHHhhhccch-hhhhccCCCceEEEeecccCC---------CcchHHHH-
Q psy1840 334 VEPESFDSVTIYFSDIVGFTQLSAESTETGRVTTRDSRRT-PDLKVGGSNPRQVITGTDMLR---------HRPHESKV- 402 (423)
Q Consensus 334 ~~~~~~~~vtv~f~di~gft~~~~~~~p~~~v~~ln~~~~-fd~~~~~~~~~~v~~~~~~~~---------~~~~~~~~- 402 (423)
|.|+.|++|||+|+||||||.+|+.++|++||++|||+|+ ||.+|+.+|+|||||+||.|| ...|+.+|
T Consensus 289 v~pe~~~~vti~fsDiv~fT~l~~~~~P~~vv~~lNdlyt~Fd~ii~~~d~yKVetiGDaYmvvSglp~~n~~~H~~eia 368 (484)
T KOG1023|consen 289 VDPESFDSVTIYFSDIVGFTVLSSNSTPIQVVTLLNDLYTTFDRIIDKHDVYKVETIGDAYMVVSGLPIRNGYRHAREIA 368 (484)
T ss_pred CCccccCceeeeeHHHHHHHHHHhcCCCceeeeeccchHHhhhhcccccCCeeEeccCcceeecccCceecHhHHHHHHH
Confidence 9999999999999999999999999999999999999999 999999999999999999999 44578887
Q ss_pred hhhhhhchHhh-hhhcCCCC
Q psy1840 403 SLALSSLSIAD-IQMLRPTN 421 (423)
Q Consensus 403 ~~~~~~~~~~~-~~~~~~~~ 421 (423)
.|+|.+++.+. +.++|++.
T Consensus 369 ~msl~~~~~~~~f~i~H~P~ 388 (484)
T KOG1023|consen 369 SMALGLRSFLESFSLPHRPW 388 (484)
T ss_pred HHHHHHHHHHhccCCCCCCc
Confidence 67888776653 56666665
|
|
| >KOG4171|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-34 Score=289.56 Aligned_cols=160 Identities=31% Similarity=0.352 Sum_probs=141.7
Q ss_pred hhhhhheeeeechhhhhhhhhhhccccccchhhhhhcccccccccchhhHHHHHHHHHHHHHHHHHHHHhhCcHHHHHHH
Q psy1840 249 LDKICTIFVFLSETKAENWALHQGRIQDFGFWAFWFTGQNLHHFRVPGLVQERTNQLTQEKKKTDALLHRMLPRSVSESL 328 (423)
Q Consensus 249 ~~~~~~~~~~~~~~~~~n~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~~~~~l~~e~~~~~~ll~~~lp~~ia~~l 328 (423)
++.+....+|++ +.+.+.++|+..+-.-...+...-+...++. +..+++.+++|+.||+|+|+|||+|+|++||++|
T Consensus 353 LdeL~~~GLyLs-DiplHDatRDlILl~~Q~~aq~el~~~lE~~--~~~Le~~~~~Le~EKkkTd~LLy~mlP~~VA~qL 429 (671)
T KOG4171|consen 353 LDELTGRGLYLS-DIPLHDATRDLVLLGQQRRAQLELNLELEKL--KEKLEKMTRELEEEKKKTDTLLYSMLPRSVAQQL 429 (671)
T ss_pred hHHHHhCCceec-cCCccccchhheecchHHHHHHHHHHHHHHH--HHHHHHHHHHHHHHHhhHHHHHHHhCCHHHHHHH
Confidence 777777777776 9999999999988887777777665555444 5699999999999999999999999999999999
Q ss_pred hCCCCCCCccccceeEEEeeccccccccccCCHhHHHHhhhccch-hhhhccCCCceEEEeecccCC-----------Cc
Q psy1840 329 KRGDFVEPESFDSVTIYFSDIVGFTQLSAESTETGRVTTRDSRRT-PDLKVGGSNPRQVITGTDMLR-----------HR 396 (423)
Q Consensus 329 ~~g~~~~~~~~~~vtv~f~di~gft~~~~~~~p~~~v~~ln~~~~-fd~~~~~~~~~~v~~~~~~~~-----------~~ 396 (423)
++|+.+.|++|++|||+|+||||||++|+.|+|+|||++||++|| ||++|+.+|||||||+||.|| ||
T Consensus 430 r~g~~v~a~~f~~vTilFsdIv~Ft~ic~~ctp~~vV~~LN~lyt~fD~~i~~~~VYKVETIGDaYm~vsG~P~~~~~HA 509 (671)
T KOG4171|consen 430 RQGESVDAKEFDDVTILFSDIVGFTAICSQCTPMQVVNMLNELYTRFDRIIDTHDVYKVETIGDAYMVVSGLPDASDYHA 509 (671)
T ss_pred HcCCCcCccccCceEEEEeccchHHhHhhccCcHHHHHHHHHHHHHHHHhhcccCeEEEeeccchheeecCCCCCChhHH
Confidence 999999999999999999999999999999999999999999999 999999999999999999999 66
Q ss_pred chHHHHhhhhhhchHhh
Q psy1840 397 PHESKVSLALSSLSIAD 413 (423)
Q Consensus 397 ~~~~~~~~~~~~~~~~~ 413 (423)
.+++.+| |.|+..|+
T Consensus 510 e~i~~~A--L~Mm~~ak 524 (671)
T KOG4171|consen 510 EHIADLA--LGMMEEAK 524 (671)
T ss_pred HHHHHHH--HHHHHHhh
Confidence 6666655 55555554
|
|
| >KOG0192|consensus | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.4e-32 Score=267.65 Aligned_cols=161 Identities=34% Similarity=0.575 Sum_probs=132.8
Q ss_pred HHHHHHHHHHHHHHHHhCC-CeeecCCCCCCEEEcCCc-cEEEeccCCcccccCCCcccccccccCCccccCCccccCCC
Q psy1840 25 SISVNTTASVGMIHLHDSE-IISHGNLRSSNCLIDSRW-VLQIADFGLHAFKAGQDETGQERKLRRRKLYKAPELLRQPH 102 (423)
Q Consensus 25 ~l~i~~qi~~gL~yLH~~~-ii~HrDLkp~NILld~~~-~vKL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~ 102 (423)
++.++.||+.||+|||+.+ || ||||||+|||++.++ ++||+|||+++...... .......||+.|||||++++.
T Consensus 144 ~l~~aldiArGm~YLH~~~~iI-HrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~~--~~~~~~~GT~~wMAPEv~~~~- 219 (362)
T KOG0192|consen 144 RLRIALDIARGMEYLHSEGPII-HRDLKSDNILVDLKGKTLKIADFGLSREKVISK--TSMTSVAGTYRWMAPEVLRGE- 219 (362)
T ss_pred HHHHHHHHHHHHHHHhcCCCee-ecccChhhEEEcCCCCEEEECCCccceeecccc--ccccCCCCCccccChhhhcCC-
Confidence 7999999999999999999 67 999999999999998 99999999998765332 122336899999999999954
Q ss_pred CCCCCCccchHHHHHHHHHHHhCCCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCchHHHHHHHHHhhhcCCCCCCCHHH
Q psy1840 103 LPRGTQKGDVYSFGLVLYEVIGRQGPWGHLRMTDEEIITSVTQGSGLRPDTSSLDCAPSIIACMRTCWEEDPELRPDLRF 182 (423)
Q Consensus 103 ~~~~s~ksDVyS~Giil~elltg~~Pf~~~~~~~~~i~~~i~~~~~~~p~~~~~~~~~~l~~Li~~C~~~dP~~RPt~~~ 182 (423)
...++.|+|||||||++|||+||+.||.+. ...++...+..+ ..+|..+. .+++.+..+|.+||+.||+.||+|.+
T Consensus 220 ~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~--~~~~~~~~v~~~-~~Rp~~p~-~~~~~l~~l~~~CW~~dp~~RP~f~e 295 (362)
T KOG0192|consen 220 KSPYTEKSDVYSFGIVLWELLTGEIPFEDL--APVQVASAVVVG-GLRPPIPK-ECPPHLSSLMERCWLVDPSRRPSFLE 295 (362)
T ss_pred CCcCCccchhhhHHHHHHHHHHCCCCCCCC--CHHHHHHHHHhc-CCCCCCCc-cCCHHHHHHHHHhCCCCCCcCCCHHH
Confidence 123499999999999999999999999854 335555555432 24454443 48999999999999999999999999
Q ss_pred HHHHHHHHhhh
Q psy1840 183 VHHKLKEMNAG 193 (423)
Q Consensus 183 I~~~L~~i~~~ 193 (423)
|+..|..+...
T Consensus 296 i~~~l~~~~~~ 306 (362)
T KOG0192|consen 296 IVSRLESIMSH 306 (362)
T ss_pred HHHHHHHHHHh
Confidence 99999887653
|
|
| >KOG0197|consensus | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-31 Score=263.98 Aligned_cols=159 Identities=28% Similarity=0.529 Sum_probs=134.4
Q ss_pred HHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCccEEEeccCCcccccCCCcccccccccCCccccCCccccCCCCC
Q psy1840 25 SISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKAPELLRQPHLP 104 (423)
Q Consensus 25 ~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~ 104 (423)
-+.++.|||+||+||+++++| ||||..+||||+.+..+||+|||+++...+. .........-...|+|||.+....+
T Consensus 305 Ll~~a~qIaeGM~YLes~~~I-HRDLAARNiLV~~~~~vKIsDFGLAr~~~d~-~Y~~~~~~kfPIkWtAPEa~~~~~F- 381 (468)
T KOG0197|consen 305 LLDFAAQIAEGMAYLESKNYI-HRDLAARNILVDEDLVVKISDFGLARLIGDD-EYTASEGGKFPIKWTAPEALNYGKF- 381 (468)
T ss_pred HHHHHHHHHHHHHHHHhCCcc-chhhhhhheeeccCceEEEcccccccccCCC-ceeecCCCCCCceecCHHHHhhCCc-
Confidence 489999999999999999999 9999999999999999999999999954333 2222222233455999999988766
Q ss_pred CCCCccchHHHHHHHHHHHh-CCCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCchHHHHHHHHHhhhcCCCCCCCHHHH
Q psy1840 105 RGTQKGDVYSFGLVLYEVIG-RQGPWGHLRMTDEEIITSVTQGSGLRPDTSSLDCAPSIIACMRTCWEEDPELRPDLRFV 183 (423)
Q Consensus 105 ~~s~ksDVyS~Giil~ellt-g~~Pf~~~~~~~~~i~~~i~~~~~~~p~~~~~~~~~~l~~Li~~C~~~dP~~RPt~~~I 183 (423)
+.|||||||||+||||+| |+.||. .++..++++.+.+|..... +..||+++.++|+.||+.+|++||||..+
T Consensus 382 --S~kSDVWSFGVlL~E~fT~G~~py~--~msn~ev~~~le~GyRlp~---P~~CP~~vY~lM~~CW~~~P~~RPtF~~L 454 (468)
T KOG0197|consen 382 --SSKSDVWSFGVLLWELFTYGRVPYP--GMSNEEVLELLERGYRLPR---PEGCPDEVYELMKSCWHEDPEDRPTFETL 454 (468)
T ss_pred --ccccceeehhhhHHHHhccCCCCCC--CCCHHHHHHHHhccCcCCC---CCCCCHHHHHHHHHHhhCCcccCCCHHHH
Confidence 999999999999999998 788987 6788999999999864432 23699999999999999999999999999
Q ss_pred HHHHHHHhhh
Q psy1840 184 HHKLKEMNAG 193 (423)
Q Consensus 184 ~~~L~~i~~~ 193 (423)
...+.++...
T Consensus 455 ~~~l~~~~~~ 464 (468)
T KOG0197|consen 455 REVLEDFFTS 464 (468)
T ss_pred HHHHHHhhhc
Confidence 9888877653
|
|
| >KOG0581|consensus | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.2e-31 Score=250.47 Aligned_cols=151 Identities=22% Similarity=0.383 Sum_probs=130.2
Q ss_pred HHHHHHHHHHHHHHHh-CCCeeecCCCCCCEEEcCCccEEEeccCCcccccCCCcccccccccCCccccCCccccCCCCC
Q psy1840 26 ISVNTTASVGMIHLHD-SEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKAPELLRQPHLP 104 (423)
Q Consensus 26 l~i~~qi~~gL~yLH~-~~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~ 104 (423)
-+++.++++||.|||. .+|| ||||||+|+||+++|.|||||||.++.+... ...++.||..|||||.+.+..+
T Consensus 181 ~~ia~~VL~GL~YLh~~~~II-HRDIKPsNlLvNskGeVKicDFGVS~~lvnS----~a~tfvGT~~YMsPERi~g~~Y- 254 (364)
T KOG0581|consen 181 GKIARAVLRGLSYLHEERKII-HRDIKPSNLLVNSKGEVKICDFGVSGILVNS----IANTFVGTSAYMSPERISGESY- 254 (364)
T ss_pred HHHHHHHHHHHHHHhhccCee-eccCCHHHeeeccCCCEEeccccccHHhhhh----hcccccccccccChhhhcCCcC-
Confidence 3899999999999996 7887 9999999999999999999999999876544 3367899999999999999876
Q ss_pred CCCCccchHHHHHHHHHHHhCCCCCCCC---CCChHHHHHHHhcCCCCCCCCCCCCchHHHHHHHHHhhhcCCCCCCCHH
Q psy1840 105 RGTQKGDVYSFGLVLYEVIGRQGPWGHL---RMTDEEIITSVTQGSGLRPDTSSLDCAPSIIACMRTCWEEDPELRPDLR 181 (423)
Q Consensus 105 ~~s~ksDVyS~Giil~elltg~~Pf~~~---~~~~~~i~~~i~~~~~~~p~~~~~~~~~~l~~Li~~C~~~dP~~RPt~~ 181 (423)
+.++||||||+.++|+.+|+.||... .....+++..|..+++.+ .+...+++++..++..|+++||.+||++.
T Consensus 255 --s~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv~~ppP~--lP~~~fS~ef~~FV~~CL~Kdp~~R~s~~ 330 (364)
T KOG0581|consen 255 --SVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAIVDEPPPR--LPEGEFSPEFRSFVSCCLRKDPSERPSAK 330 (364)
T ss_pred --CcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHHhcCCCCC--CCcccCCHHHHHHHHHHhcCCcccCCCHH
Confidence 89999999999999999999999753 345677888888764333 33335999999999999999999999999
Q ss_pred HHHHH
Q psy1840 182 FVHHK 186 (423)
Q Consensus 182 ~I~~~ 186 (423)
+++++
T Consensus 331 qLl~H 335 (364)
T KOG0581|consen 331 QLLQH 335 (364)
T ss_pred HHhcC
Confidence 99775
|
|
| >KOG0193|consensus | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-30 Score=260.21 Aligned_cols=165 Identities=28% Similarity=0.445 Sum_probs=135.1
Q ss_pred HHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCccEEEeccCCcccccCCCcccccccccCCccccCCccccCCCCC
Q psy1840 25 SISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKAPELLRQPHLP 104 (423)
Q Consensus 25 ~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~ 104 (423)
-+.|+.||++||.|||.++|| |||||+.||++.++++|||+|||++....--..........|...|||||+++.....
T Consensus 490 ~idIAqQiaqGM~YLHAK~II-HrDLKSnNIFl~~~~kVkIgDFGLatvk~~w~g~~q~~qp~gsilwmAPEvIRmqd~n 568 (678)
T KOG0193|consen 490 TIDIAQQIAQGMDYLHAKNII-HRDLKSNNIFLHEDLKVKIGDFGLATVKTRWSGEQQLEQPHGSLLWMAPEVIRMQDDN 568 (678)
T ss_pred HHHHHHHHHHhhhhhhhhhhh-hhhccccceEEccCCcEEEecccceeeeeeeccccccCCCccchhhhcHHHHhhcccC
Confidence 379999999999999999999 9999999999999999999999997643222222223445678889999999977655
Q ss_pred CCCCccchHHHHHHHHHHHhCCCCCCCCCCChHHHHHHHhcCCC-CCCCCCCCCchHHHHHHHHHhhhcCCCCCCCHHHH
Q psy1840 105 RGTQKGDVYSFGLVLYEVIGRQGPWGHLRMTDEEIITSVTQGSG-LRPDTSSLDCAPSIIACMRTCWEEDPELRPDLRFV 183 (423)
Q Consensus 105 ~~s~ksDVyS~Giil~elltg~~Pf~~~~~~~~~i~~~i~~~~~-~~p~~~~~~~~~~l~~Li~~C~~~dP~~RPt~~~I 183 (423)
+++..+||||||||+|||++|..||. ....++++-.+-+|.. .++.....+|+.++.+|+..||..++++||.|.+|
T Consensus 569 PfS~qSDVYaFGiV~YELltg~lPys--i~~~dqIifmVGrG~l~pd~s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~i 646 (678)
T KOG0193|consen 569 PFSFQSDVYAFGIVWYELLTGELPYS--IQNRDQIIFMVGRGYLMPDLSKIRSNCPKAMKRLLSDCWKFDREERPLFPQL 646 (678)
T ss_pred CCCcccchhhhhHHHHHHHhCcCCcC--CCChhheEEEecccccCccchhhhccCHHHHHHHHHHHHhcCcccCccHHHH
Confidence 77999999999999999999999997 3445666666666521 22333356899999999999999999999999999
Q ss_pred HHHHHHHhh
Q psy1840 184 HHKLKEMNA 192 (423)
Q Consensus 184 ~~~L~~i~~ 192 (423)
+..|..+..
T Consensus 647 l~~l~~l~~ 655 (678)
T KOG0193|consen 647 LSKLEELLP 655 (678)
T ss_pred HHHHHHhhh
Confidence 998877765
|
|
| >KOG0591|consensus | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.1e-28 Score=226.34 Aligned_cols=153 Identities=22% Similarity=0.367 Sum_probs=130.0
Q ss_pred HHHHHHHHHHHHHHHh---CCCeeecCCCCCCEEEcCCccEEEeccCCcccccCCCcccccccccCCccccCCccccCCC
Q psy1840 26 ISVNTTASVGMIHLHD---SEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKAPELLRQPH 102 (423)
Q Consensus 26 l~i~~qi~~gL~yLH~---~~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~ 102 (423)
.++..|++.||.++|+ +|.|.||||||.||+|+.+|.|||+|||+++++.... ....+..|||.||+||.+.+..
T Consensus 127 wk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~l~s~~--tfA~S~VGTPyYMSPE~i~~~~ 204 (375)
T KOG0591|consen 127 WKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGRFLSSKT--TFAHSLVGTPYYMSPERIHESG 204 (375)
T ss_pred HHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHhHhcchh--HHHHhhcCCCcccCHHHHhcCC
Confidence 5889999999999998 3666799999999999999999999999999875332 2345789999999999999887
Q ss_pred CCCCCCccchHHHHHHHHHHHhCCCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCchHHHHHHHHHhhhcCCCCCCCHHH
Q psy1840 103 LPRGTQKGDVYSFGLVLYEVIGRQGPWGHLRMTDEEIITSVTQGSGLRPDTSSLDCAPSIIACMRTCWEEDPELRPDLRF 182 (423)
Q Consensus 103 ~~~~s~ksDVyS~Giil~elltg~~Pf~~~~~~~~~i~~~i~~~~~~~p~~~~~~~~~~l~~Li~~C~~~dP~~RPt~~~ 182 (423)
+ +.|+||||+||++|||+.-+.||.+. +..++..++.++.. |+.+...++..+..|+..|+..||+.||+...
T Consensus 205 Y---~~kSDiWslGCllyEMcaL~~PF~g~--n~~~L~~KI~qgd~--~~~p~~~YS~~l~~li~~ci~vd~~~RP~t~~ 277 (375)
T KOG0591|consen 205 Y---NFKSDIWSLGCLLYEMCALQSPFYGD--NLLSLCKKIEQGDY--PPLPDEHYSTDLRELINMCIAVDPEQRPDTVP 277 (375)
T ss_pred C---CcchhHHHHHHHHHHHHhcCCCcccc--cHHHHHHHHHcCCC--CCCcHHHhhhHHHHHHHHHccCCcccCCCcch
Confidence 6 99999999999999999999999864 66788899998843 44444568899999999999999999998644
Q ss_pred HHHHH
Q psy1840 183 VHHKL 187 (423)
Q Consensus 183 I~~~L 187 (423)
++..+
T Consensus 278 ~v~di 282 (375)
T KOG0591|consen 278 YVQDI 282 (375)
T ss_pred HHHHH
Confidence 44433
|
|
| >KOG0575|consensus | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.5e-29 Score=249.25 Aligned_cols=157 Identities=24% Similarity=0.350 Sum_probs=137.7
Q ss_pred CCCCChHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCccEEEeccCCcccccCCCcccccccccCCccccCCc
Q psy1840 17 SPFNIPIGSISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKAPE 96 (423)
Q Consensus 17 ~~~~~p~~~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE 96 (423)
.++.-|+ ...++.||+.||.|||+.+|| |||||..|++++.+.+|||+|||+|..+....+ ...+.+||+.|.|||
T Consensus 113 k~ltEpE-ary~l~QIv~GlkYLH~~~Ii-HRDLKLGNlfL~~~~~VKIgDFGLAt~le~~~E--rk~TlCGTPNYIAPE 188 (592)
T KOG0575|consen 113 KPLTEPE-ARYFLRQIVEGLKYLHSLGII-HRDLKLGNLFLNENMNVKIGDFGLATQLEYDGE--RKKTLCGTPNYIAPE 188 (592)
T ss_pred CCCCcHH-HHHHHHHHHHHHHHHHhcCce-ecccchhheeecCcCcEEecccceeeeecCccc--ccceecCCCcccChh
Confidence 4566666 468999999999999999988 999999999999999999999999987754433 336789999999999
Q ss_pred cccCCCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCchHHHHHHHHHhhhcCCCC
Q psy1840 97 LLRQPHLPRGTQKGDVYSFGLVLYEVIGRQGPWGHLRMTDEEIITSVTQGSGLRPDTSSLDCAPSIIACMRTCWEEDPEL 176 (423)
Q Consensus 97 ~l~~~~~~~~s~ksDVyS~Giil~elltg~~Pf~~~~~~~~~i~~~i~~~~~~~p~~~~~~~~~~l~~Li~~C~~~dP~~ 176 (423)
++..... +..+||||+|||+|-|+.|++||. ..+.++...+|+......|. ..+.+..+||..+|+.||.+
T Consensus 189 Vl~k~gH---sfEvDiWSlGcvmYtLL~G~PPFe--tk~vkety~~Ik~~~Y~~P~----~ls~~A~dLI~~lL~~~P~~ 259 (592)
T KOG0575|consen 189 VLNKSGH---SFEVDIWSLGCVMYTLLVGRPPFE--TKTVKETYNKIKLNEYSMPS----HLSAEAKDLIRKLLRPNPSE 259 (592)
T ss_pred HhccCCC---CCchhhhhhhhHHHhhhhCCCCcc--cchHHHHHHHHHhcCccccc----ccCHHHHHHHHHHhcCCccc
Confidence 9987655 899999999999999999999997 34568889999988877775 57889999999999999999
Q ss_pred CCCHHHHHHH
Q psy1840 177 RPDLRFVHHK 186 (423)
Q Consensus 177 RPt~~~I~~~ 186 (423)
|||+++|+..
T Consensus 260 Rpsl~~vL~h 269 (592)
T KOG0575|consen 260 RPSLDEVLDH 269 (592)
T ss_pred CCCHHHHhcC
Confidence 9999999875
|
|
| >KOG4721|consensus | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.7e-29 Score=249.74 Aligned_cols=188 Identities=25% Similarity=0.416 Sum_probs=146.2
Q ss_pred HHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCccEEEeccCCcccccCCCcccccccccCCccccCCccccCCCCC
Q psy1840 25 SISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKAPELLRQPHLP 104 (423)
Q Consensus 25 ~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~ 104 (423)
-+.|..+||.||.|||.++|| |||||+-||||..+-.|||+|||.++..... .....+.||..|||||++++...
T Consensus 214 lv~Wsk~IA~GM~YLH~hKII-HRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~---STkMSFaGTVaWMAPEvIrnePc- 288 (904)
T KOG4721|consen 214 LVDWSKGIAGGMNYLHLHKII-HRDLKSPNILISYDDVVKISDFGTSKELSDK---STKMSFAGTVAWMAPEVIRNEPC- 288 (904)
T ss_pred HHHHHHHhhhhhHHHHHhhHh-hhccCCCceEeeccceEEeccccchHhhhhh---hhhhhhhhhHhhhCHHHhhcCCc-
Confidence 478999999999999999998 9999999999999999999999998876433 33467899999999999999876
Q ss_pred CCCCccchHHHHHHHHHHHhCCCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCchHHHHHHHHHhhhcCCCCCCCHHHHH
Q psy1840 105 RGTQKGDVYSFGLVLYEVIGRQGPWGHLRMTDEEIITSVTQGSGLRPDTSSLDCAPSIIACMRTCWEEDPELRPDLRFVH 184 (423)
Q Consensus 105 ~~s~ksDVyS~Giil~elltg~~Pf~~~~~~~~~i~~~i~~~~~~~p~~~~~~~~~~l~~Li~~C~~~dP~~RPt~~~I~ 184 (423)
+.|+||||||||||||+||..||.+. ....||.-+-......| .+..||..+.-||++||+..|..||+|.+|+
T Consensus 289 --sEKVDIwSfGVVLWEmLT~EiPYkdV--dssAIIwGVGsNsL~Lp--vPstcP~GfklL~Kqcw~sKpRNRPSFrqil 362 (904)
T KOG4721|consen 289 --SEKVDIWSFGVVLWEMLTGEIPYKDV--DSSAIIWGVGSNSLHLP--VPSTCPDGFKLLLKQCWNSKPRNRPSFRQIL 362 (904)
T ss_pred --ccccceehhHHHHHHHHhcCCCcccc--chheeEEeccCCccccc--CcccCchHHHHHHHHHHhcCCCCCccHHHHH
Confidence 99999999999999999999999743 23334444433322222 2347999999999999999999999999999
Q ss_pred HHHHHHhhhcCCChHHHHHHHHHHhhhcccccchhhHHhhccCCCCC
Q psy1840 185 HKLKEMNAGLKANIFDNMLAIMEKYAFNLEGEWTDWTASLRRRPKMG 231 (423)
Q Consensus 185 ~~L~~i~~~~~~~~~d~~~~~~e~~~~~lE~~~~~~~~~~~~~~~~~ 231 (423)
..|.-... .++.+-|+--+...++|++.+...-...+..
T Consensus 363 ~HldIa~p--------ell~~tee~yf~sq~swrEevk~h~~~it~~ 401 (904)
T KOG4721|consen 363 LHLDIASP--------ELLSTTEETYFKSQASWREEVKLHFEKITSE 401 (904)
T ss_pred HHHhhcCH--------HHhcccHHHHHHHHHHHHHHHHHhhhhhccC
Confidence 99865543 3344444433444455777666655554443
|
|
| >KOG0615|consensus | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.3e-29 Score=242.99 Aligned_cols=156 Identities=22% Similarity=0.286 Sum_probs=133.7
Q ss_pred HHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCC---ccEEEeccCCcccccCCCcccccccccCCccccCCccccCCCC
Q psy1840 27 SVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSR---WVLQIADFGLHAFKAGQDETGQERKLRRRKLYKAPELLRQPHL 103 (423)
Q Consensus 27 ~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~---~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~ 103 (423)
.++.|++.|+.|||+.||+ ||||||+|||+..+ ..+||+|||+|++.. ......+.+||+.|.|||++.++..
T Consensus 280 ~~f~Qll~avkYLH~~GI~-HRDiKPeNILl~~~~e~~llKItDFGlAK~~g---~~sfm~TlCGTpsYvAPEVl~~kg~ 355 (475)
T KOG0615|consen 280 LLFKQLLTAVKYLHSQGII-HRDIKPENILLSNDAEDCLLKITDFGLAKVSG---EGSFMKTLCGTPSYVAPEVLASKGV 355 (475)
T ss_pred HHHHHHHHHHHHHHHcCcc-cccCCcceEEeccCCcceEEEecccchhhccc---cceehhhhcCCccccChhheecCCe
Confidence 5789999999999999999 99999999999766 889999999999864 2233467899999999999998775
Q ss_pred CCCCCccchHHHHHHHHHHHhCCCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCchHHHHHHHHHhhhcCCCCCCCHHHH
Q psy1840 104 PRGTQKGDVYSFGLVLYEVIGRQGPWGHLRMTDEEIITSVTQGSGLRPDTSSLDCAPSIIACMRTCWEEDPELRPDLRFV 183 (423)
Q Consensus 104 ~~~s~ksDVyS~Giil~elltg~~Pf~~~~~~~~~i~~~i~~~~~~~p~~~~~~~~~~l~~Li~~C~~~dP~~RPt~~~I 183 (423)
..+..++|+||+||++|-+++|..||.+. ..+..+.+++.+|....-+.....++++..+||..+|..||++||++.++
T Consensus 356 ~~~~~kVDiWSlGcvLfvcLsG~pPFS~~-~~~~sl~eQI~~G~y~f~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~ea 434 (475)
T KOG0615|consen 356 EYYPSKVDIWSLGCVLFVCLSGYPPFSEE-YTDPSLKEQILKGRYAFGPLQWDRISEEALDLINWMLVVDPENRPSADEA 434 (475)
T ss_pred ecccchheeeeccceEEEEeccCCCcccc-cCCccHHHHHhcCcccccChhhhhhhHHHHHHHHHhhEeCcccCcCHHHH
Confidence 44467999999999999999999999753 33445788888887766555667899999999999999999999999999
Q ss_pred HHHH
Q psy1840 184 HHKL 187 (423)
Q Consensus 184 ~~~L 187 (423)
++.-
T Consensus 435 L~hp 438 (475)
T KOG0615|consen 435 LNHP 438 (475)
T ss_pred hcCh
Confidence 8754
|
|
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.3e-28 Score=252.17 Aligned_cols=153 Identities=22% Similarity=0.383 Sum_probs=125.3
Q ss_pred HHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCccEEEeccCCcccccCCCcccccccccCCccccCCccccCCCCC
Q psy1840 25 SISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKAPELLRQPHLP 104 (423)
Q Consensus 25 ~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~ 104 (423)
...++.|++.||.|||+.+++ ||||||+|||++.++.+||+|||+++...............|++.|+|||++.+..+
T Consensus 145 ~~~i~~qll~aL~~lH~~~Ii-HrDLKP~NILl~~~~~vkL~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~- 222 (496)
T PTZ00283 145 AGLLFIQVLLAVHHVHSKHMI-HRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPY- 222 (496)
T ss_pred HHHHHHHHHHHHHHHHhCCEe-cCCCCHHHEEEeCCCCEEEEecccCeeccccccccccccccCCcceeCHHHhCCCCC-
Confidence 567899999999999999998 999999999999999999999999876543322222345678999999999987655
Q ss_pred CCCCccchHHHHHHHHHHHhCCCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCchHHHHHHHHHhhhcCCCCCCCHHHHH
Q psy1840 105 RGTQKGDVYSFGLVLYEVIGRQGPWGHLRMTDEEIITSVTQGSGLRPDTSSLDCAPSIIACMRTCWEEDPELRPDLRFVH 184 (423)
Q Consensus 105 ~~s~ksDVyS~Giil~elltg~~Pf~~~~~~~~~i~~~i~~~~~~~p~~~~~~~~~~l~~Li~~C~~~dP~~RPt~~~I~ 184 (423)
+.++|||||||++|||++|+.||.. ....++...+..+... . .+..+++++.+++.+||+.||.+||++.+++
T Consensus 223 --s~k~DVwSlGvilyeLltG~~Pf~~--~~~~~~~~~~~~~~~~--~-~~~~~~~~l~~li~~~L~~dP~~RPs~~ell 295 (496)
T PTZ00283 223 --SKKADMFSLGVLLYELLTLKRPFDG--ENMEEVMHKTLAGRYD--P-LPPSISPEMQEIVTALLSSDPKRRPSSSKLL 295 (496)
T ss_pred --CcHHHHHHHHHHHHHHHHCCCCCCC--CCHHHHHHHHhcCCCC--C-CCCCCCHHHHHHHHHHcccChhhCcCHHHHH
Confidence 8999999999999999999999974 3445666665544321 1 2235789999999999999999999999987
Q ss_pred HH
Q psy1840 185 HK 186 (423)
Q Consensus 185 ~~ 186 (423)
..
T Consensus 296 ~~ 297 (496)
T PTZ00283 296 NM 297 (496)
T ss_pred hC
Confidence 64
|
|
| >KOG1026|consensus | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.1e-28 Score=253.47 Aligned_cols=163 Identities=26% Similarity=0.503 Sum_probs=138.8
Q ss_pred HHHHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCccEEEeccCCcccccCCCcccccccccCCccccCCccccCCC
Q psy1840 23 IGSISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKAPELLRQPH 102 (423)
Q Consensus 23 ~~~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~ 102 (423)
.+.+.|+.|||.||+||-++.++ ||||..+||||..+..|||+|||+++-.-..+.........-...|||||.+..+.
T Consensus 603 ~q~L~iA~QIAaGM~YLs~~~FV-HRDLATRNCLVge~l~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~k 681 (774)
T KOG1026|consen 603 SQFLHIATQIAAGMEYLSSHHFV-HRDLATRNCLVGENLVVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGK 681 (774)
T ss_pred HHHHHHHHHHHHHHHHHHhCccc-ccchhhhhceeccceEEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCc
Confidence 44799999999999999999998 99999999999999999999999998654444433222223345699999999876
Q ss_pred CCCCCCccchHHHHHHHHHHHh-CCCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCchHHHHHHHHHhhhcCCCCCCCHH
Q psy1840 103 LPRGTQKGDVYSFGLVLYEVIG-RQGPWGHLRMTDEEIITSVTQGSGLRPDTSSLDCAPSIIACMRTCWEEDPELRPDLR 181 (423)
Q Consensus 103 ~~~~s~ksDVyS~Giil~ellt-g~~Pf~~~~~~~~~i~~~i~~~~~~~p~~~~~~~~~~l~~Li~~C~~~dP~~RPt~~ 181 (423)
+ |.+||||||||+|||+++ |.-||. +.+.+|+++.+.++.... .+.+||.++.+||..||+.+|.+||+|+
T Consensus 682 F---TteSDVWs~GVvLWEIFsyG~QPy~--glSn~EVIe~i~~g~lL~---~Pe~CP~~vY~LM~~CW~~~P~~RPsF~ 753 (774)
T KOG1026|consen 682 F---TTESDVWSFGVVLWEIFSYGKQPYY--GLSNQEVIECIRAGQLLS---CPENCPTEVYSLMLECWNENPKRRPSFK 753 (774)
T ss_pred c---cchhhhhhhhhhhhhhhccccCccc--ccchHHHHHHHHcCCccc---CCCCCCHHHHHHHHHHhhcCcccCCCHH
Confidence 6 999999999999999996 888987 567899999999987532 2458999999999999999999999999
Q ss_pred HHHHHHHHHhhhc
Q psy1840 182 FVHHKLKEMNAGL 194 (423)
Q Consensus 182 ~I~~~L~~i~~~~ 194 (423)
+|...|+......
T Consensus 754 eI~~~L~~~~~~s 766 (774)
T KOG1026|consen 754 EIHSRLQAWAQAS 766 (774)
T ss_pred HHHHHHHHHHhcC
Confidence 9999999887644
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=99.95 E-value=8e-28 Score=237.17 Aligned_cols=160 Identities=26% Similarity=0.461 Sum_probs=126.9
Q ss_pred HHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCccEEEeccCCcccccCCCcccccccccCCccccCCccccCCCCC
Q psy1840 25 SISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKAPELLRQPHLP 104 (423)
Q Consensus 25 ~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~ 104 (423)
.+.++.||+.||.|||+.|++ ||||||+||+++.++.+||+|||+++...............++..|+|||.+.+..+
T Consensus 176 ~~~~~~qi~~aL~~LH~~~iv-HrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~- 253 (338)
T cd05102 176 LICYSFQVARGMEFLASRKCI-HRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKWMAPESIFDKVY- 253 (338)
T ss_pred HHHHHHHHHHHHHHHHHCCEE-CCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCccccCcHHhhcCCC-
Confidence 578999999999999999988 999999999999999999999999875432222112223345678999999977655
Q ss_pred CCCCccchHHHHHHHHHHHh-CCCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCchHHHHHHHHHhhhcCCCCCCCHHHH
Q psy1840 105 RGTQKGDVYSFGLVLYEVIG-RQGPWGHLRMTDEEIITSVTQGSGLRPDTSSLDCAPSIIACMRTCWEEDPELRPDLRFV 183 (423)
Q Consensus 105 ~~s~ksDVyS~Giil~ellt-g~~Pf~~~~~~~~~i~~~i~~~~~~~p~~~~~~~~~~l~~Li~~C~~~dP~~RPt~~~I 183 (423)
+.++|||||||++|||++ |..||..... ...+...+..+...++ +..+++.+.+++.+||+.||++|||+.+|
T Consensus 254 --~~~sDiwslG~il~el~~~g~~pf~~~~~-~~~~~~~~~~~~~~~~---~~~~~~~l~~li~~cl~~dp~~RPs~~el 327 (338)
T cd05102 254 --TTQSDVWSFGVLLWEIFSLGASPYPGVQI-NEEFCQRLKDGTRMRA---PENATPEIYRIMLACWQGDPKERPTFSAL 327 (338)
T ss_pred --CcccCHHHHHHHHHHHHhCCCCCCCCCCc-cHHHHHHHhcCCCCCC---CCCCCHHHHHHHHHHccCChhhCcCHHHH
Confidence 899999999999999997 9999975433 2344445544433222 23578899999999999999999999999
Q ss_pred HHHHHHHhh
Q psy1840 184 HHKLKEMNA 192 (423)
Q Consensus 184 ~~~L~~i~~ 192 (423)
++.|+.+..
T Consensus 328 ~~~l~~~~~ 336 (338)
T cd05102 328 VEILGDLLQ 336 (338)
T ss_pred HHHHHHHHh
Confidence 999987654
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG0582|consensus | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.5e-27 Score=229.30 Aligned_cols=165 Identities=22% Similarity=0.296 Sum_probs=127.7
Q ss_pred CCCChHHH-HHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCccEEEeccCCcccccCCCcc-ccc-ccccCCccccC
Q psy1840 18 PFNIPIGS-ISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDET-GQE-RKLRRRKLYKA 94 (423)
Q Consensus 18 ~~~~p~~~-l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~~-~~~-~~~~gt~~y~A 94 (423)
||...+.. ..|+.++++||.|||++|.| |||||+.||||+++|.|||+|||.+..+...... ... ....|+++|||
T Consensus 120 ~~Gl~E~~Ia~iLre~LkaL~YLH~~G~I-HRdvKAgnILi~~dG~VkLadFgvsa~l~~~G~R~~~rf~tfvgtp~wmA 198 (516)
T KOG0582|consen 120 PDGLEEASIATILREVLKALDYLHQNGHI-HRDVKAGNILIDSDGTVKLADFGVSASLFDSGDRQVTRFNTFVGTPCWMA 198 (516)
T ss_pred cccccHHHHHHHHHHHHHHHHHHHhcCce-ecccccccEEEcCCCcEEEcCceeeeeecccCceeeEeeccccCcccccC
Confidence 45555554 36789999999999999999 9999999999999999999999997765443321 112 56689999999
Q ss_pred CccccCCCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCChHHHHHHHhcCCCCCCCCC------CCCchHHHHHHHHH
Q psy1840 95 PELLRQPHLPRGTQKGDVYSFGLVLYEVIGRQGPWGHLRMTDEEIITSVTQGSGLRPDTS------SLDCAPSIIACMRT 168 (423)
Q Consensus 95 PE~l~~~~~~~~s~ksDVyS~Giil~elltg~~Pf~~~~~~~~~i~~~i~~~~~~~p~~~------~~~~~~~l~~Li~~ 168 (423)
||++..... -|+.|+|||||||+..|+.+|..||.. +.+-.++-.-.++.+..+... ...++.++++++..
T Consensus 199 PEvl~q~~~-GYdfKaDIwSfGITA~ELA~G~aPf~k--~pPmkvLl~tLqn~pp~~~t~~~~~d~~k~~~ksf~e~i~~ 275 (516)
T KOG0582|consen 199 PEVLMQQLH-GYDFKADIWSFGITACELAHGHAPFSK--YPPMKVLLLTLQNDPPTLLTSGLDKDEDKKFSKSFREMIAL 275 (516)
T ss_pred hHHhhhccc-CccchhhhhhhhHHHHHHhcCCCCccc--CChHHHHHHHhcCCCCCcccccCChHHhhhhcHHHHHHHHH
Confidence 999655432 459999999999999999999999974 444444444344444332221 24567789999999
Q ss_pred hhhcCCCCCCCHHHHHHH
Q psy1840 169 CWEEDPELRPDLRFVHHK 186 (423)
Q Consensus 169 C~~~dP~~RPt~~~I~~~ 186 (423)
|+++||.+|||++++++.
T Consensus 276 CL~kDP~kRptAskLlkh 293 (516)
T KOG0582|consen 276 CLVKDPSKRPTASKLLKH 293 (516)
T ss_pred HhhcCcccCCCHHHHhcc
Confidence 999999999999998764
|
|
| >KOG0198|consensus | Back alignment and domain information |
|---|
Probab=99.95 E-value=6e-28 Score=232.11 Aligned_cols=161 Identities=21% Similarity=0.400 Sum_probs=124.9
Q ss_pred HHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcC-CccEEEeccCCcccccC-CCcccccccccCCccccCCccccCCC
Q psy1840 25 SISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDS-RWVLQIADFGLHAFKAG-QDETGQERKLRRRKLYKAPELLRQPH 102 (423)
Q Consensus 25 ~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~-~~~vKL~DFGla~~~~~-~~~~~~~~~~~gt~~y~APE~l~~~~ 102 (423)
...+..||++||+|||++|++ ||||||+|||++. ++.+||+|||+++.... ...........||+.|||||++..+.
T Consensus 119 v~~ytr~iL~GL~ylHs~g~v-H~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~~~~~~~~~~~~Gtp~~maPEvi~~g~ 197 (313)
T KOG0198|consen 119 VRRYTRQILEGLAYLHSKGIV-HCDIKPANILLDPSNGDVKLADFGLAKKLESKGTKSDSELSVQGTPNYMAPEVIRNGE 197 (313)
T ss_pred HHHHHHHHHHHHHHHHhCCEe-ccCcccceEEEeCCCCeEEeccCccccccccccccccccccccCCccccCchhhcCCC
Confidence 358899999999999999998 9999999999999 79999999999886653 11122234578999999999998632
Q ss_pred CCCCCCccchHHHHHHHHHHHhCCCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCchHHHHHHHHHhhhcCCCCCCCHHH
Q psy1840 103 LPRGTQKGDVYSFGLVLYEVIGRQGPWGHLRMTDEEIITSVTQGSGLRPDTSSLDCAPSIIACMRTCWEEDPELRPDLRF 182 (423)
Q Consensus 103 ~~~~s~ksDVyS~Giil~elltg~~Pf~~~~~~~~~i~~~i~~~~~~~p~~~~~~~~~~l~~Li~~C~~~dP~~RPt~~~ 182 (423)
. ...++|||||||++.||+||+.||... ....+.+-.+.... ..|.. +..++.+..+++..|+..||++|||+.+
T Consensus 198 ~--~~~~sDiWSlGCtVvEM~Tg~~PW~~~-~~~~~~~~~ig~~~-~~P~i-p~~ls~~a~~Fl~~C~~~~p~~Rpta~e 272 (313)
T KOG0198|consen 198 V--ARRESDIWSLGCTVVEMLTGKPPWSEF-FEEAEALLLIGRED-SLPEI-PDSLSDEAKDFLRKCFKRDPEKRPTAEE 272 (313)
T ss_pred c--CCccchhhhcCCEEEeccCCCCcchhh-cchHHHHHHHhccC-CCCCC-CcccCHHHHHHHHHHhhcCcccCcCHHH
Confidence 1 135999999999999999999999753 22223233333222 23333 3468999999999999999999999999
Q ss_pred HHHHHHHHh
Q psy1840 183 VHHKLKEMN 191 (423)
Q Consensus 183 I~~~L~~i~ 191 (423)
++.......
T Consensus 273 LL~hpf~~~ 281 (313)
T KOG0198|consen 273 LLEHPFLKQ 281 (313)
T ss_pred HhhChhhhc
Confidence 988764433
|
|
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.5e-27 Score=226.54 Aligned_cols=156 Identities=22% Similarity=0.338 Sum_probs=125.9
Q ss_pred HHHHHHHHHHHHHHHHhC-CCeeecCCCCCCEEEcCCccEEEeccCCcccccCCCcccccccccCCccccCCccccCCCC
Q psy1840 25 SISVNTTASVGMIHLHDS-EIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKAPELLRQPHL 103 (423)
Q Consensus 25 ~l~i~~qi~~gL~yLH~~-~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~ 103 (423)
+++++.|++.||.|||+. +++ ||||||+||+++.++.+||+|||+++...... ....++..|+|||++.+..
T Consensus 124 ~~~i~~~i~~~l~~lH~~~~~~-Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~~-----~~~~~~~~y~aPE~~~~~~- 196 (283)
T PHA02988 124 KLDMAIDCCKGLYNLYKYTNKP-YKNLTSVSFLVTENYKLKIICHGLEKILSSPP-----FKNVNFMVYFSYKMLNDIF- 196 (283)
T ss_pred HHHHHHHHHHHHHHHHhcCCCC-CCcCChhhEEECCCCcEEEcccchHhhhcccc-----ccccCcccccCHHHhhhcc-
Confidence 689999999999999985 777 99999999999999999999999987543221 2345778899999987621
Q ss_pred CCCCCccchHHHHHHHHHHHhCCCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCchHHHHHHHHHhhhcCCCCCCCHHHH
Q psy1840 104 PRGTQKGDVYSFGLVLYEVIGRQGPWGHLRMTDEEIITSVTQGSGLRPDTSSLDCAPSIIACMRTCWEEDPELRPDLRFV 183 (423)
Q Consensus 104 ~~~s~ksDVyS~Giil~elltg~~Pf~~~~~~~~~i~~~i~~~~~~~p~~~~~~~~~~l~~Li~~C~~~dP~~RPt~~~I 183 (423)
..++.++|||||||++|||++|+.||.. .+..++...+..+.. ++..+ ..+++.+.+++.+||+.||++|||+.++
T Consensus 197 ~~~~~k~Di~SlGvil~el~~g~~Pf~~--~~~~~~~~~i~~~~~-~~~~~-~~~~~~l~~li~~cl~~dp~~Rps~~el 272 (283)
T PHA02988 197 SEYTIKDDIYSLGVVLWEIFTGKIPFEN--LTTKEIYDLIINKNN-SLKLP-LDCPLEIKCIVEACTSHDSIKRPNIKEI 272 (283)
T ss_pred ccccchhhhhHHHHHHHHHHHCCCCCCC--CCHHHHHHHHHhcCC-CCCCC-CcCcHHHHHHHHHHhcCCcccCcCHHHH
Confidence 1348999999999999999999999974 345666666644322 22222 3578999999999999999999999999
Q ss_pred HHHHHHHh
Q psy1840 184 HHKLKEMN 191 (423)
Q Consensus 184 ~~~L~~i~ 191 (423)
++.|+.+.
T Consensus 273 l~~l~~~~ 280 (283)
T PHA02988 273 LYNLSLYK 280 (283)
T ss_pred HHHHHHHH
Confidence 99988764
|
|
| >KOG0592|consensus | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.8e-27 Score=235.09 Aligned_cols=151 Identities=19% Similarity=0.298 Sum_probs=126.1
Q ss_pred HHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCccEEEeccCCcccccCCCcc-----------cccccccCCccccC
Q psy1840 26 ISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDET-----------GQERKLRRRKLYKA 94 (423)
Q Consensus 26 l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~~-----------~~~~~~~gt~~y~A 94 (423)
--.+.+|+.|++|||++||| ||||||+|||+|.++++||+|||-++.+...... .....+.||..|.+
T Consensus 177 R~YAAeIldAleylH~~GII-HRDlKPENILLd~dmhikITDFGsAK~l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVS 255 (604)
T KOG0592|consen 177 RFYAAEILDALEYLHSNGII-HRDLKPENILLDKDGHIKITDFGSAKILSPSQKSQENPVDPNQASSRRSSFVGTAEYVS 255 (604)
T ss_pred HHHHHHHHHHHHHHHhcCce-eccCChhheeEcCCCcEEEeeccccccCChhhccccCccCcccccCcccceeeeecccC
Confidence 35789999999999999999 9999999999999999999999999876543221 11245889999999
Q ss_pred CccccCCCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCchHHHHHHHHHhhhcCC
Q psy1840 95 PELLRQPHLPRGTQKGDVYSFGLVLYEVIGRQGPWGHLRMTDEEIITSVTQGSGLRPDTSSLDCAPSIIACMRTCWEEDP 174 (423)
Q Consensus 95 PE~l~~~~~~~~s~ksDVyS~Giil~elltg~~Pf~~~~~~~~~i~~~i~~~~~~~p~~~~~~~~~~l~~Li~~C~~~dP 174 (423)
||++..... +..+|+|+||||+|.|+.|++||... +.--+.++|.......|+ +.++.+.+|+++.|..||
T Consensus 256 PElL~~~~~---~~~sDiWAlGCilyQmlaG~PPFra~--NeyliFqkI~~l~y~fp~----~fp~~a~dLv~KLLv~dp 326 (604)
T KOG0592|consen 256 PELLNDSPA---GPSSDLWALGCILYQMLAGQPPFRAA--NEYLIFQKIQALDYEFPE----GFPEDARDLIKKLLVRDP 326 (604)
T ss_pred HHHhcCCCC---CcccchHHHHHHHHHHhcCCCCCccc--cHHHHHHHHHHhcccCCC----CCCHHHHHHHHHHHccCc
Confidence 999998766 89999999999999999999999743 334456666665544443 567999999999999999
Q ss_pred CCCCCHHHHHHH
Q psy1840 175 ELRPDLRFVHHK 186 (423)
Q Consensus 175 ~~RPt~~~I~~~ 186 (423)
.+|+|..+|.++
T Consensus 327 ~~Rlt~~qIk~H 338 (604)
T KOG0592|consen 327 SDRLTSQQIKAH 338 (604)
T ss_pred cccccHHHHhhC
Confidence 999999998775
|
|
| >KOG1095|consensus | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.8e-27 Score=254.64 Aligned_cols=166 Identities=28% Similarity=0.494 Sum_probs=133.9
Q ss_pred HHHHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCccEEEeccCCcccccCCCcccccccccCCccccCCccccCCC
Q psy1840 23 IGSISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKAPELLRQPH 102 (423)
Q Consensus 23 ~~~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~ 102 (423)
.+-+.|+.|||+|+.||+++++| ||||..+||||+.+.+|||+|||+|+-+.............-...|||||.+..+.
T Consensus 802 ~dLl~~a~dvA~G~~YLe~~~fv-HRDLAaRNCLL~~~r~VKIaDFGlArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~i 880 (1025)
T KOG1095|consen 802 RDLLAFALDVAKGMNYLESKHFV-HRDLAARNCLLDERRVVKIADFGLARDIYDKDYYRKHGEAMLPVKWMPPESLKDGI 880 (1025)
T ss_pred HHHHHHHHHHhhhhHHHHhCCCc-CcchhhhheeecccCcEEEcccchhHhhhhchheeccCccccceecCCHHHHhhcc
Confidence 44589999999999999999998 99999999999999999999999998443333322222222234599999999866
Q ss_pred CCCCCCccchHHHHHHHHHHHh-CCCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCchHHHHHHHHHhhhcCCCCCCCHH
Q psy1840 103 LPRGTQKGDVYSFGLVLYEVIG-RQGPWGHLRMTDEEIITSVTQGSGLRPDTSSLDCAPSIIACMRTCWEEDPELRPDLR 181 (423)
Q Consensus 103 ~~~~s~ksDVyS~Giil~ellt-g~~Pf~~~~~~~~~i~~~i~~~~~~~p~~~~~~~~~~l~~Li~~C~~~dP~~RPt~~ 181 (423)
+ +.|+|||||||++||++| |..||++ .+..++...+..+....+ +..|+..+.++|.+||+.+|++||+|.
T Consensus 881 F---tskSDvWsFGVllWEifslG~~PY~~--~~n~~v~~~~~~ggRL~~---P~~CP~~ly~lM~~CW~~~pe~RP~F~ 952 (1025)
T KOG1095|consen 881 F---TSKSDVWSFGVLLWEIFSLGATPYPS--RSNFEVLLDVLEGGRLDP---PSYCPEKLYQLMLQCWKHDPEDRPSFR 952 (1025)
T ss_pred c---ccccchhhhHHHHHHHHhCCCCCCCC--cchHHHHHHHHhCCccCC---CCCCChHHHHHHHHHccCChhhCccHH
Confidence 5 999999999999999998 6789974 556777776666553333 247999999999999999999999999
Q ss_pred HHHHHHHHHhhhcCCC
Q psy1840 182 FVHHKLKEMNAGLKAN 197 (423)
Q Consensus 182 ~I~~~L~~i~~~~~~~ 197 (423)
.|++.+..+.......
T Consensus 953 ~i~~q~~~i~~~~~~~ 968 (1025)
T KOG1095|consen 953 TIVEQDPAISNAALGT 968 (1025)
T ss_pred HHHhhhhhhhhhhccC
Confidence 9999887776654433
|
|
| >KOG0598|consensus | Back alignment and domain information |
|---|
Probab=99.95 E-value=2e-27 Score=225.96 Aligned_cols=140 Identities=21% Similarity=0.307 Sum_probs=119.5
Q ss_pred HHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCccEEEeccCCcccccCCCcccccccccCCccccCCccccCCCCCCCC
Q psy1840 28 VNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKAPELLRQPHLPRGT 107 (423)
Q Consensus 28 i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~s 107 (423)
.+..|+.||.|||++||| ||||||+|||+|.+|+++|+|||+++...... ..+.+++||+.|||||++.+..+ +
T Consensus 130 YlaEi~lAL~~LH~~gIi-yRDlKPENILLd~~GHi~LtDFgL~k~~~~~~--~~t~tfcGT~eYmAPEil~~~gy---~ 203 (357)
T KOG0598|consen 130 YLAEIVLALGYLHSKGII-YRDLKPENILLDEQGHIKLTDFGLCKEDLKDG--DATRTFCGTPEYMAPEILLGKGY---D 203 (357)
T ss_pred HHHHHHHHHHHHHhCCee-eccCCHHHeeecCCCcEEEeccccchhcccCC--CccccccCCccccChHHHhcCCC---C
Confidence 477999999999999999 99999999999999999999999998543332 23356899999999999998866 9
Q ss_pred CccchHHHHHHHHHHHhCCCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCchHHHHHHHHHhhhcCCCCCC
Q psy1840 108 QKGDVYSFGLVLYEVIGRQGPWGHLRMTDEEIITSVTQGSGLRPDTSSLDCAPSIIACMRTCWEEDPELRP 178 (423)
Q Consensus 108 ~ksDVyS~Giil~elltg~~Pf~~~~~~~~~i~~~i~~~~~~~p~~~~~~~~~~l~~Li~~C~~~dP~~RP 178 (423)
..+|.||+|+++|||++|..||.. .+..++++.+..++...++ ...+.+.++++++.+..||++|.
T Consensus 204 ~~vDWWsLGillYeML~G~pPF~~--~~~~~~~~~I~~~k~~~~p---~~ls~~ardll~~LL~rdp~~RL 269 (357)
T KOG0598|consen 204 KAVDWWSLGILLYEMLTGKPPFYA--EDVKKMYDKILKGKLPLPP---GYLSEEARDLLKKLLKRDPRQRL 269 (357)
T ss_pred cccchHhHHHHHHHHhhCCCCCcC--ccHHHHHHHHhcCcCCCCC---ccCCHHHHHHHHHHhccCHHHhc
Confidence 999999999999999999999973 4557788888887632222 23678999999999999999995
|
|
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.3e-27 Score=224.88 Aligned_cols=156 Identities=26% Similarity=0.492 Sum_probs=126.9
Q ss_pred HHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCccEEEeccCCcccccCCCcccccccccCCccccCCccccCCCCC
Q psy1840 25 SISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKAPELLRQPHLP 104 (423)
Q Consensus 25 ~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~ 104 (423)
.+.++.|++.||.|||+++++ ||||||+||++++++.+||+|||++................+++.|+|||.+.+..+
T Consensus 126 ~~~~~~~l~~al~~lH~~~i~-H~dlkp~Nil~~~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~- 203 (283)
T cd05048 126 FLHIAIQIAAGMEYLSSHHFV-HRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKF- 203 (283)
T ss_pred HHHHHHHHHHHHHHHHhCCee-ccccccceEEEcCCCcEEECCCcceeeccccccccccCCCcccccccCHHHhccCcC-
Confidence 578999999999999999987 999999999999999999999999875433222222233455678999999877654
Q ss_pred CCCCccchHHHHHHHHHHHh-CCCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCchHHHHHHHHHhhhcCCCCCCCHHHH
Q psy1840 105 RGTQKGDVYSFGLVLYEVIG-RQGPWGHLRMTDEEIITSVTQGSGLRPDTSSLDCAPSIIACMRTCWEEDPELRPDLRFV 183 (423)
Q Consensus 105 ~~s~ksDVyS~Giil~ellt-g~~Pf~~~~~~~~~i~~~i~~~~~~~p~~~~~~~~~~l~~Li~~C~~~dP~~RPt~~~I 183 (423)
+.++|||||||++|||++ |..||.+ ....++...+..+... . .+..++.++.+|+.+||+.||.+||++.+|
T Consensus 204 --~~~sDv~slG~il~el~~~g~~p~~~--~~~~~~~~~i~~~~~~--~-~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i 276 (283)
T cd05048 204 --TTESDIWSFGVVLWEIFSYGLQPYYG--FSNQEVIEMIRSRQLL--P-CPEDCPARVYALMIECWNEIPARRPRFKDI 276 (283)
T ss_pred --chhhhHHHHHHHHHHHHcCCCCCCCC--CCHHHHHHHHHcCCcC--C-CcccCCHHHHHHHHHHccCChhhCcCHHHH
Confidence 889999999999999998 9999874 3456677776654322 1 234689999999999999999999999999
Q ss_pred HHHHHH
Q psy1840 184 HHKLKE 189 (423)
Q Consensus 184 ~~~L~~ 189 (423)
.+.|+.
T Consensus 277 ~~~l~~ 282 (283)
T cd05048 277 HTRLRS 282 (283)
T ss_pred HHHHhc
Confidence 998864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >KOG0201|consensus | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.6e-27 Score=230.40 Aligned_cols=175 Identities=18% Similarity=0.375 Sum_probs=142.1
Q ss_pred HHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCccEEEeccCCcccccCCCcccccccccCCccccCCccccCCCCCC
Q psy1840 26 ISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKAPELLRQPHLPR 105 (423)
Q Consensus 26 l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~ 105 (423)
.-++.++..|+.|||..+.+ |||||+.|||+..+|.+|++|||++..+...... ..++.||+.|||||++.+..|
T Consensus 114 ~~ilre~l~~l~ylH~~~ki-HrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~r--r~tfvGTPfwMAPEVI~~~~Y-- 188 (467)
T KOG0201|consen 114 AVILREVLKGLDYLHSEKKI-HRDIKAANILLSESGDVKLADFGVAGQLTNTVKR--RKTFVGTPFWMAPEVIKQSGY-- 188 (467)
T ss_pred eeehHHHHHHhhhhhhccee-cccccccceeEeccCcEEEEecceeeeeechhhc--cccccccccccchhhhccccc--
Confidence 45788999999999999998 9999999999999999999999998766433322 267899999999999997665
Q ss_pred CCCccchHHHHHHHHHHHhCCCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCchHHHHHHHHHhhhcCCCCCCCHHHHHH
Q psy1840 106 GTQKGDVYSFGLVLYEVIGRQGPWGHLRMTDEEIITSVTQGSGLRPDTSSLDCAPSIIACMRTCWEEDPELRPDLRFVHH 185 (423)
Q Consensus 106 ~s~ksDVyS~Giil~elltg~~Pf~~~~~~~~~i~~~i~~~~~~~p~~~~~~~~~~l~~Li~~C~~~dP~~RPt~~~I~~ 185 (423)
+.|+|||||||+.+||.+|.+|+... .+..++..+.. ..|+.....+++.++++|..|+++||+.||++.++++
T Consensus 189 -~~KADIWSLGITaiEla~GePP~s~~--hPmrvlflIpk---~~PP~L~~~~S~~~kEFV~~CL~k~P~~RpsA~~LLK 262 (467)
T KOG0201|consen 189 -DTKADIWSLGITAIELAKGEPPHSKL--HPMRVLFLIPK---SAPPRLDGDFSPPFKEFVEACLDKNPEFRPSAKELLK 262 (467)
T ss_pred -cchhhhhhhhHHHHHHhcCCCCCccc--CcceEEEeccC---CCCCccccccCHHHHHHHHHHhhcCcccCcCHHHHhh
Confidence 99999999999999999999999743 22222222222 2233333488999999999999999999999999987
Q ss_pred HHHHHhhhcCCChHHHHHHHHHHhhhc
Q psy1840 186 KLKEMNAGLKANIFDNMLAIMEKYAFN 212 (423)
Q Consensus 186 ~L~~i~~~~~~~~~d~~~~~~e~~~~~ 212 (423)
. +.+....+.+.+.+++.+..+|-..
T Consensus 263 h-~FIk~a~k~s~L~~~i~r~~~~~~~ 288 (467)
T KOG0201|consen 263 H-KFIKRAKKTSELKELIDRYKRWRVK 288 (467)
T ss_pred h-HHHHhcCCchHHHHHHHHHHHHhhc
Confidence 5 5566677788888999988888765
|
|
| >KOG0578|consensus | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.7e-27 Score=234.37 Aligned_cols=152 Identities=18% Similarity=0.318 Sum_probs=126.4
Q ss_pred HHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCccEEEeccCCcccccCCCcccccccccCCccccCCccccCCCCCC
Q psy1840 26 ISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKAPELLRQPHLPR 105 (423)
Q Consensus 26 l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~ 105 (423)
..++.++++||+|||.+||+ |||||++|||++.+|.+||+|||++..+..... ...+..||+.|||||++....|
T Consensus 372 A~Icre~l~aL~fLH~~gIi-HrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~--KR~TmVGTPYWMAPEVvtrk~Y-- 446 (550)
T KOG0578|consen 372 AAICREILQGLKFLHARGII-HRDIKSDNILLTMDGSVKLTDFGFCAQISEEQS--KRSTMVGTPYWMAPEVVTRKPY-- 446 (550)
T ss_pred HHHHHHHHHHHHHHHhccee-eeccccceeEeccCCcEEEeeeeeeeccccccC--ccccccCCCCccchhhhhhccc--
Confidence 58999999999999999999 999999999999999999999999876654332 3467889999999999988766
Q ss_pred CCCccchHHHHHHHHHHHhCCCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCchHHHHHHHHHhhhcCCCCCCCHHHHHH
Q psy1840 106 GTQKGDVYSFGLVLYEVIGRQGPWGHLRMTDEEIITSVTQGSGLRPDTSSLDCAPSIIACMRTCWEEDPELRPDLRFVHH 185 (423)
Q Consensus 106 ~s~ksDVyS~Giil~elltg~~Pf~~~~~~~~~i~~~i~~~~~~~p~~~~~~~~~~l~~Li~~C~~~dP~~RPt~~~I~~ 185 (423)
+.|+||||||++.+||+-|++||.. ..+-.-+..+......... .....++.+.+++.+||+.|+++|+++.++++
T Consensus 447 -G~KVDIWSLGIMaIEMveGEPPYln--E~PlrAlyLIa~ng~P~lk-~~~klS~~~kdFL~~cL~~dv~~RasA~eLL~ 522 (550)
T KOG0578|consen 447 -GPKVDIWSLGIMAIEMVEGEPPYLN--ENPLRALYLIATNGTPKLK-NPEKLSPELKDFLDRCLVVDVEQRASAKELLE 522 (550)
T ss_pred -CccccchhhhhHHHHHhcCCCCccC--CChHHHHHHHhhcCCCCcC-CccccCHHHHHHHHHHhhcchhcCCCHHHHhc
Confidence 9999999999999999999999963 3344444455443222111 23468999999999999999999999999987
Q ss_pred H
Q psy1840 186 K 186 (423)
Q Consensus 186 ~ 186 (423)
+
T Consensus 523 H 523 (550)
T KOG0578|consen 523 H 523 (550)
T ss_pred C
Confidence 5
|
|
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.3e-26 Score=220.69 Aligned_cols=156 Identities=23% Similarity=0.429 Sum_probs=125.9
Q ss_pred HHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCccEEEeccCCcccccCCCcccccccccCCccccCCccccCCCCC
Q psy1840 25 SISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKAPELLRQPHLP 104 (423)
Q Consensus 25 ~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~ 104 (423)
.+.++.|++.||.|||++|++ ||||||+||+++.++.+||+|||+++...............+++.|+|||.+.+..+
T Consensus 126 ~~~~~~ql~~aL~~lH~~gi~-H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~- 203 (283)
T cd05091 126 FVHIVTQIAAGMEFLSSHHVV-HKDLATRNVLVFDKLNVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKF- 203 (283)
T ss_pred HHHHHHHHHHHHHHHHHcCcc-ccccchhheEecCCCceEecccccccccccchheeeccCccCCccccCHHHHhcCCC-
Confidence 578999999999999999998 999999999999999999999999876533322222223345678999999876654
Q ss_pred CCCCccchHHHHHHHHHHHh-CCCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCchHHHHHHHHHhhhcCCCCCCCHHHH
Q psy1840 105 RGTQKGDVYSFGLVLYEVIG-RQGPWGHLRMTDEEIITSVTQGSGLRPDTSSLDCAPSIIACMRTCWEEDPELRPDLRFV 183 (423)
Q Consensus 105 ~~s~ksDVyS~Giil~ellt-g~~Pf~~~~~~~~~i~~~i~~~~~~~p~~~~~~~~~~l~~Li~~C~~~dP~~RPt~~~I 183 (423)
+.++|||||||++|||++ |..||.. ....++.+.+..+.... ....++..+.+++.+||+.+|++||++.+|
T Consensus 204 --~~~~Dv~slG~~l~el~~~g~~p~~~--~~~~~~~~~i~~~~~~~---~~~~~~~~~~~li~~cl~~~p~~RP~~~~i 276 (283)
T cd05091 204 --SIDSDIWSYGVVLWEVFSYGLQPYCG--YSNQDVIEMIRNRQVLP---CPDDCPAWVYTLMLECWNEFPSRRPRFKDI 276 (283)
T ss_pred --CcchhHHHHHHHHHHHHcCCCCCCCC--CCHHHHHHHHHcCCcCC---CCCCCCHHHHHHHHHHhCCCcccCCCHHHH
Confidence 889999999999999998 7788864 34566777776654321 234688999999999999999999999999
Q ss_pred HHHHHH
Q psy1840 184 HHKLKE 189 (423)
Q Consensus 184 ~~~L~~ 189 (423)
+..|+.
T Consensus 277 ~~~l~~ 282 (283)
T cd05091 277 HSRLRT 282 (283)
T ss_pred HHHhhC
Confidence 988763
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=99.94 E-value=4.2e-26 Score=218.87 Aligned_cols=161 Identities=22% Similarity=0.401 Sum_probs=127.3
Q ss_pred HHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCccEEEeccCCcccccCCCcccccccccCCccccCCccccCCCCC
Q psy1840 25 SISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKAPELLRQPHLP 104 (423)
Q Consensus 25 ~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~ 104 (423)
.+.++.||+.||.|||+++++ ||||||+||+++.++.+||+|||+++...............++..|+|||.+.+..+
T Consensus 111 ~~~i~~qi~~~l~~lH~~~ii-H~dlkp~nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~- 188 (279)
T cd05111 111 LLNWCVQIAKGMYYLEEHRMV-HRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALESILFGRY- 188 (279)
T ss_pred HHHHHHHHHHHHHHHHHCCEe-ccccCcceEEEcCCCcEEEcCCccceeccCCCcccccCCCCCcccccCHHHhccCCc-
Confidence 678999999999999999987 999999999999999999999999876533322222233456678999999977654
Q ss_pred CCCCccchHHHHHHHHHHHh-CCCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCchHHHHHHHHHhhhcCCCCCCCHHHH
Q psy1840 105 RGTQKGDVYSFGLVLYEVIG-RQGPWGHLRMTDEEIITSVTQGSGLRPDTSSLDCAPSIIACMRTCWEEDPELRPDLRFV 183 (423)
Q Consensus 105 ~~s~ksDVyS~Giil~ellt-g~~Pf~~~~~~~~~i~~~i~~~~~~~p~~~~~~~~~~l~~Li~~C~~~dP~~RPt~~~I 183 (423)
+.++||||||+++||+++ |..||.+. ...++...+..+.... ....++..+..++.+||..+|++||++.++
T Consensus 189 --~~~~Dv~slG~il~el~t~g~~p~~~~--~~~~~~~~~~~~~~~~---~~~~~~~~~~~li~~c~~~~p~~Rps~~el 261 (279)
T cd05111 189 --THQSDVWSYGVTVWEMMSYGAEPYAGM--RPHEVPDLLEKGERLA---QPQICTIDVYMVMVKCWMIDENVRPTFKEL 261 (279)
T ss_pred --CchhhHHHHHHHHHHHHcCCCCCCCCC--CHHHHHHHHHCCCcCC---CCCCCCHHHHHHHHHHcCCCcccCcCHHHH
Confidence 899999999999999998 99999643 3344444454433221 123467889999999999999999999999
Q ss_pred HHHHHHHhhhc
Q psy1840 184 HHKLKEMNAGL 194 (423)
Q Consensus 184 ~~~L~~i~~~~ 194 (423)
.+.|..+....
T Consensus 262 ~~~l~~~~~~~ 272 (279)
T cd05111 262 ANEFTRMARDP 272 (279)
T ss_pred HHHHHHHHhCC
Confidence 99888876543
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.8e-26 Score=221.39 Aligned_cols=160 Identities=24% Similarity=0.508 Sum_probs=128.6
Q ss_pred HHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCccEEEeccCCcccccCCCcccccccccCCccccCCccccCCCCC
Q psy1840 25 SISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKAPELLRQPHLP 104 (423)
Q Consensus 25 ~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~ 104 (423)
.++++.||+.|++|||+++++ ||||||+||+++.++.+||+|||++................++..|+|||.+.+..+
T Consensus 125 ~~~i~~~i~~al~~lH~~~i~-H~dlkp~Nil~~~~~~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~- 202 (291)
T cd05094 125 MLHIASQIASGMVYLASQHFV-HRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKF- 202 (291)
T ss_pred HHHHHHHHHHHHHHHHhCCee-ecccCcceEEEccCCcEEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCC-
Confidence 689999999999999999998 999999999999999999999999875433222112223445678999999887654
Q ss_pred CCCCccchHHHHHHHHHHHh-CCCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCchHHHHHHHHHhhhcCCCCCCCHHHH
Q psy1840 105 RGTQKGDVYSFGLVLYEVIG-RQGPWGHLRMTDEEIITSVTQGSGLRPDTSSLDCAPSIIACMRTCWEEDPELRPDLRFV 183 (423)
Q Consensus 105 ~~s~ksDVyS~Giil~ellt-g~~Pf~~~~~~~~~i~~~i~~~~~~~p~~~~~~~~~~l~~Li~~C~~~dP~~RPt~~~I 183 (423)
+.++||||||+++|||++ |..||.. ....+.++.+..+.... ....++..+.+++.+||+.+|++||++.+|
T Consensus 203 --~~~~Di~slG~il~el~t~g~~p~~~--~~~~~~~~~~~~~~~~~---~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v 275 (291)
T cd05094 203 --TTESDVWSFGVILWEIFTYGKQPWFQ--LSNTEVIECITQGRVLE---RPRVCPKEVYDIMLGCWQREPQQRLNIKEI 275 (291)
T ss_pred --CchhhHHHHHHHHHHHHhCCCCCCCC--CCHHHHHHHHhCCCCCC---CCccCCHHHHHHHHHHcccChhhCcCHHHH
Confidence 889999999999999998 9999863 34455666665543222 123568899999999999999999999999
Q ss_pred HHHHHHHhhh
Q psy1840 184 HHKLKEMNAG 193 (423)
Q Consensus 184 ~~~L~~i~~~ 193 (423)
.+.|..+...
T Consensus 276 ~~~l~~~~~~ 285 (291)
T cd05094 276 YKILHALGKA 285 (291)
T ss_pred HHHHHHHHhh
Confidence 9999988653
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.5e-26 Score=224.02 Aligned_cols=154 Identities=17% Similarity=0.258 Sum_probs=121.1
Q ss_pred HHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCccEEEeccCCcccccCCCcc-----cccccccCCccccCCcccc
Q psy1840 25 SISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDET-----GQERKLRRRKLYKAPELLR 99 (423)
Q Consensus 25 ~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~~-----~~~~~~~gt~~y~APE~l~ 99 (423)
...++.|++.||.|||+.+++ ||||||+|||++.++.+||+|||+++........ .......||+.|+|||...
T Consensus 128 ~~~i~~qi~~~l~~lH~~~ii-HrDiKp~Nill~~~~~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~ 206 (294)
T PHA02882 128 IKNIMKDMLTTLEYIHEHGIS-HGDIKPENIMVDGNNRGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHN 206 (294)
T ss_pred HHHHHHHHHHHHHHHHhCCee-cCCCCHHHEEEcCCCcEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhC
Confidence 468999999999999999998 9999999999999999999999998765322111 1112346899999999988
Q ss_pred CCCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCChH-------HHHHHHhcCCCCCCCCCCCCchHHHHHHHHHhhhc
Q psy1840 100 QPHLPRGTQKGDVYSFGLVLYEVIGRQGPWGHLRMTDE-------EIITSVTQGSGLRPDTSSLDCAPSIIACMRTCWEE 172 (423)
Q Consensus 100 ~~~~~~~s~ksDVyS~Giil~elltg~~Pf~~~~~~~~-------~i~~~i~~~~~~~p~~~~~~~~~~l~~Li~~C~~~ 172 (423)
+..+ +.++|||||||++|||++|+.||........ +++..+..+.. ....++..+.+++..||..
T Consensus 207 ~~~~---~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~ 278 (294)
T PHA02882 207 GACV---TRRGDLESLGYCMLKWAGIKLPWKGFGHNGNLIHAAKCDFIKRLHEGKI-----KIKNANKFIYDFIECVTKL 278 (294)
T ss_pred CCCC---CcHHHHHHHHHHHHHHHhCCCCCCccccchHHHHHhHHHHHHHhhhhhh-----ccCCCCHHHHHHHHHHHhC
Confidence 7665 8999999999999999999999976532221 22233332221 1235678999999999999
Q ss_pred CCCCCCCHHHHHHHH
Q psy1840 173 DPELRPDLRFVHHKL 187 (423)
Q Consensus 173 dP~~RPt~~~I~~~L 187 (423)
+|++||++.+|.+.+
T Consensus 279 ~~~~rp~~~~l~~~~ 293 (294)
T PHA02882 279 SYEEKPDYDALIKIF 293 (294)
T ss_pred CCCCCCCHHHHHHhh
Confidence 999999999998765
|
|
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.94 E-value=5.9e-27 Score=222.59 Aligned_cols=156 Identities=33% Similarity=0.599 Sum_probs=122.5
Q ss_pred HHHHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCccEEEeccCCcccccCCCcccccccccCCccccCCccccCCC
Q psy1840 23 IGSISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKAPELLRQPH 102 (423)
Q Consensus 23 ~~~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~ 102 (423)
..+++++.||+.||.|||+++++ ||||+++||++++++.+||+|||++....................|+|||.+.+..
T Consensus 103 ~~~~~i~~~i~~~l~~Lh~~~ii-H~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~ 181 (259)
T PF07714_consen 103 QQRLSIAIQIAEALSYLHSNNII-HGNLSPSNILLDSNGQVKLSDFGLSRPISEKSKYKNDSSQQLPLRYLAPEVLKDGE 181 (259)
T ss_dssp HHHHHHHHHHHHHHHHHHHTTEE-EST-SGGGEEEETTTEEEEESTTTGEETTTSSSEEESTTSESGGGGS-HHHHHHSE
T ss_pred ccccccccccccccccccccccc-cccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 34789999999999999999987 99999999999999999999999987653222222223344567799999998765
Q ss_pred CCCCCCccchHHHHHHHHHHHh-CCCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCchHHHHHHHHHhhhcCCCCCCCHH
Q psy1840 103 LPRGTQKGDVYSFGLVLYEVIG-RQGPWGHLRMTDEEIITSVTQGSGLRPDTSSLDCAPSIIACMRTCWEEDPELRPDLR 181 (423)
Q Consensus 103 ~~~~s~ksDVyS~Giil~ellt-g~~Pf~~~~~~~~~i~~~i~~~~~~~p~~~~~~~~~~l~~Li~~C~~~dP~~RPt~~ 181 (423)
+ +.++||||||+++||+++ |+.||.. ....++...+..+.... ....++..+.+++.+||+.+|++||++.
T Consensus 182 ~---~~ksDVysfG~~l~ei~~~~~~p~~~--~~~~~~~~~~~~~~~~~---~~~~~~~~~~~li~~C~~~~p~~RPs~~ 253 (259)
T PF07714_consen 182 Y---TKKSDVYSFGMLLYEILTLGKFPFSD--YDNEEIIEKLKQGQRLP---IPDNCPKDIYSLIQQCWSHDPEKRPSFQ 253 (259)
T ss_dssp E---SHHHHHHHHHHHHHHHHTTSSGTTTT--SCHHHHHHHHHTTEETT---SBTTSBHHHHHHHHHHT-SSGGGS--HH
T ss_pred c---cccccccccccccccccccccccccc--cccccccccccccccce---eccchhHHHHHHHHHHcCCChhhCcCHH
Confidence 4 899999999999999999 6789864 46677788876553322 2236899999999999999999999999
Q ss_pred HHHHHH
Q psy1840 182 FVHHKL 187 (423)
Q Consensus 182 ~I~~~L 187 (423)
+|++.|
T Consensus 254 ~i~~~L 259 (259)
T PF07714_consen 254 EILQEL 259 (259)
T ss_dssp HHHHHH
T ss_pred HHHhcC
Confidence 998875
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.9e-26 Score=223.92 Aligned_cols=158 Identities=25% Similarity=0.410 Sum_probs=119.7
Q ss_pred HHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCccEEEeccCCcccccCCCcccccccccCCccccCCccccCCCCC
Q psy1840 25 SISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKAPELLRQPHLP 104 (423)
Q Consensus 25 ~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~ 104 (423)
.++++.||+.||.|||+.|++ ||||||+||+++.++.+||+|||+++...............++..|+|||.+.+..+
T Consensus 140 ~~~i~~~i~~al~~lH~~~iv-H~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~- 217 (304)
T cd05096 140 LLHVALQIASGMKYLSSLNFV-HRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKF- 217 (304)
T ss_pred HHHHHHHHHHHHHHHHHCCcc-ccCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCC-
Confidence 578999999999999999998 999999999999999999999999875433222112223345678999999877654
Q ss_pred CCCCccchHHHHHHHHHHHhC--CCCCCCCCCChHHHHHHHhc----CCCCCCCCCCCCchHHHHHHHHHhhhcCCCCCC
Q psy1840 105 RGTQKGDVYSFGLVLYEVIGR--QGPWGHLRMTDEEIITSVTQ----GSGLRPDTSSLDCAPSIIACMRTCWEEDPELRP 178 (423)
Q Consensus 105 ~~s~ksDVyS~Giil~elltg--~~Pf~~~~~~~~~i~~~i~~----~~~~~p~~~~~~~~~~l~~Li~~C~~~dP~~RP 178 (423)
+.++||||||+++|||+++ ..||.. .+..+++..+.. .........+..++..+.+++.+||+.+|++||
T Consensus 218 --~~~~Dv~slG~~l~el~~~~~~~p~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RP 293 (304)
T cd05096 218 --TTASDVWAFGVTLWEILMLCKEQPYGE--LTDEQVIENAGEFFRDQGRQVYLFRPPPCPQGLYELMLQCWSRDCRERP 293 (304)
T ss_pred --CchhhhHHHHHHHHHHHHccCCCCCCc--CCHHHHHHHHHHHhhhccccccccCCCCCCHHHHHHHHHHccCCchhCc
Confidence 8899999999999999974 567754 344444443321 111111111235788999999999999999999
Q ss_pred CHHHHHHHHH
Q psy1840 179 DLRFVHHKLK 188 (423)
Q Consensus 179 t~~~I~~~L~ 188 (423)
|+.+|.+.|+
T Consensus 294 s~~~i~~~l~ 303 (304)
T cd05096 294 SFSDIHAFLT 303 (304)
T ss_pred CHHHHHHHHh
Confidence 9999988775
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=99.94 E-value=4e-26 Score=217.37 Aligned_cols=157 Identities=28% Similarity=0.471 Sum_probs=125.6
Q ss_pred HHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCccEEEeccCCcccccCCCcccccccccCCccccCCccccCCCCC
Q psy1840 25 SISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKAPELLRQPHLP 104 (423)
Q Consensus 25 ~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~ 104 (423)
.+.++.|++.||.|||+++++ ||||||+||+++.++.+||+|||+++...............++..|+|||.+.+..+
T Consensus 114 ~~~~~~~i~~~l~~lH~~~i~-H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~- 191 (272)
T cd05075 114 LVKFMTDIASGMEYLSSKSFI-HRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVY- 191 (272)
T ss_pred HHHHHHHHHHHHHHHHHCCee-ccccchhheEEcCCCCEEECCCCcccccCcccceecCCcccCCcccCCHHHccCCCc-
Confidence 578999999999999999998 999999999999999999999999876533221111122345567999999887654
Q ss_pred CCCCccchHHHHHHHHHHHh-CCCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCchHHHHHHHHHhhhcCCCCCCCHHHH
Q psy1840 105 RGTQKGDVYSFGLVLYEVIG-RQGPWGHLRMTDEEIITSVTQGSGLRPDTSSLDCAPSIIACMRTCWEEDPELRPDLRFV 183 (423)
Q Consensus 105 ~~s~ksDVyS~Giil~ellt-g~~Pf~~~~~~~~~i~~~i~~~~~~~p~~~~~~~~~~l~~Li~~C~~~dP~~RPt~~~I 183 (423)
+.++||||||+++||+++ |+.||.. ....++...+..+..... ...++..+.+++.+||+.+|++|||+.+|
T Consensus 192 --~~~~Di~slG~il~el~~~g~~p~~~--~~~~~~~~~~~~~~~~~~---~~~~~~~~~~li~~~l~~~p~~Rps~~~l 264 (272)
T cd05075 192 --TTKSDVWSFGVTMWEIATRGQTPYPG--VENSEIYDYLRQGNRLKQ---PPDCLDGLYSLMSSCWLLNPKDRPSFETL 264 (272)
T ss_pred --ChHHHHHHHHHHHHHHHcCCCCCCCC--CCHHHHHHHHHcCCCCCC---CCCCCHHHHHHHHHHcCCCcccCcCHHHH
Confidence 889999999999999999 7889864 345566666665543221 23578899999999999999999999999
Q ss_pred HHHHHHH
Q psy1840 184 HHKLKEM 190 (423)
Q Consensus 184 ~~~L~~i 190 (423)
++.|+.+
T Consensus 265 ~~~l~~~ 271 (272)
T cd05075 265 RCELEKA 271 (272)
T ss_pred HHHHHhh
Confidence 9988763
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >KOG0583|consensus | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.9e-26 Score=228.00 Aligned_cols=152 Identities=22% Similarity=0.343 Sum_probs=129.0
Q ss_pred HHHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCC-ccEEEeccCCcccccCCCcccccccccCCccccCCccccCCC
Q psy1840 24 GSISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSR-WVLQIADFGLHAFKAGQDETGQERKLRRRKLYKAPELLRQPH 102 (423)
Q Consensus 24 ~~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~-~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~ 102 (423)
..-.+..|++.|++|+|++|++ ||||||+|+|+|.+ +++||+|||++.... .......+.+|++.|+|||++.+..
T Consensus 121 ~ar~~F~Qlisav~y~H~~gi~-HRDLK~ENilld~~~~~~Kl~DFG~s~~~~--~~~~~l~t~cGsp~Y~aPEvl~~~~ 197 (370)
T KOG0583|consen 121 EARKYFRQLISAVAYCHSRGIV-HRDLKPENILLDGNEGNLKLSDFGLSAISP--GEDGLLKTFCGSPAYAAPEVLSGKG 197 (370)
T ss_pred HHHHHHHHHHHHHHHHHhCCEe-eCCCCHHHEEecCCCCCEEEeccccccccC--CCCCcccCCCCCcccCCHHHhCCCC
Confidence 3568999999999999999998 99999999999999 999999999988763 1223346789999999999999866
Q ss_pred -CCCCCCccchHHHHHHHHHHHhCCCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCchHHHHHHHHHhhhcCCCCCCCHH
Q psy1840 103 -LPRGTQKGDVYSFGLVLYEVIGRQGPWGHLRMTDEEIITSVTQGSGLRPDTSSLDCAPSIIACMRTCWEEDPELRPDLR 181 (423)
Q Consensus 103 -~~~~s~ksDVyS~Giil~elltg~~Pf~~~~~~~~~i~~~i~~~~~~~p~~~~~~~~~~l~~Li~~C~~~dP~~RPt~~ 181 (423)
+ .+.++||||+||+||.|++|..||.+ .....+...+..+....|.... ++++..|+.+|+..||.+|+++.
T Consensus 198 ~Y--~g~~aDvWS~GViLy~ml~G~~PF~d--~~~~~l~~ki~~~~~~~p~~~~---S~~~~~Li~~mL~~~P~~R~t~~ 270 (370)
T KOG0583|consen 198 TY--SGKAADVWSLGVILYVLLCGRLPFDD--SNVPNLYRKIRKGEFKIPSYLL---SPEARSLIEKMLVPDPSTRITLL 270 (370)
T ss_pred Cc--CCchhhhhhhHHHHHHHHhCCCCCCC--ccHHHHHHHHhcCCccCCCCcC---CHHHHHHHHHHcCCCcccCCCHH
Confidence 4 36899999999999999999999985 4455667777776655554321 89999999999999999999999
Q ss_pred HHHH
Q psy1840 182 FVHH 185 (423)
Q Consensus 182 ~I~~ 185 (423)
+|+.
T Consensus 271 ~i~~ 274 (370)
T KOG0583|consen 271 EILE 274 (370)
T ss_pred HHhh
Confidence 9984
|
|
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=99.94 E-value=4.5e-26 Score=222.68 Aligned_cols=160 Identities=21% Similarity=0.399 Sum_probs=125.3
Q ss_pred HHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCccEEEeccCCcccccCCCcccccccccCCccccCCccccCCCCC
Q psy1840 25 SISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKAPELLRQPHLP 104 (423)
Q Consensus 25 ~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~ 104 (423)
.+.++.||+.||+|||+.+++ ||||||+||+++.++.+||+|||+++................+..|+|||.+.+..+
T Consensus 111 ~~~~~~qi~~~L~~LH~~~ii-H~dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~- 188 (316)
T cd05108 111 LLNWCVQIAKGMNYLEERRLV-HRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVPIKWMALESILHRIY- 188 (316)
T ss_pred HHHHHHHHHHHHHHHHhcCee-ccccchhheEecCCCcEEEccccccccccCCCcceeccCCccceeecChHHhccCCC-
Confidence 578999999999999999998 999999999999999999999999886543322211122334567999999987655
Q ss_pred CCCCccchHHHHHHHHHHHh-CCCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCchHHHHHHHHHhhhcCCCCCCCHHHH
Q psy1840 105 RGTQKGDVYSFGLVLYEVIG-RQGPWGHLRMTDEEIITSVTQGSGLRPDTSSLDCAPSIIACMRTCWEEDPELRPDLRFV 183 (423)
Q Consensus 105 ~~s~ksDVyS~Giil~ellt-g~~Pf~~~~~~~~~i~~~i~~~~~~~p~~~~~~~~~~l~~Li~~C~~~dP~~RPt~~~I 183 (423)
+.++||||||+++||+++ |..||.+ ....++...+..+.. .| . ...++.++.+++.+||..+|++||++.++
T Consensus 189 --~~~~Di~slGv~l~el~t~g~~p~~~--~~~~~~~~~~~~~~~-~~-~-~~~~~~~~~~li~~cl~~~p~~Rps~~~l 261 (316)
T cd05108 189 --THQSDVWSYGVTVWELMTFGSKPYDG--IPASEISSILEKGER-LP-Q-PPICTIDVYMIMVKCWMIDADSRPKFREL 261 (316)
T ss_pred --CchhhhHHHHHHHHHHHcCCCCCCCC--CCHHHHHHHHhCCCC-CC-C-CCCCCHHHHHHHHHHccCChhhCcCHHHH
Confidence 899999999999999997 8999964 334444444443321 12 1 23577899999999999999999999999
Q ss_pred HHHHHHHhhh
Q psy1840 184 HHKLKEMNAG 193 (423)
Q Consensus 184 ~~~L~~i~~~ 193 (423)
+..+..+...
T Consensus 262 ~~~l~~~~~~ 271 (316)
T cd05108 262 IIEFSKMARD 271 (316)
T ss_pred HHHHHHHHcC
Confidence 9988777543
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=99.94 E-value=5.7e-26 Score=218.87 Aligned_cols=160 Identities=24% Similarity=0.531 Sum_probs=128.5
Q ss_pred HHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCccEEEeccCCcccccCCCcccccccccCCccccCCccccCCCCC
Q psy1840 25 SISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKAPELLRQPHLP 104 (423)
Q Consensus 25 ~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~ 104 (423)
.+.++.|++.||+|||++|++ ||||||+||+++.++.+||+|||++................++..|+|||.+.+..+
T Consensus 122 ~~~~~~ql~~aL~~lH~~~i~-H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~- 199 (288)
T cd05093 122 MLHIAQQIAAGMVYLASQHFV-HRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKF- 199 (288)
T ss_pred HHHHHHHHHHHHHHHHhCCee-ecccCcceEEEccCCcEEeccCCccccccCCceeecCCCCCccccccCHHHhccCCC-
Confidence 678999999999999999987 999999999999999999999999875432222111223345677999999987654
Q ss_pred CCCCccchHHHHHHHHHHHh-CCCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCchHHHHHHHHHhhhcCCCCCCCHHHH
Q psy1840 105 RGTQKGDVYSFGLVLYEVIG-RQGPWGHLRMTDEEIITSVTQGSGLRPDTSSLDCAPSIIACMRTCWEEDPELRPDLRFV 183 (423)
Q Consensus 105 ~~s~ksDVyS~Giil~ellt-g~~Pf~~~~~~~~~i~~~i~~~~~~~p~~~~~~~~~~l~~Li~~C~~~dP~~RPt~~~I 183 (423)
+.++|||||||++|+|++ |..||.. ....+....+..+.... ....++.++.+++.+||+.||.+|||+.++
T Consensus 200 --~~~sDiwslG~il~~l~t~g~~p~~~--~~~~~~~~~i~~~~~~~---~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v 272 (288)
T cd05093 200 --TTESDVWSLGVVLWEIFTYGKQPWYQ--LSNNEVIECITQGRVLQ---RPRTCPKEVYDLMLGCWQREPHMRLNIKEI 272 (288)
T ss_pred --CchhhHHHHHHHHHHHHhCCCCCCCC--CCHHHHHHHHHcCCcCC---CCCCCCHHHHHHHHHHccCChhhCCCHHHH
Confidence 889999999999999998 8889864 34456666766654322 123578899999999999999999999999
Q ss_pred HHHHHHHhhh
Q psy1840 184 HHKLKEMNAG 193 (423)
Q Consensus 184 ~~~L~~i~~~ 193 (423)
...|+.+...
T Consensus 273 ~~~l~~~~~~ 282 (288)
T cd05093 273 HSLLQNLAKA 282 (288)
T ss_pred HHHHHHHHHh
Confidence 9999888754
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >KOG0983|consensus | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.9e-26 Score=208.79 Aligned_cols=153 Identities=23% Similarity=0.414 Sum_probs=125.9
Q ss_pred HHHHHHHHHHHHHHhC-CCeeecCCCCCCEEEcCCccEEEeccCCcccccCCCcccccccccCCccccCCccccCCCCCC
Q psy1840 27 SVNTTASVGMIHLHDS-EIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKAPELLRQPHLPR 105 (423)
Q Consensus 27 ~i~~qi~~gL~yLH~~-~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~ 105 (423)
++...+++||.||..+ ++| |||+||+|||+|.+|++|+||||++..+.+.... ....|.+.|||||.+.-...+.
T Consensus 195 k~tva~v~AL~YLKeKH~vi-HRDvKPSNILlDe~GniKlCDFGIsGrlvdSkAh---trsAGC~~YMaPERidp~~~~k 270 (391)
T KOG0983|consen 195 KMTVAIVKALYYLKEKHGVI-HRDVKPSNILLDERGNIKLCDFGISGRLVDSKAH---TRSAGCAAYMAPERIDPPDKPK 270 (391)
T ss_pred hhHHHHHHHHHHHHHhccee-ecccCccceEEccCCCEEeecccccceeeccccc---ccccCCccccCccccCCCCCCc
Confidence 6778889999999876 666 9999999999999999999999998876544332 3456788999999998776667
Q ss_pred CCCccchHHHHHHHHHHHhCCCCCCCCCCChHHHHHHHhcCCCCCCCCCC-CCchHHHHHHHHHhhhcCCCCCCCHHHHH
Q psy1840 106 GTQKGDVYSFGLVLYEVIGRQGPWGHLRMTDEEIITSVTQGSGLRPDTSS-LDCAPSIIACMRTCWEEDPELRPDLRFVH 184 (423)
Q Consensus 106 ~s~ksDVyS~Giil~elltg~~Pf~~~~~~~~~i~~~i~~~~~~~p~~~~-~~~~~~l~~Li~~C~~~dP~~RPt~~~I~ 184 (423)
+.-.+|||||||.++|+.||+.||.+... +-+.+..+.+..+ |.++. ..+++.+.+++..||..|+.+||...+++
T Consensus 271 YDiRaDVWSlGITlveLaTg~yPy~~c~t-dFe~ltkvln~eP--P~L~~~~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll 347 (391)
T KOG0983|consen 271 YDIRADVWSLGITLVELATGQYPYKGCKT-DFEVLTKVLNEEP--PLLPGHMGFSPDFQSFVKDCLTKDHRKRPKYNKLL 347 (391)
T ss_pred cchhhhhhhhccchhhhhcccCCCCCCCc-cHHHHHHHHhcCC--CCCCcccCcCHHHHHHHHHHhhcCcccCcchHHHh
Confidence 79999999999999999999999987544 4566666666433 33332 34899999999999999999999999887
Q ss_pred HH
Q psy1840 185 HK 186 (423)
Q Consensus 185 ~~ 186 (423)
++
T Consensus 348 ~h 349 (391)
T KOG0983|consen 348 EH 349 (391)
T ss_pred cC
Confidence 64
|
|
| >KOG0588|consensus | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.4e-26 Score=231.49 Aligned_cols=151 Identities=20% Similarity=0.289 Sum_probs=134.2
Q ss_pred HHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCccEEEeccCCcccccCCCcccccccccCCccccCCccccCCCCC
Q psy1840 25 SISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKAPELLRQPHLP 104 (423)
Q Consensus 25 ~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~ 104 (423)
.+++..||+.|+.|+|..+|+ ||||||+|+|||.++.+||+|||+|..-. ......+.||++.|.|||++.|..|
T Consensus 114 aa~ff~QIi~gv~yCH~~~ic-HRDLKpENlLLd~~~nIKIADFGMAsLe~---~gklLeTSCGSPHYA~PEIV~G~pY- 188 (786)
T KOG0588|consen 114 AAHFFRQILDGVSYCHAFNIC-HRDLKPENLLLDVKNNIKIADFGMASLEV---PGKLLETSCGSPHYAAPEIVSGRPY- 188 (786)
T ss_pred HHHHHHHHHHHHHHHhhhcce-eccCCchhhhhhcccCEeeeccceeeccc---CCccccccCCCcccCCchhhcCCCC-
Confidence 689999999999999999998 99999999999999999999999987532 2233456799999999999999876
Q ss_pred CCCCccchHHHHHHHHHHHhCCCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCchHHHHHHHHHhhhcCCCCCCCHHHHH
Q psy1840 105 RGTQKGDVYSFGLVLYEVIGRQGPWGHLRMTDEEIITSVTQGSGLRPDTSSLDCAPSIIACMRTCWEEDPELRPDLRFVH 184 (423)
Q Consensus 105 ~~s~ksDVyS~Giil~elltg~~Pf~~~~~~~~~i~~~i~~~~~~~p~~~~~~~~~~l~~Li~~C~~~dP~~RPt~~~I~ 184 (423)
.+.++||||.|||||.|++|..||++ .+...++.++++|....| ..++++.++|+.+|+..||+.|.|+.+|+
T Consensus 189 -dG~~sDVWSCGVILfALLtG~LPFdD--dNir~LLlKV~~G~f~MP----s~Is~eaQdLLr~ml~VDp~~RiT~~eI~ 261 (786)
T KOG0588|consen 189 -DGRPSDVWSCGVILFALLTGKLPFDD--DNIRVLLLKVQRGVFEMP----SNISSEAQDLLRRMLDVDPSTRITTEEIL 261 (786)
T ss_pred -CCCccccchhHHHHHHHHhCCCCCCC--ccHHHHHHHHHcCcccCC----CcCCHHHHHHHHHHhccCccccccHHHHh
Confidence 48999999999999999999999984 456889999999987776 36889999999999999999999999998
Q ss_pred HHH
Q psy1840 185 HKL 187 (423)
Q Consensus 185 ~~L 187 (423)
++.
T Consensus 262 kHP 264 (786)
T KOG0588|consen 262 KHP 264 (786)
T ss_pred hCc
Confidence 764
|
|
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=99.94 E-value=4.6e-26 Score=216.33 Aligned_cols=159 Identities=23% Similarity=0.418 Sum_probs=129.2
Q ss_pred HHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCccEEEeccCCcccccCCCcccccccccCCccccCCccccCCCCC
Q psy1840 25 SISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKAPELLRQPHLP 104 (423)
Q Consensus 25 ~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~ 104 (423)
...++.|++.||.|||+++++ ||||||+||+++.++.++|+|||++........ ......++..|+|||.+.+...
T Consensus 108 ~~~~~~~i~~~l~~LH~~~i~-H~dl~~~nil~~~~~~~~l~d~g~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~- 183 (267)
T cd08228 108 VWKYFVQLCSAVEHMHSRRVM-HRDIKPANVFITATGVVKLGDLGLGRFFSSKTT--AAHSLVGTPYYMSPERIHENGY- 183 (267)
T ss_pred HHHHHHHHHHHHHHHhhCCee-CCCCCHHHEEEcCCCCEEECccccceeccchhH--HHhcCCCCccccChhhhccCCC-
Confidence 578999999999999999998 999999999999999999999999876532221 1123457788999999877654
Q ss_pred CCCCccchHHHHHHHHHHHhCCCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCchHHHHHHHHHhhhcCCCCCCCHHHHH
Q psy1840 105 RGTQKGDVYSFGLVLYEVIGRQGPWGHLRMTDEEIITSVTQGSGLRPDTSSLDCAPSIIACMRTCWEEDPELRPDLRFVH 184 (423)
Q Consensus 105 ~~s~ksDVyS~Giil~elltg~~Pf~~~~~~~~~i~~~i~~~~~~~p~~~~~~~~~~l~~Li~~C~~~dP~~RPt~~~I~ 184 (423)
+.++|+||||+++|||++|..||.....+...+...+.... .|......++..+.+++.+||+.+|++||++.+|+
T Consensus 184 --~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl 259 (267)
T cd08228 184 --NFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQCD--YPPLPTEHYSEKLRELVSMCIYPDPDQRPDIGYVH 259 (267)
T ss_pred --CchhhHHHHHHHHHHHhcCCCCCccccccHHHHHHHHhcCC--CCCCChhhcCHHHHHHHHHHCCCCcccCcCHHHHH
Confidence 78999999999999999999999765555556666655432 23333345778999999999999999999999999
Q ss_pred HHHHHHh
Q psy1840 185 HKLKEMN 191 (423)
Q Consensus 185 ~~L~~i~ 191 (423)
+.++.+.
T Consensus 260 ~~~~~~~ 266 (267)
T cd08228 260 QIAKQMH 266 (267)
T ss_pred HHHHHhc
Confidence 9998763
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=99.93 E-value=8.5e-26 Score=216.38 Aligned_cols=160 Identities=23% Similarity=0.388 Sum_probs=125.5
Q ss_pred HHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCccEEEeccCCcccccCCCcccccccccCCccccCCccccCCCCC
Q psy1840 25 SISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKAPELLRQPHLP 104 (423)
Q Consensus 25 ~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~ 104 (423)
.+.++.|++.||.|||+.+++ ||||||+||++++++.+||+|||+++...............++..|+|||.+.+..+
T Consensus 111 ~~~~~~qi~~~L~~lH~~~ii-H~dlkp~Nil~~~~~~~kL~dfG~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~- 188 (279)
T cd05109 111 LLNWCVQIAKGMSYLEEVRLV-HRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALESILHRRF- 188 (279)
T ss_pred HHHHHHHHHHHHHHHHHCCee-ccccccceEEEcCCCcEEECCCCceeecccccceeecCCCccchhhCCHHHhccCCC-
Confidence 688999999999999999988 999999999999999999999999876543222111122234567999999876654
Q ss_pred CCCCccchHHHHHHHHHHHh-CCCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCchHHHHHHHHHhhhcCCCCCCCHHHH
Q psy1840 105 RGTQKGDVYSFGLVLYEVIG-RQGPWGHLRMTDEEIITSVTQGSGLRPDTSSLDCAPSIIACMRTCWEEDPELRPDLRFV 183 (423)
Q Consensus 105 ~~s~ksDVyS~Giil~ellt-g~~Pf~~~~~~~~~i~~~i~~~~~~~p~~~~~~~~~~l~~Li~~C~~~dP~~RPt~~~I 183 (423)
+.++|||||||++||+++ |..||.. .....+...+..+.... . ...++.++.+++.+||+.||++||++.++
T Consensus 189 --~~~~Di~slG~~l~el~t~g~~p~~~--~~~~~~~~~~~~~~~~~--~-~~~~~~~~~~li~~~l~~dp~~Rp~~~~l 261 (279)
T cd05109 189 --THQSDVWSYGVTVWELMTFGAKPYDG--IPAREIPDLLEKGERLP--Q-PPICTIDVYMIMVKCWMIDSECRPRFREL 261 (279)
T ss_pred --CchhHHHHHHHHHHHHHcCCCCCCCC--CCHHHHHHHHHCCCcCC--C-CccCCHHHHHHHHHHcCCChhhCcCHHHH
Confidence 889999999999999998 8889864 23444555554433221 1 23578899999999999999999999999
Q ss_pred HHHHHHHhhh
Q psy1840 184 HHKLKEMNAG 193 (423)
Q Consensus 184 ~~~L~~i~~~ 193 (423)
++.|..+...
T Consensus 262 ~~~l~~~~~~ 271 (279)
T cd05109 262 VDEFSRMARD 271 (279)
T ss_pred HHHHHHhhcC
Confidence 9988877553
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.93 E-value=1e-25 Score=214.37 Aligned_cols=157 Identities=27% Similarity=0.474 Sum_probs=125.0
Q ss_pred HHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCccEEEeccCCcccccCCCcccccccccCCccccCCccccCCCCC
Q psy1840 25 SISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKAPELLRQPHLP 104 (423)
Q Consensus 25 ~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~ 104 (423)
.+.++.|++.||.|||+.+++ ||||||+||++++++.+||+|||+++................+..|+|||.+.+..+
T Consensus 115 ~~~~~~~i~~aL~~lH~~~i~-H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~- 192 (273)
T cd05035 115 LLKFMVDIALGMEYLSNRNFI-HRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVY- 192 (273)
T ss_pred HHHHHHHHHHHHHHHHhCCee-ccccchheEEECCCCeEEECCccceeeccccccccccccccCCccccCHhhcccCCC-
Confidence 578999999999999999998 999999999999999999999999876533322111122234567999999876554
Q ss_pred CCCCccchHHHHHHHHHHHh-CCCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCchHHHHHHHHHhhhcCCCCCCCHHHH
Q psy1840 105 RGTQKGDVYSFGLVLYEVIG-RQGPWGHLRMTDEEIITSVTQGSGLRPDTSSLDCAPSIIACMRTCWEEDPELRPDLRFV 183 (423)
Q Consensus 105 ~~s~ksDVyS~Giil~ellt-g~~Pf~~~~~~~~~i~~~i~~~~~~~p~~~~~~~~~~l~~Li~~C~~~dP~~RPt~~~I 183 (423)
+.++|||||||++|||++ |..||.+ ....++...+..+... .. +..++.++.+++.+||+.||++||++.++
T Consensus 193 --~~~~Dv~SlG~il~el~~~g~~p~~~--~~~~~~~~~~~~~~~~--~~-~~~~~~~~~~li~~~l~~~p~~Rp~~~e~ 265 (273)
T cd05035 193 --TSKSDVWAFGVTMWEIATRGQTPYPG--VENHEIYDYLRHGNRL--KQ-PEDCLDELYDLMYSCWRADPKDRPTFTKL 265 (273)
T ss_pred --CcccchHHHHHHHHHHHhCCCCCCCC--CCHHHHHHHHHcCCCC--CC-CcCCCHHHHHHHHHHcCCChhhCcCHHHH
Confidence 889999999999999999 8888864 3445666666554322 12 23678999999999999999999999999
Q ss_pred HHHHHHH
Q psy1840 184 HHKLKEM 190 (423)
Q Consensus 184 ~~~L~~i 190 (423)
++.|+.+
T Consensus 266 ~~~l~~~ 272 (273)
T cd05035 266 REVLENI 272 (273)
T ss_pred HHHHHhh
Confidence 9998765
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=99.93 E-value=6.3e-26 Score=227.33 Aligned_cols=158 Identities=22% Similarity=0.406 Sum_probs=121.8
Q ss_pred HHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCccEEEeccCCcccccCCCcccccccccCCccccCCccccCCCCC
Q psy1840 25 SISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKAPELLRQPHLP 104 (423)
Q Consensus 25 ~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~ 104 (423)
.++++.||+.||.|||++|++ ||||||+||+++.++.+||+|||+++...............++..|+|||++.+..+
T Consensus 214 ~~~i~~qi~~aL~yLH~~gii-HrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~- 291 (374)
T cd05106 214 LLRFSSQVAQGMDFLASKNCI-HRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGNARLPVKWMAPESIFDCVY- 291 (374)
T ss_pred HHHHHHHHHHHHHHHHHCCEE-eccCchheEEEeCCCeEEEeeceeeeeccCCcceeeccCCCCccceeCHHHhcCCCC-
Confidence 578999999999999999998 999999999999999999999999875432221111122334567999999876554
Q ss_pred CCCCccchHHHHHHHHHHHh-CCCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCchHHHHHHHHHhhhcCCCCCCCHHHH
Q psy1840 105 RGTQKGDVYSFGLVLYEVIG-RQGPWGHLRMTDEEIITSVTQGSGLRPDTSSLDCAPSIIACMRTCWEEDPELRPDLRFV 183 (423)
Q Consensus 105 ~~s~ksDVyS~Giil~ellt-g~~Pf~~~~~~~~~i~~~i~~~~~~~p~~~~~~~~~~l~~Li~~C~~~dP~~RPt~~~I 183 (423)
+.++|||||||++|||++ |+.||..... .......+..+. .+. .+...++++.+++.+||+.||++||++.+|
T Consensus 292 --~~~~DvwSlGvil~ellt~G~~Pf~~~~~-~~~~~~~~~~~~--~~~-~~~~~~~~l~~li~~cl~~dp~~RPs~~~l 365 (374)
T cd05106 292 --TVQSDVWSYGILLWEIFSLGKSPYPGILV-NSKFYKMVKRGY--QMS-RPDFAPPEIYSIMKMCWNLEPTERPTFSQI 365 (374)
T ss_pred --CccccHHHHHHHHHHHHhCCCCCCccccc-cHHHHHHHHccc--Ccc-CCCCCCHHHHHHHHHHcCCChhhCcCHHHH
Confidence 899999999999999997 9999975322 222333333221 111 122467899999999999999999999999
Q ss_pred HHHHHHH
Q psy1840 184 HHKLKEM 190 (423)
Q Consensus 184 ~~~L~~i 190 (423)
.+.|+++
T Consensus 366 ~~~l~~~ 372 (374)
T cd05106 366 SQLIQRQ 372 (374)
T ss_pred HHHHHHH
Confidence 9998875
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=99.93 E-value=8.3e-26 Score=216.10 Aligned_cols=155 Identities=28% Similarity=0.549 Sum_probs=124.6
Q ss_pred HHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCccEEEeccCCcccccCCCcccccccccCCccccCCccccCCCCC
Q psy1840 25 SISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKAPELLRQPHLP 104 (423)
Q Consensus 25 ~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~ 104 (423)
...++.|++.|+.|||++|++ ||||||+||+++.++.+||+|||++................++..|+|||.+.+..+
T Consensus 124 ~~~~~~~i~~~l~~lH~~~i~-h~dlkp~nili~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~- 201 (280)
T cd05049 124 LLQIAVQIASGMVYLASQHFV-HRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKF- 201 (280)
T ss_pred HHHHHHHHHHHHHHHhhCCee-ccccccceEEEcCCCeEEECCcccceecccCcceecCCCCcccceecChhhhccCCc-
Confidence 578999999999999999988 999999999999999999999999875432221111123344677999999987655
Q ss_pred CCCCccchHHHHHHHHHHHh-CCCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCchHHHHHHHHHhhhcCCCCCCCHHHH
Q psy1840 105 RGTQKGDVYSFGLVLYEVIG-RQGPWGHLRMTDEEIITSVTQGSGLRPDTSSLDCAPSIIACMRTCWEEDPELRPDLRFV 183 (423)
Q Consensus 105 ~~s~ksDVyS~Giil~ellt-g~~Pf~~~~~~~~~i~~~i~~~~~~~p~~~~~~~~~~l~~Li~~C~~~dP~~RPt~~~I 183 (423)
+.++|||||||++|||++ |..||.. ....+....+..+....+ ...++..+.+++.+||+.||++||++.+|
T Consensus 202 --~~~~Di~slG~il~e~~~~g~~p~~~--~~~~~~~~~~~~~~~~~~---~~~~~~~~~~li~~~l~~~p~~Rp~~~ei 274 (280)
T cd05049 202 --TTESDVWSFGVVLWEIFTYGKQPWYG--LSNEEVIECITQGRLLQR---PRTCPSEVYDIMLGCWKRDPQQRINIKDI 274 (280)
T ss_pred --chhhhHHHHHHHHHHHHhcCCCCCCC--CCHHHHHHHHHcCCcCCC---CCCCCHHHHHHHHHHcCCCcccCCCHHHH
Confidence 889999999999999998 9999864 345566666665443222 23578999999999999999999999999
Q ss_pred HHHHH
Q psy1840 184 HHKLK 188 (423)
Q Consensus 184 ~~~L~ 188 (423)
++.|+
T Consensus 275 l~~l~ 279 (280)
T cd05049 275 HERLQ 279 (280)
T ss_pred HHHhh
Confidence 98875
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >KOG0661|consensus | Back alignment and domain information |
|---|
Probab=99.93 E-value=4.3e-26 Score=222.21 Aligned_cols=155 Identities=19% Similarity=0.275 Sum_probs=122.7
Q ss_pred HHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCccEEEeccCCcccccCCCcccccccccCCccccCCccccCCCCC
Q psy1840 25 SISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKAPELLRQPHLP 104 (423)
Q Consensus 25 ~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~ 104 (423)
...|+.||++||+|+|++|+. |||+||+|||+..+..+||+|||+|+........ +....|.+|.|||++....
T Consensus 112 irnim~QilqGL~hiHk~GfF-HRDlKPENiLi~~~~~iKiaDFGLARev~SkpPY---TeYVSTRWYRAPEvLLrs~-- 185 (538)
T KOG0661|consen 112 IRNIMYQILQGLAHIHKHGFF-HRDLKPENILISGNDVIKIADFGLAREVRSKPPY---TEYVSTRWYRAPEVLLRSG-- 185 (538)
T ss_pred HHHHHHHHHHHHHHHHhcCcc-cccCChhheEecccceeEecccccccccccCCCc---chhhhcccccchHHhhhcc--
Confidence 469999999999999999998 9999999999999999999999999977554433 4567889999999987654
Q ss_pred CCCCccchHHHHHHHHHHHhCCCCCCCCCCChHHHHHHHhc--C-----------------CCCCCCCC-------CCCc
Q psy1840 105 RGTQKGDVYSFGLVLYEVIGRQGPWGHLRMTDEEIITSVTQ--G-----------------SGLRPDTS-------SLDC 158 (423)
Q Consensus 105 ~~s~ksDVyS~Giil~elltg~~Pf~~~~~~~~~i~~~i~~--~-----------------~~~~p~~~-------~~~~ 158 (423)
.++.+.|+||+|||++|+.+-+.-|++... -+.+.++.. | ....|... ...+
T Consensus 186 ~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE--~Dqi~KIc~VLGtP~~~~~~eg~~La~~mnf~~P~~~~~~l~~L~p~~ 263 (538)
T KOG0661|consen 186 YYSSPVDMWAVGCIMAELYSLRPLFPGASE--IDQIYKICEVLGTPDKDSWPEGYNLASAMNFRFPQVKPSPLKDLLPNA 263 (538)
T ss_pred ccCCchHHHHHHHHHHHHHHhcccCCCCcH--HHHHHHHHHHhCCCccccchhHHHHHHHhccCCCcCCCCChHHhCccc
Confidence 359999999999999999999998986432 222222221 0 01111111 1347
Q ss_pred hHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q psy1840 159 APSIIACMRTCWEEDPELRPDLRFVHHKL 187 (423)
Q Consensus 159 ~~~l~~Li~~C~~~dP~~RPt~~~I~~~L 187 (423)
+.+..++|.+|+++||++|||+.+.++.-
T Consensus 264 s~~~~~li~~ll~WDP~kRpTA~~al~~p 292 (538)
T KOG0661|consen 264 SSEAASLIERLLAWDPDKRPTASQALQHP 292 (538)
T ss_pred CHHHHHHHHHHhcCCCccCccHHHHhcCc
Confidence 88999999999999999999999998753
|
|
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.2e-25 Score=222.11 Aligned_cols=160 Identities=27% Similarity=0.439 Sum_probs=125.3
Q ss_pred HHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCccEEEeccCCcccccCCCcccccccccCCccccCCccccCCCCC
Q psy1840 25 SISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKAPELLRQPHLP 104 (423)
Q Consensus 25 ~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~ 104 (423)
..+++.||+.||+|||++|++ ||||||+||+++.++.+||+|||++................++..|+|||.+.+..+
T Consensus 175 ~~~~~~qi~~aL~~lH~~~iv-HrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~- 252 (337)
T cd05054 175 LISYSFQVARGMEFLASRKCI-HRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPESIFDKVY- 252 (337)
T ss_pred HHHHHHHHHHHHHHHHhCCee-cCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCccccCcHHhcCCCC-
Confidence 678999999999999999998 999999999999999999999999876533222222233445677999999887655
Q ss_pred CCCCccchHHHHHHHHHHHh-CCCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCchHHHHHHHHHhhhcCCCCCCCHHHH
Q psy1840 105 RGTQKGDVYSFGLVLYEVIG-RQGPWGHLRMTDEEIITSVTQGSGLRPDTSSLDCAPSIIACMRTCWEEDPELRPDLRFV 183 (423)
Q Consensus 105 ~~s~ksDVyS~Giil~ellt-g~~Pf~~~~~~~~~i~~~i~~~~~~~p~~~~~~~~~~l~~Li~~C~~~dP~~RPt~~~I 183 (423)
+.++|||||||++||+++ |..||.+... .+.+...+..+.. +.. ...+++++.+++.+||+.+|++||++.+|
T Consensus 253 --~~~~Di~SlGv~l~el~t~g~~p~~~~~~-~~~~~~~~~~~~~--~~~-~~~~~~~~~~l~~~cl~~~p~~RPs~~el 326 (337)
T cd05054 253 --TTQSDVWSFGVLLWEIFSLGASPYPGVQI-DEEFCRRLKEGTR--MRA-PEYATPEIYSIMLDCWHNNPEDRPTFSEL 326 (337)
T ss_pred --CccccHHHHHHHHHHHHHcCCCCCCCCCc-cHHHHHHHhccCC--CCC-CccCCHHHHHHHHHHccCChhhCcCHHHH
Confidence 899999999999999997 9999975322 2233333433322 211 23567899999999999999999999999
Q ss_pred HHHHHHHhh
Q psy1840 184 HHKLKEMNA 192 (423)
Q Consensus 184 ~~~L~~i~~ 192 (423)
++.|+.+..
T Consensus 327 l~~l~~~~~ 335 (337)
T cd05054 327 VEILGDLLQ 335 (337)
T ss_pred HHHHHHHHh
Confidence 999987643
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=99.93 E-value=4e-26 Score=219.76 Aligned_cols=152 Identities=21% Similarity=0.250 Sum_probs=117.8
Q ss_pred HHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCccEEEeccCCcccccCCCcccccccccCCccccCCccccCCCCC
Q psy1840 25 SISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKAPELLRQPHLP 104 (423)
Q Consensus 25 ~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~ 104 (423)
...++.|++.||.|||+.|++ ||||||+||+++.++.+||+|||++...... .......+++.|+|||.+.+..+
T Consensus 112 ~~~i~~qi~~aL~~lH~~~ii-H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~- 186 (290)
T cd07862 112 IKDMMFQLLRGLDFLHSHRVV-HRDLKPQNILVTSSGQIKLADFGLARIYSFQ---MALTSVVVTLWYRAPEVLLQSSY- 186 (290)
T ss_pred HHHHHHHHHHHHHHHHHCCee-eCCCCHHHEEEcCCCCEEEccccceEeccCC---cccccccccccccChHHHhCCCC-
Confidence 578999999999999999998 9999999999999999999999998754322 12234567889999999977654
Q ss_pred CCCCccchHHHHHHHHHHHhCCCCCCCCCCChHHHHHHHhcCCCC-----C--------------CCC----CCCCchHH
Q psy1840 105 RGTQKGDVYSFGLVLYEVIGRQGPWGHLRMTDEEIITSVTQGSGL-----R--------------PDT----SSLDCAPS 161 (423)
Q Consensus 105 ~~s~ksDVyS~Giil~elltg~~Pf~~~~~~~~~i~~~i~~~~~~-----~--------------p~~----~~~~~~~~ 161 (423)
+.++|||||||++|||++|..||... ...+.+..+...... . +.. ....+++.
T Consensus 187 --~~~~DiwslG~il~el~~g~~~f~~~--~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (290)
T cd07862 187 --ATPVDLWSVGCIFAEMFRRKPLFRGS--SDVDQLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDEL 262 (290)
T ss_pred --CCccchHHHHHHHHHHHcCCCCcCCC--CHHHHHHHHHHHhCCCChhhchhhhcccchhccCCCCCCHHHHccCCCHH
Confidence 88999999999999999999999743 233333333221000 0 000 01246778
Q ss_pred HHHHHHHhhhcCCCCCCCHHHHHH
Q psy1840 162 IIACMRTCWEEDPELRPDLRFVHH 185 (423)
Q Consensus 162 l~~Li~~C~~~dP~~RPt~~~I~~ 185 (423)
+.+++.+||+.||++|||+.++++
T Consensus 263 ~~~li~~~l~~~P~~R~s~~~~l~ 286 (290)
T cd07862 263 GKDLLLKCLTFNPAKRISAYSALS 286 (290)
T ss_pred HHHHHHHHhccCchhcCCHHHHhc
Confidence 899999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.2e-25 Score=212.69 Aligned_cols=156 Identities=24% Similarity=0.473 Sum_probs=124.9
Q ss_pred HHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCccEEEeccCCcccccCCCccc-ccccccCCccccCCccccCCCC
Q psy1840 25 SISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETG-QERKLRRRKLYKAPELLRQPHL 103 (423)
Q Consensus 25 ~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~~~-~~~~~~gt~~y~APE~l~~~~~ 103 (423)
.+.++.|++.||.|||++|++ ||||||.||+++.++.+||+|||++.......... ......++..|+|||.+.....
T Consensus 97 ~~~i~~qi~~al~~lH~~~i~-H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~ 175 (257)
T cd05116 97 ITELVHQVSMGMKYLEETNFV-HRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPECMNYYKF 175 (257)
T ss_pred HHHHHHHHHHHHHHHHHCCEe-ecccchhhEEEcCCCeEEECCCccccccCCCCCeeeecCCCCCCccccCHhHhccCCc
Confidence 679999999999999999987 99999999999999999999999987654332211 1112233567999999876544
Q ss_pred CCCCCccchHHHHHHHHHHHh-CCCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCchHHHHHHHHHhhhcCCCCCCCHHH
Q psy1840 104 PRGTQKGDVYSFGLVLYEVIG-RQGPWGHLRMTDEEIITSVTQGSGLRPDTSSLDCAPSIIACMRTCWEEDPELRPDLRF 182 (423)
Q Consensus 104 ~~~s~ksDVyS~Giil~ellt-g~~Pf~~~~~~~~~i~~~i~~~~~~~p~~~~~~~~~~l~~Li~~C~~~dP~~RPt~~~ 182 (423)
+.++|+|||||++||+++ |..||.. ....++...+..+.. +.. +..+++++.++|.+||+.||++||++.+
T Consensus 176 ---~~~~Di~slG~~l~el~t~g~~p~~~--~~~~~~~~~i~~~~~--~~~-~~~~~~~l~~li~~~~~~~p~~Rp~~~~ 247 (257)
T cd05116 176 ---SSKSDVWSFGVLMWEAFSYGQKPYKG--MKGNEVTQMIESGER--MEC-PQRCPPEMYDLMKLCWTYGVDERPGFAV 247 (257)
T ss_pred ---CchhHHHHHHHHHHHHHhCCCCCCCC--CCHHHHHHHHHCCCC--CCC-CCCCCHHHHHHHHHHhccCchhCcCHHH
Confidence 789999999999999998 9999974 345667777765432 222 2357899999999999999999999999
Q ss_pred HHHHHHH
Q psy1840 183 VHHKLKE 189 (423)
Q Consensus 183 I~~~L~~ 189 (423)
|.+.|+.
T Consensus 248 i~~~l~~ 254 (257)
T cd05116 248 VELRLRN 254 (257)
T ss_pred HHHHHhc
Confidence 9988865
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=99.93 E-value=2e-25 Score=216.80 Aligned_cols=159 Identities=27% Similarity=0.469 Sum_probs=127.8
Q ss_pred HHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCccEEEeccCCcccccCCCcccccccccCCccccCCccccCCCCC
Q psy1840 25 SISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKAPELLRQPHLP 104 (423)
Q Consensus 25 ~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~ 104 (423)
.++++.||+.||.|||++|++ ||||||+||+++.++.+||+|||+++...............++..|+|||.+.+..+
T Consensus 139 ~~~~~~qi~~al~~LH~~giv-H~dlkp~Nili~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~- 216 (304)
T cd05101 139 LVSCTYQVARGMEYLASQKCI-HRDLAARNVLVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVY- 216 (304)
T ss_pred HHHHHHHHHHHHHHHHHCCee-ecccccceEEEcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCC-
Confidence 578999999999999999998 999999999999999999999999876543222222223345567999999877654
Q ss_pred CCCCccchHHHHHHHHHHHh-CCCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCchHHHHHHHHHhhhcCCCCCCCHHHH
Q psy1840 105 RGTQKGDVYSFGLVLYEVIG-RQGPWGHLRMTDEEIITSVTQGSGLRPDTSSLDCAPSIIACMRTCWEEDPELRPDLRFV 183 (423)
Q Consensus 105 ~~s~ksDVyS~Giil~ellt-g~~Pf~~~~~~~~~i~~~i~~~~~~~p~~~~~~~~~~l~~Li~~C~~~dP~~RPt~~~I 183 (423)
+.++||||||+++|++++ |..||.. .+..++...+..+... . ....++..+.+++.+||+.+|++||++.+|
T Consensus 217 --~~~~Di~slG~~l~el~~~g~~p~~~--~~~~~~~~~~~~~~~~--~-~~~~~~~~~~~li~~cl~~~p~~Rps~~e~ 289 (304)
T cd05101 217 --THQSDVWSFGVLMWEIFTLGGSPYPG--IPVEELFKLLKEGHRM--D-KPANCTNELYMMMRDCWHAIPSHRPTFKQL 289 (304)
T ss_pred --CchhhHHHHHHHHHHHHcCCCCCccc--CCHHHHHHHHHcCCcC--C-CCCCCCHHHHHHHHHHcccChhhCCCHHHH
Confidence 889999999999999998 7788863 4556677666554322 1 223678999999999999999999999999
Q ss_pred HHHHHHHhh
Q psy1840 184 HHKLKEMNA 192 (423)
Q Consensus 184 ~~~L~~i~~ 192 (423)
++.|+++..
T Consensus 290 l~~l~~~~~ 298 (304)
T cd05101 290 VEDLDRILT 298 (304)
T ss_pred HHHHHHHHH
Confidence 999988764
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.3e-25 Score=211.60 Aligned_cols=156 Identities=27% Similarity=0.536 Sum_probs=123.8
Q ss_pred HHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCccEEEeccCCcccccCCCcccccccccCCccccCCccccCCCCC
Q psy1840 25 SISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKAPELLRQPHLP 104 (423)
Q Consensus 25 ~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~ 104 (423)
.+.++.|++.||.|||+.+++ ||||||+||+++.++.+||+|||++......... .......+..|+|||.+.+...
T Consensus 106 ~~~~~~ql~~~l~~lH~~~i~-H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~- 182 (263)
T cd05052 106 LLYMATQISSAMEYLEKKNFI-HRDLAARNCLVGENHLVKVADFGLSRLMTGDTYT-AHAGAKFPIKWTAPESLAYNKF- 182 (263)
T ss_pred HHHHHHHHHHHHHHHHhCCEe-ecccCcceEEEcCCCcEEeCCCccccccccceee-ccCCCCCccccCCHHHhccCCC-
Confidence 678999999999999999988 9999999999999999999999998765432211 1112233457999999877654
Q ss_pred CCCCccchHHHHHHHHHHHh-CCCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCchHHHHHHHHHhhhcCCCCCCCHHHH
Q psy1840 105 RGTQKGDVYSFGLVLYEVIG-RQGPWGHLRMTDEEIITSVTQGSGLRPDTSSLDCAPSIIACMRTCWEEDPELRPDLRFV 183 (423)
Q Consensus 105 ~~s~ksDVyS~Giil~ellt-g~~Pf~~~~~~~~~i~~~i~~~~~~~p~~~~~~~~~~l~~Li~~C~~~dP~~RPt~~~I 183 (423)
+.++|||||||++|||++ |..||.+. ...+....+..+. .+. ....++.++.+++.+||+.+|++||++.++
T Consensus 183 --~~~~Dv~slG~il~el~t~g~~p~~~~--~~~~~~~~~~~~~--~~~-~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l 255 (263)
T cd05052 183 --SIKSDVWAFGVLLWEIATYGMSPYPGI--DLSQVYELLEKGY--RME-RPEGCPPKVYELMRACWQWNPSDRPSFAEI 255 (263)
T ss_pred --CchhHHHHHHHHHHHHHcCCCCCCCCC--CHHHHHHHHHCCC--CCC-CCCCCCHHHHHHHHHHccCCcccCCCHHHH
Confidence 889999999999999998 88998743 4455555555432 222 234678999999999999999999999999
Q ss_pred HHHHHHH
Q psy1840 184 HHKLKEM 190 (423)
Q Consensus 184 ~~~L~~i 190 (423)
.+.|+.+
T Consensus 256 ~~~l~~~ 262 (263)
T cd05052 256 HQAFETM 262 (263)
T ss_pred HHHHHhh
Confidence 9988764
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >KOG0599|consensus | Back alignment and domain information |
|---|
Probab=99.93 E-value=3.1e-26 Score=209.33 Aligned_cols=155 Identities=19% Similarity=0.307 Sum_probs=131.2
Q ss_pred HHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCccEEEeccCCcccccCCCcccccccccCCccccCCccccCC---C
Q psy1840 26 ISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKAPELLRQP---H 102 (423)
Q Consensus 26 l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~---~ 102 (423)
-+|+.|+..|++|||.++|+ ||||||+|||+|++.++||+|||++..+.... .....+||+.|+|||.+... .
T Consensus 126 R~iMrqlfegVeylHa~~IV-HRDLKpENILlddn~~i~isDFGFa~~l~~Ge---kLrelCGTPgYLAPEtikC~m~e~ 201 (411)
T KOG0599|consen 126 RRIMRQLFEGVEYLHARNIV-HRDLKPENILLDDNMNIKISDFGFACQLEPGE---KLRELCGTPGYLAPETIKCSMYEN 201 (411)
T ss_pred HHHHHHHHHHHHHHHHhhhh-hcccChhheeeccccceEEeccceeeccCCch---hHHHhcCCCcccChhheeeecccC
Confidence 58999999999999999998 99999999999999999999999988765333 33568999999999999742 2
Q ss_pred CCCCCCccchHHHHHHHHHHHhCCCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCchHHHHHHHHHhhhcCCCCCCCHHH
Q psy1840 103 LPRGTQKGDVYSFGLVLYEVIGRQGPWGHLRMTDEEIITSVTQGSGLRPDTSSLDCAPSIIACMRTCWEEDPELRPDLRF 182 (423)
Q Consensus 103 ~~~~s~ksDVyS~Giil~elltg~~Pf~~~~~~~~~i~~~i~~~~~~~p~~~~~~~~~~l~~Li~~C~~~dP~~RPt~~~ 182 (423)
.+-++...|+||.|+|+|-++.|..||.+.. .--.+..+..|+.........+++....+||.+|++.||.+|.|..+
T Consensus 202 ~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRk--QmlMLR~ImeGkyqF~speWadis~~~KdLIsrlLqVdp~~Ritake 279 (411)
T KOG0599|consen 202 HPGYSKEVDEWACGVIMYTLLAGCPPFWHRK--QMLMLRMIMEGKYQFRSPEWADISATVKDLISRLLQVDPTKRITAKE 279 (411)
T ss_pred CCCccchhhHHHHHHHHHHHHcCCCchhHHH--HHHHHHHHHhcccccCCcchhhccccHHHHHHHHHeeCchhcccHHH
Confidence 3356899999999999999999999997531 12245667778776666667789999999999999999999999999
Q ss_pred HHHH
Q psy1840 183 VHHK 186 (423)
Q Consensus 183 I~~~ 186 (423)
++..
T Consensus 280 ~LaH 283 (411)
T KOG0599|consen 280 ALAH 283 (411)
T ss_pred HhcC
Confidence 8764
|
|
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.3e-25 Score=214.86 Aligned_cols=155 Identities=26% Similarity=0.511 Sum_probs=122.2
Q ss_pred HHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCccEEEeccCCcccccCCCcccccccccCCccccCCccccCCCCC
Q psy1840 25 SISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKAPELLRQPHLP 104 (423)
Q Consensus 25 ~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~ 104 (423)
.+.++.|++.|+.|||+.+++ ||||||+||+++.++.+||+|||++................++..|+|||.+.+..+
T Consensus 121 ~~~~~~~l~~~l~~lH~~~~v-H~dlkp~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~- 198 (277)
T cd05062 121 MIQMAGEIADGMAYLNANKFV-HRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVF- 198 (277)
T ss_pred HHHHHHHHHHHHHHHHHCCcc-cCCcchheEEEcCCCCEEECCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCc-
Confidence 578999999999999999988 999999999999999999999999875432222111122344667999999877654
Q ss_pred CCCCccchHHHHHHHHHHHh-CCCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCchHHHHHHHHHhhhcCCCCCCCHHHH
Q psy1840 105 RGTQKGDVYSFGLVLYEVIG-RQGPWGHLRMTDEEIITSVTQGSGLRPDTSSLDCAPSIIACMRTCWEEDPELRPDLRFV 183 (423)
Q Consensus 105 ~~s~ksDVyS~Giil~ellt-g~~Pf~~~~~~~~~i~~~i~~~~~~~p~~~~~~~~~~l~~Li~~C~~~dP~~RPt~~~I 183 (423)
+.++|||||||++|||++ |..||.. ....+....+..+.... ....++..+.+++.+||+.+|++||++.++
T Consensus 199 --~~~~Di~slG~~l~el~~~~~~p~~~--~~~~~~~~~~~~~~~~~---~~~~~~~~~~~li~~~l~~~p~~Rps~~e~ 271 (277)
T cd05062 199 --TTYSDVWSFGVVLWEIATLAEQPYQG--MSNEQVLRFVMEGGLLD---KPDNCPDMLFELMRMCWQYNPKMRPSFLEI 271 (277)
T ss_pred --CchhHHHHHHHHHHHHHcCCCCCCCC--CCHHHHHHHHHcCCcCC---CCCCCCHHHHHHHHHHcCCChhhCcCHHHH
Confidence 889999999999999998 6888864 34455665555443221 123578899999999999999999999999
Q ss_pred HHHHH
Q psy1840 184 HHKLK 188 (423)
Q Consensus 184 ~~~L~ 188 (423)
++.|+
T Consensus 272 l~~l~ 276 (277)
T cd05062 272 ISSIK 276 (277)
T ss_pred HHHhh
Confidence 88764
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.4e-25 Score=216.19 Aligned_cols=157 Identities=29% Similarity=0.479 Sum_probs=124.7
Q ss_pred HHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCccEEEeccCCcccccCCCcccccccccCCccccCCccccCCCCC
Q psy1840 25 SISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKAPELLRQPHLP 104 (423)
Q Consensus 25 ~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~ 104 (423)
.++++.|++.|+.|||+.+++ ||||||+||+++.++.+||+|||+++...............++..|+|||.+.+..+
T Consensus 134 ~~~i~~qi~~al~~LH~~~iv-H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~- 211 (293)
T cd05053 134 LVSFAYQVARGMEFLASKKCI-HRDLAARNVLVTEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVY- 211 (293)
T ss_pred HHHHHHHHHHHHHHHHHCCcc-ccccceeeEEEcCCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCc-
Confidence 678999999999999999998 999999999999999999999999876543322222222334567999999876554
Q ss_pred CCCCccchHHHHHHHHHHHh-CCCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCchHHHHHHHHHhhhcCCCCCCCHHHH
Q psy1840 105 RGTQKGDVYSFGLVLYEVIG-RQGPWGHLRMTDEEIITSVTQGSGLRPDTSSLDCAPSIIACMRTCWEEDPELRPDLRFV 183 (423)
Q Consensus 105 ~~s~ksDVyS~Giil~ellt-g~~Pf~~~~~~~~~i~~~i~~~~~~~p~~~~~~~~~~l~~Li~~C~~~dP~~RPt~~~I 183 (423)
+.++|||||||++||+++ |..||.. ....+....+..+.. +. .+..++..+.+++.+||..+|++|||+.++
T Consensus 212 --~~~~Di~slG~il~el~~~g~~p~~~--~~~~~~~~~~~~~~~--~~-~~~~~~~~~~~li~~~l~~~p~~Rps~~ei 284 (293)
T cd05053 212 --THQSDVWSFGVLLWEIFTLGGSPYPG--IPVEELFKLLKEGYR--ME-KPQNCTQELYHLMRDCWHEVPSQRPTFKQL 284 (293)
T ss_pred --CcccceeehhhHHHHHhcCCCCCCCC--CCHHHHHHHHHcCCc--CC-CCCCCCHHHHHHHHHHcccCcccCcCHHHH
Confidence 889999999999999997 8889864 344555555554322 11 123578899999999999999999999999
Q ss_pred HHHHHHH
Q psy1840 184 HHKLKEM 190 (423)
Q Consensus 184 ~~~L~~i 190 (423)
++.|..+
T Consensus 285 l~~l~~~ 291 (293)
T cd05053 285 VEDLDRM 291 (293)
T ss_pred HHHHHHh
Confidence 9998765
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.9e-25 Score=223.95 Aligned_cols=157 Identities=23% Similarity=0.415 Sum_probs=122.1
Q ss_pred HHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCccEEEeccCCcccccCCCcccccccccCCccccCCccccCCCCC
Q psy1840 25 SISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKAPELLRQPHLP 104 (423)
Q Consensus 25 ~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~ 104 (423)
.++++.||+.||.|||+.+++ ||||||+||+++.++.+||+|||+++...............++..|+|||.+.+..+
T Consensus 216 ~~~~~~qi~~~l~~lH~~~iv-H~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~- 293 (375)
T cd05104 216 LLSFSYQVAKGMSFLASKNCI-HRDLAARNILLTHGRITKICDFGLARDIRNDSNYVVKGNARLPVKWMAPESIFNCVY- 293 (375)
T ss_pred HHHHHHHHHHHHHHHHHCCee-ccCCchhhEEEECCCcEEEecCccceeccCcccccccCCCCCCcceeChhHhcCCCC-
Confidence 679999999999999999988 999999999999999999999999875533222111122334567999999987655
Q ss_pred CCCCccchHHHHHHHHHHHh-CCCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCchHHHHHHHHHhhhcCCCCCCCHHHH
Q psy1840 105 RGTQKGDVYSFGLVLYEVIG-RQGPWGHLRMTDEEIITSVTQGSGLRPDTSSLDCAPSIIACMRTCWEEDPELRPDLRFV 183 (423)
Q Consensus 105 ~~s~ksDVyS~Giil~ellt-g~~Pf~~~~~~~~~i~~~i~~~~~~~p~~~~~~~~~~l~~Li~~C~~~dP~~RPt~~~I 183 (423)
+.++|||||||++|||++ |..||.... ....+...+..+. ++.. +...+.++.+++.+||+.||++||++.+|
T Consensus 294 --~~~sDi~slG~~l~ellt~g~~p~~~~~-~~~~~~~~~~~~~--~~~~-~~~~~~~l~~li~~cl~~dP~~RPs~~ei 367 (375)
T cd05104 294 --TFESDVWSYGILLWEIFSLGSSPYPGMP-VDSKFYKMIKEGY--RMLS-PECAPSEMYDIMKSCWDADPLKRPTFKQI 367 (375)
T ss_pred --CCCCCHHHHHHHHHHHHhcCCCCCCCCC-chHHHHHHHHhCc--cCCC-CCCCCHHHHHHHHHHccCChhHCcCHHHH
Confidence 899999999999999998 888986432 2234444444432 1111 22457899999999999999999999999
Q ss_pred HHHHHH
Q psy1840 184 HHKLKE 189 (423)
Q Consensus 184 ~~~L~~ 189 (423)
++.|++
T Consensus 368 l~~l~~ 373 (375)
T cd05104 368 VQLIEQ 373 (375)
T ss_pred HHHHHh
Confidence 998875
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >KOG0585|consensus | Back alignment and domain information |
|---|
Probab=99.93 E-value=5.2e-26 Score=221.49 Aligned_cols=161 Identities=20% Similarity=0.259 Sum_probs=131.8
Q ss_pred HHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCccEEEeccCCcccccCCCc---ccccccccCCccccCCccccCC
Q psy1840 25 SISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDE---TGQERKLRRRKLYKAPELLRQP 101 (423)
Q Consensus 25 ~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~---~~~~~~~~gt~~y~APE~l~~~ 101 (423)
+-+++.+++.||+|||.+||| ||||||+|+||+++|++||+|||.+........ ........||+.|+|||.+.++
T Consensus 212 Ar~ylrDvv~GLEYLH~Qgii-HRDIKPsNLLl~~~g~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~ 290 (576)
T KOG0585|consen 212 ARKYLRDVVLGLEYLHYQGII-HRDIKPSNLLLSSDGTVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGG 290 (576)
T ss_pred HHHHHHHHHHHHHHHHhcCee-ccccchhheEEcCCCcEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCC
Confidence 568999999999999999999 999999999999999999999999876532211 1222346899999999999874
Q ss_pred C-CCCCCCccchHHHHHHHHHHHhCCCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCchHHHHHHHHHhhhcCCCCCCCH
Q psy1840 102 H-LPRGTQKGDVYSFGLVLYEVIGRQGPWGHLRMTDEEIITSVTQGSGLRPDTSSLDCAPSIIACMRTCWEEDPELRPDL 180 (423)
Q Consensus 102 ~-~~~~s~ksDVyS~Giil~elltg~~Pf~~~~~~~~~i~~~i~~~~~~~p~~~~~~~~~~l~~Li~~C~~~dP~~RPt~ 180 (423)
. ....+.+.||||+||+||.++.|+.||.+ ...-++..+|...+...|..+ +..+.+.+||+++|++||++|.++
T Consensus 291 ~~~~~~g~a~DiWalGVTLYCllfG~~PF~~--~~~~~l~~KIvn~pL~fP~~p--e~~e~~kDli~~lL~KdP~~Ri~l 366 (576)
T KOG0585|consen 291 NSFSYSGFALDIWALGVTLYCLLFGQLPFFD--DFELELFDKIVNDPLEFPENP--EINEDLKDLIKRLLEKDPEQRITL 366 (576)
T ss_pred CCccccchhhhhhhhhhhHHHhhhccCCccc--chHHHHHHHHhcCcccCCCcc--cccHHHHHHHHHHhhcChhheeeh
Confidence 4 33457899999999999999999999963 344667778877665555543 467899999999999999999999
Q ss_pred HHHHHHHHHH
Q psy1840 181 RFVHHKLKEM 190 (423)
Q Consensus 181 ~~I~~~L~~i 190 (423)
.+|.....--
T Consensus 367 ~~ik~Hpwvt 376 (576)
T KOG0585|consen 367 PDIKLHPWVT 376 (576)
T ss_pred hhheecceec
Confidence 9998766443
|
|
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=99.93 E-value=6.6e-26 Score=218.28 Aligned_cols=150 Identities=23% Similarity=0.310 Sum_probs=118.0
Q ss_pred HHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCccEEEeccCCcccccCCCcccccccccCCccccCCccccCCCCC
Q psy1840 25 SISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKAPELLRQPHLP 104 (423)
Q Consensus 25 ~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~ 104 (423)
.+.++.|++.||+|||+.+++ ||||||+||+++.++.+||+|||++....... ......|+..|+|||.+.+..+
T Consensus 104 ~~~~~~qi~~~l~~lH~~~ii-H~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~---~~~~~~g~~~y~aPE~~~~~~~- 178 (285)
T cd05631 104 AIFYAAELCCGLEDLQRERIV-YRDLKPENILLDDRGHIRISDLGLAVQIPEGE---TVRGRVGTVGYMAPEVINNEKY- 178 (285)
T ss_pred HHHHHHHHHHHHHHHHhCCEE-eCCCCHHHEEECCCCCEEEeeCCCcEEcCCCC---eecCCCCCCCccCHhhhcCCCC-
Confidence 578899999999999999998 99999999999999999999999987643221 1134468899999999987655
Q ss_pred CCCCccchHHHHHHHHHHHhCCCCCCCCCCC--hHHHHHHHhcCCCCCCCCCCCCchHHHHHHHHHhhhcCCCCCCC---
Q psy1840 105 RGTQKGDVYSFGLVLYEVIGRQGPWGHLRMT--DEEIITSVTQGSGLRPDTSSLDCAPSIIACMRTCWEEDPELRPD--- 179 (423)
Q Consensus 105 ~~s~ksDVyS~Giil~elltg~~Pf~~~~~~--~~~i~~~i~~~~~~~p~~~~~~~~~~l~~Li~~C~~~dP~~RPt--- 179 (423)
+.++|||||||++|||++|+.||...... ...+...+..... .....+++.+.+|+.+||+.||++||+
T Consensus 179 --~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~----~~~~~~s~~~~~li~~~l~~~P~~R~~~~~ 252 (285)
T cd05631 179 --TFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVKEDQE----EYSEKFSEDAKSICRMLLTKNPKERLGCRG 252 (285)
T ss_pred --CcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHHHHHhhcccc----cCCccCCHHHHHHHHHHhhcCHHHhcCCCC
Confidence 88999999999999999999999753321 1223333322211 122357889999999999999999997
Q ss_pred --HHHHHH
Q psy1840 180 --LRFVHH 185 (423)
Q Consensus 180 --~~~I~~ 185 (423)
+.++++
T Consensus 253 ~~~~~~~~ 260 (285)
T cd05631 253 NGAAGVKQ 260 (285)
T ss_pred CCHHHHhc
Confidence 677765
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.7e-25 Score=214.18 Aligned_cols=159 Identities=26% Similarity=0.444 Sum_probs=127.0
Q ss_pred HHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCccEEEeccCCcccccCCCcccccccccCCccccCCccccCCCCC
Q psy1840 25 SISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKAPELLRQPHLP 104 (423)
Q Consensus 25 ~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~ 104 (423)
.+.++.|++.||+|||+++++ ||||||+||+++.++.+||+|||+++...............++..|+|||.+.+..+
T Consensus 119 ~~~i~~~i~~~l~~LH~~~i~-H~di~p~nil~~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~- 196 (280)
T cd05043 119 LVHMAIQIACGMSYLHKRGVI-HKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEY- 196 (280)
T ss_pred HHHHHHHHHHHHHHHHHCCEe-ecccCHhhEEEcCCCcEEECCCCCcccccCCceEEeCCCCCcchhccCHHHHhcCCC-
Confidence 578999999999999999988 999999999999999999999999875433221111122345667999999876554
Q ss_pred CCCCccchHHHHHHHHHHHh-CCCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCchHHHHHHHHHhhhcCCCCCCCHHHH
Q psy1840 105 RGTQKGDVYSFGLVLYEVIG-RQGPWGHLRMTDEEIITSVTQGSGLRPDTSSLDCAPSIIACMRTCWEEDPELRPDLRFV 183 (423)
Q Consensus 105 ~~s~ksDVyS~Giil~ellt-g~~Pf~~~~~~~~~i~~~i~~~~~~~p~~~~~~~~~~l~~Li~~C~~~dP~~RPt~~~I 183 (423)
+.++||||||+++||+++ |..||.. ....++...+..+.. +.. ...+++++.+++.+||..+|++|||+.++
T Consensus 197 --~~~~Di~slG~~l~el~~~g~~p~~~--~~~~~~~~~~~~~~~--~~~-~~~~~~~~~~li~~~l~~~p~~Rps~~~~ 269 (280)
T cd05043 197 --SSASDVWSFGVLLWELMTLGQTPYVE--IDPFEMAAYLKDGYR--LAQ-PINCPDELFAVMACCWALDPEERPSFSQL 269 (280)
T ss_pred --CchhhHHHhHHHHHHHhcCCCCCcCc--CCHHHHHHHHHcCCC--CCC-CCcCCHHHHHHHHHHcCCChhhCCCHHHH
Confidence 899999999999999998 9999964 344555555554322 222 23578999999999999999999999999
Q ss_pred HHHHHHHhh
Q psy1840 184 HHKLKEMNA 192 (423)
Q Consensus 184 ~~~L~~i~~ 192 (423)
++.|+.+..
T Consensus 270 ~~~l~~~~~ 278 (280)
T cd05043 270 VQCLTDFHA 278 (280)
T ss_pred HHHHHHHHh
Confidence 999988764
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.8e-25 Score=212.24 Aligned_cols=159 Identities=23% Similarity=0.412 Sum_probs=128.0
Q ss_pred HHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCccEEEeccCCcccccCCCcccccccccCCccccCCccccCCCCC
Q psy1840 25 SISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKAPELLRQPHLP 104 (423)
Q Consensus 25 ~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~ 104 (423)
...++.||+.||.|||+.|++ |+||||+||+++.++.++|+|||++........ ......++..|+|||.+.+...
T Consensus 108 ~~~~~~~i~~~l~~LH~~~i~-H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~~~~ape~~~~~~~- 183 (267)
T cd08229 108 VWKYFVQLCSALEHMHSRRVM-HRDIKPANVFITATGVVKLGDLGLGRFFSSKTT--AAHSLVGTPYYMSPERIHENGY- 183 (267)
T ss_pred HHHHHHHHHHHHHHHHHCCee-cCCCCHHHEEEcCCCCEEECcchhhhccccCCc--ccccccCCcCccCHHHhcCCCc-
Confidence 578999999999999999998 999999999999999999999999775532221 1123457788999999977654
Q ss_pred CCCCccchHHHHHHHHHHHhCCCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCchHHHHHHHHHhhhcCCCCCCCHHHHH
Q psy1840 105 RGTQKGDVYSFGLVLYEVIGRQGPWGHLRMTDEEIITSVTQGSGLRPDTSSLDCAPSIIACMRTCWEEDPELRPDLRFVH 184 (423)
Q Consensus 105 ~~s~ksDVyS~Giil~elltg~~Pf~~~~~~~~~i~~~i~~~~~~~p~~~~~~~~~~l~~Li~~C~~~dP~~RPt~~~I~ 184 (423)
+.++|+||||+++|+|++|..||........+....+.... .+......+++.+.+++.+||+.+|++|||+.+|.
T Consensus 184 --~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~ 259 (267)
T cd08229 184 --NFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCD--YPPLPSDHYSEELRQLVNMCINPDPEKRPDITYVY 259 (267)
T ss_pred --cchhhHHHHHHHHHHHHhCCCCcccccchHHHHhhhhhcCC--CCCCCcccccHHHHHHHHHhcCCCcccCCCHHHHH
Confidence 88999999999999999999999755444445555554332 23333345788999999999999999999999999
Q ss_pred HHHHHHh
Q psy1840 185 HKLKEMN 191 (423)
Q Consensus 185 ~~L~~i~ 191 (423)
+.++++.
T Consensus 260 ~~~~~~~ 266 (267)
T cd08229 260 DVAKRMH 266 (267)
T ss_pred HHHhhhc
Confidence 9988764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.2e-25 Score=211.39 Aligned_cols=157 Identities=25% Similarity=0.500 Sum_probs=124.7
Q ss_pred HHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCccEEEeccCCcccccCCCcccc-cccccCCccccCCccccCCCC
Q psy1840 25 SISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQ-ERKLRRRKLYKAPELLRQPHL 103 (423)
Q Consensus 25 ~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~~~~-~~~~~gt~~y~APE~l~~~~~ 103 (423)
.+.++.|++.||.|||++|++ ||||||+||+++.++.+||+|||++........... .....++..|+|||.+.+..+
T Consensus 97 ~~~~~~~i~~~l~~lH~~~i~-H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~ 175 (257)
T cd05115 97 VVELMHQVSMGMKYLEGKNFV-HRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPECINFRKF 175 (257)
T ss_pred HHHHHHHHHHHHHHHHhcCee-ecccchheEEEcCCCcEEeccCCccccccCCccceeccCCCCCCcccCCHHHHccCCC
Confidence 679999999999999999987 999999999999999999999999875432221111 111223467999999876554
Q ss_pred CCCCCccchHHHHHHHHHHHh-CCCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCchHHHHHHHHHhhhcCCCCCCCHHH
Q psy1840 104 PRGTQKGDVYSFGLVLYEVIG-RQGPWGHLRMTDEEIITSVTQGSGLRPDTSSLDCAPSIIACMRTCWEEDPELRPDLRF 182 (423)
Q Consensus 104 ~~~s~ksDVyS~Giil~ellt-g~~Pf~~~~~~~~~i~~~i~~~~~~~p~~~~~~~~~~l~~Li~~C~~~dP~~RPt~~~ 182 (423)
+.++||||||+++||+++ |..||.. ....++...+..+... . .+..+++++.+++.+||..+|++||++.+
T Consensus 176 ---~~~~Di~slG~~l~el~~~g~~p~~~--~~~~~~~~~~~~~~~~--~-~~~~~~~~l~~li~~c~~~~~~~Rp~~~~ 247 (257)
T cd05115 176 ---SSRSDVWSYGITMWEAFSYGQKPYKK--MKGPEVMSFIEQGKRL--D-CPAECPPEMYALMKDCWIYKWEDRPNFAK 247 (257)
T ss_pred ---CchhhHHHHHHHHHHHhcCCCCCcCc--CCHHHHHHHHHCCCCC--C-CCCCCCHHHHHHHHHHcCCChhhCcCHHH
Confidence 889999999999999996 9999974 3456666666665322 2 22357899999999999999999999999
Q ss_pred HHHHHHHH
Q psy1840 183 VHHKLKEM 190 (423)
Q Consensus 183 I~~~L~~i 190 (423)
|.+.|+.+
T Consensus 248 i~~~l~~~ 255 (257)
T cd05115 248 VEERMRTY 255 (257)
T ss_pred HHHHHhhh
Confidence 99988764
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >KOG0593|consensus | Back alignment and domain information |
|---|
Probab=99.93 E-value=4.5e-26 Score=211.08 Aligned_cols=154 Identities=19% Similarity=0.327 Sum_probs=120.0
Q ss_pred HHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCccEEEeccCCcccccCCCcccccccccCCccccCCccccCCCCCC
Q psy1840 26 ISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKAPELLRQPHLPR 105 (423)
Q Consensus 26 l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~ 105 (423)
-+++.|++.|+.|+|++++| ||||||+||||+.+|.+||||||+|+.+..... ..+....|.+|.|||.+.+.. .
T Consensus 104 k~~l~Q~l~ai~~cHk~n~I-HRDIKPENILit~~gvvKLCDFGFAR~L~~pgd--~YTDYVATRWYRaPELLvGDt--q 178 (396)
T KOG0593|consen 104 KKYLYQLLKAIHFCHKNNCI-HRDIKPENILITQNGVVKLCDFGFARTLSAPGD--NYTDYVATRWYRAPELLVGDT--Q 178 (396)
T ss_pred HHHHHHHHHHhhhhhhcCee-cccCChhheEEecCCcEEeccchhhHhhcCCcc--hhhhhhhhhhccChhhhcccC--c
Confidence 58999999999999999998 999999999999999999999999998764322 234567889999999999854 3
Q ss_pred CCCccchHHHHHHHHHHHhCCCCCCCCCCChHHHHHHHhc---------------CCC---CC-CCCC--------CCCc
Q psy1840 106 GTQKGDVYSFGLVLYEVIGRQGPWGHLRMTDEEIITSVTQ---------------GSG---LR-PDTS--------SLDC 158 (423)
Q Consensus 106 ~s~ksDVyS~Giil~elltg~~Pf~~~~~~~~~i~~~i~~---------------~~~---~~-p~~~--------~~~~ 158 (423)
++..+||||+||++.||++|++-|++.+ +-+.+..|.. .+. .+ |... ..+.
T Consensus 179 YG~pVDiWAiGCv~aEl~~G~pL~PG~S--DiDQLy~I~ktLG~L~prhq~iF~~N~~F~Gv~lP~~~~~epLe~k~p~~ 256 (396)
T KOG0593|consen 179 YGKPVDIWAIGCVFAELLTGEPLWPGRS--DIDQLYLIRKTLGNLIPRHQSIFSSNPFFHGVRLPEPEHPEPLERKYPKI 256 (396)
T ss_pred CCCcccchhhhHHHHHHhcCCcCCCCcc--hHHHHHHHHHHHcccCHHHHHHhccCCceeeeecCCCCCccchhhhcccc
Confidence 4899999999999999999999997542 2222222221 110 00 1110 1345
Q ss_pred hHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q psy1840 159 APSIIACMRTCWEEDPELRPDLRFVHHK 186 (423)
Q Consensus 159 ~~~l~~Li~~C~~~dP~~RPt~~~I~~~ 186 (423)
+.-+.++++.|++.||++|++-++++..
T Consensus 257 s~~~ld~~k~cL~~dP~~R~sc~qll~H 284 (396)
T KOG0593|consen 257 SNVLLDLLKKCLKMDPDDRLSCEQLLHH 284 (396)
T ss_pred hHHHHHHHHHHhcCCccccccHHHHhcC
Confidence 6678999999999999999999988753
|
|
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=99.93 E-value=2e-25 Score=214.23 Aligned_cols=156 Identities=27% Similarity=0.496 Sum_probs=124.7
Q ss_pred HHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCccEEEeccCCcccccCCCcccccccccCCccccCCccccCCCCC
Q psy1840 25 SISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKAPELLRQPHLP 104 (423)
Q Consensus 25 ~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~ 104 (423)
.+.++.|++.||.|||+++++ ||||||+||+++.++.+||+|||+++...............++..|+|||.+.+..+
T Consensus 126 ~~~i~~~i~~al~~lH~~~i~-H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~- 203 (283)
T cd05090 126 FLHIAIQIAAGMEYLSSHFFV-HKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKF- 203 (283)
T ss_pred HHHHHHHHHHHHHHHHhcCee-hhccccceEEEcCCCcEEeccccccccccCCcceecccCCCccceecChHHhccCCC-
Confidence 578999999999999999988 999999999999999999999999876533322222233345667999999876554
Q ss_pred CCCCccchHHHHHHHHHHHh-CCCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCchHHHHHHHHHhhhcCCCCCCCHHHH
Q psy1840 105 RGTQKGDVYSFGLVLYEVIG-RQGPWGHLRMTDEEIITSVTQGSGLRPDTSSLDCAPSIIACMRTCWEEDPELRPDLRFV 183 (423)
Q Consensus 105 ~~s~ksDVyS~Giil~ellt-g~~Pf~~~~~~~~~i~~~i~~~~~~~p~~~~~~~~~~l~~Li~~C~~~dP~~RPt~~~I 183 (423)
+.++||||||+++|||++ |..||.. ....++.+.+...... + ....+++.+.+++.+||+.||.+||++.+|
T Consensus 204 --~~~~Dv~slG~il~el~~~g~~p~~~--~~~~~~~~~~~~~~~~-~--~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i 276 (283)
T cd05090 204 --SSDSDIWSFGVVLWEIFSFGLQPYYG--FSNQEVIEMVRKRQLL-P--CSEDCPPRMYSLMTECWQEGPSRRPRFKDI 276 (283)
T ss_pred --CchhhhHHHHHHHHHHHcCCCCCCCC--CCHHHHHHHHHcCCcC-C--CCCCCCHHHHHHHHHHcccCcccCcCHHHH
Confidence 889999999999999998 8889864 3445666666554322 1 223678999999999999999999999999
Q ss_pred HHHHHH
Q psy1840 184 HHKLKE 189 (423)
Q Consensus 184 ~~~L~~ 189 (423)
.+.|+.
T Consensus 277 ~~~l~~ 282 (283)
T cd05090 277 HTRLRS 282 (283)
T ss_pred HHHhhc
Confidence 888753
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.4e-25 Score=214.54 Aligned_cols=159 Identities=27% Similarity=0.459 Sum_probs=127.0
Q ss_pred HHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCccEEEeccCCcccccCCCcccccccccCCccccCCccccCCCCC
Q psy1840 25 SISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKAPELLRQPHLP 104 (423)
Q Consensus 25 ~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~ 104 (423)
.+.++.|++.|+.|||+.+++ ||||||+||++++++.+||+|||+++...............++..|+|||.+.+...
T Consensus 129 ~~~i~~~i~~~l~~LH~~~iv-H~dikp~nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~- 206 (290)
T cd05045 129 LISFAWQISRGMQYLAEMKLV-HRDLAARNVLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIY- 206 (290)
T ss_pred HHHHHHHHHHHHHHHHHCCee-hhhhhhheEEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCc-
Confidence 579999999999999999998 999999999999999999999999875433222111223345567999998876554
Q ss_pred CCCCccchHHHHHHHHHHHh-CCCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCchHHHHHHHHHhhhcCCCCCCCHHHH
Q psy1840 105 RGTQKGDVYSFGLVLYEVIG-RQGPWGHLRMTDEEIITSVTQGSGLRPDTSSLDCAPSIIACMRTCWEEDPELRPDLRFV 183 (423)
Q Consensus 105 ~~s~ksDVyS~Giil~ellt-g~~Pf~~~~~~~~~i~~~i~~~~~~~p~~~~~~~~~~l~~Li~~C~~~dP~~RPt~~~I 183 (423)
+.++||||||+++|||++ |..||.. ....++.+.+..+. .+. ....++.++.+++.+||+.+|++||++.++
T Consensus 207 --~~~~Di~slG~~l~el~t~g~~p~~~--~~~~~~~~~~~~~~--~~~-~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i 279 (290)
T cd05045 207 --TTQSDVWSFGVLLWEIVTLGGNPYPG--IAPERLFNLLKTGY--RME-RPENCSEEMYNLMLTCWKQEPDKRPTFADI 279 (290)
T ss_pred --chHhHHHHHHHHHHHHHhcCCCCCCC--CCHHHHHHHHhCCC--CCC-CCCCCCHHHHHHHHHHccCCcccCCCHHHH
Confidence 899999999999999998 9999964 34566666655432 222 124578899999999999999999999999
Q ss_pred HHHHHHHhh
Q psy1840 184 HHKLKEMNA 192 (423)
Q Consensus 184 ~~~L~~i~~ 192 (423)
.+.|+++..
T Consensus 280 ~~~l~~~~~ 288 (290)
T cd05045 280 SKELEKMMV 288 (290)
T ss_pred HHHHHHHHh
Confidence 999988754
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >KOG0595|consensus | Back alignment and domain information |
|---|
Probab=99.93 E-value=4.2e-26 Score=219.00 Aligned_cols=150 Identities=23% Similarity=0.421 Sum_probs=126.9
Q ss_pred HHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCC------ccEEEeccCCcccccCCCcccccccccCCccccCCccc
Q psy1840 25 SISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSR------WVLQIADFGLHAFKAGQDETGQERKLRRRKLYKAPELL 98 (423)
Q Consensus 25 ~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~------~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l 98 (423)
.-.++.||+.||++||+++|| ||||||+||||+.. -.+||+|||+++.+.... ...+.+|++.|||||++
T Consensus 111 ~r~Fm~QLA~alq~L~~~~Ii-HRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~L~~~~---~a~tlcGSplYMAPEV~ 186 (429)
T KOG0595|consen 111 ARHFMQQLASALQFLHENNII-HRDLKPQNILLSTTARNDTSPVLKIADFGFARFLQPGS---MAETLCGSPLYMAPEVI 186 (429)
T ss_pred HHHHHHHHHHHHHHHHHCCee-eccCCcceEEeccCCCCCCCceEEecccchhhhCCchh---HHHHhhCCccccCHHHH
Confidence 458999999999999999998 99999999999764 578999999999876332 33578999999999999
Q ss_pred cCCCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCchHHHHHHHHHhhhcCCCCCC
Q psy1840 99 RQPHLPRGTQKGDVYSFGLVLYEVIGRQGPWGHLRMTDEEIITSVTQGSGLRPDTSSLDCAPSIIACMRTCWEEDPELRP 178 (423)
Q Consensus 99 ~~~~~~~~s~ksDVyS~Giil~elltg~~Pf~~~~~~~~~i~~~i~~~~~~~p~~~~~~~~~~l~~Li~~C~~~dP~~RP 178 (423)
+...| +.|+|+||.|+|+|++++|+.||. ..+..++...++.+....|.... .++..+.+++...+..+|.+|.
T Consensus 187 ~~~~Y---dAKADLWSiG~Ilyq~l~g~~Pf~--a~t~~eL~~~~~k~~~~~~~~~~-~~s~~~~~Ll~~ll~~~~~~~~ 260 (429)
T KOG0595|consen 187 MSQQY---DAKADLWSIGTILYQCLTGKPPFD--AETPKELLLYIKKGNEIVPVLPA-ELSNPLRELLISLLQRNPKDRI 260 (429)
T ss_pred Hhccc---cchhhHHHHHHHHHHHHhCCCCcc--ccCHHHHHHHHhccccccCchhh-hccCchhhhhhHHHhcCccccC
Confidence 87766 999999999999999999999997 46778899888888776665543 4556667899999999999998
Q ss_pred CHHHHH
Q psy1840 179 DLRFVH 184 (423)
Q Consensus 179 t~~~I~ 184 (423)
++.+..
T Consensus 261 ~~~~~~ 266 (429)
T KOG0595|consen 261 SFEDFF 266 (429)
T ss_pred chHHhh
Confidence 876543
|
|
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.1e-25 Score=212.39 Aligned_cols=156 Identities=24% Similarity=0.452 Sum_probs=124.1
Q ss_pred HHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCccEEEeccCCcccccCCCcccccccccCCccccCCccccCCCCC
Q psy1840 25 SISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKAPELLRQPHLP 104 (423)
Q Consensus 25 ~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~ 104 (423)
.++++.|++.||+|||+.|++ ||||||+||+++.++.+|++|||.+........ .......++..|+|||.+.+..+
T Consensus 109 ~~~~~~~i~~al~~lH~~~ii-H~dikp~nili~~~~~~~l~dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~- 185 (266)
T cd05064 109 LMGMLPGLASGMKYLSEMGYV-HKGLAAHKVLVNSDLVCKISGFRRLQEDKSEAI-YTTMSGKSPVLWAAPEAIQYHHF- 185 (266)
T ss_pred HHHHHHHHHHHHHHHHHCCEe-eccccHhhEEEcCCCcEEECCCcccccccccch-hcccCCCCceeecCHHHHhhCCc-
Confidence 689999999999999999988 999999999999999999999998654322111 11112334567999999877655
Q ss_pred CCCCccchHHHHHHHHHHHh-CCCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCchHHHHHHHHHhhhcCCCCCCCHHHH
Q psy1840 105 RGTQKGDVYSFGLVLYEVIG-RQGPWGHLRMTDEEIITSVTQGSGLRPDTSSLDCAPSIIACMRTCWEEDPELRPDLRFV 183 (423)
Q Consensus 105 ~~s~ksDVyS~Giil~ellt-g~~Pf~~~~~~~~~i~~~i~~~~~~~p~~~~~~~~~~l~~Li~~C~~~dP~~RPt~~~I 183 (423)
+.++|||||||++||+++ |..||.+ ....+++..+..+... .. +..++..+.+++.+||+.+|++||++.+|
T Consensus 186 --~~~~Di~slG~~l~ell~~g~~p~~~--~~~~~~~~~~~~~~~~--~~-~~~~~~~~~~li~~c~~~~p~~RP~~~~i 258 (266)
T cd05064 186 --SSASDVWSFGIVMWEVMSYGERPYWD--MSGQDVIKAVEDGFRL--PA-PRNCPNLLHQLMLDCWQKERGERPRFSQI 258 (266)
T ss_pred --cchhHHHHHHHHHHHHhcCCCCCcCc--CCHHHHHHHHHCCCCC--CC-CCCCCHHHHHHHHHHcCCCchhCCCHHHH
Confidence 889999999999999875 9999974 3456666766654322 22 34688999999999999999999999999
Q ss_pred HHHHHHH
Q psy1840 184 HHKLKEM 190 (423)
Q Consensus 184 ~~~L~~i 190 (423)
.+.|..+
T Consensus 259 ~~~l~~~ 265 (266)
T cd05064 259 HSILSKM 265 (266)
T ss_pred HHHHHhh
Confidence 9987654
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=99.93 E-value=3e-25 Score=216.65 Aligned_cols=161 Identities=27% Similarity=0.463 Sum_probs=127.7
Q ss_pred HHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCccEEEeccCCcccccCCCcccccccccCCccccCCccccCCCCC
Q psy1840 25 SISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKAPELLRQPHLP 104 (423)
Q Consensus 25 ~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~ 104 (423)
.++++.|++.||.|||++|++ ||||||+||+++.++.+||+|||+++...............++..|+|||.+.+..+
T Consensus 136 ~~~~~~qi~~aL~~lH~~gi~-H~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~- 213 (314)
T cd05099 136 LVSCAYQVARGMEYLESRRCI-HRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVY- 213 (314)
T ss_pred HHHHHHHHHHHHHHHHHCCee-eccccceeEEEcCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCc-
Confidence 578999999999999999998 999999999999999999999999876533221111122234457999999877654
Q ss_pred CCCCccchHHHHHHHHHHHh-CCCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCchHHHHHHHHHhhhcCCCCCCCHHHH
Q psy1840 105 RGTQKGDVYSFGLVLYEVIG-RQGPWGHLRMTDEEIITSVTQGSGLRPDTSSLDCAPSIIACMRTCWEEDPELRPDLRFV 183 (423)
Q Consensus 105 ~~s~ksDVyS~Giil~ellt-g~~Pf~~~~~~~~~i~~~i~~~~~~~p~~~~~~~~~~l~~Li~~C~~~dP~~RPt~~~I 183 (423)
+.++||||||+++||+++ |..||.. .+..++...+..+... . ....++.++.+++.+||+.+|++||++.++
T Consensus 214 --~~~~DiwslG~~l~el~~~g~~p~~~--~~~~~~~~~~~~~~~~--~-~~~~~~~~l~~li~~cl~~~p~~Rps~~~l 286 (314)
T cd05099 214 --THQSDVWSFGILMWEIFTLGGSPYPG--IPVEELFKLLREGHRM--D-KPSNCTHELYMLMRECWHAVPTQRPTFKQL 286 (314)
T ss_pred --CccchhhHHHHHHHHHHhCCCCCCCC--CCHHHHHHHHHcCCCC--C-CCCCCCHHHHHHHHHHcCCCcccCcCHHHH
Confidence 889999999999999998 8888863 4456666666554321 1 123678899999999999999999999999
Q ss_pred HHHHHHHhhhc
Q psy1840 184 HHKLKEMNAGL 194 (423)
Q Consensus 184 ~~~L~~i~~~~ 194 (423)
++.|+.+....
T Consensus 287 l~~l~~~~~~~ 297 (314)
T cd05099 287 VEALDKVLAAV 297 (314)
T ss_pred HHHHHHHHHHh
Confidence 99998876544
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.3e-25 Score=212.74 Aligned_cols=155 Identities=28% Similarity=0.519 Sum_probs=124.0
Q ss_pred HHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCccEEEeccCCcccccCCCcccccccccCCccccCCccccCCCCC
Q psy1840 25 SISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKAPELLRQPHLP 104 (423)
Q Consensus 25 ~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~ 104 (423)
.+.++.|++.||.|||+.+++ ||||||+||+++.++.+||+|||+++...............++..|+|||.+.+...
T Consensus 121 ~~~~~~~i~~~l~~lH~~~i~-H~di~p~nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~- 198 (277)
T cd05032 121 FIQMAAEIADGMAYLAAKKFV-HRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVF- 198 (277)
T ss_pred HHHHHHHHHHHHHHHHhCCcc-ccccChheEEEcCCCCEEECCcccchhhccCcccccCCCCCccccccCHHHHhcCCC-
Confidence 678999999999999999998 999999999999999999999999875543322222223345678999999876654
Q ss_pred CCCCccchHHHHHHHHHHHh-CCCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCchHHHHHHHHHhhhcCCCCCCCHHHH
Q psy1840 105 RGTQKGDVYSFGLVLYEVIG-RQGPWGHLRMTDEEIITSVTQGSGLRPDTSSLDCAPSIIACMRTCWEEDPELRPDLRFV 183 (423)
Q Consensus 105 ~~s~ksDVyS~Giil~ellt-g~~Pf~~~~~~~~~i~~~i~~~~~~~p~~~~~~~~~~l~~Li~~C~~~dP~~RPt~~~I 183 (423)
+.++|||||||++||+++ |..||.. .+..+....+..+.. +.. +..++..+.+++.+||+.+|++|||+.++
T Consensus 199 --~~~~Di~slG~il~el~t~g~~p~~~--~~~~~~~~~~~~~~~--~~~-~~~~~~~~~~li~~~l~~~p~~Rpt~~~l 271 (277)
T cd05032 199 --TTKSDVWSFGVVLWEMATLAEQPYQG--LSNEEVLKFVIDGGH--LDL-PENCPDKLLELMRMCWQYNPKMRPTFLEI 271 (277)
T ss_pred --CcccchHHHHHHHHHhhccCCCCCcc--CCHHHHHHHHhcCCC--CCC-CCCCCHHHHHHHHHHcCCChhhCCCHHHH
Confidence 889999999999999998 8889863 345666666654322 222 23568999999999999999999999999
Q ss_pred HHHHH
Q psy1840 184 HHKLK 188 (423)
Q Consensus 184 ~~~L~ 188 (423)
++.|+
T Consensus 272 ~~~l~ 276 (277)
T cd05032 272 VSSLK 276 (277)
T ss_pred HHHhc
Confidence 98774
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=99.93 E-value=3.6e-25 Score=214.35 Aligned_cols=160 Identities=29% Similarity=0.459 Sum_probs=125.9
Q ss_pred HHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCccEEEeccCCcccccCCCcccccccccCCccccCCccccCCCCC
Q psy1840 25 SISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKAPELLRQPHLP 104 (423)
Q Consensus 25 ~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~ 104 (423)
.+.++.|++.|++|||++|++ ||||||+||+++.++.+||+|||++....... .......+..|+|||.+.+..+
T Consensus 121 ~~~i~~qi~~al~~lH~~~iv-H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~- 195 (297)
T cd05089 121 LLQFASDVATGMQYLSEKQFI-HRDLAARNVLVGENLASKIADFGLSRGEEVYV---KKTMGRLPVRWMAIESLNYSVY- 195 (297)
T ss_pred HHHHHHHHHHHHHHHHHCCcc-cCcCCcceEEECCCCeEEECCcCCCcccccee---ccCCCCcCccccCchhhccCCC-
Confidence 578999999999999999998 99999999999999999999999975422111 1111223456999999876654
Q ss_pred CCCCccchHHHHHHHHHHHh-CCCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCchHHHHHHHHHhhhcCCCCCCCHHHH
Q psy1840 105 RGTQKGDVYSFGLVLYEVIG-RQGPWGHLRMTDEEIITSVTQGSGLRPDTSSLDCAPSIIACMRTCWEEDPELRPDLRFV 183 (423)
Q Consensus 105 ~~s~ksDVyS~Giil~ellt-g~~Pf~~~~~~~~~i~~~i~~~~~~~p~~~~~~~~~~l~~Li~~C~~~dP~~RPt~~~I 183 (423)
+.++|||||||++|||++ |..||.. ....++...+..+. .+.. ...++.++.+++.+||+.+|.+||++.+|
T Consensus 196 --~~~~DvwSlG~il~el~t~g~~pf~~--~~~~~~~~~~~~~~--~~~~-~~~~~~~~~~li~~~l~~~p~~Rp~~~~i 268 (297)
T cd05089 196 --TTKSDVWSFGVLLWEIVSLGGTPYCG--MTCAELYEKLPQGY--RMEK-PRNCDDEVYELMRQCWRDRPYERPPFAQI 268 (297)
T ss_pred --CchhhHHHHHHHHHHHHcCCCCCCCC--CCHHHHHHHHhcCC--CCCC-CCCCCHHHHHHHHHHcCCChhhCcCHHHH
Confidence 889999999999999997 9999964 34455666655432 2221 23578999999999999999999999999
Q ss_pred HHHHHHHhhhcCC
Q psy1840 184 HHKLKEMNAGLKA 196 (423)
Q Consensus 184 ~~~L~~i~~~~~~ 196 (423)
.+.|..+..+.+.
T Consensus 269 ~~~l~~~~~~~~~ 281 (297)
T cd05089 269 SVQLSRMLEARKA 281 (297)
T ss_pred HHHHHHHHHhhcc
Confidence 9999888765543
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >KOG1187|consensus | Back alignment and domain information |
|---|
Probab=99.93 E-value=9.8e-26 Score=223.61 Aligned_cols=168 Identities=26% Similarity=0.385 Sum_probs=122.9
Q ss_pred CCCCCChHHHHHHHHHHHHHHHHHHhCC--CeeecCCCCCCEEEcCCccEEEeccCCcccccCCCcccccccc-cCCccc
Q psy1840 16 LSPFNIPIGSISVNTTASVGMIHLHDSE--IISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKL-RRRKLY 92 (423)
Q Consensus 16 ~~~~~~p~~~l~i~~qi~~gL~yLH~~~--ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~-~gt~~y 92 (423)
.++|.. |++|+.++|+||+|||... .|+||||||+|||+|.++.+||+|||+++..... .... ... .||..|
T Consensus 170 ~L~W~~---R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKlsDFGLa~~~~~~-~~~~-~~~~~gt~gY 244 (361)
T KOG1187|consen 170 PLDWET---RLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLSDFGLAKLGPEG-DTSV-STTVMGTFGY 244 (361)
T ss_pred CCCHHH---HHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEccCccCcccCCcc-ccce-eeecCCCCcc
Confidence 347877 9999999999999999864 3559999999999999999999999999665431 1111 122 789999
Q ss_pred cCCccccCCCCCCCCCccchHHHHHHHHHHHhCCCCCCCCC-CChHHHHH----HHhcC---CCCCCCCCCC-----Cch
Q psy1840 93 KAPELLRQPHLPRGTQKGDVYSFGLVLYEVIGRQGPWGHLR-MTDEEIIT----SVTQG---SGLRPDTSSL-----DCA 159 (423)
Q Consensus 93 ~APE~l~~~~~~~~s~ksDVyS~Giil~elltg~~Pf~~~~-~~~~~i~~----~i~~~---~~~~p~~~~~-----~~~ 159 (423)
+|||++..+.. +.|+||||||+++.|+++|+.|..... .....+.. .+..+ ....|..... ..-
T Consensus 245 ~~PEy~~~g~l---t~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~~~~~~~eiiD~~l~~~~~~~~~~~ 321 (361)
T KOG1187|consen 245 LAPEYASTGKL---TEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLLEEGKLREIVDPRLKEGEYPDEKEV 321 (361)
T ss_pred CChhhhccCCc---CcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHHHCcchhheeCCCccCCCCChHHHH
Confidence 99999987655 999999999999999999998876432 11111222 12222 1112222111 123
Q ss_pred HHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHh
Q psy1840 160 PSIIACMRTCWEEDPELRPDLRFVHHKLKEMN 191 (423)
Q Consensus 160 ~~l~~Li~~C~~~dP~~RPt~~~I~~~L~~i~ 191 (423)
..+..+..+|++.+|.+||+|.+|++.|+.+.
T Consensus 322 ~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~ 353 (361)
T KOG1187|consen 322 KKLAELALRCLRPDPKERPTMSQVVKELEGIL 353 (361)
T ss_pred HHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhc
Confidence 44777889999999999999999988885554
|
|
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=99.93 E-value=8.9e-26 Score=222.07 Aligned_cols=160 Identities=19% Similarity=0.229 Sum_probs=116.5
Q ss_pred HHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCccEEEeccCCcccccCCCcc-cccccccCCccccCCccccCCCC
Q psy1840 25 SISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDET-GQERKLRRRKLYKAPELLRQPHL 103 (423)
Q Consensus 25 ~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~~-~~~~~~~gt~~y~APE~l~~~~~ 103 (423)
...++.||+.||.|||+.|++ ||||||+||+++.++.+||+|||+++........ .......++..|+|||++.+..
T Consensus 105 ~~~i~~qi~~aL~~LH~~~iv-H~dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~- 182 (338)
T cd07859 105 HQFFLYQLLRALKYIHTANVF-HRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFF- 182 (338)
T ss_pred HHHHHHHHHHHHHHHHHCCee-cCCCCHHHeEECCCCcEEEccCccccccccccCccccccCCCCCCCcCCHHHHhccc-
Confidence 578999999999999999988 9999999999999999999999998754322111 1123456889999999986521
Q ss_pred CCCCCccchHHHHHHHHHHHhCCCCCCCCCCC-------------hHHHHHHHh------------cCCCCCCCCCCCCc
Q psy1840 104 PRGTQKGDVYSFGLVLYEVIGRQGPWGHLRMT-------------DEEIITSVT------------QGSGLRPDTSSLDC 158 (423)
Q Consensus 104 ~~~s~ksDVyS~Giil~elltg~~Pf~~~~~~-------------~~~i~~~i~------------~~~~~~p~~~~~~~ 158 (423)
..++.++|||||||++|||++|+.||...... ..+....+. ...+.........+
T Consensus 183 ~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (338)
T cd07859 183 SKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETISRVRNEKARRYLSSMRKKQPVPFSQKFPNA 262 (338)
T ss_pred cccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhhhhhHHHHHHhhcccCCCchHHhcCCC
Confidence 13488999999999999999999999643210 011111111 10110000011246
Q ss_pred hHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q psy1840 159 APSIIACMRTCWEEDPELRPDLRFVHHK 186 (423)
Q Consensus 159 ~~~l~~Li~~C~~~dP~~RPt~~~I~~~ 186 (423)
++.+.+++.+||+.||++||++.++++.
T Consensus 263 ~~~~~~li~~~l~~~P~~Rpt~~e~l~h 290 (338)
T cd07859 263 DPLALRLLERLLAFDPKDRPTAEEALAD 290 (338)
T ss_pred ChHHHHHHHHHcCcCcccCCCHHHHhcC
Confidence 7889999999999999999999999864
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=99.93 E-value=7.7e-26 Score=221.98 Aligned_cols=149 Identities=19% Similarity=0.293 Sum_probs=120.3
Q ss_pred HHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCccEEEeccCCcccccCCCcccccccccCCccccCCccccCCCCC
Q psy1840 25 SISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKAPELLRQPHLP 104 (423)
Q Consensus 25 ~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~ 104 (423)
...++.||+.||+|||+.|++ ||||||+||+++.++.+||+|||+++...... .......|++.|+|||.+.+..+
T Consensus 97 ~~~~~~qi~~~L~~lH~~~iv-HrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~- 172 (323)
T cd05571 97 ARFYGAEIVSALGYLHSCDVV-YRDLKLENLMLDKDGHIKITDFGLCKEGISDG--ATMKTFCGTPEYLAPEVLEDNDY- 172 (323)
T ss_pred HHHHHHHHHHHHHHHHhCCeE-eCCCCHHHEEECCCCCEEEeeCCCCcccccCC--CcccceecCccccChhhhcCCCC-
Confidence 467889999999999999998 99999999999999999999999986432211 11234568999999999987655
Q ss_pred CCCCccchHHHHHHHHHHHhCCCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCchHHHHHHHHHhhhcCCCCCC-----C
Q psy1840 105 RGTQKGDVYSFGLVLYEVIGRQGPWGHLRMTDEEIITSVTQGSGLRPDTSSLDCAPSIIACMRTCWEEDPELRP-----D 179 (423)
Q Consensus 105 ~~s~ksDVyS~Giil~elltg~~Pf~~~~~~~~~i~~~i~~~~~~~p~~~~~~~~~~l~~Li~~C~~~dP~~RP-----t 179 (423)
+.++|||||||++|||++|..||.. .+...+...+..+....| ..+++++.+++.+||+.||++|| +
T Consensus 173 --~~~~DiwSlG~il~elltg~~Pf~~--~~~~~~~~~~~~~~~~~p----~~~~~~~~~li~~~L~~dP~~R~~~~~~~ 244 (323)
T cd05571 173 --GRAVDWWGLGVVMYEMMCGRLPFYN--QDHEKLFELILMEEIRFP----RTLSPEAKSLLAGLLKKDPKQRLGGGPED 244 (323)
T ss_pred --CccccCcccchhhhhhhcCCCCCCC--CCHHHHHHHHHcCCCCCC----CCCCHHHHHHHHHHccCCHHHcCCCCCCC
Confidence 8999999999999999999999964 334555555554433222 35788999999999999999999 7
Q ss_pred HHHHHH
Q psy1840 180 LRFVHH 185 (423)
Q Consensus 180 ~~~I~~ 185 (423)
+.++++
T Consensus 245 ~~~ll~ 250 (323)
T cd05571 245 AKEIME 250 (323)
T ss_pred HHHHHc
Confidence 888765
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.5e-25 Score=213.46 Aligned_cols=155 Identities=27% Similarity=0.568 Sum_probs=122.6
Q ss_pred HHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCccEEEeccCCcccccCCCcccccccccCCccccCCccccCCCCC
Q psy1840 25 SISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKAPELLRQPHLP 104 (423)
Q Consensus 25 ~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~ 104 (423)
.+.++.|++.|++|||+.|++ ||||||+||++++++.+||+|||++................+++.|+|||.+.+..+
T Consensus 124 ~~~~~~qi~~al~~LH~~~i~-H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~- 201 (280)
T cd05092 124 MLAIASQIASGMVYLASLHFV-HRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKF- 201 (280)
T ss_pred HHHHHHHHHHHHHHHHHCCee-cccccHhhEEEcCCCCEEECCCCceeEcCCCceeecCCCccccccccCHHHhccCCc-
Confidence 578999999999999999998 999999999999999999999999865432221111122334567999999887654
Q ss_pred CCCCccchHHHHHHHHHHHh-CCCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCchHHHHHHHHHhhhcCCCCCCCHHHH
Q psy1840 105 RGTQKGDVYSFGLVLYEVIG-RQGPWGHLRMTDEEIITSVTQGSGLRPDTSSLDCAPSIIACMRTCWEEDPELRPDLRFV 183 (423)
Q Consensus 105 ~~s~ksDVyS~Giil~ellt-g~~Pf~~~~~~~~~i~~~i~~~~~~~p~~~~~~~~~~l~~Li~~C~~~dP~~RPt~~~I 183 (423)
+.++|||||||++|||++ |..||.. ....+....+..+... .....+++.+.+++.+||+.||++||++.+|
T Consensus 202 --~~~~Di~slG~il~el~~~g~~p~~~--~~~~~~~~~~~~~~~~---~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l 274 (280)
T cd05092 202 --TTESDIWSFGVVLWEIFTYGKQPWYQ--LSNTEAIECITQGREL---ERPRTCPPEVYAIMQGCWQREPQQRMVIKDI 274 (280)
T ss_pred --CchhhHHHHHHHHHHHHcCCCCCCcc--CCHHHHHHHHHcCccC---CCCCCCCHHHHHHHHHHccCChhhCCCHHHH
Confidence 889999999999999998 8889863 3345555555554322 1223678999999999999999999999999
Q ss_pred HHHHH
Q psy1840 184 HHKLK 188 (423)
Q Consensus 184 ~~~L~ 188 (423)
.+.|+
T Consensus 275 ~~~l~ 279 (280)
T cd05092 275 HSRLQ 279 (280)
T ss_pred HHHHh
Confidence 98775
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.3e-25 Score=210.54 Aligned_cols=151 Identities=24% Similarity=0.492 Sum_probs=122.3
Q ss_pred HHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCccEEEeccCCcccccCCCcccccccccCCccccCCccccCCCCC
Q psy1840 25 SISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKAPELLRQPHLP 104 (423)
Q Consensus 25 ~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~ 104 (423)
.+.++.|++.||+|||++|++ ||||||+||+++.++.+||+|||++....... .....+..|+|||.+.+..+
T Consensus 104 ~~~~~~~i~~~l~~lH~~~i~-H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~- 176 (256)
T cd05082 104 LLKFSLDVCEAMEYLEANNFV-HRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ-----DTGKLPVKWTAPEALREKKF- 176 (256)
T ss_pred HHHHHHHHHHHHHHHHhCCEe-ccccchheEEEcCCCcEEecCCccceeccccC-----CCCccceeecCHHHHccCCC-
Confidence 578999999999999999988 99999999999999999999999976543221 12234457999999877654
Q ss_pred CCCCccchHHHHHHHHHHHh-CCCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCchHHHHHHHHHhhhcCCCCCCCHHHH
Q psy1840 105 RGTQKGDVYSFGLVLYEVIG-RQGPWGHLRMTDEEIITSVTQGSGLRPDTSSLDCAPSIIACMRTCWEEDPELRPDLRFV 183 (423)
Q Consensus 105 ~~s~ksDVyS~Giil~ellt-g~~Pf~~~~~~~~~i~~~i~~~~~~~p~~~~~~~~~~l~~Li~~C~~~dP~~RPt~~~I 183 (423)
+.++|||||||++|||++ |..||.. ....++...+..+.. + .....+++.+.+++.+||+.+|++|||+.++
T Consensus 177 --~~~~Dv~slG~i~~~l~~~g~~p~~~--~~~~~~~~~~~~~~~--~-~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l 249 (256)
T cd05082 177 --STKSDVWSFGILLWEIYSFGRVPYPR--IPLKDVVPRVEKGYK--M-DAPDGCPPVVYDVMKQCWHLDAATRPSFLQL 249 (256)
T ss_pred --CchhhhHHHHHHHHHHHhCCCCCCCC--CCHHHHHHHHhcCCC--C-CCCCCCCHHHHHHHHHHhcCChhhCcCHHHH
Confidence 889999999999999997 8999863 344566666654321 2 2234678999999999999999999999999
Q ss_pred HHHHHH
Q psy1840 184 HHKLKE 189 (423)
Q Consensus 184 ~~~L~~ 189 (423)
.+.|+.
T Consensus 250 ~~~l~~ 255 (256)
T cd05082 250 REQLEH 255 (256)
T ss_pred HHHHhc
Confidence 988865
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=99.93 E-value=4.1e-25 Score=209.20 Aligned_cols=158 Identities=25% Similarity=0.489 Sum_probs=122.5
Q ss_pred HHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCccEEEeccCCcccccCCCc--ccccccccCCccccCCccccCCC
Q psy1840 25 SISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDE--TGQERKLRRRKLYKAPELLRQPH 102 (423)
Q Consensus 25 ~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~--~~~~~~~~gt~~y~APE~l~~~~ 102 (423)
.+.++.|++.|+.|||+.+++ ||||||+||+++.++.+||+|||+++....... ........++..|+|||.+.+..
T Consensus 100 ~~~~~~~i~~~l~~lH~~~i~-H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~ 178 (262)
T cd05058 100 LIGFGLQVAKGMEYLASKKFV-HRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMALESLQTQK 178 (262)
T ss_pred HHHHHHHHHHHHHHHHhCCcc-ccccCcceEEEcCCCcEEECCccccccccCCcceeecccccCcCCccccChhHhccCc
Confidence 578899999999999999998 999999999999999999999999865432211 11112334566799999987655
Q ss_pred CCCCCCccchHHHHHHHHHHHhC-CCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCchHHHHHHHHHhhhcCCCCCCCHH
Q psy1840 103 LPRGTQKGDVYSFGLVLYEVIGR-QGPWGHLRMTDEEIITSVTQGSGLRPDTSSLDCAPSIIACMRTCWEEDPELRPDLR 181 (423)
Q Consensus 103 ~~~~s~ksDVyS~Giil~elltg-~~Pf~~~~~~~~~i~~~i~~~~~~~p~~~~~~~~~~l~~Li~~C~~~dP~~RPt~~ 181 (423)
+ +.++|||||||++|||++| ..||.. ....++...+..+... . ....++..+.+++.+||+.+|++||++.
T Consensus 179 ~---~~~~Di~slG~~l~el~~~~~~~~~~--~~~~~~~~~~~~~~~~--~-~~~~~~~~~~~li~~cl~~~p~~Rp~~~ 250 (262)
T cd05058 179 F---TTKSDVWSFGVLLWELMTRGAPPYPD--VDSFDITVYLLQGRRL--L-QPEYCPDPLYEVMLSCWHPKPEMRPTFS 250 (262)
T ss_pred c---chHHHHHHHHHHHHHHHcCCCCCCCC--CCHHHHHHHHhcCCCC--C-CCCcCCHHHHHHHHHHcCCChhhCCCHH
Confidence 4 8899999999999999995 556653 3445555555544322 1 1234678999999999999999999999
Q ss_pred HHHHHHHHHh
Q psy1840 182 FVHHKLKEMN 191 (423)
Q Consensus 182 ~I~~~L~~i~ 191 (423)
+|+..|+.+.
T Consensus 251 ~il~~l~~~~ 260 (262)
T cd05058 251 ELVSRIEQIF 260 (262)
T ss_pred HHHHHHHHHh
Confidence 9999988765
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.3e-25 Score=230.25 Aligned_cols=152 Identities=20% Similarity=0.358 Sum_probs=124.6
Q ss_pred HHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCccEEEeccCCcccccCCCcccccccccCCccccCCccccCCCCC
Q psy1840 25 SISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKAPELLRQPHLP 104 (423)
Q Consensus 25 ~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~ 104 (423)
...++.||+.||.|||+.+++ ||||||+|||++.++.+||+|||+++...............||+.|+|||++.+..+
T Consensus 171 ~~~i~~qi~~aL~~lH~~~iv-HrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~- 248 (478)
T PTZ00267 171 VGLLFYQIVLALDEVHSRKMM-HRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVASSFCGTPYYLAPELWERKRY- 248 (478)
T ss_pred HHHHHHHHHHHHHHHHhCCEE-ECCcCHHhEEECCCCcEEEEeCcCceecCCccccccccccCCCccccCHhHhCCCCC-
Confidence 567899999999999999988 999999999999999999999999886543322222345578999999999987654
Q ss_pred CCCCccchHHHHHHHHHHHhCCCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCchHHHHHHHHHhhhcCCCCCCCHHHHH
Q psy1840 105 RGTQKGDVYSFGLVLYEVIGRQGPWGHLRMTDEEIITSVTQGSGLRPDTSSLDCAPSIIACMRTCWEEDPELRPDLRFVH 184 (423)
Q Consensus 105 ~~s~ksDVyS~Giil~elltg~~Pf~~~~~~~~~i~~~i~~~~~~~p~~~~~~~~~~l~~Li~~C~~~dP~~RPt~~~I~ 184 (423)
+.++|||||||++|||++|+.||.. ....++...+..+.... .+..++.++.+++.+||+.||++||++.+++
T Consensus 249 --~~~~Dv~slG~~l~el~tg~~Pf~~--~~~~~~~~~~~~~~~~~---~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l 321 (478)
T PTZ00267 249 --SKKADMWSLGVILYELLTLHRPFKG--PSQREIMQQVLYGKYDP---FPCPVSSGMKALLDPLLSKNPALRPTTQQLL 321 (478)
T ss_pred --CcHHhHHHHHHHHHHHHhCCCCCCC--CCHHHHHHHHHhCCCCC---CCccCCHHHHHHHHHHhccChhhCcCHHHHH
Confidence 8999999999999999999999964 34556666665543221 1235788999999999999999999999987
Q ss_pred H
Q psy1840 185 H 185 (423)
Q Consensus 185 ~ 185 (423)
.
T Consensus 322 ~ 322 (478)
T PTZ00267 322 H 322 (478)
T ss_pred h
Confidence 5
|
|
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.93 E-value=9.3e-26 Score=220.27 Aligned_cols=146 Identities=21% Similarity=0.269 Sum_probs=118.2
Q ss_pred HHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCccEEEeccCCcccccCCCcccccccccCCccccCCccccCCCCC
Q psy1840 25 SISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKAPELLRQPHLP 104 (423)
Q Consensus 25 ~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~ 104 (423)
...++.||+.||.|||+.|++ ||||||+||+++.++.+||+|||+++...... .......|++.|+|||.+.+..+
T Consensus 95 ~~~~~~qi~~~l~~lH~~~i~-HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~- 170 (312)
T cd05585 95 ARFYTAELLCALENLHKFNVI-YRDLKPENILLDYQGHIALCDFGLCKLNMKDD--DKTNTFCGTPEYLAPELLLGHGY- 170 (312)
T ss_pred HHHHHHHHHHHHHHHHhCCeE-eCCCCHHHeEECCCCcEEEEECcccccCccCC--CccccccCCcccCCHHHHcCCCC-
Confidence 567899999999999999998 99999999999999999999999987532221 12234568899999999987655
Q ss_pred CCCCccchHHHHHHHHHHHhCCCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCchHHHHHHHHHhhhcCCCCCCCHHH
Q psy1840 105 RGTQKGDVYSFGLVLYEVIGRQGPWGHLRMTDEEIITSVTQGSGLRPDTSSLDCAPSIIACMRTCWEEDPELRPDLRF 182 (423)
Q Consensus 105 ~~s~ksDVyS~Giil~elltg~~Pf~~~~~~~~~i~~~i~~~~~~~p~~~~~~~~~~l~~Li~~C~~~dP~~RPt~~~ 182 (423)
+.++|||||||++|||++|..||.. ....+....+.......| ..+++++.+++.+||+.||.+||++..
T Consensus 171 --~~~~DvwslGvil~el~tg~~pf~~--~~~~~~~~~~~~~~~~~~----~~~~~~~~~li~~~L~~dp~~R~~~~~ 240 (312)
T cd05585 171 --TKAVDWWTLGVLLYEMLTGLPPFYD--ENVNEMYRKILQEPLRFP----DGFDRDAKDLLIGLLSRDPTRRLGYNG 240 (312)
T ss_pred --CCccceechhHHHHHHHhCCCCcCC--CCHHHHHHHHHcCCCCCC----CcCCHHHHHHHHHHcCCCHHHcCCCCC
Confidence 8999999999999999999999974 344556666555433222 357889999999999999999986543
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=99.93 E-value=4.2e-25 Score=209.40 Aligned_cols=159 Identities=23% Similarity=0.417 Sum_probs=129.0
Q ss_pred HHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCccEEEeccCCcccccCCCcccccccccCCccccCCccccCCCCC
Q psy1840 25 SISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKAPELLRQPHLP 104 (423)
Q Consensus 25 ~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~ 104 (423)
.+.++.|++.|+.|||+.|++ ||||+|+||+++.++.++|+|||++........ ......++..|+|||.+.+..+
T Consensus 108 ~~~~~~~l~~~l~~lh~~~i~-h~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~--~~~~~~~~~~y~apE~~~~~~~- 183 (267)
T cd08224 108 IWKYFVQLCSALEHMHSKRIM-HRDIKPANVFITATGVVKLGDLGLGRFFSSKTT--AAHSLVGTPYYMSPERIHENGY- 183 (267)
T ss_pred HHHHHHHHHHHHHHHHhCCEe-cCCcChhhEEECCCCcEEEeccceeeeccCCCc--ccceecCCccccCHHHhccCCC-
Confidence 579999999999999999998 999999999999999999999999875432221 1123457788999999877654
Q ss_pred CCCCccchHHHHHHHHHHHhCCCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCchHHHHHHHHHhhhcCCCCCCCHHHHH
Q psy1840 105 RGTQKGDVYSFGLVLYEVIGRQGPWGHLRMTDEEIITSVTQGSGLRPDTSSLDCAPSIIACMRTCWEEDPELRPDLRFVH 184 (423)
Q Consensus 105 ~~s~ksDVyS~Giil~elltg~~Pf~~~~~~~~~i~~~i~~~~~~~p~~~~~~~~~~l~~Li~~C~~~dP~~RPt~~~I~ 184 (423)
+.++|+||||+++|++++|..||.....+..++...+..+. .+..+...++..+.+++.+||..+|++||++.+|+
T Consensus 184 --~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il 259 (267)
T cd08224 184 --NFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEKCD--YPPLPADHYSEELRDLVSRCINPDPEKRPDISYVL 259 (267)
T ss_pred --CchhcHHHHHHHHHHHHHCCCCcccCCccHHHHHhhhhcCC--CCCCChhhcCHHHHHHHHHHcCCCcccCCCHHHHH
Confidence 88999999999999999999999765555555555555432 22233335788999999999999999999999999
Q ss_pred HHHHHHh
Q psy1840 185 HKLKEMN 191 (423)
Q Consensus 185 ~~L~~i~ 191 (423)
+.++.+.
T Consensus 260 ~~~~~~~ 266 (267)
T cd08224 260 QVAKEMH 266 (267)
T ss_pred HHHHHhc
Confidence 9998764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=99.93 E-value=3.1e-25 Score=214.01 Aligned_cols=158 Identities=27% Similarity=0.465 Sum_probs=120.8
Q ss_pred HHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCccEEEeccCCcccccCCCcccccccccCCccccCCccccCCCCC
Q psy1840 25 SISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKAPELLRQPHLP 104 (423)
Q Consensus 25 ~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~ 104 (423)
.+.++.|++.||.|||+++++ ||||||+||+++.++.++|+|||+++...............++..|+|||.+.+..+
T Consensus 132 ~~~~~~~i~~al~~LH~~~i~-H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~- 209 (296)
T cd05051 132 LLYMATQIASGMRYLESLNFV-HRDLATRNCLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKF- 209 (296)
T ss_pred HHHHHHHHHHHHHHHHHcCcc-ccccchhceeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCC-
Confidence 578999999999999999998 999999999999999999999999875433322222233445677999999877554
Q ss_pred CCCCccchHHHHHHHHHHHh--CCCCCCCCCCChHHHHHHHhcC----CCCCCCCCCCCchHHHHHHHHHhhhcCCCCCC
Q psy1840 105 RGTQKGDVYSFGLVLYEVIG--RQGPWGHLRMTDEEIITSVTQG----SGLRPDTSSLDCAPSIIACMRTCWEEDPELRP 178 (423)
Q Consensus 105 ~~s~ksDVyS~Giil~ellt--g~~Pf~~~~~~~~~i~~~i~~~----~~~~p~~~~~~~~~~l~~Li~~C~~~dP~~RP 178 (423)
+.++|||||||++||+++ +..||.. .+..+++..+... ...........++.++.+++.+||+.||++||
T Consensus 210 --~~~~Dv~slG~~l~el~~~~~~~p~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp 285 (296)
T cd05051 210 --TTKSDVWAFGVTLWEILTLCREQPYEH--LTDQQVIENAGHFFRDDGRQIYLPRPPNCPKDIYELMLECWRRDEEDRP 285 (296)
T ss_pred --CccchhhhhHHHHHHHHhcCCCCCCCC--cChHHHHHHHHhccccccccccCCCccCCCHHHHHHHHHHhccChhcCC
Confidence 899999999999999998 5667753 3344555444322 11111111235678999999999999999999
Q ss_pred CHHHHHHHHH
Q psy1840 179 DLRFVHHKLK 188 (423)
Q Consensus 179 t~~~I~~~L~ 188 (423)
|+.+|++.|+
T Consensus 286 t~~el~~~L~ 295 (296)
T cd05051 286 TFREIHLFLQ 295 (296)
T ss_pred CHHHHHHHhc
Confidence 9999988875
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.93 E-value=6.4e-25 Score=208.71 Aligned_cols=157 Identities=27% Similarity=0.521 Sum_probs=125.7
Q ss_pred HHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCccEEEeccCCcccccCCCcccccccccCCccccCCccccCCCCC
Q psy1840 25 SISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKAPELLRQPHLP 104 (423)
Q Consensus 25 ~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~ 104 (423)
.++++.|++.|+.|||+.+++ ||||||+||+++.++.+||+|||++................++..|+|||.+.+..+
T Consensus 108 ~~~~~~~l~~~l~~Lh~~~i~-H~di~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~- 185 (266)
T cd05033 108 LVGMLRGIASGMKYLSEMNYV-HRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKIPIRWTAPEAIAYRKF- 185 (266)
T ss_pred HHHHHHHHHHHHHHHHhCCcc-cCCCCcceEEEcCCCCEEECccchhhcccccccceeccCCCCCccccChhhhccCCC-
Confidence 679999999999999999998 999999999999999999999999886642222211122334567999999887654
Q ss_pred CCCCccchHHHHHHHHHHHh-CCCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCchHHHHHHHHHhhhcCCCCCCCHHHH
Q psy1840 105 RGTQKGDVYSFGLVLYEVIG-RQGPWGHLRMTDEEIITSVTQGSGLRPDTSSLDCAPSIIACMRTCWEEDPELRPDLRFV 183 (423)
Q Consensus 105 ~~s~ksDVyS~Giil~ellt-g~~Pf~~~~~~~~~i~~~i~~~~~~~p~~~~~~~~~~l~~Li~~C~~~dP~~RPt~~~I 183 (423)
+.++||||||+++|++++ |..||.. ....++...+..+.... ....++..+.+++.+||+.+|++||++.+|
T Consensus 186 --~~~~Dv~slG~~l~~l~~~g~~p~~~--~~~~~~~~~~~~~~~~~---~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei 258 (266)
T cd05033 186 --TSASDVWSFGIVMWEVMSYGERPYWD--MSNQDVIKAVEDGYRLP---PPMDCPSALYQLMLDCWQKDRNERPTFSQI 258 (266)
T ss_pred --ccccchHHHHHHHHHHHccCCCCCCC--CCHHHHHHHHHcCCCCC---CCCCCCHHHHHHHHHHcCCCcccCcCHHHH
Confidence 889999999999999997 9999864 44566666665542221 123678999999999999999999999999
Q ss_pred HHHHHHH
Q psy1840 184 HHKLKEM 190 (423)
Q Consensus 184 ~~~L~~i 190 (423)
.+.|..+
T Consensus 259 ~~~l~~~ 265 (266)
T cd05033 259 VSTLDKM 265 (266)
T ss_pred HHHHHhh
Confidence 9988764
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=99.93 E-value=4.9e-25 Score=211.02 Aligned_cols=174 Identities=17% Similarity=0.349 Sum_probs=140.2
Q ss_pred HHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCccEEEeccCCcccccCCCcccccccccCCccccCCccccCCCCC
Q psy1840 25 SISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKAPELLRQPHLP 104 (423)
Q Consensus 25 ~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~ 104 (423)
...++.|++.|+.|||+.+++ |+||+|+||+++.++.++|+|||++........ ......++..|+|||.+.+...
T Consensus 103 ~~~~~~~l~~~l~~lh~~~iv-H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~~y~apE~~~~~~~- 178 (277)
T cd06640 103 IATMLKEILKGLDYLHSEKKI-HRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI--KRNTFVGTPFWMAPEVIQQSAY- 178 (277)
T ss_pred HHHHHHHHHHHHHHHHhCCcc-CcCCChhhEEEcCCCCEEEcccccceeccCCcc--ccccccCcccccCHhHhccCCC-
Confidence 568899999999999999998 999999999999999999999999865433221 1123456778999999876654
Q ss_pred CCCCccchHHHHHHHHHHHhCCCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCchHHHHHHHHHhhhcCCCCCCCHHHHH
Q psy1840 105 RGTQKGDVYSFGLVLYEVIGRQGPWGHLRMTDEEIITSVTQGSGLRPDTSSLDCAPSIIACMRTCWEEDPELRPDLRFVH 184 (423)
Q Consensus 105 ~~s~ksDVyS~Giil~elltg~~Pf~~~~~~~~~i~~~i~~~~~~~p~~~~~~~~~~l~~Li~~C~~~dP~~RPt~~~I~ 184 (423)
+.++|+||||+++|||++|..||... ........+..+. +......++..+.+++.+||+.+|++||++.+++
T Consensus 179 --~~~~Dv~slG~il~el~tg~~p~~~~--~~~~~~~~~~~~~---~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il 251 (277)
T cd06640 179 --DSKADIWSLGITAIELAKGEPPNSDM--HPMRVLFLIPKNN---PPTLTGEFSKPFKEFIDACLNKDPSFRPTAKELL 251 (277)
T ss_pred --ccHHHHHHHHHHHHHHHHCCCCCCCc--ChHhHhhhhhcCC---CCCCchhhhHHHHHHHHHHcccCcccCcCHHHHH
Confidence 88999999999999999999999642 3333343333221 2222335788999999999999999999999999
Q ss_pred HHHHHHhhhcCCChHHHHHHHHHHh
Q psy1840 185 HKLKEMNAGLKANIFDNMLAIMEKY 209 (423)
Q Consensus 185 ~~L~~i~~~~~~~~~d~~~~~~e~~ 209 (423)
..--......+.+..+.+.+++++|
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~ 276 (277)
T cd06640 252 KHKFIVKNAKKTSYLTELIDRFKRW 276 (277)
T ss_pred hChHhhhcchhhhHHHHHHHHHHhc
Confidence 8877777778899999999999987
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=99.93 E-value=4.3e-25 Score=214.79 Aligned_cols=160 Identities=28% Similarity=0.442 Sum_probs=126.2
Q ss_pred HHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCccEEEeccCCcccccCCCcccccccccCCccccCCccccCCCCC
Q psy1840 25 SISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKAPELLRQPHLP 104 (423)
Q Consensus 25 ~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~ 104 (423)
.++++.|++.||+|||+.|++ ||||||+||+++.++.+||+|||++................++..|+|||.+.+..+
T Consensus 142 ~~~~~~qi~~aL~~lH~~gi~-H~dlkp~Nill~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~- 219 (307)
T cd05098 142 LVSCAYQVARGMEYLASKKCI-HRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIY- 219 (307)
T ss_pred HHHHHHHHHHHHHHHHHCCcc-cccccHHheEEcCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCC-
Confidence 678999999999999999998 999999999999999999999999875432211111122233467999999877654
Q ss_pred CCCCccchHHHHHHHHHHHh-CCCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCchHHHHHHHHHhhhcCCCCCCCHHHH
Q psy1840 105 RGTQKGDVYSFGLVLYEVIG-RQGPWGHLRMTDEEIITSVTQGSGLRPDTSSLDCAPSIIACMRTCWEEDPELRPDLRFV 183 (423)
Q Consensus 105 ~~s~ksDVyS~Giil~ellt-g~~Pf~~~~~~~~~i~~~i~~~~~~~p~~~~~~~~~~l~~Li~~C~~~dP~~RPt~~~I 183 (423)
+.++|||||||++|||++ |..||.. ....++...+..+.. +. ....++.++.+++.+||..+|++||++.+|
T Consensus 220 --~~~~DvwslG~~l~el~~~g~~p~~~--~~~~~~~~~~~~~~~--~~-~~~~~~~~~~~li~~~l~~~p~~Rps~~ev 292 (307)
T cd05098 220 --THQSDVWSFGVLLWEIFTLGGSPYPG--VPVEELFKLLKEGHR--MD-KPSNCTNELYMMMRDCWHAVPSQRPTFKQL 292 (307)
T ss_pred --CcHHHHHHHHHHHHHHHcCCCCCCCc--CCHHHHHHHHHcCCC--CC-CCCcCCHHHHHHHHHHcccChhhCcCHHHH
Confidence 889999999999999998 7888863 344556666554432 11 223578899999999999999999999999
Q ss_pred HHHHHHHhhh
Q psy1840 184 HHKLKEMNAG 193 (423)
Q Consensus 184 ~~~L~~i~~~ 193 (423)
++.|+++...
T Consensus 293 l~~l~~~~~~ 302 (307)
T cd05098 293 VEDLDRILAL 302 (307)
T ss_pred HHHHHHHHHH
Confidence 9999887654
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.93 E-value=6.9e-25 Score=207.41 Aligned_cols=157 Identities=25% Similarity=0.470 Sum_probs=124.9
Q ss_pred HHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCccEEEeccCCcccccCCCccc-ccccccCCccccCCccccCCCC
Q psy1840 25 SISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETG-QERKLRRRKLYKAPELLRQPHL 103 (423)
Q Consensus 25 ~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~~~-~~~~~~gt~~y~APE~l~~~~~ 103 (423)
.+.++.|++.|+.|||..+++ ||||||+||+++.++.+||+|||+++......... ......++..|+|||.+.+..+
T Consensus 97 ~~~~~~qi~~~l~~lh~~~i~-H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~ 175 (257)
T cd05060 97 LKELAHQVAMGMAYLESKHFV-HRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGRWPLKWYAPECINYGKF 175 (257)
T ss_pred HHHHHHHHHHHHHHHhhcCee-ccCcccceEEEcCCCcEEeccccccceeecCCcccccccCccccccccCHHHhcCCCC
Confidence 689999999999999999987 99999999999999999999999987553222111 1111223457999999877654
Q ss_pred CCCCCccchHHHHHHHHHHHh-CCCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCchHHHHHHHHHhhhcCCCCCCCHHH
Q psy1840 104 PRGTQKGDVYSFGLVLYEVIG-RQGPWGHLRMTDEEIITSVTQGSGLRPDTSSLDCAPSIIACMRTCWEEDPELRPDLRF 182 (423)
Q Consensus 104 ~~~s~ksDVyS~Giil~ellt-g~~Pf~~~~~~~~~i~~~i~~~~~~~p~~~~~~~~~~l~~Li~~C~~~dP~~RPt~~~ 182 (423)
+.++||||||+++||+++ |..||.. ....++...+...... .....++..+.+++.+||..+|++||++.+
T Consensus 176 ---~~~~Di~slG~~l~~~~~~g~~p~~~--~~~~~~~~~~~~~~~~---~~~~~~~~~l~~li~~cl~~~p~~Rp~~~~ 247 (257)
T cd05060 176 ---SSKSDVWSYGVTLWEAFSYGAKPYGE--MKGAEVIAMLESGERL---PRPEECPQEIYSIMLSCWKYRPEDRPTFSE 247 (257)
T ss_pred ---CccchHHHHHHHHHHHHcCCCCCccc--CCHHHHHHHHHcCCcC---CCCCCCCHHHHHHHHHHhcCChhhCcCHHH
Confidence 889999999999999998 9999964 3445666666554322 223457889999999999999999999999
Q ss_pred HHHHHHHH
Q psy1840 183 VHHKLKEM 190 (423)
Q Consensus 183 I~~~L~~i 190 (423)
+.+.|+.+
T Consensus 248 l~~~l~~~ 255 (257)
T cd05060 248 LESTFRRD 255 (257)
T ss_pred HHHHHHhc
Confidence 99988764
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >KOG4278|consensus | Back alignment and domain information |
|---|
Probab=99.92 E-value=4.4e-25 Score=220.21 Aligned_cols=173 Identities=26% Similarity=0.500 Sum_probs=139.5
Q ss_pred HHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCccEEEeccCCcccccCCCcccccccccCCccccCCccccCCCCC
Q psy1840 25 SISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKAPELLRQPHLP 104 (423)
Q Consensus 25 ~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~ 104 (423)
-+.++.||..||+||..+++| ||||..+|||+..+..||++|||++++..+...... ....-..-|+|||.+....+
T Consensus 367 LlyMAtQIsSaMeYLEkknFI-HRDLAARNCLVgEnhiVKvADFGLsRlMtgDTYTAH-AGAKFPIKWTAPEsLAyNtF- 443 (1157)
T KOG4278|consen 367 LLYMATQISSAMEYLEKKNFI-HRDLAARNCLVGENHIVKVADFGLSRLMTGDTYTAH-AGAKFPIKWTAPESLAYNTF- 443 (1157)
T ss_pred HHHHHHHHHHHHHHHHHhhhh-hhhhhhhhccccccceEEeeccchhhhhcCCceecc-cCccCcccccCccccccccc-
Confidence 578999999999999999999 999999999999999999999999998866544322 11222345999999987665
Q ss_pred CCCCccchHHHHHHHHHHHh-CCCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCchHHHHHHHHHhhhcCCCCCCCHHHH
Q psy1840 105 RGTQKGDVYSFGLVLYEVIG-RQGPWGHLRMTDEEIITSVTQGSGLRPDTSSLDCAPSIIACMRTCWEEDPELRPDLRFV 183 (423)
Q Consensus 105 ~~s~ksDVyS~Giil~ellt-g~~Pf~~~~~~~~~i~~~i~~~~~~~p~~~~~~~~~~l~~Li~~C~~~dP~~RPt~~~I 183 (423)
+.|+|||+||++||||.| |-.||.+. +..++...+..+-.. . .+..|++.+.+||.+||+++|.+||+|.+|
T Consensus 444 --SiKSDVWAFGVLLWEIATYGMsPYPGi--dlSqVY~LLEkgyRM--~-~PeGCPpkVYeLMraCW~WsPsDRPsFaei 516 (1157)
T KOG4278|consen 444 --SIKSDVWAFGVLLWEIATYGMSPYPGI--DLSQVYGLLEKGYRM--D-GPEGCPPKVYELMRACWNWSPSDRPSFAEI 516 (1157)
T ss_pred --ccchhhHHHHHHHHHHHhcCCCCCCCc--cHHHHHHHHhccccc--c-CCCCCCHHHHHHHHHHhcCCcccCccHHHH
Confidence 899999999999999997 77899854 446667767665322 2 234799999999999999999999999999
Q ss_pred HHHHHHHhhhcCCChHHHHHHHHHHh
Q psy1840 184 HHKLKEMNAGLKANIFDNMLAIMEKY 209 (423)
Q Consensus 184 ~~~L~~i~~~~~~~~~d~~~~~~e~~ 209 (423)
.+.++.+... .++-|.+.+.+.+.
T Consensus 517 HqafEtmf~~--sSisdEV~keLgk~ 540 (1157)
T KOG4278|consen 517 HQAFETMFSS--SSISDEVQKELGKN 540 (1157)
T ss_pred HHHHHHHhcc--ccccHHHHHHHhhc
Confidence 9999988764 35556666655553
|
|
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.92 E-value=6.2e-25 Score=209.70 Aligned_cols=175 Identities=18% Similarity=0.353 Sum_probs=138.2
Q ss_pred HHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCccEEEeccCCcccccCCCcccccccccCCccccCCccccCCCCC
Q psy1840 25 SISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKAPELLRQPHLP 104 (423)
Q Consensus 25 ~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~ 104 (423)
...++.|++.|+.|||+.+++ ||||+|+||++++++.++|+|||++....... .......++..|+|||.+.+..+
T Consensus 100 ~~~~~~ql~~~l~~lh~~~i~-h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~--~~~~~~~~~~~y~~PE~~~~~~~- 175 (274)
T cd06609 100 IAFILREVLLGLEYLHEEGKI-HRDIKAANILLSEEGDVKLADFGVSGQLTSTM--SKRNTFVGTPFWMAPEVIKQSGY- 175 (274)
T ss_pred HHHHHHHHHHHHHHHHhCCcc-cCCCCHHHEEECCCCCEEEcccccceeecccc--cccccccCCccccChhhhccCCC-
Confidence 578999999999999999988 99999999999999999999999987654332 12234467788999999987654
Q ss_pred CCCCccchHHHHHHHHHHHhCCCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCchHHHHHHHHHhhhcCCCCCCCHHHHH
Q psy1840 105 RGTQKGDVYSFGLVLYEVIGRQGPWGHLRMTDEEIITSVTQGSGLRPDTSSLDCAPSIIACMRTCWEEDPELRPDLRFVH 184 (423)
Q Consensus 105 ~~s~ksDVyS~Giil~elltg~~Pf~~~~~~~~~i~~~i~~~~~~~p~~~~~~~~~~l~~Li~~C~~~dP~~RPt~~~I~ 184 (423)
+.++||||||+++|++++|+.||... ........+.... .+......++..+.+++.+||..+|++||++.+++
T Consensus 176 --~~~sDv~slG~il~~l~tg~~p~~~~--~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~l~~~l~~~p~~Rpt~~~il 249 (274)
T cd06609 176 --DEKADIWSLGITAIELAKGEPPLSDL--HPMRVLFLIPKNN--PPSLEGNKFSKPFKDFVSLCLNKDPKERPSAKELL 249 (274)
T ss_pred --CchhhHHHHHHHHHHHHhCCCCcccC--chHHHHHHhhhcC--CCCCcccccCHHHHHHHHHHhhCChhhCcCHHHHh
Confidence 89999999999999999999999643 2334444444332 22222223788999999999999999999999997
Q ss_pred HHHHHHhhhcCCChHHHHHHHHHHhh
Q psy1840 185 HKLKEMNAGLKANIFDNMLAIMEKYA 210 (423)
Q Consensus 185 ~~L~~i~~~~~~~~~d~~~~~~e~~~ 210 (423)
+. .-+....+.+..+.+..++++|.
T Consensus 250 ~~-~~~~~~~~~~~~~~~~~~~~~~~ 274 (274)
T cd06609 250 KH-KFIKKAKKTSYLTLLIERIKKWK 274 (274)
T ss_pred hC-hhhcCCCcccHHHHHHHHHHhcC
Confidence 75 33344455689999999999873
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.7e-25 Score=214.74 Aligned_cols=147 Identities=18% Similarity=0.230 Sum_probs=121.1
Q ss_pred HHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCccEEEeccCCcccccCCCcccccccccCCccccCCccccCCCCC
Q psy1840 25 SISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKAPELLRQPHLP 104 (423)
Q Consensus 25 ~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~ 104 (423)
...++.|++.||+|||++|++ ||||||+||+++.++.+||+|||++...... .....|++.|+|||.+.+..+
T Consensus 103 ~~~~~~qi~~~l~~lH~~~i~-H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~- 175 (291)
T cd05612 103 GLFYASEIVCALEYLHSKEIV-YRDLKPENILLDKEGHIKLTDFGFAKKLRDR-----TWTLCGTPEYLAPEVIQSKGH- 175 (291)
T ss_pred HHHHHHHHHHHHHHHHHCCee-ecCCCHHHeEECCCCCEEEEecCcchhccCC-----cccccCChhhcCHHHHcCCCC-
Confidence 578999999999999999998 9999999999999999999999998754322 123468889999999987654
Q ss_pred CCCCccchHHHHHHHHHHHhCCCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCchHHHHHHHHHhhhcCCCCCCC-----
Q psy1840 105 RGTQKGDVYSFGLVLYEVIGRQGPWGHLRMTDEEIITSVTQGSGLRPDTSSLDCAPSIIACMRTCWEEDPELRPD----- 179 (423)
Q Consensus 105 ~~s~ksDVyS~Giil~elltg~~Pf~~~~~~~~~i~~~i~~~~~~~p~~~~~~~~~~l~~Li~~C~~~dP~~RPt----- 179 (423)
+.++|||||||++|||++|+.||.. ....++...+..+....| ...+..+.+++++||+.||.+||+
T Consensus 176 --~~~~DiwSlG~il~~l~~g~~pf~~--~~~~~~~~~i~~~~~~~~----~~~~~~~~~li~~~l~~dp~~R~~~~~~~ 247 (291)
T cd05612 176 --NKAVDWWALGILIYEMLVGYPPFFD--DNPFGIYEKILAGKLEFP----RHLDLYAKDLIKKLLVVDRTRRLGNMKNG 247 (291)
T ss_pred --CchhhHHHHHHHHHHHHhCCCCCCC--CCHHHHHHHHHhCCcCCC----ccCCHHHHHHHHHHcCCCHHHccCCccCC
Confidence 8999999999999999999999974 345666666666543322 245789999999999999999995
Q ss_pred HHHHHHH
Q psy1840 180 LRFVHHK 186 (423)
Q Consensus 180 ~~~I~~~ 186 (423)
+.++++.
T Consensus 248 ~~~~l~h 254 (291)
T cd05612 248 ADDVKNH 254 (291)
T ss_pred HHHHhcC
Confidence 7776643
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >KOG0033|consensus | Back alignment and domain information |
|---|
Probab=99.92 E-value=3.6e-25 Score=199.61 Aligned_cols=151 Identities=17% Similarity=0.257 Sum_probs=132.1
Q ss_pred HHHHHHHHHHHHHHhCCCeeecCCCCCCEEEc---CCccEEEeccCCcccccCCCcccccccccCCccccCCccccCCCC
Q psy1840 27 SVNTTASVGMIHLHDSEIISHGNLRSSNCLID---SRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKAPELLRQPHL 103 (423)
Q Consensus 27 ~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld---~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~ 103 (423)
..+.||+.+|.|+|.+||+ |||+||+|+++. ...-+||+|||++..+.+. .......||+.|||||+++..++
T Consensus 114 H~~rQiLeal~yCH~n~Iv-HRDvkP~nllLASK~~~A~vKL~~FGvAi~l~~g---~~~~G~~GtP~fmaPEvvrkdpy 189 (355)
T KOG0033|consen 114 HCIQQILEALAYCHSNGIV-HRDLKPENLLLASKAKGAAVKLADFGLAIEVNDG---EAWHGFAGTPGYLSPEVLKKDPY 189 (355)
T ss_pred HHHHHHHHHHHHHHhcCce-eccCChhheeeeeccCCCceeecccceEEEeCCc---cccccccCCCcccCHHHhhcCCC
Confidence 5789999999999999998 999999999995 3456999999999876522 23356789999999999998766
Q ss_pred CCCCCccchHHHHHHHHHHHhCCCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCchHHHHHHHHHhhhcCCCCCCCHHHH
Q psy1840 104 PRGTQKGDVYSFGLVLYEVIGRQGPWGHLRMTDEEIITSVTQGSGLRPDTSSLDCAPSIIACMRTCWEEDPELRPDLRFV 183 (423)
Q Consensus 104 ~~~s~ksDVyS~Giil~elltg~~Pf~~~~~~~~~i~~~i~~~~~~~p~~~~~~~~~~l~~Li~~C~~~dP~~RPt~~~I 183 (423)
+..+|||+-|+|+|-++.|..||.+ .+...+.+.+..+....|......++++.++|+.+|+..||.+|.|+.|.
T Consensus 190 ---~kpvDiW~cGViLfiLL~G~~PF~~--~~~~rlye~I~~g~yd~~~~~w~~is~~Ak~LvrrML~~dP~kRIta~EA 264 (355)
T KOG0033|consen 190 ---SKPVDIWACGVILYILLVGYPPFWD--EDQHRLYEQIKAGAYDYPSPEWDTVTPEAKSLIRRMLTVNPKKRITADEA 264 (355)
T ss_pred ---CCcchhhhhhHHHHHHHhCCCCCCC--ccHHHHHHHHhccccCCCCcccCcCCHHHHHHHHHHhccChhhhccHHHH
Confidence 8999999999999999999999974 46688999999998877776677899999999999999999999999988
Q ss_pred HHH
Q psy1840 184 HHK 186 (423)
Q Consensus 184 ~~~ 186 (423)
++.
T Consensus 265 L~H 267 (355)
T KOG0033|consen 265 LKH 267 (355)
T ss_pred hCC
Confidence 764
|
|
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.92 E-value=9.3e-25 Score=206.98 Aligned_cols=155 Identities=28% Similarity=0.483 Sum_probs=122.9
Q ss_pred HHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCccEEEeccCCcccccCCCcccccccccCCccccCCccccCCCCC
Q psy1840 25 SISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKAPELLRQPHLP 104 (423)
Q Consensus 25 ~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~ 104 (423)
...++.|++.|+.|||+.|++ ||||||+||+++.++.+||+|||++......... .......+..|+|||.+.+...
T Consensus 105 ~~~~~~~i~~~l~~lH~~~i~-H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~- 181 (261)
T cd05068 105 LIDMAAQVASGMAYLEAQNYI-HRDLAARNVLVGENNICKVADFGLARVIKEDIYE-AREGAKFPIKWTAPEAALYNRF- 181 (261)
T ss_pred HHHHHHHHHHHHHHHHhCCee-eccCCcceEEEcCCCCEEECCcceEEEccCCccc-ccCCCcCceeccCccccccCCC-
Confidence 689999999999999999988 9999999999999999999999998765422111 1111223356999999877654
Q ss_pred CCCCccchHHHHHHHHHHHh-CCCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCchHHHHHHHHHhhhcCCCCCCCHHHH
Q psy1840 105 RGTQKGDVYSFGLVLYEVIG-RQGPWGHLRMTDEEIITSVTQGSGLRPDTSSLDCAPSIIACMRTCWEEDPELRPDLRFV 183 (423)
Q Consensus 105 ~~s~ksDVyS~Giil~ellt-g~~Pf~~~~~~~~~i~~~i~~~~~~~p~~~~~~~~~~l~~Li~~C~~~dP~~RPt~~~I 183 (423)
+.++||||||+++||+++ |+.||.. .....+...+..... +. ....++..+.+++.+||+.+|++||++.++
T Consensus 182 --~~~~Di~slG~~l~el~t~g~~p~~~--~~~~~~~~~~~~~~~--~~-~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l 254 (261)
T cd05068 182 --SIKSDVWSFGILLTEIVTYGRMPYPG--MTNAEVLQQVDQGYR--MP-CPPGCPKELYDIMLDCWKEDPDDRPTFETL 254 (261)
T ss_pred --CchhhHHHHHHHHHHHHhcCCCCCCC--CCHHHHHHHHHcCCC--CC-CCCcCCHHHHHHHHHHhhcCcccCCCHHHH
Confidence 889999999999999999 9999964 344556666554322 11 123578899999999999999999999999
Q ss_pred HHHHHH
Q psy1840 184 HHKLKE 189 (423)
Q Consensus 184 ~~~L~~ 189 (423)
...|+.
T Consensus 255 ~~~l~~ 260 (261)
T cd05068 255 QWKLED 260 (261)
T ss_pred HHHHhc
Confidence 998864
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=99.92 E-value=5.4e-25 Score=208.48 Aligned_cols=155 Identities=28% Similarity=0.568 Sum_probs=123.4
Q ss_pred HHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCccEEEeccCCcccccCCCcccccccccCCccccCCccccCCCCC
Q psy1840 25 SISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKAPELLRQPHLP 104 (423)
Q Consensus 25 ~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~ 104 (423)
.+.++.|++.||+|||+.+++ ||||||+||+++.++.+||+|||++......... ......++..|+|||.+.+...
T Consensus 105 ~~~~~~~l~~~l~~LH~~~i~-H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~- 181 (261)
T cd05072 105 LIDFSAQIAEGMAYIERKNYI-HRDLRAANVLVSESLMCKIADFGLARVIEDNEYT-AREGAKFPIKWTAPEAINFGSF- 181 (261)
T ss_pred HHHHHHHHHHHHHHHHHCCee-ccccchhhEEecCCCcEEECCCccceecCCCcee-ccCCCccceecCCHHHhccCCC-
Confidence 578999999999999999988 9999999999999999999999998765332211 1122334567999999877654
Q ss_pred CCCCccchHHHHHHHHHHHh-CCCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCchHHHHHHHHHhhhcCCCCCCCHHHH
Q psy1840 105 RGTQKGDVYSFGLVLYEVIG-RQGPWGHLRMTDEEIITSVTQGSGLRPDTSSLDCAPSIIACMRTCWEEDPELRPDLRFV 183 (423)
Q Consensus 105 ~~s~ksDVyS~Giil~ellt-g~~Pf~~~~~~~~~i~~~i~~~~~~~p~~~~~~~~~~l~~Li~~C~~~dP~~RPt~~~I 183 (423)
+.++||||||+++|+|++ |..||.. ....+....+..+... + ....++.++.+++.+||..+|++||++.++
T Consensus 182 --~~~~Di~slG~~l~~l~t~g~~p~~~--~~~~~~~~~~~~~~~~-~--~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i 254 (261)
T cd05072 182 --TIKSDVWSFGILLYEIVTYGKIPYPG--MSNSDVMSALQRGYRM-P--RMENCPDELYDIMKTCWKEKAEERPTFDYL 254 (261)
T ss_pred --ChhhhhhhhHHHHHHHHccCCCCCCC--CCHHHHHHHHHcCCCC-C--CCCCCCHHHHHHHHHHccCCcccCcCHHHH
Confidence 889999999999999998 8999964 3445566666544221 1 123578899999999999999999999999
Q ss_pred HHHHHH
Q psy1840 184 HHKLKE 189 (423)
Q Consensus 184 ~~~L~~ 189 (423)
.+.|++
T Consensus 255 ~~~l~~ 260 (261)
T cd05072 255 QSVLDD 260 (261)
T ss_pred HHHHhc
Confidence 988864
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=99.92 E-value=3.2e-25 Score=217.05 Aligned_cols=145 Identities=26% Similarity=0.414 Sum_probs=118.4
Q ss_pred HHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCccEEEeccCCcccccCCCcccccccccCCccccCCccccCCCCC
Q psy1840 25 SISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKAPELLRQPHLP 104 (423)
Q Consensus 25 ~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~ 104 (423)
...++.||+.||.|||+.+++ ||||||+||+++.++.+||+|||+++...... .......|++.|+|||.+.+..+
T Consensus 98 ~~~~~~qi~~al~~LH~~~iv-H~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~- 173 (316)
T cd05592 98 ARFYAAEIICGLQFLHKKGII-YRDLKLDNVLLDKDGHIKIADFGMCKENMNGE--GKASTFCGTPDYIAPEILKGQKY- 173 (316)
T ss_pred HHHHHHHHHHHHHHHHHCCEE-eCCCCHHHeEECCCCCEEEccCcCCeECCCCC--CccccccCCccccCHHHHcCCCC-
Confidence 467899999999999999988 99999999999999999999999987543222 12234568999999999987654
Q ss_pred CCCCccchHHHHHHHHHHHhCCCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCchHHHHHHHHHhhhcCCCCCCCHH
Q psy1840 105 RGTQKGDVYSFGLVLYEVIGRQGPWGHLRMTDEEIITSVTQGSGLRPDTSSLDCAPSIIACMRTCWEEDPELRPDLR 181 (423)
Q Consensus 105 ~~s~ksDVyS~Giil~elltg~~Pf~~~~~~~~~i~~~i~~~~~~~p~~~~~~~~~~l~~Li~~C~~~dP~~RPt~~ 181 (423)
+.++|||||||++|||++|..||.. ....++...+....+..| ..++.++.+++.+||+.||++||++.
T Consensus 174 --~~~~DvwslG~il~ell~G~~Pf~~--~~~~~~~~~i~~~~~~~~----~~~~~~~~~ll~~~l~~~P~~R~~~~ 242 (316)
T cd05592 174 --NESVDWWSFGVLLYEMLIGQSPFHG--EDEDELFDSILNDRPHFP----RWISKEAKDCLSKLFERDPTKRLGVD 242 (316)
T ss_pred --CCcccchhHHHHHHHHHhCCCCCCC--CCHHHHHHHHHcCCCCCC----CCCCHHHHHHHHHHccCCHHHcCCCh
Confidence 8899999999999999999999974 344666666655432222 34788999999999999999999875
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=99.92 E-value=3.9e-25 Score=212.20 Aligned_cols=160 Identities=27% Similarity=0.452 Sum_probs=120.7
Q ss_pred HHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCccEEEeccCCcccccCCCccc-ccccccCCccccCCccccCCCC
Q psy1840 25 SISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETG-QERKLRRRKLYKAPELLRQPHL 103 (423)
Q Consensus 25 ~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~~~-~~~~~~gt~~y~APE~l~~~~~ 103 (423)
.+.++.|++.|+.|||+++++ ||||||+||+++.++.+||+|||++.......... ......++..|+|||.+.+...
T Consensus 109 ~~~i~~~l~~~l~~lH~~~i~-H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~ 187 (283)
T cd05080 109 LLLFAQQICEGMAYLHSQHYI-HRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAVECLKENKF 187 (283)
T ss_pred HHHHHHHHHHHHHHHHHCCee-ccccChheEEEcCCCcEEEeecccccccCCcchhhccCCCCCCCceeeCHhHhcccCC
Confidence 678999999999999999988 99999999999999999999999987654322111 1112234566999999876654
Q ss_pred CCCCCccchHHHHHHHHHHHhCCCCCCCCCCChH-------------HHHHHHhcCCCCCCCCCCCCchHHHHHHHHHhh
Q psy1840 104 PRGTQKGDVYSFGLVLYEVIGRQGPWGHLRMTDE-------------EIITSVTQGSGLRPDTSSLDCAPSIIACMRTCW 170 (423)
Q Consensus 104 ~~~s~ksDVyS~Giil~elltg~~Pf~~~~~~~~-------------~i~~~i~~~~~~~p~~~~~~~~~~l~~Li~~C~ 170 (423)
+.++||||||+++|||++|..||........ .+...+..+ ..+.. ...++.++.+++.+||
T Consensus 188 ---~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~-~~~~~~~~~~li~~cl 261 (283)
T cd05080 188 ---SYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVRLIELLERG--MRLPC-PKNCPQEVYILMKNCW 261 (283)
T ss_pred ---CcccccHHHHHHHHHHHhCCCCCCCCcchhhhhhcccccccchhhhhhhhhcC--CCCCC-CCCCCHHHHHHHHHHh
Confidence 8899999999999999999999854221111 111111111 11111 2357899999999999
Q ss_pred hcCCCCCCCHHHHHHHHHHHh
Q psy1840 171 EEDPELRPDLRFVHHKLKEMN 191 (423)
Q Consensus 171 ~~dP~~RPt~~~I~~~L~~i~ 191 (423)
+.+|++|||+.+|++.|+.+.
T Consensus 262 ~~~p~~Rps~~~i~~~l~~~~ 282 (283)
T cd05080 262 ETEAKFRPTFRSLIPILKEMH 282 (283)
T ss_pred ccChhhCCCHHHHHHHHHHhh
Confidence 999999999999999988764
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=99.92 E-value=7.7e-25 Score=212.72 Aligned_cols=159 Identities=23% Similarity=0.444 Sum_probs=124.1
Q ss_pred HHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCccEEEeccCCcccccCCCcccccccccCCccccCCccccCCCCC
Q psy1840 25 SISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKAPELLRQPHLP 104 (423)
Q Consensus 25 ~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~ 104 (423)
.+.++.|++.||.|||+++++ ||||||+||+++.++.+||+|||+++...............++..|+|||.+.+..+
T Consensus 111 ~~~~~~qi~~~L~~LH~~~iv-H~dikp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~- 188 (303)
T cd05110 111 LLNWCVQIAKGMMYLEERRLV-HRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHYRKF- 188 (303)
T ss_pred HHHHHHHHHHHHHHHhhcCee-ccccccceeeecCCCceEEccccccccccCcccccccCCCccccccCCHHHhccCCC-
Confidence 578999999999999999998 999999999999999999999999876543322212223344667999999876554
Q ss_pred CCCCccchHHHHHHHHHHHh-CCCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCchHHHHHHHHHhhhcCCCCCCCHHHH
Q psy1840 105 RGTQKGDVYSFGLVLYEVIG-RQGPWGHLRMTDEEIITSVTQGSGLRPDTSSLDCAPSIIACMRTCWEEDPELRPDLRFV 183 (423)
Q Consensus 105 ~~s~ksDVyS~Giil~ellt-g~~Pf~~~~~~~~~i~~~i~~~~~~~p~~~~~~~~~~l~~Li~~C~~~dP~~RPt~~~I 183 (423)
+.++||||||+++||+++ |+.||.+. ...++...+..+... + . ...++..+.+++.+||..+|++||++.++
T Consensus 189 --~~~~DiwslG~~l~el~t~g~~p~~~~--~~~~~~~~~~~~~~~-~-~-~~~~~~~~~~li~~c~~~~p~~Rp~~~~l 261 (303)
T cd05110 189 --THQSDVWSYGVTIWELMTFGGKPYDGI--PTREIPDLLEKGERL-P-Q-PPICTIDVYMVMVKCWMIDADSRPKFKEL 261 (303)
T ss_pred --ChHHHHHHHHHHHHHHHhCCCCCCCCC--CHHHHHHHHHCCCCC-C-C-CCCCCHHHHHHHHHHcCCChhhCcCHHHH
Confidence 889999999999999997 88998643 334444444433221 1 1 23467899999999999999999999999
Q ss_pred HHHHHHHhh
Q psy1840 184 HHKLKEMNA 192 (423)
Q Consensus 184 ~~~L~~i~~ 192 (423)
++.+..+..
T Consensus 262 ~~~l~~~~~ 270 (303)
T cd05110 262 AAEFSRMAR 270 (303)
T ss_pred HHHHHHHHh
Confidence 998887643
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >KOG2345|consensus | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.4e-25 Score=202.65 Aligned_cols=164 Identities=20% Similarity=0.307 Sum_probs=126.9
Q ss_pred HHHHHHHHHHHHHHHHHhCC--CeeecCCCCCCEEEcCCccEEEeccCCcccccCCCccc-------ccccccCCccccC
Q psy1840 24 GSISVNTTASVGMIHLHDSE--IISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETG-------QERKLRRRKLYKA 94 (423)
Q Consensus 24 ~~l~i~~qi~~gL~yLH~~~--ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~~~-------~~~~~~gt~~y~A 94 (423)
+.+.++.+|++||++||... .. ||||||.|||+.+.+.+++.|||.+....-..... .......|..|.|
T Consensus 128 ~iL~if~gic~gL~~lH~~~~~yA-H~DiKP~NILls~~~~~vl~D~GS~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRA 206 (302)
T KOG2345|consen 128 QILWIFLGICRGLEALHEKEPPYA-HRDIKPANILLSDSGLPVLMDLGSATQAPIQIEGSRQALRLQEWAEERCTIPYRA 206 (302)
T ss_pred HHHHHHHHHHHHHHHHhccCCccc-ccCCCcceeEecCCCceEEEeccCccccceEeechHHHHHHHHHHHHhCCCcccC
Confidence 35899999999999999986 66 99999999999999999999999876432211111 1123356788999
Q ss_pred CccccCCCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCchHHHHHHHHHhhhcCC
Q psy1840 95 PELLRQPHLPRGTQKGDVYSFGLVLYEVIGRQGPWGHLRMTDEEIITSVTQGSGLRPDTSSLDCAPSIIACMRTCWEEDP 174 (423)
Q Consensus 95 PE~l~~~~~~~~s~ksDVyS~Giil~elltg~~Pf~~~~~~~~~i~~~i~~~~~~~p~~~~~~~~~~l~~Li~~C~~~dP 174 (423)
||.+.-+.....+.++|||||||++|+|+.|..||.........+.-.+..+....|.... +++.+.++++.|++.||
T Consensus 207 PELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~GgSlaLAv~n~q~s~P~~~~--yse~l~~lik~mlqvdP 284 (302)
T KOG2345|consen 207 PELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQGGSLALAVQNAQISIPNSSR--YSEALHQLIKSMLQVDP 284 (302)
T ss_pred chheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhcCCeEEEeeeccccccCCCCC--ccHHHHHHHHHHhcCCc
Confidence 9999876655668999999999999999999999963222222223334444445555443 89999999999999999
Q ss_pred CCCCCHHHHHHHHHHH
Q psy1840 175 ELRPDLRFVHHKLKEM 190 (423)
Q Consensus 175 ~~RPt~~~I~~~L~~i 190 (423)
.+||++.+++..+..+
T Consensus 285 ~qRP~i~~ll~~~d~L 300 (302)
T KOG2345|consen 285 NQRPTIPELLSKLDDL 300 (302)
T ss_pred ccCCCHHHHHHHHHhh
Confidence 9999999999887654
|
|
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=99.92 E-value=5.9e-25 Score=208.98 Aligned_cols=155 Identities=28% Similarity=0.537 Sum_probs=121.9
Q ss_pred HHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCc-----cEEEeccCCcccccCCCcccccccccCCccccCCcccc
Q psy1840 25 SISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRW-----VLQIADFGLHAFKAGQDETGQERKLRRRKLYKAPELLR 99 (423)
Q Consensus 25 ~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~-----~vKL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~ 99 (423)
.+.++.|++.|+.|||+.+++ ||||||+||+++.++ .+|++|||++................++..|+|||.+.
T Consensus 108 ~~~~~~~l~~~l~~lH~~~i~-H~dl~p~nil~~~~~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~ 186 (269)
T cd05044 108 LLDICLDVAKGCVYLEQMHFI-HRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLPVRWMAPESLL 186 (269)
T ss_pred HHHHHHHHHHHHHHHHhCCcc-cCCCChheEEEecCCCCCCcceEECCcccccccccccccccCcccCCCccccCHHHHc
Confidence 678999999999999999987 999999999999887 89999999987543322211112234456799999998
Q ss_pred CCCCCCCCCccchHHHHHHHHHHHh-CCCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCchHHHHHHHHHhhhcCCCCCC
Q psy1840 100 QPHLPRGTQKGDVYSFGLVLYEVIG-RQGPWGHLRMTDEEIITSVTQGSGLRPDTSSLDCAPSIIACMRTCWEEDPELRP 178 (423)
Q Consensus 100 ~~~~~~~s~ksDVyS~Giil~ellt-g~~Pf~~~~~~~~~i~~~i~~~~~~~p~~~~~~~~~~l~~Li~~C~~~dP~~RP 178 (423)
+... +.++||||||+++|||++ |..||.. ....+....+..+.... ....++..+.+++.+||..+|.+||
T Consensus 187 ~~~~---~~~~Dv~slG~il~ellt~g~~p~~~--~~~~~~~~~~~~~~~~~---~~~~~~~~~~~li~~~l~~~p~~Rp 258 (269)
T cd05044 187 DGKF---TTQSDVWSFGVLMWEILTLGQQPYPA--LNNQEVLQHVTAGGRLQ---KPENCPDKIYQLMTNCWAQDPSERP 258 (269)
T ss_pred cCCc---ccchhHHHHHHHHHHHHHcCCCCCcc--cCHHHHHHHHhcCCccC---CcccchHHHHHHHHHHcCCCcccCC
Confidence 7655 899999999999999998 9999963 33445555554432221 1235788999999999999999999
Q ss_pred CHHHHHHHHH
Q psy1840 179 DLRFVHHKLK 188 (423)
Q Consensus 179 t~~~I~~~L~ 188 (423)
++.+|.+.|+
T Consensus 259 ~~~~i~~~l~ 268 (269)
T cd05044 259 TFDRIQEILQ 268 (269)
T ss_pred CHHHHHHHHh
Confidence 9999998875
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >KOG0660|consensus | Back alignment and domain information |
|---|
Probab=99.92 E-value=2e-25 Score=211.62 Aligned_cols=158 Identities=23% Similarity=0.291 Sum_probs=122.5
Q ss_pred HHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCccEEEeccCCcccccCCCcccccccccCCccccCCccccCCCCCC
Q psy1840 26 ISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKAPELLRQPHLPR 105 (423)
Q Consensus 26 l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~ 105 (423)
--+++||+.||.|+|+.+++ ||||||+|++++.+..+||+|||+++...........+....|.+|.|||++.... .
T Consensus 128 q~f~YQiLrgLKyiHSAnVi-HRDLKPsNll~n~~c~lKI~DFGLAR~~~~~~~~~~mTeYVaTRWYRAPElll~~~--~ 204 (359)
T KOG0660|consen 128 QYFLYQILRGLKYIHSANVI-HRDLKPSNLLLNADCDLKICDFGLARYLDKFFEDGFMTEYVATRWYRAPELLLNSS--E 204 (359)
T ss_pred HHHHHHHHHhcchhhccccc-ccccchhheeeccCCCEEeccccceeeccccCcccchhcceeeeeecCHHHHhccc--c
Confidence 36799999999999999998 99999999999999999999999999775432222335567889999999986543 5
Q ss_pred CCCccchHHHHHHHHHHHhCCCCCCCCCC-------------ChHHHHHHHh--------cCCCCCCCCC----CCCchH
Q psy1840 106 GTQKGDVYSFGLVLYEVIGRQGPWGHLRM-------------TDEEIITSVT--------QGSGLRPDTS----SLDCAP 160 (423)
Q Consensus 106 ~s~ksDVyS~Giil~elltg~~Pf~~~~~-------------~~~~i~~~i~--------~~~~~~p~~~----~~~~~~ 160 (423)
++++.||||.|||+.||++|++-|.+... ..++.+..+. ...+..|..+ -...++
T Consensus 205 Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l~~i~s~~ar~yi~slp~~p~~~f~~~fp~a~p 284 (359)
T KOG0660|consen 205 YTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDLQKIRSEKARPYIKSLPQIPKQPFSSIFPNANP 284 (359)
T ss_pred ccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHHHHhccHHHHHHHHhCCCCCCCCHHHHcCCCCH
Confidence 69999999999999999999998875421 1223333332 1112222222 146788
Q ss_pred HHHHHHHHhhhcCCCCCCCHHHHHHH
Q psy1840 161 SIIACMRTCWEEDPELRPDLRFVHHK 186 (423)
Q Consensus 161 ~l~~Li~~C~~~dP~~RPt~~~I~~~ 186 (423)
...+|+++||..||.+|+|+.+.+..
T Consensus 285 ~AidLlekmL~fdP~kRita~eAL~h 310 (359)
T KOG0660|consen 285 LAIDLLEKMLVFDPKKRITAEEALAH 310 (359)
T ss_pred HHHHHHHHHhccCccccCCHHHHhcC
Confidence 99999999999999999999998764
|
|
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=99.92 E-value=3.2e-25 Score=217.01 Aligned_cols=148 Identities=24% Similarity=0.344 Sum_probs=119.6
Q ss_pred HHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCccEEEeccCCcccccCCCcccccccccCCccccCCccccCCCCC
Q psy1840 25 SISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKAPELLRQPHLP 104 (423)
Q Consensus 25 ~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~ 104 (423)
...++.|++.||+|||+.|++ ||||||+||+++.++.+||+|||+++...... .......|+..|+|||++.+..+
T Consensus 98 ~~~~~~qi~~~l~~lH~~~iv-HrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~- 173 (316)
T cd05620 98 ATFYAAEIVCGLQFLHSKGII-YRDLKLDNVMLDRDGHIKIADFGMCKENVFGD--NRASTFCGTPDYIAPEILQGLKY- 173 (316)
T ss_pred HHHHHHHHHHHHHHHHHCCeE-ecCCCHHHeEECCCCCEEeCccCCCeecccCC--CceeccCCCcCccCHHHHcCCCC-
Confidence 568899999999999999998 99999999999999999999999976432111 11234568899999999987655
Q ss_pred CCCCccchHHHHHHHHHHHhCCCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCchHHHHHHHHHhhhcCCCCCCCHH-HH
Q psy1840 105 RGTQKGDVYSFGLVLYEVIGRQGPWGHLRMTDEEIITSVTQGSGLRPDTSSLDCAPSIIACMRTCWEEDPELRPDLR-FV 183 (423)
Q Consensus 105 ~~s~ksDVyS~Giil~elltg~~Pf~~~~~~~~~i~~~i~~~~~~~p~~~~~~~~~~l~~Li~~C~~~dP~~RPt~~-~I 183 (423)
+.++|||||||++|||++|..||.. .+..++.+.+....+..| ..++.++.+++.+||+.||++||++. ++
T Consensus 174 --~~~~DiwslGvil~el~~g~~Pf~~--~~~~~~~~~~~~~~~~~~----~~~~~~~~~li~~~l~~dP~~R~~~~~~~ 245 (316)
T cd05620 174 --TFSVDWWSFGVLLYEMLIGQSPFHG--DDEDELFESIRVDTPHYP----RWITKESKDILEKLFERDPTRRLGVVGNI 245 (316)
T ss_pred --CcccchhhhHHHHHHHHhCCCCCCC--CCHHHHHHHHHhCCCCCC----CCCCHHHHHHHHHHccCCHHHcCCChHHH
Confidence 8899999999999999999999964 345566666655433222 24688999999999999999999974 55
Q ss_pred H
Q psy1840 184 H 184 (423)
Q Consensus 184 ~ 184 (423)
.
T Consensus 246 ~ 246 (316)
T cd05620 246 R 246 (316)
T ss_pred H
Confidence 4
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=99.92 E-value=3e-25 Score=218.40 Aligned_cols=150 Identities=19% Similarity=0.266 Sum_probs=120.5
Q ss_pred HHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCccEEEeccCCcccccCCCcccccccccCCccccCCccccCCCCC
Q psy1840 25 SISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKAPELLRQPHLP 104 (423)
Q Consensus 25 ~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~ 104 (423)
...++.||+.||.|||++|++ ||||||+|||++.++.+||+|||+++...... .......|++.|+|||.+.+..+
T Consensus 97 ~~~~~~qi~~aL~~LH~~~iv-HrDikp~NIll~~~~~~kL~DfG~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~- 172 (328)
T cd05593 97 TRFYGAEIVSALDYLHSGKIV-YRDLKLENLMLDKDGHIKITDFGLCKEGITDA--ATMKTFCGTPEYLAPEVLEDNDY- 172 (328)
T ss_pred HHHHHHHHHHHHHHHHhCCeE-ecccCHHHeEECCCCcEEEecCcCCccCCCcc--cccccccCCcCccChhhhcCCCC-
Confidence 568899999999999999998 99999999999999999999999986532211 11234568899999999987655
Q ss_pred CCCCccchHHHHHHHHHHHhCCCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCchHHHHHHHHHhhhcCCCCCC-----C
Q psy1840 105 RGTQKGDVYSFGLVLYEVIGRQGPWGHLRMTDEEIITSVTQGSGLRPDTSSLDCAPSIIACMRTCWEEDPELRP-----D 179 (423)
Q Consensus 105 ~~s~ksDVyS~Giil~elltg~~Pf~~~~~~~~~i~~~i~~~~~~~p~~~~~~~~~~l~~Li~~C~~~dP~~RP-----t 179 (423)
+.++|||||||++|||++|+.||.. ....++...+.......| ..+++++.+++.+||+.||++|| +
T Consensus 173 --~~~~DiwslGvil~elltG~~Pf~~--~~~~~~~~~~~~~~~~~p----~~~~~~~~~li~~~L~~dP~~R~~~~~~~ 244 (328)
T cd05593 173 --GRAVDWWGLGVVMYEMMCGRLPFYN--QDHEKLFELILMEDIKFP----RTLSADAKSLLSGLLIKDPNKRLGGGPDD 244 (328)
T ss_pred --CccCCccccchHHHHHhhCCCCCCC--CCHHHHHHHhccCCccCC----CCCCHHHHHHHHHHcCCCHHHcCCCCCCC
Confidence 8999999999999999999999964 234455555544332222 35788999999999999999997 7
Q ss_pred HHHHHHH
Q psy1840 180 LRFVHHK 186 (423)
Q Consensus 180 ~~~I~~~ 186 (423)
+.++++.
T Consensus 245 ~~~il~h 251 (328)
T cd05593 245 AKEIMRH 251 (328)
T ss_pred HHHHhcC
Confidence 8887654
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=99.92 E-value=6.4e-25 Score=210.21 Aligned_cols=155 Identities=26% Similarity=0.472 Sum_probs=119.9
Q ss_pred HHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCc---cEEEeccCCcccccCCCcccccccccCCccccCCccccCC
Q psy1840 25 SISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRW---VLQIADFGLHAFKAGQDETGQERKLRRRKLYKAPELLRQP 101 (423)
Q Consensus 25 ~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~---~vKL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~ 101 (423)
.+.++.||+.|+.|||+++++ ||||||+||+++.++ .+||+|||+++................+..|+|||.+.+.
T Consensus 118 ~~~~~~qi~~~l~~LH~~~iv-H~dlkp~nil~~~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~ 196 (277)
T cd05036 118 LLFCARDVAKGCKYLEENHFI-HRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDG 196 (277)
T ss_pred HHHHHHHHHHHHHHHHHCCEe-ecccchheEEEeccCCCcceEeccCccccccCCccceecCCCCCccHhhCCHHHHhcC
Confidence 578999999999999999987 999999999998754 6999999998765322211111122334579999999776
Q ss_pred CCCCCCCccchHHHHHHHHHHHh-CCCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCchHHHHHHHHHhhhcCCCCCCCH
Q psy1840 102 HLPRGTQKGDVYSFGLVLYEVIG-RQGPWGHLRMTDEEIITSVTQGSGLRPDTSSLDCAPSIIACMRTCWEEDPELRPDL 180 (423)
Q Consensus 102 ~~~~~s~ksDVyS~Giil~ellt-g~~Pf~~~~~~~~~i~~~i~~~~~~~p~~~~~~~~~~l~~Li~~C~~~dP~~RPt~ 180 (423)
.+ +.++|||||||++|||++ |..||.. .+..++...+...... . .+..++..+.+++.+||+.+|++||++
T Consensus 197 ~~---~~~~DiwslG~il~el~~~g~~pf~~--~~~~~~~~~~~~~~~~--~-~~~~~~~~~~~~i~~cl~~~p~~Rps~ 268 (277)
T cd05036 197 IF---TSKTDVWSFGVLLWEIFSLGYMPYPG--RTNQEVMEFVTGGGRL--D-PPKGCPGPVYRIMTDCWQHTPEDRPNF 268 (277)
T ss_pred Cc---CchhHHHHHHHHHHHHHcCCCCCCCC--CCHHHHHHHHHcCCcC--C-CCCCCCHHHHHHHHHHcCCCcccCcCH
Confidence 55 899999999999999996 8999974 3345555555443221 1 123578899999999999999999999
Q ss_pred HHHHHHHH
Q psy1840 181 RFVHHKLK 188 (423)
Q Consensus 181 ~~I~~~L~ 188 (423)
.+|++.|+
T Consensus 269 ~~vl~~l~ 276 (277)
T cd05036 269 ATILERIQ 276 (277)
T ss_pred HHHHHHhh
Confidence 99998875
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=99.92 E-value=9.5e-25 Score=205.69 Aligned_cols=155 Identities=28% Similarity=0.509 Sum_probs=119.6
Q ss_pred HHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCccEEEeccCCcccccCCCcccccccccCCccccCCccccCCCCC
Q psy1840 25 SISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKAPELLRQPHLP 104 (423)
Q Consensus 25 ~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~ 104 (423)
.+.++.|++.||.|||+++++ ||||||+||+++.++.+||+|||++.................+..|+|||.+.+..+
T Consensus 96 ~~~~~~qi~~~L~~lH~~~i~-H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~- 173 (252)
T cd05084 96 LIQMVENAAAGMEYLESKHCI-HRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQIPVKWTAPEALNYGRY- 173 (252)
T ss_pred HHHHHHHHHHHHHHHHhCCcc-ccccchheEEEcCCCcEEECccccCcccccccccccCCCCCCceeecCchhhcCCCC-
Confidence 578999999999999999998 999999999999999999999999865432211111111122356999999877654
Q ss_pred CCCCccchHHHHHHHHHHHh-CCCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCchHHHHHHHHHhhhcCCCCCCCHHHH
Q psy1840 105 RGTQKGDVYSFGLVLYEVIG-RQGPWGHLRMTDEEIITSVTQGSGLRPDTSSLDCAPSIIACMRTCWEEDPELRPDLRFV 183 (423)
Q Consensus 105 ~~s~ksDVyS~Giil~ellt-g~~Pf~~~~~~~~~i~~~i~~~~~~~p~~~~~~~~~~l~~Li~~C~~~dP~~RPt~~~I 183 (423)
+.++||||||+++||+++ |..||.. .+.......+..... +. ....++..+.+++.+||+.+|++||++.++
T Consensus 174 --~~~~Dv~slG~il~e~~~~~~~p~~~--~~~~~~~~~~~~~~~--~~-~~~~~~~~~~~li~~~l~~~p~~Rps~~~~ 246 (252)
T cd05084 174 --SSESDVWSFGILLWEAFSLGAVPYAN--LSNQQTREAIEQGVR--LP-CPELCPDAVYRLMERCWEYDPGQRPSFSTV 246 (252)
T ss_pred --ChHHHHHHHHHHHHHHHhCCCCCccc--cCHHHHHHHHHcCCC--CC-CcccCCHHHHHHHHHHcCCChhhCcCHHHH
Confidence 889999999999999997 8888863 334444444444321 11 223578899999999999999999999999
Q ss_pred HHHHH
Q psy1840 184 HHKLK 188 (423)
Q Consensus 184 ~~~L~ 188 (423)
.+.|+
T Consensus 247 ~~~l~ 251 (252)
T cd05084 247 HQELQ 251 (252)
T ss_pred HHHHh
Confidence 98775
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.92 E-value=3.7e-25 Score=219.86 Aligned_cols=156 Identities=21% Similarity=0.297 Sum_probs=118.4
Q ss_pred HHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCccEEEeccCCcccccCCCcccccccccCCccccCCccccCCC--
Q psy1840 25 SISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKAPELLRQPH-- 102 (423)
Q Consensus 25 ~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~-- 102 (423)
...++.||+.||.|||+.|++ ||||||+|||++.++.+||+|||++........ ......|+..|+|||.+....
T Consensus 170 ~~~i~~qi~~aL~~LH~~~iv-HrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~ 246 (353)
T PLN00034 170 LADVARQILSGIAYLHRRHIV-HRDIKPSNLLINSAKNVKIADFGVSRILAQTMD--PCNSSVGTIAYMSPERINTDLNH 246 (353)
T ss_pred HHHHHHHHHHHHHHHHHCCEe-ecCCCHHHEEEcCCCCEEEcccccceecccccc--cccccccCccccCcccccccccc
Confidence 468999999999999999998 999999999999999999999999876532211 113456889999999885421
Q ss_pred CCCCCCccchHHHHHHHHHHHhCCCCCCCCCC-ChHHHHHHHhcCCCCCCCCCCCCchHHHHHHHHHhhhcCCCCCCCHH
Q psy1840 103 LPRGTQKGDVYSFGLVLYEVIGRQGPWGHLRM-TDEEIITSVTQGSGLRPDTSSLDCAPSIIACMRTCWEEDPELRPDLR 181 (423)
Q Consensus 103 ~~~~s~ksDVyS~Giil~elltg~~Pf~~~~~-~~~~i~~~i~~~~~~~p~~~~~~~~~~l~~Li~~C~~~dP~~RPt~~ 181 (423)
....+.++|||||||++|||++|+.||..... ....+...+.... +......++.++.++|.+||+.||++||++.
T Consensus 247 ~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ 323 (353)
T PLN00034 247 GAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAICMSQ---PPEAPATASREFRHFISCCLQREPAKRWSAM 323 (353)
T ss_pred CcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHHhccC---CCCCCCccCHHHHHHHHHHccCChhhCcCHH
Confidence 11225689999999999999999999974322 1222333332221 1122336788999999999999999999999
Q ss_pred HHHHH
Q psy1840 182 FVHHK 186 (423)
Q Consensus 182 ~I~~~ 186 (423)
++++.
T Consensus 324 ell~h 328 (353)
T PLN00034 324 QLLQH 328 (353)
T ss_pred HHhcC
Confidence 99874
|
|
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=99.92 E-value=3.5e-25 Score=217.11 Aligned_cols=145 Identities=19% Similarity=0.323 Sum_probs=118.9
Q ss_pred HHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCccEEEeccCCcccccCCCcccccccccCCccccCCccccCCCCC
Q psy1840 25 SISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKAPELLRQPHLP 104 (423)
Q Consensus 25 ~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~ 104 (423)
...++.|++.||.|||+.+++ ||||||+||+++.++.+||+|||+++...... .......|++.|+|||.+.+..+
T Consensus 98 ~~~~~~ql~~~L~~lH~~~iv-H~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~- 173 (320)
T cd05590 98 ARFYAAEITSALMFLHDKGII-YRDLKLDNVLLDHEGHCKLADFGMCKEGIFNG--KTTSTFCGTPDYIAPEILQEMLY- 173 (320)
T ss_pred HHHHHHHHHHHHHHHHHCCeE-eCCCCHHHeEECCCCcEEEeeCCCCeecCcCC--CcccccccCccccCHHHHcCCCC-
Confidence 567899999999999999998 99999999999999999999999976432111 11234568899999999987654
Q ss_pred CCCCccchHHHHHHHHHHHhCCCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCchHHHHHHHHHhhhcCCCCCCCHH
Q psy1840 105 RGTQKGDVYSFGLVLYEVIGRQGPWGHLRMTDEEIITSVTQGSGLRPDTSSLDCAPSIIACMRTCWEEDPELRPDLR 181 (423)
Q Consensus 105 ~~s~ksDVyS~Giil~elltg~~Pf~~~~~~~~~i~~~i~~~~~~~p~~~~~~~~~~l~~Li~~C~~~dP~~RPt~~ 181 (423)
+.++|||||||++|||++|+.||.. .+..++...+..+....| ..++.++.+++.+||+.||++||+..
T Consensus 174 --~~~~DiwslG~il~el~~g~~Pf~~--~~~~~~~~~i~~~~~~~~----~~~~~~~~~li~~~L~~dP~~R~~~~ 242 (320)
T cd05590 174 --GPSVDWWAMGVLLYEMLCGHAPFEA--ENEDDLFEAILNDEVVYP----TWLSQDAVDILKAFMTKNPTMRLGSL 242 (320)
T ss_pred --CCccchhhhHHHHHHHhhCCCCCCC--CCHHHHHHHHhcCCCCCC----CCCCHHHHHHHHHHcccCHHHCCCCC
Confidence 8899999999999999999999974 345666777766543333 24688999999999999999999973
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=99.92 E-value=5.2e-25 Score=216.16 Aligned_cols=149 Identities=24% Similarity=0.382 Sum_probs=120.5
Q ss_pred HHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCccEEEeccCCcccccCCCcccccccccCCccccCCccccCCCCC
Q psy1840 25 SISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKAPELLRQPHLP 104 (423)
Q Consensus 25 ~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~ 104 (423)
...++.||+.||.|||+.|++ ||||||+||+++.++.+||+|||+++...... .......|++.|+|||.+.+..+
T Consensus 103 ~~~~~~qi~~al~~lH~~~iv-Hrdlkp~Nill~~~~~~kL~Dfg~~~~~~~~~--~~~~~~~g~~~y~aPE~~~~~~~- 178 (324)
T cd05589 103 AVFYAACVVLGLQYLHENKIV-YRDLKLDNLLLDTEGFVKIADFGLCKEGMGFG--DRTSTFCGTPEFLAPEVLTETSY- 178 (324)
T ss_pred HHHHHHHHHHHHHHHHhCCeE-ecCCCHHHeEECCCCcEEeCcccCCccCCCCC--CcccccccCccccCHhHhcCCCC-
Confidence 678999999999999999998 99999999999999999999999976432211 12234568899999999987654
Q ss_pred CCCCccchHHHHHHHHHHHhCCCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCchHHHHHHHHHhhhcCCCCCCC-----
Q psy1840 105 RGTQKGDVYSFGLVLYEVIGRQGPWGHLRMTDEEIITSVTQGSGLRPDTSSLDCAPSIIACMRTCWEEDPELRPD----- 179 (423)
Q Consensus 105 ~~s~ksDVyS~Giil~elltg~~Pf~~~~~~~~~i~~~i~~~~~~~p~~~~~~~~~~l~~Li~~C~~~dP~~RPt----- 179 (423)
+.++|||||||++|||++|+.||.. .+..++...+..+....| ..++..+.+++.+||+.||.+||+
T Consensus 179 --~~~~DiwslG~il~el~~G~~pf~~--~~~~~~~~~i~~~~~~~p----~~~~~~~~~li~~~L~~dP~~R~~~~~~~ 250 (324)
T cd05589 179 --TRAVDWWGLGVLIYEMLVGESPFPG--DDEEEVFDSIVNDEVRYP----RFLSREAISIMRRLLRRNPERRLGSGEKD 250 (324)
T ss_pred --CcccchhhHHHHHHHHHhCCCCCCC--CCHHHHHHHHHhCCCCCC----CCCCHHHHHHHHHHhhcCHhHcCCCCCCC
Confidence 8899999999999999999999974 345566666665543333 256889999999999999999994
Q ss_pred HHHHHH
Q psy1840 180 LRFVHH 185 (423)
Q Consensus 180 ~~~I~~ 185 (423)
+.++++
T Consensus 251 ~~~l~~ 256 (324)
T cd05589 251 AEDVKK 256 (324)
T ss_pred HHHHhh
Confidence 555543
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=99.92 E-value=3e-25 Score=217.56 Aligned_cols=149 Identities=19% Similarity=0.330 Sum_probs=121.3
Q ss_pred HHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCccEEEeccCCcccccCCCcccccccccCCccccCCccccCCCCC
Q psy1840 25 SISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKAPELLRQPHLP 104 (423)
Q Consensus 25 ~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~ 104 (423)
...++.||+.||.|||++|++ ||||||+||+++.++.+||+|||++....... .......|+..|+|||++.+..+
T Consensus 98 ~~~~~~qi~~aL~~LH~~~iv-HrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~- 173 (321)
T cd05591 98 SRFYAAEVTLALMFLHRHGVI-YRDLKLDNILLDAEGHCKLADFGMCKEGILNG--VTTTTFCGTPDYIAPEILQELEY- 173 (321)
T ss_pred HHHHHHHHHHHHHHHHHCCee-ccCCCHHHeEECCCCCEEEeecccceecccCC--ccccccccCccccCHHHHcCCCC-
Confidence 568899999999999999988 99999999999999999999999986532221 11234568899999999987654
Q ss_pred CCCCccchHHHHHHHHHHHhCCCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCchHHHHHHHHHhhhcCCCCCC------
Q psy1840 105 RGTQKGDVYSFGLVLYEVIGRQGPWGHLRMTDEEIITSVTQGSGLRPDTSSLDCAPSIIACMRTCWEEDPELRP------ 178 (423)
Q Consensus 105 ~~s~ksDVyS~Giil~elltg~~Pf~~~~~~~~~i~~~i~~~~~~~p~~~~~~~~~~l~~Li~~C~~~dP~~RP------ 178 (423)
+.++|||||||++|||++|+.||.. .+..+....+..+....| ..++.++.+++.+||+.||++||
T Consensus 174 --~~~~DvwslG~il~el~tg~~Pf~~--~~~~~~~~~i~~~~~~~p----~~~~~~~~~ll~~~L~~dp~~R~~~~~~~ 245 (321)
T cd05591 174 --GPSVDWWALGVLMYEMMAGQPPFEA--DNEDDLFESILHDDVLYP----VWLSKEAVSILKAFMTKNPNKRLGCVASQ 245 (321)
T ss_pred --CCccceechhHHHHHHhcCCCCCCC--CCHHHHHHHHHcCCCCCC----CCCCHHHHHHHHHHhccCHHHcCCCCCCC
Confidence 8899999999999999999999974 345667777766543333 24678999999999999999999
Q ss_pred -CHHHHHH
Q psy1840 179 -DLRFVHH 185 (423)
Q Consensus 179 -t~~~I~~ 185 (423)
++.++++
T Consensus 246 ~~~~~~~~ 253 (321)
T cd05591 246 GGEDAIKQ 253 (321)
T ss_pred CCHHHHhc
Confidence 6666654
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=99.92 E-value=3.8e-25 Score=217.16 Aligned_cols=149 Identities=19% Similarity=0.293 Sum_probs=119.5
Q ss_pred HHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCccEEEeccCCcccccCCCcccccccccCCccccCCccccCCCCC
Q psy1840 25 SISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKAPELLRQPHLP 104 (423)
Q Consensus 25 ~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~ 104 (423)
...++.||+.||.|||++|++ ||||||+||+++.++.+||+|||++....... .......|++.|+|||.+.+..+
T Consensus 97 ~~~~~~qi~~aL~~LH~~~iv-H~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~- 172 (323)
T cd05595 97 ARFYGAEIVSALEYLHSRDVV-YRDIKLENLMLDKDGHIKITDFGLCKEGISDG--ATMKTFCGTPEYLAPEVLEDNDY- 172 (323)
T ss_pred HHHHHHHHHHHHHHHHHCCeE-ecCCCHHHEEEcCCCCEEecccHHhccccCCC--CccccccCCcCcCCcccccCCCC-
Confidence 568899999999999999998 99999999999999999999999976432211 11234568899999999987655
Q ss_pred CCCCccchHHHHHHHHHHHhCCCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCchHHHHHHHHHhhhcCCCCCC-----C
Q psy1840 105 RGTQKGDVYSFGLVLYEVIGRQGPWGHLRMTDEEIITSVTQGSGLRPDTSSLDCAPSIIACMRTCWEEDPELRP-----D 179 (423)
Q Consensus 105 ~~s~ksDVyS~Giil~elltg~~Pf~~~~~~~~~i~~~i~~~~~~~p~~~~~~~~~~l~~Li~~C~~~dP~~RP-----t 179 (423)
+.++|||||||++|||++|..||.. .+..+....+.......| ..+++++.+++.+||+.||++|| +
T Consensus 173 --~~~~DiwSlGvil~ell~g~~Pf~~--~~~~~~~~~~~~~~~~~p----~~~~~~~~~li~~~L~~dP~~R~~~~~~~ 244 (323)
T cd05595 173 --GRAVDWWGLGVVMYEMMCGRLPFYN--QDHERLFELILMEEIRFP----RTLSPEAKSLLAGLLKKDPKQRLGGGPSD 244 (323)
T ss_pred --CchhchhhhHHHHHHHHhCCCCCCC--CCHHHHHHHHhcCCCCCC----CCCCHHHHHHHHHHccCCHHHhCCCCCCC
Confidence 8899999999999999999999964 334555555544332222 35789999999999999999998 7
Q ss_pred HHHHHH
Q psy1840 180 LRFVHH 185 (423)
Q Consensus 180 ~~~I~~ 185 (423)
+.++++
T Consensus 245 ~~~~l~ 250 (323)
T cd05595 245 AKEVME 250 (323)
T ss_pred HHHHHc
Confidence 777765
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >KOG0196|consensus | Back alignment and domain information |
|---|
Probab=99.92 E-value=6.2e-26 Score=231.69 Aligned_cols=160 Identities=27% Similarity=0.535 Sum_probs=136.7
Q ss_pred HHHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCccEEEeccCCcccccCCCcccccccccC--CccccCCccccCC
Q psy1840 24 GSISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRR--RKLYKAPELLRQP 101 (423)
Q Consensus 24 ~~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~~g--t~~y~APE~l~~~ 101 (423)
+-+.++..|+.||.||-+.+.+ ||||..+|||++++-.+|++|||+++.+.+..+... .+..| ...|+|||.+...
T Consensus 732 QLVgMLrGIAsGMkYLsdm~YV-HRDLAARNILVNsnLvCKVsDFGLSRvledd~~~~y-tt~GGKIPiRWTAPEAIa~R 809 (996)
T KOG0196|consen 732 QLVGMLRGIASGMKYLSDMNYV-HRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAY-TTLGGKIPIRWTAPEAIAYR 809 (996)
T ss_pred hHHHHHHHHHHHhHHHhhcCch-hhhhhhhheeeccceEEEeccccceeecccCCCccc-cccCCccceeecChhHhhhc
Confidence 3578999999999999999998 999999999999999999999999998765542221 22222 3469999999876
Q ss_pred CCCCCCCccchHHHHHHHHHHHh-CCCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCchHHHHHHHHHhhhcCCCCCCCH
Q psy1840 102 HLPRGTQKGDVYSFGLVLYEVIG-RQGPWGHLRMTDEEIITSVTQGSGLRPDTSSLDCAPSIIACMRTCWEEDPELRPDL 180 (423)
Q Consensus 102 ~~~~~s~ksDVyS~Giil~ellt-g~~Pf~~~~~~~~~i~~~i~~~~~~~p~~~~~~~~~~l~~Li~~C~~~dP~~RPt~ 180 (423)
.+ |.++|||||||++||.++ |..||. .++.++++..+.++-.+.|+ .+||..|.+||..||++|-..||.|
T Consensus 810 KF---TsASDVWSyGIVmWEVmSyGERPYW--dmSNQdVIkaIe~gyRLPpP---mDCP~aL~qLMldCWqkdR~~RP~F 881 (996)
T KOG0196|consen 810 KF---TSASDVWSYGIVMWEVMSYGERPYW--DMSNQDVIKAIEQGYRLPPP---MDCPAALYQLMLDCWQKDRNRRPKF 881 (996)
T ss_pred cc---CchhhccccceEEEEecccCCCccc--ccchHHHHHHHHhccCCCCC---CCCcHHHHHHHHHHHHHHhhcCCCH
Confidence 55 999999999999999885 899996 68889999999998665553 4899999999999999999999999
Q ss_pred HHHHHHHHHHhhh
Q psy1840 181 RFVHHKLKEMNAG 193 (423)
Q Consensus 181 ~~I~~~L~~i~~~ 193 (423)
.+|+..|.++-..
T Consensus 882 ~qiV~~lDklIrn 894 (996)
T KOG0196|consen 882 AQIVSTLDKLIRN 894 (996)
T ss_pred HHHHHHHHHHhcC
Confidence 9999999887654
|
|
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.92 E-value=8.8e-25 Score=211.31 Aligned_cols=157 Identities=24% Similarity=0.469 Sum_probs=119.5
Q ss_pred HHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCccEEEeccCCcccccCCCcccccccccCCccccCCccccCCCCC
Q psy1840 25 SISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKAPELLRQPHLP 104 (423)
Q Consensus 25 ~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~ 104 (423)
.+.++.|++.||.|||+.+++ ||||||+||+++.++.+||+|||++................++..|+|||.+.+..+
T Consensus 131 ~~~i~~~i~~al~~lH~~~i~-H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~- 208 (295)
T cd05097 131 LLYMAVQIASGMKYLASLNFV-HRDLATRNCLVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKF- 208 (295)
T ss_pred HHHHHHHHHHHHHHHHhcCee-ccccChhhEEEcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCc-
Confidence 578999999999999999998 999999999999999999999999875432221111222344667999999877654
Q ss_pred CCCCccchHHHHHHHHHHHh--CCCCCCCCCCChHHHHHHHhc-----CCCCCCCCCCCCchHHHHHHHHHhhhcCCCCC
Q psy1840 105 RGTQKGDVYSFGLVLYEVIG--RQGPWGHLRMTDEEIITSVTQ-----GSGLRPDTSSLDCAPSIIACMRTCWEEDPELR 177 (423)
Q Consensus 105 ~~s~ksDVyS~Giil~ellt--g~~Pf~~~~~~~~~i~~~i~~-----~~~~~p~~~~~~~~~~l~~Li~~C~~~dP~~R 177 (423)
+.++|||||||++|+|++ +..||.. .+..+++..+.. +...... ....+++.+.+++.+||+.+|++|
T Consensus 209 --~~~~DvwSlG~~l~el~~~~~~~p~~~--~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~l~~li~~~l~~~p~~R 283 (295)
T cd05097 209 --TTASDVWAFGVTLWEMFTLCKEQPYSL--LSDEQVIENTGEFFRNQGRQIYLS-QTPLCPSPVFKLMMRCWSRDIKDR 283 (295)
T ss_pred --CchhhHHHHHHHHHHHHHcCCCCCCcc--cChHHHHHHHHHhhhhccccccCC-CCCCCCHHHHHHHHHHcCCCchhC
Confidence 899999999999999998 4567753 334444444321 1111111 123468899999999999999999
Q ss_pred CCHHHHHHHHH
Q psy1840 178 PDLRFVHHKLK 188 (423)
Q Consensus 178 Pt~~~I~~~L~ 188 (423)
|++.+|++.|+
T Consensus 284 Ps~~~i~~~l~ 294 (295)
T cd05097 284 PTFNKIHHFLR 294 (295)
T ss_pred cCHHHHHHHHh
Confidence 99999998875
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.1e-24 Score=205.89 Aligned_cols=153 Identities=25% Similarity=0.493 Sum_probs=121.4
Q ss_pred HHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCccEEEeccCCcccccCCCcccccccccCCccccCCccccCCCCC
Q psy1840 25 SISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKAPELLRQPHLP 104 (423)
Q Consensus 25 ~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~ 104 (423)
.+.++.|++.||.|||++|++ ||||||+||+++.++.+||+|||.+......... ......++..|+|||.+.+..+
T Consensus 102 ~~~~~~~i~~~l~~lH~~~i~-H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~- 178 (256)
T cd05114 102 LLSMCQDVCEGMEYLERNSFI-HRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYT-SSSGAKFPVKWSPPEVFNFSKY- 178 (256)
T ss_pred HHHHHHHHHHHHHHHHHCCcc-ccccCcceEEEcCCCeEEECCCCCccccCCCcee-ccCCCCCchhhCChhhcccCcc-
Confidence 689999999999999999998 9999999999999999999999998754322211 1122234557999999876654
Q ss_pred CCCCccchHHHHHHHHHHHh-CCCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCchHHHHHHHHHhhhcCCCCCCCHHHH
Q psy1840 105 RGTQKGDVYSFGLVLYEVIG-RQGPWGHLRMTDEEIITSVTQGSGLRPDTSSLDCAPSIIACMRTCWEEDPELRPDLRFV 183 (423)
Q Consensus 105 ~~s~ksDVyS~Giil~ellt-g~~Pf~~~~~~~~~i~~~i~~~~~~~p~~~~~~~~~~l~~Li~~C~~~dP~~RPt~~~I 183 (423)
+.++||||||+++||+++ |+.||.. ....+....+..+.... .+...+..+.+++.+||+.+|++||++.++
T Consensus 179 --~~~~Di~s~G~~l~el~~~g~~p~~~--~~~~~~~~~i~~~~~~~---~~~~~~~~~~~li~~c~~~~p~~Rps~~~l 251 (256)
T cd05114 179 --SSKSDVWSFGVLMWEVFTEGKMPFEK--KSNYEVVEMISRGFRLY---RPKLASMTVYEVMYSCWHEKPEGRPTFAEL 251 (256)
T ss_pred --chhhhhHHHHHHHHHHHcCCCCCCCC--CCHHHHHHHHHCCCCCC---CCCCCCHHHHHHHHHHccCCcccCcCHHHH
Confidence 889999999999999999 8899963 34456666666543221 122457889999999999999999999999
Q ss_pred HHHH
Q psy1840 184 HHKL 187 (423)
Q Consensus 184 ~~~L 187 (423)
++.|
T Consensus 252 ~~~l 255 (256)
T cd05114 252 LRAI 255 (256)
T ss_pred HHhh
Confidence 8765
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.1e-24 Score=205.06 Aligned_cols=154 Identities=29% Similarity=0.503 Sum_probs=125.6
Q ss_pred HHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCccEEEeccCCcccccCCCcccccccccCCccccCCccccCCCCC
Q psy1840 25 SISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKAPELLRQPHLP 104 (423)
Q Consensus 25 ~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~ 104 (423)
...++.|++.|++|||+++++ ||||||+||+++.++.+||+|||.+................++..|+|||.+....+
T Consensus 107 ~~~~~~~l~~al~~lH~~~i~-H~di~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~- 184 (262)
T cd00192 107 LLSFAIQIAKGMEYLASKKFV-HRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIRWMAPESLKDGIF- 184 (262)
T ss_pred HHHHHHHHHHHHHHHHcCCcc-cCccCcceEEECCCCcEEEcccccccccccccccccccCCCcCccccCHHHhccCCc-
Confidence 689999999999999999998 999999999999999999999999876543322222234456778999999877644
Q ss_pred CCCCccchHHHHHHHHHHHh-CCCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCchHHHHHHHHHhhhcCCCCCCCHHHH
Q psy1840 105 RGTQKGDVYSFGLVLYEVIG-RQGPWGHLRMTDEEIITSVTQGSGLRPDTSSLDCAPSIIACMRTCWEEDPELRPDLRFV 183 (423)
Q Consensus 105 ~~s~ksDVyS~Giil~ellt-g~~Pf~~~~~~~~~i~~~i~~~~~~~p~~~~~~~~~~l~~Li~~C~~~dP~~RPt~~~I 183 (423)
+.++||||+|+++||+++ |..||... ...++...+..+.. +.. ...++.++.+++.+||+.+|++||++.++
T Consensus 185 --~~~~Di~slG~il~~l~~~g~~p~~~~--~~~~~~~~~~~~~~--~~~-~~~~~~~~~~li~~~l~~~p~~Rps~~~l 257 (262)
T cd00192 185 --TSKSDVWSFGVLLWEIFTLGATPYPGL--SNEEVLEYLRKGYR--LPK-PEYCPDELYELMLSCWQLDPEDRPTFSEL 257 (262)
T ss_pred --chhhccHHHHHHHHHHHhcCCCCCCCC--CHHHHHHHHHcCCC--CCC-CccCChHHHHHHHHHccCCcccCcCHHHH
Confidence 899999999999999999 58999753 55667777765322 221 23568999999999999999999999999
Q ss_pred HHHH
Q psy1840 184 HHKL 187 (423)
Q Consensus 184 ~~~L 187 (423)
++.|
T Consensus 258 ~~~l 261 (262)
T cd00192 258 VERL 261 (262)
T ss_pred HHhh
Confidence 8876
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=99.92 E-value=6.2e-25 Score=216.43 Aligned_cols=160 Identities=28% Similarity=0.447 Sum_probs=126.9
Q ss_pred HHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCccEEEeccCCcccccCCCcccccccccCCccccCCccccCCCCC
Q psy1840 25 SISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKAPELLRQPHLP 104 (423)
Q Consensus 25 ~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~ 104 (423)
.++++.|++.||.|||++|++ ||||||+||+++.++.+||+|||+++...............++..|+|||.+.+..+
T Consensus 136 ~~~~~~qi~~al~~LH~~giv-H~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~- 213 (334)
T cd05100 136 LVSCAYQVARGMEYLASQKCI-HRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVY- 213 (334)
T ss_pred HHHHHHHHHHHHHHHHHCCee-ccccccceEEEcCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCc-
Confidence 578999999999999999998 999999999999999999999999875433221111122234467999999977655
Q ss_pred CCCCccchHHHHHHHHHHHh-CCCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCchHHHHHHHHHhhhcCCCCCCCHHHH
Q psy1840 105 RGTQKGDVYSFGLVLYEVIG-RQGPWGHLRMTDEEIITSVTQGSGLRPDTSSLDCAPSIIACMRTCWEEDPELRPDLRFV 183 (423)
Q Consensus 105 ~~s~ksDVyS~Giil~ellt-g~~Pf~~~~~~~~~i~~~i~~~~~~~p~~~~~~~~~~l~~Li~~C~~~dP~~RPt~~~I 183 (423)
+.++||||||+++|||++ |..||.. .+..++...+..+.. +. ....++.++.+++.+||+.+|++||++.++
T Consensus 214 --~~~~Di~slG~il~el~~~g~~p~~~--~~~~~~~~~~~~~~~--~~-~~~~~~~~l~~li~~cl~~~p~~Rps~~el 286 (334)
T cd05100 214 --THQSDVWSFGVLLWEIFTLGGSPYPG--IPVEELFKLLKEGHR--MD-KPANCTHELYMIMRECWHAVPSQRPTFKQL 286 (334)
T ss_pred --CchhhhHHHHHHHHHHHhcCCCCCCC--CCHHHHHHHHHcCCC--CC-CCCCCCHHHHHHHHHHcccChhhCcCHHHH
Confidence 889999999999999998 7888864 345666666654322 11 123578899999999999999999999999
Q ss_pred HHHHHHHhhh
Q psy1840 184 HHKLKEMNAG 193 (423)
Q Consensus 184 ~~~L~~i~~~ 193 (423)
+..|+.+...
T Consensus 287 l~~l~~~~~~ 296 (334)
T cd05100 287 VEDLDRVLTV 296 (334)
T ss_pred HHHHHHHhhh
Confidence 9999888653
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.1e-24 Score=207.89 Aligned_cols=155 Identities=28% Similarity=0.459 Sum_probs=121.4
Q ss_pred HHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCccEEEeccCCcccccCCCcccccccccCCccccCCccccCCCCC
Q psy1840 25 SISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKAPELLRQPHLP 104 (423)
Q Consensus 25 ~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~ 104 (423)
.+.++.|++.|++|||+.|++ ||||||+||+++.++.+||+|||++...... ........+..|+|||.+....+
T Consensus 114 ~~~~~~~i~~al~~lH~~~i~-H~dikp~nili~~~~~~kl~dfgl~~~~~~~---~~~~~~~~~~~y~apE~~~~~~~- 188 (270)
T cd05047 114 LLHFAADVARGMDYLSQKQFI-HRDLAARNILVGENYVAKIADFGLSRGQEVY---VKKTMGRLPVRWMAIESLNYSVY- 188 (270)
T ss_pred HHHHHHHHHHHHHHHHHCCEe-ecccccceEEEcCCCeEEECCCCCccccchh---hhccCCCCccccCChHHHccCCC-
Confidence 679999999999999999998 9999999999999999999999997532111 11111223456999999876554
Q ss_pred CCCCccchHHHHHHHHHHHh-CCCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCchHHHHHHHHHhhhcCCCCCCCHHHH
Q psy1840 105 RGTQKGDVYSFGLVLYEVIG-RQGPWGHLRMTDEEIITSVTQGSGLRPDTSSLDCAPSIIACMRTCWEEDPELRPDLRFV 183 (423)
Q Consensus 105 ~~s~ksDVyS~Giil~ellt-g~~Pf~~~~~~~~~i~~~i~~~~~~~p~~~~~~~~~~l~~Li~~C~~~dP~~RPt~~~I 183 (423)
+.++||||||+++|||++ |..||.. .+..+....+..+.. +.. ...++.++.+++.+||..+|.+||++.++
T Consensus 189 --~~~~Di~slG~il~el~~~g~~pf~~--~~~~~~~~~~~~~~~--~~~-~~~~~~~~~~li~~~l~~~p~~Rps~~~i 261 (270)
T cd05047 189 --TTNSDVWSYGVLLWEIVSLGGTPYCG--MTCAELYEKLPQGYR--LEK-PLNCDDEVYDLMRQCWREKPYERPSFAQI 261 (270)
T ss_pred --CchhhHHHHHHHHHHHHcCCCCCccc--cCHHHHHHHHhCCCC--CCC-CCcCCHHHHHHHHHHcccChhhCCCHHHH
Confidence 889999999999999997 9999964 344455555544321 111 23567899999999999999999999999
Q ss_pred HHHHHHHh
Q psy1840 184 HHKLKEMN 191 (423)
Q Consensus 184 ~~~L~~i~ 191 (423)
+..|..+.
T Consensus 262 l~~l~~~~ 269 (270)
T cd05047 262 LVSLNRML 269 (270)
T ss_pred HHHHHHhh
Confidence 99987763
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=99.92 E-value=6.7e-25 Score=210.89 Aligned_cols=154 Identities=18% Similarity=0.193 Sum_probs=116.2
Q ss_pred HHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCccEEEeccCCcccccCCCcccccccccCCccccCCccccCCCCC
Q psy1840 25 SISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKAPELLRQPHLP 104 (423)
Q Consensus 25 ~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~ 104 (423)
...++.||+.||.|||+.+++ ||||||+||+++.++.+||+|||++........ .......+++.|+|||++.+..+
T Consensus 102 ~~~~~~qi~~~L~~lH~~~i~-H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~- 178 (287)
T cd07848 102 VRSYIYQLIKAIHWCHKNDIV-HRDIKPENLLISHNDVLKLCDFGFARNLSEGSN-ANYTEYVATRWYRSPELLLGAPY- 178 (287)
T ss_pred HHHHHHHHHHHHHHHHHCCee-cCCCCHHHEEEcCCCcEEEeeccCccccccccc-ccccccccccccCCcHHHcCCCC-
Confidence 568999999999999999998 999999999999999999999999876532221 11233467889999999987654
Q ss_pred CCCCccchHHHHHHHHHHHhCCCCCCCCCCChHHHHHHHhcC---------------C----CCCCCCC---------CC
Q psy1840 105 RGTQKGDVYSFGLVLYEVIGRQGPWGHLRMTDEEIITSVTQG---------------S----GLRPDTS---------SL 156 (423)
Q Consensus 105 ~~s~ksDVyS~Giil~elltg~~Pf~~~~~~~~~i~~~i~~~---------------~----~~~p~~~---------~~ 156 (423)
+.++|||||||++|||++|+.||.... ..+....+... . ...|... ..
T Consensus 179 --~~~~DiwslGvil~el~~g~~pf~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (287)
T cd07848 179 --GKAVDMWSVGCILGELSDGQPLFPGES--EIDQLFTIQKVLGPLPAEQMKLFYSNPRFHGLRFPAVNHPQSLERRYLG 254 (287)
T ss_pred --CCchhHHhHHHHHHHHHhCCCCCCCCC--HHHHHHHHHHhhCCCCHHHHHhhhccchhcccccCcccCcccHHHhhhc
Confidence 889999999999999999999997532 11111111100 0 0001000 11
Q ss_pred CchHHHHHHHHHhhhcCCCCCCCHHHHHH
Q psy1840 157 DCAPSIIACMRTCWEEDPELRPDLRFVHH 185 (423)
Q Consensus 157 ~~~~~l~~Li~~C~~~dP~~RPt~~~I~~ 185 (423)
.++.++.+++++||+.||++|||+.++++
T Consensus 255 ~~s~~~~dll~~~L~~~P~~R~s~~~~l~ 283 (287)
T cd07848 255 ILSGVLLDLMKNLLKLNPTDRYLTEQCLN 283 (287)
T ss_pred ccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 35778999999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=99.92 E-value=5e-25 Score=216.24 Aligned_cols=144 Identities=22% Similarity=0.372 Sum_probs=118.0
Q ss_pred HHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCccEEEeccCCcccccCCCcccccccccCCccccCCccccCCCCC
Q psy1840 25 SISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKAPELLRQPHLP 104 (423)
Q Consensus 25 ~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~ 104 (423)
...++.||+.||.|||+.|++ ||||||+|||++.++.+||+|||++....... .......|++.|+|||++.+..+
T Consensus 103 ~~~~~~qi~~al~~lH~~~iv-H~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~- 178 (324)
T cd05587 103 AVFYAAEIAIGLFFLHSKGII-YRDLKLDNVMLDAEGHIKIADFGMCKENIFGG--KTTRTFCGTPDYIAPEIIAYQPY- 178 (324)
T ss_pred HHHHHHHHHHHHHHHHHCCeE-ecCCCHHHeEEcCCCCEEEeecCcceecCCCC--CceeeecCCccccChhhhcCCCC-
Confidence 578899999999999999998 99999999999999999999999976432111 11234568899999999987655
Q ss_pred CCCCccchHHHHHHHHHHHhCCCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCchHHHHHHHHHhhhcCCCCCCCH
Q psy1840 105 RGTQKGDVYSFGLVLYEVIGRQGPWGHLRMTDEEIITSVTQGSGLRPDTSSLDCAPSIIACMRTCWEEDPELRPDL 180 (423)
Q Consensus 105 ~~s~ksDVyS~Giil~elltg~~Pf~~~~~~~~~i~~~i~~~~~~~p~~~~~~~~~~l~~Li~~C~~~dP~~RPt~ 180 (423)
+.++|||||||++|||++|+.||.. ....+....+.......| ..+++++.+++.+||..||.+|++.
T Consensus 179 --~~~~DiwslGvil~elltG~~pf~~--~~~~~~~~~i~~~~~~~~----~~~~~~~~~li~~~l~~~P~~R~~~ 246 (324)
T cd05587 179 --GKSVDWWAFGVLLYEMLAGQPPFDG--EDEDELFQSIMEHNVSYP----KSLSKEAVSICKGLLTKHPAKRLGC 246 (324)
T ss_pred --CcccchhhhHHHHHHHHhCCCCCCC--CCHHHHHHHHHcCCCCCC----CCCCHHHHHHHHHHhhcCHHHcCCC
Confidence 8899999999999999999999974 345666666665433222 2578899999999999999999986
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.2e-24 Score=207.19 Aligned_cols=160 Identities=28% Similarity=0.490 Sum_probs=116.6
Q ss_pred HHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCccEEEeccCCcccccCCCcccccccccCCccccCCccccCCCC-
Q psy1840 25 SISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKAPELLRQPHL- 103 (423)
Q Consensus 25 ~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~- 103 (423)
...++.|++.|+.|||+.+++ ||||||+||+++.++.+||+|||++................++..|+|||++.+...
T Consensus 102 ~~~~~~qi~~al~~lH~~~i~-H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~ 180 (269)
T cd05087 102 LQRMACEIALGLLHLHKNNFI-HSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWIAPELVDEVHGN 180 (269)
T ss_pred HHHHHHHHHHHHHHHHHCCEe-ccccCcceEEEcCCCcEEECCccccccccCcceeecCCCcCCcccccCHhHhcccccc
Confidence 467899999999999999988 999999999999999999999999865432221111223456778999999864321
Q ss_pred ---CCCCCccchHHHHHHHHHHHh-CCCCCCCCCCChHHHHHHHhcCCCC--CCCCCCCCchHHHHHHHHHhhhcCCCCC
Q psy1840 104 ---PRGTQKGDVYSFGLVLYEVIG-RQGPWGHLRMTDEEIITSVTQGSGL--RPDTSSLDCAPSIIACMRTCWEEDPELR 177 (423)
Q Consensus 104 ---~~~s~ksDVyS~Giil~ellt-g~~Pf~~~~~~~~~i~~~i~~~~~~--~p~~~~~~~~~~l~~Li~~C~~~dP~~R 177 (423)
...+.++|+||||+++|||++ |..||... ...+........... ..+......+..+.+++++|| .+|++|
T Consensus 181 ~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~-~~P~~R 257 (269)
T cd05087 181 LLVVDQTKESNVWSLGVTIWELFELGSQPYRHL--SDEQVLTYTVREQQLKLPKPRLKLPLSDRWYEVMQFCW-LQPEQR 257 (269)
T ss_pred ccccCCCccchhHHHHHHHHHHHhCCCCCCCCC--ChHHHHHHHhhcccCCCCCCccCCCCChHHHHHHHHHh-cCcccC
Confidence 124789999999999999996 99999643 223332222221111 111112346788999999999 689999
Q ss_pred CCHHHHHHHHH
Q psy1840 178 PDLRFVHHKLK 188 (423)
Q Consensus 178 Pt~~~I~~~L~ 188 (423)
||+.+|+..|.
T Consensus 258 pt~~~l~~~l~ 268 (269)
T cd05087 258 PSAEEVHLLLS 268 (269)
T ss_pred CCHHHHHHHhc
Confidence 99999987763
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=99.92 E-value=3.5e-25 Score=217.94 Aligned_cols=147 Identities=20% Similarity=0.245 Sum_probs=120.3
Q ss_pred HHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCccEEEeccCCcccccCCCcccccccccCCccccCCccccCCCCC
Q psy1840 25 SISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKAPELLRQPHLP 104 (423)
Q Consensus 25 ~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~ 104 (423)
...++.||+.||.|||++|++ ||||||+||+++.++.+||+|||++....... ....|++.|+|||.+.+..+
T Consensus 120 ~~~~~~qi~~aL~~LH~~~iv-H~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~-----~~~~gt~~y~aPE~~~~~~~- 192 (329)
T PTZ00263 120 AKFYHAELVLAFEYLHSKDII-YRDLKPENLLLDNKGHVKVTDFGFAKKVPDRT-----FTLCGTPEYLAPEVIQSKGH- 192 (329)
T ss_pred HHHHHHHHHHHHHHHHHCCee-ecCCCHHHEEECCCCCEEEeeccCceEcCCCc-----ceecCChhhcCHHHHcCCCC-
Confidence 457889999999999999998 99999999999999999999999987543221 23568899999999987655
Q ss_pred CCCCccchHHHHHHHHHHHhCCCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCchHHHHHHHHHhhhcCCCCCCC-----
Q psy1840 105 RGTQKGDVYSFGLVLYEVIGRQGPWGHLRMTDEEIITSVTQGSGLRPDTSSLDCAPSIIACMRTCWEEDPELRPD----- 179 (423)
Q Consensus 105 ~~s~ksDVyS~Giil~elltg~~Pf~~~~~~~~~i~~~i~~~~~~~p~~~~~~~~~~l~~Li~~C~~~dP~~RPt----- 179 (423)
+.++|||||||++|||++|..||.. ....+..+.+..+....| ..++..+.+++.+||+.||.+||+
T Consensus 193 --~~~~DiwslG~il~elltg~~pf~~--~~~~~~~~~i~~~~~~~p----~~~~~~~~~li~~~L~~dP~~R~~~~~~~ 264 (329)
T PTZ00263 193 --GKAVDWWTMGVLLYEFIAGYPPFFD--DTPFRIYEKILAGRLKFP----NWFDGRARDLVKGLLQTDHTKRLGTLKGG 264 (329)
T ss_pred --CCcceeechHHHHHHHHcCCCCCCC--CCHHHHHHHHhcCCcCCC----CCCCHHHHHHHHHHhhcCHHHcCCCCCCC
Confidence 8899999999999999999999964 345566666666543322 246789999999999999999996
Q ss_pred HHHHHHH
Q psy1840 180 LRFVHHK 186 (423)
Q Consensus 180 ~~~I~~~ 186 (423)
+.+++..
T Consensus 265 ~~~ll~h 271 (329)
T PTZ00263 265 VADVKNH 271 (329)
T ss_pred HHHHhcC
Confidence 5666543
|
|
| >KOG0616|consensus | Back alignment and domain information |
|---|
Probab=99.92 E-value=3.5e-25 Score=204.62 Aligned_cols=144 Identities=21% Similarity=0.326 Sum_probs=125.7
Q ss_pred CCCChHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCccEEEeccCCcccccCCCcccccccccCCccccCCcc
Q psy1840 18 PFNIPIGSISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKAPEL 97 (423)
Q Consensus 18 ~~~~p~~~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~ 97 (423)
+|+.|.. .-.+.||+.|++|||+.+|+ +|||||+|||+|.+|.+||+|||+++...+. +.+.+||+.|+|||+
T Consensus 140 rF~e~~a-rFYAAeivlAleylH~~~ii-YRDLKPENiLlD~~G~iKitDFGFAK~v~~r-----T~TlCGTPeYLAPEi 212 (355)
T KOG0616|consen 140 RFSEPHA-RFYAAEIVLALEYLHSLDII-YRDLKPENLLLDQNGHIKITDFGFAKRVSGR-----TWTLCGTPEYLAPEI 212 (355)
T ss_pred CCCchhH-HHHHHHHHHHHHHHHhcCee-eccCChHHeeeccCCcEEEEeccceEEecCc-----EEEecCCccccChHH
Confidence 3555443 35789999999999999998 9999999999999999999999999876433 467899999999999
Q ss_pred ccCCCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCchHHHHHHHHHhhhcCCCCC
Q psy1840 98 LRQPHLPRGTQKGDVYSFGLVLYEVIGRQGPWGHLRMTDEEIITSVTQGSGLRPDTSSLDCAPSIIACMRTCWEEDPELR 177 (423)
Q Consensus 98 l~~~~~~~~s~ksDVyS~Giil~elltg~~Pf~~~~~~~~~i~~~i~~~~~~~p~~~~~~~~~~l~~Li~~C~~~dP~~R 177 (423)
+..+.+ +.++|-|||||++|||+.|..||.. .++-.+.++|..++...|.. .++++.+|+...++.|-.+|
T Consensus 213 i~sk~y---nkavDWWalGVLIYEMlaG~pPF~~--~~~~~iY~KI~~~~v~fP~~----fs~~~kdLl~~LL~vD~t~R 283 (355)
T KOG0616|consen 213 IQSKGY---NKAVDWWALGVLIYEMLAGYPPFYD--DNPIQIYEKILEGKVKFPSY----FSSDAKDLLKKLLQVDLTKR 283 (355)
T ss_pred hhcCCC---CcchhHHHHHHHHHHHHcCCCCCcC--CChHHHHHHHHhCcccCCcc----cCHHHHHHHHHHHhhhhHhh
Confidence 998876 8999999999999999999999974 44578899999988776653 67899999999999999988
|
|
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=99.92 E-value=9.8e-25 Score=212.09 Aligned_cols=162 Identities=28% Similarity=0.456 Sum_probs=125.3
Q ss_pred HHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCccEEEeccCCcccccCCCcccccccccCCccccCCccccCCCCC
Q psy1840 25 SISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKAPELLRQPHLP 104 (423)
Q Consensus 25 ~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~ 104 (423)
.+.++.|++.|++|||+.|++ ||||||+||+++.++.+||+|||++...... ........+..|+|||.+.+..+
T Consensus 126 ~~~~~~qi~~al~~LH~~gi~-H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~- 200 (303)
T cd05088 126 LLHFAADVARGMDYLSQKQFI-HRDLAARNILVGENYVAKIADFGLSRGQEVY---VKKTMGRLPVRWMAIESLNYSVY- 200 (303)
T ss_pred HHHHHHHHHHHHHHHHhCCcc-ccccchheEEecCCCcEEeCccccCcccchh---hhcccCCCcccccCHHHHhccCC-
Confidence 678999999999999999998 9999999999999999999999997532111 11111223456999998876544
Q ss_pred CCCCccchHHHHHHHHHHHh-CCCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCchHHHHHHHHHhhhcCCCCCCCHHHH
Q psy1840 105 RGTQKGDVYSFGLVLYEVIG-RQGPWGHLRMTDEEIITSVTQGSGLRPDTSSLDCAPSIIACMRTCWEEDPELRPDLRFV 183 (423)
Q Consensus 105 ~~s~ksDVyS~Giil~ellt-g~~Pf~~~~~~~~~i~~~i~~~~~~~p~~~~~~~~~~l~~Li~~C~~~dP~~RPt~~~I 183 (423)
+.++|||||||++||+++ |..||.. .+..+....+..+. .+. ....+++++.+++.+||+.+|++||++.++
T Consensus 201 --~~~~Di~slG~il~ellt~g~~p~~~--~~~~~~~~~~~~~~--~~~-~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i 273 (303)
T cd05088 201 --TTNSDVWSYGVLLWEIVSLGGTPYCG--MTCAELYEKLPQGY--RLE-KPLNCDDEVYDLMRQCWREKPYERPSFAQI 273 (303)
T ss_pred --cccccchhhhhHHHHHHhcCCCCccc--CChHHHHHHHhcCC--cCC-CCCCCCHHHHHHHHHHcCCChhhCcCHHHH
Confidence 889999999999999998 9999964 33345555554331 111 123467899999999999999999999999
Q ss_pred HHHHHHHhhhcCCCh
Q psy1840 184 HHKLKEMNAGLKANI 198 (423)
Q Consensus 184 ~~~L~~i~~~~~~~~ 198 (423)
+..+..+....+...
T Consensus 274 l~~l~~~~~~~~~~~ 288 (303)
T cd05088 274 LVSLNRMLEERKTYV 288 (303)
T ss_pred HHHHHHHHHhhhhhh
Confidence 999988876654433
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=99.92 E-value=4.1e-25 Score=216.76 Aligned_cols=144 Identities=22% Similarity=0.379 Sum_probs=118.9
Q ss_pred HHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCccEEEeccCCcccccCCCcccccccccCCccccCCccccCCCCC
Q psy1840 25 SISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKAPELLRQPHLP 104 (423)
Q Consensus 25 ~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~ 104 (423)
...++.||+.||.|||+.|++ ||||||+|||++.++.+||+|||+++...... .......|++.|+|||++.+..+
T Consensus 103 ~~~~~~qi~~aL~~LH~~~iv-HrDlkp~Nill~~~~~~kL~DfG~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~- 178 (323)
T cd05616 103 AVFYAAEIAIGLFFLHSKGII-YRDLKLDNVMLDSEGHIKIADFGMCKENMWDG--VTTKTFCGTPDYIAPEIIAYQPY- 178 (323)
T ss_pred HHHHHHHHHHHHHHHHHCCEE-ecCCCHHHeEECCCCcEEEccCCCceecCCCC--CccccCCCChhhcCHHHhcCCCC-
Confidence 678999999999999999988 99999999999999999999999986432111 12234568899999999987655
Q ss_pred CCCCccchHHHHHHHHHHHhCCCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCchHHHHHHHHHhhhcCCCCCCCH
Q psy1840 105 RGTQKGDVYSFGLVLYEVIGRQGPWGHLRMTDEEIITSVTQGSGLRPDTSSLDCAPSIIACMRTCWEEDPELRPDL 180 (423)
Q Consensus 105 ~~s~ksDVyS~Giil~elltg~~Pf~~~~~~~~~i~~~i~~~~~~~p~~~~~~~~~~l~~Li~~C~~~dP~~RPt~ 180 (423)
+.++|||||||++|||++|+.||.. ....++...+.......| ...+.++.+++.+|++.+|++|++.
T Consensus 179 --~~~~DiwSlGvil~elltg~~Pf~~--~~~~~~~~~i~~~~~~~p----~~~s~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05616 179 --GKSVDWWAFGVLLYEMLAGQAPFEG--EDEDELFQSIMEHNVAYP----KSMSKEAVAICKGLMTKHPGKRLGC 246 (323)
T ss_pred --CCccchhchhHHHHHHHhCCCCCCC--CCHHHHHHHHHhCCCCCC----CcCCHHHHHHHHHHcccCHHhcCCC
Confidence 8999999999999999999999974 345666666665443333 2578899999999999999999985
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=99.92 E-value=6.4e-25 Score=215.46 Aligned_cols=149 Identities=21% Similarity=0.322 Sum_probs=119.7
Q ss_pred HHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCccEEEeccCCcccccCCCcccccccccCCccccCCccccCCCCC
Q psy1840 25 SISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKAPELLRQPHLP 104 (423)
Q Consensus 25 ~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~ 104 (423)
...++.||+.||.|||+.|++ ||||||+||+++.++.+||+|||+++...... .......|++.|+|||++.+...
T Consensus 102 ~~~~~~qi~~~l~~lH~~~iv-H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~- 177 (323)
T cd05584 102 ACFYLSEISLALEHLHQQGII-YRDLKPENILLDAQGHVKLTDFGLCKESIHEG--TVTHTFCGTIEYMAPEILMRSGH- 177 (323)
T ss_pred HHHHHHHHHHHHHHHHHCCee-cCCCCHHHeEECCCCCEEEeeCcCCeecccCC--CcccccCCCccccChhhccCCCC-
Confidence 457889999999999999998 99999999999999999999999986432221 11234568899999999987654
Q ss_pred CCCCccchHHHHHHHHHHHhCCCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCchHHHHHHHHHhhhcCCCCCC-----C
Q psy1840 105 RGTQKGDVYSFGLVLYEVIGRQGPWGHLRMTDEEIITSVTQGSGLRPDTSSLDCAPSIIACMRTCWEEDPELRP-----D 179 (423)
Q Consensus 105 ~~s~ksDVyS~Giil~elltg~~Pf~~~~~~~~~i~~~i~~~~~~~p~~~~~~~~~~l~~Li~~C~~~dP~~RP-----t 179 (423)
+.++|||||||++|||++|+.||.. .........+..+....| ..+++.+.+++.+||+.+|++|| +
T Consensus 178 --~~~~DiwslG~il~ell~G~~pf~~--~~~~~~~~~~~~~~~~~~----~~~~~~~~~li~~~l~~~p~~R~~~~~~~ 249 (323)
T cd05584 178 --GKAVDWWSLGALMYDMLTGAPPFTA--ENRKKTIDKILKGKLNLP----PYLTPEARDLLKKLLKRNPSSRLGAGPGD 249 (323)
T ss_pred --CCcceecccHHHHHHHhcCCCCCCC--CCHHHHHHHHHcCCCCCC----CCCCHHHHHHHHHHcccCHhHcCCCCCCC
Confidence 7899999999999999999999974 334555566655433222 24678999999999999999999 7
Q ss_pred HHHHHH
Q psy1840 180 LRFVHH 185 (423)
Q Consensus 180 ~~~I~~ 185 (423)
..++++
T Consensus 250 ~~~l~~ 255 (323)
T cd05584 250 AAEVQS 255 (323)
T ss_pred HHHHhc
Confidence 777655
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >KOG0194|consensus | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.9e-25 Score=224.22 Aligned_cols=162 Identities=26% Similarity=0.461 Sum_probs=130.8
Q ss_pred HHHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCccEEEeccCCcccccCCCcccccccccCCccccCCccccCCCC
Q psy1840 24 GSISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKAPELLRQPHL 103 (423)
Q Consensus 24 ~~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~ 103 (423)
+++.++.+.+.||+|||++++| ||||-.+|||++.++.+||+|||+++... . .........-...|+|||.+..+.+
T Consensus 263 ek~~~~~~AA~Gl~YLh~k~~I-HRDIAARNcL~~~~~~vKISDFGLs~~~~-~-~~~~~~~~klPirWLAPEtl~~~~~ 339 (474)
T KOG0194|consen 263 EKLRFCYDAARGLEYLHSKNCI-HRDIAARNCLYSKKGVVKISDFGLSRAGS-Q-YVMKKFLKKLPIRWLAPETLNTGIF 339 (474)
T ss_pred HHHHHHHHHHhHHHHHHHCCCc-chhHhHHHheecCCCeEEeCccccccCCc-c-eeeccccccCcceecChhhhccCcc
Confidence 4899999999999999999999 99999999999999999999999987543 1 1111111123456999999988755
Q ss_pred CCCCCccchHHHHHHHHHHHh-CCCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCchHHHHHHHHHhhhcCCCCCCCHHH
Q psy1840 104 PRGTQKGDVYSFGLVLYEVIG-RQGPWGHLRMTDEEIITSVTQGSGLRPDTSSLDCAPSIIACMRTCWEEDPELRPDLRF 182 (423)
Q Consensus 104 ~~~s~ksDVyS~Giil~ellt-g~~Pf~~~~~~~~~i~~~i~~~~~~~p~~~~~~~~~~l~~Li~~C~~~dP~~RPt~~~ 182 (423)
+.++|||||||++||+++ |..||. .+...++...+.......+ . +...+..+..++.+||..+|++||+|.+
T Consensus 340 ---s~kTDV~sfGV~~~Eif~~g~~Py~--g~~~~~v~~kI~~~~~r~~-~-~~~~p~~~~~~~~~c~~~~p~~R~tm~~ 412 (474)
T KOG0194|consen 340 ---SFKTDVWSFGVLLWEIFENGAEPYP--GMKNYEVKAKIVKNGYRMP-I-PSKTPKELAKVMKQCWKKDPEDRPTMST 412 (474)
T ss_pred ---ccccchhheeeeEEeeeccCCCCCC--CCCHHHHHHHHHhcCccCC-C-CCCCHHHHHHHHHHhccCChhhccCHHH
Confidence 999999999999999998 788997 4566788888844322222 1 2257889999999999999999999999
Q ss_pred HHHHHHHHhhhcC
Q psy1840 183 VHHKLKEMNAGLK 195 (423)
Q Consensus 183 I~~~L~~i~~~~~ 195 (423)
+.+.++.+.....
T Consensus 413 i~~~l~~~~~~~~ 425 (474)
T KOG0194|consen 413 IKKKLEALEKKKE 425 (474)
T ss_pred HHHHHHHHHhccc
Confidence 9999998876543
|
|
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.3e-24 Score=207.14 Aligned_cols=157 Identities=25% Similarity=0.476 Sum_probs=123.3
Q ss_pred HHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCccEEEeccCCcccccCCCcccccccccCCccccCCccccCCCCC
Q psy1840 25 SISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKAPELLRQPHLP 104 (423)
Q Consensus 25 ~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~ 104 (423)
...++.|++.|++|||+++++ ||||||+||+++.++.+||+|||+++...............++..|++||.+.+...
T Consensus 115 ~~~~~~~i~~~l~~lH~~~i~-H~dikp~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~- 192 (273)
T cd05074 115 LVRFMIDIASGMEYLSSKNFI-HRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKLPVKWLALESLADNVY- 192 (273)
T ss_pred HHHHHHHHHHHHHHHHhCCEe-ecccchhhEEEcCCCCEEECcccccccccCCcceecCCCccCchhhcCHhHHhcCcc-
Confidence 578999999999999999987 999999999999999999999999875432221111122344567999999876654
Q ss_pred CCCCccchHHHHHHHHHHHh-CCCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCchHHHHHHHHHhhhcCCCCCCCHHHH
Q psy1840 105 RGTQKGDVYSFGLVLYEVIG-RQGPWGHLRMTDEEIITSVTQGSGLRPDTSSLDCAPSIIACMRTCWEEDPELRPDLRFV 183 (423)
Q Consensus 105 ~~s~ksDVyS~Giil~ellt-g~~Pf~~~~~~~~~i~~~i~~~~~~~p~~~~~~~~~~l~~Li~~C~~~dP~~RPt~~~I 183 (423)
+.++||||||+++|||++ |+.||.. ....++...+..+..... ...++..+.+++.+||+.+|++||++.++
T Consensus 193 --~~~sDi~slG~il~el~~~g~~p~~~--~~~~~~~~~~~~~~~~~~---~~~~~~~~~~l~~~~l~~~p~~Rps~~~~ 265 (273)
T cd05074 193 --TTHSDVWAFGVTMWEIMTRGQTPYAG--VENSEIYNYLIKGNRLKQ---PPDCLEDVYELMCQCWSPEPKCRPSFQHL 265 (273)
T ss_pred --chhhhhHHHHHHHHHHhhCCCCCCCC--CCHHHHHHHHHcCCcCCC---CCCCCHHHHHHHHHHcCCChhhCcCHHHH
Confidence 789999999999999998 7888864 334455555554432221 13567899999999999999999999999
Q ss_pred HHHHHHH
Q psy1840 184 HHKLKEM 190 (423)
Q Consensus 184 ~~~L~~i 190 (423)
...|+.+
T Consensus 266 ~~~l~~~ 272 (273)
T cd05074 266 RDQLELI 272 (273)
T ss_pred HHHHHhh
Confidence 9998764
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=99.92 E-value=4.4e-25 Score=214.31 Aligned_cols=157 Identities=17% Similarity=0.212 Sum_probs=115.5
Q ss_pred HHHHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCccEEEeccCCcccccCCCcccccccccCCccccCCccccCCC
Q psy1840 23 IGSISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKAPELLRQPH 102 (423)
Q Consensus 23 ~~~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~ 102 (423)
.....++.||+.||.|||+.|++ ||||||+||+++.++.+||+|||++....... .......+++.|+|||++.+..
T Consensus 103 ~~~~~~~~qi~~al~~lH~~~iv-H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~ 179 (303)
T cd07869 103 ENVKLFLFQLLRGLSYIHQRYIL-HRDLKPQNLLISDTGELKLADFGLARAKSVPS--HTYSNEVVTLWYRPPDVLLGST 179 (303)
T ss_pred HHHHHHHHHHHHHHHHHHHCCee-cCCCCHHHEEECCCCCEEECCCCcceeccCCC--ccCCCCcccCCCCChHHHcCCC
Confidence 33578899999999999999988 99999999999999999999999986543221 1123456788999999986543
Q ss_pred CCCCCCccchHHHHHHHHHHHhCCCCCCCCCCChHHHHHHHhc--CC-------------CCCCCC-------------C
Q psy1840 103 LPRGTQKGDVYSFGLVLYEVIGRQGPWGHLRMTDEEIITSVTQ--GS-------------GLRPDT-------------S 154 (423)
Q Consensus 103 ~~~~s~ksDVyS~Giil~elltg~~Pf~~~~~~~~~i~~~i~~--~~-------------~~~p~~-------------~ 154 (423)
..+.++||||+||++|||++|..||.+... ..+.+..+.. +. ...+.. .
T Consensus 180 --~~~~~~DiwslG~il~~l~~g~~pf~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (303)
T cd07869 180 --EYSTCLDMWGVGCIFVEMIQGVAAFPGMKD-IQDQLERIFLVLGTPNEDTWPGVHSLPHFKPERFTLYSPKNLRQAWN 256 (303)
T ss_pred --CCCcHHHHHHHHHHHHHHHhCCCCCCCCcc-HHHHHHHHHHHhCCCChhhccchhhccccccccccccCCccHHHHhh
Confidence 237889999999999999999999975432 2222222211 00 000000 0
Q ss_pred CCCchHHHHHHHHHhhhcCCCCCCCHHHHHH
Q psy1840 155 SLDCAPSIIACMRTCWEEDPELRPDLRFVHH 185 (423)
Q Consensus 155 ~~~~~~~l~~Li~~C~~~dP~~RPt~~~I~~ 185 (423)
....+..+.+++.+||+.||.+|||+.++++
T Consensus 257 ~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~ 287 (303)
T cd07869 257 KLSYVNHAEDLASKLLQCFPKNRLSAQAALS 287 (303)
T ss_pred ccCCChHHHHHHHHHhccCchhccCHHHHhc
Confidence 1123467889999999999999999999876
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.5e-24 Score=207.54 Aligned_cols=174 Identities=17% Similarity=0.329 Sum_probs=134.2
Q ss_pred HHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCccEEEeccCCcccccCCCcccccccccCCccccCCccccCCCCC
Q psy1840 25 SISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKAPELLRQPHLP 104 (423)
Q Consensus 25 ~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~ 104 (423)
...++.|++.|+.|||+++++ |+||+|+||+++.++.++|+|||++........ ......++..|+|||.+.+..+
T Consensus 103 ~~~~~~~i~~~l~~lH~~~iv-H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~- 178 (277)
T cd06642 103 IATILREILKGLDYLHSERKI-HRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI--KRNTFVGTPFWMAPEVIKQSAY- 178 (277)
T ss_pred HHHHHHHHHHHHHHHhcCCee-ccCCChheEEEeCCCCEEEccccccccccCcch--hhhcccCcccccCHHHhCcCCC-
Confidence 568899999999999999998 999999999999999999999999876533211 1123456788999999987654
Q ss_pred CCCCccchHHHHHHHHHHHhCCCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCchHHHHHHHHHhhhcCCCCCCCHHHHH
Q psy1840 105 RGTQKGDVYSFGLVLYEVIGRQGPWGHLRMTDEEIITSVTQGSGLRPDTSSLDCAPSIIACMRTCWEEDPELRPDLRFVH 184 (423)
Q Consensus 105 ~~s~ksDVyS~Giil~elltg~~Pf~~~~~~~~~i~~~i~~~~~~~p~~~~~~~~~~l~~Li~~C~~~dP~~RPt~~~I~ 184 (423)
+.++||||||+++||+++|..||... ........+..+. .+. ....++.++.+++.+||+.+|++||++.+++
T Consensus 179 --~~~~Dv~slG~il~el~tg~~p~~~~--~~~~~~~~~~~~~--~~~-~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il 251 (277)
T cd06642 179 --DFKADIWSLGITAIELAKGEPPNSDL--HPMRVLFLIPKNS--PPT-LEGQYSKPFKEFVEACLNKDPRFRPTAKELL 251 (277)
T ss_pred --chhhhHHHHHHHHHHHHhCCCCCccc--chhhHHhhhhcCC--CCC-CCcccCHHHHHHHHHHccCCcccCcCHHHHH
Confidence 88999999999999999999998632 2233333332221 222 2235788999999999999999999999999
Q ss_pred HHHHHHhhhcCCChHHHHHHHHHHh
Q psy1840 185 HKLKEMNAGLKANIFDNMLAIMEKY 209 (423)
Q Consensus 185 ~~L~~i~~~~~~~~~d~~~~~~e~~ 209 (423)
..-.-.....+.+...++..++++|
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~ 276 (277)
T cd06642 252 KHKFITRYTKKTSFLTELIDRYKRW 276 (277)
T ss_pred HhHHHHHHhhhHHHHHHHHHHhhcc
Confidence 8654444455667777787777665
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.3e-24 Score=219.61 Aligned_cols=159 Identities=21% Similarity=0.377 Sum_probs=124.8
Q ss_pred HHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCccEEEeccCCcccccCCCcccccccccCCccccCCccccCCCCC
Q psy1840 25 SISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKAPELLRQPHLP 104 (423)
Q Consensus 25 ~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~ 104 (423)
.++++.|++.||.|||+.+++ ||||||+||+++.++.+||+|||+++...............++..|+|||.+.+..+
T Consensus 239 ~~~~~~qi~~aL~~LH~~~iv-H~dikp~Nill~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~- 316 (400)
T cd05105 239 LLSFTYQVARGMEFLASKNCV-HRDLAARNVLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLY- 316 (400)
T ss_pred HHHHHHHHHHHHHHHHhCCee-CCCCChHhEEEeCCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCC-
Confidence 578999999999999999988 999999999999999999999999875533222222223345677999999877654
Q ss_pred CCCCccchHHHHHHHHHHHh-CCCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCchHHHHHHHHHhhhcCCCCCCCHHHH
Q psy1840 105 RGTQKGDVYSFGLVLYEVIG-RQGPWGHLRMTDEEIITSVTQGSGLRPDTSSLDCAPSIIACMRTCWEEDPELRPDLRFV 183 (423)
Q Consensus 105 ~~s~ksDVyS~Giil~ellt-g~~Pf~~~~~~~~~i~~~i~~~~~~~p~~~~~~~~~~l~~Li~~C~~~dP~~RPt~~~I 183 (423)
+.++|||||||++|||++ |..||.... ....+...+..+. ++. ....++..+.+++.+||+.+|++||++.+|
T Consensus 317 --~~~~DiwSlGvil~ellt~g~~P~~~~~-~~~~~~~~~~~~~--~~~-~~~~~~~~l~~li~~cl~~dP~~RPt~~~l 390 (400)
T cd05105 317 --TTLSDVWSYGILLWEIFSLGGTPYPGMI-VDSTFYNKIKSGY--RMA-KPDHATQEVYDIMVKCWNSEPEKRPSFLHL 390 (400)
T ss_pred --CchhhHHHHHHHHHHHHHCCCCCCcccc-hhHHHHHHHhcCC--CCC-CCccCCHHHHHHHHHHCccCHhHCcCHHHH
Confidence 889999999999999997 889986432 2233444444432 222 123578899999999999999999999999
Q ss_pred HHHHHHHh
Q psy1840 184 HHKLKEMN 191 (423)
Q Consensus 184 ~~~L~~i~ 191 (423)
.+.|+++.
T Consensus 391 ~~~l~~l~ 398 (400)
T cd05105 391 SDIVESLL 398 (400)
T ss_pred HHHHHHHc
Confidence 99988764
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.92 E-value=5.7e-25 Score=216.60 Aligned_cols=151 Identities=21% Similarity=0.232 Sum_probs=121.2
Q ss_pred HHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCccEEEeccCCcccccCCCcccccccccCCccccCCccccCCCCC
Q psy1840 25 SISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKAPELLRQPHLP 104 (423)
Q Consensus 25 ~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~ 104 (423)
...++.||+.||.|||+.|++ ||||||+||+++.++.+||+|||++..... ......|++.|+|||++.+..+
T Consensus 103 ~~~~~~qi~~~l~~lH~~~iv-H~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~-----~~~~~~gt~~y~aPE~~~~~~~- 175 (333)
T cd05600 103 ARFYMAEMFEAVDALHELGYI-HRDLKPENFLIDASGHIKLTDFGLSKGIVT-----YANSVVGSPDYMAPEVLRGKGY- 175 (333)
T ss_pred HHHHHHHHHHHHHHHHHCCcc-ccCCCHHHEEECCCCCEEEEeCcCCccccc-----ccCCcccCccccChhHhcCCCC-
Confidence 567899999999999999998 999999999999999999999999875432 2234568899999999987654
Q ss_pred CCCCccchHHHHHHHHHHHhCCCCCCCCCCChHHHHHHHhcCCC--CCCCC--CCCCchHHHHHHHHHhhhcCCCCCCCH
Q psy1840 105 RGTQKGDVYSFGLVLYEVIGRQGPWGHLRMTDEEIITSVTQGSG--LRPDT--SSLDCAPSIIACMRTCWEEDPELRPDL 180 (423)
Q Consensus 105 ~~s~ksDVyS~Giil~elltg~~Pf~~~~~~~~~i~~~i~~~~~--~~p~~--~~~~~~~~l~~Li~~C~~~dP~~RPt~ 180 (423)
+.++|||||||++|||++|..||.. .+..+....+..... ..|.. ....++.++.+++.+||..+|++||++
T Consensus 176 --~~~~DvwslG~il~ell~g~~pf~~--~~~~~~~~~i~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~~~~rr~s~ 251 (333)
T cd05600 176 --DFTVDYWSLGCMLYEFLCGFPPFSG--STPNETWENLKYWKETLQRPVYDDPRFNLSDEAWDLITKLINDPSRRFGSL 251 (333)
T ss_pred --CCccceecchHHHhhhhhCCCCCCC--CCHHHHHHHHHhccccccCCCCCccccccCHHHHHHHHHHhhChhhhcCCH
Confidence 8999999999999999999999974 344555555443221 11111 112568899999999999999999999
Q ss_pred HHHHHH
Q psy1840 181 RFVHHK 186 (423)
Q Consensus 181 ~~I~~~ 186 (423)
.++++.
T Consensus 252 ~~ll~h 257 (333)
T cd05600 252 EDIKNH 257 (333)
T ss_pred HHHHhC
Confidence 998764
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >KOG4257|consensus | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.4e-25 Score=222.34 Aligned_cols=168 Identities=20% Similarity=0.412 Sum_probs=137.5
Q ss_pred HHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCccEEEeccCCcccccCCCcccccccccCCccccCCccccCCCCC
Q psy1840 25 SISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKAPELLRQPHLP 104 (423)
Q Consensus 25 ~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~ 104 (423)
-+..+.||+.+|.|||++.++ ||||..+|||+.+...|||+|||+++...+....... ...-..-|||||.+.-..+
T Consensus 493 L~ly~~Qi~talaYLeSkrfV-HRDIAaRNiLVsSp~CVKLaDFGLSR~~ed~~yYkaS-~~kLPIKWmaPESINfRrF- 569 (974)
T KOG4257|consen 493 LTLYCYQICTALAYLESKRFV-HRDIAARNILVSSPQCVKLADFGLSRYLEDDAYYKAS-RGKLPIKWMAPESINFRRF- 569 (974)
T ss_pred HHHHHHHHHHHHHHHHhhchh-hhhhhhhheeecCcceeeecccchhhhccccchhhcc-ccccceeecCccccchhcc-
Confidence 367899999999999999998 9999999999999999999999999988765544322 2233445999999876655
Q ss_pred CCCCccchHHHHHHHHHHHh-CCCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCchHHHHHHHHHhhhcCCCCCCCHHHH
Q psy1840 105 RGTQKGDVYSFGLVLYEVIG-RQGPWGHLRMTDEEIITSVTQGSGLRPDTSSLDCAPSIIACMRTCWEEDPELRPDLRFV 183 (423)
Q Consensus 105 ~~s~ksDVyS~Giil~ellt-g~~Pf~~~~~~~~~i~~~i~~~~~~~p~~~~~~~~~~l~~Li~~C~~~dP~~RPt~~~I 183 (423)
+.++|||-||+.+||++. |..||.+.. ..+++-.+++|.. ++.+ .+||+.+..||.+||+++|.+||+|.+|
T Consensus 570 --TtASDVWMFgVCmWEIl~lGvkPfqgvk--NsDVI~~iEnGeR--lP~P-~nCPp~LYslmskcWayeP~kRPrftei 642 (974)
T KOG4257|consen 570 --TTASDVWMFGVCMWEILSLGVKPFQGVK--NSDVIGHIENGER--LPCP-PNCPPALYSLMSKCWAYEPSKRPRFTEI 642 (974)
T ss_pred --cchhhHHHHHHHHHHHHHhcCCcccccc--ccceEEEecCCCC--CCCC-CCCChHHHHHHHHHhccCcccCCcHHHH
Confidence 999999999999999995 889998543 3456666776643 3332 3799999999999999999999999999
Q ss_pred HHHHHHHhhhcCCChHHHH
Q psy1840 184 HHKLKEMNAGLKANIFDNM 202 (423)
Q Consensus 184 ~~~L~~i~~~~~~~~~d~~ 202 (423)
...|.++...-+.+..+++
T Consensus 643 ~~~lsdv~qeek~~~~Eq~ 661 (974)
T KOG4257|consen 643 KAILSDVLQEEKINSSEQL 661 (974)
T ss_pred HHHHHHHHHHhhhhhHHHH
Confidence 9999998876666555554
|
|
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.3e-24 Score=205.87 Aligned_cols=153 Identities=25% Similarity=0.500 Sum_probs=121.2
Q ss_pred HHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCccEEEeccCCcccccCCCcccccccccCCccccCCccccCCCCC
Q psy1840 25 SISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKAPELLRQPHLP 104 (423)
Q Consensus 25 ~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~ 104 (423)
.++++.||+.||.|||+.|++ |+||||+||+++.++.+||+|||.++....... .......++..|+|||.+.+..+
T Consensus 102 ~~~~~~~i~~~l~~lH~~~i~-H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~-~~~~~~~~~~~y~~pe~~~~~~~- 178 (256)
T cd05113 102 LLEMCKDVCEGMAYLESKQFI-HRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEY-TSSVGSKFPVRWSPPEVLLYSKF- 178 (256)
T ss_pred HHHHHHHHHHHHHHHHhCCee-ccccCcceEEEcCCCCEEECCCccceecCCCce-eecCCCccChhhCCHHHHhcCcc-
Confidence 689999999999999999998 999999999999999999999999875432221 11122334567999999976554
Q ss_pred CCCCccchHHHHHHHHHHHh-CCCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCchHHHHHHHHHhhhcCCCCCCCHHHH
Q psy1840 105 RGTQKGDVYSFGLVLYEVIG-RQGPWGHLRMTDEEIITSVTQGSGLRPDTSSLDCAPSIIACMRTCWEEDPELRPDLRFV 183 (423)
Q Consensus 105 ~~s~ksDVyS~Giil~ellt-g~~Pf~~~~~~~~~i~~~i~~~~~~~p~~~~~~~~~~l~~Li~~C~~~dP~~RPt~~~I 183 (423)
+.++||||||+++|||++ |..||.. ....++...+..+.... .....+..+.+++.+||+.+|++||++.+|
T Consensus 179 --~~~~Di~slG~~l~~l~~~g~~p~~~--~~~~~~~~~~~~~~~~~---~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l 251 (256)
T cd05113 179 --SSKSDVWAFGVLMWEVYSLGKMPYER--FNNSETVEKVSQGLRLY---RPHLASEKVYAIMYSCWHEKAEERPTFQQL 251 (256)
T ss_pred --cchhHHHHHHHHHHHHhcCCCCCcCc--CCHHHHHHHHhcCCCCC---CCCCCCHHHHHHHHHHcCCCcccCCCHHHH
Confidence 889999999999999998 8899864 33455666665543221 122467899999999999999999999999
Q ss_pred HHHH
Q psy1840 184 HHKL 187 (423)
Q Consensus 184 ~~~L 187 (423)
+..+
T Consensus 252 l~~~ 255 (256)
T cd05113 252 LSSI 255 (256)
T ss_pred HHhh
Confidence 8765
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.8e-24 Score=204.91 Aligned_cols=155 Identities=30% Similarity=0.528 Sum_probs=122.8
Q ss_pred HHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCccEEEeccCCcccccCCCcccccccccCCccccCCccccCCCCC
Q psy1840 25 SISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKAPELLRQPHLP 104 (423)
Q Consensus 25 ~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~ 104 (423)
...++.|++.||.|||+++++ ||||||+||+++.++.+||+|||++......... ......++..|+|||.+.+...
T Consensus 104 ~~~~~~~l~~al~~lH~~~i~-H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~- 180 (260)
T cd05070 104 LVDMAAQVAAGMAYIERMNYI-HRDLRSANILVGDGLVCKIADFGLARLIEDNEYT-ARQGAKFPIKWTAPEAALYGRF- 180 (260)
T ss_pred HHHHHHHHHHHHHHHHHCCcc-cCCCccceEEEeCCceEEeCCceeeeeccCcccc-cccCCCCCccccChHHHhcCCC-
Confidence 679999999999999999988 9999999999999999999999998754322211 1122234567999998876544
Q ss_pred CCCCccchHHHHHHHHHHHh-CCCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCchHHHHHHHHHhhhcCCCCCCCHHHH
Q psy1840 105 RGTQKGDVYSFGLVLYEVIG-RQGPWGHLRMTDEEIITSVTQGSGLRPDTSSLDCAPSIIACMRTCWEEDPELRPDLRFV 183 (423)
Q Consensus 105 ~~s~ksDVyS~Giil~ellt-g~~Pf~~~~~~~~~i~~~i~~~~~~~p~~~~~~~~~~l~~Li~~C~~~dP~~RPt~~~I 183 (423)
+.++|+||||+++||+++ |..||.. ....+....+..+.. +.. ....+..+.+++.+||+.+|++|||+.++
T Consensus 181 --~~~~Di~slG~~l~~l~~~g~~p~~~--~~~~~~~~~~~~~~~--~~~-~~~~~~~~~~li~~~l~~~p~~Rpt~~~l 253 (260)
T cd05070 181 --TIKSDVWSFGILLTELVTKGRVPYPG--MNNREVLEQVERGYR--MPC-PQDCPISLHELMLQCWKKDPEERPTFEYL 253 (260)
T ss_pred --cchhhhHHHHHHHHHHHhcCCCCCCC--CCHHHHHHHHHcCCC--CCC-CCcCCHHHHHHHHHHcccCcccCcCHHHH
Confidence 889999999999999999 8889864 344556666654321 222 23578899999999999999999999999
Q ss_pred HHHHHH
Q psy1840 184 HHKLKE 189 (423)
Q Consensus 184 ~~~L~~ 189 (423)
.+.|+.
T Consensus 254 ~~~l~~ 259 (260)
T cd05070 254 QSFLED 259 (260)
T ss_pred HHHHhc
Confidence 988764
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=99.92 E-value=6.5e-25 Score=211.73 Aligned_cols=154 Identities=19% Similarity=0.210 Sum_probs=115.8
Q ss_pred HHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCccEEEeccCCcccccCCCcccccccccCCccccCCccccCCCCC
Q psy1840 25 SISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKAPELLRQPHLP 104 (423)
Q Consensus 25 ~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~ 104 (423)
...++.||+.||+|||+.|++ ||||||+||+++.++.+||+|||+++....... ......+++.|+|||.+.+..
T Consensus 105 ~~~~~~qi~~aL~~LH~~~iv-H~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~-- 179 (288)
T cd07871 105 VKIFMFQLLRGLSYCHKRKIL-HRDLKPQNLLINEKGELKLADFGLARAKSVPTK--TYSNEVVTLWYRPPDVLLGST-- 179 (288)
T ss_pred HHHHHHHHHHHHHHHHhCCcc-cCCCCHHHEEECCCCCEEECcCcceeeccCCCc--cccCceecccccChHHhcCCc--
Confidence 578899999999999999998 999999999999999999999999875432211 113345788899999987533
Q ss_pred CCCCccchHHHHHHHHHHHhCCCCCCCCCCChHHHHHHHhcCCC-------------------CCCCC-------CCCCc
Q psy1840 105 RGTQKGDVYSFGLVLYEVIGRQGPWGHLRMTDEEIITSVTQGSG-------------------LRPDT-------SSLDC 158 (423)
Q Consensus 105 ~~s~ksDVyS~Giil~elltg~~Pf~~~~~~~~~i~~~i~~~~~-------------------~~p~~-------~~~~~ 158 (423)
.++.++||||+||++|||++|+.||... +..+.+..+..... ..|.. .....
T Consensus 180 ~~~~~~DiwslG~~l~~l~~g~~pf~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (288)
T cd07871 180 EYSTPIDMWGVGCILYEMATGRPMFPGS--TVKEELHLIFRLLGTPTEETWPGITSNEEFRSYLFPQYRAQPLINHAPRL 257 (288)
T ss_pred ccCcHHHHHHHHHHHHHHHhCCCCCCCC--CHHHHHHHHHHHhCCCChHHhhccccchhhhccccCccCCCchHHhCCCC
Confidence 2388999999999999999999999743 22332222211000 00100 01245
Q ss_pred hHHHHHHHHHhhhcCCCCCCCHHHHHH
Q psy1840 159 APSIIACMRTCWEEDPELRPDLRFVHH 185 (423)
Q Consensus 159 ~~~l~~Li~~C~~~dP~~RPt~~~I~~ 185 (423)
+.++.+++.+|++.||.+|||+.++++
T Consensus 258 ~~~~~dll~~mL~~dp~~R~t~~~~l~ 284 (288)
T cd07871 258 DTDGIDLLSSLLLYETKSRISAEAALR 284 (288)
T ss_pred CHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence 778999999999999999999999875
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=99.92 E-value=5.7e-25 Score=216.38 Aligned_cols=153 Identities=19% Similarity=0.271 Sum_probs=118.8
Q ss_pred HHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCccEEEeccCCcccccCCCcccccccccCCccccCCccccCCCCC
Q psy1840 25 SISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKAPELLRQPHLP 104 (423)
Q Consensus 25 ~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~ 104 (423)
...++.||+.||.|||++|++ ||||||+|||++.++.+||+|||+++....... .......|+..|+|||.+.+..
T Consensus 107 ~~~~~~qi~~~l~~lH~~~iv-HrDlkp~Nili~~~~~~kl~DfG~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~-- 182 (332)
T cd05614 107 VRFYSGEIILALEHLHKLGIV-YRDIKLENILLDSEGHVVLTDFGLSKEFLSEEK-ERTYSFCGTIEYMAPEIIRGKG-- 182 (332)
T ss_pred HHHHHHHHHHHHHHHHHCCcE-ecCCCHHHeEECCCCCEEEeeCcCCccccccCC-CccccccCCccccCHHHhcCCC--
Confidence 567889999999999999998 999999999999999999999999875432221 1223456899999999987643
Q ss_pred CCCCccchHHHHHHHHHHHhCCCCCCCCC--CChHHHHHHHhcCCCCCCCCCCCCchHHHHHHHHHhhhcCCCCCC----
Q psy1840 105 RGTQKGDVYSFGLVLYEVIGRQGPWGHLR--MTDEEIITSVTQGSGLRPDTSSLDCAPSIIACMRTCWEEDPELRP---- 178 (423)
Q Consensus 105 ~~s~ksDVyS~Giil~elltg~~Pf~~~~--~~~~~i~~~i~~~~~~~p~~~~~~~~~~l~~Li~~C~~~dP~~RP---- 178 (423)
..+.++|||||||++|||++|..||.... .....+...+.......| ..+++.+.+++.+||+.||++||
T Consensus 183 ~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~li~~~l~~dp~~R~~~~~ 258 (332)
T cd05614 183 GHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRILKCDPPFP----SFIGPEAQDLLHKLLRKDPKKRLGAGP 258 (332)
T ss_pred CCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHHHHHhcCCCCCC----CCCCHHHHHHHHHHcCCCHHHcCCCCC
Confidence 23789999999999999999999996432 233444444444332222 24788999999999999999999
Q ss_pred -CHHHHHH
Q psy1840 179 -DLRFVHH 185 (423)
Q Consensus 179 -t~~~I~~ 185 (423)
++.++++
T Consensus 259 ~~~~~~l~ 266 (332)
T cd05614 259 QGASEIKE 266 (332)
T ss_pred CCHHHHHc
Confidence 6667654
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >KOG0200|consensus | Back alignment and domain information |
|---|
Probab=99.92 E-value=1e-24 Score=230.75 Aligned_cols=159 Identities=28% Similarity=0.459 Sum_probs=128.1
Q ss_pred HHHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCccEEEeccCCcccccCCCcccccccc-cCCccccCCccccCCC
Q psy1840 24 GSISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKL-RRRKLYKAPELLRQPH 102 (423)
Q Consensus 24 ~~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~-~gt~~y~APE~l~~~~ 102 (423)
+-++++.||+.||+||++++++ ||||..+|||+..+..+||+|||+++.............. .-...|||||.+....
T Consensus 419 dLlsfa~QIa~GMe~L~~~~~v-HRDLAaRNVLi~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ 497 (609)
T KOG0200|consen 419 DLLSFAYQIANGMEYLASVPCV-HRDLAARNVLITKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRV 497 (609)
T ss_pred HHHHHHHHHHHHHHHHhhCCcc-chhhhhhhEEecCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCc
Confidence 3589999999999999999988 9999999999999999999999999854433332211111 1123499999998855
Q ss_pred CCCCCCccchHHHHHHHHHHHh-CCCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCchHHHHHHHHHhhhcCCCCCCCHH
Q psy1840 103 LPRGTQKGDVYSFGLVLYEVIG-RQGPWGHLRMTDEEIITSVTQGSGLRPDTSSLDCAPSIIACMRTCWEEDPELRPDLR 181 (423)
Q Consensus 103 ~~~~s~ksDVyS~Giil~ellt-g~~Pf~~~~~~~~~i~~~i~~~~~~~p~~~~~~~~~~l~~Li~~C~~~dP~~RPt~~ 181 (423)
+ +.++|||||||++|||++ |..||.+.. ...++.+.+..|..... +..|+.++.++|+.||+.+|++||+|.
T Consensus 498 f---t~kSDVWSfGI~L~EifsLG~~PYp~~~-~~~~l~~~l~~G~r~~~---P~~c~~eiY~iM~~CW~~~p~~RP~F~ 570 (609)
T KOG0200|consen 498 F---TSKSDVWSFGILLWEIFTLGGTPYPGIP-PTEELLEFLKEGNRMEQ---PEHCSDEIYDLMKSCWNADPEDRPTFS 570 (609)
T ss_pred c---cccchhhHHHHHHHHHhhCCCCCCCCCC-cHHHHHHHHhcCCCCCC---CCCCCHHHHHHHHHHhCCCcccCCCHH
Confidence 5 999999999999999998 778997522 25667777877754332 236899999999999999999999999
Q ss_pred HHHHHHHHH
Q psy1840 182 FVHHKLKEM 190 (423)
Q Consensus 182 ~I~~~L~~i 190 (423)
++.+.+...
T Consensus 571 ~~~~~~~~~ 579 (609)
T KOG0200|consen 571 ECVEFFEKH 579 (609)
T ss_pred HHHHHHHHH
Confidence 999998874
|
|
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.6e-24 Score=205.43 Aligned_cols=155 Identities=28% Similarity=0.534 Sum_probs=122.5
Q ss_pred HHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCccEEEeccCCcccccCCCcccccccccCCccccCCccccCCCCC
Q psy1840 25 SISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKAPELLRQPHLP 104 (423)
Q Consensus 25 ~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~ 104 (423)
.+.++.|++.||.|||+.|++ ||||||+||+++.++.+||+|||++......... ......++..|+|||...+...
T Consensus 104 ~~~~~~~l~~al~~lH~~~i~-H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~~-~~~~~~~~~~y~~Pe~~~~~~~- 180 (260)
T cd05069 104 LVDMAAQIADGMAYIERMNYI-HRDLRAANILVGDNLVCKIADFGLARLIEDNEYT-ARQGAKFPIKWTAPEAALYGRF- 180 (260)
T ss_pred HHHHHHHHHHHHHHHHhCCEe-ecccCcceEEEcCCCeEEECCCccceEccCCccc-ccCCCccchhhCCHHHhccCCc-
Confidence 578999999999999999987 9999999999999999999999998765322211 1122345567999998876554
Q ss_pred CCCCccchHHHHHHHHHHHh-CCCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCchHHHHHHHHHhhhcCCCCCCCHHHH
Q psy1840 105 RGTQKGDVYSFGLVLYEVIG-RQGPWGHLRMTDEEIITSVTQGSGLRPDTSSLDCAPSIIACMRTCWEEDPELRPDLRFV 183 (423)
Q Consensus 105 ~~s~ksDVyS~Giil~ellt-g~~Pf~~~~~~~~~i~~~i~~~~~~~p~~~~~~~~~~l~~Li~~C~~~dP~~RPt~~~I 183 (423)
+.++||||||+++||+++ |..||.+ ....+....+..+. .+.. ....+..+.+++.+||..||++||++.+|
T Consensus 181 --~~~~Di~slG~~l~el~t~g~~p~~~--~~~~~~~~~~~~~~--~~~~-~~~~~~~~~~li~~~l~~~p~~Rp~~~~i 253 (260)
T cd05069 181 --TIKSDVWSFGILLTELVTKGRVPYPG--MVNREVLEQVERGY--RMPC-PQGCPESLHELMKLCWKKDPDERPTFEYI 253 (260)
T ss_pred --ChHHHHHHHHHHHHHHHhCCCCCCCC--CCHHHHHHHHHcCC--CCCC-CcccCHHHHHHHHHHccCCcccCcCHHHH
Confidence 889999999999999999 8889974 34455555555432 1211 23578899999999999999999999999
Q ss_pred HHHHHH
Q psy1840 184 HHKLKE 189 (423)
Q Consensus 184 ~~~L~~ 189 (423)
.+.|++
T Consensus 254 ~~~l~~ 259 (260)
T cd05069 254 QSFLED 259 (260)
T ss_pred HHHHhc
Confidence 998864
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=99.92 E-value=7.2e-25 Score=214.58 Aligned_cols=148 Identities=24% Similarity=0.339 Sum_probs=119.9
Q ss_pred HHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCccEEEeccCCcccccCCCcccccccccCCccccCCccccCCCCC
Q psy1840 25 SISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKAPELLRQPHLP 104 (423)
Q Consensus 25 ~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~ 104 (423)
...++.|++.||.|||++|++ ||||||+||+++.++.+||+|||++....... .......|+..|+|||++.+..+
T Consensus 98 ~~~~~~qi~~al~~LH~~~iv-Hrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~- 173 (316)
T cd05619 98 ATFYAAEIICGLQFLHSKGIV-YRDLKLDNILLDTDGHIKIADFGMCKENMLGD--AKTCTFCGTPDYIAPEILLGQKY- 173 (316)
T ss_pred HHHHHHHHHHHHHHHHhCCeE-eCCCCHHHEEECCCCCEEEccCCcceECCCCC--CceeeecCCccccCHHHHcCCCC-
Confidence 568899999999999999998 99999999999999999999999976432111 11234568899999999987654
Q ss_pred CCCCccchHHHHHHHHHHHhCCCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCchHHHHHHHHHhhhcCCCCCCCHH-HH
Q psy1840 105 RGTQKGDVYSFGLVLYEVIGRQGPWGHLRMTDEEIITSVTQGSGLRPDTSSLDCAPSIIACMRTCWEEDPELRPDLR-FV 183 (423)
Q Consensus 105 ~~s~ksDVyS~Giil~elltg~~Pf~~~~~~~~~i~~~i~~~~~~~p~~~~~~~~~~l~~Li~~C~~~dP~~RPt~~-~I 183 (423)
+.++|||||||++|||++|..||.. .+..++...+....+..| ..++.++.+++.+||+.||++||++. ++
T Consensus 174 --~~~~DvwslG~il~el~~G~~pf~~--~~~~~~~~~i~~~~~~~~----~~~~~~~~~li~~~l~~~P~~R~~~~~~l 245 (316)
T cd05619 174 --NTSVDWWSFGVLLYEMLIGQSPFHG--HDEEELFQSIRMDNPCYP----RWLTREAKDILVKLFVREPERRLGVKGDI 245 (316)
T ss_pred --CchhhhhhHHHHHHHHHhCCCCCCC--CCHHHHHHHHHhCCCCCC----ccCCHHHHHHHHHHhccCHhhcCCChHHH
Confidence 8999999999999999999999974 345666666665433322 24678999999999999999999986 55
Q ss_pred H
Q psy1840 184 H 184 (423)
Q Consensus 184 ~ 184 (423)
.
T Consensus 246 ~ 246 (316)
T cd05619 246 R 246 (316)
T ss_pred H
Confidence 3
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >KOG1024|consensus | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.1e-24 Score=207.59 Aligned_cols=163 Identities=25% Similarity=0.445 Sum_probs=139.5
Q ss_pred HHHHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCccEEEeccCCcccccCCCcccccccccCCccccCCccccCCC
Q psy1840 23 IGSISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKAPELLRQPH 102 (423)
Q Consensus 23 ~~~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~ 102 (423)
++-+.++.|++.||+|||++|+| |.||..+||+||+.-.+||+|=.+++-+...+...-.........||+||.+....
T Consensus 396 ~qlV~masQla~am~hlh~~~Vi-HkDiAaRNCvIdd~LqVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~ 474 (563)
T KOG1024|consen 396 IQLVLMASQLAMAMEHLHNHGVI-HKDIAARNCVIDDQLQVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSH 474 (563)
T ss_pred HHHHHHHHHHHHHHHHHHhcCcc-cchhhhhcceehhheeEEeccchhccccCcccccccCCCCCCcccccCHHHHhhhh
Confidence 44578999999999999999998 99999999999999999999999988665555443333444556799999999887
Q ss_pred CCCCCCccchHHHHHHHHHHHh-CCCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCchHHHHHHHHHhhhcCCCCCCCHH
Q psy1840 103 LPRGTQKGDVYSFGLVLYEVIG-RQGPWGHLRMTDEEIITSVTQGSGLRPDTSSLDCAPSIIACMRTCWEEDPELRPDLR 181 (423)
Q Consensus 103 ~~~~s~ksDVyS~Giil~ellt-g~~Pf~~~~~~~~~i~~~i~~~~~~~p~~~~~~~~~~l~~Li~~C~~~dP~~RPt~~ 181 (423)
+ +.++||||||+++|||+| |+.||. ..++.|....+++|.....+ .+||.++..+|..||...|++||+++
T Consensus 475 y---ssasDvWsfGVllWELmtlg~~Pya--eIDPfEm~~ylkdGyRlaQP---~NCPDeLf~vMacCWallpeeRPsf~ 546 (563)
T KOG1024|consen 475 Y---SSASDVWSFGVLLWELMTLGKLPYA--EIDPFEMEHYLKDGYRLAQP---FNCPDELFTVMACCWALLPEERPSFS 546 (563)
T ss_pred h---cchhhhHHHHHHHHHHHhcCCCCcc--ccCHHHHHHHHhccceecCC---CCCcHHHHHHHHHHHhcCcccCCCHH
Confidence 6 999999999999999997 888997 46778888888887655443 37999999999999999999999999
Q ss_pred HHHHHHHHHhhhc
Q psy1840 182 FVHHKLKEMNAGL 194 (423)
Q Consensus 182 ~I~~~L~~i~~~~ 194 (423)
++...|.+++...
T Consensus 547 Qlv~cLseF~~ql 559 (563)
T KOG1024|consen 547 QLVICLSEFHTQL 559 (563)
T ss_pred HHHHHHHHHHHHH
Confidence 9999999887643
|
|
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.7e-24 Score=207.16 Aligned_cols=157 Identities=26% Similarity=0.506 Sum_probs=123.8
Q ss_pred HHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCccEEEeccCCcccccCCCcccccccccCCccccCCccccCCCCC
Q psy1840 25 SISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKAPELLRQPHLP 104 (423)
Q Consensus 25 ~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~ 104 (423)
.+.++.|++.||.|||+++++ ||||||+||+++.++.+||+|||+++...............++..|+|||.+.+...
T Consensus 121 ~~~~~~~l~~~l~~lH~~~i~-H~dikp~nili~~~~~~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~- 198 (288)
T cd05061 121 MIQMAAEIADGMAYLNAKKFV-HRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVF- 198 (288)
T ss_pred HHHHHHHHHHHHHHHHhCCCc-CCCCChheEEEcCCCcEEECcCCccccccccccccccCCCcccccccCHHHhccCCC-
Confidence 578999999999999999998 999999999999999999999999875433222111122334567999999877654
Q ss_pred CCCCccchHHHHHHHHHHHh-CCCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCchHHHHHHHHHhhhcCCCCCCCHHHH
Q psy1840 105 RGTQKGDVYSFGLVLYEVIG-RQGPWGHLRMTDEEIITSVTQGSGLRPDTSSLDCAPSIIACMRTCWEEDPELRPDLRFV 183 (423)
Q Consensus 105 ~~s~ksDVyS~Giil~ellt-g~~Pf~~~~~~~~~i~~~i~~~~~~~p~~~~~~~~~~l~~Li~~C~~~dP~~RPt~~~I 183 (423)
+.++|||||||++||+++ |..||.. ....++...+..+.... . ...+++.+.+++.+||+.+|++||++.++
T Consensus 199 --~~~~DvwslG~~l~el~~~~~~p~~~--~~~~~~~~~~~~~~~~~--~-~~~~~~~~~~li~~~l~~~p~~Rps~~~l 271 (288)
T cd05061 199 --TTSSDMWSFGVVLWEITSLAEQPYQG--LSNEQVLKFVMDGGYLD--Q-PDNCPERVTDLMRMCWQFNPKMRPTFLEI 271 (288)
T ss_pred --ChHhHHHHHHHHHHHHHhCCCCCCCC--CCHHHHHHHHHcCCCCC--C-CCCCCHHHHHHHHHHcCCChhHCcCHHHH
Confidence 889999999999999998 7888864 34455666555432221 1 23567899999999999999999999999
Q ss_pred HHHHHHH
Q psy1840 184 HHKLKEM 190 (423)
Q Consensus 184 ~~~L~~i 190 (423)
++.++..
T Consensus 272 l~~l~~~ 278 (288)
T cd05061 272 VNLLKDD 278 (288)
T ss_pred HHHHHhh
Confidence 9888764
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.8e-24 Score=204.63 Aligned_cols=153 Identities=25% Similarity=0.501 Sum_probs=120.6
Q ss_pred HHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCccEEEeccCCcccccCCCcccccccccCCccccCCccccCCCCC
Q psy1840 25 SISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKAPELLRQPHLP 104 (423)
Q Consensus 25 ~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~ 104 (423)
.+.++.|++.|+.|||+.+++ ||||||+||+++.++.+||+|||+++........ ......++..|+|||.+.+..+
T Consensus 102 ~~~i~~qi~~~l~~lH~~~i~-H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~-~~~~~~~~~~y~~Pe~~~~~~~- 178 (256)
T cd05059 102 LLDMCSDVCEAMEYLESNGFI-HRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYT-SSQGTKFPVKWAPPEVFDYSRF- 178 (256)
T ss_pred HHHHHHHHHHHHHHHHHCCcc-cccccHhhEEECCCCcEEECCcccceeccccccc-ccCCCCCCccccCHHHhccCCC-
Confidence 578999999999999999988 9999999999999999999999998754322111 1111223456999999987655
Q ss_pred CCCCccchHHHHHHHHHHHh-CCCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCchHHHHHHHHHhhhcCCCCCCCHHHH
Q psy1840 105 RGTQKGDVYSFGLVLYEVIG-RQGPWGHLRMTDEEIITSVTQGSGLRPDTSSLDCAPSIIACMRTCWEEDPELRPDLRFV 183 (423)
Q Consensus 105 ~~s~ksDVyS~Giil~ellt-g~~Pf~~~~~~~~~i~~~i~~~~~~~p~~~~~~~~~~l~~Li~~C~~~dP~~RPt~~~I 183 (423)
+.++||||||+++||+++ |..||.. .+..+....+..+.. +.. ...++.++.+++.+||..+|++||++.++
T Consensus 179 --~~~~Di~slG~il~~l~~~g~~p~~~--~~~~~~~~~~~~~~~--~~~-~~~~~~~~~~li~~cl~~~p~~Rpt~~~~ 251 (256)
T cd05059 179 --SSKSDVWSFGVLMWEVFSEGKMPYER--FSNSEVVESVSAGYR--LYR-PKLAPTEVYTIMYSCWHEKPEDRPAFKKL 251 (256)
T ss_pred --CchhhHHHHHHHHHHHhccCCCCCCC--CCHHHHHHHHHcCCc--CCC-CCCCCHHHHHHHHHHhcCChhhCcCHHHH
Confidence 789999999999999998 7889864 344556666654421 221 23578999999999999999999999999
Q ss_pred HHHH
Q psy1840 184 HHKL 187 (423)
Q Consensus 184 ~~~L 187 (423)
++.|
T Consensus 252 l~~l 255 (256)
T cd05059 252 LSQL 255 (256)
T ss_pred HHHh
Confidence 8875
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.3e-24 Score=206.87 Aligned_cols=159 Identities=25% Similarity=0.466 Sum_probs=116.7
Q ss_pred HHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCccEEEeccCCcccccCCCcccccccccCCccccCCccccCCC--
Q psy1840 25 SISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKAPELLRQPH-- 102 (423)
Q Consensus 25 ~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~-- 102 (423)
...++.||+.|++|||+.+++ ||||||+||+++.++.+||+|||++................++..|+|||++....
T Consensus 102 ~~~~~~qi~~~l~~lH~~~iv-H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~ 180 (269)
T cd05042 102 LQRMACEVASGLLWLHQADFI-HSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLRWLAPELVEIRGQD 180 (269)
T ss_pred HHHHHHHHHHHHHHHHhcCEe-cccccHhheEecCCCcEEEeccccccccccchheeccCCCCCcccccCHHHHhhcccc
Confidence 468999999999999999987 99999999999999999999999976432221111112234456799999875421
Q ss_pred --CCCCCCccchHHHHHHHHHHHh-CCCCCCCCCCChHHHHHHHhcCCCCC-C-CCCCCCchHHHHHHHHHhhhcCCCCC
Q psy1840 103 --LPRGTQKGDVYSFGLVLYEVIG-RQGPWGHLRMTDEEIITSVTQGSGLR-P-DTSSLDCAPSIIACMRTCWEEDPELR 177 (423)
Q Consensus 103 --~~~~s~ksDVyS~Giil~ellt-g~~Pf~~~~~~~~~i~~~i~~~~~~~-p-~~~~~~~~~~l~~Li~~C~~~dP~~R 177 (423)
....+.++|||||||++|||++ |..||.. ....+............ + ......++..+..++..|| .||++|
T Consensus 181 ~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~dp~~R 257 (269)
T cd05042 181 LLPKDQTKKSNIWSLGVTMWELFTAADQPYPD--LSDEQVLKQVVREQDIKLPKPQLDLKYSDRWYEVMQFCW-LDPETR 257 (269)
T ss_pred ccccccchhhHHHHHHHHHHHHHhCCCCCCCc--CCHHHHHHHHhhccCccCCCCcccccCCHHHHHHHHHHh-cCcccc
Confidence 1134789999999999999998 6778863 23344444433322111 1 1123467888999999999 599999
Q ss_pred CCHHHHHHHH
Q psy1840 178 PDLRFVHHKL 187 (423)
Q Consensus 178 Pt~~~I~~~L 187 (423)
|++.+|.+.|
T Consensus 258 pt~~~v~~~l 267 (269)
T cd05042 258 PTAEEVHELL 267 (269)
T ss_pred cCHHHHHHHh
Confidence 9999998876
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.7e-24 Score=204.82 Aligned_cols=154 Identities=29% Similarity=0.512 Sum_probs=123.3
Q ss_pred HHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCccEEEeccCCcccccCCCcccccccccCCccccCCccccCCCCC
Q psy1840 25 SISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKAPELLRQPHLP 104 (423)
Q Consensus 25 ~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~ 104 (423)
...++.||+.|+.|||++|++ ||||||+||+++.++.+||+|||++......... .....++..|+|||.+.+..+
T Consensus 106 ~~~~~~~i~~al~~lH~~~i~-h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~~~--~~~~~~~~~~~~PE~~~~~~~- 181 (261)
T cd05148 106 LIDMACQVAEGMAYLEEQNSI-HRDLAARNILVGEDLVCKVADFGLARLIKEDVYL--SSDKKIPYKWTAPEAASHGTF- 181 (261)
T ss_pred HHHHHHHHHHHHHHHHHCCee-ccccCcceEEEcCCceEEEccccchhhcCCcccc--ccCCCCceEecCHHHHccCCC-
Confidence 578999999999999999987 9999999999999999999999998765322111 123334567999999876554
Q ss_pred CCCCccchHHHHHHHHHHHh-CCCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCchHHHHHHHHHhhhcCCCCCCCHHHH
Q psy1840 105 RGTQKGDVYSFGLVLYEVIG-RQGPWGHLRMTDEEIITSVTQGSGLRPDTSSLDCAPSIIACMRTCWEEDPELRPDLRFV 183 (423)
Q Consensus 105 ~~s~ksDVyS~Giil~ellt-g~~Pf~~~~~~~~~i~~~i~~~~~~~p~~~~~~~~~~l~~Li~~C~~~dP~~RPt~~~I 183 (423)
+.++||||||+++|++++ |..||.. ....+....+..+. ++.. ...+++.+.+++.+||+.+|++|||+.++
T Consensus 182 --~~~~DiwslG~~l~~l~~~g~~p~~~--~~~~~~~~~~~~~~--~~~~-~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l 254 (261)
T cd05148 182 --STKSDVWSFGILLYEMFTYGQVPYPG--MNNHEVYDQITAGY--RMPC-PAKCPQEIYKIMLECWAAEPEDRPSFKAL 254 (261)
T ss_pred --CchhhHHHHHHHHHHHHcCCCCCCCc--CCHHHHHHHHHhCC--cCCC-CCCCCHHHHHHHHHHcCCCchhCcCHHHH
Confidence 889999999999999998 8899964 34455666655432 2222 23678999999999999999999999999
Q ss_pred HHHHHH
Q psy1840 184 HHKLKE 189 (423)
Q Consensus 184 ~~~L~~ 189 (423)
.+.|+.
T Consensus 255 ~~~L~~ 260 (261)
T cd05148 255 REELDN 260 (261)
T ss_pred HHHHhc
Confidence 998864
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=99.92 E-value=8.8e-25 Score=209.92 Aligned_cols=151 Identities=23% Similarity=0.339 Sum_probs=117.5
Q ss_pred HHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCccEEEeccCCcccccCCCcccccccccCCccccCCccccCCCCC
Q psy1840 25 SISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKAPELLRQPHLP 104 (423)
Q Consensus 25 ~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~ 104 (423)
.+.++.||+.||.|||+.+++ ||||||+||+++.++.+||+|||++........ ......|++.|+|||.+.+..+
T Consensus 99 ~~~~~~qi~~~l~~lH~~~i~-H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~- 174 (280)
T cd05608 99 ACFYTAQIISGLEHLHQRRII-YRDLKPENVLLDNDGNVRISDLGLAVELKDGQS--KTKGYAGTPGFMAPELLQGEEY- 174 (280)
T ss_pred HHHHHHHHHHHHHHHHHCCcc-cCCCCHHHEEECCCCCEEEeeCccceecCCCCc--cccccCCCcCccCHHHhcCCCC-
Confidence 578999999999999999998 999999999999999999999999865432221 1234568889999999987655
Q ss_pred CCCCccchHHHHHHHHHHHhCCCCCCCCCCC--hHHHHHHHhcCCCCCCCCCCCCchHHHHHHHHHhhhcCCCCCC----
Q psy1840 105 RGTQKGDVYSFGLVLYEVIGRQGPWGHLRMT--DEEIITSVTQGSGLRPDTSSLDCAPSIIACMRTCWEEDPELRP---- 178 (423)
Q Consensus 105 ~~s~ksDVyS~Giil~elltg~~Pf~~~~~~--~~~i~~~i~~~~~~~p~~~~~~~~~~l~~Li~~C~~~dP~~RP---- 178 (423)
+.++|||||||++|||++|+.||...... ..++...+... +......+++.+.+++.+||+.||++||
T Consensus 175 --~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~ 248 (280)
T cd05608 175 --DFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRILND----SVTYPDKFSPASKSFCEALLAKDPEKRLGFRD 248 (280)
T ss_pred --CccccHHHHHHHHHHHHhCCCCCCCCCcchhHHHHHHhhccc----CCCCcccCCHHHHHHHHHHhcCCHHHhcCCCC
Confidence 88999999999999999999999753221 22333333222 1112235789999999999999999999
Q ss_pred -CHHHHHH
Q psy1840 179 -DLRFVHH 185 (423)
Q Consensus 179 -t~~~I~~ 185 (423)
++.++++
T Consensus 249 ~~~~~~l~ 256 (280)
T cd05608 249 GNCDGLRT 256 (280)
T ss_pred CCHHHHhc
Confidence 5566654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.8e-24 Score=205.83 Aligned_cols=160 Identities=21% Similarity=0.381 Sum_probs=126.8
Q ss_pred HHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCccEEEeccCCcccccCCCcccccccccCCccccCCccccCCCCC
Q psy1840 25 SISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKAPELLRQPHLP 104 (423)
Q Consensus 25 ~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~ 104 (423)
.+.++.|++.|++|||+.+++ ||||||+||+++.++.+||+|||+++...............++..|+|||.+....+
T Consensus 111 ~~~~~~qi~~~l~~LH~~~i~-H~di~p~nil~~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~- 188 (279)
T cd05057 111 LLNWCVQIAKGMSYLEEKRLV-HRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALESILHRIY- 188 (279)
T ss_pred HHHHHHHHHHHHHHHHhCCEE-ecccCcceEEEcCCCeEEECCCcccccccCcccceecCCCcccccccCHHHhhcCCc-
Confidence 689999999999999999988 999999999999999999999999876543222111112223457999998876544
Q ss_pred CCCCccchHHHHHHHHHHHh-CCCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCchHHHHHHHHHhhhcCCCCCCCHHHH
Q psy1840 105 RGTQKGDVYSFGLVLYEVIG-RQGPWGHLRMTDEEIITSVTQGSGLRPDTSSLDCAPSIIACMRTCWEEDPELRPDLRFV 183 (423)
Q Consensus 105 ~~s~ksDVyS~Giil~ellt-g~~Pf~~~~~~~~~i~~~i~~~~~~~p~~~~~~~~~~l~~Li~~C~~~dP~~RPt~~~I 183 (423)
+.++|+||||+++||+++ |..||.. ....++...+..+..... +..++..+.+++.+||..+|.+||++.++
T Consensus 189 --~~~~Di~slG~~l~el~~~g~~p~~~--~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l 261 (279)
T cd05057 189 --THKSDVWSYGVTVWELMTFGAKPYEG--IPAVEIPDLLEKGERLPQ---PPICTIDVYMVLVKCWMIDAESRPTFKEL 261 (279)
T ss_pred --CchhhHHHHHHHHHHHhcCCCCCCCC--CCHHHHHHHHhCCCCCCC---CCCCCHHHHHHHHHHcCCChhhCCCHHHH
Confidence 889999999999999998 9999974 345666666665432211 22467899999999999999999999999
Q ss_pred HHHHHHHhhh
Q psy1840 184 HHKLKEMNAG 193 (423)
Q Consensus 184 ~~~L~~i~~~ 193 (423)
.+.|.++...
T Consensus 262 ~~~l~~~~~~ 271 (279)
T cd05057 262 INEFSKMARD 271 (279)
T ss_pred HHHHHHHHhC
Confidence 9999887553
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.5e-24 Score=208.71 Aligned_cols=155 Identities=27% Similarity=0.497 Sum_probs=123.0
Q ss_pred HHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCccEEEeccCCcccccCCCcccccccccCCccccCCccccCCCCC
Q psy1840 25 SISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKAPELLRQPHLP 104 (423)
Q Consensus 25 ~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~ 104 (423)
.+.++.|++.||.|||+++++ ||||||+||+++.++.+||+|||++.................+..|+|||.+.+..+
T Consensus 132 ~~~~~~~i~~aL~~lH~~~i~-H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~- 209 (288)
T cd05050 132 QLCIAKQVAAGMAYLSERKFV-HRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRY- 209 (288)
T ss_pred HHHHHHHHHHHHHHHHhCCee-cccccHhheEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCC-
Confidence 579999999999999999998 999999999999999999999999765432221111122234567999999876654
Q ss_pred CCCCccchHHHHHHHHHHHh-CCCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCchHHHHHHHHHhhhcCCCCCCCHHHH
Q psy1840 105 RGTQKGDVYSFGLVLYEVIG-RQGPWGHLRMTDEEIITSVTQGSGLRPDTSSLDCAPSIIACMRTCWEEDPELRPDLRFV 183 (423)
Q Consensus 105 ~~s~ksDVyS~Giil~ellt-g~~Pf~~~~~~~~~i~~~i~~~~~~~p~~~~~~~~~~l~~Li~~C~~~dP~~RPt~~~I 183 (423)
+.++|||||||++|||++ |..||.+ ....++...+..+.... ....++.++.+++.+||+.+|++||++.++
T Consensus 210 --~~~~Dv~slG~il~el~~~~~~p~~~--~~~~~~~~~~~~~~~~~---~~~~~~~~l~~li~~~l~~~p~~Rpt~~el 282 (288)
T cd05050 210 --TTESDVWAYGVVLWEIFSYGMQPYYG--MAHEEVIYYVRDGNVLS---CPDNCPLELYNLMRLCWSKLPSDRPSFASI 282 (288)
T ss_pred --CchhHHHHHHHHHHHHHhCCCCCCCC--CCHHHHHHHHhcCCCCC---CCCCCCHHHHHHHHHHcccCcccCCCHHHH
Confidence 889999999999999997 7788863 34566666666544321 123578899999999999999999999999
Q ss_pred HHHHH
Q psy1840 184 HHKLK 188 (423)
Q Consensus 184 ~~~L~ 188 (423)
.+.|+
T Consensus 283 ~~~l~ 287 (288)
T cd05050 283 NRILQ 287 (288)
T ss_pred HHHhh
Confidence 98875
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.9e-24 Score=210.01 Aligned_cols=158 Identities=24% Similarity=0.430 Sum_probs=122.8
Q ss_pred HHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCccEEEeccCCcccccCCCcccccccccCCccccCCccccCCCCC
Q psy1840 25 SISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKAPELLRQPHLP 104 (423)
Q Consensus 25 ~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~ 104 (423)
.+.++.|++.|+.|||+++++ |+||||+||+++.++.+|++|||+++...............++..|+|||.+.+...
T Consensus 143 ~~~i~~~i~~~l~~lH~~~iv-H~dlkp~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~- 220 (302)
T cd05055 143 LLSFSYQVAKGMAFLASKNCI-HRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYVVKGNARLPVKWMAPESIFNCVY- 220 (302)
T ss_pred HHHHHHHHHHHHHHHHHCCee-hhhhccceEEEcCCCeEEECCCcccccccCCCceeecCCCCcccccCCHhhhccCCC-
Confidence 678999999999999999988 999999999999999999999999875533222111122345677999999877654
Q ss_pred CCCCccchHHHHHHHHHHHh-CCCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCchHHHHHHHHHhhhcCCCCCCCHHHH
Q psy1840 105 RGTQKGDVYSFGLVLYEVIG-RQGPWGHLRMTDEEIITSVTQGSGLRPDTSSLDCAPSIIACMRTCWEEDPELRPDLRFV 183 (423)
Q Consensus 105 ~~s~ksDVyS~Giil~ellt-g~~Pf~~~~~~~~~i~~~i~~~~~~~p~~~~~~~~~~l~~Li~~C~~~dP~~RPt~~~I 183 (423)
+.++|||||||++||+++ |..||..... .......+..+. .+. .....++.+.+++.+||+.+|++||++.++
T Consensus 221 --~~~~DiwslGvil~el~t~g~~p~~~~~~-~~~~~~~~~~~~--~~~-~~~~~~~~~~~li~~cl~~~p~~Rpt~~el 294 (302)
T cd05055 221 --TFESDVWSYGILLWEIFSLGSNPYPGMPV-DSKFYKLIKEGY--RMA-QPEHAPAEIYDIMKTCWDADPLKRPTFKQI 294 (302)
T ss_pred --CcHhHHHHHHHHHHHHHhCCCCCcCCCCc-hHHHHHHHHcCC--cCC-CCCCCCHHHHHHHHHHcCCCchhCcCHHHH
Confidence 889999999999999998 8999875332 233334443332 121 123467899999999999999999999999
Q ss_pred HHHHHHH
Q psy1840 184 HHKLKEM 190 (423)
Q Consensus 184 ~~~L~~i 190 (423)
++.|+++
T Consensus 295 l~~l~~~ 301 (302)
T cd05055 295 VQLIGKQ 301 (302)
T ss_pred HHHHHhh
Confidence 9988764
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.1e-24 Score=219.45 Aligned_cols=157 Identities=18% Similarity=0.260 Sum_probs=115.6
Q ss_pred HHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCccEEEeccCCcccccCCCcccccccccCCccccCCccccCCCCC
Q psy1840 25 SISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKAPELLRQPHLP 104 (423)
Q Consensus 25 ~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~ 104 (423)
.+.++.||+.||.|||+.|++ ||||||+||+++.++.+||+|||++........ .......||+.|+|||++.+..+
T Consensus 184 ~~~i~~qi~~aL~ylH~~~Iv-HrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~- 260 (391)
T PHA03212 184 ILAIERSVLRAIQYLHENRII-HRDIKAENIFINHPGDVCLGDFGAACFPVDINA-NKYYGWAGTIATNAPELLARDPY- 260 (391)
T ss_pred HHHHHHHHHHHHHHHHhCCcc-cCCCChHhEEEcCCCCEEEEeCCcccccccccc-cccccccCccCCCChhhhcCCCC-
Confidence 679999999999999999998 999999999999999999999999865332211 12234578999999999987654
Q ss_pred CCCCccchHHHHHHHHHHHhCCCCCCCCC-C----ChHHHHHHHh--------------------------cCCCCCCCC
Q psy1840 105 RGTQKGDVYSFGLVLYEVIGRQGPWGHLR-M----TDEEIITSVT--------------------------QGSGLRPDT 153 (423)
Q Consensus 105 ~~s~ksDVyS~Giil~elltg~~Pf~~~~-~----~~~~i~~~i~--------------------------~~~~~~p~~ 153 (423)
+.++|||||||++|||++|..||.... . .....+..+. ......+..
T Consensus 261 --~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 338 (391)
T PHA03212 261 --GPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPIDAQANLDEIYIGLAKKSSRKPGS 338 (391)
T ss_pred --CcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCcchhHHHHHHHHHHHhccCCCCCC
Confidence 899999999999999999998764311 0 0111111111 100111110
Q ss_pred C-----CCCchHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q psy1840 154 S-----SLDCAPSIIACMRTCWEEDPELRPDLRFVHHK 186 (423)
Q Consensus 154 ~-----~~~~~~~l~~Li~~C~~~dP~~RPt~~~I~~~ 186 (423)
. ....+.++.+++.+||+.||++|||+.++++.
T Consensus 339 ~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~h 376 (391)
T PHA03212 339 RPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLDF 376 (391)
T ss_pred CCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhcC
Confidence 0 01346789999999999999999999999863
|
|
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.6e-24 Score=203.16 Aligned_cols=156 Identities=25% Similarity=0.461 Sum_probs=122.8
Q ss_pred HHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCccEEEeccCCcccccCCCcc-cccccccCCccccCCccccCCCC
Q psy1840 25 SISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDET-GQERKLRRRKLYKAPELLRQPHL 103 (423)
Q Consensus 25 ~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~~-~~~~~~~gt~~y~APE~l~~~~~ 103 (423)
...++.|++.||.|||+++++ ||||||+||+++.++.+||+|||++......... .......++..|+|||.+.+..+
T Consensus 99 ~~~~~~qi~~~L~~lH~~~i~-H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~ 177 (257)
T cd05040 99 LCDYAVQIANGMRYLESKRFI-HRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCAPESLRTRTF 177 (257)
T ss_pred HHHHHHHHHHHHHHHHhCCcc-ccccCcccEEEecCCEEEeccccccccccccccceecccCCCCCceecCHHHhcccCc
Confidence 578999999999999999998 9999999999999999999999998765432211 11123345678999999877654
Q ss_pred CCCCCccchHHHHHHHHHHHh-CCCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCchHHHHHHHHHhhhcCCCCCCCHHH
Q psy1840 104 PRGTQKGDVYSFGLVLYEVIG-RQGPWGHLRMTDEEIITSVTQGSGLRPDTSSLDCAPSIIACMRTCWEEDPELRPDLRF 182 (423)
Q Consensus 104 ~~~s~ksDVyS~Giil~ellt-g~~Pf~~~~~~~~~i~~~i~~~~~~~p~~~~~~~~~~l~~Li~~C~~~dP~~RPt~~~ 182 (423)
+.++|||||||++|||++ |..||.. .+..++...+...... .. ....++..+.+++.+||+.+|++||++.+
T Consensus 178 ---~~~~Di~slG~~l~el~t~g~~p~~~--~~~~~~~~~~~~~~~~-~~-~~~~~~~~~~~li~~~l~~~p~~Rps~~~ 250 (257)
T cd05040 178 ---SHASDVWMFGVTLWEMFTYGEEPWAG--LSGSQILKKIDKEGER-LE-RPEACPQDIYNVMLQCWAHNPADRPTFAA 250 (257)
T ss_pred ---CchhhhHHHHHHHHHHHhCCCCCCCC--CCHHHHHHHHHhcCCc-CC-CCccCCHHHHHHHHHHCCCCcccCCCHHH
Confidence 889999999999999998 9999963 3445555555432211 11 12356889999999999999999999999
Q ss_pred HHHHHH
Q psy1840 183 VHHKLK 188 (423)
Q Consensus 183 I~~~L~ 188 (423)
+++.|.
T Consensus 251 ~~~~l~ 256 (257)
T cd05040 251 LREFLP 256 (257)
T ss_pred HHHHhc
Confidence 998764
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.6e-24 Score=212.98 Aligned_cols=160 Identities=26% Similarity=0.444 Sum_probs=124.0
Q ss_pred HHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCccEEEeccCCcccccCCCcccccccccCCccccCCccccCCCCC
Q psy1840 25 SISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKAPELLRQPHLP 104 (423)
Q Consensus 25 ~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~ 104 (423)
.+.++.||+.||.|||+.+++ ||||||+||+++.++.+||+|||++................++..|+|||.+.+..+
T Consensus 181 ~~~~~~qi~~al~~lH~~~i~-H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~- 258 (343)
T cd05103 181 LICYSFQVAKGMEFLASRKCI-HRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVY- 258 (343)
T ss_pred HHHHHHHHHHHHHHHHhCCee-cCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCCCCCcceECcHHhcCCCC-
Confidence 578999999999999999998 999999999999999999999999875432222111122344567999999876654
Q ss_pred CCCCccchHHHHHHHHHHHh-CCCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCchHHHHHHHHHhhhcCCCCCCCHHHH
Q psy1840 105 RGTQKGDVYSFGLVLYEVIG-RQGPWGHLRMTDEEIITSVTQGSGLRPDTSSLDCAPSIIACMRTCWEEDPELRPDLRFV 183 (423)
Q Consensus 105 ~~s~ksDVyS~Giil~ellt-g~~Pf~~~~~~~~~i~~~i~~~~~~~p~~~~~~~~~~l~~Li~~C~~~dP~~RPt~~~I 183 (423)
+.++||||||+++|++++ |..||..... ...+...+..+.... . +...++++.+++.+||+.+|++||++.+|
T Consensus 259 --~~~~Di~slG~~l~el~~~g~~p~~~~~~-~~~~~~~~~~~~~~~--~-~~~~~~~~~~~~~~cl~~~p~~Rps~~ei 332 (343)
T cd05103 259 --TIQSDVWSFGVLLWEIFSLGASPYPGVKI-DEEFCRRLKEGTRMR--A-PDYTTPEMYQTMLDCWHGEPSQRPTFSEL 332 (343)
T ss_pred --CchhhHHHHHHHHHHHHHCCCCCCCCccc-cHHHHHHHhccCCCC--C-CCCCCHHHHHHHHHHccCChhhCcCHHHH
Confidence 889999999999999997 8899875432 233444444432221 1 12357889999999999999999999999
Q ss_pred HHHHHHHhh
Q psy1840 184 HHKLKEMNA 192 (423)
Q Consensus 184 ~~~L~~i~~ 192 (423)
++.|+.+..
T Consensus 333 l~~l~~~~~ 341 (343)
T cd05103 333 VEHLGNLLQ 341 (343)
T ss_pred HHHHHHHHh
Confidence 999988754
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=99.92 E-value=7.6e-25 Score=214.49 Aligned_cols=149 Identities=22% Similarity=0.314 Sum_probs=120.7
Q ss_pred HHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCccEEEeccCCcccccCCCcccccccccCCccccCCccccCCCCC
Q psy1840 25 SISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKAPELLRQPHLP 104 (423)
Q Consensus 25 ~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~ 104 (423)
...++.||+.||.|||+.+++ ||||||+||+++.++.+||+|||++....... .......|+..|+|||.+.+..+
T Consensus 98 ~~~~~~qi~~~l~~LH~~~iv-H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~g~~~y~aPE~~~~~~~- 173 (318)
T cd05570 98 ARFYAAEIVLGLQFLHERGII-YRDLKLDNVLLDSEGHIKIADFGMCKEGILGG--VTTSTFCGTPDYIAPEILSYQPY- 173 (318)
T ss_pred HHHHHHHHHHHHHHHHhCCeE-ccCCCHHHeEECCCCcEEecccCCCeecCcCC--CcccceecCccccCHHHhcCCCC-
Confidence 578899999999999999998 99999999999999999999999976432111 11234468889999999987655
Q ss_pred CCCCccchHHHHHHHHHHHhCCCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCchHHHHHHHHHhhhcCCCCCCCH----
Q psy1840 105 RGTQKGDVYSFGLVLYEVIGRQGPWGHLRMTDEEIITSVTQGSGLRPDTSSLDCAPSIIACMRTCWEEDPELRPDL---- 180 (423)
Q Consensus 105 ~~s~ksDVyS~Giil~elltg~~Pf~~~~~~~~~i~~~i~~~~~~~p~~~~~~~~~~l~~Li~~C~~~dP~~RPt~---- 180 (423)
+.++|||||||++|+|++|..||.. .+..++...+.......| ..++..+.+++++||+.||.+||++
T Consensus 174 --~~~~DiwslGvil~~l~~G~~pf~~--~~~~~~~~~i~~~~~~~~----~~~~~~~~~li~~~l~~dP~~R~s~~~~~ 245 (318)
T cd05570 174 --GPAVDWWALGVLLYEMLAGQSPFEG--DDEDELFQSILEDEVRYP----RWLSKEAKSILKSFLTKNPEKRLGCLPTG 245 (318)
T ss_pred --CcchhhhhHHHHHHHHhhCCCCCCC--CCHHHHHHHHHcCCCCCC----CcCCHHHHHHHHHHccCCHHHcCCCCCCC
Confidence 8899999999999999999999964 345566666655443322 3468899999999999999999998
Q ss_pred -HHHHH
Q psy1840 181 -RFVHH 185 (423)
Q Consensus 181 -~~I~~ 185 (423)
.++++
T Consensus 246 ~~~ll~ 251 (318)
T cd05570 246 EQDIKG 251 (318)
T ss_pred HHHHhc
Confidence 66654
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.6e-24 Score=204.63 Aligned_cols=157 Identities=25% Similarity=0.503 Sum_probs=123.7
Q ss_pred HHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCccEEEeccCCcccccCCCcccc-cccccCCccccCCccccCCCC
Q psy1840 25 SISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQ-ERKLRRRKLYKAPELLRQPHL 103 (423)
Q Consensus 25 ~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~~~~-~~~~~gt~~y~APE~l~~~~~ 103 (423)
.+.++.|++.|++|||+.|++ ||||||+||+++.++.+||+|||++........... ......+..|+|||.+.+..+
T Consensus 109 ~~~~~~~l~~al~~lH~~~i~-H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~ 187 (268)
T cd05063 109 LVGMLRGIAAGMKYLSDMNYV-HRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAPEAIAYRKF 187 (268)
T ss_pred HHHHHHHHHHHHHHHHHCCee-ccccchhhEEEcCCCcEEECCCccceecccccccceeccCCCcCceecCHHHhhcCCc
Confidence 678999999999999999988 999999999999999999999999875543221111 111223456999999876554
Q ss_pred CCCCCccchHHHHHHHHHHHh-CCCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCchHHHHHHHHHhhhcCCCCCCCHHH
Q psy1840 104 PRGTQKGDVYSFGLVLYEVIG-RQGPWGHLRMTDEEIITSVTQGSGLRPDTSSLDCAPSIIACMRTCWEEDPELRPDLRF 182 (423)
Q Consensus 104 ~~~s~ksDVyS~Giil~ellt-g~~Pf~~~~~~~~~i~~~i~~~~~~~p~~~~~~~~~~l~~Li~~C~~~dP~~RPt~~~ 182 (423)
+.++|||||||++||+++ |..||.. .+..++...+..+.. .| ....++.++.+++.+||+.+|++||++.+
T Consensus 188 ---~~~~Dv~slG~il~ell~~g~~p~~~--~~~~~~~~~i~~~~~-~~--~~~~~~~~~~~li~~c~~~~p~~Rp~~~~ 259 (268)
T cd05063 188 ---TSASDVWSFGIVMWEVMSFGERPYWD--MSNHEVMKAINDGFR-LP--APMDCPSAVYQLMLQCWQQDRARRPRFVD 259 (268)
T ss_pred ---ChHhHHHHHHHHHHHHHhCCCCCCCc--CCHHHHHHHHhcCCC-CC--CCCCCCHHHHHHHHHHcCCCcccCcCHHH
Confidence 889999999999999997 9999964 344566666655321 12 12357899999999999999999999999
Q ss_pred HHHHHHHH
Q psy1840 183 VHHKLKEM 190 (423)
Q Consensus 183 I~~~L~~i 190 (423)
|.+.|.++
T Consensus 260 i~~~l~~~ 267 (268)
T cd05063 260 IVNLLDKL 267 (268)
T ss_pred HHHHHHhh
Confidence 99988764
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=99.92 E-value=3.4e-24 Score=204.14 Aligned_cols=158 Identities=22% Similarity=0.458 Sum_probs=125.3
Q ss_pred HHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCccEEEeccCCcccccCCCcccccccccCCccccCCccccCCCCC
Q psy1840 25 SISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKAPELLRQPHLP 104 (423)
Q Consensus 25 ~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~ 104 (423)
.+.++.|++.|++|||+.+++ ||||||+||+++.++.+||+|||+++......... .....++..|+|||.+....+
T Consensus 109 ~~~~~~~l~~~l~~lH~~~~~-H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~- 185 (270)
T cd05056 109 LILYSYQLSTALAYLESKRFV-HRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYK-ASKGKLPIKWMAPESINFRRF- 185 (270)
T ss_pred HHHHHHHHHHHHHHHHhCCee-ccccChheEEEecCCCeEEccCceeeeccccccee-cCCCCccccccChhhhccCCC-
Confidence 678999999999999999998 99999999999999999999999987654332111 122234457999999876554
Q ss_pred CCCCccchHHHHHHHHHHHh-CCCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCchHHHHHHHHHhhhcCCCCCCCHHHH
Q psy1840 105 RGTQKGDVYSFGLVLYEVIG-RQGPWGHLRMTDEEIITSVTQGSGLRPDTSSLDCAPSIIACMRTCWEEDPELRPDLRFV 183 (423)
Q Consensus 105 ~~s~ksDVyS~Giil~ellt-g~~Pf~~~~~~~~~i~~~i~~~~~~~p~~~~~~~~~~l~~Li~~C~~~dP~~RPt~~~I 183 (423)
+.++||||||+++||+++ |..||... +..+....+..+... .. ...++..+.+++.+||..+|++|||+.++
T Consensus 186 --~~~~Di~slG~il~el~~~g~~pf~~~--~~~~~~~~~~~~~~~--~~-~~~~~~~~~~li~~~l~~~P~~Rpt~~~~ 258 (270)
T cd05056 186 --TSASDVWMFGVCMWEILMLGVKPFQGV--KNNDVIGRIENGERL--PM-PPNCPPTLYSLMTKCWAYDPSKRPRFTEL 258 (270)
T ss_pred --CchhhhHHHHHHHHHHHHcCCCCCCCC--CHHHHHHHHHcCCcC--CC-CCCCCHHHHHHHHHHcCCChhhCcCHHHH
Confidence 889999999999999996 99999643 334555555554322 11 23578999999999999999999999999
Q ss_pred HHHHHHHhh
Q psy1840 184 HHKLKEMNA 192 (423)
Q Consensus 184 ~~~L~~i~~ 192 (423)
+..|..+..
T Consensus 259 ~~~l~~~~~ 267 (270)
T cd05056 259 KAQLSDILQ 267 (270)
T ss_pred HHHHHHHHh
Confidence 999988754
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >KOG0694|consensus | Back alignment and domain information |
|---|
Probab=99.92 E-value=8.2e-25 Score=221.79 Aligned_cols=143 Identities=27% Similarity=0.403 Sum_probs=125.2
Q ss_pred HHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCccEEEeccCCcccccCCCcccccccccCCccccCCccccCCCCCC
Q psy1840 26 ISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKAPELLRQPHLPR 105 (423)
Q Consensus 26 l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~ 105 (423)
.-++..++.||.|||++||| +||||.+|||+|.+|.+||+|||+++...... ..+.+++||+.|+|||++.+..|
T Consensus 471 rfyaAev~l~L~fLH~~~II-YRDlKLdNiLLD~eGh~kiADFGlcKe~m~~g--~~TsTfCGTpey~aPEil~e~~Y-- 545 (694)
T KOG0694|consen 471 RFYAAEVVLGLQFLHENGII-YRDLKLDNLLLDTEGHVKIADFGLCKEGMGQG--DRTSTFCGTPEFLAPEVLTEQSY-- 545 (694)
T ss_pred HHHHHHHHHHHHHHHhcCce-eeecchhheEEcccCcEEecccccccccCCCC--CccccccCChhhcChhhhccCcc--
Confidence 35688999999999999999 99999999999999999999999998644332 34578999999999999999877
Q ss_pred CCCccchHHHHHHHHHHHhCCCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCchHHHHHHHHHhhhcCCCCCCCH
Q psy1840 106 GTQKGDVYSFGLVLYEVIGRQGPWGHLRMTDEEIITSVTQGSGLRPDTSSLDCAPSIIACMRTCWEEDPELRPDL 180 (423)
Q Consensus 106 ~s~ksDVyS~Giil~elltg~~Pf~~~~~~~~~i~~~i~~~~~~~p~~~~~~~~~~l~~Li~~C~~~dP~~RPt~ 180 (423)
+.++|-|||||+||||+.|+.||.+ .+.+++...|.......|. .++.+..++|++++..+|++|.-.
T Consensus 546 -t~aVDWW~lGVLlyeML~Gq~PF~g--ddEee~FdsI~~d~~~yP~----~ls~ea~~il~~ll~k~p~kRLG~ 613 (694)
T KOG0694|consen 546 -TRAVDWWGLGVLLYEMLVGESPFPG--DDEEEVFDSIVNDEVRYPR----FLSKEAIAIMRRLLRKNPEKRLGS 613 (694)
T ss_pred -cchhhHHHHHHHHHHHHcCCCCCCC--CCHHHHHHHHhcCCCCCCC----cccHHHHHHHHHHhccCcccccCC
Confidence 9999999999999999999999984 4568899998876655553 578999999999999999999654
|
|
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=99.92 E-value=6.6e-25 Score=215.30 Aligned_cols=145 Identities=21% Similarity=0.241 Sum_probs=117.5
Q ss_pred HHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCccEEEeccCCcccccCCCcccccccccCCccccCCccccCCCCC
Q psy1840 25 SISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKAPELLRQPHLP 104 (423)
Q Consensus 25 ~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~ 104 (423)
...++.||+.||.|||++|++ ||||||+|||++.++.+||+|||+++...... .......|++.|+|||++.+..+
T Consensus 98 ~~~~~~qi~~~l~~lH~~giv-H~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~- 173 (323)
T cd05575 98 ARFYAAEIASALGYLHSLNII-YRDLKPENILLDSQGHVVLTDFGLCKEGIEHS--KTTSTFCGTPEYLAPEVLRKQPY- 173 (323)
T ss_pred HHHHHHHHHHHHHHHHHCCeE-eCCCCHHHeEECCCCcEEEeccCCCcccccCC--CccccccCChhhcChhhhcCCCC-
Confidence 467899999999999999988 99999999999999999999999986432221 12234568899999999987655
Q ss_pred CCCCccchHHHHHHHHHHHhCCCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCchHHHHHHHHHhhhcCCCCCCCHH
Q psy1840 105 RGTQKGDVYSFGLVLYEVIGRQGPWGHLRMTDEEIITSVTQGSGLRPDTSSLDCAPSIIACMRTCWEEDPELRPDLR 181 (423)
Q Consensus 105 ~~s~ksDVyS~Giil~elltg~~Pf~~~~~~~~~i~~~i~~~~~~~p~~~~~~~~~~l~~Li~~C~~~dP~~RPt~~ 181 (423)
+.++|||||||++|||++|..||.. .+..++...+..+....+ ...+..+.+++.+||+.||.+||+..
T Consensus 174 --~~~~DvwslG~il~ell~g~~pf~~--~~~~~~~~~i~~~~~~~~----~~~~~~~~~li~~~l~~~p~~R~~~~ 242 (323)
T cd05575 174 --DRTVDWWCLGAVLYEMLYGLPPFYS--RDTAEMYDNILNKPLRLK----PNISVSARHLLEGLLQKDRTKRLGAK 242 (323)
T ss_pred --CccccccccchhhhhhhcCCCCCCC--CCHHHHHHHHHcCCCCCC----CCCCHHHHHHHHHHhhcCHHhCCCCC
Confidence 8899999999999999999999974 344566666655432222 24688999999999999999999875
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >KOG0597|consensus | Back alignment and domain information |
|---|
Probab=99.92 E-value=5.9e-25 Score=217.75 Aligned_cols=153 Identities=22% Similarity=0.367 Sum_probs=127.1
Q ss_pred ChHH-HHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCccEEEeccCCcccccCCCcccccccccCCccccCCcccc
Q psy1840 21 IPIG-SISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKAPELLR 99 (423)
Q Consensus 21 ~p~~-~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~ 99 (423)
.|++ ...++.|++.||.|||+.+|+ |||+||.|||++..|++|+||||+++.... .........||+.|||||.+.
T Consensus 97 lpEe~v~~~a~~LVsaL~yLhs~ril-hrd~kPqniLl~~~~~~KlcdFg~Ar~m~~--~t~vltsikGtPlYmAPElv~ 173 (808)
T KOG0597|consen 97 LPEEQVRAIAYDLVSALYYLHSNRIL-HRDMKPQNILLEKGGTLKLCDFGLARAMST--NTSVLTSIKGTPLYMAPELVE 173 (808)
T ss_pred CCHHHHHHHHHHHHHHHHHHHhcCcc-cccCCcceeeecCCCceeechhhhhhhccc--CceeeeeccCcccccCHHHHc
Confidence 4555 358999999999999999998 999999999999999999999999986543 334456778999999999999
Q ss_pred CCCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCchHHHHHHHHHhhhcCCCCCCC
Q psy1840 100 QPHLPRGTQKGDVYSFGLVLYEVIGRQGPWGHLRMTDEEIITSVTQGSGLRPDTSSLDCAPSIIACMRTCWEEDPELRPD 179 (423)
Q Consensus 100 ~~~~~~~s~ksDVyS~Giil~elltg~~Pf~~~~~~~~~i~~~i~~~~~~~p~~~~~~~~~~l~~Li~~C~~~dP~~RPt 179 (423)
+..+ +..+|.||+|||+||++.|++||.. .+.-++++.|...+...| ...+..+.++++..+.+||.+|.+
T Consensus 174 e~py---d~~sDlWslGcilYE~~~G~PPF~a--~si~~Lv~~I~~d~v~~p----~~~S~~f~nfl~gLL~kdP~~Rlt 244 (808)
T KOG0597|consen 174 EQPY---DHTSDLWSLGCILYELYVGQPPFYA--RSITQLVKSILKDPVKPP----STASSSFVNFLQGLLIKDPAQRLT 244 (808)
T ss_pred CCCc---cchhhHHHHHHHHHHHhcCCCCchH--HHHHHHHHHHhcCCCCCc----ccccHHHHHHHHHHhhcChhhccc
Confidence 8766 8999999999999999999999963 233445555554333322 367899999999999999999999
Q ss_pred HHHHHH
Q psy1840 180 LRFVHH 185 (423)
Q Consensus 180 ~~~I~~ 185 (423)
..+++.
T Consensus 245 W~~Ll~ 250 (808)
T KOG0597|consen 245 WTDLLG 250 (808)
T ss_pred HHHHhc
Confidence 988765
|
|
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.3e-24 Score=219.05 Aligned_cols=159 Identities=21% Similarity=0.244 Sum_probs=119.8
Q ss_pred HHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCccEEEeccCCcccccCCCcccccccccCCccccCCccccCCCCC
Q psy1840 25 SISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKAPELLRQPHLP 104 (423)
Q Consensus 25 ~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~ 104 (423)
.+.++.||+.||.|||+.|++ ||||||+|||++.++.+||+|||++................||..|+|||++.+..+
T Consensus 187 ~~~i~~ql~~aL~~LH~~giv-HrDlkp~Nill~~~~~~~l~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~- 264 (392)
T PHA03207 187 AITIQRRLLEALAYLHGRGII-HRDVKTENIFLDEPENAVLGDFGAACKLDAHPDTPQCYGWSGTLETNSPELLALDPY- 264 (392)
T ss_pred HHHHHHHHHHHHHHHHHCCcc-ccCCCHHHEEEcCCCCEEEccCccccccCcccccccccccccccCccCHhHhcCCCC-
Confidence 689999999999999999998 999999999999999999999999876543332222334578999999999987655
Q ss_pred CCCCccchHHHHHHHHHHHhCCCCCCCCCCC--hHHH---HHHHhcCC--------------------CCCCCC------
Q psy1840 105 RGTQKGDVYSFGLVLYEVIGRQGPWGHLRMT--DEEI---ITSVTQGS--------------------GLRPDT------ 153 (423)
Q Consensus 105 ~~s~ksDVyS~Giil~elltg~~Pf~~~~~~--~~~i---~~~i~~~~--------------------~~~p~~------ 153 (423)
+.++|||||||++|||++|+.||.+.... ...+ +..+.... ..++..
T Consensus 265 --~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 342 (392)
T PHA03207 265 --CAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQNGSTNLCKHFKQYAIVLRPPYTIPPVI 342 (392)
T ss_pred --CchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCccchhHHHHHHhhcccccCCccccchh
Confidence 88999999999999999999999653221 1111 11111000 011111
Q ss_pred CCCCchHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q psy1840 154 SSLDCAPSIIACMRTCWEEDPELRPDLRFVHHKL 187 (423)
Q Consensus 154 ~~~~~~~~l~~Li~~C~~~dP~~RPt~~~I~~~L 187 (423)
.....+.++.++|.+||..||++||++.+++..-
T Consensus 343 ~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~p 376 (392)
T PHA03207 343 RKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSLP 376 (392)
T ss_pred hccCcchhHHHHHHHHhccChhhCCCHHHHhhCc
Confidence 1123567889999999999999999999998753
|
|
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=99.92 E-value=3.1e-24 Score=202.16 Aligned_cols=150 Identities=23% Similarity=0.399 Sum_probs=121.0
Q ss_pred HHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCccEEEeccCCcccccCCCcccccccccCCccccCCccccCCCCC
Q psy1840 25 SISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKAPELLRQPHLP 104 (423)
Q Consensus 25 ~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~ 104 (423)
...++.|++.||.|||+.|++ ||||||+||+++.++.+||+|||++........ ......++..|+|||++.+..+
T Consensus 103 ~~~i~~~l~~al~~lH~~~i~-h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~- 178 (256)
T cd08529 103 VWRFFIQILLGLAHLHSKKIL-HRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTN--FANTIVGTPYYLSPELCEDKPY- 178 (256)
T ss_pred HHHHHHHHHHHHHHHHHCCcc-cCCCCcceEEEeCCCCEEEcccccceeccCccc--hhhccccCccccCHHHhcCCCC-
Confidence 578999999999999999998 999999999999999999999999875543221 1133457788999999987654
Q ss_pred CCCCccchHHHHHHHHHHHhCCCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCchHHHHHHHHHhhhcCCCCCCCHHHHH
Q psy1840 105 RGTQKGDVYSFGLVLYEVIGRQGPWGHLRMTDEEIITSVTQGSGLRPDTSSLDCAPSIIACMRTCWEEDPELRPDLRFVH 184 (423)
Q Consensus 105 ~~s~ksDVyS~Giil~elltg~~Pf~~~~~~~~~i~~~i~~~~~~~p~~~~~~~~~~l~~Li~~C~~~dP~~RPt~~~I~ 184 (423)
+.++|+||||+++|+|++|+.||... ...+....+..+. .+... ..++.++.+++.+||+.+|++||++.+++
T Consensus 179 --~~~~Di~slG~il~~l~~g~~p~~~~--~~~~~~~~~~~~~--~~~~~-~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll 251 (256)
T cd08529 179 --NEKSDVWALGVVLYECCTGKHPFDAN--NQGALILKIIRGV--FPPVS-QMYSQQLAQLIDQCLTKDYRQRPDTFQLL 251 (256)
T ss_pred --CCccchHHHHHHHHHHHhCCCCCCCC--CHHHHHHHHHcCC--CCCCc-cccCHHHHHHHHHHccCCcccCcCHHHHh
Confidence 78999999999999999999999643 3445555554432 22222 25788999999999999999999999987
Q ss_pred H
Q psy1840 185 H 185 (423)
Q Consensus 185 ~ 185 (423)
+
T Consensus 252 ~ 252 (256)
T cd08529 252 R 252 (256)
T ss_pred h
Confidence 5
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=99.92 E-value=3.9e-24 Score=203.25 Aligned_cols=156 Identities=26% Similarity=0.497 Sum_probs=123.6
Q ss_pred HHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCccEEEeccCCcccccCCCcccccccccCCccccCCccccCCCCC
Q psy1840 25 SISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKAPELLRQPHLP 104 (423)
Q Consensus 25 ~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~ 104 (423)
.+.++.|++.||.|||+.+++ ||||||+||+++.++.+||+|||.+......... ......++..|+|||...+..+
T Consensus 104 ~~~~~~~l~~aL~~lH~~~i~-H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~- 180 (262)
T cd05071 104 LVDMAAQIASGMAYVERMNYV-HRDLRAANILVGENLVCKVADFGLARLIEDNEYT-ARQGAKFPIKWTAPEAALYGRF- 180 (262)
T ss_pred HHHHHHHHHHHHHHHHHCCcc-ccccCcccEEEcCCCcEEeccCCceeeccccccc-cccCCcccceecCHhHhccCCC-
Confidence 578999999999999999998 9999999999999999999999998755322211 1122345567999998876554
Q ss_pred CCCCccchHHHHHHHHHHHh-CCCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCchHHHHHHHHHhhhcCCCCCCCHHHH
Q psy1840 105 RGTQKGDVYSFGLVLYEVIG-RQGPWGHLRMTDEEIITSVTQGSGLRPDTSSLDCAPSIIACMRTCWEEDPELRPDLRFV 183 (423)
Q Consensus 105 ~~s~ksDVyS~Giil~ellt-g~~Pf~~~~~~~~~i~~~i~~~~~~~p~~~~~~~~~~l~~Li~~C~~~dP~~RPt~~~I 183 (423)
+.++||||||+++||+++ |..||.. ....+....+..+.. +. ....++..+.+++.+||+.+|++||++.++
T Consensus 181 --~~~~DvwslG~~l~ellt~g~~p~~~--~~~~~~~~~~~~~~~--~~-~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~ 253 (262)
T cd05071 181 --TIKSDVWSFGILLTELTTKGRVPYPG--MVNREVLDQVERGYR--MP-CPPECPESLHDLMCQCWRKEPEERPTFEYL 253 (262)
T ss_pred --CchhhHHHHHHHHHHHHcCCCCCCCC--CChHHHHHHHhcCCC--CC-CccccCHHHHHHHHHHccCCcccCCCHHHH
Confidence 889999999999999999 7888864 334555555544321 11 123578899999999999999999999999
Q ss_pred HHHHHHH
Q psy1840 184 HHKLKEM 190 (423)
Q Consensus 184 ~~~L~~i 190 (423)
.+.|+..
T Consensus 254 ~~~l~~~ 260 (262)
T cd05071 254 QAFLEDY 260 (262)
T ss_pred HHHHHHh
Confidence 9988764
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=99.92 E-value=4.1e-25 Score=216.94 Aligned_cols=150 Identities=19% Similarity=0.288 Sum_probs=119.7
Q ss_pred HHHHHHHHHHHHHHHHh-CCCeeecCCCCCCEEEcCCccEEEeccCCcccccCCCcccccccccCCccccCCccccCCCC
Q psy1840 25 SISVNTTASVGMIHLHD-SEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKAPELLRQPHL 103 (423)
Q Consensus 25 ~l~i~~qi~~gL~yLH~-~~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~ 103 (423)
...++.||+.||.|||+ .|++ ||||||+|||++.++.+||+|||+++....... ......|++.|+|||++.+..+
T Consensus 97 ~~~~~~qi~~aL~~lH~~~~iv-HrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~ 173 (325)
T cd05594 97 ARFYGAEIVSALDYLHSEKNVV-YRDLKLENLMLDKDGHIKITDFGLCKEGIKDGA--TMKTFCGTPEYLAPEVLEDNDY 173 (325)
T ss_pred HHHHHHHHHHHHHHHHhcCCEE-ecCCCCCeEEECCCCCEEEecCCCCeecCCCCc--ccccccCCcccCCHHHHccCCC
Confidence 56889999999999997 6887 999999999999999999999999864322211 1234568899999999987655
Q ss_pred CCCCCccchHHHHHHHHHHHhCCCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCchHHHHHHHHHhhhcCCCCCC-----
Q psy1840 104 PRGTQKGDVYSFGLVLYEVIGRQGPWGHLRMTDEEIITSVTQGSGLRPDTSSLDCAPSIIACMRTCWEEDPELRP----- 178 (423)
Q Consensus 104 ~~~s~ksDVyS~Giil~elltg~~Pf~~~~~~~~~i~~~i~~~~~~~p~~~~~~~~~~l~~Li~~C~~~dP~~RP----- 178 (423)
+.++|||||||++|||++|..||.. ....++...+.......| ..+++++.+++.+||+.||++|+
T Consensus 174 ---~~~~DiwslG~il~el~tG~~Pf~~--~~~~~~~~~i~~~~~~~p----~~~~~~~~~li~~~L~~dP~~R~~~~~~ 244 (325)
T cd05594 174 ---GRAVDWWGLGVVMYEMMCGRLPFYN--QDHEKLFELILMEEIRFP----RTLSPEAKSLLSGLLKKDPKQRLGGGPD 244 (325)
T ss_pred ---CCccccccccceeeeeccCCCCCCC--CCHHHHHHHHhcCCCCCC----CCCCHHHHHHHHHHhhcCHHHhCCCCCC
Confidence 8999999999999999999999964 334555555544332222 24688999999999999999996
Q ss_pred CHHHHHHH
Q psy1840 179 DLRFVHHK 186 (423)
Q Consensus 179 t~~~I~~~ 186 (423)
++.++++.
T Consensus 245 ~~~~il~h 252 (325)
T cd05594 245 DAKEIMQH 252 (325)
T ss_pred CHHHHhcC
Confidence 88887653
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.5e-24 Score=208.34 Aligned_cols=152 Identities=20% Similarity=0.229 Sum_probs=115.7
Q ss_pred HHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCccEEEeccCCcccccCCCcccccccccCCccccCCccccCCCCC
Q psy1840 25 SISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKAPELLRQPHLP 104 (423)
Q Consensus 25 ~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~ 104 (423)
...++.|++.||.|||+.|++ ||||||+||+++.++.+||+|||++........ .....++..|+|||.+.+..+
T Consensus 110 ~~~~~~qi~~al~~lH~~~iv-H~dikp~Nili~~~~~~kl~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~- 184 (288)
T cd07863 110 IKDLMRQFLRGLDFLHANCIV-HRDLKPENILVTSGGQVKLADFGLARIYSCQMA---LTPVVVTLWYRAPEVLLQSTY- 184 (288)
T ss_pred HHHHHHHHHHHHHHHHhCCee-cCCCCHHHEEECCCCCEEECccCccccccCccc---CCCccccccccCchHhhCCCC-
Confidence 578999999999999999988 999999999999999999999999876532211 123457888999999977654
Q ss_pred CCCCccchHHHHHHHHHHHhCCCCCCCCCCChHHHHHHHhcCC-----------------CCCCC------CCCCCchHH
Q psy1840 105 RGTQKGDVYSFGLVLYEVIGRQGPWGHLRMTDEEIITSVTQGS-----------------GLRPD------TSSLDCAPS 161 (423)
Q Consensus 105 ~~s~ksDVyS~Giil~elltg~~Pf~~~~~~~~~i~~~i~~~~-----------------~~~p~------~~~~~~~~~ 161 (423)
+.++|||||||++|||++|..||... ...+....+.... ...+. .....++..
T Consensus 185 --~~~~DiwslG~~l~~l~~g~~~f~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (288)
T cd07863 185 --ATPVDMWSVGCIFAEMFRRKPLFCGN--SEADQLGKIFDLIGLPPEDDWPRDVTLPRGAFSPRGPRPVQSVVPEIEES 260 (288)
T ss_pred --CCcchhhhHHHHHHHHHhCCcCcCCC--CHHHHHHHHHHHhCCCChhhCcccccccccccCCCCCCchHHhCcCcCHH
Confidence 89999999999999999999998643 2222222221100 00000 001246778
Q ss_pred HHHHHHHhhhcCCCCCCCHHHHHH
Q psy1840 162 IIACMRTCWEEDPELRPDLRFVHH 185 (423)
Q Consensus 162 l~~Li~~C~~~dP~~RPt~~~I~~ 185 (423)
+.+++.+|++.||++|||+.+++.
T Consensus 261 ~~~li~~~L~~dP~~R~t~~~~l~ 284 (288)
T cd07863 261 GAQLLLEMLTFNPHKRISAFRALQ 284 (288)
T ss_pred HHHHHHHHhccCcccCCCHHHHhc
Confidence 999999999999999999998875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.4e-24 Score=208.35 Aligned_cols=157 Identities=24% Similarity=0.469 Sum_probs=118.5
Q ss_pred HHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCccEEEeccCCcccccCCCcccccccccCCccccCCccccCCCCC
Q psy1840 25 SISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKAPELLRQPHLP 104 (423)
Q Consensus 25 ~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~ 104 (423)
...++.|++.|++|||+.|++ ||||||+||+++.++.++|+|||++................++..|++||...++.+
T Consensus 132 ~~~~~~~i~~al~~lH~~~i~-H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~- 209 (296)
T cd05095 132 LIFMATQIASGMKYLSSLNFV-HRDLATRNCLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKF- 209 (296)
T ss_pred HHHHHHHHHHHHHHHHHCCee-cccCChheEEEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCc-
Confidence 678999999999999999988 999999999999999999999999875432221111122334567999998776554
Q ss_pred CCCCccchHHHHHHHHHHHh--CCCCCCCCCCChHHHHHHHhc-----CCCCCCCCCCCCchHHHHHHHHHhhhcCCCCC
Q psy1840 105 RGTQKGDVYSFGLVLYEVIG--RQGPWGHLRMTDEEIITSVTQ-----GSGLRPDTSSLDCAPSIIACMRTCWEEDPELR 177 (423)
Q Consensus 105 ~~s~ksDVyS~Giil~ellt--g~~Pf~~~~~~~~~i~~~i~~-----~~~~~p~~~~~~~~~~l~~Li~~C~~~dP~~R 177 (423)
+.++|||||||++|||++ |..||.. .+..+++..... ....... ....+++.+.+++.+||+.||++|
T Consensus 210 --~~~~DiwSlG~~l~el~~~~~~~p~~~--~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~cl~~~p~~R 284 (296)
T cd05095 210 --TTASDVWAFGVTLWEILTLCKEQPYSQ--LSDEQVIENTGEFFRDQGRQVYLP-KPALCPDSLYKLMLSCWRRNAKER 284 (296)
T ss_pred --cchhhhhHHHHHHHHHHHhCCCCCccc--cChHHHHHHHHHHHhhccccccCC-CCCCCCHHHHHHHHHHcCCCcccC
Confidence 889999999999999998 6678753 334444433221 1111111 123577899999999999999999
Q ss_pred CCHHHHHHHHH
Q psy1840 178 PDLRFVHHKLK 188 (423)
Q Consensus 178 Pt~~~I~~~L~ 188 (423)
|++.+|.+.|+
T Consensus 285 p~~~~i~~~l~ 295 (296)
T cd05095 285 PSFQEIHATLL 295 (296)
T ss_pred CCHHHHHHHHh
Confidence 99999998875
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.5e-24 Score=211.94 Aligned_cols=153 Identities=22% Similarity=0.348 Sum_probs=116.8
Q ss_pred HHHHHHHHHHHHHHHHhCC-CeeecCCCCCCEEEcCCccEEEeccCCcccccCCCcccccccccCCccccCCccccCCCC
Q psy1840 25 SISVNTTASVGMIHLHDSE-IISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKAPELLRQPHL 103 (423)
Q Consensus 25 ~l~i~~qi~~gL~yLH~~~-ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~ 103 (423)
...++.|++.||.|||+.+ ++ ||||||+||+++.++.+||+|||++....... .....++..|+|||.+.+..+
T Consensus 105 ~~~~~~~i~~~l~~lH~~~~iv-H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~----~~~~~g~~~y~aPE~~~~~~~ 179 (331)
T cd06649 105 LGKVSIAVLRGLAYLREKHQIM-HRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM----ANSFVGTRSYMSPERLQGTHY 179 (331)
T ss_pred HHHHHHHHHHHHHHHhhcCCEE-cCCCChhhEEEcCCCcEEEccCcccccccccc----cccCCCCcCcCCHhHhcCCCC
Confidence 4688999999999999874 65 99999999999999999999999987543221 234568889999999987654
Q ss_pred CCCCCccchHHHHHHHHHHHhCCCCCCCCCCChHHHHHHHhcC-------------------------------------
Q psy1840 104 PRGTQKGDVYSFGLVLYEVIGRQGPWGHLRMTDEEIITSVTQG------------------------------------- 146 (423)
Q Consensus 104 ~~~s~ksDVyS~Giil~elltg~~Pf~~~~~~~~~i~~~i~~~------------------------------------- 146 (423)
+.++|||||||++|||++|+.||.... ..++...+...
T Consensus 180 ---~~~~DiwslG~il~el~tg~~p~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (331)
T cd06649 180 ---SVQSDIWSMGLSLVELAIGRYPIPPPD--AKELEAIFGRPVVDGEEGEPHSISPRPRPPGRPVSGHGMDSRPAMAIF 254 (331)
T ss_pred ---CchHhHHHHHHHHHHHHhCCCCCCCCC--HHHHHHHhcccccccccCCccccCcccccccccccccccccccchhHH
Confidence 889999999999999999999996322 22222111100
Q ss_pred -------CCCCCCCCCCCchHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q psy1840 147 -------SGLRPDTSSLDCAPSIIACMRTCWEEDPELRPDLRFVHHKL 187 (423)
Q Consensus 147 -------~~~~p~~~~~~~~~~l~~Li~~C~~~dP~~RPt~~~I~~~L 187 (423)
....|......+++++.+++.+||+.||++|||+.+|++..
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h~ 302 (331)
T cd06649 255 ELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNHT 302 (331)
T ss_pred HHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcCh
Confidence 00112222234678999999999999999999999998754
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.92 E-value=8.3e-25 Score=223.75 Aligned_cols=154 Identities=19% Similarity=0.197 Sum_probs=114.8
Q ss_pred HHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCc-cEEEeccCCcccccCCCcccccccccCCccccCCccccCCCC
Q psy1840 25 SISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRW-VLQIADFGLHAFKAGQDETGQERKLRRRKLYKAPELLRQPHL 103 (423)
Q Consensus 25 ~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~-~vKL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~ 103 (423)
...++.||+.||.|||+.+++ ||||||+|||++.++ .+||+|||+++....... .....+++.|+|||++.+..
T Consensus 172 ~~~~~~qi~~gL~yLH~~~Ii-HrDLKp~NILl~~~~~~vkL~DFGla~~~~~~~~---~~~~~~t~~y~aPE~~~~~~- 246 (440)
T PTZ00036 172 VKLYSYQLCRALAYIHSKFIC-HRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQR---SVSYICSRFYRAPELMLGAT- 246 (440)
T ss_pred HHHHHHHHHHHHHHHHHCCEe-cCCcCHHHEEEcCCCCceeeeccccchhccCCCC---cccCCCCcCccCHHHhcCCC-
Confidence 467889999999999999988 999999999999664 799999999876543221 12346788999999987643
Q ss_pred CCCCCccchHHHHHHHHHHHhCCCCCCCCCCChHHHHHHHhcC--C---------------CCCCCC--------CCCCc
Q psy1840 104 PRGTQKGDVYSFGLVLYEVIGRQGPWGHLRMTDEEIITSVTQG--S---------------GLRPDT--------SSLDC 158 (423)
Q Consensus 104 ~~~s~ksDVyS~Giil~elltg~~Pf~~~~~~~~~i~~~i~~~--~---------------~~~p~~--------~~~~~ 158 (423)
.++.++|||||||++|||++|..||.+.. ..+.+..+... . ...|.. .+...
T Consensus 247 -~~~~~~DiwSlGvil~elltG~~pf~~~~--~~~~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~ 323 (440)
T PTZ00036 247 -NYTTHIDLWSLGCIIAEMILGYPIFSGQS--SVDQLVRIIQVLGTPTEDQLKEMNPNYADIKFPDVKPKDLKKVFPKGT 323 (440)
T ss_pred -CCCcHHHHHHHHHHHHHHHhCCCCCCCCC--hHHHHHHHHHHhCCCCHHHHHHhchhhhcccCCccCchhHHHHhccCC
Confidence 23889999999999999999999997532 22222222110 0 000111 11235
Q ss_pred hHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q psy1840 159 APSIIACMRTCWEEDPELRPDLRFVHHK 186 (423)
Q Consensus 159 ~~~l~~Li~~C~~~dP~~RPt~~~I~~~ 186 (423)
+.++.+|+.+||..||.+|||+.+++..
T Consensus 324 ~~~~~~li~~~L~~dP~~R~ta~e~l~h 351 (440)
T PTZ00036 324 PDDAINFISQFLKYEPLKRLNPIEALAD 351 (440)
T ss_pred CHHHHHHHHHHCCCChhHCcCHHHHhCC
Confidence 7889999999999999999999998754
|
|
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.92 E-value=3.4e-24 Score=202.85 Aligned_cols=154 Identities=19% Similarity=0.343 Sum_probs=119.4
Q ss_pred HHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCccEEEeccCCcccccCCCccc-ccccccCCccccCCccccCCCC
Q psy1840 25 SISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETG-QERKLRRRKLYKAPELLRQPHL 103 (423)
Q Consensus 25 ~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~~~-~~~~~~gt~~y~APE~l~~~~~ 103 (423)
...++.|++.|+.|||+.|++ ||||+|+||+++.++.++|+|||+++......... ......++..|+|||.+.+...
T Consensus 106 ~~~~~~~l~~~l~~lH~~~i~-H~dl~p~nilv~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~ 184 (263)
T cd06625 106 TRKYTRQILEGVEYLHSNMIV-HRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPEVISGEGY 184 (263)
T ss_pred HHHHHHHHHHHHHHHHhCCee-cCCCCHHHEEEcCCCCEEEeecccceeccccccccccccCCCcCccccCcceeccCCC
Confidence 578999999999999999998 99999999999999999999999986543221111 1123456778999999987654
Q ss_pred CCCCCccchHHHHHHHHHHHhCCCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCchHHHHHHHHHhhhcCCCCCCCHHHH
Q psy1840 104 PRGTQKGDVYSFGLVLYEVIGRQGPWGHLRMTDEEIITSVTQGSGLRPDTSSLDCAPSIIACMRTCWEEDPELRPDLRFV 183 (423)
Q Consensus 104 ~~~s~ksDVyS~Giil~elltg~~Pf~~~~~~~~~i~~~i~~~~~~~p~~~~~~~~~~l~~Li~~C~~~dP~~RPt~~~I 183 (423)
+.++||||||+++||+++|+.||... ............. ..+. .+..++..+.+++.+||..+|++|||+.++
T Consensus 185 ---~~~~Di~slG~il~el~~g~~p~~~~--~~~~~~~~~~~~~-~~~~-~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l 257 (263)
T cd06625 185 ---GRKADVWSVGCTVVEMLTEKPPWAEF--EAMAAIFKIATQP-TNPQ-LPSHVSPDARNFLRRTFVENAKKRPSAEEL 257 (263)
T ss_pred ---CchhhhHHHHHHHHHHHhCCCCcccc--chHHHHHHHhccC-CCCC-CCccCCHHHHHHHHHHhhcCcccCCCHHHH
Confidence 89999999999999999999999643 2233333333222 1222 233578899999999999999999999998
Q ss_pred HHH
Q psy1840 184 HHK 186 (423)
Q Consensus 184 ~~~ 186 (423)
+..
T Consensus 258 l~~ 260 (263)
T cd06625 258 LRH 260 (263)
T ss_pred hhC
Confidence 764
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.92 E-value=8.1e-25 Score=216.58 Aligned_cols=153 Identities=23% Similarity=0.263 Sum_probs=121.0
Q ss_pred HHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCccEEEeccCCcccccCCC--------------------------
Q psy1840 25 SISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQD-------------------------- 78 (423)
Q Consensus 25 ~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~-------------------------- 78 (423)
...++.||+.||.|||+.|++ ||||||+||+++.++.+||+|||++.......
T Consensus 103 ~~~i~~qi~~aL~~LH~~gii-H~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 181 (350)
T cd05573 103 ARFYIAELVLALDSVHKLGFI-HRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVRRRDHK 181 (350)
T ss_pred HHHHHHHHHHHHHHHHHCCee-ccCCCHHHeEECCCCCEEeecCCCCccCcccCcccccccccccccccccccccccccc
Confidence 568899999999999999998 99999999999999999999999987543322
Q ss_pred -cccccccccCCccccCCccccCCCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCChHHHHHHHhcC--CCCCCCCCC
Q psy1840 79 -ETGQERKLRRRKLYKAPELLRQPHLPRGTQKGDVYSFGLVLYEVIGRQGPWGHLRMTDEEIITSVTQG--SGLRPDTSS 155 (423)
Q Consensus 79 -~~~~~~~~~gt~~y~APE~l~~~~~~~~s~ksDVyS~Giil~elltg~~Pf~~~~~~~~~i~~~i~~~--~~~~p~~~~ 155 (423)
.........|++.|+|||++.+..+ +.++|||||||++|||++|+.||... ...+....+... ....|..
T Consensus 182 ~~~~~~~~~~gt~~y~aPE~~~~~~~---~~~~DiwSlG~il~ell~g~~Pf~~~--~~~~~~~~i~~~~~~~~~p~~-- 254 (350)
T cd05573 182 QRRVRANSTVGTPDYIAPEVLRGTPY---GLECDWWSLGVILYEMLYGFPPFYSD--TLQETYNKIINWKESLRFPPD-- 254 (350)
T ss_pred cccccccccccCccccCHHHHcCCCC---CCceeeEecchhhhhhccCCCCCCCC--CHHHHHHHHhccCCcccCCCC--
Confidence 0011234568899999999988755 89999999999999999999999753 344455555442 1122221
Q ss_pred CCchHHHHHHHHHhhhcCCCCCCC-HHHHHHH
Q psy1840 156 LDCAPSIIACMRTCWEEDPELRPD-LRFVHHK 186 (423)
Q Consensus 156 ~~~~~~l~~Li~~C~~~dP~~RPt-~~~I~~~ 186 (423)
..+++++.+++.+||. ||.+||+ +.++++.
T Consensus 255 ~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~h 285 (350)
T cd05573 255 PPVSPEAIDLICRLLC-DPEDRLGSFEEIKSH 285 (350)
T ss_pred CCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcC
Confidence 2378999999999997 9999999 9998764
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.3e-24 Score=209.03 Aligned_cols=157 Identities=21% Similarity=0.355 Sum_probs=118.1
Q ss_pred HHHHHHHHHHHHHHHHhC-CCeeecCCCCCCEEEcCCccEEEeccCCcccccCCCcccccccccCCccccCCccccCCCC
Q psy1840 25 SISVNTTASVGMIHLHDS-EIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKAPELLRQPHL 103 (423)
Q Consensus 25 ~l~i~~qi~~gL~yLH~~-~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~ 103 (423)
...++.|++.||+|||+. +++ ||||||+||+++.++.+||+|||++........ .....++..|+|||.+.+...
T Consensus 109 ~~~i~~~i~~~l~~lh~~~~i~-H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~ 184 (288)
T cd06616 109 LGKIAVATVKALNYLKEELKII-HRDVKPSNILLDRNGNIKLCDFGISGQLVDSIA---KTRDAGCRPYMAPERIDPSAR 184 (288)
T ss_pred HHHHHHHHHHHHHHHhhcCCee-ccCCCHHHEEEccCCcEEEeecchhHHhccCCc---cccccCccCccCHHHhccccc
Confidence 578999999999999985 777 999999999999999999999999875432221 123357788999999876521
Q ss_pred CCCCCccchHHHHHHHHHHHhCCCCCCCCCCChHHHHHHHhcCC-CCCCCCCCCCchHHHHHHHHHhhhcCCCCCCCHHH
Q psy1840 104 PRGTQKGDVYSFGLVLYEVIGRQGPWGHLRMTDEEIITSVTQGS-GLRPDTSSLDCAPSIIACMRTCWEEDPELRPDLRF 182 (423)
Q Consensus 104 ~~~s~ksDVyS~Giil~elltg~~Pf~~~~~~~~~i~~~i~~~~-~~~p~~~~~~~~~~l~~Li~~C~~~dP~~RPt~~~ 182 (423)
..++.++||||||+++||+++|+.||.... ...+.+..+..+. +..+......++.++.+++.+||+.+|++|||+.+
T Consensus 185 ~~~~~~~Di~slG~il~el~~g~~p~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~ 263 (288)
T cd06616 185 DGYDVRSDVWSLGITLYEVATGKFPYPKWN-SVFDQLTQVVKGDPPILSNSEEREFSPSFVNFINLCLIKDESKRPKYKE 263 (288)
T ss_pred cCCcchhhhhHHHHHHHHHHhCCCCchhcc-hHHHHHhhhcCCCCCcCCCcCCCccCHHHHHHHHHHccCChhhCcCHHH
Confidence 134889999999999999999999996433 1122222222221 11122222357899999999999999999999999
Q ss_pred HHHH
Q psy1840 183 VHHK 186 (423)
Q Consensus 183 I~~~ 186 (423)
|+..
T Consensus 264 i~~~ 267 (288)
T cd06616 264 LLEH 267 (288)
T ss_pred HhcC
Confidence 8764
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.4e-24 Score=208.13 Aligned_cols=152 Identities=19% Similarity=0.302 Sum_probs=118.5
Q ss_pred HHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCccEEEeccCCcccccCCCcccccccccCCccccCCccccCCCCC
Q psy1840 25 SISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKAPELLRQPHLP 104 (423)
Q Consensus 25 ~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~ 104 (423)
.+.++.||+.||+|||+.|++ ||||||+||+++.++.+||+|||++....... ......++..|+|||++.+..+
T Consensus 97 ~~~~~~qi~~al~~lH~~~iv-H~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~- 171 (277)
T cd05607 97 VIHYSAQITCGILHLHSMDIV-YRDMKPENVLLDDQGNCRLSDLGLAVELKDGK---TITQRAGTNGYMAPEILKEEPY- 171 (277)
T ss_pred HHHHHHHHHHHHHHHHHCCEE-EccCChHhEEEcCCCCEEEeeceeeeecCCCc---eeeccCCCCCccCHHHHccCCC-
Confidence 467899999999999999998 99999999999999999999999987553221 1123467889999999987654
Q ss_pred CCCCccchHHHHHHHHHHHhCCCCCCCCCC--ChHHHHHHHhcCCCCCCCCCCCCchHHHHHHHHHhhhcCCCCCCCHHH
Q psy1840 105 RGTQKGDVYSFGLVLYEVIGRQGPWGHLRM--TDEEIITSVTQGSGLRPDTSSLDCAPSIIACMRTCWEEDPELRPDLRF 182 (423)
Q Consensus 105 ~~s~ksDVyS~Giil~elltg~~Pf~~~~~--~~~~i~~~i~~~~~~~p~~~~~~~~~~l~~Li~~C~~~dP~~RPt~~~ 182 (423)
+.++||||+||++|||++|..||..... ...++.......... .....++.++.+++.+||+.||++||++.+
T Consensus 172 --~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~li~~~L~~~P~~R~~~~~ 246 (277)
T cd05607 172 --SYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLEDEVK---FEHQNFTEESKDICRLFLAKKPEDRLGSRE 246 (277)
T ss_pred --CCchhHHHHHHHHHHHHhCCCCCCCCcchhhHHHHHHHhhccccc---cccccCCHHHHHHHHHHhccCHhhCCCCcc
Confidence 8999999999999999999999964322 223333333322211 122357889999999999999999999977
Q ss_pred HHHH
Q psy1840 183 VHHK 186 (423)
Q Consensus 183 I~~~ 186 (423)
+.+.
T Consensus 247 ~~~~ 250 (277)
T cd05607 247 KNDD 250 (277)
T ss_pred chhh
Confidence 6543
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=99.91 E-value=2.9e-24 Score=203.47 Aligned_cols=155 Identities=28% Similarity=0.533 Sum_probs=123.4
Q ss_pred HHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCccEEEeccCCcccccCCCcccccccccCCccccCCccccCCCCC
Q psy1840 25 SISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKAPELLRQPHLP 104 (423)
Q Consensus 25 ~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~ 104 (423)
.+.++.|++.||+|||+.|++ ||||||+||+++.++.++|+|||++........ .......++..|+|||.+.+...
T Consensus 104 ~~~i~~~i~~al~~LH~~~i~-H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~-~~~~~~~~~~~y~~pe~~~~~~~- 180 (260)
T cd05067 104 LIDMAAQIAEGMAFIERKNYI-HRDLRAANILVSETLCCKIADFGLARLIEDNEY-TAREGAKFPIKWTAPEAINYGTF- 180 (260)
T ss_pred HHHHHHHHHHHHHHHhcCCee-cccccHHhEEEcCCCCEEEccCcceeecCCCCc-ccccCCcccccccCHHHhccCCc-
Confidence 578999999999999999987 999999999999999999999999865432211 11122334567999999876654
Q ss_pred CCCCccchHHHHHHHHHHHh-CCCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCchHHHHHHHHHhhhcCCCCCCCHHHH
Q psy1840 105 RGTQKGDVYSFGLVLYEVIG-RQGPWGHLRMTDEEIITSVTQGSGLRPDTSSLDCAPSIIACMRTCWEEDPELRPDLRFV 183 (423)
Q Consensus 105 ~~s~ksDVyS~Giil~ellt-g~~Pf~~~~~~~~~i~~~i~~~~~~~p~~~~~~~~~~l~~Li~~C~~~dP~~RPt~~~I 183 (423)
+.++||||||+++||+++ |..||.. .+..+....+..+.. +. ....++.++.+++.+||+.+|++||++.++
T Consensus 181 --~~~~Di~slG~~l~el~~~g~~p~~~--~~~~~~~~~~~~~~~--~~-~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l 253 (260)
T cd05067 181 --TIKSDVWSFGILLTEIVTYGRIPYPG--MTNPEVIQNLERGYR--MP-RPDNCPEELYELMRLCWKEKPEERPTFEYL 253 (260)
T ss_pred --CcccchHHHHHHHHHHHhCCCCCCCC--CChHHHHHHHHcCCC--CC-CCCCCCHHHHHHHHHHccCChhhCCCHHHH
Confidence 889999999999999998 9999974 345566666655422 22 223578899999999999999999999999
Q ss_pred HHHHHH
Q psy1840 184 HHKLKE 189 (423)
Q Consensus 184 ~~~L~~ 189 (423)
...|+.
T Consensus 254 ~~~l~~ 259 (260)
T cd05067 254 RSVLED 259 (260)
T ss_pred HHHhhc
Confidence 988864
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=99.91 E-value=6.4e-25 Score=215.58 Aligned_cols=147 Identities=20% Similarity=0.242 Sum_probs=117.8
Q ss_pred HHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCccEEEeccCCcccccCCCcccccccccCCccccCCccccCCCCC
Q psy1840 25 SISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKAPELLRQPHLP 104 (423)
Q Consensus 25 ~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~ 104 (423)
...++.||+.||.|||+.|++ ||||||+||+++.++.+||+|||+++...... .......|++.|+|||++.+..+
T Consensus 98 ~~~~~~qi~~~L~~lH~~gii-HrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~- 173 (325)
T cd05602 98 ARFYAAEIASALGYLHSLNIV-YRDLKPENILLDSQGHIVLTDFGLCKENIEHN--GTTSTFCGTPEYLAPEVLHKQPY- 173 (325)
T ss_pred HHHHHHHHHHHHHHHHHCCeE-ecCCCHHHeEECCCCCEEEccCCCCcccccCC--CCcccccCCccccCHHHHcCCCC-
Confidence 356889999999999999998 99999999999999999999999986432211 12234568999999999987655
Q ss_pred CCCCccchHHHHHHHHHHHhCCCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCchHHHHHHHHHhhhcCCCCCCCHHHH
Q psy1840 105 RGTQKGDVYSFGLVLYEVIGRQGPWGHLRMTDEEIITSVTQGSGLRPDTSSLDCAPSIIACMRTCWEEDPELRPDLRFV 183 (423)
Q Consensus 105 ~~s~ksDVyS~Giil~elltg~~Pf~~~~~~~~~i~~~i~~~~~~~p~~~~~~~~~~l~~Li~~C~~~dP~~RPt~~~I 183 (423)
+.++|||||||++|||++|..||.. ....+....+...... ....++..+.+++.+||+.||.+||+..+.
T Consensus 174 --~~~~DiwslG~il~el~~g~~pf~~--~~~~~~~~~i~~~~~~----~~~~~~~~~~~li~~~l~~~p~~R~~~~~~ 244 (325)
T cd05602 174 --DRTVDWWCLGAVLYEMLYGLPPFYS--RNTAEMYDNILNKPLQ----LKPNITNSARHLLEGLLQKDRTKRLGAKDD 244 (325)
T ss_pred --CCccccccccHHHHHHhcCCCCCCC--CCHHHHHHHHHhCCcC----CCCCCCHHHHHHHHHHcccCHHHCCCCCCC
Confidence 8899999999999999999999974 3445555555543221 123578899999999999999999987643
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=99.91 E-value=2.1e-24 Score=214.86 Aligned_cols=155 Identities=20% Similarity=0.252 Sum_probs=114.8
Q ss_pred HHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCccEEEeccCCcccccCCCcccccccccCCccccCCccccCCCCC
Q psy1840 25 SISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKAPELLRQPHLP 104 (423)
Q Consensus 25 ~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~ 104 (423)
...++.|++.||.|||++|++ ||||||+||+++.++.+||+|||+++...... ......++..|+|||.+.+..+
T Consensus 125 ~~~~~~qi~~~L~~LH~~~iv-HrDlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~- 199 (359)
T cd07876 125 MSYLLYQMLCGIKHLHSAGII-HRDLKPSNIVVKSDCTLKILDFGLARTACTNF---MMTPYVVTRYYRAPEVILGMGY- 199 (359)
T ss_pred HHHHHHHHHHHHHHHHhCCcc-cCCCCHHHEEECCCCCEEEecCCCccccccCc---cCCCCcccCCCCCchhccCCCC-
Confidence 457899999999999999998 99999999999999999999999986542221 1233467889999999987655
Q ss_pred CCCCccchHHHHHHHHHHHhCCCCCCCCCCCh-------------HHHHH-------HHhcCCCCCCCC-----------
Q psy1840 105 RGTQKGDVYSFGLVLYEVIGRQGPWGHLRMTD-------------EEIIT-------SVTQGSGLRPDT----------- 153 (423)
Q Consensus 105 ~~s~ksDVyS~Giil~elltg~~Pf~~~~~~~-------------~~i~~-------~i~~~~~~~p~~----------- 153 (423)
+.++|||||||++|+|++|+.||....... .++.. ......+..+..
T Consensus 200 --~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 277 (359)
T cd07876 200 --KENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRLQPTVRNYVENRPQYPGISFEELFPDWIF 277 (359)
T ss_pred --CcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHhhCCCCCCcchhhhcccccc
Confidence 889999999999999999999997532100 00000 000111010000
Q ss_pred -----CCCCchHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q psy1840 154 -----SSLDCAPSIIACMRTCWEEDPELRPDLRFVHHK 186 (423)
Q Consensus 154 -----~~~~~~~~l~~Li~~C~~~dP~~RPt~~~I~~~ 186 (423)
.....+..+.+++.+||+.||++|||+.+++..
T Consensus 278 ~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 315 (359)
T cd07876 278 PSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRH 315 (359)
T ss_pred ccccccccccchhHHHHHHHHhccCcccCCCHHHHhcC
Confidence 011235678999999999999999999999864
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >KOG0596|consensus | Back alignment and domain information |
|---|
Probab=99.91 E-value=7.9e-25 Score=216.58 Aligned_cols=153 Identities=21% Similarity=0.321 Sum_probs=120.0
Q ss_pred HHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCccEEEeccCCcccccCCCcccccccccCCccccCCccccCCCC-
Q psy1840 25 SISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKAPELLRQPHL- 103 (423)
Q Consensus 25 ~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~- 103 (423)
...+-.|++.++.++|..||| |.||||.|.|+-+ |.+||+|||++...............+||+.||+||.+.....
T Consensus 462 lk~ywkqML~aV~~IH~~gIV-HSDLKPANFLlVk-G~LKLIDFGIA~aI~~DTTsI~kdsQvGT~NYMsPEAl~~~~s~ 539 (677)
T KOG0596|consen 462 LKFYWKQMLLAVKTIHQHGIV-HSDLKPANFLLVK-GRLKLIDFGIANAIQPDTTSIVKDSQVGTVNYMSPEALTDMSSS 539 (677)
T ss_pred HHHHHHHHHHHHHHHHHhcee-ecCCCcccEEEEe-eeEEeeeechhcccCccccceeeccccCcccccCHHHHhhcccc
Confidence 456788999999999999998 9999999998854 7899999999988766655555677899999999999975332
Q ss_pred -------CCCCCccchHHHHHHHHHHHhCCCCCCCCCCChHHHHHHHhc---C--CCCCCCCCCCCchHHHHHHHHHhhh
Q psy1840 104 -------PRGTQKGDVYSFGLVLYEVIGRQGPWGHLRMTDEEIITSVTQ---G--SGLRPDTSSLDCAPSIIACMRTCWE 171 (423)
Q Consensus 104 -------~~~s~ksDVyS~Giil~elltg~~Pf~~~~~~~~~i~~~i~~---~--~~~~p~~~~~~~~~~l~~Li~~C~~ 171 (423)
.+.++++||||+|||||+|+.|+.||++. ...+.++.. . ....|..+. ..++.++|+.||+
T Consensus 540 ~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~----~n~~aKl~aI~~P~~~Iefp~~~~---~~~li~~mK~CL~ 612 (677)
T KOG0596|consen 540 RENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQI----INQIAKLHAITDPNHEIEFPDIPE---NDELIDVMKCCLA 612 (677)
T ss_pred ccCCCcceeecCccchhhhhhHHHHHHhcCCchHHH----HHHHHHHHhhcCCCccccccCCCC---chHHHHHHHHHHh
Confidence 13478999999999999999999999743 223333321 1 112333332 3349999999999
Q ss_pred cCCCCCCCHHHHHHH
Q psy1840 172 EDPELRPDLRFVHHK 186 (423)
Q Consensus 172 ~dP~~RPt~~~I~~~ 186 (423)
.||.+||++.++++.
T Consensus 613 rdPkkR~si~eLLqh 627 (677)
T KOG0596|consen 613 RDPKKRWSIPELLQH 627 (677)
T ss_pred cCcccCCCcHHHhcC
Confidence 999999999999874
|
|
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=99.91 E-value=3.3e-24 Score=205.69 Aligned_cols=156 Identities=19% Similarity=0.254 Sum_probs=119.4
Q ss_pred HHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCccEEEeccCCcccccCCCcccccccccCCccccCCccccCCC--
Q psy1840 25 SISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKAPELLRQPH-- 102 (423)
Q Consensus 25 ~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~-- 102 (423)
...++.|++.||.|||+.|++ ||||||+||+++.++.+||+|||++....... .......++..|+|||.+....
T Consensus 105 ~~~~~~qi~~~L~~LH~~~i~-H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~ 181 (282)
T cd06643 105 IRVVCKQTLEALNYLHENKII-HRDLKAGNILFTLDGDIKLADFGVSAKNTRTI--QRRDSFIGTPYWMAPEVVMCETSK 181 (282)
T ss_pred HHHHHHHHHHHHHHHHHCCee-ecCCCcccEEEccCCCEEEccccccccccccc--cccccccccccccCHhhccccCCC
Confidence 678999999999999999998 99999999999999999999999986543221 1123446788899999985321
Q ss_pred CCCCCCccchHHHHHHHHHHHhCCCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCchHHHHHHHHHhhhcCCCCCCCHHH
Q psy1840 103 LPRGTQKGDVYSFGLVLYEVIGRQGPWGHLRMTDEEIITSVTQGSGLRPDTSSLDCAPSIIACMRTCWEEDPELRPDLRF 182 (423)
Q Consensus 103 ~~~~s~ksDVyS~Giil~elltg~~Pf~~~~~~~~~i~~~i~~~~~~~p~~~~~~~~~~l~~Li~~C~~~dP~~RPt~~~ 182 (423)
....+.++|||||||++|||++|+.||... +..+....+......... .+..++.++.+++.+||+.+|++||++.+
T Consensus 182 ~~~~~~~~Dv~slGvil~el~~g~~p~~~~--~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ 258 (282)
T cd06643 182 DRPYDYKADVWSLGITLIEMAQIEPPHHEL--NPMRVLLKIAKSEPPTLA-QPSRWSSEFKDFLKKCLEKNVDARWTTTQ 258 (282)
T ss_pred CCCCCccchhhhHHHHHHHHccCCCCcccc--CHHHHHHHHhhcCCCCCC-CccccCHHHHHHHHHHccCChhhCcCHHH
Confidence 113478999999999999999999999643 334444444333222111 12357889999999999999999999999
Q ss_pred HHHH
Q psy1840 183 VHHK 186 (423)
Q Consensus 183 I~~~ 186 (423)
+++.
T Consensus 259 il~~ 262 (282)
T cd06643 259 LLQH 262 (282)
T ss_pred HhcC
Confidence 8754
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.2e-24 Score=215.38 Aligned_cols=147 Identities=18% Similarity=0.210 Sum_probs=120.9
Q ss_pred HHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCccEEEeccCCcccccCCCcccccccccCCccccCCccccCCCCC
Q psy1840 25 SISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKAPELLRQPHLP 104 (423)
Q Consensus 25 ~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~ 104 (423)
...++.||+.||.|||+.|++ ||||||+|||++.++.+||+|||++...... .....||+.|+|||++.+..+
T Consensus 133 ~~~~~~qi~~aL~~LH~~~iv-HrDLkp~NILl~~~~~ikL~DFG~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~- 205 (340)
T PTZ00426 133 GCFYAAQIVLIFEYLQSLNIV-YRDLKPENLLLDKDGFIKMTDFGFAKVVDTR-----TYTLCGTPEYIAPEILLNVGH- 205 (340)
T ss_pred HHHHHHHHHHHHHHHHHCCeE-ccCCCHHHEEECCCCCEEEecCCCCeecCCC-----cceecCChhhcCHHHHhCCCC-
Confidence 568899999999999999998 9999999999999999999999998764321 134568899999999987654
Q ss_pred CCCCccchHHHHHHHHHHHhCCCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCchHHHHHHHHHhhhcCCCCCC-----C
Q psy1840 105 RGTQKGDVYSFGLVLYEVIGRQGPWGHLRMTDEEIITSVTQGSGLRPDTSSLDCAPSIIACMRTCWEEDPELRP-----D 179 (423)
Q Consensus 105 ~~s~ksDVyS~Giil~elltg~~Pf~~~~~~~~~i~~~i~~~~~~~p~~~~~~~~~~l~~Li~~C~~~dP~~RP-----t 179 (423)
+.++|||||||++|||++|..||.. .+.......+..+....| ..+++.+.+++++||+.||++|+ +
T Consensus 206 --~~~~DiwSlGvil~ell~G~~Pf~~--~~~~~~~~~i~~~~~~~p----~~~~~~~~~li~~~l~~dp~~R~~~~~~~ 277 (340)
T PTZ00426 206 --GKAADWWTLGIFIYEILVGCPPFYA--NEPLLIYQKILEGIIYFP----KFLDNNCKHLMKKLLSHDLTKRYGNLKKG 277 (340)
T ss_pred --CccccccchhhHHHHHhcCCCCCCC--CCHHHHHHHHhcCCCCCC----CCCCHHHHHHHHHHcccCHHHcCCCCCCC
Confidence 8899999999999999999999974 344556666666543333 24678899999999999999995 7
Q ss_pred HHHHHHH
Q psy1840 180 LRFVHHK 186 (423)
Q Consensus 180 ~~~I~~~ 186 (423)
+.++++.
T Consensus 278 ~~~~~~h 284 (340)
T PTZ00426 278 AQNVKEH 284 (340)
T ss_pred HHHHHcC
Confidence 7777643
|
|
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=99.91 E-value=2.8e-24 Score=213.57 Aligned_cols=154 Identities=19% Similarity=0.231 Sum_probs=114.8
Q ss_pred HHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCccEEEeccCCcccccCCCcccccccccCCccccCCccccCCCCC
Q psy1840 25 SISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKAPELLRQPHLP 104 (423)
Q Consensus 25 ~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~ 104 (423)
...++.|++.||.|||++|++ ||||||+||+++.++.+||+|||+++...... ......++..|+|||.+.+..+
T Consensus 121 ~~~~~~qi~~aL~~LH~~giv-HrDikp~Nill~~~~~~kl~Dfg~~~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~- 195 (355)
T cd07874 121 MSYLLYQMLCGIKHLHSAGII-HRDLKPSNIVVKSDCTLKILDFGLARTAGTSF---MMTPYVVTRYYRAPEVILGMGY- 195 (355)
T ss_pred HHHHHHHHHHHHHHHHhCCcc-cCCCChHHEEECCCCCEEEeeCcccccCCCcc---ccCCccccCCccCHHHHcCCCC-
Confidence 457899999999999999998 99999999999999999999999987543221 1234567889999999987655
Q ss_pred CCCCccchHHHHHHHHHHHhCCCCCCCCCCChHHHHHHH----------------------hcCCC----CCCC------
Q psy1840 105 RGTQKGDVYSFGLVLYEVIGRQGPWGHLRMTDEEIITSV----------------------TQGSG----LRPD------ 152 (423)
Q Consensus 105 ~~s~ksDVyS~Giil~elltg~~Pf~~~~~~~~~i~~~i----------------------~~~~~----~~p~------ 152 (423)
+.++|||||||++|+|++|+.||.+.... ..+...+ ..... ..+.
T Consensus 196 --~~~~DiwslG~il~el~~g~~pf~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 272 (355)
T cd07874 196 --KENVDIWSVGCIMGEMVRHKILFPGRDYI-DQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSL 272 (355)
T ss_pred --CchhhHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHHHhCCCCHHHHHhhcHHHHHHHhcCCccccccchhhccccc
Confidence 88999999999999999999999753211 1111000 00000 0000
Q ss_pred -----CCCCCchHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q psy1840 153 -----TSSLDCAPSIIACMRTCWEEDPELRPDLRFVHHK 186 (423)
Q Consensus 153 -----~~~~~~~~~l~~Li~~C~~~dP~~RPt~~~I~~~ 186 (423)
......+..+.+++.+||+.||++|||+.++++.
T Consensus 273 ~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~h 311 (355)
T cd07874 273 FPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQH 311 (355)
T ss_pred cccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcC
Confidence 0011235678999999999999999999999874
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >KOG0600|consensus | Back alignment and domain information |
|---|
Probab=99.91 E-value=2.7e-24 Score=211.12 Aligned_cols=167 Identities=22% Similarity=0.243 Sum_probs=126.8
Q ss_pred CCCCCCCChHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCccEEEeccCCcccccCCCcccccccccCCcccc
Q psy1840 14 NPLSPFNIPIGSISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYK 93 (423)
Q Consensus 14 ~p~~~~~~p~~~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~y~ 93 (423)
+|.-.|..|.- -.++.||+.||+|+|++|++ |||||.+|||||++|.+||+|||++++........ .+...-|.+|.
T Consensus 210 ~p~vkft~~qI-Kc~mkQLl~Gl~~cH~~gvl-HRDIK~SNiLidn~G~LKiaDFGLAr~y~~~~~~~-~T~rVvTLWYR 286 (560)
T KOG0600|consen 210 SPGVKFTEPQI-KCYMKQLLEGLEYCHSRGVL-HRDIKGSNILIDNNGVLKIADFGLARFYTPSGSAP-YTSRVVTLWYR 286 (560)
T ss_pred CCCcccChHHH-HHHHHHHHHHHHHHhhcCee-eccccccceEEcCCCCEEeccccceeeccCCCCcc-cccceEEeecc
Confidence 44445666553 48999999999999999998 99999999999999999999999999775544322 34556789999
Q ss_pred CCccccCCCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCC-ChHHHHHHHhcC--------------CCCCCCCC----
Q psy1840 94 APELLRQPHLPRGTQKGDVYSFGLVLYEVIGRQGPWGHLRM-TDEEIITSVTQG--------------SGLRPDTS---- 154 (423)
Q Consensus 94 APE~l~~~~~~~~s~ksDVyS~Giil~elltg~~Pf~~~~~-~~~~i~~~i~~~--------------~~~~p~~~---- 154 (423)
|||++.|.. .|+.+.|+||.|||+.||+.|++.|.+... ..-+.|.+++.. ..++|..+
T Consensus 287 pPELLLG~t--~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~~~kLP~~~~~kp~~~y~r~ 364 (560)
T KOG0600|consen 287 PPELLLGAT--SYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWPVSKLPHATIFKPQQPYKRR 364 (560)
T ss_pred ChHHhcCCc--ccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhccccccCCcccccCCCCcccch
Confidence 999999876 469999999999999999999999975321 111122222211 01111111
Q ss_pred ----CCCchHHHHHHHHHhhhcCCCCCCCHHHHHH
Q psy1840 155 ----SLDCAPSIIACMRTCWEEDPELRPDLRFVHH 185 (423)
Q Consensus 155 ----~~~~~~~l~~Li~~C~~~dP~~RPt~~~I~~ 185 (423)
....++...+|+..+|..||++|.|+.+++.
T Consensus 365 l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~ 399 (560)
T KOG0600|consen 365 LRETFKDFPASALDLLEKLLSLDPDKRGTASSALQ 399 (560)
T ss_pred HHHHhccCCHHHHHHHHHHhccCccccccHHHHhc
Confidence 1346788999999999999999999998765
|
|
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=99.91 E-value=4.4e-24 Score=203.24 Aligned_cols=158 Identities=27% Similarity=0.547 Sum_probs=122.3
Q ss_pred HHHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCccEEEeccCCcccccCCCcccccc-cc--cCCccccCCccccC
Q psy1840 24 GSISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQER-KL--RRRKLYKAPELLRQ 100 (423)
Q Consensus 24 ~~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~-~~--~gt~~y~APE~l~~ 100 (423)
..+.++.|++.|+.|||++|++ ||||||+||+++.++.+||+|||++............. .. ..+..|+|||.+.+
T Consensus 107 ~~~~i~~~l~~al~~lH~~g~~-H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~ 185 (269)
T cd05065 107 QLVGMLRGIAAGMKYLSEMNYV-HRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEAIAY 185 (269)
T ss_pred HHHHHHHHHHHHHHHHHHCCEe-ecccChheEEEcCCCcEEECCCccccccccCccccccccccCCCcceeecCHhHhcc
Confidence 3689999999999999999998 99999999999999999999999987653322111111 11 12346999999876
Q ss_pred CCCCCCCCccchHHHHHHHHHHHh-CCCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCchHHHHHHHHHhhhcCCCCCCC
Q psy1840 101 PHLPRGTQKGDVYSFGLVLYEVIG-RQGPWGHLRMTDEEIITSVTQGSGLRPDTSSLDCAPSIIACMRTCWEEDPELRPD 179 (423)
Q Consensus 101 ~~~~~~s~ksDVyS~Giil~ellt-g~~Pf~~~~~~~~~i~~~i~~~~~~~p~~~~~~~~~~l~~Li~~C~~~dP~~RPt 179 (423)
..+ +.++|||||||++||+++ |..||.. ....++...+...... | ....++..+.+++.+||+.+|++||+
T Consensus 186 ~~~---~~~~DvwslG~~l~e~l~~g~~p~~~--~~~~~~~~~i~~~~~~-~--~~~~~~~~~~~li~~~l~~~p~~Rp~ 257 (269)
T cd05065 186 RKF---TSASDVWSYGIVMWEVMSYGERPYWD--MSNQDVINAIEQDYRL-P--PPMDCPTALHQLMLDCWQKDRNARPK 257 (269)
T ss_pred Ccc---cchhhhhhhHHHHHHHhcCCCCCCCC--CCHHHHHHHHHcCCcC-C--CcccCCHHHHHHHHHHcCCChhhCcC
Confidence 654 889999999999999886 9999964 3345566666543221 1 12367889999999999999999999
Q ss_pred HHHHHHHHHHH
Q psy1840 180 LRFVHHKLKEM 190 (423)
Q Consensus 180 ~~~I~~~L~~i 190 (423)
+.+|+..|+.+
T Consensus 258 ~~~i~~~l~~~ 268 (269)
T cd05065 258 FGQIVSTLDKM 268 (269)
T ss_pred HHHHHHHHHhh
Confidence 99999887653
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.91 E-value=5.6e-24 Score=200.15 Aligned_cols=155 Identities=27% Similarity=0.481 Sum_probs=119.7
Q ss_pred HHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCccEEEeccCCcccccCCCcccccccccCCccccCCccccCCCCC
Q psy1840 25 SISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKAPELLRQPHLP 104 (423)
Q Consensus 25 ~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~ 104 (423)
.+.++.+++.|+.|||+++++ ||||||+||+++.++.+||+|||++.................+..|+|||.+.+..+
T Consensus 95 ~~~~~~~~~~~l~~lH~~~i~-h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~- 172 (251)
T cd05041 95 LLQMSLDAAAGMEYLESKNCI-HRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQIPIKWTAPEALNYGRY- 172 (251)
T ss_pred HHHHHHHHHHHHHHHHhCCEe-hhhcCcceEEEcCCCcEEEeeccccccccCCcceeccccCcceeccCChHhhccCCC-
Confidence 578999999999999999987 999999999999999999999999875432211111112233456999999876654
Q ss_pred CCCCccchHHHHHHHHHHHh-CCCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCchHHHHHHHHHhhhcCCCCCCCHHHH
Q psy1840 105 RGTQKGDVYSFGLVLYEVIG-RQGPWGHLRMTDEEIITSVTQGSGLRPDTSSLDCAPSIIACMRTCWEEDPELRPDLRFV 183 (423)
Q Consensus 105 ~~s~ksDVyS~Giil~ellt-g~~Pf~~~~~~~~~i~~~i~~~~~~~p~~~~~~~~~~l~~Li~~C~~~dP~~RPt~~~I 183 (423)
+.++|+||||+++||+++ |..||... ........+..... +. .+..++.++.+++.+||..+|++||++.++
T Consensus 173 --~~~~Di~slG~i~~~l~t~~~~p~~~~--~~~~~~~~~~~~~~--~~-~~~~~~~~~~~li~~~l~~~p~~Rp~~~el 245 (251)
T cd05041 173 --TSESDVWSYGILLWETFSLGDTPYPGM--SNQQTRERIESGYR--MP-APQLCPEEIYRLMLQCWAYDPENRPSFSEI 245 (251)
T ss_pred --CcchhHHHHHHHHHHHHhccCCCCccC--CHHHHHHHHhcCCC--CC-CCccCCHHHHHHHHHHhccChhhCcCHHHH
Confidence 889999999999999998 78888643 33444444444321 11 124578899999999999999999999999
Q ss_pred HHHHH
Q psy1840 184 HHKLK 188 (423)
Q Consensus 184 ~~~L~ 188 (423)
++.|+
T Consensus 246 l~~l~ 250 (251)
T cd05041 246 YNELQ 250 (251)
T ss_pred HHHhh
Confidence 98774
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=99.91 E-value=4.8e-24 Score=201.27 Aligned_cols=150 Identities=25% Similarity=0.523 Sum_probs=120.5
Q ss_pred HHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCccEEEeccCCcccccCCCcccccccccCCccccCCccccCCCCC
Q psy1840 25 SISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKAPELLRQPHLP 104 (423)
Q Consensus 25 ~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~ 104 (423)
.++++.|++.|+.|||+.|++ ||||||+||+++.++.+||+|||++....... .....+..|+|||.+.+..+
T Consensus 102 ~~~~~~qi~~al~~lH~~~~~-H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~~-----~~~~~~~~y~~pe~~~~~~~- 174 (254)
T cd05083 102 LLQFSLDVAEGMEYLESKKLV-HRDLAARNILVSEDGVAKVSDFGLARVGSMGV-----DNSKLPVKWTAPEALKHKKF- 174 (254)
T ss_pred HHHHHHHHHHHHHHHHhCCee-ccccCcceEEEcCCCcEEECCCccceeccccC-----CCCCCCceecCHHHhccCCc-
Confidence 578999999999999999998 99999999999999999999999976532211 12233457999999876654
Q ss_pred CCCCccchHHHHHHHHHHHh-CCCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCchHHHHHHHHHhhhcCCCCCCCHHHH
Q psy1840 105 RGTQKGDVYSFGLVLYEVIG-RQGPWGHLRMTDEEIITSVTQGSGLRPDTSSLDCAPSIIACMRTCWEEDPELRPDLRFV 183 (423)
Q Consensus 105 ~~s~ksDVyS~Giil~ellt-g~~Pf~~~~~~~~~i~~~i~~~~~~~p~~~~~~~~~~l~~Li~~C~~~dP~~RPt~~~I 183 (423)
+.++|+||||+++|||++ |..||... +..+....+..+.. +. ....++..+.+++.+||+.+|++||++.++
T Consensus 175 --~~~~Dv~slG~~l~el~~~g~~p~~~~--~~~~~~~~~~~~~~--~~-~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l 247 (254)
T cd05083 175 --SSKSDVWSYGVLLWEVFSYGRAPYPKM--SLKEVKECVEKGYR--ME-PPEGCPADVYVLMTSCWETEPKKRPSFHKL 247 (254)
T ss_pred --CchhhHHHHHHHHHHHHhCCCCCCccC--CHHHHHHHHhCCCC--CC-CCCcCCHHHHHHHHHHcCCChhhCcCHHHH
Confidence 889999999999999997 88999643 34555565555422 22 223678999999999999999999999999
Q ss_pred HHHHH
Q psy1840 184 HHKLK 188 (423)
Q Consensus 184 ~~~L~ 188 (423)
...|+
T Consensus 248 ~~~l~ 252 (254)
T cd05083 248 REKLE 252 (254)
T ss_pred HHHHc
Confidence 98775
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=99.91 E-value=2.7e-24 Score=202.92 Aligned_cols=151 Identities=19% Similarity=0.360 Sum_probs=121.0
Q ss_pred HHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCccEEEeccCCcccccCCCcccccccccCCccccCCccccCCCCC
Q psy1840 25 SISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKAPELLRQPHLP 104 (423)
Q Consensus 25 ~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~ 104 (423)
.+.++.|++.||.|||+.|++ |+||||+||+++.++.++++|||.+........ ......++..|+|||.+.+...
T Consensus 102 ~~~~~~~i~~al~~lH~~~i~-H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~- 177 (255)
T cd08219 102 ILQWFVQMCLGVQHIHEKRVL-HRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGA--YACTYVGTPYYVPPEIWENMPY- 177 (255)
T ss_pred HHHHHHHHHHHHHHHhhCCcc-cCCCCcceEEECCCCcEEEcccCcceeeccccc--ccccccCCccccCHHHHccCCc-
Confidence 578899999999999999998 999999999999999999999999875532221 1123457788999999877654
Q ss_pred CCCCccchHHHHHHHHHHHhCCCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCchHHHHHHHHHhhhcCCCCCCCHHHHH
Q psy1840 105 RGTQKGDVYSFGLVLYEVIGRQGPWGHLRMTDEEIITSVTQGSGLRPDTSSLDCAPSIIACMRTCWEEDPELRPDLRFVH 184 (423)
Q Consensus 105 ~~s~ksDVyS~Giil~elltg~~Pf~~~~~~~~~i~~~i~~~~~~~p~~~~~~~~~~l~~Li~~C~~~dP~~RPt~~~I~ 184 (423)
+.++|+||||+++|+|++|..||.. .+.......+..+... .. +..++..+.+++.+||+.||++||++.+|+
T Consensus 178 --~~~~Dv~slG~i~~~l~~g~~p~~~--~~~~~~~~~~~~~~~~--~~-~~~~~~~~~~li~~~l~~~P~~Rp~~~~il 250 (255)
T cd08219 178 --NNKSDIWSLGCILYELCTLKHPFQA--NSWKNLILKVCQGSYK--PL-PSHYSYELRSLIKQMFKRNPRSRPSATTIL 250 (255)
T ss_pred --CchhhhhhhchhheehhhccCCCCC--CCHHHHHHHHhcCCCC--CC-CcccCHHHHHHHHHHHhCCcccCCCHHHHh
Confidence 8899999999999999999999974 3344555555544322 11 235678899999999999999999999987
Q ss_pred HH
Q psy1840 185 HK 186 (423)
Q Consensus 185 ~~ 186 (423)
..
T Consensus 251 ~~ 252 (255)
T cd08219 251 SR 252 (255)
T ss_pred hc
Confidence 53
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=99.91 E-value=7.1e-24 Score=199.35 Aligned_cols=154 Identities=26% Similarity=0.492 Sum_probs=120.7
Q ss_pred HHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCccEEEeccCCcccccCCCcccccccccCCccccCCccccCCCCC
Q psy1840 25 SISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKAPELLRQPHLP 104 (423)
Q Consensus 25 ~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~ 104 (423)
.+.++.|++.||.|+|+.|++ ||||||+||+++.++.+||+|||++........ .......++..|+|||.+.+..+
T Consensus 95 ~~~~~~~i~~~l~~lH~~~~~-H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~- 171 (250)
T cd05085 95 LVKFALDAAAGMAYLESKNCI-HRDLAARNCLVGENNVLKISDFGMSRQEDDGIY-SSSGLKQIPIKWTAPEALNYGRY- 171 (250)
T ss_pred HHHHHHHHHHHHHHHHhCCee-ecccChheEEEcCCCeEEECCCccceecccccc-ccCCCCCCcccccCHHHhccCCC-
Confidence 688999999999999999998 999999999999999999999999865332211 11112233566999999876654
Q ss_pred CCCCccchHHHHHHHHHHHh-CCCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCchHHHHHHHHHhhhcCCCCCCCHHHH
Q psy1840 105 RGTQKGDVYSFGLVLYEVIG-RQGPWGHLRMTDEEIITSVTQGSGLRPDTSSLDCAPSIIACMRTCWEEDPELRPDLRFV 183 (423)
Q Consensus 105 ~~s~ksDVyS~Giil~ellt-g~~Pf~~~~~~~~~i~~~i~~~~~~~p~~~~~~~~~~l~~Li~~C~~~dP~~RPt~~~I 183 (423)
+.++||||||+++|++++ |..||... ........+..+. ++.. ...++..+.+++.+||+.+|++||++.++
T Consensus 172 --~~~~Di~slG~ll~~~~~~g~~p~~~~--~~~~~~~~~~~~~--~~~~-~~~~~~~~~~li~~~l~~~p~~Rp~~~~l 244 (250)
T cd05085 172 --SSESDVWSYGILLWETFSLGVCPYPGM--TNQQAREQVEKGY--RMSC-PQKCPDDVYKVMQRCWDYKPENRPKFSEL 244 (250)
T ss_pred --CchhHHHHHHHHHHHHhcCCCCCCCCC--CHHHHHHHHHcCC--CCCC-CCCCCHHHHHHHHHHcccCcccCCCHHHH
Confidence 889999999999999998 89999743 3445555554432 2222 23578999999999999999999999999
Q ss_pred HHHHH
Q psy1840 184 HHKLK 188 (423)
Q Consensus 184 ~~~L~ 188 (423)
.+.|.
T Consensus 245 ~~~l~ 249 (250)
T cd05085 245 QKELA 249 (250)
T ss_pred HHHhc
Confidence 88763
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=99.91 E-value=6.6e-24 Score=202.34 Aligned_cols=158 Identities=23% Similarity=0.491 Sum_probs=116.8
Q ss_pred HHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCccEEEeccCCcccccCCCcccccccccCCccccCCccccCCC--
Q psy1840 25 SISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKAPELLRQPH-- 102 (423)
Q Consensus 25 ~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~-- 102 (423)
...++.||+.||.|||+++++ ||||||+||+++.++.+||+|||++................++..|+|||++....
T Consensus 101 ~~~~~~~i~~al~~lH~~~i~-H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~ 179 (268)
T cd05086 101 LQRMACEIAAGVTHMHKHNFL-HSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKCVPLRWLAPELVGEFHGG 179 (268)
T ss_pred HHHHHHHHHHHHHHHHHCCee-ccCCccceEEEcCCccEEecccccccccCcchhhhcccCCcCcccccCchhcccccCc
Confidence 357899999999999999988 99999999999999999999999975432221111223445778899999885421
Q ss_pred --CCCCCCccchHHHHHHHHHHHhC-CCCCCCCCCChHHHHHHHhcCCC---CCCCCCCCCchHHHHHHHHHhhhcCCCC
Q psy1840 103 --LPRGTQKGDVYSFGLVLYEVIGR-QGPWGHLRMTDEEIITSVTQGSG---LRPDTSSLDCAPSIIACMRTCWEEDPEL 176 (423)
Q Consensus 103 --~~~~s~ksDVyS~Giil~elltg-~~Pf~~~~~~~~~i~~~i~~~~~---~~p~~~~~~~~~~l~~Li~~C~~~dP~~ 176 (423)
....+.++||||||+++|||+++ ..||.. ....+.+..+..+.. .+|.. ....++.+.+++..|| .+|++
T Consensus 180 ~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~--~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~~c~-~~P~~ 255 (268)
T cd05086 180 LITAEQTKPSNVWALGVTLWELFENAAQPYSH--LSDREVLNHVIKDQQVKLFKPQL-ELPYSERWYEVLQFCW-LSPEK 255 (268)
T ss_pred cccCCCCCcchhHHHHHHHHHHHhCCCCCCCC--CCHHHHHHHHHhhcccccCCCcc-CCCCcHHHHHHHHHHh-hCccc
Confidence 11347899999999999999974 667753 334455554433221 22322 2357888999999999 67999
Q ss_pred CCCHHHHHHHH
Q psy1840 177 RPDLRFVHHKL 187 (423)
Q Consensus 177 RPt~~~I~~~L 187 (423)
||++.+|++.|
T Consensus 256 Rp~~~~i~~~l 266 (268)
T cd05086 256 RATAEEVHRLL 266 (268)
T ss_pred CCCHHHHHHHh
Confidence 99999998876
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.9e-24 Score=208.20 Aligned_cols=150 Identities=22% Similarity=0.325 Sum_probs=116.6
Q ss_pred HHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCccEEEeccCCcccccCCCcccccccccCCccccCCccccCCCCC
Q psy1840 25 SISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKAPELLRQPHLP 104 (423)
Q Consensus 25 ~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~ 104 (423)
...++.|++.||.|||+.+++ ||||||+||++++++.++|+|||++........ .....|+..|+|||.+.+..+
T Consensus 104 ~~~~~~qi~~~l~~lH~~~iv-H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~- 178 (285)
T cd05605 104 AVFYAAEITCGLEDLHRERIV-YRDLKPENILLDDYGHIRISDLGLAVEIPEGET---IRGRVGTVGYMAPEVVKNERY- 178 (285)
T ss_pred HHHHHHHHHHHHHHHHHCCcE-ecCCCHHHEEECCCCCEEEeeCCCceecCCCCc---cccccCCCCccCcHHhcCCCC-
Confidence 578899999999999999998 999999999999999999999999876432211 123467889999999976554
Q ss_pred CCCCccchHHHHHHHHHHHhCCCCCCCCCCCh--HHHHHHHhcCCCCCCCCCCCCchHHHHHHHHHhhhcCCCCCC----
Q psy1840 105 RGTQKGDVYSFGLVLYEVIGRQGPWGHLRMTD--EEIITSVTQGSGLRPDTSSLDCAPSIIACMRTCWEEDPELRP---- 178 (423)
Q Consensus 105 ~~s~ksDVyS~Giil~elltg~~Pf~~~~~~~--~~i~~~i~~~~~~~p~~~~~~~~~~l~~Li~~C~~~dP~~RP---- 178 (423)
+.++||||+|+++||+++|+.||....... .++...+.... ......++..+.+++.+||+.||.+||
T Consensus 179 --~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~ 252 (285)
T cd05605 179 --TFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVKEDQ----EEYSEKFSEAARSICRQLLTKDPGFRLGCRG 252 (285)
T ss_pred --CccccchhHHHHHHHHHHCCCCCCCCchhhHHHHHHHHhhhcc----cccCcccCHHHHHHHHHHccCCHHHhcCCCC
Confidence 889999999999999999999997532211 22233332221 112235788999999999999999999
Q ss_pred -CHHHHHH
Q psy1840 179 -DLRFVHH 185 (423)
Q Consensus 179 -t~~~I~~ 185 (423)
++.+++.
T Consensus 253 ~~~~~l~~ 260 (285)
T cd05605 253 EGAEEVKA 260 (285)
T ss_pred CCHHHHhc
Confidence 6777654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.91 E-value=2.8e-24 Score=220.21 Aligned_cols=158 Identities=20% Similarity=0.223 Sum_probs=117.6
Q ss_pred HHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCccEEEeccCCcccccCCCcccccccccCCccccCCccccCCCCC
Q psy1840 25 SISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKAPELLRQPHLP 104 (423)
Q Consensus 25 ~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~ 104 (423)
.+.++.||+.||.|||++|++ ||||||+|||++.++.+||+|||+++...............||..|+|||++.+..+
T Consensus 262 ~~~i~~qi~~aL~yLH~~gIv-HrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~- 339 (461)
T PHA03211 262 VTAVARQLLSAIDYIHGEGII-HRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPFHYGIAGTVDTNAPEVLAGDPY- 339 (461)
T ss_pred HHHHHHHHHHHHHHHHHCCEE-ECcCCHHHEEECCCCCEEEcccCCceecccccccccccccCCCcCCcCHHHHcCCCC-
Confidence 679999999999999999988 999999999999999999999999876543322222234568999999999987655
Q ss_pred CCCCccchHHHHHHHHHHHhCCCCCCCCC------CChHHHHHHHhcCCCC------------------------CCCCC
Q psy1840 105 RGTQKGDVYSFGLVLYEVIGRQGPWGHLR------MTDEEIITSVTQGSGL------------------------RPDTS 154 (423)
Q Consensus 105 ~~s~ksDVyS~Giil~elltg~~Pf~~~~------~~~~~i~~~i~~~~~~------------------------~p~~~ 154 (423)
+.++|||||||++|||++|..|+.... ....++...+...... ++...
T Consensus 340 --~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 417 (461)
T PHA03211 340 --TPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFPQHAGSRLVSQYRHRAARNRRPAYT 417 (461)
T ss_pred --CchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCCCCcchHHHHHHHhhhhcccCCccC
Confidence 899999999999999999876543211 1123333333322110 00000
Q ss_pred ------CCCchHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q psy1840 155 ------SLDCAPSIIACMRTCWEEDPELRPDLRFVHHK 186 (423)
Q Consensus 155 ------~~~~~~~l~~Li~~C~~~dP~~RPt~~~I~~~ 186 (423)
....+..+.+|+.+||+.||.+|||+.++++.
T Consensus 418 ~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~h 455 (461)
T PHA03211 418 RPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRL 455 (461)
T ss_pred CcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhC
Confidence 01234578999999999999999999999864
|
|
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.9e-24 Score=212.73 Aligned_cols=146 Identities=18% Similarity=0.317 Sum_probs=113.9
Q ss_pred HHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCccEEEeccCCcccccCCCcccccccccCCccccCCccccCCCCC
Q psy1840 25 SISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKAPELLRQPHLP 104 (423)
Q Consensus 25 ~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~ 104 (423)
...++.||+.||.|||+++++ ||||||+||+++.++.+||+|||+++...... .......|+..|+|||++.+..+
T Consensus 98 ~~~i~~qi~~~l~~lH~~~iv-H~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~- 173 (329)
T cd05618 98 ARFYSAEISLALNYLHERGII-YRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG--DTTSTFCGTPNYIAPEILRGEDY- 173 (329)
T ss_pred HHHHHHHHHHHHHHHHHCCee-eCCCCHHHEEECCCCCEEEeeCCccccccCCC--CccccccCCccccCHHHHcCCCC-
Confidence 578999999999999999998 99999999999999999999999986532211 11234578899999999987655
Q ss_pred CCCCccchHHHHHHHHHHHhCCCCCCCCCC-------ChHHHHHHHhcCCCCCCCCCCCCchHHHHHHHHHhhhcCCCCC
Q psy1840 105 RGTQKGDVYSFGLVLYEVIGRQGPWGHLRM-------TDEEIITSVTQGSGLRPDTSSLDCAPSIIACMRTCWEEDPELR 177 (423)
Q Consensus 105 ~~s~ksDVyS~Giil~elltg~~Pf~~~~~-------~~~~i~~~i~~~~~~~p~~~~~~~~~~l~~Li~~C~~~dP~~R 177 (423)
+.++|||||||++|||++|..||..... ....+...+.......| ..++..+.+++++||+.||.+|
T Consensus 174 --~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p----~~~~~~~~~ll~~~L~~dP~~R 247 (329)
T cd05618 174 --GFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIP----RSLSVKAASVLKSFLNKDPKER 247 (329)
T ss_pred --CCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCCCCCC----CCCCHHHHHHHHHHhcCCHHHc
Confidence 8899999999999999999999953211 11223333333322222 3567899999999999999999
Q ss_pred CCH
Q psy1840 178 PDL 180 (423)
Q Consensus 178 Pt~ 180 (423)
|+.
T Consensus 248 ~~~ 250 (329)
T cd05618 248 LGC 250 (329)
T ss_pred CCC
Confidence 984
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=99.91 E-value=2.2e-24 Score=210.60 Aligned_cols=158 Identities=16% Similarity=0.182 Sum_probs=112.8
Q ss_pred HHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEE----cCCccEEEeccCCcccccCCCcc-cccccccCCccccCCcccc
Q psy1840 25 SISVNTTASVGMIHLHDSEIISHGNLRSSNCLI----DSRWVLQIADFGLHAFKAGQDET-GQERKLRRRKLYKAPELLR 99 (423)
Q Consensus 25 ~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILl----d~~~~vKL~DFGla~~~~~~~~~-~~~~~~~gt~~y~APE~l~ 99 (423)
...++.||+.||.|||+.|++ ||||||+|||+ +.++.+||+|||+++........ .......+|+.|+|||++.
T Consensus 110 ~~~i~~qi~~al~~LH~~~iv-HrDlkp~Nil~~~~~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~ 188 (317)
T cd07868 110 VKSLLYQILDGIHYLHANWVL-HRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLL 188 (317)
T ss_pred HHHHHHHHHHHHHHHHhCCEE-cCCCCHHHEEEecCCCCcCcEEEeecCceeccCCCCccccccCCccccccccCCHHHc
Confidence 468999999999999999988 99999999999 46689999999998765432211 1223456788999999987
Q ss_pred CCCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCh-------HHHHHHHhcCC-------------------------
Q psy1840 100 QPHLPRGTQKGDVYSFGLVLYEVIGRQGPWGHLRMTD-------EEIITSVTQGS------------------------- 147 (423)
Q Consensus 100 ~~~~~~~s~ksDVyS~Giil~elltg~~Pf~~~~~~~-------~~i~~~i~~~~------------------------- 147 (423)
+.. .++.++||||+||++|||++|+.||....... ...+..+....
T Consensus 189 ~~~--~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (317)
T cd07868 189 GAR--HYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFR 266 (317)
T ss_pred CCC--CcCchhhHHHHHHHHHHHHhCCCCccCCcccccccccccHHHHHHHHHhcCCCChHHhHHHhhccchhhhhhhhh
Confidence 643 23889999999999999999999996322110 01111111000
Q ss_pred ---CCCC------CCCCCCchHHHHHHHHHhhhcCCCCCCCHHHHHH
Q psy1840 148 ---GLRP------DTSSLDCAPSIIACMRTCWEEDPELRPDLRFVHH 185 (423)
Q Consensus 148 ---~~~p------~~~~~~~~~~l~~Li~~C~~~dP~~RPt~~~I~~ 185 (423)
.... .......+.++.+++.+||+.||.+|||+.++++
T Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~t~~e~l~ 313 (317)
T cd07868 267 RNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQ 313 (317)
T ss_pred ccccCcccccchHHhcCCCCChHHHHHHHHHhccCcccCCCHHHHhc
Confidence 0000 0001123457889999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=99.91 E-value=5.8e-24 Score=200.60 Aligned_cols=150 Identities=19% Similarity=0.387 Sum_probs=120.6
Q ss_pred HHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCccEEEeccCCcccccCCCcccccccccCCccccCCccccCCCCC
Q psy1840 25 SISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKAPELLRQPHLP 104 (423)
Q Consensus 25 ~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~ 104 (423)
..+++.|++.|+.|||+.|++ ||||||+||+++.++.++|+|||++........ ......+++.|+|||.+.+...
T Consensus 104 ~~~~~~~l~~~l~~lH~~~i~-H~di~p~nil~~~~~~~~l~df~~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~- 179 (257)
T cd08223 104 VVEWFVQIAMALQYLHEKHIL-HRDLKTQNVFLTRTNIIKVGDLGIARVLENQCD--MASTLIGTPYYMSPELFSNKPY- 179 (257)
T ss_pred HHHHHHHHHHHHHHHHhCCee-ccCCCchhEEEecCCcEEEecccceEEecccCC--ccccccCCcCccChhHhcCCCC-
Confidence 679999999999999999998 999999999999999999999999876532221 1234457788999999887654
Q ss_pred CCCCccchHHHHHHHHHHHhCCCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCchHHHHHHHHHhhhcCCCCCCCHHHHH
Q psy1840 105 RGTQKGDVYSFGLVLYEVIGRQGPWGHLRMTDEEIITSVTQGSGLRPDTSSLDCAPSIIACMRTCWEEDPELRPDLRFVH 184 (423)
Q Consensus 105 ~~s~ksDVyS~Giil~elltg~~Pf~~~~~~~~~i~~~i~~~~~~~p~~~~~~~~~~l~~Li~~C~~~dP~~RPt~~~I~ 184 (423)
+.++||||||++++++++|+.||... +.......+..+.. +.. ....++.+.+++.+||+.+|++||++.+++
T Consensus 180 --~~~~Dv~slG~il~~l~~g~~~~~~~--~~~~~~~~~~~~~~--~~~-~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l 252 (257)
T cd08223 180 --NYKSDVWALGCCVYEMATLKHAFNAK--DMNSLVYRIIEGKL--PPM-PKDYSPELGELIATMLSKRPEKRPSVKSIL 252 (257)
T ss_pred --CchhhhHHHHHHHHHHHcCCCCCCCC--CHHHHHHHHHhcCC--CCC-ccccCHHHHHHHHHHhccCcccCCCHHHHh
Confidence 78999999999999999999999643 33444444444322 222 235788999999999999999999999987
Q ss_pred H
Q psy1840 185 H 185 (423)
Q Consensus 185 ~ 185 (423)
.
T Consensus 253 ~ 253 (257)
T cd08223 253 R 253 (257)
T ss_pred c
Confidence 5
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=99.91 E-value=8.7e-25 Score=214.93 Aligned_cols=156 Identities=16% Similarity=0.187 Sum_probs=118.9
Q ss_pred HHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCccEEEeccCCcccccCCCcccccccccCCccccCCccccCCC--
Q psy1840 25 SISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKAPELLRQPH-- 102 (423)
Q Consensus 25 ~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~-- 102 (423)
...++.||+.||.|||+.+++ ||||||+||+++.++.+||+|||++......... ......+++.|+|||++....
T Consensus 104 ~~~~~~qi~~aL~~lH~~~i~-H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~ 181 (330)
T cd05601 104 AQFYLAELVLAIHSVHQMGYV-HRDIKPENVLIDRTGHIKLADFGSAARLTANKMV-NSKLPVGTPDYIAPEVLTTMNGD 181 (330)
T ss_pred HHHHHHHHHHHHHHHHHCCeE-cccCchHheEECCCCCEEeccCCCCeECCCCCce-eeecccCCccccCHHHhcccccc
Confidence 457889999999999999998 9999999999999999999999998765432211 223346888999999986421
Q ss_pred -CCCCCCccchHHHHHHHHHHHhCCCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCchHHHHHHHHHhhhcCCCCCCCHH
Q psy1840 103 -LPRGTQKGDVYSFGLVLYEVIGRQGPWGHLRMTDEEIITSVTQGSGLRPDTSSLDCAPSIIACMRTCWEEDPELRPDLR 181 (423)
Q Consensus 103 -~~~~s~ksDVyS~Giil~elltg~~Pf~~~~~~~~~i~~~i~~~~~~~p~~~~~~~~~~l~~Li~~C~~~dP~~RPt~~ 181 (423)
...++.++|||||||++|||++|..||... +..+....+..............++..+.+++..||. +|.+||++.
T Consensus 182 ~~~~~~~~~DiwslG~il~el~~g~~Pf~~~--~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~ll~-~p~~R~t~~ 258 (330)
T cd05601 182 GKGTYGVECDWWSLGVIAYEMIYGRSPFHEG--TSAKTYNNIMNFQRFLKFPEDPKVSSDFLDLIQSLLC-GQKERLGYE 258 (330)
T ss_pred ccCCCCCcceeecccceeeeeccCCCCCCCC--CHHHHHHHHHcCCCccCCCCCCCCCHHHHHHHHHHcc-ChhhCCCHH
Confidence 113478999999999999999999999642 3344555554432211111122578899999999997 999999999
Q ss_pred HHHH
Q psy1840 182 FVHH 185 (423)
Q Consensus 182 ~I~~ 185 (423)
+++.
T Consensus 259 ~l~~ 262 (330)
T cd05601 259 GLCC 262 (330)
T ss_pred HHhC
Confidence 9875
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.91 E-value=7.1e-25 Score=215.64 Aligned_cols=151 Identities=19% Similarity=0.269 Sum_probs=119.2
Q ss_pred HHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCccEEEeccCCcccccCCCcccccccccCCccccCCccccCCCCC
Q psy1840 25 SISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKAPELLRQPHLP 104 (423)
Q Consensus 25 ~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~ 104 (423)
...++.||+.||+|||+.|++ ||||||+|||++.++.+||+|||++....... .......|+..|+|||.+.+..
T Consensus 98 ~~~~~~qil~al~~LH~~~iv-HrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~-- 172 (330)
T cd05586 98 AKFYIAELVLALEHLHKYDIV-YRDLKPENILLDATGHIALCDFGLSKANLTDN--KTTNTFCGTTEYLAPEVLLDEK-- 172 (330)
T ss_pred HHHHHHHHHHHHHHHHHCCeE-eccCCHHHeEECCCCCEEEecCCcCcCCCCCC--CCccCccCCccccCHHHHcCCC--
Confidence 467899999999999999988 99999999999999999999999986532221 1123456889999999987543
Q ss_pred CCCCccchHHHHHHHHHHHhCCCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCchHHHHHHHHHhhhcCCCCCC----CH
Q psy1840 105 RGTQKGDVYSFGLVLYEVIGRQGPWGHLRMTDEEIITSVTQGSGLRPDTSSLDCAPSIIACMRTCWEEDPELRP----DL 180 (423)
Q Consensus 105 ~~s~ksDVyS~Giil~elltg~~Pf~~~~~~~~~i~~~i~~~~~~~p~~~~~~~~~~l~~Li~~C~~~dP~~RP----t~ 180 (423)
.++.++|||||||++|||++|..||.. ....+....+..+....| ...++.++.+++++||+.||.+|| ++
T Consensus 173 ~~~~~~DvwslGvil~elltG~~Pf~~--~~~~~~~~~i~~~~~~~~---~~~~~~~~~~li~~~L~~~P~~R~~~~~~~ 247 (330)
T cd05586 173 GYTKHVDFWSLGVLVFEMCCGWSPFYA--EDTQQMYRNIAFGKVRFP---KNVLSDEGRQFVKGLLNRNPQHRLGAHRDA 247 (330)
T ss_pred CCCCccceeccccEEEEeccCCCCCCC--CCHHHHHHHHHcCCCCCC---CccCCHHHHHHHHHHcCCCHHHCCCCCCCH
Confidence 237899999999999999999999964 344566666665543322 234688999999999999999998 45
Q ss_pred HHHHH
Q psy1840 181 RFVHH 185 (423)
Q Consensus 181 ~~I~~ 185 (423)
.++++
T Consensus 248 ~~ll~ 252 (330)
T cd05586 248 VELKE 252 (330)
T ss_pred HHHhc
Confidence 55544
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=99.91 E-value=3.4e-24 Score=213.74 Aligned_cols=153 Identities=22% Similarity=0.235 Sum_probs=115.0
Q ss_pred HHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCccEEEeccCCcccccCCCcccccccccCCccccCCccccCCCCC
Q psy1840 25 SISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKAPELLRQPHLP 104 (423)
Q Consensus 25 ~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~ 104 (423)
...++.|++.||.|||++|++ ||||||+||+++.++.+||+|||+++...... ......++..|+|||++.+..+
T Consensus 128 ~~~~~~qi~~aL~~LH~~~iv-H~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~- 202 (364)
T cd07875 128 MSYLLYQMLCGIKHLHSAGII-HRDLKPSNIVVKSDCTLKILDFGLARTAGTSF---MMTPYVVTRYYRAPEVILGMGY- 202 (364)
T ss_pred HHHHHHHHHHHHHHHhhCCee-cCCCCHHHEEECCCCcEEEEeCCCccccCCCC---cccCCcccCCcCCHHHHhCCCC-
Confidence 457899999999999999998 99999999999999999999999987543221 1234567889999999987655
Q ss_pred CCCCccchHHHHHHHHHHHhCCCCCCCCCCChHHHHHHHhcCCC-------------------CCCCC------------
Q psy1840 105 RGTQKGDVYSFGLVLYEVIGRQGPWGHLRMTDEEIITSVTQGSG-------------------LRPDT------------ 153 (423)
Q Consensus 105 ~~s~ksDVyS~Giil~elltg~~Pf~~~~~~~~~i~~~i~~~~~-------------------~~p~~------------ 153 (423)
+.++|||||||++|||++|+.||.... ..+....+..... .+|..
T Consensus 203 --~~~~DiwSlG~il~ell~g~~pf~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 278 (364)
T cd07875 203 --KENVDIWSVGCIMGEMIKGGVLFPGTD--HIDQWNKVIEQLGTPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDV 278 (364)
T ss_pred --CchhhHHhHHHHHHHHHhCCCCCCCCC--HHHHHHHHHHhcCCCCHHHHHhhhHHHHHHHhhCCCcCCCChHhhCccc
Confidence 889999999999999999999996432 2222221111000 00000
Q ss_pred -------CCCCchHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q psy1840 154 -------SSLDCAPSIIACMRTCWEEDPELRPDLRFVHHK 186 (423)
Q Consensus 154 -------~~~~~~~~l~~Li~~C~~~dP~~RPt~~~I~~~ 186 (423)
.....+..+.+++.+|++.||.+|||+.++++.
T Consensus 279 ~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~h 318 (364)
T cd07875 279 LFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH 318 (364)
T ss_pred cccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 001134578999999999999999999998764
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=99.91 E-value=2.1e-24 Score=212.38 Aligned_cols=145 Identities=19% Similarity=0.330 Sum_probs=113.4
Q ss_pred HHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCccEEEeccCCcccccCCCcccccccccCCccccCCccccCCCCC
Q psy1840 25 SISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKAPELLRQPHLP 104 (423)
Q Consensus 25 ~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~ 104 (423)
...++.||+.||.|||++|++ ||||||+||+++.++.+||+|||+++...... .......|++.|+|||++.+..+
T Consensus 98 ~~~~~~qi~~~l~~lH~~~iv-H~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~- 173 (329)
T cd05588 98 ARFYSAEISLALNFLHERGII-YRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPG--DTTSTFCGTPNYIAPEILRGEDY- 173 (329)
T ss_pred HHHHHHHHHHHHHHHHHCCeE-ecCCCHHHeEECCCCCEEECcCccccccccCC--CccccccCCccccCHHHHcCCCC-
Confidence 578999999999999999998 99999999999999999999999986422111 12234578899999999987655
Q ss_pred CCCCccchHHHHHHHHHHHhCCCCCCCCCC-------ChHHHHHHHhcCCCCCCCCCCCCchHHHHHHHHHhhhcCCCCC
Q psy1840 105 RGTQKGDVYSFGLVLYEVIGRQGPWGHLRM-------TDEEIITSVTQGSGLRPDTSSLDCAPSIIACMRTCWEEDPELR 177 (423)
Q Consensus 105 ~~s~ksDVyS~Giil~elltg~~Pf~~~~~-------~~~~i~~~i~~~~~~~p~~~~~~~~~~l~~Li~~C~~~dP~~R 177 (423)
+.++|+|||||++|||++|+.||..... ....+.+.+.......| ..++.++.+++.+||+.||.+|
T Consensus 174 --~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~p----~~~~~~~~~li~~~L~~dP~~R 247 (329)
T cd05588 174 --GFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQIRIP----RSLSVKASSVLKGFLNKDPKER 247 (329)
T ss_pred --CCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCCCCCC----CCCCHHHHHHHHHHhccCHHHc
Confidence 8899999999999999999999963221 11223333333322222 3568899999999999999999
Q ss_pred CC
Q psy1840 178 PD 179 (423)
Q Consensus 178 Pt 179 (423)
|+
T Consensus 248 ~~ 249 (329)
T cd05588 248 LG 249 (329)
T ss_pred CC
Confidence 97
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.91 E-value=7.8e-24 Score=199.92 Aligned_cols=151 Identities=26% Similarity=0.556 Sum_probs=121.9
Q ss_pred HHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCccEEEeccCCcccccCCCcccccccccCCccccCCccccCCCCC
Q psy1840 25 SISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKAPELLRQPHLP 104 (423)
Q Consensus 25 ~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~ 104 (423)
...++.|++.|+.|||+++++ ||||||+||+++.++.+||+|||.++...... .....+..|+|||.+.....
T Consensus 104 ~~~~~~qi~~~l~~lh~~~i~-H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~-----~~~~~~~~~~ape~~~~~~~- 176 (256)
T cd05039 104 QLGFALDVCEGMEYLEEKNFV-HRDLAARNVLVSEDLVAKVSDFGLAKEASQGQ-----DSGKLPVKWTAPEALREKKF- 176 (256)
T ss_pred HHHHHHHHHHHHHHHHhCCcc-chhcccceEEEeCCCCEEEccccccccccccc-----ccCCCcccccCchhhcCCcC-
Confidence 678999999999999999998 99999999999999999999999987652211 12234456999999876654
Q ss_pred CCCCccchHHHHHHHHHHHh-CCCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCchHHHHHHHHHhhhcCCCCCCCHHHH
Q psy1840 105 RGTQKGDVYSFGLVLYEVIG-RQGPWGHLRMTDEEIITSVTQGSGLRPDTSSLDCAPSIIACMRTCWEEDPELRPDLRFV 183 (423)
Q Consensus 105 ~~s~ksDVyS~Giil~ellt-g~~Pf~~~~~~~~~i~~~i~~~~~~~p~~~~~~~~~~l~~Li~~C~~~dP~~RPt~~~I 183 (423)
+.++||||||+++||+++ |..||.. .+..++...+..+. ++.. ...+++.+.+++.+||..+|++||++.++
T Consensus 177 --~~~~Di~slG~il~~l~~~g~~p~~~--~~~~~~~~~~~~~~--~~~~-~~~~~~~~~~li~~~l~~~p~~Rp~~~~l 249 (256)
T cd05039 177 --STKSDVWSFGILLWEIYSFGRVPYPR--IPLKDVVPHVEKGY--RMEA-PEGCPPEVYKVMKDCWELDPAKRPTFKQL 249 (256)
T ss_pred --CcHHHHHHHHHHHHHHHhcCCCCCCC--CCHHHHHHHHhcCC--CCCC-ccCCCHHHHHHHHHHhccChhhCcCHHHH
Confidence 789999999999999997 9999864 34455555555432 2222 23578999999999999999999999999
Q ss_pred HHHHHH
Q psy1840 184 HHKLKE 189 (423)
Q Consensus 184 ~~~L~~ 189 (423)
+..|+.
T Consensus 250 ~~~l~~ 255 (256)
T cd05039 250 REQLAL 255 (256)
T ss_pred HHHHhc
Confidence 998864
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.4e-24 Score=223.85 Aligned_cols=151 Identities=17% Similarity=0.229 Sum_probs=111.7
Q ss_pred HHHHHHHHHHHHHHHHh-CCCeeecCCCCCCEEEcCCc----------------cEEEeccCCcccccCCCccccccccc
Q psy1840 25 SISVNTTASVGMIHLHD-SEIISHGNLRSSNCLIDSRW----------------VLQIADFGLHAFKAGQDETGQERKLR 87 (423)
Q Consensus 25 ~l~i~~qi~~gL~yLH~-~~ii~HrDLkp~NILld~~~----------------~vKL~DFGla~~~~~~~~~~~~~~~~ 87 (423)
...++.||+.||.|||+ .|+| ||||||+|||++.++ .+||+|||.+.... .......
T Consensus 233 ~~~i~~qi~~aL~yLH~~~gIi-HrDlKP~NILl~~~~~~~~~~~~~~~~~~~~~vkl~DfG~~~~~~-----~~~~~~~ 306 (467)
T PTZ00284 233 LAQIIFQTGVALDYFHTELHLM-HTDLKPENILMETSDTVVDPVTNRALPPDPCRVRICDLGGCCDER-----HSRTAIV 306 (467)
T ss_pred HHHHHHHHHHHHHHHHhcCCee-cCCCCHHHEEEecCCcccccccccccCCCCceEEECCCCccccCc-----ccccccc
Confidence 46899999999999998 4888 999999999998765 49999999865321 1123457
Q ss_pred CCccccCCccccCCCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCChHHHHHHHhcCC--------------------
Q psy1840 88 RRKLYKAPELLRQPHLPRGTQKGDVYSFGLVLYEVIGRQGPWGHLRMTDEEIITSVTQGS-------------------- 147 (423)
Q Consensus 88 gt~~y~APE~l~~~~~~~~s~ksDVyS~Giil~elltg~~Pf~~~~~~~~~i~~~i~~~~-------------------- 147 (423)
||+.|+|||++.+..+ +.++|||||||++|||++|+.||.... ..+.+..+....
T Consensus 307 gt~~Y~APE~~~~~~~---~~~~DiwSlGvil~elltG~~pf~~~~--~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~ 381 (467)
T PTZ00284 307 STRHYRSPEVVLGLGW---MYSTDMWSMGCIIYELYTGKLLYDTHD--NLEHLHLMEKTLGRLPSEWAGRCGTEEARLLY 381 (467)
T ss_pred CCccccCcHHhhcCCC---CcHHHHHHHHHHHHHHHhCCCCCCCCC--hHHHHHHHHHHcCCCCHHHHhhccchhHHHHh
Confidence 8999999999987665 899999999999999999999997432 222222111100
Q ss_pred ----CCCCCCC--------------CCCchHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q psy1840 148 ----GLRPDTS--------------SLDCAPSIIACMRTCWEEDPELRPDLRFVHHK 186 (423)
Q Consensus 148 ----~~~p~~~--------------~~~~~~~l~~Li~~C~~~dP~~RPt~~~I~~~ 186 (423)
..++... .....+.+.+||.+||..||++|||+.+++++
T Consensus 382 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~ta~e~L~H 438 (467)
T PTZ00284 382 NSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLNARQMTTH 438 (467)
T ss_pred hhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCCHHHHhcC
Confidence 0000000 00123567899999999999999999999873
|
|
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=99.91 E-value=2.9e-24 Score=210.91 Aligned_cols=144 Identities=23% Similarity=0.374 Sum_probs=117.9
Q ss_pred HHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCccEEEeccCCcccccCCCcccccccccCCccccCCccccCCCCC
Q psy1840 25 SISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKAPELLRQPHLP 104 (423)
Q Consensus 25 ~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~ 104 (423)
...++.||+.||.|||++|++ ||||||+||+++.++.+||+|||+++...... .......|++.|+|||++.+..+
T Consensus 103 ~~~i~~qi~~al~~lH~~~iv-HrDikp~Nill~~~~~ikL~Dfg~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~- 178 (323)
T cd05615 103 AVFYAAEISVGLFFLHRRGII-YRDLKLDNVMLDSEGHIKIADFGMCKEHMVDG--VTTRTFCGTPDYIAPEIIAYQPY- 178 (323)
T ss_pred HHHHHHHHHHHHHHHHHCCee-ccCCCHHHeEECCCCCEEEeccccccccCCCC--ccccCccCCccccCHHHHcCCCC-
Confidence 678999999999999999998 99999999999999999999999986532221 11234568899999999987654
Q ss_pred CCCCccchHHHHHHHHHHHhCCCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCchHHHHHHHHHhhhcCCCCCCCH
Q psy1840 105 RGTQKGDVYSFGLVLYEVIGRQGPWGHLRMTDEEIITSVTQGSGLRPDTSSLDCAPSIIACMRTCWEEDPELRPDL 180 (423)
Q Consensus 105 ~~s~ksDVyS~Giil~elltg~~Pf~~~~~~~~~i~~~i~~~~~~~p~~~~~~~~~~l~~Li~~C~~~dP~~RPt~ 180 (423)
+.++|||||||++|||++|..||.. .....+...+.......| ..++.++.+++.+||+.+|.+|++.
T Consensus 179 --~~~~DiwslGvil~elltG~~pf~~--~~~~~~~~~i~~~~~~~p----~~~~~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05615 179 --GKSVDWWAYGVLLYEMLAGQPPFDG--EDEDELFQSIMEHNVSYP----KSLSKEAVSICKGLMTKHPSKRLGC 246 (323)
T ss_pred --CCccchhhhHHHHHHHHhCCCCCCC--CCHHHHHHHHHhCCCCCC----ccCCHHHHHHHHHHcccCHhhCCCC
Confidence 8899999999999999999999974 345666666665443322 2467899999999999999999985
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=99.91 E-value=6.6e-24 Score=214.40 Aligned_cols=158 Identities=26% Similarity=0.430 Sum_probs=123.0
Q ss_pred HHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCccEEEeccCCcccccCCCcccccccccCCccccCCccccCCCCC
Q psy1840 25 SISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKAPELLRQPHLP 104 (423)
Q Consensus 25 ~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~ 104 (423)
.++++.||+.||.|||+.+++ ||||||+||+++.++.+||+|||+++...............++..|+|||.+.+..+
T Consensus 241 ~~~~~~qi~~aL~~LH~~~iv-Hrdlkp~NiLl~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~- 318 (401)
T cd05107 241 LVGFSYQVANGMEFLASKNCV-HRDLAARNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLY- 318 (401)
T ss_pred HHHHHHHHHHHHHHHhcCCcC-cccCCcceEEEeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCC-
Confidence 578999999999999999998 999999999999999999999999875432221111223346678999999977654
Q ss_pred CCCCccchHHHHHHHHHHHh-CCCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCchHHHHHHHHHhhhcCCCCCCCHHHH
Q psy1840 105 RGTQKGDVYSFGLVLYEVIG-RQGPWGHLRMTDEEIITSVTQGSGLRPDTSSLDCAPSIIACMRTCWEEDPELRPDLRFV 183 (423)
Q Consensus 105 ~~s~ksDVyS~Giil~ellt-g~~Pf~~~~~~~~~i~~~i~~~~~~~p~~~~~~~~~~l~~Li~~C~~~dP~~RPt~~~I 183 (423)
+.++||||||+++|||++ |..||..... .+.....+..+. ++.. +..++.++.+++.+||..+|++||++.+|
T Consensus 319 --~~~~DvwslGvil~e~l~~g~~P~~~~~~-~~~~~~~~~~~~--~~~~-p~~~~~~l~~li~~cl~~~P~~RPs~~el 392 (401)
T cd05107 319 --TTLSDVWSFGILLWEIFTLGGTPYPELPM-NEQFYNAIKRGY--RMAK-PAHASDEIYEIMQKCWEEKFEIRPDFSQL 392 (401)
T ss_pred --CcHhHHHHHHHHHHHHHHcCCCCCCCCCc-hHHHHHHHHcCC--CCCC-CCCCCHHHHHHHHHHcCCChhHCcCHHHH
Confidence 889999999999999998 8889864321 222333333332 2222 23578999999999999999999999999
Q ss_pred HHHHHHH
Q psy1840 184 HHKLKEM 190 (423)
Q Consensus 184 ~~~L~~i 190 (423)
++.|+.+
T Consensus 393 l~~L~~~ 399 (401)
T cd05107 393 VHLVGDL 399 (401)
T ss_pred HHHHHHH
Confidence 9998875
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=99.91 E-value=3e-24 Score=214.82 Aligned_cols=158 Identities=15% Similarity=0.161 Sum_probs=121.6
Q ss_pred HHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCccEEEeccCCcccccCCCcccccccccCCccccCCccccCCC-C
Q psy1840 25 SISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKAPELLRQPH-L 103 (423)
Q Consensus 25 ~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~-~ 103 (423)
...++.||+.||.|||+.|++ ||||||+|||++.++.+||+|||++........ .......|++.|+|||.+.+.. .
T Consensus 144 ~~~~~~qi~~aL~~LH~~~iv-HrDLkp~NILl~~~~~~kL~DfG~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~ 221 (370)
T cd05596 144 ARFYTAEVVLALDAIHSMGFI-HRDVKPDNMLLDKSGHLKLADFGTCMKMDANGM-VRCDTAVGTPDYISPEVLKSQGGD 221 (370)
T ss_pred HHHHHHHHHHHHHHHHHCCee-ccCCCHHHEEEcCCCCEEEEeccceeeccCCCc-ccCCCCCCCcCeECHHHhccCCCC
Confidence 467889999999999999998 999999999999999999999999875432211 1123457899999999987543 1
Q ss_pred CCCCCccchHHHHHHHHHHHhCCCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCchHHHHHHHHHhhhcCCCC--CCCHH
Q psy1840 104 PRGTQKGDVYSFGLVLYEVIGRQGPWGHLRMTDEEIITSVTQGSGLRPDTSSLDCAPSIIACMRTCWEEDPEL--RPDLR 181 (423)
Q Consensus 104 ~~~s~ksDVyS~Giil~elltg~~Pf~~~~~~~~~i~~~i~~~~~~~p~~~~~~~~~~l~~Li~~C~~~dP~~--RPt~~ 181 (423)
..++.++|||||||++|||++|..||... +.......+..............++.++.+++.+|++.+|.+ ||++.
T Consensus 222 ~~~~~~~DiwSlGvilyelltG~~Pf~~~--~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~~p~r~~R~s~~ 299 (370)
T cd05596 222 GYYGRECDWWSVGVFLYEMLVGDTPFYAD--SLVGTYSKIMDHKNSLTFPDDIEISKQAKDLICAFLTDREVRLGRNGVD 299 (370)
T ss_pred CCCCCceeeeehhHHHHHHHhCCCCcCCC--CHHHHHHHHHcCCCcCCCCCcCCCCHHHHHHHHHHccChhhccCCCCHH
Confidence 13488999999999999999999999743 334555555543221111112357899999999999999987 99999
Q ss_pred HHHHH
Q psy1840 182 FVHHK 186 (423)
Q Consensus 182 ~I~~~ 186 (423)
+++..
T Consensus 300 ell~h 304 (370)
T cd05596 300 EIKSH 304 (370)
T ss_pred HHhcC
Confidence 98765
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.91 E-value=6.7e-24 Score=189.33 Aligned_cols=148 Identities=24% Similarity=0.363 Sum_probs=111.8
Q ss_pred HHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCccEEEeccCCcccccCCCcccccccccCCccccCCccccCCCCC
Q psy1840 25 SISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKAPELLRQPHLP 104 (423)
Q Consensus 25 ~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~ 104 (423)
...++.||+.||.|||+.+ ||+||+++.++.+|+ ||++...... ...|++.|+|||++.+..+
T Consensus 19 ~~~i~~qi~~~L~~lH~~~-------kp~Nil~~~~~~~~~--fG~~~~~~~~-------~~~g~~~y~aPE~~~~~~~- 81 (176)
T smart00750 19 IWAVCLQCLRALRELHRQA-------KSGNILLTWDGLLKL--DGSVAFKTPE-------QSRVDPYFMAPEVIQGQSY- 81 (176)
T ss_pred HHHHHHHHHHHHHHHHhcC-------CcccEeEcCccceee--ccceEeeccc-------cCCCcccccChHHhcCCCC-
Confidence 6899999999999999865 999999999999999 9998764322 1257889999999988765
Q ss_pred CCCCccchHHHHHHHHHHHhCCCCCCCCCCChHHHHHHHhcC-CCCCCC--CCCCCchH--HHHHHHHHhhhcCCCCCCC
Q psy1840 105 RGTQKGDVYSFGLVLYEVIGRQGPWGHLRMTDEEIITSVTQG-SGLRPD--TSSLDCAP--SIIACMRTCWEEDPELRPD 179 (423)
Q Consensus 105 ~~s~ksDVyS~Giil~elltg~~Pf~~~~~~~~~i~~~i~~~-~~~~p~--~~~~~~~~--~l~~Li~~C~~~dP~~RPt 179 (423)
+.++|||||||++|||++|+.||...... ......+... ....+. ......+. ++.+++.+||+.+|++||+
T Consensus 82 --~~~~DiwSlG~il~elltg~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~ 158 (176)
T smart00750 82 --TEKADIYSLGITLYEALDYELPYNEEREL-SAILEILLNGMPADDPRDRSNLESVSAARSFADFMRVCASRLPQRREA 158 (176)
T ss_pred --cchhhHHHHHHHHHHHHhCCCCccccchh-cHHHHHHHHHhccCCccccccHHHHHhhhhHHHHHHHHHhcccccccC
Confidence 88999999999999999999999643221 2222222221 111111 01112333 6999999999999999999
Q ss_pred HHHHHHHHHHHhh
Q psy1840 180 LRFVHHKLKEMNA 192 (423)
Q Consensus 180 ~~~I~~~L~~i~~ 192 (423)
+.++++.+..+..
T Consensus 159 ~~~ll~~~~~~~~ 171 (176)
T smart00750 159 ANHYLAHCRALFA 171 (176)
T ss_pred HHHHHHHHHHHHH
Confidence 9999998876643
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.6e-23 Score=204.83 Aligned_cols=179 Identities=17% Similarity=0.288 Sum_probs=137.7
Q ss_pred HHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCccEEEeccCCcccccCCCcccccccccCCccccCCccccCCCCC
Q psy1840 25 SISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKAPELLRQPHLP 104 (423)
Q Consensus 25 ~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~ 104 (423)
...++.|++.|+.|||+++++ ||||+|+||+++.++.+||+|||++...... ....++..|+|||.+......
T Consensus 127 ~~~i~~~i~~~l~~lH~~~i~-H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~ 199 (317)
T cd06635 127 IAAITHGALQGLAYLHSHNMI-HRDIKAGNILLTEPGQVKLADFGSASIASPA------NSFVGTPYWMAPEVILAMDEG 199 (317)
T ss_pred HHHHHHHHHHHHHHHHHCCcc-cCCCCcccEEECCCCCEEEecCCCccccCCc------ccccCCccccChhhhhcCCCC
Confidence 578999999999999999998 9999999999999999999999987643221 234577889999998532212
Q ss_pred CCCCccchHHHHHHHHHHHhCCCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCchHHHHHHHHHhhhcCCCCCCCHHHHH
Q psy1840 105 RGTQKGDVYSFGLVLYEVIGRQGPWGHLRMTDEEIITSVTQGSGLRPDTSSLDCAPSIIACMRTCWEEDPELRPDLRFVH 184 (423)
Q Consensus 105 ~~s~ksDVyS~Giil~elltg~~Pf~~~~~~~~~i~~~i~~~~~~~p~~~~~~~~~~l~~Li~~C~~~dP~~RPt~~~I~ 184 (423)
..+.++||||||+++|||++|..||... ........+..... +......+++.+.+++.+||+.+|.+||++.+|+
T Consensus 200 ~~~~~~Dv~slGvil~el~~g~~p~~~~--~~~~~~~~~~~~~~--~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il 275 (317)
T cd06635 200 QYDGKVDVWSLGITCIELAERKPPLFNM--NAMSALYHIAQNES--PTLQSNEWSDYFRNFVDSCLQKIPQDRPTSEELL 275 (317)
T ss_pred CCCccccHHHHHHHHHHHHhCCCCCCCc--cHHHHHHHHHhccC--CCCCCccccHHHHHHHHHHccCCcccCcCHHHHH
Confidence 3488999999999999999999998643 33344444443322 2222335778899999999999999999999999
Q ss_pred HHHHHHhhhcCCChHHHHHHHHHHhhhcccc
Q psy1840 185 HKLKEMNAGLKANIFDNMLAIMEKYAFNLEG 215 (423)
Q Consensus 185 ~~L~~i~~~~~~~~~d~~~~~~e~~~~~lE~ 215 (423)
+.+....... .....+.+...+++..++|.
T Consensus 276 ~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~ 305 (317)
T cd06635 276 KHMFVLRERP-ETVLIDLIQRTKDAVRELDN 305 (317)
T ss_pred hChhhhccCc-ccchhhHHHHHHHHHHHHhh
Confidence 8776655433 33556777888888888886
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=99.91 E-value=2.5e-24 Score=204.54 Aligned_cols=157 Identities=17% Similarity=0.231 Sum_probs=116.9
Q ss_pred HHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCccEEEeccCCcccccCCCcccccccccCCccccCCccccCCCCC
Q psy1840 25 SISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKAPELLRQPHLP 104 (423)
Q Consensus 25 ~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~ 104 (423)
...++.|++.|+.|||+.+++ ||||||+||+++.++.+||+|||++........ ......++..|+|||.+......
T Consensus 108 ~~~~~~qi~~~l~~lH~~~i~-H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~ 184 (267)
T cd06646 108 IAYVCRETLQGLAYLHSKGKM-HRDIKGANILLTDNGDVKLADFGVAAKITATIA--KRKSFIGTPYWMAPEVAAVEKNG 184 (267)
T ss_pred HHHHHHHHHHHHHHHHHCCcc-ccCCCHHHEEECCCCCEEECcCccceeeccccc--ccCccccCccccCHhHcccccCC
Confidence 578899999999999999998 999999999999999999999999875432211 11234577889999988543222
Q ss_pred CCCCccchHHHHHHHHHHHhCCCCCCCCCCChHHHHHHHhcCCCCCCCC-CCCCchHHHHHHHHHhhhcCCCCCCCHHHH
Q psy1840 105 RGTQKGDVYSFGLVLYEVIGRQGPWGHLRMTDEEIITSVTQGSGLRPDT-SSLDCAPSIIACMRTCWEEDPELRPDLRFV 183 (423)
Q Consensus 105 ~~s~ksDVyS~Giil~elltg~~Pf~~~~~~~~~i~~~i~~~~~~~p~~-~~~~~~~~l~~Li~~C~~~dP~~RPt~~~I 183 (423)
..+.++|||||||++|||++|+.||.... ..+....+.......+.. ....++..+.+++.+||+.+|++||++.+|
T Consensus 185 ~~~~~~Dvws~G~il~el~~g~~p~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~i 262 (267)
T cd06646 185 GYNQLCDIWAVGITAIELAELQPPMFDLH--PMRALFLMSKSNFQPPKLKDKTKWSSTFHNFVKISLTKNPKKRPTAERL 262 (267)
T ss_pred CCcchhhHHHHHHHHHHHHhCCCCccccc--hhhhheeeecCCCCCCCCccccccCHHHHHHHHHHhhCChhhCcCHHHH
Confidence 34789999999999999999999985322 121111221211111111 123467899999999999999999999998
Q ss_pred HHH
Q psy1840 184 HHK 186 (423)
Q Consensus 184 ~~~ 186 (423)
++.
T Consensus 263 l~~ 265 (267)
T cd06646 263 LTH 265 (267)
T ss_pred hcC
Confidence 764
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.9e-23 Score=203.20 Aligned_cols=153 Identities=22% Similarity=0.299 Sum_probs=119.3
Q ss_pred HHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCccEEEeccCCcccccCCCcccccccccCCccccCCccccCCCCC
Q psy1840 25 SISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKAPELLRQPHLP 104 (423)
Q Consensus 25 ~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~ 104 (423)
...++.|++.||.|||+.+++ ||||+|+||+++.++.+||+|||++...... ....++..|+|||.+.+....
T Consensus 117 ~~~~~~ql~~~L~~LH~~~i~-H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~ 189 (307)
T cd06607 117 IAAICHGALQGLAYLHSHERI-HRDIKAGNILLTEPGTVKLADFGSASLVSPA------NSFVGTPYWMAPEVILAMDEG 189 (307)
T ss_pred HHHHHHHHHHHHHHHHHCCce-ecCCCcccEEECCCCCEEEeecCcceecCCC------CCccCCccccCceeeeccCCC
Confidence 678999999999999999998 9999999999999999999999998654322 234567789999988532212
Q ss_pred CCCCccchHHHHHHHHHHHhCCCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCchHHHHHHHHHhhhcCCCCCCCHHHHH
Q psy1840 105 RGTQKGDVYSFGLVLYEVIGRQGPWGHLRMTDEEIITSVTQGSGLRPDTSSLDCAPSIIACMRTCWEEDPELRPDLRFVH 184 (423)
Q Consensus 105 ~~s~ksDVyS~Giil~elltg~~Pf~~~~~~~~~i~~~i~~~~~~~p~~~~~~~~~~l~~Li~~C~~~dP~~RPt~~~I~ 184 (423)
..+.++||||||+++||+++|..||... ........+... ..+......++..+.+++.+||+.+|++||++.+|+
T Consensus 190 ~~~~~sDv~s~G~il~el~tg~~p~~~~--~~~~~~~~~~~~--~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il 265 (307)
T cd06607 190 QYDGKVDVWSLGITCIELAERKPPLFNM--NAMSALYHIAQN--DSPTLSSNDWSDYFRNFVDSCLQKIPQDRPSSEELL 265 (307)
T ss_pred CCCcccchHHHHHHHHHHHcCCCCCCCc--cHHHHHHHHhcC--CCCCCCchhhCHHHHHHHHHHhcCChhhCcCHHHHh
Confidence 3478999999999999999999998642 333333333322 122333345788999999999999999999999998
Q ss_pred HHHH
Q psy1840 185 HKLK 188 (423)
Q Consensus 185 ~~L~ 188 (423)
....
T Consensus 266 ~~~~ 269 (307)
T cd06607 266 KHRF 269 (307)
T ss_pred cChh
Confidence 7654
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=99.91 E-value=2.9e-24 Score=211.27 Aligned_cols=147 Identities=17% Similarity=0.298 Sum_probs=114.5
Q ss_pred HHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCccEEEeccCCcccccCCCcccccccccCCccccCCccccCCCCC
Q psy1840 25 SISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKAPELLRQPHLP 104 (423)
Q Consensus 25 ~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~ 104 (423)
...++.||+.||.|||++|++ ||||||+||+++.++.+||+|||+++...... .......|++.|+|||++.+..+
T Consensus 98 ~~~~~~qi~~al~~lH~~~iv-HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~- 173 (327)
T cd05617 98 ARFYAAEICIALNFLHERGII-YRDLKLDNVLLDADGHIKLTDYGMCKEGLGPG--DTTSTFCGTPNYIAPEILRGEEY- 173 (327)
T ss_pred HHHHHHHHHHHHHHHHHCCee-ccCCCHHHEEEeCCCCEEEeccccceeccCCC--CceecccCCcccCCHHHHCCCCC-
Confidence 578999999999999999998 99999999999999999999999986432211 11234568899999999987655
Q ss_pred CCCCccchHHHHHHHHHHHhCCCCCCCCC----CCh-HHHHHHHhcCCCCCCCCCCCCchHHHHHHHHHhhhcCCCCCCC
Q psy1840 105 RGTQKGDVYSFGLVLYEVIGRQGPWGHLR----MTD-EEIITSVTQGSGLRPDTSSLDCAPSIIACMRTCWEEDPELRPD 179 (423)
Q Consensus 105 ~~s~ksDVyS~Giil~elltg~~Pf~~~~----~~~-~~i~~~i~~~~~~~p~~~~~~~~~~l~~Li~~C~~~dP~~RPt 179 (423)
+.++|||||||++|||++|..||.... ... ..+...+....... +...+..+.+++.+||+.||.+|++
T Consensus 174 --~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~----p~~~~~~~~~li~~~L~~dP~~R~~ 247 (327)
T cd05617 174 --GFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKPIRI----PRFLSVKASHVLKGFLNKDPKERLG 247 (327)
T ss_pred --CchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhCCCCC----CCCCCHHHHHHHHHHhccCHHHcCC
Confidence 889999999999999999999995321 112 23333333322222 2346789999999999999999998
Q ss_pred HH
Q psy1840 180 LR 181 (423)
Q Consensus 180 ~~ 181 (423)
+.
T Consensus 248 ~~ 249 (327)
T cd05617 248 CQ 249 (327)
T ss_pred CC
Confidence 53
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=99.91 E-value=6.9e-24 Score=201.74 Aligned_cols=147 Identities=20% Similarity=0.329 Sum_probs=111.0
Q ss_pred HHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCcc-------EEEeccCCcccccCCCcccccccccCCccccCCcc
Q psy1840 25 SISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWV-------LQIADFGLHAFKAGQDETGQERKLRRRKLYKAPEL 97 (423)
Q Consensus 25 ~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~~-------vKL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~ 97 (423)
.++++.||+.||.|||+++++ ||||||+||+++.++. +|++|||++...... ....++..|+|||.
T Consensus 107 ~~~i~~qi~~~l~~lH~~~iv-H~dlkp~Nill~~~~~~~~~~~~~~l~d~g~~~~~~~~------~~~~~~~~y~aPE~ 179 (262)
T cd05077 107 KFKVAKQLASALSYLEDKDLV-HGNVCTKNILLAREGIDGECGPFIKLSDPGIPITVLSR------QECVERIPWIAPEC 179 (262)
T ss_pred HHHHHHHHHHHHHHhhhCCeE-CCCCCcccEEEecCCccCCCCceeEeCCCCCCccccCc------ccccccccccChhh
Confidence 689999999999999999998 9999999999987664 899999997644211 22356778999998
Q ss_pred ccCCCCCCCCCccchHHHHHHHHHHH-hCCCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCchHHHHHHHHHhhhcCCCC
Q psy1840 98 LRQPHLPRGTQKGDVYSFGLVLYEVI-GRQGPWGHLRMTDEEIITSVTQGSGLRPDTSSLDCAPSIIACMRTCWEEDPEL 176 (423)
Q Consensus 98 l~~~~~~~~s~ksDVyS~Giil~ell-tg~~Pf~~~~~~~~~i~~~i~~~~~~~p~~~~~~~~~~l~~Li~~C~~~dP~~ 176 (423)
+.... ..+.++|||||||++|||+ +|..||.... ..+... ...+.. . .....+.++.+++.+||+.||++
T Consensus 180 ~~~~~--~~~~~~DiwslG~~l~el~~~~~~p~~~~~--~~~~~~-~~~~~~-~---~~~~~~~~~~~li~~cl~~dp~~ 250 (262)
T cd05077 180 VEDSK--NLSIAADKWSFGTTLWEICYNGEIPLKDKT--LAEKER-FYEGQC-M---LVTPSCKELADLMTHCMNYDPNQ 250 (262)
T ss_pred hcCCC--CCCchhHHHHHHHHHHHHHhCCCCCCCCcc--hhHHHH-HHhcCc-c---CCCCChHHHHHHHHHHcCCChhh
Confidence 86432 2388999999999999998 5788886432 222221 111111 1 11234678999999999999999
Q ss_pred CCCHHHHHHHH
Q psy1840 177 RPDLRFVHHKL 187 (423)
Q Consensus 177 RPt~~~I~~~L 187 (423)
||++.+|++.+
T Consensus 251 Rp~~~~il~~~ 261 (262)
T cd05077 251 RPFFRAIMRDI 261 (262)
T ss_pred CcCHHHHHHhc
Confidence 99999998764
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.2e-24 Score=213.72 Aligned_cols=146 Identities=20% Similarity=0.247 Sum_probs=117.7
Q ss_pred HHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCccEEEeccCCcccccCCCcccccccccCCccccCCccccCCCCC
Q psy1840 25 SISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKAPELLRQPHLP 104 (423)
Q Consensus 25 ~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~ 104 (423)
...++.||+.||.|||+.|++ ||||||+||+++.++.+||+|||+++...... .......|+..|+|||.+.+..+
T Consensus 98 ~~~~~~qi~~al~~lH~~giv-H~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~- 173 (325)
T cd05604 98 ARFYAAEIASALGYLHSINIV-YRDLKPENILLDSQGHVVLTDFGLCKEGIAQS--DTTTTFCGTPEYLAPEVIRKQPY- 173 (325)
T ss_pred HHHHHHHHHHHHHHHHHCCee-ecCCCHHHeEECCCCCEEEeecCCcccCCCCC--CCcccccCChhhCCHHHHcCCCC-
Confidence 567899999999999999998 99999999999999999999999986432221 12234568899999999987655
Q ss_pred CCCCccchHHHHHHHHHHHhCCCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCchHHHHHHHHHhhhcCCCCCCCHHH
Q psy1840 105 RGTQKGDVYSFGLVLYEVIGRQGPWGHLRMTDEEIITSVTQGSGLRPDTSSLDCAPSIIACMRTCWEEDPELRPDLRF 182 (423)
Q Consensus 105 ~~s~ksDVyS~Giil~elltg~~Pf~~~~~~~~~i~~~i~~~~~~~p~~~~~~~~~~l~~Li~~C~~~dP~~RPt~~~ 182 (423)
+.++|||||||++|||++|..||.. .+..++...+.......+ ...+..+.+++.+|++.+|.+||++.+
T Consensus 174 --~~~~DvwslG~il~el~~G~~pf~~--~~~~~~~~~~~~~~~~~~----~~~~~~~~~ll~~ll~~~p~~R~~~~~ 243 (325)
T cd05604 174 --DNTVDWWCLGAVLYEMLYGLPPFYC--RDVAEMYDNILHKPLVLR----PGASLTAWSILEELLEKDRQRRLGAKE 243 (325)
T ss_pred --CCcCccccccceehhhhcCCCCCCC--CCHHHHHHHHHcCCccCC----CCCCHHHHHHHHHHhccCHHhcCCCCC
Confidence 8899999999999999999999974 344556666655432221 246788999999999999999998753
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=99.91 E-value=4.3e-24 Score=203.39 Aligned_cols=154 Identities=18% Similarity=0.309 Sum_probs=117.3
Q ss_pred HHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCccEEEeccCCcccccCCCcccccccccCCccccCCccccCCC--
Q psy1840 25 SISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKAPELLRQPH-- 102 (423)
Q Consensus 25 ~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~-- 102 (423)
...++.|++.|++|||+++++ ||||||+||+++.++.+||+|||++....... .......++..|+|||.+.+..
T Consensus 113 ~~~~~~qi~~~l~~LH~~~iv-h~dl~~~nili~~~~~~~l~Dfg~~~~~~~~~--~~~~~~~g~~~y~aPE~~~~~~~~ 189 (272)
T cd06637 113 IAYICREILRGLSHLHQHKVI-HRDIKGQNVLLTENAEVKLVDFGVSAQLDRTV--GRRNTFIGTPYWMAPEVIACDENP 189 (272)
T ss_pred HHHHHHHHHHHHHHHHHCCCc-cCCCCHHHEEECCCCCEEEccCCCceeccccc--ccCCcccccccccCHhHhccccCc
Confidence 567899999999999999998 99999999999999999999999987543221 1223456788899999986432
Q ss_pred CCCCCCccchHHHHHHHHHHHhCCCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCchHHHHHHHHHhhhcCCCCCCCHHH
Q psy1840 103 LPRGTQKGDVYSFGLVLYEVIGRQGPWGHLRMTDEEIITSVTQGSGLRPDTSSLDCAPSIIACMRTCWEEDPELRPDLRF 182 (423)
Q Consensus 103 ~~~~s~ksDVyS~Giil~elltg~~Pf~~~~~~~~~i~~~i~~~~~~~p~~~~~~~~~~l~~Li~~C~~~dP~~RPt~~~ 182 (423)
...++.++|||||||++|||++|..||.... ............ .+......++.++.+++.+||..+|.+||++.+
T Consensus 190 ~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~--~~~~~~~~~~~~--~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ 265 (272)
T cd06637 190 DATYDFKSDLWSLGITAIEMAEGAPPLCDMH--PMRALFLIPRNP--APRLKSKKWSKKFQSFIESCLVKNHSQRPTTEQ 265 (272)
T ss_pred CCCCCchhhHHHHHHHHHHHHhCCCCccccC--HHHHHHHHhcCC--CCCCCCCCcCHHHHHHHHHHcCCChhhCCCHHH
Confidence 1134789999999999999999999996432 222222222211 122223357889999999999999999999999
Q ss_pred HHH
Q psy1840 183 VHH 185 (423)
Q Consensus 183 I~~ 185 (423)
+++
T Consensus 266 il~ 268 (272)
T cd06637 266 LMK 268 (272)
T ss_pred Hhh
Confidence 875
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=99.91 E-value=9.9e-24 Score=199.96 Aligned_cols=155 Identities=27% Similarity=0.536 Sum_probs=122.4
Q ss_pred HHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCccEEEeccCCcccccCCCcccccccccCCccccCCccccCCCCC
Q psy1840 25 SISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKAPELLRQPHLP 104 (423)
Q Consensus 25 ~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~ 104 (423)
.+.++.|++.||.|||++|++ ||||||+||+++.++.+||+|||.+........ .......++..|+|||.+.....
T Consensus 104 ~~~~~~~l~~aL~~lH~~~i~-H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~- 180 (260)
T cd05073 104 LIDFSAQIAEGMAFIEQRNYI-HRDLRAANILVSASLVCKIADFGLARVIEDNEY-TAREGAKFPIKWTAPEAINFGSF- 180 (260)
T ss_pred HHHHHHHHHHHHHHHHhCCcc-ccccCcceEEEcCCCcEEECCCcceeeccCCCc-ccccCCcccccccCHhHhccCCc-
Confidence 578999999999999999998 999999999999999999999999875432211 11122234567999999976554
Q ss_pred CCCCccchHHHHHHHHHHHh-CCCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCchHHHHHHHHHhhhcCCCCCCCHHHH
Q psy1840 105 RGTQKGDVYSFGLVLYEVIG-RQGPWGHLRMTDEEIITSVTQGSGLRPDTSSLDCAPSIIACMRTCWEEDPELRPDLRFV 183 (423)
Q Consensus 105 ~~s~ksDVyS~Giil~ellt-g~~Pf~~~~~~~~~i~~~i~~~~~~~p~~~~~~~~~~l~~Li~~C~~~dP~~RPt~~~I 183 (423)
+.++|+||||+++|++++ |..||.. .+...+...+..+... . .....+.++.+++.+||+.+|++||++.++
T Consensus 181 --~~~~Di~slG~~l~~l~t~g~~p~~~--~~~~~~~~~~~~~~~~--~-~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l 253 (260)
T cd05073 181 --TIKSDVWSFGILLMEIVTYGRIPYPG--MSNPEVIRALERGYRM--P-RPENCPEELYNIMMRCWKNRPEERPTFEYI 253 (260)
T ss_pred --CccccchHHHHHHHHHHhcCCCCCCC--CCHHHHHHHHhCCCCC--C-CcccCCHHHHHHHHHHcccCcccCcCHHHH
Confidence 889999999999999998 8889974 3345555555554222 1 123578899999999999999999999999
Q ss_pred HHHHHH
Q psy1840 184 HHKLKE 189 (423)
Q Consensus 184 ~~~L~~ 189 (423)
.+.|+.
T Consensus 254 ~~~L~~ 259 (260)
T cd05073 254 QSVLDD 259 (260)
T ss_pred HHHHhc
Confidence 988764
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=99.91 E-value=8.9e-24 Score=203.04 Aligned_cols=159 Identities=25% Similarity=0.423 Sum_probs=120.3
Q ss_pred HHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCccEEEeccCCcccccCCCcc-cccccccCCccccCCccccCCCC
Q psy1840 25 SISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDET-GQERKLRRRKLYKAPELLRQPHL 103 (423)
Q Consensus 25 ~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~~-~~~~~~~gt~~y~APE~l~~~~~ 103 (423)
.+.++.|++.||+|||++|++ ||||||+||+++.++.+||+|||++......... .......++..|+|||.+.+..+
T Consensus 111 ~~~i~~~i~~aL~~lH~~gi~-H~dlkp~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~ 189 (284)
T cd05079 111 QLKYAVQICKGMDYLGSRQYV-HRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECLIQSKF 189 (284)
T ss_pred HHHHHHHHHHHHHHHHHCCee-ecccchheEEEcCCCCEEECCCccccccccCccceeecCCCCCCccccCHHHhccCCC
Confidence 689999999999999999998 9999999999999999999999998765432221 11123445667999999877654
Q ss_pred CCCCCccchHHHHHHHHHHHhCCCCCCCC-------------CCChHHHHHHHhcCCCCCCCCCCCCchHHHHHHHHHhh
Q psy1840 104 PRGTQKGDVYSFGLVLYEVIGRQGPWGHL-------------RMTDEEIITSVTQGSGLRPDTSSLDCAPSIIACMRTCW 170 (423)
Q Consensus 104 ~~~s~ksDVyS~Giil~elltg~~Pf~~~-------------~~~~~~i~~~i~~~~~~~p~~~~~~~~~~l~~Li~~C~ 170 (423)
+.++||||||+++||++++..|+... ..........+..+.. .+ ....++..+.+++.+||
T Consensus 190 ---~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~-~~~~~~~~~~~li~~~l 263 (284)
T cd05079 190 ---YIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVRVLEEGKR--LP-RPPNCPEEVYQLMRKCW 263 (284)
T ss_pred ---CccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHHHHHHcCcc--CC-CCCCCCHHHHHHHHHHc
Confidence 88999999999999999987664211 0111222222323221 11 12357899999999999
Q ss_pred hcCCCCCCCHHHHHHHHHHH
Q psy1840 171 EEDPELRPDLRFVHHKLKEM 190 (423)
Q Consensus 171 ~~dP~~RPt~~~I~~~L~~i 190 (423)
+.+|++||++.++++.++.+
T Consensus 264 ~~~p~~Rpt~~~il~~l~~~ 283 (284)
T cd05079 264 EFQPSKRTTFQNLIEGFEAI 283 (284)
T ss_pred cCCcccCcCHHHHHHHHHhh
Confidence 99999999999999988765
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >KOG0589|consensus | Back alignment and domain information |
|---|
Probab=99.91 E-value=2.2e-24 Score=213.04 Aligned_cols=156 Identities=19% Similarity=0.343 Sum_probs=132.9
Q ss_pred CChHHH-HHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCccEEEeccCCcccccCCCcccccccccCCccccCCccc
Q psy1840 20 NIPIGS-ISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKAPELL 98 (423)
Q Consensus 20 ~~p~~~-l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l 98 (423)
..|+++ ..+..|++.|+.|||++.|. |||||+.||+++.++.+||+|||+++...... ....+..||+.|++||++
T Consensus 102 ~f~E~~i~~~~~Q~~~av~ylH~~~iL-HRDlK~~Nifltk~~~VkLgDfGlaK~l~~~~--~~a~tvvGTp~YmcPEil 178 (426)
T KOG0589|consen 102 LFPEERILKWFVQILLAVNYLHENRVL-HRDLKCANIFLTKDKKVKLGDFGLAKILNPED--SLASTVVGTPYYMCPEIL 178 (426)
T ss_pred cccHHHHHHHHHHHHHHHHHHHhhhhh-cccchhhhhhccccCceeecchhhhhhcCCch--hhhheecCCCcccCHHHh
Confidence 345665 58999999999999988887 99999999999999999999999999875443 233578899999999999
Q ss_pred cCCCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCchHHHHHHHHHhhhcCCCCCC
Q psy1840 99 RQPHLPRGTQKGDVYSFGLVLYEVIGRQGPWGHLRMTDEEIITSVTQGSGLRPDTSSLDCAPSIIACMRTCWEEDPELRP 178 (423)
Q Consensus 99 ~~~~~~~~s~ksDVyS~Giil~elltg~~Pf~~~~~~~~~i~~~i~~~~~~~p~~~~~~~~~~l~~Li~~C~~~dP~~RP 178 (423)
.+.++ +.|+|||||||++|||++-+.+|... +..+++.++.++... | .+..++.++..+|+.|+..+|+.||
T Consensus 179 ~d~pY---n~KSDiWsLGC~~yEm~~lk~aF~a~--~m~~Li~ki~~~~~~-P--lp~~ys~el~~lv~~~l~~~P~~RP 250 (426)
T KOG0589|consen 179 SDIPY---NEKSDIWSLGCCLYEMCTLKPAFKAS--NMSELILKINRGLYS-P--LPSMYSSELRSLVKSMLRKNPEHRP 250 (426)
T ss_pred CCCCC---CccCcchhhcchHHHHHhcccccCcc--chHHHHHHHhhccCC-C--CCccccHHHHHHHHHHhhcCCccCC
Confidence 99876 99999999999999999999999754 457788888776521 1 1236789999999999999999999
Q ss_pred CHHHHHHH
Q psy1840 179 DLRFVHHK 186 (423)
Q Consensus 179 t~~~I~~~ 186 (423)
++.+++..
T Consensus 251 sa~~LL~~ 258 (426)
T KOG0589|consen 251 SALELLRR 258 (426)
T ss_pred CHHHHhhC
Confidence 99999875
|
|
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.1e-24 Score=213.32 Aligned_cols=146 Identities=22% Similarity=0.324 Sum_probs=118.7
Q ss_pred HHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCccEEEeccCCcccccCCCcccccccccCCccccCCccccCCCCC
Q psy1840 25 SISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKAPELLRQPHLP 104 (423)
Q Consensus 25 ~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~ 104 (423)
...++.||+.||.|||+.+++ ||||||+||+++.++.+||+|||++....... .......|+..|+|||.+.+..+
T Consensus 100 ~~~~~~qi~~~l~~lH~~~i~-H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~--~~~~~~~g~~~y~aPE~~~~~~~- 175 (318)
T cd05582 100 VKFYLAELALALDHLHSLGII-YRDLKPENILLDEEGHIKLTDFGLSKESIDHE--KKAYSFCGTVEYMAPEVVNRRGH- 175 (318)
T ss_pred HHHHHHHHHHHHHHHHHCCEe-cCCCCHHHeEECCCCcEEEeeccCCcccCCCC--CceecccCChhhcCHHHHcCCCC-
Confidence 578899999999999999988 99999999999999999999999987543221 12234568899999999987654
Q ss_pred CCCCccchHHHHHHHHHHHhCCCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCchHHHHHHHHHhhhcCCCCCCCHHH
Q psy1840 105 RGTQKGDVYSFGLVLYEVIGRQGPWGHLRMTDEEIITSVTQGSGLRPDTSSLDCAPSIIACMRTCWEEDPELRPDLRF 182 (423)
Q Consensus 105 ~~s~ksDVyS~Giil~elltg~~Pf~~~~~~~~~i~~~i~~~~~~~p~~~~~~~~~~l~~Li~~C~~~dP~~RPt~~~ 182 (423)
+.++|||||||++|||++|+.||.. .+..+....+.......| ..+++.+.+++.+||+.||++||++.+
T Consensus 176 --~~~~DiwslG~il~el~tg~~p~~~--~~~~~~~~~i~~~~~~~p----~~~~~~~~~li~~~l~~~P~~R~~a~~ 245 (318)
T cd05582 176 --TQSADWWSFGVLMFEMLTGSLPFQG--KDRKETMTMILKAKLGMP----QFLSPEAQSLLRALFKRNPANRLGAGP 245 (318)
T ss_pred --CCccceeccceEeeeeccCCCCCCC--CCHHHHHHHHHcCCCCCC----CCCCHHHHHHHHHHhhcCHhHcCCCCC
Confidence 8899999999999999999999974 344556666655433222 246889999999999999999999544
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >KOG1094|consensus | Back alignment and domain information |
|---|
Probab=99.91 E-value=3e-24 Score=213.43 Aligned_cols=160 Identities=27% Similarity=0.481 Sum_probs=129.8
Q ss_pred HHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCccEEEeccCCcccccCCCcccccccccCCccccCCccccCCCCC
Q psy1840 25 SISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKAPELLRQPHLP 104 (423)
Q Consensus 25 ~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~ 104 (423)
-++++.||+.||+||.+.+++ ||||.++|||+|.++++||+|||+++.+-............-...|||+|.+..+.+
T Consensus 639 ~vsi~tqiasgmaYLes~nfV-Hrd~a~rNcLv~~e~~iKiadfgmsR~lysg~yy~vqgr~vlpiRwmawEsillgkF- 716 (807)
T KOG1094|consen 639 GVSICTQIASGMAYLESLNFV-HRDLATRNCLVDGEFTIKIADFGMSRNLYSGDYYRVQGRAVLPIRWMAWESILLGKF- 716 (807)
T ss_pred hHHHHHHHHHHHHHHHhhchh-hccccccceeecCcccEEecCcccccccccCCceeeecceeeeeeehhHHHHHhccc-
Confidence 478999999999999999998 999999999999999999999999987655554444444455567999999987766
Q ss_pred CCCCccchHHHHHHHHHHHh--CCCCCCCCCCChHHHHHHHhcC---CCCC-CCCCCCCchHHHHHHHHHhhhcCCCCCC
Q psy1840 105 RGTQKGDVYSFGLVLYEVIG--RQGPWGHLRMTDEEIITSVTQG---SGLR-PDTSSLDCAPSIIACMRTCWEEDPELRP 178 (423)
Q Consensus 105 ~~s~ksDVyS~Giil~ellt--g~~Pf~~~~~~~~~i~~~i~~~---~~~~-p~~~~~~~~~~l~~Li~~C~~~dP~~RP 178 (423)
+.++|||+||+++||+++ ++.||. .++++++++....- .+.. -...+.-|+.++.++|.+||..+.++||
T Consensus 717 --ttaSDvWafgvTlwE~~~~C~e~Py~--~lt~e~vven~~~~~~~~~~~~~l~~P~~cp~~lyelml~Cw~~es~~RP 792 (807)
T KOG1094|consen 717 --TTASDVWAFGVTLWEVFMLCREQPYS--QLTDEQVVENAGEFFRDQGRQVVLSRPPACPQGLYELMLRCWRRESEQRP 792 (807)
T ss_pred --cchhhhhhhHHHHHHHHHHHhhCchh--hhhHHHHHHhhhhhcCCCCcceeccCCCcCcHHHHHHHHHHhchhhhcCC
Confidence 999999999999999885 678997 46667777665421 1111 0111346899999999999999999999
Q ss_pred CHHHHHHHHHHH
Q psy1840 179 DLRFVHHKLKEM 190 (423)
Q Consensus 179 t~~~I~~~L~~i 190 (423)
+|+++...|++.
T Consensus 793 sFe~lh~~lq~~ 804 (807)
T KOG1094|consen 793 SFEQLHLFLQED 804 (807)
T ss_pred CHHHHHHHHHHh
Confidence 999999888754
|
|
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=99.91 E-value=7.5e-24 Score=199.56 Aligned_cols=152 Identities=18% Similarity=0.343 Sum_probs=117.1
Q ss_pred HHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCccEEEeccCCcccccCCCcccccccccCCccccCCccccCCCCC
Q psy1840 25 SISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKAPELLRQPHLP 104 (423)
Q Consensus 25 ~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~ 104 (423)
...++.|++.|+.|||+.+++ ||||+|+||+++.++.+||+|||++........ ......++..|+|||.+.+...
T Consensus 101 ~~~~~~~l~~~l~~lh~~~i~-H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~- 176 (256)
T cd06612 101 IAAILYQTLKGLEYLHSNKKI-HRDIKAGNILLNEEGQAKLADFGVSGQLTDTMA--KRNTVIGTPFWMAPEVIQEIGY- 176 (256)
T ss_pred HHHHHHHHHHHHHHHHHCCcc-cCCCCcceEEECCCCcEEEcccccchhcccCcc--ccccccCCccccCHHHHhcCCC-
Confidence 678999999999999999998 999999999999999999999999876543221 1223456788999999877654
Q ss_pred CCCCccchHHHHHHHHHHHhCCCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCchHHHHHHHHHhhhcCCCCCCCHHHHH
Q psy1840 105 RGTQKGDVYSFGLVLYEVIGRQGPWGHLRMTDEEIITSVTQGSGLRPDTSSLDCAPSIIACMRTCWEEDPELRPDLRFVH 184 (423)
Q Consensus 105 ~~s~ksDVyS~Giil~elltg~~Pf~~~~~~~~~i~~~i~~~~~~~p~~~~~~~~~~l~~Li~~C~~~dP~~RPt~~~I~ 184 (423)
+.++||||||+++|+|++|+.||.... .......+........ .....++..+.+++.+||+.+|++||++.+|+
T Consensus 177 --~~~~Di~s~G~il~~l~~g~~p~~~~~--~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il 251 (256)
T cd06612 177 --NNKADIWSLGITAIEMAEGKPPYSDIH--PMRAIFMIPNKPPPTL-SDPEKWSPEFNDFVKKCLVKDPEERPSAIQLL 251 (256)
T ss_pred --CchhhHHHHHHHHHHHHhCCCCCCCcc--hhhhhhhhccCCCCCC-CchhhcCHHHHHHHHHHHhcChhhCcCHHHHh
Confidence 889999999999999999999997432 2222222222111111 11234678999999999999999999999987
Q ss_pred H
Q psy1840 185 H 185 (423)
Q Consensus 185 ~ 185 (423)
.
T Consensus 252 ~ 252 (256)
T cd06612 252 Q 252 (256)
T ss_pred c
Confidence 5
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=99.91 E-value=3.3e-24 Score=210.07 Aligned_cols=145 Identities=20% Similarity=0.236 Sum_probs=116.3
Q ss_pred HHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCccEEEeccCCcccccCCCcccccccccCCccccCCccccCCCCC
Q psy1840 25 SISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKAPELLRQPHLP 104 (423)
Q Consensus 25 ~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~ 104 (423)
...++.||+.||.|||+.|++ ||||||+||+++.++.+||+|||+++...... .......|++.|+|||.+.+..+
T Consensus 98 ~~~~~~qi~~~L~~lH~~~iv-H~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~- 173 (321)
T cd05603 98 ARFYAAEVASAIGYLHSLNII-YRDLKPENILLDSQGHVVLTDFGLCKEGVEPE--ETTSTFCGTPEYLAPEVLRKEPY- 173 (321)
T ss_pred HHHHHHHHHHHHHHHHHCCeE-eccCCHHHeEECCCCCEEEccCCCCccCCCCC--CccccccCCcccCCHHHhcCCCC-
Confidence 457899999999999999998 99999999999999999999999976432211 12234568899999999987654
Q ss_pred CCCCccchHHHHHHHHHHHhCCCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCchHHHHHHHHHhhhcCCCCCCCHH
Q psy1840 105 RGTQKGDVYSFGLVLYEVIGRQGPWGHLRMTDEEIITSVTQGSGLRPDTSSLDCAPSIIACMRTCWEEDPELRPDLR 181 (423)
Q Consensus 105 ~~s~ksDVyS~Giil~elltg~~Pf~~~~~~~~~i~~~i~~~~~~~p~~~~~~~~~~l~~Li~~C~~~dP~~RPt~~ 181 (423)
+.++|||||||++|||++|..||... +..++...+.......| ...+..+.+++.+||+.+|.+||+..
T Consensus 174 --~~~~DiwslG~il~el~~g~~pf~~~--~~~~~~~~i~~~~~~~~----~~~~~~~~~li~~~l~~~p~~R~~~~ 242 (321)
T cd05603 174 --DRTVDWWCLGAVLYEMLYGLPPFYSR--DVSQMYDNILHKPLQLP----GGKTVAACDLLVGLLHKDQRRRLGAK 242 (321)
T ss_pred --CCcCcccccchhhhhhhcCCCCCCCC--CHHHHHHHHhcCCCCCC----CCCCHHHHHHHHHHccCCHhhcCCCC
Confidence 88999999999999999999999743 34555666655432222 24678899999999999999999753
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >KOG0658|consensus | Back alignment and domain information |
|---|
Probab=99.91 E-value=3.6e-24 Score=203.54 Aligned_cols=152 Identities=20% Similarity=0.229 Sum_probs=117.2
Q ss_pred HHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCC-ccEEEeccCCcccccCCCcccccccccCCccccCCccccCCCCCC
Q psy1840 27 SVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSR-WVLQIADFGLHAFKAGQDETGQERKLRRRKLYKAPELLRQPHLPR 105 (423)
Q Consensus 27 ~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~-~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~ 105 (423)
-...||.+||.|||+.||+ ||||||.|+|+|.+ |.+||||||-|+.+...... .+...+..|.|||.+.|.. .
T Consensus 129 LYt~Qlfrgl~yLh~~~Ic-HRDIKPqNlLvD~~tg~LKicDFGSAK~L~~~epn---iSYicSRyYRaPELifga~--~ 202 (364)
T KOG0658|consen 129 LYTYQLFRGLAYLHSHGIC-HRDIKPQNLLVDPDTGVLKICDFGSAKVLVKGEPN---ISYICSRYYRAPELIFGAT--E 202 (364)
T ss_pred HHHHHHHHHHHHHHhcCcc-cCCCChheEEEcCCCCeEEeccCCcceeeccCCCc---eeEEEeccccCHHHHcCcc--c
Confidence 4689999999999999998 99999999999966 99999999999977544433 3456678899999998865 4
Q ss_pred CCCccchHHHHHHHHHHHhCCCCCCCCCCChHHHHHHHh--------------cC--CCCCCCC--------CCCCchHH
Q psy1840 106 GTQKGDVYSFGLVLYEVIGRQGPWGHLRMTDEEIITSVT--------------QG--SGLRPDT--------SSLDCAPS 161 (423)
Q Consensus 106 ~s~ksDVyS~Giil~elltg~~Pf~~~~~~~~~i~~~i~--------------~~--~~~~p~~--------~~~~~~~~ 161 (423)
++.+.||||.|||+.||+.|+.-|.+.. ...++.+-+. .. ....|.. .....+++
T Consensus 203 Yt~~IDiWSaGCV~aELl~g~plFpG~s-~~dQL~eIik~lG~Pt~e~I~~mn~~y~~~~~p~ik~~~~~~~~~~~~~~d 281 (364)
T KOG0658|consen 203 YTTSIDIWSAGCVMAELLKGQPLFPGDS-SVDQLVEIIKVLGTPTREDIKSMNPNYTEFKFPQIKAHPWHKVFFKRLPPD 281 (364)
T ss_pred cCceeEEhhhhHHHHHHhcCCcccCCCC-HHHHHHHHHHHhCCCCHHHHhhcCcccccccCcccccccceeecccCCCHH
Confidence 6999999999999999999999997632 1122211111 00 0001111 22457899
Q ss_pred HHHHHHHhhhcCCCCCCCHHHHHH
Q psy1840 162 IIACMRTCWEEDPELRPDLRFVHH 185 (423)
Q Consensus 162 l~~Li~~C~~~dP~~RPt~~~I~~ 185 (423)
..+++.+++..+|.+|.+..+++.
T Consensus 282 ~~dll~~~L~Y~P~~R~~~~~~l~ 305 (364)
T KOG0658|consen 282 ALDLLSKLLQYSPSKRLSALEALA 305 (364)
T ss_pred HHHHHHHHhccChhhcCCHHHHhc
Confidence 999999999999999999988765
|
|
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.91 E-value=5e-24 Score=212.16 Aligned_cols=155 Identities=19% Similarity=0.239 Sum_probs=112.7
Q ss_pred HHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCccEEEeccCCcccccCCCcccccccccCCccccCCccccCCCCC
Q psy1840 25 SISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKAPELLRQPHLP 104 (423)
Q Consensus 25 ~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~ 104 (423)
...++.||+.||.|||+.|++ ||||||+||+++.++.+||+|||+++...... ......|+..|+|||++.+..+
T Consensus 159 ~~~i~~qi~~aL~~LH~~~iv-HrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~- 233 (357)
T PHA03209 159 ALIIEKQILEGLRYLHAQRII-HRDVKTENIFINDVDQVCIGDLGAAQFPVVAP---AFLGLAGTVETNAPEVLARDKY- 233 (357)
T ss_pred HHHHHHHHHHHHHHHHHCCee-cCCCCHHHEEECCCCCEEEecCccccccccCc---ccccccccccccCCeecCCCCC-
Confidence 678999999999999999998 99999999999999999999999987532221 1234568889999999987655
Q ss_pred CCCCccchHHHHHHHHHHHhCCCCC-CCCCCCh--------HHHHHHHhcC---CCCCC---------------------
Q psy1840 105 RGTQKGDVYSFGLVLYEVIGRQGPW-GHLRMTD--------EEIITSVTQG---SGLRP--------------------- 151 (423)
Q Consensus 105 ~~s~ksDVyS~Giil~elltg~~Pf-~~~~~~~--------~~i~~~i~~~---~~~~p--------------------- 151 (423)
+.++|||||||++|||+++..|+ ....... ..+...+... ....+
T Consensus 234 --~~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 311 (357)
T PHA03209 234 --NSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKVHPEEFPRDPGSRLVRGFIEYASLERQP 311 (357)
T ss_pred --CchhhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHHHHHHHHHhccChhhcCCCCccHHHHHHHhhcccCCCc
Confidence 89999999999999999865544 3221111 1111111110 00000
Q ss_pred -----CCCCCCchHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q psy1840 152 -----DTSSLDCAPSIIACMRTCWEEDPELRPDLRFVHHK 186 (423)
Q Consensus 152 -----~~~~~~~~~~l~~Li~~C~~~dP~~RPt~~~I~~~ 186 (423)
......++..+..+|.+||+.||.+|||+.+++..
T Consensus 312 ~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpta~e~l~h 351 (357)
T PHA03209 312 YTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEILNY 351 (357)
T ss_pred ccccHHHhccCCCchHHHHHHHHHcCCcccCcCHHHHhcC
Confidence 00112456677789999999999999999998764
|
|
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=99.91 E-value=6e-24 Score=205.54 Aligned_cols=153 Identities=17% Similarity=0.288 Sum_probs=119.6
Q ss_pred HHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCccEEEeccCCcccccCCCcccccccccCCccccCCccccCCCCC
Q psy1840 25 SISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKAPELLRQPHLP 104 (423)
Q Consensus 25 ~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~ 104 (423)
...++.||+.||.|||+.+++ ||||||+||+++.++.+||+|||++........ ......++..|+|||.+.+...
T Consensus 120 ~~~~~~qi~~~l~~LH~~~iv-H~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~- 195 (292)
T cd06658 120 IATVCLSVLRALSYLHNQGVI-HRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVP--KRKSLVGTPYWMAPEVISRLPY- 195 (292)
T ss_pred HHHHHHHHHHHHHHHHHCCEe-ecCCCHHHEEEcCCCCEEEccCcchhhcccccc--cCceeecCccccCHHHHccCCC-
Confidence 679999999999999999988 999999999999999999999999865432221 1233467888999999876554
Q ss_pred CCCCccchHHHHHHHHHHHhCCCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCchHHHHHHHHHhhhcCCCCCCCHHHHH
Q psy1840 105 RGTQKGDVYSFGLVLYEVIGRQGPWGHLRMTDEEIITSVTQGSGLRPDTSSLDCAPSIIACMRTCWEEDPELRPDLRFVH 184 (423)
Q Consensus 105 ~~s~ksDVyS~Giil~elltg~~Pf~~~~~~~~~i~~~i~~~~~~~p~~~~~~~~~~l~~Li~~C~~~dP~~RPt~~~I~ 184 (423)
+.++||||||+++||+++|..||... ...+....+......... .....+..+.+++.+||..||.+|||+.+++
T Consensus 196 --~~~~Dv~slGvil~el~~g~~p~~~~--~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il 270 (292)
T cd06658 196 --GTEVDIWSLGIMVIEMIDGEPPYFNE--PPLQAMRRIRDNLPPRVK-DSHKVSSVLRGFLDLMLVREPSQRATAQELL 270 (292)
T ss_pred --CchhhHHHHHHHHHHHHhCCCCCCCC--CHHHHHHHHHhcCCCccc-cccccCHHHHHHHHHHccCChhHCcCHHHHh
Confidence 88999999999999999999999642 333344444332111111 1224678899999999999999999999998
Q ss_pred HH
Q psy1840 185 HK 186 (423)
Q Consensus 185 ~~ 186 (423)
+.
T Consensus 271 ~~ 272 (292)
T cd06658 271 QH 272 (292)
T ss_pred hC
Confidence 75
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.91 E-value=4.5e-24 Score=210.97 Aligned_cols=152 Identities=18% Similarity=0.214 Sum_probs=114.8
Q ss_pred HHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCccEEEeccCCcccccCCCcccccccccCCccccCCccccCCCCC
Q psy1840 25 SISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKAPELLRQPHLP 104 (423)
Q Consensus 25 ~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~ 104 (423)
...++.||+.||.|||+.|++ ||||||+||+++.++.+||+|||++...... .....+++.|+|||.+.+..
T Consensus 120 ~~~i~~qi~~aL~~LH~~~iv-Hrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~-----~~~~~~t~~y~aPE~~~~~~-- 191 (343)
T cd07878 120 VQFLIYQLLRGLKYIHSAGII-HRDLKPSNVAVNEDCELRILDFGLARQADDE-----MTGYVATRWYRAPEIMLNWM-- 191 (343)
T ss_pred HHHHHHHHHHHHHHHHHCCee-cccCChhhEEECCCCCEEEcCCccceecCCC-----cCCccccccccCchHhcCCc--
Confidence 568999999999999999998 9999999999999999999999998754321 13346788999999987632
Q ss_pred CCCCccchHHHHHHHHHHHhCCCCCCCCCCChHHHHHHHhcC-----------------------CCCCCCC----CCCC
Q psy1840 105 RGTQKGDVYSFGLVLYEVIGRQGPWGHLRMTDEEIITSVTQG-----------------------SGLRPDT----SSLD 157 (423)
Q Consensus 105 ~~s~ksDVyS~Giil~elltg~~Pf~~~~~~~~~i~~~i~~~-----------------------~~~~p~~----~~~~ 157 (423)
.++.++|||||||++|+|++|+.||.... ..+.+..+... .+..+.. ....
T Consensus 192 ~~~~~~DiwslG~il~el~~g~~pf~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 269 (343)
T cd07878 192 HYNQTVDIWSVGCIMAELLKGKALFPGND--YIDQLKRIMEVVGTPSPEVLKKISSEHARKYIQSLPHMPQQDLKKIFRG 269 (343)
T ss_pred cCCchhhhHhHHHHHHHHHHCCCCCCCCC--HHHHHHHHHHHhCCCCHHHHHhcchhhHHHHhhccccccchhHHHhccC
Confidence 23889999999999999999999996432 11111111110 0000000 0123
Q ss_pred chHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q psy1840 158 CAPSIIACMRTCWEEDPELRPDLRFVHHK 186 (423)
Q Consensus 158 ~~~~l~~Li~~C~~~dP~~RPt~~~I~~~ 186 (423)
.++.+.+++.+||..||++|||+.+++..
T Consensus 270 ~~~~~~~li~~mL~~dp~~R~s~~ell~h 298 (343)
T cd07878 270 ANPLAIDLLEKMLVLDSDKRISASEALAH 298 (343)
T ss_pred CCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 46678999999999999999999999864
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=99.91 E-value=5.6e-24 Score=204.87 Aligned_cols=150 Identities=22% Similarity=0.295 Sum_probs=115.8
Q ss_pred HHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCccEEEeccCCcccccCCCcccccccccCCccccCCccccCCCCC
Q psy1840 25 SISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKAPELLRQPHLP 104 (423)
Q Consensus 25 ~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~ 104 (423)
.+.++.|++.||.|||+.+++ ||||||+||+++.++.+||+|||++....... ......|+..|+|||.+.+..+
T Consensus 104 ~~~~~~ql~~~l~~lH~~~ii-H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~---~~~~~~g~~~~~aPE~~~~~~~- 178 (285)
T cd05632 104 ALFYAAEILCGLEDLHRENTV-YRDLKPENILLDDYGHIRISDLGLAVKIPEGE---SIRGRVGTVGYMAPEVLNNQRY- 178 (285)
T ss_pred HHHHHHHHHHHHHHHHhCCee-ecCCCHHHEEECCCCCEEEecCCcceecCCCC---cccCCCCCcCccChHHhcCCCC-
Confidence 578999999999999999998 99999999999999999999999986543221 1123467889999999977654
Q ss_pred CCCCccchHHHHHHHHHHHhCCCCCCCCCCC--hHHHHHHHhcCCCCCCCCCCCCchHHHHHHHHHhhhcCCCCCCC---
Q psy1840 105 RGTQKGDVYSFGLVLYEVIGRQGPWGHLRMT--DEEIITSVTQGSGLRPDTSSLDCAPSIIACMRTCWEEDPELRPD--- 179 (423)
Q Consensus 105 ~~s~ksDVyS~Giil~elltg~~Pf~~~~~~--~~~i~~~i~~~~~~~p~~~~~~~~~~l~~Li~~C~~~dP~~RPt--- 179 (423)
+.++|+||||+++||+++|..||...... ...+...+..... .....++.++.+++..||+.||++||+
T Consensus 179 --~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~li~~~l~~~P~~R~~~~~ 252 (285)
T cd05632 179 --TLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLETEE----VYSAKFSEEAKSICKMLLTKDPKQRLGCQE 252 (285)
T ss_pred --CcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhhcccc----ccCccCCHHHHHHHHHHccCCHhHcCCCcc
Confidence 88999999999999999999999743211 1122222222211 122357889999999999999999999
Q ss_pred --HHHHHH
Q psy1840 180 --LRFVHH 185 (423)
Q Consensus 180 --~~~I~~ 185 (423)
+.+++.
T Consensus 253 ~~~~~l~~ 260 (285)
T cd05632 253 EGAGEVKR 260 (285)
T ss_pred cChHHHHc
Confidence 555554
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.1e-23 Score=202.08 Aligned_cols=159 Identities=25% Similarity=0.405 Sum_probs=117.8
Q ss_pred HHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCccEEEeccCCcccccCCCccc-ccccccCCccccCCccccCCCC
Q psy1840 25 SISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETG-QERKLRRRKLYKAPELLRQPHL 103 (423)
Q Consensus 25 ~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~~~-~~~~~~gt~~y~APE~l~~~~~ 103 (423)
...++.|++.||.|||++|++ ||||||+||+++.++.+||+|||++.......... ......++..|+|||.+.+..+
T Consensus 110 ~~~~~~~l~~aL~~LH~~~i~-H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~ 188 (284)
T cd05081 110 LLLYASQICKGMEYLGSKRYV-HRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGESPIFWYAPESLTESKF 188 (284)
T ss_pred HHHHHHHHHHHHHHHHHCCce-eccCCHhhEEECCCCeEEECCCcccccccCCCcceeecCCCCCceEeeCHHHhccCCc
Confidence 578999999999999999998 99999999999999999999999987654322211 1111223445999999877654
Q ss_pred CCCCCccchHHHHHHHHHHHhCCCCCCCCCCC--------------hHHHHHHHhcCCCCCCCCCCCCchHHHHHHHHHh
Q psy1840 104 PRGTQKGDVYSFGLVLYEVIGRQGPWGHLRMT--------------DEEIITSVTQGSGLRPDTSSLDCAPSIIACMRTC 169 (423)
Q Consensus 104 ~~~s~ksDVyS~Giil~elltg~~Pf~~~~~~--------------~~~i~~~i~~~~~~~p~~~~~~~~~~l~~Li~~C 169 (423)
+.++||||||+++|||++|..|+...... ...+...+.... .+. ....++.++.+++.+|
T Consensus 189 ---~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~-~~~~~~~~~~~li~~c 262 (284)
T cd05081 189 ---SVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLIELLKNNG--RLP-APPGCPAEIYAIMKEC 262 (284)
T ss_pred ---ChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccchHHHHHHHhcCC--cCC-CCCCCCHHHHHHHHHH
Confidence 88999999999999999987665321100 011112222221 111 1235788999999999
Q ss_pred hhcCCCCCCCHHHHHHHHHHH
Q psy1840 170 WEEDPELRPDLRFVHHKLKEM 190 (423)
Q Consensus 170 ~~~dP~~RPt~~~I~~~L~~i 190 (423)
|+.+|++|||+.+|...|..+
T Consensus 263 l~~~p~~Rpt~~ei~~~l~~~ 283 (284)
T cd05081 263 WNNDPSQRPSFSELALQVEAI 283 (284)
T ss_pred ccCChhhCCCHHHHHHHHHhc
Confidence 999999999999999988754
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=99.91 E-value=6.6e-24 Score=211.70 Aligned_cols=154 Identities=19% Similarity=0.235 Sum_probs=116.3
Q ss_pred HHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCccEEEeccCCcccccCCCcc------------------------
Q psy1840 25 SISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDET------------------------ 80 (423)
Q Consensus 25 ~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~~------------------------ 80 (423)
...++.|++.||+|||+.|++ ||||||+|||++.++.+||+|||+++........
T Consensus 103 ~~~~~~qi~~aL~~lH~~giv-HrDlKp~NILi~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 181 (363)
T cd05628 103 TQFYIAETVLAIDSIHQLGFI-HRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRK 181 (363)
T ss_pred HHHHHHHHHHHHHHHHhCCeE-ecCCCHHHeEECCCCCEEEeeccCcccccccccccccccccccccccccccccccccc
Confidence 578899999999999999998 9999999999999999999999998654221100
Q ss_pred ---------cccccccCCccccCCccccCCCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCChHHHHHHHhcCCC--C
Q psy1840 81 ---------GQERKLRRRKLYKAPELLRQPHLPRGTQKGDVYSFGLVLYEVIGRQGPWGHLRMTDEEIITSVTQGSG--L 149 (423)
Q Consensus 81 ---------~~~~~~~gt~~y~APE~l~~~~~~~~s~ksDVyS~Giil~elltg~~Pf~~~~~~~~~i~~~i~~~~~--~ 149 (423)
.......||+.|+|||++.+..+ +.++|||||||++|||++|..||.. .+..+....+..... .
T Consensus 182 ~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~---~~~~DvwSlGvil~ell~G~~Pf~~--~~~~~~~~~i~~~~~~~~ 256 (363)
T cd05628 182 AETWKRNRRQLAFSTVGTPDYIAPEVFMQTGY---NKLCDWWSLGVIMYEMLIGYPPFCS--ETPQETYKKVMNWKETLI 256 (363)
T ss_pred cchhhhccccccccccCCccccCHHHHcCCCC---CCchhhhhhHHHHHHHHhCCCCCCC--CCHHHHHHHHHcCcCccc
Confidence 00123478999999999987655 8899999999999999999999974 345566666654321 1
Q ss_pred CCCCCCCCchHHHHHHHHHhhh--cCCCCCCCHHHHHHH
Q psy1840 150 RPDTSSLDCAPSIIACMRTCWE--EDPELRPDLRFVHHK 186 (423)
Q Consensus 150 ~p~~~~~~~~~~l~~Li~~C~~--~dP~~RPt~~~I~~~ 186 (423)
.|. ...+++++.+++.+++. .++..||++.+|++.
T Consensus 257 ~p~--~~~~s~~~~~li~~l~~~~~~r~~r~~~~ei~~h 293 (363)
T cd05628 257 FPP--EVPISEKAKDLILRFCCEWEHRIGAPGVEEIKTN 293 (363)
T ss_pred CCC--cCCCCHHHHHHHHHHcCChhhcCCCCCHHHHhCC
Confidence 222 12467889999987543 334456899998764
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >KOG0199|consensus | Back alignment and domain information |
|---|
Probab=99.91 E-value=3.2e-24 Score=216.77 Aligned_cols=154 Identities=23% Similarity=0.458 Sum_probs=126.8
Q ss_pred HHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCccEEEeccCCcccccCCCccc-ccccccCCccccCCccccCCCCC
Q psy1840 26 ISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETG-QERKLRRRKLYKAPELLRQPHLP 104 (423)
Q Consensus 26 l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~~~-~~~~~~gt~~y~APE~l~~~~~~ 104 (423)
..++.||+.||.||.++++| ||||..+|+|+-..-.|||+|||+.+.+....... ......-...|+|||.++...+
T Consensus 215 cdya~QiA~aM~YLeskrlv-HRDLAARNlllasprtVKI~DFGLmRaLg~ned~Yvm~p~rkvPfAWCaPEsLrh~kF- 292 (1039)
T KOG0199|consen 215 CDYAMQIAKAMQYLESKRLV-HRDLAARNLLLASPRTVKICDFGLMRALGENEDMYVMAPQRKVPFAWCAPESLRHRKF- 292 (1039)
T ss_pred HHHHHHHHHHHHHHhhhhhh-hhhhhhhhheecccceeeeecccceeccCCCCcceEecCCCcCcccccCHhHhccccc-
Confidence 47899999999999999998 99999999999999999999999998776444322 1122233456999999998766
Q ss_pred CCCCccchHHHHHHHHHHHh-CCCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCchHHHHHHHHHhhhcCCCCCCCHHHH
Q psy1840 105 RGTQKGDVYSFGLVLYEVIG-RQGPWGHLRMTDEEIITSVTQGSGLRPDTSSLDCAPSIIACMRTCWEEDPELRPDLRFV 183 (423)
Q Consensus 105 ~~s~ksDVyS~Giil~ellt-g~~Pf~~~~~~~~~i~~~i~~~~~~~p~~~~~~~~~~l~~Li~~C~~~dP~~RPt~~~I 183 (423)
+.++|||+|||++|||++ |+.||.+ ...-.|++.+..+..+.. +..|++.+.++|++||..+|.+||||..|
T Consensus 293 --ShaSDvWmyGVTiWEMFtyGEePW~G--~~g~qIL~~iD~~erLpR---Pk~csedIY~imk~cWah~paDRptFsai 365 (1039)
T KOG0199|consen 293 --SHASDVWMYGVTIWEMFTYGEEPWVG--CRGIQILKNIDAGERLPR---PKYCSEDIYQIMKNCWAHNPADRPTFSAI 365 (1039)
T ss_pred --cccchhhhhhhhHHhhhccCCCCCCC--CCHHHHHHhccccccCCC---CCCChHHHHHHHHHhccCCccccccHHHH
Confidence 999999999999999997 7889974 566788888886543321 23699999999999999999999999999
Q ss_pred HHHHH
Q psy1840 184 HHKLK 188 (423)
Q Consensus 184 ~~~L~ 188 (423)
.+.+-
T Consensus 366 r~~~~ 370 (1039)
T KOG0199|consen 366 REDLV 370 (1039)
T ss_pred HHhHH
Confidence 85543
|
|
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=99.91 E-value=6.2e-24 Score=212.54 Aligned_cols=156 Identities=22% Similarity=0.312 Sum_probs=116.8
Q ss_pred HHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCccEEEeccCCcccccCCCcccccccccCCccccCCccccCCCCC
Q psy1840 25 SISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKAPELLRQPHLP 104 (423)
Q Consensus 25 ~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~ 104 (423)
...++.||+.||.|||+.|++ ||||||+||+++.++.+||+|||++........ .......++..|+|||.+.+..
T Consensus 105 ~~~~~~qi~~aL~~LH~~~iv-H~dlkp~Nili~~~~~~kL~Dfg~a~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~-- 180 (372)
T cd07853 105 VKVFLYQILRGLKYLHSAGIL-HRDIKPGNLLVNSNCVLKICDFGLARVEEPDES-KHMTQEVVTQYYRAPEILMGSR-- 180 (372)
T ss_pred HHHHHHHHHHHHHHHHhCCee-CCCCChHHEEECCCCCEEeccccceeecccCcc-ccCCCCCcCCCcCCHHHHcCCC--
Confidence 568899999999999999998 999999999999999999999999875432211 1122345678899999987643
Q ss_pred CCCCccchHHHHHHHHHHHhCCCCCCCCCCChHHHHHHHh-----------------------cCCCCCCC-----CCCC
Q psy1840 105 RGTQKGDVYSFGLVLYEVIGRQGPWGHLRMTDEEIITSVT-----------------------QGSGLRPD-----TSSL 156 (423)
Q Consensus 105 ~~s~ksDVyS~Giil~elltg~~Pf~~~~~~~~~i~~~i~-----------------------~~~~~~p~-----~~~~ 156 (423)
.++.++|||||||++|||++|+.||.... ..+.+..+. ......+. ....
T Consensus 181 ~~~~~~DiwslG~il~el~~g~~pf~~~~--~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (372)
T cd07853 181 HYTSAVDIWSVGCIFAELLGRRILFQAQS--PIQQLDLITDLLGTPSLEAMRSACEGARAHILRGPHKPPSLPVLYTLSS 258 (372)
T ss_pred CCCcHHHHHhHHHHHHHHHcCCCCCCCCC--HHHHHHHHHHHcCCCCHHHHHHhhHHHHHHHHhCCCCCCchHHhcccCC
Confidence 23789999999999999999999996432 222222211 11111111 0113
Q ss_pred CchHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q psy1840 157 DCAPSIIACMRTCWEEDPELRPDLRFVHHK 186 (423)
Q Consensus 157 ~~~~~l~~Li~~C~~~dP~~RPt~~~I~~~ 186 (423)
..++++.+++.+||+.||++|||+.+++..
T Consensus 259 ~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 288 (372)
T cd07853 259 QATHEAVHLLCRMLVFDPDKRISAADALAH 288 (372)
T ss_pred CCCHHHHHHHHHhCCCChhhCcCHHHHhcC
Confidence 457889999999999999999999998764
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=99.91 E-value=8.7e-24 Score=204.74 Aligned_cols=154 Identities=18% Similarity=0.290 Sum_probs=118.3
Q ss_pred HHHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCccEEEeccCCcccccCCCcccccccccCCccccCCccccCCCC
Q psy1840 24 GSISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKAPELLRQPHL 103 (423)
Q Consensus 24 ~~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~ 103 (423)
..+.++.|++.||.|||+.|++ ||||||+||+++.++.+||+|||++........ ......+++.|+|||.+.+...
T Consensus 117 ~~~~i~~ql~~aL~~LH~~gi~-H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~ 193 (296)
T cd06654 117 QIAAVCRECLQALEFLHSNQVI-HRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS--KRSTMVGTPYWMAPEVVTRKAY 193 (296)
T ss_pred HHHHHHHHHHHHHHHHHHCCcc-cCCCCHHHEEEcCCCCEEECccccchhcccccc--ccCcccCCccccCHHHHcCCCC
Confidence 3678999999999999999988 999999999999999999999999765432211 1123467788999999877554
Q ss_pred CCCCCccchHHHHHHHHHHHhCCCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCchHHHHHHHHHhhhcCCCCCCCHHHH
Q psy1840 104 PRGTQKGDVYSFGLVLYEVIGRQGPWGHLRMTDEEIITSVTQGSGLRPDTSSLDCAPSIIACMRTCWEEDPELRPDLRFV 183 (423)
Q Consensus 104 ~~~s~ksDVyS~Giil~elltg~~Pf~~~~~~~~~i~~~i~~~~~~~p~~~~~~~~~~l~~Li~~C~~~dP~~RPt~~~I 183 (423)
+.++|||||||++|+|++|+.||..... ...+........ .+.......+..+.+++.+||..+|++||++.+|
T Consensus 194 ---~~~~Dv~s~Gvil~~l~~g~~pf~~~~~-~~~~~~~~~~~~--~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~ei 267 (296)
T cd06654 194 ---GPKVDIWSLGIMAIEMIEGEPPYLNENP-LRALYLIATNGT--PELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKEL 267 (296)
T ss_pred ---CccchHHHHHHHHHHHHhCCCCCCCCCH-HHhHHHHhcCCC--CCCCCccccCHHHHHHHHHHCcCCcccCcCHHHH
Confidence 7899999999999999999999964321 122222222211 1111223577889999999999999999999999
Q ss_pred HHH
Q psy1840 184 HHK 186 (423)
Q Consensus 184 ~~~ 186 (423)
+..
T Consensus 268 l~~ 270 (296)
T cd06654 268 LQH 270 (296)
T ss_pred hhC
Confidence 873
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.6e-23 Score=200.54 Aligned_cols=174 Identities=16% Similarity=0.340 Sum_probs=135.8
Q ss_pred HHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCccEEEeccCCcccccCCCcccccccccCCccccCCccccCCCCC
Q psy1840 25 SISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKAPELLRQPHLP 104 (423)
Q Consensus 25 ~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~ 104 (423)
...++.|++.|+.|||+.|++ |+||+|+||+++.++.++|+|||++....... .......++..|+|||.+.+...
T Consensus 103 ~~~~~~~l~~~l~~lh~~~i~-h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~--~~~~~~~~~~~y~~PE~~~~~~~- 178 (277)
T cd06641 103 IATILREILKGLDYLHSEKKI-HRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ--IKRNTFVGTPFWMAPEVIKQSAY- 178 (277)
T ss_pred HHHHHHHHHHHHHHHccCCee-cCCCCHHhEEECCCCCEEEeecccceecccch--hhhccccCCccccChhhhccCCC-
Confidence 678999999999999999998 99999999999999999999999986543221 11223456778999999876544
Q ss_pred CCCCccchHHHHHHHHHHHhCCCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCchHHHHHHHHHhhhcCCCCCCCHHHHH
Q psy1840 105 RGTQKGDVYSFGLVLYEVIGRQGPWGHLRMTDEEIITSVTQGSGLRPDTSSLDCAPSIIACMRTCWEEDPELRPDLRFVH 184 (423)
Q Consensus 105 ~~s~ksDVyS~Giil~elltg~~Pf~~~~~~~~~i~~~i~~~~~~~p~~~~~~~~~~l~~Li~~C~~~dP~~RPt~~~I~ 184 (423)
+.++|+|||||++|++++|..||.. .........+..+. .+. ....++.++.+++.+||+.+|++||++.+++
T Consensus 179 --~~~~Dv~slG~~l~~l~~g~~p~~~--~~~~~~~~~~~~~~--~~~-~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l 251 (277)
T cd06641 179 --DSKADIWSLGITAIELAKGEPPHSE--LHPMKVLFLIPKNN--PPT-LEGNYSKPLKEFVEACLNKEPSFRPTAKELL 251 (277)
T ss_pred --CchhhHHHHHHHHHHHHcCCCCCCc--cchHHHHHHHhcCC--CCC-CCcccCHHHHHHHHHHccCChhhCcCHHHHH
Confidence 7899999999999999999999964 23344444443322 222 2335788999999999999999999999999
Q ss_pred HHHHHHhhhcCCChHHHHHHHHHHh
Q psy1840 185 HKLKEMNAGLKANIFDNMLAIMEKY 209 (423)
Q Consensus 185 ~~L~~i~~~~~~~~~d~~~~~~e~~ 209 (423)
..--......+.+...++++.+++|
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~ 276 (277)
T cd06641 252 KHKFIVRFAKKTSYLTELIDRYKRW 276 (277)
T ss_pred hCHHHhhhhhccchHHHHHHHhhcc
Confidence 8644444555677788888887665
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.4e-23 Score=199.75 Aligned_cols=157 Identities=25% Similarity=0.521 Sum_probs=123.6
Q ss_pred HHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCccEEEeccCCcccccCCCcccc-cccccCCccccCCccccCCCC
Q psy1840 25 SISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQ-ERKLRRRKLYKAPELLRQPHL 103 (423)
Q Consensus 25 ~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~~~~-~~~~~gt~~y~APE~l~~~~~ 103 (423)
.+.++.|++.|+.|||+.+++ ||||||+||+++.++.+||+|||++........... .....++..|+|||.+.+..+
T Consensus 108 ~~~i~~~i~~~l~~lH~~~i~-h~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~ 186 (267)
T cd05066 108 LVGMLRGIASGMKYLSDMGYV-HRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRKF 186 (267)
T ss_pred HHHHHHHHHHHHHHHHHCCEe-ehhhchhcEEECCCCeEEeCCCCcccccccccceeeecCCCccceeecCHhHhccCcc
Confidence 688999999999999999988 999999999999999999999999876543221111 111223457999999987554
Q ss_pred CCCCCccchHHHHHHHHHHHh-CCCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCchHHHHHHHHHhhhcCCCCCCCHHH
Q psy1840 104 PRGTQKGDVYSFGLVLYEVIG-RQGPWGHLRMTDEEIITSVTQGSGLRPDTSSLDCAPSIIACMRTCWEEDPELRPDLRF 182 (423)
Q Consensus 104 ~~~s~ksDVyS~Giil~ellt-g~~Pf~~~~~~~~~i~~~i~~~~~~~p~~~~~~~~~~l~~Li~~C~~~dP~~RPt~~~ 182 (423)
+.++|+||||+++||+++ |..||... ...+....+..+. +++. ...+++.+.+++.+||+.+|++||++.+
T Consensus 187 ---~~~~Dv~slG~~l~ell~~g~~p~~~~--~~~~~~~~~~~~~--~~~~-~~~~~~~~~~li~~~l~~~p~~Rp~~~~ 258 (267)
T cd05066 187 ---TSASDVWSYGIVMWEVMSYGERPYWEM--SNQDVIKAIEEGY--RLPA-PMDCPAALHQLMLDCWQKDRNERPKFEQ 258 (267)
T ss_pred ---CchhhhHHHHHHHHHHhcCCCCCcccC--CHHHHHHHHhCCC--cCCC-CCCCCHHHHHHHHHHcccCchhCCCHHH
Confidence 889999999999999886 99999643 3445556665542 2222 2357889999999999999999999999
Q ss_pred HHHHHHHH
Q psy1840 183 VHHKLKEM 190 (423)
Q Consensus 183 I~~~L~~i 190 (423)
+++.|+.+
T Consensus 259 i~~~l~~~ 266 (267)
T cd05066 259 IVSILDKL 266 (267)
T ss_pred HHHHHHhh
Confidence 99988764
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.2e-23 Score=198.46 Aligned_cols=148 Identities=23% Similarity=0.372 Sum_probs=113.4
Q ss_pred HHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCc-------cEEEeccCCcccccCCCcccccccccCCccccCCcc
Q psy1840 25 SISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRW-------VLQIADFGLHAFKAGQDETGQERKLRRRKLYKAPEL 97 (423)
Q Consensus 25 ~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~-------~vKL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~ 97 (423)
++.++.||+.||.|||+.|++ ||||||+||+++.++ .+||+|||++...... ....++..|+|||.
T Consensus 103 ~~~~~~~i~~~l~~LH~~~i~-H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~a~~~~~~------~~~~~~~~y~aPE~ 175 (259)
T cd05037 103 KLDVAKQLASALHYLEDKKLV-HGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITVLSR------EERVERIPWIAPEC 175 (259)
T ss_pred HHHHHHHHHHHHHHHhhCCee-cccCccceEEEecCccccCCceeEEeCCCCcccccccc------cccccCCCccChhh
Confidence 688999999999999999998 999999999999888 8999999998754321 22345567999999
Q ss_pred ccCCCCCCCCCccchHHHHHHHHHHHh-CCCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCchHHHHHHHHHhhhcCCCC
Q psy1840 98 LRQPHLPRGTQKGDVYSFGLVLYEVIG-RQGPWGHLRMTDEEIITSVTQGSGLRPDTSSLDCAPSIIACMRTCWEEDPEL 176 (423)
Q Consensus 98 l~~~~~~~~s~ksDVyS~Giil~ellt-g~~Pf~~~~~~~~~i~~~i~~~~~~~p~~~~~~~~~~l~~Li~~C~~~dP~~ 176 (423)
+.+.. ...+.++||||||+++||+++ |..||.... ..+......... ..+. .....+.+++.+||..+|++
T Consensus 176 ~~~~~-~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~--~~~~~~~~~~~~-~~~~----~~~~~~~~li~~~l~~~p~~ 247 (259)
T cd05037 176 IRNGQ-ASLTIAADKWSFGTTLLEICSNGEEPLSTLS--SSEKERFYQDQH-RLPM----PDCAELANLINQCWTYDPTK 247 (259)
T ss_pred hcCCC-CCcchhhHHHHHHHHHHHHHhCCCCCcccCC--chhHHHHHhcCC-CCCC----CCchHHHHHHHHHhccChhh
Confidence 87752 134889999999999999999 577776443 222222222211 1111 12378999999999999999
Q ss_pred CCCHHHHHHHH
Q psy1840 177 RPDLRFVHHKL 187 (423)
Q Consensus 177 RPt~~~I~~~L 187 (423)
||++.+|++.|
T Consensus 248 Rpt~~~il~~l 258 (259)
T cd05037 248 RPSFRAILRDL 258 (259)
T ss_pred CCCHHHHHHhc
Confidence 99999998865
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >KOG0594|consensus | Back alignment and domain information |
|---|
Probab=99.91 E-value=6.7e-24 Score=201.56 Aligned_cols=155 Identities=23% Similarity=0.252 Sum_probs=118.0
Q ss_pred HHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCccEEEeccCCcccccCCCcccccccccCCccccCCccccCCCCC
Q psy1840 25 SISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKAPELLRQPHLP 104 (423)
Q Consensus 25 ~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~ 104 (423)
.-+++.||+.||+|||+++|+ ||||||+|+||+++|.+||+|||+++...-.. .......+|.+|.|||++.+..
T Consensus 122 ik~~m~Qll~gl~~~H~~~Il-HRDLKPQNlLi~~~G~lKlaDFGlAra~~ip~--~~yt~evvTlWYRaPEvLlGs~-- 196 (323)
T KOG0594|consen 122 IKSFMRQLLRGLAFLHSHGIL-HRDLKPQNLLISSSGVLKLADFGLARAFSIPM--RTYTPEVVTLWYRAPEVLLGST-- 196 (323)
T ss_pred HHHHHHHHHHHHHHHHhCCee-cccCCcceEEECCCCcEeeeccchHHHhcCCc--ccccccEEEeeccCHHHhcCCC--
Confidence 468999999999999999998 99999999999999999999999998543222 2234567888999999999875
Q ss_pred CCCCccchHHHHHHHHHHHhCCCCCCCCCCChHHHHHHHhc--C----------------CCCCCCCC-C-------CCc
Q psy1840 105 RGTQKGDVYSFGLVLYEVIGRQGPWGHLRMTDEEIITSVTQ--G----------------SGLRPDTS-S-------LDC 158 (423)
Q Consensus 105 ~~s~ksDVyS~Giil~elltg~~Pf~~~~~~~~~i~~~i~~--~----------------~~~~p~~~-~-------~~~ 158 (423)
.++...||||+|||+.||++++.-|.+.. ..+.+..+-. | +...+... . ...
T Consensus 197 ~Ys~~vDiWs~GcIfaEm~~~~~LFpG~s--e~~ql~~If~~lGtP~e~~Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~ 274 (323)
T KOG0594|consen 197 SYSTSVDIWSLGCIFAEMFTRRPLFPGDS--EIDQLFRIFRLLGTPNEKDWPGVSSLPDYKAPFPKWPGPKDLSSILPKL 274 (323)
T ss_pred cCCCCcchHhHHHHHHHHHhCCCCCCCCc--HHHHHHHHHHHcCCCCccCCCCccccccccccCcCCCCccchHHhcccc
Confidence 25899999999999999999999887532 2332322221 0 00001000 1 122
Q ss_pred hHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q psy1840 159 APSIIACMRTCWEEDPELRPDLRFVHHK 186 (423)
Q Consensus 159 ~~~l~~Li~~C~~~dP~~RPt~~~I~~~ 186 (423)
.+...+++..|++.+|.+|.++..++.+
T Consensus 275 ~~~~~dll~~~L~y~p~~R~Sa~~al~h 302 (323)
T KOG0594|consen 275 DPDGIELLSKLLQYDPAKRISAKGALTH 302 (323)
T ss_pred CccHHHHHHHHhccCcccCcCHHHHhcC
Confidence 3578999999999999999999988765
|
|
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.3e-23 Score=198.92 Aligned_cols=155 Identities=28% Similarity=0.516 Sum_probs=122.2
Q ss_pred HHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCccEEEeccCCcccccCCCcccccccccCCccccCCccccCCCCC
Q psy1840 25 SISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKAPELLRQPHLP 104 (423)
Q Consensus 25 ~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~ 104 (423)
...++.|++.|+.|||+++++ ||||||+||+++.++.+||+|||++........ ........+..|+|||.+.+...
T Consensus 105 ~~~~~~~i~~al~~lh~~~i~-h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~- 181 (261)
T cd05034 105 LVDMAAQIAEGMAYLESRNYI-HRDLAARNILVGENLVCKIADFGLARLIEDDEY-TAREGAKFPIKWTAPEAANYGRF- 181 (261)
T ss_pred HHHHHHHHHHHHHHHHhCCcc-cCCcchheEEEcCCCCEEECccccceeccchhh-hhhhccCCCccccCHHHhccCCc-
Confidence 578999999999999999988 999999999999999999999999875532211 11112234467999999887654
Q ss_pred CCCCccchHHHHHHHHHHHh-CCCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCchHHHHHHHHHhhhcCCCCCCCHHHH
Q psy1840 105 RGTQKGDVYSFGLVLYEVIG-RQGPWGHLRMTDEEIITSVTQGSGLRPDTSSLDCAPSIIACMRTCWEEDPELRPDLRFV 183 (423)
Q Consensus 105 ~~s~ksDVyS~Giil~ellt-g~~Pf~~~~~~~~~i~~~i~~~~~~~p~~~~~~~~~~l~~Li~~C~~~dP~~RPt~~~I 183 (423)
+.++|+||||+++||+++ |+.||.. .+.......+..+.. +.. ...++.++.+++.+||+.+|++||++.++
T Consensus 182 --~~~~Di~slG~il~~l~t~g~~p~~~--~~~~~~~~~~~~~~~--~~~-~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l 254 (261)
T cd05034 182 --TIKSDVWSFGILLTEIVTYGRVPYPG--MTNREVLEQVERGYR--MPR-PPNCPEELYDLMLQCWDKDPEERPTFEYL 254 (261)
T ss_pred --CchhHHHHHHHHHHHHHhCCCCCCCC--CCHHHHHHHHHcCCC--CCC-CCCCCHHHHHHHHHHcccCcccCCCHHHH
Confidence 889999999999999998 8999963 345556666654321 111 23468899999999999999999999999
Q ss_pred HHHHHH
Q psy1840 184 HHKLKE 189 (423)
Q Consensus 184 ~~~L~~ 189 (423)
.+.|+.
T Consensus 255 ~~~l~~ 260 (261)
T cd05034 255 QSFLED 260 (261)
T ss_pred HHHHhc
Confidence 988764
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >KOG0659|consensus | Back alignment and domain information |
|---|
Probab=99.91 E-value=9.4e-24 Score=192.60 Aligned_cols=157 Identities=20% Similarity=0.253 Sum_probs=119.3
Q ss_pred HHHHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCccEEEeccCCcccccCCCcccccccccCCccccCCccccCCC
Q psy1840 23 IGSISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKAPELLRQPH 102 (423)
Q Consensus 23 ~~~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~ 102 (423)
-..-+++.++.+|++|||++.|+ ||||||.|+|++++|.+||+|||+++.......... ...-|.+|.|||.+.|..
T Consensus 101 a~iK~y~~m~LkGl~y~H~~~Il-HRDlKPnNLLis~~g~lKiADFGLAr~f~~p~~~~~--~~V~TRWYRAPELLfGsr 177 (318)
T KOG0659|consen 101 ADIKSYMLMTLKGLAYCHSKWIL-HRDLKPNNLLISSDGQLKIADFGLARFFGSPNRIQT--HQVVTRWYRAPELLFGSR 177 (318)
T ss_pred HHHHHHHHHHHHHHHHHHhhhhh-cccCCccceEEcCCCcEEeecccchhccCCCCcccc--cceeeeeccChHHhccch
Confidence 33458999999999999999998 999999999999999999999999998765443322 226688999999998865
Q ss_pred CCCCCCccchHHHHHHHHHHHhCCCCCCCCCCChHHHHHHHhcC--C---C---------------CCCCCC----CCCc
Q psy1840 103 LPRGTQKGDVYSFGLVLYEVIGRQGPWGHLRMTDEEIITSVTQG--S---G---------------LRPDTS----SLDC 158 (423)
Q Consensus 103 ~~~~s~ksDVyS~Giil~elltg~~Pf~~~~~~~~~i~~~i~~~--~---~---------------~~p~~~----~~~~ 158 (423)
.++...||||.|||+.||+-|.+-|.+. ++-+.+..+-.. . . ..|..+ -..+
T Consensus 178 --~Yg~~VDmWavGCI~AELllr~P~fpG~--sDidQL~~If~~LGTP~~~~WP~~~~lpdY~~~~~~P~~~~~~lf~aa 253 (318)
T KOG0659|consen 178 --QYGTGVDMWAVGCIFAELLLRVPFFPGD--SDIDQLSKIFRALGTPTPDQWPEMTSLPDYVKIQQFPKPPLNNLFPAA 253 (318)
T ss_pred --hcCCcchhhhHHHHHHHHHccCCCCCCC--chHHHHHHHHHHcCCCCcccCccccccccHHHHhcCCCCccccccccc
Confidence 4589999999999999999988777643 222222222110 0 0 001111 1346
Q ss_pred hHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q psy1840 159 APSIIACMRTCWEEDPELRPDLRFVHHK 186 (423)
Q Consensus 159 ~~~l~~Li~~C~~~dP~~RPt~~~I~~~ 186 (423)
+.+..+|+..+|..||.+|+++++.+++
T Consensus 254 s~d~ldLl~~m~~ynP~~Rita~qaL~~ 281 (318)
T KOG0659|consen 254 SSDALDLLSKMLTYNPKKRITASQALKH 281 (318)
T ss_pred cHHHHHHHHhhhccCchhcccHHHHhcc
Confidence 7788999999999999999999998765
|
|
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.5e-23 Score=203.26 Aligned_cols=154 Identities=18% Similarity=0.292 Sum_probs=119.5
Q ss_pred HHHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCccEEEeccCCcccccCCCcccccccccCCccccCCccccCCCC
Q psy1840 24 GSISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKAPELLRQPHL 103 (423)
Q Consensus 24 ~~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~ 103 (423)
....++.|++.|+.|||+.|++ ||||||+||+++.++.+||+|||++........ ......++..|+|||.+.+..+
T Consensus 116 ~~~~i~~~l~~al~~LH~~~i~-H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~ 192 (296)
T cd06655 116 QIAAVCRECLQALEFLHANQVI-HRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQS--KRSTMVGTPYWMAPEVVTRKAY 192 (296)
T ss_pred HHHHHHHHHHHHHHHHHHCCcc-cCCCCHHHEEECCCCCEEEccCccchhcccccc--cCCCcCCCccccCcchhcCCCC
Confidence 3689999999999999999998 999999999999999999999999775432221 1123457788999999877654
Q ss_pred CCCCCccchHHHHHHHHHHHhCCCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCchHHHHHHHHHhhhcCCCCCCCHHHH
Q psy1840 104 PRGTQKGDVYSFGLVLYEVIGRQGPWGHLRMTDEEIITSVTQGSGLRPDTSSLDCAPSIIACMRTCWEEDPELRPDLRFV 183 (423)
Q Consensus 104 ~~~s~ksDVyS~Giil~elltg~~Pf~~~~~~~~~i~~~i~~~~~~~p~~~~~~~~~~l~~Li~~C~~~dP~~RPt~~~I 183 (423)
+.++|||||||++|++++|..||.... ..+....+.... ..+......+++.+.+++.+||..||++||++.+|
T Consensus 193 ---~~~~Dv~slGvil~~lltg~~pf~~~~--~~~~~~~~~~~~-~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~i 266 (296)
T cd06655 193 ---GPKVDIWSLGIMAIEMVEGEPPYLNEN--PLRALYLIATNG-TPELQNPEKLSPIFRDFLNRCLEMDVEKRGSAKEL 266 (296)
T ss_pred ---CchhhHHHHHHHHHHHHhCCCCCCCCC--HHHHHHHHHhcC-CcccCCcccCCHHHHHHHHHHhhcChhhCCCHHHH
Confidence 789999999999999999999996432 222222232221 11111234578899999999999999999999998
Q ss_pred HHH
Q psy1840 184 HHK 186 (423)
Q Consensus 184 ~~~ 186 (423)
+..
T Consensus 267 l~~ 269 (296)
T cd06655 267 LQH 269 (296)
T ss_pred hhC
Confidence 763
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.91 E-value=4.9e-24 Score=212.40 Aligned_cols=155 Identities=17% Similarity=0.233 Sum_probs=118.5
Q ss_pred HHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCccEEEeccCCcccccCCCccc-----------------------
Q psy1840 25 SISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETG----------------------- 81 (423)
Q Consensus 25 ~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~~~----------------------- 81 (423)
...++.||+.||+|||+.|++ ||||||+|||++.++.+||+|||++..........
T Consensus 103 ~~~~~~qi~~aL~~lH~~~iv-H~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 181 (364)
T cd05599 103 TRFYIAETILAIDSIHKLGYI-HRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDFISKPMSS 181 (364)
T ss_pred HHHHHHHHHHHHHHHHHCCeE-eccCCHHHeEECCCCCEEEeecccceeccccccccccccccccccccccccccccccc
Confidence 567899999999999999998 99999999999999999999999986532211000
Q ss_pred -------------ccccccCCccccCCccccCCCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCChHHHHHHHhcCCC
Q psy1840 82 -------------QERKLRRRKLYKAPELLRQPHLPRGTQKGDVYSFGLVLYEVIGRQGPWGHLRMTDEEIITSVTQGSG 148 (423)
Q Consensus 82 -------------~~~~~~gt~~y~APE~l~~~~~~~~s~ksDVyS~Giil~elltg~~Pf~~~~~~~~~i~~~i~~~~~ 148 (423)
......||+.|+|||++.+..+ +.++|||||||++|||++|..||... +..+....+.....
T Consensus 182 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~---~~~~DiwSlG~il~el~~G~~Pf~~~--~~~~~~~~i~~~~~ 256 (364)
T cd05599 182 KRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGY---NKECDWWSLGVIMYEMLVGYPPFCSD--NPQETYRKIINWKE 256 (364)
T ss_pred cccccchhhcccccccccccCccccCHHHHcCCCC---CCeeeeecchhHHHHhhcCCCCCCCC--CHHHHHHHHHcCCC
Confidence 0112458999999999977655 89999999999999999999999743 34555555544322
Q ss_pred CCCCCCCCCchHHHHHHHHHhhhcCCCCCCC---HHHHHHH
Q psy1840 149 LRPDTSSLDCAPSIIACMRTCWEEDPELRPD---LRFVHHK 186 (423)
Q Consensus 149 ~~p~~~~~~~~~~l~~Li~~C~~~dP~~RPt---~~~I~~~ 186 (423)
..+......+++++.+++.+|+. +|.+|++ +.+++..
T Consensus 257 ~~~~~~~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~h 296 (364)
T cd05599 257 TLQFPDEVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKSH 296 (364)
T ss_pred ccCCCCCCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhcC
Confidence 21111223568899999999996 9999998 7777653
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.1e-23 Score=200.29 Aligned_cols=157 Identities=18% Similarity=0.254 Sum_probs=116.9
Q ss_pred HHHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCccEEEeccCCcccccCCCcccccccccCCccccCCccccCCCC
Q psy1840 24 GSISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKAPELLRQPHL 103 (423)
Q Consensus 24 ~~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~ 103 (423)
....++.|++.|+.|||+.|++ |+||||+||+++.++.+||+|||++....... .......++..|+|||.+.....
T Consensus 107 ~~~~~~~~i~~~l~~lH~~~i~-H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~ 183 (267)
T cd06645 107 QIAYVSRETLQGLYYLHSKGKM-HRDIKGANILLTDNGHVKLADFGVSAQITATI--AKRKSFIGTPYWMAPEVAAVERK 183 (267)
T ss_pred HHHHHHHHHHHHHHHHHHCCee-cCCCCHHHEEECCCCCEEECcceeeeEccCcc--cccccccCcccccChhhhccccC
Confidence 3578999999999999999998 99999999999999999999999976543221 11234467889999998753221
Q ss_pred CCCCCccchHHHHHHHHHHHhCCCCCCCCCCChHHHHHHHhcCCCCCCCC-CCCCchHHHHHHHHHhhhcCCCCCCCHHH
Q psy1840 104 PRGTQKGDVYSFGLVLYEVIGRQGPWGHLRMTDEEIITSVTQGSGLRPDT-SSLDCAPSIIACMRTCWEEDPELRPDLRF 182 (423)
Q Consensus 104 ~~~s~ksDVyS~Giil~elltg~~Pf~~~~~~~~~i~~~i~~~~~~~p~~-~~~~~~~~l~~Li~~C~~~dP~~RPt~~~ 182 (423)
...+.++|+|||||++|++++|..||.... ...............+.. ....++..+.+++.+||+.+|++||++.+
T Consensus 184 ~~~~~~~DvwSlG~il~~l~~~~~p~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~ 261 (267)
T cd06645 184 GGYNQLCDIWAVGITAIELAELQPPMFDLH--PMRALFLMTKSNFQPPKLKDKMKWSNSFHHFVKMALTKNPKKRPTAEK 261 (267)
T ss_pred CCCCchhhhHHHHHHHHHHhcCCCCccccc--chhhHHhhhccCCCCCcccccCCCCHHHHHHHHHHccCCchhCcCHHH
Confidence 234789999999999999999999986432 122222222222111111 12356788999999999999999999998
Q ss_pred HHH
Q psy1840 183 VHH 185 (423)
Q Consensus 183 I~~ 185 (423)
|++
T Consensus 262 ll~ 264 (267)
T cd06645 262 LLQ 264 (267)
T ss_pred Hhc
Confidence 875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.3e-23 Score=198.28 Aligned_cols=151 Identities=19% Similarity=0.353 Sum_probs=122.2
Q ss_pred HHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCccEEEeccCCcccccCCCcccccccccCCccccCCccccCCCCC
Q psy1840 25 SISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKAPELLRQPHLP 104 (423)
Q Consensus 25 ~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~ 104 (423)
...++.|++.|+.|||+.|++ ||||+|+||+++.++.+||+|||++........ ......++..|+|||.+.+...
T Consensus 103 ~~~~~~~l~~~l~~lh~~~i~-h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~--~~~~~~~~~~y~ape~~~~~~~- 178 (256)
T cd08221 103 VLWYLFQIVSAVSYIHKAGIL-HRDIKTLNIFLTKAGLIKLGDFGISKILGSEYS--MAETVVGTPYYMSPELCQGVKY- 178 (256)
T ss_pred HHHHHHHHHHHHHHHHhCCcc-ccCCChHhEEEeCCCCEEECcCcceEEcccccc--cccccCCCccccCHhhcCCCCC-
Confidence 678999999999999999988 999999999999999999999999875533221 1234567889999999877554
Q ss_pred CCCCccchHHHHHHHHHHHhCCCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCchHHHHHHHHHhhhcCCCCCCCHHHHH
Q psy1840 105 RGTQKGDVYSFGLVLYEVIGRQGPWGHLRMTDEEIITSVTQGSGLRPDTSSLDCAPSIIACMRTCWEEDPELRPDLRFVH 184 (423)
Q Consensus 105 ~~s~ksDVyS~Giil~elltg~~Pf~~~~~~~~~i~~~i~~~~~~~p~~~~~~~~~~l~~Li~~C~~~dP~~RPt~~~I~ 184 (423)
+.++||||||+++|||++|..||.. ....+....+..+... + ....++.++.+++.+||..+|++||++.+++
T Consensus 179 --~~~~Dv~slG~i~~~l~~g~~~~~~--~~~~~~~~~~~~~~~~-~--~~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll 251 (256)
T cd08221 179 --NFKSDIWALGCVLYELLTLKRTFDA--TNPLNLVVKIVQGNYT-P--VVSVYSSELISLVHSLLQQDPEKRPTADEVL 251 (256)
T ss_pred --CCcchhHHHHHHHHHHHHCCCCCCC--CCHHHHHHHHHcCCCC-C--CccccCHHHHHHHHHHcccCcccCCCHHHHh
Confidence 7899999999999999999999964 3345555555544322 1 1245788999999999999999999999987
Q ss_pred HH
Q psy1840 185 HK 186 (423)
Q Consensus 185 ~~ 186 (423)
+.
T Consensus 252 ~~ 253 (256)
T cd08221 252 DQ 253 (256)
T ss_pred hC
Confidence 64
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.6e-23 Score=200.55 Aligned_cols=155 Identities=19% Similarity=0.308 Sum_probs=118.7
Q ss_pred HHHHHHHHHHHHHHHHhC-CCeeecCCCCCCEEEcCCccEEEeccCCcccccCCCcccccccccCCccccCCccccCCCC
Q psy1840 25 SISVNTTASVGMIHLHDS-EIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKAPELLRQPHL 103 (423)
Q Consensus 25 ~l~i~~qi~~gL~yLH~~-~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~ 103 (423)
...++.|++.||.|||++ +++ ||||||+||+++.++.+||+|||++....... ......++..|+|||.+.+...
T Consensus 105 ~~~~~~qi~~~l~~lH~~~~i~-h~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~ 180 (283)
T cd06617 105 LGKIAVSIVKALEYLHSKLSVI-HRDVKPSNVLINRNGQVKLCDFGISGYLVDSV---AKTIDAGCKPYMAPERINPELN 180 (283)
T ss_pred HHHHHHHHHHHHHHHhhcCCee-cCCCCHHHEEECCCCCEEEeeccccccccccc---ccccccCCccccChhhcCCccc
Confidence 569999999999999997 887 99999999999999999999999987543221 1122456778999998865321
Q ss_pred -CCCCCccchHHHHHHHHHHHhCCCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCchHHHHHHHHHhhhcCCCCCCCHHH
Q psy1840 104 -PRGTQKGDVYSFGLVLYEVIGRQGPWGHLRMTDEEIITSVTQGSGLRPDTSSLDCAPSIIACMRTCWEEDPELRPDLRF 182 (423)
Q Consensus 104 -~~~s~ksDVyS~Giil~elltg~~Pf~~~~~~~~~i~~~i~~~~~~~p~~~~~~~~~~l~~Li~~C~~~dP~~RPt~~~ 182 (423)
...+.++|+||||+++|+|++|+.||.......+.+...+ .+ ..+..+...++.++.+++.+||..+|++||++.+
T Consensus 181 ~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~-~~--~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~ 257 (283)
T cd06617 181 QKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVV-EE--PSPQLPAEKFSPEFQDFVNKCLKKNYKERPNYPE 257 (283)
T ss_pred ccccCccccchhhHHHHHHHHhCCCCCCccccCHHHHHHHH-hc--CCCCCCccccCHHHHHHHHHHccCChhhCcCHHH
Confidence 2347899999999999999999999964333333333322 22 2233333457899999999999999999999999
Q ss_pred HHHH
Q psy1840 183 VHHK 186 (423)
Q Consensus 183 I~~~ 186 (423)
|++.
T Consensus 258 il~~ 261 (283)
T cd06617 258 LLQH 261 (283)
T ss_pred HhcC
Confidence 9874
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.4e-23 Score=199.27 Aligned_cols=152 Identities=22% Similarity=0.399 Sum_probs=118.5
Q ss_pred HHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCccEEEeccCCcccccCCCcc----cccccccCCccccCCccccC
Q psy1840 25 SISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDET----GQERKLRRRKLYKAPELLRQ 100 (423)
Q Consensus 25 ~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~~----~~~~~~~gt~~y~APE~l~~ 100 (423)
...++.|++.||.|||+.|++ ||||+|+||++++++.+||+|||.++........ .......++..|+|||.+.+
T Consensus 108 ~~~~~~~l~~~l~~lH~~~iv-H~di~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~ 186 (267)
T cd06628 108 VRNFVRQILKGLNYLHNRGII-HRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFWMAPEVVKQ 186 (267)
T ss_pred HHHHHHHHHHHHHHHHhcCcc-cccCCHHHEEEcCCCCEEecccCCCcccccccccCCccccccccCCCcCccChhHhcc
Confidence 468999999999999999998 9999999999999999999999998765422111 11123457788999999877
Q ss_pred CCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCchHHHHHHHHHhhhcCCCCCCCH
Q psy1840 101 PHLPRGTQKGDVYSFGLVLYEVIGRQGPWGHLRMTDEEIITSVTQGSGLRPDTSSLDCAPSIIACMRTCWEEDPELRPDL 180 (423)
Q Consensus 101 ~~~~~~s~ksDVyS~Giil~elltg~~Pf~~~~~~~~~i~~~i~~~~~~~p~~~~~~~~~~l~~Li~~C~~~dP~~RPt~ 180 (423)
..+ +.++|+||||+++|+|++|..||... .....+..+.. ...+.. +..++..+.+++++||+.+|.+||++
T Consensus 187 ~~~---~~~~Dv~slG~il~~l~~g~~p~~~~--~~~~~~~~~~~--~~~~~~-~~~~~~~~~~li~~~l~~~p~~Rp~~ 258 (267)
T cd06628 187 TSY---TRKADIWSLGCLVVEMLTGKHPFPDC--TQLQAIFKIGE--NASPEI-PSNISSEAIDFLEKTFEIDHNKRPTA 258 (267)
T ss_pred CCC---CchhhhHHHHHHHHHHhhCCCCCCCc--cHHHHHHHHhc--cCCCcC-CcccCHHHHHHHHHHccCCchhCcCH
Confidence 654 78999999999999999999999743 22222333322 122322 23578999999999999999999999
Q ss_pred HHHHH
Q psy1840 181 RFVHH 185 (423)
Q Consensus 181 ~~I~~ 185 (423)
.+|++
T Consensus 259 ~~il~ 263 (267)
T cd06628 259 AELLK 263 (267)
T ss_pred HHHhh
Confidence 99875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.90 E-value=9.3e-24 Score=199.58 Aligned_cols=156 Identities=19% Similarity=0.294 Sum_probs=117.7
Q ss_pred HHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCccEEEeccCCcccccCCCcccccccccCCccccCCccccCCCCC
Q psy1840 25 SISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKAPELLRQPHLP 104 (423)
Q Consensus 25 ~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~ 104 (423)
...++.|++.||.|||+.+++ ||||+|+||+++.++.+||+|||++........ ......++..|+|||.+.+....
T Consensus 103 ~~~~~~ql~~~l~~lh~~~i~-h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~--~~~~~~~~~~y~~Pe~~~~~~~~ 179 (262)
T cd06613 103 IAYVCRETLKGLAYLHETGKI-HRDIKGANILLTEDGDVKLADFGVSAQLTATIA--KRKSFIGTPYWMAPEVAAVERKG 179 (262)
T ss_pred HHHHHHHHHHHHHHHHhCCce-ecCCChhhEEECCCCCEEECccccchhhhhhhh--ccccccCCccccCchhhcccccC
Confidence 578999999999999999998 999999999999999999999999865432211 11234577789999998765212
Q ss_pred CCCCccchHHHHHHHHHHHhCCCCCCCCCCChHHHHHHHhcCCCCCCCC-CCCCchHHHHHHHHHhhhcCCCCCCCHHHH
Q psy1840 105 RGTQKGDVYSFGLVLYEVIGRQGPWGHLRMTDEEIITSVTQGSGLRPDT-SSLDCAPSIIACMRTCWEEDPELRPDLRFV 183 (423)
Q Consensus 105 ~~s~ksDVyS~Giil~elltg~~Pf~~~~~~~~~i~~~i~~~~~~~p~~-~~~~~~~~l~~Li~~C~~~dP~~RPt~~~I 183 (423)
..+.++|+||||+++|||++|..||.... ..+....+.......+.. .....+.++.+++.+||..+|.+|||+.+|
T Consensus 180 ~~~~~~Di~slG~~l~~~~tg~~p~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i 257 (262)
T cd06613 180 GYDGKCDIWALGITAIELAELQPPMFDLH--PMRALFLISKSNFPPPKLKDKEKWSPVFHDFIKKCLTKDPKKRPTATKL 257 (262)
T ss_pred CcCchhhhHHHHHHHHHHHhCCCCCCCCC--HHHHHHHHHhccCCCccccchhhhhHHHHHHHHHHcCCChhhCCCHHHH
Confidence 33789999999999999999999997533 223333333221111111 123457889999999999999999999998
Q ss_pred HH
Q psy1840 184 HH 185 (423)
Q Consensus 184 ~~ 185 (423)
+.
T Consensus 258 l~ 259 (262)
T cd06613 258 LQ 259 (262)
T ss_pred hc
Confidence 74
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.1e-23 Score=202.09 Aligned_cols=153 Identities=17% Similarity=0.323 Sum_probs=119.4
Q ss_pred HHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCccEEEeccCCcccccCCCcccccccccCCccccCCccccCCCCC
Q psy1840 25 SISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKAPELLRQPHLP 104 (423)
Q Consensus 25 ~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~ 104 (423)
...++.|++.||.|||+.|++ |+||||+||+++.++.+||+|||++...... ......++..|+|||.+.+..+
T Consensus 97 ~~~~~~qi~~~l~~lH~~~i~-H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~- 170 (279)
T cd06619 97 LGRIAVAVVKGLTYLWSLKIL-HRDVKPSNMLVNTRGQVKLCDFGVSTQLVNS----IAKTYVGTNAYMAPERISGEQY- 170 (279)
T ss_pred HHHHHHHHHHHHHHHHHCCEe-eCCCCHHHEEECCCCCEEEeeCCcceecccc----cccCCCCChhhcCceeecCCCC-
Confidence 468999999999999999998 9999999999999999999999998754322 1233567889999999987654
Q ss_pred CCCCccchHHHHHHHHHHHhCCCCCCCCCC-----ChHHHHHHHhcCCCCCCCCCCCCchHHHHHHHHHhhhcCCCCCCC
Q psy1840 105 RGTQKGDVYSFGLVLYEVIGRQGPWGHLRM-----TDEEIITSVTQGSGLRPDTSSLDCAPSIIACMRTCWEEDPELRPD 179 (423)
Q Consensus 105 ~~s~ksDVyS~Giil~elltg~~Pf~~~~~-----~~~~i~~~i~~~~~~~p~~~~~~~~~~l~~Li~~C~~~dP~~RPt 179 (423)
+.++|+||||+++|+|++|+.||..... ...+....+.... .+.......++++.+++.+||+.+|++||+
T Consensus 171 --~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~ 246 (279)
T cd06619 171 --GIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDED--PPVLPVGQFSEKFVHFITQCMRKQPKERPA 246 (279)
T ss_pred --CCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhccC--CCCCCCCcCCHHHHHHHHHHhhCChhhCCC
Confidence 8899999999999999999999964221 1122222222221 222223346789999999999999999999
Q ss_pred HHHHHHHH
Q psy1840 180 LRFVHHKL 187 (423)
Q Consensus 180 ~~~I~~~L 187 (423)
+.++++..
T Consensus 247 ~~eil~~~ 254 (279)
T cd06619 247 PENLMDHP 254 (279)
T ss_pred HHHHhcCc
Confidence 99998753
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.1e-23 Score=201.20 Aligned_cols=156 Identities=19% Similarity=0.271 Sum_probs=118.2
Q ss_pred HHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCccEEEeccCCcccccCCCcccccccccCCccccCCccccCCC--
Q psy1840 25 SISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKAPELLRQPH-- 102 (423)
Q Consensus 25 ~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~-- 102 (423)
...++.|++.|+.|||+.+++ ||||||+||+++.++.+||+|||++....... .......++..|+|||.+.+..
T Consensus 112 ~~~~~~ql~~~l~~lH~~~i~-H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~ 188 (292)
T cd06644 112 IQVICRQMLEALQYLHSMKII-HRDLKAGNVLLTLDGDIKLADFGVSAKNVKTL--QRRDSFIGTPYWMAPEVVMCETMK 188 (292)
T ss_pred HHHHHHHHHHHHHHHhcCCee-ecCCCcceEEEcCCCCEEEccCccceeccccc--cccceecCCccccCceeecccccc
Confidence 678999999999999999998 99999999999999999999999876432211 1113345778899999986422
Q ss_pred CCCCCCccchHHHHHHHHHHHhCCCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCchHHHHHHHHHhhhcCCCCCCCHHH
Q psy1840 103 LPRGTQKGDVYSFGLVLYEVIGRQGPWGHLRMTDEEIITSVTQGSGLRPDTSSLDCAPSIIACMRTCWEEDPELRPDLRF 182 (423)
Q Consensus 103 ~~~~s~ksDVyS~Giil~elltg~~Pf~~~~~~~~~i~~~i~~~~~~~p~~~~~~~~~~l~~Li~~C~~~dP~~RPt~~~ 182 (423)
....+.++|||||||++|||++|..||.... ..+....+........ .....++.++.+++.+||+.+|++||++.+
T Consensus 189 ~~~~~~~~Dv~slG~il~el~~g~~p~~~~~--~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ 265 (292)
T cd06644 189 DTPYDYKADIWSLGITLIEMAQIEPPHHELN--PMRVLLKIAKSEPPTL-SQPSKWSMEFRDFLKTALDKHPETRPSAAQ 265 (292)
T ss_pred CCCCCchhhhHhHHHHHHHHhcCCCCCcccc--HHHHHHHHhcCCCccC-CCCcccCHHHHHHHHHHhcCCcccCcCHHH
Confidence 1134789999999999999999999996432 3333333333221111 123357789999999999999999999999
Q ss_pred HHHH
Q psy1840 183 VHHK 186 (423)
Q Consensus 183 I~~~ 186 (423)
+++.
T Consensus 266 il~~ 269 (292)
T cd06644 266 LLEH 269 (292)
T ss_pred HhcC
Confidence 8763
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=99.90 E-value=6.8e-24 Score=203.36 Aligned_cols=155 Identities=18% Similarity=0.182 Sum_probs=114.0
Q ss_pred HHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCccEEEeccCCcccccCCCcccccccccCCccccCCccccCCCCC
Q psy1840 25 SISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKAPELLRQPHLP 104 (423)
Q Consensus 25 ~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~ 104 (423)
...++.||+.||.|||+.+++ ||||||+||+++.++.+||+|||++....... .......+++.|+|||.+.+..
T Consensus 103 ~~~~~~qi~~~L~~lH~~~i~-H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~-- 177 (285)
T cd07861 103 VKSYLYQILQGILFCHSRRVL-HRDLKPQNLLIDNKGVIKLADFGLARAFGIPV--RVYTHEVVTLWYRAPEVLLGSP-- 177 (285)
T ss_pred HHHHHHHHHHHHHHHHhCCee-ecCCCHHHEEEcCCCcEEECcccceeecCCCc--ccccCCcccccccChHHhcCCC--
Confidence 467999999999999999998 99999999999999999999999986543221 1112335677899999886543
Q ss_pred CCCCccchHHHHHHHHHHHhCCCCCCCCCCChHHHHHHHhcC------------------------CCCCCCCCCCCchH
Q psy1840 105 RGTQKGDVYSFGLVLYEVIGRQGPWGHLRMTDEEIITSVTQG------------------------SGLRPDTSSLDCAP 160 (423)
Q Consensus 105 ~~s~ksDVyS~Giil~elltg~~Pf~~~~~~~~~i~~~i~~~------------------------~~~~p~~~~~~~~~ 160 (423)
..+.++|||||||++|+|++|+.||..... ........... ...........+++
T Consensus 178 ~~~~~~Dv~slG~il~~l~tg~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (285)
T cd07861 178 RYSTPVDIWSIGTIFAEMATKKPLFHGDSE-IDQLFRIFRILGTPTEDVWPGVTSLPDYKNTFPKWKKGSLRSAVKNLDE 256 (285)
T ss_pred CcCcHHHHHHHHHHHHHHHHCCCCCCCCCH-HHHHHHHHHHhCCCChhhhhcchhhHHHHhhccccCcchhHHhcCCCCH
Confidence 237899999999999999999999964321 11111111100 00000001234688
Q ss_pred HHHHHHHHhhhcCCCCCCCHHHHHH
Q psy1840 161 SIIACMRTCWEEDPELRPDLRFVHH 185 (423)
Q Consensus 161 ~l~~Li~~C~~~dP~~RPt~~~I~~ 185 (423)
++.+++++||+.||++|||+.+|+.
T Consensus 257 ~~~~li~~~l~~dP~~Rpt~~~ll~ 281 (285)
T cd07861 257 DGLDLLEKMLIYDPAKRISAKKALN 281 (285)
T ss_pred HHHHHHHHHhcCChhhCCCHHHHhc
Confidence 9999999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.3e-23 Score=199.80 Aligned_cols=153 Identities=22% Similarity=0.374 Sum_probs=121.5
Q ss_pred HHHHHHHHHHHHHHHHh-CCCeeecCCCCCCEEEcCCccEEEeccCCcccccCCCcccccccccCCccccCCccccCCCC
Q psy1840 25 SISVNTTASVGMIHLHD-SEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKAPELLRQPHL 103 (423)
Q Consensus 25 ~l~i~~qi~~gL~yLH~-~~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~ 103 (423)
...++.|++.||.|||+ .+++ ||||+|+||+++.++.+||+|||++....... ......++..|+|||.+.+..+
T Consensus 115 ~~~~~~~l~~~l~~lh~~~~i~-H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~---~~~~~~~~~~~~~Pe~~~~~~~ 190 (269)
T cd08528 115 IWNIFVQMVLALRYLHKEKRIV-HRDLTPNNIMLGEDDKVTITDFGLAKQKQPES---KLTSVVGTILYSCPEIVKNEPY 190 (269)
T ss_pred HHHHHHHHHHHHHHhccCCcee-ecCCCHHHEEECCCCcEEEecccceeeccccc---ccccccCcccCcChhhhcCCCC
Confidence 57899999999999996 5676 99999999999999999999999987643322 2234567888999999987554
Q ss_pred CCCCCccchHHHHHHHHHHHhCCCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCchHHHHHHHHHhhhcCCCCCCCHHHH
Q psy1840 104 PRGTQKGDVYSFGLVLYEVIGRQGPWGHLRMTDEEIITSVTQGSGLRPDTSSLDCAPSIIACMRTCWEEDPELRPDLRFV 183 (423)
Q Consensus 104 ~~~s~ksDVyS~Giil~elltg~~Pf~~~~~~~~~i~~~i~~~~~~~p~~~~~~~~~~l~~Li~~C~~~dP~~RPt~~~I 183 (423)
+.++||||||+++||+++|..||... ........+..+... | .....+++.+.+++.+||+.||++||++.++
T Consensus 191 ---~~~~Dv~slG~ll~~l~~g~~p~~~~--~~~~~~~~~~~~~~~-~-~~~~~~~~~l~~li~~cl~~~p~~Rp~~~e~ 263 (269)
T cd08528 191 ---GEKADVWAFGCILYQMCTLQPPFYST--NMLSLATKIVEAVYE-P-LPEGMYSEDVTDVITSCLTPDAEARPDIIQV 263 (269)
T ss_pred ---chHHHHHHHHHHHHHHHhCCCccccc--CHHHHHHHHhhccCC-c-CCcccCCHHHHHHHHHHCCCCCccCCCHHHH
Confidence 88999999999999999999999632 233444444443221 2 2223578899999999999999999999999
Q ss_pred HHHHH
Q psy1840 184 HHKLK 188 (423)
Q Consensus 184 ~~~L~ 188 (423)
...++
T Consensus 264 ~~~~~ 268 (269)
T cd08528 264 SAMIS 268 (269)
T ss_pred HHHhc
Confidence 88764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=99.90 E-value=2e-23 Score=196.44 Aligned_cols=153 Identities=32% Similarity=0.567 Sum_probs=121.6
Q ss_pred HHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCccEEEeccCCcccccCCCcccccccccCCccccCCccccCCCCC
Q psy1840 25 SISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKAPELLRQPHLP 104 (423)
Q Consensus 25 ~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~ 104 (423)
...++.|++.|+.|||+.+++ ||||||+||++++++.++|+|||++........... ....++..|+|||.+.+...
T Consensus 105 ~~~~~~ql~~~l~~lh~~~~~-h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~-~~~~~~~~y~~Pe~~~~~~~- 181 (258)
T smart00219 105 LLSFALQIARGMEYLESKNFI-HRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKK-KGGKLPIRWMAPESLKDGKF- 181 (258)
T ss_pred HHHHHHHHHHHHHHHhcCCee-ecccccceEEEccCCeEEEcccCCceeccccccccc-ccCCCcccccChHHhccCCC-
Confidence 578999999999999999998 999999999999999999999999876543321111 12235678999999866544
Q ss_pred CCCCccchHHHHHHHHHHHh-CCCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCchHHHHHHHHHhhhcCCCCCCCHHHH
Q psy1840 105 RGTQKGDVYSFGLVLYEVIG-RQGPWGHLRMTDEEIITSVTQGSGLRPDTSSLDCAPSIIACMRTCWEEDPELRPDLRFV 183 (423)
Q Consensus 105 ~~s~ksDVyS~Giil~ellt-g~~Pf~~~~~~~~~i~~~i~~~~~~~p~~~~~~~~~~l~~Li~~C~~~dP~~RPt~~~I 183 (423)
+.++||||+|+++++|++ |..||.. .....+...+..+... .. ...++.++.+++.+||..+|++|||+.++
T Consensus 182 --~~~~Di~slG~i~~~l~~~g~~p~~~--~~~~~~~~~~~~~~~~--~~-~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l 254 (258)
T smart00219 182 --TSKSDVWSFGVLLWEIFTLGESPYPG--MSNEEVLEYLKKGYRL--PK-PENCPPEIYKLMLQCWAEDPEDRPTFSEL 254 (258)
T ss_pred --CcchhHHHHHHHHHHHHhCCCCCCCC--CCHHHHHHHHhcCCCC--CC-CCcCCHHHHHHHHHHCcCChhhCcCHHHH
Confidence 899999999999999998 7788864 4556666666654322 11 23478999999999999999999999998
Q ss_pred HHHH
Q psy1840 184 HHKL 187 (423)
Q Consensus 184 ~~~L 187 (423)
++.|
T Consensus 255 l~~l 258 (258)
T smart00219 255 VEIL 258 (258)
T ss_pred HhhC
Confidence 8753
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=99.90 E-value=6.4e-24 Score=206.75 Aligned_cols=155 Identities=16% Similarity=0.191 Sum_probs=115.4
Q ss_pred HHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCccEEEeccCCcccccCCCcccccccccCCccccCCccccCCCCC
Q psy1840 25 SISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKAPELLRQPHLP 104 (423)
Q Consensus 25 ~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~ 104 (423)
...++.||+.||.|||+.|++ ||||||+||+++.++.+||+|||++........ ......++..|+|||.+.+..
T Consensus 106 ~~~~~~qi~~aL~~lH~~~iv-H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~-- 180 (309)
T cd07872 106 VKIFLYQILRGLAYCHRRKVL-HRDLKPQNLLINERGELKLADFGLARAKSVPTK--TYSNEVVTLWYRPPDVLLGSS-- 180 (309)
T ss_pred HHHHHHHHHHHHHHHHHCCee-cCCCCHHHEEECCCCCEEECccccceecCCCcc--ccccccccccccCCHHHhCCC--
Confidence 567899999999999999998 999999999999999999999999865432211 112345678899999886543
Q ss_pred CCCCccchHHHHHHHHHHHhCCCCCCCCCCChHHHHHHHhcC---C----------------CCCCCC-------CCCCc
Q psy1840 105 RGTQKGDVYSFGLVLYEVIGRQGPWGHLRMTDEEIITSVTQG---S----------------GLRPDT-------SSLDC 158 (423)
Q Consensus 105 ~~s~ksDVyS~Giil~elltg~~Pf~~~~~~~~~i~~~i~~~---~----------------~~~p~~-------~~~~~ 158 (423)
..+.++|||||||++|||++|+.||..... .+....+... . ...+.. ....+
T Consensus 181 ~~~~~~DiwslG~il~el~tg~~pf~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (309)
T cd07872 181 EYSTQIDMWGVGCIFFEMASGRPLFPGSTV--EDELHLIFRLLGTPTEETWPGISSNDEFKNYNFPKYKPQPLINHAPRL 258 (309)
T ss_pred CCCcHHHHHHHHHHHHHHHhCCCCCCCCCh--HHHHHHHHHHhCCCCHHHHhhhcchhhhhhhhcCccCCCchhhhccCC
Confidence 237899999999999999999999975322 2222211110 0 000000 01246
Q ss_pred hHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q psy1840 159 APSIIACMRTCWEEDPELRPDLRFVHHK 186 (423)
Q Consensus 159 ~~~l~~Li~~C~~~dP~~RPt~~~I~~~ 186 (423)
++++.+++.+||+.||.+|||+.++++.
T Consensus 259 ~~~~~~li~~~L~~dp~~R~t~~e~l~h 286 (309)
T cd07872 259 DTEGIELLTKFLQYESKKRISAEEAMKH 286 (309)
T ss_pred CHHHHHHHHHhccCChhhCCCHHHHhcC
Confidence 7889999999999999999999999763
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.3e-23 Score=203.71 Aligned_cols=155 Identities=15% Similarity=0.276 Sum_probs=121.9
Q ss_pred HHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCccEEEeccCCcccccCCCcccccccccCCccccCCccccCCCCC
Q psy1840 25 SISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKAPELLRQPHLP 104 (423)
Q Consensus 25 ~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~ 104 (423)
...++.|++.||.|||+.+++ ||||||+||+++.++.+||+|||++....... .......++..|+|||.+.+..+
T Consensus 119 ~~~~~~qi~~~L~~LH~~~iv-H~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~- 194 (297)
T cd06659 119 IATVCESVLQALCYLHSQGVI-HRDIKSDSILLTLDGRVKLSDFGFCAQISKDV--PKRKSLVGTPYWMAPEVISRTPY- 194 (297)
T ss_pred HHHHHHHHHHHHHHHHhCCee-cCCCCHHHeEEccCCcEEEeechhHhhccccc--ccccceecCccccCHHHHccCCC-
Confidence 578999999999999999988 99999999999999999999999976543221 11234567889999999977654
Q ss_pred CCCCccchHHHHHHHHHHHhCCCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCchHHHHHHHHHhhhcCCCCCCCHHHHH
Q psy1840 105 RGTQKGDVYSFGLVLYEVIGRQGPWGHLRMTDEEIITSVTQGSGLRPDTSSLDCAPSIIACMRTCWEEDPELRPDLRFVH 184 (423)
Q Consensus 105 ~~s~ksDVyS~Giil~elltg~~Pf~~~~~~~~~i~~~i~~~~~~~p~~~~~~~~~~l~~Li~~C~~~dP~~RPt~~~I~ 184 (423)
+.++|||||||++|||++|..||.. ....+....+......... .....+..+.+++.+||+.+|++||++.+++
T Consensus 195 --~~~~Dv~slG~il~el~~g~~p~~~--~~~~~~~~~~~~~~~~~~~-~~~~~~~~l~~~i~~~l~~~P~~Rps~~~ll 269 (297)
T cd06659 195 --GTEVDIWSLGIMVIEMVDGEPPYFS--DSPVQAMKRLRDSPPPKLK-NAHKISPVLRDFLERMLTREPQERATAQELL 269 (297)
T ss_pred --CchhhHHHHHHHHHHHHhCCCCCCC--CCHHHHHHHHhccCCCCcc-ccCCCCHHHHHHHHHHhcCCcccCcCHHHHh
Confidence 8899999999999999999999964 2334444444433222111 2235678999999999999999999999998
Q ss_pred HHHH
Q psy1840 185 HKLK 188 (423)
Q Consensus 185 ~~L~ 188 (423)
+.--
T Consensus 270 ~~~~ 273 (297)
T cd06659 270 DHPF 273 (297)
T ss_pred hChh
Confidence 8543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >KOG0579|consensus | Back alignment and domain information |
|---|
Probab=99.90 E-value=7.7e-24 Score=211.76 Aligned_cols=155 Identities=19% Similarity=0.283 Sum_probs=125.3
Q ss_pred HHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCccEEEeccCCcccccCCCcccccccccCCccccCCccccCCC--CC
Q psy1840 27 SVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKAPELLRQPH--LP 104 (423)
Q Consensus 27 ~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~--~~ 104 (423)
-+++|++.+|.|||+++|| |||||..|||++-+|.++|+|||++.... .......++.||++|||||+..... -.
T Consensus 134 vvc~q~ldALn~LHs~~iI-HRDLKAGNiL~TldGdirLADFGVSAKn~--~t~qkRDsFIGTPYWMAPEVvmCET~KD~ 210 (1187)
T KOG0579|consen 134 VVCYQVLDALNWLHSQNII-HRDLKAGNILLTLDGDIRLADFGVSAKNK--STRQKRDSFIGTPYWMAPEVVMCETFKDQ 210 (1187)
T ss_pred HHHHHHHHHHHHHhhcchh-hhhccccceEEEecCcEeeecccccccch--hHHhhhccccCCcccccchheeeccccCC
Confidence 5689999999999999998 99999999999999999999999975432 1222346789999999999887543 22
Q ss_pred CCCCccchHHHHHHHHHHHhCCCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCchHHHHHHHHHhhhcCCCCCCCHHHHH
Q psy1840 105 RGTQKGDVYSFGLVLYEVIGRQGPWGHLRMTDEEIITSVTQGSGLRPDTSSLDCAPSIIACMRTCWEEDPELRPDLRFVH 184 (423)
Q Consensus 105 ~~s~ksDVyS~Giil~elltg~~Pf~~~~~~~~~i~~~i~~~~~~~p~~~~~~~~~~l~~Li~~C~~~dP~~RPt~~~I~ 184 (423)
+|..++|||||||.|.||..+.+|... .++-.++-++....+.-. ..+..++..+.+++++||..||+.||+..+++
T Consensus 211 PYDykaDiWSlGITLIEMAqiEPPHhe--lnpMRVllKiaKSePPTL-lqPS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll 287 (1187)
T KOG0579|consen 211 PYDYKADIWSLGITLIEMAQIEPPHHE--LNPMRVLLKIAKSEPPTL-LQPSHWSRSFSDFLKRCLVKNPRNRPPAAQLL 287 (1187)
T ss_pred CchhhhhHHhhhhHHHHHhccCCCccc--cchHHHHHHHhhcCCCcc-cCcchhhhHHHHHHHHHHhcCCccCCCHHHHh
Confidence 468999999999999999999999763 455566666655432211 22457889999999999999999999999998
Q ss_pred HHH
Q psy1840 185 HKL 187 (423)
Q Consensus 185 ~~L 187 (423)
+.-
T Consensus 288 ~Hp 290 (1187)
T KOG0579|consen 288 KHP 290 (1187)
T ss_pred hCc
Confidence 764
|
|
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.90 E-value=9.9e-24 Score=199.69 Aligned_cols=149 Identities=22% Similarity=0.306 Sum_probs=119.1
Q ss_pred HHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCccEEEeccCCcccccCCCcccccccccCCccccCCccccCCCCC
Q psy1840 25 SISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKAPELLRQPHLP 104 (423)
Q Consensus 25 ~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~ 104 (423)
...++.|++.||.|||+.+++ ||||+|+||+++.++.+||+|||++..... .....++..|+|||.+.+..+
T Consensus 99 ~~~i~~qi~~aL~~lH~~~i~-H~dl~p~nil~~~~~~~~l~dfg~~~~~~~------~~~~~~~~~y~~pe~~~~~~~- 170 (260)
T cd05611 99 AKQYIAEVVLGVEDLHQRGII-HRDIKPENLLIDQTGHLKLTDFGLSRNGLE------NKKFVGTPDYLAPETILGVGD- 170 (260)
T ss_pred HHHHHHHHHHHHHHHHHCCee-cCCCCHHHeEECCCCcEEEeecccceeccc------cccCCCCcCccChhhhcCCCC-
Confidence 578999999999999999998 999999999999999999999999765322 123456778999999877653
Q ss_pred CCCCccchHHHHHHHHHHHhCCCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCchHHHHHHHHHhhhcCCCCCCCHHHHH
Q psy1840 105 RGTQKGDVYSFGLVLYEVIGRQGPWGHLRMTDEEIITSVTQGSGLRPDTSSLDCAPSIIACMRTCWEEDPELRPDLRFVH 184 (423)
Q Consensus 105 ~~s~ksDVyS~Giil~elltg~~Pf~~~~~~~~~i~~~i~~~~~~~p~~~~~~~~~~l~~Li~~C~~~dP~~RPt~~~I~ 184 (423)
+.++||||||+++|++++|..||.. .+..+....+..+....+......++..+.+++.+||+.+|++||++.++.
T Consensus 171 --~~~~Dv~slG~il~~l~~g~~p~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~ 246 (260)
T cd05611 171 --DKMSDWWSLGCVIFEFLFGYPPFHA--ETPDAVFDNILSRRINWPEEVKEFCSPEAVDLINRLLCMDPAKRLGANGYQ 246 (260)
T ss_pred --cchhhhHHHHHHHHHHHHCCCCCCC--CCHHHHHHHHHhcccCCCCcccccCCHHHHHHHHHHccCCHHHccCCCcHH
Confidence 8899999999999999999999964 334555555554433333333335789999999999999999999765443
Q ss_pred H
Q psy1840 185 H 185 (423)
Q Consensus 185 ~ 185 (423)
+
T Consensus 247 ~ 247 (260)
T cd05611 247 E 247 (260)
T ss_pred H
Confidence 3
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >KOG1035|consensus | Back alignment and domain information |
|---|
Probab=99.90 E-value=8.7e-24 Score=224.97 Aligned_cols=158 Identities=29% Similarity=0.407 Sum_probs=125.3
Q ss_pred HHHHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCccEEEeccCCccccc----C------------CCcccccccc
Q psy1840 23 IGSISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKA----G------------QDETGQERKL 86 (423)
Q Consensus 23 ~~~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~----~------------~~~~~~~~~~ 86 (423)
....++..+|+.||.|+|+.|+| ||||||.||++|++..|||+|||++.... . .......+..
T Consensus 697 d~~wrLFreIlEGLaYIH~~giI-HRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~ 775 (1351)
T KOG1035|consen 697 DEAWRLFREILEGLAYIHDQGII-HRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQ 775 (1351)
T ss_pred HHHHHHHHHHHHHHHHHHhCcee-eccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccc
Confidence 33578999999999999999987 99999999999999999999999987621 0 0111234567
Q ss_pred cCCccccCCccccCCCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCchHHHHHHH
Q psy1840 87 RRRKLYKAPELLRQPHLPRGTQKGDVYSFGLVLYEVIGRQGPWGHLRMTDEEIITSVTQGSGLRPDTSSLDCAPSIIACM 166 (423)
Q Consensus 87 ~gt~~y~APE~l~~~~~~~~s~ksDVyS~Giil~elltg~~Pf~~~~~~~~~i~~~i~~~~~~~p~~~~~~~~~~l~~Li 166 (423)
.||..|+|||++.+.....++.|+|+||+|||++||+. ||. ..|....++..++.+....|.....+--+.-..+|
T Consensus 776 VGTalYvAPEll~~~~~~~Yn~KiDmYSLGIVlFEM~y---PF~-TsMERa~iL~~LR~g~iP~~~~f~~~~~~~e~slI 851 (1351)
T KOG1035|consen 776 VGTALYVAPELLSDTSSNKYNSKIDMYSLGIVLFEMLY---PFG-TSMERASILTNLRKGSIPEPADFFDPEHPEEASLI 851 (1351)
T ss_pred cceeeeecHHHhcccccccccchhhhHHHHHHHHHHhc---cCC-chHHHHHHHHhcccCCCCCCcccccccchHHHHHH
Confidence 89999999999987653457999999999999999985 565 35667778888887655444222333345667899
Q ss_pred HHhhhcCCCCCCCHHHHHH
Q psy1840 167 RTCWEEDPELRPDLRFVHH 185 (423)
Q Consensus 167 ~~C~~~dP~~RPt~~~I~~ 185 (423)
+.+++.||.+|||+.+++.
T Consensus 852 ~~Ll~hdP~kRPtA~eLL~ 870 (1351)
T KOG1035|consen 852 RWLLSHDPSKRPTATELLN 870 (1351)
T ss_pred HHHhcCCCccCCCHHHHhh
Confidence 9999999999999999875
|
|
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.7e-23 Score=198.60 Aligned_cols=153 Identities=16% Similarity=0.336 Sum_probs=119.1
Q ss_pred HHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCccEEEeccCCcccccCCCcccccccccCCccccCCccccCCCCC
Q psy1840 25 SISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKAPELLRQPHLP 104 (423)
Q Consensus 25 ~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~ 104 (423)
.+.++.|++.||.|||+.|++ ||||+|+||+++.++.++|+|||++........ ......++..|+|||.+.++.
T Consensus 103 ~~~i~~~i~~~l~~lh~~~i~-H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~-- 177 (277)
T cd06917 103 ISVIIREVLVALKYIHKVGVI-HRDIKAANILVTNTGNVKLCDFGVAALLNQNSS--KRSTFVGTPYWMAPEVITEGK-- 177 (277)
T ss_pred HHHHHHHHHHHHHHHHhCCcc-cCCcCHHHEEEcCCCCEEEccCCceeecCCCcc--ccccccCCcceeCHHHhccCC--
Confidence 678999999999999999998 999999999999999999999999876543321 123345788899999986543
Q ss_pred CCCCccchHHHHHHHHHHHhCCCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCchHHHHHHHHHhhhcCCCCCCCHHHHH
Q psy1840 105 RGTQKGDVYSFGLVLYEVIGRQGPWGHLRMTDEEIITSVTQGSGLRPDTSSLDCAPSIIACMRTCWEEDPELRPDLRFVH 184 (423)
Q Consensus 105 ~~s~ksDVyS~Giil~elltg~~Pf~~~~~~~~~i~~~i~~~~~~~p~~~~~~~~~~l~~Li~~C~~~dP~~RPt~~~I~ 184 (423)
..+.++|+||||+++|+|++|..||... ........+... ..+......++.++.+++.+||+.||++||++.+++
T Consensus 178 ~~~~~~Dv~slG~~l~~ll~g~~p~~~~--~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~il 253 (277)
T cd06917 178 YYDTKADIWSLGITIYEMATGNPPYSDV--DAFRAMMLIPKS--KPPRLEDNGYSKLLREFVAACLDEEPKERLSAEELL 253 (277)
T ss_pred ccccchhHHHHHHHHHHHHhCCCCCCCC--ChhhhhhccccC--CCCCCCcccCCHHHHHHHHHHcCCCcccCcCHHHHh
Confidence 2378999999999999999999999743 222222222221 222333334788999999999999999999999997
Q ss_pred HH
Q psy1840 185 HK 186 (423)
Q Consensus 185 ~~ 186 (423)
..
T Consensus 254 ~~ 255 (277)
T cd06917 254 KS 255 (277)
T ss_pred hC
Confidence 74
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=99.90 E-value=1e-23 Score=201.75 Aligned_cols=159 Identities=23% Similarity=0.411 Sum_probs=120.6
Q ss_pred HHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCccEEEeccCCcccccCCCcc-cccccccCCccccCCccccCCCC
Q psy1840 25 SISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDET-GQERKLRRRKLYKAPELLRQPHL 103 (423)
Q Consensus 25 ~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~~-~~~~~~~gt~~y~APE~l~~~~~ 103 (423)
...++.|++.||+|||++|++ ||||||+||+++.++.+||+|||++......... .......++..|+|||.+.+...
T Consensus 111 ~~~~~~~l~~aL~~lH~~~i~-H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~ 189 (284)
T cd05038 111 LLLFSSQICKGMDYLGSQRYI-HRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWYAPECLRTSKF 189 (284)
T ss_pred HHHHHHHHHHHHHHHHhCCee-cCCCCHHhEEEcCCCCEEEcccccccccccCCcceeccCCCCCcccccCcHHHccCCC
Confidence 578999999999999999987 9999999999999999999999998765422211 11112234456999999876644
Q ss_pred CCCCCccchHHHHHHHHHHHhCCCCCCCCCCC-------------hHHHHHHHhcCCCCCCCCCCCCchHHHHHHHHHhh
Q psy1840 104 PRGTQKGDVYSFGLVLYEVIGRQGPWGHLRMT-------------DEEIITSVTQGSGLRPDTSSLDCAPSIIACMRTCW 170 (423)
Q Consensus 104 ~~~s~ksDVyS~Giil~elltg~~Pf~~~~~~-------------~~~i~~~i~~~~~~~p~~~~~~~~~~l~~Li~~C~ 170 (423)
+.++||||||+++|||++|..|+...... ...+...+..... .. ....++.++.+++.+||
T Consensus 190 ---~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~-~~~~~~~~~~~li~~cl 263 (284)
T cd05038 190 ---SSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLELLKEGER--LP-RPPSCPDEVYDLMKLCW 263 (284)
T ss_pred ---CcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHHHHHHcCCc--CC-CCccCCHHHHHHHHHHh
Confidence 88999999999999999999988542111 1222233332221 11 12357789999999999
Q ss_pred hcCCCCCCCHHHHHHHHHHH
Q psy1840 171 EEDPELRPDLRFVHHKLKEM 190 (423)
Q Consensus 171 ~~dP~~RPt~~~I~~~L~~i 190 (423)
+.+|++||++.+|++.|+.+
T Consensus 264 ~~~p~~Rpt~~ei~~~l~~i 283 (284)
T cd05038 264 EAEPQDRPSFADLILIVDRL 283 (284)
T ss_pred ccChhhCCCHHHHHHHHhhc
Confidence 99999999999999998765
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=99.90 E-value=2e-23 Score=196.93 Aligned_cols=153 Identities=26% Similarity=0.550 Sum_probs=120.1
Q ss_pred HHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCccEEEeccCCcccccCCCcccccccccCCccccCCccccCCCCC
Q psy1840 25 SISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKAPELLRQPHLP 104 (423)
Q Consensus 25 ~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~ 104 (423)
...++.|++.|++|||+.+++ ||||||+||+++.++.+||+|||++........ .......++..|+|||.+.+..+
T Consensus 102 ~~~~~~~l~~~l~~lH~~~i~-h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~-~~~~~~~~~~~~~aPe~~~~~~~- 178 (256)
T cd05112 102 LLGMCLDVCEGMAYLESSNVI-HRDLAARNCLVGENQVVKVSDFGMTRFVLDDQY-TSSTGTKFPVKWSSPEVFSFSKY- 178 (256)
T ss_pred HHHHHHHHHHHHHHHHHCCcc-ccccccceEEEcCCCeEEECCCcceeecccCcc-cccCCCccchhhcCHhHhccCCc-
Confidence 578999999999999999988 999999999999999999999999875432211 11122234567999999887654
Q ss_pred CCCCccchHHHHHHHHHHHh-CCCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCchHHHHHHHHHhhhcCCCCCCCHHHH
Q psy1840 105 RGTQKGDVYSFGLVLYEVIG-RQGPWGHLRMTDEEIITSVTQGSGLRPDTSSLDCAPSIIACMRTCWEEDPELRPDLRFV 183 (423)
Q Consensus 105 ~~s~ksDVyS~Giil~ellt-g~~Pf~~~~~~~~~i~~~i~~~~~~~p~~~~~~~~~~l~~Li~~C~~~dP~~RPt~~~I 183 (423)
+.++||||||+++||+++ |..||.. ....++...+..+.... .+...+..+.+++.+||+.+|++||++.++
T Consensus 179 --~~~~Dv~slG~~l~el~~~g~~p~~~--~~~~~~~~~~~~~~~~~---~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~~ 251 (256)
T cd05112 179 --SSKSDVWSFGVLMWEVFSEGKTPYEN--RSNSEVVETINAGFRLY---KPRLASQSVYELMQHCWKERPEDRPSFSLL 251 (256)
T ss_pred --ChHHHHHHHHHHHHHHHcCCCCCCCc--CCHHHHHHHHhCCCCCC---CCCCCCHHHHHHHHHHcccChhhCCCHHHH
Confidence 789999999999999998 8899863 33455666665442211 122367899999999999999999999999
Q ss_pred HHHH
Q psy1840 184 HHKL 187 (423)
Q Consensus 184 ~~~L 187 (423)
++.|
T Consensus 252 l~~l 255 (256)
T cd05112 252 LHQL 255 (256)
T ss_pred HHhh
Confidence 8876
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.4e-23 Score=198.83 Aligned_cols=156 Identities=22% Similarity=0.332 Sum_probs=119.3
Q ss_pred HHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCccEEEeccCCcccccCCCccc--ccccccCCccccCCccccCCC
Q psy1840 25 SISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETG--QERKLRRRKLYKAPELLRQPH 102 (423)
Q Consensus 25 ~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~~~--~~~~~~gt~~y~APE~l~~~~ 102 (423)
...++.|++.|+.|||+.|++ ||||+|+||+++.++.+||+|||++.......... ......++..|+|||.+....
T Consensus 104 ~~~~~~ql~~al~~lh~~~i~-h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~ 182 (267)
T cd06610 104 IATVLKEVLKGLEYLHSNGQI-HRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEVMEQVH 182 (267)
T ss_pred HHHHHHHHHHHHHHHHhCCee-cCCCCHHhEEEcCCCCEEEcccchHHHhccCccccccccccccCChhhcChHHHcccc
Confidence 568899999999999999988 99999999999999999999999987654332221 223445788899999987652
Q ss_pred CCCCCCccchHHHHHHHHHHHhCCCCCCCCCCChHHHHHHHhcCCCC-CCCC-CCCCchHHHHHHHHHhhhcCCCCCCCH
Q psy1840 103 LPRGTQKGDVYSFGLVLYEVIGRQGPWGHLRMTDEEIITSVTQGSGL-RPDT-SSLDCAPSIIACMRTCWEEDPELRPDL 180 (423)
Q Consensus 103 ~~~~s~ksDVyS~Giil~elltg~~Pf~~~~~~~~~i~~~i~~~~~~-~p~~-~~~~~~~~l~~Li~~C~~~dP~~RPt~ 180 (423)
..+.++|+||||+++|+|++|+.||... +..+........... .+.. ....+++.+.+++.+||..||++||++
T Consensus 183 --~~~~~~Dv~slG~i~~~l~~g~~p~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~ 258 (267)
T cd06610 183 --GYDFKADIWSFGITAIELATGAAPYSKY--PPMKVLMLTLQNDPPSLETGADYKKYSKSFRKMISLCLQKDPSKRPTA 258 (267)
T ss_pred --CcCcccchHhHhHHHHHHHhCCCCcccc--ChhhhHHHHhcCCCCCcCCccccccccHHHHHHHHHHcCCChhhCcCH
Confidence 2388999999999999999999999643 222333333332211 1111 113578899999999999999999999
Q ss_pred HHHHH
Q psy1840 181 RFVHH 185 (423)
Q Consensus 181 ~~I~~ 185 (423)
.+|+.
T Consensus 259 ~~ll~ 263 (267)
T cd06610 259 EELLK 263 (267)
T ss_pred HHHhh
Confidence 99875
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >KOG0603|consensus | Back alignment and domain information |
|---|
Probab=99.90 E-value=8.1e-24 Score=213.40 Aligned_cols=147 Identities=20% Similarity=0.221 Sum_probs=122.0
Q ss_pred HHHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEE-cCCccEEEeccCCcccccCCCcccccccccCCccccCCccccCCC
Q psy1840 24 GSISVNTTASVGMIHLHDSEIISHGNLRSSNCLI-DSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKAPELLRQPH 102 (423)
Q Consensus 24 ~~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILl-d~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~ 102 (423)
.+..|+.+|+.++.|||.+|++ ||||||+|||+ ++.++++|+|||.++..... ....+-|..|.|||++....
T Consensus 416 e~~~w~~~lv~Av~~LH~~gvv-hRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~-----~~tp~~t~~y~APEvl~~~~ 489 (612)
T KOG0603|consen 416 EASQWAAELVSAVDYLHEQGVV-HRDLKPGNILLDGSAGHLRLTYFGFWSELERS-----CDTPALTLQYVAPEVLAIQE 489 (612)
T ss_pred HHHHHHHHHHHHHHHHHhcCee-ecCCChhheeecCCCCcEEEEEechhhhCchh-----hcccchhhcccChhhhccCC
Confidence 3567999999999999999998 99999999999 69999999999998765433 23445677899999998665
Q ss_pred CCCCCCccchHHHHHHHHHHHhCCCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCchHHHHHHHHHhhhcCCCCCCCHHH
Q psy1840 103 LPRGTQKGDVYSFGLVLYEVIGRQGPWGHLRMTDEEIITSVTQGSGLRPDTSSLDCAPSIIACMRTCWEEDPELRPDLRF 182 (423)
Q Consensus 103 ~~~~s~ksDVyS~Giil~elltg~~Pf~~~~~~~~~i~~~i~~~~~~~p~~~~~~~~~~l~~Li~~C~~~dP~~RPt~~~ 182 (423)
+ +.++|+||||++||+|++|+.||..- ....++..++..++.. ..++...++|+..||+.||.+||++.+
T Consensus 490 y---t~acD~WSLGvlLy~ML~G~tp~~~~-P~~~ei~~~i~~~~~s------~~vS~~AKdLl~~LL~~dP~~Rl~~~~ 559 (612)
T KOG0603|consen 490 Y---TEACDWWSLGVLLYEMLTGRTLFAAH-PAGIEIHTRIQMPKFS------ECVSDEAKDLLQQLLQVDPALRLGADE 559 (612)
T ss_pred C---CcchhhHHHHHHHHHHHhCCCccccC-CchHHHHHhhcCCccc------cccCHHHHHHHHHhccCChhhCcChhh
Confidence 5 99999999999999999999999632 2234666666553321 468899999999999999999999999
Q ss_pred HHHH
Q psy1840 183 VHHK 186 (423)
Q Consensus 183 I~~~ 186 (423)
+...
T Consensus 560 i~~h 563 (612)
T KOG0603|consen 560 IGAH 563 (612)
T ss_pred hccC
Confidence 8654
|
|
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.4e-24 Score=203.19 Aligned_cols=156 Identities=21% Similarity=0.355 Sum_probs=117.5
Q ss_pred HHHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCccEEEeccCCcccccCCCcccccccccCCccccCCcccc-CCC
Q psy1840 24 GSISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKAPELLR-QPH 102 (423)
Q Consensus 24 ~~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~-~~~ 102 (423)
....++.|++.||.|||+++++ |+||||+||+++.++.++|+|||.+.... ..........++..|+|||.+. +..
T Consensus 99 ~~~~~~~qi~~~L~~Lh~~~i~-H~dikp~NIl~~~~~~~~l~Dfg~~~~~~--~~~~~~~~~~~~~~y~aPE~~~~~~~ 175 (260)
T PF00069_consen 99 EILKIAYQILEALAYLHSKGIV-HRDIKPENILLDENGEVKLIDFGSSVKLS--ENNENFNPFVGTPEYMAPEVLQQGKK 175 (260)
T ss_dssp HHHHHHHHHHHHHHHHHHTTEE-ESSBSGGGEEESTTSEEEESSGTTTEEST--STTSEBSSSSSSGGGSCHHHHTTTSS
T ss_pred cccccccccccccccccccccc-ccccccccccccccccccccccccccccc--cccccccccccccccccccccccccc
Confidence 3689999999999999999998 99999999999999999999999986531 1122234556788899999988 444
Q ss_pred CCCCCCccchHHHHHHHHHHHhCCCCCCCCC-CChHHHHHHHhcCCCCCCCCCCCCchHHHHHHHHHhhhcCCCCCCCHH
Q psy1840 103 LPRGTQKGDVYSFGLVLYEVIGRQGPWGHLR-MTDEEIITSVTQGSGLRPDTSSLDCAPSIIACMRTCWEEDPELRPDLR 181 (423)
Q Consensus 103 ~~~~s~ksDVyS~Giil~elltg~~Pf~~~~-~~~~~i~~~i~~~~~~~p~~~~~~~~~~l~~Li~~C~~~dP~~RPt~~ 181 (423)
. +.++||||+|+++|+|++|..||.... .........................+..+.+++.+||+.||++||++.
T Consensus 176 ~---~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~ 252 (260)
T PF00069_consen 176 Y---TRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILKRPLPSSSQQSREKSEELRDLIKKMLSKDPEQRPSAE 252 (260)
T ss_dssp B---STHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHTHHHHHTTSHTTSHHHHHHHHHHHSSSSGGGSTTHH
T ss_pred c---cccccccccccccccccccccccccccchhhhhhhhhcccccccccccccchhHHHHHHHHHHHccCChhHCcCHH
Confidence 4 899999999999999999999997531 112222222222111111111112358999999999999999999999
Q ss_pred HHHH
Q psy1840 182 FVHH 185 (423)
Q Consensus 182 ~I~~ 185 (423)
++++
T Consensus 253 ~l~~ 256 (260)
T PF00069_consen 253 ELLK 256 (260)
T ss_dssp HHHT
T ss_pred HHhc
Confidence 9875
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=99.90 E-value=1e-23 Score=202.10 Aligned_cols=154 Identities=17% Similarity=0.283 Sum_probs=116.9
Q ss_pred HHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCccEEEeccCCcccccCCCcccccccccCCccccCCccccCCC--
Q psy1840 25 SISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKAPELLRQPH-- 102 (423)
Q Consensus 25 ~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~-- 102 (423)
...++.||+.|+.|||+.+++ ||||+|+||+++.++.++|+|||++........ ......++..|+|||.+....
T Consensus 123 ~~~~~~qi~~al~~LH~~~iv-H~dl~~~nili~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~l~~~~~~ 199 (282)
T cd06636 123 IAYICREILRGLAHLHAHKVI-HRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVG--RRNTFIGTPYWMAPEVIACDENP 199 (282)
T ss_pred HHHHHHHHHHHHHHHHHCCcc-cCCCCHHHEEECCCCCEEEeeCcchhhhhcccc--CCCcccccccccCHhhcCcccCc
Confidence 467889999999999999998 999999999999999999999999765432111 123356788899999886321
Q ss_pred CCCCCCccchHHHHHHHHHHHhCCCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCchHHHHHHHHHhhhcCCCCCCCHHH
Q psy1840 103 LPRGTQKGDVYSFGLVLYEVIGRQGPWGHLRMTDEEIITSVTQGSGLRPDTSSLDCAPSIIACMRTCWEEDPELRPDLRF 182 (423)
Q Consensus 103 ~~~~s~ksDVyS~Giil~elltg~~Pf~~~~~~~~~i~~~i~~~~~~~p~~~~~~~~~~l~~Li~~C~~~dP~~RPt~~~ 182 (423)
...++.++|||||||++|||++|..||.... ..+.+..+... ..+......++.++.++|.+||+.||.+||++.+
T Consensus 200 ~~~~~~~~DvwslG~~l~el~~g~~p~~~~~--~~~~~~~~~~~--~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~e 275 (282)
T cd06636 200 DATYDYRSDIWSLGITAIEMAEGAPPLCDMH--PMRALFLIPRN--PPPKLKSKKWSKKFIDFIEGCLVKNYLSRPSTEQ 275 (282)
T ss_pred CcCCCcccchhHHHHHHHHHHhCCCCccccC--HHhhhhhHhhC--CCCCCcccccCHHHHHHHHHHhCCChhhCcCHHH
Confidence 1234789999999999999999999996432 22222222221 1222233467899999999999999999999999
Q ss_pred HHH
Q psy1840 183 VHH 185 (423)
Q Consensus 183 I~~ 185 (423)
|++
T Consensus 276 ll~ 278 (282)
T cd06636 276 LLK 278 (282)
T ss_pred Hhc
Confidence 864
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.1e-23 Score=205.46 Aligned_cols=158 Identities=17% Similarity=0.224 Sum_probs=112.3
Q ss_pred HHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEE----cCCccEEEeccCCcccccCCCcc-cccccccCCccccCCcccc
Q psy1840 25 SISVNTTASVGMIHLHDSEIISHGNLRSSNCLI----DSRWVLQIADFGLHAFKAGQDET-GQERKLRRRKLYKAPELLR 99 (423)
Q Consensus 25 ~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILl----d~~~~vKL~DFGla~~~~~~~~~-~~~~~~~gt~~y~APE~l~ 99 (423)
..+++.||+.||.|||+.+++ ||||||+||++ +.++.+||+|||+++........ .......++..|+|||.+.
T Consensus 110 ~~~i~~qi~~aL~~lH~~~iv-H~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~ 188 (317)
T cd07867 110 VKSLLYQILDGIHYLHANWVL-HRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLL 188 (317)
T ss_pred HHHHHHHHHHHHHHHHhCCEE-cCCCCHHHEEEccCCCCCCcEEEeeccceeccCCCcccccccCcceecccccCcHHhc
Confidence 468999999999999999988 99999999999 56789999999998765432211 1223456788899999987
Q ss_pred CCCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCC--------hHHHHHHHh--------------cCCC--------C
Q psy1840 100 QPHLPRGTQKGDVYSFGLVLYEVIGRQGPWGHLRMT--------DEEIITSVT--------------QGSG--------L 149 (423)
Q Consensus 100 ~~~~~~~s~ksDVyS~Giil~elltg~~Pf~~~~~~--------~~~i~~~i~--------------~~~~--------~ 149 (423)
+.. .++.++|||||||++|||++|..||...... ...+..... .... .
T Consensus 189 ~~~--~~~~~~DiwSlG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (317)
T cd07867 189 GAR--HYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDRIFSVMGFPADKDWEDIRKMPEYPTLQKDFR 266 (317)
T ss_pred CCC--ccCcHHHHHhHHHHHHHHHhCCCCcccccccccccccccHHHHHHHHHhcCCCChhhhhhhhhcccchhhhhhhc
Confidence 643 2388999999999999999999999642211 011110000 0000 0
Q ss_pred CC-----------CCCCCCchHHHHHHHHHhhhcCCCCCCCHHHHHH
Q psy1840 150 RP-----------DTSSLDCAPSIIACMRTCWEEDPELRPDLRFVHH 185 (423)
Q Consensus 150 ~p-----------~~~~~~~~~~l~~Li~~C~~~dP~~RPt~~~I~~ 185 (423)
.. .......+..+.+|+.+|++.||.+|||+.++++
T Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~e~l~ 313 (317)
T cd07867 267 RTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTMDPTKRITSEQALQ 313 (317)
T ss_pred ccccCCchhhhhhhcccCCCChHHHHHHHHHhccCcccccCHHHHhc
Confidence 00 0001123456888999999999999999999875
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.1e-23 Score=211.38 Aligned_cols=156 Identities=21% Similarity=0.244 Sum_probs=115.0
Q ss_pred HHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCccEEEeccCCcccccCCCc-------------------------
Q psy1840 25 SISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDE------------------------- 79 (423)
Q Consensus 25 ~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~------------------------- 79 (423)
...++.||+.||.|||+.|++ ||||||+|||++.++++||+|||++........
T Consensus 103 ~~~~~~qi~~aL~~LH~~giv-HrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 181 (381)
T cd05626 103 ARFYIAELTLAIESVHKMGFI-HRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVS 181 (381)
T ss_pred HHHHHHHHHHHHHHHHhCCee-ecCCcHHHEEECCCCCEEEeeCcCCcccccccccccccccccccccccCccccccccc
Confidence 456788999999999999998 999999999999999999999999753210000
Q ss_pred --------------------ccccccccCCccccCCccccCCCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCChHHH
Q psy1840 80 --------------------TGQERKLRRRKLYKAPELLRQPHLPRGTQKGDVYSFGLVLYEVIGRQGPWGHLRMTDEEI 139 (423)
Q Consensus 80 --------------------~~~~~~~~gt~~y~APE~l~~~~~~~~s~ksDVyS~Giil~elltg~~Pf~~~~~~~~~i 139 (423)
........||+.|+|||.+.+..+ +.++|||||||++|||++|..||... +..+.
T Consensus 182 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~---~~~~DiwSlG~il~elltG~~Pf~~~--~~~~~ 256 (381)
T cd05626 182 NCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGY---TQLCDWWSVGVILFEMLVGQPPFLAP--TPTET 256 (381)
T ss_pred ccccccccchhhccccccccccccccccCCccccCHHHHcCCCC---CCccceeehhhHHHHHHhCCCCCcCC--CHHHH
Confidence 000123468999999999987654 88999999999999999999999743 23333
Q ss_pred HHHHhcCCCCCCCCCCCCchHHHHHHHHH--hhhcCCCCCCCHHHHHHH
Q psy1840 140 ITSVTQGSGLRPDTSSLDCAPSIIACMRT--CWEEDPELRPDLRFVHHK 186 (423)
Q Consensus 140 ~~~i~~~~~~~p~~~~~~~~~~l~~Li~~--C~~~dP~~RPt~~~I~~~ 186 (423)
...+..............+++++.+++.+ |+..+|..||++.+++..
T Consensus 257 ~~~i~~~~~~~~~~~~~~~s~~~~dli~~ll~~~~~~~~R~~~~~~l~h 305 (381)
T cd05626 257 QLKVINWENTLHIPPQVKLSPEAVDLITKLCCSAEERLGRNGADDIKAH 305 (381)
T ss_pred HHHHHccccccCCCCCCCCCHHHHHHHHHHccCcccccCCCCHHHHhcC
Confidence 33333221111111123578899999988 556677779999998764
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.1e-23 Score=200.85 Aligned_cols=152 Identities=16% Similarity=0.291 Sum_probs=119.9
Q ss_pred HHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCccEEEeccCCcccccCCCcccccccccCCccccCCccccCCCCC
Q psy1840 25 SISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKAPELLRQPHLP 104 (423)
Q Consensus 25 ~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~ 104 (423)
...++.|++.||.|||+.|++ ||||+|+||+++.++.++|+|||++........ ......++..|+|||.+.+..+
T Consensus 117 ~~~~~~ql~~~l~~lH~~~i~-H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~- 192 (285)
T cd06648 117 IATVCLAVLKALSFLHAQGVI-HRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVP--RRKSLVGTPYWMAPEVISRLPY- 192 (285)
T ss_pred HHHHHHHHHHHHHHHHhCCee-cCCCChhhEEEcCCCcEEEcccccchhhccCCc--ccccccCCccccCHHHhcCCCC-
Confidence 578999999999999999998 999999999999999999999998765432211 1233457888999999877654
Q ss_pred CCCCccchHHHHHHHHHHHhCCCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCchHHHHHHHHHhhhcCCCCCCCHHHHH
Q psy1840 105 RGTQKGDVYSFGLVLYEVIGRQGPWGHLRMTDEEIITSVTQGSGLRPDTSSLDCAPSIIACMRTCWEEDPELRPDLRFVH 184 (423)
Q Consensus 105 ~~s~ksDVyS~Giil~elltg~~Pf~~~~~~~~~i~~~i~~~~~~~p~~~~~~~~~~l~~Li~~C~~~dP~~RPt~~~I~ 184 (423)
+.++||||||+++||+++|+.||.. ....+....+......... ....++..+.+++.+||+.+|++||++.+++
T Consensus 193 --~~~~Dv~slGv~l~ell~g~~p~~~--~~~~~~~~~~~~~~~~~~~-~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il 267 (285)
T cd06648 193 --GTEVDIWSLGIMVIEMVDGEPPYFN--EPPLQAMKRIRDNLPPKLK-NLHKVSPRLRSFLDRMLVRDPAQRATAAELL 267 (285)
T ss_pred --CCcccHHHHHHHHHHHHhCCCCCcC--CCHHHHHHHHHhcCCCCCc-ccccCCHHHHHHHHHHcccChhhCcCHHHHc
Confidence 8899999999999999999999864 2334445555544221111 1223778999999999999999999999987
Q ss_pred H
Q psy1840 185 H 185 (423)
Q Consensus 185 ~ 185 (423)
+
T Consensus 268 ~ 268 (285)
T cd06648 268 N 268 (285)
T ss_pred c
Confidence 5
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.5e-23 Score=197.14 Aligned_cols=147 Identities=20% Similarity=0.361 Sum_probs=111.3
Q ss_pred HHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCcc--------EEEeccCCcccccCCCcccccccccCCccccCCc
Q psy1840 25 SISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWV--------LQIADFGLHAFKAGQDETGQERKLRRRKLYKAPE 96 (423)
Q Consensus 25 ~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~~--------vKL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE 96 (423)
.+.++.||+.||+|||+.|++ ||||||+||+++.++. +|++|||++...... ....++..|+|||
T Consensus 102 ~~~~~~qi~~~l~~lH~~~ii-H~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~~~~~~------~~~~~~~~y~aPE 174 (258)
T cd05078 102 KLEVAKQLAWALHFLEDKGLT-HGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVLPK------EILLERIPWVPPE 174 (258)
T ss_pred HHHHHHHHHHHHHHHHHCCee-cCCCccceEEEecccccccCCCceEEecccccccccCCc------hhccccCCccCch
Confidence 678999999999999999998 9999999999987664 699999987543211 2345677899999
Q ss_pred cccCCCCCCCCCccchHHHHHHHHHHHhCC-CCCCCCCCChHHHHHHHhcCCCCCCCCCCCCchHHHHHHHHHhhhcCCC
Q psy1840 97 LLRQPHLPRGTQKGDVYSFGLVLYEVIGRQ-GPWGHLRMTDEEIITSVTQGSGLRPDTSSLDCAPSIIACMRTCWEEDPE 175 (423)
Q Consensus 97 ~l~~~~~~~~s~ksDVyS~Giil~elltg~-~Pf~~~~~~~~~i~~~i~~~~~~~p~~~~~~~~~~l~~Li~~C~~~dP~ 175 (423)
.+.+.. ..+.++||||||+++||+++|. .||... +.......... ....| ...+.++.+++.+||+.+|+
T Consensus 175 ~~~~~~--~~~~~~DiwslG~~l~~l~~g~~~~~~~~--~~~~~~~~~~~-~~~~~----~~~~~~~~~li~~~l~~~p~ 245 (258)
T cd05078 175 CIENPQ--NLSLAADKWSFGTTLWEIFSGGDKPLSAL--DSQKKLQFYED-RHQLP----APKWTELANLINQCMDYEPD 245 (258)
T ss_pred hccCCC--CCCchhhHHHHHHHHHHHHcCCCCChhhc--cHHHHHHHHHc-cccCC----CCCcHHHHHHHHHHhccChh
Confidence 997643 2378999999999999999985 565432 22222222221 11111 23457899999999999999
Q ss_pred CCCCHHHHHHHH
Q psy1840 176 LRPDLRFVHHKL 187 (423)
Q Consensus 176 ~RPt~~~I~~~L 187 (423)
+|||+.+|++.|
T Consensus 246 ~Rps~~~il~~l 257 (258)
T cd05078 246 FRPSFRAIIRDL 257 (258)
T ss_pred hCCCHHHHHHhc
Confidence 999999998875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.6e-23 Score=200.33 Aligned_cols=156 Identities=19% Similarity=0.261 Sum_probs=118.2
Q ss_pred HHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCccEEEeccCCcccccCCCcccccccccCCccccCCccccCCCC-
Q psy1840 25 SISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKAPELLRQPHL- 103 (423)
Q Consensus 25 ~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~- 103 (423)
...++.|++.||.|||+.+++ ||||||+||+++.++.+||+|||++......... .....++..|+|||.+.....
T Consensus 130 ~~~~~~qi~~al~~lH~~~iv-H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~ 206 (291)
T cd06639 130 ISYILYGALLGLQHLHNNRII-HRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLR--RNTSVGTPFWMAPEVIACEQQY 206 (291)
T ss_pred HHHHHHHHHHHHHHHHhCCee-ccCCCHHHEEEcCCCCEEEeecccchhccccccc--ccCccCCccccChhhhcCCCCc
Confidence 568999999999999999998 9999999999999999999999998754322211 123457788999999865321
Q ss_pred -CCCCCccchHHHHHHHHHHHhCCCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCchHHHHHHHHHhhhcCCCCCCCHHH
Q psy1840 104 -PRGTQKGDVYSFGLVLYEVIGRQGPWGHLRMTDEEIITSVTQGSGLRPDTSSLDCAPSIIACMRTCWEEDPELRPDLRF 182 (423)
Q Consensus 104 -~~~s~ksDVyS~Giil~elltg~~Pf~~~~~~~~~i~~~i~~~~~~~p~~~~~~~~~~l~~Li~~C~~~dP~~RPt~~~ 182 (423)
...+.++|||||||++|||++|+.||... ...+.+..+......... .....+..+.+++.+||+.+|++||++.+
T Consensus 207 ~~~~~~~~Di~slGvi~~el~~g~~p~~~~--~~~~~~~~~~~~~~~~~~-~~~~~~~~l~~li~~~l~~~p~~Rps~~~ 283 (291)
T cd06639 207 DYSYDARCDVWSLGITAIELGDGDPPLFDM--HPVKTLFKIPRNPPPTLL-HPEKWCRSFNHFISQCLIKDFEARPSVTH 283 (291)
T ss_pred ccccCCccchHHHHHHHHHHhhCCCCCCCC--cHHHHHHHHhcCCCCCCC-cccccCHHHHHHHHHHhhcChhhCcCHHH
Confidence 12478999999999999999999999642 333333344333221111 12346678999999999999999999999
Q ss_pred HHHH
Q psy1840 183 VHHK 186 (423)
Q Consensus 183 I~~~ 186 (423)
+++.
T Consensus 284 il~~ 287 (291)
T cd06639 284 LLEH 287 (291)
T ss_pred HhcC
Confidence 8753
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=99.90 E-value=9.9e-24 Score=203.25 Aligned_cols=152 Identities=22% Similarity=0.340 Sum_probs=116.7
Q ss_pred HHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCccEEEeccCCcccccCCCcccccccccCCccccCCccccCCCCC
Q psy1840 25 SISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKAPELLRQPHLP 104 (423)
Q Consensus 25 ~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~ 104 (423)
.+.++.|++.||.|||+.+++ ||||||+||+++.++.++|+|||++........ .....|+..|+|||.+.+..+
T Consensus 104 ~~~~~~qi~~~l~~lH~~~ii-H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~---~~~~~g~~~y~aPE~~~~~~~- 178 (285)
T cd05630 104 AVFYAAEICCGLEDLHQERIV-YRDLKPENILLDDHGHIRISDLGLAVHVPEGQT---IKGRVGTVGYMAPEVVKNERY- 178 (285)
T ss_pred HHHHHHHHHHHHHHHHhCCEE-eCCCCHHHEEECCCCCEEEeeccceeecCCCcc---ccCCCCCccccChHHHcCCCC-
Confidence 578899999999999999998 999999999999999999999999865432211 123467889999999987654
Q ss_pred CCCCccchHHHHHHHHHHHhCCCCCCCCCCC-hHHHHHHHhcCCCCCCCCCCCCchHHHHHHHHHhhhcCCCCCCC----
Q psy1840 105 RGTQKGDVYSFGLVLYEVIGRQGPWGHLRMT-DEEIITSVTQGSGLRPDTSSLDCAPSIIACMRTCWEEDPELRPD---- 179 (423)
Q Consensus 105 ~~s~ksDVyS~Giil~elltg~~Pf~~~~~~-~~~i~~~i~~~~~~~p~~~~~~~~~~l~~Li~~C~~~dP~~RPt---- 179 (423)
+.++||||||+++|+|++|..||...... ..+......... +......+++++.+++.+||+.||++|||
T Consensus 179 --~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~ 253 (285)
T cd05630 179 --TFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEV---QEEYSEKFSPDARSLCKMLLCKDPKERLGCQGG 253 (285)
T ss_pred --CCccccHHHHHHHHHHHhCCCCCCCCCccchHHHHHhhhhhh---hhhcCccCCHHHHHHHHHHhhcCHHHccCCCCC
Confidence 88999999999999999999999753221 112222221111 11122357889999999999999999999
Q ss_pred -HHHHHHH
Q psy1840 180 -LRFVHHK 186 (423)
Q Consensus 180 -~~~I~~~ 186 (423)
+.++++.
T Consensus 254 ~~~~~~~h 261 (285)
T cd05630 254 GAREVKEH 261 (285)
T ss_pred chHHHHcC
Confidence 7777653
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.6e-23 Score=205.06 Aligned_cols=152 Identities=22% Similarity=0.318 Sum_probs=113.9
Q ss_pred HHHHHHHHHHHHHHHHhC-CCeeecCCCCCCEEEcCCccEEEeccCCcccccCCCcccccccccCCccccCCccccCCCC
Q psy1840 25 SISVNTTASVGMIHLHDS-EIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKAPELLRQPHL 103 (423)
Q Consensus 25 ~l~i~~qi~~gL~yLH~~-~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~ 103 (423)
...++.|++.||.|||+. +++ ||||||+||+++.++.+||+|||++....... .....++..|+|||.+.+..+
T Consensus 105 ~~~~~~~l~~~l~~lH~~~~iv-H~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~ 179 (333)
T cd06650 105 LGKVSIAVIKGLTYLREKHKIM-HRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM----ANSFVGTRSYMSPERLQGTHY 179 (333)
T ss_pred HHHHHHHHHHHHHHHHhcCCEE-ecCCChhhEEEcCCCCEEEeeCCcchhhhhhc----cccCCCCccccCHHHhcCCCC
Confidence 468999999999999986 566 99999999999999999999999986543221 123467889999999987654
Q ss_pred CCCCCccchHHHHHHHHHHHhCCCCCCCCCCChHHHHHHHh---c-----------------------------------
Q psy1840 104 PRGTQKGDVYSFGLVLYEVIGRQGPWGHLRMTDEEIITSVT---Q----------------------------------- 145 (423)
Q Consensus 104 ~~~s~ksDVyS~Giil~elltg~~Pf~~~~~~~~~i~~~i~---~----------------------------------- 145 (423)
+.++|||||||++||+++|+.||..... .++...+. .
T Consensus 180 ---~~~~DvwslG~il~~l~~g~~p~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (333)
T cd06650 180 ---SVQSDIWSMGLSLVEMAIGRYPIPPPDA--KELELMFGCPVEGDPAESETSPRPRPPGRPLSSYGPDSRPPMAIFEL 254 (333)
T ss_pred ---CcHHHHHHHHHHHHHHHHCCCCCCCcch--hHHHHHhcCcccCCccccccCcccCCccchhhhhcccccccccHHHH
Confidence 8899999999999999999999964221 11111110 0
Q ss_pred ----CCCCCCCCCCCCchHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q psy1840 146 ----GSGLRPDTSSLDCAPSIIACMRTCWEEDPELRPDLRFVHHK 186 (423)
Q Consensus 146 ----~~~~~p~~~~~~~~~~l~~Li~~C~~~dP~~RPt~~~I~~~ 186 (423)
.....|.......+.++.+++.+||+.||++|||+.+++..
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~h 299 (333)
T cd06650 255 LDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMVH 299 (333)
T ss_pred HHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhhC
Confidence 00011111122356789999999999999999999999754
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.4e-23 Score=202.27 Aligned_cols=157 Identities=19% Similarity=0.225 Sum_probs=120.4
Q ss_pred HHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCccEEEeccCCcccccCCCc-------------ccccccccCCcc
Q psy1840 25 SISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDE-------------TGQERKLRRRKL 91 (423)
Q Consensus 25 ~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~-------------~~~~~~~~gt~~ 91 (423)
...++.|++.||.|||+.+++ ||||||+||+++.++.+||+|||+++....... ........++..
T Consensus 103 ~~~~~~~i~~~l~~lH~~~i~-H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 181 (305)
T cd05609 103 ARMYFAETVLALEYLHNYGIV-HRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQVCGTPE 181 (305)
T ss_pred HHHHHHHHHHHHHHHHHCCcc-ccCCchHHEEECCCCCEEEeeCCCccccCcCccccccccccccchhhccccCCccCcc
Confidence 467889999999999999998 999999999999999999999998764211100 000112346778
Q ss_pred ccCCccccCCCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCchHHHHHHHHHhhh
Q psy1840 92 YKAPELLRQPHLPRGTQKGDVYSFGLVLYEVIGRQGPWGHLRMTDEEIITSVTQGSGLRPDTSSLDCAPSIIACMRTCWE 171 (423)
Q Consensus 92 y~APE~l~~~~~~~~s~ksDVyS~Giil~elltg~~Pf~~~~~~~~~i~~~i~~~~~~~p~~~~~~~~~~l~~Li~~C~~ 171 (423)
|+|||.+.+... +.++|+||||+++||+++|..||.+ ....++......+....|.... .++.++.+++.+||+
T Consensus 182 y~aPE~~~~~~~---~~~~Di~slG~vl~el~~g~~pf~~--~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~li~~~l~ 255 (305)
T cd05609 182 YIAPEVILRQGY---GKPVDWWAMGIILYEFLVGCVPFFG--DTPEELFGQVISDDIEWPEGDE-ALPADAQDLISRLLR 255 (305)
T ss_pred ccCchhccCCCC---CchhhHHHHHHHHHHHHhCCCCCCC--CCHHHHHHHHHhcccCCCCccc-cCCHHHHHHHHHHhc
Confidence 999999876554 8999999999999999999999964 3456666666554433333322 578899999999999
Q ss_pred cCCCCCCCHHHHHHHHH
Q psy1840 172 EDPELRPDLRFVHHKLK 188 (423)
Q Consensus 172 ~dP~~RPt~~~I~~~L~ 188 (423)
.+|++||++.++.+.++
T Consensus 256 ~~P~~R~~~~~~~~ll~ 272 (305)
T cd05609 256 QNPLERLGTGGAFEVKQ 272 (305)
T ss_pred cChhhccCccCHHHHHh
Confidence 99999999765555443
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.6e-23 Score=200.84 Aligned_cols=155 Identities=16% Similarity=0.120 Sum_probs=114.1
Q ss_pred HHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCccEEEeccCCcccccCCCcccccccccCCccccCCccccCCCCC
Q psy1840 25 SISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKAPELLRQPHLP 104 (423)
Q Consensus 25 ~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~ 104 (423)
...++.||+.||.|||+.+++ ||||||+||+++.++.+||+|||++........ ......++..|+|||.+.+..
T Consensus 101 ~~~~~~qi~~al~~LH~~~i~-H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~-- 175 (284)
T cd07839 101 VKSFMFQLLKGLAFCHSHNVL-HRDLKPQNLLINKNGELKLADFGLARAFGIPVR--CYSAEVVTLWYRPPDVLFGAK-- 175 (284)
T ss_pred HHHHHHHHHHHHHHHHHCCEe-cCCCCHHHEEEcCCCcEEECccchhhccCCCCC--CcCCCccccCCcChHHHhCCc--
Confidence 579999999999999999988 999999999999999999999999875432211 112345678899999987643
Q ss_pred CCCCccchHHHHHHHHHHHhCCCCCCCCCCChHHHHHHHhcC---------------C--CCCCCC--------CCCCch
Q psy1840 105 RGTQKGDVYSFGLVLYEVIGRQGPWGHLRMTDEEIITSVTQG---------------S--GLRPDT--------SSLDCA 159 (423)
Q Consensus 105 ~~s~ksDVyS~Giil~elltg~~Pf~~~~~~~~~i~~~i~~~---------------~--~~~p~~--------~~~~~~ 159 (423)
..+.++|||||||++|||++|..|+.... +..+....+... . ...+.. ....++
T Consensus 176 ~~~~~~DiwslG~il~~l~tg~~p~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (284)
T cd07839 176 LYSTSIDMWSAGCIFAELANAGRPLFPGN-DVDDQLKRIFRLLGTPTEESWPGVSKLPDYKPYPMYPATTSLVNVVPKLN 254 (284)
T ss_pred ccCcHHHHHHHHHHHHHHHhcCCCCcCCC-CHHHHHHHHHHHhCCCChHHhHHhhhcccccccCCCCCcchhhhhcccCC
Confidence 23789999999999999999998864322 222222222110 0 000000 012467
Q ss_pred HHHHHHHHHhhhcCCCCCCCHHHHHH
Q psy1840 160 PSIIACMRTCWEEDPELRPDLRFVHH 185 (423)
Q Consensus 160 ~~l~~Li~~C~~~dP~~RPt~~~I~~ 185 (423)
+++.+++++||+.||.+|||+.+++.
T Consensus 255 ~~~~~li~~~l~~~P~~R~t~~~il~ 280 (284)
T cd07839 255 STGRDLLQNLLVCNPVQRISAEEALQ 280 (284)
T ss_pred HHHHHHHHHHhcCChhhcCCHHHHhc
Confidence 88999999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=99.90 E-value=9.2e-24 Score=200.15 Aligned_cols=152 Identities=23% Similarity=0.365 Sum_probs=118.7
Q ss_pred HHHHHHHHHHHHHHHHh-CCCeeecCCCCCCEEEcCCccEEEeccCCcccccCCCcccccccccCCccccCCccccCCCC
Q psy1840 25 SISVNTTASVGMIHLHD-SEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKAPELLRQPHL 103 (423)
Q Consensus 25 ~l~i~~qi~~gL~yLH~-~~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~ 103 (423)
...++.|++.|++|||+ .+++ ||||||+||+++.++.+||+|||.+........ ....++..|+|||.+.+..+
T Consensus 102 ~~~~~~~l~~~l~~lH~~~~i~-H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~~----~~~~~~~~y~~PE~~~~~~~ 176 (265)
T cd06605 102 LGKIAVAVLKGLTYLHEKHKII-HRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLA----KTFVGTSSYMAPERIQGNDY 176 (265)
T ss_pred HHHHHHHHHHHHHHHcCCCCee-cCCCCHHHEEECCCCCEEEeecccchhhHHHHh----hcccCChhccCHHHHcCCCC
Confidence 46899999999999999 8987 999999999999999999999999765432111 12567788999999877654
Q ss_pred CCCCCccchHHHHHHHHHHHhCCCCCCCCC---CChHHHHHHHhcCCCCCCCCCCCCchHHHHHHHHHhhhcCCCCCCCH
Q psy1840 104 PRGTQKGDVYSFGLVLYEVIGRQGPWGHLR---MTDEEIITSVTQGSGLRPDTSSLDCAPSIIACMRTCWEEDPELRPDL 180 (423)
Q Consensus 104 ~~~s~ksDVyS~Giil~elltg~~Pf~~~~---~~~~~i~~~i~~~~~~~p~~~~~~~~~~l~~Li~~C~~~dP~~RPt~ 180 (423)
+.++||||||+++|++++|..||.... ....+....+... ..+..+...++.++.++|.+||..+|++|||+
T Consensus 177 ---~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~ 251 (265)
T cd06605 177 ---SVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNE--PPPRLPSGKFSPDFQDFVNLCLIKDPRERPSY 251 (265)
T ss_pred ---CchhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHHHhcC--CCCCCChhhcCHHHHHHHHHHcCCCchhCcCH
Confidence 899999999999999999999996432 1222333333332 22233332378899999999999999999999
Q ss_pred HHHHHH
Q psy1840 181 RFVHHK 186 (423)
Q Consensus 181 ~~I~~~ 186 (423)
.+++..
T Consensus 252 ~~ll~~ 257 (265)
T cd06605 252 KELLEH 257 (265)
T ss_pred HHHhhC
Confidence 998753
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >KOG0577|consensus | Back alignment and domain information |
|---|
Probab=99.90 E-value=9.5e-24 Score=209.94 Aligned_cols=151 Identities=21% Similarity=0.324 Sum_probs=127.1
Q ss_pred HHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCccEEEeccCCcccccCCCcccccccccCCccccCCccccCCCCC
Q psy1840 25 SISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKAPELLRQPHLP 104 (423)
Q Consensus 25 ~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~ 104 (423)
...|+.+.+.||.|||+.+.| |||||..|||++..|.|||+|||.+...... .++.||+.|||||++..-.-.
T Consensus 128 IAAi~~gaL~gLaYLHS~~~I-HRDiKAGNILLse~g~VKLaDFGSAsi~~PA------nsFvGTPywMAPEVILAMDEG 200 (948)
T KOG0577|consen 128 IAAITHGALQGLAYLHSHNRI-HRDIKAGNILLSEPGLVKLADFGSASIMAPA------NSFVGTPYWMAPEVILAMDEG 200 (948)
T ss_pred HHHHHHHHHHHHHHHHHhhHH-hhhccccceEecCCCeeeeccccchhhcCch------hcccCCccccchhHheecccc
Confidence 468899999999999999999 9999999999999999999999987765332 568999999999999754433
Q ss_pred CCCCccchHHHHHHHHHHHhCCCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCchHHHHHHHHHhhhcCCCCCCCHHHHH
Q psy1840 105 RGTQKGDVYSFGLVLYEVIGRQGPWGHLRMTDEEIITSVTQGSGLRPDTSSLDCAPSIIACMRTCWEEDPELRPDLRFVH 184 (423)
Q Consensus 105 ~~s~ksDVyS~Giil~elltg~~Pf~~~~~~~~~i~~~i~~~~~~~p~~~~~~~~~~l~~Li~~C~~~dP~~RPt~~~I~ 184 (423)
.++-++||||+||++.|+.-+++|+. .|+.-..+..|.+.. .|......++..+.+++..|++.-|.+|||..+++
T Consensus 201 qYdgkvDvWSLGITCIELAERkPPlF--nMNAMSALYHIAQNe--sPtLqs~eWS~~F~~Fvd~CLqKipqeRptse~ll 276 (948)
T KOG0577|consen 201 QYDGKVDVWSLGITCIELAERKPPLF--NMNAMSALYHIAQNE--SPTLQSNEWSDYFRNFVDSCLQKIPQERPTSEELL 276 (948)
T ss_pred ccCCccceeeccchhhhhhhcCCCcc--CchHHHHHHHHHhcC--CCCCCCchhHHHHHHHHHHHHhhCcccCCcHHHHh
Confidence 45899999999999999999999975 455555566666543 34555567899999999999999999999999887
Q ss_pred HH
Q psy1840 185 HK 186 (423)
Q Consensus 185 ~~ 186 (423)
..
T Consensus 277 ~H 278 (948)
T KOG0577|consen 277 KH 278 (948)
T ss_pred hc
Confidence 64
|
|
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.90 E-value=2e-23 Score=216.93 Aligned_cols=157 Identities=17% Similarity=0.202 Sum_probs=115.5
Q ss_pred HHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCccEEEeccCCcccccCCCcccccccccCCccccCCccccCCCCC
Q psy1840 25 SISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKAPELLRQPHLP 104 (423)
Q Consensus 25 ~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~ 104 (423)
...++.||+.||.|||++|++ ||||||+|||++.++.+||+|||+++........ ......|+..|+|||++.+..+
T Consensus 269 ~~~i~~ql~~aL~yLH~~gIi-HrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~- 345 (501)
T PHA03210 269 TRAIMKQLLCAVEYIHDKKLI-HRDIKLENIFLNCDGKIVLGDFGTAMPFEKEREA-FDYGWVGTVATNSPEILAGDGY- 345 (501)
T ss_pred HHHHHHHHHHHHHHHHhCCee-cCCCCHHHEEECCCCCEEEEeCCCceecCccccc-ccccccCCcCCCCchhhcCCCC-
Confidence 457999999999999999998 9999999999999999999999998765432221 1234568999999999987655
Q ss_pred CCCCccchHHHHHHHHHHHhCCC-CCCCCCCCh-HHHHHHHhcCC---CCCC------------------------CCCC
Q psy1840 105 RGTQKGDVYSFGLVLYEVIGRQG-PWGHLRMTD-EEIITSVTQGS---GLRP------------------------DTSS 155 (423)
Q Consensus 105 ~~s~ksDVyS~Giil~elltg~~-Pf~~~~~~~-~~i~~~i~~~~---~~~p------------------------~~~~ 155 (423)
+.++|||||||++|||++|.. |+....... .++...+.... ...| ....
T Consensus 346 --~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 423 (501)
T PHA03210 346 --CEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQLLKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRN 423 (501)
T ss_pred --CcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHHHHHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHh
Confidence 899999999999999999875 444322222 22222221100 0000 0011
Q ss_pred CCchHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q psy1840 156 LDCAPSIIACMRTCWEEDPELRPDLRFVHHK 186 (423)
Q Consensus 156 ~~~~~~l~~Li~~C~~~dP~~RPt~~~I~~~ 186 (423)
...+..+.+++.+|++.||.+|||+.+++..
T Consensus 424 ~~~~~~~~~li~kmL~~DP~~Rpsa~elL~h 454 (501)
T PHA03210 424 LGLPADFEYPLVKMLTFDWHLRPGAAELLAL 454 (501)
T ss_pred cCCChHHHHHHHHHhccCcccCcCHHHHhhC
Confidence 2355678888999999999999999999864
|
|
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.4e-23 Score=210.02 Aligned_cols=158 Identities=17% Similarity=0.189 Sum_probs=119.0
Q ss_pred HHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCccEEEeccCCcccccCCCcccccccccCCccccCCccccCCC-C
Q psy1840 25 SISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKAPELLRQPH-L 103 (423)
Q Consensus 25 ~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~-~ 103 (423)
...++.||+.||.|||++|++ ||||||+||+++.++.+||+|||++........ .......||+.|+|||++.+.. .
T Consensus 144 ~~~~~~qi~~aL~~LH~~~iv-HrDLkp~NIll~~~~~ikL~DfG~a~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~ 221 (371)
T cd05622 144 ARFYTAEVVLALDAIHSMGFI-HRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGM-VRCDTAVGTPDYISPEVLKSQGGD 221 (371)
T ss_pred HHHHHHHHHHHHHHHHHCCEE-eCCCCHHHEEECCCCCEEEEeCCceeEcCcCCc-ccccCcccCccccCHHHHhccCCC
Confidence 467889999999999999998 999999999999999999999999876532211 1223457899999999987543 1
Q ss_pred CCCCCccchHHHHHHHHHHHhCCCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCchHHHHHHHHHhhhcCCCC---CCCH
Q psy1840 104 PRGTQKGDVYSFGLVLYEVIGRQGPWGHLRMTDEEIITSVTQGSGLRPDTSSLDCAPSIIACMRTCWEEDPEL---RPDL 180 (423)
Q Consensus 104 ~~~s~ksDVyS~Giil~elltg~~Pf~~~~~~~~~i~~~i~~~~~~~p~~~~~~~~~~l~~Li~~C~~~dP~~---RPt~ 180 (423)
..++.++|||||||++|||++|..||.. .+.......+.......+......++..+.+++..|+. +|.. ||++
T Consensus 222 ~~~~~~~DiwSlGvilyell~G~~Pf~~--~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~-~~~~r~~r~~~ 298 (371)
T cd05622 222 GYYGRECDWWSVGVFLYEMLVGDTPFYA--DSLVGTYSKIMNHKNSLTFPDDNDISKEAKNLICAFLT-DREVRLGRNGV 298 (371)
T ss_pred ccCCCccceeehhHHHHHHHhCCCCCCC--CCHHHHHHHHHcCCCcccCCCcCCCCHHHHHHHHHHcC-ChhhhcCCCCH
Confidence 1247899999999999999999999974 33445555555433221111223578999999999998 4444 6788
Q ss_pred HHHHHHH
Q psy1840 181 RFVHHKL 187 (423)
Q Consensus 181 ~~I~~~L 187 (423)
.+|++..
T Consensus 299 ~ei~~h~ 305 (371)
T cd05622 299 EEIKRHL 305 (371)
T ss_pred HHHhcCc
Confidence 8887643
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=99.90 E-value=3.1e-23 Score=197.90 Aligned_cols=155 Identities=25% Similarity=0.470 Sum_probs=122.2
Q ss_pred HHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCccEEEeccCCcccccCCCcccccccccCCccccCCccccCCCCC
Q psy1840 25 SISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKAPELLRQPHLP 104 (423)
Q Consensus 25 ~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~ 104 (423)
+..++.|++.||.|||+.+++ ||||||+||+++.++.++++|||++........ .......++..|+|||.+.+...
T Consensus 119 ~~~~~~~l~~~l~~LH~~~i~-H~dlkp~Nili~~~~~~~l~~~~~~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~- 195 (275)
T cd05046 119 KVALCTQIALGMDHLSNARFV-HRDLAARNCLVSSQREVKVSLLSLSKDVYNSEY-YKLRNALIPLRWLAPEAVQEDDF- 195 (275)
T ss_pred HHHHHHHHHHHHHHhhhcCcc-cCcCccceEEEeCCCcEEEcccccccccCcccc-cccCCceeEEeecChhhhccCCC-
Confidence 688999999999999999988 999999999999999999999999765432211 11123345667999999876654
Q ss_pred CCCCccchHHHHHHHHHHHh-CCCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCchHHHHHHHHHhhhcCCCCCCCHHHH
Q psy1840 105 RGTQKGDVYSFGLVLYEVIG-RQGPWGHLRMTDEEIITSVTQGSGLRPDTSSLDCAPSIIACMRTCWEEDPELRPDLRFV 183 (423)
Q Consensus 105 ~~s~ksDVyS~Giil~ellt-g~~Pf~~~~~~~~~i~~~i~~~~~~~p~~~~~~~~~~l~~Li~~C~~~dP~~RPt~~~I 183 (423)
+.++||||||+++|++++ |..||.. .....+...+..+....+ ....++..+.+++.+||+.+|++||++.++
T Consensus 196 --~~~~Di~slG~~l~~l~~~~~~p~~~--~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~ 269 (275)
T cd05046 196 --STKSDVWSFGVLMWEVFTQGELPFYG--LSDEEVLNRLQAGKLELP--VPEGCPSRLYKLMTRCWAVNPKDRPSFSEL 269 (275)
T ss_pred --CchhhHHHHHHHHHHHHhCCCCCccc--cchHHHHHHHHcCCcCCC--CCCCCCHHHHHHHHHHcCCCcccCCCHHHH
Confidence 789999999999999998 7788863 344555666554432222 123578999999999999999999999999
Q ss_pred HHHHH
Q psy1840 184 HHKLK 188 (423)
Q Consensus 184 ~~~L~ 188 (423)
+..|.
T Consensus 270 l~~l~ 274 (275)
T cd05046 270 VSALG 274 (275)
T ss_pred HHHhc
Confidence 88764
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >KOG1989|consensus | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.2e-23 Score=219.04 Aligned_cols=161 Identities=19% Similarity=0.285 Sum_probs=128.7
Q ss_pred HHHHHHHHHHHHHHHHhCC--CeeecCCCCCCEEEcCCccEEEeccCCcccccCCCccc-------ccccccCCccccCC
Q psy1840 25 SISVNTTASVGMIHLHDSE--IISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETG-------QERKLRRRKLYKAP 95 (423)
Q Consensus 25 ~l~i~~qi~~gL~yLH~~~--ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~~~-------~~~~~~gt~~y~AP 95 (423)
.++|+.|+++|+.+||..+ +| |||||-+||||+.++..||||||-+.-........ ..-....|+.|.||
T Consensus 146 VLkIf~dv~~AVa~mH~~~pPiI-HRDLKiENvLls~~g~~KLCDFGSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsP 224 (738)
T KOG1989|consen 146 VLKIFYDVCEAVAAMHYLKPPII-HRDLKIENVLLSADGNYKLCDFGSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSP 224 (738)
T ss_pred HHHHHHHHHHHHHHHhcCCCccc-hhhhhhhheEEcCCCCEEeCcccccccccCCCccHHHHHHHHHHHHhhCCccccCh
Confidence 6999999999999999975 66 99999999999999999999999875332211110 01123578899999
Q ss_pred ccccCCCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCchHHHHHHHHHhhhcCCC
Q psy1840 96 ELLRQPHLPRGTQKGDVYSFGLVLYEVIGRQGPWGHLRMTDEEIITSVTQGSGLRPDTSSLDCAPSIIACMRTCWEEDPE 175 (423)
Q Consensus 96 E~l~~~~~~~~s~ksDVyS~Giil~elltg~~Pf~~~~~~~~~i~~~i~~~~~~~p~~~~~~~~~~l~~Li~~C~~~dP~ 175 (423)
|++.-......+.|+|||+|||+||-|++...||.+.+ .-.|..+.+..|..+ .++..+.+||..||+.||+
T Consensus 225 EMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg------~laIlng~Y~~P~~p--~ys~~l~~LI~~mL~~nP~ 296 (738)
T KOG1989|consen 225 EMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESG------KLAILNGNYSFPPFP--NYSDRLKDLIRTMLQPNPD 296 (738)
T ss_pred HHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCc------ceeEEeccccCCCCc--cHHHHHHHHHHHHhccCcc
Confidence 99864332245899999999999999999999997532 124556666666653 5889999999999999999
Q ss_pred CCCCHHHHHHHHHHHhhhc
Q psy1840 176 LRPDLRFVHHKLKEMNAGL 194 (423)
Q Consensus 176 ~RPt~~~I~~~L~~i~~~~ 194 (423)
+||++.+|+..+.++....
T Consensus 297 ~RPnI~Qv~~~~~~l~~~~ 315 (738)
T KOG1989|consen 297 ERPNIYQVLEEIFELANKP 315 (738)
T ss_pred cCCCHHHHHHHHHHHhcCC
Confidence 9999999999998887643
|
|
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=99.90 E-value=3e-23 Score=196.95 Aligned_cols=154 Identities=17% Similarity=0.319 Sum_probs=118.1
Q ss_pred HHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCccEEEeccCCcccccCCC----cccccccccCCccccCCccccC
Q psy1840 25 SISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQD----ETGQERKLRRRKLYKAPELLRQ 100 (423)
Q Consensus 25 ~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~----~~~~~~~~~gt~~y~APE~l~~ 100 (423)
...++.|++.||+|||+.+++ |+||+|+||++++++.+||+|||++....... .........++..|+|||.+.+
T Consensus 104 ~~~~~~qi~~~l~~lH~~~i~-H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~ 182 (265)
T cd06631 104 FCKYTKQILDGVAYLHNNCVV-HRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEVINE 182 (265)
T ss_pred HHHHHHHHHHHHHHHHhCCcc-cCCcCHHhEEECCCCeEEeccchhhHhhhhccccccccccccccCCCccccChhhhcC
Confidence 457899999999999999987 99999999999999999999999977542211 1111223457888999999987
Q ss_pred CCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCchHHHHHHHHHhhhcCCCCCCCH
Q psy1840 101 PHLPRGTQKGDVYSFGLVLYEVIGRQGPWGHLRMTDEEIITSVTQGSGLRPDTSSLDCAPSIIACMRTCWEEDPELRPDL 180 (423)
Q Consensus 101 ~~~~~~s~ksDVyS~Giil~elltg~~Pf~~~~~~~~~i~~~i~~~~~~~p~~~~~~~~~~l~~Li~~C~~~dP~~RPt~ 180 (423)
... +.++||||||+++|++++|..||.... .......+.......+.. ...++.++.+++++||+.+|++||++
T Consensus 183 ~~~---~~~~Dv~slG~~~~~l~~g~~p~~~~~--~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~i~~~l~~~p~~Rp~~ 256 (265)
T cd06631 183 SGY---GRKSDIWSIGCTVFEMATGKPPLASMD--RLAAMFYIGAHRGLMPRL-PDSFSAAAIDFVTSCLTRDQHERPSA 256 (265)
T ss_pred CCC---cchhhHHHHHHHHHHHHhCCCccccCC--hHHHHHHhhhccCCCCCC-CCCCCHHHHHHHHHHhcCCcccCCCH
Confidence 654 789999999999999999999996432 222222222222222322 23578999999999999999999999
Q ss_pred HHHHH
Q psy1840 181 RFVHH 185 (423)
Q Consensus 181 ~~I~~ 185 (423)
.+++.
T Consensus 257 ~~~l~ 261 (265)
T cd06631 257 LQLLR 261 (265)
T ss_pred HHHhc
Confidence 98865
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.1e-23 Score=210.72 Aligned_cols=158 Identities=14% Similarity=0.151 Sum_probs=118.9
Q ss_pred HHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCccEEEeccCCcccccCCCcccccccccCCccccCCccccCCCC-
Q psy1840 25 SISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKAPELLRQPHL- 103 (423)
Q Consensus 25 ~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~- 103 (423)
...++.||+.||+|||+.+++ ||||||+|||++.++.+||+|||++........ .......||+.|+|||++.+...
T Consensus 144 ~~~~~~qil~aL~~LH~~~Iv-HrDLKp~NILl~~~~~~kL~DFG~a~~~~~~~~-~~~~~~~gt~~Y~aPE~~~~~~~~ 221 (370)
T cd05621 144 AKFYTAEVVLALDAIHSMGLI-HRDVKPDNMLLDKHGHLKLADFGTCMKMDETGM-VRCDTAVGTPDYISPEVLKSQGGD 221 (370)
T ss_pred HHHHHHHHHHHHHHHHHCCeE-ecCCCHHHEEECCCCCEEEEecccceecccCCc-eecccCCCCcccCCHHHHhccCCC
Confidence 567899999999999999998 999999999999999999999999876532211 12235578999999999875431
Q ss_pred CCCCCccchHHHHHHHHHHHhCCCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCchHHHHHHHHHhhhcCCC--CCCCHH
Q psy1840 104 PRGTQKGDVYSFGLVLYEVIGRQGPWGHLRMTDEEIITSVTQGSGLRPDTSSLDCAPSIIACMRTCWEEDPE--LRPDLR 181 (423)
Q Consensus 104 ~~~s~ksDVyS~Giil~elltg~~Pf~~~~~~~~~i~~~i~~~~~~~p~~~~~~~~~~l~~Li~~C~~~dP~--~RPt~~ 181 (423)
...+.++||||+||++|||++|..||... +..+....+..............++..+.+++..|+..++. .|+++.
T Consensus 222 ~~~~~~~DiwSlG~ilyell~G~~Pf~~~--~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~~L~~~~~r~~R~~~~ 299 (370)
T cd05621 222 GYYGRECDWWSVGVFLFEMLVGDTPFYAD--SLVGTYSKIMDHKNSLNFPEDVEISKHAKNLICAFLTDREVRLGRNGVE 299 (370)
T ss_pred CCCCcccCEEeehHHHHHHHhCCCCCCCC--CHHHHHHHHHhCCcccCCCCcccCCHHHHHHHHHHccCchhccCCCCHH
Confidence 12478999999999999999999999743 34455555554322111111235688999999999985554 388999
Q ss_pred HHHHH
Q psy1840 182 FVHHK 186 (423)
Q Consensus 182 ~I~~~ 186 (423)
++++.
T Consensus 300 e~l~h 304 (370)
T cd05621 300 EIKQH 304 (370)
T ss_pred HHhcC
Confidence 88764
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=99.90 E-value=3.3e-23 Score=198.48 Aligned_cols=147 Identities=21% Similarity=0.314 Sum_probs=111.2
Q ss_pred HHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCc-------cEEEeccCCcccccCCCcccccccccCCccccCCcc
Q psy1840 25 SISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRW-------VLQIADFGLHAFKAGQDETGQERKLRRRKLYKAPEL 97 (423)
Q Consensus 25 ~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~-------~vKL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~ 97 (423)
++.++.||+.||+|||+++++ ||||||+||+++..+ .+|++|||++...... ....++..|+|||.
T Consensus 119 ~~~i~~qi~~~l~~lH~~~ii-H~dlkp~Nill~~~~~~~~~~~~~kl~d~g~~~~~~~~------~~~~~~~~~~aPe~ 191 (274)
T cd05076 119 KITVAQQLASALSYLEDKNLV-HGNVCAKNILLARLGLAEGTSPFIKLSDPGVSFTALSR------EERVERIPWIAPEC 191 (274)
T ss_pred HHHHHHHHHHHHHHHHcCCcc-CCCCCcccEEEeccCcccCccceeeecCCccccccccc------cccccCCcccCchh
Confidence 789999999999999999998 999999999997643 4899999987543211 12345677999998
Q ss_pred ccCCCCCCCCCccchHHHHHHHHHHH-hCCCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCchHHHHHHHHHhhhcCCCC
Q psy1840 98 LRQPHLPRGTQKGDVYSFGLVLYEVI-GRQGPWGHLRMTDEEIITSVTQGSGLRPDTSSLDCAPSIIACMRTCWEEDPEL 176 (423)
Q Consensus 98 l~~~~~~~~s~ksDVyS~Giil~ell-tg~~Pf~~~~~~~~~i~~~i~~~~~~~p~~~~~~~~~~l~~Li~~C~~~dP~~ 176 (423)
+.+.. ..+.++||||||+++||++ +|..||... ...+......... ..| ....+.+.+++.+||+.+|++
T Consensus 192 ~~~~~--~~~~~~Dv~slG~~l~el~~~g~~p~~~~--~~~~~~~~~~~~~-~~~----~~~~~~~~~li~~cl~~~p~~ 262 (274)
T cd05076 192 VPGGN--SLSTAADKWSFGTTLLEICFDGEVPLKER--TPSEKERFYEKKH-RLP----EPSCKELATLISQCLTYEPTQ 262 (274)
T ss_pred hcCCC--CCCcHHHHHHHHHHHHHHHhCCCCCcccc--ChHHHHHHHHhcc-CCC----CCCChHHHHHHHHHcccChhh
Confidence 87642 2489999999999999995 688898643 2233322222211 111 123568999999999999999
Q ss_pred CCCHHHHHHHH
Q psy1840 177 RPDLRFVHHKL 187 (423)
Q Consensus 177 RPt~~~I~~~L 187 (423)
||++.+|++.|
T Consensus 263 Rps~~~il~~L 273 (274)
T cd05076 263 RPSFRTILRDL 273 (274)
T ss_pred CcCHHHHHHhh
Confidence 99999998876
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.5e-23 Score=197.65 Aligned_cols=155 Identities=17% Similarity=0.276 Sum_probs=117.7
Q ss_pred HHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCccEEEeccCCcccccCCCcccccccccCCccccCCccccCCC--
Q psy1840 25 SISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKAPELLRQPH-- 102 (423)
Q Consensus 25 ~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~-- 102 (423)
...++.|++.||.|||+.+++ ||||+|+||+++.++.+||+|||++....... .......++..|+|||.+....
T Consensus 115 ~~~~~~ql~~al~~lH~~~i~-H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~ 191 (275)
T cd06608 115 IAYILRETLRGLAYLHENKVI-HRDIKGQNILLTKNAEVKLVDFGVSAQLDSTL--GRRNTFIGTPYWMAPEVIACDEQP 191 (275)
T ss_pred HHHHHHHHHHHHHHHhcCCcc-cCCCCHHHEEEccCCeEEECCCccceecccch--hhhcCccccccccCHhHhcccccc
Confidence 568999999999999999998 99999999999999999999999976543221 1123445788899999886432
Q ss_pred CCCCCCccchHHHHHHHHHHHhCCCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCchHHHHHHHHHhhhcCCCCCCCHHH
Q psy1840 103 LPRGTQKGDVYSFGLVLYEVIGRQGPWGHLRMTDEEIITSVTQGSGLRPDTSSLDCAPSIIACMRTCWEEDPELRPDLRF 182 (423)
Q Consensus 103 ~~~~s~ksDVyS~Giil~elltg~~Pf~~~~~~~~~i~~~i~~~~~~~p~~~~~~~~~~l~~Li~~C~~~dP~~RPt~~~ 182 (423)
....+.++||||||+++|++++|..||... ........+........ .....++..+.+++.+||..||++|||+.+
T Consensus 192 ~~~~~~~~Dv~slG~il~~l~~g~~p~~~~--~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ 268 (275)
T cd06608 192 DASYDARSDVWSLGITAIELADGKPPLCDM--HPMRALFKIPRNPPPTL-KSPENWSKKFNDFISECLIKNYEQRPFMEE 268 (275)
T ss_pred cCCccccccHHHhHHHHHHHHhCCCCcccc--chHHHHHHhhccCCCCC-CchhhcCHHHHHHHHHHhhcChhhCcCHHH
Confidence 123478899999999999999999999642 22233333333221111 112246789999999999999999999999
Q ss_pred HHH
Q psy1840 183 VHH 185 (423)
Q Consensus 183 I~~ 185 (423)
+++
T Consensus 269 ll~ 271 (275)
T cd06608 269 LLE 271 (275)
T ss_pred Hhc
Confidence 875
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=99.90 E-value=3e-23 Score=202.08 Aligned_cols=159 Identities=19% Similarity=0.292 Sum_probs=122.5
Q ss_pred HHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCccEEEeccCCcccccCCCcccccccccCCccccCCccccCCCCC
Q psy1840 25 SISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKAPELLRQPHLP 104 (423)
Q Consensus 25 ~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~ 104 (423)
...++.|++.|+.|||+.+++ ||||+|+||+++.++.+||+|||++...... ....++..|+|||.+.+....
T Consensus 117 ~~~~~~~l~~~l~~LH~~~i~-H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~ 189 (308)
T cd06634 117 IAAVTHGALQGLAYLHSHNMI-HRDVKAGNILLSEPGLVKLGDFGSASIMAPA------NXFVGTPYWMAPEVILAMDEG 189 (308)
T ss_pred HHHHHHHHHHHHHHHHhCCcc-cCCCCHHhEEECCCCcEEECCcccceeecCc------ccccCCccccCHHHHhhcccC
Confidence 578899999999999999998 9999999999999999999999997654321 234567789999997532211
Q ss_pred CCCCccchHHHHHHHHHHHhCCCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCchHHHHHHHHHhhhcCCCCCCCHHHHH
Q psy1840 105 RGTQKGDVYSFGLVLYEVIGRQGPWGHLRMTDEEIITSVTQGSGLRPDTSSLDCAPSIIACMRTCWEEDPELRPDLRFVH 184 (423)
Q Consensus 105 ~~s~ksDVyS~Giil~elltg~~Pf~~~~~~~~~i~~~i~~~~~~~p~~~~~~~~~~l~~Li~~C~~~dP~~RPt~~~I~ 184 (423)
..+.++|||||||++|+|++|..||... ...+....+..+. .+......++..+.+++.+||+.+|++||++.+++
T Consensus 190 ~~~~~~Di~slG~il~el~~g~~p~~~~--~~~~~~~~~~~~~--~~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll 265 (308)
T cd06634 190 QYDGKVDVWSLGITCIELAERKPPLFNM--NAMSALYHIAQNE--SPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLL 265 (308)
T ss_pred CCCcccchHHHHHHHHHHHcCCCCCccc--cHHHHHHHHhhcC--CCCcCcccccHHHHHHHHHHhhCCcccCCCHHHHh
Confidence 3478999999999999999999998642 2333333333322 22223345788999999999999999999999999
Q ss_pred HHHHHHhhhc
Q psy1840 185 HKLKEMNAGL 194 (423)
Q Consensus 185 ~~L~~i~~~~ 194 (423)
..........
T Consensus 266 ~~~~~~~~~~ 275 (308)
T cd06634 266 KHRFVLRERP 275 (308)
T ss_pred hCccccccCC
Confidence 8765555433
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.8e-23 Score=198.81 Aligned_cols=152 Identities=19% Similarity=0.293 Sum_probs=115.0
Q ss_pred HHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCccEEEeccCCcccccCCCc-ccccccccCCccccCCccccCCCC
Q psy1840 25 SISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDE-TGQERKLRRRKLYKAPELLRQPHL 103 (423)
Q Consensus 25 ~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~-~~~~~~~~gt~~y~APE~l~~~~~ 103 (423)
...++.|++.||.|||+.+++ ||||||+||+++.++.+||+|||++........ ........++..|+|||.+.+..+
T Consensus 108 ~~~~~~qi~~~l~~LH~~~i~-H~~l~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~ 186 (266)
T cd06651 108 TRKYTRQILEGMSYLHSNMIV-HRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPEVISGEGY 186 (266)
T ss_pred HHHHHHHHHHHHHHHHhCCee-eCCCCHHHEEECCCCCEEEccCCCccccccccccCCccccCCccccccCHHHhCCCCC
Confidence 568999999999999999987 999999999999999999999999875432111 111123457788999999977654
Q ss_pred CCCCCccchHHHHHHHHHHHhCCCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCchHHHHHHHHHhhhcCCCCCCCHHHH
Q psy1840 104 PRGTQKGDVYSFGLVLYEVIGRQGPWGHLRMTDEEIITSVTQGSGLRPDTSSLDCAPSIIACMRTCWEEDPELRPDLRFV 183 (423)
Q Consensus 104 ~~~s~ksDVyS~Giil~elltg~~Pf~~~~~~~~~i~~~i~~~~~~~p~~~~~~~~~~l~~Li~~C~~~dP~~RPt~~~I 183 (423)
+.++|||||||++||+++|+.||... ...+.+..... ....|..+ ..+++.+..++ +||..+|++||++.+|
T Consensus 187 ---~~~~Dv~slG~i~~el~~g~~pf~~~--~~~~~~~~~~~-~~~~~~~~-~~~~~~~~~li-~~~~~~p~~Rp~~~ei 258 (266)
T cd06651 187 ---GRKADVWSLGCTVVEMLTEKPPWAEY--EAMAAIFKIAT-QPTNPQLP-SHISEHARDFL-GCIFVEARHRPSAEEL 258 (266)
T ss_pred ---CchhhhHHHHHHHHHHHHCCCCcccc--chHHHHHHHhc-CCCCCCCc-hhcCHHHHHHH-HHhcCChhhCcCHHHH
Confidence 88999999999999999999999743 22222222222 11223222 24577888888 7888999999999998
Q ss_pred HH
Q psy1840 184 HH 185 (423)
Q Consensus 184 ~~ 185 (423)
++
T Consensus 259 l~ 260 (266)
T cd06651 259 LR 260 (266)
T ss_pred hc
Confidence 75
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=99.90 E-value=6.2e-24 Score=212.77 Aligned_cols=155 Identities=21% Similarity=0.185 Sum_probs=116.1
Q ss_pred HHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCccEEEeccCCcccccCCC--------------------------
Q psy1840 25 SISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQD-------------------------- 78 (423)
Q Consensus 25 ~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~-------------------------- 78 (423)
...++.||+.||+|||+.|++ ||||||+||+++.++.+||+|||++.......
T Consensus 103 ~~~~~~qi~~al~~lH~~~iv-HrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 181 (376)
T cd05598 103 ARFYIAELTCAIESVHKMGFI-HRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEID 181 (376)
T ss_pred HHHHHHHHHHHHHHHHHCCeE-eCCCCHHHEEECCCCCEEEEeCCCCccccccccccccccccccccccccccccccccc
Confidence 356789999999999999998 99999999999999999999999974221000
Q ss_pred ---------------cccccccccCCccccCCccccCCCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCChHHHHHHH
Q psy1840 79 ---------------ETGQERKLRRRKLYKAPELLRQPHLPRGTQKGDVYSFGLVLYEVIGRQGPWGHLRMTDEEIITSV 143 (423)
Q Consensus 79 ---------------~~~~~~~~~gt~~y~APE~l~~~~~~~~s~ksDVyS~Giil~elltg~~Pf~~~~~~~~~i~~~i 143 (423)
.........||+.|+|||++.+..+ +.++|||||||++|||++|+.||... ...+....+
T Consensus 182 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~---~~~~DiwSlGvilyell~G~~Pf~~~--~~~~~~~~i 256 (376)
T cd05598 182 RCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGY---TQLCDWWSVGVILYEMLVGQPPFLAD--TPAETQLKV 256 (376)
T ss_pred cccccchhhhhhhhcccccccccCCCccccCHHHHcCCCC---CcceeeeeccceeeehhhCCCCCCCC--CHHHHHHHH
Confidence 0000123468999999999987655 88999999999999999999999743 334444444
Q ss_pred hcCCCCCCCCCCCCchHHHHHHHHHhhhcCCCCCC---CHHHHHHH
Q psy1840 144 TQGSGLRPDTSSLDCAPSIIACMRTCWEEDPELRP---DLRFVHHK 186 (423)
Q Consensus 144 ~~~~~~~p~~~~~~~~~~l~~Li~~C~~~dP~~RP---t~~~I~~~ 186 (423)
.......+......+++++.+++.+|+ .+|.+|+ ++.+++..
T Consensus 257 ~~~~~~~~~~~~~~~s~~~~~li~~l~-~~p~~R~~~~t~~ell~h 301 (376)
T cd05598 257 INWETTLHIPSQAKLSREASDLILRLC-CGAEDRLGKNGADEIKAH 301 (376)
T ss_pred hccCccccCCCCCCCCHHHHHHHHHHh-cCHhhcCCCCCHHHHhCC
Confidence 432222221122357889999999987 5999999 88888654
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=99.90 E-value=3.7e-23 Score=197.09 Aligned_cols=158 Identities=21% Similarity=0.396 Sum_probs=117.7
Q ss_pred HHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCccEEEeccCCcccccCCCcccccccccCCccccCCccccCCCCC
Q psy1840 25 SISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKAPELLRQPHLP 104 (423)
Q Consensus 25 ~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~ 104 (423)
...++.||+.||.|||+.+++ ||||+|+||+++.++.++|+|||++................++..|+|||.+.... .
T Consensus 110 ~~~~~~qi~~~l~~lH~~~i~-H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~-~ 187 (272)
T cd06629 110 VRFFTEQVLEGLAYLHSKGIL-HRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSVFWMAPEVIHSYS-Q 187 (272)
T ss_pred HHHHHHHHHHHHHHHhhCCee-ecCCChhhEEEcCCCeEEEeeccccccccccccccccccccCCccccCHHHhcccc-C
Confidence 467899999999999999988 99999999999999999999999987543222222223445778899999987644 1
Q ss_pred CCCCccchHHHHHHHHHHHhCCCCCCCCCCChHHHHHHHhcC--CCCCCCCCCCCchHHHHHHHHHhhhcCCCCCCCHHH
Q psy1840 105 RGTQKGDVYSFGLVLYEVIGRQGPWGHLRMTDEEIITSVTQG--SGLRPDTSSLDCAPSIIACMRTCWEEDPELRPDLRF 182 (423)
Q Consensus 105 ~~s~ksDVyS~Giil~elltg~~Pf~~~~~~~~~i~~~i~~~--~~~~p~~~~~~~~~~l~~Li~~C~~~dP~~RPt~~~ 182 (423)
..+.++|+||||+++|++++|..||.... ..+....+... ....+......++.++.+++.+||..+|++||++.+
T Consensus 188 ~~~~~~Dv~slG~~l~~l~~g~~p~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ 265 (272)
T cd06629 188 GYSAKVDIWSLGCVVLEMFAGRRPWSDEE--AIAAMFKLGNKRSAPPIPPDVSMNLSPVALDFLNACFTINPDNRPTARE 265 (272)
T ss_pred CCCccchhHHHHHHHHHHHhCCCCCcCcc--hHHHHHHhhccccCCcCCccccccCCHHHHHHHHHHhcCChhhCCCHHH
Confidence 24889999999999999999999996322 22222222111 111122222356889999999999999999999999
Q ss_pred HHHH
Q psy1840 183 VHHK 186 (423)
Q Consensus 183 I~~~ 186 (423)
|++.
T Consensus 266 il~~ 269 (272)
T cd06629 266 LLQH 269 (272)
T ss_pred HhhC
Confidence 8753
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.9e-23 Score=200.74 Aligned_cols=157 Identities=22% Similarity=0.351 Sum_probs=118.1
Q ss_pred HHHHHHHHHHHHHHHHhC-CCeeecCCCCCCEEEcCCccEEEeccCCcccccCCCcccccccccCCccccCCccccCCC-
Q psy1840 25 SISVNTTASVGMIHLHDS-EIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKAPELLRQPH- 102 (423)
Q Consensus 25 ~l~i~~qi~~gL~yLH~~-~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~- 102 (423)
...++.|++.||.|||+. |++ ||||+|+||++++++.+||+|||++......... ....++..|+|||.+.+..
T Consensus 116 ~~~i~~~i~~~l~~lH~~~~i~-H~dl~p~nill~~~~~~kL~dfg~~~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~ 191 (296)
T cd06618 116 LGKMTVAIVKALHYLKEKHGVI-HRDVKPSNILLDASGNVKLCDFGISGRLVDSKAK---TRSAGCAAYMAPERIDPPDP 191 (296)
T ss_pred HHHHHHHHHHHHHHHHhhCCEe-cCCCcHHHEEEcCCCCEEECccccchhccCCCcc---cCCCCCccccCHhhcCCCCC
Confidence 568999999999999974 776 9999999999999999999999998654322111 2234667899999987543
Q ss_pred CCCCCCccchHHHHHHHHHHHhCCCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCchHHHHHHHHHhhhcCCCCCCCHHH
Q psy1840 103 LPRGTQKGDVYSFGLVLYEVIGRQGPWGHLRMTDEEIITSVTQGSGLRPDTSSLDCAPSIIACMRTCWEEDPELRPDLRF 182 (423)
Q Consensus 103 ~~~~s~ksDVyS~Giil~elltg~~Pf~~~~~~~~~i~~~i~~~~~~~p~~~~~~~~~~l~~Li~~C~~~dP~~RPt~~~ 182 (423)
....+.++||||||+++|+|++|+.||.... ...+....+......... ....++.++.+++.+||+.||++||++.+
T Consensus 192 ~~~~~~~~Di~slG~il~el~~g~~p~~~~~-~~~~~~~~~~~~~~~~~~-~~~~~~~~l~~li~~~l~~~p~~Rp~~~~ 269 (296)
T cd06618 192 NPKYDIRADVWSLGISLVELATGQFPYKNCK-TEFEVLTKILQEEPPSLP-PNEGFSPDFCSFVDLCLTKDHRKRPKYRE 269 (296)
T ss_pred ccccccchhHHHHHHHHHHHHhCCCCCCcch-hHHHHHHHHhcCCCCCCC-CCCCCCHHHHHHHHHHccCChhhCCCHHH
Confidence 1234789999999999999999999996422 223334444333211111 11247889999999999999999999999
Q ss_pred HHHHH
Q psy1840 183 VHHKL 187 (423)
Q Consensus 183 I~~~L 187 (423)
++...
T Consensus 270 il~~~ 274 (296)
T cd06618 270 LLQHP 274 (296)
T ss_pred HhcCh
Confidence 97653
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.90 E-value=3.6e-23 Score=198.16 Aligned_cols=156 Identities=20% Similarity=0.299 Sum_probs=120.3
Q ss_pred HHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCccEEEeccCCcccccCCCcccccccccCCccccCCccccCCC--
Q psy1840 25 SISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKAPELLRQPH-- 102 (423)
Q Consensus 25 ~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~-- 102 (423)
...++.|++.||.|||+.+++ ||||||+||+++.++.++|+|||++........ ......++..|+|||.+....
T Consensus 105 ~~~~~~ql~~~l~~lh~~~i~-h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~ 181 (280)
T cd06611 105 IRYVCRQMLEALNFLHSHKVI-HRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQ--KRDTFIGTPYWMAPEVVACETFK 181 (280)
T ss_pred HHHHHHHHHHHHHHHHHCCcc-cCCCChhhEEECCCCCEEEccCccchhhccccc--ccceeecchhhcCHHHHhhcccC
Confidence 578999999999999999998 999999999999999999999998765432211 112345788899999986332
Q ss_pred CCCCCCccchHHHHHHHHHHHhCCCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCchHHHHHHHHHhhhcCCCCCCCHHH
Q psy1840 103 LPRGTQKGDVYSFGLVLYEVIGRQGPWGHLRMTDEEIITSVTQGSGLRPDTSSLDCAPSIIACMRTCWEEDPELRPDLRF 182 (423)
Q Consensus 103 ~~~~s~ksDVyS~Giil~elltg~~Pf~~~~~~~~~i~~~i~~~~~~~p~~~~~~~~~~l~~Li~~C~~~dP~~RPt~~~ 182 (423)
....+.++|+||||+++|||++|..||... ...+....+..+...... .+..++.++.+++.+||+.+|++||++.+
T Consensus 182 ~~~~~~~sDi~slG~il~~l~~g~~p~~~~--~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~p~~Rps~~~ 258 (280)
T cd06611 182 DNPYDYKADIWSLGITLIELAQMEPPHHEL--NPMRVLLKILKSEPPTLD-QPSKWSSSFNDFLKSCLVKDPDDRPTAAE 258 (280)
T ss_pred CCCCCccccHHHHHHHHHHHHhCCCCcccC--CHHHHHHHHhcCCCCCcC-CcccCCHHHHHHHHHHhccChhhCcCHHH
Confidence 112477999999999999999999999643 334444555443222111 12357889999999999999999999999
Q ss_pred HHHH
Q psy1840 183 VHHK 186 (423)
Q Consensus 183 I~~~ 186 (423)
+++.
T Consensus 259 il~~ 262 (280)
T cd06611 259 LLKH 262 (280)
T ss_pred HhcC
Confidence 9764
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=99.90 E-value=3.2e-23 Score=198.94 Aligned_cols=156 Identities=19% Similarity=0.270 Sum_probs=116.9
Q ss_pred HHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCccEEEeccCCcccccCCCcccccccccCCccccCCccccCCC--
Q psy1840 25 SISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKAPELLRQPH-- 102 (423)
Q Consensus 25 ~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~-- 102 (423)
...++.|++.||.|||+.+++ ||||||+||+++.++.+||+|||++........ ......++..|+|||.+....
T Consensus 126 ~~~~~~~i~~~l~~lH~~~i~-H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~ 202 (286)
T cd06638 126 IAYILHEALMGLQHLHVNKTI-HRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRL--RRNTSVGTPFWMAPEVIACEQQL 202 (286)
T ss_pred HHHHHHHHHHHHHHHHhCCcc-ccCCCHHhEEECCCCCEEEccCCceeecccCCC--ccccccCCCcccChhhhchhhhc
Confidence 457899999999999999998 999999999999999999999999875532211 123346788899999986432
Q ss_pred CCCCCCccchHHHHHHHHHHHhCCCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCchHHHHHHHHHhhhcCCCCCCCHHH
Q psy1840 103 LPRGTQKGDVYSFGLVLYEVIGRQGPWGHLRMTDEEIITSVTQGSGLRPDTSSLDCAPSIIACMRTCWEEDPELRPDLRF 182 (423)
Q Consensus 103 ~~~~s~ksDVyS~Giil~elltg~~Pf~~~~~~~~~i~~~i~~~~~~~p~~~~~~~~~~l~~Li~~C~~~dP~~RPt~~~ 182 (423)
...++.++|||||||++|||++|+.||.... ............... ......++..+.+++.+||+.+|++||++.+
T Consensus 203 ~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~--~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e 279 (286)
T cd06638 203 DSTYDARCDVWSLGITAIELGDGDPPLADLH--PMRALFKIPRNPPPT-LHQPELWSNEFNDFIRKCLTKDYEKRPTVSD 279 (286)
T ss_pred cccccchhhhhhHHHHHHHHhcCCCCCCCCc--hhHHHhhccccCCCc-ccCCCCcCHHHHHHHHHHccCCcccCCCHHH
Confidence 1134789999999999999999999996432 222222222221111 1112346788999999999999999999999
Q ss_pred HHHH
Q psy1840 183 VHHK 186 (423)
Q Consensus 183 I~~~ 186 (423)
|++.
T Consensus 280 ll~~ 283 (286)
T cd06638 280 LLQH 283 (286)
T ss_pred Hhhc
Confidence 9864
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=99.90 E-value=3.7e-23 Score=195.15 Aligned_cols=151 Identities=20% Similarity=0.377 Sum_probs=120.9
Q ss_pred HHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCccEEEeccCCcccccCCCcccccccccCCccccCCccccCCCCC
Q psy1840 25 SISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKAPELLRQPHLP 104 (423)
Q Consensus 25 ~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~ 104 (423)
.+.++.|++.|+.|||+.+++ |+||+|+||+++.++.++|+|||++......... .....++..|+|||.+.+...
T Consensus 103 ~~~~~~~l~~~l~~lh~~~i~-h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~~~--~~~~~~~~~~~~pe~~~~~~~- 178 (256)
T cd08218 103 ILDWFVQICLALKHVHDRKIL-HRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVEL--ARTCIGTPYYLSPEICENRPY- 178 (256)
T ss_pred HHHHHHHHHHHHHHHHhCCEe-cCCCCHHHEEEcCCCCEEEeeccceeecCcchhh--hhhccCCccccCHHHhCCCCC-
Confidence 578999999999999999988 9999999999999999999999998754322211 123457788999999877654
Q ss_pred CCCCccchHHHHHHHHHHHhCCCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCchHHHHHHHHHhhhcCCCCCCCHHHHH
Q psy1840 105 RGTQKGDVYSFGLVLYEVIGRQGPWGHLRMTDEEIITSVTQGSGLRPDTSSLDCAPSIIACMRTCWEEDPELRPDLRFVH 184 (423)
Q Consensus 105 ~~s~ksDVyS~Giil~elltg~~Pf~~~~~~~~~i~~~i~~~~~~~p~~~~~~~~~~l~~Li~~C~~~dP~~RPt~~~I~ 184 (423)
+.++|+||||++++++++|..||.. ....+....+..+.. +.. ...++.++.+++.+||+.+|++||++.+|+
T Consensus 179 --~~~~Dv~slG~i~~~l~~g~~~~~~--~~~~~~~~~~~~~~~--~~~-~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl 251 (256)
T cd08218 179 --NNKSDIWALGCVLYEMCTLKHAFEA--GNMKNLVLKIIRGSY--PPV-SSHYSYDLRNLVSQLFKRNPRDRPSVNSIL 251 (256)
T ss_pred --CCccchhHHHHHHHHHHcCCCCccC--CCHHHHHHHHhcCCC--CCC-cccCCHHHHHHHHHHhhCChhhCcCHHHHh
Confidence 7899999999999999999999963 234555555544432 222 235788999999999999999999999997
Q ss_pred HH
Q psy1840 185 HK 186 (423)
Q Consensus 185 ~~ 186 (423)
+.
T Consensus 252 ~~ 253 (256)
T cd08218 252 EK 253 (256)
T ss_pred hC
Confidence 63
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >KOG0611|consensus | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.8e-23 Score=198.78 Aligned_cols=150 Identities=20% Similarity=0.350 Sum_probs=131.3
Q ss_pred HHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCccEEEeccCCcccccCCCcccccccccCCccccCCccccCCCCC
Q psy1840 25 SISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKAPELLRQPHLP 104 (423)
Q Consensus 25 ~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~ 104 (423)
.-.|..||++++.|+|+++++ |||||.+|||+|.++++||+|||++....... ...+++|++.|.+||++.|..|
T Consensus 155 aRhfFRQIvSAVhYCHknrVv-HRDLKLENILLD~N~NiKIADFGLSNly~~~k---fLqTFCGSPLYASPEIvNG~PY- 229 (668)
T KOG0611|consen 155 ARHFFRQIVSAVHYCHKNRVV-HRDLKLENILLDQNNNIKIADFGLSNLYADKK---FLQTFCGSPLYASPEIVNGTPY- 229 (668)
T ss_pred HHHHHHHHHHHHHHHhhccce-ecccchhheeecCCCCeeeeccchhhhhcccc---HHHHhcCCcccCCccccCCCCC-
Confidence 468999999999999999998 99999999999999999999999987764332 2367899999999999998876
Q ss_pred CCCCccchHHHHHHHHHHHhCCCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCchHHHHHHHHHhhhcCCCCCCCHHHHH
Q psy1840 105 RGTQKGDVYSFGLVLYEVIGRQGPWGHLRMTDEEIITSVTQGSGLRPDTSSLDCAPSIIACMRTCWEEDPELRPDLRFVH 184 (423)
Q Consensus 105 ~~s~ksDVyS~Giil~elltg~~Pf~~~~~~~~~i~~~i~~~~~~~p~~~~~~~~~~l~~Li~~C~~~dP~~RPt~~~I~ 184 (423)
-++.+|.||+|++||-++.|..||++ .+...++.++..|....|..+ .....||..||-.||+.|-|+.+|.
T Consensus 230 -~GPEVDsWsLGvLLYtLVyGtMPFDG--~Dhk~lvrQIs~GaYrEP~~P-----SdA~gLIRwmLmVNP~RRATieDiA 301 (668)
T KOG0611|consen 230 -KGPEVDSWSLGVLLYTLVYGTMPFDG--RDHKRLVRQISRGAYREPETP-----SDASGLIRWMLMVNPERRATIEDIA 301 (668)
T ss_pred -CCCccchhhHHHHHHHHhhcccccCC--chHHHHHHHhhcccccCCCCC-----chHHHHHHHHHhcCcccchhHHHHh
Confidence 37899999999999999999999984 456788999999988777653 4677899999999999999999997
Q ss_pred HHH
Q psy1840 185 HKL 187 (423)
Q Consensus 185 ~~L 187 (423)
...
T Consensus 302 sHW 304 (668)
T KOG0611|consen 302 SHW 304 (668)
T ss_pred hhh
Confidence 754
|
|
| >KOG0605|consensus | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.1e-23 Score=208.43 Aligned_cols=153 Identities=19% Similarity=0.238 Sum_probs=120.8
Q ss_pred HHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCccEEEeccCCcccccCC-------------------C--ccc---
Q psy1840 26 ISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQ-------------------D--ETG--- 81 (423)
Q Consensus 26 l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~-------------------~--~~~--- 81 (423)
-..+.+++.|++-||+.|+| ||||||+|+|||..|++||+||||+.-+... . ...
T Consensus 244 rfYiaE~vlAI~~iH~~gyI-HRDIKPdNlLiD~~GHiKLSDFGLs~gl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 322 (550)
T KOG0605|consen 244 RFYIAETVLAIESIHQLGYI-HRDIKPDNLLIDAKGHIKLSDFGLSTGLDKKHRIESYRLDEQMQINLSEAKPSDFPKFN 322 (550)
T ss_pred HHHHHHHHHHHHHHHHcCcc-cccCChhheeecCCCCEeeccccccchhhhhhhhhhhcchhhhhhhhccCCCccccccc
Confidence 35678999999999999999 9999999999999999999999997432110 0 000
Q ss_pred --c-------------------cccccCCccccCCccccCCCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCChHHHH
Q psy1840 82 --Q-------------------ERKLRRRKLYKAPELLRQPHLPRGTQKGDVYSFGLVLYEVIGRQGPWGHLRMTDEEII 140 (423)
Q Consensus 82 --~-------------------~~~~~gt~~y~APE~l~~~~~~~~s~ksDVyS~Giil~elltg~~Pf~~~~~~~~~i~ 140 (423)
. .....|||-|+|||++.+..+ +..+|.||+|||+|||+.|-+||. ..++.+..
T Consensus 323 ~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY---~~~cDwWSLG~ImyEmLvGyPPF~--s~tp~~T~ 397 (550)
T KOG0605|consen 323 TPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGY---GKECDWWSLGCIMYEMLVGYPPFC--SETPQETY 397 (550)
T ss_pred cccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCC---CccccHHHHHHHHHHHHhCCCCCC--CCCHHHHH
Confidence 0 123578999999999999876 999999999999999999999997 45678888
Q ss_pred HHHhcCCCCCCCCCCCCchHHHHHHHHHhhhcCCCCCCC---HHHHHH
Q psy1840 141 TSVTQGSGLRPDTSSLDCAPSIIACMRTCWEEDPELRPD---LRFVHH 185 (423)
Q Consensus 141 ~~i~~~~~~~p~~~~~~~~~~l~~Li~~C~~~dP~~RPt---~~~I~~ 185 (423)
.++..............++.+..+||.+|+. ||++|.- +.||.+
T Consensus 398 rkI~nwr~~l~fP~~~~~s~eA~DLI~rll~-d~~~RLG~~G~~EIK~ 444 (550)
T KOG0605|consen 398 RKIVNWRETLKFPEEVDLSDEAKDLITRLLC-DPENRLGSKGAEEIKK 444 (550)
T ss_pred HHHHHHhhhccCCCcCcccHHHHHHHHHHhc-CHHHhcCcccHHHHhc
Confidence 8887654222222234577999999999999 9999964 566644
|
|
| >KOG4279|consensus | Back alignment and domain information |
|---|
Probab=99.90 E-value=3.4e-24 Score=216.27 Aligned_cols=152 Identities=23% Similarity=0.362 Sum_probs=122.5
Q ss_pred HHHHHHHHHHHHHHhCCCeeecCCCCCCEEEc-CCccEEEeccCCcccccCCCcccccccccCCccccCCccccCCCCCC
Q psy1840 27 SVNTTASVGMIHLHDSEIISHGNLRSSNCLID-SRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKAPELLRQPHLPR 105 (423)
Q Consensus 27 ~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld-~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~ 105 (423)
-...||++||.|||.+.|+ |||||-.||||+ -.|.+||+|||.++.+.+-.+ .+.++.||..|||||++..+.. -
T Consensus 679 fYtkQILeGLkYLHen~IV-HRDIKGDNVLvNTySGvlKISDFGTsKRLAginP--~TETFTGTLQYMAPEvIDqG~R-G 754 (1226)
T KOG4279|consen 679 FYTKQILEGLKYLHENKIV-HRDIKGDNVLVNTYSGVLKISDFGTSKRLAGINP--CTETFTGTLQYMAPEVIDQGPR-G 754 (1226)
T ss_pred HHHHHHHHHhhhhhhccee-eccccCCcEEEeeccceEEecccccchhhccCCc--cccccccchhhhChHhhccCCc-C
Confidence 3478999999999999998 999999999996 689999999999988765543 3457889999999999987653 4
Q ss_pred CCCccchHHHHHHHHHHHhCCCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCchHHHHHHHHHhhhcCCCCCCCHHHHHH
Q psy1840 106 GTQKGDVYSFGLVLYEVIGRQGPWGHLRMTDEEIITSVTQGSGLRPDTSSLDCAPSIIACMRTCWEEDPELRPDLRFVHH 185 (423)
Q Consensus 106 ~s~ksDVyS~Giil~elltg~~Pf~~~~~~~~~i~~~i~~~~~~~p~~~~~~~~~~l~~Li~~C~~~dP~~RPt~~~I~~ 185 (423)
++.++|||||||++.||.||++||...+..... .-++-.-+ ..|+. +...+.+.+++|.+|+..+|.+||++.+++.
T Consensus 755 YG~aADIWS~GCT~vEMATGrPPF~ElgspqAA-MFkVGmyK-vHP~i-Peelsaeak~FilrcFepd~~~R~sA~~LL~ 831 (1226)
T KOG4279|consen 755 YGKAADIWSFGCTMVEMATGRPPFVELGSPQAA-MFKVGMYK-VHPPI-PEELSAEAKNFILRCFEPDPCDRPSAKDLLQ 831 (1226)
T ss_pred CCchhhhhhccceeEeeccCCCCeeecCChhHh-hhhhccee-cCCCC-cHHHHHHHHHHHHHHcCCCcccCccHHHhcc
Confidence 589999999999999999999999765543322 22222211 12333 3467889999999999999999999999876
|
|
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=99.90 E-value=7.5e-23 Score=193.62 Aligned_cols=157 Identities=24% Similarity=0.403 Sum_probs=119.6
Q ss_pred HHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCccEEEeccCCcccccCCCcccc--cccccCCccccCCccccCCC
Q psy1840 25 SISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQ--ERKLRRRKLYKAPELLRQPH 102 (423)
Q Consensus 25 ~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~~~~--~~~~~gt~~y~APE~l~~~~ 102 (423)
...++.|++.||.|||+.+++ ||||+|+||+++.++.+||+|||++........... .....++..|+|||.+.+..
T Consensus 101 ~~~i~~~i~~~l~~lh~~~i~-H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~ 179 (264)
T cd06626 101 IRVYTLQLLEGLAYLHSHGIV-HRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITGGK 179 (264)
T ss_pred HHHHHHHHHHHHHHHHHCCcc-cCCCCHHHEEECCCCCEEEcccccccccCCCCCcccccccCCcCCcCccChhhccCCC
Confidence 578899999999999999998 999999999999999999999999876543322111 12345678899999998754
Q ss_pred CCCCCCccchHHHHHHHHHHHhCCCCCCCCCCChHHHHHHHhcCCCCCCCCC-CCCchHHHHHHHHHhhhcCCCCCCCHH
Q psy1840 103 LPRGTQKGDVYSFGLVLYEVIGRQGPWGHLRMTDEEIITSVTQGSGLRPDTS-SLDCAPSIIACMRTCWEEDPELRPDLR 181 (423)
Q Consensus 103 ~~~~s~ksDVyS~Giil~elltg~~Pf~~~~~~~~~i~~~i~~~~~~~p~~~-~~~~~~~l~~Li~~C~~~dP~~RPt~~ 181 (423)
....+.++||||||+++|++++|+.||.... ........+..+ ..+..+ ...+++.+.+++.+||+.+|++||++.
T Consensus 180 ~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~-~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~ 256 (264)
T cd06626 180 GKGHGRAADIWSLGCVVLEMATGKRPWSELD-NEFQIMFHVGAG--HKPPIPDSLQLSPEGKDFLDRCLESDPKKRPTAS 256 (264)
T ss_pred CCCCCcccchHHHHHHHHHHHhCCCCccCCc-chHHHHHHHhcC--CCCCCCcccccCHHHHHHHHHHccCCcccCCCHH
Confidence 2234899999999999999999999996433 222333333322 122221 224588999999999999999999999
Q ss_pred HHHH
Q psy1840 182 FVHH 185 (423)
Q Consensus 182 ~I~~ 185 (423)
+++.
T Consensus 257 ~i~~ 260 (264)
T cd06626 257 ELLQ 260 (264)
T ss_pred HHhc
Confidence 9864
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=99.90 E-value=3.4e-23 Score=195.49 Aligned_cols=155 Identities=25% Similarity=0.358 Sum_probs=121.2
Q ss_pred HHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCccEEEeccCCcccccCCCc------ccccccccCCccccCCccc
Q psy1840 25 SISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDE------TGQERKLRRRKLYKAPELL 98 (423)
Q Consensus 25 ~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~------~~~~~~~~gt~~y~APE~l 98 (423)
+..++.|++.||.|||+.+++ ||||+|+||+++.++.+||+|||++........ ........++..|+|||..
T Consensus 95 ~~~i~~qi~~~L~~lH~~~i~-H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~ 173 (265)
T cd05579 95 ARIYIAEIVLALEYLHSNGII-HRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVI 173 (265)
T ss_pred HHHHHHHHHHHHHHHHHcCee-cCCCCHHHeEEcCCCCEEEEecccchhcccCcccccccccccccCcccCccccCHHHh
Confidence 678999999999999999988 999999999999999999999999765432211 1122334567789999998
Q ss_pred cCCCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCchHHHHHHHHHhhhcCCCCCC
Q psy1840 99 RQPHLPRGTQKGDVYSFGLVLYEVIGRQGPWGHLRMTDEEIITSVTQGSGLRPDTSSLDCAPSIIACMRTCWEEDPELRP 178 (423)
Q Consensus 99 ~~~~~~~~s~ksDVyS~Giil~elltg~~Pf~~~~~~~~~i~~~i~~~~~~~p~~~~~~~~~~l~~Li~~C~~~dP~~RP 178 (423)
..... +.++||||||+++|++++|..||.. ....+....+..+....|.. ...+..+.+++.+||+.+|.+||
T Consensus 174 ~~~~~---~~~~Dv~slG~~~~~l~~g~~p~~~--~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~i~~~l~~~p~~Rp 246 (265)
T cd05579 174 LGQGH---SKTVDWWSLGCILYEFLVGIPPFHG--ETPEEIFQNILNGKIEWPED--VEVSDEAIDLISKLLVPDPEKRL 246 (265)
T ss_pred cCCCC---CcchhhHHHHHHHHHHHhCCCCCCC--CCHHHHHHHHhcCCcCCCcc--ccCCHHHHHHHHHHhcCCHhhcC
Confidence 77554 8899999999999999999999963 34556666665544333322 12488999999999999999999
Q ss_pred CHHHHHHHH
Q psy1840 179 DLRFVHHKL 187 (423)
Q Consensus 179 t~~~I~~~L 187 (423)
|+..+.+.|
T Consensus 247 t~~~~~~~l 255 (265)
T cd05579 247 GAKSIEEIK 255 (265)
T ss_pred CCccHHHHh
Confidence 995555443
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=99.90 E-value=3.1e-23 Score=204.51 Aligned_cols=157 Identities=18% Similarity=0.225 Sum_probs=116.7
Q ss_pred HHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCccEEEeccCCcccccCCCcc---cccccccCCccccCCccccCC
Q psy1840 25 SISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDET---GQERKLRRRKLYKAPELLRQP 101 (423)
Q Consensus 25 ~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~~---~~~~~~~gt~~y~APE~l~~~ 101 (423)
+..++.|++.||.|||+.|++ ||||||+||+++.++.+||+|||++......... .......++..|+|||.+.+.
T Consensus 109 ~~~i~~qi~~~L~~LH~~~i~-H~dl~p~nill~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~ 187 (337)
T cd07852 109 KRYIMYQLLKALKYIHSGNVI-HRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLTDYVATRWYRAPEILLGS 187 (337)
T ss_pred HHHHHHHHHHHHHHHHHCCee-cCCCCHHHEEEcCCCcEEEeeccchhccccccccccCcchhcccccccccCceeeecc
Confidence 567999999999999999998 9999999999999999999999998765433211 122334578889999988653
Q ss_pred CCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCChHHHHHHHhc---------------------------CCCCCCCCC
Q psy1840 102 HLPRGTQKGDVYSFGLVLYEVIGRQGPWGHLRMTDEEIITSVTQ---------------------------GSGLRPDTS 154 (423)
Q Consensus 102 ~~~~~s~ksDVyS~Giil~elltg~~Pf~~~~~~~~~i~~~i~~---------------------------~~~~~p~~~ 154 (423)
. ..+.++||||||+++|+|++|+.||.... ..+....+.. .....+...
T Consensus 188 ~--~~~~~sDi~slG~~l~el~tg~~pf~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (337)
T cd07852 188 T--RYTKGVDMWSVGCILGEMLLGKPLFPGTS--TLNQLEKIIEVIGPPSAEDIESIKSPFAATMLDSLPSRPRKPLDEL 263 (337)
T ss_pred c--cccccchHHHHHHHHHHHHhCCCCCCCCC--hHHHHHHHHHHhCCCCHHHHHHHHhhhHHHhhhhcccccccchhhh
Confidence 3 23789999999999999999999996422 1111111111 000111111
Q ss_pred CCCchHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q psy1840 155 SLDCAPSIIACMRTCWEEDPELRPDLRFVHHK 186 (423)
Q Consensus 155 ~~~~~~~l~~Li~~C~~~dP~~RPt~~~I~~~ 186 (423)
...++.++.+++.+||+.+|++|||+.++++.
T Consensus 264 ~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~ 295 (337)
T cd07852 264 LPKASDDALDLLKKLLVFNPNKRLTAEEALEH 295 (337)
T ss_pred ccCCCHHHHHHHHHhccCCcccccCHHHHhhC
Confidence 12368899999999999999999999998863
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=99.89 E-value=5.1e-23 Score=195.84 Aligned_cols=154 Identities=21% Similarity=0.356 Sum_probs=115.3
Q ss_pred HHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcC-CccEEEeccCCcccccCCCcccccccccCCccccCCccccCCCC
Q psy1840 25 SISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDS-RWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKAPELLRQPHL 103 (423)
Q Consensus 25 ~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~-~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~ 103 (423)
...++.||+.|+.|||+.|++ ||||||+||+++. ++.+||+|||++........ ......++..|+|||.+.+...
T Consensus 110 ~~~~~~qi~~al~~lH~~~i~-h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~ 186 (268)
T cd06624 110 IIFYTKQILEGLKYLHDNQIV-HRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINP--CTETFTGTLQYMAPEVIDKGPR 186 (268)
T ss_pred HHHHHHHHHHHHHHHHHCCEe-ecCCCHHHEEEcCCCCeEEEecchhheecccCCC--ccccCCCCccccChhhhccccc
Confidence 567889999999999999988 9999999999986 67999999999865432221 1123356788999999865431
Q ss_pred CCCCCccchHHHHHHHHHHHhCCCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCchHHHHHHHHHhhhcCCCCCCCHHHH
Q psy1840 104 PRGTQKGDVYSFGLVLYEVIGRQGPWGHLRMTDEEIITSVTQGSGLRPDTSSLDCAPSIIACMRTCWEEDPELRPDLRFV 183 (423)
Q Consensus 104 ~~~s~ksDVyS~Giil~elltg~~Pf~~~~~~~~~i~~~i~~~~~~~p~~~~~~~~~~l~~Li~~C~~~dP~~RPt~~~I 183 (423)
..+.++||||||+++|++++|..||........... .... ....+.. +..+++++.+++.+||+.+|++||++.++
T Consensus 187 -~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~~-~~~~-~~~~~~~-~~~~~~~~~~li~~~l~~~p~~Rpt~~~l 262 (268)
T cd06624 187 -GYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMF-KVGM-FKIHPEI-PESLSAEAKNFILRCFEPDPDKRASAHDL 262 (268)
T ss_pred -cCCchhhhHHHHHHHHHHHhCCCCCccccChhhhHh-hhhh-hccCCCC-CcccCHHHHHHHHHHcCCCchhCCCHHHH
Confidence 247899999999999999999999965332222111 1111 1112222 23578899999999999999999999998
Q ss_pred HH
Q psy1840 184 HH 185 (423)
Q Consensus 184 ~~ 185 (423)
+.
T Consensus 263 l~ 264 (268)
T cd06624 263 LQ 264 (268)
T ss_pred Hh
Confidence 75
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.9e-23 Score=209.72 Aligned_cols=154 Identities=22% Similarity=0.222 Sum_probs=113.5
Q ss_pred HHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCccEEEeccCCcccccCCCc-------------------------
Q psy1840 25 SISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDE------------------------- 79 (423)
Q Consensus 25 ~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~------------------------- 79 (423)
...++.||+.||+|||+.|++ ||||||+|||++.++.+||+|||++........
T Consensus 103 ~~~~~~qi~~al~~lH~~~iv-HrDlKp~NILl~~~g~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 181 (382)
T cd05625 103 ARFYIAELTCAVESVHKMGFI-HRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPA 181 (382)
T ss_pred HHHHHHHHHHHHHHHHhCCee-cCCCCHHHEEECCCCCEEEeECCCCccccccccccccccccccccccccccccccccc
Confidence 356789999999999999988 999999999999999999999999643210000
Q ss_pred --------------------ccccccccCCccccCCccccCCCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCChHHH
Q psy1840 80 --------------------TGQERKLRRRKLYKAPELLRQPHLPRGTQKGDVYSFGLVLYEVIGRQGPWGHLRMTDEEI 139 (423)
Q Consensus 80 --------------------~~~~~~~~gt~~y~APE~l~~~~~~~~s~ksDVyS~Giil~elltg~~Pf~~~~~~~~~i 139 (423)
........||+.|+|||++.+..+ +.++|||||||++|||++|+.||... +..+.
T Consensus 182 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~---~~~~DiwSlGvil~elltG~~Pf~~~--~~~~~ 256 (382)
T cd05625 182 NCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGY---TQLCDWWSVGVILYEMLVGQPPFLAQ--TPLET 256 (382)
T ss_pred cccccccccchhhhhccccccccccccccCcccCCHHHhcCCCC---CCeeeEEechHHHHHHHhCCCCCCCC--CHHHH
Confidence 000123468899999999987655 88999999999999999999999742 33444
Q ss_pred HHHHhcCCCCCCCCCCCCchHHHHHHHHHhhhcCCCCCCC---HHHHHH
Q psy1840 140 ITSVTQGSGLRPDTSSLDCAPSIIACMRTCWEEDPELRPD---LRFVHH 185 (423)
Q Consensus 140 ~~~i~~~~~~~p~~~~~~~~~~l~~Li~~C~~~dP~~RPt---~~~I~~ 185 (423)
...+.......+.......++++.+++.+++ .+|++|++ +.+++.
T Consensus 257 ~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~ 304 (382)
T cd05625 257 QMKVINWQTSLHIPPQAKLSPEASDLIIKLC-RGPEDRLGKNGADEIKA 304 (382)
T ss_pred HHHHHccCCCcCCCCcccCCHHHHHHHHHHc-cCHhHcCCCCCHHHHhc
Confidence 4444432211111122356889999998876 59999987 776654
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=99.89 E-value=5.4e-23 Score=194.86 Aligned_cols=152 Identities=20% Similarity=0.320 Sum_probs=120.2
Q ss_pred HHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCccEEEeccCCcccccCCCcccccccccCCccccCCccccCCCCC
Q psy1840 25 SISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKAPELLRQPHLP 104 (423)
Q Consensus 25 ~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~ 104 (423)
...++.||+.||.|||+.+++ |+||+|+||+++.++.+||+|||++....... ......++..|++||.+.+..+
T Consensus 95 ~~~~~~~i~~~l~~lH~~~~~-h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~---~~~~~~~~~~~~~PE~~~~~~~- 169 (262)
T cd05572 95 ARFYIACVVLAFEYLHNRGII-YRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ---KTWTFCGTPEYVAPEIILNKGY- 169 (262)
T ss_pred HHHHHHHHHHHHHHHhhCCcc-cCCCCHHHEEEcCCCCEEEeeCCcccccCccc---ccccccCCcCccChhHhcCCCC-
Confidence 567899999999999999998 99999999999999999999999987654332 1123457788999999876554
Q ss_pred CCCCccchHHHHHHHHHHHhCCCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCchHHHHHHHHHhhhcCCCCCCC-----
Q psy1840 105 RGTQKGDVYSFGLVLYEVIGRQGPWGHLRMTDEEIITSVTQGSGLRPDTSSLDCAPSIIACMRTCWEEDPELRPD----- 179 (423)
Q Consensus 105 ~~s~ksDVyS~Giil~elltg~~Pf~~~~~~~~~i~~~i~~~~~~~p~~~~~~~~~~l~~Li~~C~~~dP~~RPt----- 179 (423)
+.++|+||||+++|++++|..||........++...+..+.. .+.. +...+.++.+++.+||+.+|++||+
T Consensus 170 --~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~-~~~~-~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~ 245 (262)
T cd05572 170 --DFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDILKGNG-KLEF-PNYIDKAAKDLIKQLLRRNPEERLGNLKGG 245 (262)
T ss_pred --CChhhhhhhHHHHHHHHhCCCCcCCCCCCHHHHHHHHhccCC-CCCC-CcccCHHHHHHHHHHccCChhhCcCCcccC
Confidence 889999999999999999999997654334555555553221 1222 2234789999999999999999999
Q ss_pred HHHHHH
Q psy1840 180 LRFVHH 185 (423)
Q Consensus 180 ~~~I~~ 185 (423)
+.++++
T Consensus 246 ~~~l~~ 251 (262)
T cd05572 246 IKDIKK 251 (262)
T ss_pred HHHHhc
Confidence 777665
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=99.89 E-value=4.6e-23 Score=197.12 Aligned_cols=152 Identities=18% Similarity=0.253 Sum_probs=113.7
Q ss_pred HHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCccEEEeccCCcccccCCCcccccccccCCccccCCccccCCCCC
Q psy1840 25 SISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKAPELLRQPHLP 104 (423)
Q Consensus 25 ~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~ 104 (423)
...++.|++.||.|||+.+++ ||||+|+||+++. +.+||+|||++......... ....++..|+|||.+....
T Consensus 102 ~~~~~~qi~~~L~~LH~~~i~-H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~~~---~~~~~~~~y~aPE~~~~~~-- 174 (282)
T cd07831 102 VKSYMYQLLKSLDHMHRNGIF-HRDIKPENILIKD-DILKLADFGSCRGIYSKPPY---TEYISTRWYRAPECLLTDG-- 174 (282)
T ss_pred HHHHHHHHHHHHHHHHHCCce-ecccCHHHEEEcC-CCeEEEecccccccccCCCc---CCCCCCcccCChhHhhcCC--
Confidence 678999999999999999998 9999999999999 99999999998765322211 2345678899999775433
Q ss_pred CCCCccchHHHHHHHHHHHhCCCCCCCCCCChHHHHHHHhc---------------CCCC---CCCCC-------CCCch
Q psy1840 105 RGTQKGDVYSFGLVLYEVIGRQGPWGHLRMTDEEIITSVTQ---------------GSGL---RPDTS-------SLDCA 159 (423)
Q Consensus 105 ~~s~ksDVyS~Giil~elltg~~Pf~~~~~~~~~i~~~i~~---------------~~~~---~p~~~-------~~~~~ 159 (423)
..+.++|||||||++|||++|..||... +..+.+..+.. .... .|... ...++
T Consensus 175 ~~~~~~Di~slGv~l~el~~~~~p~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 252 (282)
T cd07831 175 YYGPKMDIWAVGCVFFEILSLFPLFPGT--NELDQIAKIHDVLGTPDAEVLKKFRKSRHMNYNFPSKKGTGLRKLLPNAS 252 (282)
T ss_pred CCCcchhHHHHHHHHHHHHcCCcCCCCC--CHHHHHHHHHHHcCCCCHHHHHhhcccccccccCcccccccHHHHccccc
Confidence 2378999999999999999999999643 22222222211 0000 00000 12457
Q ss_pred HHHHHHHHHhhhcCCCCCCCHHHHHH
Q psy1840 160 PSIIACMRTCWEEDPELRPDLRFVHH 185 (423)
Q Consensus 160 ~~l~~Li~~C~~~dP~~RPt~~~I~~ 185 (423)
.++.+++.+||+.+|++||++.+++.
T Consensus 253 ~~~~~li~~~l~~~P~~R~~~~~~l~ 278 (282)
T cd07831 253 AEGLDLLKKLLAYDPDERITAKQALR 278 (282)
T ss_pred HHHHHHHHHHhccCcccccCHHHHhh
Confidence 89999999999999999999999875
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=99.89 E-value=4e-23 Score=198.01 Aligned_cols=154 Identities=19% Similarity=0.298 Sum_probs=115.2
Q ss_pred HHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCccEEEeccCCcccccCCCcccccccccCCccccCCccccCCCCC
Q psy1840 25 SISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKAPELLRQPHLP 104 (423)
Q Consensus 25 ~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~ 104 (423)
...++.|++.||.|||+.+++ ||||||+||+++.++.+||+|||++........ ......++..|+|||.+.+..
T Consensus 102 ~~~~~~ql~~~l~~LH~~~i~-H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~-- 176 (286)
T cd07847 102 IKKIIWQTLQAVNFCHKHNCI-HRDVKPENILITKQGQIKLCDFGFARILTGPGD--DYTDYVATRWYRAPELLVGDT-- 176 (286)
T ss_pred HHHHHHHHHHHHHHHHHCCce-ecCCChhhEEEcCCCcEEECccccceecCCCcc--cccCcccccccCCHHHHhCCC--
Confidence 689999999999999999998 999999999999999999999999876543321 112334677899999987533
Q ss_pred CCCCccchHHHHHHHHHHHhCCCCCCCCCCChHHHHHHHhcC---------------C----CCCCCCC--------CCC
Q psy1840 105 RGTQKGDVYSFGLVLYEVIGRQGPWGHLRMTDEEIITSVTQG---------------S----GLRPDTS--------SLD 157 (423)
Q Consensus 105 ~~s~ksDVyS~Giil~elltg~~Pf~~~~~~~~~i~~~i~~~---------------~----~~~p~~~--------~~~ 157 (423)
..+.++||||||+++|||++|..||.... ..+....+... . ...|... ...
T Consensus 177 ~~~~~~Di~slG~i~~~l~~g~~p~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (286)
T cd07847 177 QYGPPVDVWAIGCVFAELLTGQPLWPGKS--DVDQLYLIRKTLGDLIPRHQQIFSTNQFFKGLSIPEPETREPLESKFPN 254 (286)
T ss_pred CcCchhhhHHHHHHHHHHHhCCCCCCCCC--hHHHHHHHHHHhCCCChHHhhhcccccccccccCCCcccccCHHHHhcc
Confidence 23789999999999999999999997532 22222211110 0 0000000 124
Q ss_pred chHHHHHHHHHhhhcCCCCCCCHHHHHH
Q psy1840 158 CAPSIIACMRTCWEEDPELRPDLRFVHH 185 (423)
Q Consensus 158 ~~~~l~~Li~~C~~~dP~~RPt~~~I~~ 185 (423)
.+..+.+++.+||+.+|++||++.+++.
T Consensus 255 ~~~~~~~li~~~l~~~p~~Rp~~~eil~ 282 (286)
T cd07847 255 ISSPALSFLKGCLQMDPTERLSCEELLE 282 (286)
T ss_pred CCHHHHHHHHHHhcCCccccCCHHHHhc
Confidence 5788999999999999999999998864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=99.89 E-value=7.6e-23 Score=193.13 Aligned_cols=151 Identities=17% Similarity=0.352 Sum_probs=122.4
Q ss_pred HHHHHHHHHHHHHHHH-----hCCCeeecCCCCCCEEEcCCccEEEeccCCcccccCCCcccccccccCCccccCCcccc
Q psy1840 25 SISVNTTASVGMIHLH-----DSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKAPELLR 99 (423)
Q Consensus 25 ~l~i~~qi~~gL~yLH-----~~~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~ 99 (423)
.+.++.||+.|+.||| +.+++ ||||+|+||+++.++.+||+|||++......... .....++..|+|||.+.
T Consensus 107 ~~~~~~~i~~~l~~lH~~~~~~~~i~-h~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~--~~~~~~~~~~~~pE~~~ 183 (265)
T cd08217 107 IWRILTQLLLALYECHNRSDPGNTVL-HRDLKPANIFLDANNNVKLGDFGLAKILGHDSSF--AKTYVGTPYYMSPEQLN 183 (265)
T ss_pred HHHHHHHHHHHHHHHhcCccccCcce-ecCCCHHHEEEecCCCEEEecccccccccCCccc--ccccccCCCccChhhhc
Confidence 6789999999999999 88888 9999999999999999999999998765433211 12346788899999987
Q ss_pred CCCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCchHHHHHHHHHhhhcCCCCCCC
Q psy1840 100 QPHLPRGTQKGDVYSFGLVLYEVIGRQGPWGHLRMTDEEIITSVTQGSGLRPDTSSLDCAPSIIACMRTCWEEDPELRPD 179 (423)
Q Consensus 100 ~~~~~~~s~ksDVyS~Giil~elltg~~Pf~~~~~~~~~i~~~i~~~~~~~p~~~~~~~~~~l~~Li~~C~~~dP~~RPt 179 (423)
+... +.++|+||||+++|++++|..||... ...++...+..+.. +. .....+..+.+++.+||+.+|++||+
T Consensus 184 ~~~~---~~~~Dv~slG~il~~l~~g~~p~~~~--~~~~~~~~~~~~~~--~~-~~~~~~~~~~~l~~~~l~~~p~~Rp~ 255 (265)
T cd08217 184 HMSY---DEKSDIWSLGCLIYELCALSPPFTAR--NQLQLASKIKEGKF--RR-IPYRYSSELNEVIKSMLNVDPDKRPS 255 (265)
T ss_pred CCCC---CchhHHHHHHHHHHHHHHCCCcccCc--CHHHHHHHHhcCCC--CC-CccccCHHHHHHHHHHccCCcccCCC
Confidence 7654 88999999999999999999999753 24556666655432 11 22357889999999999999999999
Q ss_pred HHHHHHH
Q psy1840 180 LRFVHHK 186 (423)
Q Consensus 180 ~~~I~~~ 186 (423)
+.+|++.
T Consensus 256 ~~~il~~ 262 (265)
T cd08217 256 TEELLQL 262 (265)
T ss_pred HHHHhhC
Confidence 9998763
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=99.89 E-value=7.4e-23 Score=196.59 Aligned_cols=155 Identities=19% Similarity=0.290 Sum_probs=116.4
Q ss_pred HHHHHHHHHHHHHHHHhC-CCeeecCCCCCCEEEcCCccEEEeccCCcccccCCCcccccccccCCccccCCccccCCCC
Q psy1840 25 SISVNTTASVGMIHLHDS-EIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKAPELLRQPHL 103 (423)
Q Consensus 25 ~l~i~~qi~~gL~yLH~~-~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~ 103 (423)
...++.|++.||.|||+. +++ ||||||+||+++.++.+||+|||++....... .....++..|+|||.+.+...
T Consensus 104 ~~~~~~~i~~~l~~LH~~~~i~-H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~ 178 (286)
T cd06622 104 LRRITYAVVKGLKFLKEEHNII-HRDVKPTNVLVNGNGQVKLCDFGVSGNLVASL----AKTNIGCQSYMAPERIKSGGP 178 (286)
T ss_pred HHHHHHHHHHHHHHHHhcCCEe-eCCCCHHHEEECCCCCEEEeecCCcccccCCc----cccCCCccCccCcchhcCCCC
Confidence 578999999999999974 777 99999999999999999999999986543221 123356778999999865421
Q ss_pred ---CCCCCccchHHHHHHHHHHHhCCCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCchHHHHHHHHHhhhcCCCCCCCH
Q psy1840 104 ---PRGTQKGDVYSFGLVLYEVIGRQGPWGHLRMTDEEIITSVTQGSGLRPDTSSLDCAPSIIACMRTCWEEDPELRPDL 180 (423)
Q Consensus 104 ---~~~s~ksDVyS~Giil~elltg~~Pf~~~~~~~~~i~~~i~~~~~~~p~~~~~~~~~~l~~Li~~C~~~dP~~RPt~ 180 (423)
...+.++|+|||||++|++++|..||.... .......+.......+......++.++.+++.+||+.+|++||++
T Consensus 179 ~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~ 256 (286)
T cd06622 179 NQNPTYTVQSDVWSLGLSILEMALGRYPYPPET--YANIFAQLSAIVDGDPPTLPSGYSDDAQDFVAKCLNKIPNRRPTY 256 (286)
T ss_pred CccCCCCcccchHhHHHHHHHHHhCCCCCCCcc--hhhHHHHHHHHhhcCCCCCCcccCHHHHHHHHHHcccCcccCCCH
Confidence 123789999999999999999999996432 222222222111111112223578999999999999999999999
Q ss_pred HHHHHH
Q psy1840 181 RFVHHK 186 (423)
Q Consensus 181 ~~I~~~ 186 (423)
.+++..
T Consensus 257 ~~l~~~ 262 (286)
T cd06622 257 AQLLEH 262 (286)
T ss_pred HHHhcC
Confidence 999874
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >KOG0604|consensus | Back alignment and domain information |
|---|
Probab=99.89 E-value=2.1e-23 Score=193.13 Aligned_cols=155 Identities=18% Similarity=0.264 Sum_probs=132.5
Q ss_pred HHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEc---CCccEEEeccCCcccccCCCcccccccccCCccccCCccccCC
Q psy1840 25 SISVNTTASVGMIHLHDSEIISHGNLRSSNCLID---SRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKAPELLRQP 101 (423)
Q Consensus 25 ~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld---~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~ 101 (423)
.-.|+.||+.++.|||+.+|- ||||||+|+|.. .+..+||+|||+++.... .....+.+-|+.|.|||++...
T Consensus 163 a~eI~~qI~~Av~~lH~~nIA-HRDlKpENLLyt~t~~na~lKLtDfGFAK~t~~---~~~L~TPc~TPyYvaPevlg~e 238 (400)
T KOG0604|consen 163 ASEIMKQIGLAVRYLHSMNIA-HRDLKPENLLYTTTSPNAPLKLTDFGFAKETQE---PGDLMTPCFTPYYVAPEVLGPE 238 (400)
T ss_pred HHHHHHHHHHHHHHHHhcchh-hccCChhheeeecCCCCcceEecccccccccCC---CccccCCcccccccCHHHhCch
Confidence 468999999999999999998 999999999996 466899999999986432 2333566789999999999776
Q ss_pred CCCCCCCccchHHHHHHHHHHHhCCCCCCCCC--CChHHHHHHHhcCCCCCCCCCCCCchHHHHHHHHHhhhcCCCCCCC
Q psy1840 102 HLPRGTQKGDVYSFGLVLYEVIGRQGPWGHLR--MTDEEIITSVTQGSGLRPDTSSLDCAPSIIACMRTCWEEDPELRPD 179 (423)
Q Consensus 102 ~~~~~s~ksDVyS~Giil~elltg~~Pf~~~~--~~~~~i~~~i~~~~~~~p~~~~~~~~~~l~~Li~~C~~~dP~~RPt 179 (423)
.+ ...+|+||+|+++|-|++|.+||.... --......++..|....|...+..+++...++|+.+|..+|.+|.|
T Consensus 239 Ky---dkscdmwSlgVimYIlLCGyPPFYS~hg~aispgMk~rI~~gqy~FP~pEWs~VSe~aKdlIR~LLkt~PteRlT 315 (400)
T KOG0604|consen 239 KY---DKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKRRIRTGQYEFPEPEWSCVSEAAKDLIRKLLKTEPTERLT 315 (400)
T ss_pred hc---CCCCCccchhHHHHHhhcCCCcccccCCccCChhHHhHhhccCccCCChhHhHHHHHHHHHHHHHhcCCchhhee
Confidence 55 899999999999999999999996432 1235677888899999998888889999999999999999999999
Q ss_pred HHHHHHH
Q psy1840 180 LRFVHHK 186 (423)
Q Consensus 180 ~~~I~~~ 186 (423)
+.++...
T Consensus 316 I~~~m~h 322 (400)
T KOG0604|consen 316 IEEVMDH 322 (400)
T ss_pred HHHhhcC
Confidence 9998764
|
|
| >KOG4645|consensus | Back alignment and domain information |
|---|
Probab=99.89 E-value=4.6e-24 Score=228.11 Aligned_cols=154 Identities=21% Similarity=0.400 Sum_probs=124.9
Q ss_pred HHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCccEEEeccCCcccccCCCc--ccccccccCCccccCCccccCCCCC
Q psy1840 27 SVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDE--TGQERKLRRRKLYKAPELLRQPHLP 104 (423)
Q Consensus 27 ~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~--~~~~~~~~gt~~y~APE~l~~~~~~ 104 (423)
.+-.|++.|+.|||++||+ ||||||.||+++.+|.+|++|||.+..+.+... ........||+.|||||++.+....
T Consensus 1338 vyt~qll~gla~LH~~gIV-HRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~~~~~~~el~~~~GT~~YMAPEvit~t~~k 1416 (1509)
T KOG4645|consen 1338 VYTKQLLEGLAYLHEHGIV-HRDIKPANILLDFNGLIKYGDFGSAVKIKNNAQTMPGELQSMMGTPMYMAPEVITGTKGK 1416 (1509)
T ss_pred HHHHHHHHHHHHHHhcCce-ecCCCccceeeecCCcEEeecccceeEecCchhcCCHHHHhhcCCchhcCchhhcccccC
Confidence 4567999999999999998 999999999999999999999999887654432 2233567899999999999886543
Q ss_pred CCCCccchHHHHHHHHHHHhCCCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCchHHHHHHHHHhhhcCCCCCCCHHHHH
Q psy1840 105 RGTQKGDVYSFGLVLYEVIGRQGPWGHLRMTDEEIITSVTQGSGLRPDTSSLDCAPSIIACMRTCWEEDPELRPDLRFVH 184 (423)
Q Consensus 105 ~~s~ksDVyS~Giil~elltg~~Pf~~~~~~~~~i~~~i~~~~~~~p~~~~~~~~~~l~~Li~~C~~~dP~~RPt~~~I~ 184 (423)
-...++||||+|||+.||+||+.||.... +.-.+...+..| ..|+.+. ..+.+-.+++.+|+..||.+|.++.+++
T Consensus 1417 G~~~A~DiWslGCVVlEM~tGkrPW~~~d-ne~aIMy~V~~g--h~Pq~P~-~ls~~g~dFle~Cl~~dP~~Rw~~~qll 1492 (1509)
T KOG4645|consen 1417 GHGGAADIWSLGCVVLEMATGKRPWAELD-NEWAIMYHVAAG--HKPQIPE-RLSSEGRDFLEHCLEQDPKMRWTASQLL 1492 (1509)
T ss_pred CCCcchhhhcccceEEEeecCCCchhhcc-chhHHHhHHhcc--CCCCCch-hhhHhHHHHHHHHHhcCchhhhHHHHHH
Confidence 34689999999999999999999997542 234566666654 3454444 4889999999999999999998887766
Q ss_pred H
Q psy1840 185 H 185 (423)
Q Consensus 185 ~ 185 (423)
+
T Consensus 1493 e 1493 (1509)
T KOG4645|consen 1493 E 1493 (1509)
T ss_pred H
Confidence 5
|
|
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=99.89 E-value=5.3e-23 Score=197.57 Aligned_cols=152 Identities=19% Similarity=0.298 Sum_probs=116.2
Q ss_pred HHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCccEEEeccCCcccccCCCcccccccccCCccccCCccccCCCCC
Q psy1840 25 SISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKAPELLRQPHLP 104 (423)
Q Consensus 25 ~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~ 104 (423)
...++.|++.||.|||+.+++ ||||||+||+++.++.+||+|||++....... .....++..|+|||.+.++.
T Consensus 99 ~~~i~~qi~~al~~lH~~~iv-H~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~-- 171 (279)
T cd05633 99 MRFYATEIILGLEHMHNRFVV-YRDLKPANILLDEHGHVRISDLGLACDFSKKK----PHASVGTHGYMAPEVLQKGT-- 171 (279)
T ss_pred HHHHHHHHHHHHHHHHHCCcC-CCCCCHHHEEECCCCCEEEccCCcceeccccC----ccCcCCCcCccCHHHhcCCC--
Confidence 578999999999999999988 99999999999999999999999976443221 12346788999999886432
Q ss_pred CCCCccchHHHHHHHHHHHhCCCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCchHHHHHHHHHhhhcCCCCCC-----C
Q psy1840 105 RGTQKGDVYSFGLVLYEVIGRQGPWGHLRMTDEEIITSVTQGSGLRPDTSSLDCAPSIIACMRTCWEEDPELRP-----D 179 (423)
Q Consensus 105 ~~s~ksDVyS~Giil~elltg~~Pf~~~~~~~~~i~~~i~~~~~~~p~~~~~~~~~~l~~Li~~C~~~dP~~RP-----t 179 (423)
..+.++|||||||++||+++|..||..........+...... ..+. .+..++.++.+++.+||..||.+|| +
T Consensus 172 ~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~--~~~~-~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~ 248 (279)
T cd05633 172 AYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLT--VNVE-LPDSFSPELKSLLEGLLQRDVSKRLGCLGRG 248 (279)
T ss_pred CCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHHHHHHhhc--CCcC-CccccCHHHHHHHHHHhcCCHHHhcCCCCCC
Confidence 237899999999999999999999965432222222222211 1111 2235788999999999999999999 5
Q ss_pred HHHHHHH
Q psy1840 180 LRFVHHK 186 (423)
Q Consensus 180 ~~~I~~~ 186 (423)
+.++++.
T Consensus 249 ~~~~~~h 255 (279)
T cd05633 249 AQEVKEH 255 (279)
T ss_pred HHHHHhC
Confidence 8887664
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=99.89 E-value=4.7e-23 Score=199.79 Aligned_cols=155 Identities=17% Similarity=0.167 Sum_probs=115.4
Q ss_pred HHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCccEEEeccCCcccccCCCcccccccccCCccccCCccccCCCCC
Q psy1840 25 SISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKAPELLRQPHLP 104 (423)
Q Consensus 25 ~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~ 104 (423)
...++.||+.||.|||+.+++ ||||||+||+++.++.+||+|||++........ ......++..|+|||.+.+..
T Consensus 106 ~~~~~~qi~~aL~~lH~~~i~-H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~-- 180 (301)
T cd07873 106 VKLFLFQLLRGLNYCHRRKVL-HRDLKPQNLLINERGELKLADFGLARAKSIPTK--TYSNEVVTLWYRPPDILLGST-- 180 (301)
T ss_pred HHHHHHHHHHHHHHHHhCCee-CCCCCHHHEEECCCCcEEECcCcchhccCCCCC--cccccceeecccCcHHHhCCC--
Confidence 467899999999999999998 999999999999999999999999865432211 112335678899999887543
Q ss_pred CCCCccchHHHHHHHHHHHhCCCCCCCCCCChHHHHHHHhcCC---------------C----CCCCC-------CCCCc
Q psy1840 105 RGTQKGDVYSFGLVLYEVIGRQGPWGHLRMTDEEIITSVTQGS---------------G----LRPDT-------SSLDC 158 (423)
Q Consensus 105 ~~s~ksDVyS~Giil~elltg~~Pf~~~~~~~~~i~~~i~~~~---------------~----~~p~~-------~~~~~ 158 (423)
..+.++||||||+++|||++|+.||... +..+....+.... . ..|.. ....+
T Consensus 181 ~~~~~~Dv~slG~~l~el~tg~~~f~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (301)
T cd07873 181 DYSTQIDMWGVGCIFYEMSTGRPLFPGS--TVEEQLHFIFRILGTPTEETWPGILSNEEFKSYNYPKYRADCLHNHAPRL 258 (301)
T ss_pred CCccHHHHHHHHHHHHHHHhCCCCCCCC--CHHHHHHHHHHHcCCCChhhchhhhccccccccccCccccccHHhhcCCC
Confidence 2378999999999999999999999743 2222222221100 0 00100 11246
Q ss_pred hHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q psy1840 159 APSIIACMRTCWEEDPELRPDLRFVHHK 186 (423)
Q Consensus 159 ~~~l~~Li~~C~~~dP~~RPt~~~I~~~ 186 (423)
+..+.+++.+||+.||.+|||+.++++.
T Consensus 259 ~~~~~~li~~ml~~dp~~R~t~~eil~h 286 (301)
T cd07873 259 DSDGAELLSKLLQFEGRKRISAEEAMKH 286 (301)
T ss_pred CHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 7889999999999999999999998763
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=99.89 E-value=3.2e-23 Score=200.90 Aligned_cols=154 Identities=16% Similarity=0.268 Sum_probs=117.9
Q ss_pred HHHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCccEEEeccCCcccccCCCcccccccccCCccccCCccccCCCC
Q psy1840 24 GSISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKAPELLRQPHL 103 (423)
Q Consensus 24 ~~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~ 103 (423)
....++.|++.||.|||+.|++ ||||||+||+++.++.+||+|||++........ ......+++.|+|||.+.+...
T Consensus 116 ~~~~~~~~l~~~L~~LH~~~i~-H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~ 192 (297)
T cd06656 116 QIAAVCRECLQALDFLHSNQVI-HRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS--KRSTMVGTPYWMAPEVVTRKAY 192 (297)
T ss_pred HHHHHHHHHHHHHHHHHHCCcc-cCCCCHHHEEECCCCCEEECcCccceEccCCcc--CcCcccCCccccCHHHHcCCCC
Confidence 3678999999999999999998 999999999999999999999999865432221 1123457788999999987654
Q ss_pred CCCCCccchHHHHHHHHHHHhCCCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCchHHHHHHHHHhhhcCCCCCCCHHHH
Q psy1840 104 PRGTQKGDVYSFGLVLYEVIGRQGPWGHLRMTDEEIITSVTQGSGLRPDTSSLDCAPSIIACMRTCWEEDPELRPDLRFV 183 (423)
Q Consensus 104 ~~~s~ksDVyS~Giil~elltg~~Pf~~~~~~~~~i~~~i~~~~~~~p~~~~~~~~~~l~~Li~~C~~~dP~~RPt~~~I 183 (423)
+.++|+||||+++|++++|..||..... ......+.... ..+.......+..+.+++.+||..+|++||++.+|
T Consensus 193 ---~~~~Di~slGvil~~l~tg~~pf~~~~~--~~~~~~~~~~~-~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~i 266 (297)
T cd06656 193 ---GPKVDIWSLGIMAIEMVEGEPPYLNENP--LRALYLIATNG-TPELQNPERLSAVFRDFLNRCLEMDVDRRGSAKEL 266 (297)
T ss_pred ---CcHHHHHHHHHHHHHHHhCCCCCCCCCc--chheeeeccCC-CCCCCCccccCHHHHHHHHHHccCChhhCcCHHHH
Confidence 7899999999999999999999964321 11111111111 11111233567889999999999999999999999
Q ss_pred HHH
Q psy1840 184 HHK 186 (423)
Q Consensus 184 ~~~ 186 (423)
++.
T Consensus 267 l~~ 269 (297)
T cd06656 267 LQH 269 (297)
T ss_pred hcC
Confidence 873
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=99.89 E-value=1e-22 Score=191.76 Aligned_cols=149 Identities=22% Similarity=0.389 Sum_probs=116.9
Q ss_pred HHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCC-ccEEEeccCCcccccCCCcccccccccCCccccCCccccCCCC
Q psy1840 25 SISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSR-WVLQIADFGLHAFKAGQDETGQERKLRRRKLYKAPELLRQPHL 103 (423)
Q Consensus 25 ~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~-~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~ 103 (423)
...++.|++.|+.|||++|++ ||||+|+||+++.+ +.+||+|||.+........ .....++..|+|||.+.+...
T Consensus 103 ~~~~~~~i~~~l~~lh~~~i~-h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~ 178 (256)
T cd08220 103 ILHFFVQILLALHHVHTKLIL-HRDLKTQNILLDKHKMVVKIGDFGISKILSSKSK---AYTVVGTPCYISPELCEGKPY 178 (256)
T ss_pred HHHHHHHHHHHHHHHHhCCee-cCCCCHHHEEEcCCCCEEEEccCCCceecCCCcc---ccccccCCcccCchhccCCCC
Confidence 578899999999999999997 99999999999854 5689999999876533221 123457778999999976544
Q ss_pred CCCCCccchHHHHHHHHHHHhCCCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCchHHHHHHHHHhhhcCCCCCCCHHHH
Q psy1840 104 PRGTQKGDVYSFGLVLYEVIGRQGPWGHLRMTDEEIITSVTQGSGLRPDTSSLDCAPSIIACMRTCWEEDPELRPDLRFV 183 (423)
Q Consensus 104 ~~~s~ksDVyS~Giil~elltg~~Pf~~~~~~~~~i~~~i~~~~~~~p~~~~~~~~~~l~~Li~~C~~~dP~~RPt~~~I 183 (423)
+.++||||||+++|++++|..||... ........+..+.. +. ....++..+.+++.+||+.+|++|||+.++
T Consensus 179 ---~~~~Dv~slG~~l~~l~~~~~~~~~~--~~~~~~~~~~~~~~--~~-~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l 250 (256)
T cd08220 179 ---NQKSDIWALGCVLYELASLKRAFEAA--NLPALVLKIMSGTF--AP-ISDRYSPDLRQLILSMLNLDPSKRPQLSQI 250 (256)
T ss_pred ---CcccchHHHHHHHHHHHhCCCCcccC--chHHHHHHHHhcCC--CC-CCCCcCHHHHHHHHHHccCChhhCCCHHHH
Confidence 88999999999999999999999743 23344444443221 11 123578899999999999999999999998
Q ss_pred HH
Q psy1840 184 HH 185 (423)
Q Consensus 184 ~~ 185 (423)
+.
T Consensus 251 l~ 252 (256)
T cd08220 251 MA 252 (256)
T ss_pred hh
Confidence 75
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.9e-23 Score=208.07 Aligned_cols=154 Identities=18% Similarity=0.215 Sum_probs=115.1
Q ss_pred HHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCccEEEeccCCcccccCCCcc------------------------
Q psy1840 25 SISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDET------------------------ 80 (423)
Q Consensus 25 ~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~~------------------------ 80 (423)
...++.|++.||.|||+.|++ ||||||+||+++.++.+||+|||++.........
T Consensus 103 ~~~~~~qi~~~L~~lH~~giv-HrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 181 (360)
T cd05627 103 TQFYIAETVLAIDAIHQLGFI-HRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRK 181 (360)
T ss_pred HHHHHHHHHHHHHHHHHCCeE-ccCCCHHHEEECCCCCEEEeeccCCcccccccccccccccccCCcccccccccccccc
Confidence 467899999999999999998 9999999999999999999999997644211100
Q ss_pred ---------cccccccCCccccCCccccCCCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCChHHHHHHHhcCCCCCC
Q psy1840 81 ---------GQERKLRRRKLYKAPELLRQPHLPRGTQKGDVYSFGLVLYEVIGRQGPWGHLRMTDEEIITSVTQGSGLRP 151 (423)
Q Consensus 81 ---------~~~~~~~gt~~y~APE~l~~~~~~~~s~ksDVyS~Giil~elltg~~Pf~~~~~~~~~i~~~i~~~~~~~p 151 (423)
.......||+.|+|||++.+..+ +.++|||||||++|||++|..||.. .+..+....+........
T Consensus 182 ~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~---~~~~DiwSlGvilyel~tG~~Pf~~--~~~~~~~~~i~~~~~~~~ 256 (360)
T cd05627 182 AETWKKNRRQLAYSTVGTPDYIAPEVFMQTGY---NKLCDWWSLGVIMYEMLIGYPPFCS--ETPQETYRKVMNWKETLV 256 (360)
T ss_pred cccccccccccccccCCCccccCHHHHcCCCC---CCcceeccccceeeecccCCCCCCC--CCHHHHHHHHHcCCCcee
Confidence 00123468999999999987655 8899999999999999999999974 344555555554221111
Q ss_pred CCCCCCchHHHHHHHHHhhhcCCCCCCC---HHHHHH
Q psy1840 152 DTSSLDCAPSIIACMRTCWEEDPELRPD---LRFVHH 185 (423)
Q Consensus 152 ~~~~~~~~~~l~~Li~~C~~~dP~~RPt---~~~I~~ 185 (423)
......+++++.+++.+++ .||.+|++ +.++++
T Consensus 257 ~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~ 292 (360)
T cd05627 257 FPPEVPISEKAKDLILRFC-TDSENRIGSNGVEEIKS 292 (360)
T ss_pred cCCCCCCCHHHHHHHHHhc-cChhhcCCCCCHHHHhc
Confidence 1111246789999999876 49999985 555543
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.89 E-value=3e-23 Score=207.93 Aligned_cols=155 Identities=17% Similarity=0.198 Sum_probs=114.5
Q ss_pred HHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCccEEEeccCCcccccCCCc------------cc-----------
Q psy1840 25 SISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDE------------TG----------- 81 (423)
Q Consensus 25 ~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~------------~~----------- 81 (423)
...++.|++.||+|||+.|++ ||||||+|||++.++.+||+|||+++....... ..
T Consensus 103 ~~~~~~ql~~aL~~LH~~giv-HrDlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 181 (377)
T cd05629 103 TRFYMAECVLAIEAVHKLGFI-HRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRIDNRNSVAV 181 (377)
T ss_pred HHHHHHHHHHHHHHHHhCCee-ccCCCHHHEEECCCCCEEEeeccccccccccccccccccccccccccccccccccccc
Confidence 356899999999999999998 999999999999999999999999853211000 00
Q ss_pred ----------------------ccccccCCccccCCccccCCCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCChHHH
Q psy1840 82 ----------------------QERKLRRRKLYKAPELLRQPHLPRGTQKGDVYSFGLVLYEVIGRQGPWGHLRMTDEEI 139 (423)
Q Consensus 82 ----------------------~~~~~~gt~~y~APE~l~~~~~~~~s~ksDVyS~Giil~elltg~~Pf~~~~~~~~~i 139 (423)
......||+.|+|||++.+..+ +.++|||||||++|||++|..||... ...+.
T Consensus 182 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~---~~~~DiwSlGvil~elltG~~Pf~~~--~~~~~ 256 (377)
T cd05629 182 DSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGY---GQECDWWSLGAIMFECLIGWPPFCSE--NSHET 256 (377)
T ss_pred ccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCC---CCceeeEecchhhhhhhcCCCCCCCC--CHHHH
Confidence 0012468899999999987655 89999999999999999999999643 33444
Q ss_pred HHHHhcCCCCCCCCCCCCchHHHHHHHHHhhhcCCCCC---CCHHHHHHH
Q psy1840 140 ITSVTQGSGLRPDTSSLDCAPSIIACMRTCWEEDPELR---PDLRFVHHK 186 (423)
Q Consensus 140 ~~~i~~~~~~~p~~~~~~~~~~l~~Li~~C~~~dP~~R---Pt~~~I~~~ 186 (423)
...+..............++.++.+++.+|+. +|.+| +++.+++..
T Consensus 257 ~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-~~~~r~~r~~~~~~l~h 305 (377)
T cd05629 257 YRKIINWRETLYFPDDIHLSVEAEDLIRRLIT-NAENRLGRGGAHEIKSH 305 (377)
T ss_pred HHHHHccCCccCCCCCCCCCHHHHHHHHHHhc-CHhhcCCCCCHHHHhcC
Confidence 44444321111111112467899999999997 77775 588887664
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.89 E-value=6.4e-23 Score=200.12 Aligned_cols=153 Identities=17% Similarity=0.228 Sum_probs=116.7
Q ss_pred HHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCccEEEeccCCcccccCCCcc------------------------
Q psy1840 25 SISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDET------------------------ 80 (423)
Q Consensus 25 ~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~~------------------------ 80 (423)
...++.|++.||.|||+.|++ ||||||+||+++.++.++|+|||++.........
T Consensus 105 ~~~~~~qi~~~l~~lH~~~i~-H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 183 (316)
T cd05574 105 ARFYAAEVLLALEYLHLLGIV-YRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIPSETFSE 183 (316)
T ss_pred HHHHHHHHHHHHHHHHHCCee-ccCCChHHeEEcCCCCEEEeecchhhcccccccccccccccccccccccccchhhhcc
Confidence 568899999999999999987 9999999999999999999999997654221110
Q ss_pred ---cccccccCCccccCCccccCCCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCChHHHHHHHhcCCCCCCCCCCCC
Q psy1840 81 ---GQERKLRRRKLYKAPELLRQPHLPRGTQKGDVYSFGLVLYEVIGRQGPWGHLRMTDEEIITSVTQGSGLRPDTSSLD 157 (423)
Q Consensus 81 ---~~~~~~~gt~~y~APE~l~~~~~~~~s~ksDVyS~Giil~elltg~~Pf~~~~~~~~~i~~~i~~~~~~~p~~~~~~ 157 (423)
.......|+..|+|||.+.+... +.++||||||+++|+|++|..||... ...+....+.......+.. ..
T Consensus 184 ~~~~~~~~~~g~~~y~aPE~~~~~~~---~~~~Di~slG~ll~~l~~g~~pf~~~--~~~~~~~~~~~~~~~~~~~--~~ 256 (316)
T cd05574 184 EPSFRSNSFVGTEEYIAPEVISGDGH---GSAVDWWTLGILLYEMLYGTTPFKGS--NRDETFSNILKKEVTFPGS--PP 256 (316)
T ss_pred cccCCCCCCcCccCCcCHHHHcCCCC---CchHHHHHHHHHHHHHhhCCCCCCCC--chHHHHHHHhcCCccCCCc--cc
Confidence 01113356788999999987654 88999999999999999999999643 2333334443332222221 23
Q ss_pred chHHHHHHHHHhhhcCCCCCCC----HHHHHH
Q psy1840 158 CAPSIIACMRTCWEEDPELRPD----LRFVHH 185 (423)
Q Consensus 158 ~~~~l~~Li~~C~~~dP~~RPt----~~~I~~ 185 (423)
.+..+.+++++||+.+|++||+ +.+++.
T Consensus 257 ~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~ 288 (316)
T cd05574 257 VSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQ 288 (316)
T ss_pred cCHHHHHHHHHHccCCHhHCCCchhhHHHHHc
Confidence 6889999999999999999999 666654
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.89 E-value=5.6e-23 Score=221.29 Aligned_cols=162 Identities=20% Similarity=0.265 Sum_probs=120.5
Q ss_pred HHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCccEEEeccCCcccccCCCc----------------ccccccccC
Q psy1840 25 SISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDE----------------TGQERKLRR 88 (423)
Q Consensus 25 ~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~----------------~~~~~~~~g 88 (423)
.++++.||+.||+|||+.|++ ||||||+||+++.++.+||+|||++........ ........|
T Consensus 115 iL~I~~QIa~AL~yLHs~GII-HRDLKPeNILLd~dg~vKLiDFGLAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vG 193 (932)
T PRK13184 115 FLSIFHKICATIEYVHSKGVL-HRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVG 193 (932)
T ss_pred HHHHHHHHHHHHHHHHHCCcc-ccCCchheEEEcCCCCEEEEecCcceecccccccccccccccccccccccccCCCCCC
Confidence 478999999999999999998 999999999999999999999999876521110 001123468
Q ss_pred CccccCCccccCCCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCchHHHHHHHHH
Q psy1840 89 RKLYKAPELLRQPHLPRGTQKGDVYSFGLVLYEVIGRQGPWGHLRMTDEEIITSVTQGSGLRPDTSSLDCAPSIIACMRT 168 (423)
Q Consensus 89 t~~y~APE~l~~~~~~~~s~ksDVyS~Giil~elltg~~Pf~~~~~~~~~i~~~i~~~~~~~p~~~~~~~~~~l~~Li~~ 168 (423)
|+.|+|||.+.+... +.++|||||||++|||++|..||.... ...+........+. ...+...+++.+.+++.+
T Consensus 194 T~~YmAPE~l~g~~~---S~kSDIWSLGVILyELLTG~~PF~~~~--~~ki~~~~~i~~P~-~~~p~~~iP~~L~~LI~r 267 (932)
T PRK13184 194 TPDYMAPERLLGVPA---SESTDIYALGVILYQMLTLSFPYRRKK--GRKISYRDVILSPI-EVAPYREIPPFLSQIAMK 267 (932)
T ss_pred CCCCCCHHHhcCCCC---CcHhHHHHHHHHHHHHHHCCCCCCCcc--hhhhhhhhhccChh-hccccccCCHHHHHHHHH
Confidence 999999999987655 899999999999999999999996422 12222111111111 011123578899999999
Q ss_pred hhhcCCCCCC-CHHHHHHHHHHHhhh
Q psy1840 169 CWEEDPELRP-DLRFVHHKLKEMNAG 193 (423)
Q Consensus 169 C~~~dP~~RP-t~~~I~~~L~~i~~~ 193 (423)
||+.||++|| ++.++.+.|+....+
T Consensus 268 cL~~DP~kR~ss~eeLl~~Le~~lq~ 293 (932)
T PRK13184 268 ALAVDPAERYSSVQELKQDLEPHLQG 293 (932)
T ss_pred HccCChhhCcCHHHHHHHHHHHHHhc
Confidence 9999999996 467777777666543
|
|
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.1e-22 Score=190.18 Aligned_cols=150 Identities=21% Similarity=0.365 Sum_probs=117.5
Q ss_pred HHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCccEEEeccCCcccccCCCcccccccccCCccccCCccccCCCCC
Q psy1840 25 SISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKAPELLRQPHLP 104 (423)
Q Consensus 25 ~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~ 104 (423)
...++.|++.|+.|||..|++ ||||+|+||+++.++.++|+|||.+........ .....++..|+|||.+.+...
T Consensus 100 ~~~i~~~i~~~l~~lh~~~i~-h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~---~~~~~~~~~~~~PE~~~~~~~- 174 (253)
T cd05122 100 IAYVCKELLKGLEYLHSNGII-HRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA---RNTMVGTPYWMAPEVINGKPY- 174 (253)
T ss_pred HHHHHHHHHHHHHHhhcCCEe-cCCCCHHHEEEccCCeEEEeecccccccccccc---ccceecCCcccCHHHHcCCCC-
Confidence 578999999999999999987 999999999999999999999999876543321 234567788999999887654
Q ss_pred CCCCccchHHHHHHHHHHHhCCCCCCCCCCChHHHHHHHhcCCCCCCCCC-CCCchHHHHHHHHHhhhcCCCCCCCHHHH
Q psy1840 105 RGTQKGDVYSFGLVLYEVIGRQGPWGHLRMTDEEIITSVTQGSGLRPDTS-SLDCAPSIIACMRTCWEEDPELRPDLRFV 183 (423)
Q Consensus 105 ~~s~ksDVyS~Giil~elltg~~Pf~~~~~~~~~i~~~i~~~~~~~p~~~-~~~~~~~l~~Li~~C~~~dP~~RPt~~~I 183 (423)
+.++|+||||++++++++|+.||.... ..+........ ..+... ...++..+.+++.+||+.||++|||+.++
T Consensus 175 --~~~~Dv~slG~il~~l~~g~~p~~~~~--~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~~~ 248 (253)
T cd05122 175 --DYKADIWSLGITAIELAEGKPPYSELP--PMKALFKIATN--GPPGLRNPEKWSDEFKDFLKKCLQKNPEKRPTAEQL 248 (253)
T ss_pred --CccccHHHHHHHHHHHHhCCCCCCCCc--hHHHHHHHHhc--CCCCcCcccccCHHHHHHHHHHccCChhhCCCHHHH
Confidence 889999999999999999999997432 22223232221 111111 22347899999999999999999999998
Q ss_pred HH
Q psy1840 184 HH 185 (423)
Q Consensus 184 ~~ 185 (423)
++
T Consensus 249 l~ 250 (253)
T cd05122 249 LK 250 (253)
T ss_pred hc
Confidence 75
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=99.89 E-value=9.6e-23 Score=194.49 Aligned_cols=149 Identities=14% Similarity=0.201 Sum_probs=114.5
Q ss_pred HHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCc-cEEEeccCCcccccCCCcccccccccCCccccCCccccCCCC
Q psy1840 25 SISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRW-VLQIADFGLHAFKAGQDETGQERKLRRRKLYKAPELLRQPHL 103 (423)
Q Consensus 25 ~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~-~vKL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~ 103 (423)
...++.|+++|+.|||+.|++ ||||||+||+++.++ .++|+|||++...... ....++..|+|||.+.+..+
T Consensus 111 ~~~~~~qi~~~l~~lH~~~i~-H~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~------~~~~~~~~y~aPE~~~~~~~ 183 (267)
T PHA03390 111 VKKIIRQLVEALNDLHKHNII-HNDIKLENVLYDRAKDRIYLCDYGLCKIIGTP------SCYDGTLDYFSPEKIKGHNY 183 (267)
T ss_pred HHHHHHHHHHHHHHHHhCCee-eCCCCHHHEEEeCCCCeEEEecCccceecCCC------ccCCCCCcccChhhhcCCCC
Confidence 578999999999999999987 999999999999998 9999999997654322 23357788999999987654
Q ss_pred CCCCCccchHHHHHHHHHHHhCCCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCchHHHHHHHHHhhhcCCCCCCC-HHH
Q psy1840 104 PRGTQKGDVYSFGLVLYEVIGRQGPWGHLRMTDEEIITSVTQGSGLRPDTSSLDCAPSIIACMRTCWEEDPELRPD-LRF 182 (423)
Q Consensus 104 ~~~s~ksDVyS~Giil~elltg~~Pf~~~~~~~~~i~~~i~~~~~~~p~~~~~~~~~~l~~Li~~C~~~dP~~RPt-~~~ 182 (423)
+.++||||||+++||+++|..||.......-. ...+.......+ .....+++.+.+++.+||+.+|.+||+ +++
T Consensus 184 ---~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~-~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~ 258 (267)
T PHA03390 184 ---DVSFDWWAVGVLTYELLTGKHPFKEDEDEELD-LESLLKRQQKKL-PFIKNVSKNANDFVQSMLKYNINYRLTNYNE 258 (267)
T ss_pred ---CchhhHHHHHHHHHHHHHCCCCCCCCCcchhh-HHHHHHhhcccC-CcccccCHHHHHHHHHHhccChhhCCchHHH
Confidence 78999999999999999999999743221111 111111111111 122357899999999999999999995 688
Q ss_pred HHH
Q psy1840 183 VHH 185 (423)
Q Consensus 183 I~~ 185 (423)
+++
T Consensus 259 ~l~ 261 (267)
T PHA03390 259 IIK 261 (267)
T ss_pred Hhc
Confidence 764
|
|
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.89 E-value=1e-22 Score=195.29 Aligned_cols=156 Identities=18% Similarity=0.259 Sum_probs=116.1
Q ss_pred HHHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCccEEEeccCCcccccCCCcccccccccCCccccCCccccCCCC
Q psy1840 24 GSISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKAPELLRQPHL 103 (423)
Q Consensus 24 ~~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~ 103 (423)
....++.|++.||.|||+.+++ ||||+|+||+++.++.+||+|||++........ .......++..|+|||.+.+..
T Consensus 101 ~~~~~~~~i~~~l~~LH~~~i~-H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~-~~~~~~~~~~~~~~PE~~~~~~- 177 (288)
T cd07833 101 AVRSYIWQLLQAIAYCHSHNII-HRDIKPENILVSESGVLKLCDFGFARALRARPA-SPLTDYVATRWYRAPELLVGDT- 177 (288)
T ss_pred HHHHHHHHHHHHHHHHHHCCee-cCCCCHHHeEECCCCCEEEEeeecccccCCCcc-ccccCcccccCCcCCchhcCCC-
Confidence 3578999999999999999987 999999999999999999999999876543322 1123345678899999998762
Q ss_pred CCCCCccchHHHHHHHHHHHhCCCCCCCCCCChHHHHHHHhcC---------------C---C-CCCC---------CCC
Q psy1840 104 PRGTQKGDVYSFGLVLYEVIGRQGPWGHLRMTDEEIITSVTQG---------------S---G-LRPD---------TSS 155 (423)
Q Consensus 104 ~~~s~ksDVyS~Giil~elltg~~Pf~~~~~~~~~i~~~i~~~---------------~---~-~~p~---------~~~ 155 (423)
..+.++||||||+++|++++|..||..... .+....+... . . ..+. ...
T Consensus 178 -~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (288)
T cd07833 178 -NYGKPVDVWAIGCIMAELLDGEPLFPGDSD--IDQLYLIQKCLGPLPPSHQELFSSNPRFAGVAFPEPSQPESLERRYP 254 (288)
T ss_pred -CcCchhhHHHHHHHHHHHHhCCCCCCCCCH--HHHHHHHHHHhCCCCHHHhhhcccCccccccccCCCCCcHHHHHhcC
Confidence 238899999999999999999999964321 1111111100 0 0 0000 011
Q ss_pred CCchHHHHHHHHHhhhcCCCCCCCHHHHHH
Q psy1840 156 LDCAPSIIACMRTCWEEDPELRPDLRFVHH 185 (423)
Q Consensus 156 ~~~~~~l~~Li~~C~~~dP~~RPt~~~I~~ 185 (423)
..++.++.+++++||..+|++||++.++++
T Consensus 255 ~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 284 (288)
T cd07833 255 GKVSSPALDFLKACLRMDPKERLTCDELLQ 284 (288)
T ss_pred CccchHHHHHHHHHhccCchhcccHHHHhc
Confidence 234788999999999999999999998865
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=99.89 E-value=9.7e-23 Score=191.99 Aligned_cols=151 Identities=21% Similarity=0.371 Sum_probs=117.9
Q ss_pred HHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCccEEEeccCCcccccCCCcccccccccCCccccCCccccCCCCC
Q psy1840 25 SISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKAPELLRQPHLP 104 (423)
Q Consensus 25 ~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~ 104 (423)
...++.|++.|+.|||+.|++ ||||+|+||+++.++.+||+|||++....... ......++..|+|||.+....
T Consensus 104 ~~~~~~~i~~~l~~lH~~~i~-H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~~---~~~~~~~~~~y~~pe~~~~~~-- 177 (258)
T cd06632 104 IRLYTRQILLGLEYLHDRNTV-HRDIKGANILVDTNGVVKLADFGMAKQVVEFS---FAKSFKGSPYWMAPEVIAQQG-- 177 (258)
T ss_pred HHHHHHHHHHHHHHHHHCCcc-cCCCCHHHEEECCCCCEEEccCccceeccccc---cccccCCCcceeCHHHhcCCC--
Confidence 568899999999999999998 99999999999999999999999977643322 123455778899999987654
Q ss_pred CCCCccchHHHHHHHHHHHhCCCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCchHHHHHHHHHhhhcCCCCCCCHHHHH
Q psy1840 105 RGTQKGDVYSFGLVLYEVIGRQGPWGHLRMTDEEIITSVTQGSGLRPDTSSLDCAPSIIACMRTCWEEDPELRPDLRFVH 184 (423)
Q Consensus 105 ~~s~ksDVyS~Giil~elltg~~Pf~~~~~~~~~i~~~i~~~~~~~p~~~~~~~~~~l~~Li~~C~~~dP~~RPt~~~I~ 184 (423)
..+.++|+||||+++|++++|+.||.... ..+....+.... ..+.. ...+++.+.+++.+||+.+|++||++.+++
T Consensus 178 ~~~~~~D~~slG~~l~~l~~g~~pf~~~~--~~~~~~~~~~~~-~~~~~-~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l 253 (258)
T cd06632 178 GYGLAADIWSLGCTVLEMATGKPPWSQLE--GVAAVFKIGRSK-ELPPI-PDHLSDEAKDFILKCLQRDPSLRPTAAELL 253 (258)
T ss_pred CCCchhhhHHHHHHHHHHHhCCCCcccCc--HHHHHHHHHhcc-cCCCc-CCCcCHHHHHHHHHHhhcCcccCcCHHHHh
Confidence 23889999999999999999999997532 222222322211 12222 235789999999999999999999999987
Q ss_pred H
Q psy1840 185 H 185 (423)
Q Consensus 185 ~ 185 (423)
.
T Consensus 254 ~ 254 (258)
T cd06632 254 E 254 (258)
T ss_pred c
Confidence 5
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.89 E-value=6.7e-23 Score=196.43 Aligned_cols=155 Identities=19% Similarity=0.193 Sum_probs=113.9
Q ss_pred HHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCccEEEeccCCcccccCCCcccccccccCCccccCCccccCCCCC
Q psy1840 25 SISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKAPELLRQPHLP 104 (423)
Q Consensus 25 ~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~ 104 (423)
.+.++.|++.||.|||+.+++ ||||+|+||+++.++.++|+|||++......... .....++..|+|||.+.+..
T Consensus 101 ~~~~~~~i~~~L~~lH~~~~~-H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~--~~~~~~~~~~~aPE~~~~~~-- 175 (283)
T cd07835 101 IKSYLYQLLQGIAYCHSHRVL-HRDLKPQNLLIDREGALKLADFGLARAFGVPVRT--YTHEVVTLWYRAPEILLGSR-- 175 (283)
T ss_pred HHHHHHHHHHHHHHHHHCCee-CCCCCHHHEEEcCCCcEEEeecccccccCCCccc--cCccccccCCCCCceeecCc--
Confidence 689999999999999999988 9999999999999999999999998654322111 12234577899999886543
Q ss_pred CCCCccchHHHHHHHHHHHhCCCCCCCCCCChHHHHHHHhc------------------------CCCCCCCCCCCCchH
Q psy1840 105 RGTQKGDVYSFGLVLYEVIGRQGPWGHLRMTDEEIITSVTQ------------------------GSGLRPDTSSLDCAP 160 (423)
Q Consensus 105 ~~s~ksDVyS~Giil~elltg~~Pf~~~~~~~~~i~~~i~~------------------------~~~~~p~~~~~~~~~ 160 (423)
..+.++|+||||+++|+|++|+.||..... ..++...... .....+.......+.
T Consensus 176 ~~~~~~Di~slG~~l~~l~~g~~pf~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (283)
T cd07835 176 QYSTPVDIWSIGCIFAEMVNRRPLFPGDSE-IDQLFRIFRTLGTPDEDVWPGVTSLPDYKPTFPKWARQDLSKVVPNLDE 254 (283)
T ss_pred ccCcHHHHHHHHHHHHHHHhCCCCCCCCCH-HHHHHHHHHHhCCCChHHhhhhhhchhhhhhcccccccchhhhcCCCCH
Confidence 237899999999999999999999964321 1111111110 000001111235678
Q ss_pred HHHHHHHHhhhcCCCCCCCHHHHHH
Q psy1840 161 SIIACMRTCWEEDPELRPDLRFVHH 185 (423)
Q Consensus 161 ~l~~Li~~C~~~dP~~RPt~~~I~~ 185 (423)
.+.+++.+||+.+|.+||++.+++.
T Consensus 255 ~~~~li~~~l~~~P~~Rpt~~~il~ 279 (283)
T cd07835 255 DGLDLLSKMLVYDPAKRISAKAALQ 279 (283)
T ss_pred HHHHHHHHHhcCChhhCcCHHHHhc
Confidence 8999999999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >KOG0032|consensus | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.1e-22 Score=202.39 Aligned_cols=153 Identities=23% Similarity=0.287 Sum_probs=132.7
Q ss_pred HHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCC----ccEEEeccCCcccccCCCcccccccccCCccccCCccccC
Q psy1840 25 SISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSR----WVLQIADFGLHAFKAGQDETGQERKLRRRKLYKAPELLRQ 100 (423)
Q Consensus 25 ~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~----~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~ 100 (423)
...++.|++.++.|||+.|++ ||||||+|+|+... +.+|++|||++..... .......+||+.|+|||++..
T Consensus 137 a~~~~~~il~av~~lH~~gvv-HrDlKpEN~L~~~~~~~~~~ik~~DFGla~~~~~---~~~~~~~~Gtp~y~APEvl~~ 212 (382)
T KOG0032|consen 137 AAGIIRQILEAVKYLHSLGVV-HRDLKPENLLLASKDEGSGRIKLIDFGLAKFIKP---GERLHTIVGTPEYVAPEVLGG 212 (382)
T ss_pred HHHHHHHHHHHHHHHHhCCce-eccCCHHHeeeccccCCCCcEEEeeCCCceEccC---CceEeeecCCccccCchhhcC
Confidence 578999999999999999998 99999999999643 5799999999987654 223457789999999999987
Q ss_pred CCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCchHHHHHHHHHhhhcCCCCCCCH
Q psy1840 101 PHLPRGTQKGDVYSFGLVLYEVIGRQGPWGHLRMTDEEIITSVTQGSGLRPDTSSLDCAPSIIACMRTCWEEDPELRPDL 180 (423)
Q Consensus 101 ~~~~~~s~ksDVyS~Giil~elltg~~Pf~~~~~~~~~i~~~i~~~~~~~p~~~~~~~~~~l~~Li~~C~~~dP~~RPt~ 180 (423)
..+ +..+||||+|+++|.|++|..||.+ .+..+....+..+....+......++..+.+++..|+..||..|+|+
T Consensus 213 ~~y---~~~~DiWS~Gvi~yiLL~G~~PF~~--~~~~~~~~~i~~~~~~f~~~~w~~is~~akd~i~~ll~~dp~~R~ta 287 (382)
T KOG0032|consen 213 RPY---GDEVDVWSIGVILYILLSGVPPFWG--ETEFEIFLAILRGDFDFTSEPWDDISESAKDFIRKLLEFDPRKRLTA 287 (382)
T ss_pred CCC---CcccchhHHHHHHHHHhhCCCCCcC--CChhHHHHHHHcCCCCCCCCCccccCHHHHHHHHHhcccCcccCCCH
Confidence 665 9999999999999999999999974 44456666888887766666677889999999999999999999999
Q ss_pred HHHHHH
Q psy1840 181 RFVHHK 186 (423)
Q Consensus 181 ~~I~~~ 186 (423)
.++++.
T Consensus 288 ~~~L~H 293 (382)
T KOG0032|consen 288 AQALQH 293 (382)
T ss_pred HHHhcC
Confidence 999885
|
|
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.2e-22 Score=194.64 Aligned_cols=152 Identities=20% Similarity=0.253 Sum_probs=115.1
Q ss_pred HHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCccEEEeccCCcccccCCCcccccccccCCccccCCccccCCCCC
Q psy1840 25 SISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKAPELLRQPHLP 104 (423)
Q Consensus 25 ~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~ 104 (423)
...++.|++.||.|||+.+++ |+||+|+||+++.++.+||+|||++........ .....++..|+|||.+.+...
T Consensus 109 ~~~~~~~i~~al~~LH~~~i~-h~~l~~~nili~~~~~~~l~dfg~~~~~~~~~~---~~~~~~~~~~~~PE~~~~~~~- 183 (287)
T cd07838 109 IKDLMRQLLRGVDFLHSHRIV-HRDLKPQNILVTSDGQVKIADFGLARIYSFEMA---LTSVVVTLWYRAPEVLLQSSY- 183 (287)
T ss_pred HHHHHHHHHHHHHHHHHCCee-eccCChhhEEEccCCCEEEeccCcceeccCCcc---cccccccccccChHHhccCCC-
Confidence 689999999999999999987 999999999999999999999999876532221 123346778999999987654
Q ss_pred CCCCccchHHHHHHHHHHHhCCCCCCCCCCChHHHHHHHhcCCC----------------CCCC-------CCCCCchHH
Q psy1840 105 RGTQKGDVYSFGLVLYEVIGRQGPWGHLRMTDEEIITSVTQGSG----------------LRPD-------TSSLDCAPS 161 (423)
Q Consensus 105 ~~s~ksDVyS~Giil~elltg~~Pf~~~~~~~~~i~~~i~~~~~----------------~~p~-------~~~~~~~~~ 161 (423)
+.++|+|||||++|||++|..||... +..+....+..... ..+. ......++.
T Consensus 184 --~~~~Di~s~G~~l~~l~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (287)
T cd07838 184 --ATPVDMWSVGCIFAELFRRRPLFRGT--SEADQLDKIFDVIGLPSEEEWPRNVSLPRSSFPSYTPRSFKSFVPEICEE 259 (287)
T ss_pred --CCcchhhhHHHHHHHHHhCCCcccCC--ChHHHHHHHHHHcCCCChHhcCCCcccchhhcccccccchhhhhhhhhHH
Confidence 88999999999999999999998643 23333333221000 0000 001134577
Q ss_pred HHHHHHHhhhcCCCCCCCHHHHHH
Q psy1840 162 IIACMRTCWEEDPELRPDLRFVHH 185 (423)
Q Consensus 162 l~~Li~~C~~~dP~~RPt~~~I~~ 185 (423)
+.+++.+||+.||.+||++.+++.
T Consensus 260 ~~~li~~~l~~dp~~Rp~~~~il~ 283 (287)
T cd07838 260 GLDLLKKMLTFNPHKRISAFEALQ 283 (287)
T ss_pred HHHHHHHHhccCCccCCCHHHHhc
Confidence 889999999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.4e-22 Score=194.87 Aligned_cols=153 Identities=21% Similarity=0.351 Sum_probs=118.5
Q ss_pred HHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCccEEEeccCCcccccCCCcccccccccCCccccCCccccCCCCC
Q psy1840 25 SISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKAPELLRQPHLP 104 (423)
Q Consensus 25 ~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~ 104 (423)
...++.|++.||.|||+.|++ |+||+|+||+++.++.++|+|||++........ ......++..|+|||.+.+..+
T Consensus 118 ~~~i~~~i~~~L~~lH~~gi~-H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~- 193 (286)
T cd06614 118 IAYVCREVLQGLEYLHSQNVI-HRDIKSDNILLSKDGSVKLADFGFAAQLTKEKS--KRNSVVGTPYWMAPEVIKRKDY- 193 (286)
T ss_pred HHHHHHHHHHHHHHHHhCCee-eCCCChhhEEEcCCCCEEECccchhhhhccchh--hhccccCCcccCCHhHhcCCCC-
Confidence 678999999999999999998 999999999999999999999998765432211 1123456778999999876554
Q ss_pred CCCCccchHHHHHHHHHHHhCCCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCchHHHHHHHHHhhhcCCCCCCCHHHHH
Q psy1840 105 RGTQKGDVYSFGLVLYEVIGRQGPWGHLRMTDEEIITSVTQGSGLRPDTSSLDCAPSIIACMRTCWEEDPELRPDLRFVH 184 (423)
Q Consensus 105 ~~s~ksDVyS~Giil~elltg~~Pf~~~~~~~~~i~~~i~~~~~~~p~~~~~~~~~~l~~Li~~C~~~dP~~RPt~~~I~ 184 (423)
+.++|+||||+++|++++|..||... ........+..... .+......++..+.+++.+||+.+|.+||++.+|+
T Consensus 194 --~~~~Dv~slGvil~~l~~g~~p~~~~--~~~~~~~~~~~~~~-~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il 268 (286)
T cd06614 194 --GPKVDIWSLGIMCIEMAEGEPPYLRE--PPLRALFLITTKGI-PPLKNPEKWSPEFKDFLNKCLVKDPEKRPSAEELL 268 (286)
T ss_pred --CCccccHHHHHHHHHHHhCCCCCCCC--CHHHHHHHHHhcCC-CCCcchhhCCHHHHHHHHHHhccChhhCcCHHHHh
Confidence 88999999999999999999999642 33333333332221 11112234788999999999999999999999997
Q ss_pred HH
Q psy1840 185 HK 186 (423)
Q Consensus 185 ~~ 186 (423)
..
T Consensus 269 ~~ 270 (286)
T cd06614 269 QH 270 (286)
T ss_pred hC
Confidence 63
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=99.89 E-value=9.9e-23 Score=195.34 Aligned_cols=155 Identities=17% Similarity=0.174 Sum_probs=113.7
Q ss_pred HHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCccEEEeccCCcccccCCCcccccccccCCccccCCccccCCCCC
Q psy1840 25 SISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKAPELLRQPHLP 104 (423)
Q Consensus 25 ~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~ 104 (423)
...++.|++.||+|||+.+++ ||||+|+||+++.++.+||+|||++........ ......++..|+|||.+.+..
T Consensus 102 ~~~~~~~i~~~l~~lh~~~i~-H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~-- 176 (284)
T cd07860 102 IKSYLFQLLQGLAFCHSHRVL-HRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--TYTHEVVTLWYRAPEILLGCK-- 176 (284)
T ss_pred HHHHHHHHHHHHHHHHHCCee-cCCCCHHHEEECCCCCEEEeeccchhhcccCcc--ccccccccccccCCeEEecCC--
Confidence 578999999999999999988 999999999999999999999999765432211 112234577899999887643
Q ss_pred CCCCccchHHHHHHHHHHHhCCCCCCCCCCChHHHHHHHhcCCC-----------------CCCC-------CCCCCchH
Q psy1840 105 RGTQKGDVYSFGLVLYEVIGRQGPWGHLRMTDEEIITSVTQGSG-----------------LRPD-------TSSLDCAP 160 (423)
Q Consensus 105 ~~s~ksDVyS~Giil~elltg~~Pf~~~~~~~~~i~~~i~~~~~-----------------~~p~-------~~~~~~~~ 160 (423)
..+.++||||||+++|||++|+.||..... .......+..... ..+. .....+++
T Consensus 177 ~~~~~~Dv~slG~il~~l~tg~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (284)
T cd07860 177 YYSTAVDIWSLGCIFAEMVTRRALFPGDSE-IDQLFRIFRTLGTPDEVVWPGVTSLPDYKPSFPKWARQDFSKVVPPLDE 255 (284)
T ss_pred CCCcHHHHHHHHHHHHHHHHCCCCCCCCCH-HHHHHHHHHHhCCCChhhhhhhhHHHHHHhhcccccccCHHHHcccCCH
Confidence 237889999999999999999999964321 1222211111000 0000 00123577
Q ss_pred HHHHHHHHhhhcCCCCCCCHHHHHH
Q psy1840 161 SIIACMRTCWEEDPELRPDLRFVHH 185 (423)
Q Consensus 161 ~l~~Li~~C~~~dP~~RPt~~~I~~ 185 (423)
++.+++.+||+.||.+||++.+++.
T Consensus 256 ~~~~li~~~l~~~P~~Rpt~~~~l~ 280 (284)
T cd07860 256 DGRDLLSQMLHYDPNKRISAKAALA 280 (284)
T ss_pred HHHHHHHHhcCCCcccCCCHHHHhc
Confidence 8999999999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.6e-22 Score=194.63 Aligned_cols=154 Identities=21% Similarity=0.358 Sum_probs=119.4
Q ss_pred HHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCccEEEeccCCcccccCCCcccccccccCCccccCCccccCCCCC
Q psy1840 25 SISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKAPELLRQPHLP 104 (423)
Q Consensus 25 ~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~ 104 (423)
...++.||+.||.|||+.+++ ||||+|.||+++.++.++|+|||++........ ....++..|+|||.+.+..+
T Consensus 107 ~~~i~~~i~~~L~~lH~~~i~-H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~----~~~~~~~~y~~pE~~~~~~~- 180 (287)
T cd06621 107 LGKIAESVLKGLSYLHSRKII-HRDIKPSNILLTRKGQVKLCDFGVSGELVNSLA----GTFTGTSFYMAPERIQGKPY- 180 (287)
T ss_pred HHHHHHHHHHHHHHHHHCCcc-cCCCCHHHEEEecCCeEEEeecccccccccccc----ccccCCccccCHHHhcCCCC-
Confidence 568999999999999999998 999999999999999999999999765432211 23456778999999877654
Q ss_pred CCCCccchHHHHHHHHHHHhCCCCCCCCC---CChHHHHHHHhcCCCCC-CCCC--CCCchHHHHHHHHHhhhcCCCCCC
Q psy1840 105 RGTQKGDVYSFGLVLYEVIGRQGPWGHLR---MTDEEIITSVTQGSGLR-PDTS--SLDCAPSIIACMRTCWEEDPELRP 178 (423)
Q Consensus 105 ~~s~ksDVyS~Giil~elltg~~Pf~~~~---~~~~~i~~~i~~~~~~~-p~~~--~~~~~~~l~~Li~~C~~~dP~~RP 178 (423)
+.++||||||+++|+|++|..||.... ....+....+....... +... ....++.+.+++.+||..+|++||
T Consensus 181 --~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp 258 (287)
T cd06621 181 --SITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMPNPELKDEPGNGIKWSEEFKDFIKQCLEKDPTRRP 258 (287)
T ss_pred --CchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhcCCchhhccCCCCCCchHHHHHHHHHHHcCCCcccCC
Confidence 889999999999999999999997542 23344444444322111 1111 124578899999999999999999
Q ss_pred CHHHHHHH
Q psy1840 179 DLRFVHHK 186 (423)
Q Consensus 179 t~~~I~~~ 186 (423)
|+.+++..
T Consensus 259 t~~eil~~ 266 (287)
T cd06621 259 TPWDMLEH 266 (287)
T ss_pred CHHHHHhC
Confidence 99999874
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.3e-22 Score=199.25 Aligned_cols=158 Identities=15% Similarity=0.256 Sum_probs=112.3
Q ss_pred HHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCccEEEeccCCcccccCCCcc-----cccccccCCccccCCcccc
Q psy1840 25 SISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDET-----GQERKLRRRKLYKAPELLR 99 (423)
Q Consensus 25 ~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~~-----~~~~~~~gt~~y~APE~l~ 99 (423)
...++.|++.||.|||+++++ ||||||+||+++.++.++++|||........... .......++..|+|||.+.
T Consensus 103 ~~~i~~qi~~~L~~LH~~~ii-H~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~ 181 (327)
T cd08227 103 IAYILQGVLKALDYIHHMGYV-HRSVKASHILISVDGKVYLSGLRSNLSMINHGQRLRVVHDFPKYSVKVLPWLSPEVLQ 181 (327)
T ss_pred HHHHHHHHHHHHHHHHHCCEe-cCCCChhhEEEecCCcEEEcccchhhccccccccccccccccccccceecccChHHhh
Confidence 578999999999999999988 9999999999999999999999864432211110 0011234566799999987
Q ss_pred CCCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCChHHHHHHHhcCC-C------------------------------
Q psy1840 100 QPHLPRGTQKGDVYSFGLVLYEVIGRQGPWGHLRMTDEEIITSVTQGS-G------------------------------ 148 (423)
Q Consensus 100 ~~~~~~~s~ksDVyS~Giil~elltg~~Pf~~~~~~~~~i~~~i~~~~-~------------------------------ 148 (423)
+... .++.++|||||||++|||++|..||..... .........+. +
T Consensus 182 ~~~~-~~~~~~DiwslG~il~el~~g~~pf~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (327)
T cd08227 182 QNLQ-GYDAKSDIYSVGITACELANGHVPFKDMPA--TQMLLEKLNGTVPCLLDTTTIPAEELTMKPSRSGANSGLGEST 258 (327)
T ss_pred cccC-CCCchhhHHHHHHHHHHHHHCCCCCCCcch--hHHHHHHhcCCccccccccchhhhhcccCCcccCCcCCCCccc
Confidence 6321 248899999999999999999999974321 11111111100 0
Q ss_pred ----CCCC-------CCCCCchHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q psy1840 149 ----LRPD-------TSSLDCAPSIIACMRTCWEEDPELRPDLRFVHHK 186 (423)
Q Consensus 149 ----~~p~-------~~~~~~~~~l~~Li~~C~~~dP~~RPt~~~I~~~ 186 (423)
.++. .....+++.+.+++.+||+.||++|||+.++++.
T Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~~ 307 (327)
T cd08227 259 TVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNH 307 (327)
T ss_pred ccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhcC
Confidence 0000 0012346789999999999999999999999864
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.5e-22 Score=194.99 Aligned_cols=156 Identities=20% Similarity=0.207 Sum_probs=112.9
Q ss_pred HHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCccEEEeccCCcccccCCCcccccccccCCccccCCccccCCCCC
Q psy1840 25 SISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKAPELLRQPHLP 104 (423)
Q Consensus 25 ~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~ 104 (423)
...++.|++.||.|||+.|++ |+||||+||+++.++.+||+|||+++........ .....++..|+|||.+.+..
T Consensus 105 ~~~~~~qi~~~L~~lH~~~i~-H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~-- 179 (291)
T cd07870 105 VRLFMFQLLRGLAYIHGQHIL-HRDLKPQNLLISYLGELKLADFGLARAKSIPSQT--YSSEVVTLWYRPPDVLLGAT-- 179 (291)
T ss_pred HHHHHHHHHHHHHHHHhCCcc-cCCCChHHEEEcCCCcEEEeccccccccCCCCCC--CCCccccccccCCceeecCC--
Confidence 567899999999999999988 9999999999999999999999998654322111 12334678899999987532
Q ss_pred CCCCccchHHHHHHHHHHHhCCCCCCCCCCChHHHHHHHhc-C-------------CCCC--------CCC-----CCCC
Q psy1840 105 RGTQKGDVYSFGLVLYEVIGRQGPWGHLRMTDEEIITSVTQ-G-------------SGLR--------PDT-----SSLD 157 (423)
Q Consensus 105 ~~s~ksDVyS~Giil~elltg~~Pf~~~~~~~~~i~~~i~~-~-------------~~~~--------p~~-----~~~~ 157 (423)
..+.++||||||+++|||++|..||.......+.+...... + .... +.. ....
T Consensus 180 ~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (291)
T cd07870 180 DYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSKLPNYKPEWFLPCKPQQLRVVWKRLS 259 (291)
T ss_pred CCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhhhhhhcccccchhccccCCcchhhhccccC
Confidence 23778999999999999999999997543221222111110 0 0000 000 0112
Q ss_pred chHHHHHHHHHhhhcCCCCCCCHHHHHH
Q psy1840 158 CAPSIIACMRTCWEEDPELRPDLRFVHH 185 (423)
Q Consensus 158 ~~~~l~~Li~~C~~~dP~~RPt~~~I~~ 185 (423)
.+..+.+++.+|+..||.+|||+.+++.
T Consensus 260 ~~~~~~~ll~~~l~~dp~~R~t~~~~l~ 287 (291)
T cd07870 260 RPPKAEDLASQMLMMFPKDRISAQDALL 287 (291)
T ss_pred CChHHHHHHHHHhCcCcccCcCHHHHhc
Confidence 3578899999999999999999998864
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=99.89 E-value=1e-22 Score=195.31 Aligned_cols=154 Identities=19% Similarity=0.291 Sum_probs=114.7
Q ss_pred HHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCccEEEeccCCcccccCCCcccccccccCCccccCCccccCCCCC
Q psy1840 25 SISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKAPELLRQPHLP 104 (423)
Q Consensus 25 ~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~ 104 (423)
...++.|++.||.|||+.+++ ||||+|+||++++++.++|+|||++........ ......++..|+|||.+.+..
T Consensus 102 ~~~~~~~i~~~l~~LH~~~i~-h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~-- 176 (286)
T cd07846 102 VRKYLFQILRGIEFCHSHNII-HRDIKPENILVSQSGVVKLCDFGFARTLAAPGE--VYTDYVATRWYRAPELLVGDT-- 176 (286)
T ss_pred HHHHHHHHHHHHHHHHHCCcc-ccCCCHHHEEECCCCcEEEEeeeeeeeccCCcc--ccCcccceeeccCcHHhcccc--
Confidence 688999999999999999988 999999999999999999999999876533221 112345678899999986533
Q ss_pred CCCCccchHHHHHHHHHHHhCCCCCCCCCCChHHHHHHHhcC-------------------CCCCCCC--------CCCC
Q psy1840 105 RGTQKGDVYSFGLVLYEVIGRQGPWGHLRMTDEEIITSVTQG-------------------SGLRPDT--------SSLD 157 (423)
Q Consensus 105 ~~s~ksDVyS~Giil~elltg~~Pf~~~~~~~~~i~~~i~~~-------------------~~~~p~~--------~~~~ 157 (423)
..+.++||||||+++|||++|..||.... ..+....+... ....+.. ....
T Consensus 177 ~~~~~~Dv~slG~~l~el~~g~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (286)
T cd07846 177 KYGRAVDIWAVGCLVTEMLTGEPLFPGDS--DIDQLYHIIKCLGNLIPRHQEIFQKNPLFAGMRLPEVKEIEPLEKRFPK 254 (286)
T ss_pred ccCchHhHHHHHHHHHHHHcCCCCCCCCc--hHHHHHHHHHHhCCCchhhHHHhccchHhhccccccccCcchHHHhCCC
Confidence 23788999999999999999999986432 11111111100 0000100 0124
Q ss_pred chHHHHHHHHHhhhcCCCCCCCHHHHHH
Q psy1840 158 CAPSIIACMRTCWEEDPELRPDLRFVHH 185 (423)
Q Consensus 158 ~~~~l~~Li~~C~~~dP~~RPt~~~I~~ 185 (423)
++..+.+++.+||+.+|++||++.+|++
T Consensus 255 ~~~~~~~li~~~l~~~P~~Rp~~~~il~ 282 (286)
T cd07846 255 LSGLVLDLAKQCLRIDPDDRPSSSQLLH 282 (286)
T ss_pred cCHHHHHHHHHHhcCCcccchhHHHHhc
Confidence 6788999999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.2e-22 Score=195.74 Aligned_cols=154 Identities=20% Similarity=0.251 Sum_probs=113.4
Q ss_pred HHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcC-CccEEEeccCCcccccCCCcccccccccCCccccCCccccCCCC
Q psy1840 25 SISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDS-RWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKAPELLRQPHL 103 (423)
Q Consensus 25 ~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~-~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~ 103 (423)
...++.||+.||.|||+.+++ ||||||+||+++. ++.+||+|||++........ ......+++.|+|||.+.+..
T Consensus 112 ~~~~~~qi~~~L~~LH~~~i~-H~dl~~~nil~~~~~~~~kl~dfg~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~- 187 (295)
T cd07837 112 IKSFMYQLLKGVAHCHKHGVM-HRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVK--SYTHEIVTLWYRAPEVLLGST- 187 (295)
T ss_pred HHHHHHHHHHHHHHHHHCCee-ecCCChHHEEEecCCCeEEEeecccceecCCCcc--ccCCcccccCCCChHHhhCCC-
Confidence 678999999999999999998 9999999999998 89999999999875432211 112234567899999886532
Q ss_pred CCCCCccchHHHHHHHHHHHhCCCCCCCCCCChHHHHHHHhcC----C-----------------CCCC---CCCCCCch
Q psy1840 104 PRGTQKGDVYSFGLVLYEVIGRQGPWGHLRMTDEEIITSVTQG----S-----------------GLRP---DTSSLDCA 159 (423)
Q Consensus 104 ~~~s~ksDVyS~Giil~elltg~~Pf~~~~~~~~~i~~~i~~~----~-----------------~~~p---~~~~~~~~ 159 (423)
..+.++|+||||+++|+|++|..||.... ..+....+... . ...+ ......++
T Consensus 188 -~~~~~~Di~slG~~l~~l~~g~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (295)
T cd07837 188 -HYSTPVDIWSVGCIFAEMSRKQPLFPGDS--ELQQLLHIFKLLGTPTEQVWPGVSKLRDWHEFPQWKPQDLSRAVPDLS 264 (295)
T ss_pred -CCCchHHHHHHHHHHHHHHcCCCCCCCCC--HHHHHHHHHHHhCCCChhhCcchhhccchhhcCcccchhHHHhccccC
Confidence 23789999999999999999999996432 22211111110 0 0000 00112467
Q ss_pred HHHHHHHHHhhhcCCCCCCCHHHHHH
Q psy1840 160 PSIIACMRTCWEEDPELRPDLRFVHH 185 (423)
Q Consensus 160 ~~l~~Li~~C~~~dP~~RPt~~~I~~ 185 (423)
.++.+++.+||..||.+||++.+++.
T Consensus 265 ~~~~~~i~~~l~~~P~~R~~~~eil~ 290 (295)
T cd07837 265 PEGLDLLQKMLRYDPAKRISAKAALT 290 (295)
T ss_pred HHHHHHHHHHccCChhhcCCHHHHhc
Confidence 88999999999999999999998875
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.3e-22 Score=195.70 Aligned_cols=154 Identities=23% Similarity=0.291 Sum_probs=115.0
Q ss_pred HHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCccEEEeccCCcccccCCCcccccccccCCccccCCccccCCCCC
Q psy1840 25 SISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKAPELLRQPHLP 104 (423)
Q Consensus 25 ~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~ 104 (423)
...++.|++.||.|||+++++ ||||||+||+++.++.+||+|||++........ ......++..|+|||.+.+..
T Consensus 108 ~~~i~~qi~~aL~~LH~~~i~-H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~-- 182 (293)
T cd07843 108 VKCLMLQLLSGVAHLHDNWIL-HRDLKTSNLLLNNRGILKICDFGLAREYGSPLK--PYTQLVVTLWYRAPELLLGAK-- 182 (293)
T ss_pred HHHHHHHHHHHHHHHHHCCee-eccCCHHHEEECCCCcEEEeecCceeeccCCcc--ccccccccccccCchhhcCCc--
Confidence 679999999999999999988 999999999999999999999999875543211 112345677899999987643
Q ss_pred CCCCccchHHHHHHHHHHHhCCCCCCCCCCChHHHHHHHhcCC----------------------------CCCCCCCCC
Q psy1840 105 RGTQKGDVYSFGLVLYEVIGRQGPWGHLRMTDEEIITSVTQGS----------------------------GLRPDTSSL 156 (423)
Q Consensus 105 ~~s~ksDVyS~Giil~elltg~~Pf~~~~~~~~~i~~~i~~~~----------------------------~~~p~~~~~ 156 (423)
..+.++|+||||+++|||++|..||.... ..+....+.... ......+..
T Consensus 183 ~~~~~~Di~slG~~l~~l~~g~~~f~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (293)
T cd07843 183 EYSTAIDMWSVGCIFAELLTKKPLFPGKS--EIDQLNKIFKLLGTPTEKIWPGFSELPGAKKKTFTKYPYNQLRKKFPAL 260 (293)
T ss_pred cccchhhHHHHHHHHHHHHhCCCCCCCCC--hHHHHHHHHHHhCCCchHHHHHhhccchhcccccccccchhhhcccccc
Confidence 23789999999999999999999996432 222222221100 000011111
Q ss_pred CchHHHHHHHHHhhhcCCCCCCCHHHHHH
Q psy1840 157 DCAPSIIACMRTCWEEDPELRPDLRFVHH 185 (423)
Q Consensus 157 ~~~~~l~~Li~~C~~~dP~~RPt~~~I~~ 185 (423)
..++.+.+++++||+.+|++|||+.+++.
T Consensus 261 ~~~~~~~~li~~~l~~~p~~R~t~~ell~ 289 (293)
T cd07843 261 SLSDNGFDLLNRLLTYDPAKRISAEDALK 289 (293)
T ss_pred CCChHHHHHHHHHhccCccccCCHHHHhc
Confidence 14788999999999999999999999875
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.9e-22 Score=190.68 Aligned_cols=155 Identities=23% Similarity=0.360 Sum_probs=122.0
Q ss_pred HHHHHHHHHHHHHHHHHh-CCCeeecCCCCCCEEEcCCccEEEeccCCcccccCCCcccccccccCCccccCCccccCCC
Q psy1840 24 GSISVNTTASVGMIHLHD-SEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKAPELLRQPH 102 (423)
Q Consensus 24 ~~l~i~~qi~~gL~yLH~-~~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~ 102 (423)
....++.|++.|+.|||+ .+++ ||||+|+||+++.++.++|+|||.+......... .....++..|+|||.+.+..
T Consensus 100 ~~~~~~~~l~~~l~~lh~~~~~~-H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~~~--~~~~~~~~~y~~pE~~~~~~ 176 (264)
T cd06623 100 VLAYIARQILKGLDYLHTKRHII-HRDIKPSNLLINSKGEVKIADFGISKVLENTLDQ--CNTFVGTVTYMSPERIQGES 176 (264)
T ss_pred HHHHHHHHHHHHHHHHhccCCCc-cCCCCHHHEEECCCCCEEEccCccceecccCCCc--ccceeecccccCHhhhCCCC
Confidence 368999999999999999 9998 9999999999999999999999998755322221 12345677899999987764
Q ss_pred CCCCCCccchHHHHHHHHHHHhCCCCCCCCCC-ChHHHHHHHhcCCCCCCCCCCCCchHHHHHHHHHhhhcCCCCCCCHH
Q psy1840 103 LPRGTQKGDVYSFGLVLYEVIGRQGPWGHLRM-TDEEIITSVTQGSGLRPDTSSLDCAPSIIACMRTCWEEDPELRPDLR 181 (423)
Q Consensus 103 ~~~~s~ksDVyS~Giil~elltg~~Pf~~~~~-~~~~i~~~i~~~~~~~p~~~~~~~~~~l~~Li~~C~~~dP~~RPt~~ 181 (423)
. +.++|+||||+++|++++|..||..... ...+....+.... .+......++..+.+++.+||..+|++||++.
T Consensus 177 ~---~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~ 251 (264)
T cd06623 177 Y---SYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICDGP--PPSLPAEEFSPEFRDFISACLQKDPKKRPSAA 251 (264)
T ss_pred C---CchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHHhcCC--CCCCCcccCCHHHHHHHHHHccCChhhCCCHH
Confidence 4 8899999999999999999999975431 3344555544321 22222222789999999999999999999999
Q ss_pred HHHHH
Q psy1840 182 FVHHK 186 (423)
Q Consensus 182 ~I~~~ 186 (423)
++++.
T Consensus 252 ~ll~~ 256 (264)
T cd06623 252 ELLQH 256 (264)
T ss_pred HHHhC
Confidence 99764
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.3e-22 Score=194.13 Aligned_cols=155 Identities=23% Similarity=0.257 Sum_probs=114.8
Q ss_pred HHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCccEEEeccCCcccccCCCcccccccccCCccccCCccccCCCCC
Q psy1840 25 SISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKAPELLRQPHLP 104 (423)
Q Consensus 25 ~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~ 104 (423)
.+.++.||+.||+|||+.|++ |+||+|+||++++++.+||+|||++......... ......++..|+|||.+.+..
T Consensus 102 ~~~i~~~i~~al~~LH~~~~~-h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~-- 177 (287)
T cd07840 102 IKCYMKQLLEGLQYLHSNGIL-HRDIKGSNILINNDGVLKLADFGLARPYTKRNSA-DYTNRVITLWYRPPELLLGAT-- 177 (287)
T ss_pred HHHHHHHHHHHHHHHHHCCce-eccCcHHHeEEcCCCCEEEccccceeeccCCCcc-cccccccccccCCceeeEccc--
Confidence 579999999999999999988 9999999999999999999999998765433211 112334567899999876543
Q ss_pred CCCCccchHHHHHHHHHHHhCCCCCCCCCCChHHHHHHHhcCCC-----CCCC----------------------CCCCC
Q psy1840 105 RGTQKGDVYSFGLVLYEVIGRQGPWGHLRMTDEEIITSVTQGSG-----LRPD----------------------TSSLD 157 (423)
Q Consensus 105 ~~s~ksDVyS~Giil~elltg~~Pf~~~~~~~~~i~~~i~~~~~-----~~p~----------------------~~~~~ 157 (423)
..+.++||||||+++|||++|..||.... .......+..... ..+. .....
T Consensus 178 ~~~~~~Dv~slG~~l~el~t~~~p~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (287)
T cd07840 178 RYGPEVDMWSVGCILAELFLGKPIFQGST--ELEQLEKIFELCGSPTDENWPGVSKLPWFENLKPKKPYKRRLREFFKHL 255 (287)
T ss_pred cCChHHHHHHHHHHHHHHHhCCCCCCCCC--hHHHHHHHHHHhCCCchhhccccccchhhhhccccccchhHHHHHhccc
Confidence 23789999999999999999999996432 2222222211000 0000 00111
Q ss_pred chHHHHHHHHHhhhcCCCCCCCHHHHHH
Q psy1840 158 CAPSIIACMRTCWEEDPELRPDLRFVHH 185 (423)
Q Consensus 158 ~~~~l~~Li~~C~~~dP~~RPt~~~I~~ 185 (423)
++..+.+++.+||+.+|++||++.++++
T Consensus 256 ~~~~~~~~i~~~l~~~P~~Rp~~~~~l~ 283 (287)
T cd07840 256 IDPSALDLLDKLLTLDPKKRISADQALQ 283 (287)
T ss_pred CCHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 3788999999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.88 E-value=5.2e-23 Score=202.90 Aligned_cols=159 Identities=18% Similarity=0.306 Sum_probs=114.4
Q ss_pred HHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCccEEEeccCCcccccCCCcc-cccccccCCccccCCccccCCCC
Q psy1840 25 SISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDET-GQERKLRRRKLYKAPELLRQPHL 103 (423)
Q Consensus 25 ~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~~-~~~~~~~gt~~y~APE~l~~~~~ 103 (423)
...++.|++.||.|||+.|++ ||||||+||+++.++.+||+|||++......... .......++..|+|||.+.+..
T Consensus 108 ~~~i~~ql~~aL~~LH~~~iv-H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~- 185 (336)
T cd07849 108 IQYFLYQILRGLKYIHSANVL-HRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEYVATRWYRAPEIMLNSK- 185 (336)
T ss_pred HHHHHHHHHHHHHHHHhCCee-ccCCCHHHEEECCCCCEEECcccceeeccccccccCCcCCcCcCCCccChHHhhCCC-
Confidence 467899999999999999988 9999999999999999999999998754322211 1122346788899999875532
Q ss_pred CCCCCccchHHHHHHHHHHHhCCCCCCCCCCCh-------------HHHHHHHhc--------CCCCCCCCC----CCCc
Q psy1840 104 PRGTQKGDVYSFGLVLYEVIGRQGPWGHLRMTD-------------EEIITSVTQ--------GSGLRPDTS----SLDC 158 (423)
Q Consensus 104 ~~~s~ksDVyS~Giil~elltg~~Pf~~~~~~~-------------~~i~~~i~~--------~~~~~p~~~----~~~~ 158 (423)
..+.++|||||||++|+|++|+.||....... .+....+.. ..+..+... ....
T Consensus 186 -~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (336)
T cd07849 186 -GYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQEDLNCIISLRARNYIKSLPFKPKVPWNKLFPNA 264 (336)
T ss_pred -CCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhchhhhhHHhhcCcCCcccHHHHhccc
Confidence 23789999999999999999999996432100 000110000 000001000 1234
Q ss_pred hHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q psy1840 159 APSIIACMRTCWEEDPELRPDLRFVHHK 186 (423)
Q Consensus 159 ~~~l~~Li~~C~~~dP~~RPt~~~I~~~ 186 (423)
+.++.+++.+||+.+|++|||+.++++.
T Consensus 265 ~~~~~~li~~~l~~dP~~Rpt~~e~l~h 292 (336)
T cd07849 265 DPKALDLLDKMLTFNPHKRITVEEALAH 292 (336)
T ss_pred CcHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 6789999999999999999999998765
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >KOG0584|consensus | Back alignment and domain information |
|---|
Probab=99.88 E-value=3.6e-23 Score=208.09 Aligned_cols=149 Identities=21% Similarity=0.355 Sum_probs=124.3
Q ss_pred HHHHHHHHHHHHHHHhC-CCeeecCCCCCCEEEcC-CccEEEeccCCcccccCCCcccccccccCCccccCCccccCCCC
Q psy1840 26 ISVNTTASVGMIHLHDS-EIISHGNLRSSNCLIDS-RWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKAPELLRQPHL 103 (423)
Q Consensus 26 l~i~~qi~~gL~yLH~~-~ii~HrDLkp~NILld~-~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~ 103 (423)
-+|+.||++||.|||++ +.|+|||||-.||+|+. -|.|||+|+|+|........ ....|||.|||||+.-. .|
T Consensus 146 k~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~s~a----ksvIGTPEFMAPEmYEE-~Y 220 (632)
T KOG0584|consen 146 KSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRKSHA----KSVIGTPEFMAPEMYEE-NY 220 (632)
T ss_pred HHHHHHHHHHhhhhhcCCCCccccccccceEEEcCCcCceeecchhHHHHhhcccc----ceeccCccccChHHHhh-hc
Confidence 48999999999999997 44559999999999975 58999999999987643322 34789999999999874 34
Q ss_pred CCCCCccchHHHHHHHHHHHhCCCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCchHHHHHHHHHhhhcCCCCCCCHHHH
Q psy1840 104 PRGTQKGDVYSFGLVLYEVIGRQGPWGHLRMTDEEIITSVTQGSGLRPDTSSLDCAPSIIACMRTCWEEDPELRPDLRFV 183 (423)
Q Consensus 104 ~~~s~ksDVyS~Giil~elltg~~Pf~~~~~~~~~i~~~i~~~~~~~p~~~~~~~~~~l~~Li~~C~~~dP~~RPt~~~I 183 (423)
+..+||||||++++||+|+..||.. ...+.+|..++..|. .|.....--.++++++|.+|+.. ...||++.++
T Consensus 221 ---nE~VDVYaFGMCmLEMvT~eYPYsE-C~n~AQIYKKV~SGi--KP~sl~kV~dPevr~fIekCl~~-~~~R~sa~eL 293 (632)
T KOG0584|consen 221 ---NELVDVYAFGMCMLEMVTSEYPYSE-CTNPAQIYKKVTSGI--KPAALSKVKDPEVREFIEKCLAT-KSERLSAKEL 293 (632)
T ss_pred ---chhhhhhhhhHHHHHHHhccCChhh-hCCHHHHHHHHHcCC--CHHHhhccCCHHHHHHHHHHhcC-chhccCHHHH
Confidence 8999999999999999999999975 567889999998874 33333323478999999999999 9999999998
Q ss_pred HHH
Q psy1840 184 HHK 186 (423)
Q Consensus 184 ~~~ 186 (423)
+..
T Consensus 294 L~d 296 (632)
T KOG0584|consen 294 LKD 296 (632)
T ss_pred hhC
Confidence 763
|
|
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.9e-22 Score=194.41 Aligned_cols=146 Identities=21% Similarity=0.297 Sum_probs=117.6
Q ss_pred HHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCccEEEeccCCcccccCCCcccccccccCCccccCCccccCCCCC
Q psy1840 25 SISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKAPELLRQPHLP 104 (423)
Q Consensus 25 ~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~ 104 (423)
...++.|++.||.|||+.|++ ||||+|+||+++.++.+||+|||++...... .....+++.|+|||.+.+...
T Consensus 103 ~~~~~~qil~~l~~lH~~~i~-H~dl~p~nili~~~~~~kl~dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~- 175 (290)
T cd05580 103 ARFYAAQVVLALEYLHSLDIV-YRDLKPENLLLDSDGYIKITDFGFAKRVKGR-----TYTLCGTPEYLAPEIILSKGY- 175 (290)
T ss_pred HHHHHHHHHHHHHHHHHCCEe-cCCCCHHHEEECCCCCEEEeeCCCccccCCC-----CCCCCCCccccChhhhcCCCC-
Confidence 568899999999999999998 9999999999999999999999998765433 234467888999999876544
Q ss_pred CCCCccchHHHHHHHHHHHhCCCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCchHHHHHHHHHhhhcCCCCCC-----C
Q psy1840 105 RGTQKGDVYSFGLVLYEVIGRQGPWGHLRMTDEEIITSVTQGSGLRPDTSSLDCAPSIIACMRTCWEEDPELRP-----D 179 (423)
Q Consensus 105 ~~s~ksDVyS~Giil~elltg~~Pf~~~~~~~~~i~~~i~~~~~~~p~~~~~~~~~~l~~Li~~C~~~dP~~RP-----t 179 (423)
+.++||||||+++|+|++|..||.... ..+....+..+....| ...+..+.+++.+||..||.+|+ +
T Consensus 176 --~~~~Di~slG~il~~l~~g~~p~~~~~--~~~~~~~~~~~~~~~~----~~~~~~l~~li~~~l~~~p~~R~~~~~~~ 247 (290)
T cd05580 176 --GKAVDWWALGILIYEMLAGYPPFFDDN--PIQIYEKILEGKVRFP----SFFSPDAKDLIRNLLQVDLTKRLGNLKNG 247 (290)
T ss_pred --CccccHHHHHHHHHHHHhCCCCCCCCC--HHHHHHHHhcCCccCC----ccCCHHHHHHHHHHccCCHHHccCcccCC
Confidence 789999999999999999999997432 4445555554433222 24578999999999999999998 6
Q ss_pred HHHHHH
Q psy1840 180 LRFVHH 185 (423)
Q Consensus 180 ~~~I~~ 185 (423)
+.+++.
T Consensus 248 ~~~l~~ 253 (290)
T cd05580 248 VNDIKN 253 (290)
T ss_pred HHHHHc
Confidence 666653
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=99.88 E-value=2e-22 Score=193.40 Aligned_cols=150 Identities=19% Similarity=0.275 Sum_probs=116.4
Q ss_pred HHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCccEEEeccCCcccccCCCcccccccccCCccccCCccccCCCCC
Q psy1840 25 SISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKAPELLRQPHLP 104 (423)
Q Consensus 25 ~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~ 104 (423)
...++.|++.|+.|||+.+++ ||||||+||+++.++.+||+|||++....... .....|+..|+|||.+.++.
T Consensus 99 ~~~~~~ql~~~l~~lH~~~i~-H~di~p~nili~~~~~~kl~dfg~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~-- 171 (278)
T cd05606 99 MRFYAAEIILGLEHMHNRFVV-YRDLKPANILLDEHGHVRISDLGLACDFSKKK----PHASVGTHGYMAPEVLQKGV-- 171 (278)
T ss_pred HHHHHHHHHHHHHHHHHCCEE-cCCCCHHHEEECCCCCEEEccCcCccccCccC----CcCcCCCcCCcCcHHhcCCC--
Confidence 678999999999999999987 99999999999999999999999976543221 12346788999999987542
Q ss_pred CCCCccchHHHHHHHHHHHhCCCCCCCCCCCh-HHHHHHHhcCCCCCCCCCCCCchHHHHHHHHHhhhcCCCCCC-----
Q psy1840 105 RGTQKGDVYSFGLVLYEVIGRQGPWGHLRMTD-EEIITSVTQGSGLRPDTSSLDCAPSIIACMRTCWEEDPELRP----- 178 (423)
Q Consensus 105 ~~s~ksDVyS~Giil~elltg~~Pf~~~~~~~-~~i~~~i~~~~~~~p~~~~~~~~~~l~~Li~~C~~~dP~~RP----- 178 (423)
.++.++||||+|+++|||++|..||....... ..+....... .+.. +..++.++.+++.+||..+|.+||
T Consensus 172 ~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~---~~~~-~~~~s~~~~~li~~~l~~~p~~R~~~~~~ 247 (278)
T cd05606 172 AYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTM---AVEL-PDSFSPELRSLLEGLLQRDVNRRLGCLGR 247 (278)
T ss_pred CCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHHHHhhcc---CCCC-CCcCCHHHHHHHHHHhhcCHHhccCCCCC
Confidence 23789999999999999999999997542222 2222222221 1222 224688999999999999999999
Q ss_pred CHHHHHH
Q psy1840 179 DLRFVHH 185 (423)
Q Consensus 179 t~~~I~~ 185 (423)
++.++++
T Consensus 248 ~~~~ll~ 254 (278)
T cd05606 248 GAQEVKE 254 (278)
T ss_pred CHHHHHh
Confidence 8888875
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=99.88 E-value=2.1e-22 Score=188.87 Aligned_cols=154 Identities=21% Similarity=0.387 Sum_probs=120.9
Q ss_pred HHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCccEEEeccCCcccccCCCcccccccccCCccccCCccccCCCCC
Q psy1840 25 SISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKAPELLRQPHLP 104 (423)
Q Consensus 25 ~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~ 104 (423)
...++.|++.|+.|||+.+++ ||||+|+||+++.++.++|+|||.+................++..|+|||.+.+...
T Consensus 103 ~~~~~~~l~~~l~~lh~~~~~-h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~- 180 (260)
T cd06606 103 IRKYTRQILEGLAYLHSNGIV-HRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIRGEEY- 180 (260)
T ss_pred HHHHHHHHHHHHHHHHHCCcc-ccCCCHHHEEEcCCCCEEEcccccEEecccccccccccCCCCCccccCHhhhcCCCC-
Confidence 679999999999999999988 999999999999999999999999876544332111234567788999999877654
Q ss_pred CCCCccchHHHHHHHHHHHhCCCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCchHHHHHHHHHhhhcCCCCCCCHHHHH
Q psy1840 105 RGTQKGDVYSFGLVLYEVIGRQGPWGHLRMTDEEIITSVTQGSGLRPDTSSLDCAPSIIACMRTCWEEDPELRPDLRFVH 184 (423)
Q Consensus 105 ~~s~ksDVyS~Giil~elltg~~Pf~~~~~~~~~i~~~i~~~~~~~p~~~~~~~~~~l~~Li~~C~~~dP~~RPt~~~I~ 184 (423)
+.++||||||++++++++|..||.... ........+.... ..+. .+...+..+.+++.+||+.+|++||++.+++
T Consensus 181 --~~~~Dv~slG~il~~l~~g~~p~~~~~-~~~~~~~~~~~~~-~~~~-~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll 255 (260)
T cd06606 181 --GRAADIWSLGCTVIEMATGKPPWSELG-NPMAALYKIGSSG-EPPE-IPEHLSEEAKDFLRKCLRRDPKKRPTADELL 255 (260)
T ss_pred --CchhhHHHHHHHHHHHHhCCCCCCCCC-chHHHHHhccccC-CCcC-CCcccCHHHHHHHHHhCcCChhhCCCHHHHh
Confidence 899999999999999999999997544 2233333333211 1122 2235688999999999999999999999987
Q ss_pred H
Q psy1840 185 H 185 (423)
Q Consensus 185 ~ 185 (423)
.
T Consensus 256 ~ 256 (260)
T cd06606 256 Q 256 (260)
T ss_pred h
Confidence 5
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.2e-22 Score=194.44 Aligned_cols=150 Identities=23% Similarity=0.328 Sum_probs=115.2
Q ss_pred HHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCccEEEeccCCcccccCCCcccccccccCCccccCCccccCCCCC
Q psy1840 25 SISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKAPELLRQPHLP 104 (423)
Q Consensus 25 ~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~ 104 (423)
...++.|++.|+.|||+.|++ ||||+|+||+++.++.+||+|||++....... ......++..|+|||.+.+..+
T Consensus 97 ~~~~~~ql~~~l~~lH~~~i~-H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~---~~~~~~~~~~y~~PE~~~~~~~- 171 (277)
T cd05577 97 AIFYAAQIICGLEHLHQRRIV-YRDLKPENVLLDDHGNVRISDLGLAVELKGGK---KIKGRAGTPGYMAPEVLQGEVY- 171 (277)
T ss_pred HHHHHHHHHHHHHHHHhCCcc-cCCCCHHHEEECCCCCEEEccCcchhhhccCC---ccccccCCCCcCCHHHhcCCCC-
Confidence 577899999999999999998 99999999999999999999999986543211 1123456778999999877654
Q ss_pred CCCCccchHHHHHHHHHHHhCCCCCCCCCC--ChHHHHHHHhcCCCCCCCCCCCCchHHHHHHHHHhhhcCCCCCC----
Q psy1840 105 RGTQKGDVYSFGLVLYEVIGRQGPWGHLRM--TDEEIITSVTQGSGLRPDTSSLDCAPSIIACMRTCWEEDPELRP---- 178 (423)
Q Consensus 105 ~~s~ksDVyS~Giil~elltg~~Pf~~~~~--~~~~i~~~i~~~~~~~p~~~~~~~~~~l~~Li~~C~~~dP~~RP---- 178 (423)
+.++||||||+++|++++|+.||..... ...++...+.. .+......+++.+.+++.+||+.+|++||
T Consensus 172 --~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~ 245 (277)
T cd05577 172 --DFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTLE----MAVEYPDKFSPEAKDLCEALLQKDPEKRLGCRG 245 (277)
T ss_pred --CchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHHhcccc----ccccCCccCCHHHHHHHHHHccCChhHccCCCc
Confidence 8899999999999999999999965432 22233222222 12222235688999999999999999999
Q ss_pred -CHHHHHH
Q psy1840 179 -DLRFVHH 185 (423)
Q Consensus 179 -t~~~I~~ 185 (423)
++.+++.
T Consensus 246 ~~~~~ll~ 253 (277)
T cd05577 246 GSADEVRE 253 (277)
T ss_pred ccHHHHHh
Confidence 5555543
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.4e-22 Score=197.16 Aligned_cols=155 Identities=23% Similarity=0.210 Sum_probs=116.2
Q ss_pred HHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCccEEEeccCCcccccCCCcccccccccCCccccCCccccCCCCC
Q psy1840 25 SISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKAPELLRQPHLP 104 (423)
Q Consensus 25 ~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~ 104 (423)
...++.|++.|+.|||+.|++ ||||||+||+++.++.+||+|||++......... .....++..|+|||.+.+..
T Consensus 110 ~~~~~~qi~~~l~~lH~~~i~-H~dl~p~nil~~~~~~~kL~dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~-- 184 (309)
T cd07845 110 VKCLMLQLLRGLQYLHENFII-HRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKP--MTPKVVTLWYRAPELLLGCT-- 184 (309)
T ss_pred HHHHHHHHHHHHHHHHhCCee-cCCCCHHHEEECCCCCEEECccceeeecCCccCC--CCcccccccccChhhhcCCC--
Confidence 578999999999999999988 9999999999999999999999998765432111 12223467799999987533
Q ss_pred CCCCccchHHHHHHHHHHHhCCCCCCCCCCChHHHHHHHhcCCCC-------------------CCCCC-------CCCc
Q psy1840 105 RGTQKGDVYSFGLVLYEVIGRQGPWGHLRMTDEEIITSVTQGSGL-------------------RPDTS-------SLDC 158 (423)
Q Consensus 105 ~~s~ksDVyS~Giil~elltg~~Pf~~~~~~~~~i~~~i~~~~~~-------------------~p~~~-------~~~~ 158 (423)
..+.++|||||||++|||++|..||.. .+..+....+...... .+... ....
T Consensus 185 ~~~~~~DvwslG~il~el~~g~~~f~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (309)
T cd07845 185 TYTTAIDMWAVGCILAELLAHKPLLPG--KSEIEQLDLIIQLLGTPNESIWPGFSDLPLVGKFTLPKQPYNNLKHKFPWL 262 (309)
T ss_pred CcCchHHHHHHHHHHHHHHhCCCCCCC--CCHHHHHHHHHHhcCCCChhhchhhhcccccccccccCCCCCchHHhcccc
Confidence 237899999999999999999999974 3334444333321000 00000 0124
Q ss_pred hHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q psy1840 159 APSIIACMRTCWEEDPELRPDLRFVHHK 186 (423)
Q Consensus 159 ~~~l~~Li~~C~~~dP~~RPt~~~I~~~ 186 (423)
++++.++|.+||+.||++|||+.+++..
T Consensus 263 ~~~~~~li~~ml~~dp~~R~t~~~il~h 290 (309)
T cd07845 263 SEAGLRLLNFLLMYDPKKRATAEEALES 290 (309)
T ss_pred CHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 7788999999999999999999998864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.3e-22 Score=219.45 Aligned_cols=151 Identities=17% Similarity=0.297 Sum_probs=116.4
Q ss_pred HHHHHHHHHHHHHHHHhCC-------CeeecCCCCCCEEEcC-----------------CccEEEeccCCcccccCCCcc
Q psy1840 25 SISVNTTASVGMIHLHDSE-------IISHGNLRSSNCLIDS-----------------RWVLQIADFGLHAFKAGQDET 80 (423)
Q Consensus 25 ~l~i~~qi~~gL~yLH~~~-------ii~HrDLkp~NILld~-----------------~~~vKL~DFGla~~~~~~~~~ 80 (423)
.+.|+.||+.||.|||+.+ |+ ||||||+||||+. .+.+||+|||++.......
T Consensus 120 Il~Ia~QIL~ALaYLHs~g~~~~~k~IV-HRDLKPeNILL~s~~~~lg~i~~~~~n~ng~~iVKLsDFGlAr~l~~~s-- 196 (1021)
T PTZ00266 120 IVDITRQLLHALAYCHNLKDGPNGERVL-HRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLSKNIGIES-- 196 (1021)
T ss_pred HHHHHHHHHHHHHHHHhcccccccCCce-eccCcHHHeEeecCccccccccccccccCCCCceEEccCCccccccccc--
Confidence 5789999999999999854 66 9999999999964 3459999999987543221
Q ss_pred cccccccCCccccCCccccCCCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCchH
Q psy1840 81 GQERKLRRRKLYKAPELLRQPHLPRGTQKGDVYSFGLVLYEVIGRQGPWGHLRMTDEEIITSVTQGSGLRPDTSSLDCAP 160 (423)
Q Consensus 81 ~~~~~~~gt~~y~APE~l~~~~~~~~s~ksDVyS~Giil~elltg~~Pf~~~~~~~~~i~~~i~~~~~~~p~~~~~~~~~ 160 (423)
......+++.|+|||++.+... .++.++||||||||+|||++|..||... .....++..+..+. ..+....+.
T Consensus 197 -~~~s~vGTp~YmAPEvL~ge~~-~~s~KSDVWSLG~ILYELLTGk~PF~~~-~~~~qli~~lk~~p----~lpi~~~S~ 269 (1021)
T PTZ00266 197 -MAHSCVGTPYYWSPELLLHETK-SYDDKSDMWALGCIIYELCSGKTPFHKA-NNFSQLISELKRGP----DLPIKGKSK 269 (1021)
T ss_pred -cccccCCCccccCHHHHhccCC-CCCchhHHHHHHHHHHHHHHCCCCCCcC-CcHHHHHHHHhcCC----CCCcCCCCH
Confidence 1234568999999999865321 2488999999999999999999999643 23344555544432 222235688
Q ss_pred HHHHHHHHhhhcCCCCCCCHHHHHH
Q psy1840 161 SIIACMRTCWEEDPELRPDLRFVHH 185 (423)
Q Consensus 161 ~l~~Li~~C~~~dP~~RPt~~~I~~ 185 (423)
++.+||..||+.+|.+||++.+++.
T Consensus 270 eL~dLI~~~L~~dPeeRPSa~QlL~ 294 (1021)
T PTZ00266 270 ELNILIKNLLNLSAKERPSALQCLG 294 (1021)
T ss_pred HHHHHHHHHhcCChhHCcCHHHHhc
Confidence 9999999999999999999999984
|
|
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.8e-22 Score=191.72 Aligned_cols=152 Identities=17% Similarity=0.289 Sum_probs=115.6
Q ss_pred HHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCccEEEeccCCcccccCCCcc-cccccccCCccccCCccccCCCC
Q psy1840 25 SISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDET-GQERKLRRRKLYKAPELLRQPHL 103 (423)
Q Consensus 25 ~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~~-~~~~~~~gt~~y~APE~l~~~~~ 103 (423)
.++++.|++.||.|||+++++ ||||||+||+++.++.+||+|||++......... .......++..|+|||.+.+...
T Consensus 108 ~~~~~~~l~~~l~~lH~~~i~-H~dl~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~ 186 (265)
T cd06652 108 TRKYTRQILEGVSYLHSNMIV-HRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSPEVISGEGY 186 (265)
T ss_pred HHHHHHHHHHHHHHHHhCCEe-cCCCCHHHEEecCCCCEEECcCccccccccccccccccccCCCCccccChhhhcCCCC
Confidence 578999999999999999987 9999999999999999999999998754322111 11223457788999999876554
Q ss_pred CCCCCccchHHHHHHHHHHHhCCCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCchHHHHHHHHHhhhcCCCCCCCHHHH
Q psy1840 104 PRGTQKGDVYSFGLVLYEVIGRQGPWGHLRMTDEEIITSVTQGSGLRPDTSSLDCAPSIIACMRTCWEEDPELRPDLRFV 183 (423)
Q Consensus 104 ~~~s~ksDVyS~Giil~elltg~~Pf~~~~~~~~~i~~~i~~~~~~~p~~~~~~~~~~l~~Li~~C~~~dP~~RPt~~~I 183 (423)
+.++||||||+++||+++|+.||... .....+...... ...+.. +...+..+.+++.+||. +|++||++.+|
T Consensus 187 ---~~~~Dv~slG~il~el~~g~~p~~~~--~~~~~~~~~~~~-~~~~~~-~~~~~~~~~~~i~~~l~-~p~~Rp~~~~i 258 (265)
T cd06652 187 ---GRKADIWSVGCTVVEMLTEKPPWAEF--EAMAAIFKIATQ-PTNPVL-PPHVSDHCRDFLKRIFV-EAKLRPSADEL 258 (265)
T ss_pred ---CcchhHHHHHHHHHHHhhCCCCCCcc--chHHHHHHHhcC-CCCCCC-chhhCHHHHHHHHHHhc-ChhhCCCHHHH
Confidence 88999999999999999999999643 222222333221 122222 23456788999999995 99999999998
Q ss_pred HH
Q psy1840 184 HH 185 (423)
Q Consensus 184 ~~ 185 (423)
++
T Consensus 259 l~ 260 (265)
T cd06652 259 LR 260 (265)
T ss_pred hc
Confidence 75
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=99.88 E-value=2.2e-22 Score=196.03 Aligned_cols=159 Identities=14% Similarity=0.223 Sum_probs=114.5
Q ss_pred HHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCccEEEeccCCcccccCCCc-----ccccccccCCccccCCcccc
Q psy1840 25 SISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDE-----TGQERKLRRRKLYKAPELLR 99 (423)
Q Consensus 25 ~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~-----~~~~~~~~gt~~y~APE~l~ 99 (423)
...++.|++.||+|||+++++ ||||||+||+++.++.+||+|||.+........ ........++..|+|||.+.
T Consensus 103 ~~~~~~~l~~~L~~LH~~~iv-H~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~ 181 (314)
T cd08216 103 IAFILKDVLNALDYIHSKGFI-HRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLPWLSPEVLQ 181 (314)
T ss_pred HHHHHHHHHHHHHHHHHCCee-cCCCCcceEEEecCCceEEecCccceeeccccccccccccccccccccccccCHHHhc
Confidence 467899999999999999988 999999999999999999999998764432211 11112334667799999987
Q ss_pred CCCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCChHHHHHHHhcCCCC-----------------------------C
Q psy1840 100 QPHLPRGTQKGDVYSFGLVLYEVIGRQGPWGHLRMTDEEIITSVTQGSGL-----------------------------R 150 (423)
Q Consensus 100 ~~~~~~~s~ksDVyS~Giil~elltg~~Pf~~~~~~~~~i~~~i~~~~~~-----------------------------~ 150 (423)
.... .++.++|+|||||++|||++|..||..... .....+.+...... .
T Consensus 182 ~~~~-~~~~~~Diws~G~il~el~~g~~pf~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (314)
T cd08216 182 QNLQ-GYNEKSDIYSVGITACELANGHVPFKDMPA-TQMLLEKVRGTVPCLLDKSTYPLYEDSMSQSRSSNEHPNNRDSV 259 (314)
T ss_pred CCCC-CCCcchhHHHHHHHHHHHHhCCCCCCCCCH-HHHHHHHHhccCccccccCchhhhcCCcCcccccccccchhhhh
Confidence 6421 247899999999999999999999975321 22222222211000 0
Q ss_pred CCCCCCCchHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q psy1840 151 PDTSSLDCAPSIIACMRTCWEEDPELRPDLRFVHHK 186 (423)
Q Consensus 151 p~~~~~~~~~~l~~Li~~C~~~dP~~RPt~~~I~~~ 186 (423)
+.......+.++.+++.+||..||++|||+.++++.
T Consensus 260 ~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 295 (314)
T cd08216 260 DHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNH 295 (314)
T ss_pred hcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcC
Confidence 000011234678899999999999999999999874
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.8e-22 Score=195.69 Aligned_cols=158 Identities=19% Similarity=0.224 Sum_probs=113.0
Q ss_pred HHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCccEEEeccCCcccccCCCcc--cccccccCCccccCCccccCCC
Q psy1840 25 SISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDET--GQERKLRRRKLYKAPELLRQPH 102 (423)
Q Consensus 25 ~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~~--~~~~~~~gt~~y~APE~l~~~~ 102 (423)
...++.||+.||.|||++|++ |+||||+||+++.++.+||+|||++......... .......++..|+|||.+.+..
T Consensus 121 ~~~i~~qi~~al~~lH~~~i~-H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~ 199 (310)
T cd07865 121 IKKVMKMLLNGLYYIHRNKIL-HRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGER 199 (310)
T ss_pred HHHHHHHHHHHHHHHHHCCee-ccCCCHHHEEECCCCcEEECcCCCcccccCCcccCCCCccCcccCccccCcHHhcCCc
Confidence 578999999999999999988 9999999999999999999999998755332211 1112334677899999886543
Q ss_pred CCCCCCccchHHHHHHHHHHHhCCCCCCCCCCC-hHHHHHHHhcCCC--C--------------CCC---------CCCC
Q psy1840 103 LPRGTQKGDVYSFGLVLYEVIGRQGPWGHLRMT-DEEIITSVTQGSG--L--------------RPD---------TSSL 156 (423)
Q Consensus 103 ~~~~s~ksDVyS~Giil~elltg~~Pf~~~~~~-~~~i~~~i~~~~~--~--------------~p~---------~~~~ 156 (423)
..+.++||||||+++|||++|..||...... ....+..+....+ . .+. ....
T Consensus 200 --~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 277 (310)
T cd07865 200 --DYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSITPEVWPGVDKLELFKKMELPQGQKRKVKERLKPY 277 (310)
T ss_pred --ccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhcccccchhhhhhccCCCccchhhHHhcccc
Confidence 2378999999999999999999998643211 0111122111000 0 000 0011
Q ss_pred CchHHHHHHHHHhhhcCCCCCCCHHHHHH
Q psy1840 157 DCAPSIIACMRTCWEEDPELRPDLRFVHH 185 (423)
Q Consensus 157 ~~~~~l~~Li~~C~~~dP~~RPt~~~I~~ 185 (423)
..+..+.+++.+||..||++|||+.++++
T Consensus 278 ~~~~~~~dli~~~l~~~P~~R~t~~e~l~ 306 (310)
T cd07865 278 VKDPHALDLIDKLLVLDPAKRIDADTALN 306 (310)
T ss_pred cCCHHHHHHHHHHhcCChhhccCHHHHhc
Confidence 23467789999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=99.88 E-value=3e-22 Score=188.43 Aligned_cols=148 Identities=22% Similarity=0.365 Sum_probs=120.1
Q ss_pred HHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCccEEEeccCCcccccCCCcccccccccCCccccCCccccCCCCC
Q psy1840 25 SISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKAPELLRQPHLP 104 (423)
Q Consensus 25 ~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~ 104 (423)
...++.|++.||.|||+.|++ ||||+|.||+++.++.+||+|||++...... ......++..|+|||.+.+..+
T Consensus 105 ~~~~~~~l~~al~~lh~~~i~-h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~----~~~~~~~~~~~~~Pe~~~~~~~- 178 (256)
T cd08530 105 IWRIFIQLLRGLQALHEQKIL-HRDLKSANILLVANDLVKIGDLGISKVLKKN----MAKTQIGTPHYMAPEVWKGRPY- 178 (256)
T ss_pred HHHHHHHHHHHHHHHhhCCcc-cCCCCcceEEEecCCcEEEeeccchhhhccC----CcccccCCccccCHHHHCCCCC-
Confidence 568999999999999999998 9999999999999999999999998765433 1123456788999999977654
Q ss_pred CCCCccchHHHHHHHHHHHhCCCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCchHHHHHHHHHhhhcCCCCCCCHHHHH
Q psy1840 105 RGTQKGDVYSFGLVLYEVIGRQGPWGHLRMTDEEIITSVTQGSGLRPDTSSLDCAPSIIACMRTCWEEDPELRPDLRFVH 184 (423)
Q Consensus 105 ~~s~ksDVyS~Giil~elltg~~Pf~~~~~~~~~i~~~i~~~~~~~p~~~~~~~~~~l~~Li~~C~~~dP~~RPt~~~I~ 184 (423)
+.++|+||||+++|++++|..||... +..++...+..+. .+... ..++.++.+++.+||+.+|++||++.+++
T Consensus 179 --~~~~D~~slG~~~~~l~~g~~p~~~~--~~~~~~~~~~~~~--~~~~~-~~~~~~~~~li~~~l~~~p~~Rp~~~~~l 251 (256)
T cd08530 179 --SYKSDIWSLGCLLYEMATFAPPFEAR--SMQDLRYKVQRGK--YPPIP-PIYSQDLQNFIRSMLQVKPKLRPNCDKIL 251 (256)
T ss_pred --CchhhHHHHHHHHHHHHhCCCCCCCC--CHHHHHHHHhcCC--CCCCc-hhhCHHHHHHHHHHcCCCcccCCCHHHHh
Confidence 78999999999999999999999743 3445555554432 22222 25788999999999999999999999987
Q ss_pred H
Q psy1840 185 H 185 (423)
Q Consensus 185 ~ 185 (423)
+
T Consensus 252 ~ 252 (256)
T cd08530 252 A 252 (256)
T ss_pred c
Confidence 5
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.1e-22 Score=201.94 Aligned_cols=155 Identities=21% Similarity=0.256 Sum_probs=114.2
Q ss_pred HHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCccEEEeccCCcccccCCCcccccccccCCccccCCccccCCCCC
Q psy1840 25 SISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKAPELLRQPHLP 104 (423)
Q Consensus 25 ~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~ 104 (423)
...++.|++.||+|||++|++ ||||||+||+++.++.+||+|||++........ .....++..|+|||.+.+..+
T Consensus 120 ~~~~~~ql~~aL~~LH~~gi~-H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~- 194 (353)
T cd07850 120 MSYLLYQMLCGIKHLHSAGII-HRDLKPSNIVVKSDCTLKILDFGLARTAGTSFM---MTPYVVTRYYRAPEVILGMGY- 194 (353)
T ss_pred HHHHHHHHHHHHHHHHhCCee-eCCCCHHHEEECCCCCEEEccCccceeCCCCCC---CCCCcccccccCHHHHhCCCC-
Confidence 457899999999999999998 999999999999999999999999875432211 223456788999999987655
Q ss_pred CCCCccchHHHHHHHHHHHhCCCCCCCCCCC-------------hHHHHHHH--------hcCCCC-------------C
Q psy1840 105 RGTQKGDVYSFGLVLYEVIGRQGPWGHLRMT-------------DEEIITSV--------TQGSGL-------------R 150 (423)
Q Consensus 105 ~~s~ksDVyS~Giil~elltg~~Pf~~~~~~-------------~~~i~~~i--------~~~~~~-------------~ 150 (423)
+.++|||||||++|+|++|+.||...... ..++...+ ...... .
T Consensus 195 --~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 272 (353)
T cd07850 195 --KENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMSRLQPTVRNYVENRPKYAGYSFEELFPDVLF 272 (353)
T ss_pred --CCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhhhhhhHHhhcCCCCCCcchhhhCccccc
Confidence 89999999999999999999999643210 01111100 000000 0
Q ss_pred CCC---CCCCchHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q psy1840 151 PDT---SSLDCAPSIIACMRTCWEEDPELRPDLRFVHHK 186 (423)
Q Consensus 151 p~~---~~~~~~~~l~~Li~~C~~~dP~~RPt~~~I~~~ 186 (423)
+.. .....+..+.+++.+||+.||++|||+.+++..
T Consensus 273 ~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~ 311 (353)
T cd07850 273 PPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQH 311 (353)
T ss_pred CcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 000 011346678999999999999999999999764
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.6e-22 Score=196.92 Aligned_cols=153 Identities=22% Similarity=0.344 Sum_probs=115.5
Q ss_pred HHHHHHHHHHHHHHHHhC-CCeeecCCCCCCEEEcCCccEEEeccCCcccccCCCcccccccccCCccccCCccccCCCC
Q psy1840 25 SISVNTTASVGMIHLHDS-EIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKAPELLRQPHL 103 (423)
Q Consensus 25 ~l~i~~qi~~gL~yLH~~-~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~ 103 (423)
...++.|++.||.|||+. +++ ||||||+||+++.++.+||+|||++...... ......++..|+|||.+.+..+
T Consensus 101 ~~~~~~~i~~~l~~lH~~~~i~-H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~----~~~~~~~~~~~~aPE~~~~~~~ 175 (308)
T cd06615 101 LGKISIAVLRGLTYLREKHKIM-HRDVKPSNILVNSRGEIKLCDFGVSGQLIDS----MANSFVGTRSYMSPERLQGTHY 175 (308)
T ss_pred HHHHHHHHHHHHHHHHhhCCEE-ECCCChHHEEEecCCcEEEccCCCccccccc----ccccCCCCcCccChhHhcCCCC
Confidence 568999999999999984 776 9999999999999999999999997654322 1134567888999999876544
Q ss_pred CCCCCccchHHHHHHHHHHHhCCCCCCCCCCChHHHHHHHhcC----------------------------------CCC
Q psy1840 104 PRGTQKGDVYSFGLVLYEVIGRQGPWGHLRMTDEEIITSVTQG----------------------------------SGL 149 (423)
Q Consensus 104 ~~~s~ksDVyS~Giil~elltg~~Pf~~~~~~~~~i~~~i~~~----------------------------------~~~ 149 (423)
+.++|+||||+++|++++|..||.... .......+... ...
T Consensus 176 ---~~~~DiwslG~~l~~l~~g~~p~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (308)
T cd06615 176 ---TVQSDIWSLGLSLVEMAIGRYPIPPPD--AKELEAMFGRPVSEGEAKESHRPVSGHPPDSPRPMAIFELLDYIVNEP 250 (308)
T ss_pred ---CccchHHHHHHHHHHHHhCCCCCCCcc--hhhHHHhhcCccccccccCCcccccCCCCCccchhhHHHHHHHHhcCC
Confidence 889999999999999999999985322 11111111100 001
Q ss_pred CCCCCCCCchHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q psy1840 150 RPDTSSLDCAPSIIACMRTCWEEDPELRPDLRFVHHKL 187 (423)
Q Consensus 150 ~p~~~~~~~~~~l~~Li~~C~~~dP~~RPt~~~I~~~L 187 (423)
.|..+...++.++.+++.+||..+|++||++.+|++..
T Consensus 251 ~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~ 288 (308)
T cd06615 251 PPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHP 288 (308)
T ss_pred CccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcCh
Confidence 12222224678899999999999999999999998764
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=99.88 E-value=2e-22 Score=189.92 Aligned_cols=150 Identities=22% Similarity=0.376 Sum_probs=117.0
Q ss_pred HHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCc-cEEEeccCCcccccCCCcccccccccCCccccCCccccCCCC
Q psy1840 25 SISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRW-VLQIADFGLHAFKAGQDETGQERKLRRRKLYKAPELLRQPHL 103 (423)
Q Consensus 25 ~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~-~vKL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~ 103 (423)
...++.|++.||.|||+.+++ ||||||+||+++.++ .+||+|||.+........ ......++..|+|||.+.+...
T Consensus 103 ~~~~~~~l~~~l~~lh~~~i~-H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~--~~~~~~~~~~~~ape~~~~~~~ 179 (257)
T cd08225 103 ILSWFVQISLGLKHIHDRKIL-HRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSME--LAYTCVGTPYYLSPEICQNRPY 179 (257)
T ss_pred HHHHHHHHHHHHHHHHHCCcc-cccCCHHHEEEcCCCCeEEecccccchhccCCcc--cccccCCCccccCHHHHcCCCC
Confidence 678999999999999999998 999999999999875 569999999876533221 1123457888999998876544
Q ss_pred CCCCCccchHHHHHHHHHHHhCCCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCchHHHHHHHHHhhhcCCCCCCCHHHH
Q psy1840 104 PRGTQKGDVYSFGLVLYEVIGRQGPWGHLRMTDEEIITSVTQGSGLRPDTSSLDCAPSIIACMRTCWEEDPELRPDLRFV 183 (423)
Q Consensus 104 ~~~s~ksDVyS~Giil~elltg~~Pf~~~~~~~~~i~~~i~~~~~~~p~~~~~~~~~~l~~Li~~C~~~dP~~RPt~~~I 183 (423)
+.++|+||||+++||+++|..||... ...+....+..+. .+.. ....+.++.+++.+||..+|++||++.++
T Consensus 180 ---~~~~Dv~slG~il~~l~~g~~p~~~~--~~~~~~~~~~~~~--~~~~-~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l 251 (257)
T cd08225 180 ---NNKTDIWSLGCVLYELCTLKHPFEGN--NLHQLVLKICQGY--FAPI-SPNFSRDLRSLISQLFKVSPRDRPSITSI 251 (257)
T ss_pred ---CchhhHHHHHHHHHHHHhCCCCCCCc--cHHHHHHHHhccc--CCCC-CCCCCHHHHHHHHHHhccChhhCcCHHHH
Confidence 88999999999999999999999643 3334444433322 1111 22467899999999999999999999998
Q ss_pred HH
Q psy1840 184 HH 185 (423)
Q Consensus 184 ~~ 185 (423)
+.
T Consensus 252 l~ 253 (257)
T cd08225 252 LK 253 (257)
T ss_pred hh
Confidence 75
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=99.88 E-value=2.4e-22 Score=188.76 Aligned_cols=150 Identities=20% Similarity=0.375 Sum_probs=121.1
Q ss_pred HHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCccEEEeccCCcccccCCCcccccccccCCccccCCccccCCCCC
Q psy1840 25 SISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKAPELLRQPHLP 104 (423)
Q Consensus 25 ~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~ 104 (423)
...++.+++.||.|||+.|++ ||||+|+||+++.++.++|+|||.+....... .......+++.|+|||.+.+...
T Consensus 105 ~~~i~~~i~~~l~~lh~~~~~-H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~--~~~~~~~~~~~y~~pe~~~~~~~- 180 (258)
T cd08215 105 ILDWFVQLCLALKYLHSRKIL-HRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV--DLAKTVVGTPYYLSPELCQNKPY- 180 (258)
T ss_pred HHHHHHHHHHHHHHHHhCCEe-cccCChHHeEEcCCCcEEECCccceeecccCc--ceecceeeeecccChhHhccCCC-
Confidence 689999999999999999998 99999999999999999999999987654332 11233467788999998876654
Q ss_pred CCCCccchHHHHHHHHHHHhCCCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCchHHHHHHHHHhhhcCCCCCCCHHHHH
Q psy1840 105 RGTQKGDVYSFGLVLYEVIGRQGPWGHLRMTDEEIITSVTQGSGLRPDTSSLDCAPSIIACMRTCWEEDPELRPDLRFVH 184 (423)
Q Consensus 105 ~~s~ksDVyS~Giil~elltg~~Pf~~~~~~~~~i~~~i~~~~~~~p~~~~~~~~~~l~~Li~~C~~~dP~~RPt~~~I~ 184 (423)
+.++|+||+|++++++++|..||... ...++........ .+.. +..++..+.+++.+||..+|++||++.+++
T Consensus 181 --~~~~Dv~slG~~~~~l~~g~~p~~~~--~~~~~~~~~~~~~--~~~~-~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll 253 (258)
T cd08215 181 --NYKSDIWSLGCVLYELCTLKHPFEGE--NLLELALKILKGQ--YPPI-PSQYSSELRNLVSSLLQKDPEERPSIAQIL 253 (258)
T ss_pred --CccccHHHHHHHHHHHHcCCCCCCCC--cHHHHHHHHhcCC--CCCC-CCCCCHHHHHHHHHHcCCChhhCcCHHHHh
Confidence 88999999999999999999999643 3455555554432 1222 236788999999999999999999999987
Q ss_pred H
Q psy1840 185 H 185 (423)
Q Consensus 185 ~ 185 (423)
+
T Consensus 254 ~ 254 (258)
T cd08215 254 Q 254 (258)
T ss_pred c
Confidence 5
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.8e-22 Score=198.16 Aligned_cols=157 Identities=24% Similarity=0.297 Sum_probs=118.2
Q ss_pred HHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCccEEEeccCCcccccCCCc-ccccccccCCccccCCccccCCCC
Q psy1840 25 SISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDE-TGQERKLRRRKLYKAPELLRQPHL 103 (423)
Q Consensus 25 ~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~-~~~~~~~~gt~~y~APE~l~~~~~ 103 (423)
...++.||+.||.|||+.|++ ||||||.||+++.++.++|+|||++........ ........++..|+|||.+.+..
T Consensus 105 ~~~i~~~l~~~l~~LH~~gi~-H~dlkp~nili~~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~- 182 (330)
T cd07834 105 IQYFLYQILRGLKYLHSANVI-HRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLTEYVVTRWYRAPELLLSSS- 182 (330)
T ss_pred HHHHHHHHHHHHHHHHhCCee-cCCCCHHHEEEcCCCCEEEcccCceEeecccccccccccccccccCcCCceeeeccc-
Confidence 567999999999999999987 999999999999999999999999876543321 01123345678899999998763
Q ss_pred CCCCCccchHHHHHHHHHHHhCCCCCCCCCCChHHHHHHHhcCCCCC-----------------------CC----CCCC
Q psy1840 104 PRGTQKGDVYSFGLVLYEVIGRQGPWGHLRMTDEEIITSVTQGSGLR-----------------------PD----TSSL 156 (423)
Q Consensus 104 ~~~s~ksDVyS~Giil~elltg~~Pf~~~~~~~~~i~~~i~~~~~~~-----------------------p~----~~~~ 156 (423)
..+.++|+||||+++|+|++|..||.... ..+....+....... .. ....
T Consensus 183 -~~~~~sDi~slG~il~~l~~g~~pf~~~~--~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (330)
T cd07834 183 -RYTKAIDIWSVGCIFAELLTRKPLFPGRD--YIDQLNLIVEVLGTPSEEDLKFITSEKARNYLKSLPKKPKKPLSKLFP 259 (330)
T ss_pred -CCCcchhHHHHHHHHHHHHcCCCCcCCCC--HHHHHHHHHHhcCCCChhHhhhccccchhhHHhhcccCCcchhHHhcc
Confidence 23889999999999999999999996432 222222222110000 00 0012
Q ss_pred CchHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q psy1840 157 DCAPSIIACMRTCWEEDPELRPDLRFVHHK 186 (423)
Q Consensus 157 ~~~~~l~~Li~~C~~~dP~~RPt~~~I~~~ 186 (423)
..+..+.+++.+||+.+|++||++.+++..
T Consensus 260 ~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 289 (330)
T cd07834 260 GASPEAIDLLEKMLVFDPKKRITADEALAH 289 (330)
T ss_pred cCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 357889999999999999999999999864
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.9e-22 Score=192.87 Aligned_cols=154 Identities=21% Similarity=0.255 Sum_probs=115.2
Q ss_pred HHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCccEEEeccCCcccccCCCcccccccccCCccccCCccccCCCCC
Q psy1840 25 SISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKAPELLRQPHLP 104 (423)
Q Consensus 25 ~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~ 104 (423)
...++.|++.||.|||+.+++ ||||||+||+++.++.+||+|||.+....... .......++..|+|||.+.+..
T Consensus 100 ~~~~~~~i~~~l~~LH~~~i~-H~dl~p~nili~~~~~~~l~df~~~~~~~~~~--~~~~~~~~~~~~~~PE~~~~~~-- 174 (283)
T cd05118 100 IKSYLYQLLQGLAFCHSHGIL-HRDLKPENLLINTEGVLKLADFGLARSFGSPV--RPYTHYVVTRWYRAPELLLGDK-- 174 (283)
T ss_pred HHHHHHHHHHHHHHHHHCCee-ecCcCHHHEEECCCCcEEEeeeeeeEecCCCc--ccccCccCcccccCcHHHhcCC--
Confidence 678999999999999999988 99999999999999999999999987654332 1112345677899999987652
Q ss_pred CCCCccchHHHHHHHHHHHhCCCCCCCCCCChHHHHHHHhc-CCC------------------CCCC-------CCCCCc
Q psy1840 105 RGTQKGDVYSFGLVLYEVIGRQGPWGHLRMTDEEIITSVTQ-GSG------------------LRPD-------TSSLDC 158 (423)
Q Consensus 105 ~~s~ksDVyS~Giil~elltg~~Pf~~~~~~~~~i~~~i~~-~~~------------------~~p~-------~~~~~~ 158 (423)
..+.++|+||||+++|++++|+.||.... ..+.+..+.. ... ..+. .....+
T Consensus 175 ~~~~~~Di~slG~~l~~l~tg~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 252 (283)
T cd05118 175 GYSTPVDIWSVGCIFAELLSRRPLFPGKS--EIDQLFKIFRTLGTPDPEVWPKFTSLARNYKFSFPKKAGMPLPKLFPNA 252 (283)
T ss_pred CCCchhHHHHHHHHHHHHHhCCCCCCCCC--HHHHHHHHHHHcCCCchHhcccchhhhhhhhhhhccccccCHHHhhhhh
Confidence 23889999999999999999999996432 1222211111 000 0000 001246
Q ss_pred hHHHHHHHHHhhhcCCCCCCCHHHHHH
Q psy1840 159 APSIIACMRTCWEEDPELRPDLRFVHH 185 (423)
Q Consensus 159 ~~~l~~Li~~C~~~dP~~RPt~~~I~~ 185 (423)
+.++.+++.+||+.||.+||++.+++.
T Consensus 253 ~~~~~~~i~~~l~~~P~~Rp~~~~ll~ 279 (283)
T cd05118 253 SPQALDLLSQMLHYDPHKRITAEQALA 279 (283)
T ss_pred CHHHHHHHHHHhccCcccCcCHHHHhh
Confidence 788999999999999999999999875
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=99.88 E-value=2.9e-22 Score=193.82 Aligned_cols=153 Identities=17% Similarity=0.279 Sum_probs=118.9
Q ss_pred HHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCccEEEeccCCcccccCCCcccccccccCCccccCCccccCCCCC
Q psy1840 25 SISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKAPELLRQPHLP 104 (423)
Q Consensus 25 ~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~ 104 (423)
...++.|++.|++|||+.|++ ||||+|+||+++.++.++|+|||++....... .......++..|+|||.+.+..+
T Consensus 118 ~~~~~~ql~~~l~~lH~~giv-H~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~--~~~~~~~~~~~y~~pE~~~~~~~- 193 (292)
T cd06657 118 IAAVCLAVLKALSVLHAQGVI-HRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV--PRRKSLVGTPYWMAPELISRLPY- 193 (292)
T ss_pred HHHHHHHHHHHHHHHHHCCee-cCCCCHHHEEECCCCCEEEcccccceeccccc--ccccccccCccccCHHHhcCCCC-
Confidence 578999999999999999988 99999999999999999999999876543221 11233457788999998876544
Q ss_pred CCCCccchHHHHHHHHHHHhCCCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCchHHHHHHHHHhhhcCCCCCCCHHHHH
Q psy1840 105 RGTQKGDVYSFGLVLYEVIGRQGPWGHLRMTDEEIITSVTQGSGLRPDTSSLDCAPSIIACMRTCWEEDPELRPDLRFVH 184 (423)
Q Consensus 105 ~~s~ksDVyS~Giil~elltg~~Pf~~~~~~~~~i~~~i~~~~~~~p~~~~~~~~~~l~~Li~~C~~~dP~~RPt~~~I~ 184 (423)
+.++|+||||+++|++++|..||... ...+....+....+.... ....+++.+.+++.+||+.+|.+||++.+++
T Consensus 194 --~~~~Dv~slGvil~el~tg~~p~~~~--~~~~~~~~~~~~~~~~~~-~~~~~~~~l~~li~~~l~~~P~~R~~~~~ll 268 (292)
T cd06657 194 --GPEVDIWSLGIMVIEMVDGEPPYFNE--PPLKAMKMIRDNLPPKLK-NLHKVSPSLKGFLDRLLVRDPAQRATAAELL 268 (292)
T ss_pred --CchhhHHHHHHHHHHHHhCCCCCCCC--CHHHHHHHHHhhCCcccC-CcccCCHHHHHHHHHHHhCCcccCcCHHHHh
Confidence 78999999999999999999999642 233333444332211111 1234678999999999999999999999988
Q ss_pred HH
Q psy1840 185 HK 186 (423)
Q Consensus 185 ~~ 186 (423)
..
T Consensus 269 ~~ 270 (292)
T cd06657 269 KH 270 (292)
T ss_pred cC
Confidence 74
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.6e-22 Score=199.02 Aligned_cols=156 Identities=21% Similarity=0.270 Sum_probs=114.7
Q ss_pred HHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCccEEEeccCCcccccCCCcc--cccccccCCccccCCccccCCC
Q psy1840 25 SISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDET--GQERKLRRRKLYKAPELLRQPH 102 (423)
Q Consensus 25 ~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~~--~~~~~~~gt~~y~APE~l~~~~ 102 (423)
...++.||+.||.|||++|++ ||||||+||+++.++.+||+|||++......... .......++..|+|||.+.+..
T Consensus 107 ~~~~~~qi~~aL~~LH~~giv-H~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~ 185 (332)
T cd07857 107 FQSFIYQILCGLKYIHSANVL-HRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEYVATRWYRAPEIMLSFQ 185 (332)
T ss_pred HHHHHHHHHHHHHHHHhCCcc-cCCCCHHHeEEcCCCCEEeCcCCCceecccccccccccccCcccCccccCcHHHhCCC
Confidence 578999999999999999998 9999999999999999999999998754322111 1123346788899999876532
Q ss_pred CCCCCCccchHHHHHHHHHHHhCCCCCCCCCCChHHHHHHHhc---------------------------CCCCCCCCCC
Q psy1840 103 LPRGTQKGDVYSFGLVLYEVIGRQGPWGHLRMTDEEIITSVTQ---------------------------GSGLRPDTSS 155 (423)
Q Consensus 103 ~~~~s~ksDVyS~Giil~elltg~~Pf~~~~~~~~~i~~~i~~---------------------------~~~~~p~~~~ 155 (423)
..+.++|+||||+++|++++|..||.... .......+.. ..........
T Consensus 186 --~~~~~~Di~slGv~l~~l~~g~~pf~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 261 (332)
T cd07857 186 --SYTKAIDVWSVGCILAELLGRKPVFKGKD--YVDQLNQILQVLGTPDEETLSRIGSPKAQNYIRSLPNIPKKPFESIF 261 (332)
T ss_pred --CCCcHHHHHHHHHHHHHHHhCCcCCCCCC--HHHHHHHHHHHhCCCCHHHHHhhhhhhHHHHHHhccccCCcchHhhC
Confidence 23889999999999999999999986432 1111111110 0000000011
Q ss_pred CCchHHHHHHHHHhhhcCCCCCCCHHHHHH
Q psy1840 156 LDCAPSIIACMRTCWEEDPELRPDLRFVHH 185 (423)
Q Consensus 156 ~~~~~~l~~Li~~C~~~dP~~RPt~~~I~~ 185 (423)
..++..+.+++.+||+.||++|||+.+++.
T Consensus 262 ~~~~~~~~~li~~~l~~~P~~R~t~~~ll~ 291 (332)
T cd07857 262 PNANPLALDLLEKLLAFDPTKRISVEEALE 291 (332)
T ss_pred CCCCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 235788999999999999999999998864
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=99.88 E-value=3.8e-22 Score=194.90 Aligned_cols=151 Identities=21% Similarity=0.316 Sum_probs=117.0
Q ss_pred HHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCccEEEeccCCcccccCCCcccccccccCCccccCCccccCCCCC
Q psy1840 25 SISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKAPELLRQPHLP 104 (423)
Q Consensus 25 ~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~ 104 (423)
.+.++.||+.|+.|||++|++ ||||+|+||+++.++.+||+|||++..... .....++..|+|||.+......
T Consensus 123 ~~~~~~qi~~al~~LH~~gi~-H~dl~p~nili~~~~~~kL~dfg~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~ 195 (313)
T cd06633 123 IAAITHGALQGLAYLHSHNMI-HRDIKAGNILLTEPGQVKLADFGSASKSSP------ANSFVGTPYWMAPEVILAMDEG 195 (313)
T ss_pred HHHHHHHHHHHHHHHHHCCee-cCCCChhhEEECCCCCEEEeecCCCcccCC------CCCccccccccChhhccccCCC
Confidence 678999999999999999988 999999999999999999999998754221 1234677889999998532112
Q ss_pred CCCCccchHHHHHHHHHHHhCCCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCchHHHHHHHHHhhhcCCCCCCCHHHHH
Q psy1840 105 RGTQKGDVYSFGLVLYEVIGRQGPWGHLRMTDEEIITSVTQGSGLRPDTSSLDCAPSIIACMRTCWEEDPELRPDLRFVH 184 (423)
Q Consensus 105 ~~s~ksDVyS~Giil~elltg~~Pf~~~~~~~~~i~~~i~~~~~~~p~~~~~~~~~~l~~Li~~C~~~dP~~RPt~~~I~ 184 (423)
..+.++||||||+++|+|++|..||... ........+.... .+......++..+.+++.+||+.+|.+||++.+++
T Consensus 196 ~~~~~sDv~slGvil~el~~g~~p~~~~--~~~~~~~~~~~~~--~~~~~~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l 271 (313)
T cd06633 196 QYDGKVDVWSLGITCIELAERKPPLFNM--NAMSALYHIAQND--SPTLQSNEWTDSFRGFVDYCLQKIPQERPASAELL 271 (313)
T ss_pred CCCchhhHHHHHHHHHHHHhCCCCCCCC--ChHHHHHHHHhcC--CCCCCccccCHHHHHHHHHHccCChhhCcCHHHHh
Confidence 3478999999999999999999998643 2233333333221 23233345678899999999999999999999988
Q ss_pred HH
Q psy1840 185 HK 186 (423)
Q Consensus 185 ~~ 186 (423)
..
T Consensus 272 ~~ 273 (313)
T cd06633 272 RH 273 (313)
T ss_pred cC
Confidence 64
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.2e-22 Score=195.19 Aligned_cols=157 Identities=20% Similarity=0.337 Sum_probs=119.0
Q ss_pred HHHHHHHHHHHHHHHHh-CCCeeecCCCCCCEEEcCCccEEEeccCCcccccCCCcccccccccCCccccCCccccCCCC
Q psy1840 25 SISVNTTASVGMIHLHD-SEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKAPELLRQPHL 103 (423)
Q Consensus 25 ~l~i~~qi~~gL~yLH~-~~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~ 103 (423)
...++.+++.|+.|||+ .+++ ||||||+||+++.++.++|+|||++....... .....++..|+|||.+.+...
T Consensus 105 ~~~~~~~i~~~l~~LH~~~~i~-H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~~----~~~~~~~~~~~aPE~~~~~~~ 179 (284)
T cd06620 105 LGKIAVAVVEGLTYLYNVHRIM-HRDIKPSNILVNSRGQIKLCDFGVSGELINSI----ADTFVGTSTYMSPERIQGGKY 179 (284)
T ss_pred HHHHHHHHHHHHHHHHHhcCee-ccCCCHHHEEECCCCcEEEccCCcccchhhhc----cCccccCcccCCHHHHccCCC
Confidence 46899999999999997 4776 99999999999999999999999976432211 123467888999999876644
Q ss_pred CCCCCccchHHHHHHHHHHHhCCCCCCCCCC------ChH---HHHHHHhcCCCCCCCCCCCCchHHHHHHHHHhhhcCC
Q psy1840 104 PRGTQKGDVYSFGLVLYEVIGRQGPWGHLRM------TDE---EIITSVTQGSGLRPDTSSLDCAPSIIACMRTCWEEDP 174 (423)
Q Consensus 104 ~~~s~ksDVyS~Giil~elltg~~Pf~~~~~------~~~---~i~~~i~~~~~~~p~~~~~~~~~~l~~Li~~C~~~dP 174 (423)
+.++|+|||||++|++++|..||..... ... +....+.... .+......++.++.+++.+||+.||
T Consensus 180 ---~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~li~~~l~~dp 254 (284)
T cd06620 180 ---TVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEP--PPRLPSSDFPEDLRDFVDACLLKDP 254 (284)
T ss_pred ---CccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhcc--CCCCCchhcCHHHHHHHHHHhcCCc
Confidence 8899999999999999999999974322 111 2222222221 2222223478899999999999999
Q ss_pred CCCCCHHHHHHHHHHHh
Q psy1840 175 ELRPDLRFVHHKLKEMN 191 (423)
Q Consensus 175 ~~RPt~~~I~~~L~~i~ 191 (423)
++||++.++++....+.
T Consensus 255 ~~Rpt~~e~~~~~~~~~ 271 (284)
T cd06620 255 TERPTPQQLCAMPPFIQ 271 (284)
T ss_pred ccCcCHHHHhcCccccc
Confidence 99999999987654433
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.9e-22 Score=190.70 Aligned_cols=150 Identities=19% Similarity=0.245 Sum_probs=117.1
Q ss_pred HHHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCccEEEeccCCcccccCCCcccccccccCCccccCCccccCCCC
Q psy1840 24 GSISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKAPELLRQPHL 103 (423)
Q Consensus 24 ~~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~ 103 (423)
....++.||+.||.|||+.+++ |+||+|+||++++++.++|+|||++....... ......++..|+|||.+.+...
T Consensus 101 ~~~~~~~~i~~~l~~lh~~~i~-h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~---~~~~~~~~~~y~~PE~~~~~~~ 176 (258)
T cd05578 101 QVKFWICEIVLALEYLHSKGII-HRDIKPDNILLDEQGHVHITDFNIATKVTPDT---LTTSTSGTPGYMAPEVLCRQGY 176 (258)
T ss_pred HHHHHHHHHHHHHHHHHhCCee-ccCCCHHHeEEcCCCCEEEeecccccccCCCc---cccccCCChhhcCHHHHcccCC
Confidence 3678999999999999999987 99999999999999999999999977543322 1234457778999999877654
Q ss_pred CCCCCccchHHHHHHHHHHHhCCCCCCCCCCC-hHHHHHHHhcCCCCCCCCCCCCchHHHHHHHHHhhhcCCCCCCCH--
Q psy1840 104 PRGTQKGDVYSFGLVLYEVIGRQGPWGHLRMT-DEEIITSVTQGSGLRPDTSSLDCAPSIIACMRTCWEEDPELRPDL-- 180 (423)
Q Consensus 104 ~~~s~ksDVyS~Giil~elltg~~Pf~~~~~~-~~~i~~~i~~~~~~~p~~~~~~~~~~l~~Li~~C~~~dP~~RPt~-- 180 (423)
+.++|+||||+++|++++|..||...... ...+........ +. .+...+..+.+++.+||..||.+||++
T Consensus 177 ---~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~---~~-~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ 249 (258)
T cd05578 177 ---SVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQETAD---VL-YPATWSTEAIDAINKLLERDPQKRLGDNL 249 (258)
T ss_pred ---CCcccchhhHHHHHHHHhCCCCCCCCCccHHHHHHHHhcccc---cc-CcccCcHHHHHHHHHHccCChhHcCCccH
Confidence 88999999999999999999999754322 233333322211 11 223567899999999999999999999
Q ss_pred HHHH
Q psy1840 181 RFVH 184 (423)
Q Consensus 181 ~~I~ 184 (423)
.+++
T Consensus 250 ~~l~ 253 (258)
T cd05578 250 KDLK 253 (258)
T ss_pred HHHh
Confidence 5543
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=99.88 E-value=2.4e-22 Score=192.58 Aligned_cols=156 Identities=23% Similarity=0.305 Sum_probs=115.3
Q ss_pred HHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCccEEEeccCCcccccCCCcccccccccCCccccCCccccCCCCC
Q psy1840 25 SISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKAPELLRQPHLP 104 (423)
Q Consensus 25 ~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~ 104 (423)
...++.||+.||.|||+.+++ |+||||+||+++.++.++|+|||++........ .......++..|+|||.+.+..
T Consensus 101 ~~~~~~~i~~~l~~lH~~~i~-H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~-- 176 (286)
T cd07832 101 VKSYMRMLLKGVAYMHANGIM-HRDLKPANLLISADGVLKIADFGLARLFSEEEP-RLYSHQVATRWYRAPELLYGAR-- 176 (286)
T ss_pred HHHHHHHHHHHHHHHHHCCee-cCCcCHHHEEEcCCCcEEEeeeeecccccCCCC-CccccccCcccccCceeeeccc--
Confidence 678999999999999999988 999999999999999999999999876543221 1122346788899999986543
Q ss_pred CCCCccchHHHHHHHHHHHhCCCCCCCCCCChHHHHHHHhcCCC-------------------CCCCC-------CCCCc
Q psy1840 105 RGTQKGDVYSFGLVLYEVIGRQGPWGHLRMTDEEIITSVTQGSG-------------------LRPDT-------SSLDC 158 (423)
Q Consensus 105 ~~s~ksDVyS~Giil~elltg~~Pf~~~~~~~~~i~~~i~~~~~-------------------~~p~~-------~~~~~ 158 (423)
..+.++||||+|++++||++|..||... ...+....+..... ..+.. ...+.
T Consensus 177 ~~~~~~Di~slG~~l~~l~tg~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (286)
T cd07832 177 KYDPGVDLWAVGCIFAELLNGSPLFPGE--NDIEQLAIVFRTLGTPNEETWPGLTSLPDYNKITFPESKPIPLEEIFPDA 254 (286)
T ss_pred cCCchhHHHHHHHHHHHHHcCCcCcCCC--CHHHHHHHHHHHcCCCChHHHhhccCcchhhcccCCCCCcchHHHhCCCc
Confidence 2378999999999999999998777532 22222222211000 00000 01245
Q ss_pred hHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q psy1840 159 APSIIACMRTCWEEDPELRPDLRFVHHK 186 (423)
Q Consensus 159 ~~~l~~Li~~C~~~dP~~RPt~~~I~~~ 186 (423)
+..+.+++++||..+|++||++.+++..
T Consensus 255 ~~~~~~li~~~l~~~p~~R~~~~~~l~h 282 (286)
T cd07832 255 SPEALDLLKGLLVYDPSKRLSAAEALRH 282 (286)
T ss_pred cHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 6899999999999999999999998753
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=99.88 E-value=2.1e-22 Score=194.62 Aligned_cols=155 Identities=23% Similarity=0.232 Sum_probs=114.2
Q ss_pred HHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCccEEEeccCCcccccCCCcccccccccCCccccCCccccCCCCC
Q psy1840 25 SISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKAPELLRQPHLP 104 (423)
Q Consensus 25 ~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~ 104 (423)
.+.++.||++||.|||++|++ ||||||+||+++.++.+||+|||++......... .....++..|+|||.+.+..
T Consensus 104 ~~~~~~qi~~al~~lH~~~i~-H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~-- 178 (298)
T cd07841 104 IKSYMLMTLRGLEYLHSNWIL-HRDLKPNNLLIASDGVLKLADFGLARSFGSPNRK--MTHQVVTRWYRAPELLFGAR-- 178 (298)
T ss_pred HHHHHHHHHHHHHHHHhCCee-ecCCChhhEEEcCCCCEEEccceeeeeccCCCcc--ccccccceeeeCHHHHhCCC--
Confidence 578999999999999999988 9999999999999999999999998765332211 12234567799999886533
Q ss_pred CCCCccchHHHHHHHHHHHhCCCCCCCCCCChHHHHHHHhcCC---------------CC-----CCCC----CCCCchH
Q psy1840 105 RGTQKGDVYSFGLVLYEVIGRQGPWGHLRMTDEEIITSVTQGS---------------GL-----RPDT----SSLDCAP 160 (423)
Q Consensus 105 ~~s~ksDVyS~Giil~elltg~~Pf~~~~~~~~~i~~~i~~~~---------------~~-----~p~~----~~~~~~~ 160 (423)
..+.++|||||||++||+++|..||.... ..+....+.... .. .+.. .....+.
T Consensus 179 ~~~~~~Dv~slG~il~e~~~g~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (298)
T cd07841 179 HYGVGVDMWSVGCIFAELLLRVPFLPGDS--DIDQLGKIFEALGTPTEENWPGVTSLPDYVEFKPFPPTPLKQIFPAASD 256 (298)
T ss_pred CCCcHHHHHHHHHHHHHHHcCCccccCCc--cHHHHHHHHHHcCCCchhhhhhcccccccccccccCCcchhhhcccccH
Confidence 23789999999999999999977775422 222222221100 00 0000 0123567
Q ss_pred HHHHHHHHhhhcCCCCCCCHHHHHHH
Q psy1840 161 SIIACMRTCWEEDPELRPDLRFVHHK 186 (423)
Q Consensus 161 ~l~~Li~~C~~~dP~~RPt~~~I~~~ 186 (423)
.+.+++.+||+.+|++||++.+++..
T Consensus 257 ~~~~li~~~l~~~P~~R~s~~e~l~~ 282 (298)
T cd07841 257 DALDLLQRLLTLNPNKRITARQALEH 282 (298)
T ss_pred HHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 89999999999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=99.88 E-value=2.4e-22 Score=194.46 Aligned_cols=155 Identities=19% Similarity=0.249 Sum_probs=114.8
Q ss_pred HHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCccEEEeccCCcccccCCCcccccccccCCccccCCccccCCCCC
Q psy1840 25 SISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKAPELLRQPHLP 104 (423)
Q Consensus 25 ~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~ 104 (423)
...++.||+.||.|||+.|++ ||||||+||++++++.+||+|||++......... ......++..|+|||.+.+..
T Consensus 118 ~~~i~~qi~~aL~~LH~~~i~-H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~-- 193 (302)
T cd07864 118 IKSFMKQLLEGLNYCHKKNFL-HRDIKCSNILLNNKGQIKLADFGLARLYNSEESR-PYTNKVITLWYRPPELLLGEE-- 193 (302)
T ss_pred HHHHHHHHHHHHHHHHhCCee-cCCCCHHHEEECCCCcEEeCcccccccccCCccc-ccccceeccCccChHHhcCCC--
Confidence 679999999999999999998 9999999999999999999999998765433211 112234566799999886533
Q ss_pred CCCCccchHHHHHHHHHHHhCCCCCCCCCCChHHHHHHHhc---CC--CCCCC---------------------CCCCCc
Q psy1840 105 RGTQKGDVYSFGLVLYEVIGRQGPWGHLRMTDEEIITSVTQ---GS--GLRPD---------------------TSSLDC 158 (423)
Q Consensus 105 ~~s~ksDVyS~Giil~elltg~~Pf~~~~~~~~~i~~~i~~---~~--~~~p~---------------------~~~~~~ 158 (423)
..+.++|||||||++|||++|+.||.... ..+....+.. .. ...|. .....+
T Consensus 194 ~~~~~~Di~slG~~~~el~~g~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 271 (302)
T cd07864 194 RYGPAIDVWSCGCILGELFTKKPIFQANQ--ELAQLELISRLCGSPCPAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFI 271 (302)
T ss_pred CCCchhHHHHHHHHHHHHHhCCCCCCCCC--hHHHHHHHHHHhCCCChhhcccccccccccccccccccccchhhhcCCC
Confidence 23789999999999999999999996422 2222222221 10 00000 011236
Q ss_pred hHHHHHHHHHhhhcCCCCCCCHHHHHH
Q psy1840 159 APSIIACMRTCWEEDPELRPDLRFVHH 185 (423)
Q Consensus 159 ~~~l~~Li~~C~~~dP~~RPt~~~I~~ 185 (423)
+..+.+++.+||+.+|++||++.+++.
T Consensus 272 ~~~~~~li~~~l~~~P~~Rp~~~~il~ 298 (302)
T cd07864 272 PTPALDLLDHMLTLDPSKRCTAEEALN 298 (302)
T ss_pred CHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 789999999999999999999998875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.5e-22 Score=199.35 Aligned_cols=158 Identities=15% Similarity=0.156 Sum_probs=117.0
Q ss_pred HHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCccEEEeccCCcccccCCCcccccccccCCccccCCccccCCC--
Q psy1840 25 SISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKAPELLRQPH-- 102 (423)
Q Consensus 25 ~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~-- 102 (423)
...++.||+.||.|||+.+++ ||||||+||+++.++.+||+|||++........ .......|++.|+|||++.+..
T Consensus 104 ~~~~~~qi~~al~~lH~~~ii-HrDlkp~Nili~~~~~~kL~DfG~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~ 181 (332)
T cd05623 104 ARFYLAEMVIAIDSVHQLHYV-HRDIKPDNILMDMNGHIRLADFGSCLKLMEDGT-VQSSVAVGTPDYISPEILQAMEDG 181 (332)
T ss_pred HHHHHHHHHHHHHHHHHCCeE-ecCCCHHHEEECCCCCEEEeecchheecccCCc-ceecccccCccccCHHHHhccccC
Confidence 457889999999999999998 999999999999999999999999865432211 1123356899999999986321
Q ss_pred CCCCCCccchHHHHHHHHHHHhCCCCCCCCCCChHHHHHHHhcCCCC-CCCCCCCCchHHHHHHHHHhhhcCCC--CCCC
Q psy1840 103 LPRGTQKGDVYSFGLVLYEVIGRQGPWGHLRMTDEEIITSVTQGSGL-RPDTSSLDCAPSIIACMRTCWEEDPE--LRPD 179 (423)
Q Consensus 103 ~~~~s~ksDVyS~Giil~elltg~~Pf~~~~~~~~~i~~~i~~~~~~-~p~~~~~~~~~~l~~Li~~C~~~dP~--~RPt 179 (423)
...++.++|||||||++|||++|+.||.. .+..+....+...... ..+.....+++++.+++.+|+..+++ .|++
T Consensus 182 ~~~~~~~~DvwSlGvil~ell~g~~Pf~~--~~~~~~~~~i~~~~~~~~~p~~~~~~s~~~~~li~~ll~~~~~r~~r~~ 259 (332)
T cd05623 182 KGKYGPECDWWSLGVCMYEMLYGETPFYA--ESLVETYGKIMNHKERFQFPAQVTDVSEDAKDLIRRLICSREHRLGQNG 259 (332)
T ss_pred CCCCCCcCCEEeeHHHHHHHhcCCCCCCC--CCHHHHHHHHhCCCccccCCCccccCCHHHHHHHHHHccChhhhcCCCC
Confidence 11348899999999999999999999974 3445555555543221 11112235789999999998865444 3678
Q ss_pred HHHHHHH
Q psy1840 180 LRFVHHK 186 (423)
Q Consensus 180 ~~~I~~~ 186 (423)
+.++++.
T Consensus 260 ~~~~~~h 266 (332)
T cd05623 260 IEDFKQH 266 (332)
T ss_pred HHHHhCC
Confidence 8888754
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.88 E-value=2e-22 Score=194.94 Aligned_cols=152 Identities=18% Similarity=0.316 Sum_probs=116.7
Q ss_pred HHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCccEEEeccCCcccccCCCcccccccccCCccccCCccccCCCCC
Q psy1840 25 SISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKAPELLRQPHLP 104 (423)
Q Consensus 25 ~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~ 104 (423)
...++.|++.|+.|||++|++ ||||||+||+++.++.+||+|||++........ ......++..|+|||.+.+..+
T Consensus 117 ~~~i~~~l~~al~~LH~~gi~-H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~- 192 (293)
T cd06647 117 IAAVCRECLQALEFLHSNQVI-HRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS--KRSTMVGTPYWMAPEVVTRKAY- 192 (293)
T ss_pred HHHHHHHHHHHHHHHHhCCEe-eccCCHHHEEEcCCCCEEEccCcceeccccccc--ccccccCChhhcCchhhccCCC-
Confidence 578999999999999999987 999999999999999999999998765432221 1123457788999999876554
Q ss_pred CCCCccchHHHHHHHHHHHhCCCCCCCCCCChHHHHHHHhcCCCCCCCC-CCCCchHHHHHHHHHhhhcCCCCCCCHHHH
Q psy1840 105 RGTQKGDVYSFGLVLYEVIGRQGPWGHLRMTDEEIITSVTQGSGLRPDT-SSLDCAPSIIACMRTCWEEDPELRPDLRFV 183 (423)
Q Consensus 105 ~~s~ksDVyS~Giil~elltg~~Pf~~~~~~~~~i~~~i~~~~~~~p~~-~~~~~~~~l~~Li~~C~~~dP~~RPt~~~I 183 (423)
+.++|+||||+++|++++|..||.... ..+....+.... .+.. .....+..+.+++.+||+.+|++||++.++
T Consensus 193 --~~~~Dv~slG~ll~~ll~g~~pf~~~~--~~~~~~~~~~~~--~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~i 266 (293)
T cd06647 193 --GPKVDIWSLGIMAIEMVEGEPPYLNEN--PLRALYLIATNG--TPELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKEL 266 (293)
T ss_pred --CchhhHHHHHHHHHHHHhCCCCCCCCC--hhhheeehhcCC--CCCCCCccccCHHHHHHHHHHccCChhhCcCHHHH
Confidence 889999999999999999999996432 112111121111 1111 123467889999999999999999999999
Q ss_pred HHH
Q psy1840 184 HHK 186 (423)
Q Consensus 184 ~~~ 186 (423)
+..
T Consensus 267 l~h 269 (293)
T cd06647 267 LQH 269 (293)
T ss_pred hcC
Confidence 865
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >KOG0667|consensus | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.2e-22 Score=205.77 Aligned_cols=110 Identities=22% Similarity=0.400 Sum_probs=90.7
Q ss_pred CCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcC--CccEEEeccCCcccccCCCcccccccccCCc
Q psy1840 13 PNPLSPFNIPIGSISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDS--RWVLQIADFGLHAFKAGQDETGQERKLRRRK 90 (423)
Q Consensus 13 ~~p~~~~~~p~~~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~--~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~ 90 (423)
.+.+.++.++. -..|+.||+.||.+||+.+|| |+||||+||||-. +..+||+|||.+.+..... .+...+.
T Consensus 280 ~n~f~Glsl~~-ir~~~~Qil~~L~~L~~l~II-HcDLKPENILL~~~~r~~vKVIDFGSSc~~~q~v-----ytYiQSR 352 (586)
T KOG0667|consen 280 NNKFRGLSLPL-VRKFAQQILTALLFLHELGII-HCDLKPENILLKDPKRSRIKVIDFGSSCFESQRV-----YTYIQSR 352 (586)
T ss_pred hcCCCCCCHHH-HHHHHHHHHHHHHHHHhCCee-eccCChhheeeccCCcCceeEEecccccccCCcc-----eeeeecc
Confidence 34445565554 358999999999999999999 9999999999963 4579999999987653222 2556778
Q ss_pred cccCCccccCCCCCCCCCccchHHHHHHHHHHHhCCCCCCCC
Q psy1840 91 LYKAPELLRQPHLPRGTQKGDVYSFGLVLYEVIGRQGPWGHL 132 (423)
Q Consensus 91 ~y~APE~l~~~~~~~~s~ksDVyS~Giil~elltg~~Pf~~~ 132 (423)
.|.|||++.|..+ +.+.||||||||+.||++|.+-|.+.
T Consensus 353 fYRAPEVILGlpY---~~~IDmWSLGCIlAEL~tG~PLfpG~ 391 (586)
T KOG0667|consen 353 FYRAPEVILGLPY---DTAIDMWSLGCILAELFTGEPLFPGD 391 (586)
T ss_pred ccccchhhccCCC---CCccceeehhhhHHhHhcCccccCCC
Confidence 8999999999877 99999999999999999998777653
|
|
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.88 E-value=2.7e-22 Score=193.14 Aligned_cols=156 Identities=17% Similarity=0.193 Sum_probs=111.4
Q ss_pred HHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCccEEEeccCCcccccCCCcccccccccCCccccCCccccCCCCC
Q psy1840 25 SISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKAPELLRQPHLP 104 (423)
Q Consensus 25 ~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~ 104 (423)
...++.|++.||.|||+.+++ ||||||+||+++.++.+||+|||++........ ......++..|+|||.+.+..
T Consensus 105 ~~~~~~ql~~al~~lH~~~i~-H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~-- 179 (291)
T cd07844 105 VRLFLFQLLRGLAYCHQRRVL-HRDLKPQNLLISERGELKLADFGLARAKSVPSK--TYSNEVVTLWYRPPDVLLGST-- 179 (291)
T ss_pred HHHHHHHHHHHHHHHHhCCee-cccCCHHHEEEcCCCCEEECccccccccCCCCc--cccccccccccCCcHHhhcCc--
Confidence 578899999999999999988 999999999999999999999999764322111 112234567899999887533
Q ss_pred CCCCccchHHHHHHHHHHHhCCCCCCCCCCChHHHHHHHh---cC---------------C----CCCCCC---CCCCch
Q psy1840 105 RGTQKGDVYSFGLVLYEVIGRQGPWGHLRMTDEEIITSVT---QG---------------S----GLRPDT---SSLDCA 159 (423)
Q Consensus 105 ~~s~ksDVyS~Giil~elltg~~Pf~~~~~~~~~i~~~i~---~~---------------~----~~~p~~---~~~~~~ 159 (423)
..+.++||||+|+++|+|++|..||.......+.+..... .. . ...+.. ......
T Consensus 180 ~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (291)
T cd07844 180 EYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSSNPEFKPYSFPFYPPRPLINHAPRLD 259 (291)
T ss_pred ccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhhhhhccccccccccccCChhHHHhCcCCC
Confidence 2378999999999999999999999654322222111110 00 0 000000 001123
Q ss_pred --HHHHHHHHHhhhcCCCCCCCHHHHHH
Q psy1840 160 --PSIIACMRTCWEEDPELRPDLRFVHH 185 (423)
Q Consensus 160 --~~l~~Li~~C~~~dP~~RPt~~~I~~ 185 (423)
..+.+++.+||+.+|++||++.+++.
T Consensus 260 ~~~~~~~li~~~L~~~p~~Rps~~e~l~ 287 (291)
T cd07844 260 RIPHGEELALKFLQYEPKKRISAAEAMK 287 (291)
T ss_pred CchhHHHHHHHHhccCcccccCHHHHhc
Confidence 78889999999999999999998864
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.6e-22 Score=199.56 Aligned_cols=155 Identities=22% Similarity=0.283 Sum_probs=115.3
Q ss_pred HHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCccEEEeccCCcccccCCCcccccccccCCccccCCccccCCCCC
Q psy1840 25 SISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKAPELLRQPHLP 104 (423)
Q Consensus 25 ~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~ 104 (423)
...++.|++.||.|||+++++ ||||||+||+++.++.+||+|||++....... .......++..|+|||.+....
T Consensus 110 ~~~i~~qi~~aL~~LH~~~i~-H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~-- 184 (337)
T cd07858 110 CQYFLYQLLRGLKYIHSANVL-HRDLKPSNLLLNANCDLKICDFGLARTTSEKG--DFMTEYVVTRWYRAPELLLNCS-- 184 (337)
T ss_pred HHHHHHHHHHHHHHHHhCCEe-cCCCCHHHEEEcCCCCEEECcCccccccCCCc--ccccccccccCccChHHHhcCC--
Confidence 578999999999999999988 99999999999999999999999987553221 1112345678899999886532
Q ss_pred CCCCccchHHHHHHHHHHHhCCCCCCCCCCChHHHHHHHh-----------------------cCCCCCCC----CCCCC
Q psy1840 105 RGTQKGDVYSFGLVLYEVIGRQGPWGHLRMTDEEIITSVT-----------------------QGSGLRPD----TSSLD 157 (423)
Q Consensus 105 ~~s~ksDVyS~Giil~elltg~~Pf~~~~~~~~~i~~~i~-----------------------~~~~~~p~----~~~~~ 157 (423)
..+.++|||||||++|+|++|+.||..... .+....+. ......+. .....
T Consensus 185 ~~~~~~DiwslG~il~~l~~g~~pf~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (337)
T cd07858 185 EYTTAIDVWSVGCIFAELLGRKPLFPGKDY--VHQLKLITELLGSPSEEDLGFIRNEKARRYIRSLPYTPRQSFARLFPH 262 (337)
T ss_pred CCCCcccHHHHHHHHHHHHcCCCCCCCCCh--HHHHHHHHHHhCCCChHHhhhcCchhhhHHHHhcCcccccCHHHHccc
Confidence 138899999999999999999999964321 11111110 00000000 01135
Q ss_pred chHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q psy1840 158 CAPSIIACMRTCWEEDPELRPDLRFVHHK 186 (423)
Q Consensus 158 ~~~~l~~Li~~C~~~dP~~RPt~~~I~~~ 186 (423)
+++++.+++++||+.+|++||++.++++.
T Consensus 263 ~~~~~~~li~~~l~~~P~~Rps~~ell~h 291 (337)
T cd07858 263 ANPLAIDLLEKMLVFDPSKRITVEEALAH 291 (337)
T ss_pred CCHHHHHHHHHHhcCChhhccCHHHHHcC
Confidence 78899999999999999999999999875
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.9e-22 Score=198.65 Aligned_cols=159 Identities=21% Similarity=0.293 Sum_probs=115.8
Q ss_pred HHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCccEEEeccCCcccccCCCcc--cccccccCCccccCCccccCCC
Q psy1840 25 SISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDET--GQERKLRRRKLYKAPELLRQPH 102 (423)
Q Consensus 25 ~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~~--~~~~~~~gt~~y~APE~l~~~~ 102 (423)
...++.||+.||.|||+.+++ ||||||+||+++.++.+||+|||++......... .......++..|+|||.+.+..
T Consensus 109 ~~~i~~qi~~aL~~LH~~~iv-H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~ 187 (334)
T cd07855 109 IRYFLYQLLRGLKYIHSANVI-HRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVATRWYRAPELLLSLP 187 (334)
T ss_pred HHHHHHHHHHHHHHHHHCCee-cCCCCHHHEEEcCCCcEEecccccceeecccCcCCCcccccccccccccChHHhcCCc
Confidence 678999999999999999988 9999999999999999999999998754322211 1112346778899999986532
Q ss_pred CCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCh-------------HHHHHHH--------hcCCCCCCCCC----CCC
Q psy1840 103 LPRGTQKGDVYSFGLVLYEVIGRQGPWGHLRMTD-------------EEIITSV--------TQGSGLRPDTS----SLD 157 (423)
Q Consensus 103 ~~~~s~ksDVyS~Giil~elltg~~Pf~~~~~~~-------------~~i~~~i--------~~~~~~~p~~~----~~~ 157 (423)
..+.++||||||+++|||++|..||....... .++...+ .......+... ...
T Consensus 188 --~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (334)
T cd07855 188 --EYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLNRIGSDRVRKYIQNLPRKQPVPWSKIFPK 265 (334)
T ss_pred --ccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHhhhhhchhhHHHHHhhcccCCCCCHHHHccc
Confidence 23889999999999999999999996432110 0111000 00001111110 124
Q ss_pred chHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q psy1840 158 CAPSIIACMRTCWEEDPELRPDLRFVHHK 186 (423)
Q Consensus 158 ~~~~l~~Li~~C~~~dP~~RPt~~~I~~~ 186 (423)
.+.++.+++++||+.+|++||++.+++..
T Consensus 266 ~~~~~~~li~~~l~~~P~~Rpt~~~~l~~ 294 (334)
T cd07855 266 ASPEALDLLSQMLQFDPEERITVEQALQH 294 (334)
T ss_pred CCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 67899999999999999999999998764
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.88 E-value=2.4e-22 Score=195.47 Aligned_cols=158 Identities=20% Similarity=0.189 Sum_probs=114.2
Q ss_pred HHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcC----CccEEEeccCCcccccCCCc-ccccccccCCccccCCcccc
Q psy1840 25 SISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDS----RWVLQIADFGLHAFKAGQDE-TGQERKLRRRKLYKAPELLR 99 (423)
Q Consensus 25 ~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~----~~~vKL~DFGla~~~~~~~~-~~~~~~~~gt~~y~APE~l~ 99 (423)
...++.|++.||.|||+.+++ ||||||+||+++. ++.+||+|||++........ ........++..|+|||.+.
T Consensus 110 ~~~i~~qi~~~l~~lH~~~i~-h~dlkp~Nil~~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~ 188 (316)
T cd07842 110 VKSLLWQILNGVHYLHSNWVL-HRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLDPVVVTIWYRAPELLL 188 (316)
T ss_pred HHHHHHHHHHHHHHHHhCCEe-eCCCCHHHEEEcCCCCccceEEECCCccccccCCCcccccccCCccccccccCHHHHh
Confidence 468999999999999999988 9999999999999 99999999999876533222 11223345678899999886
Q ss_pred CCCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCh-----------HHHHHHHhcC-------------------CCC
Q psy1840 100 QPHLPRGTQKGDVYSFGLVLYEVIGRQGPWGHLRMTD-----------EEIITSVTQG-------------------SGL 149 (423)
Q Consensus 100 ~~~~~~~s~ksDVyS~Giil~elltg~~Pf~~~~~~~-----------~~i~~~i~~~-------------------~~~ 149 (423)
+.. ..+.++||||||+++++|++|..||....... ..+...+... ...
T Consensus 189 ~~~--~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (316)
T cd07842 189 GAR--HYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLERIFEVLGTPTEKDWPDIKKMPEYDTLMKDFK 266 (316)
T ss_pred CCC--CCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHHHHHHhCCCchhHHHHHhhcccchhhhhhcc
Confidence 643 23789999999999999999999996432211 0111111000 000
Q ss_pred CCCCC----------CCCchHHHHHHHHHhhhcCCCCCCCHHHHHH
Q psy1840 150 RPDTS----------SLDCAPSIIACMRTCWEEDPELRPDLRFVHH 185 (423)
Q Consensus 150 ~p~~~----------~~~~~~~l~~Li~~C~~~dP~~RPt~~~I~~ 185 (423)
..... ....+.++.+++.+||+.||++|||+.+++.
T Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~ 312 (316)
T cd07842 267 TKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALE 312 (316)
T ss_pred CCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 00000 0145678999999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.88 E-value=2.6e-22 Score=198.59 Aligned_cols=152 Identities=18% Similarity=0.238 Sum_probs=113.5
Q ss_pred HHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCccEEEeccCCcccccCCCcccccccccCCccccCCccccCCCCC
Q psy1840 25 SISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKAPELLRQPHLP 104 (423)
Q Consensus 25 ~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~ 104 (423)
...++.|++.||.|||+.+++ ||||||+||+++.++.+||+|||+++..... .....++..|+|||.+.+..
T Consensus 119 ~~~~~~qi~~aL~~LH~~~i~-H~dlkp~NIll~~~~~~kL~dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~-- 190 (342)
T cd07879 119 VQYLVYQMLCGLKYIHSAGII-HRDLKPGNLAVNEDCELKILDFGLARHADAE-----MTGYVVTRWYRAPEVILNWM-- 190 (342)
T ss_pred HHHHHHHHHHHHHHHHHCCcc-cCCCCHHHEEECCCCCEEEeeCCCCcCCCCC-----CCCceeeecccChhhhcCcc--
Confidence 467899999999999999988 9999999999999999999999998654221 12335677899999987632
Q ss_pred CCCCccchHHHHHHHHHHHhCCCCCCCCCCChHHHHHHHhcC-----------------------CCCCCCCC----CCC
Q psy1840 105 RGTQKGDVYSFGLVLYEVIGRQGPWGHLRMTDEEIITSVTQG-----------------------SGLRPDTS----SLD 157 (423)
Q Consensus 105 ~~s~ksDVyS~Giil~elltg~~Pf~~~~~~~~~i~~~i~~~-----------------------~~~~p~~~----~~~ 157 (423)
..+.++|||||||++|||++|+.||.... ....+..+... .+..+... ...
T Consensus 191 ~~~~~~Dv~slGvil~el~~g~~pf~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 268 (342)
T cd07879 191 HYNQTVDIWSVGCIMAEMLTGKTLFKGKD--YLDQLTQILKVTGVPGPEFVQKLEDKAAKSYIKSLPKYPRKDFSTLFPK 268 (342)
T ss_pred ccCchHHHHHHHHHHHHHHhCCCCCCCCC--HHHHHHHHHHhcCCCCHHHHHHhcccchHHHHhhcCCcccchHHHHhcC
Confidence 23789999999999999999999997532 11112211110 00000000 123
Q ss_pred chHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q psy1840 158 CAPSIIACMRTCWEEDPELRPDLRFVHHK 186 (423)
Q Consensus 158 ~~~~l~~Li~~C~~~dP~~RPt~~~I~~~ 186 (423)
.+..+.+++.+||+.||++||++.+++..
T Consensus 269 ~~~~~~~li~~~l~~dP~~R~~~~e~l~h 297 (342)
T cd07879 269 ASPQAVDLLEKMLELDVDKRLTATEALEH 297 (342)
T ss_pred CCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 56789999999999999999999999753
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.87 E-value=4.1e-22 Score=196.28 Aligned_cols=158 Identities=16% Similarity=0.173 Sum_probs=115.1
Q ss_pred HHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCccEEEeccCCcccccCCCcccccccccCCccccCCccccCCC--
Q psy1840 25 SISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKAPELLRQPH-- 102 (423)
Q Consensus 25 ~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~-- 102 (423)
...++.||+.||+|||+++++ ||||||+|||++.++.+||+|||++........ .......|++.|+|||++....
T Consensus 104 ~~~~~~qi~~~l~~lH~~~iv-H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~ 181 (331)
T cd05597 104 ARFYLAEMVLAIDSVHQLGYV-HRDIKPDNVLLDKNGHIRLADFGSCLRLLADGT-VQSNVAVGTPDYISPEILQAMEDG 181 (331)
T ss_pred HHHHHHHHHHHHHHHHhCCeE-ECCCCHHHEEECCCCCEEEEECCceeecCCCCC-ccccceeccccccCHHHHhhcccc
Confidence 467899999999999999998 999999999999999999999999865432221 1112346889999999987421
Q ss_pred CCCCCCccchHHHHHHHHHHHhCCCCCCCCCCChHHHHHHHhcCCC-CCCCCCCCCchHHHHHHHHHhhhcCC--CCCCC
Q psy1840 103 LPRGTQKGDVYSFGLVLYEVIGRQGPWGHLRMTDEEIITSVTQGSG-LRPDTSSLDCAPSIIACMRTCWEEDP--ELRPD 179 (423)
Q Consensus 103 ~~~~s~ksDVyS~Giil~elltg~~Pf~~~~~~~~~i~~~i~~~~~-~~p~~~~~~~~~~l~~Li~~C~~~dP--~~RPt 179 (423)
....+.++|||||||++|||++|+.||... +..+....+..... .........++..+.+++++|+..++ ..||+
T Consensus 182 ~~~~~~~~DiwslG~~l~el~~g~~Pf~~~--~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~ll~~~~~r~~r~~ 259 (331)
T cd05597 182 KGRYGPECDWWSLGVCMYEMLYGETPFYAE--SLVETYGKIMNHKEHFQFPPDVTDVSEEAKDLIRRLICSPETRLGRNG 259 (331)
T ss_pred ccCCCCcceeehhhhHHHHHhhCCCCCCCC--CHHHHHHHHHcCCCcccCCCccCCCCHHHHHHHHHHccCcccccCCCC
Confidence 113478999999999999999999999743 33444444443221 11111123478899999999886433 34788
Q ss_pred HHHHHHH
Q psy1840 180 LRFVHHK 186 (423)
Q Consensus 180 ~~~I~~~ 186 (423)
+.+++..
T Consensus 260 ~~~~l~h 266 (331)
T cd05597 260 LQDFKDH 266 (331)
T ss_pred HHHHhcC
Confidence 8888764
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=99.87 E-value=5.7e-22 Score=188.13 Aligned_cols=155 Identities=28% Similarity=0.420 Sum_probs=116.5
Q ss_pred HHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCc-cEEEeccCCcccccCCCcc--cccccccCCccccCCccccCC
Q psy1840 25 SISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRW-VLQIADFGLHAFKAGQDET--GQERKLRRRKLYKAPELLRQP 101 (423)
Q Consensus 25 ~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~-~vKL~DFGla~~~~~~~~~--~~~~~~~gt~~y~APE~l~~~ 101 (423)
...++.|++.||.|||++|++ |+||+|+||+++.++ .+||+|||.+......... .......++..|+|||.+.+.
T Consensus 105 ~~~~~~ql~~al~~LH~~~i~-H~~i~~~nil~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~ 183 (268)
T cd06630 105 IINYTEQLLRGLSYLHENQII-HRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPEVLRGE 183 (268)
T ss_pred HHHHHHHHHHHHHHHHhCCee-cCCCCHHHEEEcCCCCEEEEcccccccccccccccCCccccccccccceeCHhHhccC
Confidence 578899999999999999998 999999999998775 6999999998765432111 111234577889999998765
Q ss_pred CCCCCCCccchHHHHHHHHHHHhCCCCCCCCCC-ChHHHHHHHhcCCCCCCCCCCCCchHHHHHHHHHhhhcCCCCCCCH
Q psy1840 102 HLPRGTQKGDVYSFGLVLYEVIGRQGPWGHLRM-TDEEIITSVTQGSGLRPDTSSLDCAPSIIACMRTCWEEDPELRPDL 180 (423)
Q Consensus 102 ~~~~~s~ksDVyS~Giil~elltg~~Pf~~~~~-~~~~i~~~i~~~~~~~p~~~~~~~~~~l~~Li~~C~~~dP~~RPt~ 180 (423)
.+ +.++|+||+|+++|++++|..||..... .....+..+.... ..+. .+...++++.+++.+||..+|++||++
T Consensus 184 ~~---~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~-~~~~-~~~~~~~~~~~~i~~~l~~~p~~R~~~ 258 (268)
T cd06630 184 QY---GRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASAT-TAPS-IPEHLSPGLRDVTLRCLELQPEDRPPS 258 (268)
T ss_pred CC---CcccchHHHHHHHHHHHhCCCCCCCCCCcchHHHHHHHhccC-CCCC-CchhhCHHHHHHHHHHcCCCcccCcCH
Confidence 54 8899999999999999999999964322 1222222222211 1122 223567899999999999999999999
Q ss_pred HHHHH
Q psy1840 181 RFVHH 185 (423)
Q Consensus 181 ~~I~~ 185 (423)
.+++.
T Consensus 259 ~~ll~ 263 (268)
T cd06630 259 RELLK 263 (268)
T ss_pred HHHhc
Confidence 99874
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=99.87 E-value=6.3e-22 Score=194.50 Aligned_cols=158 Identities=22% Similarity=0.307 Sum_probs=111.6
Q ss_pred HHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCccEEEeccCCcccccCCCcc-----cccccccCCccccCCcccc
Q psy1840 25 SISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDET-----GQERKLRRRKLYKAPELLR 99 (423)
Q Consensus 25 ~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~~-----~~~~~~~gt~~y~APE~l~ 99 (423)
...++.|++.||+|||+.|++ ||||||+||+++.++.+|++|||........... .......++..|+|||.+.
T Consensus 103 ~~~~~~qi~~aL~~lH~~~iv-HrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~ 181 (328)
T cd08226 103 IGNILFGALRGLNYLHQNGYI-HRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKVVYDFPQFSTSVLPWLSPELLR 181 (328)
T ss_pred HHHHHHHHHHHHHHHHhCCee-cCCCCHHHEEEeCCCcEEEechHHHhhhhccCccccccccccccccCccCccChhhhc
Confidence 358999999999999999998 9999999999999999999999864322111100 0001123455699999997
Q ss_pred CCCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCChHHHHHHHhcCCCCCC----------------------------
Q psy1840 100 QPHLPRGTQKGDVYSFGLVLYEVIGRQGPWGHLRMTDEEIITSVTQGSGLRP---------------------------- 151 (423)
Q Consensus 100 ~~~~~~~s~ksDVyS~Giil~elltg~~Pf~~~~~~~~~i~~~i~~~~~~~p---------------------------- 151 (423)
+... .++.++|||||||++||+++|..||..... .......+. .....|
T Consensus 182 ~~~~-~~~~~~DiwslG~~l~el~~g~~p~~~~~~-~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (328)
T cd08226 182 QDLY-GYNVKSDIYSVGITACELATGRVPFQDMLR-TQMLLQKLK-GPPYSPLDITTFPCEESRMKNSQSGVDSGIGESV 258 (328)
T ss_pred CCCC-CCCchhhHHHHHHHHHHHHhCCCCCCCcCh-HHHHHHHhc-CCCCCCccccccchhhhhhccchhhhhcccccch
Confidence 6432 347899999999999999999999975321 122222211 111100
Q ss_pred ---------------CCCCCCchHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q psy1840 152 ---------------DTSSLDCAPSIIACMRTCWEEDPELRPDLRFVHHK 186 (423)
Q Consensus 152 ---------------~~~~~~~~~~l~~Li~~C~~~dP~~RPt~~~I~~~ 186 (423)
......++..+.+++.+||+.||++|||+.++++.
T Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~ 308 (328)
T cd08226 259 VAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSH 308 (328)
T ss_pred hccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence 00012356789999999999999999999999754
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >KOG0663|consensus | Back alignment and domain information |
|---|
Probab=99.87 E-value=2.4e-22 Score=188.62 Aligned_cols=161 Identities=22% Similarity=0.287 Sum_probs=120.1
Q ss_pred CCCChHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCccEEEeccCCcccccCCCcccccccccCCccccCCcc
Q psy1840 18 PFNIPIGSISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKAPEL 97 (423)
Q Consensus 18 ~~~~p~~~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~ 97 (423)
||...+ .-.++.|++.|++|||.+.|+ |||||++|+|+...|.+||+|||+|+...... ...+...-|.+|.|||.
T Consensus 173 ~F~~~e-vK~L~~QlL~glk~lH~~wil-HRDLK~SNLLm~~~G~lKiaDFGLAR~ygsp~--k~~T~lVVTLWYRaPEL 248 (419)
T KOG0663|consen 173 PFLPGE-VKTLMLQLLRGLKHLHDNWIL-HRDLKTSNLLLSHKGILKIADFGLAREYGSPL--KPYTPLVVTLWYRAPEL 248 (419)
T ss_pred CCchHH-HHHHHHHHHHHHHHHhhceeE-ecccchhheeeccCCcEEecccchhhhhcCCc--ccCcceEEEeeecCHHH
Confidence 454433 346889999999999999988 99999999999999999999999998765442 22245567889999999
Q ss_pred ccCCCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCChHHHHHHHhc--C---CCC--------------CCCC-----
Q psy1840 98 LRQPHLPRGTQKGDVYSFGLVLYEVIGRQGPWGHLRMTDEEIITSVTQ--G---SGL--------------RPDT----- 153 (423)
Q Consensus 98 l~~~~~~~~s~ksDVyS~Giil~elltg~~Pf~~~~~~~~~i~~~i~~--~---~~~--------------~p~~----- 153 (423)
+.+.. .++.+.|+||+|||+.|++++++-|.+...- ++ +.+|-+ | ... ++..
T Consensus 249 LLG~~--tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~-dQ-l~~If~llGtPte~iwpg~~~lp~~k~~~f~~~pyn~l 324 (419)
T KOG0663|consen 249 LLGAK--TYSTAVDMWSVGCIFAELLTQKPLFPGKSEI-DQ-LDKIFKLLGTPSEAIWPGYSELPAVKKMTFSEHPYNNL 324 (419)
T ss_pred hcCCc--ccCcchhhhhHHHHHHHHHhcCCCCCCCchH-HH-HHHHHHHhCCCccccCCCccccchhhccccCCCCchhh
Confidence 99865 3599999999999999999999888764321 11 222110 0 000 0111
Q ss_pred ----CCCCchHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q psy1840 154 ----SSLDCAPSIIACMRTCWEEDPELRPDLRFVHHK 186 (423)
Q Consensus 154 ----~~~~~~~~l~~Li~~C~~~dP~~RPt~~~I~~~ 186 (423)
.....+..-.+|+...+..||.+|.|+.+.++.
T Consensus 325 r~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h 361 (419)
T KOG0663|consen 325 RKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKH 361 (419)
T ss_pred hhhccccccchhHHHHHHHHhccCccccccHHHhhcc
Confidence 111245778899999999999999999987653
|
|
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=99.87 E-value=5.1e-22 Score=191.07 Aligned_cols=158 Identities=19% Similarity=0.226 Sum_probs=119.4
Q ss_pred HHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCccEEEeccCCcccccCCCcccccccccCCccccCCccccCCCCC
Q psy1840 25 SISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKAPELLRQPHLP 104 (423)
Q Consensus 25 ~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~ 104 (423)
...++.|++.||.|||+.+++ ||||+|+||+++.++.++|+|||++........ .......++..|+|||.+.+...
T Consensus 107 ~~~~~~ql~~~l~~lH~~~~~-H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~- 183 (288)
T cd05583 107 VRVYIAEIVLALDHLHQLGII-YRDIKLENILLDSEGHVVLTDFGLSKEFLAEEE-ERAYSFCGTIEYMAPEVIRGGSG- 183 (288)
T ss_pred HHHHHHHHHHHHHHHHHCCee-ccCCCHHHeEECCCCCEEEEECccccccccccc-cccccccCCccccCHHHhcCCCC-
Confidence 467888999999999999988 999999999999999999999999775432221 11123457788999999866431
Q ss_pred CCCCccchHHHHHHHHHHHhCCCCCCCCC--CChHHHHHHHhcCCCCCCCCCCCCchHHHHHHHHHhhhcCCCCCCCHHH
Q psy1840 105 RGTQKGDVYSFGLVLYEVIGRQGPWGHLR--MTDEEIITSVTQGSGLRPDTSSLDCAPSIIACMRTCWEEDPELRPDLRF 182 (423)
Q Consensus 105 ~~s~ksDVyS~Giil~elltg~~Pf~~~~--~~~~~i~~~i~~~~~~~p~~~~~~~~~~l~~Li~~C~~~dP~~RPt~~~ 182 (423)
..+.++||||||+++|||++|..||.... ....++...+....... +..++..+.+++.+||+.+|++|||+.+
T Consensus 184 ~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~l~~li~~~l~~~p~~R~t~~~ 259 (288)
T cd05583 184 GHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRILKSKPPF----PKTMSAEARDFIQKLLEKDPKKRLGANG 259 (288)
T ss_pred CCcchhhhHHHHHHHHHHHhCCCCcccCcccchHHHHHHHHHccCCCC----CcccCHHHHHHHHHHhcCCHhhccCcch
Confidence 23789999999999999999999995321 22344444443332211 2246789999999999999999999888
Q ss_pred HHHHHHH
Q psy1840 183 VHHKLKE 189 (423)
Q Consensus 183 I~~~L~~ 189 (423)
+...|..
T Consensus 260 ~~~~l~~ 266 (288)
T cd05583 260 ADEIKNH 266 (288)
T ss_pred HHHHhcC
Confidence 7765543
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=99.87 E-value=5e-22 Score=192.70 Aligned_cols=156 Identities=22% Similarity=0.253 Sum_probs=113.0
Q ss_pred HHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCccEEEeccCCcccccCCCccc---------ccccccCCccccCC
Q psy1840 25 SISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETG---------QERKLRRRKLYKAP 95 (423)
Q Consensus 25 ~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~~~---------~~~~~~gt~~y~AP 95 (423)
...++.|+++||.|||+.|++ ||||||+||++++++.+||+|||++.......... ......+++.|+||
T Consensus 117 ~~~i~~~l~~al~~lH~~~i~-H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aP 195 (311)
T cd07866 117 IKCYMLQLLEGINYLHENHIL-HRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPP 195 (311)
T ss_pred HHHHHHHHHHHHHHHHhCCee-cCCCCHHHEEECCCCCEEECcCccchhccCCCcccccCCcccccccccceeccCcCCh
Confidence 578999999999999999988 99999999999999999999999987543222111 11223457789999
Q ss_pred ccccCCCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCChHHHHHHHhcC---CC-----------------CCCCCC-
Q psy1840 96 ELLRQPHLPRGTQKGDVYSFGLVLYEVIGRQGPWGHLRMTDEEIITSVTQG---SG-----------------LRPDTS- 154 (423)
Q Consensus 96 E~l~~~~~~~~s~ksDVyS~Giil~elltg~~Pf~~~~~~~~~i~~~i~~~---~~-----------------~~p~~~- 154 (423)
|.+.+.. ..+.++|||||||++|||++|..||.... .....+.+... .. ..+...
T Consensus 196 E~~~~~~--~~~~~~Dv~slG~il~el~~g~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 271 (311)
T cd07866 196 ELLLGER--RYTTAVDIWGIGCVFAEMFTRRPILQGKS--DIDQLHLIFKLCGTPTEETWPGWRSLPGCEGVHSFTNYPR 271 (311)
T ss_pred HHhhCCC--ccCchhHhHHHHHHHHHHHhCCCCCCCCC--HHHHHHHHHHHhCCCChhhchhhhhcccccccccCCCCCc
Confidence 9886543 23789999999999999999999996422 22222221110 00 000000
Q ss_pred -----CCCchHHHHHHHHHhhhcCCCCCCCHHHHHH
Q psy1840 155 -----SLDCAPSIIACMRTCWEEDPELRPDLRFVHH 185 (423)
Q Consensus 155 -----~~~~~~~l~~Li~~C~~~dP~~RPt~~~I~~ 185 (423)
.....+.+.+++.+||+.||++|||+.+++.
T Consensus 272 ~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~ 307 (311)
T cd07866 272 TLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALE 307 (311)
T ss_pred cHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhc
Confidence 0234467899999999999999999998864
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.87 E-value=8.9e-22 Score=184.81 Aligned_cols=150 Identities=20% Similarity=0.390 Sum_probs=118.4
Q ss_pred HHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCccEEEeccCCcccccCCCcccccccccCCccccCCccccCCCCC
Q psy1840 25 SISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKAPELLRQPHLP 104 (423)
Q Consensus 25 ~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~ 104 (423)
...++.|++.|+.|||+.|++ ||||+|+||+++.++.++|+|||++......... .....++..|+|||...+...
T Consensus 101 ~~~~~~~i~~~l~~lH~~~i~-H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~--~~~~~~~~~y~~pe~~~~~~~- 176 (254)
T cd06627 101 VAVYVYQVLQGLAYLHEQGVI-HRDIKAANILTTKDGVVKLADFGVATKLNDVSKD--DASVVGTPYWMAPEVIEMSGA- 176 (254)
T ss_pred HHHHHHHHHHHHHHHhhCCcc-cCCCCHHHEEECCCCCEEEeccccceecCCCccc--ccccccchhhcCHhhhcCCCC-
Confidence 578999999999999999998 9999999999999999999999998765433221 233457788999999876543
Q ss_pred CCCCccchHHHHHHHHHHHhCCCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCchHHHHHHHHHhhhcCCCCCCCHHHHH
Q psy1840 105 RGTQKGDVYSFGLVLYEVIGRQGPWGHLRMTDEEIITSVTQGSGLRPDTSSLDCAPSIIACMRTCWEEDPELRPDLRFVH 184 (423)
Q Consensus 105 ~~s~ksDVyS~Giil~elltg~~Pf~~~~~~~~~i~~~i~~~~~~~p~~~~~~~~~~l~~Li~~C~~~dP~~RPt~~~I~ 184 (423)
+.++||||+|+++|++++|..||.... ........... ..+.. ...++..+.+++.+||..+|++||++.+++
T Consensus 177 --~~~~Dv~~lG~~l~~l~~g~~p~~~~~--~~~~~~~~~~~--~~~~~-~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l 249 (254)
T cd06627 177 --STASDIWSLGCTVIELLTGNPPYYDLN--PMAALFRIVQD--DHPPL-PEGISPELKDFLMQCFQKDPNLRPTAKQLL 249 (254)
T ss_pred --CcchhHHHHHHHHHHHHhCCCCCCCcc--HHHHHHHHhcc--CCCCC-CCCCCHHHHHHHHHHHhCChhhCcCHHHHh
Confidence 889999999999999999999997432 22223333222 12222 235688999999999999999999999886
Q ss_pred H
Q psy1840 185 H 185 (423)
Q Consensus 185 ~ 185 (423)
.
T Consensus 250 ~ 250 (254)
T cd06627 250 K 250 (254)
T ss_pred c
Confidence 4
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >KOG1027|consensus | Back alignment and domain information |
|---|
Probab=99.87 E-value=2.6e-23 Score=214.34 Aligned_cols=174 Identities=26% Similarity=0.378 Sum_probs=127.0
Q ss_pred HHHHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcC-----CccEEEeccCCcccccCCCcc-cccccccCCccccCCc
Q psy1840 23 IGSISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDS-----RWVLQIADFGLHAFKAGQDET-GQERKLRRRKLYKAPE 96 (423)
Q Consensus 23 ~~~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~-----~~~vKL~DFGla~~~~~~~~~-~~~~~~~gt~~y~APE 96 (423)
+.-+.+..|+++||+|||+.+|+ ||||||.||||+. ...++|+|||+++.+...... .......||-+|+|||
T Consensus 606 i~~~~~l~q~~~GlaHLHsl~iV-HRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~~~~sS~~r~s~~sGt~GW~APE 684 (903)
T KOG1027|consen 606 IDPISVLSQIASGLAHLHSLKIV-HRDLKPQNILISVPSADGTLRAKISDFGLSKKLAGGKSSFSRLSGGSGTSGWQAPE 684 (903)
T ss_pred ccHHHHHHHHHHHHHHHHhcccc-cccCCCceEEEEccCCCcceeEEecccccccccCCCcchhhcccCCCCcccccCHH
Confidence 34578999999999999999998 9999999999975 257899999999887654432 3345678999999999
Q ss_pred cccCCCCCCCCCccchHHHHHHHHHHHhC-CCCCCCCCCChHHHHHHHhcCCCCCCCCCC-CCchHHHHHHHHHhhhcCC
Q psy1840 97 LLRQPHLPRGTQKGDVYSFGLVLYEVIGR-QGPWGHLRMTDEEIITSVTQGSGLRPDTSS-LDCAPSIIACMRTCWEEDP 174 (423)
Q Consensus 97 ~l~~~~~~~~s~ksDVyS~Giil~elltg-~~Pf~~~~~~~~~i~~~i~~~~~~~p~~~~-~~~~~~l~~Li~~C~~~dP 174 (423)
++..... ++++||||+||++|..++| ..||++..... ..|..+....-.... .++ +..+||.+|++.+|
T Consensus 685 ~L~~~~~---~~avDiFslGCvfyYvltgG~HpFGd~~~R~----~NIl~~~~~L~~L~~~~d~--eA~dLI~~ml~~dP 755 (903)
T KOG1027|consen 685 QLREDRK---TQAVDIFSLGCVFYYVLTGGSHPFGDSLERQ----ANILTGNYTLVHLEPLPDC--EAKDLISRMLNPDP 755 (903)
T ss_pred HHhcccc---CcccchhhcCceEEEEecCCccCCCchHHhh----hhhhcCccceeeeccCchH--HHHHHHHHhcCCCc
Confidence 9998765 7899999999999999986 78997532211 223333322211111 122 88999999999999
Q ss_pred CCCCCHHHHHHHHHHHhhhcCCChHHHHHHHH
Q psy1840 175 ELRPDLRFVHHKLKEMNAGLKANIFDNMLAIM 206 (423)
Q Consensus 175 ~~RPt~~~I~~~L~~i~~~~~~~~~d~~~~~~ 206 (423)
..||++.+|+.+--......+..+..+.-.+.
T Consensus 756 ~~RPsa~~VL~HPlFW~~ekrL~Fl~dvSDRv 787 (903)
T KOG1027|consen 756 QLRPSATDVLNHPLFWDSEKRLSFLRDVSDRV 787 (903)
T ss_pred ccCCCHHHHhCCCccCChHHHHHHHHhhhhhh
Confidence 99999999987554444333333333333333
|
|
| >KOG0580|consensus | Back alignment and domain information |
|---|
Probab=99.87 E-value=3.6e-22 Score=179.84 Aligned_cols=148 Identities=19% Similarity=0.249 Sum_probs=128.1
Q ss_pred HHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCccEEEeccCCcccccCCCcccccccccCCccccCCccccCCCCCC
Q psy1840 26 ISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKAPELLRQPHLPR 105 (423)
Q Consensus 26 l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~ 105 (423)
-..+.|++.|+.|+|.+++| ||||||+|+|++..+.+||+|||-+.... .....+.+||.-|.+||+..+...
T Consensus 127 a~Yi~q~A~Al~y~h~k~VI-hRdiKpenlLlg~~~~lkiAdfGwsV~~p----~~kR~tlcgt~dyl~pEmv~~~~h-- 199 (281)
T KOG0580|consen 127 ATYIKQLANALLYCHLKRVI-HRDIKPENLLLGSAGELKIADFGWSVHAP----SNKRKTLCGTLDYLPPEMVEGRGH-- 199 (281)
T ss_pred hHHHHHHHHHHHHhccCCcc-cCCCCHHHhccCCCCCeeccCCCceeecC----CCCceeeecccccCCHhhcCCCCc--
Confidence 46899999999999999998 99999999999999999999999865432 233467899999999999988765
Q ss_pred CCCccchHHHHHHHHHHHhCCCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCchHHHHHHHHHhhhcCCCCCCCHHHHHH
Q psy1840 106 GTQKGDVYSFGLVLYEVIGRQGPWGHLRMTDEEIITSVTQGSGLRPDTSSLDCAPSIIACMRTCWEEDPELRPDLRFVHH 185 (423)
Q Consensus 106 ~s~ksDVyS~Giil~elltg~~Pf~~~~~~~~~i~~~i~~~~~~~p~~~~~~~~~~l~~Li~~C~~~dP~~RPt~~~I~~ 185 (423)
+...|+|++|++.||++.|..||.. .+..+...++.......| ..++.+..++|.+|+..+|.+|.+..+++.
T Consensus 200 -d~~Vd~w~lgvl~yeflvg~ppFes--~~~~etYkrI~k~~~~~p----~~is~~a~dlI~~ll~~~p~~r~~l~~v~~ 272 (281)
T KOG0580|consen 200 -DKFVDLWSLGVLCYEFLVGLPPFES--QSHSETYKRIRKVDLKFP----STISGGAADLISRLLVKNPIERLALTEVMD 272 (281)
T ss_pred -cchhhHHHHHHHHHHHHhcCCchhh--hhhHHHHHHHHHccccCC----cccChhHHHHHHHHhccCccccccHHHHhh
Confidence 8999999999999999999999974 346788888887666655 357889999999999999999999999876
Q ss_pred HH
Q psy1840 186 KL 187 (423)
Q Consensus 186 ~L 187 (423)
.-
T Consensus 273 hp 274 (281)
T KOG0580|consen 273 HP 274 (281)
T ss_pred hH
Confidence 53
|
|
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.1e-21 Score=187.55 Aligned_cols=154 Identities=21% Similarity=0.212 Sum_probs=114.0
Q ss_pred HHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCccEEEeccCCcccccCCCcccccccccCCccccCCccccCCCCC
Q psy1840 25 SISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKAPELLRQPHLP 104 (423)
Q Consensus 25 ~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~ 104 (423)
...++.|++.||.|||+.|++ ||||+|+||+++.++.+||+|||++........ ......++..|+|||.+.+..
T Consensus 100 ~~~~~~~i~~~l~~LH~~~i~-H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~-- 174 (282)
T cd07829 100 IKSIMYQLLRGLAYCHSHRIL-HRDLKPQNILINRDGVLKLADFGLARAFGIPLR--TYTHEVVTLWYRAPEILLGSK-- 174 (282)
T ss_pred HHHHHHHHHHHHHHHHHCCcc-cCCCChheEEEcCCCCEEEecCCcccccCCCcc--ccCccccCcCcCChHHhcCCc--
Confidence 689999999999999999998 999999999999999999999999876533221 112234567799999987652
Q ss_pred CCCCccchHHHHHHHHHHHhCCCCCCCCCCChHHHHHHHhc---------------C---CCCCCC-------CCCCCch
Q psy1840 105 RGTQKGDVYSFGLVLYEVIGRQGPWGHLRMTDEEIITSVTQ---------------G---SGLRPD-------TSSLDCA 159 (423)
Q Consensus 105 ~~s~ksDVyS~Giil~elltg~~Pf~~~~~~~~~i~~~i~~---------------~---~~~~p~-------~~~~~~~ 159 (423)
..+.++||||||+++||+++|..||.... ..+.+..+.. . ....+. ......+
T Consensus 175 ~~~~~~Dv~slG~~l~~l~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 252 (282)
T cd07829 175 HYSTAVDIWSVGCIFAEMITGKPLFPGDS--EIDQLFKIFQILGTPTEESWPGVTKLPDYKPTFPKFPPKDLEKVLPRLD 252 (282)
T ss_pred CCCccccHHHHHHHHHHHHhCCCCCCCcc--HHHHHHHHHHHhCCCcHHHHHhhcccccccccccccCccchHHhccccc
Confidence 23889999999999999999999996432 1122111110 0 000000 0011346
Q ss_pred HHHHHHHHHhhhcCCCCCCCHHHHHH
Q psy1840 160 PSIIACMRTCWEEDPELRPDLRFVHH 185 (423)
Q Consensus 160 ~~l~~Li~~C~~~dP~~RPt~~~I~~ 185 (423)
..+.+++.+||..+|++||++.+++.
T Consensus 253 ~~~~~~i~~~l~~~P~~Rp~~~~~l~ 278 (282)
T cd07829 253 PEGIDLLSKMLQYNPAKRISAKEALK 278 (282)
T ss_pred HHHHHHHHHhhccCcccCCCHHHHhh
Confidence 78999999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=99.87 E-value=2.7e-22 Score=197.64 Aligned_cols=157 Identities=15% Similarity=0.192 Sum_probs=115.6
Q ss_pred HHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCccEEEeccCCcccccCCCcccccccccCCccccCCccccCCC--
Q psy1840 25 SISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKAPELLRQPH-- 102 (423)
Q Consensus 25 ~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~-- 102 (423)
...++.|++.||.|||+.+++ ||||||+||+++.++.+||+|||++........ .......|++.|+|||++.+..
T Consensus 104 ~~~~~~qi~~~L~~lH~~~ii-HrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~ 181 (331)
T cd05624 104 ARFYIAEMVLAIHSIHQLHYV-HRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGT-VQSSVAVGTPDYISPEILQAMEDG 181 (331)
T ss_pred HHHHHHHHHHHHHHHHHCCee-eccCchHHEEEcCCCCEEEEeccceeeccCCCc-eeeccccCCcccCCHHHHhccccC
Confidence 467889999999999999998 999999999999999999999999875432221 1123356899999999987521
Q ss_pred CCCCCCccchHHHHHHHHHHHhCCCCCCCCCCChHHHHHHHhcCCC-C-CCCCCCCCchHHHHHHHHHhhhcCCCC--CC
Q psy1840 103 LPRGTQKGDVYSFGLVLYEVIGRQGPWGHLRMTDEEIITSVTQGSG-L-RPDTSSLDCAPSIIACMRTCWEEDPEL--RP 178 (423)
Q Consensus 103 ~~~~s~ksDVyS~Giil~elltg~~Pf~~~~~~~~~i~~~i~~~~~-~-~p~~~~~~~~~~l~~Li~~C~~~dP~~--RP 178 (423)
....+.++|||||||++|||++|+.||... ...+....+..... . .|. ....+++++.+++.+|+..++.. |+
T Consensus 182 ~~~~~~~~DiwSlGvil~ell~g~~Pf~~~--~~~~~~~~i~~~~~~~~~p~-~~~~~~~~~~~li~~ll~~~~~~~~~~ 258 (331)
T cd05624 182 MGKYGPECDWWSLGVCMYEMLYGETPFYAE--SLVETYGKIMNHEERFQFPS-HITDVSEEAKDLIQRLICSRERRLGQN 258 (331)
T ss_pred CCCCCCcccEEeeehhhhhhhhCCCCccCC--CHHHHHHHHHcCCCcccCCC-ccccCCHHHHHHHHHHccCchhhcCCC
Confidence 113478999999999999999999999743 33455555544321 1 121 12357889999999999865543 45
Q ss_pred CHHHHHHH
Q psy1840 179 DLRFVHHK 186 (423)
Q Consensus 179 t~~~I~~~ 186 (423)
++.++++.
T Consensus 259 ~~~~~~~h 266 (331)
T cd05624 259 GIEDFKKH 266 (331)
T ss_pred CHHHHhcC
Confidence 77776543
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.2e-21 Score=187.48 Aligned_cols=153 Identities=20% Similarity=0.274 Sum_probs=113.4
Q ss_pred HHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCccEEEeccCCcccccCCCcccccccccCCccccCCccccCCCCC
Q psy1840 25 SISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKAPELLRQPHLP 104 (423)
Q Consensus 25 ~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~ 104 (423)
.+.++.|++.||.|||+++++ |+||+|+||+++.++.++|+|||++........ .....++..|+|||.+....
T Consensus 101 ~~~~~~~l~~~l~~Lh~~~i~-H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~-- 174 (283)
T cd07830 101 IRSIIYQILQGLAHIHKHGFF-HRDLKPENLLVSGPEVVKIADFGLAREIRSRPP---YTDYVSTRWYRAPEILLRST-- 174 (283)
T ss_pred HHHHHHHHHHHHHHHHHCCcc-cCCCChhhEEEcCCCCEEEeecccceeccCCCC---cCCCCCcccccCceeeecCc--
Confidence 689999999999999999998 999999999999999999999999875533221 12345677899999886533
Q ss_pred CCCCccchHHHHHHHHHHHhCCCCCCCCCCChHHHHHHHhcC-------------------CCCCCCC-------CCCCc
Q psy1840 105 RGTQKGDVYSFGLVLYEVIGRQGPWGHLRMTDEEIITSVTQG-------------------SGLRPDT-------SSLDC 158 (423)
Q Consensus 105 ~~s~ksDVyS~Giil~elltg~~Pf~~~~~~~~~i~~~i~~~-------------------~~~~p~~-------~~~~~ 158 (423)
..+.++|+||||++++|+++|..||..... .+....+... ....+.. .....
T Consensus 175 ~~~~~~Di~s~G~~l~el~~g~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 252 (283)
T cd07830 175 SYSSPVDIWALGCIMAELYTLRPLFPGSSE--IDQLYKICSVLGTPTKQDWPEGYKLASKLGFRFPQFAPTSLHQLIPNA 252 (283)
T ss_pred CcCCccchhhHHHHHHHHHhCCCccCCCCh--HHHHHHHHHhcCCCChhhhhhHhhhhccccccccccccccHHHHcccC
Confidence 238899999999999999999999864321 1111111100 0000000 00123
Q ss_pred hHHHHHHHHHhhhcCCCCCCCHHHHHH
Q psy1840 159 APSIIACMRTCWEEDPELRPDLRFVHH 185 (423)
Q Consensus 159 ~~~l~~Li~~C~~~dP~~RPt~~~I~~ 185 (423)
+..+.+++.+||+.+|++||++.+++.
T Consensus 253 ~~~~~~li~~cl~~~p~~Rpt~~ei~~ 279 (283)
T cd07830 253 SPEAIDLIKDMLRWDPKKRPTASQALQ 279 (283)
T ss_pred CHHHHHHHHHhcccCcccCCCHHHHhh
Confidence 578999999999999999999999865
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >KOG0986|consensus | Back alignment and domain information |
|---|
Probab=99.87 E-value=2e-22 Score=195.45 Aligned_cols=148 Identities=24% Similarity=0.313 Sum_probs=119.9
Q ss_pred hHHH-HHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCccEEEeccCCcccccCCCcccccccccCCccccCCccccC
Q psy1840 22 PIGS-ISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKAPELLRQ 100 (423)
Q Consensus 22 p~~~-l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~ 100 (423)
++.+ +-.+.+|+.||+|||..+|+ .|||||+|||+|++|+++|+|.|++..+...... ....||..|||||++.+
T Consensus 285 ~e~ra~FYAAEi~cGLehlH~~~iV-YRDLKPeNILLDd~GhvRISDLGLAvei~~g~~~---~~rvGT~GYMAPEvl~n 360 (591)
T KOG0986|consen 285 DEQRARFYAAEIICGLEHLHRRRIV-YRDLKPENILLDDHGHVRISDLGLAVEIPEGKPI---RGRVGTVGYMAPEVLQN 360 (591)
T ss_pred chHHHHHHHHHHHhhHHHHHhccee-eccCChhheeeccCCCeEeeccceEEecCCCCcc---ccccCcccccCHHHHcC
Confidence 3444 56699999999999999998 9999999999999999999999998766544332 33489999999999998
Q ss_pred CCCCCCCCccchHHHHHHHHHHHhCCCCCCCCC--CChHHHHHHHhcCCCCCCCCCCCCchHHHHHHHHHhhhcCCCCCC
Q psy1840 101 PHLPRGTQKGDVYSFGLVLYEVIGRQGPWGHLR--MTDEEIITSVTQGSGLRPDTSSLDCAPSIIACMRTCWEEDPELRP 178 (423)
Q Consensus 101 ~~~~~~s~ksDVyS~Giil~elltg~~Pf~~~~--~~~~~i~~~i~~~~~~~p~~~~~~~~~~l~~Li~~C~~~dP~~RP 178 (423)
+.| +.+.|-||+||++|||+.|+.||.... ...+++-+++... +...+..++++...+.+..|+.||.+|.
T Consensus 361 e~Y---~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~eEvdrr~~~~----~~ey~~kFS~eakslc~~LL~Kdp~~RL 433 (591)
T KOG0986|consen 361 EVY---DFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKREEVDRRTLED----PEEYSDKFSEEAKSLCEGLLTKDPEKRL 433 (591)
T ss_pred Ccc---cCCccHHHHHhHHHHHHcccCchhhhhhhhhHHHHHHHHhcc----hhhcccccCHHHHHHHHHHHccCHHHhc
Confidence 876 999999999999999999999996432 2234555555443 2233357899999999999999999996
Q ss_pred CH
Q psy1840 179 DL 180 (423)
Q Consensus 179 t~ 180 (423)
..
T Consensus 434 Gc 435 (591)
T KOG0986|consen 434 GC 435 (591)
T ss_pred cC
Confidence 43
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.87 E-value=2.6e-22 Score=219.53 Aligned_cols=151 Identities=16% Similarity=0.138 Sum_probs=105.9
Q ss_pred HHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCC-------------------ccEEEeccCCcccccCCCc------
Q psy1840 25 SISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSR-------------------WVLQIADFGLHAFKAGQDE------ 79 (423)
Q Consensus 25 ~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~-------------------~~vKL~DFGla~~~~~~~~------ 79 (423)
.+.++.||+.||.|||++||+ ||||||+||||+.. +.+|++|||+++.......
T Consensus 82 ~~~i~~qi~~al~~lH~~gIv-HrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~ 160 (793)
T PLN00181 82 CFHVFRQIVEIVNAAHSQGIV-VHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKL 160 (793)
T ss_pred HHHHHHHHHHHHHHHHhCCee-eccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhh
Confidence 679999999999999999988 99999999999654 4455666666543211000
Q ss_pred --------ccccccccCCccccCCccccCCCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCChHHHHHHHhcCCCCCC
Q psy1840 80 --------TGQERKLRRRKLYKAPELLRQPHLPRGTQKGDVYSFGLVLYEVIGRQGPWGHLRMTDEEIITSVTQGSGLRP 151 (423)
Q Consensus 80 --------~~~~~~~~gt~~y~APE~l~~~~~~~~s~ksDVyS~Giil~elltg~~Pf~~~~~~~~~i~~~i~~~~~~~p 151 (423)
........||+.|+|||++.+..+ +.++|||||||++|||++|..|+... ......+.... .|
T Consensus 161 ~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~---~~~sDVwSlGviL~ELl~~~~~~~~~----~~~~~~~~~~~--~~ 231 (793)
T PLN00181 161 EEVKKQPFPMKQILAMEMSWYTSPEEDNGSSS---NCASDVYRLGVLLFELFCPVSSREEK----SRTMSSLRHRV--LP 231 (793)
T ss_pred hccccCCCcccccccCCCcceEChhhhccCCC---CchhhhhhHHHHHHHHhhCCCchhhH----HHHHHHHHHhh--cC
Confidence 000112357888999999987665 89999999999999999988887421 12222222211 11
Q ss_pred CCCCCCchHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q psy1840 152 DTSSLDCAPSIIACMRTCWEEDPELRPDLRFVHHK 186 (423)
Q Consensus 152 ~~~~~~~~~~l~~Li~~C~~~dP~~RPt~~~I~~~ 186 (423)
.... ...+....++.+||+.+|.+||++.+|++.
T Consensus 232 ~~~~-~~~~~~~~~~~~~L~~~P~~Rps~~eil~h 265 (793)
T PLN00181 232 PQIL-LNWPKEASFCLWLLHPEPSCRPSMSELLQS 265 (793)
T ss_pred hhhh-hcCHHHHHHHHHhCCCChhhCcChHHHhhc
Confidence 1111 123456788999999999999999999763
|
|
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=99.87 E-value=9.5e-22 Score=189.75 Aligned_cols=154 Identities=20% Similarity=0.254 Sum_probs=111.8
Q ss_pred HHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcC-CccEEEeccCCcccccCCCcccccccccCCccccCCccccCCCCC
Q psy1840 26 ISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDS-RWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKAPELLRQPHLP 104 (423)
Q Consensus 26 l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~-~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~ 104 (423)
..++.||+.||+|||+++++ ||||+|+||+++. ++.+||+|||++....... .......++..|+|||.+.+..
T Consensus 105 ~~~~~qi~~aL~~LH~~~i~-H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~~--~~~~~~~~~~~y~~PE~~~~~~-- 179 (294)
T PLN00009 105 KTYLYQILRGIAYCHSHRVL-HRDLKPQNLLIDRRTNALKLADFGLARAFGIPV--RTFTHEVVTLWYRAPEILLGSR-- 179 (294)
T ss_pred HHHHHHHHHHHHHHHhCCee-CCCCCcceEEEECCCCEEEEcccccccccCCCc--cccccCceeecccCHHHHhCCC--
Confidence 47899999999999999988 9999999999985 5679999999986543221 1112335677899999886533
Q ss_pred CCCCccchHHHHHHHHHHHhCCCCCCCCCCChHHHHHHHhc--CCC--------------------CCCC---CCCCCch
Q psy1840 105 RGTQKGDVYSFGLVLYEVIGRQGPWGHLRMTDEEIITSVTQ--GSG--------------------LRPD---TSSLDCA 159 (423)
Q Consensus 105 ~~s~ksDVyS~Giil~elltg~~Pf~~~~~~~~~i~~~i~~--~~~--------------------~~p~---~~~~~~~ 159 (423)
..+.++||||||+++|++++|..||... +..+.+..+.. +.+ ..+. ......+
T Consensus 180 ~~~~~~Dv~slG~i~~~l~tg~~pf~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (294)
T PLN00009 180 HYSTPVDIWSVGCIFAEMVNQKPLFPGD--SEIDELFKIFRILGTPNEETWPGVTSLPDYKSAFPKWPPKDLATVVPTLE 257 (294)
T ss_pred CCCcHHHHHHHHHHHHHHHhCCCCCCCC--CHHHHHHHHHHHhCCCChhhccccccchhhhhhcccCCCCCHHHhCcCCC
Confidence 2378999999999999999999999642 22222222110 000 0000 0012467
Q ss_pred HHHHHHHHHhhhcCCCCCCCHHHHHHH
Q psy1840 160 PSIIACMRTCWEEDPELRPDLRFVHHK 186 (423)
Q Consensus 160 ~~l~~Li~~C~~~dP~~RPt~~~I~~~ 186 (423)
+++.+++.+||+.+|++||++.++++.
T Consensus 258 ~~~~~~i~~~l~~~P~~Rps~~~~l~~ 284 (294)
T PLN00009 258 PAGVDLLSKMLRLDPSKRITARAALEH 284 (294)
T ss_pred hHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 889999999999999999999998763
|
|
| >KOG1025|consensus | Back alignment and domain information |
|---|
Probab=99.87 E-value=8e-22 Score=202.54 Aligned_cols=162 Identities=23% Similarity=0.404 Sum_probs=135.9
Q ss_pred HHHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCccEEEeccCCcccccCCCcccccccccCCccccCCccccCCCC
Q psy1840 24 GSISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKAPELLRQPHL 103 (423)
Q Consensus 24 ~~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~ 103 (423)
..+.|+.||++||.|||.++++ ||||-.+||||.....+||+|||+++.+.............-.+.|||-|.++...+
T Consensus 799 ~lLnw~~QIAkgM~YLe~qrlV-HrdLaaRNVLVksP~hvkitdfgla~ll~~d~~ey~~~~gK~pikwmale~i~~~~~ 877 (1177)
T KOG1025|consen 799 DLLNWCYQIAKGMKYLEEQRLV-HRDLAARNVLVKSPNHVKITDFGLAKLLAPDEKEYSAPGGKVPIKWMALESIRIRKY 877 (1177)
T ss_pred HHHHHHHHHHHHHHHHHhcchh-hhhhhhhheeecCCCeEEEEecchhhccCcccccccccccccCcHHHHHHHhhccCC
Confidence 3589999999999999999998 999999999999999999999999998765544333333334456999999987765
Q ss_pred CCCCCccchHHHHHHHHHHHh-CCCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCchHHHHHHHHHhhhcCCCCCCCHHH
Q psy1840 104 PRGTQKGDVYSFGLVLYEVIG-RQGPWGHLRMTDEEIITSVTQGSGLRPDTSSLDCAPSIIACMRTCWEEDPELRPDLRF 182 (423)
Q Consensus 104 ~~~s~ksDVyS~Giil~ellt-g~~Pf~~~~~~~~~i~~~i~~~~~~~p~~~~~~~~~~l~~Li~~C~~~dP~~RPt~~~ 182 (423)
+.++|||||||.+||++| |..||. .++.+++-..++.+..+.. +..|+-++..+|.+||..|+..||+|++
T Consensus 878 ---thqSDVWsfGVtiWElmTFGa~Py~--gi~~~eI~dlle~geRLsq---PpiCtiDVy~~mvkCwmid~~~rp~fke 949 (1177)
T KOG1025|consen 878 ---THQSDVWSFGVTIWELMTFGAKPYD--GIPAEEIPDLLEKGERLSQ---PPICTIDVYMVMVKCWMIDADSRPTFKE 949 (1177)
T ss_pred ---CchhhhhhhhhhHHHHHhcCCCccC--CCCHHHhhHHHhccccCCC---CCCccHHHHHHHHHHhccCcccCccHHH
Confidence 999999999999999997 889997 4667888888887765322 2368999999999999999999999999
Q ss_pred HHHHHHHHhhhc
Q psy1840 183 VHHKLKEMNAGL 194 (423)
Q Consensus 183 I~~~L~~i~~~~ 194 (423)
+...+.++....
T Consensus 950 l~~~fs~~ardp 961 (1177)
T KOG1025|consen 950 LAEEFSRMARDP 961 (1177)
T ss_pred HHHHHHHHhcCc
Confidence 999988876654
|
|
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.87 E-value=9.9e-22 Score=186.65 Aligned_cols=152 Identities=17% Similarity=0.281 Sum_probs=115.9
Q ss_pred HHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCccEEEeccCCcccccCCCc-ccccccccCCccccCCccccCCCC
Q psy1840 25 SISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDE-TGQERKLRRRKLYKAPELLRQPHL 103 (423)
Q Consensus 25 ~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~-~~~~~~~~gt~~y~APE~l~~~~~ 103 (423)
...++.|++.||.|||+.+++ |+||||+||+++.++.++|+|||+++....... ........++..|+|||.+.+...
T Consensus 108 ~~~~~~~i~~al~~LH~~~i~-H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~ 186 (264)
T cd06653 108 TRRYTRQILQGVSYLHSNMIV-HRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTPYWMSPEVISGEGY 186 (264)
T ss_pred HHHHHHHHHHHHHHHHhCCEe-cCCCCHHHEEEcCCCCEEECccccccccccccccCccccccCCcccccCHhhhcCCCC
Confidence 468999999999999999987 999999999999999999999999875432111 111123457888999999987544
Q ss_pred CCCCCccchHHHHHHHHHHHhCCCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCchHHHHHHHHHhhhcCCCCCCCHHHH
Q psy1840 104 PRGTQKGDVYSFGLVLYEVIGRQGPWGHLRMTDEEIITSVTQGSGLRPDTSSLDCAPSIIACMRTCWEEDPELRPDLRFV 183 (423)
Q Consensus 104 ~~~s~ksDVyS~Giil~elltg~~Pf~~~~~~~~~i~~~i~~~~~~~p~~~~~~~~~~l~~Li~~C~~~dP~~RPt~~~I 183 (423)
+.++|+|||||++|++++|+.||... ...+.+..+... +.++. .+...++.+.+++.+||. +|..||+..++
T Consensus 187 ---~~~~Di~slG~il~~l~~g~~p~~~~--~~~~~~~~~~~~-~~~~~-~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~ 258 (264)
T cd06653 187 ---GRKADVWSVACTVVEMLTEKPPWAEY--EAMAAIFKIATQ-PTKPM-LPDGVSDACRDFLKQIFV-EEKRRPTAEFL 258 (264)
T ss_pred ---CccccHHHHHHHHHHHHhCCCCCCcc--CHHHHHHHHHcC-CCCCC-CCcccCHHHHHHHHHHhc-CcccCccHHHH
Confidence 78999999999999999999999743 222222232221 12222 234578899999999999 57999999987
Q ss_pred HH
Q psy1840 184 HH 185 (423)
Q Consensus 184 ~~ 185 (423)
+.
T Consensus 259 ~~ 260 (264)
T cd06653 259 LR 260 (264)
T ss_pred hc
Confidence 64
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.6e-21 Score=184.59 Aligned_cols=149 Identities=21% Similarity=0.395 Sum_probs=116.6
Q ss_pred HHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCccEEEeccCCcccccCCCcccccccccCCccccCCccccCCCCC
Q psy1840 25 SISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKAPELLRQPHLP 104 (423)
Q Consensus 25 ~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~ 104 (423)
...++.|++.|+.|||+.|++ |+||+|+||+++. +.+||+|||++........ ......++..|+|||.+.+...
T Consensus 108 ~~~~~~~l~~~l~~lH~~~i~-h~~l~~~nili~~-~~~~l~d~g~~~~~~~~~~--~~~~~~~~~~~~~pe~~~~~~~- 182 (260)
T cd08222 108 VCEWFIQLLLGVHYMHQRRIL-HRDLKAKNIFLKN-NLLKIGDFGVSRLLMGSCD--LATTFTGTPYYMSPEALKHQGY- 182 (260)
T ss_pred HHHHHHHHHHHHHHHHHcCcc-ccCCChhheEeec-CCEeecccCceeecCCCcc--cccCCCCCcCccCHHHHccCCC-
Confidence 578999999999999999998 9999999999986 5699999999876533221 1223457788999998876544
Q ss_pred CCCCccchHHHHHHHHHHHhCCCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCchHHHHHHHHHhhhcCCCCCCCHHHHH
Q psy1840 105 RGTQKGDVYSFGLVLYEVIGRQGPWGHLRMTDEEIITSVTQGSGLRPDTSSLDCAPSIIACMRTCWEEDPELRPDLRFVH 184 (423)
Q Consensus 105 ~~s~ksDVyS~Giil~elltg~~Pf~~~~~~~~~i~~~i~~~~~~~p~~~~~~~~~~l~~Li~~C~~~dP~~RPt~~~I~ 184 (423)
+.++|+||||+++|++++|..||.. .........+..+. .+.. ...++.++.+++.+||..+|++||++.+++
T Consensus 183 --~~~~Dv~slG~~~~~l~~~~~~~~~--~~~~~~~~~~~~~~--~~~~-~~~~~~~~~~li~~~l~~~p~~Rp~~~~il 255 (260)
T cd08222 183 --DSKSDIWSLGCILYEMCCLAHAFEG--QNFLSVVLRIVEGP--TPSL-PETYSRQLNSIMQSMLNKDPSLRPSAAEIL 255 (260)
T ss_pred --CchhhHHHHHHHHHHHHhCCCCCCC--ccHHHHHHHHHcCC--CCCC-cchhcHHHHHHHHHHhcCChhhCcCHHHHh
Confidence 7889999999999999999999963 23334444443322 2222 235788999999999999999999999987
Q ss_pred H
Q psy1840 185 H 185 (423)
Q Consensus 185 ~ 185 (423)
+
T Consensus 256 ~ 256 (260)
T cd08222 256 R 256 (260)
T ss_pred h
Confidence 5
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.87 E-value=2e-21 Score=182.37 Aligned_cols=146 Identities=21% Similarity=0.252 Sum_probs=116.3
Q ss_pred HHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCccEEEeccCCcccccCCCcccccccccCCccccCCccccCCCCC
Q psy1840 25 SISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKAPELLRQPHLP 104 (423)
Q Consensus 25 ~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~ 104 (423)
...++.|++.|+.|||+.+++ |+||+|+||+++.++.++|+|||++........ ......++..|++||...+...
T Consensus 95 ~~~~~~qi~~~l~~lh~~~~~-H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~--~~~~~~~~~~~~~Pe~~~~~~~- 170 (250)
T cd05123 95 ARFYAAEIVLALEYLHSLGII-YRDLKPENILLDADGHIKLTDFGLAKELSSEGS--RTNTFCGTPEYLAPEVLLGKGY- 170 (250)
T ss_pred HHHHHHHHHHHHHHHHHCCce-ecCCCcceEEEcCCCcEEEeecCcceecccCCC--cccCCcCCccccChHHhCCCCC-
Confidence 578999999999999999998 999999999999999999999999876533221 1234456778999999876554
Q ss_pred CCCCccchHHHHHHHHHHHhCCCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCchHHHHHHHHHhhhcCCCCCCCHHH
Q psy1840 105 RGTQKGDVYSFGLVLYEVIGRQGPWGHLRMTDEEIITSVTQGSGLRPDTSSLDCAPSIIACMRTCWEEDPELRPDLRF 182 (423)
Q Consensus 105 ~~s~ksDVyS~Giil~elltg~~Pf~~~~~~~~~i~~~i~~~~~~~p~~~~~~~~~~l~~Li~~C~~~dP~~RPt~~~ 182 (423)
+.++|+||||+++|++++|+.||... ...+....+....... +...+..+.+++++||..||++||++.+
T Consensus 171 --~~~~D~~slG~~~~~l~~g~~p~~~~--~~~~~~~~~~~~~~~~----~~~~~~~l~~~i~~~l~~~p~~R~~~~~ 240 (250)
T cd05123 171 --GKAVDWWSLGVLLYEMLTGKPPFYAE--DRKEIYEKILKDPLRF----PEFLSPEARDLISGLLQKDPTKRLGSGG 240 (250)
T ss_pred --CchhhHHHHHHHHHHHHHCCCCCCCC--CHHHHHHHHhcCCCCC----CCCCCHHHHHHHHHHhcCCHhhCCCccc
Confidence 88999999999999999999999643 3345555555432211 2245789999999999999999999943
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=99.87 E-value=7.1e-22 Score=189.27 Aligned_cols=154 Identities=21% Similarity=0.266 Sum_probs=114.1
Q ss_pred HHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCccEEEeccCCcccccCCCcccccccccCCccccCCccccCCCCC
Q psy1840 25 SISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKAPELLRQPHLP 104 (423)
Q Consensus 25 ~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~ 104 (423)
...++.|++.||.|||+.|++ ||||||+||++++++.+||+|||++........ ......++..|++||.+.+..
T Consensus 102 ~~~~~~qi~~~l~~lH~~~i~-h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~-- 176 (284)
T cd07836 102 VKSFTYQLLKGIAFCHENRVL-HRDLKPQNLLINKRGELKLADFGLARAFGIPVN--TFSNEVVTLWYRAPDVLLGSR-- 176 (284)
T ss_pred HHHHHHHHHHHHHHHHHCCee-eCCCCHHHEEECCCCcEEEeecchhhhhcCCcc--ccccccccccccChHHhcCCC--
Confidence 679999999999999999988 999999999999999999999999865432211 112334677899999886543
Q ss_pred CCCCccchHHHHHHHHHHHhCCCCCCCCCCChHHHHHHHhc---------------CCCCCCCCC----------CCCch
Q psy1840 105 RGTQKGDVYSFGLVLYEVIGRQGPWGHLRMTDEEIITSVTQ---------------GSGLRPDTS----------SLDCA 159 (423)
Q Consensus 105 ~~s~ksDVyS~Giil~elltg~~Pf~~~~~~~~~i~~~i~~---------------~~~~~p~~~----------~~~~~ 159 (423)
..+.++||||||+++|++++|..||.+.. ..+....+.. ........+ ...++
T Consensus 177 ~~~~~~Dv~slG~~l~~l~~g~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (284)
T cd07836 177 TYSTSIDIWSVGCIMAEMITGRPLFPGTN--NEDQLLKIFRIMGTPTESTWPGISQLPEYKPTFPRYPPQDLQQLFPHAD 254 (284)
T ss_pred CCCcHHHHHHHHHHHHHHHhCCCCCCCCC--cHHHHHHHHHHhCCCChhhHHHHhcCchhcccccCCChHHHHHHhhhcC
Confidence 23789999999999999999999997532 2222222111 000000000 01346
Q ss_pred HHHHHHHHHhhhcCCCCCCCHHHHHH
Q psy1840 160 PSIIACMRTCWEEDPELRPDLRFVHH 185 (423)
Q Consensus 160 ~~l~~Li~~C~~~dP~~RPt~~~I~~ 185 (423)
..+.+++.+||+.||.+||++.++++
T Consensus 255 ~~~~~~i~~~l~~~p~~R~~~~~~l~ 280 (284)
T cd07836 255 PLGIDLLHRLLQLNPELRISAHDALQ 280 (284)
T ss_pred cHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 78899999999999999999999874
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >KOG4717|consensus | Back alignment and domain information |
|---|
Probab=99.87 E-value=6.9e-22 Score=194.08 Aligned_cols=148 Identities=18% Similarity=0.288 Sum_probs=125.5
Q ss_pred HHHHHHHHHHHHHHHhCCCeeecCCCCCCEEE-cCCccEEEeccCCcccccCCCcccccccccCCccccCCccccCCCCC
Q psy1840 26 ISVNTTASVGMIHLHDSEIISHGNLRSSNCLI-DSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKAPELLRQPHLP 104 (423)
Q Consensus 26 l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILl-d~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~ 104 (423)
-+...||+.++.|+|+-.++ ||||||+||++ ..-|-|||+|||++..+... ....+.+|+..|.|||++.|..|
T Consensus 121 ~kYF~QI~~AI~YCHqLHVV-HRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG---~kL~TsCGSLAYSAPEILLGDsY- 195 (864)
T KOG4717|consen 121 KKYFAQIVHAISYCHQLHVV-HRDLKPENVVFFEKLGLVKLTDFGFSNKFQPG---KKLTTSCGSLAYSAPEILLGDSY- 195 (864)
T ss_pred HHHHHHHHHHHHHHhhhhhh-cccCCcceeEEeeecCceEeeeccccccCCCc---chhhcccchhhccCchhhhcCcc-
Confidence 47889999999999999988 99999999865 67899999999997654322 23457799999999999999876
Q ss_pred CCCCccchHHHHHHHHHHHhCCCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCchHHHHHHHHHhhhcCCCCCCCHHHHH
Q psy1840 105 RGTQKGDVYSFGLVLYEVIGRQGPWGHLRMTDEEIITSVTQGSGLRPDTSSLDCAPSIIACMRTCWEEDPELRPDLRFVH 184 (423)
Q Consensus 105 ~~s~ksDVyS~Giil~elltg~~Pf~~~~~~~~~i~~~i~~~~~~~p~~~~~~~~~~l~~Li~~C~~~dP~~RPt~~~I~ 184 (423)
..+++||||+|+|||.+++|+.||.. ..+.+-+..|.+.++.-|. .++.+..+||..||..||.+|-+..+|.
T Consensus 196 -DAPAVDiWSLGVILyMLVCGq~PFqe--ANDSETLTmImDCKYtvPs----hvS~eCrdLI~sMLvRdPkkRAslEeI~ 268 (864)
T KOG4717|consen 196 -DAPAVDIWSLGVILYMLVCGQPPFQE--ANDSETLTMIMDCKYTVPS----HVSKECRDLIQSMLVRDPKKRASLEEIV 268 (864)
T ss_pred -CCcchhhhHHHHHHHHHHhCCCcccc--ccchhhhhhhhcccccCch----hhhHHHHHHHHHHHhcCchhhccHHHHh
Confidence 47899999999999999999999984 3456677777777665554 4688999999999999999999999987
Q ss_pred H
Q psy1840 185 H 185 (423)
Q Consensus 185 ~ 185 (423)
.
T Consensus 269 s 269 (864)
T KOG4717|consen 269 S 269 (864)
T ss_pred c
Confidence 5
|
|
| >KOG1006|consensus | Back alignment and domain information |
|---|
Probab=99.87 E-value=5.4e-23 Score=187.64 Aligned_cols=154 Identities=21% Similarity=0.278 Sum_probs=116.3
Q ss_pred HHHHHHHHHHHHHHhC-CCeeecCCCCCCEEEcCCccEEEeccCCcccccCCCcccccccccCCccccCCccccCCCCCC
Q psy1840 27 SVNTTASVGMIHLHDS-EIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKAPELLRQPHLPR 105 (423)
Q Consensus 27 ~i~~qi~~gL~yLH~~-~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~ 105 (423)
.|..-.+.||+||-.. .|| |||+||+|||+|..|.+||||||++..+.++. ..+...|...|||||.+....- -
T Consensus 171 ~ItvatV~AL~yLK~~lkiI-HRDvKPSNILldr~G~vKLCDFGIcGqLv~Si---AkT~daGCrpYmAPERi~p~~~-g 245 (361)
T KOG1006|consen 171 HITVATVDALDYLKEELKII-HRDVKPSNILLDRHGDVKLCDFGICGQLVDSI---AKTVDAGCRPYMAPERIDPSDK-G 245 (361)
T ss_pred heeeeehhHHHHHHHHhhhh-hccCChhheEEecCCCEeeecccchHhHHHHH---HhhhccCCccccChhccCCccC-C
Confidence 4455567899999876 566 99999999999999999999999987654332 2234467778999999875432 3
Q ss_pred CCCccchHHHHHHHHHHHhCCCCCCCCCCChHHHHHHHhcCCCCCCCC--CCCCchHHHHHHHHHhhhcCCCCCCCHHHH
Q psy1840 106 GTQKGDVYSFGLVLYEVIGRQGPWGHLRMTDEEIITSVTQGSGLRPDT--SSLDCAPSIIACMRTCWEEDPELRPDLRFV 183 (423)
Q Consensus 106 ~s~ksDVyS~Giil~elltg~~Pf~~~~~~~~~i~~~i~~~~~~~p~~--~~~~~~~~l~~Li~~C~~~dP~~RPt~~~I 183 (423)
+.-++|||||||+++|+.||..||..... .-+.+..+..|.+..... ....++..+..++..|+-+|-.+||.+.++
T Consensus 246 yDiRSDvWSLGITL~EvAtG~fPyr~w~s-vfeql~~Vv~gdpp~l~~~~~~~~~s~~~~~fintCl~Kd~~~Rpky~~L 324 (361)
T KOG1006|consen 246 YDIRSDVWSLGITLYEVATGNFPYRKWDS-VFEQLCQVVIGDPPILLFDKECVHYSFSMVRFINTCLIKDRSDRPKYDDL 324 (361)
T ss_pred cchhhhhhhhcceEeeeecCCCCcchHHH-HHHHHHHHHcCCCCeecCcccccccCHHHHHHHHHHhhcccccCcchhhh
Confidence 47899999999999999999999975422 333444444444332221 123578899999999999999999999988
Q ss_pred HHH
Q psy1840 184 HHK 186 (423)
Q Consensus 184 ~~~ 186 (423)
++.
T Consensus 325 k~~ 327 (361)
T KOG1006|consen 325 KKF 327 (361)
T ss_pred hcC
Confidence 653
|
|
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=99.86 E-value=1.1e-21 Score=194.09 Aligned_cols=156 Identities=19% Similarity=0.273 Sum_probs=112.0
Q ss_pred HHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEc-CCccEEEeccCCcccccCCCcc-cccccccCCccccCCccccCCC
Q psy1840 25 SISVNTTASVGMIHLHDSEIISHGNLRSSNCLID-SRWVLQIADFGLHAFKAGQDET-GQERKLRRRKLYKAPELLRQPH 102 (423)
Q Consensus 25 ~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld-~~~~vKL~DFGla~~~~~~~~~-~~~~~~~gt~~y~APE~l~~~~ 102 (423)
...++.||+.||.|||+.|++ ||||||+||+++ .++.+||+|||++......... .......++..|+|||.+.+..
T Consensus 116 ~~~~~~qi~~aL~~LH~~giv-H~dikp~Nili~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~ 194 (342)
T cd07854 116 ARLFMYQLLRGLKYIHSANVL-HRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPN 194 (342)
T ss_pred HHHHHHHHHHHHHHHHhCCcc-cCCCCHHHEEEcCCCceEEECCcccceecCCccccccccccccccccccCHHHHhCcc
Confidence 578999999999999999998 999999999997 4567899999998754322111 1112235677899999875533
Q ss_pred CCCCCCccchHHHHHHHHHHHhCCCCCCCCCCChHHHHHHHhcCC----------------------CCCCCC----CCC
Q psy1840 103 LPRGTQKGDVYSFGLVLYEVIGRQGPWGHLRMTDEEIITSVTQGS----------------------GLRPDT----SSL 156 (423)
Q Consensus 103 ~~~~s~ksDVyS~Giil~elltg~~Pf~~~~~~~~~i~~~i~~~~----------------------~~~p~~----~~~ 156 (423)
..+.++|||||||++|+|++|+.||... ...+....+.... ...+.. ...
T Consensus 195 --~~~~~~DiwSlGvil~el~~g~~pf~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 270 (342)
T cd07854 195 --NYTKAIDMWAAGCIFAEMLTGKPLFAGA--HELEQMQLILESVPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLP 270 (342)
T ss_pred --ccCchhhHHHHHHHHHHHHhCCCCCCCC--CHHHHHHHHHHhcCCCChHHhhhhhhhhhhhhhhcccccCCCHHHHcc
Confidence 2378999999999999999999999632 1111111111100 000000 012
Q ss_pred CchHHHHHHHHHhhhcCCCCCCCHHHHHH
Q psy1840 157 DCAPSIIACMRTCWEEDPELRPDLRFVHH 185 (423)
Q Consensus 157 ~~~~~l~~Li~~C~~~dP~~RPt~~~I~~ 185 (423)
..+.++.+++.+||+.||++||++.+++.
T Consensus 271 ~~~~~~~~li~~~L~~dP~~R~t~~ell~ 299 (342)
T cd07854 271 GVNPEALDFLEQILTFNPMDRLTAEEALM 299 (342)
T ss_pred CCCHHHHHHHHHHhCCCchhccCHHHHhC
Confidence 46778999999999999999999999975
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.86 E-value=7.7e-22 Score=195.26 Aligned_cols=152 Identities=20% Similarity=0.260 Sum_probs=114.6
Q ss_pred HHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCccEEEeccCCcccccCCCcccccccccCCccccCCccccCCCCC
Q psy1840 25 SISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKAPELLRQPHLP 104 (423)
Q Consensus 25 ~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~ 104 (423)
...++.|++.||.|||+.|++ ||||||+||+++.++.+||+|||++...... .....++..|+|||.+.+..
T Consensus 120 ~~~~~~ql~~aL~~LH~~gi~-H~dlkp~Nill~~~~~~kL~dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~-- 191 (343)
T cd07851 120 IQFLVYQILRGLKYIHSAGII-HRDLKPSNIAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRAPEIMLNWM-- 191 (343)
T ss_pred HHHHHHHHHHHHHHHHHCCee-cCCCCHHHeEECCCCCEEEcccccccccccc-----ccCCcccccccCHHHHhCCC--
Confidence 578999999999999999988 9999999999999999999999998754322 12345677899999886532
Q ss_pred CCCCccchHHHHHHHHHHHhCCCCCCCCCCChHHHHHHHhcCCC-----------------------CCC--CC--CCCC
Q psy1840 105 RGTQKGDVYSFGLVLYEVIGRQGPWGHLRMTDEEIITSVTQGSG-----------------------LRP--DT--SSLD 157 (423)
Q Consensus 105 ~~s~ksDVyS~Giil~elltg~~Pf~~~~~~~~~i~~~i~~~~~-----------------------~~p--~~--~~~~ 157 (423)
..+.++||||||+++||+++|+.||.... ..+....+..... ..+ .. ....
T Consensus 192 ~~~~~~DvwslGv~l~elltg~~pf~~~~--~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 269 (343)
T cd07851 192 HYNQTVDIWSVGCIMAELLTGKTLFPGSD--HIDQLKRIMNLVGTPDEELLQKISSESARNYIQSLPQMPKKDFKEVFSG 269 (343)
T ss_pred CCCchHhHHHHHHHHHHHHhCCCCCCCCC--hHHHHHHHHHhcCCCCHHHHhhccchhHHHHHHhccccCCCCHHHHhcc
Confidence 23789999999999999999999996432 2222222211100 000 00 0123
Q ss_pred chHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q psy1840 158 CAPSIIACMRTCWEEDPELRPDLRFVHHK 186 (423)
Q Consensus 158 ~~~~l~~Li~~C~~~dP~~RPt~~~I~~~ 186 (423)
.++.+.+++.+||+.+|++|||+.+|+..
T Consensus 270 ~s~~l~dli~~~l~~~P~~Rpt~~ell~h 298 (343)
T cd07851 270 ANPLAIDLLEKMLVLDPDKRITAAEALAH 298 (343)
T ss_pred CCHHHHHHHHHhCCCChhhCCCHHHHhcC
Confidence 57889999999999999999999998763
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=99.86 E-value=1.9e-21 Score=187.28 Aligned_cols=154 Identities=19% Similarity=0.256 Sum_probs=115.4
Q ss_pred HHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCccEEEeccCCcccccCCCcccccccccCCccccCCccccCCCCC
Q psy1840 25 SISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKAPELLRQPHLP 104 (423)
Q Consensus 25 ~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~ 104 (423)
...++.|++.||.|||+.|++ ||||+|+||+++.++.+||+|||++....... ........++..|+|||.+.....
T Consensus 107 ~~~~~~qi~~al~~lH~~~i~-H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~- 183 (290)
T cd05613 107 VQIYSGEIVLALEHLHKLGII-YRDIKLENILLDSNGHVVLTDFGLSKEFHEDE-VERAYSFCGTIEYMAPDIVRGGDG- 183 (290)
T ss_pred HHHHHHHHHHHHHHHHhCCee-ccCCCHHHeEECCCCCEEEeeCccceeccccc-ccccccccCCcccCChhhccCCCC-
Confidence 456777999999999999988 99999999999999999999999987543221 111234457888999999875321
Q ss_pred CCCCccchHHHHHHHHHHHhCCCCCCCCC--CChHHHHHHHhcCCCCCCCCCCCCchHHHHHHHHHhhhcCCCCCC----
Q psy1840 105 RGTQKGDVYSFGLVLYEVIGRQGPWGHLR--MTDEEIITSVTQGSGLRPDTSSLDCAPSIIACMRTCWEEDPELRP---- 178 (423)
Q Consensus 105 ~~s~ksDVyS~Giil~elltg~~Pf~~~~--~~~~~i~~~i~~~~~~~p~~~~~~~~~~l~~Li~~C~~~dP~~RP---- 178 (423)
..+.++||||||+++|++++|..||.... ....++...+....... +..+++.+.+++++||+.+|++||
T Consensus 184 ~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~ll~~~l~~~p~~R~~~~~ 259 (290)
T cd05613 184 GHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPY----PQEMSALAKDIIQRLLMKDPKKRLGCGP 259 (290)
T ss_pred CCCccccHHHHHHHHHHHhcCCCCCCcCCccccHHHHHHHhhccCCCC----CccCCHHHHHHHHHHhcCCHHHhcCCCC
Confidence 23788999999999999999999996322 22344444444332221 234788999999999999999997
Q ss_pred -CHHHHHH
Q psy1840 179 -DLRFVHH 185 (423)
Q Consensus 179 -t~~~I~~ 185 (423)
+..++..
T Consensus 260 ~~~~~l~~ 267 (290)
T cd05613 260 SDADEIKK 267 (290)
T ss_pred CCHHHHHc
Confidence 5555543
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=99.86 E-value=1.1e-21 Score=192.96 Aligned_cols=154 Identities=19% Similarity=0.271 Sum_probs=112.9
Q ss_pred HHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCccEEEeccCCcccccCCCcccccccccCCccccCCccccCCCCC
Q psy1840 25 SISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKAPELLRQPHLP 104 (423)
Q Consensus 25 ~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~ 104 (423)
...++.|++.||.|||+.+++ ||||+|+||+++.++.+||+|||++...... .....++..|+|||.+.+..
T Consensus 110 ~~~~~~ql~~aL~~LH~~~ii-H~dl~p~Nili~~~~~~~l~dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~-- 181 (328)
T cd07856 110 IQYFLYQILRGLKYVHSAGVV-HRDLKPSNILINENCDLKICDFGLARIQDPQ-----MTGYVSTRYYRAPEIMLTWQ-- 181 (328)
T ss_pred HHHHHHHHHHHHHHHHhCCcc-cCCCCHHHEeECCCCCEEeCccccccccCCC-----cCCCcccccccCceeeeccC--
Confidence 457899999999999999988 9999999999999999999999998643221 12335677899999876532
Q ss_pred CCCCccchHHHHHHHHHHHhCCCCCCCCCC-------------ChHHHHHHHhc------------CCCCCCCCCCCCch
Q psy1840 105 RGTQKGDVYSFGLVLYEVIGRQGPWGHLRM-------------TDEEIITSVTQ------------GSGLRPDTSSLDCA 159 (423)
Q Consensus 105 ~~s~ksDVyS~Giil~elltg~~Pf~~~~~-------------~~~~i~~~i~~------------~~~~~p~~~~~~~~ 159 (423)
..+.++||||||+++|++++|+.||..... ...++...+.. ............++
T Consensus 182 ~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 261 (328)
T cd07856 182 KYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTICSENTLRFVQSLPKREPVPFSEKFKNAD 261 (328)
T ss_pred CcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhccchhhHHHHhhccccCCCcHHHHcCCCC
Confidence 238899999999999999999999964221 00111111100 00000000112467
Q ss_pred HHHHHHHHHhhhcCCCCCCCHHHHHHH
Q psy1840 160 PSIIACMRTCWEEDPELRPDLRFVHHK 186 (423)
Q Consensus 160 ~~l~~Li~~C~~~dP~~RPt~~~I~~~ 186 (423)
.++.++|++||+.+|++||++.+++..
T Consensus 262 ~~~~~li~~~l~~~P~~R~t~~ell~~ 288 (328)
T cd07856 262 PSAIDLLEKMLVFDPQKRISAAEALAH 288 (328)
T ss_pred HHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 899999999999999999999998654
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.86 E-value=1.3e-21 Score=193.80 Aligned_cols=152 Identities=18% Similarity=0.236 Sum_probs=113.5
Q ss_pred HHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCccEEEeccCCcccccCCCcccccccccCCccccCCccccCCCCC
Q psy1840 25 SISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKAPELLRQPHLP 104 (423)
Q Consensus 25 ~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~ 104 (423)
...++.|++.||.|||+.|++ ||||||+||+++.++.+||+|||++...... .....++..|+|||.+.+..
T Consensus 122 ~~~i~~qi~~aL~~LH~~~iv-H~dlkp~NIll~~~~~~kl~dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~-- 193 (345)
T cd07877 122 VQFLIYQILRGLKYIHSADII-HRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRAPEIMLNWM-- 193 (345)
T ss_pred HHHHHHHHHHHHHHHHHCCee-ecCCChHHEEEcCCCCEEEeccccccccccc-----ccccccCCCccCHHHHhCcc--
Confidence 567899999999999999988 9999999999999999999999997654221 12345678899999886532
Q ss_pred CCCCccchHHHHHHHHHHHhCCCCCCCCCCChHHHHHHHhcC-----------------------CCCCCCC----CCCC
Q psy1840 105 RGTQKGDVYSFGLVLYEVIGRQGPWGHLRMTDEEIITSVTQG-----------------------SGLRPDT----SSLD 157 (423)
Q Consensus 105 ~~s~ksDVyS~Giil~elltg~~Pf~~~~~~~~~i~~~i~~~-----------------------~~~~p~~----~~~~ 157 (423)
..+.++|||||||++||+++|+.||.... .......+... ....+.. ....
T Consensus 194 ~~~~~~DvwslG~il~el~~g~~pf~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 271 (345)
T cd07877 194 HYNQTVDIWSVGCIMAELLTGRTLFPGTD--HIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIG 271 (345)
T ss_pred CCCchhhHHHHHHHHHHHHhCCCCCCCCC--HHHHHHHHHHHhCCCCHHHHhhcccHhHHHHHHHhcccCCcchhhhcCC
Confidence 23789999999999999999999996422 11111111110 0001110 0123
Q ss_pred chHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q psy1840 158 CAPSIIACMRTCWEEDPELRPDLRFVHHK 186 (423)
Q Consensus 158 ~~~~l~~Li~~C~~~dP~~RPt~~~I~~~ 186 (423)
.++++.+++.+|++.||.+||++.+++..
T Consensus 272 ~~~~~~~li~~~L~~dp~~R~t~~e~l~h 300 (345)
T cd07877 272 ANPLAVDLLEKMLVLDSDKRITAAQALAH 300 (345)
T ss_pred CCHHHHHHHHHHcCCChhhcCCHHHHhcC
Confidence 57789999999999999999999998764
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=99.86 E-value=1.6e-21 Score=186.02 Aligned_cols=151 Identities=18% Similarity=0.279 Sum_probs=117.8
Q ss_pred HHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCccEEEeccCCcccccCCCcc------------------cccccc
Q psy1840 25 SISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDET------------------GQERKL 86 (423)
Q Consensus 25 ~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~~------------------~~~~~~ 86 (423)
...++.|++.||.|||+.|++ ||||+|+||+++.++.++++|||++......... ......
T Consensus 104 ~~~i~~ql~~~l~~Lh~~~~~-H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 182 (280)
T cd05581 104 TRFYAAEILLALEYLHSKGII-HRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNRRRFASF 182 (280)
T ss_pred HHHHHHHHHHHHHHHHHCCee-ecCCCHHHeEECCCCCEEecCCccccccCCccccccCCCCCccccccccccccccccc
Confidence 689999999999999999987 9999999999999999999999998765432211 112234
Q ss_pred cCCccccCCccccCCCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCchHHHHHHH
Q psy1840 87 RRRKLYKAPELLRQPHLPRGTQKGDVYSFGLVLYEVIGRQGPWGHLRMTDEEIITSVTQGSGLRPDTSSLDCAPSIIACM 166 (423)
Q Consensus 87 ~gt~~y~APE~l~~~~~~~~s~ksDVyS~Giil~elltg~~Pf~~~~~~~~~i~~~i~~~~~~~p~~~~~~~~~~l~~Li 166 (423)
.++..|+|||....... +.++|+||||++++++++|..||.... .......+.......| ...++.+.+++
T Consensus 183 ~~~~~~~~Pe~~~~~~~---~~~~Di~slG~~l~~l~~g~~p~~~~~--~~~~~~~~~~~~~~~~----~~~~~~~~~li 253 (280)
T cd05581 183 VGTAEYVSPELLNEKPA---GKSSDLWALGCIIYQMLTGKPPFRGSN--EYLTFQKILKLEYSFP----PNFPPDAKDLI 253 (280)
T ss_pred cCCccccCHHHhCCCCC---ChhhhHHHHHHHHHHHHhCCCCCCCcc--HHHHHHHHHhcCCCCC----CccCHHHHHHH
Confidence 56778999998876554 889999999999999999999997432 2333344433222222 24688999999
Q ss_pred HHhhhcCCCCCCCH----HHHHH
Q psy1840 167 RTCWEEDPELRPDL----RFVHH 185 (423)
Q Consensus 167 ~~C~~~dP~~RPt~----~~I~~ 185 (423)
++||+.+|++||++ .+++.
T Consensus 254 ~~~l~~~p~~R~~~~~~~~~ll~ 276 (280)
T cd05581 254 EKLLVLDPQDRLGVNEGYDELKA 276 (280)
T ss_pred HHHhcCCHhhCCCcccCHHHHhc
Confidence 99999999999999 66654
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.86 E-value=2.1e-21 Score=191.20 Aligned_cols=157 Identities=18% Similarity=0.206 Sum_probs=115.2
Q ss_pred HHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCccEEEeccCCcccccCCCc------------ccccccccCCccc
Q psy1840 25 SISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDE------------TGQERKLRRRKLY 92 (423)
Q Consensus 25 ~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~------------~~~~~~~~gt~~y 92 (423)
...++.|++.||.|||++|++ ||||+|+||+++.++.+||+|||++........ ........++..|
T Consensus 121 ~~~~~~ql~~aL~~LH~~~i~-H~dl~~~nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y 199 (335)
T PTZ00024 121 VKCILLQILNGLNVLHKWYFM-HRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWY 199 (335)
T ss_pred HHHHHHHHHHHHHHHHhCCee-cccccHHHeEECCCCCEEECCccceeecccccccccccccccccccccccccccccCC
Confidence 578999999999999999998 999999999999999999999999875431110 0111223456789
Q ss_pred cCCccccCCCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCChHHHHHHHhc----CCCC-----------------CC
Q psy1840 93 KAPELLRQPHLPRGTQKGDVYSFGLVLYEVIGRQGPWGHLRMTDEEIITSVTQ----GSGL-----------------RP 151 (423)
Q Consensus 93 ~APE~l~~~~~~~~s~ksDVyS~Giil~elltg~~Pf~~~~~~~~~i~~~i~~----~~~~-----------------~p 151 (423)
+|||.+.+.. ..+.++|+|||||++|||++|..||.... ..+....+.. .... .+
T Consensus 200 ~aPE~~~~~~--~~~~~~Dv~slG~~l~el~tg~~p~~~~~--~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 275 (335)
T PTZ00024 200 RAPELLMGAE--KYHFAVDMWSVGCIFAELLTGKPLFPGEN--EIDQLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKP 275 (335)
T ss_pred CCChhcccCC--CCCcHHHHHHHHHHHHHHHhCCCCCCCCC--HHHHHHHHHHHhCCCchhhCcchhhcccccccCcCCc
Confidence 9999987643 23789999999999999999999997432 2222222211 0000 00
Q ss_pred C---CCCCCchHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q psy1840 152 D---TSSLDCAPSIIACMRTCWEEDPELRPDLRFVHHK 186 (423)
Q Consensus 152 ~---~~~~~~~~~l~~Li~~C~~~dP~~RPt~~~I~~~ 186 (423)
. .....++..+.+++.+||+.+|++||++.+++..
T Consensus 276 ~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~ 313 (335)
T PTZ00024 276 KDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALKH 313 (335)
T ss_pred ccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhcC
Confidence 0 0012357789999999999999999999999864
|
|
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=99.86 E-value=1.5e-21 Score=182.86 Aligned_cols=137 Identities=18% Similarity=0.162 Sum_probs=106.6
Q ss_pred HHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCccEEEeccCCcccccCCCcccccccccCCccccCCccccCCCCC
Q psy1840 25 SISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKAPELLRQPHLP 104 (423)
Q Consensus 25 ~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~ 104 (423)
...++.|++.||.|||+.|++ ||||||+||+++.++.++++|||.+....... ....++..|+|||.+.+...
T Consensus 87 ~~~~~~ql~~~l~~lH~~~i~-H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~- 159 (237)
T cd05576 87 VKRWAAEMVVALDALHREGIV-CRDLNPNNILLDDRGHIQLTYFSRWSEVEDSC-----DGEAVENMYCAPEVGGISEE- 159 (237)
T ss_pred HHHHHHHHHHHHHHHHhCCee-ccCCCHHHEEEcCCCCEEEecccchhcccccc-----ccCCcCccccCCcccCCCCC-
Confidence 578999999999999999988 99999999999999999999999875543221 22345667999999876544
Q ss_pred CCCCccchHHHHHHHHHHHhCCCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCchHHHHHHHHHhhhcCCCCCCCH
Q psy1840 105 RGTQKGDVYSFGLVLYEVIGRQGPWGHLRMTDEEIITSVTQGSGLRPDTSSLDCAPSIIACMRTCWEEDPELRPDL 180 (423)
Q Consensus 105 ~~s~ksDVyS~Giil~elltg~~Pf~~~~~~~~~i~~~i~~~~~~~p~~~~~~~~~~l~~Li~~C~~~dP~~RPt~ 180 (423)
+.++|+||+|+++||+++|..|+.... ..+ ... ..... +..+++.+.+++.+||+.||++||++
T Consensus 160 --~~~~DvwslG~il~el~~g~~~~~~~~---~~~----~~~--~~~~~-~~~~~~~~~~li~~~l~~dp~~R~~~ 223 (237)
T cd05576 160 --TEACDWWSLGAILFELLTGKTLVECHP---SGI----NTH--TTLNI-PEWVSEEARSLLQQLLQFNPTERLGA 223 (237)
T ss_pred --CchhhHHHHHHHHHHHHHCcchhhcCc---hhc----ccc--cccCC-cccCCHHHHHHHHHHccCCHHHhcCC
Confidence 789999999999999999998875321 110 000 01111 23467899999999999999999986
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.86 E-value=1.2e-21 Score=194.01 Aligned_cols=158 Identities=18% Similarity=0.233 Sum_probs=116.8
Q ss_pred HHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCccEEEeccCCcccccCCCcccccccccCCccccCCccccCCCCC
Q psy1840 25 SISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKAPELLRQPHLP 104 (423)
Q Consensus 25 ~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~ 104 (423)
...++.|++.||.|||+.|++ ||||||+||+++.++.+||+|||++...... .....++..|+|||.+.+..
T Consensus 120 ~~~i~~qi~~al~~LH~~gi~-H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~-- 191 (343)
T cd07880 120 IQFLVYQMLKGLKYIHAAGII-HRDLKPGNLAVNEDCELKILDFGLARQTDSE-----MTGYVVTRWYRAPEVILNWM-- 191 (343)
T ss_pred HHHHHHHHHHHHHHHHhCCee-cCCCCHHHEEEcCCCCEEEeecccccccccC-----ccccccCCcccCHHHHhCCC--
Confidence 568899999999999999988 9999999999999999999999998754321 12345677899999987532
Q ss_pred CCCCccchHHHHHHHHHHHhCCCCCCCCCCChHHHHHHHhcC------------------------CCCCCC---CCCCC
Q psy1840 105 RGTQKGDVYSFGLVLYEVIGRQGPWGHLRMTDEEIITSVTQG------------------------SGLRPD---TSSLD 157 (423)
Q Consensus 105 ~~s~ksDVyS~Giil~elltg~~Pf~~~~~~~~~i~~~i~~~------------------------~~~~p~---~~~~~ 157 (423)
..+.++|+||||+++|++++|..||..... ......+... ....+. .....
T Consensus 192 ~~~~~~Di~slG~ll~~l~~g~~pf~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 269 (343)
T cd07880 192 HYTQTVDIWSVGCIMAEMLTGKPLFKGHDH--LDQLMEIMKVTGTPSKEFVQKLQSEDAKNYVKKLPRFRKKDFRSLLPN 269 (343)
T ss_pred CCCcHHHHHHHHHHHHHHHhCCCCCCCCCH--HHHHHHHHHhcCCCCHHHHHhhcchhHHHHHHhccccCcchHHHhccC
Confidence 238899999999999999999999964321 1111111100 000000 01135
Q ss_pred chHHHHHHHHHhhhcCCCCCCCHHHHHH--HHHHHhh
Q psy1840 158 CAPSIIACMRTCWEEDPELRPDLRFVHH--KLKEMNA 192 (423)
Q Consensus 158 ~~~~l~~Li~~C~~~dP~~RPt~~~I~~--~L~~i~~ 192 (423)
+++.+.+++.+|++.||++|||+.+++. .++....
T Consensus 270 ~~~~~~~li~~~l~~dP~~R~t~~~~l~~~~~~~~~~ 306 (343)
T cd07880 270 ANPLAVNVLEKMLVLDAESRITAAEALAHPYFEEFHD 306 (343)
T ss_pred CChHHHHHHHHHcCCChhhCCCHHHHhcCccHhhhcC
Confidence 6778999999999999999999999984 4444433
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.86 E-value=5.5e-22 Score=208.13 Aligned_cols=156 Identities=13% Similarity=0.079 Sum_probs=106.8
Q ss_pred HHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcC-CccEEEeccCCcccccCCCcccccccccCCccccCCccccCCCCC
Q psy1840 26 ISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDS-RWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKAPELLRQPHLP 104 (423)
Q Consensus 26 l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~-~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~ 104 (423)
..++.||+.||.|||+.+++ ||||||+|||++. ++.+||+|||+++....... .......+++.|+|||.+......
T Consensus 258 ~~i~~qll~aL~yLH~~gIi-HRDLKP~NILl~~~~~~~KL~DFGlA~~l~~~~~-~~~~~~~~t~~Y~APE~~~~~~~~ 335 (566)
T PLN03225 258 QTIMRQILFALDGLHSTGIV-HRDVKPQNIIFSEGSGSFKIIDLGAAADLRVGIN-YIPKEFLLDPRYAAPEQYIMSTQT 335 (566)
T ss_pred HHHHHHHHHHHHHHHHCCEE-eCcCCHHHEEEeCCCCcEEEEeCCCccccccccc-cCCcccccCCCccChHHhhccCCC
Confidence 36899999999999999988 9999999999985 68999999999875432211 122345778899999976432210
Q ss_pred -------------------CCCCccchHHHHHHHHHHHhCCCCCCCCCCChHHHHHHHhcCC------------CCCCCC
Q psy1840 105 -------------------RGTQKGDVYSFGLVLYEVIGRQGPWGHLRMTDEEIITSVTQGS------------GLRPDT 153 (423)
Q Consensus 105 -------------------~~s~ksDVyS~Giil~elltg~~Pf~~~~~~~~~i~~~i~~~~------------~~~p~~ 153 (423)
.++.++|||||||++|||+++..|+... ...+...+.... ...+..
T Consensus 336 ~~~~~~~~~~~~sp~l~~~~~~~k~DVwSlGviL~el~~~~~~~~~~---~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 412 (566)
T PLN03225 336 PSAPSAPVATALSPVLWQLNLPDRFDIYSAGLIFLQMAFPNLRSDSN---LIQFNRQLKRNDYDLVAWRKLVEPRASPDL 412 (566)
T ss_pred CCCccccccccccchhccccCCCCcccHHHHHHHHHHHhCcCCCchH---HHHHHHHHHhcCCcHHHHHHhhccccchhh
Confidence 1235679999999999999877665321 111111111110 000000
Q ss_pred C-----CCCchHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q psy1840 154 S-----SLDCAPSIIACMRTCWEEDPELRPDLRFVHHK 186 (423)
Q Consensus 154 ~-----~~~~~~~l~~Li~~C~~~dP~~RPt~~~I~~~ 186 (423)
. .........+|+.+|++.||++|||+.++++.
T Consensus 413 ~~~~~~~d~~~~~~~dLi~~mL~~dP~kR~ta~e~L~H 450 (566)
T PLN03225 413 RRGFEVLDLDGGAGWELLKSMMRFKGRQRISAKAALAH 450 (566)
T ss_pred hhhhhhccccchHHHHHHHHHccCCcccCCCHHHHhCC
Confidence 0 01123345689999999999999999999875
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.85 E-value=5.5e-21 Score=177.13 Aligned_cols=152 Identities=23% Similarity=0.285 Sum_probs=120.0
Q ss_pred HHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCccEEEeccCCcccccCCCcccccccccCCccccCCccccCCCCC
Q psy1840 25 SISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKAPELLRQPHLP 104 (423)
Q Consensus 25 ~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~ 104 (423)
...++.+++.|+.|||+.+++ |+||+|+||+++.++.++|+|||.+....... ......++..|++||.+.+...
T Consensus 89 ~~~~~~~l~~~l~~lh~~~i~-h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~---~~~~~~~~~~~~~pE~~~~~~~- 163 (244)
T smart00220 89 ARFYARQILSALEYLHSNGII-HRDLKPENILLDEDGHVKLADFGLARQLDPGG---LLTTFVGTPEYMAPEVLLGKGY- 163 (244)
T ss_pred HHHHHHHHHHHHHHHHHcCee-cCCcCHHHeEECCCCcEEEccccceeeecccc---ccccccCCcCCCCHHHHccCCC-
Confidence 678999999999999999988 99999999999999999999999987654332 2234456778999999876544
Q ss_pred CCCCccchHHHHHHHHHHHhCCCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCchHHHHHHHHHhhhcCCCCCCCHHHHH
Q psy1840 105 RGTQKGDVYSFGLVLYEVIGRQGPWGHLRMTDEEIITSVTQGSGLRPDTSSLDCAPSIIACMRTCWEEDPELRPDLRFVH 184 (423)
Q Consensus 105 ~~s~ksDVyS~Giil~elltg~~Pf~~~~~~~~~i~~~i~~~~~~~p~~~~~~~~~~l~~Li~~C~~~dP~~RPt~~~I~ 184 (423)
+.++||||||++++++++|..||... .....+...+........ .....++.++.+++.+||..+|++||++.+++
T Consensus 164 --~~~~Di~slG~~l~~l~~~~~p~~~~-~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~~ 239 (244)
T smart00220 164 --GKAVDVWSLGVILYELLTGKPPFPGD-DQLLELFKKIGKPKPPFP-PPEWKISPEAKDLIRKLLVKDPEKRLTAEEAL 239 (244)
T ss_pred --CchhhHHHHHHHHHHHHhCCCCCCCC-CcHHHHHHHHhccCCCCc-cccccCCHHHHHHHHHHccCCchhccCHHHHh
Confidence 78999999999999999999999642 233444555444322211 11112788999999999999999999999987
Q ss_pred H
Q psy1840 185 H 185 (423)
Q Consensus 185 ~ 185 (423)
+
T Consensus 240 ~ 240 (244)
T smart00220 240 Q 240 (244)
T ss_pred h
Confidence 5
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG0614|consensus | Back alignment and domain information |
|---|
Probab=99.85 E-value=1.3e-21 Score=191.89 Aligned_cols=149 Identities=17% Similarity=0.260 Sum_probs=118.1
Q ss_pred CCChHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCccEEEeccCCcccccCCCcccccccccCCccccCCccc
Q psy1840 19 FNIPIGSISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKAPELL 98 (423)
Q Consensus 19 ~~~p~~~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l 98 (423)
|.-+..+ -++.-+.+|++|||++||| .|||||+|+++|.+|-+||.|||+++.+... ..+.+++||+.|.|||++
T Consensus 517 Fdd~tar-F~~acv~EAfeYLH~k~iI-YRDLKPENllLd~~Gy~KLVDFGFAKki~~g---~KTwTFcGTpEYVAPEII 591 (732)
T KOG0614|consen 517 FDDYTAR-FYVACVLEAFEYLHRKGII-YRDLKPENLLLDNRGYLKLVDFGFAKKIGSG---RKTWTFCGTPEYVAPEII 591 (732)
T ss_pred cccchhh-hhHHHHHHHHHHHHhcCce-eccCChhheeeccCCceEEeehhhHHHhccC---CceeeecCCcccccchhh
Confidence 4443333 3456788999999999999 9999999999999999999999999987543 345789999999999999
Q ss_pred cCCCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCchHHHHHHHHHhhhcCCCCCC
Q psy1840 99 RQPHLPRGTQKGDVYSFGLVLYEVIGRQGPWGHLRMTDEEIITSVTQGSGLRPDTSSLDCAPSIIACMRTCWEEDPELRP 178 (423)
Q Consensus 99 ~~~~~~~~s~ksDVyS~Giil~elltg~~Pf~~~~~~~~~i~~~i~~~~~~~p~~~~~~~~~~l~~Li~~C~~~dP~~RP 178 (423)
.++.. ..++|.||+||++||+++|.+||.+. ++-.....+..|... -..+..++....+||++....+|.+|.
T Consensus 592 LnKGH---D~avDyWaLGIli~ELL~G~pPFs~~--dpmktYn~ILkGid~--i~~Pr~I~k~a~~Lik~LCr~~P~ERL 664 (732)
T KOG0614|consen 592 LNKGH---DRAVDYWALGILIYELLTGSPPFSGV--DPMKTYNLILKGIDK--IEFPRRITKTATDLIKKLCRDNPTERL 664 (732)
T ss_pred hccCc---chhhHHHHHHHHHHHHHcCCCCCCCC--chHHHHHHHHhhhhh--hhcccccchhHHHHHHHHHhcCcHhhh
Confidence 88765 89999999999999999999999743 333344444444211 111235678899999999999999996
Q ss_pred C
Q psy1840 179 D 179 (423)
Q Consensus 179 t 179 (423)
.
T Consensus 665 G 665 (732)
T KOG0614|consen 665 G 665 (732)
T ss_pred c
Confidence 4
|
|
| >KOG2052|consensus | Back alignment and domain information |
|---|
Probab=99.85 E-value=2.8e-21 Score=187.43 Aligned_cols=171 Identities=26% Similarity=0.407 Sum_probs=126.7
Q ss_pred hHHHHHHHHHHHHHHHHHHh-------CCCeeecCCCCCCEEEcCCccEEEeccCCcccccCCCc--ccccccccCCccc
Q psy1840 22 PIGSISVNTTASVGMIHLHD-------SEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDE--TGQERKLRRRKLY 92 (423)
Q Consensus 22 p~~~l~i~~qi~~gL~yLH~-------~~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~--~~~~~~~~gt~~y 92 (423)
+...++++..+|.||+|||. ++-|.|||||+.||||.+++++-|+|+|++-....... ........||..|
T Consensus 307 ~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IADLGLAv~h~~~t~~idi~~N~rVGTKRY 386 (513)
T KOG2052|consen 307 TEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSDTDTIDIPPNPRVGTKRY 386 (513)
T ss_pred HHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEeeceeeEEecccCCcccCCCCCccceeec
Confidence 35579999999999999996 33456999999999999999999999999865433221 2233567899999
Q ss_pred cCCccccCCC---CCCCCCccchHHHHHHHHHHHhC----------CCCCCCCCCCh--HHHHHHHhcCCCCCCCCCC--
Q psy1840 93 KAPELLRQPH---LPRGTQKGDVYSFGLVLYEVIGR----------QGPWGHLRMTD--EEIITSVTQGSGLRPDTSS-- 155 (423)
Q Consensus 93 ~APE~l~~~~---~~~~s~ksDVyS~Giil~elltg----------~~Pf~~~~~~~--~~i~~~i~~~~~~~p~~~~-- 155 (423)
||||++...- ....-..+||||||.|+||+..+ +.||.+...++ .+-...+.--...+|..++
T Consensus 387 MAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~Vp~DPs~eeMrkVVCv~~~RP~ipnrW 466 (513)
T KOG2052|consen 387 MAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDVVPSDPSFEEMRKVVCVQKLRPNIPNRW 466 (513)
T ss_pred cChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccCCCCCCCHHHHhcceeecccCCCCCccc
Confidence 9999997632 11123569999999999999864 57887542222 2223333333455666553
Q ss_pred --CCchHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHhh
Q psy1840 156 --LDCAPSIIACMRTCWEEDPELRPDLRFVHHKLKEMNA 192 (423)
Q Consensus 156 --~~~~~~l~~Li~~C~~~dP~~RPt~~~I~~~L~~i~~ 192 (423)
..+-..+.++|+.||..||.-|-|+-.|.+.|.++.+
T Consensus 467 ~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l~~ 505 (513)
T KOG2052|consen 467 KSDPALRVMAKLMKECWYANPAARLTALRIKKTLAKLSN 505 (513)
T ss_pred ccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHHhc
Confidence 3344578889999999999999999999999988864
|
|
| >KOG3653|consensus | Back alignment and domain information |
|---|
Probab=99.85 E-value=2.9e-21 Score=188.54 Aligned_cols=167 Identities=27% Similarity=0.418 Sum_probs=124.9
Q ss_pred HHHHHHHHHHHHHHHHh--------CCCeeecCCCCCCEEEcCCccEEEeccCCcccccCCCcccccccccCCccccCCc
Q psy1840 25 SISVNTTASVGMIHLHD--------SEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKAPE 96 (423)
Q Consensus 25 ~l~i~~qi~~gL~yLH~--------~~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE 96 (423)
..+++..+++||+|||. +.-|+|||||++||||.+++++.|+|||++..+.............||..|||||
T Consensus 309 ~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFGLAl~~~p~~~~~d~~~qVGT~RYMAPE 388 (534)
T KOG3653|consen 309 LCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFGLALRLEPGKPQGDTHGQVGTRRYMAPE 388 (534)
T ss_pred HHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeeccceeEEecCCCCCcchhhhhhhhhhcCHH
Confidence 67999999999999997 3345599999999999999999999999998776555544445578999999999
Q ss_pred cccCCCCCC---CCCccchHHHHHHHHHHHhCCC------------CCC---CCCCChHHHHHHHhcCCCCCCCCCC---
Q psy1840 97 LLRQPHLPR---GTQKGDVYSFGLVLYEVIGRQG------------PWG---HLRMTDEEIITSVTQGSGLRPDTSS--- 155 (423)
Q Consensus 97 ~l~~~~~~~---~s~ksDVyS~Giil~elltg~~------------Pf~---~~~~~~~~i~~~i~~~~~~~p~~~~--- 155 (423)
++.+..-.. .-.+.||||+|.|+|||+++.. ||. +...+.+++.+.+.+. ..||..+.
T Consensus 389 vLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~evG~hPt~e~mq~~VV~k-K~RP~~p~~W~ 467 (534)
T KOG3653|consen 389 VLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEVGNHPTLEEMQELVVRK-KQRPKIPDAWR 467 (534)
T ss_pred HHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHhcCCCCHHHHHHHHHhh-ccCCCChhhhh
Confidence 998753111 1256999999999999998743 232 1122334554444432 23444432
Q ss_pred -CCchHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHhh
Q psy1840 156 -LDCAPSIIACMRTCWEEDPELRPDLRFVHHKLKEMNA 192 (423)
Q Consensus 156 -~~~~~~l~~Li~~C~~~dP~~RPt~~~I~~~L~~i~~ 192 (423)
......+.+.+..||+.||+.|.|+.=+.+++.++..
T Consensus 468 ~h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~~ 505 (534)
T KOG3653|consen 468 KHAGMAVLCETIEECWDHDAEARLTAGCVEERMAELMM 505 (534)
T ss_pred cCccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHhc
Confidence 3445678999999999999999999988888777654
|
|
| >KOG0690|consensus | Back alignment and domain information |
|---|
Probab=99.85 E-value=2.8e-21 Score=180.76 Aligned_cols=139 Identities=21% Similarity=0.310 Sum_probs=116.3
Q ss_pred HHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCccEEEeccCCcccccCCCcccccccccCCccccCCccccCCCCCCCC
Q psy1840 28 VNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKAPELLRQPHLPRGT 107 (423)
Q Consensus 28 i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~s 107 (423)
....|+.+|.|||+++|+ .||||.+|.++|.+|++||+|||+++.-. .......+++||+.|+|||++....+ +
T Consensus 273 YGaEIvsAL~YLHs~~iv-YRDlKLENLlLDkDGHIKitDFGLCKE~I--~~g~t~kTFCGTPEYLAPEVleDnDY---g 346 (516)
T KOG0690|consen 273 YGAEIVSALGYLHSRNIV-YRDLKLENLLLDKDGHIKITDFGLCKEEI--KYGDTTKTFCGTPEYLAPEVLEDNDY---G 346 (516)
T ss_pred hhHHHHHHhhhhhhCCee-eeechhhhheeccCCceEeeecccchhcc--cccceeccccCChhhcCchhhccccc---c
Confidence 467899999999999998 99999999999999999999999987432 22334468899999999999988766 8
Q ss_pred CccchHHHHHHHHHHHhCCCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCchHHHHHHHHHhhhcCCCCCC
Q psy1840 108 QKGDVYSFGLVLYEVIGRQGPWGHLRMTDEEIITSVTQGSGLRPDTSSLDCAPSIIACMRTCWEEDPELRP 178 (423)
Q Consensus 108 ~ksDVyS~Giil~elltg~~Pf~~~~~~~~~i~~~i~~~~~~~p~~~~~~~~~~l~~Li~~C~~~dP~~RP 178 (423)
+++|-|.+|+++|||++|+.||.. .+.+.+.+.+.......|. ..+++...|+...+..||.+|.
T Consensus 347 raVDWWG~GVVMYEMmCGRLPFyn--~dh~kLFeLIl~ed~kFPr----~ls~eAktLLsGLL~kdP~kRL 411 (516)
T KOG0690|consen 347 RAVDWWGVGVVMYEMMCGRLPFYN--KDHEKLFELILMEDLKFPR----TLSPEAKTLLSGLLKKDPKKRL 411 (516)
T ss_pred ceeehhhhhHHHHHHHhccCcccc--cchhHHHHHHHhhhccCCc----cCCHHHHHHHHHHhhcChHhhc
Confidence 999999999999999999999974 3345566666655444443 5788999999999999999994
|
|
| >KOG0574|consensus | Back alignment and domain information |
|---|
Probab=99.85 E-value=2.8e-22 Score=185.57 Aligned_cols=167 Identities=19% Similarity=0.327 Sum_probs=127.2
Q ss_pred HHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCccEEEeccCCcccccCCCcccccccccCCccccCCccccCCCCC
Q psy1840 25 SISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKAPELLRQPHLP 104 (423)
Q Consensus 25 ~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~ 104 (423)
.-.++.+-++||+|||...-| |||||..|||++-+|..||+|||++..+.+... ...+..||+.|||||++..-.+
T Consensus 131 Is~iL~~TLKGL~YLH~~~KI-HRDIKAGNILLNT~G~AKLADFGVAGQLTDTMA--KRNTVIGTPFWMAPEVI~EIGY- 206 (502)
T KOG0574|consen 131 ISAVLRDTLKGLQYLHDLKKI-HRDIKAGNILLNTDGIAKLADFGVAGQLTDTMA--KRNTVIGTPFWMAPEVIEEIGY- 206 (502)
T ss_pred HHHHHHHHHhHHHHHHHHHHH-HhhcccccEEEcccchhhhhhccccchhhhhHH--hhCccccCcccccHHHHHHhcc-
Confidence 346788899999999998877 999999999999999999999999876654332 3357789999999999988766
Q ss_pred CCCCccchHHHHHHHHHHHhCCCCCCCCCCChHHHHHHHhcCCCCCCCCC--CCCchHHHHHHHHHhhhcCCCCCCCHHH
Q psy1840 105 RGTQKGDVYSFGLVLYEVIGRQGPWGHLRMTDEEIITSVTQGSGLRPDTS--SLDCAPSIIACMRTCWEEDPELRPDLRF 182 (423)
Q Consensus 105 ~~s~ksDVyS~Giil~elltg~~Pf~~~~~~~~~i~~~i~~~~~~~p~~~--~~~~~~~l~~Li~~C~~~dP~~RPt~~~ 182 (423)
..++||||+|+...||..|++||.+.. +-..+-.+.. ..|+.. +..++.++.++++.|+-.+|++|-|+.+
T Consensus 207 --~~~ADIWSLGITaIEMAEG~PPYsDIH--PMRAIFMIPT---~PPPTF~KPE~WS~~F~DFi~~CLiK~PE~R~TA~~ 279 (502)
T KOG0574|consen 207 --DTKADIWSLGITAIEMAEGRPPYSDIH--PMRAIFMIPT---KPPPTFKKPEEWSSEFNDFIRSCLIKKPEERKTALR 279 (502)
T ss_pred --chhhhHhhhcchhhhhhcCCCCccccc--ccceeEeccC---CCCCCCCChHhhhhHHHHHHHHHhcCCHHHHHHHHH
Confidence 899999999999999999999997532 1111111111 122221 2457889999999999999999999998
Q ss_pred HHHHHHHHhhhcCCChHHHHH
Q psy1840 183 VHHKLKEMNAGLKANIFDNML 203 (423)
Q Consensus 183 I~~~L~~i~~~~~~~~~d~~~ 203 (423)
+++.- .+......+++..++
T Consensus 280 L~~H~-FiknA~g~~I~~~~I 299 (502)
T KOG0574|consen 280 LCEHT-FIKNAPGCDIMQLMI 299 (502)
T ss_pred Hhhhh-hhcCCCcccHHHHHH
Confidence 87753 333333445554443
|
|
| >KOG0696|consensus | Back alignment and domain information |
|---|
Probab=99.84 E-value=8.1e-21 Score=182.37 Aligned_cols=142 Identities=22% Similarity=0.385 Sum_probs=121.1
Q ss_pred HHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCccEEEeccCCcccccCCCcccccccccCCccccCCccccCCCCC
Q psy1840 25 SISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKAPELLRQPHLP 104 (423)
Q Consensus 25 ~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~ 104 (423)
++-.+..|+.||-|||++||| .||||..||++|.+|++||+|||+++.-. .....+.+++||+-|+|||++...++
T Consensus 452 AvFYAaEiaigLFFLh~kgIi-YRDLKLDNvmLd~eGHiKi~DFGmcKEni--~~~~TTkTFCGTPdYiAPEIi~YqPY- 527 (683)
T KOG0696|consen 452 AVFYAAEIAIGLFFLHSKGII-YRDLKLDNVMLDSEGHIKIADFGMCKENI--FDGVTTKTFCGTPDYIAPEIIAYQPY- 527 (683)
T ss_pred hhhhhHHHHHHhhhhhcCCee-eeeccccceEeccCCceEeeecccccccc--cCCcceeeecCCCcccccceEEeccc-
Confidence 456788999999999999999 99999999999999999999999987432 22233467899999999999987765
Q ss_pred CCCCccchHHHHHHHHHHHhCCCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCchHHHHHHHHHhhhcCCCCCC
Q psy1840 105 RGTQKGDVYSFGLVLYEVIGRQGPWGHLRMTDEEIITSVTQGSGLRPDTSSLDCAPSIIACMRTCWEEDPELRP 178 (423)
Q Consensus 105 ~~s~ksDVyS~Giil~elltg~~Pf~~~~~~~~~i~~~i~~~~~~~p~~~~~~~~~~l~~Li~~C~~~dP~~RP 178 (423)
+.++|-||||++||||+.|+.||.+ .+.+++.+.+.......|. ..+.+...+.+..+...|.+|.
T Consensus 528 --gksvDWWa~GVLLyEmlaGQpPFdG--eDE~elF~aI~ehnvsyPK----slSkEAv~ickg~ltK~P~kRL 593 (683)
T KOG0696|consen 528 --GKSVDWWAFGVLLYEMLAGQPPFDG--EDEDELFQAIMEHNVSYPK----SLSKEAVAICKGLLTKHPGKRL 593 (683)
T ss_pred --ccchhHHHHHHHHHHHHcCCCCCCC--CCHHHHHHHHHHccCcCcc----cccHHHHHHHHHHhhcCCcccc
Confidence 9999999999999999999999985 4567888888775544443 4688999999999999999995
|
|
| >KOG0984|consensus | Back alignment and domain information |
|---|
Probab=99.84 E-value=2.6e-21 Score=170.87 Aligned_cols=115 Identities=21% Similarity=0.284 Sum_probs=90.5
Q ss_pred HHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCccEEEeccCCcccccCCCcccccccccCCccccCCccccCCC-CCC
Q psy1840 27 SVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKAPELLRQPH-LPR 105 (423)
Q Consensus 27 ~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~-~~~ 105 (423)
+|+..++.||.|||++=-++|||+||+||||+.+|.||+||||++..+.++... +...|...|||||.+..+. ...
T Consensus 152 kIa~Svv~al~~L~~kL~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~dSiAk---t~daGCkpYmaPEri~~e~n~~g 228 (282)
T KOG0984|consen 152 KIAVSVVHALEFLHSKLSVIHRDVKPSNILINYDGQVKICDFGISGYLVDSIAK---TMDAGCKPYMAPERINPELNQKG 228 (282)
T ss_pred HhHHHHHHHHHHHHHHhhhhhccCCcceEEEccCCcEEEcccccceeehhhhHH---HHhcCCCccCChhhcCcccCccc
Confidence 789999999999999843449999999999999999999999998876544321 2245667899999987543 224
Q ss_pred CCCccchHHHHHHHHHHHhCCCCCCCCCCChHHHHHHHhc
Q psy1840 106 GTQKGDVYSFGLVLYEVIGRQGPWGHLRMTDEEIITSVTQ 145 (423)
Q Consensus 106 ~s~ksDVyS~Giil~elltg~~Pf~~~~~~~~~i~~~i~~ 145 (423)
++-++||||||+.+.||.+++.||..... +-+.+.++..
T Consensus 229 Y~vksDvWSLGItmiElA~lr~PY~~w~t-pF~qLkqvVe 267 (282)
T KOG0984|consen 229 YSVKSDVWSLGITMIEMAILRFPYESWGT-PFQQLKQVVE 267 (282)
T ss_pred ceeehhhhhhhhhhhhhhhccccccccCC-HHHHHHHHhc
Confidence 58899999999999999999999986544 4444444433
|
|
| >KOG0610|consensus | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.6e-20 Score=180.79 Aligned_cols=151 Identities=18% Similarity=0.267 Sum_probs=121.0
Q ss_pred HHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCccEEEeccCCcccccC-------C----------------------
Q psy1840 27 SVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAG-------Q---------------------- 77 (423)
Q Consensus 27 ~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~-------~---------------------- 77 (423)
-.+..++.||+|||-.||| .|||||+||||-.+|++-|+||.++..... .
T Consensus 183 FYaAEvl~ALEYLHmlGiv-YRDLKPENILvredGHIMLsDFDLS~~~~~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r 261 (459)
T KOG0610|consen 183 FYAAEVLLALEYLHMLGIV-YRDLKPENILVREDGHIMLSDFDLSLRCPVSPTLVKSSSPRSSGSQPSCRSRQPSCFSPR 261 (459)
T ss_pred HHHHHHHHHHHHHHhhcee-eccCCcceeEEecCCcEEeeeccccccCCCCCeeeccCCCCCCCCCcccccccccccccc
Confidence 4588999999999999999 999999999999999999999988532110 0
Q ss_pred ---C-c---------------------ccccccccCCccccCCccccCCCCCCCCCccchHHHHHHHHHHHhCCCCCCCC
Q psy1840 78 ---D-E---------------------TGQERKLRRRKLYKAPELLRQPHLPRGTQKGDVYSFGLVLYEVIGRQGPWGHL 132 (423)
Q Consensus 78 ---~-~---------------------~~~~~~~~gt~~y~APE~l~~~~~~~~s~ksDVyS~Giil~elltg~~Pf~~~ 132 (423)
. . ......+.||-.|.|||+++|... +.++|-|+|||++|||++|..||.+
T Consensus 262 ~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~GH---gsAVDWWtfGIflYEmLyG~TPFKG- 337 (459)
T KOG0610|consen 262 CLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEGH---GSAVDWWTFGIFLYEMLYGTTPFKG- 337 (459)
T ss_pred hhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCCC---CchhhHHHHHHHHHHHHhCCCCcCC-
Confidence 0 0 001134567778999999998776 8999999999999999999999975
Q ss_pred CCChHHHHHHHhcCCCCCCCCCCCCchHHHHHHHHHhhhcCCCCCCC----HHHHHH
Q psy1840 133 RMTDEEIITSVTQGSGLRPDTSSLDCAPSIIACMRTCWEEDPELRPD----LRFVHH 185 (423)
Q Consensus 133 ~~~~~~i~~~i~~~~~~~p~~~~~~~~~~l~~Li~~C~~~dP~~RPt----~~~I~~ 185 (423)
.+.++.+.+|.......|..+ ..+..+.+||++.|.+||.+|.. +.+|.+
T Consensus 338 -~~~~~Tl~NIv~~~l~Fp~~~--~vs~~akDLIr~LLvKdP~kRlg~~rGA~eIK~ 391 (459)
T KOG0610|consen 338 -SNNKETLRNIVGQPLKFPEEP--EVSSAAKDLIRKLLVKDPSKRLGSKRGAAEIKR 391 (459)
T ss_pred -CCchhhHHHHhcCCCcCCCCC--cchhHHHHHHHHHhccChhhhhccccchHHhhc
Confidence 344666777776655556544 56789999999999999999987 677755
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.84 E-value=8.8e-21 Score=212.07 Aligned_cols=158 Identities=20% Similarity=0.300 Sum_probs=114.2
Q ss_pred HHHHHHHHHHHHHHHH---hCCCeeecCCCCCCEEEcCCccEEEeccCCcccccCCCcccccccccCCccccCCccccCC
Q psy1840 25 SISVNTTASVGMIHLH---DSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKAPELLRQP 101 (423)
Q Consensus 25 ~l~i~~qi~~gL~yLH---~~~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~ 101 (423)
+.+++.|++.||+||| +.+++ ||||||+||+++.++.+++. ||........ ....++..|+|||++.+.
T Consensus 782 ~~~i~~~ia~~L~yLH~~~~~~ii-H~dlkp~Nil~~~~~~~~~~-~~~~~~~~~~------~~~~~t~~y~aPE~~~~~ 853 (968)
T PLN00113 782 RRKIAIGIAKALRFLHCRCSPAVV-VGNLSPEKIIIDGKDEPHLR-LSLPGLLCTD------TKCFISSAYVAPETRETK 853 (968)
T ss_pred HHHHHHHHHHHHHHhccCCCCCee-cCCCCHHhEEECCCCceEEE-eccccccccC------CCccccccccCcccccCC
Confidence 7899999999999999 55777 99999999999999888876 6654332111 223567889999999876
Q ss_pred CCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCChHHHHHHHh---cCC----CCCCCC-----CCCCchHHHHHHHHHh
Q psy1840 102 HLPRGTQKGDVYSFGLVLYEVIGRQGPWGHLRMTDEEIITSVT---QGS----GLRPDT-----SSLDCAPSIIACMRTC 169 (423)
Q Consensus 102 ~~~~~s~ksDVyS~Giil~elltg~~Pf~~~~~~~~~i~~~i~---~~~----~~~p~~-----~~~~~~~~l~~Li~~C 169 (423)
.+ +.++|||||||++|||++|+.||.........+..... ... ...|.. .......++.+++.+|
T Consensus 854 ~~---~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C 930 (968)
T PLN00113 854 DI---TEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLDMWIDPSIRGDVSVNQNEIVEVMNLALHC 930 (968)
T ss_pred CC---CcccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhcCccchhheeCccccCCCCccHHHHHHHHHHHHhh
Confidence 55 89999999999999999999998532211112222111 000 001111 0112334678899999
Q ss_pred hhcCCCCCCCHHHHHHHHHHHhhh
Q psy1840 170 WEEDPELRPDLRFVHHKLKEMNAG 193 (423)
Q Consensus 170 ~~~dP~~RPt~~~I~~~L~~i~~~ 193 (423)
|+.||++||++.+|++.|+.+...
T Consensus 931 l~~~P~~RPt~~evl~~L~~~~~~ 954 (968)
T PLN00113 931 TATDPTARPCANDVLKTLESASRS 954 (968)
T ss_pred CcCCchhCcCHHHHHHHHHHhhcc
Confidence 999999999999999999887653
|
|
| >KOG0666|consensus | Back alignment and domain information |
|---|
Probab=99.83 E-value=6.6e-21 Score=177.39 Aligned_cols=158 Identities=20% Similarity=0.223 Sum_probs=114.0
Q ss_pred HHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCC----ccEEEeccCCcccccCCCccc-ccccccCCccccCCccccC
Q psy1840 26 ISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSR----WVLQIADFGLHAFKAGQDETG-QERKLRRRKLYKAPELLRQ 100 (423)
Q Consensus 26 l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~----~~vKL~DFGla~~~~~~~~~~-~~~~~~gt~~y~APE~l~~ 100 (423)
-+|+.||+.|+.|||++=++ ||||||.||||..+ |.|||+|+|+++.....-... ......-|.+|.|||.+.|
T Consensus 135 KsilwQil~Gv~YLH~NWvl-HRDLKPaNIlvmgdgperG~VKIaDlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLG 213 (438)
T KOG0666|consen 135 KSILWQILDGVHYLHSNWVL-HRDLKPANILVMGDGPERGRVKIADLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLG 213 (438)
T ss_pred HHHHHHHHhhhHHHhhhhee-eccCCcceEEEeccCCccCeeEeecccHHHHhhccccccccCCceEEEEEecChHHhcc
Confidence 48999999999999998666 99999999999877 999999999999765543332 3345667889999999998
Q ss_pred CCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCC--------ChHHHHHHHhc--CC---CCC------CCC--------
Q psy1840 101 PHLPRGTQKGDVYSFGLVLYEVIGRQGPWGHLRM--------TDEEIITSVTQ--GS---GLR------PDT-------- 153 (423)
Q Consensus 101 ~~~~~~s~ksDVyS~Giil~elltg~~Pf~~~~~--------~~~~i~~~i~~--~~---~~~------p~~-------- 153 (423)
.. .+|.+.||||.|||+.||++-++-|.+... ...+ +.++-. |- ... |..
T Consensus 214 a~--hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQ-l~rIf~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~ 290 (438)
T KOG0666|consen 214 AR--HYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQ-LDRIFEVLGTPTDKDWPDLKKMPEYQTLLSDFR 290 (438)
T ss_pred cc--cccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHH-HHHHHHHcCCCccccchhhhhCcchHHHHHHhH
Confidence 76 459999999999999999998766643210 0011 111110 00 000 000
Q ss_pred ----C----------CCCchHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q psy1840 154 ----S----------SLDCAPSIIACMRTCWEEDPELRPDLRFVHHKL 187 (423)
Q Consensus 154 ----~----------~~~~~~~l~~Li~~C~~~dP~~RPt~~~I~~~L 187 (423)
. ...-++...+|+..++..||-+|.|..+.++..
T Consensus 291 ~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAleh~ 338 (438)
T KOG0666|consen 291 RHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQALEHP 338 (438)
T ss_pred HhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHhccc
Confidence 0 011234578899999999999999999877654
|
|
| >KOG0671|consensus | Back alignment and domain information |
|---|
Probab=99.83 E-value=6.5e-21 Score=181.92 Aligned_cols=161 Identities=23% Similarity=0.313 Sum_probs=117.0
Q ss_pred CCCCCCCChHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcC--------------------CccEEEeccCCccc
Q psy1840 14 NPLSPFNIPIGSISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDS--------------------RWVLQIADFGLHAF 73 (423)
Q Consensus 14 ~p~~~~~~p~~~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~--------------------~~~vKL~DFGla~~ 73 (423)
+.-.||.+.. .-.++.|++++++|||+.+++ |-||||+|||+-+ +..+||+|||-+.+
T Consensus 184 N~y~~fpi~~-ir~m~~QL~~sv~fLh~~kl~-HTDLKPENILfvss~~~~~~~~k~~~~~~r~~ks~~I~vIDFGsAtf 261 (415)
T KOG0671|consen 184 NNYIPFPIDH-IRHMGYQLLESVAFLHDLKLT-HTDLKPENILFVSSEYFKTYNPKKKVCFIRPLKSTAIKVIDFGSATF 261 (415)
T ss_pred CCccccchHH-HHHHHHHHHHHHHHHHhccee-ecCCChheEEEeccceEEEeccCCccceeccCCCcceEEEecCCcce
Confidence 3445665533 358999999999999999998 9999999999821 34689999999876
Q ss_pred ccCCCcccccccccCCccccCCccccCCCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCChHH---HHHHHhcCC---
Q psy1840 74 KAGQDETGQERKLRRRKLYKAPELLRQPHLPRGTQKGDVYSFGLVLYEVIGRQGPWGHLRMTDEE---IITSVTQGS--- 147 (423)
Q Consensus 74 ~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~s~ksDVyS~Giil~elltg~~Pf~~~~~~~~~---i~~~i~~~~--- 147 (423)
..... .....|..|.|||++.+-.+ ++.+||||+||||.|+++|..-|+.-. ..| ..+++....
T Consensus 262 ~~e~h-----s~iVsTRHYRAPEViLgLGw---S~pCDvWSiGCIL~ElytG~~LFqtHe--n~EHLaMMerIlGp~P~~ 331 (415)
T KOG0671|consen 262 DHEHH-----STIVSTRHYRAPEVILGLGW---SQPCDVWSIGCILVELYTGETLFQTHE--NLEHLAMMERILGPIPSR 331 (415)
T ss_pred eccCc-----ceeeeccccCCchheeccCc---CCccCceeeeeEEEEeeccceecccCC--cHHHHHHHHHhhCCCcHH
Confidence 43222 45567888999999999887 999999999999999999999886422 122 222222100
Q ss_pred --------------CC-CCCC---------------------CCCCchHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q psy1840 148 --------------GL-RPDT---------------------SSLDCAPSIIACMRTCWEEDPELRPDLRFVHHK 186 (423)
Q Consensus 148 --------------~~-~p~~---------------------~~~~~~~~l~~Li~~C~~~dP~~RPt~~~I~~~ 186 (423)
.. .|.. .......++.+|+++++..||.+|+|+.|++..
T Consensus 332 mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~fDP~~RiTl~EAL~H 406 (415)
T KOG0671|consen 332 MIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEFDPARRITLREALSH 406 (415)
T ss_pred HhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHccCccccccHHHHhcC
Confidence 00 0000 011123468999999999999999999998764
|
|
| >KOG0669|consensus | Back alignment and domain information |
|---|
Probab=99.83 E-value=6.1e-20 Score=166.58 Aligned_cols=163 Identities=17% Similarity=0.208 Sum_probs=119.0
Q ss_pred HHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCccEEEeccCCcccccCCCcc--cccccccCCccccCCccccCCC
Q psy1840 25 SISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDET--GQERKLRRRKLYKAPELLRQPH 102 (423)
Q Consensus 25 ~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~~--~~~~~~~gt~~y~APE~l~~~~ 102 (423)
.-+++.++.+||.|+|.+.++ |||+|+.|+||+.+|.+||+|||+++.+...... ...+...-|.+|.+||.+.|..
T Consensus 126 Ikk~Mk~Lm~GL~~iHr~kil-HRDmKaaNvLIt~dgilklADFGlar~fs~~~n~~kprytnrvvTLwYrppEllLG~r 204 (376)
T KOG0669|consen 126 IKKVMKGLMNGLYYIHRNKIL-HRDMKAANVLITKDGILKLADFGLARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDR 204 (376)
T ss_pred HHHHHHHHHHHHHHHHHhhHH-hhcccHhhEEEcCCceEEeeccccccceecccccCCCCcccceeeeecCCHHHhhccc
Confidence 347899999999999999998 9999999999999999999999999755433221 1123344588999999998865
Q ss_pred CCCCCCccchHHHHHHHHHHHhCCCCCCCCCCChHHHHHHHh---cC--CCCCCC--------------CC---------
Q psy1840 103 LPRGTQKGDVYSFGLVLYEVIGRQGPWGHLRMTDEEIITSVT---QG--SGLRPD--------------TS--------- 154 (423)
Q Consensus 103 ~~~~s~ksDVyS~Giil~elltg~~Pf~~~~~~~~~i~~~i~---~~--~~~~p~--------------~~--------- 154 (423)
.++++.|||.-|||+.||++|++-+.+.. ....+..+. .. +...|. .+
T Consensus 205 --~yg~~iDiWgAgCimaeMwtrspimqgnt--eqqql~~Is~LcGs~tkevWP~~d~lpL~~sie~ePl~~~~~rkv~n 280 (376)
T KOG0669|consen 205 --EYGPPIDIWGAGCIMAEMWTRSPIMQGNT--EQQQLHLISQLCGSITKEVWPNVDNLPLYQSIELEPLPKGQKRKVKN 280 (376)
T ss_pred --ccCCcchhHhHHHHHHHHHccCccccCCh--HHHHHHHHHHHhccCCcccCCCcccchHHHhccCCCCCcchhhhhhh
Confidence 45999999999999999999998886432 222222222 10 000000 00
Q ss_pred ---CCCchHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHhh
Q psy1840 155 ---SLDCAPSIIACMRTCWEEDPELRPDLRFVHHKLKEMNA 192 (423)
Q Consensus 155 ---~~~~~~~l~~Li~~C~~~dP~~RPt~~~I~~~L~~i~~ 192 (423)
+..-.++..+|+..++..||.+|++.++++..--....
T Consensus 281 ~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh~~F~kd 321 (376)
T KOG0669|consen 281 RLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNHDFFWKD 321 (376)
T ss_pred hcccccCChhHHHHHHHHhccCcccCcchHhhhchhhhhcC
Confidence 01123478899999999999999999999887655544
|
|
| >KOG0664|consensus | Back alignment and domain information |
|---|
Probab=99.82 E-value=1.6e-20 Score=172.06 Aligned_cols=155 Identities=24% Similarity=0.315 Sum_probs=111.1
Q ss_pred HHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCccEEEeccCCcccccCCCcccccccccCCccccCCccccCCCCCCC
Q psy1840 27 SVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKAPELLRQPHLPRG 106 (423)
Q Consensus 27 ~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~ 106 (423)
-+++||+.||.|||+.+|. ||||||.|.|++++-.+||||||+++...... ....+...-|..|.|||++.|.. .+
T Consensus 160 VFlYQILRGLKYLHsA~IL-HRDIKPGNLLVNSNCvLKICDFGLARvee~d~-~~hMTqEVVTQYYRAPEiLMGaR--hY 235 (449)
T KOG0664|consen 160 VFVYQILRGLKYLHTANIL-HRDIKPGNLLVNSNCILKICDFGLARTWDQRD-RLNMTHEVVTQYYRAPELLMGAR--RY 235 (449)
T ss_pred hhHHHHHhhhHHHhhcchh-hccCCCccEEeccCceEEecccccccccchhh-hhhhHHHHHHHHhccHHHhhcch--hh
Confidence 4789999999999999998 99999999999999999999999998654332 22223344567799999999875 45
Q ss_pred CCccchHHHHHHHHHHHhCCCCCCCCCC-ChHHHH--------------------HHHhcCCCCCCCCC-------CCCc
Q psy1840 107 TQKGDVYSFGLVLYEVIGRQGPWGHLRM-TDEEII--------------------TSVTQGSGLRPDTS-------SLDC 158 (423)
Q Consensus 107 s~ksDVyS~Giil~elltg~~Pf~~~~~-~~~~i~--------------------~~i~~~~~~~p~~~-------~~~~ 158 (423)
+.+.||||.|||+.|++.++.-|...+. ..-+++ ..+.++....|..+ ....
T Consensus 236 s~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~ACEGAk~H~LR~~~k~Ps~~vLYtlsS~~~~ 315 (449)
T KOG0664|consen 236 TGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYACEGAKNHVLRAGLRAPDTQRLYKIASPDDK 315 (449)
T ss_pred cCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHHhhhhHHHhhccCCCCCCccceeeecCCccc
Confidence 9999999999999999998877753211 001111 11112222223222 1233
Q ss_pred hHHHHHHHHHhhhcCCCCCCCHHHHHH
Q psy1840 159 APSIIACMRTCWEEDPELRPDLRFVHH 185 (423)
Q Consensus 159 ~~~l~~Li~~C~~~dP~~RPt~~~I~~ 185 (423)
..+...+...++..||++|.+..+.+.
T Consensus 316 ~heav~~~~~~l~~d~dkris~~~A~~ 342 (449)
T KOG0664|consen 316 NHEAVDLLQKLLHFDPDKRISVEEALQ 342 (449)
T ss_pred chHHHHHHHHHhCCCCcccccHhhhcc
Confidence 446677888899999999988776554
|
|
| >KOG4236|consensus | Back alignment and domain information |
|---|
Probab=99.81 E-value=4.8e-21 Score=188.62 Aligned_cols=148 Identities=22% Similarity=0.330 Sum_probs=129.9
Q ss_pred HHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCC---ccEEEeccCCcccccCCCcccccccccCCccccCCccccCCCC
Q psy1840 27 SVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSR---WVLQIADFGLHAFKAGQDETGQERKLRRRKLYKAPELLRQPHL 103 (423)
Q Consensus 27 ~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~---~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~ 103 (423)
-++.||+.+|.|||-++|+ |+||||+|||+.+. -.+||||||+++++.... -.....||+.|+|||+++.+.+
T Consensus 668 FlvtQIL~ALr~LH~knIv-HCDLKPENVLLas~~~FPQvKlCDFGfARiIgEks---FRrsVVGTPAYLaPEVLrnkGy 743 (888)
T KOG4236|consen 668 FLVTQILVALRYLHFKNIV-HCDLKPENVLLASASPFPQVKLCDFGFARIIGEKS---FRRSVVGTPAYLAPEVLRNKGY 743 (888)
T ss_pred HHHHHHHHHHHHhhhccee-eccCCchheeeccCCCCCceeeccccceeecchhh---hhhhhcCCccccCHHHHhhccc
Confidence 4678999999999999998 99999999999643 479999999999875443 2256789999999999999877
Q ss_pred CCCCCccchHHHHHHHHHHHhCCCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCchHHHHHHHHHhhhcCCCCCCCHHHH
Q psy1840 104 PRGTQKGDVYSFGLVLYEVIGRQGPWGHLRMTDEEIITSVTQGSGLRPDTSSLDCAPSIIACMRTCWEEDPELRPDLRFV 183 (423)
Q Consensus 104 ~~~s~ksDVyS~Giil~elltg~~Pf~~~~~~~~~i~~~i~~~~~~~p~~~~~~~~~~l~~Li~~C~~~dP~~RPt~~~I 183 (423)
+.+-|+||.|+|+|--++|..||.. ++++-.++.......|+.++..++++..+||...++..-.+|-+....
T Consensus 744 ---NrSLDMWSVGVIiYVsLSGTFPFNE----dEdIndQIQNAaFMyPp~PW~eis~~AidlIn~LLqVkm~kRysvdk~ 816 (888)
T KOG4236|consen 744 ---NRSLDMWSVGVIIYVSLSGTFPFNE----DEDINDQIQNAAFMYPPNPWSEISPEAIDLINNLLQVKMRKRYSVDKS 816 (888)
T ss_pred ---cccccceeeeEEEEEEecccccCCC----ccchhHHhhccccccCCCchhhcCHHHHHHHHHHHHHHHHHhcchHhh
Confidence 8999999999999999999999964 477888888888888988889999999999999999999999998766
Q ss_pred HH
Q psy1840 184 HH 185 (423)
Q Consensus 184 ~~ 185 (423)
+.
T Consensus 817 ls 818 (888)
T KOG4236|consen 817 LS 818 (888)
T ss_pred cc
Confidence 54
|
|
| >KOG1151|consensus | Back alignment and domain information |
|---|
Probab=99.80 E-value=8.9e-20 Score=176.56 Aligned_cols=157 Identities=22% Similarity=0.293 Sum_probs=119.9
Q ss_pred HHHHHHHHHHHHHHHHhC-CCeeecCCCCCCEEEc---CCccEEEeccCCcccccCCCccc-----ccccccCCccccCC
Q psy1840 25 SISVNTTASVGMIHLHDS-EIISHGNLRSSNCLID---SRWVLQIADFGLHAFKAGQDETG-----QERKLRRRKLYKAP 95 (423)
Q Consensus 25 ~l~i~~qi~~gL~yLH~~-~ii~HrDLkp~NILld---~~~~vKL~DFGla~~~~~~~~~~-----~~~~~~gt~~y~AP 95 (423)
+-+|+.||+.+|.||... ..|+|-||||.|||+- ..|.+||+|||+++...+..... .+....||.+|++|
T Consensus 570 ARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILLv~GtacGeIKITDFGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPP 649 (775)
T KOG1151|consen 570 ARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLVNGTACGEIKITDFGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPP 649 (775)
T ss_pred HHHHHHHHHHHHHHHhccCCCeeeeccCCccEEEecCcccceeEeeecchhhhccCCccCcccceeeecccCceeeecCc
Confidence 569999999999999875 3445999999999994 46889999999999876554332 23456799999999
Q ss_pred ccccCC-CCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCChHHHHHHHh--c-CCCCCCCCCCCCchHHHHHHHHHhhh
Q psy1840 96 ELLRQP-HLPRGTQKGDVYSFGLVLYEVIGRQGPWGHLRMTDEEIITSVT--Q-GSGLRPDTSSLDCAPSIIACMRTCWE 171 (423)
Q Consensus 96 E~l~~~-~~~~~s~ksDVyS~Giil~elltg~~Pf~~~~~~~~~i~~~i~--~-~~~~~p~~~~~~~~~~l~~Li~~C~~ 171 (423)
|.+.-+ ..++.+.|+||||.|||+|..+.|+.||++. .+...+++.-. . ..-..|.- ..++.+...+|++||+
T Consensus 650 EcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhn-qsQQdILqeNTIlkAtEVqFP~K--PvVsseAkaFIRRCLa 726 (775)
T KOG1151|consen 650 ECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHN-QSQQDILQENTILKATEVQFPPK--PVVSSEAKAFIRRCLA 726 (775)
T ss_pred ceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCc-hhHHHHHhhhchhcceeccCCCC--CccCHHHHHHHHHHHH
Confidence 988643 4557799999999999999999999999864 33444444321 1 11122222 2467899999999999
Q ss_pred cCCCCCCCHHHHH
Q psy1840 172 EDPELRPDLRFVH 184 (423)
Q Consensus 172 ~dP~~RPt~~~I~ 184 (423)
+.-++|.+..++.
T Consensus 727 YRKeDR~DV~qLA 739 (775)
T KOG1151|consen 727 YRKEDRIDVQQLA 739 (775)
T ss_pred hhhhhhhhHHHHc
Confidence 9999998877664
|
|
| >KOG0586|consensus | Back alignment and domain information |
|---|
Probab=99.80 E-value=3.1e-20 Score=186.74 Aligned_cols=150 Identities=21% Similarity=0.276 Sum_probs=124.9
Q ss_pred HHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCccEEEeccCCcccccCCCcccccccccCCccccCCccccCCCCC
Q psy1840 25 SISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKAPELLRQPHLP 104 (423)
Q Consensus 25 ~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~ 104 (423)
+-....|++++++|||+++++ |||||.+|++|+.+.++||+|||++.++... ....+.+|++.|.|||++.+..+
T Consensus 157 ar~~F~q~vsaveYcH~k~iv-HrdLk~eNilL~~~mnikIaDfgfS~~~~~~---~~lqt~cgsppyAaPEl~~g~~y- 231 (596)
T KOG0586|consen 157 ARAKFRQIVSAVEYCHSKNIV-HRDLKAENILLDENMNIKIADFGFSTFFDYG---LMLQTFCGSPPYAAPELFNGKKY- 231 (596)
T ss_pred hhhhhHHHHHHHHHHhhccee-ccccchhhcccccccceeeeccccceeeccc---ccccccCCCCCccChHhhcCccc-
Confidence 446788999999999999998 9999999999999999999999999877522 23467899999999999998774
Q ss_pred CCCCccchHHHHHHHHHHHhCCCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCchHHHHHHHHHhhhcCCCCCCCHHHHH
Q psy1840 105 RGTQKGDVYSFGLVLYEVIGRQGPWGHLRMTDEEIITSVTQGSGLRPDTSSLDCAPSIIACMRTCWEEDPELRPDLRFVH 184 (423)
Q Consensus 105 ~~s~ksDVyS~Giil~elltg~~Pf~~~~~~~~~i~~~i~~~~~~~p~~~~~~~~~~l~~Li~~C~~~dP~~RPt~~~I~ 184 (423)
.++.+|+||+|+++|-|+.|..||++. +..++-.++..++..-|. ..+.+..+++.+++-.+|.+|+++++|.
T Consensus 232 -~gpe~D~Wslgvvly~LV~GsLPFDG~--~lk~Lr~rvl~gk~rIp~----~ms~dce~lLrk~lvl~Pskr~~~dqim 304 (596)
T KOG0586|consen 232 -DGPEVDIWSLGVVLYALVEGSLPFDGQ--NLKELRPRVLRGKYRIPF----YMSCDCEDLLRKFLVLNPSKRGPCDQIM 304 (596)
T ss_pred -CCcceehhhhhhhheeeeecccccCCc--ccccccchheeeeecccc----eeechhHHHHHHhhccCccccCCHHHhh
Confidence 489999999999999999999999853 335555566665544333 3466788999999999999999999986
Q ss_pred HH
Q psy1840 185 HK 186 (423)
Q Consensus 185 ~~ 186 (423)
+.
T Consensus 305 ~~ 306 (596)
T KOG0586|consen 305 KD 306 (596)
T ss_pred hh
Confidence 53
|
|
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=99.80 E-value=3.2e-19 Score=191.35 Aligned_cols=93 Identities=18% Similarity=0.269 Sum_probs=75.0
Q ss_pred CCccccCCccccCCCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCchHHHHHHHH
Q psy1840 88 RRKLYKAPELLRQPHLPRGTQKGDVYSFGLVLYEVIGRQGPWGHLRMTDEEIITSVTQGSGLRPDTSSLDCAPSIIACMR 167 (423)
Q Consensus 88 gt~~y~APE~l~~~~~~~~s~ksDVyS~Giil~elltg~~Pf~~~~~~~~~i~~~i~~~~~~~p~~~~~~~~~~l~~Li~ 167 (423)
||+.|+|||++.+..+ +.++|||||||++|||++|..||.. ....++...+.......|... ..++..+.+++.
T Consensus 542 GT~~Y~APE~l~~~~~---~~~~DiwSlG~il~ElltG~~pf~~--~~~~~~~~~il~~~~~~p~~~-~~~~~~~~~~l~ 615 (669)
T cd05610 542 GTPDYLAPELLLGKPH---GPAVDWWALGVCLFEFLTGIPPFND--ETPQQVFQNILNRDIPWPEGE-EKLSVNAQNAIE 615 (669)
T ss_pred eCccccCHHHcCCCCC---CcHHHHHHHHHHHHHHHHCCCCCCC--CCHHHHHHHHHhcCCCCCccc-ccCCHHHHHHHH
Confidence 4778999999987655 8999999999999999999999964 445666666655443333332 357888999999
Q ss_pred HhhhcCCCCCCCHHHHHHH
Q psy1840 168 TCWEEDPELRPDLRFVHHK 186 (423)
Q Consensus 168 ~C~~~dP~~RPt~~~I~~~ 186 (423)
.||..||.+||++.+++..
T Consensus 616 ~lL~~dP~~R~ta~e~l~h 634 (669)
T cd05610 616 ILLTMDPTKRAGLKELKQH 634 (669)
T ss_pred HHcccChhHCcCHHHHHhC
Confidence 9999999999999999875
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >KOG0612|consensus | Back alignment and domain information |
|---|
Probab=99.80 E-value=1.8e-19 Score=191.03 Aligned_cols=161 Identities=19% Similarity=0.250 Sum_probs=123.3
Q ss_pred CC-ChHHH-HHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCccEEEeccCCcccccCCCcccccccccCCccccCCc
Q psy1840 19 FN-IPIGS-ISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKAPE 96 (423)
Q Consensus 19 ~~-~p~~~-l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE 96 (423)
|. +|++- .-.+..|+.||.-||+.|.| ||||||+|||||.+|++||+|||-+-..... .........|||-|.+||
T Consensus 169 ~~~~pE~~ArFY~aEiVlAldslH~mgyV-HRDiKPDNvLld~~GHikLADFGsClkm~~d-G~V~s~~aVGTPDYISPE 246 (1317)
T KOG0612|consen 169 FDRLPEDWARFYTAEIVLALDSLHSMGYV-HRDIKPDNVLLDKSGHIKLADFGSCLKMDAD-GTVRSSVAVGTPDYISPE 246 (1317)
T ss_pred cCCChHHHHHHHHHHHHHHHHHHHhccce-eccCCcceeEecccCcEeeccchhHHhcCCC-CcEEeccccCCCCccCHH
Confidence 44 56653 34578999999999999999 9999999999999999999999986554322 233346678999999999
Q ss_pred cccCCC--CCCCCCccchHHHHHHHHHHHhCCCCCCCCCCChHHHHHHHhcC--CCCCCCCCCCCchHHHHHHHHHhhhc
Q psy1840 97 LLRQPH--LPRGTQKGDVYSFGLVLYEVIGRQGPWGHLRMTDEEIITSVTQG--SGLRPDTSSLDCAPSIIACMRTCWEE 172 (423)
Q Consensus 97 ~l~~~~--~~~~s~ksDVyS~Giil~elltg~~Pf~~~~~~~~~i~~~i~~~--~~~~p~~~~~~~~~~l~~Li~~C~~~ 172 (423)
+++... ...++..+|.||+||++|||+.|..||+. .+..+-..+|... ....|. ..+++++..+||.+.+ -
T Consensus 247 vLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYa--dslveTY~KIm~hk~~l~FP~--~~~VSeeakdLI~~ll-~ 321 (1317)
T KOG0612|consen 247 VLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYA--DSLVETYGKIMNHKESLSFPD--ETDVSEEAKDLIEALL-C 321 (1317)
T ss_pred HHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchH--HHHHHHHHHHhchhhhcCCCc--ccccCHHHHHHHHHHh-c
Confidence 997432 24669999999999999999999999973 2334445555543 223342 2358999999999888 4
Q ss_pred CCCCCCC---HHHHHHH
Q psy1840 173 DPELRPD---LRFVHHK 186 (423)
Q Consensus 173 dP~~RPt---~~~I~~~ 186 (423)
+|+.|.. +.+|..+
T Consensus 322 ~~e~RLgrngiedik~H 338 (1317)
T KOG0612|consen 322 DREVRLGRNGIEDIKNH 338 (1317)
T ss_pred ChhhhcccccHHHHHhC
Confidence 6888877 8887664
|
|
| >KOG0607|consensus | Back alignment and domain information |
|---|
Probab=99.80 E-value=2.6e-19 Score=167.33 Aligned_cols=160 Identities=19% Similarity=0.217 Sum_probs=126.9
Q ss_pred HHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCc---cEEEeccCCcccccCCC-----cccccccccCCccccCCc
Q psy1840 25 SISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRW---VLQIADFGLHAFKAGQD-----ETGQERKLRRRKLYKAPE 96 (423)
Q Consensus 25 ~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~---~vKL~DFGla~~~~~~~-----~~~~~~~~~gt~~y~APE 96 (423)
+-.+..+|+.||.|||.+||. ||||||+|||-.+.. -+|||||.+..-..... ......+.+|+..|||||
T Consensus 178 As~vvkdia~aLdFlH~kgIA-HRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~~spastP~L~tPvGSAEfMAPE 256 (463)
T KOG0607|consen 178 ASRVVKDIASALDFLHTKGIA-HRDLKPENILCESPNKVSPVKICDFDLGSGIKLNNDCSPASTPELLTPVGSAEFMAPE 256 (463)
T ss_pred HHHHHHHHHHHHHHHhhcCcc-cccCCccceeecCCCCcCceeeeccccccccccCCCCCCCCCccccCcccchhhcchh
Confidence 568999999999999999998 999999999996544 48999998854322111 112234567788899999
Q ss_pred cccCC--CCCCCCCccchHHHHHHHHHHHhCCCCCCCCC-------------CChHHHHHHHhcCCCCCCCCCCCCchHH
Q psy1840 97 LLRQP--HLPRGTQKGDVYSFGLVLYEVIGRQGPWGHLR-------------MTDEEIITSVTQGSGLRPDTSSLDCAPS 161 (423)
Q Consensus 97 ~l~~~--~~~~~s~ksDVyS~Giil~elltg~~Pf~~~~-------------~~~~~i~~~i~~~~~~~p~~~~~~~~~~ 161 (423)
+..-- ....+..++|.||||+|+|-|++|..||.+.. ...+.+.+.|..|....|...+..++.+
T Consensus 257 VVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~Cr~CQ~~LFesIQEGkYeFPdkdWahIS~e 336 (463)
T KOG0607|consen 257 VVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSE 336 (463)
T ss_pred HHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCCccHHHHHHHHHHHhccCCcCChhhhHHhhHH
Confidence 87531 12245899999999999999999999995421 1235678889999999998888889999
Q ss_pred HHHHHHHhhhcCCCCCCCHHHHHH
Q psy1840 162 IIACMRTCWEEDPELRPDLRFVHH 185 (423)
Q Consensus 162 l~~Li~~C~~~dP~~RPt~~~I~~ 185 (423)
..+++...+..++.+|-++.+++.
T Consensus 337 akdlisnLlvrda~~rlsa~~vln 360 (463)
T KOG0607|consen 337 AKDLISNLLVRDAKQRLSAAQVLN 360 (463)
T ss_pred HHHHHHHHHhccHHhhhhhhhccC
Confidence 999999999999999988887765
|
|
| >KOG0665|consensus | Back alignment and domain information |
|---|
Probab=99.79 E-value=2.2e-19 Score=167.95 Aligned_cols=153 Identities=23% Similarity=0.277 Sum_probs=113.0
Q ss_pred HHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCccEEEeccCCcccccCCCcccccccccCCccccCCccccCCCCCCC
Q psy1840 27 SVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKAPELLRQPHLPRG 106 (423)
Q Consensus 27 ~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~ 106 (423)
.+..|++.|+.|||+.||+ ||||||+||++..+..+||.|||+++..... ...+....+..|.|||++.+..+
T Consensus 122 ~i~yq~~~~ik~lhs~~Ii-hRdLkPsnivv~~~~~lKi~dfg~ar~e~~~---~~mtpyVvtRyyrapevil~~~~--- 194 (369)
T KOG0665|consen 122 YILYQMLCGIKHLHSAGII-HRDLKPSNIVVNSDCTLKILDFGLARTEDTD---FMMTPYVVTRYYRAPEVILGMGY--- 194 (369)
T ss_pred HHHHHHHHHHHHHHhccee-ecccCcccceecchhheeeccchhhcccCcc---cccCchhheeeccCchheeccCC---
Confidence 7899999999999999998 9999999999999999999999998753222 22345667888999999998765
Q ss_pred CCccchHHHHHHHHHHHhCCCCCCCCCC-------------ChHHHHHHHhc-------------C---CCCCCC-----
Q psy1840 107 TQKGDVYSFGLVLYEVIGRQGPWGHLRM-------------TDEEIITSVTQ-------------G---SGLRPD----- 152 (423)
Q Consensus 107 s~ksDVyS~Giil~elltg~~Pf~~~~~-------------~~~~i~~~i~~-------------~---~~~~p~----- 152 (423)
...+||||.||++.||++|..-|.+... .+.....++.. + ....|+
T Consensus 195 ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~qL~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~ 274 (369)
T KOG0665|consen 195 KENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMKQLQPTVRNYVENRPQYQAISFSELFPDSLFPV 274 (369)
T ss_pred cccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHHHHhhHHHHHHhhcChHhhccchhhhCCcccccc
Confidence 8899999999999999999988764311 11111111110 0 000111
Q ss_pred C-CCC-CchHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q psy1840 153 T-SSL-DCAPSIIACMRTCWEEDPELRPDLRFVHHK 186 (423)
Q Consensus 153 ~-~~~-~~~~~l~~Li~~C~~~dP~~RPt~~~I~~~ 186 (423)
. ... .-...+.+++.+||..||++|.++.+++..
T Consensus 275 ~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~H 310 (369)
T KOG0665|consen 275 VLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRH 310 (369)
T ss_pred cccCCccchHHHHHHHHHhhccChhhcccHHHHhcC
Confidence 0 011 123457889999999999999999998764
|
|
| >KOG0695|consensus | Back alignment and domain information |
|---|
Probab=99.79 E-value=6.9e-19 Score=165.28 Aligned_cols=149 Identities=19% Similarity=0.345 Sum_probs=114.7
Q ss_pred ChHHHH-HHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCccEEEeccCCcccccCCCcccccccccCCccccCCcccc
Q psy1840 21 IPIGSI-SVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKAPELLR 99 (423)
Q Consensus 21 ~p~~~l-~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~ 99 (423)
+|++.. -....|+.+|.|||++||| .||||..|+|+|..|.+||+|||.++..... ...+.+++||+.|.|||+++
T Consensus 348 lpeeharfys~ei~lal~flh~rgii-yrdlkldnvlldaeghikltdygmcke~l~~--gd~tstfcgtpnyiapeilr 424 (593)
T KOG0695|consen 348 LPEEHARFYSAEICLALNFLHERGII-YRDLKLDNVLLDAEGHIKLTDYGMCKEGLGP--GDTTSTFCGTPNYIAPEILR 424 (593)
T ss_pred CcHHHhhhhhHHHHHHHHHHhhcCee-eeeccccceEEccCCceeecccchhhcCCCC--CcccccccCCCcccchhhhc
Confidence 345533 3467899999999999999 9999999999999999999999998753322 23346889999999999999
Q ss_pred CCCCCCCCCccchHHHHHHHHHHHhCCCCCCCCC-----CChHHHHHHHhcCCCCCCCCCCCCchHHHHHHHHHhhhcCC
Q psy1840 100 QPHLPRGTQKGDVYSFGLVLYEVIGRQGPWGHLR-----MTDEEIITSVTQGSGLRPDTSSLDCAPSIIACMRTCWEEDP 174 (423)
Q Consensus 100 ~~~~~~~s~ksDVyS~Giil~elltg~~Pf~~~~-----~~~~~i~~~i~~~~~~~p~~~~~~~~~~l~~Li~~C~~~dP 174 (423)
+..+ +.+.|-|++|++++||+.|+.||...+ ++.++.+-++.-.+..+.+ ...+-....+++..+++||
T Consensus 425 geey---gfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvilekqirip---rslsvkas~vlkgflnkdp 498 (593)
T KOG0695|consen 425 GEEY---GFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILEKQIRIP---RSLSVKASHVLKGFLNKDP 498 (593)
T ss_pred cccc---CceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhhhccccc---ceeehhhHHHHHHhhcCCc
Confidence 9877 899999999999999999999996432 2333433333322222221 2345567788999999999
Q ss_pred CCCC
Q psy1840 175 ELRP 178 (423)
Q Consensus 175 ~~RP 178 (423)
.+|.
T Consensus 499 ~erl 502 (593)
T KOG0695|consen 499 KERL 502 (593)
T ss_pred HHhc
Confidence 9994
|
|
| >KOG4250|consensus | Back alignment and domain information |
|---|
Probab=99.76 E-value=2.1e-18 Score=175.97 Aligned_cols=168 Identities=20% Similarity=0.332 Sum_probs=119.2
Q ss_pred CCCCChHHH-HHHHHHHHHHHHHHHhCCCeeecCCCCCCEEE----cCCccEEEeccCCcccccCCCcccccccccCCcc
Q psy1840 17 SPFNIPIGS-ISVNTTASVGMIHLHDSEIISHGNLRSSNCLI----DSRWVLQIADFGLHAFKAGQDETGQERKLRRRKL 91 (423)
Q Consensus 17 ~~~~~p~~~-l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILl----d~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~ 91 (423)
--+.+|+.. +.++.+++.||.|||.+||+ ||||||.||++ |+.-.-||+|||.|+.+.+.. ...+..||..
T Consensus 113 N~~GLpE~e~l~lL~d~~~al~~LrEn~Iv-HRDlKP~NIvl~~Gedgq~IyKLtDfG~Arel~d~s---~~~S~vGT~~ 188 (732)
T KOG4250|consen 113 NAYGLPESEFLDLLSDLVSALRHLRENGIV-HRDLKPGNIVLQIGEDGQSIYKLTDFGAARELDDNS---LFTSLVGTEE 188 (732)
T ss_pred cccCCCHHHHHHHHHHHHHHHHHHHHcCce-eccCCCCcEEEeecCCCceEEeeecccccccCCCCC---eeeeecCchh
Confidence 346677764 78999999999999999998 99999999988 344467999999999876544 3467899999
Q ss_pred ccCCccccC-CCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCC--hHHHHHHHhcCCC-------------------C
Q psy1840 92 YKAPELLRQ-PHLPRGTQKGDVYSFGLVLYEVIGRQGPWGHLRMT--DEEIITSVTQGSG-------------------L 149 (423)
Q Consensus 92 y~APE~l~~-~~~~~~s~ksDVyS~Giil~elltg~~Pf~~~~~~--~~~i~~~i~~~~~-------------------~ 149 (423)
|.+||.+.. +.+ +..+|.|||||++|+.+||..||...... ..++...+...++ .
T Consensus 189 YLhPel~E~q~~y---~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~~~~~~~~tkkp~~v~i~~~~~eNgpv~~s~~ 265 (732)
T KOG4250|consen 189 YLHPELYERQKKY---TATVDLWSFGVTLYECATGELPFIPFGGPKNNKEIMWHIITKKPSGVAIGAQEEENGPVEWSST 265 (732)
T ss_pred hcChHHHhhccCc---CceeehhhhhhHHHHHhccCCCCCcCCCccccchhhhhhhccCCCceeEeeecccCCceeeecc
Confidence 999999974 434 89999999999999999999999643222 2234433332110 0
Q ss_pred CCC--CCCCCchHHHHHHHHHhhhcCCCCCC--CHHHHHHHHHHHh
Q psy1840 150 RPD--TSSLDCAPSIIACMRTCWEEDPELRP--DLRFVHHKLKEMN 191 (423)
Q Consensus 150 ~p~--~~~~~~~~~l~~Li~~C~~~dP~~RP--t~~~I~~~L~~i~ 191 (423)
.|. .........+-..+..++..+|.+|- .+.+....+..+.
T Consensus 266 lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~~~~~~~~Fa~~~dIL 311 (732)
T KOG4250|consen 266 LPQPNHLSRGLATRLTKWLASMLEWNPRKRGHEGFDRFFAEVDDIL 311 (732)
T ss_pred CCCcccccHHHHhhhhHHHHHHHhhhHHHhCCCCcchHHHHHHHHH
Confidence 111 00111223455566777888888887 6666655555543
|
|
| >KOG0587|consensus | Back alignment and domain information |
|---|
Probab=99.76 E-value=8.6e-19 Score=182.01 Aligned_cols=155 Identities=19% Similarity=0.323 Sum_probs=123.3
Q ss_pred HHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCccEEEeccCCcccccCCCcccccccccCCccccCCccccCCC--
Q psy1840 25 SISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKAPELLRQPH-- 102 (423)
Q Consensus 25 ~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~-- 102 (423)
..-|+..++.|+.|||.+.+| |||+|-.|||++.++.|||+|||++..+... .....+..||++|||||++....
T Consensus 125 IaYI~re~lrgl~HLH~nkvi-HRDikG~NiLLT~e~~VKLvDFGvSaQldsT--~grRnT~iGtP~WMAPEViac~e~~ 201 (953)
T KOG0587|consen 125 IAYILREILRGLAHLHNNKVI-HRDIKGQNVLLTENAEVKLVDFGVSAQLDST--VGRRNTFIGTPYWMAPEVIACDESP 201 (953)
T ss_pred HHHHHHHHHHHHHHHhhccee-eecccCceEEEeccCcEEEeeeeeeeeeecc--cccccCcCCCcccccceeeecccCC
Confidence 467899999999999999888 9999999999999999999999998765432 23346778999999999997643
Q ss_pred CCCCCCccchHHHHHHHHHHHhCCCCCCCCCCChHHHHHHHhcCCCCCCCCC-CCCchHHHHHHHHHhhhcCCCCCCCHH
Q psy1840 103 LPRGTQKGDVYSFGLVLYEVIGRQGPWGHLRMTDEEIITSVTQGSGLRPDTS-SLDCAPSIIACMRTCWEEDPELRPDLR 181 (423)
Q Consensus 103 ~~~~s~ksDVyS~Giil~elltg~~Pf~~~~~~~~~i~~~i~~~~~~~p~~~-~~~~~~~l~~Li~~C~~~dP~~RPt~~ 181 (423)
-..++..+|+|||||+..||.-|.+|+.+ +.+...+-.+.+.+ +|... +..++.++.++|..|+..|-++||+..
T Consensus 202 d~tyd~R~D~WsLGITaIEladG~PPl~D--mHPmraLF~IpRNP--PPkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~ 277 (953)
T KOG0587|consen 202 DATYDYRSDLWSLGITAIEMAEGAPPLCD--MHPMRALFLIPRNP--PPKLKRPKKWSKKFNDFISTCLVKDYEQRPSTE 277 (953)
T ss_pred CCCcccccchhhccceeehhcCCCCCccC--cchhhhhccCCCCC--CccccchhhHHHHHHHHHHHHHhhccccCcchh
Confidence 22457889999999999999999999864 44433333333322 22222 457889999999999999999999998
Q ss_pred HHHHH
Q psy1840 182 FVHHK 186 (423)
Q Consensus 182 ~I~~~ 186 (423)
++++.
T Consensus 278 ~ll~h 282 (953)
T KOG0587|consen 278 ELLKH 282 (953)
T ss_pred hhccC
Confidence 87653
|
|
| >KOG0668|consensus | Back alignment and domain information |
|---|
Probab=99.75 E-value=8e-18 Score=150.98 Aligned_cols=154 Identities=19% Similarity=0.230 Sum_probs=115.3
Q ss_pred HHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcC-CccEEEeccCCcccccCCCcccccccccCCccccCCccccCCCCCC
Q psy1840 27 SVNTTASVGMIHLHDSEIISHGNLRSSNCLIDS-RWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKAPELLRQPHLPR 105 (423)
Q Consensus 27 ~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~-~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~ 105 (423)
-.+.+++.||.|+|+.||+ |||+||.|++||. .-.++|+|+|++.+.....+.. ....+..|-.||.+..-. .
T Consensus 136 yY~~elLkALdyCHS~GIm-HRDVKPhNvmIdh~~rkLrlIDWGLAEFYHp~~eYn---VRVASRyfKGPELLVdy~--~ 209 (338)
T KOG0668|consen 136 YYIYELLKALDYCHSMGIM-HRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYN---VRVASRYFKGPELLVDYQ--M 209 (338)
T ss_pred HHHHHHHHHHhHHHhcCcc-cccCCcceeeechhhceeeeeecchHhhcCCCceee---eeeehhhcCCchheeech--h
Confidence 4688999999999999999 9999999999995 4579999999998875544332 234456688999998644 4
Q ss_pred CCCccchHHHHHHHHHHHhCCCCCCCCCCChHHHHHHHh------------c-------------CCC-------CCCCC
Q psy1840 106 GTQKGDVYSFGLVLYEVIGRQGPWGHLRMTDEEIITSVT------------Q-------------GSG-------LRPDT 153 (423)
Q Consensus 106 ~s~ksDVyS~Giil~elltg~~Pf~~~~~~~~~i~~~i~------------~-------------~~~-------~~p~~ 153 (423)
+..+-|+|||||++..|+.++.||.+.....+++..-.. . +.. +-+..
T Consensus 210 YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Yl~KY~i~Ldp~~~~i~~~~~rk~w~~Fi~~~ 289 (338)
T KOG0668|consen 210 YDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAYLNKYQIDLDPQFEDILGRHSRKPWSRFINSE 289 (338)
T ss_pred ccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHHHHHHccCCChhHhhHhhccccccHHHhCCcc
Confidence 588899999999999999999999765544444332111 0 000 00111
Q ss_pred CCCCchHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q psy1840 154 SSLDCAPSIIACMRTCWEEDPELRPDLRFVHHK 186 (423)
Q Consensus 154 ~~~~~~~~l~~Li~~C~~~dP~~RPt~~~I~~~ 186 (423)
...-.+++..+++...+..|-.+|+|+.|....
T Consensus 290 n~hl~~peaiDlldklLrYDHqeRlTakEam~H 322 (338)
T KOG0668|consen 290 NQHLVSPEAIDLLDKLLRYDHQERLTAKEAMAH 322 (338)
T ss_pred ccccCChHHHHHHHHHHhhccccccchHHHhcC
Confidence 122356899999999999999999999987653
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.74 E-value=1e-17 Score=172.45 Aligned_cols=158 Identities=16% Similarity=0.089 Sum_probs=108.9
Q ss_pred HHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCccEEEeccCCcccccCCCcccccccccCCccccCCccccCCCCC
Q psy1840 25 SISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKAPELLRQPHLP 104 (423)
Q Consensus 25 ~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~ 104 (423)
...++.|++.||.|||+.+++ ||||||+||+++.++.+||+|||++........ .......+++.|+|||.+......
T Consensus 311 ~~~i~~ql~~aL~~lH~~~iv-HrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~-~~~~~g~~tp~Y~aPE~l~~~~~~ 388 (507)
T PLN03224 311 IKGVMRQVLTGLRKLHRIGIV-HRDIKPENLLVTVDGQVKIIDFGAAVDMCTGIN-FNPLYGMLDPRYSPPEELVMPQSC 388 (507)
T ss_pred HHHHHHHHHHHHHHHHHCCee-cCCCchHhEEECCCCcEEEEeCcCccccccCCc-cCccccCCCcceeChhhhcCCCCC
Confidence 467899999999999999988 999999999999999999999999865432211 111122346789999988643210
Q ss_pred -------------------CCCCccchHHHHHHHHHHHhCCC-CCCCCCCChHHH------HH---HHhcCCCCCCCCCC
Q psy1840 105 -------------------RGTQKGDVYSFGLVLYEVIGRQG-PWGHLRMTDEEI------IT---SVTQGSGLRPDTSS 155 (423)
Q Consensus 105 -------------------~~s~ksDVyS~Giil~elltg~~-Pf~~~~~~~~~i------~~---~i~~~~~~~p~~~~ 155 (423)
....+.||||+||++++|+++.. ||.....-..+. .. .+.......+ ..
T Consensus 389 ~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~~~~~~~~~--~~ 466 (507)
T PLN03224 389 PRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRMYKGQKYDFS--LL 466 (507)
T ss_pred CccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHhhcccCCCcc--cc
Confidence 01235799999999999999875 664321111111 11 1111111111 12
Q ss_pred CCchHHHHHHHHHhhhcCC---CCCCCHHHHHHH
Q psy1840 156 LDCAPSIIACMRTCWEEDP---ELRPDLRFVHHK 186 (423)
Q Consensus 156 ~~~~~~l~~Li~~C~~~dP---~~RPt~~~I~~~ 186 (423)
...++...+++.+++..+| .+|+|+.+++++
T Consensus 467 d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~H 500 (507)
T PLN03224 467 DRNKEAGWDLACKLITKRDQANRGRLSVGQALSH 500 (507)
T ss_pred cccChHHHHHHHHHhccCCCCcccCCCHHHHhCC
Confidence 3567899999999999766 689999998764
|
|
| >KOG0608|consensus | Back alignment and domain information |
|---|
Probab=99.73 E-value=4.9e-18 Score=170.66 Aligned_cols=144 Identities=23% Similarity=0.243 Sum_probs=100.6
Q ss_pred HHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCccEEEeccCCcccccCC---------C-------cc-----------
Q psy1840 28 VNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQ---------D-------ET----------- 80 (423)
Q Consensus 28 i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~---------~-------~~----------- 80 (423)
.+..+..++++.|+.|+| ||||||+|||||.+|++||+||||+.-+... + +.
T Consensus 734 YIAEltcAiesVHkmGFI-HRDiKPDNILIDrdGHIKLTDFGLCTGfRWTHdskYYq~gdH~RqDSmep~~e~~d~~~~l 812 (1034)
T KOG0608|consen 734 YIAELTCAIESVHKMGFI-HRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQEGDHHRQDSMEPSPEWADISKCL 812 (1034)
T ss_pred HHHHHHHHHHHHHhccce-ecccCccceEEccCCceeeeeccccccceeccccccccCCCccccccCCCchhhccccccc
Confidence 466889999999999999 9999999999999999999999996422110 0 00
Q ss_pred -------------cccccccCCccccCCccccCCCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCChHHHHHHHhcCC
Q psy1840 81 -------------GQERKLRRRKLYKAPELLRQPHLPRGTQKGDVYSFGLVLYEVIGRQGPWGHLRMTDEEIITSVTQGS 147 (423)
Q Consensus 81 -------------~~~~~~~gt~~y~APE~l~~~~~~~~s~ksDVyS~Giil~elltg~~Pf~~~~~~~~~i~~~i~~~~ 147 (423)
.......||+.|+|||++....+ ++.+|.||.|+|||||+.|+.||... ++.+...++....
T Consensus 813 kvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~---~q~cdwws~gvil~em~~g~~pf~~~--tp~~tq~kv~nw~ 887 (1034)
T KOG0608|consen 813 KVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGY---TQLCDWWSVGVILYEMLVGQPPFLAD--TPGETQYKVINWR 887 (1034)
T ss_pred hHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCc---cccchhhHhhHHHHHHhhCCCCccCC--CCCcceeeeeehh
Confidence 00124568999999999987766 99999999999999999999999642 2222222222221
Q ss_pred CCCCCCCCCCchHHHHHHHHHhhhcCCCCCC
Q psy1840 148 GLRPDTSSLDCAPSIIACMRTCWEEDPELRP 178 (423)
Q Consensus 148 ~~~p~~~~~~~~~~l~~Li~~C~~~dP~~RP 178 (423)
...--....+.+.+..++|.+.+ -+++.|.
T Consensus 888 ~~l~~~~~~~ls~e~~~li~kLc-~sad~RL 917 (1034)
T KOG0608|consen 888 NFLHIPYQGNLSKEALDLIQKLC-CSADSRL 917 (1034)
T ss_pred hccccccccccCHHHHHHHHHHh-cChhhhh
Confidence 11111122356788888776544 2355663
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.71 E-value=4.1e-17 Score=147.00 Aligned_cols=121 Identities=29% Similarity=0.496 Sum_probs=101.5
Q ss_pred HHHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcC-CccEEEeccCCcccccCCCcccccccccCCccccCCccccCCC
Q psy1840 24 GSISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDS-RWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKAPELLRQPH 102 (423)
Q Consensus 24 ~~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~-~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~ 102 (423)
....++.+++.++.|||+.|++ |+||+|.||+++. ++.++|+|||.+........ ......+...|++||.+....
T Consensus 93 ~~~~~~~~l~~~l~~lh~~~~~-H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~--~~~~~~~~~~~~~pe~~~~~~ 169 (215)
T cd00180 93 EILRILLQILEGLEYLHSNGII-HRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS--LLKTIVGTPAYMAPEVLLGKG 169 (215)
T ss_pred HHHHHHHHHHHHHHHHHhCCee-ccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc--hhhcccCCCCccChhHhcccC
Confidence 3689999999999999999998 9999999999999 89999999999875533221 112345667799999987651
Q ss_pred CCCCCCccchHHHHHHHHHHHhCCCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCchHHHHHHHHHhhhcCCCCCCCHHH
Q psy1840 103 LPRGTQKGDVYSFGLVLYEVIGRQGPWGHLRMTDEEIITSVTQGSGLRPDTSSLDCAPSIIACMRTCWEEDPELRPDLRF 182 (423)
Q Consensus 103 ~~~~s~ksDVyS~Giil~elltg~~Pf~~~~~~~~~i~~~i~~~~~~~p~~~~~~~~~~l~~Li~~C~~~dP~~RPt~~~ 182 (423)
..+.++|+|++|++++++ ..+.+++..|++.+|++||++.+
T Consensus 170 --~~~~~~D~~~lg~~~~~l-------------------------------------~~~~~~l~~~l~~~p~~R~~~~~ 210 (215)
T cd00180 170 --YYSEKSDIWSLGVILYEL-------------------------------------PELKDLIRKMLQKDPEKRPSAKE 210 (215)
T ss_pred --CCCchhhhHHHHHHHHHH-------------------------------------HHHHHHHHHHhhCCcccCcCHHH
Confidence 238899999999999998 57889999999999999999998
Q ss_pred HHHH
Q psy1840 183 VHHK 186 (423)
Q Consensus 183 I~~~ 186 (423)
+++.
T Consensus 211 l~~~ 214 (215)
T cd00180 211 ILEH 214 (215)
T ss_pred HhhC
Confidence 8754
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG0662|consensus | Back alignment and domain information |
|---|
Probab=99.70 E-value=9.2e-17 Score=139.29 Aligned_cols=156 Identities=16% Similarity=0.167 Sum_probs=111.8
Q ss_pred HHHHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCccEEEeccCCcccccCCCcccccccccCCccccCCccccCCC
Q psy1840 23 IGSISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKAPELLRQPH 102 (423)
Q Consensus 23 ~~~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~ 102 (423)
+..-+++.|+..|+.|+|++++. ||||||.|.||+.+|.+|++|||+++...-. ........-|.+|.+|.++.+..
T Consensus 101 ~~~rsfmlqllrgl~fchshnvl-hrdlkpqnllin~ngelkladfglarafgip--vrcysaevvtlwyrppdvlfgak 177 (292)
T KOG0662|consen 101 EIVRSFMLQLLRGLGFCHSHNVL-HRDLKPQNLLINRNGELKLADFGLARAFGIP--VRCYSAEVVTLWYRPPDVLFGAK 177 (292)
T ss_pred HHHHHHHHHHHhhhhhhhhhhhh-hccCCcceEEeccCCcEEecccchhhhcCCc--eEeeeceeeeeeccCcceeeeee
Confidence 33568999999999999999998 9999999999999999999999998865322 22223456688899999998876
Q ss_pred CCCCCCccchHHHHHHHHHHHh-CCCCCCCCCCChHHHHHHHhc--C---CCCCCC------------CCC--------C
Q psy1840 103 LPRGTQKGDVYSFGLVLYEVIG-RQGPWGHLRMTDEEIITSVTQ--G---SGLRPD------------TSS--------L 156 (423)
Q Consensus 103 ~~~~s~ksDVyS~Giil~ellt-g~~Pf~~~~~~~~~i~~~i~~--~---~~~~p~------------~~~--------~ 156 (423)
-++.+.|+||-|||+.|+.. |++-|++.... +++ .++-. | ....|. .+. .
T Consensus 178 --ly~tsidmwsagcifaelanagrplfpg~dvd-dql-krif~~lg~p~ed~wps~t~lpdyk~yp~ypattswsqivp 253 (292)
T KOG0662|consen 178 --LYSTSIDMWSAGCIFAELANAGRPLFPGNDVD-DQL-KRIFRLLGTPTEDQWPSMTKLPDYKPYPIYPATTSWSQIVP 253 (292)
T ss_pred --hhccchHhhhcchHHHHHhhcCCCCCCCCcHH-HHH-HHHHHHhCCCccccCCccccCCCCcccCCccccchHHHHhh
Confidence 35899999999999999996 55556654332 222 22210 0 000010 000 1
Q ss_pred CchHHHHHHHHHhhhcCCCCCCCHHHHHH
Q psy1840 157 DCAPSIIACMRTCWEEDPELRPDLRFVHH 185 (423)
Q Consensus 157 ~~~~~l~~Li~~C~~~dP~~RPt~~~I~~ 185 (423)
.....-+++++..+.-+|.+|.+++..++
T Consensus 254 ~lns~grdllqkll~cnp~qrisaeaalq 282 (292)
T KOG0662|consen 254 KLNSTGRDLLQKLLKCNPAQRISAEAALQ 282 (292)
T ss_pred hhcchhHHHHHHHhccCcccccCHHHHhc
Confidence 12234577889999999999999887654
|
|
| >KOG0670|consensus | Back alignment and domain information |
|---|
Probab=99.70 E-value=1.1e-17 Score=165.09 Aligned_cols=98 Identities=22% Similarity=0.392 Sum_probs=83.5
Q ss_pred HHHHHHHHHHHHHHhCCCeeecCCCCCCEEEc-CCccEEEeccCCcccccCCCcccccccccCCccccCCccccCCCCCC
Q psy1840 27 SVNTTASVGMIHLHDSEIISHGNLRSSNCLID-SRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKAPELLRQPHLPR 105 (423)
Q Consensus 27 ~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld-~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~ 105 (423)
+.+.|+..+|.+|-..|++ |.||||.|||++ +...+||||||-|.+......+ .+.-+.+|.|||++.|..+
T Consensus 540 sYaqQLflALklLK~c~vl-HaDIKPDNiLVNE~k~iLKLCDfGSA~~~~eneit----PYLVSRFYRaPEIiLG~~y-- 612 (752)
T KOG0670|consen 540 SYAQQLFLALKLLKKCGVL-HADIKPDNILVNESKNILKLCDFGSASFASENEIT----PYLVSRFYRAPEIILGLPY-- 612 (752)
T ss_pred HHHHHHHHHHHHHHhcCee-ecccCccceEeccCcceeeeccCcccccccccccc----HHHHHHhccCcceeecCcc--
Confidence 6799999999999999998 999999999997 4668899999998776544322 2344567999999999876
Q ss_pred CCCccchHHHHHHHHHHHhCCCCCCCC
Q psy1840 106 GTQKGDVYSFGLVLYEVIGRQGPWGHL 132 (423)
Q Consensus 106 ~s~ksDVyS~Giil~elltg~~Pf~~~ 132 (423)
....|+||.||+|||++||+.-|++.
T Consensus 613 -d~~iD~WSvgctLYElYtGkIlFpG~ 638 (752)
T KOG0670|consen 613 -DYPIDTWSVGCTLYELYTGKILFPGR 638 (752)
T ss_pred -cCCccceeeceeeEEeeccceecCCC
Confidence 88999999999999999999888753
|
|
| >KOG1345|consensus | Back alignment and domain information |
|---|
Probab=99.69 E-value=2.7e-17 Score=150.92 Aligned_cols=156 Identities=19% Similarity=0.284 Sum_probs=110.7
Q ss_pred HHHHHHHHHHHHHHHhCCCeeecCCCCCCEEE-c-CCccEEEeccCCcccccCCCcccccccccCCccccCCccccCC--
Q psy1840 26 ISVNTTASVGMIHLHDSEIISHGNLRSSNCLI-D-SRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKAPELLRQP-- 101 (423)
Q Consensus 26 l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILl-d-~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~-- 101 (423)
-.++.|+++++.|+|+++++ |||||.+|||| + +...+||||||+........ .....+..|.+||.+...
T Consensus 124 K~v~~ql~SAi~fMHsknlV-HRdlK~eNiLif~~df~rvKlcDFG~t~k~g~tV-----~~~~~~~~y~~pe~~~~~~n 197 (378)
T KOG1345|consen 124 KKVFAQLLSAIEFMHSKNLV-HRDLKAENILIFDADFYRVKLCDFGLTRKVGTTV-----KYLEYVNNYHAPELCDTVVN 197 (378)
T ss_pred HHHHHHHHHHHHHhhccchh-hcccccceEEEecCCccEEEeeecccccccCcee-----hhhhhhcccCCcHHHhhccc
Confidence 47899999999999999998 99999999999 3 33489999999976432211 112234558999876532
Q ss_pred -CCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCChH---HHHHHHhcCCCCCCCCCCCCchHHHHHHHHHhhhcCCCCC
Q psy1840 102 -HLPRGTQKGDVYSFGLVLYEVIGRQGPWGHLRMTDE---EIITSVTQGSGLRPDTSSLDCAPSIIACMRTCWEEDPELR 177 (423)
Q Consensus 102 -~~~~~s~ksDVyS~Giil~elltg~~Pf~~~~~~~~---~i~~~i~~~~~~~p~~~~~~~~~~l~~Li~~C~~~dP~~R 177 (423)
.+ ...+.+|+|.|||+++.++||..||+.....+. +..+......+..|... ..+++.+..+.++-+..+|++|
T Consensus 198 e~~-~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~~~w~~rk~~~~P~~F-~~fs~~a~r~Fkk~lt~~~~dr 275 (378)
T KOG1345|consen 198 EKL-VVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWEWEQWLKRKNPALPKKF-NPFSEKALRLFKKSLTPRFKDR 275 (378)
T ss_pred cce-EecccccchheeeeeeeeecCCCcchhhhccCchHHHHHHHhcccCccCchhh-cccCHHHHHHHHHhcCCccccc
Confidence 22 347889999999999999999999974433332 33333333222223222 3578889999999999999999
Q ss_pred CCHHHHHHHHHH
Q psy1840 178 PDLRFVHHKLKE 189 (423)
Q Consensus 178 Pt~~~I~~~L~~ 189 (423)
-.+.++.+..+.
T Consensus 276 cki~~~kk~rk~ 287 (378)
T KOG1345|consen 276 CKIWTAKKMRKC 287 (378)
T ss_pred chhHHHHHHHHH
Confidence 666665554433
|
|
| >KOG0195|consensus | Back alignment and domain information |
|---|
Probab=99.68 E-value=9.4e-17 Score=147.38 Aligned_cols=157 Identities=24% Similarity=0.326 Sum_probs=116.0
Q ss_pred HHHHHHHHHHHHHHHHHhC-CCeeecCCCCCCEEEcCCccEEEeccCCcccccCCCcccccccccCCccccCCccccCCC
Q psy1840 24 GSISVNTTASVGMIHLHDS-EIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKAPELLRQPH 102 (423)
Q Consensus 24 ~~l~i~~qi~~gL~yLH~~-~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~ 102 (423)
+.++++.+++.||+|||+- .++.---|.+..++||.+.+.+|+-- -.++. .......-.+.|++||.++..+
T Consensus 290 qav~faldiargmaflhslep~ipr~~lns~hvmidedltarisma-d~kfs------fqe~gr~y~pawmspealqrkp 362 (448)
T KOG0195|consen 290 QAVRFALDIARGMAFLHSLEPMIPRFYLNSKHVMIDEDLTARISMA-DTKFS------FQEVGRAYSPAWMSPEALQRKP 362 (448)
T ss_pred hHHHHHHHHHhhHHHHhhcchhhhhhhcccceEEecchhhhheecc-cceee------eeccccccCcccCCHHHHhcCc
Confidence 3689999999999999997 44444568999999999998887521 11111 1112223457799999998766
Q ss_pred CCCCCCccchHHHHHHHHHHHhCCCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCchHHHHHHHHHhhhcCCCCCCCHHH
Q psy1840 103 LPRGTQKGDVYSFGLVLYEVIGRQGPWGHLRMTDEEIITSVTQGSGLRPDTSSLDCAPSIIACMRTCWEEDPELRPDLRF 182 (423)
Q Consensus 103 ~~~~s~ksDVyS~Giil~elltg~~Pf~~~~~~~~~i~~~i~~~~~~~p~~~~~~~~~~l~~Li~~C~~~dP~~RPt~~~ 182 (423)
-.....++|+|||++++||+.|+..||.+... -+.--++. -.+.++.+++ ..++.+..||.-|+++||.+||.|+.
T Consensus 363 ed~n~raadmwsfaillwel~trevpfadlsp--mecgmkia-leglrv~ipp-gis~hm~klm~icmnedpgkrpkfdm 438 (448)
T KOG0195|consen 363 EDLNIRAADMWSFAILLWELNTREVPFADLSP--MECGMKIA-LEGLRVHIPP-GISRHMNKLMNICMNEDPGKRPKFDM 438 (448)
T ss_pred hhcchhhhhHHHHHHHHHHhhccccccccCCc--hhhhhhhh-hccccccCCC-CccHHHHHHHHHHhcCCCCcCCCcce
Confidence 44456789999999999999999999986432 22222221 1235555544 67899999999999999999999999
Q ss_pred HHHHHHHHh
Q psy1840 183 VHHKLKEMN 191 (423)
Q Consensus 183 I~~~L~~i~ 191 (423)
|+..|+++.
T Consensus 439 ivpilekm~ 447 (448)
T KOG0195|consen 439 IVPILEKMI 447 (448)
T ss_pred ehhhHHHhc
Confidence 999888763
|
|
| >KOG0590|consensus | Back alignment and domain information |
|---|
Probab=99.68 E-value=4e-17 Score=171.56 Aligned_cols=164 Identities=20% Similarity=0.210 Sum_probs=126.3
Q ss_pred CCChHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCccEEEeccCCcccccCCCcc--cccccccCCccccCCc
Q psy1840 19 FNIPIGSISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDET--GQERKLRRRKLYKAPE 96 (423)
Q Consensus 19 ~~~p~~~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~~--~~~~~~~gt~~y~APE 96 (423)
+..+.+.-.+..|+..|++|+|..|+. |||||++|++++.+|.+||+|||.+.......+. .......|+..|+|||
T Consensus 416 ~~~~~e~~c~fKqL~~Gv~y~h~~Gia-hrdlK~enll~~~~g~lki~Dfg~~~vf~~~~e~~~~~~~g~~gS~pY~apE 494 (601)
T KOG0590|consen 416 KLTPLEADCFFKQLLRGVKYLHSMGLA-HRDLKLENLLVTENGILKIIDFGAASVFRYPWEKNIHESSGIVGSDPYLAPE 494 (601)
T ss_pred ccchhhhhHHHHHHHHHHHHHHhcCce-eccCccccEEEecCCceEEeecCcceeeccCcchhhhhhcCcccCCcCcCcc
Confidence 344566789999999999999999998 9999999999999999999999998765443333 4456778899999999
Q ss_pred cccCCCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCChHHHHHHHhcCC---CCCCCCCCCCchHHHHHHHHHhhhcC
Q psy1840 97 LLRQPHLPRGTQKGDVYSFGLVLYEVIGRQGPWGHLRMTDEEIITSVTQGS---GLRPDTSSLDCAPSIIACMRTCWEED 173 (423)
Q Consensus 97 ~l~~~~~~~~s~ksDVyS~Giil~elltg~~Pf~~~~~~~~~i~~~i~~~~---~~~p~~~~~~~~~~l~~Li~~C~~~d 173 (423)
.+.+..+ .....||||.|+++..|++|+.||.................. ...|.......+...+.+|.++++.|
T Consensus 495 ~~~~~~y--dpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~lp~~~~~~~~~~l~~~ 572 (601)
T KOG0590|consen 495 VLTGKEY--DPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTNNYSDQRNIFEGPNRLLSLLPRETRIIIYRMLQLD 572 (601)
T ss_pred ccccccc--CcchhhhhhccceEEEEecCCCccccccccccchhhhccccccccccChHHHHHhchhhHHHHHHHHccCC
Confidence 9998876 357799999999999999999999654333322211111100 01111112456788999999999999
Q ss_pred CCCCCCHHHHHH
Q psy1840 174 PELRPDLRFVHH 185 (423)
Q Consensus 174 P~~RPt~~~I~~ 185 (423)
|.+|.|+.+|++
T Consensus 573 P~~R~ti~~i~~ 584 (601)
T KOG0590|consen 573 PTKRITIEQILN 584 (601)
T ss_pred hhheecHHHHhh
Confidence 999999999976
|
|
| >KOG0576|consensus | Back alignment and domain information |
|---|
Probab=99.63 E-value=4e-16 Score=158.09 Aligned_cols=154 Identities=18% Similarity=0.237 Sum_probs=118.3
Q ss_pred HHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCccEEEeccCCcccccCCCcccccccccCCccccCCccccCCCCCCC
Q psy1840 27 SVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKAPELLRQPHLPRG 106 (423)
Q Consensus 27 ~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~ 106 (423)
-.++...+|++|||+.|-+ |||||-.||++++.|.+|++|||.+..+... ......+.||+.|||||+..-+.-.-+
T Consensus 116 yvcRetl~gl~ylhs~gk~-hRdiKGanilltd~gDvklaDfgvsaqitat--i~KrksfiGtpywmapEvaaverkggy 192 (829)
T KOG0576|consen 116 YVCRETLQGLKYLHSQGKI-HRDIKGANILLTDEGDVKLADFGVSAQITAT--IAKRKSFIGTPYWMAPEVAAVERKGGY 192 (829)
T ss_pred HHHhhhhccchhhhcCCcc-cccccccceeecccCceeecccCchhhhhhh--hhhhhcccCCccccchhHHHHHhcccc
Confidence 4577889999999999988 9999999999999999999999997654322 123357899999999998754332234
Q ss_pred CCccchHHHHHHHHHHHhCCCCCCCCCCChHHHHHHHhcCCCCCCCCC-CCCchHHHHHHHHHhhhcCCCCCCCHHHHHH
Q psy1840 107 TQKGDVYSFGLVLYEVIGRQGPWGHLRMTDEEIITSVTQGSGLRPDTS-SLDCAPSIIACMRTCWEEDPELRPDLRFVHH 185 (423)
Q Consensus 107 s~ksDVyS~Giil~elltg~~Pf~~~~~~~~~i~~~i~~~~~~~p~~~-~~~~~~~l~~Li~~C~~~dP~~RPt~~~I~~ 185 (423)
.+++|||+.|+...|+---++|..+ ..+......+....+..|... ....++.+.++++.|+..+|.+||+...++.
T Consensus 193 nqlcdiwa~gitAiel~eLqpplfd--lhpmr~l~LmTkS~~qpp~lkDk~kws~~fh~fvK~altknpKkRptaeklL~ 270 (829)
T KOG0576|consen 193 NQLCDIWALGITAIELGELQPPLFD--LHPMRALFLMTKSGFQPPTLKDKTKWSEFFHNFVKGALTKNPKKRPTAEKLLQ 270 (829)
T ss_pred cccccccccccchhhhhhcCCcccc--cchHHHHHHhhccCCCCCcccCCccchHHHHHHHHHHhcCCCccCCChhhhee
Confidence 8999999999999999888888643 333333333333333333222 3568899999999999999999999987665
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.62 E-value=1.7e-15 Score=139.00 Aligned_cols=119 Identities=22% Similarity=0.304 Sum_probs=94.1
Q ss_pred HHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCccEEEeccCCcccccCCCcccccccccCCccccCCcccc-CCCC
Q psy1840 25 SISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKAPELLR-QPHL 103 (423)
Q Consensus 25 ~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~-~~~~ 103 (423)
...++.+++.++.|||+.+++ |+||+|.||+++.++.++|+|||.+......... ......++..|++||.+. ..
T Consensus 100 ~~~~~~~l~~~l~~lh~~~i~-h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~-~~~~~~~~~~~~~pe~~~~~~-- 175 (225)
T smart00221 100 ARFYLRQILEALEYLHSLGIV-HRDLKPENILLGMDGLVKLADFGLARFIHRDLAA-LLKTVKGTPFYLAPEVLLGGK-- 175 (225)
T ss_pred HHHHHHHHHHHHHHHHhCCee-cCCCCHHHEEEcCCCCEEEeeCceeeEecCcccc-cccceeccCCcCCHhHhcCCC--
Confidence 578999999999999999998 9999999999999999999999998765433210 112345667799999984 22
Q ss_pred CCCCCccchHHHHHHHHHHHhCCCCCCCCCCChHHHHHHHhcCCC
Q psy1840 104 PRGTQKGDVYSFGLVLYEVIGRQGPWGHLRMTDEEIITSVTQGSG 148 (423)
Q Consensus 104 ~~~s~ksDVyS~Giil~elltg~~Pf~~~~~~~~~i~~~i~~~~~ 148 (423)
..+.++|+||||++++|+++|+.||........++.+.+..+.+
T Consensus 176 -~~~~~~Dv~~lG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~~ 219 (225)
T smart00221 176 -GYGEAVDIWSLGVILYELLWGPEPFSGEGEFTSLLSDVWSFGVP 219 (225)
T ss_pred -CCCchhhHHHHHHHHHHHHHCCCCccccchhHHHHHHHHhcCCc
Confidence 33679999999999999999999996534445567777766543
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG1152|consensus | Back alignment and domain information |
|---|
Probab=99.59 E-value=4.2e-16 Score=155.63 Aligned_cols=99 Identities=24% Similarity=0.483 Sum_probs=87.5
Q ss_pred HHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCccEEEeccCCcccccCCCcccccccccCCccccCCccccCCCCCC
Q psy1840 26 ISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKAPELLRQPHLPR 105 (423)
Q Consensus 26 l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~ 105 (423)
-.|..|++.|++|||+.||| |||||-+|+.+|++|-+||+|||-+...... ....+.||..|.|||++.|..|
T Consensus 673 k~IFkQV~agi~hlh~~~iv-hrdikdenvivd~~g~~klidfgsaa~~ksg----pfd~f~gtv~~aapevl~g~~y-- 745 (772)
T KOG1152|consen 673 KLIFKQVVAGIKHLHDQGIV-HRDIKDENVIVDSNGFVKLIDFGSAAYTKSG----PFDVFVGTVDYAAPEVLGGEKY-- 745 (772)
T ss_pred HHHHHHHHhccccccccCce-ecccccccEEEecCCeEEEeeccchhhhcCC----CcceeeeeccccchhhhCCCcc--
Confidence 46889999999999999998 9999999999999999999999998765322 2356789999999999999875
Q ss_pred CCCccchHHHHHHHHHHHhCCCCCCC
Q psy1840 106 GTQKGDVYSFGLVLYEVIGRQGPWGH 131 (423)
Q Consensus 106 ~s~ksDVyS~Giil~elltg~~Pf~~ 131 (423)
.++.-|||++|+++|-++.+..||..
T Consensus 746 ~gk~qdiwalgillytivykenpyyn 771 (772)
T KOG1152|consen 746 LGKPQDIWALGILLYTIVYKENPYYN 771 (772)
T ss_pred CCCcchhhhhhheeeEEEeccCCCcC
Confidence 37889999999999999999999863
|
|
| >KOG1240|consensus | Back alignment and domain information |
|---|
Probab=99.59 E-value=1.8e-15 Score=160.73 Aligned_cols=177 Identities=21% Similarity=0.205 Sum_probs=121.7
Q ss_pred ccchhhhhcCCCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCccEEEeccCCccc--ccCCCc
Q psy1840 2 RRSVRETEAITPNPLSPFNIPIGSISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAF--KAGQDE 79 (423)
Q Consensus 2 r~~~~~~~~~~~~p~~~~~~p~~~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~~vKL~DFGla~~--~~~~~~ 79 (423)
|.-++.+...... ..||..-+++-.++.||..|+..+|..|++ |||||.+||||++-..+.|+||.-.+. +...++
T Consensus 100 RqyvkhnLyDRlS-TRPFL~~iEKkWiaFQLL~al~qcH~~gVc-HGDIKsENILiTSWNW~~LtDFAsFKPtYLPeDNP 177 (1431)
T KOG1240|consen 100 RQYVKHNLYDRLS-TRPFLVLIEKKWIAFQLLKALSQCHKLGVC-HGDIKSENILITSWNWLYLTDFASFKPTYLPEDNP 177 (1431)
T ss_pred HHHHhhhhhhhhc-cchHHHHHHHHHHHHHHHHHHHHHHHcCcc-ccccccceEEEeeechhhhhcccccCCccCCCCCc
Confidence 4455556655554 457877788999999999999999999998 999999999999988899999986542 222221
Q ss_pred ccc---cccccCCccccCCccccCCC--------CCCCCCccchHHHHHHHHHHHh-CCCCCCCCCCChHHHHHHHhcCC
Q psy1840 80 TGQ---ERKLRRRKLYKAPELLRQPH--------LPRGTQKGDVYSFGLVLYEVIG-RQGPWGHLRMTDEEIITSVTQGS 147 (423)
Q Consensus 80 ~~~---~~~~~gt~~y~APE~l~~~~--------~~~~s~ksDVyS~Giil~ellt-g~~Pf~~~~~~~~~i~~~i~~~~ 147 (423)
... -.+.....+|.|||.+.... -+..+++.||||+||++.|+++ |++||.- .++...- .+.
T Consensus 178 adf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~L-----SQL~aYr-~~~ 251 (1431)
T KOG1240|consen 178 ADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTL-----SQLLAYR-SGN 251 (1431)
T ss_pred ccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccH-----HHHHhHh-ccC
Confidence 111 12223445799999886521 1124789999999999999997 6777741 2222221 111
Q ss_pred CCCCCC-CCCCchHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q psy1840 148 GLRPDT-SSLDCAPSIIACMRTCWEEDPELRPDLRFVHHK 186 (423)
Q Consensus 148 ~~~p~~-~~~~~~~~l~~Li~~C~~~dP~~RPt~~~I~~~ 186 (423)
...+.. ...--+..+++++..|++.||++|.++++.++.
T Consensus 252 ~~~~e~~Le~Ied~~~Rnlil~Mi~rdPs~RlSAedyL~~ 291 (1431)
T KOG1240|consen 252 ADDPEQLLEKIEDVSLRNLILSMIQRDPSKRLSAEDYLQK 291 (1431)
T ss_pred ccCHHHHHHhCcCccHHHHHHHHHccCchhccCHHHHHHh
Confidence 111100 000113478999999999999999999988764
|
|
| >KOG3618|consensus | Back alignment and domain information |
|---|
Probab=99.59 E-value=8.4e-16 Score=156.29 Aligned_cols=109 Identities=26% Similarity=0.398 Sum_probs=91.9
Q ss_pred HHHHHHHHHHHHHHHhhCcHHHHHHHh-CCCC-----------------------CC---------CccccceeEEEeec
Q psy1840 303 NQLTQEKKKTDALLHRMLPRSVSESLK-RGDF-----------------------VE---------PESFDSVTIYFSDI 349 (423)
Q Consensus 303 ~~l~~e~~~~~~ll~~~lp~~ia~~l~-~g~~-----------------------~~---------~~~~~~vtv~f~di 349 (423)
++||.||+-.|+...+.+|+-||+.|. +|.. |. -..-++|+|+||||
T Consensus 269 kdLE~EkqlKe~MIhSVMP~kvAD~Llk~g~~pS~nd~~~~~~~s~~~r~~~s~~vk~~~~FRPF~M~~menVSILFADI 348 (1318)
T KOG3618|consen 269 KDLEVEKQLKERMIHSVMPRKVADDLLKQGDEPSENDVKRHATSSPKNRKKKSSIVKAPIAFRPFKMQQMENVSILFADI 348 (1318)
T ss_pred hhhHHHHHHHHHHHHhhcChHHHHHHHhhcCCCCcccccCCCCCCcccccchhhccccccccCchhhhhhhhhhhhhhhh
Confidence 468999999999999999999999764 3430 00 01248999999999
Q ss_pred cccccccccCCHhHHHHhhhccch-hh--------hhccC-CCceEEEeecccCCCcchHHHHhhhhhhchH
Q psy1840 350 VGFTQLSAESTETGRVTTRDSRRT-PD--------LKVGG-SNPRQVITGTDMLRHRPHESKVSLALSSLSI 411 (423)
Q Consensus 350 ~gft~~~~~~~p~~~v~~ln~~~~-fd--------~~~~~-~~~~~v~~~~~~~~~~~~~~~~~~~~~~~~~ 411 (423)
||||.+++..++.++|.+|||+|. || ++|.+ ||||.|+.|.|..+-+|+...+.|+|.|..+
T Consensus 349 vGFTkMSsnKsA~~LV~lLNDLFgRFD~LC~l~gcEKISTLGDCYYCVaGCPEPraDHA~ccvEMGLgMI~A 420 (1318)
T KOG3618|consen 349 VGFTKMSSNKSAHALVGLLNDLFGRFDRLCELTGCEKISTLGDCYYCVAGCPEPRADHAYCCVEMGLGMIKA 420 (1318)
T ss_pred hchhhccccccHHHHHHHHHHHHHHHHHHHHhcCcchhccccceeeeecCCCCCcccceeeehhhcchHHHH
Confidence 999999999999999999999999 99 77888 9999999999999877777777887776543
|
|
| >KOG3619|consensus | Back alignment and domain information |
|---|
Probab=99.56 E-value=1.2e-15 Score=161.61 Aligned_cols=113 Identities=25% Similarity=0.329 Sum_probs=93.5
Q ss_pred hHHHHHHHHHHHHHHHHHHHHhhCcHHHHHHHhCCCC--------------CCCccccceeEEEeeccccccccccCCHh
Q psy1840 297 LVQERTNQLTQEKKKTDALLHRMLPRSVSESLKRGDF--------------VEPESFDSVTIYFSDIVGFTQLSAESTET 362 (423)
Q Consensus 297 ~v~~~~~~l~~e~~~~~~ll~~~lp~~ia~~l~~g~~--------------~~~~~~~~vtv~f~di~gft~~~~~~~p~ 362 (423)
.++.+ -.++.|+++.++||.+++|+.||.++++.-. .--+.|++|+|+||||||||.+++.++++
T Consensus 55 ~i~~r-~~l~~~~~~qerlllsvlp~~va~~m~~~i~~~~~~~~~~~~f~~iy~~~h~nVSIl~adivgft~l~s~~saq 133 (867)
T KOG3619|consen 55 CIEVR-MELETEKQQQERLLLSVLPAHVAMEMKKDIIESSARCKNDNQFHKLYIQRHDNVSILFADIVGFTQLASQCSAQ 133 (867)
T ss_pred HHHHH-HHHHHHHHHHHHHHHHhhhHHHHHHHHHHHHhhhhcchhhhccchhheeeccchHhhHHHHhhhhhhhcCCCHH
Confidence 44444 4589999999999999999999998885411 22356999999999999999999999999
Q ss_pred HHHHhhhccch-hhhh--------ccC-CCceEEEeecccCCCcchHHHHhhhhhhch
Q psy1840 363 GRVTTRDSRRT-PDLK--------VGG-SNPRQVITGTDMLRHRPHESKVSLALSSLS 410 (423)
Q Consensus 363 ~~v~~ln~~~~-fd~~--------~~~-~~~~~v~~~~~~~~~~~~~~~~~~~~~~~~ 410 (423)
++|.+||++|. ||.+ |+- ||||.|++|+|..+++|+...+.|.|+|..
T Consensus 134 elv~~LneLf~rfd~lA~~~~clRiKiLGdcyyCvsglp~~~~dHA~~~v~mgl~Mi~ 191 (867)
T KOG3619|consen 134 ELVKVLNELFARFDRLAAENHCLRIKILGDCYYCVSGLPEARPDHAVCCVEMGLDMIK 191 (867)
T ss_pred HHHHHHHHHHHHHHHHHHhcceEeeeeecceeEEecCCCCCChhHHHHHHHHHHHHHH
Confidence 99999999999 9954 444 899999999998886666666667666654
|
|
| >KOG0606|consensus | Back alignment and domain information |
|---|
Probab=99.55 E-value=6.5e-15 Score=156.31 Aligned_cols=140 Identities=23% Similarity=0.298 Sum_probs=116.3
Q ss_pred HHHHHHHHHhCCCeeecCCCCCCEEEcCCccEEEeccCCcccccCCCc-------------ccccccccCCccccCCccc
Q psy1840 32 ASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDE-------------TGQERKLRRRKLYKAPELL 98 (423)
Q Consensus 32 i~~gL~yLH~~~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~-------------~~~~~~~~gt~~y~APE~l 98 (423)
.+.+++|||+.||+ |||+||+|.+|+.-|++|++|||+++....... .......+||+.|.|||++
T Consensus 152 mvla~Eylh~ygiv-hrdlkpdnllIT~mGhiKlTDfgLsk~GLms~atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVi 230 (1205)
T KOG0606|consen 152 MVLAVEYLHSYGIV-HRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVI 230 (1205)
T ss_pred hhHHhHhhccCCee-cCCCCCCcceeeecccccccchhhhhhhhhhccchhhhcchHHHHHHhhhccccCCccccChhhh
Confidence 37899999999998 999999999999999999999999765321110 0112456899999999999
Q ss_pred cCCCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCchHHHHHHHHHhhhcCCCCCC
Q psy1840 99 RQPHLPRGTQKGDVYSFGLVLYEVIGRQGPWGHLRMTDEEIITSVTQGSGLRPDTSSLDCAPSIIACMRTCWEEDPELRP 178 (423)
Q Consensus 99 ~~~~~~~~s~ksDVyS~Giil~elltg~~Pf~~~~~~~~~i~~~i~~~~~~~p~~~~~~~~~~l~~Li~~C~~~dP~~RP 178 (423)
....| +..+|.|++|+|+||.+-|..||. +.+++++...+.......|.. ....+++.++++.+.+..+|..|-
T Consensus 231 lrqgy---gkpvdwwamGiIlyeFLVgcvpff--Gdtpeelfg~visd~i~wpE~-dea~p~Ea~dli~~LL~qnp~~Rl 304 (1205)
T KOG0606|consen 231 LRQGY---GKPVDWWAMGIILYEFLVGCVPFF--GDTPEELFGQVISDDIEWPEE-DEALPPEAQDLIEQLLRQNPLCRL 304 (1205)
T ss_pred hhhcc---CCCccHHHHHHHHHHHheeeeecc--CCCHHHHHhhhhhhhcccccc-CcCCCHHHHHHHHHHHHhChHhhc
Confidence 87766 889999999999999999999997 467888888877665555655 456789999999999999999994
|
|
| >KOG4158|consensus | Back alignment and domain information |
|---|
Probab=99.54 E-value=6.3e-14 Score=134.99 Aligned_cols=186 Identities=20% Similarity=0.227 Sum_probs=121.0
Q ss_pred HHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEc--CC--ccEEEeccCCcccccC---CC-cccccccccCCccccCCc
Q psy1840 25 SISVNTTASVGMIHLHDSEIISHGNLRSSNCLID--SR--WVLQIADFGLHAFKAG---QD-ETGQERKLRRRKLYKAPE 96 (423)
Q Consensus 25 ~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld--~~--~~vKL~DFGla~~~~~---~~-~~~~~~~~~gt~~y~APE 96 (423)
+.-++.|+++|+.|||++|+- |||||++|||+. ++ -.+.|+|||++---.. +- .....-...|+-.-||||
T Consensus 343 ~~~~laQlLEav~hL~~hgvA-hRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPE 421 (598)
T KOG4158|consen 343 GRVILAQLLEAVTHLHKHGVA-HRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPE 421 (598)
T ss_pred HHHHHHHHHHHHHHHHHccch-hhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchh
Confidence 467889999999999999998 999999999993 33 3578899998532111 00 111122345677799999
Q ss_pred cccCCC---CCCCCCccchHHHHHHHHHHHhCCCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCchHHHHHHHHHhhhcC
Q psy1840 97 LLRQPH---LPRGTQKGDVYSFGLVLYEVIGRQGPWGHLRMTDEEIITSVTQGSGLRPDTSSLDCAPSIIACMRTCWEED 173 (423)
Q Consensus 97 ~l~~~~---~~~~s~ksDVyS~Giil~elltg~~Pf~~~~~~~~~i~~~i~~~~~~~p~~~~~~~~~~l~~Li~~C~~~d 173 (423)
+...-+ ....-.|+|.|+.|.+.||+++...||...+... +..-.......|.. +..+++.+.+++...++.|
T Consensus 422 i~ta~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~---L~~r~Yqe~qLPal-p~~vpp~~rqlV~~lL~r~ 497 (598)
T KOG4158|consen 422 IATAVPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEML---LDTRTYQESQLPAL-PSRVPPVARQLVFDLLKRD 497 (598)
T ss_pred hhhcCCCCceeeccchhhhhhhhhhHHHHhccCCcccccchhe---echhhhhhhhCCCC-cccCChHHHHHHHHHhcCC
Confidence 986532 1122468999999999999999999997522111 11100111122333 3468999999999999999
Q ss_pred CCCCCCHHHHHHHHH--------HHhhhcCCChHHHHHHHHHHhhhcccc
Q psy1840 174 PELRPDLRFVHHKLK--------EMNAGLKANIFDNMLAIMEKYAFNLEG 215 (423)
Q Consensus 174 P~~RPt~~~I~~~L~--------~i~~~~~~~~~d~~~~~~e~~~~~lE~ 215 (423)
|.+|++..-....|. .+......+....+...+..-+..+-+
T Consensus 498 pskRvsp~iAANvl~LsLw~~~~~vka~~~~~~~~~~~wLL~~sskvl~~ 547 (598)
T KOG4158|consen 498 PSKRVSPNIAANVLNLSLWRMGEDVKAMMEKCGISQMTWLLAGSSKVLSQ 547 (598)
T ss_pred ccccCCccHHHhHHHHHHhcCchHHHHhcccccHHHHHHHHHhhHHHHhc
Confidence 999988654333322 122233345555555555555544443
|
|
| >KOG1290|consensus | Back alignment and domain information |
|---|
Probab=99.53 E-value=2.4e-14 Score=140.82 Aligned_cols=95 Identities=23% Similarity=0.300 Sum_probs=63.9
Q ss_pred CccccCCccccCCCCCCCCCccchHHHHHHHHHHHhCCCCCC---CCCCC-hHHHHHHHh------------cCCC----
Q psy1840 89 RKLYKAPELLRQPHLPRGTQKGDVYSFGLVLYEVIGRQGPWG---HLRMT-DEEIITSVT------------QGSG---- 148 (423)
Q Consensus 89 t~~y~APE~l~~~~~~~~s~ksDVyS~Giil~elltg~~Pf~---~~~~~-~~~i~~~i~------------~~~~---- 148 (423)
|..|.|||++.+..| +..+||||++|+++||+||-.-|. +...+ +++.+..+. .|+.
T Consensus 414 TRQYRapEVllGsgY---~~~ADiWS~AC~~FELaTGDyLFePhsG~~Y~rDEDHiA~i~ELLG~iPr~ia~~Gk~SRdF 490 (590)
T KOG1290|consen 414 TRQYRAPEVLLGSGY---STSADIWSTACMAFELATGDYLFEPHSGENYSRDEDHIALIMELLGKIPRKIALGGKYSRDF 490 (590)
T ss_pred hhhccCcceeecCCC---CCchhHHHHHHHHHHhhcCceeecCCCCCCCCccHHHHHHHHHHHhhccHHHHhcCcchHhh
Confidence 445999999999877 999999999999999999987663 11111 222222222 1110
Q ss_pred ------------CCCCC----------CCCCchHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q psy1840 149 ------------LRPDT----------SSLDCAPSIIACMRTCWEEDPELRPDLRFVHHK 186 (423)
Q Consensus 149 ------------~~p~~----------~~~~~~~~l~~Li~~C~~~dP~~RPt~~~I~~~ 186 (423)
++|.. ....-..++.+++.-||+.+|++|||+.+.++.
T Consensus 491 Fnr~G~LrhI~~LK~WpL~~VL~eKY~~s~e~A~~fsdFL~PmLef~PeKR~tA~~cl~h 550 (590)
T KOG1290|consen 491 FNRRGELRHIRRLKPWPLYEVLIEKYEWSEEDAQQFSDFLSPMLEFDPEKRPTAAQCLKH 550 (590)
T ss_pred hccccceecccccCCCcHHHHHHHHhCCCHHHHHHHHHHHHHHHhcCccccccHHHHhcC
Confidence 00100 001123568889999999999999999998754
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.52 E-value=1.7e-13 Score=130.83 Aligned_cols=161 Identities=19% Similarity=0.272 Sum_probs=117.9
Q ss_pred HHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCc-cEEEeccCCcccccCCCccc----ccccccCCccccCCcccc
Q psy1840 25 SISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRW-VLQIADFGLHAFKAGQDETG----QERKLRRRKLYKAPELLR 99 (423)
Q Consensus 25 ~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~-~vKL~DFGla~~~~~~~~~~----~~~~~~gt~~y~APE~l~ 99 (423)
...+..|++.|+.|+|+.+++ |||+||+||+++..+ .++++|||.+.......... ......++..|++||.+.
T Consensus 103 ~~~~~~~~~~~l~~~H~~~~~-hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~t~~~~~pe~~~ 181 (384)
T COG0515 103 ALFILAQILSALEYLHSKGII-HRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEVLL 181 (384)
T ss_pred HHHHHHHHHHHHHHHHhCCee-ccCCCHHHeeecCCCCeEEEeccCcceecCCCCccccccccccccccccccCCHHHhc
Confidence 578999999999999999987 999999999999988 79999999987544332211 235667889999999998
Q ss_pred CCCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCC--ChHHHHHHHhcCCCC-CCCCCCCC----chHHHHHHHHHhhhc
Q psy1840 100 QPHLPRGTQKGDVYSFGLVLYEVIGRQGPWGHLRM--TDEEIITSVTQGSGL-RPDTSSLD----CAPSIIACMRTCWEE 172 (423)
Q Consensus 100 ~~~~~~~s~ksDVyS~Giil~elltg~~Pf~~~~~--~~~~i~~~i~~~~~~-~p~~~~~~----~~~~l~~Li~~C~~~ 172 (423)
+......+...|+||+|++++++++|..||..... ........+...... ........ ....+.+++..|+..
T Consensus 182 ~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 261 (384)
T COG0515 182 GLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSLASPLSPSNPELISKAASDLLKKLLAK 261 (384)
T ss_pred CCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcCCcccccccCccccchhhHHHHHHHHHHHhc
Confidence 73101238899999999999999999999764432 133444444433211 11111111 125788999999999
Q ss_pred CCCCCCCHHHHHHH
Q psy1840 173 DPELRPDLRFVHHK 186 (423)
Q Consensus 173 dP~~RPt~~~I~~~ 186 (423)
+|..|.+.......
T Consensus 262 ~~~~r~~~~~~~~~ 275 (384)
T COG0515 262 DPKNRLSSSSDLSH 275 (384)
T ss_pred CchhcCCHHHHhhc
Confidence 99999988776553
|
|
| >KOG1033|consensus | Back alignment and domain information |
|---|
Probab=99.52 E-value=7e-15 Score=146.47 Aligned_cols=147 Identities=21% Similarity=0.354 Sum_probs=106.9
Q ss_pred CCCCChHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCccEEEeccCCcccccCCC----cccccccccCCccc
Q psy1840 17 SPFNIPIGSISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQD----ETGQERKLRRRKLY 92 (423)
Q Consensus 17 ~~~~~p~~~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~----~~~~~~~~~gt~~y 92 (423)
.+|.. .+.++.|++.|++| ++.+ |+|+||.||+...+..+||+|||+........ .........||..|
T Consensus 356 ~s~s~---~~~~~~q~~~~~~y---k~~i-hrdlkp~nif~~~d~q~kIgDFgl~ts~~~~~~~~~~~a~~t~~~gt~~Y 428 (516)
T KOG1033|consen 356 RSLSL---MLDIFKQIAPAVEY---KGLI-HRDLKPSNIFFSDDDQLKIGDFGLVTSQDKDETVAPAAASHTQQVGTLLY 428 (516)
T ss_pred cchhH---HHHHHHhhccchhh---ccch-hhhccccccccccchhhhhhhhhheeecccCCcccchhhhhhhccccccc
Confidence 34554 57899999999999 8888 99999999999999999999999976544333 11223456799999
Q ss_pred cCCccccCCCCCCCCCccchHHHHHHHHHHHh-CCCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCchHHHHHHHHHhhh
Q psy1840 93 KAPELLRQPHLPRGTQKGDVYSFGLVLYEVIG-RQGPWGHLRMTDEEIITSVTQGSGLRPDTSSLDCAPSIIACMRTCWE 171 (423)
Q Consensus 93 ~APE~l~~~~~~~~s~ksDVyS~Giil~ellt-g~~Pf~~~~~~~~~i~~~i~~~~~~~p~~~~~~~~~~l~~Li~~C~~ 171 (423)
|+||.+.+..+ +.++||||||+|++|++. -..++. .......+..+ ..|+....+.+ .-..++++++.
T Consensus 429 msPEQi~g~~y---~~kvdIyaLGlil~EL~~~f~T~~e-----r~~t~~d~r~g--~ip~~~~~d~p-~e~~ll~~lls 497 (516)
T KOG1033|consen 429 MSPEQIRGQQY---SEKVDIYALGLILAELLIQFSTQFE-----RIATLTDIRDG--IIPPEFLQDYP-EEYTLLQQLLS 497 (516)
T ss_pred CCHHHHhhhhh---hhhcchhhHHHHHHHHHHHhccHHH-----HHHhhhhhhcC--CCChHHhhcCc-HHHHHHHHhcC
Confidence 99999998876 999999999999999997 233332 11122223333 22322222333 44579999999
Q ss_pred cCCCCCCCHH
Q psy1840 172 EDPELRPDLR 181 (423)
Q Consensus 172 ~dP~~RPt~~ 181 (423)
..|.+||++.
T Consensus 498 ~~p~~RP~~~ 507 (516)
T KOG1033|consen 498 PSPEERPSAI 507 (516)
T ss_pred CCcccCchHH
Confidence 9999999443
|
|
| >KOG1164|consensus | Back alignment and domain information |
|---|
Probab=99.51 E-value=3.3e-13 Score=132.62 Aligned_cols=164 Identities=18% Similarity=0.186 Sum_probs=120.8
Q ss_pred HHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCC-----ccEEEeccCCccccc--CCCc-----c-cccccccCCcc
Q psy1840 25 SISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSR-----WVLQIADFGLHAFKA--GQDE-----T-GQERKLRRRKL 91 (423)
Q Consensus 25 ~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~-----~~vKL~DFGla~~~~--~~~~-----~-~~~~~~~gt~~ 91 (423)
.+.++.|++.+|++||+.|++ ||||||.|+++... ..+.|.|||+++... .... . .......||..
T Consensus 124 ~l~ia~q~l~~l~~lH~~G~i-HRDiKp~N~~~g~~~~~~~~~~~llDfGlar~~~~~~~~~~~~~~~r~~~~~~rGT~r 202 (322)
T KOG1164|consen 124 VLRIAIQNLNALEDLHSKGFI-HRDIKPENFVVGQSSRSEVRTLYLLDFGLARRFKYVGDSGGNLRPPRPQKGLFRGTLR 202 (322)
T ss_pred HHHHHHHHHHHHHHHHhcCcc-cCCcCHHHeeecCCCCcccceEEEEecCCCccccccCCCCcccccCCCCccCCCCccc
Confidence 589999999999999999999 99999999999754 469999999998322 1111 1 11234569999
Q ss_pred ccCCccccCCCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCChH-HHHHHHhcCCCCCCCCCCCCchHHHHHHHHHhh
Q psy1840 92 YKAPELLRQPHLPRGTQKGDVYSFGLVLYEVIGRQGPWGHLRMTDE-EIITSVTQGSGLRPDTSSLDCAPSIIACMRTCW 170 (423)
Q Consensus 92 y~APE~l~~~~~~~~s~ksDVyS~Giil~elltg~~Pf~~~~~~~~-~i~~~i~~~~~~~p~~~~~~~~~~l~~Li~~C~ 170 (423)
|+++....+... +.+.|+||++.++.|++.|..||........ .-............ .....+.++..++..+-
T Consensus 203 y~S~~~H~~~e~---~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~ 277 (322)
T KOG1164|consen 203 YASINVHLGIEQ---GRRDDLESLFYMLLELLKGSLPWEALEMTDLKSKFEKDPRKLLTDR--FGDLKPEEFAKILEYID 277 (322)
T ss_pred cccHHHhCCCcc---CCchhhhhHHHHHHHHhcCCCCCccccccchHHHHHHHhhhhcccc--ccCCChHHHHHHHHHhh
Confidence 999998888765 8999999999999999999999975543222 11111111111110 12235678888888888
Q ss_pred hcCCCCCCCHHHHHHHHHHHhhhc
Q psy1840 171 EEDPELRPDLRFVHHKLKEMNAGL 194 (423)
Q Consensus 171 ~~dP~~RPt~~~I~~~L~~i~~~~ 194 (423)
..+...+|....+...++......
T Consensus 278 ~~~~~~~Pdy~~~~~~l~~~~~~~ 301 (322)
T KOG1164|consen 278 SLDYEDKPDYEKLAELLKDVFDSE 301 (322)
T ss_pred ccCCcCCCCHHHHHHHHHHHHHhc
Confidence 899999999999998887766543
|
|
| >KOG1167|consensus | Back alignment and domain information |
|---|
Probab=99.50 E-value=3.5e-14 Score=137.64 Aligned_cols=159 Identities=20% Similarity=0.284 Sum_probs=109.4
Q ss_pred HHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcC-CccEEEeccCCcccccC--------C------Cc----------
Q psy1840 25 SISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDS-RWVLQIADFGLHAFKAG--------Q------DE---------- 79 (423)
Q Consensus 25 ~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~-~~~vKL~DFGla~~~~~--------~------~~---------- 79 (423)
....+..+..||.|+|++||| |||+||+|+|.+. -+.-.|.|||++..... . ..
T Consensus 134 i~~Yl~~ll~Al~~~h~~GIv-HRDiKpsNFL~n~~t~rg~LvDFgLA~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~ 212 (418)
T KOG1167|consen 134 IRWYLRNLLKALAHLHKNGIV-HRDIKPSNFLYNRRTQRGVLVDFGLAQRYDGYQQTEHSRSYSGRHATPAMGKDVHCQS 212 (418)
T ss_pred HHHHHHHHHHHhhhhhccCcc-ccCCCccccccccccCCceEEechhHHHHHhhhhhhhhhhhhcccCCccccCcccccc
Confidence 356788999999999999999 9999999999974 45678999999761100 0 00
Q ss_pred ------c------------cccccccCCccccCCccccCCCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCChHHHHH
Q psy1840 80 ------T------------GQERKLRRRKLYKAPELLRQPHLPRGTQKGDVYSFGLVLYEVIGRQGPWGHLRMTDEEIIT 141 (423)
Q Consensus 80 ------~------------~~~~~~~gt~~y~APE~l~~~~~~~~s~ksDVyS~Giil~elltg~~Pf~~~~~~~~~i~~ 141 (423)
. ...-...||++|.|||++..-. .-+.+.||||-|+|+..++++..||.....+...+.+
T Consensus 213 ~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~--~QttaiDiws~GVI~Lslls~~~PFf~a~dd~~al~e 290 (418)
T KOG1167|consen 213 VATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCP--RQTTAIDIWSAGVILLSLLSRRYPFFKAKDDADALAE 290 (418)
T ss_pred cccccCCCCceeccCCCccceecccCCCCCCCchHHHhhcc--CcCCccceeeccceeehhhccccccccCccccchHHH
Confidence 0 0001245889999999987532 3388999999999999999999998543222211111
Q ss_pred HHh-------------cCC-------------------------CCC--------CCCCCCCchHHHHHHHHHhhhcCCC
Q psy1840 142 SVT-------------QGS-------------------------GLR--------PDTSSLDCAPSIIACMRTCWEEDPE 175 (423)
Q Consensus 142 ~i~-------------~~~-------------------------~~~--------p~~~~~~~~~~l~~Li~~C~~~dP~ 175 (423)
.+. .|. ... +.......+..+.+++.+|++.||.
T Consensus 291 i~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~~q~n~~~~~~~d~~~~~~~dlLdk~le~np~ 370 (418)
T KOG1167|consen 291 IATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYKSRQPNTEREIGSDVFPALLLDLLDKCLELNPQ 370 (418)
T ss_pred HHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhcccccccceeeccccccccHHHHHHHHHHccCChh
Confidence 100 000 000 1111123455899999999999999
Q ss_pred CCCCHHHHHHH
Q psy1840 176 LRPDLRFVHHK 186 (423)
Q Consensus 176 ~RPt~~~I~~~ 186 (423)
+|.|+++.++.
T Consensus 371 kRitAEeALkH 381 (418)
T KOG1167|consen 371 KRITAEDALKH 381 (418)
T ss_pred hcccHHHHhcC
Confidence 99999987653
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.49 E-value=8.7e-15 Score=139.44 Aligned_cols=137 Identities=18% Similarity=0.223 Sum_probs=89.7
Q ss_pred HHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCccEEEeccCCcccccCCCcccccccccCCccccCCccccCC---
Q psy1840 25 SISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKAPELLRQP--- 101 (423)
Q Consensus 25 ~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~--- 101 (423)
++.+..|+++-+++||+.|++ |+||+|+|++++.+|.+.|+||+....... ... . ...+..|.+||.....
T Consensus 147 rl~lT~Q~I~lvA~Lh~~GlV-Hgdi~~~nfll~~~G~v~Lg~F~~~~r~g~--~~~--~-~~~~~~~~PPe~~~~~~~~ 220 (288)
T PF14531_consen 147 RLSLTVQMIRLVANLHSYGLV-HGDIKPENFLLDQDGGVFLGDFSSLVRAGT--RYR--C-SEFPVAFTPPELESCAGQF 220 (288)
T ss_dssp HHHHHHHHHHHHHHHHHTTEE-EST-SGGGEEE-TTS-EEE--GGGEEETTE--EEE--G-GGS-TTTS-HHHHHHHTSC
T ss_pred HHHHHHHHHHHHHHHhhcceE-ecccceeeEEEcCCCCEEEcChHHHeecCc--eee--c-cCCCcccCChhhhhhhccc
Confidence 678889999999999999988 999999999999999999999986433211 111 0 2234668999977442
Q ss_pred --CCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCchHHHHHHHHHhhhcCCCCC
Q psy1840 102 --HLPRGTQKGDVYSFGLVLYEVIGRQGPWGHLRMTDEEIITSVTQGSGLRPDTSSLDCAPSIIACMRTCWEEDPELR 177 (423)
Q Consensus 102 --~~~~~s~ksDVyS~Giil~elltg~~Pf~~~~~~~~~i~~~i~~~~~~~p~~~~~~~~~~l~~Li~~C~~~dP~~R 177 (423)
....++.+.|.|++|+++|.|+++..||...... ..... .-.... +.|+.++.||..+|+.||++|
T Consensus 221 ~~~~~~~t~~~DaW~LG~~ly~lWC~~lPf~~~~~~---~~~~~------~f~~C~-~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 221 GQNNAPYTFATDAWQLGITLYSLWCGRLPFGLSSPE---ADPEW------DFSRCR-DMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp HHSEEEE-HHHHHHHHHHHHHHHHHSS-STCCCGGG---STSGG------GGTTSS----HHHHHHHHHHT-SSGGGS
T ss_pred CcccceeeeccCHHHHHHHHHHHHHccCCCCCCCcc---ccccc------cchhcC-CcCHHHHHHHHHHccCCcccC
Confidence 1113488999999999999999999999742110 00000 011122 678999999999999999988
|
|
| >KOG0603|consensus | Back alignment and domain information |
|---|
Probab=99.46 E-value=3.1e-14 Score=144.43 Aligned_cols=132 Identities=20% Similarity=0.321 Sum_probs=108.7
Q ss_pred HHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCccEEEeccCCcccccCCCcccccccccCCccccCCccccCCCCCCC
Q psy1840 27 SVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKAPELLRQPHLPRG 106 (423)
Q Consensus 27 ~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~ 106 (423)
.....++.+++++|+.+++ |||+|++||+++.+|++|+.|||+++....... .+||..|||||++.+.
T Consensus 101 ~~~aelaLald~lh~l~ii-yrd~k~enilld~~Ghi~~tdfglske~v~~~~------~cgt~eymApEI~~gh----- 168 (612)
T KOG0603|consen 101 FYLAELALALDHLHKLGIA-YRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKI------ACGTYEYRAPEIINGH----- 168 (612)
T ss_pred HHHHHHHHHHhhcchhHHH-HhcccccceeecccCccccCCchhhhHhHhhhh------cccchhhhhhHhhhcc-----
Confidence 4566788999999999998 999999999999999999999999886543322 2889999999999832
Q ss_pred CCccchHHHHHHHHHHHhCCCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCchHHHHHHHHHhhhcCCCCCCCH
Q psy1840 107 TQKGDVYSFGLVLYEVIGRQGPWGHLRMTDEEIITSVTQGSGLRPDTSSLDCAPSIIACMRTCWEEDPELRPDL 180 (423)
Q Consensus 107 s~ksDVyS~Giil~elltg~~Pf~~~~~~~~~i~~~i~~~~~~~p~~~~~~~~~~l~~Li~~C~~~dP~~RPt~ 180 (423)
...+|.||||++++|+++|..||.. ++...|.......|. ..+..+..++.++...+|.+|--.
T Consensus 169 ~~a~D~ws~gvl~felltg~~pf~~------~~~~~Il~~~~~~p~----~l~~~a~~~~~~l~~r~p~nrLg~ 232 (612)
T KOG0603|consen 169 LSAADWWSFGVLAFELLTGTLPFGG------DTMKRILKAELEMPR----ELSAEARSLFRQLFKRNPENRLGA 232 (612)
T ss_pred CCcccchhhhhhHHHHhhCCCCCch------HHHHHHhhhccCCch----hhhHHHHHHHHHHHhhCHHHHhcc
Confidence 7899999999999999999999974 566666554444333 467788899999999999999543
|
|
| >smart00044 CYCc Adenylyl- / guanylyl cyclase, catalytic domain | Back alignment and domain information |
|---|
Probab=99.35 E-value=1.3e-12 Score=118.78 Aligned_cols=88 Identities=47% Similarity=0.566 Sum_probs=83.4
Q ss_pred HHHHHHHHHHHhhCcHHHHHHHhCCC-CCCCccccceeEEEeeccccccccccCCHhHHHHhhhccch-hhhhccCCCce
Q psy1840 307 QEKKKTDALLHRMLPRSVSESLKRGD-FVEPESFDSVTIYFSDIVGFTQLSAESTETGRVTTRDSRRT-PDLKVGGSNPR 384 (423)
Q Consensus 307 ~e~~~~~~ll~~~lp~~ia~~l~~g~-~~~~~~~~~vtv~f~di~gft~~~~~~~p~~~v~~ln~~~~-fd~~~~~~~~~ 384 (423)
+|++++.+||.+++|++|+++|..|+ ...+..+.+|||+|+||+|||.+++..+|.+++.+||++|. +++++..++.+
T Consensus 1 ~~~~~~~~ll~~~lP~~v~~~l~~g~~~~~~~~~~~~tvlf~di~g~t~l~~~~~~~~~~~~l~~~~~~~~~~i~~~gg~ 80 (194)
T smart00044 1 EEKRKTDRLLDQLLPASVAESLKRGGSPVPAESYDNVTILFTDIVGFTTLSSEATPEQVVTLLNDLYSRFDRIIDRHGGY 80 (194)
T ss_pred ChHHHHHHHHHHhCCHHHHHHHHhCCCCccccccCeEEEEEeEhhhhhhhhhhCCHHHHHHHHHHHHHHHHHHHHhcCeE
Confidence 37899999999999999999999997 66778899999999999999999999999999999999999 99999999999
Q ss_pred EEEeecccCC
Q psy1840 385 QVITGTDMLR 394 (423)
Q Consensus 385 ~v~~~~~~~~ 394 (423)
.+.+.||.++
T Consensus 81 v~~~~Gd~~l 90 (194)
T smart00044 81 KVKTIGDAYM 90 (194)
T ss_pred EEEEeCCEEE
Confidence 9999999888
|
Present in two copies in mammalian adenylyl cyclases. Eubacterial homologues are known. Two residues (Asn, Arg) are thought to be involved in catalysis. These cyclases have important roles in a diverse range of cellular processes. |
| >KOG1163|consensus | Back alignment and domain information |
|---|
Probab=99.19 E-value=5.9e-11 Score=107.89 Aligned_cols=165 Identities=16% Similarity=0.237 Sum_probs=123.3
Q ss_pred HHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEc---CCccEEEeccCCcccccCCCcc-----cccccccCCccccCCcc
Q psy1840 26 ISVNTTASVGMIHLHDSEIISHGNLRSSNCLID---SRWVLQIADFGLHAFKAGQDET-----GQERKLRRRKLYKAPEL 97 (423)
Q Consensus 26 l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld---~~~~vKL~DFGla~~~~~~~~~-----~~~~~~~gt~~y~APE~ 97 (423)
+-++.|++.-++|+|.++.| ||||||+|.|.. ....+-++|||+++...+.... .......||..|.+--.
T Consensus 114 LMLaDQml~RiEyvH~r~fi-HRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~d~~t~~HIpyre~r~ltGTaRYASinA 192 (341)
T KOG1163|consen 114 LMLADQMLSRIEYVHLRNFI-HRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYRDIRTRQHIPYREDRNLTGTARYASINA 192 (341)
T ss_pred HHHHHHHHHHHHHHHhhccc-cccCCccceeeccccccceEEEEeccchhhhccccccccCccccCCccceeeeehhhhh
Confidence 67889999999999999999 999999999985 3457889999999865433221 22244568888888766
Q ss_pred ccCCCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCh-HHHHHHHhcCCCCCC-CCCCCCchHHHHHHHHHhhhcCCC
Q psy1840 98 LRQPHLPRGTQKGDVYSFGLVLYEVIGRQGPWGHLRMTD-EEIITSVTQGSGLRP-DTSSLDCAPSIIACMRTCWEEDPE 175 (423)
Q Consensus 98 l~~~~~~~~s~ksDVyS~Giil~elltg~~Pf~~~~~~~-~~i~~~i~~~~~~~p-~~~~~~~~~~l~~Li~~C~~~dP~ 175 (423)
..+... +...|+-|+|.++...-.|..||++..... .+-.+++...+..-| ...-...|.++...+..|-..--+
T Consensus 193 h~g~eq---SRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKyEkI~EkK~s~~ie~LC~G~P~EF~myl~Y~R~L~F~ 269 (341)
T KOG1163|consen 193 HLGIEQ---SRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKYEKISEKKMSTPIEVLCKGFPAEFAMYLNYCRGLGFE 269 (341)
T ss_pred hhhhhh---hhhhhhhhhcceeeeeecCCCcccccchhhHHHHHHHHHHhhcCCCHHHHhCCCcHHHHHHHHHHhhcCCC
Confidence 655443 788999999999999999999998764433 333444444332222 112256889999999999999999
Q ss_pred CCCCHHHHHHHHHHHhhhc
Q psy1840 176 LRPDLRFVHHKLKEMNAGL 194 (423)
Q Consensus 176 ~RPt~~~I~~~L~~i~~~~ 194 (423)
+-|+..-+.+.+.-+....
T Consensus 270 E~Pdy~ylrqlFriLfr~l 288 (341)
T KOG1163|consen 270 EKPDYMYLRQLFRILFRTL 288 (341)
T ss_pred CCCcHHHHHHHHHHHHhhc
Confidence 9999988888777666544
|
|
| >KOG1165|consensus | Back alignment and domain information |
|---|
Probab=99.19 E-value=2e-10 Score=108.79 Aligned_cols=163 Identities=15% Similarity=0.236 Sum_probs=127.0
Q ss_pred HHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcC-----CccEEEeccCCcccccCCCc-----ccccccccCCccccCC
Q psy1840 26 ISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDS-----RWVLQIADFGLHAFKAGQDE-----TGQERKLRRRKLYKAP 95 (423)
Q Consensus 26 l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~-----~~~vKL~DFGla~~~~~~~~-----~~~~~~~~gt~~y~AP 95 (423)
+.++.|++.-++|+|++.+| .|||||+|.||.. ...+.++|||+++...+... ........||..||+-
T Consensus 127 ~miA~Qmi~rie~vH~k~LI-YRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~YrDp~TkqHIPYrE~KSLsGTARYMSI 205 (449)
T KOG1165|consen 127 AMIAKQMITRIEYVHEKDLI-YRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEYRDPKTKQHIPYREHKSLSGTARYMSI 205 (449)
T ss_pred HHHHHHHHHHHHHHHhccee-ecccCccceeecCCCCCCCceEEEEeccchhhhcCccccccCccccccccccceeeeEe
Confidence 67899999999999999999 9999999999964 34689999999987654332 2234567799999998
Q ss_pred ccccCCCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCC-ChHHHHHHHhcCCCCCCC-CCCCCchHHHHHHHHHhhhcC
Q psy1840 96 ELLRQPHLPRGTQKGDVYSFGLVLYEVIGRQGPWGHLRM-TDEEIITSVTQGSGLRPD-TSSLDCAPSIIACMRTCWEED 173 (423)
Q Consensus 96 E~l~~~~~~~~s~ksDVyS~Giil~elltg~~Pf~~~~~-~~~~i~~~i~~~~~~~p~-~~~~~~~~~l~~Li~~C~~~d 173 (423)
-...+... +...|.-|+|-+++..+.|..||.+... +.++-.++|-..+..-|. ..-.++|.++...+...-..+
T Consensus 206 NTHlGrEQ---SRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~kYeKIGe~Kr~T~i~~Lc~g~P~efa~Yl~yvR~L~ 282 (449)
T KOG1165|consen 206 NTHLGREQ---SRRDDLEALGHVFMYFLRGSLPWQGLKADTNKEKYEKIGETKRSTPIEVLCEGFPEEFATYLRYVRRLD 282 (449)
T ss_pred eccccchh---hhhhhHHHhhhhhhhhccCCCccccccCcchHHHHHHhccccccCCHHHHHhcCHHHHHHHHHHHHhcC
Confidence 87777655 8899999999999999999999988643 445556666554332221 112467889999999888888
Q ss_pred CCCCCCHHHHHHHHHHHhh
Q psy1840 174 PELRPDLRFVHHKLKEMNA 192 (423)
Q Consensus 174 P~~RPt~~~I~~~L~~i~~ 192 (423)
-++-|+.+-+...+..+..
T Consensus 283 F~E~PDYdylr~Lf~dvld 301 (449)
T KOG1165|consen 283 FFETPDYDYLRKLFDDVLD 301 (449)
T ss_pred cccCCCHHHHHHHHHHHHH
Confidence 8999999988777666554
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.14 E-value=4.8e-11 Score=118.37 Aligned_cols=76 Identities=22% Similarity=0.247 Sum_probs=61.2
Q ss_pred HHHHHHHHHHHHHHHhCCCeeecCC-CCCCEEEcCCccEEEeccCCcccccCCCccc------ccccccCCccccCCccc
Q psy1840 26 ISVNTTASVGMIHLHDSEIISHGNL-RSSNCLIDSRWVLQIADFGLHAFKAGQDETG------QERKLRRRKLYKAPELL 98 (423)
Q Consensus 26 l~i~~qi~~gL~yLH~~~ii~HrDL-kp~NILld~~~~vKL~DFGla~~~~~~~~~~------~~~~~~gt~~y~APE~l 98 (423)
..++.|+++||.|||+.|++ |||| ||+|||++.++.+||+|||+++......... ......+++.|+|||.+
T Consensus 114 ~~~~~~i~~aL~~lH~~gIi-HrDL~KP~NILv~~~~~ikLiDFGlA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~ 192 (365)
T PRK09188 114 PAWFRSAHRALRDLHRAGIT-HNDLAKPQNWLMGPDGEAAVIDFQLASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDAL 192 (365)
T ss_pred HHHHHHHHHHHHHHHHCCCe-eCCCCCcceEEEcCCCCEEEEECccceecccCcchhhhhhhhhhhhhhccCccCCcccC
Confidence 57899999999999999998 9999 9999999999999999999988654332111 11345677789999999
Q ss_pred cCCC
Q psy1840 99 RQPH 102 (423)
Q Consensus 99 ~~~~ 102 (423)
....
T Consensus 193 ~~~~ 196 (365)
T PRK09188 193 TPRE 196 (365)
T ss_pred Chhh
Confidence 7643
|
|
| >KOG0590|consensus | Back alignment and domain information |
|---|
Probab=99.05 E-value=3.6e-11 Score=126.78 Aligned_cols=157 Identities=21% Similarity=0.280 Sum_probs=118.6
Q ss_pred HHHHHHHHHHHHHHHH-hCCCeeecCCCCCCEEEcCCc-cEEEeccCCcccccC-CCcccccccccC-CccccCCccccC
Q psy1840 25 SISVNTTASVGMIHLH-DSEIISHGNLRSSNCLIDSRW-VLQIADFGLHAFKAG-QDETGQERKLRR-RKLYKAPELLRQ 100 (423)
Q Consensus 25 ~l~i~~qi~~gL~yLH-~~~ii~HrDLkp~NILld~~~-~vKL~DFGla~~~~~-~~~~~~~~~~~g-t~~y~APE~l~~ 100 (423)
+=....|+..|+.|+| ..++. |+|+||+|.+++.++ ..|++|||++..... ..........+| ++.|+|||...+
T Consensus 125 ~~~~~~ql~s~l~~~H~~~~~~-h~~ikP~n~~l~~s~~~l~~~df~~At~~~~~~g~~~~~~~~~g~s~~y~a~E~~~~ 203 (601)
T KOG0590|consen 125 ASRYLPQLNSGLSYLHPENGVT-HRDIKPSNSLLDESGSALKIADFGLATAYRNKNGAERSLKDRCGSSPPYGAPEHLSG 203 (601)
T ss_pred hhhhhhhhccCccccCcccccc-cCCCCCccchhccCCCcccCCCchhhccccccCCcceeeecccCCCCCCCCcccccc
Confidence 3467889999999999 88887 999999999999999 999999999886654 333334445567 899999999987
Q ss_pred CCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCchHHHHHHHHHhhhcCCCCCCCH
Q psy1840 101 PHLPRGTQKGDVYSFGLVLYEVIGRQGPWGHLRMTDEEIITSVTQGSGLRPDTSSLDCAPSIIACMRTCWEEDPELRPDL 180 (423)
Q Consensus 101 ~~~~~~s~ksDVyS~Giil~elltg~~Pf~~~~~~~~~i~~~i~~~~~~~p~~~~~~~~~~l~~Li~~C~~~dP~~RPt~ 180 (423)
..+ .....|+||.|+++.-+++|..|+................. ...-..+.........+++..++..+|+.|.+.
T Consensus 204 ~~~--~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~ 280 (601)
T KOG0590|consen 204 KAY--RGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRYSSWKSNK-GRFTQLPWNSISDQAHDLLHKILKENPSNRLSI 280 (601)
T ss_pred hhh--cCCCcccccccccccccccCCCCccccccccccceeecccc-cccccCccccCChhhhhcccccccCCchhcccc
Confidence 532 37889999999999999999999865433222222222221 111122344667888999999999999999998
Q ss_pred HHHHH
Q psy1840 181 RFVHH 185 (423)
Q Consensus 181 ~~I~~ 185 (423)
.++..
T Consensus 281 ~~~~~ 285 (601)
T KOG0590|consen 281 EELKL 285 (601)
T ss_pred ccccc
Confidence 88754
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.00 E-value=5.6e-10 Score=101.76 Aligned_cols=104 Identities=15% Similarity=0.118 Sum_probs=74.5
Q ss_pred HHHHHHHHHHHHHHHHhCCCeeecCC-CCCCEEEcCCccEEEeccCCcccccCCCcc----cc-------cccccCCccc
Q psy1840 25 SISVNTTASVGMIHLHDSEIISHGNL-RSSNCLIDSRWVLQIADFGLHAFKAGQDET----GQ-------ERKLRRRKLY 92 (423)
Q Consensus 25 ~l~i~~qi~~gL~yLH~~~ii~HrDL-kp~NILld~~~~vKL~DFGla~~~~~~~~~----~~-------~~~~~gt~~y 92 (423)
...+..|++.++.++|+.|++ |||| ||.|||++.++.++|+|||++......... .. ......++.|
T Consensus 93 ~~~~~~qi~~~L~~lH~~GIv-HrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~~~r~L~~rDl~~llk~~~~y~~~~ 171 (218)
T PRK12274 93 DLAYFRAARRLLQQLHRCGVA-HNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRARWMRLLAREDLRHLLKHKRMYCPAA 171 (218)
T ss_pred hHHHHHHHHHHHHHHHHCcCc-cCCCCCcceEEEcCCCCEEEEECCCceecCCcchHHHHHHHHHHHHHHHHHHhcCCCC
Confidence 356888999999999999998 9999 799999999999999999998754322210 00 0111244556
Q ss_pred cCCccccCCCCCCCCCccchHHHHHHHHHHHhCCCCCC
Q psy1840 93 KAPELLRQPHLPRGTQKGDVYSFGLVLYEVIGRQGPWG 130 (423)
Q Consensus 93 ~APE~l~~~~~~~~s~ksDVyS~Giil~elltg~~Pf~ 130 (423)
++|+.-..-.. ..-...+-++.|.-+|.++||..++.
T Consensus 172 l~~~~~~~l~~-~~~~~~~w~~~g~~~~~~~~~~~~~~ 208 (218)
T PRK12274 172 LTPVERRVLKR-TSWIRELWFATGKPVYRFVTRRVLHW 208 (218)
T ss_pred CCHHHHhhhcc-chhHHHHHHHhcchHHHHHhccCCcc
Confidence 66664432211 11256788889999999999998864
|
|
| >KOG1166|consensus | Back alignment and domain information |
|---|
Probab=98.91 E-value=7.6e-09 Score=112.30 Aligned_cols=157 Identities=17% Similarity=0.144 Sum_probs=107.1
Q ss_pred CCCCCChHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEc-------CCccEEEeccCCcccccCCCcccccccccC
Q psy1840 16 LSPFNIPIGSISVNTTASVGMIHLHDSEIISHGNLRSSNCLID-------SRWVLQIADFGLHAFKAGQDETGQERKLRR 88 (423)
Q Consensus 16 ~~~~~~p~~~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld-------~~~~vKL~DFGla~~~~~~~~~~~~~~~~g 88 (423)
.++|.+ -+.|+.|++.-+++||..+|| ||||||+|++|. ....++|+|||.+--..-..........++
T Consensus 790 ~m~e~l---v~~~~~qml~ive~lH~~~II-HgDiKPDNfll~~~~~~~~~~~~l~lIDfG~siDm~lfp~~~~F~~~~~ 865 (974)
T KOG1166|consen 790 VMDEYL---VMFFSCQMLRIVEHLHAMGII-HGDIKPDNFLLRREICADSDSKGLYLIDFGRSIDMKLFPDGTKFKAVWH 865 (974)
T ss_pred CCCchh---hhHHHHHHHHHHHHHHhccee-cccCCcceeEeecccCCCCcccceEEEecccceeeeEcCCCcEEeeeec
Confidence 456666 679999999999999999999 999999999993 345799999998753222222223345677
Q ss_pred CccccCCccccCCCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCChHHHHHHHhcCCCCCCCC-CCCCchHH-HHHHH
Q psy1840 89 RKLYKAPELLRQPHLPRGTQKGDVYSFGLVLYEVIGRQGPWGHLRMTDEEIITSVTQGSGLRPDT-SSLDCAPS-IIACM 166 (423)
Q Consensus 89 t~~y~APE~l~~~~~~~~s~ksDVyS~Giil~elltg~~Pf~~~~~~~~~i~~~i~~~~~~~p~~-~~~~~~~~-l~~Li 166 (423)
|-.+-++|+..|..+ +..+|-|.++-+++-|+.|+.- + +..+....+.. .......+ ..++.
T Consensus 866 td~f~C~EM~~grpW---tYq~DyfGlAa~~h~mLFG~y~------------q-~~~g~~~~~~~~~~Ry~~~~~W~~~F 929 (974)
T KOG1166|consen 866 TDLFDCIEMREGRPW---TYQIDYFGLAATVHVMLFGKYM------------E-VKNGSSWMVKTNFPRYWKRDMWNKFF 929 (974)
T ss_pred cccchhHHHhcCCCC---chhhhhHHHHHHHHHHHHHHHH------------H-hcCCcceeccccchhhhhHHHHHHHH
Confidence 888999999999888 9999999999999999987521 1 22221111111 11112222 33466
Q ss_pred HHhhhcCCCCCCCHHHHHHHHHHHhh
Q psy1840 167 RTCWEEDPELRPDLRFVHHKLKEMNA 192 (423)
Q Consensus 167 ~~C~~~dP~~RPt~~~I~~~L~~i~~ 192 (423)
..+|+.|-..=|...++...++++..
T Consensus 930 ~~lLN~~~~~~p~l~~lr~~~~~~~~ 955 (974)
T KOG1166|consen 930 DLLLNPDCDTLPNLQELRTELEEVLA 955 (974)
T ss_pred HHHhCcCcccchhHHHHHHHHHHHHH
Confidence 67777444444677777776665543
|
|
| >KOG2137|consensus | Back alignment and domain information |
|---|
Probab=98.79 E-value=3.2e-09 Score=109.68 Aligned_cols=152 Identities=18% Similarity=0.252 Sum_probs=103.3
Q ss_pred HHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCccEEEeccCCcccccCCCcc-------cccccccCCccccCCcccc
Q psy1840 27 SVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDET-------GQERKLRRRKLYKAPELLR 99 (423)
Q Consensus 27 ~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~~-------~~~~~~~gt~~y~APE~l~ 99 (423)
.=+.+.+.|+.|+|.+.-++|++|.|++|.++.++.+||+.|+.+....+.... ...........|.|||++.
T Consensus 103 ~nl~~v~dgl~flh~sAk~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~ 182 (700)
T KOG2137|consen 103 ANLGNVADGLAFLHRSAKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLL 182 (700)
T ss_pred hhhhcccchhhhhccCcceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhc
Confidence 334566689999999855559999999999999999999999986544332111 1111223445699999998
Q ss_pred CCCCCCCCCccchHHHHHHHHHHHh-CCCCCCCCCCChHHHHHHHhcCC-CCCCCCCCCCchHHHHHHHHHhhhcCCCCC
Q psy1840 100 QPHLPRGTQKGDVYSFGLVLYEVIG-RQGPWGHLRMTDEEIITSVTQGS-GLRPDTSSLDCAPSIIACMRTCWEEDPELR 177 (423)
Q Consensus 100 ~~~~~~~s~ksDVyS~Giil~ellt-g~~Pf~~~~~~~~~i~~~i~~~~-~~~p~~~~~~~~~~l~~Li~~C~~~dP~~R 177 (423)
+... +.++|+||+|+++|-+.. |+.-+...+.. +........ ..........++.++.+-+.+.+..++..|
T Consensus 183 ~~~~---~~~sd~fSlG~li~~i~~~gk~i~~a~~~~---~~~~~~~~~~~~~~~~~s~~~p~el~~~l~k~l~~~~~~r 256 (700)
T KOG2137|consen 183 GTTN---TPASDVFSLGVLIYTIYNGGKSIIAANGGL---LSYSFSRNLLNAGAFGYSNNLPSELRESLKKLLNGDSAVR 256 (700)
T ss_pred cccc---cccccceeeeeEEEEEecCCcchhhccCCc---chhhhhhcccccccccccccCcHHHHHHHHHHhcCCcccC
Confidence 7544 899999999999999984 44333322111 111111111 011111224789999999999999999999
Q ss_pred CCHHHHH
Q psy1840 178 PDLRFVH 184 (423)
Q Consensus 178 Pt~~~I~ 184 (423)
|++..+.
T Consensus 257 p~~~~l~ 263 (700)
T KOG2137|consen 257 PTLDLLL 263 (700)
T ss_pred cchhhhh
Confidence 9877663
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=98.79 E-value=2.3e-09 Score=99.45 Aligned_cols=78 Identities=17% Similarity=0.265 Sum_probs=57.9
Q ss_pred HHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCccEEEeccCCcccccCCCcccccccccCCccccCCccccCCCCCCC
Q psy1840 27 SVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKAPELLRQPHLPRG 106 (423)
Q Consensus 27 ~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~ 106 (423)
....+++.++..+|..|++ |||+||+|++++.++ ++|+|||........... . .++....+
T Consensus 139 ~~~~~i~~~l~~lH~~gi~-H~Dikp~Nili~~~g-i~liDfg~~~~~~e~~a~---d-----------~~vler~y--- 199 (232)
T PRK10359 139 DVKAKIKASIESLHQHGMV-SGDPHKGNFIVSKNG-LRIIDLSGKRCTAQRKAK---D-----------RIDLERHY--- 199 (232)
T ss_pred HHHHHHHHHHHHHHHcCCc-cCCCChHHEEEeCCC-EEEEECCCcccccchhhH---H-----------HHHHHhHh---
Confidence 4567999999999999998 999999999999988 999999986543211100 0 02223333
Q ss_pred CCccchHHHHHHHHHHH
Q psy1840 107 TQKGDVYSFGLVLYEVI 123 (423)
Q Consensus 107 s~ksDVyS~Giil~ell 123 (423)
..++|+||||+.+.-..
T Consensus 200 ~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 200 GIKNEIKDLGYYLLIYK 216 (232)
T ss_pred cccccccceeEeehHHH
Confidence 46899999999876543
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=98.78 E-value=8.2e-09 Score=93.54 Aligned_cols=50 Identities=18% Similarity=0.127 Sum_probs=45.6
Q ss_pred HHHHHHHHHHHHHHHHHh-CCCeeecCCCCCCEEEcCCccEEEeccCCccccc
Q psy1840 24 GSISVNTTASVGMIHLHD-SEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKA 75 (423)
Q Consensus 24 ~~l~i~~qi~~gL~yLH~-~~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~ 75 (423)
....++.|++.++.++|+ .|++ ||||||+||+++ ++.++|+|||++....
T Consensus 118 ~~~~i~~~l~~~l~~lH~~~giv-HrDlkP~NIll~-~~~~~liDFG~a~~~~ 168 (190)
T cd05145 118 EAEELYEQVVEQMRRLYQEAGLV-HGDLSEYNILYH-DGKPYIIDVSQAVELD 168 (190)
T ss_pred HHHHHHHHHHHHHHHHHHhCCEe-cCCCChhhEEEE-CCCEEEEEcccceecC
Confidence 467999999999999999 9998 999999999999 7899999999987653
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=98.76 E-value=9.4e-09 Score=93.24 Aligned_cols=48 Identities=21% Similarity=0.160 Sum_probs=43.2
Q ss_pred HHHHHHHHHHHHHHH-HhCCCeeecCCCCCCEEEcCCccEEEeccCCcccc
Q psy1840 25 SISVNTTASVGMIHL-HDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFK 74 (423)
Q Consensus 25 ~l~i~~qi~~gL~yL-H~~~ii~HrDLkp~NILld~~~~vKL~DFGla~~~ 74 (423)
...++.|++.+|.|+ |+.|++ ||||||+||+++ ++.++|+|||++...
T Consensus 119 ~~~i~~qi~~~L~~l~H~~gii-HrDlkP~NIli~-~~~v~LiDFG~a~~~ 167 (190)
T cd05147 119 ARELYLQVIQIMRILYQDCRLV-HADLSEYNLLYH-DGKLYIIDVSQSVEH 167 (190)
T ss_pred HHHHHHHHHHHHHHHHHhCCcc-cCCCCHHHEEEE-CCcEEEEEccccccC
Confidence 578999999999999 688988 999999999998 478999999998654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >PF00211 Guanylate_cyc: Adenylate and Guanylate cyclase catalytic domain; InterPro: IPR001054 Guanylate cyclases (4 | Back alignment and domain information |
|---|
Probab=98.71 E-value=4.3e-09 Score=94.61 Aligned_cols=58 Identities=26% Similarity=0.264 Sum_probs=55.8
Q ss_pred ccccceeEEEeeccccccccccCCHhHHHHhhhccch-hhhhccCCCceEEEeecccCC
Q psy1840 337 ESFDSVTIYFSDIVGFTQLSAESTETGRVTTRDSRRT-PDLKVGGSNPRQVITGTDMLR 394 (423)
Q Consensus 337 ~~~~~vtv~f~di~gft~~~~~~~p~~~v~~ln~~~~-fd~~~~~~~~~~v~~~~~~~~ 394 (423)
+.+++|||+|+||+|||.+++..+|.+++.+||++|+ ++.++++++.+.+++.||.++
T Consensus 4 ~~~~~vtvlf~di~~ft~l~~~~~~~~~~~~l~~~~~~~~~~v~~~~g~~~~~~Gd~~~ 62 (184)
T PF00211_consen 4 EQYRNVTVLFADIVGFTDLTEQLDPEELVRLLNDFFSSLDRIVKQHGGEIIKFIGDGVM 62 (184)
T ss_dssp EEEEEEEEEEEEETTHHHHHHHSHHHHHHHHHHHHHHHHHHHHHHTTEEEEEEETTEEE
T ss_pred cccCeEEEEEEEecCcHHHHHhCCchhHHHHHHHHHHHhhhccccccccccccccceeE
Confidence 6789999999999999999999999999999999999 999999999999999999988
|
6.1.2 from EC) catalyse the formation of cyclic GMP (cGMP) from GTP. cGMP acts as an intracellular messenger, activating cGMP-dependent kinases and regulating cGMP-sensitive ion channels. The role of cGMP as a second messenger in vascular smooth muscle relaxation and retinal photo-transduction is well established. Guanylate cyclase is found both in the soluble and particulate fractions of eukaryotic cells. The soluble and plasma membrane-bound forms differ in structure, regulation and other properties [, , , ]. Most currently known plasma membrane-bound forms are receptors for small polypeptides. The soluble forms of guanylate cyclase are cytoplasmic heterodimers having alpha and beta subunits. In all characterised eukaryote guanylyl- and adenylyl cyclases, cyclic nucleotide synthesis is carried out by the conserved class III cyclase domain. ; GO: 0016849 phosphorus-oxygen lyase activity, 0009190 cyclic nucleotide biosynthetic process, 0035556 intracellular signal transduction; PDB: 3UVJ_A 1FX4_A 1WC4_B 2BW7_D 1WC1_A 1WC0_A 1WC3_A 1WC5_A 1WC6_A 3ET6_B .... |
| >KOG3618|consensus | Back alignment and domain information |
|---|
Probab=98.70 E-value=9.1e-09 Score=105.86 Aligned_cols=94 Identities=19% Similarity=0.214 Sum_probs=81.7
Q ss_pred HHHHHHHHHHHHHHHHHHhhCcHHHHHHHhCCCCCCCccccceeEEEeecccccccccc--CCHhHHHHhhhccch-hhh
Q psy1840 300 ERTNQLTQEKKKTDALLHRMLPRSVSESLKRGDFVEPESFDSVTIYFSDIVGFTQLSAE--STETGRVTTRDSRRT-PDL 376 (423)
Q Consensus 300 ~~~~~l~~e~~~~~~ll~~~lp~~ia~~l~~g~~~~~~~~~~vtv~f~di~gft~~~~~--~~p~~~v~~ln~~~~-fd~ 376 (423)
.-+...+.-+.++|-||.+++|.++||+||...+. .+.++++-|+||.||||.++-.+ -.-.|-...||++.. ||+
T Consensus 1043 ~d~~riQ~mrdQADwLL~NiIP~HvaE~LK~~~kY-SeNH~~~gviFASIvNfnemYeEnyeGGkEflRVLNElIGDFDE 1121 (1318)
T KOG3618|consen 1043 LDRTRIQSMRDQADWLLRNIIPYHVAEQLKVSQKY-SENHDSGGVIFASIVNFNEMYEENYEGGKEFLRVLNELIGDFDE 1121 (1318)
T ss_pred hhHHHHHHHHHHHHHHHhccchHHHHHHhhccccc-cccCccceEEEEEeccHHHHHHHhhhchHHHHHHHHHHhccHHH
Confidence 33445677788999999999999999999998776 57889999999999999988654 356788999999998 999
Q ss_pred hccCC---CceEEEeecccCC
Q psy1840 377 KVGGS---NPRQVITGTDMLR 394 (423)
Q Consensus 377 ~~~~~---~~~~v~~~~~~~~ 394 (423)
+.++. -++||+|+|+.||
T Consensus 1122 LLsrPdf~~iEKIKTIG~tyM 1142 (1318)
T KOG3618|consen 1122 LLSRPDFSSIEKIKTIGATYM 1142 (1318)
T ss_pred HhccccchhhHHHhhhhHHHH
Confidence 99994 5899999999999
|
|
| >COG2114 CyaA Adenylate cyclase, family 3 (some proteins contain HAMP domain) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.62 E-value=9.6e-08 Score=89.13 Aligned_cols=86 Identities=27% Similarity=0.248 Sum_probs=75.9
Q ss_pred HHHHHHHHHHHHHhhCcHHHHHHHhCCCCCCCccccceeEEEeeccccccccccCCHhHHHHhhhccch-hhhhccCCCc
Q psy1840 305 LTQEKKKTDALLHRMLPRSVSESLKRGDFVEPESFDSVTIYFSDIVGFTQLSAESTETGRVTTRDSRRT-PDLKVGGSNP 383 (423)
Q Consensus 305 l~~e~~~~~~ll~~~lp~~ia~~l~~g~~~~~~~~~~vtv~f~di~gft~~~~~~~p~~~v~~ln~~~~-fd~~~~~~~~ 383 (423)
...+....+.++...++..+.+++..+. . .. ..|||+|+||+|||.++....|..++.+||.+|. ++..|..|+.
T Consensus 14 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~--~~-~~vtilfaDi~g~T~l~~~~~~~~~~~ll~~~~~~~~~~v~~~gG 89 (227)
T COG2114 14 VAAAGLRSDLVLRLYLARVVGRLLARGG-A--GD-RRVTLLFADIVGSTELSESLGDEALVELLNLYFDAVAEVVARHGG 89 (227)
T ss_pred HHhhhhhhhHHHHHHhhhccchhhcccc-c--cC-ceEEEEEEeeccchHHhhhCCHHHHHHHHHHHHHHHHHHHHHcCC
Confidence 3455666778888899999999999886 2 22 9999999999999999999999999999999999 9999999999
Q ss_pred eEEEeecccCC
Q psy1840 384 RQVITGTDMLR 394 (423)
Q Consensus 384 ~~v~~~~~~~~ 394 (423)
..++++||.++
T Consensus 90 ~v~k~iGD~~l 100 (227)
T COG2114 90 RVVKFIGDGFL 100 (227)
T ss_pred EEEEEecceEE
Confidence 99999999888
|
|
| >KOG1266|consensus | Back alignment and domain information |
|---|
Probab=98.61 E-value=3.5e-08 Score=93.76 Aligned_cols=148 Identities=21% Similarity=0.257 Sum_probs=95.7
Q ss_pred HHHHHHHHHHHHHHhC-CCeeecCCCCCCEEEcCCccEEEeccCCcccccC--CCcccccccccCCccccCCccccCCCC
Q psy1840 27 SVNTTASVGMIHLHDS-EIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAG--QDETGQERKLRRRKLYKAPELLRQPHL 103 (423)
Q Consensus 27 ~i~~qi~~gL~yLH~~-~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~--~~~~~~~~~~~gt~~y~APE~l~~~~~ 103 (423)
+|+.||.+||.|||+. ..++|+++..+.|++..+|-+|++--.-...-.. ...........+-+.|.+||.-.....
T Consensus 180 kw~tqIlsal~yLhs~~PpiihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~ 259 (458)
T KOG1266|consen 180 KWCTQILSALSYLHSCDPPIIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNT 259 (458)
T ss_pred HHHHHHHhhhhhhhccCCccccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCccccc
Confidence 7999999999999986 4555999999999999999888764322111100 000111122345567999997654443
Q ss_pred CCCCCccchHHHHHHHHHHHhCCCCCCC--CCCChHHHHHHHhcCCCCCCCCCCCCchHHHHHHHHHhhhcCCCCCCCHH
Q psy1840 104 PRGTQKGDVYSFGLVLYEVIGRQGPWGH--LRMTDEEIITSVTQGSGLRPDTSSLDCAPSIIACMRTCWEEDPELRPDLR 181 (423)
Q Consensus 104 ~~~s~ksDVyS~Giil~elltg~~Pf~~--~~~~~~~i~~~i~~~~~~~p~~~~~~~~~~l~~Li~~C~~~dP~~RPt~~ 181 (423)
+..+|||+||+...||..+..--.. .....++-+..+..+.. ..--..++..|++..|..||++.
T Consensus 260 ---~~a~dIy~fgmcAlemailEiq~tnseS~~~~ee~ia~~i~~le----------n~lqr~~i~kcl~~eP~~rp~ar 326 (458)
T KOG1266|consen 260 ---TGASDIYKFGMCALEMAILEIQSTNSESKVEVEENIANVIIGLE----------NGLQRGSITKCLEGEPNGRPDAR 326 (458)
T ss_pred ---ccchhhhhhhHHHHHHHHheeccCCCcceeehhhhhhhheeecc----------CccccCcCcccccCCCCCCcchh
Confidence 7889999999999999877543211 11222333333322210 01123467899999999999999
Q ss_pred HHHHHH
Q psy1840 182 FVHHKL 187 (423)
Q Consensus 182 ~I~~~L 187 (423)
.++...
T Consensus 327 ~llfHp 332 (458)
T KOG1266|consen 327 LLLFHP 332 (458)
T ss_pred hhhcCc
Confidence 876543
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.61 E-value=7.7e-07 Score=87.52 Aligned_cols=170 Identities=16% Similarity=0.258 Sum_probs=117.4
Q ss_pred HHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCccEEEeccCCcccccCCCcccccccccCCccccCCccccCCCC-
Q psy1840 25 SISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKAPELLRQPHL- 103 (423)
Q Consensus 25 ~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~- 103 (423)
.+..+..++.+.+-||.+|.. -||++++|+|+++++.|.|.|-.-..... . ........|...|++||.-.-+.+
T Consensus 119 llrvaRnlA~aFA~lH~~Gh~-vGDVn~~~~lVsd~~~V~LVdsDsfqi~~-n--g~~~~cpVg~~eftPPElQ~~~sf~ 194 (637)
T COG4248 119 LLRVARNLASAFATLHEHGHV-VGDVNQNSFLVSDDSKVVLVDSDSFQINA-N--GTLHLCPVGVSEFTPPELQTLPSFV 194 (637)
T ss_pred HHHHHHHHHHHHHHHHhcCCc-ccccCccceeeecCceEEEEcccceeecc-C--CceEecccCccccCCHHHhcccccc
Confidence 689999999999999999987 89999999999999999998754322211 1 111123457778999998763321
Q ss_pred -CCCCCccchHHHHHHHHHHHhC-CCCCCCCCCC---hHHHHHHHh---------cCCCCCCCC---CCCCchHHHHHHH
Q psy1840 104 -PRGTQKGDVYSFGLVLYEVIGR-QGPWGHLRMT---DEEIITSVT---------QGSGLRPDT---SSLDCAPSIIACM 166 (423)
Q Consensus 104 -~~~s~ksDVyS~Giil~elltg-~~Pf~~~~~~---~~~i~~~i~---------~~~~~~p~~---~~~~~~~~l~~Li 166 (423)
...+...|-|.+|+++++++.| +.||.+...- +...-..|. ++.+.+|.. +..-.++++..+.
T Consensus 195 g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~Ia~g~f~ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF 274 (637)
T COG4248 195 GFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETDIAHGRFAYASDQRRGLKPPPRSIPLSMLPPDVQALF 274 (637)
T ss_pred ccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhhhhcceeeechhccCCCCCCCCCCChhhcCHHHHHHH
Confidence 1236789999999999999976 8899754210 101111121 222222221 2245688999999
Q ss_pred HHhhhc--CCCCCCCHHHHHHHHHHHhhhcCCCh
Q psy1840 167 RTCWEE--DPELRPDLRFVHHKLKEMNAGLKANI 198 (423)
Q Consensus 167 ~~C~~~--dP~~RPt~~~I~~~L~~i~~~~~~~~ 198 (423)
.+|+.. ++.-|||.+..+..|..+..+++...
T Consensus 275 ~qaF~~~~~~~~RP~a~aW~aAl~al~~~L~~C~ 308 (637)
T COG4248 275 QQAFTESGVATPRPTAKAWVAALDALRQQLKKCT 308 (637)
T ss_pred HHHhcccCCCCCCCCHHHHHHHHHHHHHhhhhhh
Confidence 999975 36689999999998888776655443
|
|
| >KOG3619|consensus | Back alignment and domain information |
|---|
Probab=98.50 E-value=2.8e-07 Score=98.77 Aligned_cols=96 Identities=19% Similarity=0.238 Sum_probs=78.3
Q ss_pred HHHHHHHHHHHHHHHHHHHhhCcHHHHHHHh----CCCCCCCccccceeEEEeeccccccccccCC----HhHHHHhhhc
Q psy1840 299 QERTNQLTQEKKKTDALLHRMLPRSVSESLK----RGDFVEPESFDSVTIYFSDIVGFTQLSAEST----ETGRVTTRDS 370 (423)
Q Consensus 299 ~~~~~~l~~e~~~~~~ll~~~lp~~ia~~l~----~g~~~~~~~~~~vtv~f~di~gft~~~~~~~----p~~~v~~ln~ 370 (423)
++..++.+.-+...+.||.|+||.+||...- ++...-.++|++|-|+||-|.||...=++++ =.|=..+||+
T Consensus 604 ~~E~ee~e~m~~~Nr~LLeNiLPaHVA~HFl~~~~r~~eLY~qSy~~VgVMFASipnF~dFYsE~d~NneGlECLRlLNE 683 (867)
T KOG3619|consen 604 QEEKEEMETMQNLNRLLLENILPSHVAAHFLGSKKRNEELYHQSYDCVGVMFASIPNFKDFYSECDVNNEGLECLRLLNE 683 (867)
T ss_pred HHHHHHHHHHHHHHHHHHHhcChHHHHHHHhhcccchHHHHHhhhceEEEEEEecCCcceeeeeecCCcccchHHHHHHH
Confidence 4444556666777889999999999999662 2245667889999999999999976644443 3577899999
Q ss_pred cch-hhhhccC---CCceEEEeecccCC
Q psy1840 371 RRT-PDLKVGG---SNPRQVITGTDMLR 394 (423)
Q Consensus 371 ~~~-fd~~~~~---~~~~~v~~~~~~~~ 394 (423)
+.+ ||+++++ .+++||+|+|-.||
T Consensus 684 IIaDFDeLL~~pkF~~IEKIKTIGSTYM 711 (867)
T KOG3619|consen 684 IIADFDELLSKPKFSGVEKIKTIGSTYM 711 (867)
T ss_pred HHhhHHHhcCccccccceeEEEecchhh
Confidence 999 9999995 79999999999999
|
|
| >KOG0606|consensus | Back alignment and domain information |
|---|
Probab=98.49 E-value=2.3e-07 Score=99.87 Aligned_cols=148 Identities=20% Similarity=0.223 Sum_probs=114.6
Q ss_pred HHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCccEEEeccCCcccccCC---------C-------------------
Q psy1840 27 SVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQ---------D------------------- 78 (423)
Q Consensus 27 ~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~---------~------------------- 78 (423)
..+..+..+.+|||...++ |+|++|.|.++..++..++++||........ .
T Consensus 908 s~i~~~vqs~e~L~s~~r~-h~~~~p~~~l~~~~gh~~l~~~~t~~~vg~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~ 986 (1205)
T KOG0606|consen 908 SPILERVQSLESLHSSLRK-HRDLKPDSLLIAYDGHRPLTDFGTLSKVGLIPPTTDLSGPSSSGTPRRLSRSERRPQLSA 986 (1205)
T ss_pred chhHHHHhhhhccccchhh-cccccccchhhcccCCcccCccccccccccccCcCCcccccccCcccccccccccccccc
Confidence 4556778899999998877 9999999999999999999999842211100 0
Q ss_pred -cccccccccCCccccCCccccCCCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCChHHHHHHHhcCCCCCCCCCCCC
Q psy1840 79 -ETGQERKLRRRKLYKAPELLRQPHLPRGTQKGDVYSFGLVLYEVIGRQGPWGHLRMTDEEIITSVTQGSGLRPDTSSLD 157 (423)
Q Consensus 79 -~~~~~~~~~gt~~y~APE~l~~~~~~~~s~ksDVyS~Giil~elltg~~Pf~~~~~~~~~i~~~i~~~~~~~p~~~~~~ 157 (423)
.........+|+-|.+||...+... ...+|.|++|++++|.++|..||. ..+++.+.+.+..+....|..+ ..
T Consensus 987 ~~~~~~~~~~~t~~~laPe~~lg~~h---gs~ad~~~~g~~l~e~l~g~pp~n--a~tpq~~f~ni~~~~~~~p~g~-~~ 1060 (1205)
T KOG0606|consen 987 DEARRKHAVVGTPDYLAPEILLGRRH---GSAADWWSSGVCLFEVLTGIPPFN--AETPQQIFENILNRDIPWPEGP-EE 1060 (1205)
T ss_pred chhhccccccCCCcccCCcccccccC---CCcchhhhhhhhhhhhhcCCCCCC--CcchhhhhhccccCCCCCCCCc-cc
Confidence 0011234467888999999988765 788999999999999999999997 4566777777777665555443 45
Q ss_pred chHHHHHHHHHhhhcCCCCCCCHH
Q psy1840 158 CAPSIIACMRTCWEEDPELRPDLR 181 (423)
Q Consensus 158 ~~~~l~~Li~~C~~~dP~~RPt~~ 181 (423)
.+.+...++.+.+..+|.+|-.+.
T Consensus 1061 ~s~~aq~~~~~ll~~~~~qr~~a~ 1084 (1205)
T KOG0606|consen 1061 GSYEAQDLINRLLTEEPTQRLGAK 1084 (1205)
T ss_pred cChhhhhhhhhhhccCchhccCcc
Confidence 788999999999999999997654
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=98.47 E-value=2.2e-07 Score=84.60 Aligned_cols=49 Identities=22% Similarity=0.227 Sum_probs=44.9
Q ss_pred HHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCccEEEeccCCcccc
Q psy1840 25 SISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFK 74 (423)
Q Consensus 25 ~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~~vKL~DFGla~~~ 74 (423)
...++.+++.++.++|+.|++ ||||||+||+++.++.++|+|||.+...
T Consensus 127 ~~~~~~~i~~~l~~lh~~gi~-H~Dl~p~Nill~~~~~~~liDfg~~~~~ 175 (198)
T cd05144 127 PEEVLDEILEEIVKAYKHGII-HGDLSEFNILVDDDEKIYIIDWPQMVST 175 (198)
T ss_pred HHHHHHHHHHHHHHHHHCCCC-cCCCCcccEEEcCCCcEEEEECCccccC
Confidence 457899999999999999998 9999999999999999999999997543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=98.45 E-value=2.2e-07 Score=87.36 Aligned_cols=46 Identities=20% Similarity=0.299 Sum_probs=42.2
Q ss_pred HHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCccEEEeccCCccc
Q psy1840 27 SVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAF 73 (423)
Q Consensus 27 ~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~~vKL~DFGla~~ 73 (423)
....+|+.++.+||+.|++ ||||||.|||++.++.++|+|||.+..
T Consensus 146 ~~~~~i~~~l~~lH~~GI~-HrDlkp~NILv~~~~~v~LIDfg~~~~ 191 (239)
T PRK01723 146 EQWQAIGQLIARFHDAGVY-HADLNAHNILLDPDGKFWLIDFDRGEL 191 (239)
T ss_pred HHHHHHHHHHHHHHHCCCC-CCCCCchhEEEcCCCCEEEEECCCccc
Confidence 3467999999999999998 999999999999989999999998765
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=98.45 E-value=2.1e-07 Score=87.37 Aligned_cols=47 Identities=19% Similarity=0.218 Sum_probs=43.3
Q ss_pred HHHHHHHHHHHHHHHHhCC-CeeecCCCCCCEEEcCCccEEEeccCCccc
Q psy1840 25 SISVNTTASVGMIHLHDSE-IISHGNLRSSNCLIDSRWVLQIADFGLHAF 73 (423)
Q Consensus 25 ~l~i~~qi~~gL~yLH~~~-ii~HrDLkp~NILld~~~~vKL~DFGla~~ 73 (423)
...++.||+.++.+||+.| ++ ||||||+||+++ ++.++|+|||.+..
T Consensus 150 ~~~i~~qi~~~l~~LH~~g~ii-H~Dikp~NIli~-~~~i~LiDFg~a~~ 197 (237)
T smart00090 150 EFELYDDILEEMRKLYKEGELV-HGDLSEYNILVH-DGKVVIIDVSQSVE 197 (237)
T ss_pred HHHHHHHHHHHHHHHHhcCCEE-eCCCChhhEEEE-CCCEEEEEChhhhc
Confidence 4689999999999999999 87 999999999999 88999999998764
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=98.30 E-value=9.1e-07 Score=79.40 Aligned_cols=49 Identities=20% Similarity=0.158 Sum_probs=44.5
Q ss_pred HHHHHHHHHHHHHHHHHh-CCCeeecCCCCCCEEEcCCccEEEeccCCcccc
Q psy1840 24 GSISVNTTASVGMIHLHD-SEIISHGNLRSSNCLIDSRWVLQIADFGLHAFK 74 (423)
Q Consensus 24 ~~l~i~~qi~~gL~yLH~-~~ii~HrDLkp~NILld~~~~vKL~DFGla~~~ 74 (423)
....++.+++.++.++|. .+++ ||||||+||+++ ++.++++|||.+...
T Consensus 115 ~~~~~~~~~~~~l~~lh~~~~iv-H~Dl~p~Nili~-~~~~~liDfg~a~~~ 164 (187)
T cd05119 115 DPEELYDQILELMRKLYREAGLV-HGDLSEYNILVD-DGKVYIIDVPQAVEI 164 (187)
T ss_pred cHHHHHHHHHHHHHHHhhccCcC-cCCCChhhEEEE-CCcEEEEECcccccc
Confidence 357899999999999999 8988 999999999999 899999999998644
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >KOG0601|consensus | Back alignment and domain information |
|---|
Probab=98.28 E-value=5.4e-07 Score=92.01 Aligned_cols=148 Identities=22% Similarity=0.284 Sum_probs=102.9
Q ss_pred HHHHHHHH----HHHHHHhCCCeeecCCCCCCEEEcCC-ccEEEeccCCcccccCCCccc---ccccccCCccccCCccc
Q psy1840 27 SVNTTASV----GMIHLHDSEIISHGNLRSSNCLIDSR-WVLQIADFGLHAFKAGQDETG---QERKLRRRKLYKAPELL 98 (423)
Q Consensus 27 ~i~~qi~~----gL~yLH~~~ii~HrDLkp~NILld~~-~~vKL~DFGla~~~~~~~~~~---~~~~~~gt~~y~APE~l 98 (423)
....+... |+.++|+.+++ |-|+||.||+...+ ..++++|||+...+....... ......+...|++||..
T Consensus 222 ~~~~~~~~~~~~al~~~hs~~~~-~~~~kp~~i~~~~~~~s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~ 300 (524)
T KOG0601|consen 222 NSLRDWLSRDVTALSHLHSNNIV-HDDLKPANIFTTSDWTSCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELL 300 (524)
T ss_pred hHHhhhhhcccccccccCCCccc-ccccchhheecccccceeecCCcceeEEccCCccccceeeeecCCCCceEeChhhh
Confidence 44555556 99999999998 99999999999999 789999999976654443221 11223566779999999
Q ss_pred cCCCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCchHHHHHHHHHhhhcCCCCCC
Q psy1840 99 RQPHLPRGTQKGDVYSFGLVLYEVIGRQGPWGHLRMTDEEIITSVTQGSGLRPDTSSLDCAPSIIACMRTCWEEDPELRP 178 (423)
Q Consensus 99 ~~~~~~~~s~ksDVyS~Giil~elltg~~Pf~~~~~~~~~i~~~i~~~~~~~p~~~~~~~~~~l~~Li~~C~~~dP~~RP 178 (423)
.+.. +..+|+||+|.++.+..++..+......+. ...+.+ ...|...-...+.++...+.++++.+|-.|+
T Consensus 301 ~~l~----~~~~di~sl~ev~l~~~l~~~~~~~g~~~~---W~~~r~--~~ip~e~~~~~s~~l~~~~~~~~d~~~~~~~ 371 (524)
T KOG0601|consen 301 NGLA----TFASDIFSLGEVILEAILGSHLPSVGKNSS---WSQLRQ--GYIPLEFCEGGSSSLRSVTSQMLDEDPRLRL 371 (524)
T ss_pred cccc----chHhhhcchhhhhHhhHhhcccccCCCCCC---cccccc--ccCchhhhcCcchhhhhHHHHhcCcchhhhh
Confidence 8754 889999999999999998865542110000 000111 1122222234456677799999999999999
Q ss_pred CHHHHH
Q psy1840 179 DLRFVH 184 (423)
Q Consensus 179 t~~~I~ 184 (423)
+...+.
T Consensus 372 ~~q~~~ 377 (524)
T KOG0601|consen 372 TAQILT 377 (524)
T ss_pred HHHHHh
Confidence 887654
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=98.28 E-value=1.2e-06 Score=80.12 Aligned_cols=47 Identities=30% Similarity=0.508 Sum_probs=43.2
Q ss_pred HHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCccEEEeccCCccc
Q psy1840 25 SISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAF 73 (423)
Q Consensus 25 ~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~~vKL~DFGla~~ 73 (423)
...++.+++.+|.++|+.+++ |||++|.||+++ ++.++|+|||.+..
T Consensus 97 ~~~i~~~i~~~l~~lH~~~i~-H~Dl~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 97 ELELSREIGRLVGKLHSAGII-HGDLTTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred HHHHHHHHHHHHHHHHhCCcc-cCCCCcccEEEE-CCCEEEEECCcccC
Confidence 568999999999999999998 999999999999 78899999998654
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=98.25 E-value=1.3e-06 Score=79.38 Aligned_cols=45 Identities=29% Similarity=0.451 Sum_probs=42.2
Q ss_pred HHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCccEEEeccCCccc
Q psy1840 27 SVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAF 73 (423)
Q Consensus 27 ~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~~vKL~DFGla~~ 73 (423)
.++.+++.+|.++|+.|++ |||++|.||+++ ++.++++|||++..
T Consensus 94 ~~~~~i~~~l~~lH~~gi~-H~Dl~~~Nil~~-~~~~~liDfg~a~~ 138 (199)
T TIGR03724 94 ELLREIGRLVGKLHKAGIV-HGDLTTSNIIVR-DDKLYLIDFGLGKY 138 (199)
T ss_pred HHHHHHHHHHHHHHHCCee-cCCCCcceEEEE-CCcEEEEECCCCcC
Confidence 7899999999999999998 999999999999 78999999998754
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.25 E-value=9.7e-07 Score=81.25 Aligned_cols=44 Identities=16% Similarity=0.085 Sum_probs=36.9
Q ss_pred HHHHHHHHHHH-HHHHhCCCeeecCCCCCCEEEcC----CccEEEeccCC
Q psy1840 26 ISVNTTASVGM-IHLHDSEIISHGNLRSSNCLIDS----RWVLQIADFGL 70 (423)
Q Consensus 26 l~i~~qi~~gL-~yLH~~~ii~HrDLkp~NILld~----~~~vKL~DFGl 70 (423)
..++.+++.++ +|||+++|+ ||||||+|||++. ++.++|+||+.
T Consensus 107 ~~~~~~~L~~l~~yLh~~~Iv-hrDlKp~NILl~~~~~~~~~~~LiDg~G 155 (210)
T PRK10345 107 VAQLRQLLKKLKRYLLDNRIV-TMELKPQNILCQRISESEVIPVVCDNIG 155 (210)
T ss_pred HHHHHHHHHHHHHHHHHCCEe-ecCCCHHHEEEeccCCCCCcEEEEECCC
Confidence 35678888888 999999998 9999999999973 44899999544
|
|
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=98.19 E-value=1.5e-06 Score=91.51 Aligned_cols=47 Identities=28% Similarity=0.461 Sum_probs=42.9
Q ss_pred HHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCccEEEeccCCccc
Q psy1840 25 SISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAF 73 (423)
Q Consensus 25 ~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~~vKL~DFGla~~ 73 (423)
...++.+++.+|.|||+.+++ ||||||+||++ .++.++|+|||+++.
T Consensus 430 ~~~~~~~i~~~L~~lH~~gii-HrDlkp~NILl-~~~~~~liDFGla~~ 476 (535)
T PRK09605 430 NPELVRKVGEIVAKLHKAGIV-HGDLTTSNFIV-RDDRLYLIDFGLGKY 476 (535)
T ss_pred HHHHHHHHHHHHHHHHhCCCc-cCCCChHHEEE-ECCcEEEEeCccccc
Confidence 467899999999999999998 99999999999 577899999999765
|
|
| >cd07302 CHD cyclase homology domain | Back alignment and domain information |
|---|
Probab=98.04 E-value=3.7e-06 Score=74.22 Aligned_cols=54 Identities=28% Similarity=0.212 Sum_probs=52.0
Q ss_pred ceeEEEeeccccccccccCCHhHHHHhhhccch-hhhhccCCCceEEEeecccCC
Q psy1840 341 SVTIYFSDIVGFTQLSAESTETGRVTTRDSRRT-PDLKVGGSNPRQVITGTDMLR 394 (423)
Q Consensus 341 ~vtv~f~di~gft~~~~~~~p~~~v~~ln~~~~-fd~~~~~~~~~~v~~~~~~~~ 394 (423)
+|||+|+||+|||.+....+|.+++.+||.++. +++++..++.+.+.+.||.++
T Consensus 1 ~~~il~~di~~~t~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~g~~~~~~gd~~~ 55 (177)
T cd07302 1 EVTVLFADIVGFTALSERLGPEELVELLNEYFSAFDEIIERHGGTVDKTIGDAVM 55 (177)
T ss_pred CEEEEEEEccChHHHHhcCCHHHHHHHHHHHHHHHHHHHHHcCCEEEEEeCceEE
Confidence 589999999999999999999999999999999 999999999999999999988
|
Catalytic domains of the mononucleotidyl cyclases (MNC's), also called cyclase homology domains (CHDs), are part of the class III nucleotidyl cyclases. This class includes eukaryotic and prokaryotic adenylate cyclases (AC's) and guanylate cyclases (GC's). They seem to share a common catalytic mechanism in their requirement for two magnesium ions to bind the polyphosphate moiety of the nucleotide. |
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=97.88 E-value=2e-05 Score=66.87 Aligned_cols=49 Identities=22% Similarity=0.388 Sum_probs=43.5
Q ss_pred HHHHHHHHHHHHHHHHHhC---CCeeecCCCCCCEEEcCCccEEEeccCCccc
Q psy1840 24 GSISVNTTASVGMIHLHDS---EIISHGNLRSSNCLIDSRWVLQIADFGLHAF 73 (423)
Q Consensus 24 ~~l~i~~qi~~gL~yLH~~---~ii~HrDLkp~NILld~~~~vKL~DFGla~~ 73 (423)
....++.+++.++.++|.. +++ |||++|.|++++..+.+++.|||.+..
T Consensus 87 ~~~~~~~~~~~~l~~lh~~~~~~i~-H~Dl~~~Nil~~~~~~~~l~Df~~~~~ 138 (155)
T cd05120 87 EKEDIAEQLAELLAKLHQLPLLVLC-HGDLHPGNILVDDGKILGIIDWEYAGY 138 (155)
T ss_pred HHHHHHHHHHHHHHHHhCCCceEEE-ecCCCcceEEEECCcEEEEEecccccC
Confidence 3578899999999999985 466 999999999999999999999998764
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >PF07701 HNOBA: Heme NO binding associated; InterPro: IPR011645 The HNOBA (Haem NO Binding) domain is found associated with the HNOB domain and IPR001054 from INTERPRO in soluble cyclases and signalling proteins | Back alignment and domain information |
|---|
Probab=97.81 E-value=2.5e-05 Score=72.20 Aligned_cols=36 Identities=44% Similarity=0.601 Sum_probs=32.0
Q ss_pred cchhhHHHHHHHHHHHHHHHHHHHHhhCcHHHHHHH
Q psy1840 293 RVPGLVQERTNQLTQEKKKTDALLHRMLPRSVSESL 328 (423)
Q Consensus 293 ~~~~~v~~~~~~l~~e~~~~~~ll~~~lp~~ia~~l 328 (423)
+.+..+++.+++|++||+|+|+|||+|||++||++|
T Consensus 184 ~~~~~Le~~~~~l~~ek~ktd~LL~~mlP~~VA~~L 219 (219)
T PF07701_consen 184 EKSAELEESMRELEEEKKKTDELLYSMLPPSVADRL 219 (219)
T ss_dssp HHHHHHHHHHHHHHHHHHHHHHHHHHTS-HHHHHHH
T ss_pred HHHHHHHHHHHHHHHHHHHHHHHHHHhCCHHHHhhC
Confidence 344588999999999999999999999999999987
|
The HNOB domain is predicted to function as a haem-dependent sensor for gaseous ligands, and transduce diverse downstream signals in both bacteria and animals.; GO: 0004383 guanylate cyclase activity, 0006182 cGMP biosynthetic process; PDB: 2P04_B 2P08_A 3HLS_E. |
| >KOG1243|consensus | Back alignment and domain information |
|---|
Probab=97.72 E-value=0.0001 Score=76.72 Aligned_cols=150 Identities=14% Similarity=0.143 Sum_probs=93.6
Q ss_pred HHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCccEEEeccCCcccccCCCcccccccccCCccccCCccccCCCCCCC
Q psy1840 27 SVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKAPELLRQPHLPRG 106 (423)
Q Consensus 27 ~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~ 106 (423)
--+.||+.+|.|||..+-++|+||.-..|+++..|..||++|-+.....+..... ....---.|..|+.+...
T Consensus 108 ~Gl~qIl~AL~FL~~d~~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~~~--~~~~~~~s~~~P~~~~~s----- 180 (690)
T KOG1243|consen 108 LGLFQILAALSFLNDDCNLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNAPA--KSLYLIESFDDPEEIDPS----- 180 (690)
T ss_pred HHHHHHHHHHHHHhccCCeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCccc--ccchhhhcccChhhcCcc-----
Confidence 4578999999999976555599999999999999999999998864432222100 111111236667655322
Q ss_pred CCccchHHHHHHHHHHHhCCCCCCC----CCCChHHHHH----HHhcCCCCCCCCCCCCchHHHHHHHHHhhhcCCCCCC
Q psy1840 107 TQKGDVYSFGLVLYEVIGRQGPWGH----LRMTDEEIIT----SVTQGSGLRPDTSSLDCAPSIIACMRTCWEEDPELRP 178 (423)
Q Consensus 107 s~ksDVyS~Giil~elltg~~Pf~~----~~~~~~~i~~----~i~~~~~~~p~~~~~~~~~~l~~Li~~C~~~dP~~RP 178 (423)
.-..|.|-|||+++|++.|..+-.. ....++..+. ++......+ +....++..|....+--|=
T Consensus 181 ~~s~D~~~Lg~li~el~ng~~~~~~~~~~~~~ipk~~~~~~~k~~~~~~~~r---------~n~~~~~~~~~~~~gff~n 251 (690)
T KOG1243|consen 181 EWSIDSWGLGCLIEELFNGSLLTKTDLSNTGKIPKALIELYCKKLGATELKR---------PNKLRFILECRLLGGFFRN 251 (690)
T ss_pred ccchhhhhHHHHHHHHhCcccCcchhhhccCccchhHHHHHHHHhccccccc---------cchhhHHHHHHhccccccc
Confidence 3467999999999999998322110 0111111111 111111111 1255677778777777777
Q ss_pred CHHHHHHHHHHHhh
Q psy1840 179 DLRFVHHKLKEMNA 192 (423)
Q Consensus 179 t~~~I~~~L~~i~~ 192 (423)
.+-++...|..+.-
T Consensus 252 ~fvd~~~fLeel~l 265 (690)
T KOG1243|consen 252 DFVDTLLFLEELRL 265 (690)
T ss_pred hHHHHHHHHHhccc
Confidence 77777777776653
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=97.70 E-value=6e-05 Score=66.23 Aligned_cols=45 Identities=22% Similarity=0.245 Sum_probs=39.2
Q ss_pred HHHHHHHHHHHHHHhCCC----eeecCCCCCCEEEcCCccEEEeccCCcc
Q psy1840 27 SVNTTASVGMIHLHDSEI----ISHGNLRSSNCLIDSRWVLQIADFGLHA 72 (423)
Q Consensus 27 ~i~~qi~~gL~yLH~~~i----i~HrDLkp~NILld~~~~vKL~DFGla~ 72 (423)
....+++..+..||+.++ ++|||++|.||+++ ++.++++|||.+.
T Consensus 87 ~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~ 135 (170)
T cd05151 87 ENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAG 135 (170)
T ss_pred HHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEeccccc
Confidence 567899999999999885 34999999999999 6689999999865
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >KOG0601|consensus | Back alignment and domain information |
|---|
Probab=97.70 E-value=2.2e-05 Score=80.46 Aligned_cols=147 Identities=18% Similarity=0.241 Sum_probs=96.1
Q ss_pred HHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCC-ccEEEeccCCcccccCCCcccccccccCCccccCCccccCCCC
Q psy1840 25 SISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSR-WVLQIADFGLHAFKAGQDETGQERKLRRRKLYKAPELLRQPHL 103 (423)
Q Consensus 25 ~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~-~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~ 103 (423)
++.+..|++.++.++|+..++ |+|+||+||++.++ +..+++|||++..+.-... .....+..|-..|++....
T Consensus 368 ~~~~~~q~~~~l~~i~s~~~~-~~d~~psni~i~~~~~~~~~~~~~~~t~~~~~~~----~~~~~~r~~p~~~~~~e~~- 441 (524)
T KOG0601|consen 368 RLRLTAQILTALNVIHSKLFV-HLDVKPSNILISNDGFFSKLGDFGCWTRLAFSSG----VFHHIDRLYPIAEILLEDY- 441 (524)
T ss_pred hhhhHHHHHhccccccchhhh-cccccccceeeccchhhhhccccccccccceecc----cccccccccccchhhcccc-
Confidence 468889999999999999988 99999999999886 8899999999753211110 1112222341244444332
Q ss_pred CCCCCccchHHHHHHHHHHHhCCCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCchHHHHHHHHHhhhcCCCCCCCHHHH
Q psy1840 104 PRGTQKGDVYSFGLVLYEVIGRQGPWGHLRMTDEEIITSVTQGSGLRPDTSSLDCAPSIIACMRTCWEEDPELRPDLRFV 183 (423)
Q Consensus 104 ~~~s~ksDVyS~Giil~elltg~~Pf~~~~~~~~~i~~~i~~~~~~~p~~~~~~~~~~l~~Li~~C~~~dP~~RPt~~~I 183 (423)
....++|+||||.-+.|.+++..--.. ..+ ...+..+.. |... .....+..+.+.+...++..||.+.++
T Consensus 442 -~~~~~~~~~sl~~~~~e~~~~~~ls~~----~~~-~~~i~~~~~--p~~~--~~~~~~q~~~kv~~~~~~~~~~l~~~l 511 (524)
T KOG0601|consen 442 -PHLSKADIFSLGLSVDEAITGSPLSES----GVQ-SLTIRSGDT--PNLP--GLKLQLQVLLKVMINPDRKRRPSAVEL 511 (524)
T ss_pred -ccccccccccccccccccccCcccCcc----ccc-ceeeecccc--cCCC--chHHhhhhhhhhhcCCccccchhhhhh
Confidence 237899999999999999887642111 011 112222221 1111 223677888889999999999988776
Q ss_pred HHHH
Q psy1840 184 HHKL 187 (423)
Q Consensus 184 ~~~L 187 (423)
....
T Consensus 512 ~~~~ 515 (524)
T KOG0601|consen 512 SLHS 515 (524)
T ss_pred cccc
Confidence 5443
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=97.63 E-value=7.7e-05 Score=67.76 Aligned_cols=48 Identities=15% Similarity=0.099 Sum_probs=41.1
Q ss_pred HHHHHHHHHHHHHHH-HhCCCeeecCCCCCCEEEcCCccEEEeccCCcccc
Q psy1840 25 SISVNTTASVGMIHL-HDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFK 74 (423)
Q Consensus 25 ~l~i~~qi~~gL~yL-H~~~ii~HrDLkp~NILld~~~~vKL~DFGla~~~ 74 (423)
...+..+++.+|..+ |..|++ ||||++.||+++ ++.+.|+|||.+-..
T Consensus 126 ~~~i~~~i~~~l~~l~H~~glV-HGDLs~~NIL~~-~~~v~iIDF~qav~~ 174 (197)
T cd05146 126 MKNAYYQVLSMMKQLYKECNLV-HADLSEYNMLWH-DGKVWFIDVSQSVEP 174 (197)
T ss_pred HHHHHHHHHHHHHHHHHhCCee-cCCCCHHHEEEE-CCcEEEEECCCceeC
Confidence 356788999999999 889998 999999999997 467999999976543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=97.62 E-value=0.0013 Score=67.49 Aligned_cols=48 Identities=13% Similarity=0.150 Sum_probs=40.9
Q ss_pred HHHHHHHHH-HHHHHHhCCCeeecCCCCCCEEEcCCccEEEeccCCcccc
Q psy1840 26 ISVNTTASV-GMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFK 74 (423)
Q Consensus 26 l~i~~qi~~-gL~yLH~~~ii~HrDLkp~NILld~~~~vKL~DFGla~~~ 74 (423)
..++.+++. .+..+|..|++ |+|++|.||+++.++.++++|||++...
T Consensus 259 ~~ia~~~~~~~l~ql~~~g~~-H~D~hPgNilv~~~g~i~liDfG~~~~l 307 (437)
T TIGR01982 259 KALAENLARSFLNQVLRDGFF-HADLHPGNIFVLKDGKIIALDFGIVGRL 307 (437)
T ss_pred HHHHHHHHHHHHHHHHhCCce-eCCCCcccEEECCCCcEEEEeCCCeeEC
Confidence 456777766 46889999998 9999999999999999999999997543
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.51 E-value=0.00016 Score=64.39 Aligned_cols=46 Identities=28% Similarity=0.466 Sum_probs=40.8
Q ss_pred HHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCccEEEeccCCccc
Q psy1840 26 ISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAF 73 (423)
Q Consensus 26 l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~~vKL~DFGla~~ 73 (423)
..++..+..-+.-||..|++ ||||.++|+++.+.. +.++|||++.+
T Consensus 95 ~~~~r~vG~~vg~lH~~giv-HGDLTtsNiIl~~~~-i~~IDfGLg~~ 140 (204)
T COG3642 95 PDLLREVGRLVGKLHKAGIV-HGDLTTSNIILSGGR-IYFIDFGLGEF 140 (204)
T ss_pred hHHHHHHHHHHHHHHhcCee-cCCCccceEEEeCCc-EEEEECCcccc
Confidence 46788888889999999998 999999999998765 89999999764
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=97.37 E-value=0.0003 Score=67.18 Aligned_cols=48 Identities=13% Similarity=0.121 Sum_probs=42.9
Q ss_pred HHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcC-------CccEEEeccCCccc
Q psy1840 25 SISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDS-------RWVLQIADFGLHAF 73 (423)
Q Consensus 25 ~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~-------~~~vKL~DFGla~~ 73 (423)
+-.++.+++..+.-||..|++ ||||+++|||++. ++.+.++||+.+..
T Consensus 140 ~~~ll~~la~~i~~LH~~Gi~-HgDL~~~NiLl~~~~~~~~~~~~~~LIDl~r~~~ 194 (268)
T PRK15123 140 KRMLIKRVATMVRDMHAAGIN-HRDCYICHFLLHLPFPGREEDLKLSVIDLHRAQI 194 (268)
T ss_pred HHHHHHHHHHHHHHHHHCcCc-cCCCChhhEEEeccccCCCCCceEEEEECCcccc
Confidence 568999999999999999998 9999999999975 57899999998653
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=97.30 E-value=0.0004 Score=63.70 Aligned_cols=49 Identities=27% Similarity=0.348 Sum_probs=44.3
Q ss_pred HHHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCc---cEEEeccCCccc
Q psy1840 24 GSISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRW---VLQIADFGLHAF 73 (423)
Q Consensus 24 ~~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~---~vKL~DFGla~~ 73 (423)
.+-.++.+++..+.-||..|++ |+|+++.|||++.+. .+.++||+.++.
T Consensus 119 ~~~~ll~~l~~~i~~lH~~gi~-H~Dl~~~NILv~~~~~~~~~~lIDld~~~~ 170 (206)
T PF06293_consen 119 QRRELLRALARLIAKLHDAGIY-HGDLNPSNILVDPDDGQYRFYLIDLDRMRF 170 (206)
T ss_pred hHHHHHHHHHHHHHHHHHCcCC-CCCCCcccEEEeCCCCceeEEEEcchhcee
Confidence 3578999999999999999998 999999999999877 899999997664
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >KOG3087|consensus | Back alignment and domain information |
|---|
Probab=97.22 E-value=0.00056 Score=60.84 Aligned_cols=48 Identities=33% Similarity=0.482 Sum_probs=41.4
Q ss_pred HHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCC---ccEEEeccCCccc
Q psy1840 25 SISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSR---WVLQIADFGLHAF 73 (423)
Q Consensus 25 ~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~---~~vKL~DFGla~~ 73 (423)
...++.+|.+-+.-||..++| ||||..+||++.++ ..+-++|||++..
T Consensus 115 ~~~~~~~iG~~igklH~ndii-HGDLTTSNill~~~~~~~~~~lIdfgls~~ 165 (229)
T KOG3087|consen 115 LAELARRIGELIGKLHDNDII-HGDLTTSNILLRSDGNQITPILIDFGLSSV 165 (229)
T ss_pred HHHHHHHHHHHHHHhhhCCee-cccccccceEEecCCCcCceEEEeecchhc
Confidence 368999999999999999998 99999999999543 4568999999653
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=96.94 E-value=0.0015 Score=58.98 Aligned_cols=47 Identities=30% Similarity=0.430 Sum_probs=36.4
Q ss_pred HHHHHHHHHHHHHH-HHhCCCeeecCCCCCCEEEcCCccEEEeccCCccc
Q psy1840 25 SISVNTTASVGMIH-LHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAF 73 (423)
Q Consensus 25 ~l~i~~qi~~gL~y-LH~~~ii~HrDLkp~NILld~~~~vKL~DFGla~~ 73 (423)
.-.+..+++..+.. +|..|++ ||||.+.||+++.+ .+.|+|||.+..
T Consensus 108 ~~~~~~~il~~~~~~~~~~giv-HGDLs~~NIlv~~~-~~~iIDf~qav~ 155 (188)
T PF01163_consen 108 PKELLEEILEEIIKMLHKAGIV-HGDLSEYNILVDDG-KVYIIDFGQAVD 155 (188)
T ss_dssp HHHHHHHHHHHHHHHHHCTTEE-ESS-STTSEEEETT-CEEE--GTTEEE
T ss_pred HHHHHHHHHHHHHHHHHhcCce-ecCCChhhEEeecc-eEEEEecCccee
Confidence 45678888886666 4788998 99999999999887 899999997654
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >KOG3741|consensus | Back alignment and domain information |
|---|
Probab=96.85 E-value=0.009 Score=60.96 Aligned_cols=133 Identities=14% Similarity=0.163 Sum_probs=93.8
Q ss_pred CChHHH-HHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCccEEEeccCCcccccCCCcccccccccCCccccCCccc
Q psy1840 20 NIPIGS-ISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKAPELL 98 (423)
Q Consensus 20 ~~p~~~-l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l 98 (423)
..|+.- ..++.|+..||.++|+.|+- -+-|.+.+|+++.+.+++|+.-|+...+.... . |-+
T Consensus 389 ~~~e~~lW~y~~QLtaaL~sIHssGLA-ck~L~~~kIlv~G~~RIriS~C~i~Dvl~~d~--------------~--~~l 451 (655)
T KOG3741|consen 389 KAPEEVLWSYISQLTAALYSIHSSGLA-CKTLDLKKILVTGKMRIRISGCGIMDVLQEDP--------------T--EPL 451 (655)
T ss_pred CchHHHHHHHHHHHHHHHHHHHhcCce-eecccHhHeEeeCcceEEEecccceeeecCCC--------------C--cch
Confidence 345443 47899999999999999998 58999999999999999998888765442221 0 112
Q ss_pred cCCCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCchHHHHHHHHHhhhcCCCCCC
Q psy1840 99 RQPHLPRGTQKGDVYSFGLVLYEVIGRQGPWGHLRMTDEEIITSVTQGSGLRPDTSSLDCAPSIIACMRTCWEEDPELRP 178 (423)
Q Consensus 99 ~~~~~~~~s~ksDVyS~Giil~elltg~~Pf~~~~~~~~~i~~~i~~~~~~~p~~~~~~~~~~l~~Li~~C~~~dP~~RP 178 (423)
.+ -++-|.=.||.++..|.+|..--.........-+..+.. .++.++.+++......++++ -
T Consensus 452 e~------~Qq~D~~~lG~ll~aLAt~~~ns~~~d~~~~s~~~~I~~-----------~yS~D~rn~v~yl~s~~~~~-k 513 (655)
T KOG3741|consen 452 ES------QQQNDLRDLGLLLLALATGTENSNRTDSTQSSHLTRITT-----------TYSTDLRNVVEYLESLNFRE-K 513 (655)
T ss_pred hH------HhhhhHHHHHHHHHHHhhcccccccccchHHHHHHHhhh-----------hhhHHHHHHHHHHHhcCccc-c
Confidence 11 467799999999999999965421111211222333332 46789999999999999987 4
Q ss_pred CHHHHHHHH
Q psy1840 179 DLRFVHHKL 187 (423)
Q Consensus 179 t~~~I~~~L 187 (423)
++.+++..+
T Consensus 514 sI~~llp~~ 522 (655)
T KOG3741|consen 514 SIQDLLPMI 522 (655)
T ss_pred cHHHHHHHH
Confidence 677776655
|
|
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=96.62 E-value=0.02 Score=59.94 Aligned_cols=37 Identities=14% Similarity=0.240 Sum_probs=31.5
Q ss_pred HHHHhCCCeeecCCCCCCEEEcCCc----cEEEeccCCcccc
Q psy1840 37 IHLHDSEIISHGNLRSSNCLIDSRW----VLQIADFGLHAFK 74 (423)
Q Consensus 37 ~yLH~~~ii~HrDLkp~NILld~~~----~vKL~DFGla~~~ 74 (423)
..++..|++ |+|++|.||+++.++ .+++.|||+...+
T Consensus 274 ~Qif~~Gff-HaDpHPGNIlv~~~g~~~~~i~llDFGivg~l 314 (537)
T PRK04750 274 TQVFRDGFF-HADMHPGNIFVSYDPPENPRYIALDFGIVGSL 314 (537)
T ss_pred HHHHhCCee-eCCCChHHeEEecCCCCCCeEEEEecceEEEC
Confidence 445668988 999999999999888 9999999996543
|
|
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=96.26 E-value=0.0075 Score=55.29 Aligned_cols=48 Identities=8% Similarity=0.074 Sum_probs=42.8
Q ss_pred HHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCcc--EEEeccCCccc
Q psy1840 25 SISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWV--LQIADFGLHAF 73 (423)
Q Consensus 25 ~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~~--vKL~DFGla~~ 73 (423)
+-.++.+++..+.-||..|+. |||+.+.||+++..+. ++++||.-++.
T Consensus 130 k~~il~~va~~ia~LH~~Gv~-Hgdly~khIll~~~g~~~v~lIDlEk~r~ 179 (216)
T PRK09902 130 RQAMLKAVALAFKKMHSVNRQ-HGCCYVRHIYVKTEGKAEAGFLDLEKSRR 179 (216)
T ss_pred HHHHHHHHHHHHHHHHHCCCc-CCCCCHhheeecCCCCeeEEEEEhhccch
Confidence 578999999999999999998 9999999999986667 99999976543
|
|
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=96.16 E-value=0.0089 Score=55.10 Aligned_cols=43 Identities=19% Similarity=0.281 Sum_probs=37.4
Q ss_pred HHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCccEEEeccCCcc
Q psy1840 28 VNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHA 72 (423)
Q Consensus 28 i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~~vKL~DFGla~ 72 (423)
+...+.+.+.-||+.|+. |||..|.|++++.++ +++.||+..+
T Consensus 140 ~~~ki~~~ikqlH~~G~~-HGD~hpgNFlv~~~~-i~iID~~~k~ 182 (229)
T PF06176_consen 140 LAEKIVEAIKQLHKHGFY-HGDPHPGNFLVSNNG-IRIIDTQGKR 182 (229)
T ss_pred HHHHHHHHHHHHHHcCCc-cCCCCcCcEEEECCc-EEEEECcccc
Confidence 556788899999999998 999999999998655 8999998754
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=94.80 E-value=0.057 Score=49.12 Aligned_cols=29 Identities=28% Similarity=0.540 Sum_probs=24.8
Q ss_pred eeecCCCCCCEEEcC--CccEEEeccCCccc
Q psy1840 45 ISHGNLRSSNCLIDS--RWVLQIADFGLHAF 73 (423)
Q Consensus 45 i~HrDLkp~NILld~--~~~vKL~DFGla~~ 73 (423)
++|||+.|.||+++. ++.+.|+||+.+..
T Consensus 176 l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 176 LVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred EEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 459999999999998 66789999998654
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=94.26 E-value=0.067 Score=50.77 Aligned_cols=43 Identities=16% Similarity=0.192 Sum_probs=35.6
Q ss_pred HHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCccEEEeccCC
Q psy1840 27 SVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGL 70 (423)
Q Consensus 27 ~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~~vKL~DFGl 70 (423)
.++..|+.-+.-+-..|++ |||+.+-||+++.+|.+.++||--
T Consensus 206 ~il~~il~~~~~~~~~GiV-HGDlSefNIlV~~dg~~~vIDwPQ 248 (304)
T COG0478 206 EILDKILEEVRKAYRRGIV-HGDLSEFNILVTEDGDIVVIDWPQ 248 (304)
T ss_pred HHHHHHHHHHHHHHHcCcc-ccCCchheEEEecCCCEEEEeCcc
Confidence 4566666666666678998 999999999999999999999954
|
|
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=93.25 E-value=0.098 Score=47.24 Aligned_cols=53 Identities=11% Similarity=0.086 Sum_probs=44.7
Q ss_pred CCCCChHHHHHHHHHHHHHHHHHHhC--CCeeecCCCCCCEEEcCCccEEEeccCCcc
Q psy1840 17 SPFNIPIGSISVNTTASVGMIHLHDS--EIISHGNLRSSNCLIDSRWVLQIADFGLHA 72 (423)
Q Consensus 17 ~~~~~p~~~l~i~~qi~~gL~yLH~~--~ii~HrDLkp~NILld~~~~vKL~DFGla~ 72 (423)
.||.. |.+++.+++..+.+++.. |.+.-.|++++|+.++++|++|++|..-..
T Consensus 56 ~~w~~---R~~iA~~lL~~l~~l~~~~~~~~~lcDv~~~nfgv~~~~~lk~iDld~v~ 110 (188)
T PF12260_consen 56 SPWEQ---RAKIALQLLELLEELDHGPLGFFYLCDVSPDNFGVNDDGRLKLIDLDDVF 110 (188)
T ss_pred cCHHH---HHHHHHHHHHHHHHHhcCCCCcEEEeecchHHeEEeCCCcEEEEechhcc
Confidence 35554 899999999999999873 446579999999999999999999997643
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >KOG1035|consensus | Back alignment and domain information |
|---|
Probab=92.87 E-value=0.24 Score=55.44 Aligned_cols=142 Identities=16% Similarity=0.197 Sum_probs=91.9
Q ss_pred HHHHHHHHHHHHHHHhCCCeeecCCCCC---CEEEcCCccEEEe--ccCCcccccCCCcccccccccCCccccCCccccC
Q psy1840 26 ISVNTTASVGMIHLHDSEIISHGNLRSS---NCLIDSRWVLQIA--DFGLHAFKAGQDETGQERKLRRRKLYKAPELLRQ 100 (423)
Q Consensus 26 l~i~~qi~~gL~yLH~~~ii~HrDLkp~---NILld~~~~vKL~--DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~ 100 (423)
..+..++..|+.|+|+.... |.-|..+ +--.+..+.+.++ ||+.++........ ........|.+||....
T Consensus 289 r~~~~~~~~GL~~~h~~~l~-~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~---~~~~~~~~~~~~e~~~~ 364 (1351)
T KOG1035|consen 289 RILHQKLLEGLAYLHSLSLE-HVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKS---FSDLLAEIRNADEDLKE 364 (1351)
T ss_pred HHHHHHHhhhHHHHHHhccc-eeEEecccccccccCccceeecchhhhcccccCCCcccc---hhhcCcccccccccccc
Confidence 45788899999999998554 5555444 4445667777777 88877655433222 22233445888888776
Q ss_pred CCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCchHHHHHHHHHhhhcCCCCCCCH
Q psy1840 101 PHLPRGTQKGDVYSFGLVLYEVIGRQGPWGHLRMTDEEIITSVTQGSGLRPDTSSLDCAPSIIACMRTCWEEDPELRPDL 180 (423)
Q Consensus 101 ~~~~~~s~ksDVyS~Giil~elltg~~Pf~~~~~~~~~i~~~i~~~~~~~p~~~~~~~~~~l~~Li~~C~~~dP~~RPt~ 180 (423)
... ......|+|.+|.....+..|..+-... . ... ......+..........|+..++++|++.
T Consensus 365 ~~~-~~~r~~dL~~lgll~~~~~~~~~i~~~~-~----~~~----------~~l~~~~~~~~~d~~~~~~~~~~~~Rl~~ 428 (1351)
T KOG1035|consen 365 NTA-KKSRLTDLWCLGLLLLQLSQGEDISEKS-A----VPV----------SLLDVLSTSELLDALPKCLDEDSEERLSA 428 (1351)
T ss_pred ccc-hhhhhhHHHHHHHHHhhhhhcCcccccc-c----chh----------hhhccccchhhhhhhhhhcchhhhhccch
Confidence 553 3355579999999999888776442210 0 000 01111222267788899999999999999
Q ss_pred HHHHHHH
Q psy1840 181 RFVHHKL 187 (423)
Q Consensus 181 ~~I~~~L 187 (423)
.+++...
T Consensus 429 ~~ll~~~ 435 (1351)
T KOG1035|consen 429 LELLTHP 435 (1351)
T ss_pred hhhhhch
Confidence 9887653
|
|
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=91.11 E-value=0.39 Score=46.64 Aligned_cols=30 Identities=30% Similarity=0.432 Sum_probs=25.8
Q ss_pred CCCeeecCCCCCCEEEcCCccEEEeccCCcc
Q psy1840 42 SEIISHGNLRSSNCLIDSRWVLQIADFGLHA 72 (423)
Q Consensus 42 ~~ii~HrDLkp~NILld~~~~vKL~DFGla~ 72 (423)
.+++ |||+.+.|++++.++.+.|.||+.+.
T Consensus 187 ~~l~-HgD~~~~Nvl~~~~~~~~vIDfd~~~ 216 (307)
T TIGR00938 187 RGVI-HADLFPDNVLFDGDSVKGVIDFYFAC 216 (307)
T ss_pred CccC-CCCCCcCcEEEECCceEEEeeccccc
Confidence 4666 99999999999998878899998753
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=90.69 E-value=0.55 Score=44.17 Aligned_cols=47 Identities=19% Similarity=0.173 Sum_probs=40.0
Q ss_pred HHHHHHHHHHHHHHHHh-CCCeeecCCCCCCEEEcCCccEEEeccCCccc
Q psy1840 25 SISVNTTASVGMIHLHD-SEIISHGNLRSSNCLIDSRWVLQIADFGLHAF 73 (423)
Q Consensus 25 ~l~i~~qi~~gL~yLH~-~~ii~HrDLkp~NILld~~~~vKL~DFGla~~ 73 (423)
.-.+..++++++.-|-. .+++ ||||..=|||+. ++.+.|+|+|-+..
T Consensus 168 ~~~~~~~~v~~~~~l~~~a~LV-HgDLSEyNiL~~-~~~p~iID~~QaV~ 215 (268)
T COG1718 168 AEGLYEDVVEYMRRLYKEAGLV-HGDLSEYNILVH-DGEPYIIDVSQAVT 215 (268)
T ss_pred HHHHHHHHHHHHHHHHHhcCcc-cccchhhheEEE-CCeEEEEECccccc
Confidence 45677888889988877 6887 999999999999 78999999997643
|
|
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=89.81 E-value=0.27 Score=45.75 Aligned_cols=28 Identities=29% Similarity=0.475 Sum_probs=23.9
Q ss_pred eeecCCCCCCEEEcCCccEEEeccCCcc
Q psy1840 45 ISHGNLRSSNCLIDSRWVLQIADFGLHA 72 (423)
Q Consensus 45 i~HrDLkp~NILld~~~~vKL~DFGla~ 72 (423)
++|||+.+.|++++.....-|.||+.+.
T Consensus 166 l~HGD~~~~Nvlv~~~~i~giIDw~~a~ 193 (235)
T cd05155 166 WFHGDLAPGNLLVQDGRLSAVIDFGCLG 193 (235)
T ss_pred EEeCCCCCCcEEEECCCEEEEEeCcccC
Confidence 3499999999999987667899999764
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=89.34 E-value=0.31 Score=47.46 Aligned_cols=30 Identities=23% Similarity=0.381 Sum_probs=25.2
Q ss_pred CCCeeecCCCCCCEEEcCCccEEEeccCCcc
Q psy1840 42 SEIISHGNLRSSNCLIDSRWVLQIADFGLHA 72 (423)
Q Consensus 42 ~~ii~HrDLkp~NILld~~~~vKL~DFGla~ 72 (423)
.+++ |||+.+.||+++.+...-|.||+.+.
T Consensus 187 ~~li-HgD~~~~Nil~~~~~~~~iIDf~~~~ 216 (319)
T PRK05231 187 RGVI-HADLFRDNVLFEGDRLSGFIDFYFAC 216 (319)
T ss_pred cccC-CCCCCCCcEEEECCceEEEEeccccc
Confidence 3666 99999999999977667899998754
|
|
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=88.86 E-value=0.69 Score=44.46 Aligned_cols=29 Identities=28% Similarity=0.413 Sum_probs=25.1
Q ss_pred CCeeecCCCCCCEEEcCCccEEEeccCCcc
Q psy1840 43 EIISHGNLRSSNCLIDSRWVLQIADFGLHA 72 (423)
Q Consensus 43 ~ii~HrDLkp~NILld~~~~vKL~DFGla~ 72 (423)
+++ |||+.|.|+++++++.+.|.||+.+.
T Consensus 176 ~l~-HgD~~~~Nil~~~~~~~~iIDfe~a~ 204 (296)
T cd05153 176 GVI-HADLFRDNVLFDGDELSGVIDFYFAC 204 (296)
T ss_pred cCC-ccCcCcccEEEeCCceEEEeehhhhc
Confidence 465 99999999999998878999998753
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >PRK10271 thiK thiamine kinase; Provisional | Back alignment and domain information |
|---|
Probab=88.50 E-value=0.4 Score=43.17 Aligned_cols=27 Identities=15% Similarity=0.223 Sum_probs=23.6
Q ss_pred eeecCCCCCCEEEcCCccEEEeccCCcc
Q psy1840 45 ISHGNLRSSNCLIDSRWVLQIADFGLHA 72 (423)
Q Consensus 45 i~HrDLkp~NILld~~~~vKL~DFGla~ 72 (423)
.+|+|+.|.|+++++++ ++++||+.+.
T Consensus 79 p~H~D~~~~N~~~~~~~-~~lIDwe~a~ 105 (188)
T PRK10271 79 PLHMDVHAGNLVHSASG-LRLIDWEYAG 105 (188)
T ss_pred eecCCCCCccEEEECCC-EEEEeCCccc
Confidence 35999999999998877 8899999864
|
|
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=88.45 E-value=0.65 Score=43.12 Aligned_cols=29 Identities=17% Similarity=0.249 Sum_probs=25.1
Q ss_pred CCeeecCCCCCCEEEcCCccEEEeccCCcc
Q psy1840 43 EIISHGNLRSSNCLIDSRWVLQIADFGLHA 72 (423)
Q Consensus 43 ~ii~HrDLkp~NILld~~~~vKL~DFGla~ 72 (423)
.+++|||+.|.|++++..+ +.++||+.+.
T Consensus 153 ~~~~HgD~~~~Nii~~~~~-~~iIDwe~a~ 181 (226)
T TIGR02172 153 STCLHGDFQIGNLITSGKG-TYWIDLGDFG 181 (226)
T ss_pred CceEecCCCCCcEEEcCCC-cEEEechhcC
Confidence 3556999999999999888 9999999764
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=88.40 E-value=0.76 Score=44.43 Aligned_cols=27 Identities=19% Similarity=0.267 Sum_probs=23.0
Q ss_pred CCeeecCCCCCCEEEcCCccEEEeccCCc
Q psy1840 43 EIISHGNLRSSNCLIDSRWVLQIADFGLH 71 (423)
Q Consensus 43 ~ii~HrDLkp~NILld~~~~vKL~DFGla 71 (423)
+++ |||+.+.||+++. +.+.|.||+.+
T Consensus 188 ~li-HgD~~~~Nil~~~-~~i~lIDfd~~ 214 (313)
T TIGR02906 188 GFC-HQDYAYHNILLKD-NEVYVIDFDYC 214 (313)
T ss_pred ceE-cCCCCcccEEEeC-CcEEEEECccc
Confidence 455 9999999999988 56889999864
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=88.33 E-value=0.89 Score=43.87 Aligned_cols=29 Identities=24% Similarity=0.402 Sum_probs=24.7
Q ss_pred CeeecCCCCCCEEEcCC----ccEEEeccCCcc
Q psy1840 44 IISHGNLRSSNCLIDSR----WVLQIADFGLHA 72 (423)
Q Consensus 44 ii~HrDLkp~NILld~~----~~vKL~DFGla~ 72 (423)
.++|+|+.+.||+++.+ +.+.++||..+.
T Consensus 180 ~lcH~Dl~~~Nil~~~~~~~~~~i~lIDwEya~ 212 (302)
T cd05156 180 VFCHNDLQEGNILLLNPSSETKKLVLIDFEYAS 212 (302)
T ss_pred eEEecCCCcCeEEecCCCCCCCcEEEEeeCCCC
Confidence 34599999999999985 889999998754
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=87.80 E-value=0.61 Score=43.09 Aligned_cols=28 Identities=18% Similarity=0.377 Sum_probs=24.2
Q ss_pred eeecCCCCCCEEEcC-CccEEEeccCCcc
Q psy1840 45 ISHGNLRSSNCLIDS-RWVLQIADFGLHA 72 (423)
Q Consensus 45 i~HrDLkp~NILld~-~~~vKL~DFGla~ 72 (423)
.+|+|+.+.||++++ ++.+.++||..+.
T Consensus 172 l~H~Dl~~~Nil~~~~~~~~~lIDwe~a~ 200 (235)
T cd05157 172 FCHNDLLSGNIIYNEEKNSVKFIDYEYAG 200 (235)
T ss_pred EEcCCCCcCcEEEeCCCCCEEEEEcccCC
Confidence 459999999999998 5789999998754
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=87.18 E-value=0.53 Score=43.88 Aligned_cols=28 Identities=21% Similarity=0.363 Sum_probs=24.6
Q ss_pred eeecCCCCCCEEEcCCccEEEeccCCcc
Q psy1840 45 ISHGNLRSSNCLIDSRWVLQIADFGLHA 72 (423)
Q Consensus 45 i~HrDLkp~NILld~~~~vKL~DFGla~ 72 (423)
.+|||+.|.||+++.+..+.|+||+.+.
T Consensus 165 l~HgD~~~~Nil~~~~~~~~iIDwe~a~ 192 (244)
T cd05150 165 VTHGDACLPNIIVDPGKFSGFIDLGRLG 192 (244)
T ss_pred EECCCCCCccEEEeCCcEEEEEEccccc
Confidence 4599999999999998888999998754
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=87.04 E-value=0.38 Score=43.80 Aligned_cols=29 Identities=34% Similarity=0.533 Sum_probs=19.4
Q ss_pred CeeecCCCCCCEEEc-CCccEEEeccCCcc
Q psy1840 44 IISHGNLRSSNCLID-SRWVLQIADFGLHA 72 (423)
Q Consensus 44 ii~HrDLkp~NILld-~~~~vKL~DFGla~ 72 (423)
.++|||+.|.||+++ .++.+-|.||+.+.
T Consensus 167 ~~~HgD~~~~Nil~~~~~~~i~iID~e~a~ 196 (239)
T PF01636_consen 167 VLIHGDLHPGNILVDPSDGRIGIIDFEDAG 196 (239)
T ss_dssp EEE-SS-SGGGEEEESSTTEEEE--GTT-E
T ss_pred EEEEeccccccceeeeccceeEEEecccce
Confidence 345999999999999 66767899998754
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >KOG0576|consensus | Back alignment and domain information |
|---|
Probab=86.98 E-value=0.25 Score=52.03 Aligned_cols=90 Identities=17% Similarity=0.137 Sum_probs=65.6
Q ss_pred HHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCccEEEeccCCcccccCCCcccccccccCCccccCCccccCCCCCCCC
Q psy1840 28 VNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKAPELLRQPHLPRGT 107 (423)
Q Consensus 28 i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~s 107 (423)
+...-.++++++|+..-+ |+| ||+..+ +..|..+|+....+.... ......+++.|+|||...+..+ .
T Consensus 341 ~~r~et~~l~~l~~~~~~-~~d----~~l~s~-~~~~~~~~~v~~~L~~~~---~~~t~~~~~~~~~pev~~~~~~---~ 408 (829)
T KOG0576|consen 341 PLRKETRPLAELHSSYKV-HRD----NILGSE-EEVKLLDFAVPPQLTRTM---KPRTAIGTPEPLAPEVIQENTI---D 408 (829)
T ss_pred hhhhhccccccccccccc-Ccc----cccccc-cccccccccCCcccCccc---ccccCCCCCCCCCchhhccccc---c
Confidence 344456788999987545 998 666654 678999999876554332 2356678899999998887765 7
Q ss_pred CccchHHHHHHHHHHHhCCCCC
Q psy1840 108 QKGDVYSFGLVLYEVIGRQGPW 129 (423)
Q Consensus 108 ~ksDVyS~Giil~elltg~~Pf 129 (423)
.+.|+||.|.--.++.-|..|-
T Consensus 409 ~~p~~~~~~~~~~~~ap~~pPr 430 (829)
T KOG0576|consen 409 GCPDSGSLAVSAIQMAPGLPPR 430 (829)
T ss_pred cCCCccCCCcchhhcCCCCCCC
Confidence 8899999998666666665553
|
|
| >COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=85.70 E-value=1.9 Score=42.95 Aligned_cols=52 Identities=23% Similarity=0.159 Sum_probs=41.4
Q ss_pred HHHHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCccEEEeccCCccccc
Q psy1840 23 IGSISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKA 75 (423)
Q Consensus 23 ~~~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~ 75 (423)
.+.++|+.+.+.-+.-+..+--.-|||+...||||+ +|.+.|+||-+++...
T Consensus 321 ~e~lsff~s~~sil~~lekkf~fehrnlt~~niLId-~GnvtLIDfklsRl~~ 372 (488)
T COG5072 321 EEELSFFWSCISILDILEKKFPFEHRNLTLDNILID-EGNVTLIDFKLSRLSY 372 (488)
T ss_pred HHHHHHHHHHHHHHhhhhhcCCcccccccccceeee-cCceEEEEeeeeeccc
Confidence 346788888777676666653334999999999999 9999999999988543
|
|
| >KOG1826|consensus | Back alignment and domain information |
|---|
Probab=84.91 E-value=0.27 Score=56.73 Aligned_cols=80 Identities=14% Similarity=0.099 Sum_probs=61.2
Q ss_pred eeecCCCCCCEEEcCCccEEEeccCCcccccCCCcccccccccCCccccCCccccCCCCCCCCCccchHHHHHHHHHHHh
Q psy1840 45 ISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKAPELLRQPHLPRGTQKGDVYSFGLVLYEVIG 124 (423)
Q Consensus 45 i~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~s~ksDVyS~Giil~ellt 124 (423)
.+|++||+-|.+|..+..+|++++|+.+...+.... .....+++.|+.|++...-.+ +.++|+|..|+-+|+...
T Consensus 1361 ~v~~~Lkf~lpmIVtny~v~~gk~gLdKIknp~~sf--~Gl~l~sp~~v~qli~N~ik~---t~rsdilr~s~~ly~rs~ 1435 (2724)
T KOG1826|consen 1361 NVSKSLKFTLPMIVTNYNVKLGKGGLDKIKNPVLSF--FGLELCSPIYVLQLIKNEIKF---TKRSDILRRSLSLYLRSD 1435 (2724)
T ss_pred chhhhhhhhccceecCCcccccccccccccCchHhh--hhhhhCCHHHHHHHHHHHHhh---hhHHHHHHHHHHHHHHhc
Confidence 459999999999999999999999998843322211 134456677888887765443 777999999999999887
Q ss_pred CCCCC
Q psy1840 125 RQGPW 129 (423)
Q Consensus 125 g~~Pf 129 (423)
|..+|
T Consensus 1436 ~n~~f 1440 (2724)
T KOG1826|consen 1436 GNAYF 1440 (2724)
T ss_pred ccHHH
Confidence 77666
|
|
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=84.73 E-value=0.72 Score=43.41 Aligned_cols=28 Identities=14% Similarity=0.254 Sum_probs=23.8
Q ss_pred CeeecCCCCCCEEEcCCccEEEeccCCcc
Q psy1840 44 IISHGNLRSSNCLIDSRWVLQIADFGLHA 72 (423)
Q Consensus 44 ii~HrDLkp~NILld~~~~vKL~DFGla~ 72 (423)
..+|+|+.|.|++++.++ +.+.||..+.
T Consensus 147 ~l~H~Dl~~~Nil~~~~~-~~lIDwE~a~ 174 (256)
T TIGR02721 147 APLHMDVHAYNLVVTPQG-LKLIDWEYAS 174 (256)
T ss_pred eeecCCCCcCcEEEeCCC-CEEEeccccC
Confidence 345999999999999877 7899998764
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2 | Back alignment and domain information |
|---|
Probab=83.41 E-value=0.7 Score=42.13 Aligned_cols=30 Identities=23% Similarity=0.509 Sum_probs=20.8
Q ss_pred CeeecCCCCCCEEE-cCCccEEEeccCCccc
Q psy1840 44 IISHGNLRSSNCLI-DSRWVLQIADFGLHAF 73 (423)
Q Consensus 44 ii~HrDLkp~NILl-d~~~~vKL~DFGla~~ 73 (423)
+.+|+||.+.||++ +.++.++++||..+..
T Consensus 144 v~cHnDl~~~Nil~~~~~~~~~lIDfEya~~ 174 (211)
T PF01633_consen 144 VFCHNDLNPGNILINNKDGEVKLIDFEYAGY 174 (211)
T ss_dssp EEE-S--SGGGEEETSSSSCEEE--GTT-EE
T ss_pred eEeeccCccccEEeccCCCeEEEecHHHHhh
Confidence 56699999999999 8889999999987653
|
7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B .... |
| >smart00587 CHK ZnF_C4 abd HLH domain containing kinases domain | Back alignment and domain information |
|---|
Probab=83.36 E-value=1 Score=40.70 Aligned_cols=31 Identities=23% Similarity=0.496 Sum_probs=24.5
Q ss_pred CCeeecCCCCCCEEEcCCc-----cEEEeccCCccc
Q psy1840 43 EIISHGNLRSSNCLIDSRW-----VLQIADFGLHAF 73 (423)
Q Consensus 43 ~ii~HrDLkp~NILld~~~-----~vKL~DFGla~~ 73 (423)
..++|||+.+.|+++..++ .+.+.||..+..
T Consensus 120 ~vl~HgD~~~~N~~~~~~~~~~~~~~~liDfq~~~~ 155 (196)
T smart00587 120 NVLNHGDLWANNIMFKYDDEGKPEDVALIDFQLSHY 155 (196)
T ss_pred eEEeeCCCCccceeeccCCCCCccceEEEecccCCc
Confidence 3556999999999997543 689999987643
|
subfamily of choline kinases |
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=82.35 E-value=1.4 Score=46.12 Aligned_cols=47 Identities=17% Similarity=0.229 Sum_probs=35.7
Q ss_pred HHHHHHHHH-HHHHHhCCCeeecCCCCCCEEEcCCccEEEeccCCcccc
Q psy1840 27 SVNTTASVG-MIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFK 74 (423)
Q Consensus 27 ~i~~qi~~g-L~yLH~~~ii~HrDLkp~NILld~~~~vKL~DFGla~~~ 74 (423)
.++..++.. +..+-..|++ |+|..|.||+++.+|.+-+.|||+....
T Consensus 268 ~ia~~~~~~f~~q~~~dgff-HaDpHpGNi~v~~~g~i~~lDfGi~g~l 315 (517)
T COG0661 268 ELAELLVRAFLRQLLRDGFF-HADPHPGNILVRSDGRIVLLDFGIVGRL 315 (517)
T ss_pred HHHHHHHHHHHHHHHhcCcc-ccCCCccceEEecCCcEEEEcCcceecC
Confidence 344444443 3444457888 9999999999999999999999996554
|
|
| >COG0510 ycfN Thiamine kinase and related kinases [Coenzyme transport and metabolism] | Back alignment and domain information |
|---|
Probab=82.31 E-value=1.9 Score=41.27 Aligned_cols=45 Identities=13% Similarity=0.163 Sum_probs=32.5
Q ss_pred HHHHHHHHHHHHHhC-CCeeecCCCCCCEEEcCCccEEEeccCCcc
Q psy1840 28 VNTTASVGMIHLHDS-EIISHGNLRSSNCLIDSRWVLQIADFGLHA 72 (423)
Q Consensus 28 i~~qi~~gL~yLH~~-~ii~HrDLkp~NILld~~~~vKL~DFGla~ 72 (423)
.+..+-..+.-.+.. -.++|+|+.|.|++.++.+.++|+||-.|.
T Consensus 137 ~~~~l~~~l~~~~~~~~v~cH~Dl~~~N~l~t~~~~l~LIDWEyAg 182 (269)
T COG0510 137 KLKELRRALEEVPKDDLVPCHNDLNPGNLLLTDKGGLFLIDWEYAG 182 (269)
T ss_pred HHHHHHHHhhhcCCCceeeecCCCCccceEEcCCCcEEEEecccCC
Confidence 333344444444444 356699999999999999999999997654
|
|
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=82.31 E-value=1.5 Score=42.14 Aligned_cols=30 Identities=23% Similarity=0.392 Sum_probs=24.0
Q ss_pred CeeecCCCCCCEEEcCCcc-EEEeccCCccc
Q psy1840 44 IISHGNLRSSNCLIDSRWV-LQIADFGLHAF 73 (423)
Q Consensus 44 ii~HrDLkp~NILld~~~~-vKL~DFGla~~ 73 (423)
.++|||+++.|++++.++. .-|.||+.+..
T Consensus 186 ~lvHGD~~~~Nilv~~~~~~~gviDWe~a~i 216 (276)
T cd05152 186 VLVHGDLHPGHILIDEDARVTGLIDWTEAKV 216 (276)
T ss_pred eeEeCCCCCCcEEEeCCCCEEEEECcHhccc
Confidence 3459999999999997554 57999997653
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >TIGR02904 spore_ysxE spore coat protein YsxE | Back alignment and domain information |
|---|
Probab=82.29 E-value=2 Score=41.69 Aligned_cols=29 Identities=24% Similarity=0.305 Sum_probs=25.0
Q ss_pred CeeecCCCCCCEEEcCCccEEEeccCCcc
Q psy1840 44 IISHGNLRSSNCLIDSRWVLQIADFGLHA 72 (423)
Q Consensus 44 ii~HrDLkp~NILld~~~~vKL~DFGla~ 72 (423)
.++|||+.++|++++.++.+.++||..+.
T Consensus 197 ~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~ 225 (309)
T TIGR02904 197 VLVHGKLSLSHFLYDETRGGYFINFEKAS 225 (309)
T ss_pred eeeCCCCcHHhEEEcCCCCEEEEEhhhcc
Confidence 34499999999999999999999997654
|
Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat. |
| >PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length | Back alignment and domain information |
|---|
Probab=82.23 E-value=1.3 Score=41.02 Aligned_cols=74 Identities=18% Similarity=0.147 Sum_probs=49.5
Q ss_pred HHHHHHHHh-CCCeeecCCCCCCEEEcCCccEEEeccCCcccccCCCcccccccccCCccccCCccccCCCCCCCCCccc
Q psy1840 33 SVGMIHLHD-SEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKAPELLRQPHLPRGTQKGD 111 (423)
Q Consensus 33 ~~gL~yLH~-~~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~s~ksD 111 (423)
++.|.-.|+ ++-.+|||-.|+||+-|+.|.+||.|-+.- ... +..|.--|+. ..|+++.
T Consensus 151 i~~L~~fH~~~~~~lHGD~np~NiM~D~~G~lKlVDP~~L--l~~------------~V~~vN~~Y~------~lT~~aE 210 (308)
T PF07387_consen 151 IKDLMDFHSENQHCLHGDCNPDNIMCDKFGYLKLVDPVCL--LEN------------QVNMVNIEYE------SLTQEAE 210 (308)
T ss_pred HHHHHHhhccCCCeecCCCChhheeecCCCCEEecChhhh--hhh------------eeeEEeeecc------ccChHHH
Confidence 345666683 444459999999999999999999998741 110 1113331211 2378888
Q ss_pred hHHHHHHHHHHHhCC
Q psy1840 112 VYSFGLVLYEVIGRQ 126 (423)
Q Consensus 112 VyS~Giil~elltg~ 126 (423)
+=+|=.-+.++...+
T Consensus 211 ~~~fv~s~l~~v~~~ 225 (308)
T PF07387_consen 211 VKVFVKSCLKLVEKQ 225 (308)
T ss_pred HHHHHHHHHHHHHHH
Confidence 888888888887654
|
The function of this family is unknown. |
Homologous Structure Templates
Structure Templates Detected by BLAST 
Original result of BLAST against Protein Data Bank
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() | |
| Query | 423 | ||||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 8e-15 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 9e-15 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 9e-15 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 5e-14 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 2e-13 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 3e-13 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 3e-13 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 4e-13 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 4e-13 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 4e-13 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 4e-13 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 4e-13 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 4e-13 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 4e-13 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 4e-13 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 8e-13 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 8e-13 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 9e-13 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 2e-12 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 3e-12 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 8e-12 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 9e-12 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 9e-12 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 9e-12 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 9e-12 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 1e-11 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 1e-11 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 1e-11 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 1e-11 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 1e-11 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 1e-11 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 1e-11 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 1e-11 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 2e-11 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 3e-11 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 5e-11 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 9e-11 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 1e-10 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 1e-10 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 1e-10 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 2e-10 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 2e-10 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 2e-10 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-10 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 2e-10 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 2e-10 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 2e-10 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 2e-10 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-10 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 2e-10 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-10 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 2e-10 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 2e-10 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 2e-10 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 2e-10 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 2e-10 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-10 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 2e-10 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 3e-10 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 3e-10 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 3e-10 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 3e-10 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 3e-10 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 3e-10 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 3e-10 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 3e-10 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 3e-10 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 3e-10 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 4e-10 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 4e-10 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 5e-10 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 7e-10 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 7e-10 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 7e-10 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 1e-09 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 1e-09 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 1e-09 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 1e-09 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 1e-09 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 1e-09 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 1e-09 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 1e-09 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 1e-09 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 2e-09 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-09 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 2e-09 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 2e-09 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 2e-09 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 2e-09 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 3e-09 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 3e-09 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 3e-09 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 4e-09 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 6e-09 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 7e-09 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 7e-09 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 7e-09 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 8e-09 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 8e-09 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 8e-09 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 8e-09 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 9e-09 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 9e-09 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 9e-09 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 1e-08 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 1e-08 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 1e-08 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 1e-08 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 1e-08 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 1e-08 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 1e-08 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 1e-08 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 1e-08 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 1e-08 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 1e-08 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 1e-08 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 1e-08 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 2e-08 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 2e-08 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 2e-08 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 2e-08 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 2e-08 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 2e-08 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 3e-08 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 3e-08 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 3e-08 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 3e-08 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 3e-08 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 3e-08 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 3e-08 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 4e-08 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 4e-08 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 4e-08 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 4e-08 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 4e-08 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 4e-08 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 4e-08 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 5e-08 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 5e-08 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 5e-08 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 5e-08 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 5e-08 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 5e-08 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 5e-08 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 5e-08 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 5e-08 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 5e-08 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 5e-08 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 5e-08 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 5e-08 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 5e-08 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 5e-08 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 5e-08 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 6e-08 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 6e-08 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 6e-08 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 6e-08 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 6e-08 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 6e-08 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 7e-08 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 7e-08 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 9e-08 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 1e-07 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 1e-07 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 1e-07 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 1e-07 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 1e-07 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 1e-07 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 1e-07 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 1e-07 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 1e-07 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 1e-07 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 1e-07 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 1e-07 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 2e-07 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 2e-07 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 2e-07 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 2e-07 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 2e-07 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 2e-07 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 2e-07 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 2e-07 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 2e-07 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 2e-07 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 2e-07 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 2e-07 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 2e-07 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 2e-07 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 3e-07 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 3e-07 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 4e-07 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 5e-07 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 6e-07 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 6e-07 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 7e-07 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 1e-06 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 1e-06 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 1e-06 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 1e-06 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 1e-06 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 1e-06 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 1e-06 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 1e-06 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 1e-06 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 2e-06 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 2e-06 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 2e-06 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-06 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 2e-06 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 2e-06 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-06 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-06 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 2e-06 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 2e-06 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-06 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-06 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 2e-06 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 2e-06 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 2e-06 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 2e-06 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-06 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-06 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 2e-06 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 2e-06 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 2e-06 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 2e-06 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 2e-06 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-06 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 2e-06 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 2e-06 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-06 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 2e-06 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 2e-06 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-06 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 2e-06 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-06 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 2e-06 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 2e-06 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 2e-06 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 2e-06 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-06 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 2e-06 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-06 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 3e-06 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 3e-06 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 3e-06 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 3e-06 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 3e-06 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 3e-06 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 3e-06 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 3e-06 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-06 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 3e-06 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 3e-06 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 3e-06 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 3e-06 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 4e-06 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 4e-06 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 4e-06 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 4e-06 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 4e-06 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 4e-06 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 4e-06 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-06 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 4e-06 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 4e-06 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 4e-06 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 4e-06 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 5e-06 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 5e-06 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 5e-06 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 5e-06 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 6e-06 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 7e-06 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 7e-06 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 7e-06 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 7e-06 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 7e-06 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 7e-06 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 8e-06 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 8e-06 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 8e-06 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 8e-06 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 8e-06 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 8e-06 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 8e-06 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 8e-06 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 8e-06 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 8e-06 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 8e-06 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 8e-06 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 8e-06 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 8e-06 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 9e-06 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 9e-06 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 9e-06 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 9e-06 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 9e-06 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 1e-05 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 1e-05 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 1e-05 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 1e-05 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 1e-05 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 1e-05 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 1e-05 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 1e-05 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 1e-05 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 1e-05 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 1e-05 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 1e-05 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 1e-05 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 1e-05 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 1e-05 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 2e-05 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 2e-05 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 2e-05 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 2e-05 | ||
| 3kmw_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 2e-05 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 3e-05 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 4e-05 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 5e-05 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 6e-05 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 6e-05 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 7e-05 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 7e-05 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 8e-05 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 8e-05 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 8e-05 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 1e-04 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 1e-04 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 1e-04 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 1e-04 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 2e-04 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 2e-04 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 2e-04 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 2e-04 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 2e-04 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 2e-04 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 2e-04 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 3e-04 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 3e-04 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 3e-04 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 3e-04 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 3e-04 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 3e-04 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 3e-04 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 4e-04 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 4e-04 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 4e-04 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 4e-04 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 4e-04 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 4e-04 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 4e-04 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 4e-04 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 4e-04 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 5e-04 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 5e-04 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 5e-04 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 5e-04 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 5e-04 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 5e-04 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 5e-04 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 5e-04 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 5e-04 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 6e-04 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 6e-04 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 6e-04 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 6e-04 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 6e-04 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 6e-04 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 6e-04 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 6e-04 | ||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 6e-04 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 6e-04 |
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST 
Original result of RPS-BLAST against PDB70 database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() |
| Query | 423 | |||
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 8e-34 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 9e-34 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 8e-33 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 2e-31 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 3e-31 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 4e-30 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 3e-28 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 2e-27 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 5e-27 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 1e-25 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 2e-25 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 2e-25 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 5e-25 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 7e-24 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 5e-21 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 5e-20 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 1e-19 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 2e-19 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 3e-19 | |
| 3v5q_A | 297 | NT-3 growth factor receptor; kinase domain, kinase | 7e-19 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 1e-18 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 1e-18 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 1e-18 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 2e-18 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 3e-18 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 3e-18 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 4e-18 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 5e-18 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 5e-18 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 5e-18 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 5e-18 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 9e-18 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 1e-17 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 1e-17 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 2e-17 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 2e-17 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 2e-17 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 2e-17 | |
| 3zzw_A | 289 | Tyrosine-protein kinase transmembrane receptor RO; | 2e-17 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 3e-17 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 4e-17 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 4e-17 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 4e-17 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 4e-17 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 4e-17 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 5e-17 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 6e-17 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 7e-17 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 7e-17 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 9e-17 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 1e-16 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 1e-16 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 1e-16 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 1e-16 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 1e-16 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 2e-16 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 2e-16 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 3e-16 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 3e-16 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 4e-16 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 4e-16 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 5e-16 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 5e-16 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 5e-16 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 7e-16 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 1e-15 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 1e-15 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 2e-15 | |
| 3uvj_A | 225 | Guanylate cyclase soluble subunit alpha-3; nitric | 5e-12 | |
| 1azs_A | 220 | VC1; complex (lyase/hydrolase), hydrolase, signal | 2e-11 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 5e-11 | |
| 3et6_A | 190 | Soluble guanylyl cyclase beta; guanylate cyclase, | 8e-11 | |
| 1yk9_A | 204 | Adenylate cyclase; beta-alpha-beta sandwich, struc | 9e-11 | |
| 2wz1_A | 219 | Guanylate cyclase soluble subunit beta-1; lyase, G | 2e-10 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 2e-10 | |
| 1ab8_A | 220 | Adenylyl cyclase; lyase, complex (transferase-inhi | 3e-10 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 3e-10 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 8e-10 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 1e-09 | |
| 1y10_A | 407 | Hypothetical protein RV1264/MT1302; adenylyl cycla | 1e-09 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 2e-09 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 2e-09 | |
| 3hls_A | 66 | Guanylate cyclase soluble subunit beta-1; coiled-c | 5e-09 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 6e-09 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 2e-08 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 4e-08 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 1e-07 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 2e-07 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 2e-07 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 3e-07 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 5e-07 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 7e-07 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 1e-06 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 1e-06 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 2e-06 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 2e-06 | |
| 4apc_A | 350 | Serine/threonine-protein kinase NEK1; transferase; | 2e-06 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 2e-06 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 4e-06 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 5e-06 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 8e-06 | |
| 1fx2_A | 235 | Receptor-type adenylate cyclase gresag 4.1; CAMP, | 9e-06 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 1e-05 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 1e-05 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 2e-05 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 2e-05 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 3e-05 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 3e-05 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 4e-05 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 6e-05 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 6e-05 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 6e-05 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 6e-05 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 6e-05 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 6e-05 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 7e-05 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 8e-05 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 9e-05 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 9e-05 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 9e-05 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 1e-04 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 1e-04 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 1e-04 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 2e-04 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 2e-04 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 2e-04 | |
| 1uu3_A | 310 | HPDK1, 3-phosphoinositide dependent protein kinase | 2e-04 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 3e-04 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 5e-04 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 5e-04 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 7e-04 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 8e-04 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 9e-04 |
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 127 bits (320), Expect = 9e-34
Identities = 48/158 (30%), Positives = 84/158 (53%), Gaps = 5/158 (3%)
Query: 35 GMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKA 94
GM +LH II H +L+S+N + ++I DFGL K+ + Q +L L+ A
Sbjct: 132 GMDYLHAKSII-HRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMA 190
Query: 95 PELLRQPHLPRGTQKGDVYSFGLVLYEVIGRQGPWGHLRMTDEEIITSVTQGSGLRPDTS 154
PE++R + + DVY+FG+VLYE++ Q P+ ++ ++II V +G L PD S
Sbjct: 191 PEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNIN-NRDQIIEMVGRG-SLSPDLS 248
Query: 155 SL--DCAPSIIACMRTCWEEDPELRPDLRFVHHKLKEM 190
+ +C + M C ++ + RP + +++E+
Sbjct: 249 KVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEEL 286
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 8e-33
Identities = 45/165 (27%), Positives = 77/165 (46%), Gaps = 15/165 (9%)
Query: 35 GMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRK---L 91
GM +LH I+ H +L+S N D+ + I DFGL + +E KLR +
Sbjct: 142 GMGYLHAKGIL-HKDLKSKNVFYDN-GKVVITDFGLFSISGVLQAGRREDKLRIQNGWLC 199
Query: 92 YKAPELLRQPHLPRG------TQKGDVYSFGLVLYEVIGRQGPWGHLRMTDEEIITSVTQ 145
+ APE++RQ ++ DV++ G + YE+ R+ P+ E II +
Sbjct: 200 HLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKT--QPAEAIIWQM-- 255
Query: 146 GSGLRPDTSSLDCAPSIIACMRTCWEEDPELRPDLRFVHHKLKEM 190
G+G++P+ S + I + CW + E RP + L+++
Sbjct: 256 GTGMKPNLSQIGMGKEISDILLFCWAFEQEERPTFTKLMDMLEKL 300
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 2e-31
Identities = 47/177 (26%), Positives = 74/177 (41%), Gaps = 21/177 (11%)
Query: 35 GMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYK- 93
GM +LH II H +L S NCL+ + +ADFGL + + + ++ K
Sbjct: 120 GMAYLHSMNII-HRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKK 178
Query: 94 -----------APELLR-QPHLPRGTQKGDVYSFGLVLYEVIGRQGPWGHLRMTDEEIIT 141
APE++ + + +K DV+SFG+VL E+IGR +
Sbjct: 179 RYTVVGNPYWMAPEMINGRSY----DEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGL 234
Query: 142 SVTQGSGLRPDTSSLDCAPSIIACMRTCWEEDPELRPDLRFVHHKLKEMNAGLKANI 198
+V L +C PS C + DPE RP + H L+ + L ++
Sbjct: 235 NVRG--FLDRYCPP-NCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRMHLAGHL 288
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 3e-31
Identities = 39/157 (24%), Positives = 67/157 (42%), Gaps = 12/157 (7%)
Query: 35 GMIHLHDSE-IISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYK 93
GM LH E +I L S + +ID +I+ + +
Sbjct: 123 GMAFLHTLEPLIPRHALNSRSVMIDEDMTARISMADVKFSFQSPGRMYAPA-------WV 175
Query: 94 APELLRQPHLPRGTQKGDVYSFGLVLYEVIGRQGPWGHLRMTDEEIITSVTQGSGLRPDT 153
APE L++ + D++SF ++L+E++ R+ P+ +++ EI V GLRP
Sbjct: 176 APEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFAD--LSNMEIGMKVALE-GLRPTI 232
Query: 154 SSLDCAPSIIACMRTCWEEDPELRPDLRFVHHKLKEM 190
+P + M+ C EDP RP + L++M
Sbjct: 233 PP-GISPHVSKLMKICMNEDPAKRPKFDMIVPILEKM 268
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 4e-30
Identities = 47/160 (29%), Positives = 80/160 (50%), Gaps = 16/160 (10%)
Query: 35 GMIHLHDSE-IISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERK--LRRRKL 91
GM +LH+ I H NL+S N L+D ++ +++ DFGL KA + +
Sbjct: 149 GMNYLHNRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSSKSAAGTPE---- 204
Query: 92 YKAPELLR-QPHLPRGTQKGDVYSFGLVLYEVIGRQGPWGHLRMTDEEIITSVTQGSGLR 150
+ APE+LR +P +K DVYSFG++L+E+ Q PWG+ + +++ +V R
Sbjct: 205 WMAPEVLRDEPS----NEKSDVYSFGVILWELATLQQPWGN--LNPAQVVAAVGFK-CKR 257
Query: 151 PDTSSLDCAPSIIACMRTCWEEDPELRPDLRFVHHKLKEM 190
+ + P + A + CW +P RP + L+ +
Sbjct: 258 LEIPR-NLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPL 296
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 3e-28
Identities = 42/162 (25%), Positives = 74/162 (45%), Gaps = 20/162 (12%)
Query: 35 GMIHLHDSE---IISHGNLRSSNCLIDSRW-VLQIADFGLHAFKAGQ--DETGQERKLRR 88
G+ +LH + +I H +L+ N L+ + VL+I DFG + G
Sbjct: 114 GVAYLHSMQPKALI-HRDLKPPNLLLVAGGTVLKICDFGTACDIQTHMTNNKGSAA---- 168
Query: 89 RKLYKAPELLRQPHLPRGTQKGDVYSFGLVLYEVIGRQGPWGHLRMTDEEIITSVTQGSG 148
+ APE+ + ++K DV+S+G++L+EVI R+ P+ + I+ +V G
Sbjct: 169 ---WMAPEVFEGSNY---SEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHN--G 220
Query: 149 LRPDTSSLDCAPSIIACMRTCWEEDPELRPDLRFVHHKLKEM 190
RP + I + M CW +DP RP + + + +
Sbjct: 221 TRPPLIK-NLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHL 261
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 2e-27
Identities = 44/168 (26%), Positives = 69/168 (41%), Gaps = 25/168 (14%)
Query: 35 GMIHLHDS---EIISHGNLRSSNCLID--------SRWVLQIADFGLHAFKAGQDETGQE 83
GM +LHD II H +L+SSN LI S +L+I DFGL +
Sbjct: 117 GMNYLHDEAIVPII-HRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTKMSAA 175
Query: 84 RKLRRRKLYKAPELLR-QPHLPRGTQKGDVYSFGLVLYEVIGRQGPWGHLRMTDEEIITS 142
+ APE++R ++ DV+S+G++L+E++ + P+ + +
Sbjct: 176 GAYA----WMAPEVIRASMF----SKGSDVWSYGVLLWELLTGEVPFRG--IDGLAVAYG 225
Query: 143 VTQGSGLRPDTSSLDCAPSIIACMRTCWEEDPELRPDLRFVHHKLKEM 190
V L S C M CW DP RP + +L +
Sbjct: 226 VAMN-KLALPIPS-TCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTTI 271
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 5e-27
Identities = 43/165 (26%), Positives = 72/165 (43%), Gaps = 20/165 (12%)
Query: 35 GMIHLHDSE--IISHGNLRSSNCLIDSRW-----VLQIADFGLHAFKAGQ--DETGQERK 85
G+ ++ + I+ H +LRS N + S ++ADFGL G +
Sbjct: 134 GIEYMQNQNPPIV-HRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSVHSVSGLLGNFQ- 191
Query: 86 LRRRKLYKAPELLRQPHLPRGTQKGDVYSFGLVLYEVIGRQGPWGHLRMTDEEIITSVTQ 145
+ APE + T+K D YSF ++LY ++ +GP+ + I + +
Sbjct: 192 ------WMAPETIGAEEESY-TEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIRE 244
Query: 146 GSGLRPDTSSLDCAPSIIACMRTCWEEDPELRPDLRFVHHKLKEM 190
GLRP DC P + + CW DP+ RP ++ +L E+
Sbjct: 245 E-GLRPTIPE-DCPPRLRNVIELCWSGDPKKRPHFSYIVKELSEL 287
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 2e-25
Identities = 46/185 (24%), Positives = 72/185 (38%), Gaps = 30/185 (16%)
Query: 35 GMIHLHDSEI-------ISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLR 87
G+ HLH + I+H +L+S N L+ IAD GL +T
Sbjct: 151 GLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNH 210
Query: 88 RR--KLYKAPELLRQPHLPRG---TQKGDVYSFGLVLYEVIGR----------QGPWGHL 132
R K Y APE+L + ++ D+Y+ GLV +E+ R Q P+ L
Sbjct: 211 RVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDL 270
Query: 133 ---RMTDEEIITSVTQGSGLRPD----TSSLDCAPSIIACMRTCWEEDPELRPDLRFVHH 185
+ EE+ V + LRP+ S + + MR CW + R +
Sbjct: 271 VPSDPSVEEMRKVVCEQ-KLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKK 329
Query: 186 KLKEM 190
L ++
Sbjct: 330 TLSQL 334
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 2e-25
Identities = 45/186 (24%), Positives = 70/186 (37%), Gaps = 30/186 (16%)
Query: 35 GMIHLHDSEI-------ISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLR 87
G+ HLH I+H +L+S N L+ IAD GL +
Sbjct: 117 GLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNP 176
Query: 88 RR--KLYKAPELLR---QPHLPRGTQKGDVYSFGLVLYEVIGRQGPWGHLR--------- 133
R K Y APE+L Q ++ D+++FGLVL+EV R G +
Sbjct: 177 RVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDV 236
Query: 134 ----MTDEEIITSVTQGSGLRP----DTSSLDCAPSIIACMRTCWEEDPELRPDLRFVHH 185
+ E++ V RP S S+ M+ CW ++P R +
Sbjct: 237 VPNDPSFEDMRKVVCVD-QQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKK 295
Query: 186 KLKEMN 191
L +++
Sbjct: 296 TLTKID 301
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 5e-25
Identities = 50/185 (27%), Positives = 68/185 (36%), Gaps = 30/185 (16%)
Query: 35 GMIHLHDSEI-------ISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLR 87
G+ HLH I+H +L+S N L+ IAD GL
Sbjct: 146 GLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNT 205
Query: 88 RR--KLYKAPELLRQPHLPRG---TQKGDVYSFGLVLYEVIGR----------QGPWGHL 132
R K Y PE+L + D+YSFGL+L+EV R Q P+ L
Sbjct: 206 RVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDL 265
Query: 133 ---RMTDEEIITSVTQGSGLRPD----TSSLDCAPSIIACMRTCWEEDPELRPDLRFVHH 185
+ E++ V LRP SS +C + M CW +P R V
Sbjct: 266 VPSDPSYEDMREIVCIK-KLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKK 324
Query: 186 KLKEM 190
L +M
Sbjct: 325 TLAKM 329
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 7e-24
Identities = 43/188 (22%), Positives = 71/188 (37%), Gaps = 36/188 (19%)
Query: 35 GMIHLHDSEI---------ISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERK 85
G+ +LH+ ISH +++S N L+ + IADFGL A K ++ +
Sbjct: 133 GLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGL-ALKFEAGKSAGDTH 191
Query: 86 LR---RRKLYKAPELLRQPHLPRG--TQKGDVYSFGLVLYEVIGRQGPWGHL-------- 132
+ RR Y APE+L + + D+Y+ GLVL+E+ R
Sbjct: 192 GQVGTRR--YMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPF 249
Query: 133 ------RMTDEEIITSVTQGSGLRPD----TSSLDCAPSIIACMRTCWEEDPELRPDLRF 182
+ E++ V RP + + CW+ D E R
Sbjct: 250 EEEIGQHPSLEDMQEVVVHK-KKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGC 308
Query: 183 VHHKLKEM 190
V ++ +M
Sbjct: 309 VGERITQM 316
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 92.6 bits (230), Expect = 5e-21
Identities = 38/195 (19%), Positives = 68/195 (34%), Gaps = 40/195 (20%)
Query: 35 GMIHLHDSEI--------ISHGNLRSSNCLIDSRWVLQIADFGL---HAFKAGQDETGQE 83
G+ +LH ISH +L S N L+ + I+DFGL ++
Sbjct: 123 GLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEED 182
Query: 84 RKLRRR---KLYKAPELLRQ----PHLPRGTQKGDVYSFGLVLYEVIGR----------- 125
Y APE+L ++ D+Y+ GL+ +E+ R
Sbjct: 183 NAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVP 242
Query: 126 --QGPWGHLRMTD---EEIITSVTQGSGLRPD-----TSSLDCAPSIIACMRTCWEEDPE 175
Q + E++ V++ RP + S+ + CW++D E
Sbjct: 243 EYQMAFQTEVGNHPTFEDMQVLVSR-EKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAE 301
Query: 176 LRPDLRFVHHKLKEM 190
R + ++ E+
Sbjct: 302 ARLTAQXAEERMAEL 316
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 91.0 bits (226), Expect = 5e-20
Identities = 45/160 (28%), Positives = 74/160 (46%), Gaps = 17/160 (10%)
Query: 35 GMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGL-HAFKAGQDETGQERKLRRRKLYK 93
GM ++ + H +LR++N L+ V ++ADFGL + + Q K +
Sbjct: 292 GMAYVERMNYV-HRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWT-- 348
Query: 94 APELLRQPHLPRGTQKGDVYSFGLVLYEVI--GRQGPWGHLRMTDEEIITSVTQGSGL-R 150
APE T K DV+SFG++L E+ GR G M + E++ V +G +
Sbjct: 349 APEAALYGRF---TIKSDVWSFGILLTELTTKGRVPYPG---MVNREVLDQVERGYRMPC 402
Query: 151 PDTSSLDCAPSIIACMRTCWEEDPELRPDLRFVHHKLKEM 190
P +C S+ M CW ++PE RP ++ L++
Sbjct: 403 PP----ECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY 438
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 90.3 bits (224), Expect = 1e-19
Identities = 45/160 (28%), Positives = 74/160 (46%), Gaps = 17/160 (10%)
Query: 35 GMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGL-HAFKAGQDETGQERKLRRRKLYK 93
GM ++ + H +LR++N L+ V ++ADFGL + + Q K +
Sbjct: 375 GMAYVERMNYV-HRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWT-- 431
Query: 94 APELLRQPHLPRGTQKGDVYSFGLVLYEVI--GRQGPWGHLRMTDEEIITSVTQGSGL-R 150
APE T K DV+SFG++L E+ GR G M + E++ V +G +
Sbjct: 432 APEAALYGRF---TIKSDVWSFGILLTELTTKGRVPYPG---MVNREVLDQVERGYRMPC 485
Query: 151 PDTSSLDCAPSIIACMRTCWEEDPELRPDLRFVHHKLKEM 190
P +C S+ M CW ++PE RP ++ L++
Sbjct: 486 PP----ECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY 521
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 88.1 bits (219), Expect = 2e-19
Identities = 44/162 (27%), Positives = 77/162 (47%), Gaps = 20/162 (12%)
Query: 35 GMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKL-YK 93
GM +L I H +L + NCL+ + VL+I+DFG+ +A R++ K
Sbjct: 225 GMEYLESKCCI-HRDLAARNCLVTEKNVLKISDFGMSREEADGVYA---ASGGLRQVPVK 280
Query: 94 --APELLRQPHLPRGTQKGDVYSFGLVLYEVI--GRQGPWGHLRMTDEEIITSVTQGSGL 149
APE L R + + DV+SFG++L+E G P+ +++++ V +G L
Sbjct: 281 WTAPEALNYG---RYSSESDVWSFGILLWETFSLGAS-PYP--NLSNQQTREFVEKGGRL 334
Query: 150 -RPDTSSLDCAPSIIACMRTCWEEDPELRPDLRFVHHKLKEM 190
P+ C ++ M CW +P RP ++ +L+ +
Sbjct: 335 PCPE----LCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSI 372
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 88.7 bits (220), Expect = 3e-19
Identities = 40/160 (25%), Positives = 67/160 (41%), Gaps = 17/160 (10%)
Query: 35 GMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGL-HAFKAGQDETGQERKLRRRKLYK 93
M +L I H NL + NCL+ ++++ADFGL K +
Sbjct: 330 AMEYLEKKNFI-HRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWT-- 386
Query: 94 APELLRQPHLPRGTQKGDVYSFGLVLYEVI--GRQGPWGHLRMTDEEIITSVTQGSGL-R 150
APE L + K DV++FG++L+E+ G G + ++ + + + R
Sbjct: 387 APESLAYNKF---SIKSDVWAFGVLLWEIATYGMSPYPG---IDLSQVYELLEKDYRMER 440
Query: 151 PDTSSLDCAPSIIACMRTCWEEDPELRPDLRFVHHKLKEM 190
P+ C + MR CW+ +P RP +H + M
Sbjct: 441 PE----GCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM 476
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 85.4 bits (212), Expect = 7e-19
Identities = 43/171 (25%), Positives = 81/171 (47%), Gaps = 38/171 (22%)
Query: 35 GMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYK- 93
GM++L + H +L + NCL+ + +++I DFG+ R + Y+
Sbjct: 145 GMVYLASQHFV-HRDLATRNCLVGANLLVKIGDFGM------------SRDVYSTDYYRV 191
Query: 94 -----------APELLRQPHLPRGTQKGDVYSFGLVLYEVI--GRQGPWGHLRMTDEEII 140
PE + + T + DV+SFG++L+E+ G+Q PW ++++ E+I
Sbjct: 192 GGHTMLPIRWMPPESI---MYRKFTTESDVWSFGVILWEIFTYGKQ-PWF--QLSNTEVI 245
Query: 141 TSVTQGSGL-RPDTSSLDCAPSIIACMRTCWEEDPELRPDLRFVHHKLKEM 190
+TQG L RP C + M CW+ +P+ R +++ ++ L +
Sbjct: 246 ECITQGRVLERPR----VCPKEVYDVMLGCWQREPQQRLNIKEIYKILHAL 292
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 85.0 bits (211), Expect = 1e-18
Identities = 40/162 (24%), Positives = 69/162 (42%), Gaps = 21/162 (12%)
Query: 35 GMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKL-YK 93
M +L I H +L + NCL+ ++++ADFGL + K K
Sbjct: 123 AMEYLEKKNFI-HRDLAARNCLVGENHLVKVADFGL----SRLMTGDTYTAHAGAKFPIK 177
Query: 94 --APELLRQPHLPRGTQKGDVYSFGLVLYEVI--GRQGPWGHLRMTDEEIITSVTQGSGL 149
APE L + + K DV++FG++L+E+ G G + ++ + + +
Sbjct: 178 WTAPESLAYN---KFSIKSDVWAFGVLLWEIATYGMSPYPG---IDLSQVYELLEKDYRM 231
Query: 150 -RPDTSSLDCAPSIIACMRTCWEEDPELRPDLRFVHHKLKEM 190
RP+ C + MR CW+ +P RP +H + M
Sbjct: 232 ERPE----GCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM 269
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 86.6 bits (215), Expect = 1e-18
Identities = 43/162 (26%), Positives = 76/162 (46%), Gaps = 25/162 (15%)
Query: 35 GMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKL-YK 93
M +L + + H +L + N L+ V +++DFGL + + Q+ KL K
Sbjct: 301 AMEYLEGNNFV-HRDLAARNVLVSEDNVAKVSDFGL----TKEASSTQDT----GKLPVK 351
Query: 94 --APELLRQPHLPRGTQKGDVYSFGLVLYEVI--GRQGPWGHLRMTDEEIITSVTQGSGL 149
APE LR+ + K DV+SFG++L+E+ GR + ++++ V +G +
Sbjct: 352 WTAPEALREKKF---STKSDVWSFGILLWEIYSFGRVPYPR---IPLKDVVPRVEKGYKM 405
Query: 150 -RPDTSSLDCAPSIIACMRTCWEEDPELRPDLRFVHHKLKEM 190
PD C P++ M+ CW D RP + +L+ +
Sbjct: 406 DAPD----GCPPAVYDVMKNCWHLDAATRPTFLQLREQLEHI 443
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 85.0 bits (211), Expect = 1e-18
Identities = 43/162 (26%), Positives = 77/162 (47%), Gaps = 20/162 (12%)
Query: 35 GMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKL--- 91
GM +L D ++ H +L + N L+ + ++I DFGL A G +E +E K+
Sbjct: 129 GMNYLEDRRLV-HRDLAARNVLVKTPQHVKITDFGL-AKLLGAEE--KEYHAEGGKVPIK 184
Query: 92 YKAPELLRQPHLPRGTQKGDVYSFGLVLYEVI--GRQGPWGHLRMTDEEIITSVTQGSGL 149
+ A E + T + DV+S+G+ ++E++ G + P+ + EI + + +G L
Sbjct: 185 WMALESI---LHRIYTHQSDVWSYGVTVWELMTFGSK-PYD--GIPASEISSILEKGERL 238
Query: 150 -RPDTSSLDCAPSIIACMRTCWEEDPELRPDLRFVHHKLKEM 190
+P C + MR CW D + RP R + + +M
Sbjct: 239 PQPP----ICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKM 276
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 84.2 bits (209), Expect = 2e-18
Identities = 43/162 (26%), Positives = 78/162 (48%), Gaps = 25/162 (15%)
Query: 35 GMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKL-YK 93
M +L + + H +L + N L+ V +++DFGL + + Q+ KL K
Sbjct: 129 AMEYLEGNNFV-HRDLAARNVLVSEDNVAKVSDFGL----TKEASSTQDTG----KLPVK 179
Query: 94 --APELLRQPHLPRGTQKGDVYSFGLVLYEVI--GRQGPWGHLRMTDEEIITSVTQGSGL 149
APE LR+ + + K DV+SFG++L+E+ GR + ++++ V +G +
Sbjct: 180 WTAPEALREK---KFSTKSDVWSFGILLWEIYSFGRVPYPR---IPLKDVVPRVEKGYKM 233
Query: 150 -RPDTSSLDCAPSIIACMRTCWEEDPELRPDLRFVHHKLKEM 190
PD C P++ M+ CW D +RP + +L+ +
Sbjct: 234 DAPD----GCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHI 271
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 83.4 bits (207), Expect = 3e-18
Identities = 52/162 (32%), Positives = 80/162 (49%), Gaps = 21/162 (12%)
Query: 35 GMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKL-YK 93
GM + + I H +LR++N L+ +IADFGL + T +E K K
Sbjct: 121 GMAFIEERNYI-HRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGA----KFPIK 175
Query: 94 --APELLRQPHLPRGTQKGDVYSFGLVLYEVI--GRQGPWGHLRMTDEEIITSVTQGSGL 149
APE + T K DV+SFG++L E++ GR G MT+ E+I ++ +G +
Sbjct: 176 WTAPEAINYG---TFTIKSDVWSFGILLTEIVTHGRIPYPG---MTNPEVIQNLERGYRM 229
Query: 150 -RPDTSSLDCAPSIIACMRTCWEEDPELRPDLRFVHHKLKEM 190
RPD +C + MR CW+E PE RP ++ L++
Sbjct: 230 VRPD----NCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDF 267
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 85.5 bits (212), Expect = 3e-18
Identities = 49/162 (30%), Positives = 78/162 (48%), Gaps = 21/162 (12%)
Query: 35 GMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKL-YK 93
GM + I H +LR++N L+ + V +IADFGL + T +E K K
Sbjct: 296 GMAFIEQRNYI-HRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGA----KFPIK 350
Query: 94 --APELLRQPHLPRGTQKGDVYSFGLVLYEVI--GRQGPWGHLRMTDEEIITSVTQGSGL 149
APE + T K DV+SFG++L E++ GR G M++ E+I ++ +G +
Sbjct: 351 WTAPEAINFGSF---TIKSDVWSFGILLMEIVTYGRIPYPG---MSNPEVIRALERGYRM 404
Query: 150 -RPDTSSLDCAPSIIACMRTCWEEDPELRPDLRFVHHKLKEM 190
RP+ +C + M CW+ PE RP ++ L +
Sbjct: 405 PRPE----NCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDF 442
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 83.1 bits (206), Expect = 4e-18
Identities = 43/163 (26%), Positives = 76/163 (46%), Gaps = 21/163 (12%)
Query: 35 GMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGL-HAFKAGQDETGQERKLRRRKL-Y 92
GM +L +S + H +L + N L+ ++ +I+DFGL A +A ++ + K
Sbjct: 129 GMKYLEESNFV-HRDLAARNVLLVTQHYAKISDFGLSKALRADENYY---KAQTHGKWPV 184
Query: 93 K--APELLRQPHLPRGTQKGDVYSFGLVLYEVI--GRQGPWGHLRMTDEEIITSVTQGSG 148
K APE + + + + K DV+SFG++++E G++ P+ M E+ + +G
Sbjct: 185 KWYAPECI---NYYKFSSKSDVWSFGVLMWEAFSYGQK-PYR--GMKGSEVTAMLEKGER 238
Query: 149 L-RPDTSSLDCAPSIIACMRTCWEEDPELRPDLRFVHHKLKEM 190
+ P C + M CW D E RP V +L+
Sbjct: 239 MGCPA----GCPREMYDLMNLCWTYDVENRPGFAAVELRLRNY 277
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 82.6 bits (205), Expect = 5e-18
Identities = 43/162 (26%), Positives = 76/162 (46%), Gaps = 21/162 (12%)
Query: 35 GMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKL-YK 93
GM +L ++ +I H +L + NCL+ V++++DFG+ F T K K
Sbjct: 116 GMAYLEEACVI-HRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGT----KFPVK 170
Query: 94 --APELLRQPHLPRGTQKGDVYSFGLVLYEVI--GRQGPWGHLRMTDEEIITSVTQGSGL 149
+PE+ R + K DV+SFG++++EV G+ ++ E++ ++ G L
Sbjct: 171 WASPEVFSFS---RYSSKSDVWSFGVLMWEVFSEGKIPYEN---RSNSEVVEDISTGFRL 224
Query: 150 -RPDTSSLDCAPSIIACMRTCWEEDPELRPDLRFVHHKLKEM 190
+P + + M CW E PE RP + +L E+
Sbjct: 225 YKPR----LASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEI 262
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 82.7 bits (205), Expect = 5e-18
Identities = 43/162 (26%), Positives = 77/162 (47%), Gaps = 19/162 (11%)
Query: 35 GMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKL-YK 93
GM +L + + H +L + N L+ +R +I+DFGL KA + K K
Sbjct: 122 GMKYLEEKNFV-HRDLAARNVLLVNRHYAKISDFGLS--KALGADDSYYTARSAGKWPLK 178
Query: 94 --APELLRQPHLPRGTQKGDVYSFGLVLYEVI--GRQGPWGHLRMTDEEIITSVTQGSGL 149
APE + + + + + DV+S+G+ ++E + G++ P+ +M E++ + QG +
Sbjct: 179 WYAPECI---NFRKFSSRSDVWSYGVTMWEALSYGQK-PYK--KMKGPEVMAFIEQGKRM 232
Query: 150 -RPDTSSLDCAPSIIACMRTCWEEDPELRPDLRFVHHKLKEM 190
P +C P + A M CW E RPD V +++
Sbjct: 233 ECPP----ECPPELYALMSDCWIYKWEDRPDFLTVEQRMRAC 270
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 82.6 bits (205), Expect = 5e-18
Identities = 43/162 (26%), Positives = 75/162 (46%), Gaps = 21/162 (12%)
Query: 35 GMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKL-YK 93
GM L + I H +L + NCL+D ++++DFG+ + K K
Sbjct: 116 GMAFLESHQFI-HRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSVGT----KFPVK 170
Query: 94 --APELLRQPHLPRGTQKGDVYSFGLVLYEVI--GRQGPWGHLRMTDEEIITSVTQGSGL 149
APE+ + + K DV++FG++++EV G+ T+ E++ V+QG L
Sbjct: 171 WSAPEVFHYF---KYSSKSDVWAFGILMWEVFSLGKMPYDL---YTNSEVVLKVSQGHRL 224
Query: 150 -RPDTSSLDCAPSIIACMRTCWEEDPELRPDLRFVHHKLKEM 190
RP + +I M +CW E PE RP + + ++ +
Sbjct: 225 YRPH----LASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPL 262
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 83.1 bits (206), Expect = 5e-18
Identities = 47/162 (29%), Positives = 83/162 (51%), Gaps = 18/162 (11%)
Query: 35 GMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKL-YK 93
GM +L + + + H +L + NC++D + +++ADFGL A E ++ R +L K
Sbjct: 136 GMEYLAEQKFV-HRDLAARNCMLDESFTVKVADFGL-ARDILDREYYSVQQHRHARLPVK 193
Query: 94 --APELLRQPHLPRGTQKGDVYSFGLVLYEVI--GRQGPWGHLRMTDEEIITSVTQGSGL 149
A E L R T K DV+SFG++L+E++ G + ++ + QG L
Sbjct: 194 WTALESL---QTYRFTTKSDVWSFGVLLWELLTRGAPPYRH---IDPFDLTHFLAQGRRL 247
Query: 150 -RPDTSSLDCAPSIIACMRTCWEEDPELRPDLRFVHHKLKEM 190
+P+ C S+ M+ CWE DP +RP R + +++++
Sbjct: 248 PQPE----YCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQI 285
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 82.7 bits (205), Expect = 9e-18
Identities = 46/162 (28%), Positives = 78/162 (48%), Gaps = 19/162 (11%)
Query: 35 GMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKL-YK 93
GM +L D + H +L + N L+DS V +++DFGL + +D+ K+ +
Sbjct: 163 GMRYLSDLGYV-HRDLAARNVLVDSNLVCKVSDFGLS--RVLEDDPDAAYTTTGGKIPIR 219
Query: 94 --APELLRQPHLPRGTQKGDVYSFGLVLYEVI--GRQGPWGHLRMTDEEIITSVTQGSGL 149
APE + + DV+SFG+V++EV+ G + P+ MT+ ++I+SV +G L
Sbjct: 220 WTAPEAI---AFRTFSSASDVWSFGVVMWEVLAYGER-PYW--NMTNRDVISSVEEGYRL 273
Query: 150 -RPDTSSLDCAPSIIACMRTCWEEDPELRPDLRFVHHKLKEM 190
P C ++ M CW +D RP + L +
Sbjct: 274 PAPM----GCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDAL 311
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 81.5 bits (202), Expect = 1e-17
Identities = 36/162 (22%), Positives = 74/162 (45%), Gaps = 21/162 (12%)
Query: 35 GMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKL-YK 93
M +L + + H +L + NCL++ + V++++DFGL + + T K +
Sbjct: 132 AMEYLESKQFL-HRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGS----KFPVR 186
Query: 94 --APELLRQPHLPRGTQKGDVYSFGLVLYEVI--GRQGPWGHLRMTDEEIITSVTQGSGL 149
PE+L + + K D+++FG++++E+ G+ T+ E + QG L
Sbjct: 187 WSPPEVLMYS---KFSSKSDIWAFGVLMWEIYSLGKMPYER---FTNSETAEHIAQGLRL 240
Query: 150 -RPDTSSLDCAPSIIACMRTCWEEDPELRPDLRFVHHKLKEM 190
RP + + M +CW E + RP + + + ++
Sbjct: 241 YRPH----LASEKVYTIMYSCWHEKADERPTFKILLSNILDV 278
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 82.3 bits (204), Expect = 1e-17
Identities = 53/164 (32%), Positives = 85/164 (51%), Gaps = 24/164 (14%)
Query: 35 GMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQD--ETGQERKLRRRKL- 91
GM++L + H +L + NCL+ V++I DFG+ +D T R R L
Sbjct: 170 GMVYLAGLHFV-HRDLATRNCLVGQGLVVKIGDFGM-----SRDIYSTDYYRVGGRTMLP 223
Query: 92 --YKAPELLRQPHLPRGTQKGDVYSFGLVLYEVI--GRQGPWGHLRMTDEEIITSVTQGS 147
+ PE + + T + DV+SFG+VL+E+ G+Q PW +++ E I +TQG
Sbjct: 224 IRWMPPESI---LYRKFTTESDVWSFGVVLWEIFTYGKQ-PWYQ--LSNTEAIDCITQGR 277
Query: 148 GL-RPDTSSLDCAPSIIACMRTCWEEDPELRPDLRFVHHKLKEM 190
L RP C P + A MR CW+ +P+ R ++ VH +L+ +
Sbjct: 278 ELERPR----ACPPEVYAIMRGCWQREPQQRHSIKDVHARLQAL 317
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 82.0 bits (203), Expect = 2e-17
Identities = 42/162 (25%), Positives = 79/162 (48%), Gaps = 19/162 (11%)
Query: 35 GMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKL-YK 93
GM +L + + H +L + N L++S V +++DFGL + +D+ K+ +
Sbjct: 159 GMKYLANMNYV-HRDLAARNILVNSNLVCKVSDFGLS--RVLEDDPEATYTTSGGKIPIR 215
Query: 94 --APELLRQPHLPRGTQKGDVYSFGLVLYEVI--GRQGPWGHLRMTDEEIITSVTQGSGL 149
APE + + T DV+SFG+V++EV+ G + W +++ E++ ++ G L
Sbjct: 216 WTAPEAI---SYRKFTSASDVWSFGIVMWEVMTYGERPYWE---LSNHEVMKAINDGFRL 269
Query: 150 -RPDTSSLDCAPSIIACMRTCWEEDPELRPDLRFVHHKLKEM 190
P DC +I M CW+++ RP + L ++
Sbjct: 270 PTPM----DCPSAIYQLMMQCWQQERARRPKFADIVSILDKL 307
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 81.9 bits (203), Expect = 2e-17
Identities = 39/164 (23%), Positives = 68/164 (41%), Gaps = 23/164 (14%)
Query: 35 GMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQD--ETGQERKLRRRKL- 91
GM L I H +L + N L+ + +I DFGL +D +L
Sbjct: 157 GMAFLASKNCI-HRDLAARNILLTHGRITKICDFGL-----ARDIKNDSNYVVKGNARLP 210
Query: 92 YK--APELLRQPHLPRGTQKGDVYSFGLVLYEVI--GRQGPWGHLRMTDEEIITSVTQGS 147
K APE + T + DV+S+G+ L+E+ G P+ + D + + +G
Sbjct: 211 VKWMAPESIFNCVY---TFESDVWSYGIFLWELFSLGSS-PYPGM-PVDSKFYKMIKEGF 265
Query: 148 GL-RPDTSSLDCAPSIIACMRTCWEEDPELRPDLRFVHHKLKEM 190
+ P+ + M+TCW+ DP RP + + +++
Sbjct: 266 RMLSPE----HAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQ 305
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 82.4 bits (204), Expect = 2e-17
Identities = 46/162 (28%), Positives = 82/162 (50%), Gaps = 19/162 (11%)
Query: 35 GMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKL--- 91
GM +L D + H +L + N LI+S V +++DFGL + +D+ R K+
Sbjct: 159 GMKYLSDMGYV-HRDLAARNILINSNLVCKVSDFGLG--RVLEDDPEAAYTTRGGKIPIR 215
Query: 92 YKAPELLRQPHLPRGTQKGDVYSFGLVLYEVI--GRQGPWGHLRMTDEEIITSVTQGSGL 149
+ +PE + + T DV+S+G+VL+EV+ G + W M+++++I +V +G L
Sbjct: 216 WTSPEAI---AYRKFTSASDVWSYGIVLWEVMSYGERPYWE---MSNQDVIKAVDEGYRL 269
Query: 150 -RPDTSSLDCAPSIIACMRTCWEEDPELRPDLRFVHHKLKEM 190
P DC ++ M CW++D RP + L ++
Sbjct: 270 PPPM----DCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKL 307
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 81.6 bits (202), Expect = 2e-17
Identities = 40/162 (24%), Positives = 76/162 (46%), Gaps = 20/162 (12%)
Query: 35 GMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKL--- 91
GM +L + ++ H NL + N L+ S +Q+ADFG+ A D+ ++ K
Sbjct: 127 GMYYLEEHGMV-HRNLAARNVLLKSPSQVQVADFGV-ADLLPPDD--KQLLYSEAKTPIK 182
Query: 92 YKAPELLRQPHLPRGTQKGDVYSFGLVLYEVI--GRQGPWGHLRMTDEEIITSVTQGSGL 149
+ A E + H + T + DV+S+G+ ++E++ G + P+ + E+ + +G L
Sbjct: 183 WMALESI---HFGKYTHQSDVWSYGVTVWELMTFGAE-PYA--GLRLAEVPDLLEKGERL 236
Query: 150 -RPDTSSLDCAPSIIACMRTCWEEDPELRPDLRFVHHKLKEM 190
+P C + M CW D +RP + + ++ M
Sbjct: 237 AQPQ----ICTIDVYMVMVKCWMIDENIRPTFKELANEFTRM 274
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 81.1 bits (201), Expect = 2e-17
Identities = 43/173 (24%), Positives = 75/173 (43%), Gaps = 42/173 (24%)
Query: 35 GMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYK- 93
GM +L ++ H +L + N L+ + ++I+D GL R++ YK
Sbjct: 140 GMEYLSSHHVV-HKDLATRNVLVYDKLNVKISDLGL------------FREVYAADYYKL 186
Query: 94 -----------APELLRQPHLPRG--TQKGDVYSFGLVLYEVI--GRQGPWGHLRMTDEE 138
APE + G + D++S+G+VL+EV G Q P+ ++++
Sbjct: 187 LGNSLLPIRWMAPEAIMY-----GKFSIDSDIWSYGVVLWEVFSYGLQ-PYCG--YSNQD 238
Query: 139 IITSVTQGSGL-RPDTSSLDCAPSIIACMRTCWEEDPELRPDLRFVHHKLKEM 190
++ + L PD DC + A M CW E P RP + +H +L+
Sbjct: 239 VVEMIRNRQVLPCPD----DCPAWVYALMIECWNEFPSRRPRFKDIHSRLRAW 287
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 80.3 bits (199), Expect = 3e-17
Identities = 38/162 (23%), Positives = 74/162 (45%), Gaps = 21/162 (12%)
Query: 35 GMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKL--- 91
M +L + H ++ N L+ S +++ DFGL + +D +L
Sbjct: 125 AMAYLESINCV-HRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVT----RLPIK 179
Query: 92 YKAPELLRQPHLPRGTQKGDVYSFGLVLYEVI--GRQGPWGHLRMTDEEIITSVTQGSGL 149
+ +PE + + R T DV+ F + ++E++ G+Q P+ + ++++I + +G L
Sbjct: 180 WMSPESI---NFRRFTTASDVWMFAVCMWEILSFGKQ-PFF--WLENKDVIGVLEKGDRL 233
Query: 150 -RPDTSSLDCAPSIIACMRTCWEEDPELRPDLRFVHHKLKEM 190
+PD C P + M CW+ DP RP + L ++
Sbjct: 234 PKPD----LCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDV 271
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 80.8 bits (200), Expect = 4e-17
Identities = 47/164 (28%), Positives = 86/164 (52%), Gaps = 24/164 (14%)
Query: 35 GMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQD--ETGQERKLRRRKL- 91
GM +L+ ++ + H +L + NC++ + ++I DFG+ +D ET RK + L
Sbjct: 150 GMAYLNANKFV-HRDLAARNCMVAEDFTVKIGDFGM-----TRDIYETDYYRKGGKGLLP 203
Query: 92 YK--APELLRQPHLPRGTQKGDVYSFGLVLYEVI--GRQGPWGHLRMTDEEIITSVTQGS 147
+ +PE L+ T DV+SFG+VL+E+ Q P+ +++E+++ V +G
Sbjct: 204 VRWMSPESLKDG---VFTTYSDVWSFGVVLWEIATLAEQ-PYQG--LSNEQVLRFVMEGG 257
Query: 148 GL-RPDTSSLDCAPSIIACMRTCWEEDPELRPDLRFVHHKLKEM 190
L +PD +C + MR CW+ +P++RP + +KE
Sbjct: 258 LLDKPD----NCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEE 297
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 80.8 bits (200), Expect = 4e-17
Identities = 45/166 (27%), Positives = 74/166 (44%), Gaps = 28/166 (16%)
Query: 35 GMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQD--ETGQERKLRRRKL- 91
GM +L + I H +L + N L+ V++IADFGL +D +K +L
Sbjct: 169 GMEYLASQKCI-HRDLAARNVLVTENNVMKIADFGL-----ARDINNIDYYKKTTNGRLP 222
Query: 92 YK--APELLRQPHLPRG--TQKGDVYSFGLVLYEVI--GRQGPWGHLRMTDEEIITSVTQ 145
K APE L T + DV+SFG++++E+ G P+ + EE+ + +
Sbjct: 223 VKWMAPEALFD-----RVYTHQSDVWSFGVLMWEIFTLGGS-PYP--GIPVEELFKLLKE 274
Query: 146 GSGL-RPDTSSLDCAPSIIACMRTCWEEDPELRPDLRFVHHKLKEM 190
G + +P +C + MR CW P RP + + L +
Sbjct: 275 GHRMDKPA----NCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 316
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 80.8 bits (200), Expect = 4e-17
Identities = 41/171 (23%), Positives = 71/171 (41%), Gaps = 38/171 (22%)
Query: 35 GMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYK- 93
GM +L I H +L + NC++ + +ADFGL RK+ Y+
Sbjct: 149 GMEYLSSRNFI-HRDLAARNCMLAEDMTVCVADFGL------------SRKIYSGDYYRQ 195
Query: 94 -----------APELLRQPHLPRGTQKGDVYSFGLVLYEVI--GRQGPWGHLRMTDEEII 140
A E L T DV++FG+ ++E++ G+ P+ + + EI
Sbjct: 196 GCASKLPVKWLALESL---ADNLYTVHSDVWAFGVTMWEIMTRGQT-PYAG--IENAEIY 249
Query: 141 TSVTQGSGL-RPDTSSLDCAPSIIACMRTCWEEDPELRPDLRFVHHKLKEM 190
+ G+ L +P +C + M CW DP+ RP + +L+ +
Sbjct: 250 NYLIGGNRLKQPP----ECMEEVYDLMYQCWSADPKQRPSFTCLRMELENI 296
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 80.4 bits (199), Expect = 4e-17
Identities = 46/166 (27%), Positives = 70/166 (42%), Gaps = 24/166 (14%)
Query: 35 GMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGL-HAFKAGQDETGQERKLRRRKL-Y 92
GM +L I H +L + N L+ +R +++I DFGL A D RK+ +
Sbjct: 133 GMGYLESKRFI-HRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHY---VMQEHRKVPF 188
Query: 93 K--APELLRQPHLPRGTQKGDVYSFGLVLYEVI--GRQGPWGHLRMTDEEIITSVTQGSG 148
APE L + D + FG+ L+E+ G++ PW + +I+ + + G
Sbjct: 189 AWCAPESL---KTRTFSHASDTWMFGVTLWEMFTYGQE-PWI--GLNGSQILHKIDK-EG 241
Query: 149 LR---PDTSSLDCAPSIIACMRTCWEEDPELRPDLRFVHHKLKEMN 191
R P+ DC I M CW PE RP + L E
Sbjct: 242 ERLPRPE----DCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQ 283
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 82.3 bits (203), Expect = 4e-17
Identities = 44/162 (27%), Positives = 77/162 (47%), Gaps = 19/162 (11%)
Query: 35 GMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKL-YK 93
GM +L + + H NL + N L+ +R +I+DFGL KA + K K
Sbjct: 448 GMKYLEEKNFV-HRNLAARNVLLVNRHYAKISDFGLS--KALGADDSYYTARSAGKWPLK 504
Query: 94 --APELLRQPHLPRGTQKGDVYSFGLVLYEVI--GRQGPWGHLRMTDEEIITSVTQGSGL 149
APE + + + + + DV+S+G+ ++E + G++ P+ +M E++ + QG +
Sbjct: 505 WYAPECI---NFRKFSSRSDVWSYGVTMWEALSYGQK-PYK--KMKGPEVMAFIEQGKRM 558
Query: 150 -RPDTSSLDCAPSIIACMRTCWEEDPELRPDLRFVHHKLKEM 190
P +C P + A M CW E RPD V +++
Sbjct: 559 ECPP----ECPPELYALMSDCWIYKWEDRPDFLTVEQRMRAC 596
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 80.0 bits (198), Expect = 5e-17
Identities = 41/173 (23%), Positives = 70/173 (40%), Gaps = 27/173 (15%)
Query: 35 GMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKL--- 91
GM +L + + H +L + N L++S ++I DFGL KA + + R
Sbjct: 138 GMDYLGSRQYV-HRDLAARNVLVESEHQVKIGDFGLT--KAIETDKEYYTVKDDRDSPVF 194
Query: 92 YKAPELLRQPHLPRGTQKGDVYSFGLVLYEVI--GRQGPWGHLR-----------MTDEE 138
+ APE L Q + DV+SFG+ L+E++ MT
Sbjct: 195 WYAPECLMQS---KFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTR 251
Query: 139 IITSVTQGSGL-RPDTSSLDCAPSIIACMRTCWEEDPELRPDLRFVHHKLKEM 190
++ ++ +G L P +C + MR CWE P R + + + +
Sbjct: 252 LVNTLKEGKRLPCPP----NCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEAL 300
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 79.6 bits (197), Expect = 6e-17
Identities = 36/159 (22%), Positives = 69/159 (43%), Gaps = 15/159 (9%)
Query: 35 GMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKA 94
+ +L + H ++ + N L+ S +++ DFGL + + K A
Sbjct: 128 ALAYLESKRFV-HRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWM-A 185
Query: 95 PELLRQPHLPRGTQKGDVYSFGLVLYEVI--GRQGPWGHLRMTDEEIITSVTQGSGL-RP 151
PE + + R T DV+ FG+ ++E++ G + G + + ++I + G L P
Sbjct: 186 PESI---NFRRFTSASDVWMFGVCMWEILMHGVKPFQG---VKNNDVIGRIENGERLPMP 239
Query: 152 DTSSLDCAPSIIACMRTCWEEDPELRPDLRFVHHKLKEM 190
+C P++ + M CW DP RP + +L +
Sbjct: 240 P----NCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTI 274
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 80.1 bits (198), Expect = 7e-17
Identities = 42/162 (25%), Positives = 76/162 (46%), Gaps = 20/162 (12%)
Query: 35 GMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKL--- 91
GM +L D ++ H +L + N L+ + ++I DFGL A G +E +E K+
Sbjct: 129 GMNYLEDRRLV-HRDLAARNVLVKTPQHVKITDFGL-AKLLGAEE--KEYHAEGGKVPIK 184
Query: 92 YKAPELLRQPHLPRGTQKGDVYSFGLVLYEVI--GRQGPWGHLRMTDEEIITSVTQGSGL 149
+ A E + T + DV+S+G+ ++E++ G + P+ + EI + + +G L
Sbjct: 185 WMALESI---LHRIYTHQSDVWSYGVTVWELMTFGSK-PYD--GIPASEISSILEKGERL 238
Query: 150 -RPDTSSLDCAPSIIACMRTCWEEDPELRPDLRFVHHKLKEM 190
+P C + M CW D + RP R + + +M
Sbjct: 239 PQPP----ICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKM 276
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 80.9 bits (200), Expect = 7e-17
Identities = 46/166 (27%), Positives = 74/166 (44%), Gaps = 28/166 (16%)
Query: 35 GMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQD--ETGQERKLRRRKL- 91
GM +L + I H +L + N L+ V++IADFGL +D +K +L
Sbjct: 203 GMEYLASKKCI-HRDLAARNVLVTEDNVMKIADFGL-----ARDIHHIDYYKKTTNGRLP 256
Query: 92 YK--APELLRQPHLPRG--TQKGDVYSFGLVLYEVI--GRQGPWGHLRMTDEEIITSVTQ 145
K APE L T + DV+SFG++L+E+ G P+ + EE+ + +
Sbjct: 257 VKWMAPEALFD-----RIYTHQSDVWSFGVLLWEIFTLGGS-PYP--GVPVEELFKLLKE 308
Query: 146 GSGL-RPDTSSLDCAPSIIACMRTCWEEDPELRPDLRFVHHKLKEM 190
G + +P +C + MR CW P RP + + L +
Sbjct: 309 GHRMDKPS----NCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 350
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 80.0 bits (198), Expect = 9e-17
Identities = 40/172 (23%), Positives = 68/172 (39%), Gaps = 39/172 (22%)
Query: 35 GMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYK- 93
GM L I H ++ + N L+ + V +I DFGL R + Y
Sbjct: 176 GMAFLASKNCI-HRDVAARNVLLTNGHVAKIGDFGL------------ARDIMNDSNYIV 222
Query: 94 -----------APELLRQPHLPRGTQKGDVYSFGLVLYEVI--GRQGPW-GHLRMTDEEI 139
APE + T + DV+S+G++L+E+ G P+ G + + +
Sbjct: 223 KGNARLPVKWMAPESIFDC---VYTVQSDVWSYGILLWEIFSLGLN-PYPG--ILVNSKF 276
Query: 140 ITSVTQGSGL-RPDTSSLDCAPSIIACMRTCWEEDPELRPDLRFVHHKLKEM 190
V G + +P +I + M+ CW +P RP + + L+E
Sbjct: 277 YKLVKDGYQMAQPA----FAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQ 324
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 79.6 bits (197), Expect = 1e-16
Identities = 43/164 (26%), Positives = 80/164 (48%), Gaps = 24/164 (14%)
Query: 35 GMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQD--ETGQERKLRRRKL- 91
GM +L + +++ H +L + N L+ ++I+DFGL +D E K + ++
Sbjct: 162 GMQYLAEMKLV-HRDLAARNILVAEGRKMKISDFGL-----SRDVYEEDSYVKRSQGRIP 215
Query: 92 YK--APELLRQPHLPRGTQKGDVYSFGLVLYEVI--GRQGPWGHLRMTDEEIITSVTQGS 147
K A E L T + DV+SFG++L+E++ G P+ + E + + G
Sbjct: 216 VKWMAIESLFDH---IYTTQSDVWSFGVLLWEIVTLGGN-PYP--GIPPERLFNLLKTGH 269
Query: 148 GL-RPDTSSLDCAPSIIACMRTCWEEDPELRPDLRFVHHKLKEM 190
+ RPD +C+ + M CW+++P+ RP + L++M
Sbjct: 270 RMERPD----NCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKM 309
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 79.6 bits (197), Expect = 1e-16
Identities = 43/162 (26%), Positives = 74/162 (45%), Gaps = 20/162 (12%)
Query: 35 GMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKL-YK 93
GM +L + + H +L + NC++ + +ADFGL D R+ R K+ K
Sbjct: 159 GMEYLSNRNFL-HRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYY---RQGRIAKMPVK 214
Query: 94 --APELLRQPHLPRGTQKGDVYSFGLVLYEVI--GRQGPWGHLRMTDEEIITSVTQGSGL 149
A E L T K DV++FG+ ++E+ G P+ + + E+ + G L
Sbjct: 215 WIAIESLADR---VYTSKSDVWAFGVTMWEIATRGMT-PYPG--VQNHEMYDYLLHGHRL 268
Query: 150 -RPDTSSLDCAPSIIACMRTCWEEDPELRPDLRFVHHKLKEM 190
+P+ DC + M +CW DP RP + +L+++
Sbjct: 269 KQPE----DCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKL 306
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 81.4 bits (201), Expect = 1e-16
Identities = 37/162 (22%), Positives = 70/162 (43%), Gaps = 21/162 (12%)
Query: 35 GMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKL--- 91
+ +L + H ++ + N L+ S +++ DFGL + K + KL
Sbjct: 503 ALAYLESKRFV-HRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYY----KASKGKLPIK 557
Query: 92 YKAPELLRQPHLPRGTQKGDVYSFGLVLYEVI--GRQGPWGHLRMTDEEIITSVTQGSGL 149
+ APE + T DV+ FG+ ++E++ G + G + + ++I + G L
Sbjct: 558 WMAPESINFRRF---TSASDVWMFGVCMWEILMHGVKPFQG---VKNNDVIGRIENGERL 611
Query: 150 -RPDTSSLDCAPSIIACMRTCWEEDPELRPDLRFVHHKLKEM 190
P +C P++ + M CW DP RP + +L +
Sbjct: 612 PMPP----NCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTI 649
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 79.8 bits (197), Expect = 1e-16
Identities = 42/162 (25%), Positives = 73/162 (45%), Gaps = 18/162 (11%)
Query: 35 GMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKL--- 91
GM L + + H +L + NC++D ++ +++ADFGL A E KL
Sbjct: 204 GMKFLASKKFV-HRDLAARNCMLDEKFTVKVADFGL-ARDMYDKEFDSVHNKTGAKLPVK 261
Query: 92 YKAPELLRQPHLPRGTQKGDVYSFGLVLYEVI--GRQGPWGHLRMTDEEIITSVTQGSGL 149
+ A E L+ + T K DV+SFG++L+E++ G + +I + QG L
Sbjct: 262 WMALESLQTQ---KFTTKSDVWSFGVLLWELMTRGAPPYPD---VNTFDITVYLLQGRRL 315
Query: 150 -RPDTSSLDCAPSIIACMRTCWEEDPELRPDLRFVHHKLKEM 190
+P+ C + M CW E+RP + ++ +
Sbjct: 316 LQPE----YCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAI 353
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 78.8 bits (195), Expect = 1e-16
Identities = 41/162 (25%), Positives = 75/162 (46%), Gaps = 18/162 (11%)
Query: 35 GMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKL--- 91
GM +L + + H +L + NC++D ++ +++ADFGL ++ K KL
Sbjct: 140 GMKYLASKKFV-HRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNK-TGAKLPVK 197
Query: 92 YKAPELLRQPHLPRGTQKGDVYSFGLVLYEVI--GRQGPWGHLRMTDEEIITSVTQGSGL 149
+ A E L+ + T K DV+SFG++L+E++ G + +I + QG L
Sbjct: 198 WMALESLQTQ---KFTTKSDVWSFGVLLWELMTRGAPPYPD---VNTFDITVYLLQGRRL 251
Query: 150 -RPDTSSLDCAPSIIACMRTCWEEDPELRPDLRFVHHKLKEM 190
+P+ C + M CW E+RP + ++ +
Sbjct: 252 LQPE----YCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAI 289
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 79.3 bits (196), Expect = 2e-16
Identities = 45/166 (27%), Positives = 74/166 (44%), Gaps = 28/166 (16%)
Query: 35 GMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQD--ETGQERKLRRRKL- 91
GM +L + I H +L + N L+ V++IADFGL +D +K +L
Sbjct: 215 GMEYLASQKCI-HRDLAARNVLVTENNVMKIADFGL-----ARDINNIDYYKKTTNGRLP 268
Query: 92 YK--APELLRQPHLPRG--TQKGDVYSFGLVLYEVI--GRQGPWGHLRMTDEEIITSVTQ 145
K APE L T + DV+SFG++++E+ G P+ + EE+ + +
Sbjct: 269 VKWMAPEALFD-----RVYTHQSDVWSFGVLMWEIFTLGGS-PYPG--IPVEELFKLLKE 320
Query: 146 GSGL-RPDTSSLDCAPSIIACMRTCWEEDPELRPDLRFVHHKLKEM 190
G + +P +C + MR CW P RP + + L +
Sbjct: 321 GHRMDKPA----NCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 362
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 78.5 bits (194), Expect = 2e-16
Identities = 46/173 (26%), Positives = 72/173 (41%), Gaps = 27/173 (15%)
Query: 35 GMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKL--- 91
GM +LH I H +L + N L+D+ +++I DFGL KA + R
Sbjct: 146 GMAYLHAQHYI-HRDLAARNVLLDNDRLVKIGDFGLA--KAVPEGHEYYRVREDGDSPVF 202
Query: 92 YKAPELLRQPHLPRGTQKGDVYSFGLVLYEVI--GRQGPWGHLR-----------MTDEE 138
+ APE L++ + DV+SFG+ LYE++ + MT
Sbjct: 203 WYAPECLKEY---KFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLR 259
Query: 139 IITSVTQGSGL-RPDTSSLDCAPSIIACMRTCWEEDPELRPDLRFVHHKLKEM 190
+ + +G L RPD C + M+ CWE + RP + LK +
Sbjct: 260 LTELLERGERLPRPD----KCPAEVYHLMKNCWETEASFRPTFENLIPILKTV 308
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 77.7 bits (192), Expect = 3e-16
Identities = 29/173 (16%), Positives = 59/173 (34%), Gaps = 41/173 (23%)
Query: 35 GMIHLHDSEIISHGNLRSSNCLIDSRWVLQ--------IADFGLHAFKAGQDETGQERKL 86
M L ++ +I HGN+ + N L+ + ++D G+ +
Sbjct: 125 AMHFLEENTLI-HGNVCAKNILLIREEDRKTGNPPFIKLSDPGI------------SITV 171
Query: 87 RRRKLYK------APELLRQPHLPRGTQKGDVYSFGLVLYEVI--GRQGPWGHLRMTDEE 138
+ + + PE + + D +SFG L+E+ G + P + +
Sbjct: 172 LPKDILQERIPWVPPECIE--NPKNLNLATDKWSFGTTLWEICSGGDK-PLS--ALDSQR 226
Query: 139 IITSVTQGSGL-RPDTSSLDCAPSIIACMRTCWEEDPELRPDLRFVHHKLKEM 190
+ L P A + + C + +P+ RP R + L +
Sbjct: 227 KLQFYEDRHQLPAP------KAAELANLINNCMDYEPDHRPSFRAIIRDLNSL 273
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 78.1 bits (193), Expect = 3e-16
Identities = 44/164 (26%), Positives = 73/164 (44%), Gaps = 23/164 (14%)
Query: 35 GMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQD--ETGQERKLRRRKL- 91
GM L + I H +L + N L+ + V++I DFGL +D + + +L
Sbjct: 160 GMEFLASRKCI-HRDLAARNILLSEKNVVKICDFGL-----ARDIYKDPDYVRKGDARLP 213
Query: 92 YK--APELLRQPHLPRGTQKGDVYSFGLVLYEVI--GRQGPWGHLRMTDEEIITSVTQGS 147
K APE + T + DV+SFG++L+E+ G P+ ++ DEE + +G+
Sbjct: 214 LKWMAPETIFDR---VYTIQSDVWSFGVLLWEIFSLGAS-PYPGVK-IDEEFCRRLKEGT 268
Query: 148 GL-RPDTSSLDCAPSIIACMRTCWEEDPELRPDLRFVHHKLKEM 190
+ PD P + M CW +P RP + L +
Sbjct: 269 RMRAPD----YTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 308
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 77.7 bits (192), Expect = 4e-16
Identities = 42/177 (23%), Positives = 68/177 (38%), Gaps = 34/177 (19%)
Query: 35 GMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKL--- 91
GM +L I H +L + N L+++ ++I DFGL K + + +
Sbjct: 126 GMEYLGTKRYI-HRDLATRNILVENENRVKIGDFGLT--KVLPQDKEFFKVKEPGESPIF 182
Query: 92 YKAPELLRQPHLPRGTQKGDVYSFGLVLYEVI-----------------GRQGPWGHLRM 134
+ APE L + + + DV+SFG+VLYE+ G M
Sbjct: 183 WYAPESLTES---KFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQ---M 236
Query: 135 TDEEIITSVTQGSGL-RPDTSSLDCAPSIIACMRTCWEEDPELRPDLRFVHHKLKEM 190
+I + L RPD C I M CW + RP R + ++ ++
Sbjct: 237 IVFHLIELLKNNGRLPRPD----GCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQI 289
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 78.1 bits (193), Expect = 4e-16
Identities = 49/163 (30%), Positives = 72/163 (44%), Gaps = 25/163 (15%)
Query: 35 GMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKL-YK 93
GM +L + I H +L + N L+ +V +IADFGL + E K +L +
Sbjct: 154 GMDYLSQKQFI-HRDLAARNILVGENYVAKIADFGL----SRGQEV--YVKKTMGRLPVR 206
Query: 94 --APELLRQPHLPRGTQKGDVYSFGLVLYEVI--GRQGP-WGHLRMTDEEIITSVTQGSG 148
A E L T DV+S+G++L+E++ G P G MT E+ + QG
Sbjct: 207 WMAIESLNYS---VYTTNSDVWSYGVLLWEIVSLGGT-PYCG---MTCAELYEKLPQGYR 259
Query: 149 L-RPDTSSLDCAPSIIACMRTCWEEDPELRPDLRFVHHKLKEM 190
L +P +C + MR CW E P RP + L M
Sbjct: 260 LEKPL----NCDDEVYDLMRQCWREKPYERPSFAQILVSLNRM 298
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 77.7 bits (192), Expect = 5e-16
Identities = 41/173 (23%), Positives = 63/173 (36%), Gaps = 41/173 (23%)
Query: 35 GMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYK- 93
GM L + H +L + N L+ V++I DFGL R + Y
Sbjct: 184 GMEFLEFKSCV-HRDLAARNVLVTHGKVVKICDFGL------------ARDIMSDSNYVV 230
Query: 94 -----------APELLRQPHLPRG--TQKGDVYSFGLVLYEVI--GRQGPWGHLRMTDEE 138
APE L + G T K DV+S+G++L+E+ G P+ + D
Sbjct: 231 RGNARLPVKWMAPESLFE-----GIYTIKSDVWSYGILLWEIFSLGVN-PYPGI-PVDAN 283
Query: 139 IITSVTQGSGL-RPDTSSLDCAPSIIACMRTCWEEDPELRPDLRFVHHKLKEM 190
+ G + +P I M++CW D RP + L
Sbjct: 284 FYKLIQNGFKMDQPF----YATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQ 332
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 77.7 bits (192), Expect = 5e-16
Identities = 49/173 (28%), Positives = 76/173 (43%), Gaps = 42/173 (24%)
Query: 35 GMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYK- 93
GM +L + + + H +L + NCL+ V++IADFGL R + YK
Sbjct: 186 GMAYLSERKFV-HRDLATRNCLVGENMVVKIADFGL------------SRNIYSADYYKA 232
Query: 94 -----------APELLRQPHLPRG--TQKGDVYSFGLVLYEVI--GRQGPWGHLRMTDEE 138
PE + T + DV+++G+VL+E+ G Q P+ M EE
Sbjct: 233 DGNDAIPIRWMPPESIFY-----NRYTTESDVWAYGVVLWEIFSYGLQ-PYYG--MAHEE 284
Query: 139 IITSVTQGSGL-RPDTSSLDCAPSIIACMRTCWEEDPELRPDLRFVHHKLKEM 190
+I V G+ L P+ +C + MR CW + P RP +H L+ M
Sbjct: 285 VIYYVRDGNILACPE----NCPLELYNLMRLCWSKLPADRPSFCSIHRILQRM 333
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 77.3 bits (191), Expect = 5e-16
Identities = 40/167 (23%), Positives = 70/167 (41%), Gaps = 27/167 (16%)
Query: 35 GMIHLHDSEIISHGNLRSSNCLIDSRW---VLQIADFGLHAFKAGQD--ETGQERKLRRR 89
G +L ++ I H ++ + NCL+ V +I DFG+ +D RK
Sbjct: 152 GCQYLEENHFI-HRDIAARNCLLTCPGPGRVAKIGDFGM-----ARDIYRASYYRKGGCA 205
Query: 90 KL---YKAPELLRQPHLPRGTQKGDVYSFGLVLYEVI--GRQGPWGHLRMTDEEIITSVT 144
L + PE T K D +SFG++L+E+ G +++E++ VT
Sbjct: 206 MLPVKWMPPEAF---MEGIFTSKTDTWSFGVLLWEIFSLGYMPYPS---KSNQEVLEFVT 259
Query: 145 QGSGL-RPDTSSLDCAPSIIACMRTCWEEDPELRPDLRFVHHKLKEM 190
G + P +C + M CW+ PE RP+ + +++
Sbjct: 260 SGGRMDPPK----NCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYC 302
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 77.4 bits (191), Expect = 7e-16
Identities = 42/177 (23%), Positives = 67/177 (37%), Gaps = 34/177 (19%)
Query: 35 GMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKL--- 91
GM +L I H +L + N L+++ ++I DFGL K + + +
Sbjct: 157 GMEYLGTKRYI-HRDLATRNILVENENRVKIGDFGLT--KVLPQDKEYYKVKEPGESPIF 213
Query: 92 YKAPELLRQPHLPRGTQKGDVYSFGLVLYEVI-----------------GRQGPWGHLRM 134
+ APE L + + DV+SFG+VLYE+ G M
Sbjct: 214 WYAPESL---TESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQ---M 267
Query: 135 TDEEIITSVTQGSGL-RPDTSSLDCAPSIIACMRTCWEEDPELRPDLRFVHHKLKEM 190
+I + L RPD C I M CW + RP R + ++ ++
Sbjct: 268 IVFHLIELLKNNGRLPRPD----GCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQI 320
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 76.6 bits (189), Expect = 1e-15
Identities = 41/175 (23%), Positives = 67/175 (38%), Gaps = 31/175 (17%)
Query: 35 GMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGL-HAFKAGQDETGQERKLRRRKL-- 91
GM +L + H +L + N L++S ++IADFGL +D +
Sbjct: 139 GMEYLGSRRCV-HRDLAARNILVESEAHVKIADFGLAKLLPLDKDYY---VVREPGQSPI 194
Query: 92 --YKAPELLRQPHLPRGTQKGDVYSFGLVLYEVI-------------GRQGPWGHLRMTD 136
Y APE L +++ DV+SFG+VLYE+ R
Sbjct: 195 FWY-APESLSDN---IFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPAL 250
Query: 137 EEIITSVTQGSGL-RPDTSSLDCAPSIIACMRTCWEEDPELRPDLRFVHHKLKEM 190
++ + +G L P C + M+ CW P+ RP + +L +
Sbjct: 251 SRLLELLEEGQRLPAPP----ACPAEVHELMKLCWAPSPQDRPSFSALGPQLDML 301
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 76.9 bits (189), Expect = 1e-15
Identities = 44/162 (27%), Positives = 73/162 (45%), Gaps = 19/162 (11%)
Query: 35 GMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKL--- 91
GM L + I H +L + N L+ + V++I DFGL A +D + +L
Sbjct: 205 GMEFLASRKCI-HRDLAARNILLSEKNVVKICDFGL-ARDIYKDPD--YVRKGDARLPLK 260
Query: 92 YKAPELLRQPHLPRGTQKGDVYSFGLVLYEVI--GRQGPWGHLRMTDEEIITSVTQGSGL 149
+ APE + T + DV+SFG++L+E+ G P+ ++ DEE + +G+ +
Sbjct: 261 WMAPETIFDR---VYTIQSDVWSFGVLLWEIFSLGAS-PYPGVK-IDEEFCRRLKEGTRM 315
Query: 150 -RPDTSSLDCAPSIIACMRTCWEEDPELRPDLRFVHHKLKEM 190
PD P + M CW +P RP + L +
Sbjct: 316 RAPD----YTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 353
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 75.9 bits (187), Expect = 2e-15
Identities = 42/167 (25%), Positives = 73/167 (43%), Gaps = 27/167 (16%)
Query: 35 GMIHLHDSEIISHGNLRSSNCLIDSRW---VLQIADFGLHAFKAGQD--ETGQERKLRRR 89
G +L ++ I H ++ + NCL+ V +I DFG+ +D G RK
Sbjct: 193 GCQYLEENHFI-HRDIAARNCLLTCPGPGRVAKIGDFGM-----ARDIYRAGYYRKGGCA 246
Query: 90 KL---YKAPELLRQPHLPRGTQKGDVYSFGLVLYEVI--GRQGPWGHLRMTDEEIITSVT 144
L + PE T K D +SFG++L+E+ G P+ +++E++ VT
Sbjct: 247 MLPVKWMPPEAF---MEGIFTSKTDTWSFGVLLWEIFSLGYM-PYPS--KSNQEVLEFVT 300
Query: 145 QGSGL-RPDTSSLDCAPSIIACMRTCWEEDPELRPDLRFVHHKLKEM 190
G + P +C + M CW+ PE RP+ + +++
Sbjct: 301 SGGRMDPPK----NCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYC 343
|
| >3uvj_A Guanylate cyclase soluble subunit alpha-3; nitric oxide, structural genomics, structural genomics conso SGC, CGMP biosynthesis; 2.08A {Homo sapiens} Length = 225 | Back alignment and structure |
|---|
Score = 64.3 bits (157), Expect = 5e-12
Identities = 13/31 (41%), Positives = 22/31 (70%)
Query: 330 RGDFVEPESFDSVTIYFSDIVGFTQLSAEST 360
+G V+ + F +VT+ FSDIVGFT + ++ +
Sbjct: 3 QGQVVQAKKFSNVTMLFSDIVGFTAICSQCS 33
|
| >1azs_A VC1; complex (lyase/hydrolase), hydrolase, signal transducing protein, cyclase, effector enzyme; HET: GSP FKP; 2.30A {Canis lupus familiaris} SCOP: d.58.29.1 PDB: 1cs4_A* 1u0h_A* 2gvd_A* 2gvz_A* 3c14_A* 3c15_A* 3c16_A* 3e8a_A* 3g82_A* 3maa_A* 1cul_A* 1cjk_A* 1cju_A* 1cjv_A* 1cjt_A* 1tl7_A* Length = 220 | Back alignment and structure |
|---|
Score = 62.7 bits (153), Expect = 2e-11
Identities = 11/56 (19%), Positives = 24/56 (42%), Gaps = 3/56 (5%)
Query: 305 LTQEKKKTDALLHRMLPRSVSESLKRGDFVEPESFDSVTIYFSDIVGFTQLSAEST 360
+ + + + + + + D+V+I F+DI GFT L+++ T
Sbjct: 1 MHHHHHHAMEMKADINAKQEDMMFHK---IYIQKHDNVSILFADIEGFTSLASQCT 53
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 62.6 bits (153), Expect = 5e-11
Identities = 35/103 (33%), Positives = 50/103 (48%), Gaps = 25/103 (24%)
Query: 35 GMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDET----------GQER 84
G+ +LH II H +++S N L+D +V +I DFG+ D+T G
Sbjct: 151 GLHYLHTRAII-HRDVKSINILLDENFVPKITDFGISKKGTELDQTHLSTVVKGTLG--- 206
Query: 85 KLRRRKLYKAPELLRQPHLPRGTQKGDVYSFGLVLYEVI-GRQ 126
Y PE + L T+K DVYSFG+VL+EV+ R
Sbjct: 207 -------YIDPEYFIKGRL---TEKSDVYSFGVVLFEVLCARS 239
|
| >3et6_A Soluble guanylyl cyclase beta; guanylate cyclase, dimethylarsenic, lyase, membrane, transmembrane; 2.55A {Chlamydomonas reinhardtii} PDB: 3et6_B Length = 190 | Back alignment and structure |
|---|
Score = 60.0 bits (146), Expect = 8e-11
Identities = 10/27 (37%), Positives = 17/27 (62%)
Query: 334 VEPESFDSVTIYFSDIVGFTQLSAEST 360
+ T+ FSDIVGFT++++ S+
Sbjct: 2 APAQEHPEATVLFSDIVGFTEIASRSS 28
|
| >1yk9_A Adenylate cyclase; beta-alpha-beta sandwich, structural genomics, PSI, protein structure initiative; 2.70A {Mycobacterium tuberculosis} Length = 204 | Back alignment and structure |
|---|
Score = 59.9 bits (146), Expect = 9e-11
Identities = 8/27 (29%), Positives = 18/27 (66%)
Query: 334 VEPESFDSVTIYFSDIVGFTQLSAEST 360
+ + +D ++ F+DIVGFT+ ++ +
Sbjct: 3 IIADKYDEASVLFADIVGFTERASSTA 29
|
| >2wz1_A Guanylate cyclase soluble subunit beta-1; lyase, GUCY1, metal-binding, CGMP biosynthesis, nucleotide-B cyclase, GUCY1B3, GTP-binding; 1.63A {Homo sapiens} PDB: 3uvj_B Length = 219 | Back alignment and structure |
|---|
Score = 59.7 bits (145), Expect = 2e-10
Identities = 11/27 (40%), Positives = 16/27 (59%)
Query: 334 VEPESFDSVTIYFSDIVGFTQLSAEST 360
V + +D+VTI FS IVGF ++
Sbjct: 5 VPAKRYDNVTILFSGIVGFNAFCSKHA 31
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 60.9 bits (148), Expect = 2e-10
Identities = 43/157 (27%), Positives = 62/157 (39%), Gaps = 21/157 (13%)
Query: 35 GMIHLHDSEIISHGNLRSSNCLI-----DSRWVLQIADFGLHAFKAGQDETGQERKLRRR 89
G+ HLH I+ H +L+ N LI + I+DFGL + G+ RR
Sbjct: 130 GLAHLHSLNIV-HRDLKPHNILISMPNAHGKIKAMISDFGL----CKKLAVGRHSFSRRS 184
Query: 90 KL-----YKAPELLRQPHLPRGTQKGDVYSFGLVLYEVIGRQG--PWGHLRMTDEEIITS 142
+ + APE+L + T D++S G V Y VI G P+G I+
Sbjct: 185 GVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISE-GSHPFGKSLQRQANILLG 243
Query: 143 VTQGSGLRPDTSSLDCAPSIIACMRTCWEEDPELRPD 179
L P+ A +I M DP+ RP
Sbjct: 244 ACSLDCLHPEKHEDVIARELIEKMIA---MDPQKRPS 277
|
| >1ab8_A Adenylyl cyclase; lyase, complex (transferase-inhibitor); HET: FOK; 2.20A {Rattus norvegicus} SCOP: d.58.29.1 PDB: 1azs_B* 1cjk_B* 1cjt_B* 1cju_B* 1cjv_B* 1cs4_B* 1tl7_B* 1u0h_B* 2gvd_B* 2gvz_B* 3c14_B* 3c15_B* 3c16_B* 3e8a_B* 3g82_B* 3maa_B* 1cul_B* Length = 220 | Back alignment and structure |
|---|
Score = 58.8 bits (143), Expect = 3e-10
Identities = 8/31 (25%), Positives = 16/31 (51%)
Query: 330 RGDFVEPESFDSVTIYFSDIVGFTQLSAEST 360
+ + + +S+D V + F+ I F + ES
Sbjct: 3 KNEELYHQSYDCVCVMFASIPDFKEFYTESD 33
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 60.4 bits (146), Expect = 3e-10
Identities = 24/167 (14%), Positives = 46/167 (27%), Gaps = 18/167 (10%)
Query: 38 HLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKAPEL 97
+L ++ HG+ N I L + D +K G + Y E
Sbjct: 209 NLQSKGLV-HGHFTPDNLFIMPDGRLMLGDVSA-LWKVGTRGPASSVPVT----YAPREF 262
Query: 98 LRQPHLPRGTQKGDVYSFGLVLYEVIGRQGPWGHLRMTDEEIITSVTQGSGLRPDTSSLD 157
L T + + GL +Y V P+G + + + +
Sbjct: 263 LNASTAT-FTHALNAWQLGLSIYRVWCLFLPFGLVTPGIKGSWKRPSLRVPGTDSLAFGS 321
Query: 158 CAP------SIIACMRTCWEEDPELRPDLR--FVHHKLKEMNAGLKA 196
C P ++I D R + ++ + +
Sbjct: 322 CTPLPDFVKTLIGRF---LNFDRRRRLLPLEAMETPEFLQLQNEISS 365
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 58.7 bits (143), Expect = 8e-10
Identities = 33/102 (32%), Positives = 49/102 (48%), Gaps = 26/102 (25%)
Query: 35 GMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDET----------GQER 84
G+ LH++ I H +++S+N L+D + +I+DFGL +T
Sbjct: 145 GINFLHENHHI-HRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTA--- 200
Query: 85 KLRRRKLYKAPELLRQPHLPRGTQKGDVYSFGLVLYEVI-GR 125
Y APE LR + T K D+YSFG+VL E+I G
Sbjct: 201 -------YMAPEALRG-EI---TPKSDIYSFGVVLLEIITGL 231
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 58.1 bits (141), Expect = 1e-09
Identities = 30/144 (20%), Positives = 54/144 (37%), Gaps = 17/144 (11%)
Query: 38 HLHDSEIISHGNLRSSNCLIDSR-WVLQIADFGLHAFKAGQDETGQERKLRRRKLYKAPE 96
H II H +L+ N I ++I D GL A + + + APE
Sbjct: 146 HTRTPPII-HRDLKCDNIFITGPTGSVKIGDLGL----ATLKRASFAKAVIGTPEFMAPE 200
Query: 97 LLRQPHLPRGTQKGDVYSFGLVLYEVIGRQGPWGHLRMTDEEIITSVTQGS--GLRPDTS 154
+ + + + DVY+FG+ + E+ + P+ + +I VT G +
Sbjct: 201 MYEEKY----DESVDVYAFGMCMLEMATSEYPYSECQNA-AQIYRRVTSGVKPASFDKVA 255
Query: 155 SLDCAPSIIACMRTCWEEDPELRP 178
+ II C ++ + R
Sbjct: 256 IPEVK-EII---EGCIRQNKDERY 275
|
| >1y10_A Hypothetical protein RV1264/MT1302; adenylyl cyclase fold, lyase; HET: 1PE; 2.30A {Mycobacterium tuberculosis} PDB: 1y11_A* Length = 407 | Back alignment and structure |
|---|
Score = 58.8 bits (142), Expect = 1e-09
Identities = 21/83 (25%), Positives = 32/83 (38%), Gaps = 3/83 (3%)
Query: 297 LVQERTNQLTQ-EKKKTDALLHRMLPRSVSESLKRGDFVEPESFDSVTIYFSDIVGFTQL 355
LV + L + L M+ + +R VT+ F+D+VGFTQL
Sbjct: 170 LVSQIVPLLGPMIQDMLFMQLRHMMETEAVNAGERAAGKPLPGARQVTVAFADLVGFTQL 229
Query: 356 SA--ESTETGRVTTRDSRRTPDL 376
+ E G + R + DL
Sbjct: 230 GEVVSAEELGHLAGRLAGLARDL 252
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 58.0 bits (140), Expect = 2e-09
Identities = 23/98 (23%), Positives = 40/98 (40%), Gaps = 16/98 (16%)
Query: 35 GMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGL-----HAFKAGQDETGQERKLRRR 89
+ LH ++ H +L+ SN V+++ DFGL + T
Sbjct: 176 AVEFLHSKGLM-HRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHT 234
Query: 90 K-----LYKAPELLR-QPHLPRGTQKGDVYSFGLVLYE 121
LY +PE + + + K D++S GL+L+E
Sbjct: 235 GQVGTKLYMSPEQIHGNNY----SHKVDIFSLGLILFE 268
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 57.3 bits (139), Expect = 2e-09
Identities = 35/167 (20%), Positives = 63/167 (37%), Gaps = 31/167 (18%)
Query: 35 GMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRK---L 91
G+ ++H ++I + +L+ SN + ++I DFGL + +R R K
Sbjct: 134 GVDYIHSKKLI-NRDLKPSNIFLVDTKQVKIGDFGL----VTSLKNDGKRT--RSKGTLR 186
Query: 92 YKAPELLR-QPHLPRGTQKGDVYSFGLVLYEVIGRQGPWGHLRMTDEEIITSVTQGSGLR 150
Y +PE + Q + ++ D+Y+ GL+L E++ + T + G
Sbjct: 187 YMSPEQISSQDY----GKEVDLYALGLILAELLHVCDT----AFETSKFFTDLRDGI--I 236
Query: 151 PDTSSLDCAPSIIACMRTCWEEDPELRPDLR------FVHHKLKEMN 191
D + + PE RP+ V K E N
Sbjct: 237 SDIFDKKEKTLLQKLLSK----KPEDRPNTSEILRTLTVWKKSPEKN 279
|
| >3hls_A Guanylate cyclase soluble subunit beta-1; coiled-coil domain, signaling helix, S-helix, CGMP biosynthesis, cytoplasm, GTP-binding, heme, iron; 2.15A {Rattus norvegicus} Length = 66 | Back alignment and structure |
|---|
Score = 51.6 bits (124), Expect = 5e-09
Identities = 15/32 (46%), Positives = 20/32 (62%)
Query: 298 VQERTNQLTQEKKKTDALLHRMLPRSVSESLK 329
+Q L EKKKTD LL+ +LP SV+ L+
Sbjct: 33 LQLTLRALEDEKKKTDTLLYSVLPPSVANELR 64
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 56.2 bits (136), Expect = 6e-09
Identities = 32/164 (19%), Positives = 62/164 (37%), Gaps = 13/164 (7%)
Query: 35 GMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKL--- 91
G+ +H H +L+ +N L+ + D G E ++ +
Sbjct: 146 GLEAIHAKGYA-HRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQR 204
Query: 92 ----YKAPELLR-QPHLPRGTQKGDVYSFGLVLYEVIGRQGPWGHLRMTDEEIITSVTQG 146
Y+APEL Q H ++ DV+S G VLY ++ +GP+ + + + +V
Sbjct: 205 CTISYRAPELFSVQSHCVID-ERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAVQNQ 263
Query: 147 SGLRPDTSSLDCAPSIIACMRTCWEEDPELRPDLRFVHHKLKEM 190
+ ++ M DP RP + + +L+ +
Sbjct: 264 LSIPQSPRHSSALWQLLNSM---MTVDPHQRPHIPLLLSQLEAL 304
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 54.6 bits (132), Expect = 2e-08
Identities = 38/165 (23%), Positives = 73/165 (44%), Gaps = 10/165 (6%)
Query: 35 GMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKA 94
+ H+H ++ H +++ +N I + V+++ D GL + +T L Y +
Sbjct: 148 ALEHMHSRRVM-HRDIKPANVFITATGVVKLGDLGL-G-RFFSSKTTAAHSLVGTPYYMS 204
Query: 95 PELLR-QPHLPRGTQKGDVYSFGLVLYEVIGRQGPWGHLRMTDEEIITSVTQGSGLRPDT 153
PE + + K D++S G +LYE+ Q P+ +M + + Q P
Sbjct: 205 PERIHENGY----NFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCD--YPPL 258
Query: 154 SSLDCAPSIIACMRTCWEEDPELRPDLRFVHHKLKEMNAGLKANI 198
S + + + C DPE RPD+ +V+ K M+A +++
Sbjct: 259 PSDHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMHACTASSL 303
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 53.5 bits (129), Expect = 4e-08
Identities = 33/146 (22%), Positives = 60/146 (41%), Gaps = 19/146 (13%)
Query: 35 GMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKA 94
+ HLH ++ H +++ +N + R ++ DFGL + G G+ ++ R Y A
Sbjct: 169 ALAHLHSQGLV-HLDVKPANIFLGPRGRCKLGDFGL-LVELGTAGAGEVQEGDPR--YMA 224
Query: 95 PELLRQPHLPRGTQKGDVYSFGLVLYEVIGRQGPWGHLRMTDE--EIITSVTQGSGLRPD 152
PELL+ + DV+S GL + EV + + +GL +
Sbjct: 225 PELLQGSY----GTAADVFSLGLTILEVACNMELPHGGEGWQQLRQGYLPPEFTAGLSSE 280
Query: 153 TSSLDCAPSIIACMRTCWEEDPELRP 178
S+ ++ + DP+LR
Sbjct: 281 LRSV-----LVMMLEP----DPKLRA 297
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 52.0 bits (125), Expect = 1e-07
Identities = 24/98 (24%), Positives = 41/98 (41%), Gaps = 16/98 (16%)
Query: 35 GMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGL-----HAFKAGQDETGQERKLRRR 89
+ LH ++ H +L+ SN V+++ DFGL + T R
Sbjct: 130 AVEFLHSKGLM-HRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHT 188
Query: 90 K-----LYKAPELLR-QPHLPRGTQKGDVYSFGLVLYE 121
LY +PE + + + K D++S GL+L+E
Sbjct: 189 GQVGTKLYMSPEQIHGNSY----SHKVDIFSLGLILFE 222
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 51.8 bits (125), Expect = 2e-07
Identities = 37/162 (22%), Positives = 70/162 (43%), Gaps = 25/162 (15%)
Query: 35 GMIHLHDS---EIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKL 91
G+ +LHD +II H +++++N L+D + + DFGL A +T +R
Sbjct: 143 GLAYLHDHCDPKII-HRDVKAANILLDEEFEAVVGDFGL-AKLMDYKDTHVTTAVRGTIG 200
Query: 92 YKAPELLRQPHLPRGTQKGDVYSFGLVLYEVIGRQGPWGHLRMTDEEIITSVTQGSGLRP 151
+ APE L ++K DV+ +G++L E+I Q + R+ +++ + + GL
Sbjct: 201 HIAPEYLSTGKS---SEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLK 257
Query: 152 DTSSLDCA-PSI--------------IACMRTCWEEDPELRP 178
+ + +A + C + P RP
Sbjct: 258 EKKLEALVDVDLQGNYKDEEVEQLIQVALL--CTQSSPMERP 297
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 51.6 bits (124), Expect = 2e-07
Identities = 36/156 (23%), Positives = 57/156 (36%), Gaps = 19/156 (12%)
Query: 35 GMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGL---------HAFKAGQDETGQERK 85
+ ++H II H +L+ N ID ++I DFGL Q+ G
Sbjct: 128 ALSYIHSQGII-HRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDN 186
Query: 86 LRRRK---LYKAPELLRQPHLPRGTQKGDVYSFGLVLYEVIGRQGPWGHLRMTDEEIITS 142
L +Y A E+L +K D+YS G++ +E+I M I+
Sbjct: 187 LTSAIGTAMYVATEVLDG--TGHYNEKIDMYSLGIIFFEMI--YPFSTG--MERVNILKK 240
Query: 143 VTQGSGLRPDTSSLDCAPSIIACMRTCWEEDPELRP 178
+ S P + +R + DP RP
Sbjct: 241 LRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRP 276
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 50.7 bits (121), Expect = 3e-07
Identities = 16/101 (15%), Positives = 37/101 (36%), Gaps = 17/101 (16%)
Query: 35 GMIHLHDSEIISHGNLRSSNCLIDSRWV-----------LQIADFGLHAFKAGQDETGQE 83
+ +HD EII HG+++ N ++ + ++ L + D G +
Sbjct: 184 MIEQVHDCEII-HGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIF 242
Query: 84 RKLRRRKLYKAPELL-RQPHLPRGTQKGDVYSFGLVLYEVI 123
++ E+L +P + D + +Y ++
Sbjct: 243 TAKCETSGFQCVEMLSNKPW----NYQIDYFGVAATVYCML 279
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 50.1 bits (120), Expect = 5e-07
Identities = 33/158 (20%), Positives = 62/158 (39%), Gaps = 25/158 (15%)
Query: 35 GMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERK-----LRRR 89
+ +H I+ H +L+ +N LI +L++ DFG+ A + D T + +
Sbjct: 120 AVHTIHQHGIV-HSDLKPANFLIVDG-MLKLIDFGI-ANQMQPDTTSVVKDSQVGTV--- 173
Query: 90 KLYKAPELLRQPHLPRGTQ--------KGDVYSFGLVLYEVIGRQGPWGHLRMTDEEIIT 141
Y PE ++ R K DV+S G +LY + + P+ + ++
Sbjct: 174 -NYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHA 232
Query: 142 SVTQGSGLR-PDTSSLDCAPSIIACMRTCWEEDPELRP 178
+ + PD D ++ C + DP+ R
Sbjct: 233 IIDPNHEIEFPDIPEKDL----QDVLKCCLKRDPKQRI 266
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 49.8 bits (119), Expect = 7e-07
Identities = 36/179 (20%), Positives = 70/179 (39%), Gaps = 29/179 (16%)
Query: 35 GMIHLHD-SEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRK--- 90
+ H+H I H +L+ N L+ ++ +++ DFG + + + R
Sbjct: 148 AVQHMHRQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEE 207
Query: 91 -------LYKAPELLRQPHLPRG---TQKGDVYSFGLVLYEVIGRQGPWGHLRMTDEEII 140
+Y+ PE++ L +K D+++ G +LY + RQ P+ ++
Sbjct: 208 ITRNTTPMYRTPEII---DLYSNFPIGEKQDIWALGCILYLLCFRQHPF------EDGAK 258
Query: 141 TSVTQGSGLRPDTS--SLDCAPSIIACMRTCWEEDPELRPDLRFVHHKLKEMNAGLKAN 197
+ G P I A ++ +PE R + V H+L+E+ A N
Sbjct: 259 LRIVNGKYSIPPHDTQYTVFHSLIRAMLQ----VNPEERLSIAEVVHQLQEIAAARNVN 313
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 49.2 bits (118), Expect = 1e-06
Identities = 33/161 (20%), Positives = 63/161 (39%), Gaps = 25/161 (15%)
Query: 35 GMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERK-----LRRR 89
+ +H I+ H +L+ +N LI +L++ DFG+ A + D T + +
Sbjct: 139 AVHTIHQHGIV-HSDLKPANFLIVDG-MLKLIDFGI-ANQMQPDTTSVVKDSQVGTV--- 192
Query: 90 KLYKAPELLRQPHLPRGTQKG--------DVYSFGLVLYEVIGRQGPWGHLRMTDEEIIT 141
Y PE ++ R K DV+S G +LY + + P+ + ++
Sbjct: 193 -NYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHA 251
Query: 142 SVTQGSGLR-PDTSSLDCAPSIIACMRTCWEEDPELRPDLR 181
+ + PD D ++ C + DP+ R +
Sbjct: 252 IIDPNHEIEFPDIPEKDL----QDVLKCCLKRDPKQRISIP 288
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 48.8 bits (117), Expect = 1e-06
Identities = 26/94 (27%), Positives = 42/94 (44%), Gaps = 19/94 (20%)
Query: 35 GMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKL--- 91
G+ +LH +II H +++ SN L+ ++IADFG+ G D L
Sbjct: 149 GIEYLHYQKII-HRDIKPSNLLVGEDGHIKIADFGVSNEFKGSDAL----------LSNT 197
Query: 92 -----YKAPELLRQPHLPRGTQKGDVYSFGLVLY 120
+ APE L + + DV++ G+ LY
Sbjct: 198 VGTPAFMAPESLSETRKIFSGKALDVWAMGVTLY 231
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 49.0 bits (117), Expect = 2e-06
Identities = 33/158 (20%), Positives = 62/158 (39%), Gaps = 25/158 (15%)
Query: 35 GMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERK-----LRRR 89
+ +H I+ H +L+ +N LI +L++ DFG+ A + D T + +
Sbjct: 167 AVHTIHQHGIV-HSDLKPANFLIVDG-MLKLIDFGI-ANQMQPDTTSVVKDSQVGAV--- 220
Query: 90 KLYKAPELLRQPHLPRGTQKG--------DVYSFGLVLYEVIGRQGPWGHLRMTDEEIIT 141
Y PE ++ R K DV+S G +LY + + P+ + ++
Sbjct: 221 -NYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHA 279
Query: 142 SVTQGSGLR-PDTSSLDCAPSIIACMRTCWEEDPELRP 178
+ + PD D ++ C + DP+ R
Sbjct: 280 IIDPNHEIEFPDIPEKDL----QDVLKCCLKRDPKQRI 313
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 48.9 bits (116), Expect = 2e-06
Identities = 18/92 (19%), Positives = 33/92 (35%), Gaps = 15/92 (16%)
Query: 38 HLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKAPEL 97
LH ++ H LR + ++D R + + F + G + ++ PEL
Sbjct: 221 SLHHYGLV-HTYLRPVDIVLDQRGGVFLTGFEH-LVRDGARVV-----SSVSRGFEPPEL 273
Query: 98 L--------RQPHLPRGTQKGDVYSFGLVLYE 121
+ T D ++ GLV+Y
Sbjct: 274 EARRATISYHRDRRTLMTFSFDAWALGLVIYW 305
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 48.2 bits (115), Expect = 2e-06
Identities = 32/159 (20%), Positives = 61/159 (38%), Gaps = 35/159 (22%)
Query: 35 GMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRK---- 90
+ H+HD +I+ H +++S N + +Q+ DFG+ R L
Sbjct: 137 ALKHVHDRKIL-HRDIKSQNIFLTKDGTVQLGDFGI------------ARVLNSTVELAR 183
Query: 91 ------LYKAPELLR-QPHLPRGTQKGDVYSFGLVLYEVIGRQGPWGHLRMTDEEIITSV 143
Y +PE+ +P+ K D+++ G VLYE+ + + M + ++ +
Sbjct: 184 ACIGTPYYLSPEICENKPY----NNKSDIWALGCVLYELCTLKHAFEAGSM--KNLVLKI 237
Query: 144 TQGSGLR-PDTSSLDCAPSIIACMRTCWEEDPELRPDLR 181
GS S D + + +P RP +
Sbjct: 238 ISGSFPPVSLHYSYDLRSLVSQLFKR----NPRDRPSVN 272
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 48.0 bits (115), Expect = 2e-06
Identities = 30/161 (18%), Positives = 55/161 (34%), Gaps = 38/161 (23%)
Query: 35 GMIHLHD----SEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRK 90
+ H + H +L+ +N +D + +++ DFGL R L
Sbjct: 123 ALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLA------------RILNHDT 170
Query: 91 ----------LYKAPELLR-QPHLPRGTQKGDVYSFGLVLYEVIGRQGPWGHLRMTDEEI 139
Y +PE + + +K D++S G +LYE+ P+ +E+
Sbjct: 171 SFAKTFVGTPYYMSPEQMNRMSY----NEKSDIWSLGCLLYELCALMPPFTAFSQ--KEL 224
Query: 140 ITSVTQGSGLR-PDTSSLDCAPSIIACMRTCWEEDPELRPD 179
+ +G R P S + I + RP
Sbjct: 225 AGKIREGKFRRIPYRYSDELNEIITRMLNL----KDYHRPS 261
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 47.5 bits (113), Expect = 4e-06
Identities = 41/167 (24%), Positives = 71/167 (42%), Gaps = 28/167 (16%)
Query: 35 GMIHLHDSEIISHGNLRSSNCLIDS-------------RWVLQIADFGLHAFKAGQDETG 81
G+ HLH +II H +L+ N L+ + + I+DFGL K ++
Sbjct: 127 GVAHLHSLKII-HRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGL-CKKLDSGQSS 184
Query: 82 QERKLRRRK---LYKAPELLRQPHLPRG----TQKGDVYSFGLVLYEVIGR-QGPWGHLR 133
L ++APELL + + + T+ D++S G V Y ++ + + P+G
Sbjct: 185 FRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKY 244
Query: 134 MTDEEIITSVTQGSGLR--PDTSSLDCAPSIIACMRTCWEEDPELRP 178
+ II + ++ D S + A +I+ M DP RP
Sbjct: 245 SRESNIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDH---DPLKRP 288
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 47.4 bits (112), Expect = 5e-06
Identities = 25/168 (14%), Positives = 47/168 (27%), Gaps = 26/168 (15%)
Query: 38 HLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKAPEL 97
LH ++ H LR + ++D R + + F + G + + PE
Sbjct: 226 SLHHYGLV-HTYLRPVDIVLDQRGGVFLTGFEH-LVRDGAS-----AVSPIGRGFAPPET 278
Query: 98 L-------RQPHLPRGTQKGDVYSFGLVLYEVIGRQGPWGHLRMTDEEIITSVTQGSGLR 150
Q H T D ++ GL +Y + P + +
Sbjct: 279 TAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLPNT--DDAALGGSEWIFRSCKNI 336
Query: 151 PDTSSLDCAPSIIACMRTCWEEDPELRPDLRFV--HHKLKEMNAGLKA 196
P + +R E R + +++ L A
Sbjct: 337 PQ----PVRALLEGFLR----YPKEDRLLPLQAMETPEYEQLRTELSA 376
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 46.5 bits (111), Expect = 8e-06
Identities = 21/73 (28%), Positives = 38/73 (52%), Gaps = 17/73 (23%)
Query: 35 GMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGL-HAFKAGQDETGQERKLRRRKL-- 91
G+ ++H ++I+ H +++++N LI VL++ADFGL AF + + +
Sbjct: 136 GLYYIHRNKIL-HRDMKAANVLITRDGVLKLADFGLARAF-------SLAKNSQPNRYTN 187
Query: 92 ------YKAPELL 98
Y+ PELL
Sbjct: 188 RVVTLWYRPPELL 200
|
| >1fx2_A Receptor-type adenylate cyclase gresag 4.1; CAMP, trypanosomes, adenylyl cyclases, monomer-dimer, catalysis, lyase; 1.46A {Trypanosoma brucei} SCOP: d.58.29.1 PDB: 1fx4_A Length = 235 | Back alignment and structure |
|---|
Score = 45.6 bits (108), Expect = 9e-06
Identities = 10/28 (35%), Positives = 13/28 (46%)
Query: 334 VEPESFDSVTIYFSDIVGFTQLSAESTE 361
E D VT+ F+DI T L A +
Sbjct: 5 APKEPTDPVTLIFTDIESSTALWAAHPD 32
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 46.2 bits (110), Expect = 1e-05
Identities = 30/92 (32%), Positives = 47/92 (51%), Gaps = 7/92 (7%)
Query: 35 GMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKA 94
G+ HLH + II H +L+ SN ++ S L+I DFGL A AG + R Y+A
Sbjct: 139 GIKHLHSAGII-HRDLKPSNIVVKSDCTLKILDFGL-ARTAGTSFMMTPYVVTR--YYRA 194
Query: 95 PELLRQPHLPRGTQKGDVYSFGLVLYEVIGRQ 126
PE++ + D++S G ++ E+I
Sbjct: 195 PEVILGMGY---KENVDIWSVGCIMGEMIKGG 223
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 45.8 bits (109), Expect = 1e-05
Identities = 38/161 (23%), Positives = 71/161 (44%), Gaps = 15/161 (9%)
Query: 23 IGSISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQ-DETG 81
+G ++V + +L + + H +++ SN L+D R +++ DFG+ +G+ +
Sbjct: 126 LGKMTVAIVK--ALYYLKEKHGVIHRDVKPSNILLDERGQIKLCDFGI----SGRLVDDK 179
Query: 82 QERKLRRRKLYKAPELLRQPHLPRGT--QKGDVYSFGLVLYEVIGRQGPWGHLRMTDEEI 139
+ + Y APE + P + + DV+S G+ L E+ Q P+ + + TD E+
Sbjct: 180 AKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCK-TDFEV 238
Query: 140 ITSVTQGS--GLRPDTSSLDCAPSIIACMRTCWEEDPELRP 178
+T V Q L S + C +D RP
Sbjct: 239 LTKVLQEEPPLLPGHMGFSGDFQSFVKD---CLTKDHRKRP 276
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 45.8 bits (109), Expect = 2e-05
Identities = 36/117 (30%), Positives = 63/117 (53%), Gaps = 23/117 (19%)
Query: 38 HLHDSEIISHGNLRSSNCLIDSRW---VLQIADFGL-HAFKAGQDETGQERKLRRR---K 90
+LH I+ H +L+ N L++S+ +++I DFGL F+ + K++ R
Sbjct: 151 YLHKHNIV-HRDLKPENLLLESKEKDALIKIVDFGLSAVFENQK-------KMKERLGTA 202
Query: 91 LYKAPELLRQPHLPRGTQKGDVYSFGLVLYEVI-GRQGPWGHLRMTDEEIITSVTQG 146
Y APE+LR+ + +K DV+S G++L+ ++ G G TD+EI+ V +G
Sbjct: 203 YYIAPEVLRKKY----DEKCDVWSIGVILFILLAGYPPFGG---QTDQEILRKVEKG 252
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 44.9 bits (107), Expect = 2e-05
Identities = 26/93 (27%), Positives = 44/93 (47%), Gaps = 18/93 (19%)
Query: 35 GMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKL--- 91
G +LH + +I H +L+ N ++ ++I DFGL E R++ L
Sbjct: 127 GCQYLHRNRVI-HRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGE-------RKKVLCGT 178
Query: 92 --YKAPELL-RQPHLPRGTQKGDVYSFGLVLYE 121
Y APE+L ++ H + DV+S G ++Y
Sbjct: 179 PNYIAPEVLSKKGHSF----EVDVWSIGCIMYT 207
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 44.5 bits (106), Expect = 3e-05
Identities = 25/93 (26%), Positives = 41/93 (44%), Gaps = 20/93 (21%)
Query: 35 GMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKL--- 91
+ + H +I H +++ N L+ S L+IADFG RR L
Sbjct: 121 ALSYCHSKRVI-HRDIKPENLLLGSAGELKIADFGWSVHAPSS---------RRTDLCGT 170
Query: 92 --YKAPELL-RQPHLPRGTQKGDVYSFGLVLYE 121
Y PE++ + H +K D++S G++ YE
Sbjct: 171 LDYLPPEMIEGRMH----DEKVDLWSLGVLCYE 199
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 45.1 bits (107), Expect = 3e-05
Identities = 37/152 (24%), Positives = 65/152 (42%), Gaps = 29/152 (19%)
Query: 38 HLHDSEIISHGNLRSSNCLIDSR---WVLQIADFGL-HAFKAGQDETGQERKLRRR---K 90
+LH I+ H +++ N L++++ ++I DFGL F KLR R
Sbjct: 161 YLHKHNIV-HRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDY-------KLRDRLGTA 212
Query: 91 LYKAPELLRQPHLPRGTQKGDVYSFGLVLYEVI-GRQGPWGHLRMTDEEIITSVTQGSGL 149
Y APE+L++ + +K DV+S G+++Y ++ G G D++II V +G
Sbjct: 213 YYIAPEVLKKKY----NEKCDVWSCGVIMYILLCGYPPFGGQ---NDQDIIKKVEKG--- 262
Query: 150 RPDTSSLDCA---PSIIACMRTCWEEDPELRP 178
+ D ++ D R
Sbjct: 263 KYYFDFNDWKNISDEAKELIKLMLTYDYNKRC 294
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 44.1 bits (105), Expect = 4e-05
Identities = 31/98 (31%), Positives = 45/98 (45%), Gaps = 19/98 (19%)
Query: 35 GMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKL--- 91
GM++LH I+ H +L SN L+ ++IADFGL E + L
Sbjct: 124 GMLYLHSHGIL-HRDLTLSNLLLTRNMNIKIADFGLATQLKMPHE-------KHYTLCGT 175
Query: 92 --YKAPELL-RQPHLPRGTQKGDVYSFGLVLYE-VIGR 125
Y +PE+ R H + DV+S G + Y +IGR
Sbjct: 176 PNYISPEIATRSAH----GLESDVWSLGCMFYTLLIGR 209
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 43.8 bits (104), Expect = 6e-05
Identities = 26/93 (27%), Positives = 45/93 (48%), Gaps = 18/93 (19%)
Query: 35 GMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKL--- 91
G +LH + +I H +L+ N ++ ++I DFGL E R++ L
Sbjct: 153 GCQYLHRNRVI-HRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGE-------RKKVLCGT 204
Query: 92 --YKAPELL-RQPHLPRGTQKGDVYSFGLVLYE 121
Y APE+L ++ H + + DV+S G ++Y
Sbjct: 205 PNYIAPEVLSKKGH----SFEVDVWSIGCIMYT 233
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 44.1 bits (104), Expect = 6e-05
Identities = 27/103 (26%), Positives = 44/103 (42%), Gaps = 23/103 (22%)
Query: 35 GMIHLHDSEIISHGNLRSSNCLI----DSRWVLQIADFGLHAFKAGQDET-----GQERK 85
GM HL ++ I+ H N++ N + D + V ++ DFG A + DE G E
Sbjct: 124 GMNHLRENGIV-HRNIKPGNIMRVIGEDGQSVYKLTDFGA-ARELEDDEQFVSLYGTE-- 179
Query: 86 LRRRKLYKAPELLRQPHLPRGTQKG-----DVYSFGLVLYEVI 123
Y P++ + L + QK D++S G+ Y
Sbjct: 180 -----EYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAA 217
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 43.8 bits (104), Expect = 6e-05
Identities = 25/94 (26%), Positives = 47/94 (50%), Gaps = 12/94 (12%)
Query: 35 GMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETG--QERKLRRRKLY 92
G+ ++H + ++ H +L+ N ++ L+I DFGL A A + TG R Y
Sbjct: 138 GLKYIHSAGVV-HRDLKPGNLAVNEDCELKILDFGL-ARHADAEMTGYVVTR------WY 189
Query: 93 KAPELLRQPHLPRGTQKGDVYSFGLVLYEVIGRQ 126
+APE++ Q D++S G ++ E++ +
Sbjct: 190 RAPEVILSWM--HYNQTVDIWSVGCIMAEMLTGK 221
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 43.5 bits (103), Expect = 6e-05
Identities = 33/167 (19%), Positives = 60/167 (35%), Gaps = 44/167 (26%)
Query: 35 GMIHLHDSEIISHGNLRSSNCLID-------------------SRWVLQIADFGLHA-FK 74
G+ ++H ++ H +++ SN I ++ + +I D G
Sbjct: 127 GLRYIHSMSLV-HMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRIS 185
Query: 75 AGQDETGQERKLRRRKLYKAPELLRQ--PHLPRGTQKGDVYSFGLVLYEVIGRQGPWGHL 132
+ Q E G R + A E+L++ HLP K D+++ L + G + +
Sbjct: 186 SPQVEEGDSR-------FLANEVLQENYTHLP----KADIFALALTVVCAAGAEPLPRNG 234
Query: 133 RMTDEEIITSVTQGSGLR-PDTSSLDCAPSIIACMRTCWEEDPELRP 178
+ QG R P S + + + DPE RP
Sbjct: 235 DQ-----WHEIRQGRLPRIPQVLSQEFTELLKVMIHP----DPERRP 272
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 43.6 bits (103), Expect = 6e-05
Identities = 27/103 (26%), Positives = 44/103 (42%), Gaps = 23/103 (22%)
Query: 35 GMIHLHDSEIISHGNLRSSNCLI----DSRWVLQIADFGLHAFKAGQDET-----GQERK 85
GM HL ++ I+ H N++ N + D + V ++ DFG A + DE G E
Sbjct: 124 GMNHLRENGIV-HRNIKPGNIMRVIGEDGQSVYKLTDFGA-ARELEDDEQFVSLYGTE-- 179
Query: 86 LRRRKLYKAPELLRQPHLPRGTQKG-----DVYSFGLVLYEVI 123
Y P++ + L + QK D++S G+ Y
Sbjct: 180 -----EYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAA 217
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 43.5 bits (103), Expect = 6e-05
Identities = 39/159 (24%), Positives = 78/159 (49%), Gaps = 10/159 (6%)
Query: 23 IGSISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQ-DETG 81
+G I++ T + HL ++ I H +++ SN L+D +++ DFG+ +GQ ++
Sbjct: 127 LGKITLATVK--ALNHLKENLKIIHRDIKPSNILLDRSGNIKLCDFGI----SGQLVDSI 180
Query: 82 QERKLRRRKLYKAPELLRQPHLPRG-TQKGDVYSFGLVLYEVIGRQGPWGHLRMTDEEII 140
+ + + Y APE + +G + DV+S G+ LYE+ + P+ + + +
Sbjct: 181 AKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWN-SVFDQL 239
Query: 141 TSVTQGSGLR-PDTSSLDCAPSIIACMRTCWEEDPELRP 178
T V +G + ++ + +PS I + C +D RP
Sbjct: 240 TQVVKGDPPQLSNSEEREFSPSFINFVNLCLTKDESKRP 278
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 43.4 bits (103), Expect = 7e-05
Identities = 23/93 (24%), Positives = 43/93 (46%), Gaps = 20/93 (21%)
Query: 35 GMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKL--- 91
+ + H+ ++I H +++ N L+ + L+IADFG RRR +
Sbjct: 126 ALHYCHERKVI-HRDIKPENLLMGYKGELKIADFGWSVHAPSL---------RRRTMCGT 175
Query: 92 --YKAPELL-RQPHLPRGTQKGDVYSFGLVLYE 121
Y PE++ + H +K D++ G++ YE
Sbjct: 176 LDYLPPEMIEGKTH----DEKVDLWCAGVLCYE 204
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 43.7 bits (103), Expect = 8e-05
Identities = 29/92 (31%), Positives = 48/92 (52%), Gaps = 7/92 (7%)
Query: 35 GMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKA 94
G+ HLH + II H +L+ SN ++ S L+I DFGL A AG + R Y+A
Sbjct: 176 GIKHLHSAGII-HRDLKPSNIVVKSDCTLKILDFGL-ARTAGTSFMMTPYVVTR--YYRA 231
Query: 95 PELLRQPHLPRGTQKGDVYSFGLVLYEVIGRQ 126
PE++ + D++S G ++ E++ +
Sbjct: 232 PEVILGMGY---KENVDIWSVGCIMGEMVRHK 260
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 43.5 bits (103), Expect = 9e-05
Identities = 32/117 (27%), Positives = 61/117 (52%), Gaps = 23/117 (19%)
Query: 38 HLHDSEIISHGNLRSSNCLIDSRW---VLQIADFGL-HAFKAGQDETGQERKLRRR---K 90
++H ++I+ H +L+ N L++S+ ++I DFGL F+A + K++ +
Sbjct: 141 YMHKNKIV-HRDLKPENLLLESKSKDANIRIIDFGLSTHFEASK-------KMKDKIGTA 192
Query: 91 LYKAPELLRQPHLPRGTQKGDVYSFGLVLYEVIGRQGP-WGHLRMTDEEIITSVTQG 146
Y APE+L + +K DV+S G++LY ++ P G + +I+ V +G
Sbjct: 193 YYIAPEVLHGTY----DEKCDVWSTGVILYILLSGCPPFNGA---NEYDILKKVEKG 242
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 43.5 bits (103), Expect = 9e-05
Identities = 30/94 (31%), Positives = 50/94 (53%), Gaps = 12/94 (12%)
Query: 35 GMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETG--QERKLRRRKLY 92
G+ ++H + II H +L+ N ++ L+I DFGL A +A + TG R Y
Sbjct: 140 GLRYIHAAGII-HRDLKPGNLAVNEDCELKILDFGL-ARQADSEMTGYVVTR------WY 191
Query: 93 KAPELLRQPHLPRGTQKGDVYSFGLVLYEVIGRQ 126
+APE++ R TQ D++S G ++ E+I +
Sbjct: 192 RAPEVILNWM--RYTQTVDIWSVGCIMAEMITGK 223
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 43.3 bits (102), Expect = 9e-05
Identities = 37/174 (21%), Positives = 66/174 (37%), Gaps = 23/174 (13%)
Query: 23 IGSISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQ 82
+G +S+ G+ +L + I H +++ SN L++SR +++ DFG+ +GQ
Sbjct: 133 LGKVSIAVIK--GLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGV----SGQLIDSM 186
Query: 83 ERKLRRRKLYKAPELLRQPHLPRGTQKGDVYSFGLVLYEV-IGR------QGPWGHLRMT 135
+ Y +PE L+ H + + D++S GL L E+ +GR L
Sbjct: 187 ANSFVGTRSYMSPERLQGTHY---SVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFG 243
Query: 136 DEEIITSVTQGSGLRPDTSSLDCAPSIIACMRTCWE-------EDPELRPDLRF 182
+ + R L+ +E E P P F
Sbjct: 244 CQVEGDAAETPPRPRTPGRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVF 297
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 43.1 bits (102), Expect = 1e-04
Identities = 27/92 (29%), Positives = 44/92 (47%), Gaps = 6/92 (6%)
Query: 35 GMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKA 94
G+ LH++ ++ H +L N L+ + I DF L A + D R Y+A
Sbjct: 146 GLHVLHEAGVV-HRDLHPGNILLADNNDITICDFNL-AREDTADANKTHYVTHR--WYRA 201
Query: 95 PELLRQPHLPRGTQKGDVYSFGLVLYEVIGRQ 126
PEL+ Q T+ D++S G V+ E+ R+
Sbjct: 202 PELVMQFK--GFTKLVDMWSAGCVMAEMFNRK 231
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 43.0 bits (102), Expect = 1e-04
Identities = 28/100 (28%), Positives = 48/100 (48%), Gaps = 11/100 (11%)
Query: 35 GMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKL--- 91
+ LH S +I H +L+ SN LI+S L++ DFGL E ++ +
Sbjct: 124 AVKVLHGSNVI-HRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEF 182
Query: 92 -----YKAPELLRQPHLPRGTQKGDVYSFGLVLYEVIGRQ 126
Y+APE++ + ++ DV+S G +L E+ R+
Sbjct: 183 VATRWYRAPEVMLTSA--KYSRAMDVWSCGCILAELFLRR 220
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 43.4 bits (102), Expect = 1e-04
Identities = 17/96 (17%), Positives = 37/96 (38%), Gaps = 15/96 (15%)
Query: 35 GMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQ-DETGQERKLRRRKLYK 93
+ ++H + H ++++S+ LI + ++ GQ +++
Sbjct: 140 ALDYIHHMGYV-HRSVKASHILISVDGKVYLSGLRS----NLSMISHGQRQRVVHDFPKY 194
Query: 94 --------APELLRQPHLPRGTQKGDVYSFGLVLYE 121
+PE+L+Q K D+YS G+ E
Sbjct: 195 SVKVLPWLSPEVLQQNLQGYDA-KSDIYSVGITACE 229
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 42.7 bits (101), Expect = 2e-04
Identities = 27/94 (28%), Positives = 48/94 (51%), Gaps = 12/94 (12%)
Query: 35 GMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETG--QERKLRRRKLY 92
G+ ++H ++II H +L+ SN ++ L+I DFGL A + TG R Y
Sbjct: 144 GLKYIHSADII-HRDLKPSNLAVNEDCELKILDFGL-ARHTADEMTGYVATR------WY 195
Query: 93 KAPELLRQPHLPRGTQKGDVYSFGLVLYEVIGRQ 126
+APE++ Q D++S G ++ E++ +
Sbjct: 196 RAPEIMLNWM--HYNQTVDIWSVGCIMAELLTGR 227
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 42.1 bits (99), Expect = 2e-04
Identities = 26/115 (22%), Positives = 53/115 (46%), Gaps = 12/115 (10%)
Query: 38 HLHDSEIISHGNLRSSNCLIDSR--WVLQIADFGLHAFKAGQDETGQERKLRRR---KLY 92
+LH+ I H +++ N L + + +++ DFGL + + + G+ + + +
Sbjct: 183 YLHNQGIC-HRDIKPENFLFSTNKSFEIKLVDFGL-SKEFYKLNNGEYYGMTTKAGTPYF 240
Query: 93 KAPELLRQPHLPRGTQKGDVYSFGLVLYEVIGRQGP-WGHLRMTDEEIITSVTQG 146
APE+L + G K D +S G++L+ ++ P G D + I+ V
Sbjct: 241 VAPEVLNTTNESYGP-KCDAWSAGVLLHLLLMGAVPFPGV---NDADTISQVLNK 291
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 41.9 bits (99), Expect = 2e-04
Identities = 28/106 (26%), Positives = 49/106 (46%), Gaps = 16/106 (15%)
Query: 35 GMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQ-DETGQERKLRRRK--- 90
G+ +LH + I H ++++ N L+ +QIADFG+ + G + + RK
Sbjct: 133 GLEYLHKNGQI-HRDVKAGNILLGEDGSVQIADFGV----SAFLATGGDITRNKVRKTFV 187
Query: 91 ---LYKAPELLRQPHLPRG-TQKGDVYSFGLVLYEVIGRQGPWGHL 132
+ APE++ Q G K D++SFG+ E+ P+
Sbjct: 188 GTPCWMAPEVMEQVR---GYDFKADIWSFGITAIELATGAAPYHKY 230
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 41.8 bits (99), Expect = 2e-04
Identities = 25/90 (27%), Positives = 41/90 (45%), Gaps = 16/90 (17%)
Query: 38 HLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKL-----Y 92
+LH II H +L+ N L++ +QI DFG K E+ Q R Y
Sbjct: 145 YLHGKGII-HRDLKPENILLNEDMHIQITDFGTA--KVLSPESKQARA---NSFVGTAQY 198
Query: 93 KAPELLR-QPHLPRGTQKGDVYSFGLVLYE 121
+PELL + + D+++ G ++Y+
Sbjct: 199 VSPELLTEKSA----CKSSDLWALGCIIYQ 224
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 41.4 bits (98), Expect = 3e-04
Identities = 20/68 (29%), Positives = 34/68 (50%), Gaps = 12/68 (17%)
Query: 35 GMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGL-HAFKAGQDETGQERKLRRRKL-- 91
G+ LH + I+ H +L+ N L+ S +++ADFGL + + L +
Sbjct: 132 GLDFLHANCIV-HRDLKPENILVTSGGTVKLADFGLARIY-------SYQMALTPVVVTL 183
Query: 92 -YKAPELL 98
Y+APE+L
Sbjct: 184 WYRAPEVL 191
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 41.0 bits (97), Expect = 5e-04
Identities = 19/68 (27%), Positives = 33/68 (48%), Gaps = 12/68 (17%)
Query: 35 GMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGL-HAFKAGQDETGQERKLRRRKL-- 91
G+ LH ++ H +L+ N L+ S +++ADFGL + + L +
Sbjct: 132 GLDFLHSHRVV-HRDLKPQNILVTSSGQIKLADFGLARIY-------SFQMALTSVVVTL 183
Query: 92 -YKAPELL 98
Y+APE+L
Sbjct: 184 WYRAPEVL 191
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 41.2 bits (97), Expect = 5e-04
Identities = 33/117 (28%), Positives = 58/117 (49%), Gaps = 23/117 (19%)
Query: 38 HLHDSEIISHGNLRSSNCLIDSRW---VLQIADFGL-HAFKAGQDETGQERKLRRR---K 90
++H I+ H +L+ N L++S+ ++I DFGL F+ K++ R
Sbjct: 136 YMHKHNIV-HRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNT-------KMKDRIGTA 187
Query: 91 LYKAPELLRQPHLPRGTQKGDVYSFGLVLYEVIGRQGP-WGHLRMTDEEIITSVTQG 146
Y APE+LR + +K DV+S G++LY ++ P +G + +I+ V G
Sbjct: 188 YYIAPEVLRGTY----DEKCDVWSAGVILYILLSGTPPFYGK---NEYDILKRVETG 237
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 40.5 bits (95), Expect = 7e-04
Identities = 19/92 (20%), Positives = 39/92 (42%), Gaps = 15/92 (16%)
Query: 35 GMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKL--- 91
++H+ + I H +++ SN L+D ++++DFG + + + +
Sbjct: 163 SFSYIHNEKNICHRDVKPSNILMDKNGRVKLSDFGESEYMVDK---------KIKGSRGT 213
Query: 92 --YKAPELLRQPHLPRGTQKGDVYSFGLVLYE 121
+ PE G K D++S G+ LY
Sbjct: 214 YEFMPPEFFSNESSYNG-AKVDIWSLGICLYV 244
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 40.0 bits (94), Expect = 8e-04
Identities = 46/210 (21%), Positives = 77/210 (36%), Gaps = 43/210 (20%)
Query: 38 HLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHA-FKAGQDETGQERKLRRR---KLYK 93
+ H I+ H +L++ N L+D+ ++IADFG F G KL Y
Sbjct: 129 YCHQKRIV-HRDLKAENLLLDADMNIKIADFGFSNEFTVGG-------KLDAFCGAPPYA 180
Query: 94 APELLR-QPHLPRGTQKGDVYSFGLVLYEVIGRQGPWGHLRMTDE---EIITSVTQGSGL 149
APEL + + + + DV+S G++LY ++ G L + E+ V +G
Sbjct: 181 APELFQGKKYDGP---EVDVWSLGVILYTLVS-----GSLPFDGQNLKELRERVLRGKYR 232
Query: 150 RPDTSSLDCAPSIIACMRTCWEEDPELRPDLR-----------FVHHKLKEMNAGLKANI 198
P S DC +++ +P R L +LK
Sbjct: 233 IPFYMSTDCE-NLLKRFLVL---NPIKRGTLEQIMKDRWINAGHEEDELKPFVEPELDIS 288
Query: 199 FDNMLAIMEKYAFNLEGEWTDWTASLRRRP 228
+ IM ++ E + SL +
Sbjct: 289 DQKRIDIMVGMGYSQE----EIQESLSKMK 314
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 40.3 bits (95), Expect = 9e-04
Identities = 16/36 (44%), Positives = 25/36 (69%), Gaps = 1/36 (2%)
Query: 35 GMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGL 70
G+ +LH I+ H +L+ +N L+D VL++ADFGL
Sbjct: 124 GLEYLHQHWIL-HRDLKPNNLLLDENGVLKLADFGL 158
|
Structure Templates Detected by HHsearch 
Original result of HHsearch against PDB70 database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Probability ![]() |
| Query | 423 | |||
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 99.98 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 99.98 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 99.98 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 99.98 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 99.97 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 99.96 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 99.96 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 99.96 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 99.96 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 99.95 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 99.95 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 99.95 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 99.95 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 99.95 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 99.95 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 99.95 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 99.95 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 99.95 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 99.95 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 99.95 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 99.95 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 99.95 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 99.95 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 99.95 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 99.95 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 99.95 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 99.95 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 99.95 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 99.95 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 99.95 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 99.95 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 99.95 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 99.95 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 99.95 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 99.95 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 99.95 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 99.95 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 99.95 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 99.95 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 99.95 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 99.95 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 99.95 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 99.95 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 99.95 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 99.94 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 99.94 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 99.94 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 99.94 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 99.94 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 99.94 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 99.94 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 99.94 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 99.94 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 99.94 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 99.94 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 99.94 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 99.94 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 99.94 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 99.94 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 99.94 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 99.94 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 99.94 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 99.94 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 99.94 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 99.94 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 99.94 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 99.94 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 99.94 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 99.94 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 99.94 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 99.94 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 99.94 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 99.94 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 99.94 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 99.94 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 99.94 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 99.94 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 99.94 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 99.94 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 99.94 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 99.94 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 99.94 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 99.94 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 99.94 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 99.94 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 99.94 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 99.94 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 99.94 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 99.94 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 99.94 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 99.94 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 99.94 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 99.94 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 99.94 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 99.94 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 99.94 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 99.94 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 99.94 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 99.94 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 99.94 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 99.94 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 99.94 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 99.94 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 99.94 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 99.94 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 99.94 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 99.94 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 99.94 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 99.94 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 99.94 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 99.94 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 99.94 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 99.94 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 99.94 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 99.94 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 99.94 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 99.93 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 99.93 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 99.93 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 99.93 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 99.93 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 99.93 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 99.93 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 99.93 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 99.93 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 99.93 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 99.93 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 99.93 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 99.93 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 99.93 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 99.93 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 99.93 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 99.93 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 99.93 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 99.93 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 99.93 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 99.93 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 99.93 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 99.93 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 99.93 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 99.93 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 99.93 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 99.93 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 99.93 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 99.93 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 99.93 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 99.93 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 99.93 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 99.93 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 99.93 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 99.93 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 99.93 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 99.93 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 99.93 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 99.93 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 99.93 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 99.93 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 99.93 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 99.93 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 99.93 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 99.93 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 99.93 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 99.93 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 99.93 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 99.93 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 99.93 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 99.93 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 99.93 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 99.93 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 99.93 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 99.93 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 99.93 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 99.93 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 99.93 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 99.93 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 99.93 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 99.93 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 99.93 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 99.93 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 99.93 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 99.93 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 99.93 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 99.93 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 99.93 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 99.93 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 99.93 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 99.93 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 99.93 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 99.93 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 99.93 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 99.92 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 99.92 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 99.92 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 99.92 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 99.92 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 99.92 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 99.92 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 99.92 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 99.92 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 99.92 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 99.92 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 99.92 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 99.92 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 99.92 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 99.92 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 99.92 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 99.92 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 99.92 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 99.92 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 99.92 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 99.92 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 99.92 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 99.92 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 99.92 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 99.92 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 99.92 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 99.92 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 99.92 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 99.92 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 99.92 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 99.92 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 99.92 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 99.92 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 99.92 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 99.92 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 99.92 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 99.92 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 99.92 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 99.92 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 99.92 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 99.92 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 99.91 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 99.91 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 99.91 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 99.9 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 99.89 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 99.88 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 99.86 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 99.85 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 99.82 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.71 | |
| 1y10_A | 407 | Hypothetical protein RV1264/MT1302; adenylyl cycla | 99.64 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.38 | |
| 3uvj_A | 225 | Guanylate cyclase soluble subunit alpha-3; nitric | 99.35 | |
| 2wz1_A | 219 | Guanylate cyclase soluble subunit beta-1; lyase, G | 99.33 | |
| 1ab8_A | 220 | Adenylyl cyclase; lyase, complex (transferase-inhi | 99.3 | |
| 1azs_A | 220 | VC1; complex (lyase/hydrolase), hydrolase, signal | 99.23 | |
| 3et6_A | 190 | Soluble guanylyl cyclase beta; guanylate cyclase, | 99.2 | |
| 1yk9_A | 204 | Adenylate cyclase; beta-alpha-beta sandwich, struc | 99.19 | |
| 1fx2_A | 235 | Receptor-type adenylate cyclase gresag 4.1; CAMP, | 99.11 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.04 | |
| 1ybt_A | 184 | Hydrolase, alpha/beta hydrolase fold family; cycla | 99.0 | |
| 2w01_A | 208 | Adenylate cyclase; guanylyl cyclase, class III nuc | 98.98 | |
| 3r5g_A | 198 | CYAB; adenylyl cyclase, lyase; 1.50A {Pseudomonas | 98.86 | |
| 1wc3_A | 219 | Adenylate cyclase; soluble adenylyl cyclase, CAMP | 98.85 | |
| 3hls_A | 66 | Guanylate cyclase soluble subunit beta-1; coiled-c | 98.78 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 98.74 | |
| 3mr7_A | 189 | Adenylate/guanylate cyclase/hydrolase, alpha/beta | 98.68 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 98.08 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 96.85 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 96.77 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 96.59 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 96.13 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 95.5 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 93.98 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 93.67 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 90.21 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 89.46 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 87.63 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 87.05 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 83.02 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 82.51 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 81.08 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 80.06 |
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-36 Score=294.98 Aligned_cols=166 Identities=27% Similarity=0.458 Sum_probs=129.4
Q ss_pred HHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCccEEEeccCCcccccCCCcccccccccCCccccCCccccCCCCC
Q psy1840 25 SISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKAPELLRQPHLP 104 (423)
Q Consensus 25 ~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~ 104 (423)
++.++.||+.||+|||+++|| ||||||+||||+.++.+||+|||+|+...............||+.|||||++.+....
T Consensus 134 ~~~i~~qia~gL~yLH~~~Ii-HRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~ 212 (307)
T 3omv_A 134 LIDIARQTAQGMDYLHAKNII-HRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNN 212 (307)
T ss_dssp HHHHHHHHHHHHHHHHHTTCB-CSCCCSSSEEEETTEEEEECCCSSCBC------------CCCCTTSCCHHHHHCCSSC
T ss_pred HHHHHHHHHHHHHHHHHCCcc-CCccCHHHEEECCCCcEEEeeccCceecccCCcceeecccccCCCccCHHHhhccCCC
Confidence 789999999999999999998 9999999999999999999999999876443333334566899999999999765433
Q ss_pred CCCCccchHHHHHHHHHHHhCCCCCCCCCCChHHHHHHHhcCCCCCCC--CCCCCchHHHHHHHHHhhhcCCCCCCCHHH
Q psy1840 105 RGTQKGDVYSFGLVLYEVIGRQGPWGHLRMTDEEIITSVTQGSGLRPD--TSSLDCAPSIIACMRTCWEEDPELRPDLRF 182 (423)
Q Consensus 105 ~~s~ksDVyS~Giil~elltg~~Pf~~~~~~~~~i~~~i~~~~~~~p~--~~~~~~~~~l~~Li~~C~~~dP~~RPt~~~ 182 (423)
.++.++|||||||++|||+||+.||.+.. ....+...+..+. ..|. .....+++++.+||.+||+.||++|||+.+
T Consensus 213 ~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~-~~~~~~~~~~~~~-~~p~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~e 290 (307)
T 3omv_A 213 PFSFQSDVYSYGIVLYELMTGELPYSHIN-NRDQIIFMVGRGY-ASPDLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQ 290 (307)
T ss_dssp CCCHHHHHHHHHHHHHHHHHSSCTTTTCC-CHHHHHHHHHTTC-CCCCSTTSCTTSCHHHHHHHHHHTCSSSTTSCCHHH
T ss_pred CCCcHHHhHhHHHHHHHHHHCCCCCCCCC-hHHHHHHHHhcCC-CCCCcccccccchHHHHHHHHHHcCCCHhHCcCHHH
Confidence 45899999999999999999999997532 2333444444432 2222 223578999999999999999999999999
Q ss_pred HHHHHHHHhhh
Q psy1840 183 VHHKLKEMNAG 193 (423)
Q Consensus 183 I~~~L~~i~~~ 193 (423)
|++.|+.+...
T Consensus 291 i~~~Le~l~~~ 301 (307)
T 3omv_A 291 ILSSIELLQHS 301 (307)
T ss_dssp HHHHHHHHHTT
T ss_pred HHHHHHHHhcc
Confidence 99999887654
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-36 Score=291.93 Aligned_cols=158 Identities=23% Similarity=0.416 Sum_probs=135.5
Q ss_pred HHHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCccEEEeccCCcccccCCCcccccccccCCccccCCccccCCCC
Q psy1840 24 GSISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKAPELLRQPHL 103 (423)
Q Consensus 24 ~~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~ 103 (423)
.++.++.||+.||+|||++++| ||||||+||||++++.+||+|||+++...............||+.|||||++.+..+
T Consensus 146 ~~~~i~~qia~gl~yLH~~~ii-HRDLK~~NILl~~~~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~ 224 (308)
T 4gt4_A 146 DFVHLVAQIAAGMEYLSSHHVV-HKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKF 224 (308)
T ss_dssp HHHHHHHHHHHHHHHHHHTTCC-CSCCSGGGEEECGGGCEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCC
T ss_pred HHHHHHHHHHHHHHHHHhCCCC-CCCccccceEECCCCCEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCC
Confidence 3789999999999999999998 999999999999999999999999987654433333345678999999999988765
Q ss_pred CCCCCccchHHHHHHHHHHHh-CCCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCchHHHHHHHHHhhhcCCCCCCCHHH
Q psy1840 104 PRGTQKGDVYSFGLVLYEVIG-RQGPWGHLRMTDEEIITSVTQGSGLRPDTSSLDCAPSIIACMRTCWEEDPELRPDLRF 182 (423)
Q Consensus 104 ~~~s~ksDVyS~Giil~ellt-g~~Pf~~~~~~~~~i~~~i~~~~~~~p~~~~~~~~~~l~~Li~~C~~~dP~~RPt~~~ 182 (423)
+.++|||||||++|||+| |..||.+ .+..+++..+..+... +. +..+++++.+||.+||+.||++||||.+
T Consensus 225 ---s~ksDVwSfGvvl~El~t~g~~Pf~~--~~~~~~~~~i~~~~~~--~~-p~~~~~~~~~li~~C~~~dP~~RPs~~e 296 (308)
T 4gt4_A 225 ---SIDSDIWSYGVVLWEVFSYGLQPYCG--YSNQDVVEMIRNRQVL--PC-PDDCPAWVYALMIECWNEFPSRRPRFKD 296 (308)
T ss_dssp ---CHHHHHHHHHHHHHHHHTTTCCTTTT--CCHHHHHHHHHTTCCC--CC-CTTCCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred ---CccchhhhHHHHHHHHHhCCCCCCCC--CCHHHHHHHHHcCCCC--CC-cccchHHHHHHHHHHcCCChhHCcCHHH
Confidence 999999999999999998 8999974 5678888888876432 22 3478999999999999999999999999
Q ss_pred HHHHHHHH
Q psy1840 183 VHHKLKEM 190 (423)
Q Consensus 183 I~~~L~~i 190 (423)
|++.|+.+
T Consensus 297 i~~~L~a~ 304 (308)
T 4gt4_A 297 IHSRLRAW 304 (308)
T ss_dssp HHHHHHTS
T ss_pred HHHHHHhc
Confidence 99998754
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-36 Score=291.77 Aligned_cols=161 Identities=28% Similarity=0.559 Sum_probs=129.5
Q ss_pred HHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCccEEEeccCCcccccCCCcccccccccCCccccCCccccCCCCC
Q psy1840 25 SISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKAPELLRQPHLP 104 (423)
Q Consensus 25 ~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~ 104 (423)
++.++.||+.||+|||++++| ||||||+||||+.++.+||+|||+++...............||+.|||||++.+..+
T Consensus 160 ~~~i~~qia~gl~yLH~~~ii-HRDLKp~NILl~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~- 237 (329)
T 4aoj_A 160 LLAVASQVAAGMVYLAGLHFV-HRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKF- 237 (329)
T ss_dssp HHHHHHHHHHHHHHHHHTTCC-CSCCCGGGEEEETTTEEEECCCC----------------CCCCGGGCCHHHHTTCCC-
T ss_pred HHHHHHHHHHHHHHHhcCCee-cccccHhhEEECCCCcEEEcccccceeccCCCcceecCcccccccccChhhhcCCCC-
Confidence 789999999999999999998 999999999999999999999999986644433333345678999999999988765
Q ss_pred CCCCccchHHHHHHHHHHHh-CCCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCchHHHHHHHHHhhhcCCCCCCCHHHH
Q psy1840 105 RGTQKGDVYSFGLVLYEVIG-RQGPWGHLRMTDEEIITSVTQGSGLRPDTSSLDCAPSIIACMRTCWEEDPELRPDLRFV 183 (423)
Q Consensus 105 ~~s~ksDVyS~Giil~ellt-g~~Pf~~~~~~~~~i~~~i~~~~~~~p~~~~~~~~~~l~~Li~~C~~~dP~~RPt~~~I 183 (423)
+.++|||||||++|||+| |+.||.+ .+..+++..+..+.. +.. +..+++++.+||.+||+.||++|||+.+|
T Consensus 238 --~~~sDvwS~Gvvl~Ellt~G~~Pf~~--~~~~~~~~~i~~g~~--~~~-p~~~~~~~~~li~~cl~~dP~~RPs~~ei 310 (329)
T 4aoj_A 238 --TTESDVWSFGVVLWEIFTYGKQPWYQ--LSNTEAIDCITQGRE--LER-PRACPPEVYAIMRGCWQREPQQRHSIKDV 310 (329)
T ss_dssp --CHHHHHHHHHHHHHHHHTTSCCTTCS--SCHHHHHHHHHHTCC--CCC-CTTCCHHHHHHHHHHCCSSTTTSCCHHHH
T ss_pred --CccccccchHHHHHHHHcCCCCCCCC--CCHHHHHHHHHcCCC--CCC-cccccHHHHHHHHHHcCcChhHCcCHHHH
Confidence 999999999999999998 8999974 567788888877643 222 24689999999999999999999999999
Q ss_pred HHHHHHHhhhc
Q psy1840 184 HHKLKEMNAGL 194 (423)
Q Consensus 184 ~~~L~~i~~~~ 194 (423)
++.|+.+....
T Consensus 311 ~~~L~~l~~~p 321 (329)
T 4aoj_A 311 HARLQALAQAP 321 (329)
T ss_dssp HHHHHHHHHSC
T ss_pred HHHHHHHhhCC
Confidence 99999887653
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-36 Score=291.29 Aligned_cols=160 Identities=24% Similarity=0.532 Sum_probs=136.8
Q ss_pred HHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCccEEEeccCCcccccCCCcccccccccCCccccCCccccCCCCC
Q psy1840 25 SISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKAPELLRQPHLP 104 (423)
Q Consensus 25 ~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~ 104 (423)
++.++.||+.||.|||+++++ ||||||+|||++.++.+||+|||+++...............||+.|||||++.+..+
T Consensus 130 ~~~i~~qia~gl~yLH~~~ii-HRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~- 207 (299)
T 4asz_A 130 MLHIAQQIAAGMVYLASQHFV-HRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKF- 207 (299)
T ss_dssp HHHHHHHHHHHHHHHHHTTCC-CSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCC-
T ss_pred HHHHHHHHHHHHHHHHhCCcc-cCccCHhhEEECCCCcEEECCcccceecCCCCceeecCceecChhhcCHHHHcCCCC-
Confidence 789999999999999999998 999999999999999999999999986544333333344568899999999988765
Q ss_pred CCCCccchHHHHHHHHHHHh-CCCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCchHHHHHHHHHhhhcCCCCCCCHHHH
Q psy1840 105 RGTQKGDVYSFGLVLYEVIG-RQGPWGHLRMTDEEIITSVTQGSGLRPDTSSLDCAPSIIACMRTCWEEDPELRPDLRFV 183 (423)
Q Consensus 105 ~~s~ksDVyS~Giil~ellt-g~~Pf~~~~~~~~~i~~~i~~~~~~~p~~~~~~~~~~l~~Li~~C~~~dP~~RPt~~~I 183 (423)
+.++|||||||++|||+| |+.||.+ .+..+++..+..+... .. +..+++++.+||.+||+.||++|||+.+|
T Consensus 208 --~~k~DVwS~Gvvl~Ellt~G~~Pf~~--~~~~~~~~~i~~~~~~--~~-p~~~~~~~~~li~~cl~~dP~~RPs~~~i 280 (299)
T 4asz_A 208 --TTESDVWSLGVVLWEIFTYGKQPWYQ--LSNNEVIECITQGRVL--QR-PRTCPQEVYELMLGCWQREPHMRKNIKGI 280 (299)
T ss_dssp --CHHHHHHHHHHHHHHHHTTTCCTTTT--SCHHHHHHHHHHTCCC--CC-CTTCCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred --CchhhHHHHHHHHHHHHcCCCCCCCC--CCHHHHHHHHHcCCCC--CC-CccchHHHHHHHHHHcCCChhHCcCHHHH
Confidence 999999999999999998 8999974 5678888888876532 22 24689999999999999999999999999
Q ss_pred HHHHHHHhhh
Q psy1840 184 HHKLKEMNAG 193 (423)
Q Consensus 184 ~~~L~~i~~~ 193 (423)
.+.|+.+.+.
T Consensus 281 ~~~L~~~~~~ 290 (299)
T 4asz_A 281 HTLLQNLAKA 290 (299)
T ss_dssp HHHHHHHHHH
T ss_pred HHHHHHHHhc
Confidence 9999887654
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-35 Score=289.67 Aligned_cols=161 Identities=25% Similarity=0.423 Sum_probs=135.1
Q ss_pred HHHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCccEEEeccCCcccccCCCcccccccccCCccccCCccccCCCC
Q psy1840 24 GSISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKAPELLRQPHL 103 (423)
Q Consensus 24 ~~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~ 103 (423)
..+.++.||+.||+|||++++| ||||||+|||++.++.+||+|||+|+...............||+.|||||++.+..+
T Consensus 186 ~~~~~~~qia~gl~yLH~~~ii-HRDLK~~NILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y 264 (353)
T 4ase_A 186 HLICYSFQVAKGMEFLASRKCI-HRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVY 264 (353)
T ss_dssp HHHHHHHHHHHHHHHHHHTTCC-CSCCSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCC
T ss_pred HHHHHHHHHHHHHHhHhhCCee-cCccCccceeeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCC
Confidence 3789999999999999999998 999999999999999999999999987654443333455678999999999988765
Q ss_pred CCCCCccchHHHHHHHHHHHh-CCCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCchHHHHHHHHHhhhcCCCCCCCHHH
Q psy1840 104 PRGTQKGDVYSFGLVLYEVIG-RQGPWGHLRMTDEEIITSVTQGSGLRPDTSSLDCAPSIIACMRTCWEEDPELRPDLRF 182 (423)
Q Consensus 104 ~~~s~ksDVyS~Giil~ellt-g~~Pf~~~~~~~~~i~~~i~~~~~~~p~~~~~~~~~~l~~Li~~C~~~dP~~RPt~~~ 182 (423)
+.++|||||||++|||+| |+.||.+... ...+...+..+.. +.. +..+++++.++|.+||+.||++|||+.+
T Consensus 265 ---~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~-~~~~~~~i~~g~~--~~~-p~~~~~~~~~li~~c~~~dP~~RPt~~e 337 (353)
T 4ase_A 265 ---TIQSDVWSFGVLLWEIFSLGASPYPGVKI-DEEFCRRLKEGTR--MRA-PDYTTPEMYQTMLDCWHGEPSQRPTFSE 337 (353)
T ss_dssp ---CHHHHHHHHHHHHHHHTTTSCCSSTTCCC-SHHHHHHHHHTCC--CCC-CTTCCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred ---CCcccEeehHHHHHHHHhCCCCCCCCCCH-HHHHHHHHHcCCC--CCC-CccCCHHHHHHHHHHcCcChhHCcCHHH
Confidence 999999999999999998 8999976433 3556666666542 222 2368999999999999999999999999
Q ss_pred HHHHHHHHhh
Q psy1840 183 VHHKLKEMNA 192 (423)
Q Consensus 183 I~~~L~~i~~ 192 (423)
|++.|+.+.+
T Consensus 338 il~~L~~llq 347 (353)
T 4ase_A 338 LVEHLGNLLQ 347 (353)
T ss_dssp HHHHHHHHHH
T ss_pred HHHHHHHHHH
Confidence 9999987754
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-34 Score=277.46 Aligned_cols=160 Identities=17% Similarity=0.232 Sum_probs=127.4
Q ss_pred HHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCc-cEEEeccCCcccccCCCcc---cccccccCCccccCCccccC
Q psy1840 25 SISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRW-VLQIADFGLHAFKAGQDET---GQERKLRRRKLYKAPELLRQ 100 (423)
Q Consensus 25 ~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~-~vKL~DFGla~~~~~~~~~---~~~~~~~gt~~y~APE~l~~ 100 (423)
...++.||+.||+|||+++|| ||||||+||||+.+| .+||+|||+++........ ......+||+.|||||++.+
T Consensus 152 ~~~~~~qi~~aL~ylH~~~Ii-HRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~ 230 (336)
T 4g3f_A 152 ALYYLGQALEGLEYLHTRRIL-HGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMG 230 (336)
T ss_dssp HHHHHHHHHHHHHHHHTTTEE-CSCCCGGGEEECTTSCCEEECCCTTCEEC------------CCCCCCGGGCCHHHHTT
T ss_pred HHHHHHHHHHHHHHHHHCCce-ecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCcccceecCCccccCccccCHHHHCC
Confidence 678999999999999999988 999999999999988 5999999999876433211 12234679999999999998
Q ss_pred CCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCchHHHHHHHHHhhhcCCCCCCCH
Q psy1840 101 PHLPRGTQKGDVYSFGLVLYEVIGRQGPWGHLRMTDEEIITSVTQGSGLRPDTSSLDCAPSIIACMRTCWEEDPELRPDL 180 (423)
Q Consensus 101 ~~~~~~s~ksDVyS~Giil~elltg~~Pf~~~~~~~~~i~~~i~~~~~~~p~~~~~~~~~~l~~Li~~C~~~dP~~RPt~ 180 (423)
..+ +.++|||||||++|||++|+.||.+.. ..++...+.......+. .+..+++.+.+++.+||+.||.+|||+
T Consensus 231 ~~y---~~~~DiwSlGvilyemltG~~Pf~~~~--~~~~~~~i~~~~~~~~~-~~~~~s~~~~~li~~~L~~dP~~R~sa 304 (336)
T 4g3f_A 231 KPC---DAKVDIWSSCCMMLHMLNGCHPWTQYF--RGPLCLKIASEPPPIRE-IPPSCAPLTAQAIQEGLRKEPVHRASA 304 (336)
T ss_dssp CCC---CTHHHHHHHHHHHHHHHHSSCSSTTTC--CSCCHHHHHHSCCGGGG-SCTTSCHHHHHHHHHHTCSSGGGSCCH
T ss_pred CCC---CcHHHHHHHHHHHHHHHHCcCCCCCCC--HHHHHHHHHcCCCCchh-cCccCCHHHHHHHHHHccCCHhHCcCH
Confidence 765 899999999999999999999997532 33455555554332222 234689999999999999999999999
Q ss_pred HHHHHHHHHHh
Q psy1840 181 RFVHHKLKEMN 191 (423)
Q Consensus 181 ~~I~~~L~~i~ 191 (423)
.++++.|....
T Consensus 305 ~el~~~l~~~l 315 (336)
T 4g3f_A 305 MELRRKVGKAL 315 (336)
T ss_dssp HHHHHHHHHHH
T ss_pred HHHHHHHHHHH
Confidence 99998876654
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-33 Score=274.85 Aligned_cols=153 Identities=18% Similarity=0.287 Sum_probs=128.9
Q ss_pred HHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCccEEEeccCCcccccCCCcccccccccCCccccCCccccCCCCC
Q psy1840 25 SISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKAPELLRQPHLP 104 (423)
Q Consensus 25 ~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~ 104 (423)
...++.||+.||+|||++||| ||||||+||||+.+|.+||+|||+++....... .....+||+.|||||++.+..+
T Consensus 172 ~~~~~~qi~~aL~ylH~~~Ii-HRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~--~~~~~~GTp~YmAPEvl~~~~y- 247 (346)
T 4fih_A 172 IAAVCLAVLQALSVLHAQGVI-HRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP--RRKSLVGTPYWMAPELISRLPY- 247 (346)
T ss_dssp HHHHHHHHHHHHHHHHHTTEE-CCCCSGGGEEECTTCCEEECCCTTCEECCSSSC--CBCCCCSCGGGCCHHHHTTCCB-
T ss_pred HHHHHHHHHHHHHHHHHCCcc-cccCCHHHEEECCCCCEEEecCcCceecCCCCC--cccccccCcCcCCHHHHCCCCC-
Confidence 578999999999999999988 999999999999999999999999986543322 2346789999999999987766
Q ss_pred CCCCccchHHHHHHHHHHHhCCCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCchHHHHHHHHHhhhcCCCCCCCHHHHH
Q psy1840 105 RGTQKGDVYSFGLVLYEVIGRQGPWGHLRMTDEEIITSVTQGSGLRPDTSSLDCAPSIIACMRTCWEEDPELRPDLRFVH 184 (423)
Q Consensus 105 ~~s~ksDVyS~Giil~elltg~~Pf~~~~~~~~~i~~~i~~~~~~~p~~~~~~~~~~l~~Li~~C~~~dP~~RPt~~~I~ 184 (423)
+.++|||||||++|||++|+.||.+ .+..+++..+.......... ...+++++.+||.+||+.||++|||+.+++
T Consensus 248 --~~~~DiWSlGvilyeml~G~~PF~~--~~~~~~~~~i~~~~~~~~~~-~~~~s~~~~dli~~~L~~dP~~R~ta~e~l 322 (346)
T 4fih_A 248 --GPEVDIWSLGIMVIEMVDGEPPYFN--EPPLKAMKMIRDNLPPRLKN-LHKVSPSLKGFLDRLLVRDPAQRATAAELL 322 (346)
T ss_dssp --CTHHHHHHHHHHHHHHHHSSCTTTT--SCHHHHHHHHHHSSCCCCSC-GGGSCHHHHHHHHHHSCSSTTTSCCHHHHT
T ss_pred --CcHHHHHHHHHHHHHHHHCCCCCCC--cCHHHHHHHHHcCCCCCCCc-cccCCHHHHHHHHHHcCCChhHCcCHHHHh
Confidence 8999999999999999999999974 45677777777654332222 236789999999999999999999999987
Q ss_pred HH
Q psy1840 185 HK 186 (423)
Q Consensus 185 ~~ 186 (423)
+.
T Consensus 323 ~H 324 (346)
T 4fih_A 323 KH 324 (346)
T ss_dssp TC
T ss_pred cC
Confidence 63
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-33 Score=266.93 Aligned_cols=149 Identities=22% Similarity=0.375 Sum_probs=122.5
Q ss_pred HHHHHHHHHHHHHHHHhCC--CeeecCCCCCCEEEcC-CccEEEeccCCcccccCCCcccccccccCCccccCCccccCC
Q psy1840 25 SISVNTTASVGMIHLHDSE--IISHGNLRSSNCLIDS-RWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKAPELLRQP 101 (423)
Q Consensus 25 ~l~i~~qi~~gL~yLH~~~--ii~HrDLkp~NILld~-~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~ 101 (423)
...++.||+.||+|||+++ |+ ||||||+||||++ ++.+||+|||+|+..... .....+||+.|||||++.+.
T Consensus 131 ~~~~~~qi~~aL~ylH~~~~~Ii-HRDlKp~NILl~~~~g~vKl~DFGla~~~~~~----~~~~~~GTp~YmAPE~~~~~ 205 (290)
T 3fpq_A 131 LRSWCRQILKGLQFLHTRTPPII-HRDLKCDNIFITGPTGSVKIGDLGLATLKRAS----FAKAVIGTPEFMAPEMYEEK 205 (290)
T ss_dssp HHHHHHHHHHHHHHHHTSSSCCC-CCCCCGGGEEESSTTSCEEECCTTGGGGCCTT----SBEESCSSCCCCCGGGGGTC
T ss_pred HHHHHHHHHHHHHHHHHCCCCEE-ecccChhheeEECCCCCEEEEeCcCCEeCCCC----ccCCcccCccccCHHHcCCC
Confidence 5789999999999999998 87 9999999999985 799999999999764322 22456899999999998753
Q ss_pred CCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCchHHHHHHHHHhhhcCCCCCCCHH
Q psy1840 102 HLPRGTQKGDVYSFGLVLYEVIGRQGPWGHLRMTDEEIITSVTQGSGLRPDTSSLDCAPSIIACMRTCWEEDPELRPDLR 181 (423)
Q Consensus 102 ~~~~~s~ksDVyS~Giil~elltg~~Pf~~~~~~~~~i~~~i~~~~~~~p~~~~~~~~~~l~~Li~~C~~~dP~~RPt~~ 181 (423)
++.++|||||||++|||++|+.||.+. .....+...+..+. .|......+++++.+|+.+||+.||++|||+.
T Consensus 206 ----y~~~~DiwSlGvilyelltg~~Pf~~~-~~~~~~~~~i~~~~--~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~ 278 (290)
T 3fpq_A 206 ----YDESVDVYAFGMCMLEMATSEYPYSEC-QNAAQIYRRVTSGV--KPASFDKVAIPEVKEIIEGCIRQNKDERYSIK 278 (290)
T ss_dssp ----CCTHHHHHHHHHHHHHHHHSSCTTTTC-SSHHHHHHHHTTTC--CCGGGGGCCCHHHHHHHHHHSCSSGGGSCCHH
T ss_pred ----CCcHHHHHHHHHHHHHHHHCCCCCCCC-CcHHHHHHHHHcCC--CCCCCCccCCHHHHHHHHHHccCChhHCcCHH
Confidence 389999999999999999999999643 34456666666543 23223345788999999999999999999999
Q ss_pred HHHH
Q psy1840 182 FVHH 185 (423)
Q Consensus 182 ~I~~ 185 (423)
++++
T Consensus 279 e~l~ 282 (290)
T 3fpq_A 279 DLLN 282 (290)
T ss_dssp HHHT
T ss_pred HHhc
Confidence 9875
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-33 Score=263.31 Aligned_cols=150 Identities=20% Similarity=0.301 Sum_probs=120.1
Q ss_pred HHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCccEEEeccCCcccccCCCcccccccccCCccccCCccccCCCCC
Q psy1840 25 SISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKAPELLRQPHLP 104 (423)
Q Consensus 25 ~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~ 104 (423)
...++.||+.||+|||++|++ ||||||+|||++.++.+||+|||+|+...... ......||+.|+|||++.+..+
T Consensus 114 ~~~~~~qi~~al~ylH~~~Ii-HRDiKP~NILl~~~~~vkl~DFGla~~~~~~~---~~~~~~GT~~Y~APE~~~~~~y- 188 (275)
T 3hyh_A 114 ARRFFQQIISAVEYCHRHKIV-HRDLKPENLLLDEHLNVKIADFGLSNIMTDGN---FLKTSCGSPNYAAPEVISGKLY- 188 (275)
T ss_dssp HHHHHHHHHHHHHHHHHTTCC-CCCCCTTTEEECTTCCEEECCSSCC------------------CTTSCHHHHSSSSC-
T ss_pred HHHHHHHHHHHHHHHHHCCcc-cccCChHHeEECCCCCEEEeecCCCeecCCCC---ccCCeeECcccCChhhhcCCCC-
Confidence 579999999999999999998 99999999999999999999999997654322 2245689999999999987653
Q ss_pred CCCCccchHHHHHHHHHHHhCCCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCchHHHHHHHHHhhhcCCCCCCCHHHHH
Q psy1840 105 RGTQKGDVYSFGLVLYEVIGRQGPWGHLRMTDEEIITSVTQGSGLRPDTSSLDCAPSIIACMRTCWEEDPELRPDLRFVH 184 (423)
Q Consensus 105 ~~s~ksDVyS~Giil~elltg~~Pf~~~~~~~~~i~~~i~~~~~~~p~~~~~~~~~~l~~Li~~C~~~dP~~RPt~~~I~ 184 (423)
.+.++||||+||++|||++|+.||.+ .+..++...+..+....| ..+++++.+++.+||+.||++|||+.+++
T Consensus 189 -~~~~~DiwSlGvily~lltg~~PF~~--~~~~~~~~~i~~~~~~~p----~~~s~~~~~li~~~L~~dP~~R~s~~eil 261 (275)
T 3hyh_A 189 -AGPEVDVWSCGVILYVMLCRRLPFDD--ESIPVLFKNISNGVYTLP----KFLSPGAAGLIKRMLIVNPLNRISIHEIM 261 (275)
T ss_dssp -CCTHHHHHHHHHHHHHHHHSSCSSCC--SSHHHHHHHHHHTCCCCC----TTSCHHHHHHHHHHSCSSGGGSCCHHHHH
T ss_pred -CCChhhhHHHHHHHHHHHHCCCCCCC--CCHHHHHHHHHcCCCCCC----CCCCHHHHHHHHHHccCChhHCcCHHHHH
Confidence 36899999999999999999999974 456777788877654433 35789999999999999999999999998
Q ss_pred HH
Q psy1840 185 HK 186 (423)
Q Consensus 185 ~~ 186 (423)
+.
T Consensus 262 ~h 263 (275)
T 3hyh_A 262 QD 263 (275)
T ss_dssp HC
T ss_pred cC
Confidence 74
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-33 Score=275.50 Aligned_cols=151 Identities=20% Similarity=0.356 Sum_probs=128.4
Q ss_pred HHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCccEEEeccCCcccccCCCcccccccccCCccccCCccccCCCCC
Q psy1840 25 SISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKAPELLRQPHLP 104 (423)
Q Consensus 25 ~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~ 104 (423)
...++.||+.||+|||++||+ ||||||+||||+.+|.+||+|||+++...... ......+||+.|||||++.+..+
T Consensus 127 ~~~~~~qi~~aL~ylH~~~Ii-HRDlKp~NILl~~~g~vKl~DFGla~~~~~~~--~~~~~~~GT~~YmAPE~l~~~~y- 202 (350)
T 4b9d_A 127 ILDWFVQICLALKHVHDRKIL-HRDIKSQNIFLTKDGTVQLGDFGIARVLNSTV--ELARACIGTPYYLSPEICENKPY- 202 (350)
T ss_dssp HHHHHHHHHHHHHHHHHTTCE-ETTCCGGGEEECTTCCEEECSTTEESCCCHHH--HHHHHHHSCCTTCCHHHHTTCCC-
T ss_pred HHHHHHHHHHHHHHHHHCCee-eccCCHHHEEECCCCCEEEcccccceeecCCc--ccccccCCCccccCHHHHCCCCC-
Confidence 468999999999999999998 99999999999999999999999998653221 12245679999999999988765
Q ss_pred CCCCccchHHHHHHHHHHHhCCCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCchHHHHHHHHHhhhcCCCCCCCHHHHH
Q psy1840 105 RGTQKGDVYSFGLVLYEVIGRQGPWGHLRMTDEEIITSVTQGSGLRPDTSSLDCAPSIIACMRTCWEEDPELRPDLRFVH 184 (423)
Q Consensus 105 ~~s~ksDVyS~Giil~elltg~~Pf~~~~~~~~~i~~~i~~~~~~~p~~~~~~~~~~l~~Li~~C~~~dP~~RPt~~~I~ 184 (423)
+.++|||||||++|||++|+.||.+ .+..+++..+..+... . ....+++++.+||.+||+.||++|||+.+++
T Consensus 203 --~~~~DiwSlGvilyemltG~~PF~~--~~~~~~~~~i~~~~~~--~-~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l 275 (350)
T 4b9d_A 203 --NNKSDIWALGCVLYELCTLKHAFEA--GSMKNLVLKIISGSFP--P-VSLHYSYDLRSLVSQLFKRNPRDRPSVNSIL 275 (350)
T ss_dssp --CHHHHHHHHHHHHHHHHHSSCSCCC--SSHHHHHHHHHHTCCC--C-CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred --CcHHHHHHHHHHHHHHHHCCCCCCC--cCHHHHHHHHHcCCCC--C-CCccCCHHHHHHHHHHccCChhHCcCHHHHh
Confidence 8999999999999999999999974 4567788888776432 2 2346899999999999999999999999997
Q ss_pred HH
Q psy1840 185 HK 186 (423)
Q Consensus 185 ~~ 186 (423)
+.
T Consensus 276 ~h 277 (350)
T 4b9d_A 276 EK 277 (350)
T ss_dssp TS
T ss_pred cC
Confidence 64
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=3.3e-33 Score=270.69 Aligned_cols=168 Identities=26% Similarity=0.397 Sum_probs=125.1
Q ss_pred HHHHHHHHHHHHHHHHHhC--------CCeeecCCCCCCEEEcCCccEEEeccCCcccccCCCcc--cccccccCCcccc
Q psy1840 24 GSISVNTTASVGMIHLHDS--------EIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDET--GQERKLRRRKLYK 93 (423)
Q Consensus 24 ~~l~i~~qi~~gL~yLH~~--------~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~~--~~~~~~~gt~~y~ 93 (423)
.+++++.|++.||+|||++ +|+ ||||||+|||||.++++||+|||+++........ .......||+.||
T Consensus 101 ~~~~i~~~ia~gl~ylH~~~~~~~~~~~Ii-HRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~~~GT~~ym 179 (303)
T 3hmm_A 101 GMIKLALSTASGLAHLHMEIVGTQGKPAIA-HRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYM 179 (303)
T ss_dssp HHHHHHHHHHHHHHHHHCCBCSTTCBCCEE-CSCCCGGGEEECTTSCEEECCCTTCEEEETTTTEESCC-----CCGGGC
T ss_pred HHHHHHHHHHHHHHHHHHhhhhccCCCCEe-eccCCcccEEECCCCCEEEEeCCCCccccCCCCceeeeccccccccccc
Confidence 3789999999999999987 777 9999999999999999999999999876443322 1223457999999
Q ss_pred CCccccCCCC---CCCCCccchHHHHHHHHHHHhCCCCCCCC-------------CCChHHHHHHHhcCCCCCCCCCC--
Q psy1840 94 APELLRQPHL---PRGTQKGDVYSFGLVLYEVIGRQGPWGHL-------------RMTDEEIITSVTQGSGLRPDTSS-- 155 (423)
Q Consensus 94 APE~l~~~~~---~~~s~ksDVyS~Giil~elltg~~Pf~~~-------------~~~~~~i~~~i~~~~~~~p~~~~-- 155 (423)
|||++.+... ..++.++|||||||++|||+||..||... .....++...+.. ...+|..+.
T Consensus 180 APE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~-~~~rp~~p~~~ 258 (303)
T 3hmm_A 180 APEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCE-QKLRPNIPNRW 258 (303)
T ss_dssp CHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTT-SCCCCCCCGGG
T ss_pred CHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhcccccchHHHHHHHHhc-ccCCCCCCccc
Confidence 9999976421 12367999999999999999997765321 1122334433333 334444432
Q ss_pred --CCchHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHhhh
Q psy1840 156 --LDCAPSIIACMRTCWEEDPELRPDLRFVHHKLKEMNAG 193 (423)
Q Consensus 156 --~~~~~~l~~Li~~C~~~dP~~RPt~~~I~~~L~~i~~~ 193 (423)
..++..+.+||.+||+.||++|||+.+|++.|+++...
T Consensus 259 ~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l~~~ 298 (303)
T 3hmm_A 259 QSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQ 298 (303)
T ss_dssp GSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred cchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHH
Confidence 23556899999999999999999999999999888653
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=99.98 E-value=4e-33 Score=269.81 Aligned_cols=150 Identities=18% Similarity=0.276 Sum_probs=130.2
Q ss_pred HHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCccEEEeccCCcccccCCCcccccccccCCccccCCccccCCCCC
Q psy1840 25 SISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKAPELLRQPHLP 104 (423)
Q Consensus 25 ~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~ 104 (423)
...++.||+.||+|||++||+ ||||||+|||++.++.+||+|||+++............+.+||+.|||||++.+..+
T Consensus 134 ~~~~~~qi~~al~ylH~~~Ii-HRDlKPeNILl~~~g~vKl~DFGla~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~y- 211 (311)
T 4aw0_A 134 TRFYTAEIVSALEYLHGKGII-HRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSA- 211 (311)
T ss_dssp HHHHHHHHHHHHHHHHHTTEE-CSCCSGGGEEECTTSCEEECCCTTCEECCTTTTCCCBCCCCSCGGGCCHHHHHHSCB-
T ss_pred HHHHHHHHHHHHHHHHHCCCc-cCCCCHHHeEEcCCCCEEEEEcCCceecCCCCCcccccCcccCcccCCHHHHcCCCC-
Confidence 568999999999999999998 999999999999999999999999987654444344456789999999999988766
Q ss_pred CCCCccchHHHHHHHHHHHhCCCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCchHHHHHHHHHhhhcCCCCCCCHHHHH
Q psy1840 105 RGTQKGDVYSFGLVLYEVIGRQGPWGHLRMTDEEIITSVTQGSGLRPDTSSLDCAPSIIACMRTCWEEDPELRPDLRFVH 184 (423)
Q Consensus 105 ~~s~ksDVyS~Giil~elltg~~Pf~~~~~~~~~i~~~i~~~~~~~p~~~~~~~~~~l~~Li~~C~~~dP~~RPt~~~I~ 184 (423)
+.++||||+||++|||++|..||.+ .+..++...+..+....| ..+++++.+|+.+||+.||++|||+.++.
T Consensus 212 --~~~~DiWSlGvilyeml~G~~PF~~--~~~~~~~~~i~~~~~~~p----~~~s~~~~dli~~lL~~dp~~R~t~~e~~ 283 (311)
T 4aw0_A 212 --CKSSDLWALGCIIYQLVAGLPPFRA--GNEGLIFAKIIKLEYDFP----EKFFPKARDLVEKLLVLDATKRLGCEEME 283 (311)
T ss_dssp --CHHHHHHHHHHHHHHHHHSSCSSCC--SSHHHHHHHHHHTCCCCC----TTCCHHHHHHHHHHSCSSGGGSTTSGGGT
T ss_pred --CcHHHHHHHHHHHHHHHhCCCCCCC--CCHHHHHHHHHcCCCCCC----cccCHHHHHHHHHHccCCHhHCcChHHHc
Confidence 8999999999999999999999974 456788888887665443 35789999999999999999999998864
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.98 E-value=2e-32 Score=275.11 Aligned_cols=153 Identities=18% Similarity=0.284 Sum_probs=129.2
Q ss_pred HHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCccEEEeccCCcccccCCCcccccccccCCccccCCccccCCCCC
Q psy1840 25 SISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKAPELLRQPHLP 104 (423)
Q Consensus 25 ~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~ 104 (423)
...++.||+.||+|||++||| ||||||+||||+.+|.+||+|||+++...... ......+||+.|||||++.+..+
T Consensus 249 ~~~~~~qil~aL~ylH~~~Ii-HRDiKp~NILl~~~g~vKl~DFGla~~~~~~~--~~~~~~~GTp~YmAPEvl~~~~y- 324 (423)
T 4fie_A 249 IAAVCLAVLQALSVLHAQGVI-HRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV--PRRKSLVGTPYWMAPELISRLPY- 324 (423)
T ss_dssp HHHHHHHHHHHHHHHHHTTEE-CCCCSTTTEEECTTCCEEECCCTTCEECCSSC--CCBCCCEECTTTCCHHHHTTCCB-
T ss_pred HHHHHHHHHHHHHHHHHCCee-cccCCHHHEEEcCCCCEEEecCccceECCCCC--ccccccccCcCcCCHHHHCCCCC-
Confidence 578999999999999999998 99999999999999999999999998654332 22346789999999999988766
Q ss_pred CCCCccchHHHHHHHHHHHhCCCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCchHHHHHHHHHhhhcCCCCCCCHHHHH
Q psy1840 105 RGTQKGDVYSFGLVLYEVIGRQGPWGHLRMTDEEIITSVTQGSGLRPDTSSLDCAPSIIACMRTCWEEDPELRPDLRFVH 184 (423)
Q Consensus 105 ~~s~ksDVyS~Giil~elltg~~Pf~~~~~~~~~i~~~i~~~~~~~p~~~~~~~~~~l~~Li~~C~~~dP~~RPt~~~I~ 184 (423)
+.++|||||||++|||++|+.||.+ .+..+++..+.......... ...+++++.+||.+||+.||++|||+.+++
T Consensus 325 --~~~~DiWSlGvilyeml~G~~PF~~--~~~~~~~~~i~~~~~~~~~~-~~~~s~~~~dli~~~L~~dP~~R~ta~ell 399 (423)
T 4fie_A 325 --GPEVDIWSLGIMVIEMVDGEPPYFN--EPPLKAMKMIRDNLPPRLKN-LHKVSPSLKGFLDRLLVRDPAQRATAAELL 399 (423)
T ss_dssp --CTHHHHHHHHHHHHHHHHSSCTTTT--SCHHHHHHHHHHSCCCCCSC-TTSSCHHHHHHHHHHSCSSTTTSCCHHHHT
T ss_pred --CcHHHHHHHHHHHHHHHHCCCCCCC--cCHHHHHHHHHcCCCCCCcc-cccCCHHHHHHHHHHcCCChhHCcCHHHHh
Confidence 8999999999999999999999974 45677777777654332222 246899999999999999999999999987
Q ss_pred HH
Q psy1840 185 HK 186 (423)
Q Consensus 185 ~~ 186 (423)
+.
T Consensus 400 ~H 401 (423)
T 4fie_A 400 KH 401 (423)
T ss_dssp TC
T ss_pred cC
Confidence 63
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=1.5e-32 Score=265.46 Aligned_cols=144 Identities=22% Similarity=0.337 Sum_probs=122.0
Q ss_pred HHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCccEEEeccCCcccccCCCcccccccccCCccccCCccccCCCCC
Q psy1840 25 SISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKAPELLRQPHLP 104 (423)
Q Consensus 25 ~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~ 104 (423)
...++.||+.||+|||++|++ ||||||+|||++.++.+||+|||+|+...... ......+||+.|||||++.+..+
T Consensus 128 ~~~~~~qi~~aL~ylH~~~Ii-HRDlKp~NILl~~~g~vKl~DFGla~~~~~~~--~~~~~~~GT~~YmAPE~~~~~~y- 203 (304)
T 3ubd_A 128 VKFYLAELALALDHLHSLGII-YRDLKPENILLDEEGHIKLTDFGLSKESIDHE--KKAYSFCGTVEYMAPEVVNRRGH- 203 (304)
T ss_dssp HHHHHHHHHHHHHHHHHTTCC-CSSCCGGGEEECTTSCEEEESSEEEEC-------CCCCSCCCCGGGCCHHHHHTSCC-
T ss_pred HHHHHHHHHHHHHHHHHCCCc-CCCCCHHHeEEcCCCCEEecccccceeccCCC--ccccccccCcccCCHHHhccCCC-
Confidence 568999999999999999998 99999999999999999999999998643322 22245789999999999988765
Q ss_pred CCCCccchHHHHHHHHHHHhCCCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCchHHHHHHHHHhhhcCCCCCCCH
Q psy1840 105 RGTQKGDVYSFGLVLYEVIGRQGPWGHLRMTDEEIITSVTQGSGLRPDTSSLDCAPSIIACMRTCWEEDPELRPDL 180 (423)
Q Consensus 105 ~~s~ksDVyS~Giil~elltg~~Pf~~~~~~~~~i~~~i~~~~~~~p~~~~~~~~~~l~~Li~~C~~~dP~~RPt~ 180 (423)
+.++||||+||++|||++|+.||.+ .+..++...+..+....| ..+++++.+|+.+||+.||++|||+
T Consensus 204 --~~~~DiwSlGvilyemltG~~PF~~--~~~~~~~~~i~~~~~~~p----~~~s~~~~~li~~~L~~dP~~R~ta 271 (304)
T 3ubd_A 204 --TQSADWWSFGVLMFEMLTGTLPFQG--KDRKETMTMILKAKLGMP----QFLSPEAQSLLRMLFKRNPANRLGA 271 (304)
T ss_dssp --CTHHHHHHHHHHHHHHHHSSCSSCC--SSHHHHHHHHHHCCCCCC----TTSCHHHHHHHHHHTCSSGGGSTTC
T ss_pred --CCCCcccchHHHHHHHHhCCCCCCC--cCHHHHHHHHHcCCCCCC----CcCCHHHHHHHHHHcccCHHHCCCC
Confidence 8999999999999999999999974 466778888877654433 3578999999999999999999984
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=2.9e-31 Score=256.42 Aligned_cols=150 Identities=22% Similarity=0.357 Sum_probs=108.7
Q ss_pred HHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCccEEEeccCCcccccCCCcc----------cccccccCCccccC
Q psy1840 25 SISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDET----------GQERKLRRRKLYKA 94 (423)
Q Consensus 25 ~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~~----------~~~~~~~gt~~y~A 94 (423)
.+.++.||+.||+|||++||+ ||||||+|||++.++.+||+|||+++........ ......+||+.|||
T Consensus 120 ~~~i~~qi~~al~ylH~~~Ii-HRDlKp~NILl~~~~~vKl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmA 198 (299)
T 4g31_A 120 CLHIFLQIAEAVEFLHSKGLM-HRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMS 198 (299)
T ss_dssp HHHHHHHHHHHHHHHHHTTCC-CCCCCGGGEEECTTCCEEECCCCCC--------------------------CCCTTSC
T ss_pred HHHHHHHHHHHHHHHHHCcCc-cccCcHHHeEECCCCcEEEccCccceecCCCccccccccccccccccCCcccCccccC
Confidence 468999999999999999998 9999999999999999999999999875432211 11234579999999
Q ss_pred CccccCCCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCchHHHHHHHHHhhhcCC
Q psy1840 95 PELLRQPHLPRGTQKGDVYSFGLVLYEVIGRQGPWGHLRMTDEEIITSVTQGSGLRPDTSSLDCAPSIIACMRTCWEEDP 174 (423)
Q Consensus 95 PE~l~~~~~~~~s~ksDVyS~Giil~elltg~~Pf~~~~~~~~~i~~~i~~~~~~~p~~~~~~~~~~l~~Li~~C~~~dP 174 (423)
||++.+..+ +.++|||||||++|||++ ||... ......+..+.... .|+.. ...++.+.+|+++||+.||
T Consensus 199 PE~~~~~~y---~~~~DiwSlGvilyell~---Pf~~~-~~~~~~~~~~~~~~--~p~~~-~~~~~~~~~li~~~L~~dP 268 (299)
T 4g31_A 199 PEQIHGNSY---SHKVDIFSLGLILFELLY---PFSTQ-MERVRTLTDVRNLK--FPPLF-TQKYPCEYVMVQDMLSPSP 268 (299)
T ss_dssp HHHHTTCCC---CTHHHHHHHHHHHHHHHS---CCSSH-HHHHHHHHHHHTTC--CCHHH-HHHCHHHHHHHHHHTCSSG
T ss_pred HHHHcCCCC---CCHHHHHHHHHHHHHHcc---CCCCc-cHHHHHHHHHhcCC--CCCCC-cccCHHHHHHHHHHcCCCh
Confidence 999988765 899999999999999996 77531 11122233333322 12111 2345677899999999999
Q ss_pred CCCCCHHHHHH
Q psy1840 175 ELRPDLRFVHH 185 (423)
Q Consensus 175 ~~RPt~~~I~~ 185 (423)
++|||+.++++
T Consensus 269 ~~Rps~~eil~ 279 (299)
T 4g31_A 269 MERPEAINIIE 279 (299)
T ss_dssp GGSCCHHHHHT
T ss_pred hHCcCHHHHhc
Confidence 99999999875
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=8.5e-30 Score=255.49 Aligned_cols=157 Identities=19% Similarity=0.234 Sum_probs=121.5
Q ss_pred HHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCccEEEeccCCcccccCCCc--ccccccccCCccccCCccccCCC
Q psy1840 25 SISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDE--TGQERKLRRRKLYKAPELLRQPH 102 (423)
Q Consensus 25 ~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~--~~~~~~~~gt~~y~APE~l~~~~ 102 (423)
...++.||+.||.|||++||+ ||||||+|||++.++.+||+|||+++....... .......+||+.|+|||++.+..
T Consensus 160 ~~~~~~qil~al~ylH~~~ii-HRDlKP~NIl~~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~ 238 (398)
T 4b99_A 160 VRYFLYQLLRGLKYMHSAQVI-HRDLKPSNLLVNENCELKIGDFGMARGLCTSPAEHQYFMTEYVATRWYRAPELMLSLH 238 (398)
T ss_dssp HHHHHHHHHHHHHHHHHTTCB-CCCCCGGGEEECTTCCEEECCCTTCBCC-------CCCCCSSCCCCTTCCHHHHTTCS
T ss_pred HHHHHHHHHHHHHHHHHCcCc-CCCcCccccccCCCCCEEEeecceeeecccCccccccccccceeChHhcCHHHhcCCC
Confidence 568999999999999999998 999999999999999999999999986543221 22335678999999999987754
Q ss_pred CCCCCCccchHHHHHHHHHHHhCCCCCCCCCCChHHHHHHHhcCCCCC--------------------CCCC-------C
Q psy1840 103 LPRGTQKGDVYSFGLVLYEVIGRQGPWGHLRMTDEEIITSVTQGSGLR--------------------PDTS-------S 155 (423)
Q Consensus 103 ~~~~s~ksDVyS~Giil~elltg~~Pf~~~~~~~~~i~~~i~~~~~~~--------------------p~~~-------~ 155 (423)
.++.++||||+||++|||++|+.||.+ .+..+.+..+....... |... .
T Consensus 239 --~~~~~~DiWSlG~il~ell~G~~pF~g--~~~~~~l~~I~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 314 (398)
T 4b99_A 239 --EYTQAIDLWSVGCIFGEMLARRQLFPG--KNYVHQLQLIMMVLGTPSPAVIQAVGAERVRAYIQSLPPRQPVPWETVY 314 (398)
T ss_dssp --CCCTHHHHHHHHHHHHHHHHTSCSSCC--SSHHHHHHHHHHHHCCCCGGGTC-----CHHHHHHSSCCCCCCCHHHHS
T ss_pred --CCCChhheehhHHHHHHHHHCCCCCCC--CCHHHHHHHHHHhcCCCChHHhhhhhhhhhhhhhhcCCCcCCCCHHHhC
Confidence 248999999999999999999999974 34444454443211100 0000 1
Q ss_pred CCchHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q psy1840 156 LDCAPSIIACMRTCWEEDPELRPDLRFVHHK 186 (423)
Q Consensus 156 ~~~~~~l~~Li~~C~~~dP~~RPt~~~I~~~ 186 (423)
..+++++.+|+.+||..||.+|||+.+++++
T Consensus 315 ~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H 345 (398)
T 4b99_A 315 PGADRQALSLLGRMLRFEPSARISAAAALRH 345 (398)
T ss_dssp TTCCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred CCCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 2467899999999999999999999998753
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=4.9e-29 Score=247.03 Aligned_cols=157 Identities=16% Similarity=0.180 Sum_probs=115.2
Q ss_pred HHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCC-ccEEEeccCCcccccCCCcc-----------------------
Q psy1840 25 SISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSR-WVLQIADFGLHAFKAGQDET----------------------- 80 (423)
Q Consensus 25 ~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~-~~vKL~DFGla~~~~~~~~~----------------------- 80 (423)
...++.||+.||+|||++||+ ||||||+|||++.+ +.+||+|||+|+........
T Consensus 119 ~~~~~~qll~al~ylH~~gIi-HRDiKPeNiLl~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 197 (361)
T 4f9c_A 119 VREYMLNLFKALKRIHQFGIV-HRDVKPSNFLYNRRLKKYALVDFGLAQGTHDTKIELLKFVQSEAQQERCSQNKCSICL 197 (361)
T ss_dssp HHHHHHHHHHHHHHHHHTTEE-CSCCSGGGEEEETTTTEEEECCCTTCEECTTCSCGGGGGC------------------
T ss_pred HHHHHHHHHHHHHHHHHCCeE-eCcCCHHHeEEeCCCCeEEECcCCCCcccCCccccccccccccccccccccccccccc
Confidence 568999999999999999998 99999999999876 89999999999754322110
Q ss_pred ---cccccccCCccccCCccccCCCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCChHHHHHHHh-------------
Q psy1840 81 ---GQERKLRRRKLYKAPELLRQPHLPRGTQKGDVYSFGLVLYEVIGRQGPWGHLRMTDEEIITSVT------------- 144 (423)
Q Consensus 81 ---~~~~~~~gt~~y~APE~l~~~~~~~~s~ksDVyS~Giil~elltg~~Pf~~~~~~~~~i~~~i~------------- 144 (423)
......+||+.|+|||++.+.. .++.++||||+||++|||++|+.||..... ..+.+..+.
T Consensus 198 ~~~~~~~~~~GT~~Y~APE~l~~~~--~y~~~~DiWSlG~il~ell~G~~Pf~~~~~-~~~~l~~I~~~~G~~~~~~~~~ 274 (361)
T 4f9c_A 198 SRRQQVAPRAGTPGFRAPEVLTKCP--NQTTAIDMWSAGVIFLSLLSGRYPFYKASD-DLTALAQIMTIRGSRETIQAAK 274 (361)
T ss_dssp --------CCCCGGGCCHHHHTTCS--CCCTHHHHHHHHHHHHHHHHTCSSSSCCSS-HHHHHHHHHHHHCHHHHHHHHH
T ss_pred cccccccccccCccccCHHHHcCCC--CCCCccchhhhHHHHHHHHHCCCCCCCCCC-HHHHHHHHHHhcCCccchhhhh
Confidence 1123457999999999997753 248999999999999999999999964322 222222111
Q ss_pred -------------------------cCCCCCCC------------CCCCCchHHHHHHHHHhhhcCCCCCCCHHHHHH
Q psy1840 145 -------------------------QGSGLRPD------------TSSLDCAPSIIACMRTCWEEDPELRPDLRFVHH 185 (423)
Q Consensus 145 -------------------------~~~~~~p~------------~~~~~~~~~l~~Li~~C~~~dP~~RPt~~~I~~ 185 (423)
......|. .....+++++.+|+.+||+.||.+|||+.++++
T Consensus 275 ~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~is~~a~DLl~~lL~~dP~~R~ta~eaL~ 352 (361)
T 4f9c_A 275 TFGKSILCSKEVPAQDLRKLCERLRGMDSSTPKLTSDIQGHATNLEGWNEVPDEAYDLLDKLLDLNPASRITAEEALL 352 (361)
T ss_dssp HTTEEEEESSCCCCCCHHHHHHHHC----------------------CTTCCHHHHHHHHHHTCSCTTTSCCHHHHHT
T ss_pred hccccccccccCcchhhhHHHHhhccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence 00000010 112356889999999999999999999999875
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=99.96 E-value=5.6e-29 Score=250.06 Aligned_cols=179 Identities=16% Similarity=0.223 Sum_probs=130.1
Q ss_pred HHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcC---CccEEEeccCCcccccCCCcccccccccCCccccCCccccCC
Q psy1840 25 SISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDS---RWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKAPELLRQP 101 (423)
Q Consensus 25 ~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~---~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~ 101 (423)
...++.||+.||.|||+.|++ ||||||+|||++. ++.+||+|||+++...... ......||+.|+|||++.+.
T Consensus 163 ~~~i~~qi~~aL~~LH~~~iv-HrDlkp~Nill~~~~~~~~~kl~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~ 238 (400)
T 1nxk_A 163 ASEIMKSIGEAIQYLHSINIA-HRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHN---SLTTPCYTPYYVAPEVLGPE 238 (400)
T ss_dssp HHHHHHHHHHHHHHHHHTTEE-CCCCCGGGEEESSSSTTCCEEECCCTTCEECC--------------CTTCCGGGSCCC
T ss_pred HHHHHHHHHHHHHHHHHCCcc-ccCcCcceEEEecCCCCccEEEEecccccccCCCC---ccccCCCCCCccCHhhcCCC
Confidence 679999999999999999988 9999999999997 7899999999987643221 12355789999999999776
Q ss_pred CCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCC--hHHHHHHHhcCCCCCCCCCCCCchHHHHHHHHHhhhcCCCCCCC
Q psy1840 102 HLPRGTQKGDVYSFGLVLYEVIGRQGPWGHLRMT--DEEIITSVTQGSGLRPDTSSLDCAPSIIACMRTCWEEDPELRPD 179 (423)
Q Consensus 102 ~~~~~s~ksDVyS~Giil~elltg~~Pf~~~~~~--~~~i~~~i~~~~~~~p~~~~~~~~~~l~~Li~~C~~~dP~~RPt 179 (423)
.+ +.++|||||||++|||++|..||...... .......+..+....+......++.++.+||.+||+.||++|||
T Consensus 239 ~~---~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt 315 (400)
T 1nxk_A 239 KY---DKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMT 315 (400)
T ss_dssp CS---SSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHHHTCCCCCTTTTTTSCHHHHHHHHTTSCSSGGGSCC
T ss_pred CC---CCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHHcCcccCCCcccccCCHHHHHHHHHHCCCChhHCcC
Confidence 55 89999999999999999999999653221 11234455555444444334568999999999999999999999
Q ss_pred HHHHHHHHHHHhhhcCCChHHHHHHHHHHhh
Q psy1840 180 LRFVHHKLKEMNAGLKANIFDNMLAIMEKYA 210 (423)
Q Consensus 180 ~~~I~~~L~~i~~~~~~~~~d~~~~~~e~~~ 210 (423)
+.++++....................++++.
T Consensus 316 ~~eil~hp~~~~~~~~~~~~~~~~~~~~~~~ 346 (400)
T 1nxk_A 316 ITEFMNHPWIMQSTKVPQTPLHTSRVLKEDK 346 (400)
T ss_dssp HHHHHHSHHHHTTTTSCCCBCSHHHHHHHC-
T ss_pred HHHHhcCccccCCCCCCCCccccchhhhhhh
Confidence 9999987554443333333333344444443
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=99.95 E-value=1.3e-28 Score=244.82 Aligned_cols=159 Identities=27% Similarity=0.458 Sum_probs=131.5
Q ss_pred HHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCccEEEeccCCcccccCCCcccccccccCCccccCCccccCCCCC
Q psy1840 25 SISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKAPELLRQPHLP 104 (423)
Q Consensus 25 ~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~ 104 (423)
.+.++.||+.||.|||++|++ ||||||+|||++.++.+||+|||+++...............+++.|+|||++.+..+
T Consensus 205 ~~~i~~qi~~aL~~LH~~~iv-HrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~- 282 (370)
T 2psq_A 205 LVSCTYQLARGMEYLASQKCI-HRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVY- 282 (370)
T ss_dssp HHHHHHHHHHHHHHHHHTTEE-CSCCCGGGEEECTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCC-
T ss_pred HHHHHHHHHHHHHHHHhCCee-ccccchhhEEECCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCC-
Confidence 678999999999999999988 999999999999999999999999886544333223334556788999999987655
Q ss_pred CCCCccchHHHHHHHHHHHh-CCCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCchHHHHHHHHHhhhcCCCCCCCHHHH
Q psy1840 105 RGTQKGDVYSFGLVLYEVIG-RQGPWGHLRMTDEEIITSVTQGSGLRPDTSSLDCAPSIIACMRTCWEEDPELRPDLRFV 183 (423)
Q Consensus 105 ~~s~ksDVyS~Giil~ellt-g~~Pf~~~~~~~~~i~~~i~~~~~~~p~~~~~~~~~~l~~Li~~C~~~dP~~RPt~~~I 183 (423)
+.++|||||||++|||++ |..||... ...++...+..+.. +.. +..++.++.+++.+||+.||++||++.++
T Consensus 283 --~~~~DvwslG~il~ellt~g~~p~~~~--~~~~~~~~~~~~~~--~~~-~~~~~~~l~~li~~~l~~dP~~Rpt~~el 355 (370)
T 2psq_A 283 --THQSDVWSFGVLMWEIFTLGGSPYPGI--PVEELFKLLKEGHR--MDK-PANCTNELYMMMRDCWHAVPSQRPTFKQL 355 (370)
T ss_dssp --CHHHHHHHHHHHHHHHHTTSCCSSTTC--CGGGHHHHHHTTCC--CCC-CTTSCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred --CcHHHHHHHHHHHHHHHcCCCCCCCCC--CHHHHHHHHhcCCC--CCC-CCCCCHHHHHHHHHHcCCChhhCcCHHHH
Confidence 899999999999999999 99999753 44566666665532 222 23688999999999999999999999999
Q ss_pred HHHHHHHhh
Q psy1840 184 HHKLKEMNA 192 (423)
Q Consensus 184 ~~~L~~i~~ 192 (423)
++.|+.+..
T Consensus 356 l~~L~~il~ 364 (370)
T 2psq_A 356 VEDLDRILT 364 (370)
T ss_dssp HHHHHHHHH
T ss_pred HHHHHHHHH
Confidence 999988764
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=99.95 E-value=8e-29 Score=259.69 Aligned_cols=153 Identities=19% Similarity=0.314 Sum_probs=130.6
Q ss_pred HHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCC--ccEEEeccCCcccccCCCcccccccccCCccccCCccccCCC
Q psy1840 25 SISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSR--WVLQIADFGLHAFKAGQDETGQERKLRRRKLYKAPELLRQPH 102 (423)
Q Consensus 25 ~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~--~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~ 102 (423)
...++.||+.||.|||+++++ ||||||+|||++.+ +.+||+|||+++...... .....+||+.|+|||++.+..
T Consensus 257 ~~~~~~qi~~al~ylH~~~ii-HRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~~---~~~~~~GT~~y~APEv~~~~~ 332 (573)
T 3uto_A 257 AVEYMRQVCKGLCHMHENNYV-HLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ---SVKVTTGTAEFAAPEVAEGKP 332 (573)
T ss_dssp HHHHHHHHHHHHHHHHHTTEE-CCCCCGGGEEESSSSCCCEEECCCSSCEECCTTS---EEEEECSSGGGCCHHHHTTCC
T ss_pred HHHHHHHHHHHHHHHHHCCee-eccCChhhccccCCCCCCEEEeeccceeEccCCC---ceeeeEECccccCHHHhCCCC
Confidence 578999999999999999998 99999999999854 899999999998764332 224568999999999999876
Q ss_pred CCCCCCccchHHHHHHHHHHHhCCCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCchHHHHHHHHHhhhcCCCCCCCHHH
Q psy1840 103 LPRGTQKGDVYSFGLVLYEVIGRQGPWGHLRMTDEEIITSVTQGSGLRPDTSSLDCAPSIIACMRTCWEEDPELRPDLRF 182 (423)
Q Consensus 103 ~~~~s~ksDVyS~Giil~elltg~~Pf~~~~~~~~~i~~~i~~~~~~~p~~~~~~~~~~l~~Li~~C~~~dP~~RPt~~~ 182 (423)
+ +.++||||+||++|||++|..||.+ .+..+.+..+..+....+......+++++.+||.+||+.||.+|||+.+
T Consensus 333 y---~~~~DiWSlGvilyeml~G~~Pf~~--~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~R~t~~e 407 (573)
T 3uto_A 333 V---GYYTDMWSVGVLSYILLSGLSPFGG--ENDDETLRNVKSCDWNMDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQ 407 (573)
T ss_dssp B---CHHHHHHHHHHHHHHHHHSCCSSCC--SSHHHHHHHHHTTCCCCCSGGGTTSCHHHHHHHHTTSCSSGGGSCCHHH
T ss_pred C---CcHHHHHHHHHHHHHHHHCCCCCCC--cCHHHHHHHHHhCCCCCCcccccCCCHHHHHHHHHHccCChhHCcCHHH
Confidence 5 8999999999999999999999974 4567788888876655444444578999999999999999999999999
Q ss_pred HHHH
Q psy1840 183 VHHK 186 (423)
Q Consensus 183 I~~~ 186 (423)
++++
T Consensus 408 ~l~H 411 (573)
T 3uto_A 408 ALEH 411 (573)
T ss_dssp HHHS
T ss_pred HhcC
Confidence 8763
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=99.95 E-value=2.4e-28 Score=233.88 Aligned_cols=165 Identities=28% Similarity=0.464 Sum_probs=120.9
Q ss_pred HHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCccEEEeccCCcccccCCCcccccccccCCccccCCccccCCCCC
Q psy1840 25 SISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKAPELLRQPHLP 104 (423)
Q Consensus 25 ~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~ 104 (423)
.+.++.|++.||.|||+.|++ ||||||+||+++.++.+||+|||++................|++.|+|||.+......
T Consensus 122 ~~~i~~qi~~~L~~lH~~~i~-H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~ 200 (289)
T 3og7_A 122 LIDIARQTARGMDYLHAKSII-HRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSN 200 (289)
T ss_dssp HHHHHHHHHHHHHHHHHTTCC-CSCCCGGGEEEETTTEEEECCCC------------------CCCTTCCHHHHC----C
T ss_pred HHHHHHHHHHHHHHHHhCCcc-cccCccceEEECCCCCEEEccceeccccccccccccccccCCCccccCchhhcccCCC
Confidence 679999999999999999998 9999999999999999999999998755432222233445789999999998743222
Q ss_pred CCCCccchHHHHHHHHHHHhCCCCCCCCCCChHHHHHHHhcCCCC-CCCCCCCCchHHHHHHHHHhhhcCCCCCCCHHHH
Q psy1840 105 RGTQKGDVYSFGLVLYEVIGRQGPWGHLRMTDEEIITSVTQGSGL-RPDTSSLDCAPSIIACMRTCWEEDPELRPDLRFV 183 (423)
Q Consensus 105 ~~s~ksDVyS~Giil~elltg~~Pf~~~~~~~~~i~~~i~~~~~~-~p~~~~~~~~~~l~~Li~~C~~~dP~~RPt~~~I 183 (423)
.++.++||||||+++|+|++|+.||.... ....+...+..+... ........+++.+.+++.+||+.||++|||+.++
T Consensus 201 ~~~~~~Di~slG~il~el~~g~~p~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~el 279 (289)
T 3og7_A 201 PYSFQSDVYAFGIVLYELMTGQLPYSNIN-NRDQIIEMVGRGSLSPDLSKVRSNCPKRMKRLMAECLKKKRDERPSFPRI 279 (289)
T ss_dssp CSCHHHHHHHHHHHHHHHHHSSCTTSSCC-CHHHHHHHHHHTSCCCCTTSSCTTSCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred CCCcccchHHHHHHHHHHHHCCCCccccc-hHHHHHHHhcccccCcchhhccccCCHHHHHHHHHHccCChhhCCCHHHH
Confidence 34889999999999999999999997532 344555555543322 1122234688999999999999999999999999
Q ss_pred HHHHHHHh
Q psy1840 184 HHKLKEMN 191 (423)
Q Consensus 184 ~~~L~~i~ 191 (423)
++.|+++.
T Consensus 280 l~~L~~l~ 287 (289)
T 3og7_A 280 LAEIEELA 287 (289)
T ss_dssp HHHHHHTT
T ss_pred HHHHHHHh
Confidence 99998775
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=2e-28 Score=238.64 Aligned_cols=159 Identities=23% Similarity=0.410 Sum_probs=128.4
Q ss_pred HHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCccEEEeccCCcccccCCCcccccccccCCccccCCccccCCCCC
Q psy1840 25 SISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKAPELLRQPHLP 104 (423)
Q Consensus 25 ~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~ 104 (423)
.+.++.||+.||.|||+.|++ ||||||+||+++.++.+||+|||+++...............++..|+|||.+.+..+
T Consensus 117 ~~~~~~qi~~~l~~lH~~~iv-H~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~- 194 (325)
T 3kex_A 117 LLNWGVQIAKGMYYLEEHGMV-HRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESIHFGKY- 194 (325)
T ss_dssp HHHHHHHHHHHHHHHHHTTCC-CSCCSSTTEEESSSSCEEECSCSGGGGSCCCTTCCC-----CCTTTSCHHHHHHCCC-
T ss_pred HHHHHHHHHHHHHHHHhCCCC-CCccchheEEECCCCeEEECCCCcccccCcccccccccCCCCcccccChHHhccCCC-
Confidence 689999999999999999998 999999999999999999999999987654433333344567778999999987655
Q ss_pred CCCCccchHHHHHHHHHHHh-CCCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCchHHHHHHHHHhhhcCCCCCCCHHHH
Q psy1840 105 RGTQKGDVYSFGLVLYEVIG-RQGPWGHLRMTDEEIITSVTQGSGLRPDTSSLDCAPSIIACMRTCWEEDPELRPDLRFV 183 (423)
Q Consensus 105 ~~s~ksDVyS~Giil~ellt-g~~Pf~~~~~~~~~i~~~i~~~~~~~p~~~~~~~~~~l~~Li~~C~~~dP~~RPt~~~I 183 (423)
+.++|||||||++|||++ |..||... ...++...+..+..... ...++.++.+++.+||+.||.+||++.++
T Consensus 195 --~~~~Di~slG~~l~el~~~g~~p~~~~--~~~~~~~~~~~~~~~~~---~~~~~~~~~~li~~~l~~dp~~Rps~~el 267 (325)
T 3kex_A 195 --THQSDVWSYGVTVWELMTFGAEPYAGL--RLAEVPDLLEKGERLAQ---PQICTIDVYMVMVKCWMIDENIRPTFKEL 267 (325)
T ss_dssp --CHHHHHHHHHHHHHHHHTTSCCTTTTS--CTTHHHHHHHTTCBCCC---CTTBCTTTTHHHHHHTCSCTTTSCCHHHH
T ss_pred --ChhhHhHHhHHHHHHHHhCCCCCcccc--CHHHHHHHHHcCCCCCC---CCcCcHHHHHHHHHHcCCChhhCcCHHHH
Confidence 899999999999999999 99999754 33455566655432221 23477889999999999999999999999
Q ss_pred HHHHHHHhh
Q psy1840 184 HHKLKEMNA 192 (423)
Q Consensus 184 ~~~L~~i~~ 192 (423)
++.|+.+..
T Consensus 268 ~~~l~~~~~ 276 (325)
T 3kex_A 268 ANEFTRMAR 276 (325)
T ss_dssp HHHHHHHTT
T ss_pred HHHHHHHHh
Confidence 999988754
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=99.95 E-value=1.3e-28 Score=240.19 Aligned_cols=159 Identities=22% Similarity=0.403 Sum_probs=128.1
Q ss_pred HHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCccEEEeccCCcccccCCCcccccccccCCccccCCccccCCCCC
Q psy1840 25 SISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKAPELLRQPHLP 104 (423)
Q Consensus 25 ~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~ 104 (423)
.+.++.||+.||.|||+.|++ ||||||+||+++.++.+||+|||+++...............++..|+|||.+.+..+
T Consensus 119 ~~~~~~qi~~~l~~LH~~~iv-H~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~- 196 (327)
T 3poz_A 119 LLNWCVQIAKGMNYLEDRRLV-HRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIY- 196 (327)
T ss_dssp HHHHHHHHHHHHHHHHHTTCC-CSCCCGGGEEEEETTEEEECCTTHHHHHTTTCC-------CCCGGGSCHHHHHHCCC-
T ss_pred HHHHHHHHHHHHHHHhhCCee-CCCCChheEEECCCCCEEEccCcceeEccCCcccccccCCCccccccChHHhccCCC-
Confidence 689999999999999999998 999999999999999999999999886644333333334456778999999987655
Q ss_pred CCCCccchHHHHHHHHHHHh-CCCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCchHHHHHHHHHhhhcCCCCCCCHHHH
Q psy1840 105 RGTQKGDVYSFGLVLYEVIG-RQGPWGHLRMTDEEIITSVTQGSGLRPDTSSLDCAPSIIACMRTCWEEDPELRPDLRFV 183 (423)
Q Consensus 105 ~~s~ksDVyS~Giil~ellt-g~~Pf~~~~~~~~~i~~~i~~~~~~~p~~~~~~~~~~l~~Li~~C~~~dP~~RPt~~~I 183 (423)
+.++|||||||++|||++ |..||... ...++...+..+.... ....++..+.+++.+||+.||++||++.++
T Consensus 197 --~~~~Di~slG~il~ellt~g~~p~~~~--~~~~~~~~~~~~~~~~---~~~~~~~~~~~li~~~l~~~p~~Rps~~el 269 (327)
T 3poz_A 197 --THQSDVWSYGVTVWELMTFGSKPYDGI--PASEISSILEKGERLP---QPPICTIDVYMIMVKCWMIDADSRPKFREL 269 (327)
T ss_dssp --CHHHHHHHHHHHHHHHHTTSCCTTTTC--CGGGHHHHHHTTCCCC---CCTTBCHHHHHHHHHHTCSCGGGSCCHHHH
T ss_pred --CchhhhhhhHHHHHHHHhcCCCCccCC--CHHHHHHHHHcCCCCC---CCccCCHHHHHHHHHHcCCChhhCCCHHHH
Confidence 899999999999999999 99999743 3445555555543221 123578999999999999999999999999
Q ss_pred HHHHHHHhh
Q psy1840 184 HHKLKEMNA 192 (423)
Q Consensus 184 ~~~L~~i~~ 192 (423)
++.|+.+..
T Consensus 270 l~~l~~~~~ 278 (327)
T 3poz_A 270 IIEFSKMAR 278 (327)
T ss_dssp HHHHHHHHT
T ss_pred HHHHHHHHh
Confidence 999988764
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=2.1e-28 Score=234.50 Aligned_cols=168 Identities=13% Similarity=0.224 Sum_probs=130.9
Q ss_pred HHHHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCcc-----EEEeccCCcccccCCCcc-----cccccccCCccc
Q psy1840 23 IGSISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWV-----LQIADFGLHAFKAGQDET-----GQERKLRRRKLY 92 (423)
Q Consensus 23 ~~~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~~-----vKL~DFGla~~~~~~~~~-----~~~~~~~gt~~y 92 (423)
.....++.||+.||.|||++|++ ||||||+||+++.++. +||+|||++......... .......||+.|
T Consensus 106 ~~~~~i~~qi~~~l~~lH~~~iv-H~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y 184 (298)
T 1csn_A 106 KTVAMAAKQMLARVQSIHEKSLV-YRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARY 184 (298)
T ss_dssp HHHHHHHHHHHHHHHHHHTTTEE-CCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTT
T ss_pred HHHHHHHHHHHHHHHHHHhCCEe-cCCCCHHHEEeccCCCCCCCeEEEEECccccccccccccccccccCccCCCCCccc
Confidence 33789999999999999999988 9999999999987766 999999998865433221 122455789999
Q ss_pred cCCccccCCCCCCCCCccchHHHHHHHHHHHhCCCCCCCCC-CChHHHHHHHhcCCCCCC-CCCCCCchHHHHHHHHHhh
Q psy1840 93 KAPELLRQPHLPRGTQKGDVYSFGLVLYEVIGRQGPWGHLR-MTDEEIITSVTQGSGLRP-DTSSLDCAPSIIACMRTCW 170 (423)
Q Consensus 93 ~APE~l~~~~~~~~s~ksDVyS~Giil~elltg~~Pf~~~~-~~~~~i~~~i~~~~~~~p-~~~~~~~~~~l~~Li~~C~ 170 (423)
+|||.+.+..+ +.++||||||+++|||++|+.||.... ....+....+.......+ ......+++++.+++.+||
T Consensus 185 ~aPE~~~~~~~---~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l 261 (298)
T 1csn_A 185 MSINTHLGREQ---SRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLRELCAGFPEEFYKYMHYAR 261 (298)
T ss_dssp CCHHHHTTCCC---CHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHSCHHHHTTTSCHHHHHHHHHHH
T ss_pred CCchhhcCCCC---ChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhhccCccHHHHHhhCcHHHHHHHHHHh
Confidence 99999987655 899999999999999999999997643 233444444432211111 1112357899999999999
Q ss_pred hcCCCCCCCHHHHHHHHHHHhhhc
Q psy1840 171 EEDPELRPDLRFVHHKLKEMNAGL 194 (423)
Q Consensus 171 ~~dP~~RPt~~~I~~~L~~i~~~~ 194 (423)
+.||++||++.+|.+.|+.+....
T Consensus 262 ~~dp~~RP~~~~l~~~l~~~~~~~ 285 (298)
T 1csn_A 262 NLAFDATPDYDYLQGLFSKVLERL 285 (298)
T ss_dssp HCCTTCCCCHHHHHHHHHHHHHHT
T ss_pred cCCcccCCCHHHHHHHHHHHHHhc
Confidence 999999999999999998886643
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=1.2e-28 Score=245.62 Aligned_cols=161 Identities=25% Similarity=0.466 Sum_probs=129.7
Q ss_pred HHHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCccEEEeccCCcccccCCCcccccccccCCccccCCccccCCCC
Q psy1840 24 GSISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKAPELLRQPHL 103 (423)
Q Consensus 24 ~~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~ 103 (423)
..+.++.||+.||+|||++|++ ||||||+|||++.++.+||+|||+++...............++..|+|||.+.+..+
T Consensus 214 ~~~~~~~qi~~~l~~LH~~~iv-HrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~ 292 (377)
T 3cbl_A 214 TLLQMVGDAAAGMEYLESKCCI-HRDLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQVPVKWTAPEALNYGRY 292 (377)
T ss_dssp HHHHHHHHHHHHHHHHHHTTEE-CSCCSGGGEEECTTCCEEECCGGGCEECTTSEEECCSSCCEEEGGGSCHHHHHHCEE
T ss_pred HHHHHHHHHHHHHHHHHHCCcC-CcccCHHHEEEcCCCcEEECcCCCceecCCCceeecCCCCCCCcCcCCHhHhccCCC
Confidence 3679999999999999999988 999999999999999999999999875432221111122234567999999987655
Q ss_pred CCCCCccchHHHHHHHHHHHh-CCCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCchHHHHHHHHHhhhcCCCCCCCHHH
Q psy1840 104 PRGTQKGDVYSFGLVLYEVIG-RQGPWGHLRMTDEEIITSVTQGSGLRPDTSSLDCAPSIIACMRTCWEEDPELRPDLRF 182 (423)
Q Consensus 104 ~~~s~ksDVyS~Giil~ellt-g~~Pf~~~~~~~~~i~~~i~~~~~~~p~~~~~~~~~~l~~Li~~C~~~dP~~RPt~~~ 182 (423)
+.++|||||||++|||++ |..||.. ....++...+..+.... . +..+++++.++|.+||+.||++|||+.+
T Consensus 293 ---~~~~DvwslG~il~el~t~g~~p~~~--~~~~~~~~~~~~~~~~~--~-~~~~~~~l~~li~~cl~~dP~~Rps~~~ 364 (377)
T 3cbl_A 293 ---SSESDVWSFGILLWETFSLGASPYPN--LSNQQTREFVEKGGRLP--C-PELCPDAVFRLMEQCWAYEPGQRPSFST 364 (377)
T ss_dssp ---EHHHHHHHHHHHHHHHHTTSCCSSTT--SCHHHHHHHHHTTCCCC--C-CTTCCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred ---CchhhHHHHHHHHHHHHhCCCCCCCC--CCHHHHHHHHHcCCCCC--C-CCCCCHHHHHHHHHHcCCCchhCcCHHH
Confidence 899999999999999998 9999974 45566666666553221 1 2358899999999999999999999999
Q ss_pred HHHHHHHHhhh
Q psy1840 183 VHHKLKEMNAG 193 (423)
Q Consensus 183 I~~~L~~i~~~ 193 (423)
|++.|+.+...
T Consensus 365 i~~~L~~i~~~ 375 (377)
T 3cbl_A 365 IYQELQSIRKR 375 (377)
T ss_dssp HHHHHHHHHHH
T ss_pred HHHHHHHHHhh
Confidence 99999988653
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=7.2e-28 Score=233.45 Aligned_cols=159 Identities=30% Similarity=0.574 Sum_probs=121.8
Q ss_pred HHHHHHHHHHHHHHHHhCC--CeeecCCCCCCEEEcCCccEEEeccCCcccccCCCcccccccccCCccccCCccccCCC
Q psy1840 25 SISVNTTASVGMIHLHDSE--IISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKAPELLRQPH 102 (423)
Q Consensus 25 ~l~i~~qi~~gL~yLH~~~--ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~ 102 (423)
.+.++.||+.||.|||+.| ++ ||||||+||+++.++.+||+|||+++...... .......||+.|+|||.+.+..
T Consensus 139 ~~~i~~qi~~aL~~LH~~~~~iv-H~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~ 215 (309)
T 3p86_A 139 RLSMAYDVAKGMNYLHNRNPPIV-HRNLKSPNLLVDKKYTVKVCDFGLSRLKASTF--LSSKSAAGTPEWMAPEVLRDEP 215 (309)
T ss_dssp HHHHHHHHHHHHHHHHTSSSCCC-CTTCCGGGEEECTTCCEEECCCC-------------------CCTTSCHHHHTTCC
T ss_pred HHHHHHHHHHHHHHHHcCCCCEE-CCCCChhhEEEeCCCcEEECCCCCCccccccc--cccccCCCCccccChhhhcCCC
Confidence 6789999999999999999 88 99999999999999999999999987543221 1223457899999999998765
Q ss_pred CCCCCCccchHHHHHHHHHHHhCCCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCchHHHHHHHHHhhhcCCCCCCCHHH
Q psy1840 103 LPRGTQKGDVYSFGLVLYEVIGRQGPWGHLRMTDEEIITSVTQGSGLRPDTSSLDCAPSIIACMRTCWEEDPELRPDLRF 182 (423)
Q Consensus 103 ~~~~s~ksDVyS~Giil~elltg~~Pf~~~~~~~~~i~~~i~~~~~~~p~~~~~~~~~~l~~Li~~C~~~dP~~RPt~~~ 182 (423)
+ +.++|||||||++|||++|+.||.. ....+....+..... .+. .+..+++.+.+++.+||+.||.+|||+.+
T Consensus 216 ~---~~~~DiwslG~il~elltg~~Pf~~--~~~~~~~~~~~~~~~-~~~-~~~~~~~~l~~li~~~l~~dP~~Rps~~~ 288 (309)
T 3p86_A 216 S---NEKSDVYSFGVILWELATLQQPWGN--LNPAQVVAAVGFKCK-RLE-IPRNLNPQVAAIIEGCWTNEPWKRPSFAT 288 (309)
T ss_dssp C---CTTHHHHHHHHHHHHHHHCCCTTTT--SCHHHHHHHHHHSCC-CCC-CCTTSCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred C---CchhhHHHHHHHHHHHHhCCCCCCC--CCHHHHHHHHHhcCC-CCC-CCccCCHHHHHHHHHHccCChhhCcCHHH
Confidence 5 8999999999999999999999974 445566655543221 111 22468899999999999999999999999
Q ss_pred HHHHHHHHhhh
Q psy1840 183 VHHKLKEMNAG 193 (423)
Q Consensus 183 I~~~L~~i~~~ 193 (423)
|++.|+.+...
T Consensus 289 ll~~L~~~~~~ 299 (309)
T 3p86_A 289 IMDLLRPLIKS 299 (309)
T ss_dssp HHHHHHHHHC-
T ss_pred HHHHHHHHHHh
Confidence 99999888654
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=99.95 E-value=2.3e-28 Score=256.89 Aligned_cols=150 Identities=19% Similarity=0.268 Sum_probs=122.5
Q ss_pred HHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCccEEEeccCCcccccCCCcccccccccCCccccCCccccCCCCC
Q psy1840 25 SISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKAPELLRQPHLP 104 (423)
Q Consensus 25 ~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~ 104 (423)
...++.||+.||+|||++||| ||||||+||||+.+|.+||+|||+|+..... ...+.+||+.|||||++..+.
T Consensus 294 a~~y~~qIl~aL~yLH~~gIi-HRDLKPeNILld~~G~vKL~DFGlA~~~~~~----~~~t~~GTp~YmAPEvl~~~~-- 366 (689)
T 3v5w_A 294 MRFYAAEIILGLEHMHNRFVV-YRDLKPANILLDEHGHVRISDLGLACDFSKK----KPHASVGTHGYMAPEVLQKGV-- 366 (689)
T ss_dssp HHHHHHHHHHHHHHHHTTTEE-CCCCSGGGEEECTTSCEEECCCTTCEECSSC----CCCSCCSCGGGCCHHHHSTTC--
T ss_pred HHHHHHHHHHHHHHHHHCCcc-ccCCchHHeEEeCCCCEEecccceeeecCCC----CCCCccCCcCccCHHHHhCCC--
Confidence 467899999999999999998 9999999999999999999999999865432 224578999999999996532
Q ss_pred CCCCccchHHHHHHHHHHHhCCCCCCCCC-CChHHHHHHHhcCCCCCCCCCCCCchHHHHHHHHHhhhcCCCCCCC----
Q psy1840 105 RGTQKGDVYSFGLVLYEVIGRQGPWGHLR-MTDEEIITSVTQGSGLRPDTSSLDCAPSIIACMRTCWEEDPELRPD---- 179 (423)
Q Consensus 105 ~~s~ksDVyS~Giil~elltg~~Pf~~~~-~~~~~i~~~i~~~~~~~p~~~~~~~~~~l~~Li~~C~~~dP~~RPt---- 179 (423)
.++.++|+||+||++|||++|..||.+.. ....++...+.......| ..+++++.+||.+||+.||.+|++
T Consensus 367 ~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~~~i~~~~~~~p----~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ 442 (689)
T 3v5w_A 367 AYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELP----DSFSPELRSLLEGLLQRDVNRRLGCLGR 442 (689)
T ss_dssp CCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHHHHHHHCCCCCC----TTSCHHHHHHHHHHTCSCGGGCTTCSSS
T ss_pred CCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCCCCC----ccCCHHHHHHHHHHccCCHhHCCCCCCC
Confidence 23899999999999999999999997532 234455666655443333 357899999999999999999998
Q ss_pred -HHHHHH
Q psy1840 180 -LRFVHH 185 (423)
Q Consensus 180 -~~~I~~ 185 (423)
+.+|++
T Consensus 443 ga~ei~~ 449 (689)
T 3v5w_A 443 GAQEVKE 449 (689)
T ss_dssp THHHHTT
T ss_pred CHHHHhc
Confidence 566654
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=9.5e-28 Score=239.35 Aligned_cols=162 Identities=27% Similarity=0.435 Sum_probs=134.8
Q ss_pred HHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCccEEEeccCCcccccCCCcccccccccCCccccCCccccCCCCC
Q psy1840 25 SISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKAPELLRQPHLP 104 (423)
Q Consensus 25 ~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~ 104 (423)
.+.++.||+.||.|||+.|++ ||||||+||+++.++.+||+|||+++...............+++.|+|||++.+..+
T Consensus 193 ~~~i~~qi~~aL~~LH~~~iv-H~Dlkp~NIll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~- 270 (382)
T 3tt0_A 193 LVSCAYQVARGMEYLASKKCI-HRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIY- 270 (382)
T ss_dssp HHHHHHHHHHHHHHHHHTTCC-CSCCCGGGEEECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCC-
T ss_pred HHHHHHHHHHHHHHHHhCCEe-cCCCCcceEEEcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCC-
Confidence 689999999999999999998 999999999999999999999999886544333233344566788999999987655
Q ss_pred CCCCccchHHHHHHHHHHHh-CCCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCchHHHHHHHHHhhhcCCCCCCCHHHH
Q psy1840 105 RGTQKGDVYSFGLVLYEVIG-RQGPWGHLRMTDEEIITSVTQGSGLRPDTSSLDCAPSIIACMRTCWEEDPELRPDLRFV 183 (423)
Q Consensus 105 ~~s~ksDVyS~Giil~ellt-g~~Pf~~~~~~~~~i~~~i~~~~~~~p~~~~~~~~~~l~~Li~~C~~~dP~~RPt~~~I 183 (423)
+.++|||||||++|||++ |..||.. ....++...+..+..... ...+++++.+++.+||+.||++|||+.+|
T Consensus 271 --~~~~DiwslG~il~ellt~g~~p~~~--~~~~~~~~~~~~~~~~~~---~~~~~~~l~~li~~~l~~dP~~Rps~~el 343 (382)
T 3tt0_A 271 --THQSDVWSFGVLLWEIFTLGGSPYPG--VPVEELFKLLKEGHRMDK---PSNCTNELYMMMRDCWHAVPSQRPTFKQL 343 (382)
T ss_dssp --CHHHHHHHHHHHHHHHHTTSCCSSTT--CCHHHHHHHHHTTCCCCC---CSSCCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred --CchhHHHHHHHHHHHHHhCCCCCCCC--CCHHHHHHHHHcCCCCCC---CccCCHHHHHHHHHHcCCChhhCcCHHHH
Confidence 899999999999999999 9999974 456677777766533222 24688999999999999999999999999
Q ss_pred HHHHHHHhhhcC
Q psy1840 184 HHKLKEMNAGLK 195 (423)
Q Consensus 184 ~~~L~~i~~~~~ 195 (423)
++.|+.+.....
T Consensus 344 l~~L~~~~~~~~ 355 (382)
T 3tt0_A 344 VEDLDRIVALTS 355 (382)
T ss_dssp HHHHHHHHHHSC
T ss_pred HHHHHHHHHHHh
Confidence 999998876543
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.95 E-value=2.8e-28 Score=238.47 Aligned_cols=163 Identities=27% Similarity=0.480 Sum_probs=131.4
Q ss_pred HHHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCccEEEeccCCcccccCCCcccccccccCCccccCCccccCCCC
Q psy1840 24 GSISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKAPELLRQPHL 103 (423)
Q Consensus 24 ~~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~ 103 (423)
..+.++.||+.||.|||++|++ ||||||+||+++.++.+||+|||++................+++.|+|||.+.+..+
T Consensus 175 ~~~~i~~qi~~~l~~LH~~~iv-H~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~ 253 (343)
T 1luf_A 175 EQLCIARQVAAGMAYLSERKFV-HRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRY 253 (343)
T ss_dssp HHHHHHHHHHHHHHHHHHTTCC-CSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCC
T ss_pred HHHHHHHHHHHHHHHHHhCCee-cCCCCcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCc
Confidence 3688999999999999999998 999999999999999999999999876533222222234567888999999987654
Q ss_pred CCCCCccchHHHHHHHHHHHh-CCCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCchHHHHHHHHHhhhcCCCCCCCHHH
Q psy1840 104 PRGTQKGDVYSFGLVLYEVIG-RQGPWGHLRMTDEEIITSVTQGSGLRPDTSSLDCAPSIIACMRTCWEEDPELRPDLRF 182 (423)
Q Consensus 104 ~~~s~ksDVyS~Giil~ellt-g~~Pf~~~~~~~~~i~~~i~~~~~~~p~~~~~~~~~~l~~Li~~C~~~dP~~RPt~~~ 182 (423)
+.++||||||+++|||++ |..||.. ....++...+..+.... .+..++..+.+++.+||+.||++||++.+
T Consensus 254 ---~~~~Di~slG~il~el~t~g~~p~~~--~~~~~~~~~~~~~~~~~---~~~~~~~~l~~li~~~l~~~p~~Rps~~~ 325 (343)
T 1luf_A 254 ---TTESDVWAYGVVLWEIFSYGLQPYYG--MAHEEVIYYVRDGNILA---CPENCPLELYNLMRLCWSKLPADRPSFCS 325 (343)
T ss_dssp ---CHHHHHHHHHHHHHHHHTTTCCTTTT--SCHHHHHHHHHTTCCCC---CCTTCCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred ---CcccccHHHHHHHHHHHhcCCCcCCC--CChHHHHHHHhCCCcCC---CCCCCCHHHHHHHHHHcccCcccCCCHHH
Confidence 899999999999999999 9999974 45667777777654322 22368899999999999999999999999
Q ss_pred HHHHHHHHhhhcC
Q psy1840 183 VHHKLKEMNAGLK 195 (423)
Q Consensus 183 I~~~L~~i~~~~~ 195 (423)
|++.|+.+.....
T Consensus 326 ~~~~L~~~~~~~~ 338 (343)
T 1luf_A 326 IHRILQRMCERAE 338 (343)
T ss_dssp HHHHHHHTTC---
T ss_pred HHHHHHHHHhhhh
Confidence 9999998876543
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=99.95 E-value=1e-28 Score=246.62 Aligned_cols=159 Identities=17% Similarity=0.239 Sum_probs=118.8
Q ss_pred HHHHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCccEEEeccCCcccccCCCc-------------------cccc
Q psy1840 23 IGSISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDE-------------------TGQE 83 (423)
Q Consensus 23 ~~~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~-------------------~~~~ 83 (423)
.....++.||+.||.|||+.|++ ||||||+|||++.++.+||+|||+++....... ....
T Consensus 109 ~~~~~i~~qi~~~L~~LH~~~iv-HrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 187 (388)
T 3oz6_A 109 VHKQYVVYQLIKVIKYLHSGGLL-HRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQPIL 187 (388)
T ss_dssp HHHHHHHHHHHHHHHHHHHTTEE-CCCCCGGGEEECTTCCEEECCCTTCEESSSCCCCCCCGGGCCC-------------
T ss_pred HHHHHHHHHHHHHHHHHHhCCEE-eCCCCHHHeEEcCCCCEEecCCcccccccccccccccccccccccccccccccccc
Confidence 34678999999999999999988 999999999999999999999999876432110 1112
Q ss_pred ccccCCccccCCccccCCCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCChHHHHHHHhcCCCCCC------------
Q psy1840 84 RKLRRRKLYKAPELLRQPHLPRGTQKGDVYSFGLVLYEVIGRQGPWGHLRMTDEEIITSVTQGSGLRP------------ 151 (423)
Q Consensus 84 ~~~~gt~~y~APE~l~~~~~~~~s~ksDVyS~Giil~elltg~~Pf~~~~~~~~~i~~~i~~~~~~~p------------ 151 (423)
....||+.|+|||++.+.. .++.++|||||||++|||++|+.||.+. +..+.+..+.......+
T Consensus 188 ~~~~gt~~y~aPE~~~~~~--~~~~~~DiwSlG~il~ell~g~~pf~~~--~~~~~~~~i~~~~~~p~~~~~~~~~~~~~ 263 (388)
T 3oz6_A 188 TDYVATRWYRAPEILLGST--KYTKGIDMWSLGCILGEILCGKPIFPGS--STMNQLERIIGVIDFPSNEDVESIQSPFA 263 (388)
T ss_dssp --CCCGGGGCCHHHHTTCC--CCCTHHHHHHHHHHHHHHHHSSCSCCCS--SHHHHHHHHHHHHCCCCHHHHHTSCCSSH
T ss_pred cCCcccCCcCCHHHhcCCC--CCCChhhHHHHHHHHHHHHhCCCCCCCC--CHHHHHHHHHHhcCCCCHHHHHhccCHHH
Confidence 3457899999999997632 3489999999999999999999999753 33333333321100000
Q ss_pred ---------------C----------------CCCCCchHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q psy1840 152 ---------------D----------------TSSLDCAPSIIACMRTCWEEDPELRPDLRFVHHK 186 (423)
Q Consensus 152 ---------------~----------------~~~~~~~~~l~~Li~~C~~~dP~~RPt~~~I~~~ 186 (423)
. .....+++++.+|+.+||+.||++|||+.++++.
T Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~dP~~R~t~~e~l~H 329 (388)
T 3oz6_A 264 KTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNPNKRISANDALKH 329 (388)
T ss_dssp HHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCSSGGGSCCHHHHTTS
T ss_pred HHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhccCcccCCCHHHHhCC
Confidence 0 0112568899999999999999999999998764
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=4.9e-28 Score=233.62 Aligned_cols=161 Identities=25% Similarity=0.433 Sum_probs=131.7
Q ss_pred HHHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCccEEEeccCCcccccCCCcccccccccCCccccCCccccCCCC
Q psy1840 24 GSISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKAPELLRQPHL 103 (423)
Q Consensus 24 ~~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~ 103 (423)
..+.++.||+.||.|||++|++ ||||||+||+++.++.+||+|||++................+++.|+|||.+.+..+
T Consensus 151 ~~~~i~~qi~~~l~~lH~~~iv-H~dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~ 229 (314)
T 2ivs_A 151 DLISFAWQISQGMQYLAEMKLV-HRDLAARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIY 229 (314)
T ss_dssp HHHHHHHHHHHHHHHHHHTTEE-CCCCSGGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEE
T ss_pred HHHHHHHHHHHHHHHHHHCCCc-ccccchheEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCc
Confidence 3689999999999999999988 999999999999999999999999876544333223334556788999999987655
Q ss_pred CCCCCccchHHHHHHHHHHHh-CCCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCchHHHHHHHHHhhhcCCCCCCCHHH
Q psy1840 104 PRGTQKGDVYSFGLVLYEVIG-RQGPWGHLRMTDEEIITSVTQGSGLRPDTSSLDCAPSIIACMRTCWEEDPELRPDLRF 182 (423)
Q Consensus 104 ~~~s~ksDVyS~Giil~ellt-g~~Pf~~~~~~~~~i~~~i~~~~~~~p~~~~~~~~~~l~~Li~~C~~~dP~~RPt~~~ 182 (423)
+.++||||||+++|||++ |..||... ...++...+..+... . ....+++.+.+++.+||+.||++||++.+
T Consensus 230 ---~~~~Di~slG~il~el~t~g~~p~~~~--~~~~~~~~~~~~~~~--~-~~~~~~~~~~~li~~~l~~dp~~Rps~~~ 301 (314)
T 2ivs_A 230 ---TTQSDVWSFGVLLWEIVTLGGNPYPGI--PPERLFNLLKTGHRM--E-RPDNCSEEMYRLMLQCWKQEPDKRPVFAD 301 (314)
T ss_dssp ---CHHHHHHHHHHHHHHHHTTSCCSSTTC--CGGGHHHHHHTTCCC--C-CCTTCCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred ---CchhhHHHHHHHHHHHHhCCCCCCCCC--CHHHHHHHhhcCCcC--C-CCccCCHHHHHHHHHHccCChhhCcCHHH
Confidence 899999999999999999 99999743 345566666554322 1 22467899999999999999999999999
Q ss_pred HHHHHHHHhhh
Q psy1840 183 VHHKLKEMNAG 193 (423)
Q Consensus 183 I~~~L~~i~~~ 193 (423)
+++.|+.+...
T Consensus 302 l~~~l~~~~~~ 312 (314)
T 2ivs_A 302 ISKDLEKMMVK 312 (314)
T ss_dssp HHHHHHHHHHT
T ss_pred HHHHHHHHHhh
Confidence 99999887654
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.95 E-value=5.4e-28 Score=234.82 Aligned_cols=161 Identities=25% Similarity=0.455 Sum_probs=123.4
Q ss_pred HHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCccEEEeccCCcccccCCCcccccccccCCccccCCccccCCCCC
Q psy1840 25 SISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKAPELLRQPHLP 104 (423)
Q Consensus 25 ~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~ 104 (423)
...++.||+.||.|||+.|++ ||||||+||+++.++.+||+|||++................+++.|+|||.+.+..+
T Consensus 139 ~~~i~~qi~~al~~LH~~~iv-H~Dikp~NIli~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~- 216 (323)
T 3qup_A 139 LVRFMVDIACGMEYLSSRNFI-HRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLY- 216 (323)
T ss_dssp HHHHHHHHHHHHHHHHHTTCC-CSCCSGGGEEECTTSCEEECCCCC-----------------CCGGGCCHHHHHHCCC-
T ss_pred HHHHHHHHHHHHHHHHcCCcc-cCCCCcceEEEcCCCCEEEeeccccccccccccccccccccCcccccCchhhcCCCC-
Confidence 679999999999999999998 999999999999999999999999876543332222234456778999999987655
Q ss_pred CCCCccchHHHHHHHHHHHh-CCCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCchHHHHHHHHHhhhcCCCCCCCHHHH
Q psy1840 105 RGTQKGDVYSFGLVLYEVIG-RQGPWGHLRMTDEEIITSVTQGSGLRPDTSSLDCAPSIIACMRTCWEEDPELRPDLRFV 183 (423)
Q Consensus 105 ~~s~ksDVyS~Giil~ellt-g~~Pf~~~~~~~~~i~~~i~~~~~~~p~~~~~~~~~~l~~Li~~C~~~dP~~RPt~~~I 183 (423)
+.++|||||||++|||++ |..||.. ....++...+..+.... ....+++++.+++.+||+.||++|||+.++
T Consensus 217 --~~~~Di~slG~il~ell~~g~~p~~~--~~~~~~~~~~~~~~~~~---~~~~~~~~l~~li~~~l~~dp~~Rps~~~l 289 (323)
T 3qup_A 217 --TVHSDVWAFGVTMWEIMTRGQTPYAG--IENAEIYNYLIGGNRLK---QPPECMEEVYDLMYQCWSADPKQRPSFTCL 289 (323)
T ss_dssp --CHHHHHHHHHHHHHHHHTTSCCTTTT--CCGGGHHHHHHTTCCCC---CCTTCCHHHHHHHHHTTCSSGGGSCCHHHH
T ss_pred --CCccchhhHHHHHHHHHhCCCCCccc--cChHHHHHHHhcCCCCC---CCCccCHHHHHHHHHHccCChhhCcCHHHH
Confidence 899999999999999999 8999974 33455566665543221 123678999999999999999999999999
Q ss_pred HHHHHHHhhhc
Q psy1840 184 HHKLKEMNAGL 194 (423)
Q Consensus 184 ~~~L~~i~~~~ 194 (423)
++.|+++....
T Consensus 290 ~~~l~~~l~~~ 300 (323)
T 3qup_A 290 RMELENILGHL 300 (323)
T ss_dssp HHHHHHHHHC-
T ss_pred HHHHHHHHHHh
Confidence 99999887643
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=2.8e-28 Score=237.41 Aligned_cols=167 Identities=24% Similarity=0.343 Sum_probs=128.8
Q ss_pred HHHHHHHHHHHHHHHHhC----------CCeeecCCCCCCEEEcCCccEEEeccCCcccccCCCcccccccccCCccccC
Q psy1840 25 SISVNTTASVGMIHLHDS----------EIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKA 94 (423)
Q Consensus 25 ~l~i~~qi~~gL~yLH~~----------~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~y~A 94 (423)
...++.|++.||.|||+. |++ ||||||+||+++.++.+||+|||+++...............||+.|+|
T Consensus 123 ~~~i~~qi~~al~~LH~~~~~l~~~~~~~iv-H~Dlkp~Nill~~~~~~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~a 201 (322)
T 3soc_A 123 LCHIAETMARGLAYLHEDIPGLKDGHKPAIS-HRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGDTHGQVGTRRYMA 201 (322)
T ss_dssp HHHHHHHHHHHHHHHTCCEEEETTEEECEEE-CSCCSGGGEEECTTCCEEECCCTTCEEECTTSCCCCCTTCCCCGGGCC
T ss_pred HHHHHHHHHHHHHHHHhhccccccccCCCEE-eCCCChHhEEECCCCeEEEccCCcccccccccCccccccCccCccccC
Confidence 689999999999999999 988 999999999999999999999999976654433333345678999999
Q ss_pred CccccCCCC--CCCCCccchHHHHHHHHHHHhCCCCCCCCCC--------------ChHHHHHHHhcCCCCCCCCC----
Q psy1840 95 PELLRQPHL--PRGTQKGDVYSFGLVLYEVIGRQGPWGHLRM--------------TDEEIITSVTQGSGLRPDTS---- 154 (423)
Q Consensus 95 PE~l~~~~~--~~~s~ksDVyS~Giil~elltg~~Pf~~~~~--------------~~~~i~~~i~~~~~~~p~~~---- 154 (423)
||++.+... ...+.++|||||||++|||++|+.||..... ....+...+... ..+|...
T Consensus 202 PE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~ 280 (322)
T 3soc_A 202 PEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIGQHPSLEDMQEVVVHK-KKRPVLRDYWQ 280 (322)
T ss_dssp HHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHHHCSSCCHHHHHHHHTTS-CCCCCCCGGGG
T ss_pred HhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhhhccCCchhhhhhhhhcc-cCCCCcccccc
Confidence 999986321 1225688999999999999999999964311 223333333332 2223222
Q ss_pred CCCchHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHhhh
Q psy1840 155 SLDCAPSIIACMRTCWEEDPELRPDLRFVHHKLKEMNAG 193 (423)
Q Consensus 155 ~~~~~~~l~~Li~~C~~~dP~~RPt~~~I~~~L~~i~~~ 193 (423)
...+++++.+++.+||+.||++|||+.+|++.|+.+...
T Consensus 281 ~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l~~~ 319 (322)
T 3soc_A 281 KHAGMAMLCETIEECWDHDAEARLSAGCVGERITQMQRL 319 (322)
T ss_dssp SSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHH
Confidence 123466799999999999999999999999999988764
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=4.4e-28 Score=236.73 Aligned_cols=160 Identities=23% Similarity=0.415 Sum_probs=123.8
Q ss_pred HHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCccEEEeccCCcccccCCCcccccccccCCccccCCccccCCCCC
Q psy1840 25 SISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKAPELLRQPHLP 104 (423)
Q Consensus 25 ~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~ 104 (423)
.+.++.||+.||.|||+.|++ ||||||+||+++.++.+||+|||+++...............+++.|+|||.+.+..+
T Consensus 119 ~~~i~~qi~~aL~~LH~~~iv-H~Dikp~NIl~~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~- 196 (327)
T 3lzb_A 119 LLNWCVQIAKGMNYLEDRRLV-HRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIY- 196 (327)
T ss_dssp HHHHHHHHHHHHHHHHHTTCC-CSCCCGGGEEEEETTEEEECCTTC----------------CCCGGGSCHHHHHHCCC-
T ss_pred HHHHHHHHHHHHHHHhhCCCc-CCCCCHHHEEEcCCCCEEEccCcceeEccCccccccccCCCccccccCHHHHcCCCC-
Confidence 679999999999999999998 999999999999999999999999886543333322334456778999999987655
Q ss_pred CCCCccchHHHHHHHHHHHh-CCCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCchHHHHHHHHHhhhcCCCCCCCHHHH
Q psy1840 105 RGTQKGDVYSFGLVLYEVIG-RQGPWGHLRMTDEEIITSVTQGSGLRPDTSSLDCAPSIIACMRTCWEEDPELRPDLRFV 183 (423)
Q Consensus 105 ~~s~ksDVyS~Giil~ellt-g~~Pf~~~~~~~~~i~~~i~~~~~~~p~~~~~~~~~~l~~Li~~C~~~dP~~RPt~~~I 183 (423)
+.++|||||||++|||++ |..||... ...++...+..+.... ....++.++.+++.+||+.||.+||++.++
T Consensus 197 --~~~~Di~slG~il~ell~~g~~p~~~~--~~~~~~~~~~~~~~~~---~~~~~~~~l~~li~~~l~~dp~~Rps~~el 269 (327)
T 3lzb_A 197 --THQSDVWSYGVTVWELMTFGSKPYDGI--PASEISSILEKGERLP---QPPICTIDVYMIMRKCWMIDADSRPKFREL 269 (327)
T ss_dssp --CHHHHHHHHHHHHHHHHTTSCCTTTTC--CGGGHHHHHHTTCCCC---CCTTBCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred --ChHHHHHHHHHHHHHHHHCCCCCCCCC--CHHHHHHHHHcCCCCC---CCccCCHHHHHHHHHHcCCChhHCcCHHHH
Confidence 899999999999999999 99999753 3445555555543222 123578999999999999999999999999
Q ss_pred HHHHHHHhhh
Q psy1840 184 HHKLKEMNAG 193 (423)
Q Consensus 184 ~~~L~~i~~~ 193 (423)
++.|+.+...
T Consensus 270 l~~L~~~~~~ 279 (327)
T 3lzb_A 270 IIEFSKMARD 279 (327)
T ss_dssp HHHHHHHHTS
T ss_pred HHHHHHHHhC
Confidence 9999888653
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=7.1e-28 Score=237.23 Aligned_cols=162 Identities=25% Similarity=0.443 Sum_probs=130.7
Q ss_pred HHHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCccEEEeccCCcccccCCCcccccccccCCccccCCccccCCCC
Q psy1840 24 GSISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKAPELLRQPHL 103 (423)
Q Consensus 24 ~~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~ 103 (423)
..+.++.||+.||.|||+.|++ ||||||+||+++.++.+||+|||++................+|+.|+|||++.+..+
T Consensus 194 ~~~~~~~ql~~aL~~LH~~~iv-H~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~ 272 (359)
T 3vhe_A 194 HLICYSFQVAKGMEFLASRKCI-HRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVY 272 (359)
T ss_dssp HHHHHHHHHHHHHHHHHHTTCC-CSCCSGGGEEECGGGCEEECCCGGGSCTTSCTTCEEC--CEECGGGCCHHHHHHCCC
T ss_pred HHHHHHHHHHHHHHHHHHCCcc-cCCCChhhEEEcCCCcEEEEeccceeeecccccchhccccCCCceeEChhhhcCCCC
Confidence 3689999999999999999998 999999999999999999999999886544333333345567888999999987655
Q ss_pred CCCCCccchHHHHHHHHHHHh-CCCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCchHHHHHHHHHhhhcCCCCCCCHHH
Q psy1840 104 PRGTQKGDVYSFGLVLYEVIG-RQGPWGHLRMTDEEIITSVTQGSGLRPDTSSLDCAPSIIACMRTCWEEDPELRPDLRF 182 (423)
Q Consensus 104 ~~~s~ksDVyS~Giil~ellt-g~~Pf~~~~~~~~~i~~~i~~~~~~~p~~~~~~~~~~l~~Li~~C~~~dP~~RPt~~~ 182 (423)
+.++|||||||++|||++ |..||..... ...+...+..+.... .+..+++++.+++.+||+.||.+|||+.+
T Consensus 273 ---~~~~Di~slG~il~ellt~g~~p~~~~~~-~~~~~~~~~~~~~~~---~~~~~~~~l~~li~~~l~~dP~~Rps~~e 345 (359)
T 3vhe_A 273 ---TIQSDVWSFGVLLWEIFSLGASPYPGVKI-DEEFCRRLKEGTRMR---APDYTTPEMYQTMLDCWHGEPSQRPTFSE 345 (359)
T ss_dssp ---CHHHHHHHHHHHHHHHTTTSCCSSTTCCC-SHHHHHHHHHTCCCC---CCTTCCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred ---CchhhhhhHHHHHHHHHhcCCCCCCccch-hHHHHHHHHcCCCCC---CCCCCCHHHHHHHHHHccCChhhCCCHHH
Confidence 899999999999999998 9999976433 344445555443222 12357899999999999999999999999
Q ss_pred HHHHHHHHhhh
Q psy1840 183 VHHKLKEMNAG 193 (423)
Q Consensus 183 I~~~L~~i~~~ 193 (423)
|++.|+.+...
T Consensus 346 ll~~L~~~~~~ 356 (359)
T 3vhe_A 346 LVEHLGNLLQA 356 (359)
T ss_dssp HHHHHHHHHHH
T ss_pred HHHHHHHHHHH
Confidence 99999887653
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=3.2e-28 Score=241.66 Aligned_cols=160 Identities=23% Similarity=0.456 Sum_probs=130.7
Q ss_pred HHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCc---cEEEeccCCcccccCCCcccccccccCCccccCCccccCC
Q psy1840 25 SISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRW---VLQIADFGLHAFKAGQDETGQERKLRRRKLYKAPELLRQP 101 (423)
Q Consensus 25 ~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~---~vKL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~ 101 (423)
.+.++.||+.||.|||++|++ ||||||+|||++.++ .+||+|||+++...............+|+.|+|||.+.+.
T Consensus 183 ~~~i~~qi~~aL~~LH~~~iv-HrDlkp~NIll~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~ 261 (367)
T 3l9p_A 183 LLHVARDIACGCQYLEENHFI-HRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEG 261 (367)
T ss_dssp HHHHHHHHHHHHHHHHHTTCC-CSCCCGGGEEESCSSTTCCEEECCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHC
T ss_pred HHHHHHHHHHHHHHHHhCCee-CCCCChhhEEEecCCCCceEEECCCccccccccccccccCCCcCCcccEECHHHhcCC
Confidence 678999999999999999998 999999999999554 5999999998754322222222345678889999999876
Q ss_pred CCCCCCCccchHHHHHHHHHHHh-CCCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCchHHHHHHHHHhhhcCCCCCCCH
Q psy1840 102 HLPRGTQKGDVYSFGLVLYEVIG-RQGPWGHLRMTDEEIITSVTQGSGLRPDTSSLDCAPSIIACMRTCWEEDPELRPDL 180 (423)
Q Consensus 102 ~~~~~s~ksDVyS~Giil~ellt-g~~Pf~~~~~~~~~i~~~i~~~~~~~p~~~~~~~~~~l~~Li~~C~~~dP~~RPt~ 180 (423)
.+ +.++|||||||++|||++ |..||.. ....++...+..+....+ ...++..+.+++.+||+.||++||++
T Consensus 262 ~~---~~~~DvwslG~il~ellt~g~~pf~~--~~~~~~~~~i~~~~~~~~---~~~~~~~l~~li~~~l~~dP~~Rps~ 333 (367)
T 3l9p_A 262 IF---TSKTDTWSFGVLLWEIFSLGYMPYPS--KSNQEVLEFVTSGGRMDP---PKNCPGPVYRIMTQCWQHQPEDRPNF 333 (367)
T ss_dssp CC---CHHHHHHHHHHHHHHHHTTSCCSSTT--CCHHHHHHHHHTTCCCCC---CTTCCHHHHHHHHHHTCSSGGGSCCH
T ss_pred CC---CcHHHHHHHHHHHHHHHhCCCCCCCC--CCHHHHHHHHHcCCCCCC---CccCCHHHHHHHHHHcCCCHhHCcCH
Confidence 55 899999999999999998 9999974 456777777776543322 23678999999999999999999999
Q ss_pred HHHHHHHHHHhhh
Q psy1840 181 RFVHHKLKEMNAG 193 (423)
Q Consensus 181 ~~I~~~L~~i~~~ 193 (423)
.+|++.|+.+...
T Consensus 334 ~eil~~l~~~~~~ 346 (367)
T 3l9p_A 334 AIILERIEYCTQD 346 (367)
T ss_dssp HHHHHHHHHHHHC
T ss_pred HHHHHHHHHHhhC
Confidence 9999999887653
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.95 E-value=5.1e-28 Score=237.02 Aligned_cols=166 Identities=23% Similarity=0.354 Sum_probs=129.2
Q ss_pred HHHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCccEEEeccCCcccccCCCcccccccccCCccccCCccccCCCC
Q psy1840 24 GSISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKAPELLRQPHL 103 (423)
Q Consensus 24 ~~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~ 103 (423)
..+.++.||+.||.|||+.|++ ||||||+||+++.++.+||+|||++................+++.|+|||.+.+..+
T Consensus 173 ~~~~i~~qi~~aL~~LH~~~iv-H~Dikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~ 251 (344)
T 1rjb_A 173 DLLCFAYQVAKGMEFLEFKSCV-HRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIY 251 (344)
T ss_dssp HHHHHHHHHHHHHHHHHHTTEE-ETTCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCC
T ss_pred HHHHHHHHHHHHHHHHHhCCcc-cCCCChhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCC
Confidence 3689999999999999999998 999999999999999999999999876543333222334556788999999977654
Q ss_pred CCCCCccchHHHHHHHHHHHh-CCCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCchHHHHHHHHHhhhcCCCCCCCHHH
Q psy1840 104 PRGTQKGDVYSFGLVLYEVIG-RQGPWGHLRMTDEEIITSVTQGSGLRPDTSSLDCAPSIIACMRTCWEEDPELRPDLRF 182 (423)
Q Consensus 104 ~~~s~ksDVyS~Giil~ellt-g~~Pf~~~~~~~~~i~~~i~~~~~~~p~~~~~~~~~~l~~Li~~C~~~dP~~RPt~~~ 182 (423)
+.++||||||+++|||++ |..||..... ...+...+..+. .+.. +..+++++.+++.+||+.||.+||++.+
T Consensus 252 ---~~~~Di~slG~il~el~t~g~~p~~~~~~-~~~~~~~~~~~~--~~~~-~~~~~~~l~~li~~~l~~dp~~Rps~~~ 324 (344)
T 1rjb_A 252 ---TIKSDVWSYGILLWEIFSLGVNPYPGIPV-DANFYKLIQNGF--KMDQ-PFYATEEIYIIMQSCWAFDSRKRPSFPN 324 (344)
T ss_dssp ---CHHHHHHHHHHHHHHHTTTSCCSSTTCCC-SHHHHHHHHTTC--CCCC-CTTCCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred ---ChhHhHHHHHHHHHHHHcCCCCCcccCCc-HHHHHHHHhcCC--CCCC-CCCCCHHHHHHHHHHcCCCchhCcCHHH
Confidence 899999999999999998 9999976433 233444444432 2221 2357899999999999999999999999
Q ss_pred HHHHHHHHhhhcCCC
Q psy1840 183 VHHKLKEMNAGLKAN 197 (423)
Q Consensus 183 I~~~L~~i~~~~~~~ 197 (423)
+++.|+.+.......
T Consensus 325 l~~~l~~~~~~~~~~ 339 (344)
T 1rjb_A 325 LTSFLGCQLADAEEA 339 (344)
T ss_dssp HHHHHHHHC------
T ss_pred HHHHHHHHHHHHHHH
Confidence 999999887655443
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=99.95 E-value=3.9e-28 Score=232.10 Aligned_cols=167 Identities=14% Similarity=0.238 Sum_probs=128.5
Q ss_pred HHHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEE---cCCccEEEeccCCcccccCCCcc-----cccccccCCccccCC
Q psy1840 24 GSISVNTTASVGMIHLHDSEIISHGNLRSSNCLI---DSRWVLQIADFGLHAFKAGQDET-----GQERKLRRRKLYKAP 95 (423)
Q Consensus 24 ~~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILl---d~~~~vKL~DFGla~~~~~~~~~-----~~~~~~~gt~~y~AP 95 (423)
....++.||+.||.|||++|++ ||||||+||++ +.++.+||+|||++......... .......+++.|+||
T Consensus 106 ~~~~i~~qi~~~l~~LH~~~iv-H~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aP 184 (296)
T 4hgt_A 106 TVLLLADQMISRIEYIHSKNFI-HRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASI 184 (296)
T ss_dssp HHHHHHHHHHHHHHHHHHTTEE-CSCCSGGGEEECCGGGTTCEEECCCTTCEECBCTTTCCBCCCCCSCCCCSCGGGCCH
T ss_pred HHHHHHHHHHHHHHHHHHCCee-cCCCCHHHeeeeccCCCCeEEEecCccceeccCcccCccCCCCcccccCCCccccch
Confidence 3689999999999999999988 99999999999 78999999999998765433221 122355789999999
Q ss_pred ccccCCCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCC-hHHHHHHHhcCCCCCC-CCCCCCchHHHHHHHHHhhhcC
Q psy1840 96 ELLRQPHLPRGTQKGDVYSFGLVLYEVIGRQGPWGHLRMT-DEEIITSVTQGSGLRP-DTSSLDCAPSIIACMRTCWEED 173 (423)
Q Consensus 96 E~l~~~~~~~~s~ksDVyS~Giil~elltg~~Pf~~~~~~-~~~i~~~i~~~~~~~p-~~~~~~~~~~l~~Li~~C~~~d 173 (423)
|.+.+..+ +.++|||||||++|||++|+.||...... ..+.+..+.......+ ......+++++.+++.+||+.|
T Consensus 185 E~~~~~~~---~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~ 261 (296)
T 4hgt_A 185 NTHLGIEQ---SRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLR 261 (296)
T ss_dssp HHHTTCCC---CHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCHHHHTTTSCHHHHHHHHHHHTSC
T ss_pred HHhcCCCC---CchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcccccchhhhhhccCCHHHHHHHHHHHhcC
Confidence 99987665 89999999999999999999999753221 1122222221111111 1111357889999999999999
Q ss_pred CCCCCCHHHHHHHHHHHhhhc
Q psy1840 174 PELRPDLRFVHHKLKEMNAGL 194 (423)
Q Consensus 174 P~~RPt~~~I~~~L~~i~~~~ 194 (423)
|++|||+.+|++.|+.+....
T Consensus 262 p~~Rpt~~~l~~~l~~~~~~~ 282 (296)
T 4hgt_A 262 FDDKPDYSYLRQLFRNLFHRQ 282 (296)
T ss_dssp TTCCCCHHHHHHHHHHHHHHH
T ss_pred CCCCCCHHHHHHHHHHHHHHh
Confidence 999999999999998887644
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=99.95 E-value=2.9e-28 Score=241.38 Aligned_cols=166 Identities=13% Similarity=0.161 Sum_probs=127.0
Q ss_pred HHHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEc--CCccEEEeccCCcccccCCCcc-----cccccccCCccccCCc
Q psy1840 24 GSISVNTTASVGMIHLHDSEIISHGNLRSSNCLID--SRWVLQIADFGLHAFKAGQDET-----GQERKLRRRKLYKAPE 96 (423)
Q Consensus 24 ~~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld--~~~~vKL~DFGla~~~~~~~~~-----~~~~~~~gt~~y~APE 96 (423)
..+.++.||+.||.|||+.|++ ||||||+|||++ .++.+||+|||+++........ .......||+.|+|||
T Consensus 153 ~~~~i~~qi~~~l~~lH~~~ii-HrDlkp~Nill~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE 231 (364)
T 3op5_A 153 TVLQLSLRILDILEYIHEHEYV-HGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSID 231 (364)
T ss_dssp HHHHHHHHHHHHHHHHHHTTEE-CCCCCGGGEEEESSCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHH
T ss_pred HHHHHHHHHHHHHHHHHHCCeE-EecCCHHHEEEecCCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHH
Confidence 3789999999999999999998 999999999999 8899999999998765432211 1113445899999999
Q ss_pred cccCCCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCChHHHHHHHhcC--CC----CCCCCCCCCchHHHHHHHHHhh
Q psy1840 97 LLRQPHLPRGTQKGDVYSFGLVLYEVIGRQGPWGHLRMTDEEIITSVTQG--SG----LRPDTSSLDCAPSIIACMRTCW 170 (423)
Q Consensus 97 ~l~~~~~~~~s~ksDVyS~Giil~elltg~~Pf~~~~~~~~~i~~~i~~~--~~----~~p~~~~~~~~~~l~~Li~~C~ 170 (423)
.+.+..+ +.++|||||||++|||++|+.||....... ......... .. ..+......++.++.+++..||
T Consensus 232 ~~~~~~~---~~~~Di~slG~~l~el~~g~~Pf~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl 307 (364)
T 3op5_A 232 AHNGVAP---SRRGDLEILGYCMIQWLTGHLPWEDNLKDP-KYVRDSKIRYRENIASLMDKCFPAANAPGEIAKYMETVK 307 (364)
T ss_dssp HHTTCCC---CHHHHHHHHHHHHHHHHHSCCTTGGGTTCH-HHHHHHHHHHHHCHHHHHHHHSCTTCCCHHHHHHHHHHH
T ss_pred HhCCCCC---CchhhHHHHHHHHHHHHhCCCCccccccCH-HHHHHHHHHhhhhHHHHHHHhcccccCHHHHHHHHHHHh
Confidence 9987655 899999999999999999999997533222 221111100 00 0001112357899999999999
Q ss_pred hcCCCCCCCHHHHHHHHHHHhhhc
Q psy1840 171 EEDPELRPDLRFVHHKLKEMNAGL 194 (423)
Q Consensus 171 ~~dP~~RPt~~~I~~~L~~i~~~~ 194 (423)
+.||++||++.+|++.|+.+....
T Consensus 308 ~~~p~~RP~~~~l~~~l~~~~~~~ 331 (364)
T 3op5_A 308 LLDYTEKPLYENLRDILLQGLKAI 331 (364)
T ss_dssp TCCTTCCCCHHHHHHHHHHHHHHT
T ss_pred cCCCCCCCCHHHHHHHHHHHHHHc
Confidence 999999999999999998876543
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=99.95 E-value=6.2e-28 Score=230.93 Aligned_cols=167 Identities=15% Similarity=0.242 Sum_probs=128.6
Q ss_pred HHHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEE---cCCccEEEeccCCcccccCCCcc-----cccccccCCccccCC
Q psy1840 24 GSISVNTTASVGMIHLHDSEIISHGNLRSSNCLI---DSRWVLQIADFGLHAFKAGQDET-----GQERKLRRRKLYKAP 95 (423)
Q Consensus 24 ~~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILl---d~~~~vKL~DFGla~~~~~~~~~-----~~~~~~~gt~~y~AP 95 (423)
....++.||+.||.|||++|++ ||||||+||++ +.++.+||+|||++......... .......|++.|+||
T Consensus 106 ~~~~i~~qi~~~l~~lH~~~iv-H~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP 184 (296)
T 3uzp_A 106 TVLLLADQMISRIEYIHSKNFI-HRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASI 184 (296)
T ss_dssp HHHHHHHHHHHHHHHHHHTTEE-CSCCCGGGEEECCGGGTTCEEECCCTTCEECBCTTTCCBCCCCCSCCCCSCTTTCCH
T ss_pred HHHHHHHHHHHHHHHHHhCCee-eCCCCHHHeEEecCCCCCeEEEeeCCCcccccccccccccccccccccccccccCCh
Confidence 3689999999999999999988 99999999999 58899999999998765433221 112455789999999
Q ss_pred ccccCCCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCC-ChHHHHHHHhcCCCCCC-CCCCCCchHHHHHHHHHhhhcC
Q psy1840 96 ELLRQPHLPRGTQKGDVYSFGLVLYEVIGRQGPWGHLRM-TDEEIITSVTQGSGLRP-DTSSLDCAPSIIACMRTCWEED 173 (423)
Q Consensus 96 E~l~~~~~~~~s~ksDVyS~Giil~elltg~~Pf~~~~~-~~~~i~~~i~~~~~~~p-~~~~~~~~~~l~~Li~~C~~~d 173 (423)
|.+.+..+ +.++|||||||++|||++|+.||..... ...+....+.......+ ......+++++.+++.+||+.|
T Consensus 185 E~~~~~~~---~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~d 261 (296)
T 3uzp_A 185 NTHLGIEQ---SRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLR 261 (296)
T ss_dssp HHHTTCCC---CHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCHHHHTTTSCHHHHHHHHHHHTSC
T ss_pred hhhcCCCC---CcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccCCchHHHHhhCCHHHHHHHHHHHhcC
Confidence 99987665 8999999999999999999999975422 11222222221110111 1112357899999999999999
Q ss_pred CCCCCCHHHHHHHHHHHhhhc
Q psy1840 174 PELRPDLRFVHHKLKEMNAGL 194 (423)
Q Consensus 174 P~~RPt~~~I~~~L~~i~~~~ 194 (423)
|++|||+.+|++.|+.+....
T Consensus 262 p~~Rps~~~l~~~l~~~~~~~ 282 (296)
T 3uzp_A 262 FDDKPDYSYLRQLFRNLFHRQ 282 (296)
T ss_dssp TTCCCCHHHHHHHHHHHHHHT
T ss_pred cCcCCCHHHHHHHHHHHHHhc
Confidence 999999999999998887654
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=1.7e-27 Score=229.72 Aligned_cols=164 Identities=22% Similarity=0.378 Sum_probs=130.9
Q ss_pred HHHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCccEEEeccCCcccccCCCcccccccccCCccccCCccccCCCC
Q psy1840 24 GSISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKAPELLRQPHL 103 (423)
Q Consensus 24 ~~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~ 103 (423)
..+.++.||+.||.|||+.|++ ||||||+||+++.++.+||+|||++................+++.|+|||.+.+..+
T Consensus 146 ~~~~~~~qi~~~l~~lH~~~i~-H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~ 224 (313)
T 1t46_A 146 DLLSFSYQVAKGMAFLASKNCI-HRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVY 224 (313)
T ss_dssp HHHHHHHHHHHHHHHHHHTTCC-CSCCSGGGEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCC
T ss_pred HHHHHHHHHHHHHHHHHHCCee-cCCCccceEEEcCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCC
Confidence 3689999999999999999998 999999999999999999999999876654433222334456778999999877654
Q ss_pred CCCCCccchHHHHHHHHHHHh-CCCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCchHHHHHHHHHhhhcCCCCCCCHHH
Q psy1840 104 PRGTQKGDVYSFGLVLYEVIG-RQGPWGHLRMTDEEIITSVTQGSGLRPDTSSLDCAPSIIACMRTCWEEDPELRPDLRF 182 (423)
Q Consensus 104 ~~~s~ksDVyS~Giil~ellt-g~~Pf~~~~~~~~~i~~~i~~~~~~~p~~~~~~~~~~l~~Li~~C~~~dP~~RPt~~~ 182 (423)
+.++||||||+++|||++ |..||...... ......+..+.. + .....++..+.+++.+||+.||.+|||+.+
T Consensus 225 ---~~~~Di~slG~il~ellt~g~~p~~~~~~~-~~~~~~~~~~~~--~-~~~~~~~~~l~~li~~~l~~dp~~Rps~~e 297 (313)
T 1t46_A 225 ---TFESDVWSYGIFLWELFSLGSSPYPGMPVD-SKFYKMIKEGFR--M-LSPEHAPAEMYDIMKTCWDADPLKRPTFKQ 297 (313)
T ss_dssp ---CHHHHHHHHHHHHHHHHTTTCCSSTTCCSS-HHHHHHHHHTCC--C-CCCTTSCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred ---ChHHHHHHHHHHHHHHHhCCCCCCCcccch-hHHHHHhccCCC--C-CCcccCCHHHHHHHHHHcCCCchhCcCHHH
Confidence 899999999999999998 99999754332 333344443321 1 122357899999999999999999999999
Q ss_pred HHHHHHHHhhhcC
Q psy1840 183 VHHKLKEMNAGLK 195 (423)
Q Consensus 183 I~~~L~~i~~~~~ 195 (423)
+++.|+++.....
T Consensus 298 ll~~L~~~~~~~~ 310 (313)
T 1t46_A 298 IVQLIEKQISEST 310 (313)
T ss_dssp HHHHHHHHHHHTC
T ss_pred HHHHHHHHHHHhh
Confidence 9999988876543
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=99.95 E-value=6.7e-28 Score=246.07 Aligned_cols=160 Identities=26% Similarity=0.521 Sum_probs=131.6
Q ss_pred HHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCccEEEeccCCcccccCCCcccccccccCCccccCCccccCCCCC
Q psy1840 25 SISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKAPELLRQPHLP 104 (423)
Q Consensus 25 ~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~ 104 (423)
.+.++.||+.||.|||+++++ ||||||+|||++.++.+||+|||+++...... ........++..|+|||.+....+
T Consensus 286 ~~~~~~qi~~~l~~LH~~~iv-HrDlkp~Nill~~~~~~kl~DFG~a~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~- 362 (454)
T 1qcf_A 286 LIDFSAQIAEGMAFIEQRNYI-HRDLRAANILVSASLVCKIADFGLARVIEDNE-YTAREGAKFPIKWTAPEAINFGSF- 362 (454)
T ss_dssp HHHHHHHHHHHHHHHHHTTCC-CSSCSGGGEEECTTCCEEECSTTGGGGBCCHH-HHTTCSSSSCGGGSCHHHHHHCCC-
T ss_pred HHHHHHHHHHHHHHHHhCCcc-CCCCCHHHEEECCCCcEEEeeCCCceEcCCCc-eeccCCCcccccccCHHHhccCCC-
Confidence 578999999999999999998 99999999999999999999999987653221 111123345678999999986655
Q ss_pred CCCCccchHHHHHHHHHHHh-CCCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCchHHHHHHHHHhhhcCCCCCCCHHHH
Q psy1840 105 RGTQKGDVYSFGLVLYEVIG-RQGPWGHLRMTDEEIITSVTQGSGLRPDTSSLDCAPSIIACMRTCWEEDPELRPDLRFV 183 (423)
Q Consensus 105 ~~s~ksDVyS~Giil~ellt-g~~Pf~~~~~~~~~i~~~i~~~~~~~p~~~~~~~~~~l~~Li~~C~~~dP~~RPt~~~I 183 (423)
+.++|||||||++|||++ |+.||.+ .+..++...+..+... .. +..+++++.++|.+||+.||++|||+.+|
T Consensus 363 --~~~~DvwslG~~l~el~t~g~~P~~~--~~~~~~~~~i~~~~~~--~~-~~~~~~~l~~li~~cl~~dp~~RPt~~~i 435 (454)
T 1qcf_A 363 --TIKSDVWSFGILLMEIVTYGRIPYPG--MSNPEVIRALERGYRM--PR-PENCPEELYNIMMRCWKNRPEERPTFEYI 435 (454)
T ss_dssp --CHHHHHHHHHHHHHHHHTTSCCSSTT--CCHHHHHHHHHHTCCC--CC-CTTSCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred --CcHHHHHhHHHHHHHHHhCCCCCCCC--CCHHHHHHHHHcCCCC--CC-CCCCCHHHHHHHHHHccCChhHCcCHHHH
Confidence 899999999999999999 9999974 5567777777765322 11 24689999999999999999999999999
Q ss_pred HHHHHHHhhhc
Q psy1840 184 HHKLKEMNAGL 194 (423)
Q Consensus 184 ~~~L~~i~~~~ 194 (423)
++.|+.+....
T Consensus 436 ~~~L~~~~~~~ 446 (454)
T 1qcf_A 436 QSVLDDFYTAT 446 (454)
T ss_dssp HHHHHTSSSSS
T ss_pred HHHHHHHHhcc
Confidence 99998876543
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=6.4e-28 Score=231.38 Aligned_cols=165 Identities=26% Similarity=0.407 Sum_probs=124.7
Q ss_pred HHHHHHHHHHHHHHHH--------hCCCeeecCCCCCCEEEcCCccEEEeccCCcccccCCCcc--cccccccCCccccC
Q psy1840 25 SISVNTTASVGMIHLH--------DSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDET--GQERKLRRRKLYKA 94 (423)
Q Consensus 25 ~l~i~~qi~~gL~yLH--------~~~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~~--~~~~~~~gt~~y~A 94 (423)
.+.++.|++.||.||| +.+++ ||||||+||+++.++.+||+|||+++........ .......||+.|+|
T Consensus 107 ~~~i~~~i~~~l~~lH~~~~~~~~~~~iv-H~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~a 185 (301)
T 3q4u_A 107 CLRIVLSIASGLAHLHIEIFGTQGKPAIA-HRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMA 185 (301)
T ss_dssp HHHHHHHHHHHHHHHHSCBCSTTCBCEEE-CSCCCGGGEEECTTSCEEECCCTTCEEEETTTTEEECCCCCCCCCGGGCC
T ss_pred HHHHHHHHHHHHHHHHHhhhhccCCCCee-cCCCChHhEEEcCCCCEEEeeCCCeeecccccccccccccccccccceeC
Confidence 6899999999999999 88988 9999999999999999999999998765433221 11234478999999
Q ss_pred CccccCCCCC---CCCCccchHHHHHHHHHHHhC----------CCCCCCCCC--ChHHHHHHHhcCCCCCCCCC----C
Q psy1840 95 PELLRQPHLP---RGTQKGDVYSFGLVLYEVIGR----------QGPWGHLRM--TDEEIITSVTQGSGLRPDTS----S 155 (423)
Q Consensus 95 PE~l~~~~~~---~~s~ksDVyS~Giil~elltg----------~~Pf~~~~~--~~~~i~~~i~~~~~~~p~~~----~ 155 (423)
||.+.+.... ..+.++|||||||++|||++| ..||..... ...............++..+ .
T Consensus 186 PE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (301)
T 3q4u_A 186 PEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSFEDMRKVVCVDQQRPNIPNRWFS 265 (301)
T ss_dssp HHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGG
T ss_pred hhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccccccCCCCcchhhhhHHHhccCCCCCCChhhcc
Confidence 9999875321 124789999999999999999 888854321 11222333322222333322 1
Q ss_pred CCchHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHH
Q psy1840 156 LDCAPSIIACMRTCWEEDPELRPDLRFVHHKLKEM 190 (423)
Q Consensus 156 ~~~~~~l~~Li~~C~~~dP~~RPt~~~I~~~L~~i 190 (423)
..+++.+.+++.+||+.||++|||+.+|++.|+.+
T Consensus 266 ~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i 300 (301)
T 3q4u_A 266 DPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI 300 (301)
T ss_dssp SHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred CccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhcc
Confidence 34678899999999999999999999999999876
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=1.1e-27 Score=230.56 Aligned_cols=154 Identities=18% Similarity=0.283 Sum_probs=123.3
Q ss_pred HHHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCccEEEeccCCcccccCCCcccccccccCCccccCCccccCCCC
Q psy1840 24 GSISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKAPELLRQPHL 103 (423)
Q Consensus 24 ~~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~ 103 (423)
....++.|++.||.|||++|++ ||||||+||+++.++.+||+|||++........ ......||+.|+|||.+.+..+
T Consensus 117 ~~~~~~~qi~~~l~~lH~~~i~-H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~ 193 (297)
T 3fxz_A 117 QIAAVCRECLQALEFLHSNQVI-HRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS--KRSTMVGTPYWMAPEVVTRKAY 193 (297)
T ss_dssp HHHHHHHHHHHHHHHHHHTTEE-CCCCSGGGEEECTTCCEEECCCTTCEECCSTTC--CBCCCCSCGGGCCHHHHHCSCB
T ss_pred HHHHHHHHHHHHHHHHHhCCce-eCCCCHHHEEECCCCCEEEeeCCCceecCCccc--ccCCccCCcCccChhhhcCCCC
Confidence 3679999999999999999988 999999999999999999999999876543322 2245678999999999987765
Q ss_pred CCCCCccchHHHHHHHHHHHhCCCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCchHHHHHHHHHhhhcCCCCCCCHHHH
Q psy1840 104 PRGTQKGDVYSFGLVLYEVIGRQGPWGHLRMTDEEIITSVTQGSGLRPDTSSLDCAPSIIACMRTCWEEDPELRPDLRFV 183 (423)
Q Consensus 104 ~~~s~ksDVyS~Giil~elltg~~Pf~~~~~~~~~i~~~i~~~~~~~p~~~~~~~~~~l~~Li~~C~~~dP~~RPt~~~I 183 (423)
+.++|||||||++|||++|..||... ........+......... ....++..+.+++.+||+.||++|||+.++
T Consensus 194 ---~~~~DiwslG~il~ell~g~~pf~~~--~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~dp~~Rps~~el 267 (297)
T 3fxz_A 194 ---GPKVDIWSLGIMAIEMIEGEPPYLNE--NPLRALYLIATNGTPELQ-NPEKLSAIFRDFLNRCLEMDVEKRGSAKEL 267 (297)
T ss_dssp ---CTHHHHHHHHHHHHHHHHSSCTTTTS--CHHHHHHHHHHHCSCCCS-CGGGSCHHHHHHHHHHSCSSTTTSCCHHHH
T ss_pred ---CcHHHHHHHHHHHHHHHhCCCCCCCC--CHHHHHHHHHhCCCCCCC-CccccCHHHHHHHHHHccCChhHCcCHHHH
Confidence 89999999999999999999999743 333444333332211111 123578899999999999999999999999
Q ss_pred HHH
Q psy1840 184 HHK 186 (423)
Q Consensus 184 ~~~ 186 (423)
++.
T Consensus 268 l~h 270 (297)
T 3fxz_A 268 LQH 270 (297)
T ss_dssp TTC
T ss_pred hhC
Confidence 764
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=9.8e-28 Score=231.93 Aligned_cols=162 Identities=25% Similarity=0.447 Sum_probs=124.6
Q ss_pred HHHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCccEEEeccCCcccccCCCcccccccccCCccccCCccccCCCC
Q psy1840 24 GSISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKAPELLRQPHL 103 (423)
Q Consensus 24 ~~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~ 103 (423)
..+.++.||+.||.|||+.|++ ||||||+||+++.++.+||+|||++................+++.|+|||.+.+..+
T Consensus 148 ~~~~i~~qi~~aL~~LH~~~iv-H~dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~ 226 (313)
T 3brb_A 148 TLLKFMVDIALGMEYLSNRNFL-HRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVY 226 (313)
T ss_dssp HHHHHHHHHHHHHHHHHTTTCC-CCCCSGGGEEECTTSCEEECSCSCC----------------CCGGGSCHHHHHSSCC
T ss_pred HHHHHHHHHHHHHHHHHhCCcc-cCCCCcceEEEcCCCcEEEeecCcceecccccccCcccccCCCccccCchhhcCCCc
Confidence 3689999999999999999998 999999999999999999999999876543322222234456778999999987655
Q ss_pred CCCCCccchHHHHHHHHHHHh-CCCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCchHHHHHHHHHhhhcCCCCCCCHHH
Q psy1840 104 PRGTQKGDVYSFGLVLYEVIG-RQGPWGHLRMTDEEIITSVTQGSGLRPDTSSLDCAPSIIACMRTCWEEDPELRPDLRF 182 (423)
Q Consensus 104 ~~~s~ksDVyS~Giil~ellt-g~~Pf~~~~~~~~~i~~~i~~~~~~~p~~~~~~~~~~l~~Li~~C~~~dP~~RPt~~~ 182 (423)
+.++||||||+++|+|++ |..||... ...++...+..+... . ....+++.+.+++.+||+.||.+||++.+
T Consensus 227 ---~~~~Di~slG~il~el~~~g~~p~~~~--~~~~~~~~~~~~~~~--~-~~~~~~~~l~~li~~~l~~dp~~Rps~~~ 298 (313)
T 3brb_A 227 ---TSKSDVWAFGVTMWEIATRGMTPYPGV--QNHEMYDYLLHGHRL--K-QPEDCLDELYEIMYSCWRTDPLDRPTFSV 298 (313)
T ss_dssp ---CHHHHHHHHHHHHHHHHTTSCCSSTTC--CGGGHHHHHHTTCCC--C-CBTTCCHHHHHHHHHTTCSSGGGSCCHHH
T ss_pred ---cchhhhHHHHHHHHHHHhcCCCCCccC--CHHHHHHHHHcCCCC--C-CCccccHHHHHHHHHHcCCChhhCcCHHH
Confidence 899999999999999999 88898743 344555555554322 1 12367899999999999999999999999
Q ss_pred HHHHHHHHhhhc
Q psy1840 183 VHHKLKEMNAGL 194 (423)
Q Consensus 183 I~~~L~~i~~~~ 194 (423)
+++.|+.+....
T Consensus 299 l~~~L~~l~~~l 310 (313)
T 3brb_A 299 LRLQLEKLLESL 310 (313)
T ss_dssp HHHHHHHHHHHC
T ss_pred HHHHHHHHHHhc
Confidence 999999887643
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=1.4e-27 Score=233.02 Aligned_cols=162 Identities=26% Similarity=0.472 Sum_probs=130.3
Q ss_pred HHHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCccEEEeccCCcccccCCCcc-cccccccCCccccCCccccCCC
Q psy1840 24 GSISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDET-GQERKLRRRKLYKAPELLRQPH 102 (423)
Q Consensus 24 ~~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~~-~~~~~~~gt~~y~APE~l~~~~ 102 (423)
..+.++.|++.||.|||+.|++ ||||||+||+++.++.+||+|||+++........ .......+++.|+|||.+.+..
T Consensus 152 ~~~~i~~qi~~~L~~LH~~~iv-H~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~ 230 (325)
T 3kul_A 152 QLVGMLRGVGAGMRYLSDLGYV-HRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEAIAFRT 230 (325)
T ss_dssp HHHHHHHHHHHHHHHHHHTTEE-CSCCSGGGEEECTTCCEEECCCSSCEECC----CCEECC---CCGGGSCHHHHHHCE
T ss_pred HHHHHHHHHHHHHHHHHHCCee-CCCCCcceEEECCCCCEEECCCCcccccccCccceeeccCCCCcccccCHhHhcCCC
Confidence 3689999999999999999988 9999999999999999999999998865433221 1122334567899999998765
Q ss_pred CCCCCCccchHHHHHHHHHHHh-CCCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCchHHHHHHHHHhhhcCCCCCCCHH
Q psy1840 103 LPRGTQKGDVYSFGLVLYEVIG-RQGPWGHLRMTDEEIITSVTQGSGLRPDTSSLDCAPSIIACMRTCWEEDPELRPDLR 181 (423)
Q Consensus 103 ~~~~s~ksDVyS~Giil~ellt-g~~Pf~~~~~~~~~i~~~i~~~~~~~p~~~~~~~~~~l~~Li~~C~~~dP~~RPt~~ 181 (423)
+ +.++||||||+++|||++ |..||.. ....++...+..+.... ....+++.+.+++.+||+.||++|||+.
T Consensus 231 ~---~~~~Di~slG~il~ell~~g~~p~~~--~~~~~~~~~~~~~~~~~---~~~~~~~~l~~li~~~l~~dp~~Rps~~ 302 (325)
T 3kul_A 231 F---SSASDVWSFGVVMWEVLAYGERPYWN--MTNRDVISSVEEGYRLP---APMGCPHALHQLMLDCWHKDRAQRPRFS 302 (325)
T ss_dssp E---CHHHHHHHHHHHHHHHHTTSCCTTTT--SCHHHHHHHHHTTCCCC---CCTTCCHHHHHHHHHHTCSSGGGSCCHH
T ss_pred C---CcHHHHHHHHHHHHHHHcCCCCCccc--CCHHHHHHHHHcCCCCC---CCCCcCHHHHHHHHHHccCChhhCcCHH
Confidence 5 889999999999999998 9999964 45677777776653222 2236889999999999999999999999
Q ss_pred HHHHHHHHHhhhc
Q psy1840 182 FVHHKLKEMNAGL 194 (423)
Q Consensus 182 ~I~~~L~~i~~~~ 194 (423)
+|++.|+.+....
T Consensus 303 eil~~L~~l~~~~ 315 (325)
T 3kul_A 303 QIVSVLDALIRSP 315 (325)
T ss_dssp HHHHHHHHHHHSC
T ss_pred HHHHHHHHHHhCc
Confidence 9999999887643
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=7.9e-28 Score=229.18 Aligned_cols=159 Identities=22% Similarity=0.444 Sum_probs=119.7
Q ss_pred HHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCccEEEeccCCcccccCCCcccccccccCCccccCCccccCCCCC
Q psy1840 25 SISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKAPELLRQPHLP 104 (423)
Q Consensus 25 ~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~ 104 (423)
.+.++.|++.||.|||+.|++ ||||||+||+++.++.+||+|||++........ .......+++.|+|||.+.+..+
T Consensus 118 ~~~~~~qi~~~l~~lH~~~i~-H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~- 194 (281)
T 1mp8_A 118 LILYAYQLSTALAYLESKRFV-HRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTY-YKASKGKLPIKWMAPESINFRRF- 194 (281)
T ss_dssp HHHHHHHHHHHHHHHHHTTCC-CSCCSGGGEEEEETTEEEECC--------------------CCGGGCCHHHHHHCCC-
T ss_pred HHHHHHHHHHHHHHHHhCCee-cccccHHHEEECCCCCEEECccccccccCcccc-cccccCCCcccccChhhcccCCC-
Confidence 678999999999999999998 999999999999999999999999876543221 11223456678999999976654
Q ss_pred CCCCccchHHHHHHHHHHHh-CCCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCchHHHHHHHHHhhhcCCCCCCCHHHH
Q psy1840 105 RGTQKGDVYSFGLVLYEVIG-RQGPWGHLRMTDEEIITSVTQGSGLRPDTSSLDCAPSIIACMRTCWEEDPELRPDLRFV 183 (423)
Q Consensus 105 ~~s~ksDVyS~Giil~ellt-g~~Pf~~~~~~~~~i~~~i~~~~~~~p~~~~~~~~~~l~~Li~~C~~~dP~~RPt~~~I 183 (423)
+.++||||||+++|||++ |..||... ...++...+..+.... ....+++.+.+++.+||+.||++|||+.++
T Consensus 195 --~~~~Di~slG~~l~ell~~g~~pf~~~--~~~~~~~~i~~~~~~~---~~~~~~~~l~~li~~~l~~~p~~Rps~~~l 267 (281)
T 1mp8_A 195 --TSASDVWMFGVCMWEILMHGVKPFQGV--KNNDVIGRIENGERLP---MPPNCPPTLYSLMTKCWAYDPSRRPRFTEL 267 (281)
T ss_dssp --SHHHHHHHHHHHHHHHHTTSCCTTTTC--CGGGHHHHHHTTCCCC---CCTTCCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred --CCccCchHHHHHHHHHHhcCCCCCCcC--CHHHHHHHHHcCCCCC---CCCCCCHHHHHHHHHHccCChhhCcCHHHH
Confidence 889999999999999996 89999743 3455666666543221 223688999999999999999999999999
Q ss_pred HHHHHHHhhh
Q psy1840 184 HHKLKEMNAG 193 (423)
Q Consensus 184 ~~~L~~i~~~ 193 (423)
++.|+.+...
T Consensus 268 ~~~l~~~~~~ 277 (281)
T 1mp8_A 268 KAQLSTILEE 277 (281)
T ss_dssp HHHHHHHHHH
T ss_pred HHHHHHHHHH
Confidence 9999887653
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=1.3e-27 Score=235.38 Aligned_cols=167 Identities=15% Similarity=0.232 Sum_probs=130.3
Q ss_pred HHHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCc--cEEEeccCCcccccCCCcc-----cccccccCCccccCCc
Q psy1840 24 GSISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRW--VLQIADFGLHAFKAGQDET-----GQERKLRRRKLYKAPE 96 (423)
Q Consensus 24 ~~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~--~vKL~DFGla~~~~~~~~~-----~~~~~~~gt~~y~APE 96 (423)
..+.++.||+.||.|||++|++ ||||||+||+++.++ .+||+|||+++........ .......|++.|+|||
T Consensus 160 ~~~~i~~qi~~~L~~LH~~~iv-H~Dikp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE 238 (352)
T 2jii_A 160 SVLQVACRLLDALEFLHENEYV-HGNVTAENIFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMD 238 (352)
T ss_dssp HHHHHHHHHHHHHHHHHHTTCB-CSCCCGGGEEEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHH
T ss_pred HHHHHHHHHHHHHHHHHhCCcc-CCCCCHHHEEEcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHH
Confidence 3689999999999999999998 999999999999998 9999999998765432211 1123447899999999
Q ss_pred cccCCCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCChHHHHHHHh---cCCCCCC--CCCCCCchHHHHHHHHHhhh
Q psy1840 97 LLRQPHLPRGTQKGDVYSFGLVLYEVIGRQGPWGHLRMTDEEIITSVT---QGSGLRP--DTSSLDCAPSIIACMRTCWE 171 (423)
Q Consensus 97 ~l~~~~~~~~s~ksDVyS~Giil~elltg~~Pf~~~~~~~~~i~~~i~---~~~~~~p--~~~~~~~~~~l~~Li~~C~~ 171 (423)
.+.+..+ +.++|||||||++|||++|+.||.........+..... ......+ ......+++++.+++.+||+
T Consensus 239 ~~~~~~~---~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~ 315 (352)
T 2jii_A 239 LHKGCGP---SRRSDLQSLGYCMLKWLYGFLPWTNCLPNTEDIMKQKQKFVDKPGPFVGPCGHWIRPSETLQKYLKVVMA 315 (352)
T ss_dssp HHTTCCC---CHHHHHHHHHHHHHHHHHSCCTTGGGTTCHHHHHHHHHHHHHSCCCEECTTSCEECCCHHHHHHHHHHHT
T ss_pred HHccCCC---CchhhHHHHHHHHHHHHhCCCCcccCCcCHHHHHHHHHhccCChhhhhhhccccCCCcHHHHHHHHHHHh
Confidence 9987654 89999999999999999999999765434444443332 1111111 11112468999999999999
Q ss_pred cCCCCCCCHHHHHHHHHHHhhhc
Q psy1840 172 EDPELRPDLRFVHHKLKEMNAGL 194 (423)
Q Consensus 172 ~dP~~RPt~~~I~~~L~~i~~~~ 194 (423)
.||++||++.+|++.|+.+....
T Consensus 316 ~dp~~Rps~~~l~~~L~~~~~~~ 338 (352)
T 2jii_A 316 LTYEEKPPYAMLRNNLEALLQDL 338 (352)
T ss_dssp CCTTCCCCHHHHHHHHHHHHHHT
T ss_pred CChhhCCCHHHHHHHHHHHHHhc
Confidence 99999999999999998887654
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=99.95 E-value=2.1e-27 Score=232.28 Aligned_cols=151 Identities=21% Similarity=0.280 Sum_probs=127.3
Q ss_pred HHHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCccEEEeccCCcccccCCCcccccccccCCccccCCccccCCCC
Q psy1840 24 GSISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKAPELLRQPHL 103 (423)
Q Consensus 24 ~~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~ 103 (423)
....++.||+.||.|||+.|++ ||||||+||+++.++.+||+|||++....... ......||+.|+|||++.+..+
T Consensus 115 ~~~~~~~qi~~al~~lH~~~iv-HrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~ 190 (328)
T 3fe3_A 115 EARSKFRQIVSAVQYCHQKRIV-HRDLKAENLLLDADMNIKIADFGFSNEFTVGG---KLDAFCGAPPYAAPELFQGKKY 190 (328)
T ss_dssp HHHHHHHHHHHHHHHHHHTTCC-CSCCCGGGEEECTTSCEEECSTTCCGGGSSSC---GGGTTSSSGGGCCHHHHHTCCC
T ss_pred HHHHHHHHHHHHHHHHHHCCEe-ccCCCHHHEEEcCCCCEEEeeccCceecCCCC---ccccccCCcceeCcccccCCCc
Confidence 3678999999999999999998 99999999999999999999999987654322 2345679999999999987653
Q ss_pred CCCCCccchHHHHHHHHHHHhCCCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCchHHHHHHHHHhhhcCCCCCCCHHHH
Q psy1840 104 PRGTQKGDVYSFGLVLYEVIGRQGPWGHLRMTDEEIITSVTQGSGLRPDTSSLDCAPSIIACMRTCWEEDPELRPDLRFV 183 (423)
Q Consensus 104 ~~~s~ksDVyS~Giil~elltg~~Pf~~~~~~~~~i~~~i~~~~~~~p~~~~~~~~~~l~~Li~~C~~~dP~~RPt~~~I 183 (423)
.+.++|||||||++|||++|+.||.+ .+..++...+..+....|. .+++++.+++.+||+.||.+|||+.++
T Consensus 191 --~~~~~DiwslG~il~ell~g~~pf~~--~~~~~~~~~i~~~~~~~p~----~~s~~~~~li~~~L~~dP~~R~t~~ei 262 (328)
T 3fe3_A 191 --DGPEVDVWSLGVILYTLVSGSLPFDG--QNLKELRERVLRGKYRIPF----YMSTDCENLLKRFLVLNPIKRGTLEQI 262 (328)
T ss_dssp --CSHHHHHHHHHHHHHHHHHSSCSSCC--SSHHHHHHHHHHCCCCCCT----TSCHHHHHHHHHHCCSSTTTSCCHHHH
T ss_pred --CCchhhhhhhHHHHHHHHhCCCCCCC--CCHHHHHHHHHhCCCCCCC----CCCHHHHHHHHHHCCCChhHCcCHHHH
Confidence 25799999999999999999999974 4567777777776544332 468999999999999999999999998
Q ss_pred HHH
Q psy1840 184 HHK 186 (423)
Q Consensus 184 ~~~ 186 (423)
++.
T Consensus 263 l~h 265 (328)
T 3fe3_A 263 MKD 265 (328)
T ss_dssp TTC
T ss_pred hcC
Confidence 763
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=1e-27 Score=234.04 Aligned_cols=166 Identities=14% Similarity=0.215 Sum_probs=129.1
Q ss_pred HHHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCcc-----EEEeccCCcccccCCCcc-----cccccccCCcccc
Q psy1840 24 GSISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWV-----LQIADFGLHAFKAGQDET-----GQERKLRRRKLYK 93 (423)
Q Consensus 24 ~~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~~-----vKL~DFGla~~~~~~~~~-----~~~~~~~gt~~y~ 93 (423)
..+.++.||+.||.|||+.|++ ||||||+||+++.++. +||+|||+++........ .......||+.|+
T Consensus 106 ~~~~i~~qi~~~l~~LH~~~ii-HrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~ 184 (330)
T 2izr_A 106 TVLMIAIQLISRMEYVHSKNLI-YRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETKKHIPYREHKSLTGTARYM 184 (330)
T ss_dssp HHHHHHHHHHHHHHHHHHTTEE-CCCCCGGGEEECCGGGTCTTSEEECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTC
T ss_pred HHHHHHHHHHHHHHHHHhCCee-ccCCCHHHeeeccCCCCCCceEEEEEcccceeeecCCCCccccccccCCcCCCcccc
Confidence 3689999999999999999988 9999999999998887 999999998865432211 1124567899999
Q ss_pred CCccccCCCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCC-ChHHHHHHHhcCCCCCC-CCCCCCchHHHHHHHHHhhh
Q psy1840 94 APELLRQPHLPRGTQKGDVYSFGLVLYEVIGRQGPWGHLRM-TDEEIITSVTQGSGLRP-DTSSLDCAPSIIACMRTCWE 171 (423)
Q Consensus 94 APE~l~~~~~~~~s~ksDVyS~Giil~elltg~~Pf~~~~~-~~~~i~~~i~~~~~~~p-~~~~~~~~~~l~~Li~~C~~ 171 (423)
|||.+.+..+ +.++|||||||++|||++|..||.+... ...+....+.......+ ......++ ++.+++.+||+
T Consensus 185 aPE~~~~~~~---~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~p-~~~~li~~~l~ 260 (330)
T 2izr_A 185 SINTHLGKEQ---SRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTKRATPIEVLCENFP-EMATYLRYVRR 260 (330)
T ss_dssp CHHHHTTCCC---CHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHHHHHHSCHHHHTTTCH-HHHHHHHHHHH
T ss_pred ChHHHcCCCC---CchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHhhhccCCHHHHhccCh-HHHHHHHHHHh
Confidence 9999988655 8999999999999999999999976432 33344444433211111 11112355 99999999999
Q ss_pred cCCCCCCCHHHHHHHHHHHhhhc
Q psy1840 172 EDPELRPDLRFVHHKLKEMNAGL 194 (423)
Q Consensus 172 ~dP~~RPt~~~I~~~L~~i~~~~ 194 (423)
.||.+||++.+|.+.|+.+....
T Consensus 261 ~~p~~RP~~~~l~~~l~~~~~~~ 283 (330)
T 2izr_A 261 LDFFEKPDYDYLRKLFTDLFDRK 283 (330)
T ss_dssp CCTTCCCCHHHHHHHHHHHHHHT
T ss_pred CCCCCCCCHHHHHHHHHHHHHHc
Confidence 99999999999999998776543
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=2.8e-27 Score=227.29 Aligned_cols=155 Identities=22% Similarity=0.238 Sum_probs=124.4
Q ss_pred HHHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCccEEEeccCCcccccCCCcccccccccCCccccCCccccCCCC
Q psy1840 24 GSISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKAPELLRQPHL 103 (423)
Q Consensus 24 ~~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~ 103 (423)
....++.||+.||.|||+.|++ ||||||+||+++.++.+||+|||++........ ......||+.|+|||.+.+...
T Consensus 138 ~~~~~~~qi~~~l~~lH~~~iv-H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~ 214 (298)
T 2zv2_A 138 QARFYFQDLIKGIEYLHYQKII-HRDIKPSNLLVGEDGHIKIADFGVSNEFKGSDA--LLSNTVGTPAFMAPESLSETRK 214 (298)
T ss_dssp HHHHHHHHHHHHHHHHHHTTEE-CCCCCGGGEEECTTSCEEECCCTTCEECSSSSC--EECCCCSCGGGCCGGGCCTTCC
T ss_pred HHHHHHHHHHHHHHHHHHCCee-ccCCCHHHEEECCCCCEEEecCCCccccccccc--cccCCcCCccccChhhhccCCC
Confidence 3678999999999999999988 999999999999999999999999876543321 1234578999999999976542
Q ss_pred CCCCCccchHHHHHHHHHHHhCCCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCchHHHHHHHHHhhhcCCCCCCCHHHH
Q psy1840 104 PRGTQKGDVYSFGLVLYEVIGRQGPWGHLRMTDEEIITSVTQGSGLRPDTSSLDCAPSIIACMRTCWEEDPELRPDLRFV 183 (423)
Q Consensus 104 ~~~s~ksDVyS~Giil~elltg~~Pf~~~~~~~~~i~~~i~~~~~~~p~~~~~~~~~~l~~Li~~C~~~dP~~RPt~~~I 183 (423)
...+.++|||||||++|||++|+.||.. .....+...+.......|. ...+++.+.+++.+||+.||++||++.++
T Consensus 215 ~~~~~~~Di~slG~~l~~l~~g~~pf~~--~~~~~~~~~~~~~~~~~~~--~~~~~~~l~~li~~~l~~dp~~R~s~~e~ 290 (298)
T 2zv2_A 215 IFSGKALDVWAMGVTLYCFVFGQCPFMD--ERIMCLHSKIKSQALEFPD--QPDIAEDLKDLITRMLDKNPESRIVVPEI 290 (298)
T ss_dssp CEESHHHHHHHHHHHHHHHHHSSCSSCC--SSHHHHHHHHHHCCCCCCS--SSCCCHHHHHHHHHHTCSCTTTSCCHHHH
T ss_pred CCCCchhhhHhHHHHHHHHHHCCCCCCC--ccHHHHHHHHhcccCCCCC--ccccCHHHHHHHHHHhhcChhhCCCHHHH
Confidence 1236789999999999999999999974 3345555555554333332 23578999999999999999999999998
Q ss_pred HH
Q psy1840 184 HH 185 (423)
Q Consensus 184 ~~ 185 (423)
++
T Consensus 291 l~ 292 (298)
T 2zv2_A 291 KL 292 (298)
T ss_dssp TT
T ss_pred hc
Confidence 65
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=1.3e-27 Score=225.70 Aligned_cols=160 Identities=24% Similarity=0.483 Sum_probs=130.1
Q ss_pred HHHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCccEEEeccCCcccccCCCcccccccccCCccccCCccccCCCC
Q psy1840 24 GSISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKAPELLRQPHL 103 (423)
Q Consensus 24 ~~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~ 103 (423)
....++.|++.||.|||+.|++ ||||||+||+++.++.+||+|||++........ .......+++.|+|||.+.+..+
T Consensus 105 ~~~~i~~qi~~~l~~lH~~~i~-H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~ 182 (268)
T 3sxs_A 105 QLLEMCYDVCEGMAFLESHQFI-HRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQY-VSSVGTKFPVKWSAPEVFHYFKY 182 (268)
T ss_dssp HHHHHHHHHHHHHHHHHHTTEE-ESSCSGGGEEECTTCCEEECCTTCEEECCTTCE-EECCSCCCCGGGCCHHHHHHSEE
T ss_pred HHHHHHHHHHHHHHHHHHCCee-cCCcCcceEEECCCCCEEEccCccceecchhhh-hcccCCCcCcccCCHHHHhccCC
Confidence 3689999999999999999988 999999999999999999999999876543322 12233456677999999987655
Q ss_pred CCCCCccchHHHHHHHHHHHh-CCCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCchHHHHHHHHHhhhcCCCCCCCHHH
Q psy1840 104 PRGTQKGDVYSFGLVLYEVIG-RQGPWGHLRMTDEEIITSVTQGSGLRPDTSSLDCAPSIIACMRTCWEEDPELRPDLRF 182 (423)
Q Consensus 104 ~~~s~ksDVyS~Giil~ellt-g~~Pf~~~~~~~~~i~~~i~~~~~~~p~~~~~~~~~~l~~Li~~C~~~dP~~RPt~~~ 182 (423)
+.++||||||+++|+|++ |..||.. ....+....+..+..... +..+++.+.+++.+||+.||++|||+.+
T Consensus 183 ---~~~~Di~slG~il~~l~~~g~~p~~~--~~~~~~~~~~~~~~~~~~---~~~~~~~l~~li~~~l~~~p~~Rps~~~ 254 (268)
T 3sxs_A 183 ---SSKSDVWAFGILMWEVFSLGKMPYDL--YTNSEVVLKVSQGHRLYR---PHLASDTIYQIMYSCWHELPEKRPTFQQ 254 (268)
T ss_dssp ---ETTHHHHHHHHHHHHHHTTTCCTTTT--SCHHHHHHHHHTTCCCCC---CTTSCHHHHHHHHHTTCSSGGGSCCHHH
T ss_pred ---chhhhhHHHHHHHHHHHcCCCCCccc--cChHHHHHHHHcCCCCCC---CCcChHHHHHHHHHHcCCChhhCcCHHH
Confidence 889999999999999998 9999974 445666666665543222 2356889999999999999999999999
Q ss_pred HHHHHHHHhhh
Q psy1840 183 VHHKLKEMNAG 193 (423)
Q Consensus 183 I~~~L~~i~~~ 193 (423)
+++.|+.+...
T Consensus 255 ll~~L~~l~~~ 265 (268)
T 3sxs_A 255 LLSSIEPLREK 265 (268)
T ss_dssp HHHHHGGGCC-
T ss_pred HHHHHHHhhhc
Confidence 99999887654
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=5.7e-27 Score=238.53 Aligned_cols=155 Identities=18% Similarity=0.265 Sum_probs=131.1
Q ss_pred HHHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEc---CCccEEEeccCCcccccCCCcccccccccCCccccCCccccC
Q psy1840 24 GSISVNTTASVGMIHLHDSEIISHGNLRSSNCLID---SRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKAPELLRQ 100 (423)
Q Consensus 24 ~~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld---~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~ 100 (423)
....++.||+.||.|||+.|++ ||||||+|||++ .++.+||+|||++........ ......||+.|+|||++.+
T Consensus 111 ~~~~i~~qil~aL~~lH~~giv-HrDlKp~NIll~~~~~~~~vkL~DFG~a~~~~~~~~--~~~~~~gt~~Y~APE~l~~ 187 (444)
T 3soa_A 111 DASHCIQQILEAVLHCHQMGVV-HRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQ--AWFGFAGTPGYLSPEVLRK 187 (444)
T ss_dssp HHHHHHHHHHHHHHHHHHTTCB-CCCCSSTTEEESBSSTTCCEEECCCSSCBCCCTTCC--BCCCSCSCGGGCCHHHHTT
T ss_pred HHHHHHHHHHHHHHHHHHCCcc-ccCCCHHHEEEeccCCCCcEEEccCceeEEecCCCc--eeecccCCcccCCHHHhcC
Confidence 3678999999999999999998 999999999998 467899999999876543322 2234678999999999987
Q ss_pred CCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCchHHHHHHHHHhhhcCCCCCCCH
Q psy1840 101 PHLPRGTQKGDVYSFGLVLYEVIGRQGPWGHLRMTDEEIITSVTQGSGLRPDTSSLDCAPSIIACMRTCWEEDPELRPDL 180 (423)
Q Consensus 101 ~~~~~~s~ksDVyS~Giil~elltg~~Pf~~~~~~~~~i~~~i~~~~~~~p~~~~~~~~~~l~~Li~~C~~~dP~~RPt~ 180 (423)
..+ +.++||||+||++|+|++|..||.. .+..++...+..+....+......+++++.+++.+||+.||.+|||+
T Consensus 188 ~~~---~~~~DIwSlGvilyell~G~~Pf~~--~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta 262 (444)
T 3soa_A 188 DPY---GKPVDLWACGVILYILLVGYPPFWD--EDQHRLYQQIKAGAYDFPSPEWDTVTPEAKDLINKMLTINPSKRITA 262 (444)
T ss_dssp CCB---CTHHHHHHHHHHHHHHHHSSCSCCC--SSHHHHHHHHHHTCCCCCTTTTTTSCHHHHHHHHHHSCSSTTTSCCH
T ss_pred CCC---CCccccHHHHHHHHHHHhCCCCCCC--ccHHHHHHHHHhCCCCCCccccccCCHHHHHHHHHHcCCChhHCCCH
Confidence 655 8999999999999999999999974 45677888888776555554455789999999999999999999999
Q ss_pred HHHHHH
Q psy1840 181 RFVHHK 186 (423)
Q Consensus 181 ~~I~~~ 186 (423)
.++++.
T Consensus 263 ~e~L~h 268 (444)
T 3soa_A 263 AEALKH 268 (444)
T ss_dssp HHHHHS
T ss_pred HHHhcC
Confidence 999874
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=4.3e-27 Score=224.44 Aligned_cols=156 Identities=27% Similarity=0.537 Sum_probs=125.7
Q ss_pred HHHHHHHHHHHHHHHHhCC--CeeecCCCCCCEEEcCCcc-----EEEeccCCcccccCCCcccccccccCCccccCCcc
Q psy1840 25 SISVNTTASVGMIHLHDSE--IISHGNLRSSNCLIDSRWV-----LQIADFGLHAFKAGQDETGQERKLRRRKLYKAPEL 97 (423)
Q Consensus 25 ~l~i~~qi~~gL~yLH~~~--ii~HrDLkp~NILld~~~~-----vKL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~ 97 (423)
.+.++.|++.||.|||+.| ++ ||||||+||+++.++. +||+|||+++.... ......+++.|+|||.
T Consensus 124 ~~~~~~~l~~~l~~lH~~~~~iv-H~dikp~Nil~~~~~~~~~~~~kl~Dfg~~~~~~~-----~~~~~~g~~~y~aPE~ 197 (287)
T 4f0f_A 124 KLRLMLDIALGIEYMQNQNPPIV-HRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSVH-----SVSGLLGNFQWMAPET 197 (287)
T ss_dssp HHHHHHHHHHHHHHHHTSSSCCB-CSCCSGGGEEESCCCTTCSCCEEECCCTTCBCCSS-----CEECCCCCCTTSCGGG
T ss_pred HHHHHHHHHHHHHHHHhCCCCee-cCCCCcceEEEeccCCCCceeEEeCCCCccccccc-----cccccCCCccccCchh
Confidence 6899999999999999999 88 9999999999987776 99999999874332 1234578899999999
Q ss_pred ccCCCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCchHHHHHHHHHhhhcCCCCC
Q psy1840 98 LRQPHLPRGTQKGDVYSFGLVLYEVIGRQGPWGHLRMTDEEIITSVTQGSGLRPDTSSLDCAPSIIACMRTCWEEDPELR 177 (423)
Q Consensus 98 l~~~~~~~~s~ksDVyS~Giil~elltg~~Pf~~~~~~~~~i~~~i~~~~~~~p~~~~~~~~~~l~~Li~~C~~~dP~~R 177 (423)
+.+... .++.++|||||||++|||++|+.||.............+.... ..+.. ...+++.+.+++.+||+.||.+|
T Consensus 198 ~~~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~-~~~~~-~~~~~~~l~~li~~~l~~dp~~R 274 (287)
T 4f0f_A 198 IGAEEE-SYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEG-LRPTI-PEDCPPRLRNVIELCWSGDPKKR 274 (287)
T ss_dssp SSCSSC-EECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHHHHHHHHSC-CCCCC-CTTSCHHHHHHHHHHTCSSGGGS
T ss_pred hccCCC-CcCchhhHHHHHHHHHHHHcCCCCCccccccHHHHHHHHhccC-CCCCC-CcccCHHHHHHHHHHhcCChhhC
Confidence 854321 2378999999999999999999999876555555455544432 22222 34688999999999999999999
Q ss_pred CCHHHHHHHHHH
Q psy1840 178 PDLRFVHHKLKE 189 (423)
Q Consensus 178 Pt~~~I~~~L~~ 189 (423)
||+.++++.|++
T Consensus 275 ps~~~ll~~L~~ 286 (287)
T 4f0f_A 275 PHFSYIVKELSE 286 (287)
T ss_dssp CCHHHHHHHHHT
T ss_pred cCHHHHHHHHHh
Confidence 999999998875
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=99.94 E-value=1.9e-27 Score=232.45 Aligned_cols=160 Identities=26% Similarity=0.446 Sum_probs=132.2
Q ss_pred HHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCccEEEeccCCcccccCCCcccccccccCCccccCCccccCCCCC
Q psy1840 25 SISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKAPELLRQPHLP 104 (423)
Q Consensus 25 ~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~ 104 (423)
.+.++.||+.||.|||+.|++ ||||||+||+++.++.+||+|||++................+++.|+|||.+.+..+
T Consensus 159 ~~~i~~qi~~aL~~LH~~~iv-H~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~- 236 (334)
T 2pvf_A 159 LVSCTYQLARGMEYLASQKCI-HRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVY- 236 (334)
T ss_dssp HHHHHHHHHHHHHHHHHTTEE-CSCCSGGGEEECTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEE-
T ss_pred HHHHHHHHHHHHHHHHhCCee-CCCCccceEEEcCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCc-
Confidence 689999999999999999988 999999999999999999999999876544332222334456778999999977655
Q ss_pred CCCCccchHHHHHHHHHHHh-CCCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCchHHHHHHHHHhhhcCCCCCCCHHHH
Q psy1840 105 RGTQKGDVYSFGLVLYEVIG-RQGPWGHLRMTDEEIITSVTQGSGLRPDTSSLDCAPSIIACMRTCWEEDPELRPDLRFV 183 (423)
Q Consensus 105 ~~s~ksDVyS~Giil~ellt-g~~Pf~~~~~~~~~i~~~i~~~~~~~p~~~~~~~~~~l~~Li~~C~~~dP~~RPt~~~I 183 (423)
+.++||||||+++|||++ |..||.. ....++...+..+.... ....++..+.+++.+||+.||.+||++.++
T Consensus 237 --~~~~Di~slG~il~ellt~g~~p~~~--~~~~~~~~~~~~~~~~~---~~~~~~~~l~~li~~~l~~dp~~Rps~~el 309 (334)
T 2pvf_A 237 --THQSDVWSFGVLMWEIFTLGGSPYPG--IPVEELFKLLKEGHRMD---KPANCTNELYMMMRDCWHAVPSQRPTFKQL 309 (334)
T ss_dssp --CHHHHHHHHHHHHHHHHTTSCCSSTT--CCHHHHHHHHHHTCCCC---CCTTCCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred --ChHHHHHHHHHHHHHHHhCCCCCcCc--CCHHHHHHHHhcCCCCC---CCccCCHHHHHHHHHHccCChhhCcCHHHH
Confidence 899999999999999999 9999974 45566776666653221 223678999999999999999999999999
Q ss_pred HHHHHHHhhh
Q psy1840 184 HHKLKEMNAG 193 (423)
Q Consensus 184 ~~~L~~i~~~ 193 (423)
++.|+.+...
T Consensus 310 l~~L~~l~~~ 319 (334)
T 2pvf_A 310 VEDLDRILTL 319 (334)
T ss_dssp HHHHHHHHHH
T ss_pred HHHHHHHHhc
Confidence 9999888654
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=2e-27 Score=224.79 Aligned_cols=160 Identities=24% Similarity=0.495 Sum_probs=130.8
Q ss_pred HHHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCccEEEeccCCcccccCCCcccccccccCCccccCCccccCCCC
Q psy1840 24 GSISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKAPELLRQPHL 103 (423)
Q Consensus 24 ~~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~ 103 (423)
..+.++.|++.||.|||+.|++ ||||||+||+++.++.+||+|||++....... ........+++.|+|||.+.+..+
T Consensus 107 ~~~~i~~~i~~~l~~lH~~~i~-H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~ 184 (269)
T 4hcu_A 107 TLLGMCLDVCEGMAYLEEACVI-HRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ-YTSSTGTKFPVKWASPEVFSFSRY 184 (269)
T ss_dssp HHHHHHHHHHHHHHHHHHTTCC-CSCCCGGGEEECGGGCEEECCTTGGGGBCCHH-HHSTTSTTCCGGGCCHHHHHHCCC
T ss_pred HHHHHHHHHHHHHHHHHhCCee-cCCcchheEEEcCCCCEEeccccccccccccc-cccccCcccccccCCHHHhcCCCC
Confidence 3678999999999999999998 99999999999999999999999987653221 112233456778999999987655
Q ss_pred CCCCCccchHHHHHHHHHHHh-CCCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCchHHHHHHHHHhhhcCCCCCCCHHH
Q psy1840 104 PRGTQKGDVYSFGLVLYEVIG-RQGPWGHLRMTDEEIITSVTQGSGLRPDTSSLDCAPSIIACMRTCWEEDPELRPDLRF 182 (423)
Q Consensus 104 ~~~s~ksDVyS~Giil~ellt-g~~Pf~~~~~~~~~i~~~i~~~~~~~p~~~~~~~~~~l~~Li~~C~~~dP~~RPt~~~ 182 (423)
+.++||||||+++|+|++ |..||.. ....++...+..+.... .+..+++.+.+++.+||+.||++||++.+
T Consensus 185 ---~~~~Di~slG~~l~~ll~~g~~p~~~--~~~~~~~~~~~~~~~~~---~~~~~~~~~~~li~~~l~~~p~~Rps~~~ 256 (269)
T 4hcu_A 185 ---SSKSDVWSFGVLMWEVFSEGKIPYEN--RSNSEVVEDISTGFRLY---KPRLASTHVYQIMNHCWRERPEDRPAFSR 256 (269)
T ss_dssp ---CHHHHHHHHHHHHHHHHTTSCCTTTT--CCHHHHHHHHHTTCCCC---CCTTSCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred ---CchhhhHHHHHHHHHHhcCCCCCCCC--CCHHHHHHHHhcCccCC---CCCcCCHHHHHHHHHHccCCcccCcCHHH
Confidence 899999999999999999 8999974 45566777776653222 22356899999999999999999999999
Q ss_pred HHHHHHHHhhh
Q psy1840 183 VHHKLKEMNAG 193 (423)
Q Consensus 183 I~~~L~~i~~~ 193 (423)
+++.|+++...
T Consensus 257 ll~~l~~l~~~ 267 (269)
T 4hcu_A 257 LLRQLAEIAES 267 (269)
T ss_dssp HHHHHHHHHHC
T ss_pred HHHHHHHHHHc
Confidence 99999988653
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=3.4e-27 Score=227.79 Aligned_cols=165 Identities=23% Similarity=0.388 Sum_probs=125.0
Q ss_pred HHHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCccEEEeccCCcccccCCCcccccccccCCccccCCccccCCCC
Q psy1840 24 GSISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKAPELLRQPHL 103 (423)
Q Consensus 24 ~~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~ 103 (423)
....++.|++.||.|||+.|++ ||||||+||+++.++.+||+|||++........ ......+++.|+|||.+.+..+
T Consensus 137 ~~~~i~~qi~~~l~~LH~~~i~-H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~ 213 (310)
T 2wqm_A 137 TVWKYFVQLCSALEHMHSRRVM-HRDIKPANVFITATGVVKLGDLGLGRFFSSKTT--AAHSLVGTPYYMSPERIHENGY 213 (310)
T ss_dssp HHHHHHHHHHHHHHHHHHTTCC-CCCCCGGGEEECTTSCEEECCC--------------------CCSSCCHHHHTTCCC
T ss_pred HHHHHHHHHHHHHHHHhhCCee-CCCCcHHHEEEcCCCCEEEEeccceeeecCCCc--cccccCCCeeEeChHHhCCCCC
Confidence 3679999999999999999998 999999999999999999999999876533221 1234568889999999987654
Q ss_pred CCCCCccchHHHHHHHHHHHhCCCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCchHHHHHHHHHhhhcCCCCCCCHHHH
Q psy1840 104 PRGTQKGDVYSFGLVLYEVIGRQGPWGHLRMTDEEIITSVTQGSGLRPDTSSLDCAPSIIACMRTCWEEDPELRPDLRFV 183 (423)
Q Consensus 104 ~~~s~ksDVyS~Giil~elltg~~Pf~~~~~~~~~i~~~i~~~~~~~p~~~~~~~~~~l~~Li~~C~~~dP~~RPt~~~I 183 (423)
+.++||||||+++|+|++|..||.........+...+..... +......+++++.+++.+||+.||++|||+.+|
T Consensus 214 ---~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~i 288 (310)
T 2wqm_A 214 ---NFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDY--PPLPSDHYSEELRQLVNMCINPDPEKRPDVTYV 288 (310)
T ss_dssp ---CHHHHHHHHHHHHHHHHHSSCTTC---CCHHHHHHHHHTTCS--CCCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred ---CchhhHHHHHHHHHHHHhCCCCCcccchhHHHHHHHhhcccC--CCCcccccCHHHHHHHHHHcCCChhhCCCHHHH
Confidence 899999999999999999999997665666666666665432 222334688999999999999999999999999
Q ss_pred HHHHHHHhhhcCC
Q psy1840 184 HHKLKEMNAGLKA 196 (423)
Q Consensus 184 ~~~L~~i~~~~~~ 196 (423)
++.|+++....+.
T Consensus 289 l~~l~~l~~~~~~ 301 (310)
T 2wqm_A 289 YDVAKRMHACTAS 301 (310)
T ss_dssp HHHHHHHHHHHC-
T ss_pred HHHHHHHHHhhhh
Confidence 9999998875543
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=99.94 E-value=1.9e-27 Score=242.55 Aligned_cols=155 Identities=24% Similarity=0.497 Sum_probs=127.5
Q ss_pred HHHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCccEEEeccCCcccccCCCcccccccccCCccccCCccccCCCC
Q psy1840 24 GSISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKAPELLRQPHL 103 (423)
Q Consensus 24 ~~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~ 103 (423)
..+.++.||+.||.|||+++++ ||||||+|||++.++.+||+|||+++...... ....++..|+|||.+.+..+
T Consensus 290 ~~~~~~~qi~~~l~~LH~~~iv-HrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~-----~~~~~~~~y~aPE~~~~~~~ 363 (450)
T 1k9a_A 290 CLLKFSLDVCEAMEYLEGNNFV-HRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ-----DTGKLPVKWTAPEALREKKF 363 (450)
T ss_dssp HHHHHHHHHHHHHHHHHHTTEE-CSCCCGGGEEECTTSCEEECCCTTCEECC-----------CCCTTTSCHHHHHSSCC
T ss_pred HHHHHHHHHHHHHHHHHhCCee-CCCCCHhhEEECCCCCEEEeeCCCcccccccc-----cCCCCCcceeCHHHhcCCCC
Confidence 3689999999999999999988 99999999999999999999999987532211 22356778999999987655
Q ss_pred CCCCCccchHHHHHHHHHHHh-CCCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCchHHHHHHHHHhhhcCCCCCCCHHH
Q psy1840 104 PRGTQKGDVYSFGLVLYEVIG-RQGPWGHLRMTDEEIITSVTQGSGLRPDTSSLDCAPSIIACMRTCWEEDPELRPDLRF 182 (423)
Q Consensus 104 ~~~s~ksDVyS~Giil~ellt-g~~Pf~~~~~~~~~i~~~i~~~~~~~p~~~~~~~~~~l~~Li~~C~~~dP~~RPt~~~ 182 (423)
+.++|||||||++|||++ |..||... +..++...+..+.. +.. +..+++.+.++|.+||+.||++|||+.+
T Consensus 364 ---~~~sDvwslG~~l~el~t~g~~P~~~~--~~~~~~~~i~~~~~--~~~-p~~~~~~l~~li~~cl~~dp~~Rpt~~~ 435 (450)
T 1k9a_A 364 ---STKSDVWSFGILLWEIYSFGRVPYPRI--PLKDVVPRVEKGYK--MDA-PDGCPPAVYDVMKNCWHLDAATRPTFLQ 435 (450)
T ss_dssp ---CHHHHHHHHHHHHHHHHTTTCCSSTTS--CTTTHHHHHHTTCC--CCC-CTTCCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred ---CcHHHHHHHHHHHHHHHhCCCCCCCCC--CHHHHHHHHHcCCC--CCC-CCcCCHHHHHHHHHHcCCChhHCcCHHH
Confidence 899999999999999998 99999753 34556666666532 222 2468999999999999999999999999
Q ss_pred HHHHHHHHhh
Q psy1840 183 VHHKLKEMNA 192 (423)
Q Consensus 183 I~~~L~~i~~ 192 (423)
|++.|+.+..
T Consensus 436 l~~~L~~i~~ 445 (450)
T 1k9a_A 436 LREQLEHIRT 445 (450)
T ss_dssp HHHHHHHHHH
T ss_pred HHHHHHHHHH
Confidence 9999988765
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=99.94 E-value=2.4e-27 Score=228.96 Aligned_cols=162 Identities=25% Similarity=0.443 Sum_probs=131.2
Q ss_pred HHHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCccEEEeccCCcccccCCCcccccccccCCccccCCccccCCCC
Q psy1840 24 GSISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKAPELLRQPHL 103 (423)
Q Consensus 24 ~~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~ 103 (423)
....++.||+.||.|||+.|++ ||||||+||+++.++.+||+|||++................+++.|+|||.+.+..+
T Consensus 149 ~~~~~~~qi~~al~~lH~~~i~-H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~ 227 (316)
T 2xir_A 149 HLICYSFQVAKGMEFLASRKCI-HRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVY 227 (316)
T ss_dssp HHHHHHHHHHHHHHHHHHTTCC-CSCCSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCC
T ss_pred HHHHHHHHHHHHHHHHHhCCcc-cccCccceEEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccc
Confidence 3679999999999999999998 999999999999999999999999876543333223334567788999999987655
Q ss_pred CCCCCccchHHHHHHHHHHHh-CCCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCchHHHHHHHHHhhhcCCCCCCCHHH
Q psy1840 104 PRGTQKGDVYSFGLVLYEVIG-RQGPWGHLRMTDEEIITSVTQGSGLRPDTSSLDCAPSIIACMRTCWEEDPELRPDLRF 182 (423)
Q Consensus 104 ~~~s~ksDVyS~Giil~ellt-g~~Pf~~~~~~~~~i~~~i~~~~~~~p~~~~~~~~~~l~~Li~~C~~~dP~~RPt~~~ 182 (423)
+.++||||||+++|||++ |..||..... ...+...+..+.... ....+++.+.+++.+||+.||.+|||+.+
T Consensus 228 ---~~~~Di~slG~il~~l~t~g~~p~~~~~~-~~~~~~~~~~~~~~~---~~~~~~~~l~~li~~~l~~dp~~Rps~~e 300 (316)
T 2xir_A 228 ---TIQSDVWSFGVLLWEIFSLGASPYPGVKI-DEEFCRRLKEGTRMR---APDYTTPEMYQTMLDCWHGEPSQRPTFSE 300 (316)
T ss_dssp ---CHHHHHHHHHHHHHHHHTTSCCSSTTCCC-SHHHHHHHHHTCCCC---CCTTCCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred ---cchhHHHHHHHHHHHHHhCCCCCCcccch-hHHHHHHhccCccCC---CCCCCCHHHHHHHHHHcCCChhhCcCHHH
Confidence 899999999999999998 9999975443 344555555543221 12357899999999999999999999999
Q ss_pred HHHHHHHHhhh
Q psy1840 183 VHHKLKEMNAG 193 (423)
Q Consensus 183 I~~~L~~i~~~ 193 (423)
|++.|+.+...
T Consensus 301 ll~~L~~~~~~ 311 (316)
T 2xir_A 301 LVEHLGNLLQA 311 (316)
T ss_dssp HHHHHHHHHHH
T ss_pred HHHHHHHHHhh
Confidence 99999887654
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=99.94 E-value=2.2e-27 Score=227.57 Aligned_cols=163 Identities=22% Similarity=0.357 Sum_probs=122.7
Q ss_pred HHHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCccEEEeccCCcccccCCCcc-cccccccCCccccCCccccCCC
Q psy1840 24 GSISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDET-GQERKLRRRKLYKAPELLRQPH 102 (423)
Q Consensus 24 ~~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~~-~~~~~~~gt~~y~APE~l~~~~ 102 (423)
..+.++.|++.||.|||+.|++ ||||||+||+++.++.+||+|||++......... .......++..|+|||.+.+..
T Consensus 115 ~~~~~~~qi~~~l~~lH~~~iv-H~Dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~ 193 (295)
T 3ugc_A 115 KLLQYTSQICKGMEYLGTKRYI-HRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWYAPESLTESK 193 (295)
T ss_dssp HHHHHHHHHHHHHHHHHHTTCC-CSCCSGGGEEEEETTEEEECCCCSCC-------------CTTCGGGGCCHHHHHHCC
T ss_pred HHHHHHHHHHHHHHHHhcCCcc-cCCCCHhhEEEcCCCeEEEccCcccccccCCcceeeeccCCCCccceeCcHHhcCCC
Confidence 3678999999999999999998 9999999999999999999999998765433221 1123345667799999998765
Q ss_pred CCCCCCccchHHHHHHHHHHHhCCCCCCCCCC----------C----hHHHHHHHhcCCCCCCCCCCCCchHHHHHHHHH
Q psy1840 103 LPRGTQKGDVYSFGLVLYEVIGRQGPWGHLRM----------T----DEEIITSVTQGSGLRPDTSSLDCAPSIIACMRT 168 (423)
Q Consensus 103 ~~~~s~ksDVyS~Giil~elltg~~Pf~~~~~----------~----~~~i~~~i~~~~~~~p~~~~~~~~~~l~~Li~~ 168 (423)
+ +.++||||||+++|||++|..||..... . ...+...+..+.. +. .+..+++++.+++.+
T Consensus 194 ~---~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~-~~~~~~~~l~~li~~ 267 (295)
T 3ugc_A 194 F---SVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGR--LP-RPDGCPDEIYMIMTE 267 (295)
T ss_dssp C---CHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHHHHHHHHHHTTCC--CC-CCTTCCHHHHHHHHH
T ss_pred C---ChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhHHHHHHHHhccCc--CC-CCcCcCHHHHHHHHH
Confidence 5 8999999999999999999998853110 0 0122233333221 11 234689999999999
Q ss_pred hhhcCCCCCCCHHHHHHHHHHHhhh
Q psy1840 169 CWEEDPELRPDLRFVHHKLKEMNAG 193 (423)
Q Consensus 169 C~~~dP~~RPt~~~I~~~L~~i~~~ 193 (423)
||+.||++|||+.++++.|+.+...
T Consensus 268 ~l~~dp~~Rps~~el~~~L~~l~~~ 292 (295)
T 3ugc_A 268 CWNNNVNQRPSFRDLALRVDQIRDN 292 (295)
T ss_dssp HSCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred HcCCChhhCCCHHHHHHHHHHHHHh
Confidence 9999999999999999999988754
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.94 E-value=5.6e-27 Score=224.48 Aligned_cols=164 Identities=29% Similarity=0.521 Sum_probs=130.1
Q ss_pred HHHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCccEEEeccCCcccccCCCc--ccccccccCCccccCCccccCC
Q psy1840 24 GSISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDE--TGQERKLRRRKLYKAPELLRQP 101 (423)
Q Consensus 24 ~~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~--~~~~~~~~gt~~y~APE~l~~~ 101 (423)
..+.++.|++.||.|||+.|++ ||||||+||+++.++.+||+|||++........ ........++..|+|||.+.+.
T Consensus 125 ~~~~i~~qi~~~l~~LH~~~i~-H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~ 203 (298)
T 3pls_A 125 DLISFGLQVARGMEYLAEQKFV-HRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWTALESLQTY 203 (298)
T ss_dssp HHHHHHHHHHHHHHHHHHTTCC-CSCCSGGGEEECTTCCEEECCTTSSCTTTTGGGGCSCCSSCTTCGGGGSCHHHHTTC
T ss_pred HHHHHHHHHHHHHHHHHhCCcc-cCCCCcceEEEcCCCcEEeCcCCCcccccCCcccccccCcCCCCCccccChhhhccC
Confidence 3679999999999999999998 999999999999999999999999875533221 1122344677889999999876
Q ss_pred CCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCchHHHHHHHHHhhhcCCCCCCCHH
Q psy1840 102 HLPRGTQKGDVYSFGLVLYEVIGRQGPWGHLRMTDEEIITSVTQGSGLRPDTSSLDCAPSIIACMRTCWEEDPELRPDLR 181 (423)
Q Consensus 102 ~~~~~s~ksDVyS~Giil~elltg~~Pf~~~~~~~~~i~~~i~~~~~~~p~~~~~~~~~~l~~Li~~C~~~dP~~RPt~~ 181 (423)
.+ +.++||||||+++|+|++|..|+.. .....++...+..+.... ....+++.+.+++.+||+.||.+|||+.
T Consensus 204 ~~---~~~~Di~slG~il~~l~~g~~~~~~-~~~~~~~~~~~~~~~~~~---~~~~~~~~l~~li~~~l~~~p~~Rps~~ 276 (298)
T 3pls_A 204 RF---TTKSDVWSFGVLLWELLTRGAPPYR-HIDPFDLTHFLAQGRRLP---QPEYCPDSLYQVMQQCWEADPAVRPTFR 276 (298)
T ss_dssp CC---CHHHHHHHHHHHHHHHHHTSCCTTT-TSCGGGHHHHHHTTCCCC---CCTTCCHHHHHHHHHHTCSSGGGSCCHH
T ss_pred CC---ChhhchhhHHHHHHHHhhCCCCCCc-cCCHHHHHHHhhcCCCCC---CCccchHHHHHHHHHHccCChhhCcCHH
Confidence 55 8999999999999999996655432 234455556665543222 2235789999999999999999999999
Q ss_pred HHHHHHHHHhhhcC
Q psy1840 182 FVHHKLKEMNAGLK 195 (423)
Q Consensus 182 ~I~~~L~~i~~~~~ 195 (423)
++++.|+++.....
T Consensus 277 ~ll~~l~~~~~~l~ 290 (298)
T 3pls_A 277 VLVGEVEQIVSALL 290 (298)
T ss_dssp HHHHHHHHHHHHCC
T ss_pred HHHHHHHHHHHHHh
Confidence 99999998876553
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=5.7e-27 Score=225.51 Aligned_cols=180 Identities=16% Similarity=0.334 Sum_probs=146.0
Q ss_pred HHHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCccEEEeccCCcccccCCCcccccccccCCccccCCccccCCCC
Q psy1840 24 GSISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKAPELLRQPHL 103 (423)
Q Consensus 24 ~~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~ 103 (423)
....++.|++.||.|||+.|++ ||||||+||+++.++.+||+|||++........ ......+++.|+|||.+.+..+
T Consensus 120 ~~~~~~~qi~~~l~~lH~~~i~-H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~ 196 (303)
T 3a7i_A 120 QIATILREILKGLDYLHSEKKI-HRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI--KRNTFVGTPFWMAPEVIKQSAY 196 (303)
T ss_dssp HHHHHHHHHHHHHHHHHHTTEE-CCCCSGGGEEECTTSCEEECCCTTCEECBTTBC--CBCCCCSCGGGCCHHHHTTCCB
T ss_pred HHHHHHHHHHHHHHHHHHCCCc-cCCCChheEEECCCCCEEEeecccceecCcccc--ccCccCCCcCccCHHHHhcCCC
Confidence 3689999999999999999988 999999999999999999999999876543221 2234568899999999987655
Q ss_pred CCCCCccchHHHHHHHHHHHhCCCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCchHHHHHHHHHhhhcCCCCCCCHHHH
Q psy1840 104 PRGTQKGDVYSFGLVLYEVIGRQGPWGHLRMTDEEIITSVTQGSGLRPDTSSLDCAPSIIACMRTCWEEDPELRPDLRFV 183 (423)
Q Consensus 104 ~~~s~ksDVyS~Giil~elltg~~Pf~~~~~~~~~i~~~i~~~~~~~p~~~~~~~~~~l~~Li~~C~~~dP~~RPt~~~I 183 (423)
+.++||||||+++|+|++|..||.. ....+....+..+.. + .....++..+.+++.+||+.||++|||+.++
T Consensus 197 ---~~~~Di~slG~il~~l~~g~~p~~~--~~~~~~~~~~~~~~~--~-~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l 268 (303)
T 3a7i_A 197 ---DSKADIWSLGITAIELARGEPPHSE--LHPMKVLFLIPKNNP--P-TLEGNYSKPLKEFVEACLNKEPSFRPTAKEL 268 (303)
T ss_dssp ---CTHHHHHHHHHHHHHHHHSSCTTTT--SCHHHHHHHHHHSCC--C-CCCSSCCHHHHHHHHHHCCSSGGGSCCHHHH
T ss_pred ---CchhhhHHHHHHHHHHccCCCCCCC--cCHHHHHHHhhcCCC--C-CCccccCHHHHHHHHHHcCCChhhCcCHHHH
Confidence 8899999999999999999999974 344555555554322 1 2234678999999999999999999999999
Q ss_pred HHHHHHHhhhcCCChHHHHHHHHHHhhhccc
Q psy1840 184 HHKLKEMNAGLKANIFDNMLAIMEKYAFNLE 214 (423)
Q Consensus 184 ~~~L~~i~~~~~~~~~d~~~~~~e~~~~~lE 214 (423)
++.........+.+..+.+...+.++....+
T Consensus 269 l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 299 (303)
T 3a7i_A 269 LKHKFILRNAKKTSYLTELIDRYKRWKAEQS 299 (303)
T ss_dssp TTCHHHHHHCCCGGGGHHHHHHHHHHHHHCC
T ss_pred hhChhhhcCCCccHHHHHHHHHHHHhhhhcc
Confidence 9877666666677788888888888765544
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=99.94 E-value=7.3e-27 Score=229.41 Aligned_cols=150 Identities=19% Similarity=0.292 Sum_probs=124.6
Q ss_pred HHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCccEEEeccCCcccccCCCcccccccccCCccccCCccccCCCCC
Q psy1840 25 SISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKAPELLRQPHLP 104 (423)
Q Consensus 25 ~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~ 104 (423)
...++.||+.||.|||++|++ ||||||+|||++.++.+||+|||+++...... .......||+.|+|||++.+..+
T Consensus 107 ~~~~~~qi~~aL~~LH~~~iv-HrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~- 182 (337)
T 1o6l_A 107 ARFYGAEIVSALEYLHSRDVV-YRDIKLENLMLDKDGHIKITDFGLCKEGISDG--ATMKTFCGTPEYLAPEVLEDNDY- 182 (337)
T ss_dssp HHHHHHHHHHHHHHHHHTTCB-CCCCCGGGEEECTTSCEEECCCTTCBCSCCTT--CCBCCCEECGGGCCGGGGSSSCB-
T ss_pred HHHHHHHHHHHHHHHHHCCee-cCcCCHHHEEECCCCCEEEeeccchhhcccCC--CcccccccChhhCChhhhcCCCC-
Confidence 568899999999999999998 99999999999999999999999987532221 12245678999999999987665
Q ss_pred CCCCccchHHHHHHHHHHHhCCCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCchHHHHHHHHHhhhcCCCCCC-----C
Q psy1840 105 RGTQKGDVYSFGLVLYEVIGRQGPWGHLRMTDEEIITSVTQGSGLRPDTSSLDCAPSIIACMRTCWEEDPELRP-----D 179 (423)
Q Consensus 105 ~~s~ksDVyS~Giil~elltg~~Pf~~~~~~~~~i~~~i~~~~~~~p~~~~~~~~~~l~~Li~~C~~~dP~~RP-----t 179 (423)
+.++|||||||++|||++|..||.. .+..++...+.......| ..+++++.+++.+||+.||.+|| +
T Consensus 183 --~~~~DiwslG~il~ell~g~~Pf~~--~~~~~~~~~i~~~~~~~p----~~~s~~~~~li~~lL~~dP~~R~g~~~~~ 254 (337)
T 1o6l_A 183 --GRAVDWWGLGVVMYEMMCGRLPFYN--QDHERLFELILMEEIRFP----RTLSPEAKSLLAGLLKKDPKQRLGGGPSD 254 (337)
T ss_dssp --CTTHHHHHHHHHHHHHHHSSCSSCC--SSHHHHHHHHHHCCCCCC----TTSCHHHHHHHHHHTCSSTTTSTTCSTTT
T ss_pred --CchhhcccchhHHHHHhcCCCCCCC--CCHHHHHHHHHcCCCCCC----CCCCHHHHHHHHHHhhcCHHHhcCCCCCC
Confidence 8999999999999999999999974 345666777666543333 35789999999999999999999 8
Q ss_pred HHHHHHH
Q psy1840 180 LRFVHHK 186 (423)
Q Consensus 180 ~~~I~~~ 186 (423)
+.+|++.
T Consensus 255 ~~ei~~h 261 (337)
T 1o6l_A 255 AKEVMEH 261 (337)
T ss_dssp HHHHHTS
T ss_pred HHHHHcC
Confidence 8887653
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.94 E-value=3.5e-27 Score=227.71 Aligned_cols=153 Identities=21% Similarity=0.249 Sum_probs=121.4
Q ss_pred HHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCccEEEeccCCcccccCCCcccccccccCCccccCCccccCCCCC
Q psy1840 25 SISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKAPELLRQPHLP 104 (423)
Q Consensus 25 ~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~ 104 (423)
...++.||+.||.|||+.|++ ||||||+||+++.++.+||+|||++....... ......+|+.|+|||++.+..+
T Consensus 122 ~~~i~~qi~~al~~lH~~~iv-H~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~- 196 (308)
T 3g33_A 122 IKDLMRQFLRGLDFLHANCIV-HRDLKPENILVTSGGTVKLADFGLARIYSYQM---ALTPVVVTLWYRAPEVLLQSTY- 196 (308)
T ss_dssp HHHHHHHHHHHHHHHHHTTCC-CSCCCTTTEEECTTSCEEECSCSCTTTSTTCC---CSGGGGCCCSSCCHHHHHTSCC-
T ss_pred HHHHHHHHHHHHHHHHHCCcc-cCCCCHHHEEEcCCCCEEEeeCccccccCCCc---ccCCccccccccCchHHcCCCC-
Confidence 679999999999999999988 99999999999999999999999987653222 2244578999999999987665
Q ss_pred CCCCccchHHHHHHHHHHHhCCCCCCCCCCChHHHHHHHhcCCCCCCCC-----------------------CCCCchHH
Q psy1840 105 RGTQKGDVYSFGLVLYEVIGRQGPWGHLRMTDEEIITSVTQGSGLRPDT-----------------------SSLDCAPS 161 (423)
Q Consensus 105 ~~s~ksDVyS~Giil~elltg~~Pf~~~~~~~~~i~~~i~~~~~~~p~~-----------------------~~~~~~~~ 161 (423)
+.++|||||||++|||++|..||.. .+..+....+.......+.. ....+++.
T Consensus 197 --~~~~DiwslG~il~~l~~g~~pf~~--~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 272 (308)
T 3g33_A 197 --ATPVDMWSVGCIFAEMFRRKPLFCG--NSEADQLGKIFDLIGLPPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEES 272 (308)
T ss_dssp --CSTHHHHHHHHHHHHTTTSSCSCCC--SSHHHHHHHHHHHHCCCCTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHH
T ss_pred --CchHHHHHHHHHHHHHHhCCCCCCC--CCHHHHHHHHHHHhCCCChhhccchhhccccccCCCCCCcHHHhCccccHH
Confidence 8999999999999999999999974 33444444443211000000 01256789
Q ss_pred HHHHHHHhhhcCCCCCCCHHHHHHH
Q psy1840 162 IIACMRTCWEEDPELRPDLRFVHHK 186 (423)
Q Consensus 162 l~~Li~~C~~~dP~~RPt~~~I~~~ 186 (423)
+.+++.+||+.||++|||+.++++.
T Consensus 273 ~~~li~~~L~~dP~~R~t~~e~l~h 297 (308)
T 3g33_A 273 GAQLLLEMLTFNPHKRISAFRALQH 297 (308)
T ss_dssp HHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred HHHHHHHHhcCCCccCCCHHHHhcC
Confidence 9999999999999999999998763
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=99.94 E-value=3.6e-28 Score=243.64 Aligned_cols=153 Identities=19% Similarity=0.203 Sum_probs=117.9
Q ss_pred HHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEc-CCccEEEeccCCcccccCCCcccccccccCCccccCCccccCCCC
Q psy1840 25 SISVNTTASVGMIHLHDSEIISHGNLRSSNCLID-SRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKAPELLRQPHL 103 (423)
Q Consensus 25 ~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld-~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~ 103 (423)
...++.||+.||.|||+.|++ ||||||+|||++ .++.+||+|||+++....... .....+|+.|+|||++.+..
T Consensus 143 ~~~~~~qi~~aL~~LH~~~iv-HrDlkp~Nill~~~~~~~kL~DFG~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~- 217 (394)
T 4e7w_A 143 IKLYMYQLLRSLAYIHSIGIC-HRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEP---NVSYICSRYYRAPELIFGAT- 217 (394)
T ss_dssp HHHHHHHHHHHHHHHHHTTEE-CSCCSGGGEEEETTTTEEEECCCTTCEECCTTCC---CCSSCSCGGGCCHHHHTTCS-
T ss_pred HHHHHHHHHHHHHHHHHCCcc-CCCCCHHHEEEcCCCCcEEEeeCCCcccccCCCC---CcccccCcCccCHHHHcCCC-
Confidence 568999999999999999988 999999999999 799999999999876533322 23456789999999987643
Q ss_pred CCCCCccchHHHHHHHHHHHhCCCCCCCCCCChHHHHHHHhcC-----------------CCCCCCC--------CCCCc
Q psy1840 104 PRGTQKGDVYSFGLVLYEVIGRQGPWGHLRMTDEEIITSVTQG-----------------SGLRPDT--------SSLDC 158 (423)
Q Consensus 104 ~~~s~ksDVyS~Giil~elltg~~Pf~~~~~~~~~i~~~i~~~-----------------~~~~p~~--------~~~~~ 158 (423)
.++.++|||||||++|||++|+.||.+. +..+.+..+... ....|.. ....+
T Consensus 218 -~~~~~~DiwSlG~il~ell~g~~pf~~~--~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 294 (394)
T 4e7w_A 218 -NYTTNIDIWSTGCVMAELMQGQPLFPGE--SGIDQLVEIIKVLGTPSREQIKTMNPNYMEHKFPQIRPHPFSKVFRPRT 294 (394)
T ss_dssp -SCCTHHHHHHHHHHHHHHHHSSCSSCCS--SHHHHHHHHHHHHCCCCHHHHHHHCGGGSSSCCCCCCCCCHHHHSCTTC
T ss_pred -CCCcHHHHHHHHHHHHHHHhCCCCCCCC--CHHHHHHHHHHHhCCCCHHHHHhhChhhhhhccccccCCcHHHhccccC
Confidence 2489999999999999999999999753 222222222110 0001111 11247
Q ss_pred hHHHHHHHHHhhhcCCCCCCCHHHHHH
Q psy1840 159 APSIIACMRTCWEEDPELRPDLRFVHH 185 (423)
Q Consensus 159 ~~~l~~Li~~C~~~dP~~RPt~~~I~~ 185 (423)
++++.+|+.+||+.||.+|||+.++++
T Consensus 295 ~~~~~~li~~~L~~dP~~R~t~~e~l~ 321 (394)
T 4e7w_A 295 PPDAIDLISRLLEYTPSARLTAIEALC 321 (394)
T ss_dssp CHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred CHHHHHHHHHHhCCChhhCCCHHHHhc
Confidence 789999999999999999999998875
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=7.1e-27 Score=230.40 Aligned_cols=175 Identities=18% Similarity=0.283 Sum_probs=132.8
Q ss_pred HHHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCccEEEeccCCcccccCCCcccccccccCCccccCCccccCCCC
Q psy1840 24 GSISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKAPELLRQPHL 103 (423)
Q Consensus 24 ~~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~ 103 (423)
....++.|++.||.|||+.|++ ||||||+||+++.++.+||+|||++...... ....||+.|+|||++.+...
T Consensus 155 ~~~~i~~qi~~aL~~LH~~~iv-H~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~------~~~~gt~~y~aPE~~~~~~~ 227 (348)
T 1u5q_A 155 EIAAVTHGALQGLAYLHSHNMI-HRDVKAGNILLSEPGLVKLGDFGSASIMAPA------NSFVGTPYWMAPEVILAMDE 227 (348)
T ss_dssp HHHHHHHHHHHHHHHHHHTTCB-CCCCSGGGEEEETTTEEEECCCTTCBSSSSB------CCCCSCGGGCCHHHHHTTSS
T ss_pred HHHHHHHHHHHHHHHHHhCCee-eCCCCHHHEEECCCCCEEEeeccCceecCCC------CcccCCcceeCHhhhccccC
Confidence 3679999999999999999998 9999999999999999999999998754321 34578999999999854221
Q ss_pred CCCCCccchHHHHHHHHHHHhCCCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCchHHHHHHHHHhhhcCCCCCCCHHHH
Q psy1840 104 PRGTQKGDVYSFGLVLYEVIGRQGPWGHLRMTDEEIITSVTQGSGLRPDTSSLDCAPSIIACMRTCWEEDPELRPDLRFV 183 (423)
Q Consensus 104 ~~~s~ksDVyS~Giil~elltg~~Pf~~~~~~~~~i~~~i~~~~~~~p~~~~~~~~~~l~~Li~~C~~~dP~~RPt~~~I 183 (423)
..++.++|||||||++|||++|..||.. ....+.+..+..+. .+......+++.+.+++.+||+.||++|||+.++
T Consensus 228 ~~~~~~~DiwslG~il~ell~g~~p~~~--~~~~~~~~~~~~~~--~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~l 303 (348)
T 1u5q_A 228 GQYDGKVDVWSLGITCIELAERKPPLFN--MNAMSALYHIAQNE--SPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVL 303 (348)
T ss_dssp CCBCTHHHHHHHHHHHHHHHHSSCTTTT--SCHHHHHHHHHHSC--CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred CCCCcHHHHHHHHHHHHHHHhCCCCCCC--CChHHHHHHHHhcC--CCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHH
Confidence 2348899999999999999999999964 33444444554433 2223334678999999999999999999999999
Q ss_pred HHHHHHHhhhcCCChHHHHHHHHHHhh
Q psy1840 184 HHKLKEMNAGLKANIFDNMLAIMEKYA 210 (423)
Q Consensus 184 ~~~L~~i~~~~~~~~~d~~~~~~e~~~ 210 (423)
++........ ......+.........
T Consensus 304 l~h~~~~~~~-~~~~~~~~~~~~~~~~ 329 (348)
T 1u5q_A 304 LKHRFVLRER-PPTVIMDLIQRTKDAV 329 (348)
T ss_dssp TTCHHHHSCC-CTTHHHHHHHHHHHHH
T ss_pred hhChhhhccC-CcchhhHHHHHHHHHH
Confidence 8875544433 3334444444443333
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.94 E-value=4.9e-28 Score=237.93 Aligned_cols=164 Identities=14% Similarity=0.201 Sum_probs=125.3
Q ss_pred HHHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCc--cEEEeccCCcccccCCCc-----ccccccccCCccccCCc
Q psy1840 24 GSISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRW--VLQIADFGLHAFKAGQDE-----TGQERKLRRRKLYKAPE 96 (423)
Q Consensus 24 ~~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~--~vKL~DFGla~~~~~~~~-----~~~~~~~~gt~~y~APE 96 (423)
..+.++.||+.||.|||+.|++ ||||||+||+++.++ .+||+|||+++....... ........|++.|+|||
T Consensus 152 ~~~~i~~qi~~aL~~LH~~~iv-H~Dlkp~NIll~~~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE 230 (345)
T 2v62_A 152 TVLQLGIRMLDVLEYIHENEYV-HGDIKAANLLLGYKNPDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLD 230 (345)
T ss_dssp HHHHHHHHHHHHHHHHHHTTEE-CSCCSGGGEEEESSSTTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHH
T ss_pred HHHHHHHHHHHHHHHHHhCCee-CCCcCHHHEEEccCCCCcEEEEeCCCceecccccccccchhccccccCCCccccCHH
Confidence 3689999999999999999988 999999999999877 999999999876532211 11123457899999999
Q ss_pred cccCCCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCChHHHHHHHhcCCCCCCC-----CCCCCchHHHHHHHHHhhh
Q psy1840 97 LLRQPHLPRGTQKGDVYSFGLVLYEVIGRQGPWGHLRMTDEEIITSVTQGSGLRPD-----TSSLDCAPSIIACMRTCWE 171 (423)
Q Consensus 97 ~l~~~~~~~~s~ksDVyS~Giil~elltg~~Pf~~~~~~~~~i~~~i~~~~~~~p~-----~~~~~~~~~l~~Li~~C~~ 171 (423)
.+.+..+ +.++|||||||++|||++|+.||.........+...........|. .....+++++.+++.+||+
T Consensus 231 ~~~~~~~---~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~ 307 (345)
T 2v62_A 231 AHKGVAL---SRRSDVEILGYCMLRWLCGKLPWEQNLKDPVAVQTAKTNLLDELPQSVLKWAPSGSSCCEIAQFLVCAHS 307 (345)
T ss_dssp HHHTCCC---CHHHHHHHHHHHHHHHHHSSCTTGGGTTCHHHHHHHHHHHHHTTTHHHHHHSCTTSCCHHHHHHHHHHHT
T ss_pred HhcCCCC---CchhhHHHHHHHHHHHHhCCCCccccccccHHHHHHHHhhcccccHHHHhhccccccHHHHHHHHHHHhh
Confidence 9987654 8999999999999999999999964333333222221111001110 1112578899999999999
Q ss_pred cCCCCCCCHHHHHHHHHHHh
Q psy1840 172 EDPELRPDLRFVHHKLKEMN 191 (423)
Q Consensus 172 ~dP~~RPt~~~I~~~L~~i~ 191 (423)
.||++||++.+|++.|+.+.
T Consensus 308 ~dp~~Rps~~~l~~~L~~~~ 327 (345)
T 2v62_A 308 LAYDEKPNYQALKKILNPHG 327 (345)
T ss_dssp CCTTCCCCHHHHHHHHCTTC
T ss_pred cCcccCCCHHHHHHHHhccC
Confidence 99999999999999987654
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=99.94 E-value=5e-27 Score=232.73 Aligned_cols=155 Identities=17% Similarity=0.264 Sum_probs=128.7
Q ss_pred HHHHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCC---ccEEEeccCCcccccCCCcccccccccCCccccCCcccc
Q psy1840 23 IGSISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSR---WVLQIADFGLHAFKAGQDETGQERKLRRRKLYKAPELLR 99 (423)
Q Consensus 23 ~~~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~---~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~ 99 (423)
.....++.||+.||.|||+.|++ ||||||+||+++.+ +.+||+|||++....... ......||+.|+|||++.
T Consensus 128 ~~~~~~~~qi~~al~~lH~~~iv-H~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~~~~---~~~~~~gt~~y~aPE~~~ 203 (362)
T 2bdw_A 128 ADASHCIQQILESIAYCHSNGIV-HRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSE---AWHGFAGTPGYLSPEVLK 203 (362)
T ss_dssp HHHHHHHHHHHHHHHHHHHTTCB-CCCCSGGGEEESCSSTTCCEEECCCTTCBCCTTCC---SCCCSCSCTTTCCHHHHT
T ss_pred HHHHHHHHHHHHHHHHHHHCCeE-eccCchHHEEEecCCCCCCEEEeecCcceEecCCc---ccccCCCCccccCHHHHc
Confidence 34679999999999999999998 99999999999865 459999999987654322 123467899999999998
Q ss_pred CCCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCchHHHHHHHHHhhhcCCCCCCC
Q psy1840 100 QPHLPRGTQKGDVYSFGLVLYEVIGRQGPWGHLRMTDEEIITSVTQGSGLRPDTSSLDCAPSIIACMRTCWEEDPELRPD 179 (423)
Q Consensus 100 ~~~~~~~s~ksDVyS~Giil~elltg~~Pf~~~~~~~~~i~~~i~~~~~~~p~~~~~~~~~~l~~Li~~C~~~dP~~RPt 179 (423)
+..+ +.++|||||||++|+|++|..||.. .+..++...+..+....|......+++++.+++.+||+.||++||+
T Consensus 204 ~~~~---~~~~DiwslG~il~~ll~g~~Pf~~--~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t 278 (362)
T 2bdw_A 204 KDPY---SKPVDIWACGVILYILLVGYPPFWD--EDQHRLYAQIKAGAYDYPSPEWDTVTPEAKSLIDSMLTVNPKKRIT 278 (362)
T ss_dssp TCCC---CTHHHHHHHHHHHHHHHHSSCSSCC--SSHHHHHHHHHHTCCCCCTTGGGGSCHHHHHHHHHHSCSSGGGSCC
T ss_pred cCCC---CchhhHHHHHHHHHHHHHCCCCCCC--CCHHHHHHHHHhCCCCCCcccccCCCHHHHHHHHHHcCCChhhCcC
Confidence 7655 8999999999999999999999974 4556777777776555444434467899999999999999999999
Q ss_pred HHHHHHH
Q psy1840 180 LRFVHHK 186 (423)
Q Consensus 180 ~~~I~~~ 186 (423)
+.++++.
T Consensus 279 ~~e~l~h 285 (362)
T 2bdw_A 279 ADQALKV 285 (362)
T ss_dssp HHHHTTS
T ss_pred HHHHhcC
Confidence 9999765
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=99.94 E-value=2.7e-27 Score=229.60 Aligned_cols=159 Identities=26% Similarity=0.492 Sum_probs=129.5
Q ss_pred HHHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCccEEEeccCCcccccCCCcccccccccCCccccCCccccCCCC
Q psy1840 24 GSISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKAPELLRQPHL 103 (423)
Q Consensus 24 ~~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~ 103 (423)
..+.++.||+.||.|||++|++ ||||||+||+++.++.+||+|||++................+++.|+|||.+.+..+
T Consensus 139 ~~~~i~~qi~~~l~~lH~~~i~-H~dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~ 217 (322)
T 1p4o_A 139 KMIQMAGEIADGMAYLNANKFV-HRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVF 217 (322)
T ss_dssp HHHHHHHHHHHHHHHHHHTTCB-CSCCSGGGEEECTTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCC
T ss_pred HHHHHHHHHHHHHHHHHHCCCc-cCCCccceEEEcCCCeEEECcCccccccccccccccccCCCCCCCccChhhhccCCC
Confidence 3678999999999999999998 999999999999999999999999876543322222234456788999999987654
Q ss_pred CCCCCccchHHHHHHHHHHHh-CCCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCchHHHHHHHHHhhhcCCCCCCCHHH
Q psy1840 104 PRGTQKGDVYSFGLVLYEVIG-RQGPWGHLRMTDEEIITSVTQGSGLRPDTSSLDCAPSIIACMRTCWEEDPELRPDLRF 182 (423)
Q Consensus 104 ~~~s~ksDVyS~Giil~ellt-g~~Pf~~~~~~~~~i~~~i~~~~~~~p~~~~~~~~~~l~~Li~~C~~~dP~~RPt~~~ 182 (423)
+.++||||||+++|+|++ |..||.. ....++...+..+.... ....++..+.+++.+||+.||++|||+.+
T Consensus 218 ---~~~~Di~slG~il~el~~~g~~p~~~--~~~~~~~~~~~~~~~~~---~~~~~~~~l~~li~~~l~~dp~~Rps~~e 289 (322)
T 1p4o_A 218 ---TTYSDVWSFGVVLWEIATLAEQPYQG--LSNEQVLRFVMEGGLLD---KPDNCPDMLFELMRMCWQYNPKMRPSFLE 289 (322)
T ss_dssp ---CHHHHHHHHHHHHHHHHHTSCCTTTT--SCHHHHHHHHHTTCCCC---CCTTCCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred ---CchhhHHHHHHHHHHHHhcCCCcccc--CCHHHHHHHHHcCCcCC---CCCCCCHHHHHHHHHHcCCCcccCcCHHH
Confidence 899999999999999999 8889974 45566666666543221 12367899999999999999999999999
Q ss_pred HHHHHHHHh
Q psy1840 183 VHHKLKEMN 191 (423)
Q Consensus 183 I~~~L~~i~ 191 (423)
+++.|+...
T Consensus 290 ~l~~L~~~~ 298 (322)
T 1p4o_A 290 IISSIKEEM 298 (322)
T ss_dssp HHHHHGGGS
T ss_pred HHHHHHHhh
Confidence 999887654
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.94 E-value=5.3e-28 Score=233.64 Aligned_cols=159 Identities=28% Similarity=0.455 Sum_probs=123.1
Q ss_pred HHHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCccEEEeccCCcccccCCCccc------------ccccccCCcc
Q psy1840 24 GSISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETG------------QERKLRRRKL 91 (423)
Q Consensus 24 ~~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~~~------------~~~~~~gt~~ 91 (423)
..+.++.|++.||.|||+.|++ ||||||+||+++.++.+||+|||++.......... ......||+.
T Consensus 109 ~~~~i~~qi~~al~~lH~~~iv-H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~ 187 (310)
T 3s95_A 109 QRVSFAKDIASGMAYLHSMNII-HRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPY 187 (310)
T ss_dssp HHHHHHHHHHHHHHHHHHTTEE-CSCCSTTSEEECTTSCEEECCCTTCEECC--------------------CCCCSCGG
T ss_pred HHHHHHHHHHHHHHHHHhCCcc-CCCCCcCeEEECCCCCEEEeecccceecccccccccccccccccccccccccCCCcc
Confidence 3689999999999999999988 99999999999999999999999987653322111 1124578999
Q ss_pred ccCCccccCCCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCChH----HHHHHHhcCCCCCCCCCCCCchHHHHHHHH
Q psy1840 92 YKAPELLRQPHLPRGTQKGDVYSFGLVLYEVIGRQGPWGHLRMTDE----EIITSVTQGSGLRPDTSSLDCAPSIIACMR 167 (423)
Q Consensus 92 y~APE~l~~~~~~~~s~ksDVyS~Giil~elltg~~Pf~~~~~~~~----~i~~~i~~~~~~~p~~~~~~~~~~l~~Li~ 167 (423)
|+|||.+.+..+ +.++||||||+++|||++|..||........ ......... .+..+++.+.+++.
T Consensus 188 y~aPE~~~~~~~---~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~-------~~~~~~~~l~~li~ 257 (310)
T 3s95_A 188 WMAPEMINGRSY---DEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFLDRY-------CPPNCPPSFFPITV 257 (310)
T ss_dssp GCCHHHHTTCCC---CTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBCHHHHHHHT-------CCTTCCTTHHHHHH
T ss_pred eeCHHHhcCCCC---CcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhhhhcccccc-------CCCCCCHHHHHHHH
Confidence 999999987655 8999999999999999999999864321110 011111110 12356788999999
Q ss_pred HhhhcCCCCCCCHHHHHHHHHHHhhh
Q psy1840 168 TCWEEDPELRPDLRFVHHKLKEMNAG 193 (423)
Q Consensus 168 ~C~~~dP~~RPt~~~I~~~L~~i~~~ 193 (423)
+||+.||++|||+.++++.|+.+...
T Consensus 258 ~~l~~dP~~Rps~~~l~~~L~~l~~~ 283 (310)
T 3s95_A 258 RCCDLDPEKRPSFVKLEHWLETLRMH 283 (310)
T ss_dssp HHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHccCChhhCcCHHHHHHHHHHHHHh
Confidence 99999999999999999999888754
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=99.94 E-value=1.8e-27 Score=228.66 Aligned_cols=163 Identities=25% Similarity=0.312 Sum_probs=123.3
Q ss_pred HHHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCccEEEeccCCcccccCCCcccccccccCCccccCCccccCCCC
Q psy1840 24 GSISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKAPELLRQPHL 103 (423)
Q Consensus 24 ~~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~ 103 (423)
....++.|++.||.|||+.|++ ||||||+||+++.++.+||+|||++........ .......||+.|+|||.+.+..+
T Consensus 112 ~~~~~~~qi~~~l~~lH~~~i~-H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~ 189 (294)
T 4eqm_A 112 TAINFTNQILDGIKHAHDMRIV-HRDIKPQNILIDSNKTLKIFDFGIAKALSETSL-TQTNHVLGTVQYFSPEQAKGEAT 189 (294)
T ss_dssp HHHHHHHHHHHHHHHHHHTTCC-CCCCCGGGEEECTTSCEEECCCSSSTTC--------------CCSSCCHHHHHTCCC
T ss_pred HHHHHHHHHHHHHHHHHHCCcc-cCCCCHHHEEECCCCCEEEEeCCCccccccccc-cccCccccCccccCHhHhcCCCC
Confidence 3689999999999999999998 999999999999999999999999876533221 22234568999999999987655
Q ss_pred CCCCCccchHHHHHHHHHHHhCCCCCCCCCCChHHHHHHHhcCC-CCCCCCCCCCchHHHHHHHHHhhhcCCCCCC-CHH
Q psy1840 104 PRGTQKGDVYSFGLVLYEVIGRQGPWGHLRMTDEEIITSVTQGS-GLRPDTSSLDCAPSIIACMRTCWEEDPELRP-DLR 181 (423)
Q Consensus 104 ~~~s~ksDVyS~Giil~elltg~~Pf~~~~~~~~~i~~~i~~~~-~~~p~~~~~~~~~~l~~Li~~C~~~dP~~RP-t~~ 181 (423)
+.++||||||+++|||++|+.||... +..+......... +..+......+++.+.+++.+||+.||.+|| ++.
T Consensus 190 ---~~~~Di~slG~~l~~ll~g~~pf~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~R~~~~~ 264 (294)
T 4eqm_A 190 ---DECTDIYSIGIVLYEMLVGEPPFNGE--TAVSIAIKHIQDSVPNVTTDVRKDIPQSLSNVILRATEKDKANRYKTIQ 264 (294)
T ss_dssp ---CTTHHHHHHHHHHHHHHHSSCSSCSS--CHHHHHHHHHSSCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCSSHH
T ss_pred ---CchHhHHHHHHHHHHHHhCCCCCCCC--ChHHHHHHHhhccCCCcchhcccCCCHHHHHHHHHHhcCCHhHccccHH
Confidence 88999999999999999999999743 3333333333222 1111122346789999999999999999998 899
Q ss_pred HHHHHHHHHhhh
Q psy1840 182 FVHHKLKEMNAG 193 (423)
Q Consensus 182 ~I~~~L~~i~~~ 193 (423)
++.+.|..+...
T Consensus 265 ~l~~~l~~~~~~ 276 (294)
T 4eqm_A 265 EMKDDLSSVLHE 276 (294)
T ss_dssp HHHHHHHTSSSS
T ss_pred HHHHHHHHHHhh
Confidence 999888876554
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.94 E-value=2.3e-27 Score=236.18 Aligned_cols=163 Identities=23% Similarity=0.456 Sum_probs=120.6
Q ss_pred HHHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCccEEEeccCCcccccCCCcc--cccccccCCccccCCccccCC
Q psy1840 24 GSISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDET--GQERKLRRRKLYKAPELLRQP 101 (423)
Q Consensus 24 ~~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~~--~~~~~~~gt~~y~APE~l~~~ 101 (423)
..+.++.||+.||.|||+.|++ ||||||+||+++.++.+||+|||+++........ .......+++.|+|||.+.+.
T Consensus 193 ~~~~i~~qi~~aL~~LH~~~iv-HrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~ 271 (373)
T 3c1x_A 193 DLIGFGLQVAKGMKFLASKKFV-HRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQ 271 (373)
T ss_dssp HHHHHHHHHHHHHHHHHHTTCC-CSCCCGGGEEECTTCCEEECCC---------------------CCGGGSCHHHHHHC
T ss_pred HHHHHHHHHHHHHHHHHHCCEe-cCccchheEEECCCCCEEEeeccccccccccccccccccCCCCCcccccChHHhcCC
Confidence 3678999999999999999998 9999999999999999999999998765332211 112334567789999999876
Q ss_pred CCCCCCCccchHHHHHHHHHHHh-CCCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCchHHHHHHHHHhhhcCCCCCCCH
Q psy1840 102 HLPRGTQKGDVYSFGLVLYEVIG-RQGPWGHLRMTDEEIITSVTQGSGLRPDTSSLDCAPSIIACMRTCWEEDPELRPDL 180 (423)
Q Consensus 102 ~~~~~s~ksDVyS~Giil~ellt-g~~Pf~~~~~~~~~i~~~i~~~~~~~p~~~~~~~~~~l~~Li~~C~~~dP~~RPt~ 180 (423)
.+ +.++|||||||++|||++ |..||.... ..++...+..+.... .+..++..+.+++.+||+.||++||++
T Consensus 272 ~~---~~~~DvwSlG~il~ellt~~~~p~~~~~--~~~~~~~~~~~~~~~---~p~~~~~~l~~li~~cl~~dp~~RPs~ 343 (373)
T 3c1x_A 272 KF---TTKSDVWSFGVLLWELMTRGAPPYPDVN--TFDITVYLLQGRRLL---QPEYCPDPLYEVMLKCWHPKAEMRPSF 343 (373)
T ss_dssp CC---CHHHHHHHHHHHHHHHHTTSCCSCTTSC--SSCHHHHHHTTCCCC---CCTTCCHHHHHHHHHHTCSSGGGSCCH
T ss_pred CC---CcHHHHHHHHHHHHHHHhCcCCCCCCCC--HHHHHHHHHcCCCCC---CCCCCCHHHHHHHHHHcCCChhhCcCH
Confidence 55 899999999999999999 677776432 233444555543221 223678999999999999999999999
Q ss_pred HHHHHHHHHHhhhcC
Q psy1840 181 RFVHHKLKEMNAGLK 195 (423)
Q Consensus 181 ~~I~~~L~~i~~~~~ 195 (423)
.++++.|+.+.....
T Consensus 344 ~ell~~L~~i~~~~~ 358 (373)
T 3c1x_A 344 SELVSRISAIFSTFI 358 (373)
T ss_dssp HHHHHHHHHHHHTCC
T ss_pred HHHHHHHHHHHHhcc
Confidence 999999998876543
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=99.94 E-value=2.5e-27 Score=241.76 Aligned_cols=161 Identities=25% Similarity=0.474 Sum_probs=127.6
Q ss_pred HHHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCccEEEeccCCcccccCCCcccccccccCCccccCCccccCCCC
Q psy1840 24 GSISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKAPELLRQPHL 103 (423)
Q Consensus 24 ~~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~ 103 (423)
..+.++.||+.||+|||+++++ ||||||+|||++.++.+||+|||+++....... .......++..|+|||.+.+..+
T Consensus 281 ~~~~i~~qi~~~l~~LH~~~iv-HrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~ 358 (452)
T 1fmk_A 281 QLVDMAAQIASGMAYVERMNYV-HRDLRAANILVGENLVCKVADFGLARLIEDNEY-TARQGAKFPIKWTAPEAALYGRF 358 (452)
T ss_dssp HHHHHHHHHHHHHHHHHHTTCC-CSCCSGGGEEECGGGCEEECCCCTTC---------------CCGGGSCHHHHHHCCC
T ss_pred HHHHHHHHHHHHHHHHHhCCee-CCCCChhhEEECCCCCEEECCCccceecCCCce-ecccCCcccccccCHhHHhcCCC
Confidence 3689999999999999999998 999999999999999999999999876543221 11223446678999999987654
Q ss_pred CCCCCccchHHHHHHHHHHHh-CCCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCchHHHHHHHHHhhhcCCCCCCCHHH
Q psy1840 104 PRGTQKGDVYSFGLVLYEVIG-RQGPWGHLRMTDEEIITSVTQGSGLRPDTSSLDCAPSIIACMRTCWEEDPELRPDLRF 182 (423)
Q Consensus 104 ~~~s~ksDVyS~Giil~ellt-g~~Pf~~~~~~~~~i~~~i~~~~~~~p~~~~~~~~~~l~~Li~~C~~~dP~~RPt~~~ 182 (423)
+.++|||||||++|||++ |..||.+ ....++...+..+... .. +..+++.+.++|.+||+.||++|||+.+
T Consensus 359 ---~~~sDvwslG~~l~el~t~g~~P~~~--~~~~~~~~~i~~~~~~--~~-~~~~~~~l~~li~~cl~~dP~~Rpt~~~ 430 (452)
T 1fmk_A 359 ---TIKSDVWSFGILLTELTTKGRVPYPG--MVNREVLDQVERGYRM--PC-PPECPESLHDLMCQCWRKEPEERPTFEY 430 (452)
T ss_dssp ---CHHHHHHHHHHHHHHHHTTTCCSSTT--CCHHHHHHHHHTTCCC--CC-CTTSCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred ---CccccHHhHHHHHHHHHhCCCCCCCC--CCHHHHHHHHHcCCCC--CC-CCCCCHHHHHHHHHHccCChhhCcCHHH
Confidence 899999999999999999 8999974 4567777777765322 22 2368999999999999999999999999
Q ss_pred HHHHHHHHhhhc
Q psy1840 183 VHHKLKEMNAGL 194 (423)
Q Consensus 183 I~~~L~~i~~~~ 194 (423)
|++.|+.+....
T Consensus 431 l~~~L~~~~~~~ 442 (452)
T 1fmk_A 431 LQAFLEDYFTST 442 (452)
T ss_dssp HHHHHHTTTSCS
T ss_pred HHHHHHHHhccC
Confidence 999998876543
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=3.7e-27 Score=229.59 Aligned_cols=155 Identities=16% Similarity=0.288 Sum_probs=126.2
Q ss_pred HHHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCccEEEeccCCcccccCCCcccccccccCCccccCCccccCCCC
Q psy1840 24 GSISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKAPELLRQPHL 103 (423)
Q Consensus 24 ~~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~ 103 (423)
....++.|++.||.|||+.|++ ||||||+||+++.++.+||+|||++........ ......||+.|+|||.+.+..+
T Consensus 142 ~~~~i~~qi~~~L~~LH~~~iv-H~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~ 218 (321)
T 2c30_A 142 QIATVCEAVLQALAYLHAQGVI-HRDIKSDSILLTLDGRVKLSDFGFCAQISKDVP--KRKSLVGTPYWMAPEVISRSLY 218 (321)
T ss_dssp HHHHHHHHHHHHHHHHHHTTEE-CCCCSGGGEEECTTCCEEECCCTTCEECCSSSC--CBCCCCSCGGGCCHHHHTTCCB
T ss_pred HHHHHHHHHHHHHHHHHHCCee-cCCCCHHHEEECCCCcEEEeeeeeeeecccCcc--ccccccCCccccCHhhhcCCCC
Confidence 3689999999999999999988 999999999999999999999999876543221 2245578999999999987655
Q ss_pred CCCCCccchHHHHHHHHHHHhCCCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCchHHHHHHHHHhhhcCCCCCCCHHHH
Q psy1840 104 PRGTQKGDVYSFGLVLYEVIGRQGPWGHLRMTDEEIITSVTQGSGLRPDTSSLDCAPSIIACMRTCWEEDPELRPDLRFV 183 (423)
Q Consensus 104 ~~~s~ksDVyS~Giil~elltg~~Pf~~~~~~~~~i~~~i~~~~~~~p~~~~~~~~~~l~~Li~~C~~~dP~~RPt~~~I 183 (423)
+.++||||||+++|||++|+.||.. ....+....+......... ....+++.+.+++.+||+.||++|||+.++
T Consensus 219 ---~~~~Dv~slG~il~el~~g~~pf~~--~~~~~~~~~~~~~~~~~~~-~~~~~~~~l~~li~~~l~~dp~~Rps~~el 292 (321)
T 2c30_A 219 ---ATEVDIWSLGIMVIEMVDGEPPYFS--DSPVQAMKRLRDSPPPKLK-NSHKVSPVLRDFLERMLVRDPQERATAQEL 292 (321)
T ss_dssp ---CTHHHHHHHHHHHHHHHHSSCTTTT--SCHHHHHHHHHHSSCCCCT-TGGGSCHHHHHHHHHHSCSSTTTSCCHHHH
T ss_pred ---CchhhHHHHHHHHHHHHhCCCCCCC--CCHHHHHHHHhcCCCCCcC-ccccCCHHHHHHHHHHccCChhhCcCHHHH
Confidence 8899999999999999999999974 3455566666554322211 123578899999999999999999999999
Q ss_pred HHHH
Q psy1840 184 HHKL 187 (423)
Q Consensus 184 ~~~L 187 (423)
++..
T Consensus 293 l~hp 296 (321)
T 2c30_A 293 LDHP 296 (321)
T ss_dssp HTSG
T ss_pred hcCh
Confidence 8754
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.94 E-value=8.9e-27 Score=225.25 Aligned_cols=159 Identities=26% Similarity=0.457 Sum_probs=124.1
Q ss_pred HHHHHHHHHHHHHHHHHHh---CCCeeecCCCCCCEEEcCCcc-EEEeccCCcccccCCCcccccccccCCccccCCccc
Q psy1840 23 IGSISVNTTASVGMIHLHD---SEIISHGNLRSSNCLIDSRWV-LQIADFGLHAFKAGQDETGQERKLRRRKLYKAPELL 98 (423)
Q Consensus 23 ~~~l~i~~qi~~gL~yLH~---~~ii~HrDLkp~NILld~~~~-vKL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l 98 (423)
...+.++.|++.||.|||+ +|++ ||||||+||+++.++. +||+|||++...... .....|++.|+|||.+
T Consensus 102 ~~~~~~~~qi~~~l~~LH~~~~~~iv-H~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~-----~~~~~gt~~y~aPE~~ 175 (307)
T 2eva_A 102 AHAMSWCLQCSQGVAYLHSMQPKALI-HRDLKPPNLLLVAGGTVLKICDFGTACDIQTH-----MTNNKGSAAWMAPEVF 175 (307)
T ss_dssp HHHHHHHHHHHHHHHHHHTCSSSCCC-CCCCSGGGEEEETTTTEEEECCCCC-----------------CCTTSSCHHHH
T ss_pred HHHHHHHHHHHHHHHHHHhCCCCCee-cCCCChhHEEEeCCCCEEEEcccccccccccc-----cccCCCCCceEChhhh
Confidence 4468999999999999999 7888 9999999999998886 799999998654321 1234588999999999
Q ss_pred cCCCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCchHHHHHHHHHhhhcCCCCCC
Q psy1840 99 RQPHLPRGTQKGDVYSFGLVLYEVIGRQGPWGHLRMTDEEIITSVTQGSGLRPDTSSLDCAPSIIACMRTCWEEDPELRP 178 (423)
Q Consensus 99 ~~~~~~~~s~ksDVyS~Giil~elltg~~Pf~~~~~~~~~i~~~i~~~~~~~p~~~~~~~~~~l~~Li~~C~~~dP~~RP 178 (423)
.+..+ +.++||||||+++|||++|+.||.........+...+..+. .+.. ...++..+.+++.+||+.||++||
T Consensus 176 ~~~~~---~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~--~~~~-~~~~~~~l~~li~~~l~~dp~~Rp 249 (307)
T 2eva_A 176 EGSNY---SEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGT--RPPL-IKNLPKPIESLMTRCWSKDPSQRP 249 (307)
T ss_dssp TCCCC---CTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHHHHHHHHTTC--CCCC-BTTCCHHHHHHHHHHTCSSGGGSC
T ss_pred CCCCC---CcHHHHHHHHHHHHHHHHCCCCchhhCccHHHHHHHHhcCC--CCCc-ccccCHHHHHHHHHHhcCChhhCc
Confidence 87654 89999999999999999999999765555545554544432 2222 236789999999999999999999
Q ss_pred CHHHHHHHHHHHhhh
Q psy1840 179 DLRFVHHKLKEMNAG 193 (423)
Q Consensus 179 t~~~I~~~L~~i~~~ 193 (423)
|+.++++.|+.+...
T Consensus 250 s~~ell~~L~~~~~~ 264 (307)
T 2eva_A 250 SMEEIVKIMTHLMRY 264 (307)
T ss_dssp CHHHHHHHHHHHGGG
T ss_pred CHHHHHHHHHHHHHh
Confidence 999999999887654
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.94 E-value=6e-27 Score=228.22 Aligned_cols=166 Identities=29% Similarity=0.422 Sum_probs=125.1
Q ss_pred HHHHHHHHHHHHHHHHhC--------CCeeecCCCCCCEEEcCCccEEEeccCCcccccCCCccc--ccccccCCccccC
Q psy1840 25 SISVNTTASVGMIHLHDS--------EIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETG--QERKLRRRKLYKA 94 (423)
Q Consensus 25 ~l~i~~qi~~gL~yLH~~--------~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~~~--~~~~~~gt~~y~A 94 (423)
.+.++.|++.||.|||+. |++ ||||||+||+++.++.+||+|||++.......... ......||+.|+|
T Consensus 136 ~~~i~~~i~~~l~~lH~~~~~~~~~~~iv-H~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~a 214 (337)
T 3mdy_A 136 MLKLAYSSVSGLCHLHTEIFSTQGKPAIA-HRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMP 214 (337)
T ss_dssp HHHHHHHHHHHHHHHHSCBCSTTCBCCEE-CSCCCGGGEEECTTSCEEECCCTTCEECC---------CCSSCSCGGGCC
T ss_pred HHHHHHHHHHHHHHHHHhhhhhccCCCEE-ecccchHHEEECCCCCEEEEeCCCceeeccccccccCCCCCCccCcceeC
Confidence 679999999999999998 887 99999999999999999999999987553322211 1234578999999
Q ss_pred CccccCCCCCCCCC------ccchHHHHHHHHHHHhC----------CCCCCCCC---CChHHHHHHHhcCCCCCCCCC-
Q psy1840 95 PELLRQPHLPRGTQ------KGDVYSFGLVLYEVIGR----------QGPWGHLR---MTDEEIITSVTQGSGLRPDTS- 154 (423)
Q Consensus 95 PE~l~~~~~~~~s~------ksDVyS~Giil~elltg----------~~Pf~~~~---~~~~~i~~~i~~~~~~~p~~~- 154 (423)
||++.+... +. ++|||||||++|||++| +.||.... .........+ .....++..+
T Consensus 215 PE~~~~~~~---~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~ 290 (337)
T 3mdy_A 215 PEVLDESLN---RNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSDPSYEDMREIV-CIKKLRPSFPN 290 (337)
T ss_dssp HHHHTTCCC---TTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHH-TTSCCCCCCCG
T ss_pred hhhcccccC---CccccCccccchHHHHHHHHHHHhccCcccccccccccHhhhcCCCCchhhhHHHH-hhhccCccccc
Confidence 999987543 33 49999999999999999 66775431 1222333333 2222333322
Q ss_pred ---CCCchHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHhhhcC
Q psy1840 155 ---SLDCAPSIIACMRTCWEEDPELRPDLRFVHHKLKEMNAGLK 195 (423)
Q Consensus 155 ---~~~~~~~l~~Li~~C~~~dP~~RPt~~~I~~~L~~i~~~~~ 195 (423)
...+++++.+++.+||+.||.+|||+.+|++.|+.+.....
T Consensus 291 ~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~~ 334 (337)
T 3mdy_A 291 RWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKMSESQD 334 (337)
T ss_dssp GGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHTTT
T ss_pred cchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHHHHHhhcc
Confidence 23578889999999999999999999999999999887543
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=3.4e-27 Score=224.65 Aligned_cols=159 Identities=21% Similarity=0.410 Sum_probs=125.5
Q ss_pred HHHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCccEEEeccCCcccccCCCcccccccccCCccccCCccccCCCC
Q psy1840 24 GSISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKAPELLRQPHL 103 (423)
Q Consensus 24 ~~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~ 103 (423)
....++.|++.||.|||+.|++ ||||||+||+++.++.+||+|||++........ .......+++.|+|||.+.+..+
T Consensus 114 ~~~~~~~~i~~~l~~lH~~~i~-H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~ 191 (281)
T 3cc6_A 114 TLVLYSLQICKAMAYLESINCV-HRDIAVRNILVASPECVKLGDFGLSRYIEDEDY-YKASVTRLPIKWMSPESINFRRF 191 (281)
T ss_dssp HHHHHHHHHHHHHHHHHHTTCC-CCCCSGGGEEEEETTEEEECCCCGGGCC----------CCCCCGGGCCHHHHHHCCC
T ss_pred HHHHHHHHHHHHHHHHHHCCcc-cCCCccceEEECCCCcEEeCccCCCcccccccc-cccccCCCCcceeCchhhccCCC
Confidence 3678999999999999999998 999999999999999999999999876543221 11233456778999999976654
Q ss_pred CCCCCccchHHHHHHHHHHHh-CCCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCchHHHHHHHHHhhhcCCCCCCCHHH
Q psy1840 104 PRGTQKGDVYSFGLVLYEVIG-RQGPWGHLRMTDEEIITSVTQGSGLRPDTSSLDCAPSIIACMRTCWEEDPELRPDLRF 182 (423)
Q Consensus 104 ~~~s~ksDVyS~Giil~ellt-g~~Pf~~~~~~~~~i~~~i~~~~~~~p~~~~~~~~~~l~~Li~~C~~~dP~~RPt~~~ 182 (423)
+.++||||||+++|||++ |..||... ...+....+..+.... ....+++.+.+++.+||+.||++||++.+
T Consensus 192 ---~~~~Di~slG~il~~llt~g~~p~~~~--~~~~~~~~~~~~~~~~---~~~~~~~~l~~li~~~l~~~p~~Rps~~e 263 (281)
T 3cc6_A 192 ---TTASDVWMFAVCMWEILSFGKQPFFWL--ENKDVIGVLEKGDRLP---KPDLCPPVLYTLMTRCWDYDPSDRPRFTE 263 (281)
T ss_dssp ---CHHHHHHHHHHHHHHHHTTTCCTTTTS--CGGGHHHHHHHTCCCC---CCTTCCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred ---CchhccHHHHHHHHHHHhCCCCCcccC--ChHHHHHHHhcCCCCC---CCCCCCHHHHHHHHHHccCCchhCcCHHH
Confidence 899999999999999998 99999643 3344555555443221 12357899999999999999999999999
Q ss_pred HHHHHHHHhh
Q psy1840 183 VHHKLKEMNA 192 (423)
Q Consensus 183 I~~~L~~i~~ 192 (423)
+++.|+.+..
T Consensus 264 ll~~L~~~~~ 273 (281)
T 3cc6_A 264 LVCSLSDVYQ 273 (281)
T ss_dssp HHHHHHHHHH
T ss_pred HHHHHHHHHH
Confidence 9999988754
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.94 E-value=3.3e-27 Score=231.81 Aligned_cols=161 Identities=17% Similarity=0.220 Sum_probs=116.6
Q ss_pred HHHHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCccEEEeccCCcccccCCCcccccccccCCccccCCccccCCC
Q psy1840 23 IGSISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKAPELLRQPH 102 (423)
Q Consensus 23 ~~~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~ 102 (423)
.....++.||+.||.|||+.|++ ||||||+|||++ ++.+||+|||+++...............||+.|+|||++.+..
T Consensus 108 ~~~~~i~~qi~~al~~lH~~~ii-HrDikp~NIll~-~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~ 185 (343)
T 3dbq_A 108 WERKSYWKNMLEAVHTIHQHGIV-HSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMS 185 (343)
T ss_dssp HHHHHHHHHHHHHHHHHHHTTCC-CCCCCGGGEEEE-TTEEEECCCSSSCCC------------CCCCSSCCHHHHHHCC
T ss_pred HHHHHHHHHHHHHHHHHHhCCee-cCCCCcceEEEE-CCcEEEeecccccccCcccccccCCCCcCCcCcCCHHHHhhcc
Confidence 34689999999999999999998 999999999997 5789999999988654333322334567899999999986411
Q ss_pred --------CCCCCCccchHHHHHHHHHHHhCCCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCchHHHHHHHHHhhhcCC
Q psy1840 103 --------LPRGTQKGDVYSFGLVLYEVIGRQGPWGHLRMTDEEIITSVTQGSGLRPDTSSLDCAPSIIACMRTCWEEDP 174 (423)
Q Consensus 103 --------~~~~s~ksDVyS~Giil~elltg~~Pf~~~~~~~~~i~~~i~~~~~~~p~~~~~~~~~~l~~Li~~C~~~dP 174 (423)
...++.++|||||||++|||++|+.||....... .....+..... ....+...+.++.+++.+||+.||
T Consensus 186 ~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~-~~~~~~~~~~~--~~~~~~~~~~~l~~li~~~L~~dp 262 (343)
T 3dbq_A 186 SSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQI-SKLHAIIDPNH--EIEFPDIPEKDLQDVLKCCLKRDP 262 (343)
T ss_dssp -----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHH-HHHHHHHCTTS--CCCCCCCSCHHHHHHHHHHTCSST
T ss_pred ccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHH-HHHHHHhcCCc--ccCCcccCCHHHHHHHHHHcCCCh
Confidence 1134889999999999999999999997533222 22333322111 111223467899999999999999
Q ss_pred CCCCCHHHHHHHHH
Q psy1840 175 ELRPDLRFVHHKLK 188 (423)
Q Consensus 175 ~~RPt~~~I~~~L~ 188 (423)
.+|||+.++++...
T Consensus 263 ~~Rpt~~e~l~hp~ 276 (343)
T 3dbq_A 263 KQRISIPELLAHPY 276 (343)
T ss_dssp TTSCCHHHHHTSHH
T ss_pred hHCCCHHHHHhCcc
Confidence 99999999987543
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=99.94 E-value=4.5e-27 Score=223.86 Aligned_cols=159 Identities=20% Similarity=0.460 Sum_probs=130.1
Q ss_pred HHHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCccEEEeccCCcccccCCCcccccccccCCccccCCccccCCCC
Q psy1840 24 GSISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKAPELLRQPHL 103 (423)
Q Consensus 24 ~~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~ 103 (423)
....++.|++.||.|||+.|++ ||||||+||+++.++.+||+|||++....... ........+++.|+|||.+.+..+
T Consensus 121 ~~~~i~~qi~~~l~~lH~~~i~-H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~ 198 (283)
T 3gen_A 121 QLLEMCKDVCEAMEYLESKQFL-HRDLAARNCLVNDQGVVKVSDFGLSRYVLDDE-YTSSVGSKFPVRWSPPEVLMYSKF 198 (283)
T ss_dssp HHHHHHHHHHHHHHHHHHTTCC-CSSCSGGGEEECTTSCEEECSTTGGGGBCCHH-HHSTTSTTSCGGGCCHHHHHHCCC
T ss_pred HHHHHHHHHHHHHHHHHHCCcc-CCCCccceEEEcCCCCEEEccccccccccccc-cccccCCccCcccCCHHHhccCCC
Confidence 3689999999999999999998 99999999999999999999999987653221 112233456678999999987654
Q ss_pred CCCCCccchHHHHHHHHHHHh-CCCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCchHHHHHHHHHhhhcCCCCCCCHHH
Q psy1840 104 PRGTQKGDVYSFGLVLYEVIG-RQGPWGHLRMTDEEIITSVTQGSGLRPDTSSLDCAPSIIACMRTCWEEDPELRPDLRF 182 (423)
Q Consensus 104 ~~~s~ksDVyS~Giil~ellt-g~~Pf~~~~~~~~~i~~~i~~~~~~~p~~~~~~~~~~l~~Li~~C~~~dP~~RPt~~~ 182 (423)
+.++||||||+++|+|++ |..||.. ....+....+..+..... +..+++.+.+++.+||+.||++|||+.+
T Consensus 199 ---~~~~Dv~slG~~l~~l~t~g~~p~~~--~~~~~~~~~~~~~~~~~~---~~~~~~~l~~li~~~l~~~p~~Rps~~~ 270 (283)
T 3gen_A 199 ---SSKSDIWAFGVLMWEIYSLGKMPYER--FTNSETAEHIAQGLRLYR---PHLASEKVYTIMYSCWHEKADERPTFKI 270 (283)
T ss_dssp ---SHHHHHHHHHHHHHHHHTTTCCTTTT--SCHHHHHHHHHTTCCCCC---CTTCCHHHHHHHHHTTCSSGGGSCCHHH
T ss_pred ---CchhhHHHHHHHHHHHHhCCCCCccc--cChhHHHHHHhcccCCCC---CCcCCHHHHHHHHHHccCChhHCcCHHH
Confidence 899999999999999998 9999974 455666666666532222 2356889999999999999999999999
Q ss_pred HHHHHHHHhh
Q psy1840 183 VHHKLKEMNA 192 (423)
Q Consensus 183 I~~~L~~i~~ 192 (423)
+++.|+.+..
T Consensus 271 ll~~L~~~~~ 280 (283)
T 3gen_A 271 LLSNILDVMD 280 (283)
T ss_dssp HHHHHHHHHH
T ss_pred HHHHHHHHhh
Confidence 9999988764
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=3.9e-27 Score=228.82 Aligned_cols=166 Identities=27% Similarity=0.344 Sum_probs=125.8
Q ss_pred HHHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCccEEEeccCCcccccCCCcccccccccCCccccCCccccCCCC
Q psy1840 24 GSISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKAPELLRQPHL 103 (423)
Q Consensus 24 ~~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~ 103 (423)
..+.++.|++.||.|||++|++ ||||||+||+++.++.+||+|||++................|++.|+|||.+.+..+
T Consensus 140 ~~~~i~~~i~~~l~~lH~~~iv-H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~ 218 (321)
T 2qkw_B 140 QRLEICIGAARGLHYLHTRAII-HRDVKSINILLDENFVPKITDFGISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRL 218 (321)
T ss_dssp HHHHHHHHHHHHHHHHHHTTEE-CSCCCSTTEEECTTCCEEECCCTTCEECSSSSCCCCBCCCEEETTTCCHHHHHHCBC
T ss_pred HHHHHHHHHHHHHHHhcCCCee-cCCCCHHHEEECCCCCEEEeecccccccccccccccccccCCCccccCHHHhcCCCC
Confidence 3689999999999999999988 999999999999999999999999876443332222334567889999999977655
Q ss_pred CCCCCccchHHHHHHHHHHHhCCCCCCCCCC----ChHHHH-HHHhcCCC---CCCC---CCCCCchHHHHHHHHHhhhc
Q psy1840 104 PRGTQKGDVYSFGLVLYEVIGRQGPWGHLRM----TDEEII-TSVTQGSG---LRPD---TSSLDCAPSIIACMRTCWEE 172 (423)
Q Consensus 104 ~~~s~ksDVyS~Giil~elltg~~Pf~~~~~----~~~~i~-~~i~~~~~---~~p~---~~~~~~~~~l~~Li~~C~~~ 172 (423)
+.++||||||+++|||++|+.||..... ...+.. .....+.. ..+. .....++..+.+++.+||+.
T Consensus 219 ---~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~ 295 (321)
T 2qkw_B 219 ---TEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLAL 295 (321)
T ss_dssp ---CTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTTTCCCSSSSSSCTTCSCHHHHHHHHHHHHHHTCS
T ss_pred ---CcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhccccccHHHhcChhhccccCHHHHHHHHHHHHHHcCC
Confidence 8999999999999999999999964321 111111 11111110 1111 11234577899999999999
Q ss_pred CCCCCCCHHHHHHHHHHHhhh
Q psy1840 173 DPELRPDLRFVHHKLKEMNAG 193 (423)
Q Consensus 173 dP~~RPt~~~I~~~L~~i~~~ 193 (423)
||++|||+.++++.|+.+...
T Consensus 296 dP~~Rps~~ell~~L~~~l~~ 316 (321)
T 2qkw_B 296 SSEDRPSMGDVLWKLEYALRL 316 (321)
T ss_dssp SGGGSCCHHHHHHHHHHHHHS
T ss_pred CcccCcCHHHHHHHHHHHhhc
Confidence 999999999999999887653
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.94 E-value=5.5e-27 Score=231.15 Aligned_cols=180 Identities=18% Similarity=0.177 Sum_probs=128.9
Q ss_pred HHHHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcC---CccEEEeccCCcccccCCCcccccccccCCccccCCcccc
Q psy1840 23 IGSISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDS---RWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKAPELLR 99 (423)
Q Consensus 23 ~~~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~---~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~ 99 (423)
.....++.||+.||.|||+.|++ ||||||+||+++. ++.+||+|||+++...... ......||+.|+|||++.
T Consensus 148 ~~~~~i~~qi~~~L~~LH~~~iv-H~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~ 223 (349)
T 2w4o_A 148 RDAADAVKQILEAVAYLHENGIV-HRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQV---LMKTVCGTPGYCAPEILR 223 (349)
T ss_dssp HHHHHHHHHHHHHHHHHHHTTCC-CCCCCGGGEEESSSSTTCCEEECCCC-------------------CGGGSCHHHHT
T ss_pred HHHHHHHHHHHHHHHHHHHCCeE-ecCCCcccEEEecCCCCCCEEEccCccccccCccc---ccccccCCCCccCHHHhc
Confidence 34689999999999999999998 9999999999975 8999999999987653221 123456899999999998
Q ss_pred CCCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCchHHHHHHHHHhhhcCCCCCCC
Q psy1840 100 QPHLPRGTQKGDVYSFGLVLYEVIGRQGPWGHLRMTDEEIITSVTQGSGLRPDTSSLDCAPSIIACMRTCWEEDPELRPD 179 (423)
Q Consensus 100 ~~~~~~~s~ksDVyS~Giil~elltg~~Pf~~~~~~~~~i~~~i~~~~~~~p~~~~~~~~~~l~~Li~~C~~~dP~~RPt 179 (423)
+..+ +.++|||||||++|||++|..||.... ....+...+.......+......++.++.+++.+||+.||++|||
T Consensus 224 ~~~~---~~~~DiwslG~il~ell~g~~pf~~~~-~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt 299 (349)
T 2w4o_A 224 GCAY---GPEVDMWSVGIITYILLCGFEPFYDER-GDQFMFRRILNCEYYFISPWWDEVSLNAKDLVRKLIVLDPKKRLT 299 (349)
T ss_dssp TCCC---CTHHHHHHHHHHHHHHHHSSCTTCCTT-CHHHHHHHHHTTCCCCCTTTTTTSCHHHHHHHHTTSCSSGGGSCC
T ss_pred CCCC---CcccchHHHHHHHHHHHhCCCCCCCCc-ccHHHHHHHHhCCCccCCchhhhCCHHHHHHHHHHccCChhhCcC
Confidence 7655 899999999999999999999997532 334455666655443333333568899999999999999999999
Q ss_pred HHHHHHHHHHHhhhcCCChHHHHHHHHHHhh
Q psy1840 180 LRFVHHKLKEMNAGLKANIFDNMLAIMEKYA 210 (423)
Q Consensus 180 ~~~I~~~L~~i~~~~~~~~~d~~~~~~e~~~ 210 (423)
+.++++.-.-..........+.....++++.
T Consensus 300 ~~e~l~hp~~~~~~~~~~~~~~~~~~~~~~~ 330 (349)
T 2w4o_A 300 TFQALQHPWVTGKAANFVHMDTAQKKLQEFN 330 (349)
T ss_dssp HHHHHHSTTTTSTTCCCSCCHHHHHHHHHHH
T ss_pred HHHHhcCcccCCCccchhhhcchHHHHHHHH
Confidence 9999875322222222334455556666654
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=99.94 E-value=7.3e-27 Score=230.38 Aligned_cols=153 Identities=16% Similarity=0.197 Sum_probs=124.2
Q ss_pred HHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCcc---EEEeccCCcccccCCCcccccccccCCccccCCccccCC
Q psy1840 25 SISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWV---LQIADFGLHAFKAGQDETGQERKLRRRKLYKAPELLRQP 101 (423)
Q Consensus 25 ~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~~---vKL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~ 101 (423)
...++.||+.||.|||++|++ ||||||+||+++.++. +||+|||++........ ......||+.|+|||++.+.
T Consensus 132 ~~~i~~qi~~al~~lH~~~iv-HrDlkp~NIl~~~~~~~~~vkl~Dfg~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~ 208 (351)
T 3c0i_A 132 ASHYMRQILEALRYCHDNNII-HRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGL--VAGGRVGTPHFMAPEVVKRE 208 (351)
T ss_dssp HHHHHHHHHHHHHHHHHTTEE-CSCCSGGGEEECSSSTTCCEEECCCTTCEECCTTSC--BCCCCCSCGGGCCHHHHTTC
T ss_pred HHHHHHHHHHHHHHHHHCCce-eccCChHHeEEecCCCCCcEEEecCcceeEecCCCe--eecCCcCCcCccCHHHHcCC
Confidence 578999999999999999988 9999999999986554 99999999876543221 12345789999999999876
Q ss_pred CCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCchHHHHHHHHHhhhcCCCCCCCHH
Q psy1840 102 HLPRGTQKGDVYSFGLVLYEVIGRQGPWGHLRMTDEEIITSVTQGSGLRPDTSSLDCAPSIIACMRTCWEEDPELRPDLR 181 (423)
Q Consensus 102 ~~~~~s~ksDVyS~Giil~elltg~~Pf~~~~~~~~~i~~~i~~~~~~~p~~~~~~~~~~l~~Li~~C~~~dP~~RPt~~ 181 (423)
.+ +.++|||||||++|+|++|..||.. ...++...+..+....+......+++++.+++.+||+.||++|||+.
T Consensus 209 ~~---~~~~DiwslG~il~~ll~g~~pf~~---~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~ 282 (351)
T 3c0i_A 209 PY---GKPVDVWGCGVILFILLSGCLPFYG---TKERLFEGIIKGKYKMNPRQWSHISESAKDLVRRMLMLDPAERITVY 282 (351)
T ss_dssp CB---CTHHHHHHHHHHHHHHHHSSCSSCS---SHHHHHHHHHHTCCCCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHH
T ss_pred CC---CchHhhHHHHHHHHHHHHCCCCCCC---cHHHHHHHHHcCCCCCCccccccCCHHHHHHHHHHCCCChhHCcCHH
Confidence 55 8999999999999999999999974 34566666665543332222235789999999999999999999999
Q ss_pred HHHHH
Q psy1840 182 FVHHK 186 (423)
Q Consensus 182 ~I~~~ 186 (423)
++++.
T Consensus 283 e~l~h 287 (351)
T 3c0i_A 283 EALNH 287 (351)
T ss_dssp HHHTS
T ss_pred HHhcC
Confidence 99864
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=2.8e-27 Score=230.69 Aligned_cols=161 Identities=22% Similarity=0.391 Sum_probs=127.7
Q ss_pred HHHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCccEEEeccCCcccccCCCcccccccccCCccccCCccccCCCC
Q psy1840 24 GSISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKAPELLRQPHL 103 (423)
Q Consensus 24 ~~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~ 103 (423)
..+.++.||+.||.|||+.|++ ||||||+||+++.++.+||+|||++................+++.|+|||.+.+..+
T Consensus 165 ~~~~~~~qi~~~l~~lH~~~iv-H~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~ 243 (333)
T 2i1m_A 165 DLLHFSSQVAQGMAFLASKNCI-HRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVY 243 (333)
T ss_dssp HHHHHHHHHHHHHHHHHHTTEE-CSCCSGGGCEEEGGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCC
T ss_pred HHHHHHHHHHHHHHHHhcCCcc-cCCcccceEEECCCCeEEECccccccccccccceeecCCCCCCccccCHHHhccCCC
Confidence 3689999999999999999988 999999999999999999999999876543332222234456778999999887654
Q ss_pred CCCCCccchHHHHHHHHHHHh-CCCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCchHHHHHHHHHhhhcCCCCCCCHHH
Q psy1840 104 PRGTQKGDVYSFGLVLYEVIG-RQGPWGHLRMTDEEIITSVTQGSGLRPDTSSLDCAPSIIACMRTCWEEDPELRPDLRF 182 (423)
Q Consensus 104 ~~~s~ksDVyS~Giil~ellt-g~~Pf~~~~~~~~~i~~~i~~~~~~~p~~~~~~~~~~l~~Li~~C~~~dP~~RPt~~~ 182 (423)
+.++||||||+++|||++ |..||...... ..+...+..+... . .+..+++.+.+++.+||+.||.+|||+.+
T Consensus 244 ---~~~~Di~slG~il~el~t~g~~p~~~~~~~-~~~~~~~~~~~~~--~-~~~~~~~~l~~li~~~l~~~p~~Rps~~~ 316 (333)
T 2i1m_A 244 ---TVQSDVWSYGILLWEIFSLGLNPYPGILVN-SKFYKLVKDGYQM--A-QPAFAPKNIYSIMQACWALEPTHRPTFQQ 316 (333)
T ss_dssp ---CHHHHHHHHHHHHHHHTTTSCCSSTTCCSS-HHHHHHHHHTCCC--C-CCTTCCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred ---ChHHHHHHHHHHHHHHHcCCCCCCcccchh-HHHHHHHhcCCCC--C-CCCCCCHHHHHHHHHHhccChhhCcCHHH
Confidence 899999999999999998 88999754332 3333333333211 1 12356899999999999999999999999
Q ss_pred HHHHHHHHhh
Q psy1840 183 VHHKLKEMNA 192 (423)
Q Consensus 183 I~~~L~~i~~ 192 (423)
|++.|+.+..
T Consensus 317 l~~~L~~~~~ 326 (333)
T 2i1m_A 317 ICSFLQEQAQ 326 (333)
T ss_dssp HHHHHHHHHH
T ss_pred HHHHHHHHHH
Confidence 9999987754
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=99.94 E-value=3.8e-27 Score=234.53 Aligned_cols=160 Identities=28% Similarity=0.527 Sum_probs=119.8
Q ss_pred HHHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCccEEEeccCCcccccCCCccc-ccccccCCccccCCccccCCC
Q psy1840 24 GSISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETG-QERKLRRRKLYKAPELLRQPH 102 (423)
Q Consensus 24 ~~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~~~-~~~~~~gt~~y~APE~l~~~~ 102 (423)
..+.++.||+.||.|||+.|++ ||||||+||+++.++.+||+|||+++......... ......++..|+|||.+.+..
T Consensus 148 ~~~~i~~qi~~aL~~LH~~~iv-H~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~ 226 (373)
T 2qol_A 148 QLVGMLRGIASGMKYLSDMGYV-HRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRK 226 (373)
T ss_dssp HHHHHHHHHHHHHHHHHHTTCC-CSCCCGGGEEECTTCCEEECCC----------------------CTTSCHHHHHHCC
T ss_pred HHHHHHHHHHHHHHHHHHCCee-CCCCCcceEEEcCCCCEEECcCccccccccCCccceeccCCCcCCCccChhhhccCC
Confidence 3689999999999999999998 99999999999999999999999987654332111 112223466799999998765
Q ss_pred CCCCCCccchHHHHHHHHHHHh-CCCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCchHHHHHHHHHhhhcCCCCCCCHH
Q psy1840 103 LPRGTQKGDVYSFGLVLYEVIG-RQGPWGHLRMTDEEIITSVTQGSGLRPDTSSLDCAPSIIACMRTCWEEDPELRPDLR 181 (423)
Q Consensus 103 ~~~~s~ksDVyS~Giil~ellt-g~~Pf~~~~~~~~~i~~~i~~~~~~~p~~~~~~~~~~l~~Li~~C~~~dP~~RPt~~ 181 (423)
+ +.++|||||||++||+++ |..||.. ....++...+..+....+ ...++..+.+++.+||+.||.+||++.
T Consensus 227 ~---~~~~Dv~SlG~il~ellt~g~~P~~~--~~~~~~~~~i~~~~~~~~---~~~~~~~l~~li~~cl~~dp~~RPs~~ 298 (373)
T 2qol_A 227 F---TSASDVWSYGIVLWEVMSYGERPYWE--MSNQDVIKAVDEGYRLPP---PMDCPAALYQLMLDCWQKDRNNRPKFE 298 (373)
T ss_dssp C---CHHHHHHHHHHHHHHHHTTC-CTTTT--CCHHHHHHHHHTTEECCC---CTTCBHHHHHHHHHHTCSSGGGSCCHH
T ss_pred c---CchhcHHHHHHHHHHHHhCCCCCCCC--CCHHHHHHHHHcCCCCCC---CccccHHHHHHHHHHhCcChhhCcCHH
Confidence 5 899999999999999998 9999974 456677777765432221 236889999999999999999999999
Q ss_pred HHHHHHHHHhh
Q psy1840 182 FVHHKLKEMNA 192 (423)
Q Consensus 182 ~I~~~L~~i~~ 192 (423)
+|++.|+.+..
T Consensus 299 ~i~~~L~~~~~ 309 (373)
T 2qol_A 299 QIVSILDKLIR 309 (373)
T ss_dssp HHHHHHHHHHH
T ss_pred HHHHHHHHHHh
Confidence 99999988764
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.94 E-value=4.5e-27 Score=224.65 Aligned_cols=162 Identities=25% Similarity=0.470 Sum_probs=131.8
Q ss_pred HHHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCccEEEeccCCcccccCCCcc-cccccccCCccccCCccccCCC
Q psy1840 24 GSISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDET-GQERKLRRRKLYKAPELLRQPH 102 (423)
Q Consensus 24 ~~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~~-~~~~~~~gt~~y~APE~l~~~~ 102 (423)
....++.|++.||.|||+.|++ ||||||+||+++.++.+||+|||++......... .......+++.|+|||.+.+..
T Consensus 111 ~~~~~~~qi~~~l~~lH~~~i~-H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~ 189 (287)
T 1u59_A 111 NVAELLHQVSMGMKYLEEKNFV-HRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRK 189 (287)
T ss_dssp HHHHHHHHHHHHHHHHHHTTEE-CCCCSGGGEEEEETTEEEECCCTTCEECTTCSCEECCCCSSCCCGGGCCHHHHHHCE
T ss_pred HHHHHHHHHHHHHHHHHHCCEe-eCCCchheEEEcCCCCEEECcccceeeeccCcceeeccccccccccccCHHHhccCC
Confidence 3689999999999999999988 9999999999999999999999998765433221 1123345678899999997655
Q ss_pred CCCCCCccchHHHHHHHHHHHh-CCCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCchHHHHHHHHHhhhcCCCCCCCHH
Q psy1840 103 LPRGTQKGDVYSFGLVLYEVIG-RQGPWGHLRMTDEEIITSVTQGSGLRPDTSSLDCAPSIIACMRTCWEEDPELRPDLR 181 (423)
Q Consensus 103 ~~~~s~ksDVyS~Giil~ellt-g~~Pf~~~~~~~~~i~~~i~~~~~~~p~~~~~~~~~~l~~Li~~C~~~dP~~RPt~~ 181 (423)
+ +.++||||||+++|||++ |..||.. ....++...+..+.. +.. +..+++.+.+++.+||+.||++||++.
T Consensus 190 ~---~~~~Di~slG~il~ellt~g~~p~~~--~~~~~~~~~i~~~~~--~~~-~~~~~~~l~~li~~~l~~~p~~Rps~~ 261 (287)
T 1u59_A 190 F---SSRSDVWSYGVTMWEALSYGQKPYKK--MKGPEVMAFIEQGKR--MEC-PPECPPELYALMSDCWIYKWEDRPDFL 261 (287)
T ss_dssp E---CHHHHHHHHHHHHHHHHTTSCCTTTT--CCTHHHHHHHHTTCC--CCC-CTTCCHHHHHHHHHTTCSSGGGSCCHH
T ss_pred C---CchhhHHHHHHHHHHHHcCCCCCccc--CCHHHHHHHHhcCCc--CCC-CCCcCHHHHHHHHHHcCCChhhCcCHH
Confidence 4 889999999999999998 9999974 344666666666532 222 236889999999999999999999999
Q ss_pred HHHHHHHHHhhhc
Q psy1840 182 FVHHKLKEMNAGL 194 (423)
Q Consensus 182 ~I~~~L~~i~~~~ 194 (423)
++++.|+.+..+.
T Consensus 262 ~l~~~l~~~~~~~ 274 (287)
T 1u59_A 262 TVEQRMRACYYSL 274 (287)
T ss_dssp HHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHhc
Confidence 9999998886543
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=99.94 E-value=7.1e-27 Score=222.00 Aligned_cols=161 Identities=27% Similarity=0.511 Sum_probs=131.5
Q ss_pred HHHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCccEEEeccCCcccccCCCcccccccccCCccccCCccccCCCC
Q psy1840 24 GSISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKAPELLRQPHL 103 (423)
Q Consensus 24 ~~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~ 103 (423)
..+.++.|++.||.|||+.|++ ||||||+||+++.++.+||+|||++........ .......++..|+|||.+.+..+
T Consensus 110 ~~~~i~~qi~~~l~~lH~~~i~-H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~ 187 (279)
T 1qpc_A 110 KLLDMAAQIAEGMAFIEERNYI-HRDLRAANILVSDTLSCKIADFGLARLIEDNEY-TAREGAKFPIKWTAPEAINYGTF 187 (279)
T ss_dssp HHHHHHHHHHHHHHHHHHTTEE-CSCCSGGGEEECTTSCEEECCCTTCEECSSSCE-ECCTTCCCCTTTSCHHHHHHCEE
T ss_pred HHHHHHHHHHHHHHHHHHCCee-ccCCCHhhEEEcCCCCEEECCCcccccccCccc-ccccCCCCccCccChhhhccCCC
Confidence 3689999999999999999988 999999999999999999999999876543321 11233456778999999976654
Q ss_pred CCCCCccchHHHHHHHHHHHh-CCCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCchHHHHHHHHHhhhcCCCCCCCHHH
Q psy1840 104 PRGTQKGDVYSFGLVLYEVIG-RQGPWGHLRMTDEEIITSVTQGSGLRPDTSSLDCAPSIIACMRTCWEEDPELRPDLRF 182 (423)
Q Consensus 104 ~~~s~ksDVyS~Giil~ellt-g~~Pf~~~~~~~~~i~~~i~~~~~~~p~~~~~~~~~~l~~Li~~C~~~dP~~RPt~~~ 182 (423)
+.++||||||+++|||++ |..||.. ....++...+..+.... ....+++.+.+++.+||+.||++|||+.+
T Consensus 188 ---~~~~Di~slG~il~el~~~g~~p~~~--~~~~~~~~~~~~~~~~~---~~~~~~~~l~~li~~~l~~~p~~Rps~~~ 259 (279)
T 1qpc_A 188 ---TIKSDVWSFGILLTEIVTHGRIPYPG--MTNPEVIQNLERGYRMV---RPDNCPEELYQLMRLCWKERPEDRPTFDY 259 (279)
T ss_dssp ---CHHHHHHHHHHHHHHHHTTTCCSSTT--CCHHHHHHHHHTTCCCC---CCTTCCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred ---CchhhhHHHHHHHHHHHhCCCCCCcc--cCHHHHHHHHhcccCCC---CcccccHHHHHHHHHHhccChhhCCCHHH
Confidence 889999999999999999 8999974 45566777776543221 22467899999999999999999999999
Q ss_pred HHHHHHHHhhhc
Q psy1840 183 VHHKLKEMNAGL 194 (423)
Q Consensus 183 I~~~L~~i~~~~ 194 (423)
+++.|+.+....
T Consensus 260 l~~~l~~~~~~~ 271 (279)
T 1qpc_A 260 LRSVLEDFFTAT 271 (279)
T ss_dssp HHHHHHHHHHHC
T ss_pred HHHHHHHHHHhc
Confidence 999998887644
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.94 E-value=1.6e-27 Score=232.33 Aligned_cols=155 Identities=17% Similarity=0.217 Sum_probs=128.9
Q ss_pred HHHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcC--CccEEEeccCCcccccCCCcccccccccCCccccCCccccCC
Q psy1840 24 GSISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDS--RWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKAPELLRQP 101 (423)
Q Consensus 24 ~~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~--~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~ 101 (423)
....++.||+.||.|||+.|++ ||||||+||+++. ++.+||+|||++....... ......+++.|+|||++.+.
T Consensus 103 ~~~~i~~qi~~al~~lH~~giv-H~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~ 178 (321)
T 1tki_A 103 EIVSYVHQVCEALQFLHSHNIG-HFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGD---NFRLLFTAPEYYAPEVHQHD 178 (321)
T ss_dssp HHHHHHHHHHHHHHHHHHTTEE-CCCCCGGGEEESSSSCCCEEECCCTTCEECCTTC---EEEEEESCGGGSCHHHHTTC
T ss_pred HHHHHHHHHHHHHHHHHHCCCC-cCCCCHHHEEEccCCCCCEEEEECCCCeECCCCC---ccccccCChhhcCcHHhcCC
Confidence 3689999999999999999998 9999999999987 7899999999987654322 12345688999999999876
Q ss_pred CCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCchHHHHHHHHHhhhcCCCCCCCHH
Q psy1840 102 HLPRGTQKGDVYSFGLVLYEVIGRQGPWGHLRMTDEEIITSVTQGSGLRPDTSSLDCAPSIIACMRTCWEEDPELRPDLR 181 (423)
Q Consensus 102 ~~~~~s~ksDVyS~Giil~elltg~~Pf~~~~~~~~~i~~~i~~~~~~~p~~~~~~~~~~l~~Li~~C~~~dP~~RPt~~ 181 (423)
.+ +.++|||||||++|+|++|..||.. .+..++...+..+....+......++.++.+++.+||..||.+|||+.
T Consensus 179 ~~---~~~~DiwslG~il~~ll~g~~pf~~--~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ 253 (321)
T 1tki_A 179 VV---STATDMWSLGTLVYVLLSGINPFLA--ETNQQIIENIMNAEYTFDEEAFKEISIEAMDFVDRLLVKERKSRMTAS 253 (321)
T ss_dssp EE---CHHHHHHHHHHHHHHHHHSSCTTCC--SSHHHHHHHHHHTCCCCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHH
T ss_pred CC---CchhhHHHHHHHHHHHHhCCCCCcC--CCHHHHHHHHHcCCCCCChhhhccCCHHHHHHHHHHcCCChhHCcCHH
Confidence 54 8999999999999999999999974 456677777776654433322346789999999999999999999999
Q ss_pred HHHHHH
Q psy1840 182 FVHHKL 187 (423)
Q Consensus 182 ~I~~~L 187 (423)
++++.-
T Consensus 254 e~l~hp 259 (321)
T 1tki_A 254 EALQHP 259 (321)
T ss_dssp HHHHSH
T ss_pred HHhcCh
Confidence 998754
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=4.5e-27 Score=233.08 Aligned_cols=154 Identities=18% Similarity=0.209 Sum_probs=127.7
Q ss_pred HHHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCc----cEEEeccCCcccccCCCcccccccccCCccccCCcccc
Q psy1840 24 GSISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRW----VLQIADFGLHAFKAGQDETGQERKLRRRKLYKAPELLR 99 (423)
Q Consensus 24 ~~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~----~vKL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~ 99 (423)
....++.||+.||.|||+.|++ ||||||+||+++.++ .+||+|||++....... ......||+.|+|||++.
T Consensus 116 ~~~~i~~qi~~aL~~LH~~giv-HrDlkp~NIll~~~~~~~~~vkl~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~ 191 (361)
T 2yab_A 116 EATSFIKQILDGVNYLHTKKIA-HFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGV---EFKNIFGTPEFVAPEIVN 191 (361)
T ss_dssp HHHHHHHHHHHHHHHHHHTTEE-CCCCSGGGEEESCTTSSSCCEEECCCSSCEECCTTC---CCCCCCSCGGGCCHHHHT
T ss_pred HHHHHHHHHHHHHHHHHHCCcc-cCCCCHHHEEEeCCCCCccCEEEEecCCceEcCCCC---ccccCCCCccEECchHHc
Confidence 3679999999999999999988 999999999998777 79999999987654322 123457899999999998
Q ss_pred CCCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCchHHHHHHHHHhhhcCCCCCCC
Q psy1840 100 QPHLPRGTQKGDVYSFGLVLYEVIGRQGPWGHLRMTDEEIITSVTQGSGLRPDTSSLDCAPSIIACMRTCWEEDPELRPD 179 (423)
Q Consensus 100 ~~~~~~~s~ksDVyS~Giil~elltg~~Pf~~~~~~~~~i~~~i~~~~~~~p~~~~~~~~~~l~~Li~~C~~~dP~~RPt 179 (423)
+..+ +.++|||||||++|+|++|..||.+ .+..++...+..+....+......+++.+.+++.+||..||.+|||
T Consensus 192 ~~~~---~~~~DiwslGvil~~ll~g~~Pf~~--~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t 266 (361)
T 2yab_A 192 YEPL---GLEADMWSIGVITYILLSGASPFLG--DTKQETLANITAVSYDFDEEFFSQTSELAKDFIRKLLVKETRKRLT 266 (361)
T ss_dssp TCCC---CTHHHHHHHHHHHHHHHHSCCSSCC--SSHHHHHHHHHTTCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCC
T ss_pred CCCC---CccccHHHHHHHHHHHHhCCCCCCC--CCHHHHHHHHHhcCCCCCchhccCCCHHHHHHHHHHCCCChhHCcC
Confidence 7655 8999999999999999999999974 4567777777766544332223467889999999999999999999
Q ss_pred HHHHHHH
Q psy1840 180 LRFVHHK 186 (423)
Q Consensus 180 ~~~I~~~ 186 (423)
+.++++.
T Consensus 267 ~~e~l~h 273 (361)
T 2yab_A 267 IQEALRH 273 (361)
T ss_dssp HHHHHTS
T ss_pred HHHHhcC
Confidence 9998763
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=6.1e-27 Score=224.18 Aligned_cols=161 Identities=25% Similarity=0.447 Sum_probs=129.9
Q ss_pred HHHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCccEEEeccCCcccccCCCcc-cccccccCCccccCCccccCCC
Q psy1840 24 GSISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDET-GQERKLRRRKLYKAPELLRQPH 102 (423)
Q Consensus 24 ~~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~~-~~~~~~~gt~~y~APE~l~~~~ 102 (423)
..+.++.||+.||.|||+.|++ ||||||+||+++.++.+||+|||++......... .......++..|+|||.+.+..
T Consensus 118 ~~~~i~~qi~~~l~~LH~~~i~-H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~ 196 (291)
T 1xbb_A 118 NIIELVHQVSMGMKYLEESNFV-HRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYK 196 (291)
T ss_dssp HHHHHHHHHHHHHHHHHHTTEE-CSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEEC----CCCGGGCCHHHHHHCE
T ss_pred HHHHHHHHHHHHHHHHHhCCeE-cCCCCcceEEEeCCCcEEEccCCcceeeccCCCcccccccCCCCceeeChHHhccCC
Confidence 3689999999999999999988 9999999999999999999999998765433221 1112334567899999997765
Q ss_pred CCCCCCccchHHHHHHHHHHHh-CCCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCchHHHHHHHHHhhhcCCCCCCCHH
Q psy1840 103 LPRGTQKGDVYSFGLVLYEVIG-RQGPWGHLRMTDEEIITSVTQGSGLRPDTSSLDCAPSIIACMRTCWEEDPELRPDLR 181 (423)
Q Consensus 103 ~~~~s~ksDVyS~Giil~ellt-g~~Pf~~~~~~~~~i~~~i~~~~~~~p~~~~~~~~~~l~~Li~~C~~~dP~~RPt~~ 181 (423)
+ +.++||||||+++|+|++ |..||.. ....++...+..+.. +.. ...+++.+.+++.+||+.||.+||++.
T Consensus 197 ~---~~~~Di~slG~il~~l~~~g~~p~~~--~~~~~~~~~~~~~~~--~~~-~~~~~~~l~~li~~~l~~dp~~Rps~~ 268 (291)
T 1xbb_A 197 F---SSKSDVWSFGVLMWEAFSYGQKPYRG--MKGSEVTAMLEKGER--MGC-PAGCPREMYDLMNLCWTYDVENRPGFA 268 (291)
T ss_dssp E---EHHHHHHHHHHHHHHHHTTTCCSSTT--CCHHHHHHHHHTTCC--CCC-CTTCCHHHHHHHHHHTCSSTTTSCCHH
T ss_pred C---ChhhhHHHHHHHHHHHHhcCCCCCCC--CCHHHHHHHHHcCCC--CCC-CCCCCHHHHHHHHHHcCCChhhCcCHH
Confidence 4 889999999999999999 9999974 455666666666532 222 236889999999999999999999999
Q ss_pred HHHHHHHHHhhh
Q psy1840 182 FVHHKLKEMNAG 193 (423)
Q Consensus 182 ~I~~~L~~i~~~ 193 (423)
++++.|+.+...
T Consensus 269 ~l~~~L~~~~~~ 280 (291)
T 1xbb_A 269 AVELRLRNYYYD 280 (291)
T ss_dssp HHHHHHHHHHHH
T ss_pred HHHHHHHHHHHH
Confidence 999999887653
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.94 E-value=3.2e-27 Score=230.47 Aligned_cols=169 Identities=23% Similarity=0.318 Sum_probs=123.4
Q ss_pred HHHHHHHHHHHHHHHHHhC---------CCeeecCCCCCCEEEcCCccEEEeccCCcccccCCCc------ccccccccC
Q psy1840 24 GSISVNTTASVGMIHLHDS---------EIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDE------TGQERKLRR 88 (423)
Q Consensus 24 ~~l~i~~qi~~gL~yLH~~---------~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~------~~~~~~~~g 88 (423)
....++.||+.||.|||+. |++ ||||||+|||++.++.+||+|||++........ ........|
T Consensus 112 ~~~~i~~qi~~~L~~LH~~~~~~~~~~~~iv-H~Dikp~Nill~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~g 190 (336)
T 3g2f_A 112 SSCRLAHSVTRGLAYLHTELPRGDHYKPAIS-HRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNAAISEVG 190 (336)
T ss_dssp HHHHHHHHHHHHHHHHHCCBCCGGGCBCCEE-CSSCSGGGEEECTTSCEEECCCTTCEECSSSSCC---------CCTTS
T ss_pred HHHHHHHHHHHHHHHHHhhhcccccccccee-ecccccceEEEcCCCcEEEeeccceeecccccccCccccccccccCCC
Confidence 3678999999999999999 988 999999999999999999999999876543221 112234568
Q ss_pred CccccCCccccCCCC----CCCCCccchHHHHHHHHHHHhCCCCCCCCCC----------------ChHHHHHHHhcCCC
Q psy1840 89 RKLYKAPELLRQPHL----PRGTQKGDVYSFGLVLYEVIGRQGPWGHLRM----------------TDEEIITSVTQGSG 148 (423)
Q Consensus 89 t~~y~APE~l~~~~~----~~~s~ksDVyS~Giil~elltg~~Pf~~~~~----------------~~~~i~~~i~~~~~ 148 (423)
|+.|+|||++.+... ...+.++|||||||++|||++|..||..... ....+...+. ...
T Consensus 191 t~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~ 269 (336)
T 3g2f_A 191 TIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPEYQMAFQTEVGNHPTFEDMQVLVS-REK 269 (336)
T ss_dssp CGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSCCCCCCCTTHHHHCSSCCHHHHHHHHT-TSC
T ss_pred ccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccchhHHHHhhhcccCCCchHHHHHhhhc-ccc
Confidence 999999999976311 1126789999999999999999776532111 1112222222 222
Q ss_pred CCCCCC-----CCCchHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHhhhc
Q psy1840 149 LRPDTS-----SLDCAPSIIACMRTCWEEDPELRPDLRFVHHKLKEMNAGL 194 (423)
Q Consensus 149 ~~p~~~-----~~~~~~~l~~Li~~C~~~dP~~RPt~~~I~~~L~~i~~~~ 194 (423)
.++..+ ...+++.+.+++.+||+.||++|||+.++++.|+.+....
T Consensus 270 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ll~~~ 320 (336)
T 3g2f_A 270 QRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELMMIW 320 (336)
T ss_dssp CCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHCC
T ss_pred cCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHHHHHH
Confidence 222222 1235678999999999999999999999999999887644
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=6.2e-27 Score=234.34 Aligned_cols=159 Identities=17% Similarity=0.244 Sum_probs=118.3
Q ss_pred HHHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCccEEEeccCCcccccCCCcccccccccCCccccCCccccCCC-
Q psy1840 24 GSISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKAPELLRQPH- 102 (423)
Q Consensus 24 ~~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~- 102 (423)
.+..++.||+.||.|||+.|++ ||||||+|||++ ++.+||+|||+++...............||+.|+|||++.+..
T Consensus 156 ~~~~i~~qi~~aL~~lH~~~iv-HrDlkp~NIll~-~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~ 233 (390)
T 2zmd_A 156 ERKSYWKNMLEAVHTIHQHGIV-HSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSS 233 (390)
T ss_dssp HHHHHHHHHHHHHHHHHTTTCC-CCCCCGGGEEES-SSCEEECCCSSSCCC---------CCSCCCGGGCCHHHHHCC--
T ss_pred HHHHHHHHHHHHHHHHHHCCee-ecCCCHHHEEEE-CCeEEEEecCccccccCCCccccCCCCCcCCCccChHHhhhccc
Confidence 4689999999999999999998 999999999995 5899999999998654333222234567999999999987521
Q ss_pred -------CCCCCCccchHHHHHHHHHHHhCCCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCchHHHHHHHHHhhhcCCC
Q psy1840 103 -------LPRGTQKGDVYSFGLVLYEVIGRQGPWGHLRMTDEEIITSVTQGSGLRPDTSSLDCAPSIIACMRTCWEEDPE 175 (423)
Q Consensus 103 -------~~~~s~ksDVyS~Giil~elltg~~Pf~~~~~~~~~i~~~i~~~~~~~p~~~~~~~~~~l~~Li~~C~~~dP~ 175 (423)
...++.++|||||||++|||++|..||.... .....+..+...... .. .+...+.++.+++.+||+.||.
T Consensus 234 ~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~-~~~~~~~~~~~~~~~-~~-~~~~~~~~~~~li~~~L~~dP~ 310 (390)
T 2zmd_A 234 SRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQII-NQISKLHAIIDPNHE-IE-FPDIPEKDLQDVLKCCLKRDPK 310 (390)
T ss_dssp ----------CCHHHHHHHHHHHHHHHHHSSCTTTTCC-CHHHHHHHHHCTTSC-CC-CCCCSCHHHHHHHHHHTCSSTT
T ss_pred cccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhh-HHHHHHHHHhCcccc-CC-CCccchHHHHHHHHHHcccChh
Confidence 1134889999999999999999999997532 223334444432211 11 1224578999999999999999
Q ss_pred CCCCHHHHHHHH
Q psy1840 176 LRPDLRFVHHKL 187 (423)
Q Consensus 176 ~RPt~~~I~~~L 187 (423)
+||++.++++..
T Consensus 311 ~Rps~~ell~hp 322 (390)
T 2zmd_A 311 QRISIPELLAHP 322 (390)
T ss_dssp TSCCHHHHHTSH
T ss_pred hCCCHHHHhhCc
Confidence 999999998754
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=5.6e-27 Score=220.99 Aligned_cols=157 Identities=24% Similarity=0.391 Sum_probs=125.9
Q ss_pred HHHHHHHHHHHHHHHHHhCC--CeeecCCCCCCEEEcCCccEEEeccCCcccccCCCcccccccccCCccccCCccccCC
Q psy1840 24 GSISVNTTASVGMIHLHDSE--IISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKAPELLRQP 101 (423)
Q Consensus 24 ~~l~i~~qi~~gL~yLH~~~--ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~ 101 (423)
..+.++.||+.||.|||+.+ ++ ||||||+||+++.++.++|+|||++..... ....+|+.|+|||.+.+.
T Consensus 112 ~~~~i~~qi~~~l~~lH~~~~~i~-H~dikp~Nil~~~~~~~~l~~~~~~~~~~~-------~~~~~t~~y~aPE~~~~~ 183 (271)
T 3kmu_A 112 QAVKFALDMARGMAFLHTLEPLIP-RHALNSRSVMIDEDMTARISMADVKFSFQS-------PGRMYAPAWVAPEALQKK 183 (271)
T ss_dssp HHHHHHHHHHHHHHHHTTSSSCCT-TCCCSGGGEEECTTSCEEEEGGGSCCTTSC-------TTCBSCGGGSCHHHHHSC
T ss_pred HHHHHHHHHHHHHHHHhcCCCcee-cCCCccceEEEcCCcceeEEeccceeeecc-------cCccCCccccChhhhccC
Confidence 36899999999999999998 87 999999999999999999999988654211 234678899999999876
Q ss_pred CCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCchHHHHHHHHHhhhcCCCCCCCHH
Q psy1840 102 HLPRGTQKGDVYSFGLVLYEVIGRQGPWGHLRMTDEEIITSVTQGSGLRPDTSSLDCAPSIIACMRTCWEEDPELRPDLR 181 (423)
Q Consensus 102 ~~~~~s~ksDVyS~Giil~elltg~~Pf~~~~~~~~~i~~~i~~~~~~~p~~~~~~~~~~l~~Li~~C~~~dP~~RPt~~ 181 (423)
.....+.++||||||+++|||++|+.||.. ....+....+.... ..+.. +..+++.+.+++.+||+.||++|||+.
T Consensus 184 ~~~~~~~~~Di~slG~il~el~~g~~p~~~--~~~~~~~~~~~~~~-~~~~~-~~~~~~~~~~li~~~l~~~p~~Rps~~ 259 (271)
T 3kmu_A 184 PEDTNRRSADMWSFAVLLWELVTREVPFAD--LSNMEIGMKVALEG-LRPTI-PPGISPHVSKLMKICMNEDPAKRPKFD 259 (271)
T ss_dssp GGGSCHHHHHHHHHHHHHHHHHHCSCTTTT--SCHHHHHHHHHHSC-CCCCC-CTTCCHHHHHHHHHHTCSSGGGSCCHH
T ss_pred CCCCCCchhhHHHHHHHHHHHHhCCCCccc--cChHHHHHHHHhcC-CCCCC-CCCCCHHHHHHHHHHcCCChhhCcCHH
Confidence 543334589999999999999999999974 34455544444332 22222 236889999999999999999999999
Q ss_pred HHHHHHHHHhh
Q psy1840 182 FVHHKLKEMNA 192 (423)
Q Consensus 182 ~I~~~L~~i~~ 192 (423)
++++.|+.+..
T Consensus 260 ~il~~L~~l~~ 270 (271)
T 3kmu_A 260 MIVPILEKMQD 270 (271)
T ss_dssp HHHHHHHHHCC
T ss_pred HHHHHHHHhhc
Confidence 99999988753
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=6e-27 Score=220.70 Aligned_cols=159 Identities=24% Similarity=0.497 Sum_probs=129.8
Q ss_pred HHHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCccEEEeccCCcccccCCCcccccccccCCccccCCccccCCCC
Q psy1840 24 GSISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKAPELLRQPHL 103 (423)
Q Consensus 24 ~~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~ 103 (423)
....++.|++.||.|||+.|++ ||||||+||+++.++.+||+|||++....... ........++..|+|||.+.+..+
T Consensus 105 ~~~~~~~~i~~~l~~lH~~~i~-H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~ 182 (267)
T 3t9t_A 105 TLLGMCLDVCEGMAYLEEACVI-HRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ-YTSSTGTKFPVKWASPEVFSFSRY 182 (267)
T ss_dssp HHHHHHHHHHHHHHHHHHTTCC-CSSCCGGGEEECGGGCEEECCTTGGGGBCCHH-HHSTTSTTCCGGGCCHHHHHHCCC
T ss_pred HHHHHHHHHHHHHHHHHhCCcc-cCCCchheEEECCCCCEEEccccccccccccc-ccccccccccccccChhhhcCCCc
Confidence 3679999999999999999998 99999999999999999999999987653221 111233456778999999986654
Q ss_pred CCCCCccchHHHHHHHHHHHh-CCCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCchHHHHHHHHHhhhcCCCCCCCHHH
Q psy1840 104 PRGTQKGDVYSFGLVLYEVIG-RQGPWGHLRMTDEEIITSVTQGSGLRPDTSSLDCAPSIIACMRTCWEEDPELRPDLRF 182 (423)
Q Consensus 104 ~~~s~ksDVyS~Giil~ellt-g~~Pf~~~~~~~~~i~~~i~~~~~~~p~~~~~~~~~~l~~Li~~C~~~dP~~RPt~~~ 182 (423)
+.++||||||+++|+|++ |..||.. ....++...+..+.... .+..++..+.+++.+||+.||++||++.+
T Consensus 183 ---~~~~Di~slG~il~~l~~~g~~p~~~--~~~~~~~~~i~~~~~~~---~~~~~~~~l~~li~~~l~~~p~~Rps~~~ 254 (267)
T 3t9t_A 183 ---SSKSDVWSFGVLMWEVFSEGKIPYEN--RSNSEVVEDISTGFRLY---KPRLASTHVYQIMNHCWRERPEDRPAFSR 254 (267)
T ss_dssp ---CHHHHHHHHHHHHHHHHTTSCCTTTT--CCHHHHHHHHHTTCCCC---CCTTSCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred ---cchhchhhhHHHHHHHhccCCCCCCC--CCHHHHHHHHhcCCcCC---CCccCcHHHHHHHHHHccCChhhCcCHHH
Confidence 899999999999999999 8999974 44566777776653221 12357899999999999999999999999
Q ss_pred HHHHHHHHhh
Q psy1840 183 VHHKLKEMNA 192 (423)
Q Consensus 183 I~~~L~~i~~ 192 (423)
+++.|+.+..
T Consensus 255 ll~~L~~l~~ 264 (267)
T 3t9t_A 255 LLRQLAEIAE 264 (267)
T ss_dssp HHHHHHHHHH
T ss_pred HHHHHHHHHh
Confidence 9999998865
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.94 E-value=1.3e-26 Score=226.70 Aligned_cols=161 Identities=25% Similarity=0.481 Sum_probs=125.0
Q ss_pred HHHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCccEEEeccCCcccccCCCcc-cccccccCCccccCCccccCCC
Q psy1840 24 GSISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDET-GQERKLRRRKLYKAPELLRQPH 102 (423)
Q Consensus 24 ~~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~~-~~~~~~~gt~~y~APE~l~~~~ 102 (423)
..+.++.||+.||.|||+.|++ ||||||+||+++.++.+||+|||++......... .......++..|+|||.+.+..
T Consensus 148 ~~~~i~~qi~~aL~~LH~~~iv-H~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~ 226 (333)
T 1mqb_A 148 QLVGMLRGIAAGMKYLANMNYV-HRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRK 226 (333)
T ss_dssp HHHHHHHHHHHHHHHHHHTTCC-CSCCCGGGEEECTTCCEEECCCCC-----------------CCCGGGSCHHHHHSCC
T ss_pred HHHHHHHHHHHHHHHHHhCCee-CCCCChheEEECCCCcEEECCCCcchhhccccccccccCCCCccccccCchhcccCC
Confidence 3689999999999999999998 9999999999999999999999998765432211 1112334567899999998765
Q ss_pred CCCCCCccchHHHHHHHHHHHh-CCCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCchHHHHHHHHHhhhcCCCCCCCHH
Q psy1840 103 LPRGTQKGDVYSFGLVLYEVIG-RQGPWGHLRMTDEEIITSVTQGSGLRPDTSSLDCAPSIIACMRTCWEEDPELRPDLR 181 (423)
Q Consensus 103 ~~~~s~ksDVyS~Giil~ellt-g~~Pf~~~~~~~~~i~~~i~~~~~~~p~~~~~~~~~~l~~Li~~C~~~dP~~RPt~~ 181 (423)
+ +.++||||||+++|||++ |..||.. ....++...+..+... .. ...++..+.+++.+||+.||++||++.
T Consensus 227 ~---~~~~Di~slG~il~ellt~g~~pf~~--~~~~~~~~~~~~~~~~--~~-~~~~~~~l~~li~~~l~~~p~~Rps~~ 298 (333)
T 1mqb_A 227 F---TSASDVWSFGIVMWEVMTYGERPYWE--LSNHEVMKAINDGFRL--PT-PMDCPSAIYQLMMQCWQQERARRPKFA 298 (333)
T ss_dssp C---CHHHHHHHHHHHHHHHHTTSCCTTTT--CCHHHHHHHHHTTCCC--CC-CTTCBHHHHHHHHHHTCSSTTTSCCHH
T ss_pred C---CchhhhHHHHHHHHHHHcCCCCCccc--CCHHHHHHHHHCCCcC--CC-cccCCHHHHHHHHHHcCCChhhCcCHH
Confidence 5 889999999999999998 9999964 4556777777665322 11 236889999999999999999999999
Q ss_pred HHHHHHHHHhhh
Q psy1840 182 FVHHKLKEMNAG 193 (423)
Q Consensus 182 ~I~~~L~~i~~~ 193 (423)
++++.|+.+...
T Consensus 299 ~l~~~L~~~~~~ 310 (333)
T 1mqb_A 299 DIVSILDKLIRA 310 (333)
T ss_dssp HHHHHHHHHHHS
T ss_pred HHHHHHHHHHhc
Confidence 999999887653
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.94 E-value=5.2e-27 Score=229.01 Aligned_cols=154 Identities=20% Similarity=0.248 Sum_probs=125.9
Q ss_pred HHHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCc----cEEEeccCCcccccCCCcccccccccCCccccCCcccc
Q psy1840 24 GSISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRW----VLQIADFGLHAFKAGQDETGQERKLRRRKLYKAPELLR 99 (423)
Q Consensus 24 ~~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~----~vKL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~ 99 (423)
....++.||+.||.|||+.|++ ||||||+||+++.++ .+||+|||++........ .....||+.|+|||++.
T Consensus 115 ~~~~i~~qi~~al~~lH~~~iv-H~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~ 190 (326)
T 2y0a_A 115 EATEFLKQILNGVYYLHSLQIA-HFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE---FKNIFGTPEFVAPEIVN 190 (326)
T ss_dssp HHHHHHHHHHHHHHHHHHTTEE-CCCCCGGGEEESCSSSSSCCEEECCCTTCEECCTTSC---CCCCCSCTTTCCHHHHT
T ss_pred HHHHHHHHHHHHHHHHHHCCeE-cCCCCHHHEEEecCCCCCCCEEEEECCCCeECCCCCc---cccccCCcCcCCceeec
Confidence 3689999999999999999988 999999999999887 899999999876543221 23457899999999998
Q ss_pred CCCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCchHHHHHHHHHhhhcCCCCCCC
Q psy1840 100 QPHLPRGTQKGDVYSFGLVLYEVIGRQGPWGHLRMTDEEIITSVTQGSGLRPDTSSLDCAPSIIACMRTCWEEDPELRPD 179 (423)
Q Consensus 100 ~~~~~~~s~ksDVyS~Giil~elltg~~Pf~~~~~~~~~i~~~i~~~~~~~p~~~~~~~~~~l~~Li~~C~~~dP~~RPt 179 (423)
+..+ +.++|||||||++|+|++|..||.. ....+....+.......+......++..+.+++.+||+.||++|||
T Consensus 191 ~~~~---~~~~DiwslG~il~~ll~g~~pf~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt 265 (326)
T 2y0a_A 191 YEPL---GLEADMWSIGVITYILLSGASPFLG--DTKQETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMT 265 (326)
T ss_dssp TCCC---CTHHHHHHHHHHHHHHHHSCCSSCC--SSHHHHHHHHHHTCCCCCHHHHTTSCHHHHHHHHHHSCSSGGGSCC
T ss_pred CCCC---CcHHHHHHHHHHHHHHHHCcCCCCC--CCHHHHHHHHHhcCCCcCccccccCCHHHHHHHHHHccCChhhCCC
Confidence 7655 8999999999999999999999964 3456666666654433332222457889999999999999999999
Q ss_pred HHHHHHH
Q psy1840 180 LRFVHHK 186 (423)
Q Consensus 180 ~~~I~~~ 186 (423)
+.++++.
T Consensus 266 ~~e~l~h 272 (326)
T 2y0a_A 266 IQDSLQH 272 (326)
T ss_dssp HHHHHHS
T ss_pred HHHHhcC
Confidence 9999874
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=8.8e-28 Score=238.48 Aligned_cols=153 Identities=14% Similarity=0.050 Sum_probs=114.6
Q ss_pred HHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCccEEEeccCCcccccCCCcccccccccCCccccCCccccCCCCCC
Q psy1840 26 ISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKAPELLRQPHLPR 105 (423)
Q Consensus 26 l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~ 105 (423)
+.++.||+.||+|||++|++ ||||||+|||++.++.+||+|||+++..... .....+++.|+|||++.+... .
T Consensus 197 ~~i~~qi~~aL~~LH~~~iv-HrDikp~NIll~~~~~~kL~DFG~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~-~ 269 (371)
T 3q60_A 197 HILTAQLIRLAANLQSKGLV-HGHFTPDNLFIMPDGRLMLGDVSALWKVGTR-----GPASSVPVTYAPREFLNASTA-T 269 (371)
T ss_dssp HHHHHHHHHHHHHHHHTTEE-ETTCSGGGEEECTTSCEEECCGGGEEETTCE-----EEGGGSCGGGCCHHHHTCSEE-E
T ss_pred HHHHHHHHHHHHHHHHCCCc-cCcCCHHHEEECCCCCEEEEecceeeecCCC-----ccCccCCcCCcChhhccCCCC-C
Confidence 67889999999999999988 9999999999999999999999998754321 113456688999999976221 2
Q ss_pred CCCccchHHHHHHHHHHHhCCCCCCCCCCChHHHHHH---HhcCCCCCCCCCCCCchHHHHHHHHHhhhcCCCCCCCHHH
Q psy1840 106 GTQKGDVYSFGLVLYEVIGRQGPWGHLRMTDEEIITS---VTQGSGLRPDTSSLDCAPSIIACMRTCWEEDPELRPDLRF 182 (423)
Q Consensus 106 ~s~ksDVyS~Giil~elltg~~Pf~~~~~~~~~i~~~---i~~~~~~~p~~~~~~~~~~l~~Li~~C~~~dP~~RPt~~~ 182 (423)
++.++|||||||++|||++|+.||............. ...............+++.+.+++.+||+.||++|||+.+
T Consensus 270 ~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e 349 (371)
T 3q60_A 270 FTHALNAWQLGLSIYRVWCLFLPFGLVTPGIKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLE 349 (371)
T ss_dssp CCHHHHHHHHHHHHHHHHHSSCSTTBCCTTCTTCCCBCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHH
T ss_pred cCccccHHHHHHHHHHHHhCCCCCCCcCcccccchhhhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHH
Confidence 3899999999999999999999997542211100000 0000000011112367899999999999999999999999
Q ss_pred HHH
Q psy1840 183 VHH 185 (423)
Q Consensus 183 I~~ 185 (423)
+++
T Consensus 350 ~l~ 352 (371)
T 3q60_A 350 AME 352 (371)
T ss_dssp HTT
T ss_pred Hhc
Confidence 865
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=99.94 E-value=4.8e-27 Score=242.41 Aligned_cols=158 Identities=25% Similarity=0.487 Sum_probs=128.9
Q ss_pred HHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCccEEEeccCCcccccCCCcccccccccCCccccCCccccCCCCC
Q psy1840 25 SISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKAPELLRQPHLP 104 (423)
Q Consensus 25 ~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~ 104 (423)
.+.++.||+.||.|||+++++ ||||||+|||++.++.+||+|||+++....... .......++..|+|||.+.+..+
T Consensus 320 ~~~i~~qi~~~L~~LH~~~iv-HrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~- 396 (495)
T 1opk_A 320 LLYMATQISSAMEYLEKKNFI-HRNLAARNCLVGENHLVKVADFGLSRLMTGDTY-TAHAGAKFPIKWTAPESLAYNKF- 396 (495)
T ss_dssp HHHHHHHHHHHHHHHHHTTEE-CSCCSGGGEEECGGGCEEECCTTCEECCTTCCE-ECCTTCCCCGGGCCHHHHHHCEE-
T ss_pred HHHHHHHHHHHHHHHHhCCcc-cCCCChhhEEECCCCcEEEeecccceeccCCce-eecCCCcCCcceeCHhHHhcCCC-
Confidence 678999999999999999988 999999999999999999999999886543321 11223445678999999987655
Q ss_pred CCCCccchHHHHHHHHHHHh-CCCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCchHHHHHHHHHhhhcCCCCCCCHHHH
Q psy1840 105 RGTQKGDVYSFGLVLYEVIG-RQGPWGHLRMTDEEIITSVTQGSGLRPDTSSLDCAPSIIACMRTCWEEDPELRPDLRFV 183 (423)
Q Consensus 105 ~~s~ksDVyS~Giil~ellt-g~~Pf~~~~~~~~~i~~~i~~~~~~~p~~~~~~~~~~l~~Li~~C~~~dP~~RPt~~~I 183 (423)
+.++|||||||++|||++ |..||... ...++...+..+... . .+..+++.+.++|.+||+.||++|||+.+|
T Consensus 397 --~~~sDvwSlG~~l~el~t~g~~p~~~~--~~~~~~~~~~~~~~~--~-~~~~~~~~l~~li~~cl~~dP~~RPs~~el 469 (495)
T 1opk_A 397 --SIKSDVWAFGVLLWEIATYGMSPYPGI--DLSQVYELLEKDYRM--E-RPEGCPEKVYELMRACWQWNPSDRPSFAEI 469 (495)
T ss_dssp --CHHHHHHHHHHHHHHHHTTSCCSSTTC--CGGGHHHHHHTTCCC--C-CCTTCCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred --CcHHhHHhHHHHHHHHHhCCCCCCCCC--CHHHHHHHHHcCCCC--C-CCCCCCHHHHHHHHHHcCcChhHCcCHHHH
Confidence 899999999999999999 89999753 345566666554322 1 224688999999999999999999999999
Q ss_pred HHHHHHHhh
Q psy1840 184 HHKLKEMNA 192 (423)
Q Consensus 184 ~~~L~~i~~ 192 (423)
++.|+.+..
T Consensus 470 ~~~L~~~~~ 478 (495)
T 1opk_A 470 HQAFETMFQ 478 (495)
T ss_dssp HHHHHTSCS
T ss_pred HHHHHHHHh
Confidence 999987754
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=99.94 E-value=7.6e-27 Score=220.68 Aligned_cols=154 Identities=27% Similarity=0.459 Sum_probs=119.3
Q ss_pred HHHHHHHHHHHHHHHHHhCC---CeeecCCCCCCEEEcC--------CccEEEeccCCcccccCCCcccccccccCCccc
Q psy1840 24 GSISVNTTASVGMIHLHDSE---IISHGNLRSSNCLIDS--------RWVLQIADFGLHAFKAGQDETGQERKLRRRKLY 92 (423)
Q Consensus 24 ~~l~i~~qi~~gL~yLH~~~---ii~HrDLkp~NILld~--------~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~y 92 (423)
....++.|++.||.|||++| ++ ||||||+||+++. ++.+||+|||++....... .....+++.|
T Consensus 106 ~~~~i~~~l~~~l~~lH~~~~~~i~-H~dikp~Nil~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~~----~~~~~~~~~y 180 (271)
T 3dtc_A 106 ILVNWAVQIARGMNYLHDEAIVPII-HRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTT----KMSAAGAYAW 180 (271)
T ss_dssp HHHHHHHHHHHHHHHHHHSSSSCCC-CSCCSGGGEEESSCCSSSCCSSCCEEECCCCC-----------------CCGGG
T ss_pred HHHHHHHHHHHHHHHHHhCCCCcee-ecCCchHHEEEecccccccccCcceEEccCCccccccccc----ccCCCCccce
Confidence 36899999999999999998 66 9999999999985 7889999999987543222 1244688899
Q ss_pred cCCccccCCCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCchHHHHHHHHHhhhc
Q psy1840 93 KAPELLRQPHLPRGTQKGDVYSFGLVLYEVIGRQGPWGHLRMTDEEIITSVTQGSGLRPDTSSLDCAPSIIACMRTCWEE 172 (423)
Q Consensus 93 ~APE~l~~~~~~~~s~ksDVyS~Giil~elltg~~Pf~~~~~~~~~i~~~i~~~~~~~p~~~~~~~~~~l~~Li~~C~~~ 172 (423)
+|||.+.+..+ +.++||||||+++|+|++|+.||.. .........+.......+ ....+++.+.+++.+||+.
T Consensus 181 ~aPE~~~~~~~---~~~~Di~slG~~l~~l~~g~~p~~~--~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~li~~~l~~ 253 (271)
T 3dtc_A 181 MAPEVIRASMF---SKGSDVWSYGVLLWELLTGEVPFRG--IDGLAVAYGVAMNKLALP--IPSTCPEPFAKLMEDCWNP 253 (271)
T ss_dssp SCHHHHHHCCC---SHHHHHHHHHHHHHHHHHCCCTTTT--SCHHHHHHHHHTSCCCCC--CCTTCCHHHHHHHHHHTCS
T ss_pred eCHHHhccCCC---CchhhHHHHHHHHHHHHhCCCCCCC--CCHHHHHHhhhcCCCCCC--CCcccCHHHHHHHHHHhcC
Confidence 99999987654 8999999999999999999999974 344555555544332222 2346789999999999999
Q ss_pred CCCCCCCHHHHHHHHHH
Q psy1840 173 DPELRPDLRFVHHKLKE 189 (423)
Q Consensus 173 dP~~RPt~~~I~~~L~~ 189 (423)
||.+|||+.++++.|+.
T Consensus 254 ~p~~Rps~~e~l~~L~~ 270 (271)
T 3dtc_A 254 DPHSRPSFTNILDQLTT 270 (271)
T ss_dssp SGGGSCCHHHHHHHHHC
T ss_pred CcccCcCHHHHHHHHhc
Confidence 99999999999998875
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=1.4e-26 Score=220.30 Aligned_cols=154 Identities=18% Similarity=0.264 Sum_probs=127.9
Q ss_pred HHHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCcc---EEEeccCCcccccCCCcccccccccCCccccCCccccC
Q psy1840 24 GSISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWV---LQIADFGLHAFKAGQDETGQERKLRRRKLYKAPELLRQ 100 (423)
Q Consensus 24 ~~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~~---vKL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~ 100 (423)
....++.|++.||.|||+.|++ ||||||+||+++.++. +||+|||++....... ......+++.|+|||.+.+
T Consensus 106 ~~~~~~~~i~~~l~~lH~~~i~-H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~ 181 (284)
T 3kk8_A 106 DASHCIQQILESIAYCHSNGIV-HRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSE---AWHGFAGTPGYLSPEVLKK 181 (284)
T ss_dssp HHHHHHHHHHHHHHHHHHTTEE-CSCCCGGGEEESSSSTTCCEEECCCTTCEECCSSC---BCCCSCSCGGGCCHHHHTT
T ss_pred HHHHHHHHHHHHHHHHHHCCcC-cCCCCHHHEEEecCCCCCcEEEeeceeeEEcccCc---cccCCCCCcCCcCchhhcC
Confidence 3678999999999999999988 9999999999986655 9999999987554322 1234578899999999987
Q ss_pred CCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCchHHHHHHHHHhhhcCCCCCCCH
Q psy1840 101 PHLPRGTQKGDVYSFGLVLYEVIGRQGPWGHLRMTDEEIITSVTQGSGLRPDTSSLDCAPSIIACMRTCWEEDPELRPDL 180 (423)
Q Consensus 101 ~~~~~~s~ksDVyS~Giil~elltg~~Pf~~~~~~~~~i~~~i~~~~~~~p~~~~~~~~~~l~~Li~~C~~~dP~~RPt~ 180 (423)
..+ +.++||||||+++|+|++|..||.. ....+....+..+....+......+++++.+++.+||+.||++|||+
T Consensus 182 ~~~---~~~~Di~slG~~l~~l~~g~~pf~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~ 256 (284)
T 3kk8_A 182 DPY---SKPVDIWACGVILYILLVGYPPFWD--EDQHRLYAQIKAGAYDYPSPEWDTVTPEAKSLIDSMLTVNPKKRITA 256 (284)
T ss_dssp CCB---CTHHHHHHHHHHHHHHHHSSCSSCC--SSHHHHHHHHHHTCCCCCTTTTTTSCHHHHHHHHHHSCSSTTTSCCH
T ss_pred CCC---CcccchHHHHHHHHHHHHCCCCCCC--CchhHHHHHHHhccccCCchhhcccCHHHHHHHHHHcccChhhCCCH
Confidence 655 8999999999999999999999974 45566777777665554544445789999999999999999999999
Q ss_pred HHHHHH
Q psy1840 181 RFVHHK 186 (423)
Q Consensus 181 ~~I~~~ 186 (423)
.++++.
T Consensus 257 ~~~l~h 262 (284)
T 3kk8_A 257 DQALKV 262 (284)
T ss_dssp HHHTTS
T ss_pred HHHhcC
Confidence 999764
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=99.94 E-value=8.7e-27 Score=223.51 Aligned_cols=162 Identities=23% Similarity=0.461 Sum_probs=126.3
Q ss_pred HHHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCccEEEeccCCcccccCCCc--ccccccccCCccccCCccccCC
Q psy1840 24 GSISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDE--TGQERKLRRRKLYKAPELLRQP 101 (423)
Q Consensus 24 ~~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~--~~~~~~~~gt~~y~APE~l~~~ 101 (423)
..+.++.|++.||.|||+.|++ ||||||+||+++.++.+||+|||++........ ........+++.|+|||.+.+.
T Consensus 129 ~~~~i~~ql~~~l~~lH~~~i~-H~dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~ 207 (298)
T 3f66_A 129 DLIGFGLQVAKGMKYLASKKFV-HRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQ 207 (298)
T ss_dssp HHHHHHHHHHHHHHHHHHTTCC-CSCCSGGGEEECTTCCEEECSCGGGCCCSCGGGCBC-----CCBCGGGSCHHHHHHC
T ss_pred HHHHHHHHHHHHHHHHHhCCcc-CCCCchheEEECCCCCEEECcccccccccccchhccccccCCCCCccccChHHhcCC
Confidence 3678999999999999999998 999999999999999999999999876543221 1122344567789999999876
Q ss_pred CCCCCCCccchHHHHHHHHHHHh-CCCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCchHHHHHHHHHhhhcCCCCCCCH
Q psy1840 102 HLPRGTQKGDVYSFGLVLYEVIG-RQGPWGHLRMTDEEIITSVTQGSGLRPDTSSLDCAPSIIACMRTCWEEDPELRPDL 180 (423)
Q Consensus 102 ~~~~~s~ksDVyS~Giil~ellt-g~~Pf~~~~~~~~~i~~~i~~~~~~~p~~~~~~~~~~l~~Li~~C~~~dP~~RPt~ 180 (423)
.+ +.++||||||+++|+|++ |..||... ...++...+..+.... .+..++..+.+++.+||+.||++|||+
T Consensus 208 ~~---~~~~Di~slG~il~~l~~~~~~~~~~~--~~~~~~~~~~~~~~~~---~~~~~~~~l~~li~~~l~~~p~~Rps~ 279 (298)
T 3f66_A 208 KF---TTKSDVWSFGVLLWELMTRGAPPYPDV--NTFDITVYLLQGRRLL---QPEYCPDPLYEVMLKCWHPKAEMRPSF 279 (298)
T ss_dssp CC---CHHHHHHHHHHHHHHHHTTSCCSSTTS--CTTTHHHHHHTTCCCC---CCTTCCHHHHHHHHHHTCSSGGGSCCH
T ss_pred CC---ChHHHHHHHHHHHHHHHhCCCCCCccC--CHHHHHHHHhcCCCCC---CCccCCHHHHHHHHHHcCCChhhCcCH
Confidence 55 899999999999999999 55566543 2333444444443222 223578999999999999999999999
Q ss_pred HHHHHHHHHHhhhc
Q psy1840 181 RFVHHKLKEMNAGL 194 (423)
Q Consensus 181 ~~I~~~L~~i~~~~ 194 (423)
.++++.|+.+....
T Consensus 280 ~ell~~L~~~~~~~ 293 (298)
T 3f66_A 280 SELVSRISAIFSTF 293 (298)
T ss_dssp HHHHHHHHHHHHTS
T ss_pred HHHHHHHHHHHHhh
Confidence 99999999887654
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=99.94 E-value=7e-27 Score=222.93 Aligned_cols=155 Identities=19% Similarity=0.316 Sum_probs=114.5
Q ss_pred HHHHHHHHHHHHHHHHhC-CCeeecCCCCCCEEEcCCccEEEeccCCcccccCCCcccccccccCCccccCCccccCC-C
Q psy1840 25 SISVNTTASVGMIHLHDS-EIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKAPELLRQP-H 102 (423)
Q Consensus 25 ~l~i~~qi~~gL~yLH~~-~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~-~ 102 (423)
...++.|++.||.|||++ |++ ||||||+||+++.++.+||+|||++....... ......+++.|+|||.+... .
T Consensus 111 ~~~i~~qi~~~l~~lH~~~~i~-H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~ 186 (290)
T 3fme_A 111 LGKIAVSIVKALEHLHSKLSVI-HRDVKPSNVLINALGQVKMCDFGISGYLVDDV---AKDIDAGCKPYMAPERINPELN 186 (290)
T ss_dssp HHHHHHHHHHHHHHHHHHSCCC-CCCCSGGGCEECTTCCEEBCCC------------------CCCCCCSCHHHHSCCTT
T ss_pred HHHHHHHHHHHHHHHhhcCCee-cCCCCHHHEEECCCCCEEEeecCCcccccccc---cccccCCCccccChhhcChhhc
Confidence 678999999999999998 998 99999999999999999999999987653322 12334688999999997421 1
Q ss_pred CCCCCCccchHHHHHHHHHHHhCCCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCchHHHHHHHHHhhhcCCCCCCCHHH
Q psy1840 103 LPRGTQKGDVYSFGLVLYEVIGRQGPWGHLRMTDEEIITSVTQGSGLRPDTSSLDCAPSIIACMRTCWEEDPELRPDLRF 182 (423)
Q Consensus 103 ~~~~s~ksDVyS~Giil~elltg~~Pf~~~~~~~~~i~~~i~~~~~~~p~~~~~~~~~~l~~Li~~C~~~dP~~RPt~~~ 182 (423)
...++.++||||||+++|+|++|..||.........+...+.... +......+++++.+++.+||+.||++|||+.+
T Consensus 187 ~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~e 263 (290)
T 3fme_A 187 QKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPS---PQLPADKFSAEFVDFTSQCLKKNSKERPTYPE 263 (290)
T ss_dssp C--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHHHHHHHHSCC---CCCCTTTSCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred CcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHHHHHHHhccCC---CCcccccCCHHHHHHHHHHhhcChhhCcCHHH
Confidence 113488999999999999999999999754444444444444432 22233467899999999999999999999999
Q ss_pred HHHH
Q psy1840 183 VHHK 186 (423)
Q Consensus 183 I~~~ 186 (423)
+++.
T Consensus 264 ~l~h 267 (290)
T 3fme_A 264 LMQH 267 (290)
T ss_dssp HTTS
T ss_pred HHhC
Confidence 9874
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=9.1e-27 Score=224.33 Aligned_cols=163 Identities=28% Similarity=0.437 Sum_probs=125.5
Q ss_pred HHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCccEEEeccCCcccccCCCcccccccccCCccccCCccccCCCCC
Q psy1840 25 SISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKAPELLRQPHLP 104 (423)
Q Consensus 25 ~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~ 104 (423)
.+.++.|++.||.|||+.|++ ||||||+||+++.++.+||+|||++................|++.|+|||.+.+. +
T Consensus 135 ~~~i~~~i~~~l~~lH~~~i~-H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~- 211 (307)
T 2nru_A 135 RCKIAQGAANGINFLHENHHI-HRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRGE-I- 211 (307)
T ss_dssp HHHHHHHHHHHHHHHHHTTEE-CSCCCGGGEEECTTCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTTE-E-
T ss_pred HHHHHHHHHHHHHHHhcCCee-cCCCCHHHEEEcCCCcEEEeecccccccccccccccccccCCCcCcCChHHhcCC-C-
Confidence 679999999999999999988 9999999999999999999999998765433332223445789999999998764 2
Q ss_pred CCCCccchHHHHHHHHHHHhCCCCCCCCCCC--hHHHHHHHhcCCC-------CCCCCCCCCchHHHHHHHHHhhhcCCC
Q psy1840 105 RGTQKGDVYSFGLVLYEVIGRQGPWGHLRMT--DEEIITSVTQGSG-------LRPDTSSLDCAPSIIACMRTCWEEDPE 175 (423)
Q Consensus 105 ~~s~ksDVyS~Giil~elltg~~Pf~~~~~~--~~~i~~~i~~~~~-------~~p~~~~~~~~~~l~~Li~~C~~~dP~ 175 (423)
+.++||||||+++|+|++|..||...... ...+...+..... .........++..+.+++.+||+.||.
T Consensus 212 --~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~ 289 (307)
T 2nru_A 212 --TPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEEKTIEDYIDKKMNDADSTSVEAMYSVASQCLHEKKN 289 (307)
T ss_dssp --CTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBTTHHHHHHHTTSCCHHHHSCSSCSCCCHHHHHHHHHHHHHHTCSSTT
T ss_pred --CccchhHHHHHHHHHHHHCCCCcccCcchHHHHHHHHHhhhhhhhhhhhccccccccchHHHHHHHHHHHHHcCCCcc
Confidence 88999999999999999999999753221 1223333322111 001111234567899999999999999
Q ss_pred CCCCHHHHHHHHHHHhh
Q psy1840 176 LRPDLRFVHHKLKEMNA 192 (423)
Q Consensus 176 ~RPt~~~I~~~L~~i~~ 192 (423)
+|||+.+|++.|+++..
T Consensus 290 ~Rps~~~l~~~L~~l~~ 306 (307)
T 2nru_A 290 KRPDIKKVQQLLQEMTA 306 (307)
T ss_dssp TSCCHHHHHHHHHHHC-
T ss_pred cCcCHHHHHHHHHHHhc
Confidence 99999999999988753
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.94 E-value=4e-27 Score=232.74 Aligned_cols=144 Identities=19% Similarity=0.316 Sum_probs=118.9
Q ss_pred HHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCccEEEeccCCcccccCCCcccccccccCCccccCCccccCCCCC
Q psy1840 25 SISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKAPELLRQPHLP 104 (423)
Q Consensus 25 ~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~ 104 (423)
...++.||+.||.|||++|++ ||||||+|||++.++.+||+|||+++...... ......+||+.|+|||++.+..+
T Consensus 126 ~~~~~~qi~~aL~~LH~~giv-HrDlkp~NILl~~~g~ikL~DFG~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~- 201 (353)
T 3txo_A 126 ARFYAAEIISALMFLHDKGII-YRDLKLDNVLLDHEGHCKLADFGMCKEGICNG--VTTATFCGTPDYIAPEILQEMLY- 201 (353)
T ss_dssp HHHHHHHHHHHHHHHHHTTCB-CCCCCGGGEEECTTSCEEECCCTTCBCSCC-----------CCGGGCCHHHHHHHHC-
T ss_pred HHHHHHHHHHHHHHHHHCCCc-ccCCCHHHEEECCCCCEEEccccceeecccCC--ccccccCCCcCeEChhhcCCCCc-
Confidence 568999999999999999998 99999999999999999999999987532221 22345679999999999987655
Q ss_pred CCCCccchHHHHHHHHHHHhCCCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCchHHHHHHHHHhhhcCCCCCCCH
Q psy1840 105 RGTQKGDVYSFGLVLYEVIGRQGPWGHLRMTDEEIITSVTQGSGLRPDTSSLDCAPSIIACMRTCWEEDPELRPDL 180 (423)
Q Consensus 105 ~~s~ksDVyS~Giil~elltg~~Pf~~~~~~~~~i~~~i~~~~~~~p~~~~~~~~~~l~~Li~~C~~~dP~~RPt~ 180 (423)
+.++|||||||++|||++|..||.. .+..++...+..+....|. .+++.+.+++++||+.||.+||++
T Consensus 202 --~~~~DiwslG~il~ell~G~~Pf~~--~~~~~~~~~i~~~~~~~p~----~~~~~~~~li~~lL~~dP~~R~~~ 269 (353)
T 3txo_A 202 --GPAVDWWAMGVLLYEMLCGHAPFEA--ENEDDLFEAILNDEVVYPT----WLHEDATGILKSFMTKNPTMRLGS 269 (353)
T ss_dssp --TTHHHHHHHHHHHHHHHHSSCSSCC--SSHHHHHHHHHHCCCCCCT----TSCHHHHHHHHHHTCSSGGGSTTS
T ss_pred --CCccCCCcchHHHHHHHhCCCCCCC--CCHHHHHHHHHcCCCCCCC----CCCHHHHHHHHHHhhhCHHHccCC
Confidence 8999999999999999999999974 4567788888776544442 478899999999999999999998
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=1.5e-26 Score=228.69 Aligned_cols=144 Identities=22% Similarity=0.368 Sum_probs=121.6
Q ss_pred HHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCccEEEeccCCcccccCCCcccccccccCCccccCCccccCCCCC
Q psy1840 25 SISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKAPELLRQPHLP 104 (423)
Q Consensus 25 ~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~ 104 (423)
...++.||+.||.|||+.|++ ||||||+|||++.++.+||+|||+++...... .......||+.|+|||++.+..+
T Consensus 123 ~~~~~~qi~~aL~~LH~~giv-HrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~- 198 (353)
T 2i0e_A 123 AVFYAAEIAIGLFFLQSKGII-YRDLKLDNVMLDSEGHIKIADFGMCKENIWDG--VTTKTFCGTPDYIAPEIIAYQPY- 198 (353)
T ss_dssp HHHHHHHHHHHHHHHHHTTCB-CCCCCGGGEEECTTSCEEECCCTTCBCCCCTT--CCBCCCCSCGGGCCHHHHTTCCB-
T ss_pred HHHHHHHHHHHHHHHHHCCEE-eccCCHHHEEEcCCCcEEEEeCCcccccccCC--cccccccCCccccChhhhcCCCc-
Confidence 578999999999999999998 99999999999999999999999987532221 12345679999999999987665
Q ss_pred CCCCccchHHHHHHHHHHHhCCCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCchHHHHHHHHHhhhcCCCCCCCH
Q psy1840 105 RGTQKGDVYSFGLVLYEVIGRQGPWGHLRMTDEEIITSVTQGSGLRPDTSSLDCAPSIIACMRTCWEEDPELRPDL 180 (423)
Q Consensus 105 ~~s~ksDVyS~Giil~elltg~~Pf~~~~~~~~~i~~~i~~~~~~~p~~~~~~~~~~l~~Li~~C~~~dP~~RPt~ 180 (423)
+.++|+|||||++|||++|+.||.. .+..++...+.......| ..+++++.+++.+||+.||.+||+.
T Consensus 199 --~~~~DiwslG~il~ell~G~~Pf~~--~~~~~~~~~i~~~~~~~p----~~~s~~~~~li~~lL~~dP~~R~~~ 266 (353)
T 2i0e_A 199 --GKSVDWWAFGVLLYEMLAGQAPFEG--EDEDELFQSIMEHNVAYP----KSMSKEAVAICKGLMTKHPGKRLGC 266 (353)
T ss_dssp --STHHHHHHHHHHHHHHHHSSCSSCC--SSHHHHHHHHHHCCCCCC----TTSCHHHHHHHHHHTCSCTTSCTTC
T ss_pred --CCcccccchHHHHHHHHcCCCCCCC--CCHHHHHHHHHhCCCCCC----CCCCHHHHHHHHHHhhcCHHHcCCC
Confidence 8999999999999999999999974 456777777776544333 3578999999999999999999964
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=4.6e-27 Score=229.18 Aligned_cols=157 Identities=22% Similarity=0.309 Sum_probs=123.6
Q ss_pred HHHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCccEEEeccCCcccccCCCcccccccccCCccccCCccccCCCC
Q psy1840 24 GSISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKAPELLRQPHL 103 (423)
Q Consensus 24 ~~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~ 103 (423)
....++.||+.||.|||+.|++ ||||||+||+++.++.+||+|||++................||+.|+|||++.+..+
T Consensus 106 ~~~~i~~qi~~aL~~LH~~giv-H~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~ 184 (323)
T 3tki_A 106 DAQRFFHQLMAGVVYLHGIGIT-HRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREF 184 (323)
T ss_dssp HHHHHHHHHHHHHHHHHHTTEE-CSCCSGGGEEECTTCCEEECCCTTCEECEETTEECCBCSCCSCGGGSCHHHHHCSSB
T ss_pred HHHHHHHHHHHHHHHHHHCCcc-ccccchHHEEEeCCCCEEEEEeeccceeccCCcccccCCCccCcCccCcHHhccCCC
Confidence 3689999999999999999988 999999999999999999999999876543333233345678999999999976542
Q ss_pred CCCCCccchHHHHHHHHHHHhCCCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCchHHHHHHHHHhhhcCCCCCCCHHHH
Q psy1840 104 PRGTQKGDVYSFGLVLYEVIGRQGPWGHLRMTDEEIITSVTQGSGLRPDTSSLDCAPSIIACMRTCWEEDPELRPDLRFV 183 (423)
Q Consensus 104 ~~~s~ksDVyS~Giil~elltg~~Pf~~~~~~~~~i~~~i~~~~~~~p~~~~~~~~~~l~~Li~~C~~~dP~~RPt~~~I 183 (423)
.+.++|||||||++|+|++|..||.................. ..+ ....+++.+.+++.+||+.||++|||+.++
T Consensus 185 --~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~-~~~--~~~~~~~~~~~li~~~L~~dP~~R~t~~ei 259 (323)
T 3tki_A 185 --HAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKT-YLN--PWKKIDSAPLALLHKILVENPSARITIPDI 259 (323)
T ss_dssp --CHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHHHHHHTTCT-TST--TGGGSCHHHHHHHHHHSCSSTTTSCCHHHH
T ss_pred --CCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhcccc-cCC--ccccCCHHHHHHHHHHccCChhhCcCHHHH
Confidence 267899999999999999999999765443333333332221 111 123578999999999999999999999998
Q ss_pred HHH
Q psy1840 184 HHK 186 (423)
Q Consensus 184 ~~~ 186 (423)
++.
T Consensus 260 l~h 262 (323)
T 3tki_A 260 KKD 262 (323)
T ss_dssp TTC
T ss_pred hhC
Confidence 753
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=9.1e-27 Score=221.31 Aligned_cols=155 Identities=24% Similarity=0.511 Sum_probs=122.9
Q ss_pred HHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCccEEEeccCCcccccCCCcccccccccCCccccCCccccCCCCC
Q psy1840 25 SISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKAPELLRQPHLP 104 (423)
Q Consensus 25 ~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~ 104 (423)
...++.|++.||.|||+.|++ ||||||+||+++.++.+||+|||++....... ....++..|+|||.+.+..+
T Consensus 119 ~~~~~~~i~~~l~~lH~~~i~-H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~- 191 (278)
T 1byg_A 119 LLKFSLDVCEAMEYLEGNNFV-HRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ-----DTGKLPVKWTAPEALREKKF- 191 (278)
T ss_dssp HHHHHHHHHHHHHHHHHTTCC-CSCCSGGGEEECTTSCEEECCCCC-----------------CCTTTSCHHHHHHCCC-
T ss_pred HHHHHHHHHHHHHHHHhCCcc-ccCCCcceEEEeCCCcEEEeeccccccccccc-----cCCCccccccCHHHhCCCCC-
Confidence 578999999999999999998 99999999999999999999999987543221 23356778999999977654
Q ss_pred CCCCccchHHHHHHHHHHHh-CCCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCchHHHHHHHHHhhhcCCCCCCCHHHH
Q psy1840 105 RGTQKGDVYSFGLVLYEVIG-RQGPWGHLRMTDEEIITSVTQGSGLRPDTSSLDCAPSIIACMRTCWEEDPELRPDLRFV 183 (423)
Q Consensus 105 ~~s~ksDVyS~Giil~ellt-g~~Pf~~~~~~~~~i~~~i~~~~~~~p~~~~~~~~~~l~~Li~~C~~~dP~~RPt~~~I 183 (423)
+.++||||||+++|||++ |..||... ...++...+..+.. +. ....+++.+.+++.+||+.||++||++.++
T Consensus 192 --~~~~Di~slG~il~~l~t~g~~p~~~~--~~~~~~~~~~~~~~--~~-~~~~~~~~l~~li~~~l~~~p~~Rps~~~l 264 (278)
T 1byg_A 192 --STKSDVWSFGILLWEIYSFGRVPYPRI--PLKDVVPRVEKGYK--MD-APDGCPPAVYEVMKNCWHLDAAMRPSFLQL 264 (278)
T ss_dssp --CHHHHHHHHHHHHHHHHTTSCCSCTTS--CGGGHHHHHTTTCC--CC-CCTTCCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred --CchhcHHHHHHHHHHHHhCCCCCCCCC--CHHHHHHHHhcCCC--CC-CcccCCHHHHHHHHHHhcCChhhCCCHHHH
Confidence 899999999999999998 99999743 34555666655422 22 234678999999999999999999999999
Q ss_pred HHHHHHHhhh
Q psy1840 184 HHKLKEMNAG 193 (423)
Q Consensus 184 ~~~L~~i~~~ 193 (423)
++.|+.+...
T Consensus 265 ~~~L~~i~~~ 274 (278)
T 1byg_A 265 REQLEHIKTH 274 (278)
T ss_dssp HHHHHHHHHH
T ss_pred HHHHHHHHhh
Confidence 9999988653
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=99.94 E-value=1.3e-26 Score=224.22 Aligned_cols=163 Identities=18% Similarity=0.224 Sum_probs=119.1
Q ss_pred HHHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCccEEEeccCCcccccCCCcccccccccCCccccCCccccCCCC
Q psy1840 24 GSISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKAPELLRQPHL 103 (423)
Q Consensus 24 ~~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~ 103 (423)
....++.|++.||.|||+.|++ ||||||+||+++.++.+||+|||++........ .......+++.|+|||.+.+..+
T Consensus 135 ~~~~i~~qi~~~l~~lH~~~i~-H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~ 212 (309)
T 2h34_A 135 RAVAIVRQIGSALDAAHAAGAT-HRDVKPENILVSADDFAYLVDFGIASATTDEKL-TQLGNTVGTLYYMAPERFSESHA 212 (309)
T ss_dssp HHHHHHHHHHHHHHHHHHTTCC-CSCCCGGGEEECTTSCEEECSCCC-----------------CCGGGCCGGGTCC---
T ss_pred HHHHHHHHHHHHHHHHHHCcCC-cCCCChHHEEEcCCCCEEEecCccCcccccccc-ccccccCCCcCccCHHHHcCCCC
Confidence 3689999999999999999998 999999999999999999999999876533221 12234568889999999987654
Q ss_pred CCCCCccchHHHHHHHHHHHhCCCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCchHHHHHHHHHhhhcCCCCCC-CHHH
Q psy1840 104 PRGTQKGDVYSFGLVLYEVIGRQGPWGHLRMTDEEIITSVTQGSGLRPDTSSLDCAPSIIACMRTCWEEDPELRP-DLRF 182 (423)
Q Consensus 104 ~~~s~ksDVyS~Giil~elltg~~Pf~~~~~~~~~i~~~i~~~~~~~p~~~~~~~~~~l~~Li~~C~~~dP~~RP-t~~~ 182 (423)
+.++||||||+++|||++|..||... ....+...+.. ....+......+++.+.+++.+||+.||++|| ++.+
T Consensus 213 ---~~~~Di~slG~il~~l~~g~~pf~~~--~~~~~~~~~~~-~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~ 286 (309)
T 2h34_A 213 ---TYRADIYALTCVLYECLTGSPPYQGD--QLSVMGAHINQ-AIPRPSTVRPGIPVAFDAVIARGMAKNPEDRYVTCGD 286 (309)
T ss_dssp ----CCCHHHHHHHHHHHHHHSSCSSCSC--HHHHHHHHHHS-CCCCGGGTSTTCCTHHHHHHHHHTCSSGGGSCSSHHH
T ss_pred ---CchHhHHHHHHHHHHHHHCCCCCCCc--hHHHHHHHhcc-CCCCccccCCCCCHHHHHHHHHhccCCHHHHHHhHHH
Confidence 88999999999999999999999743 22233333333 22223233446888999999999999999999 9999
Q ss_pred HHHHHHHHhhhc
Q psy1840 183 VHHKLKEMNAGL 194 (423)
Q Consensus 183 I~~~L~~i~~~~ 194 (423)
+.+.|+......
T Consensus 287 l~~~l~~~l~~~ 298 (309)
T 2h34_A 287 LSAAAHAALATA 298 (309)
T ss_dssp HHHHHHHTCC--
T ss_pred HHHHHHHHHHhh
Confidence 999998776544
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.94 E-value=9.4e-27 Score=246.19 Aligned_cols=159 Identities=26% Similarity=0.484 Sum_probs=127.5
Q ss_pred HHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCccEEEeccCCcccccCCCcc-cccccccCCccccCCccccCCCC
Q psy1840 25 SISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDET-GQERKLRRRKLYKAPELLRQPHL 103 (423)
Q Consensus 25 ~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~~-~~~~~~~gt~~y~APE~l~~~~~ 103 (423)
.+.++.||+.||.|||+++++ ||||||+|||++.++.+||+|||+++........ .......+++.|+|||++.+..+
T Consensus 438 ~~~i~~qi~~~L~~LH~~~ii-HrDlkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~y~APE~~~~~~~ 516 (613)
T 2ozo_A 438 VAELLHQVSMGMKYLEEKNFV-HRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKF 516 (613)
T ss_dssp HHHHHHHHHHHHHHHHHTTCC-CSCCSGGGEEEEETTEEEECCCSTTTTCC--------------CCTTSCHHHHHHCCC
T ss_pred HHHHHHHHHHHHHHHHHCCEE-cCcCCHHHEEEcCCCcEEEeeccCcccccCCCceeeeccCCCCccceeCHhhhcCCCC
Confidence 689999999999999999998 9999999999999999999999999865432211 11122345578999999987655
Q ss_pred CCCCCccchHHHHHHHHHHHh-CCCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCchHHHHHHHHHhhhcCCCCCCCHHH
Q psy1840 104 PRGTQKGDVYSFGLVLYEVIG-RQGPWGHLRMTDEEIITSVTQGSGLRPDTSSLDCAPSIIACMRTCWEEDPELRPDLRF 182 (423)
Q Consensus 104 ~~~s~ksDVyS~Giil~ellt-g~~Pf~~~~~~~~~i~~~i~~~~~~~p~~~~~~~~~~l~~Li~~C~~~dP~~RPt~~~ 182 (423)
+.++|||||||++|||++ |+.||.. ....++...+..+... . .+..+++++.++|.+||+.||++||++.+
T Consensus 517 ---~~~sDvwSlGv~l~ellt~G~~Pf~~--~~~~~~~~~i~~~~~~--~-~p~~~~~~l~~li~~cl~~dP~~RPs~~~ 588 (613)
T 2ozo_A 517 ---SSRSDVWSYGVTMWEALSYGQKPYKK--MKGPEVMAFIEQGKRM--E-CPPECPPELYALMSDCWIYKWEDRPDFLT 588 (613)
T ss_dssp ---CHHHHHHHHHHHHHHHHTTSCCTTTT--CCSHHHHHHHHTTCCC--C-CCTTCCHHHHHHHHHTTCSSTTTSCCHHH
T ss_pred ---CcHHHHHHHHHHHHHHHHCCCCCCCC--CCHHHHHHHHHcCCCC--C-CCCcCCHHHHHHHHHHcCCChhHCcCHHH
Confidence 899999999999999998 9999974 4456777777776432 2 22368999999999999999999999999
Q ss_pred HHHHHHHHhh
Q psy1840 183 VHHKLKEMNA 192 (423)
Q Consensus 183 I~~~L~~i~~ 192 (423)
|++.|+.+..
T Consensus 589 l~~~L~~~~~ 598 (613)
T 2ozo_A 589 VEQRMRACYY 598 (613)
T ss_dssp HHHHHHHHHH
T ss_pred HHHHHHHHHH
Confidence 9999987754
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=4.2e-27 Score=227.71 Aligned_cols=162 Identities=22% Similarity=0.330 Sum_probs=118.9
Q ss_pred HHHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCccEEEeccCCcccccCCCcc-cccccccCCccccCCccccCCC
Q psy1840 24 GSISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDET-GQERKLRRRKLYKAPELLRQPH 102 (423)
Q Consensus 24 ~~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~~-~~~~~~~gt~~y~APE~l~~~~ 102 (423)
....++.|++.||.|||++|++ ||||||+||+++.++.+||+|||++......... .......|++.|+|||.+.+..
T Consensus 117 ~~~~~~~qi~~~l~~lH~~~iv-H~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~ 195 (311)
T 3ork_A 117 RAIEVIADACQALNFSHQNGII-HRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDS 195 (311)
T ss_dssp HHHHHHHHHHHHHHHHHHTTCC-CCCCCGGGEEEETTSCEEECCCSCC------------------CCTTCCHHHHHTCC
T ss_pred HHHHHHHHHHHHHHHHHHCCCC-cCCCCHHHEEEcCCCCEEEeeccCcccccccccccccccccCcCcccCCHHHhcCCC
Confidence 3689999999999999999998 9999999999999999999999998765433221 2223456899999999998765
Q ss_pred CCCCCCccchHHHHHHHHHHHhCCCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCchHHHHHHHHHhhhcCCCCCCCHHH
Q psy1840 103 LPRGTQKGDVYSFGLVLYEVIGRQGPWGHLRMTDEEIITSVTQGSGLRPDTSSLDCAPSIIACMRTCWEEDPELRPDLRF 182 (423)
Q Consensus 103 ~~~~s~ksDVyS~Giil~elltg~~Pf~~~~~~~~~i~~~i~~~~~~~p~~~~~~~~~~l~~Li~~C~~~dP~~RPt~~~ 182 (423)
+ +.++||||||+++|||++|+.||.. ....+............+......++.++.+++.+||+.||++||+..+
T Consensus 196 ~---~~~~Di~slG~~l~~ll~g~~pf~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~ 270 (311)
T 3ork_A 196 V---DARSDVYSLGCVLYEVLTGEPPFTG--DSPVSVAYQHVREDPIPPSARHEGLSADLDAVVLKALAKNPENRYQTAA 270 (311)
T ss_dssp C---CHHHHHHHHHHHHHHHHHSSCSCCC--SSHHHHHHHHHHCCCCCHHHHSTTCCHHHHHHHHHHTCSSGGGSCSSHH
T ss_pred C---CchHhHHHHHHHHHHHHhCCCCCCC--CChHHHHHHHhcCCCCCcccccCCCCHHHHHHHHHHHhcCHhhChhhHH
Confidence 5 8999999999999999999999974 3444554444444333332223467899999999999999999997655
Q ss_pred H-HHHHHHHh
Q psy1840 183 V-HHKLKEMN 191 (423)
Q Consensus 183 I-~~~L~~i~ 191 (423)
+ .+.+....
T Consensus 271 ~l~~~l~~~~ 280 (311)
T 3ork_A 271 EMRADLVRVH 280 (311)
T ss_dssp HHHHHHHHHH
T ss_pred HHHHHHHHHh
Confidence 4 44444443
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.94 E-value=5e-27 Score=228.36 Aligned_cols=175 Identities=21% Similarity=0.320 Sum_probs=115.1
Q ss_pred HHHHHHHHHHHHHHHHhCC--CeeecCCCCCCEEEcCCccEEEeccCCcccccCCCccc----------ccccccCCccc
Q psy1840 25 SISVNTTASVGMIHLHDSE--IISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETG----------QERKLRRRKLY 92 (423)
Q Consensus 25 ~l~i~~qi~~gL~yLH~~~--ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~~~----------~~~~~~gt~~y 92 (423)
...++.||+.||.|||+.| ++ ||||||+||+++.++.+||+|||++.......... ......+++.|
T Consensus 138 ~~~i~~qi~~~l~~LH~~~~~iv-H~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y 216 (337)
T 3ll6_A 138 VLKIFYQTCRAVQHMHRQKPPII-HRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMY 216 (337)
T ss_dssp HHHHHHHHHHHHHHHHTSSSCCB-CCCCCGGGCEECTTSCEEBCCCTTCBCCSSCC------------------------
T ss_pred HHHHHHHHHHHHHHHHhCCCCEE-EccCCcccEEECCCCCEEEecCccceeccccCcccccccccccchhhccccCCCCc
Confidence 6899999999999999998 88 99999999999999999999999987654322111 11234588899
Q ss_pred cCCccccCCCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCchHHHHHHHHHhhhc
Q psy1840 93 KAPELLRQPHLPRGTQKGDVYSFGLVLYEVIGRQGPWGHLRMTDEEIITSVTQGSGLRPDTSSLDCAPSIIACMRTCWEE 172 (423)
Q Consensus 93 ~APE~l~~~~~~~~s~ksDVyS~Giil~elltg~~Pf~~~~~~~~~i~~~i~~~~~~~p~~~~~~~~~~l~~Li~~C~~~ 172 (423)
+|||.+.......++.++|||||||++|||++|+.||.... ...+. ......+ ....++..+.+++.+||+.
T Consensus 217 ~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~--~~~~~----~~~~~~~--~~~~~~~~~~~li~~~l~~ 288 (337)
T 3ll6_A 217 RTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGA--KLRIV----NGKYSIP--PHDTQYTVFHSLIRAMLQV 288 (337)
T ss_dssp -------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC------------------CCCC--TTCCSSGGGHHHHHHHSCS
T ss_pred CChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchh--HHHhh----cCcccCC--cccccchHHHHHHHHHccC
Confidence 99999843222234889999999999999999999996421 11111 1111111 1235677899999999999
Q ss_pred CCCCCCCHHHHHHHHHHHhhhcCCChHHHHHHHHHH
Q psy1840 173 DPELRPDLRFVHHKLKEMNAGLKANIFDNMLAIMEK 208 (423)
Q Consensus 173 dP~~RPt~~~I~~~L~~i~~~~~~~~~d~~~~~~e~ 208 (423)
||++||++.++++.|+.+......+....+...+++
T Consensus 289 ~p~~Rps~~e~l~~l~~~~~~~~~~~~~~~~~~~~~ 324 (337)
T 3ll6_A 289 NPEERLSIAEVVHQLQEIAAARNVNPKSPITELLEQ 324 (337)
T ss_dssp SGGGSCCHHHHHHHHHHHHHHTTCCTTSCCHHHHTC
T ss_pred ChhhCcCHHHHHHHHHHHHhccCCCCCccHHHHHHH
Confidence 999999999999999998876655544444444443
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=1e-26 Score=226.50 Aligned_cols=160 Identities=29% Similarity=0.452 Sum_probs=129.1
Q ss_pred HHHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCccEEEeccCCcccccCCCcccccccccCCccccCCccccCCCC
Q psy1840 24 GSISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKAPELLRQPHL 103 (423)
Q Consensus 24 ~~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~ 103 (423)
....++.||+.||.|||+.|++ ||||||+||+++.++.+||+|||+++..... .......+++.|+|||.+.+..+
T Consensus 143 ~~~~i~~qi~~aL~~LH~~~iv-H~dlkp~NIl~~~~~~~kL~Dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~ 218 (327)
T 1fvr_A 143 QLLHFAADVARGMDYLSQKQFI-HRDLAARNILVGENYVAKIADFGLSRGQEVY---VKKTMGRLPVRWMAIESLNYSVY 218 (327)
T ss_dssp HHHHHHHHHHHHHHHHHHTTEE-CSCCSGGGEEECGGGCEEECCTTCEESSCEE---CCC----CCTTTCCHHHHHHCEE
T ss_pred HHHHHHHHHHHHHHHHHhCCcc-CCCCccceEEEcCCCeEEEcccCcCcccccc---ccccCCCCCccccChhhhccccC
Confidence 3689999999999999999998 9999999999999999999999998643211 11123456778999999977654
Q ss_pred CCCCCccchHHHHHHHHHHHh-CCCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCchHHHHHHHHHhhhcCCCCCCCHHH
Q psy1840 104 PRGTQKGDVYSFGLVLYEVIG-RQGPWGHLRMTDEEIITSVTQGSGLRPDTSSLDCAPSIIACMRTCWEEDPELRPDLRF 182 (423)
Q Consensus 104 ~~~s~ksDVyS~Giil~ellt-g~~Pf~~~~~~~~~i~~~i~~~~~~~p~~~~~~~~~~l~~Li~~C~~~dP~~RPt~~~ 182 (423)
+.++||||||+++|||++ |..||.. ....++...+..+.... ....+++.+.+++.+||+.||.+|||+.+
T Consensus 219 ---~~~~Di~slG~il~ellt~g~~pf~~--~~~~~~~~~~~~~~~~~---~~~~~~~~l~~li~~~l~~dp~~Rps~~e 290 (327)
T 1fvr_A 219 ---TTNSDVWSYGVLLWEIVSLGGTPYCG--MTCAELYEKLPQGYRLE---KPLNCDDEVYDLMRQCWREKPYERPSFAQ 290 (327)
T ss_dssp ---CHHHHHHHHHHHHHHHHTTSCCTTTT--CCHHHHHHHGGGTCCCC---CCTTBCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred ---CchhcchHHHHHHHHHHcCCCCCCCC--CcHHHHHHHhhcCCCCC---CCCCCCHHHHHHHHHHccCChhhCcCHHH
Confidence 899999999999999998 9999974 45566777766653221 22368899999999999999999999999
Q ss_pred HHHHHHHHhhhcC
Q psy1840 183 VHHKLKEMNAGLK 195 (423)
Q Consensus 183 I~~~L~~i~~~~~ 195 (423)
+++.|..+....+
T Consensus 291 ll~~L~~~~~~~~ 303 (327)
T 1fvr_A 291 ILVSLNRMLEERK 303 (327)
T ss_dssp HHHHHHHHHHSSS
T ss_pred HHHHHHHHHHhhc
Confidence 9999988876543
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=6.9e-27 Score=230.31 Aligned_cols=148 Identities=24% Similarity=0.359 Sum_probs=124.1
Q ss_pred HHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCccEEEeccCCcccccCCCcccccccccCCccccCCccccCCCCC
Q psy1840 25 SISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKAPELLRQPHLP 104 (423)
Q Consensus 25 ~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~ 104 (423)
...++.||+.||.|||++|++ ||||||+||+++.++.+||+|||+++...... .......||+.|+|||++.+..+
T Consensus 120 ~~~~~~qi~~aL~~LH~~~iv-HrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~- 195 (345)
T 1xjd_A 120 ATFYAAEIILGLQFLHSKGIV-YRDLKLDNILLDKDGHIKIADFGMCKENMLGD--AKTNTFCGTPDYIAPEILLGQKY- 195 (345)
T ss_dssp HHHHHHHHHHHHHHHHHTTCB-CCCCCGGGEEECTTSCEEECCCTTCBCCCCTT--CCBCCCCSCGGGCCHHHHTTCCB-
T ss_pred HHHHHHHHHHHHHHHHHCCeE-eCCCChhhEEECCCCCEEEeEChhhhhcccCC--CcccCCCCCcccCChhhhcCCCC-
Confidence 578999999999999999998 99999999999999999999999987542221 12345689999999999988655
Q ss_pred CCCCccchHHHHHHHHHHHhCCCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCchHHHHHHHHHhhhcCCCCCCCHH-HH
Q psy1840 105 RGTQKGDVYSFGLVLYEVIGRQGPWGHLRMTDEEIITSVTQGSGLRPDTSSLDCAPSIIACMRTCWEEDPELRPDLR-FV 183 (423)
Q Consensus 105 ~~s~ksDVyS~Giil~elltg~~Pf~~~~~~~~~i~~~i~~~~~~~p~~~~~~~~~~l~~Li~~C~~~dP~~RPt~~-~I 183 (423)
+.++|+|||||++|||++|..||.. .+..++...+..+....| ..+++++.+++.+||+.||.+||++. +|
T Consensus 196 --~~~~DiwslG~il~ell~g~~Pf~~--~~~~~~~~~i~~~~~~~p----~~~s~~~~~li~~lL~~dp~~R~~~~~~i 267 (345)
T 1xjd_A 196 --NHSVDWWSFGVLLYEMLIGQSPFHG--QDEEELFHSIRMDNPFYP----RWLEKEAKDLLVKLFVREPEKRLGVRGDI 267 (345)
T ss_dssp --CTHHHHHHHHHHHHHHHHSSCSSCC--SSHHHHHHHHHHCCCCCC----TTSCHHHHHHHHHHSCSSGGGSBTTBSCG
T ss_pred --CChhhhHHHHHHHHHHhcCCCCCCC--CCHHHHHHHHHhCCCCCC----cccCHHHHHHHHHHhcCCHhHcCCChHHH
Confidence 8999999999999999999999974 456777777776544333 35789999999999999999999986 54
Q ss_pred H
Q psy1840 184 H 184 (423)
Q Consensus 184 ~ 184 (423)
+
T Consensus 268 ~ 268 (345)
T 1xjd_A 268 R 268 (345)
T ss_dssp G
T ss_pred H
Confidence 3
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=99.94 E-value=1.7e-26 Score=226.11 Aligned_cols=158 Identities=16% Similarity=0.162 Sum_probs=122.0
Q ss_pred HHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCc--cEEEeccCCcccccCCCc--ccccccccCCccccCCccccC
Q psy1840 25 SISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRW--VLQIADFGLHAFKAGQDE--TGQERKLRRRKLYKAPELLRQ 100 (423)
Q Consensus 25 ~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~--~vKL~DFGla~~~~~~~~--~~~~~~~~gt~~y~APE~l~~ 100 (423)
...++.||+.||.|||+.|++ ||||||+||+++.++ .+||+|||++........ ........|++.|+|||.+.+
T Consensus 170 ~~~i~~qi~~~l~~LH~~~iv-H~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 248 (345)
T 3hko_A 170 ISNIMRQIFSALHYLHNQGIC-HRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNT 248 (345)
T ss_dssp HHHHHHHHHHHHHHHHHTTEE-CCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTC
T ss_pred HHHHHHHHHHHHHHHHHCCcc-ccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhcc
Confidence 457999999999999999988 999999999998766 899999999875432211 112245578999999999975
Q ss_pred CCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCchHHHHHHHHHhhhcCCCCCCCH
Q psy1840 101 PHLPRGTQKGDVYSFGLVLYEVIGRQGPWGHLRMTDEEIITSVTQGSGLRPDTSSLDCAPSIIACMRTCWEEDPELRPDL 180 (423)
Q Consensus 101 ~~~~~~s~ksDVyS~Giil~elltg~~Pf~~~~~~~~~i~~~i~~~~~~~p~~~~~~~~~~l~~Li~~C~~~dP~~RPt~ 180 (423)
... .++.++|||||||++|||++|..||.. ....+....+.......+......+++.+.+++.+||+.||.+||++
T Consensus 249 ~~~-~~~~~~DiwslG~il~el~~g~~pf~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~ 325 (345)
T 3hko_A 249 TNE-SYGPKCDAWSAGVLLHLLLMGAVPFPG--VNDADTISQVLNKKLCFENPNYNVLSPLARDLLSNLLNRNVDERFDA 325 (345)
T ss_dssp SSS-CCCTHHHHHHHHHHHHHHHHSSCSSCC--SSHHHHHHHHHHCCCCTTSGGGGGSCHHHHHHHHHHSCSCTTTSCCH
T ss_pred CCC-CCCcHHHHHHHHHHHHHHHHCCCCCCC--CChHHHHHHHHhcccccCCcccccCCHHHHHHHHHHcCCChhHCCCH
Confidence 321 348899999999999999999999974 34556666666544333332233578999999999999999999999
Q ss_pred HHHHHH
Q psy1840 181 RFVHHK 186 (423)
Q Consensus 181 ~~I~~~ 186 (423)
.++++.
T Consensus 326 ~~~l~h 331 (345)
T 3hko_A 326 MRALQH 331 (345)
T ss_dssp HHHHHS
T ss_pred HHHhcC
Confidence 999774
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=99.94 E-value=1e-26 Score=221.99 Aligned_cols=161 Identities=25% Similarity=0.448 Sum_probs=128.3
Q ss_pred HHHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCccEEEeccCCcccccCCCcc-cccccccCCccccCCccccCCC
Q psy1840 24 GSISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDET-GQERKLRRRKLYKAPELLRQPH 102 (423)
Q Consensus 24 ~~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~~-~~~~~~~gt~~y~APE~l~~~~ 102 (423)
....++.||+.||.|||+.|++ ||||||+||+++.++.+||+|||++......... .......++..|+|||.+.+..
T Consensus 122 ~~~~~~~~i~~~l~~lH~~~i~-H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~ 200 (291)
T 1u46_A 122 TLSRYAVQVAEGMGYLESKRFI-HRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRT 200 (291)
T ss_dssp HHHHHHHHHHHHHHHHHHTTEE-CSCCCGGGEEEEETTEEEECCCTTCEECCC-CCEEEC-----CCGGGCCHHHHHHCE
T ss_pred HHHHHHHHHHHHHHHHHhCCcc-cCCCchheEEEcCCCCEEEccccccccccccccchhhhccCCCCceeeCchhhcCCC
Confidence 3678999999999999999988 9999999999999999999999998765433221 1123345677899999998765
Q ss_pred CCCCCCccchHHHHHHHHHHHh-CCCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCchHHHHHHHHHhhhcCCCCCCCHH
Q psy1840 103 LPRGTQKGDVYSFGLVLYEVIG-RQGPWGHLRMTDEEIITSVTQGSGLRPDTSSLDCAPSIIACMRTCWEEDPELRPDLR 181 (423)
Q Consensus 103 ~~~~s~ksDVyS~Giil~ellt-g~~Pf~~~~~~~~~i~~~i~~~~~~~p~~~~~~~~~~l~~Li~~C~~~dP~~RPt~~ 181 (423)
+ +.++||||||+++|+|++ |..||.. ....++...+.......+ ....++.++.+++.+||+.||++|||+.
T Consensus 201 ~---~~~~Di~slG~il~~l~~~g~~p~~~--~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~li~~~l~~~p~~Rps~~ 273 (291)
T 1u46_A 201 F---SHASDTWMFGVTLWEMFTYGQEPWIG--LNGSQILHKIDKEGERLP--RPEDCPQDIYNVMVQCWAHKPEDRPTFV 273 (291)
T ss_dssp E---EHHHHHHHHHHHHHHHHTTSCCTTTT--CCHHHHHHHHHTSCCCCC--CCTTCCHHHHHHHHHHTCSSGGGSCCHH
T ss_pred C---CchhhHHHHHHHHHHHHhCCCCCccc--CCHHHHHHHHHccCCCCC--CCcCcCHHHHHHHHHHccCCcccCcCHH
Confidence 4 889999999999999999 9999974 455666766665433222 2246889999999999999999999999
Q ss_pred HHHHHHHHHhh
Q psy1840 182 FVHHKLKEMNA 192 (423)
Q Consensus 182 ~I~~~L~~i~~ 192 (423)
++++.|+++..
T Consensus 274 ~l~~~l~~~~~ 284 (291)
T 1u46_A 274 ALRDFLLEAQP 284 (291)
T ss_dssp HHHHHHHHHC-
T ss_pred HHHHHHHHhCc
Confidence 99999988764
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=99.94 E-value=1.3e-26 Score=221.73 Aligned_cols=155 Identities=20% Similarity=0.257 Sum_probs=116.2
Q ss_pred HHHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCccEEEeccCCcccccCCCcccccccccCCccccCCccccCCCC
Q psy1840 24 GSISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKAPELLRQPHL 103 (423)
Q Consensus 24 ~~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~ 103 (423)
....++.||+.||.|||++|++ ||||||+||+++.++.+||+|||++........ ......+|+.|+|||.+.+..
T Consensus 101 ~~~~~~~qi~~~l~~lH~~~i~-H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~- 176 (288)
T 1ob3_A 101 TAKSFLLQLLNGIAYCHDRRVL-HRDLKPQNLLINREGELKIADFGLARAFGIPVR--KYTHEIVTLWYRAPDVLMGSK- 176 (288)
T ss_dssp HHHHHHHHHHHHHHHHHHTTCC-CSCCCGGGEEECTTSCEEECCTTHHHHHCC-----------CCCTTCCHHHHTTCC-
T ss_pred HHHHHHHHHHHHHHHHHHCCee-cCCCCHHHEEEcCCCCEEEeECccccccCcccc--ccccccccccccCchheeCCC-
Confidence 3678999999999999999998 999999999999999999999999875432211 123446789999999987643
Q ss_pred CCCCCccchHHHHHHHHHHHhCCCCCCCCCCChHHHHHHHhc--CCC-------------CCCCC----------CCCCc
Q psy1840 104 PRGTQKGDVYSFGLVLYEVIGRQGPWGHLRMTDEEIITSVTQ--GSG-------------LRPDT----------SSLDC 158 (423)
Q Consensus 104 ~~~s~ksDVyS~Giil~elltg~~Pf~~~~~~~~~i~~~i~~--~~~-------------~~p~~----------~~~~~ 158 (423)
.++.++|||||||++|||++|..||... +..+....+.. +.+ ..+.. ....+
T Consensus 177 -~~~~~~DiwslG~il~~l~~g~~pf~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 253 (288)
T 1ob3_A 177 -KYSTTIDIWSVGCIFAEMVNGTPLFPGV--SEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTVYEPLPWESFLKGL 253 (288)
T ss_dssp -SCCTHHHHHHHHHHHHHHHHSSCSCCCS--SHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTCCCCCCCCGGGTCCSC
T ss_pred -CCCcHHHHHHHHHHHHHHHhCCCCCCCC--CHHHHHHHHHHHHCCCChhhchhhhcccccccccccccCccHHHHhhhc
Confidence 2489999999999999999999999743 33333333321 000 00000 11347
Q ss_pred hHHHHHHHHHhhhcCCCCCCCHHHHHH
Q psy1840 159 APSIIACMRTCWEEDPELRPDLRFVHH 185 (423)
Q Consensus 159 ~~~l~~Li~~C~~~dP~~RPt~~~I~~ 185 (423)
++++.+++.+||+.||++|||+.++++
T Consensus 254 ~~~~~~li~~~L~~dP~~Rpt~~e~l~ 280 (288)
T 1ob3_A 254 DESGIDLLSKMLKLDPNQRITAKQALE 280 (288)
T ss_dssp CHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred CHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 889999999999999999999999875
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.94 E-value=3.8e-26 Score=229.03 Aligned_cols=146 Identities=18% Similarity=0.315 Sum_probs=118.9
Q ss_pred HHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCccEEEeccCCcccccCCCcccccccccCCccccCCccccCCCCC
Q psy1840 25 SISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKAPELLRQPHLP 104 (423)
Q Consensus 25 ~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~ 104 (423)
...++.||+.||.|||+.|++ ||||||+|||++.++.+||+|||+++...... ......+||+.|+|||++.+..+
T Consensus 155 ~~~~~~qi~~aL~~LH~~giv-HrDLKp~NILl~~~g~ikL~DFGla~~~~~~~--~~~~~~~gt~~Y~aPE~l~~~~~- 230 (396)
T 4dc2_A 155 ARFYSAEISLALNYLHERGII-YRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG--DTTSTFCGTPNYIAPEILRGEDY- 230 (396)
T ss_dssp HHHHHHHHHHHHHHHHHTTCB-CCCCCGGGEEECTTSCEEECCCTTCBCCCCTT--CCBCCCCBCGGGCCHHHHTTCCB-
T ss_pred HHHHHHHHHHHHHHHHHCCEE-eccCCHHHEEECCCCCEEEeecceeeecccCC--CccccccCCcccCCchhhcCCCC-
Confidence 568899999999999999998 99999999999999999999999987532221 22345689999999999988765
Q ss_pred CCCCccchHHHHHHHHHHHhCCCCCCCCC-------CChHHHHHHHhcCCCCCCCCCCCCchHHHHHHHHHhhhcCCCCC
Q psy1840 105 RGTQKGDVYSFGLVLYEVIGRQGPWGHLR-------MTDEEIITSVTQGSGLRPDTSSLDCAPSIIACMRTCWEEDPELR 177 (423)
Q Consensus 105 ~~s~ksDVyS~Giil~elltg~~Pf~~~~-------~~~~~i~~~i~~~~~~~p~~~~~~~~~~l~~Li~~C~~~dP~~R 177 (423)
+.++|||||||++|||++|+.||.... .....+...+.......| ..+++++.+++++||+.||.+|
T Consensus 231 --~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p----~~~s~~~~~li~~lL~~dP~~R 304 (396)
T 4dc2_A 231 --GFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIP----RSLSVKAASVLKSFLNKDPKER 304 (396)
T ss_dssp --CTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHCCCCCC----TTSCHHHHHHHHHHTCSCTTTS
T ss_pred --ChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhccccCCC----CcCCHHHHHHHHHHhcCCHhHc
Confidence 899999999999999999999996432 122334555555443333 2578999999999999999999
Q ss_pred CCH
Q psy1840 178 PDL 180 (423)
Q Consensus 178 Pt~ 180 (423)
|++
T Consensus 305 ~~~ 307 (396)
T 4dc2_A 305 LGC 307 (396)
T ss_dssp TTC
T ss_pred CCC
Confidence 985
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=1.2e-26 Score=226.01 Aligned_cols=160 Identities=23% Similarity=0.462 Sum_probs=127.8
Q ss_pred HHHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcC---CccEEEeccCCcccccCCCcccccccccCCccccCCccccC
Q psy1840 24 GSISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDS---RWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKAPELLRQ 100 (423)
Q Consensus 24 ~~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~---~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~ 100 (423)
..+.++.||+.||.|||+.|++ ||||||+||+++. +..+||+|||++................+++.|+|||.+.+
T Consensus 141 ~~~~i~~qi~~al~~LH~~~i~-H~dlkp~NIli~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 219 (327)
T 2yfx_A 141 DLLHVARDIACGCQYLEENHFI-HRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFME 219 (327)
T ss_dssp HHHHHHHHHHHHHHHHHHTTCC-CSCCCGGGEEESCSSTTCCEEECCCHHHHHHHC------CCGGGSCGGGCCHHHHHH
T ss_pred HHHHHHHHHHHHHHHHhhCCee-cCcCCHhHEEEecCCCcceEEECccccccccccccccccCCCcCCCcceeCHhHhcC
Confidence 3689999999999999999998 9999999999984 45699999999875433322222234567888999999977
Q ss_pred CCCCCCCCccchHHHHHHHHHHHh-CCCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCchHHHHHHHHHhhhcCCCCCCC
Q psy1840 101 PHLPRGTQKGDVYSFGLVLYEVIG-RQGPWGHLRMTDEEIITSVTQGSGLRPDTSSLDCAPSIIACMRTCWEEDPELRPD 179 (423)
Q Consensus 101 ~~~~~~s~ksDVyS~Giil~ellt-g~~Pf~~~~~~~~~i~~~i~~~~~~~p~~~~~~~~~~l~~Li~~C~~~dP~~RPt 179 (423)
..+ +.++||||||+++|+|++ |..||.. ....++...+..+....+ ...++..+.+++.+||+.||.+||+
T Consensus 220 ~~~---~~~~Di~slG~il~ellt~g~~p~~~--~~~~~~~~~~~~~~~~~~---~~~~~~~l~~li~~~l~~dp~~Rps 291 (327)
T 2yfx_A 220 GIF---TSKTDTWSFGVLLWEIFSLGYMPYPS--KSNQEVLEFVTSGGRMDP---PKNCPGPVYRIMTQCWQHQPEDRPN 291 (327)
T ss_dssp CCC---CHHHHHHHHHHHHHHHHTTSCCSSTT--CCHHHHHHHHHTTCCCCC---CTTCCHHHHHHHHHHTCSSGGGSCC
T ss_pred CCC---CchhhHHHHHHHHHHHHcCCCCCCCC--cCHHHHHHHHhcCCCCCC---CCCCCHHHHHHHHHHhcCChhhCcC
Confidence 654 899999999999999998 8899974 345667777766543222 2367899999999999999999999
Q ss_pred HHHHHHHHHHHhh
Q psy1840 180 LRFVHHKLKEMNA 192 (423)
Q Consensus 180 ~~~I~~~L~~i~~ 192 (423)
+.+|++.|..+..
T Consensus 292 ~~~ll~~l~~~~~ 304 (327)
T 2yfx_A 292 FAIILERIEYCTQ 304 (327)
T ss_dssp HHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHhc
Confidence 9999999987754
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.94 E-value=1.5e-26 Score=230.20 Aligned_cols=154 Identities=18% Similarity=0.217 Sum_probs=125.9
Q ss_pred HHHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEE--cCCccEEEeccCCcccccCCCcccccccccCCccccCCccccCC
Q psy1840 24 GSISVNTTASVGMIHLHDSEIISHGNLRSSNCLI--DSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKAPELLRQP 101 (423)
Q Consensus 24 ~~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILl--d~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~ 101 (423)
..+.++.||+.||.|||+.|++ ||||||+|||+ +.++.+||+|||+++....... .....||+.|+|||++.+.
T Consensus 188 ~~~~i~~qi~~aL~~LH~~~iv-H~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~ 263 (373)
T 2x4f_A 188 DTILFMKQICEGIRHMHQMYIL-HLDLKPENILCVNRDAKQIKIIDFGLARRYKPREK---LKVNFGTPEFLAPEVVNYD 263 (373)
T ss_dssp HHHHHHHHHHHHHHHHHHTTEE-CCCCCGGGEEEEETTTTEEEECCCSSCEECCTTCB---CCCCCSSCTTCCHHHHTTC
T ss_pred HHHHHHHHHHHHHHHHHHCCcc-cccCCHHHEEEecCCCCcEEEEeCCCceecCCccc---cccccCCCcEeChhhccCC
Confidence 3678999999999999999988 99999999999 5678999999999876543322 2345689999999999876
Q ss_pred CCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCchHHHHHHHHHhhhcCCCCCCCHH
Q psy1840 102 HLPRGTQKGDVYSFGLVLYEVIGRQGPWGHLRMTDEEIITSVTQGSGLRPDTSSLDCAPSIIACMRTCWEEDPELRPDLR 181 (423)
Q Consensus 102 ~~~~~s~ksDVyS~Giil~elltg~~Pf~~~~~~~~~i~~~i~~~~~~~p~~~~~~~~~~l~~Li~~C~~~dP~~RPt~~ 181 (423)
.+ +.++|||||||++|||++|..||.+ ....+.+..+.......+......+++++.+++.+||+.||.+|||+.
T Consensus 264 ~~---~~~~DiwslG~il~elltg~~pf~~--~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~ 338 (373)
T 2x4f_A 264 FV---SFPTDMWSVGVIAYMLLSGLSPFLG--DNDAETLNNILACRWDLEDEEFQDISEEAKEFISKLLIKEKSWRISAS 338 (373)
T ss_dssp BC---CHHHHHHHHHHHHHHHHHSSCTTCC--SSHHHHHHHHHHTCCCSCSGGGTTSCHHHHHHHHTTSCSSGGGSCCHH
T ss_pred CC---CcHHhHHHHHHHHHHHHhCCCCCCC--CCHHHHHHHHHhccCCCChhhhccCCHHHHHHHHHHcCCChhhCCCHH
Confidence 54 8899999999999999999999974 345666666665543333322346789999999999999999999999
Q ss_pred HHHHH
Q psy1840 182 FVHHK 186 (423)
Q Consensus 182 ~I~~~ 186 (423)
++++.
T Consensus 339 e~l~h 343 (373)
T 2x4f_A 339 EALKH 343 (373)
T ss_dssp HHHHS
T ss_pred HHhcC
Confidence 99873
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=1.3e-26 Score=245.94 Aligned_cols=160 Identities=25% Similarity=0.457 Sum_probs=128.6
Q ss_pred HHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCccEEEeccCCcccccCCCcc-cccccccCCccccCCccccCCCC
Q psy1840 25 SISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDET-GQERKLRRRKLYKAPELLRQPHL 103 (423)
Q Consensus 25 ~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~~-~~~~~~~gt~~y~APE~l~~~~~ 103 (423)
.+.++.||+.||.|||++|++ ||||||+|||++.++.+||+|||+++........ .......++..|+|||++.+..+
T Consensus 471 ~~~i~~qi~~~L~yLH~~~ii-HrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~t~~y~APE~~~~~~~ 549 (635)
T 4fl3_A 471 IIELVHQVSMGMKYLEESNFV-HRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKF 549 (635)
T ss_dssp HHHHHHHHHHHHHHHHHTTCC-CSCCSGGGEEEEETTEEEECCTTHHHHTTC-------------CGGGSCHHHHHHCCC
T ss_pred HHHHHHHHHHHHHHHHHCCEe-CCCCChHhEEEeCCCCEEEEEcCCccccccCccccccccCCCCceeeeChhhhcCCCC
Confidence 689999999999999999998 9999999999999999999999998765433221 12233446678999999987655
Q ss_pred CCCCCccchHHHHHHHHHHHh-CCCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCchHHHHHHHHHhhhcCCCCCCCHHH
Q psy1840 104 PRGTQKGDVYSFGLVLYEVIG-RQGPWGHLRMTDEEIITSVTQGSGLRPDTSSLDCAPSIIACMRTCWEEDPELRPDLRF 182 (423)
Q Consensus 104 ~~~s~ksDVyS~Giil~ellt-g~~Pf~~~~~~~~~i~~~i~~~~~~~p~~~~~~~~~~l~~Li~~C~~~dP~~RPt~~~ 182 (423)
+.++|||||||++|||++ |+.||.+ ....++...+..+.... . +..++.++.++|.+||+.||++||++.+
T Consensus 550 ---~~~sDvwSlGv~l~ellt~G~~Pf~~--~~~~~~~~~i~~~~~~~--~-p~~~~~~l~~li~~cl~~dP~~RPs~~~ 621 (635)
T 4fl3_A 550 ---SSKSDVWSFGVLMWEAFSYGQKPYRG--MKGSEVTAMLEKGERMG--C-PAGCPREMYDLMNLCWTYDVENRPGFAA 621 (635)
T ss_dssp ---CHHHHHHHHHHHHHHHHTTTCCSSTT--CCHHHHHHHHHTTCCCC--C-CTTCCHHHHHHHHHHTCSSTTTSCCHHH
T ss_pred ---CcHHHHHHHHHHHHHHHhCCCCCCCC--CCHHHHHHHHHcCCCCC--C-CCCCCHHHHHHHHHHcCCCHhHCcCHHH
Confidence 899999999999999998 9999974 45677777777654322 1 2368999999999999999999999999
Q ss_pred HHHHHHHHhhh
Q psy1840 183 VHHKLKEMNAG 193 (423)
Q Consensus 183 I~~~L~~i~~~ 193 (423)
|++.|+.+...
T Consensus 622 l~~~L~~~~~~ 632 (635)
T 4fl3_A 622 VELRLRNYYYD 632 (635)
T ss_dssp HHHHHHHHHHH
T ss_pred HHHHHHHHHHH
Confidence 99999887543
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=1.4e-26 Score=225.87 Aligned_cols=154 Identities=21% Similarity=0.319 Sum_probs=124.1
Q ss_pred HHHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcC---CccEEEeccCCcccccCCCcccccccccCCccccCCccccC
Q psy1840 24 GSISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDS---RWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKAPELLRQ 100 (423)
Q Consensus 24 ~~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~---~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~ 100 (423)
....++.||+.||.|||+.|++ ||||||+||+++. ++.+||+|||++........ .....|++.|+|||++.+
T Consensus 132 ~~~~i~~ql~~~L~~LH~~giv-H~Dikp~NIl~~~~~~~~~~kL~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~ 207 (327)
T 3lm5_A 132 DVIRLIKQILEGVYYLHQNNIV-HLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACE---LREIMGTPEYLAPEILNY 207 (327)
T ss_dssp HHHHHHHHHHHHHHHHHHTTEE-CSCCCGGGEEESCBTTBCCEEECCGGGCEEC------------CCCGGGCCHHHHTT
T ss_pred HHHHHHHHHHHHHHHHHHCCee-cCcCChHHEEEecCCCCCcEEEeeCccccccCCccc---cccccCCcCccCCeeecC
Confidence 3689999999999999999988 9999999999987 78999999999876532221 234578999999999987
Q ss_pred CCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCchHHHHHHHHHhhhcCCCCCCCH
Q psy1840 101 PHLPRGTQKGDVYSFGLVLYEVIGRQGPWGHLRMTDEEIITSVTQGSGLRPDTSSLDCAPSIIACMRTCWEEDPELRPDL 180 (423)
Q Consensus 101 ~~~~~~s~ksDVyS~Giil~elltg~~Pf~~~~~~~~~i~~~i~~~~~~~p~~~~~~~~~~l~~Li~~C~~~dP~~RPt~ 180 (423)
..+ +.++||||||+++|+|++|..||.. ....+....+.......+......+++.+.+++.+||+.||++|||+
T Consensus 208 ~~~---~~~~DiwslG~il~~ll~g~~pf~~--~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~ 282 (327)
T 3lm5_A 208 DPI---TTATDMWNIGIIAYMLLTHTSPFVG--EDNQETYLNISQVNVDYSEETFSSVSQLATDFIQSLLVKNPEKRPTA 282 (327)
T ss_dssp CCC---CTHHHHHHHHHHHHHHHHSSCSSCC--SSHHHHHHHHHHTCCCCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCH
T ss_pred CCC---CchhhHHHHHHHHHHHHhCCCCCCC--CCchHHHHHHHhcccccCchhhcccCHHHHHHHHHHcCCChhhCcCH
Confidence 655 8999999999999999999999974 34555666665554444444445789999999999999999999999
Q ss_pred HHHHHH
Q psy1840 181 RFVHHK 186 (423)
Q Consensus 181 ~~I~~~ 186 (423)
.++++.
T Consensus 283 ~~ll~h 288 (327)
T 3lm5_A 283 EICLSH 288 (327)
T ss_dssp HHHTTC
T ss_pred HHHhCC
Confidence 998763
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.94 E-value=4.2e-26 Score=227.90 Aligned_cols=152 Identities=20% Similarity=0.310 Sum_probs=122.5
Q ss_pred HHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCccEEEeccCCcccccCCCcccccccccCCccccCCccccCCCCC
Q psy1840 25 SISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKAPELLRQPHLP 104 (423)
Q Consensus 25 ~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~ 104 (423)
...++.||+.||.|||+.|++ ||||||+|||++.++.+||+|||++....... ......||+.|+|||++.+....
T Consensus 117 ~~~~~~qi~~aL~~LH~~giv-HrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~---~~~~~~gt~~Y~aPE~~~~~~~~ 192 (384)
T 4fr4_A 117 VKLFICELVMALDYLQNQRII-HRDMKPDNILLDEHGHVHITDFNIAAMLPRET---QITTMAGTKPYMAPEMFSSRKGA 192 (384)
T ss_dssp HHHHHHHHHHHHHHHHHTTEE-CCCCSGGGEEECTTSCEEECCCTTCEECCTTC---CBCCCCSCGGGCCGGGTCCCSSC
T ss_pred HHHHHHHHHHHHHHHHHCCce-eccCcHHHeEECCCCCEEEeccceeeeccCCC---ceeccCCCccccCCeeeccCCCC
Confidence 578999999999999999988 99999999999999999999999997654322 22456799999999999754322
Q ss_pred CCCCccchHHHHHHHHHHHhCCCCCCCCC-CChHHHHHHHhcCCCCCCCCCCCCchHHHHHHHHHhhhcCCCCCCC-HHH
Q psy1840 105 RGTQKGDVYSFGLVLYEVIGRQGPWGHLR-MTDEEIITSVTQGSGLRPDTSSLDCAPSIIACMRTCWEEDPELRPD-LRF 182 (423)
Q Consensus 105 ~~s~ksDVyS~Giil~elltg~~Pf~~~~-~~~~~i~~~i~~~~~~~p~~~~~~~~~~l~~Li~~C~~~dP~~RPt-~~~ 182 (423)
.++.++|||||||++|||++|..||.... ....++...+.......| ..+++.+.+++.+||+.||.+||+ +.+
T Consensus 193 ~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~p----~~~s~~~~~li~~lL~~dP~~R~s~~~~ 268 (384)
T 4fr4_A 193 GYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETTVVTYP----SAWSQEMVSLLKKLLEPNPDQRFSQLSD 268 (384)
T ss_dssp CBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHHHHHCCCCCC----TTSCHHHHHHHHHHSCSSGGGSCCSHHH
T ss_pred CCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHHHhhcccCCC----CcCCHHHHHHHHHHhcCCHhHhcccHHH
Confidence 34899999999999999999999997532 334555555555433333 357899999999999999999998 666
Q ss_pred HH
Q psy1840 183 VH 184 (423)
Q Consensus 183 I~ 184 (423)
|.
T Consensus 269 l~ 270 (384)
T 4fr4_A 269 VQ 270 (384)
T ss_dssp HH
T ss_pred HH
Confidence 54
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.94 E-value=1.5e-26 Score=231.34 Aligned_cols=154 Identities=17% Similarity=0.292 Sum_probs=126.8
Q ss_pred HHHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcC--CccEEEeccCCcccccCCCcccccccccCCccccCCccccCC
Q psy1840 24 GSISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDS--RWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKAPELLRQP 101 (423)
Q Consensus 24 ~~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~--~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~ 101 (423)
....++.||+.||.|||+.|++ ||||||+||+++. .+.+||+|||++........ .....||+.|+|||++.+.
T Consensus 150 ~~~~i~~qi~~aL~~LH~~giv-HrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~ 225 (387)
T 1kob_A 150 EVINYMRQACEGLKHMHEHSIV-HLDIKPENIMCETKKASSVKIIDFGLATKLNPDEI---VKVTTATAEFAAPEIVDRE 225 (387)
T ss_dssp HHHHHHHHHHHHHHHHHHTTEE-CCCCCGGGEEESSTTCCCEEECCCTTCEECCTTSC---EEEECSSGGGCCHHHHTTC
T ss_pred HHHHHHHHHHHHHHHHHhCCee-ecccchHHeEEecCCCCceEEEecccceecCCCcc---eeeeccCCCccCchhccCC
Confidence 3689999999999999999988 9999999999974 57899999999876543221 2344689999999999876
Q ss_pred CCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCchHHHHHHHHHhhhcCCCCCCCHH
Q psy1840 102 HLPRGTQKGDVYSFGLVLYEVIGRQGPWGHLRMTDEEIITSVTQGSGLRPDTSSLDCAPSIIACMRTCWEEDPELRPDLR 181 (423)
Q Consensus 102 ~~~~~s~ksDVyS~Giil~elltg~~Pf~~~~~~~~~i~~~i~~~~~~~p~~~~~~~~~~l~~Li~~C~~~dP~~RPt~~ 181 (423)
.+ +.++|||||||++|||++|..||.. ....+....+.......+......+++++.+++.+||+.||++|||+.
T Consensus 226 ~~---~~~~DiwSlG~il~elltg~~Pf~~--~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ 300 (387)
T 1kob_A 226 PV---GFYTDMWAIGVLGYVLLSGLSPFAG--EDDLETLQNVKRCDWEFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVH 300 (387)
T ss_dssp CB---CHHHHHHHHHHHHHHHHHSCCSSCC--SSHHHHHHHHHHCCCCCCSSTTTTSCHHHHHHHHTTSCSSGGGSCCHH
T ss_pred CC---CCcccEeeHhHHHHHHHhCCCCCCC--CCHHHHHHHHHhCCCCCCccccccCCHHHHHHHHHHcCCChhHCcCHH
Confidence 55 8999999999999999999999974 345666666666544433333456899999999999999999999999
Q ss_pred HHHHH
Q psy1840 182 FVHHK 186 (423)
Q Consensus 182 ~I~~~ 186 (423)
++++.
T Consensus 301 ell~h 305 (387)
T 1kob_A 301 DALEH 305 (387)
T ss_dssp HHHTS
T ss_pred HHhhC
Confidence 99864
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.94 E-value=2e-26 Score=223.03 Aligned_cols=164 Identities=25% Similarity=0.385 Sum_probs=124.3
Q ss_pred HHHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCccEEEeccCCcccccCCC---cccccccccCCccccCCccccC
Q psy1840 24 GSISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQD---ETGQERKLRRRKLYKAPELLRQ 100 (423)
Q Consensus 24 ~~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~---~~~~~~~~~gt~~y~APE~l~~ 100 (423)
....++.||+.||.|||+.|++ ||||||+||+++ ++.+||+|||++....... .........|++.|+|||.+.+
T Consensus 131 ~~~~i~~qi~~al~~lH~~~i~-H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~ 208 (319)
T 2y4i_B 131 KTRQIAQEIVKGMGYLHAKGIL-HKDLKSKNVFYD-NGKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQ 208 (319)
T ss_dssp HHHHHHHHHHHHHHHHHHTTCC-CCCCCSTTEEEC---CCEECCCSCCC----------CCSCBCCSGGGGTSCHHHHSC
T ss_pred HHHHHHHHHHHHHHHHHhCCcc-ccCCChhhEEEe-CCCEEEeecCCccccccccccccccccccCCCcccccChHHhhh
Confidence 3689999999999999999998 999999999998 6899999999976542211 1112234457889999999875
Q ss_pred CC------CCCCCCccchHHHHHHHHHHHhCCCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCchHHHHHHHHHhhhcCC
Q psy1840 101 PH------LPRGTQKGDVYSFGLVLYEVIGRQGPWGHLRMTDEEIITSVTQGSGLRPDTSSLDCAPSIIACMRTCWEEDP 174 (423)
Q Consensus 101 ~~------~~~~s~ksDVyS~Giil~elltg~~Pf~~~~~~~~~i~~~i~~~~~~~p~~~~~~~~~~l~~Li~~C~~~dP 174 (423)
.. ...++.++||||||+++|||++|..||.. ....++...+..+. .+......++.++.+++.+||+.||
T Consensus 209 ~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~--~~~~~~~~~~~~~~--~~~~~~~~~~~~l~~li~~~l~~~p 284 (319)
T 2y4i_B 209 LSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKT--QPAEAIIWQMGTGM--KPNLSQIGMGKEISDILLFCWAFEQ 284 (319)
T ss_dssp BSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSS--CCHHHHHHHHHTTC--CCCCCCSSCCTTHHHHHHHHHCSST
T ss_pred ccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCC--CCHHHHHHHhccCC--CCCCCcCCCCHHHHHHHHHHhcCCh
Confidence 22 11348899999999999999999999974 44566666665543 3333334678899999999999999
Q ss_pred CCCCCHHHHHHHHHHHhhh
Q psy1840 175 ELRPDLRFVHHKLKEMNAG 193 (423)
Q Consensus 175 ~~RPt~~~I~~~L~~i~~~ 193 (423)
++|||+.++++.|+.+...
T Consensus 285 ~~Rpt~~~l~~~l~~l~~~ 303 (319)
T 2y4i_B 285 EERPTFTKLMDMLEKLPKR 303 (319)
T ss_dssp TTSCCHHHHHHHHTTC---
T ss_pred hhCcCHHHHHHHHHHHHHh
Confidence 9999999999999877654
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=99.93 E-value=2.1e-26 Score=227.25 Aligned_cols=146 Identities=19% Similarity=0.261 Sum_probs=124.5
Q ss_pred HHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCccEEEeccCCcccccCCCcccccccccCCccccCCccccCCCCC
Q psy1840 25 SISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKAPELLRQPHLP 104 (423)
Q Consensus 25 ~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~ 104 (423)
...++.||+.||.|||++|++ ||||||+||+++.++.+||+|||+++..... .....||+.|+|||++.+..+
T Consensus 143 ~~~~~~qi~~aL~~LH~~~iv-HrDlkp~NIll~~~g~~kL~DFg~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~- 215 (350)
T 1rdq_E 143 ARFYAAQIVLTFEYLHSLDLI-YRDLKPENLLIDQQGYIQVTDFGFAKRVKGR-----TWTLCGTPEALAPEIILSKGY- 215 (350)
T ss_dssp HHHHHHHHHHHHHHHHHTTEE-CCCCSGGGEEECTTSCEEECCCTTCEECSSC-----BCCCEECGGGCCHHHHTTCCB-
T ss_pred HHHHHHHHHHHHHHHHHCCcc-cccCccceEEECCCCCEEEcccccceeccCC-----cccccCCccccCHHHhcCCCC-
Confidence 578999999999999999988 9999999999999999999999998765332 234578999999999987655
Q ss_pred CCCCccchHHHHHHHHHHHhCCCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCchHHHHHHHHHhhhcCCCCCCC-----
Q psy1840 105 RGTQKGDVYSFGLVLYEVIGRQGPWGHLRMTDEEIITSVTQGSGLRPDTSSLDCAPSIIACMRTCWEEDPELRPD----- 179 (423)
Q Consensus 105 ~~s~ksDVyS~Giil~elltg~~Pf~~~~~~~~~i~~~i~~~~~~~p~~~~~~~~~~l~~Li~~C~~~dP~~RPt----- 179 (423)
+.++|||||||++|||++|..||.. .+..++...+..+....| ..+++++.+++.+||+.||.+||+
T Consensus 216 --~~~~DiwslG~il~ell~g~~Pf~~--~~~~~~~~~i~~~~~~~p----~~~~~~~~~li~~lL~~dp~~R~~~~~~~ 287 (350)
T 1rdq_E 216 --NKAVDWWALGVLIYEMAAGYPPFFA--DQPIQIYEKIVSGKVRFP----SHFSSDLKDLLRNLLQVDLTKRFGNLKNG 287 (350)
T ss_dssp --CTHHHHHHHHHHHHHHHHSSCSSCC--SSHHHHHHHHHHCCCCCC----TTCCHHHHHHHHHHSCSCTTTCTTSSTTT
T ss_pred --CCcCCEecccHhHhHHhhCCCCCCC--CCHHHHHHHHHcCCCCCC----CCCCHHHHHHHHHHhhcCHHhccCCccCC
Confidence 8999999999999999999999974 456777777777654333 357899999999999999999998
Q ss_pred HHHHHH
Q psy1840 180 LRFVHH 185 (423)
Q Consensus 180 ~~~I~~ 185 (423)
+.+|++
T Consensus 288 ~~ei~~ 293 (350)
T 1rdq_E 288 VNDIKN 293 (350)
T ss_dssp THHHHT
T ss_pred HHHHHh
Confidence 777654
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=99.93 E-value=8.6e-27 Score=242.74 Aligned_cols=161 Identities=25% Similarity=0.476 Sum_probs=131.9
Q ss_pred HHHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCccEEEeccCCcccccCCCcccccccccCCccccCCccccCCCC
Q psy1840 24 GSISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKAPELLRQPHL 103 (423)
Q Consensus 24 ~~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~ 103 (423)
..+.++.||+.||.|||+++++ ||||||+|||++.++.+||+|||+++...... ........++..|+|||.+.+..+
T Consensus 364 ~~~~i~~qi~~~L~~LH~~~iv-HrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~ 441 (535)
T 2h8h_A 364 QLVDMAAQIASGMAYVERMNYV-HRDLRAANILVGENLVCKVADFGLARLIEDNE-YTARQGAKFPIKWTAPEAALYGRF 441 (535)
T ss_dssp HHHHHHHHHHHHHHHHHHTTCC-CSCCSGGGEEECGGGCEEECCTTSTTTCCCHH-HHTTCSTTSCGGGSCHHHHHHCCC
T ss_pred HHHHHHHHHHHHHHHHHhCCee-CCCCCHhhEEEcCCCcEEEcccccceecCCCc-eecccCCcCcccccCHHHhccCCC
Confidence 3689999999999999999998 99999999999999999999999987653221 111123345678999999987654
Q ss_pred CCCCCccchHHHHHHHHHHHh-CCCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCchHHHHHHHHHhhhcCCCCCCCHHH
Q psy1840 104 PRGTQKGDVYSFGLVLYEVIG-RQGPWGHLRMTDEEIITSVTQGSGLRPDTSSLDCAPSIIACMRTCWEEDPELRPDLRF 182 (423)
Q Consensus 104 ~~~s~ksDVyS~Giil~ellt-g~~Pf~~~~~~~~~i~~~i~~~~~~~p~~~~~~~~~~l~~Li~~C~~~dP~~RPt~~~ 182 (423)
+.++|||||||++|||++ |..||.+ ....++...+..+... .. ...++..+.+||.+||+.||++|||+.+
T Consensus 442 ---~~~sDvwSlGv~l~el~t~g~~P~~~--~~~~~~~~~i~~~~~~--~~-~~~~~~~l~~li~~cl~~dP~~RPt~~~ 513 (535)
T 2h8h_A 442 ---TIKSDVWSFGILLTELTTKGRVPYPG--MVNREVLDQVERGYRM--PC-PPECPESLHDLMCQCWRKEPEERPTFEY 513 (535)
T ss_dssp ---CHHHHHHHHHHHHHHHTTTTCCSSTT--CCHHHHHHHHHTTCCC--CC-CTTCCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred ---CchhhHHHHHHHHHHHHhCCCCCCCC--CCHHHHHHHHHcCCCC--CC-CCCCCHHHHHHHHHHcCCChhHCcCHHH
Confidence 899999999999999999 8999974 4567777777765322 21 2368899999999999999999999999
Q ss_pred HHHHHHHHhhhc
Q psy1840 183 VHHKLKEMNAGL 194 (423)
Q Consensus 183 I~~~L~~i~~~~ 194 (423)
|++.|+.+....
T Consensus 514 l~~~L~~~~~~~ 525 (535)
T 2h8h_A 514 LQAFLEDYFTST 525 (535)
T ss_dssp HHHHHHTSSCCC
T ss_pred HHHHHHHHhhcc
Confidence 999998876544
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.93 E-value=3.4e-26 Score=222.82 Aligned_cols=146 Identities=19% Similarity=0.268 Sum_probs=123.1
Q ss_pred HHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCccEEEeccCCcccccCCCcccccccccCCccccCCccccCCCCC
Q psy1840 25 SISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKAPELLRQPHLP 104 (423)
Q Consensus 25 ~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~ 104 (423)
...++.||+.||.|||++|++ ||||||+||+++.++.+||+|||+++..... .....||+.|+|||++.+..+
T Consensus 108 ~~~~~~qi~~aL~~LH~~~iv-HrDlkp~NIll~~~g~~kL~Dfg~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~- 180 (318)
T 1fot_A 108 AKFYAAEVCLALEYLHSKDII-YRDLKPENILLDKNGHIKITDFGFAKYVPDV-----TYTLCGTPDYIAPEVVSTKPY- 180 (318)
T ss_dssp HHHHHHHHHHHHHHHHTTTEE-CCCCCGGGEEECTTSCEEECCCSSCEECSSC-----BCCCCSCTTTCCHHHHTTCCB-
T ss_pred HHHHHHHHHHHHHHHHHCCcc-ccCCChheEEEcCCCCEEEeecCcceecCCc-----cccccCCccccCHhHhcCCCC-
Confidence 568899999999999999988 9999999999999999999999998765322 234678999999999987655
Q ss_pred CCCCccchHHHHHHHHHHHhCCCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCchHHHHHHHHHhhhcCCCCCC-----C
Q psy1840 105 RGTQKGDVYSFGLVLYEVIGRQGPWGHLRMTDEEIITSVTQGSGLRPDTSSLDCAPSIIACMRTCWEEDPELRP-----D 179 (423)
Q Consensus 105 ~~s~ksDVyS~Giil~elltg~~Pf~~~~~~~~~i~~~i~~~~~~~p~~~~~~~~~~l~~Li~~C~~~dP~~RP-----t 179 (423)
+.++|+|||||++|||++|..||.. .+..+....+..+....| ..+++++.+++.+||..||.+|| +
T Consensus 181 --~~~~DiwslG~il~ell~g~~pf~~--~~~~~~~~~i~~~~~~~p----~~~~~~~~~li~~lL~~dp~~R~~~~~~~ 252 (318)
T 1fot_A 181 --NKSIDWWSFGILIYEMLAGYTPFYD--SNTMKTYEKILNAELRFP----PFFNEDVKDLLSRLITRDLSQRLGNLQNG 252 (318)
T ss_dssp --CTTHHHHHHHHHHHHHHHSSCTTCC--SSHHHHHHHHHHCCCCCC----TTSCHHHHHHHHHHTCSCTTTCTTSSTTT
T ss_pred --CcccchhhhHHHHHHHHhCCCCCCC--CCHHHHHHHHHhCCCCCC----CCCCHHHHHHHHHHhccCHHHcCCCcCCC
Confidence 8999999999999999999999974 345666677766543333 25789999999999999999999 7
Q ss_pred HHHHHH
Q psy1840 180 LRFVHH 185 (423)
Q Consensus 180 ~~~I~~ 185 (423)
+.+|++
T Consensus 253 ~~~i~~ 258 (318)
T 1fot_A 253 TEDVKN 258 (318)
T ss_dssp THHHHT
T ss_pred HHHHhc
Confidence 777764
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=99.93 E-value=1.1e-26 Score=228.49 Aligned_cols=158 Identities=20% Similarity=0.246 Sum_probs=128.9
Q ss_pred HHHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCC----ccEEEeccCCcccccCCCcccccccccCCccccCCcccc
Q psy1840 24 GSISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSR----WVLQIADFGLHAFKAGQDETGQERKLRRRKLYKAPELLR 99 (423)
Q Consensus 24 ~~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~----~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~ 99 (423)
....++.||+.||.|||++|++ ||||||+||++... +.+||+|||+++....... ......+|+.|+|||++.
T Consensus 117 ~~~~~~~qi~~al~~lH~~giv-HrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~~~~~~--~~~~~~gt~~y~aPE~~~ 193 (342)
T 2qr7_A 117 EASAVLFTITKTVEYLHAQGVV-HRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENG--LLMTPCYTANFVAPEVLE 193 (342)
T ss_dssp HHHHHHHHHHHHHHHHHHTTEE-CSCCCGGGEEESSSSCSGGGEEECCCTTCEECBCTTC--CBCCSSCCSSCCCHHHHH
T ss_pred HHHHHHHHHHHHHHHHHHCCcE-eccCCHHHEEEecCCCCcCeEEEEECCCcccCcCCCC--ceeccCCCccccCHHHhc
Confidence 3679999999999999999988 99999999998432 4699999999876543322 223557899999999998
Q ss_pred CCCCCCCCCccchHHHHHHHHHHHhCCCCCCCC-CCChHHHHHHHhcCCCCCCCCCCCCchHHHHHHHHHhhhcCCCCCC
Q psy1840 100 QPHLPRGTQKGDVYSFGLVLYEVIGRQGPWGHL-RMTDEEIITSVTQGSGLRPDTSSLDCAPSIIACMRTCWEEDPELRP 178 (423)
Q Consensus 100 ~~~~~~~s~ksDVyS~Giil~elltg~~Pf~~~-~~~~~~i~~~i~~~~~~~p~~~~~~~~~~l~~Li~~C~~~dP~~RP 178 (423)
+..+ +.++|||||||++|||++|..||... ..+..++...+..+....+......+++++.+++.+||..||++||
T Consensus 194 ~~~~---~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ 270 (342)
T 2qr7_A 194 RQGY---DAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGKFSLSGGYWNSVSDTAKDLVSKMLHVDPHQRL 270 (342)
T ss_dssp HHHH---HHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHHHHHCCCCCCSTTTTTSCHHHHHHHHHHTCSSTTTSC
T ss_pred CCCC---CCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHHHccCCcccCccccccCCHHHHHHHHHHCCCChhHCc
Confidence 7554 78999999999999999999999753 3456778888877665544444456899999999999999999999
Q ss_pred CHHHHHHHH
Q psy1840 179 DLRFVHHKL 187 (423)
Q Consensus 179 t~~~I~~~L 187 (423)
++.++++.-
T Consensus 271 t~~~il~hp 279 (342)
T 2qr7_A 271 TAALVLRHP 279 (342)
T ss_dssp CHHHHTTSH
T ss_pred CHHHHhcCC
Confidence 999987643
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=4.6e-26 Score=222.37 Aligned_cols=150 Identities=18% Similarity=0.245 Sum_probs=119.8
Q ss_pred HHHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCccEEEeccCCcccccCCCcccccccccCCccccCCccccCCCC
Q psy1840 24 GSISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKAPELLRQPHL 103 (423)
Q Consensus 24 ~~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~ 103 (423)
....++.||+.||.|||++|++ ||||||+||+++.++.+||+|||+++...... .......||+.|+|||++.+..+
T Consensus 122 ~~~~~~~qi~~al~~lH~~~iv-H~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~ 198 (327)
T 3a62_A 122 TACFYLAEISMALGHLHQKGII-YRDLKPENIMLNHQGHVKLTDFGLCKESIHDG--TVTHTFCGTIEYMAPEILMRSGH 198 (327)
T ss_dssp HHHHHHHHHHHHHHHHHHTTCC-CCCCCTTTEEECTTSCEEECCCSCC------------CTTSSCCTTSCHHHHTTSCC
T ss_pred HHHHHHHHHHHHHHHHHhCCEE-cccCCHHHeEECCCCcEEEEeCCcccccccCC--ccccccCCCcCccCHhhCcCCCC
Confidence 3578999999999999999998 99999999999999999999999987533221 12234578999999999987655
Q ss_pred CCCCCccchHHHHHHHHHHHhCCCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCchHHHHHHHHHhhhcCCCCCC-----
Q psy1840 104 PRGTQKGDVYSFGLVLYEVIGRQGPWGHLRMTDEEIITSVTQGSGLRPDTSSLDCAPSIIACMRTCWEEDPELRP----- 178 (423)
Q Consensus 104 ~~~s~ksDVyS~Giil~elltg~~Pf~~~~~~~~~i~~~i~~~~~~~p~~~~~~~~~~l~~Li~~C~~~dP~~RP----- 178 (423)
+.++|||||||++|||++|..||.. .+..+....+.......| ..++.++.+++.+||+.||.+||
T Consensus 199 ---~~~~DiwslG~il~el~~g~~pf~~--~~~~~~~~~i~~~~~~~p----~~~~~~~~~li~~~L~~dp~~R~~~~~~ 269 (327)
T 3a62_A 199 ---NRAVDWWSLGALMYDMLTGAPPFTG--ENRKKTIDKILKCKLNLP----PYLTQEARDLLKKLLKRNAASRLGAGPG 269 (327)
T ss_dssp ---CTHHHHHHHHHHHHHHHHSSCSCCC--SSHHHHHHHHHHTCCCCC----TTSCHHHHHHHHHHSCSCGGGSTTSSTT
T ss_pred ---CCcccchhHHHHHHHHHHCCCCCCC--CCHHHHHHHHHhCCCCCC----CCCCHHHHHHHHHHHhcCHhhccCCCCC
Confidence 8999999999999999999999974 345666666666543333 25789999999999999999999
Q ss_pred CHHHHHH
Q psy1840 179 DLRFVHH 185 (423)
Q Consensus 179 t~~~I~~ 185 (423)
++.++++
T Consensus 270 ~~~e~l~ 276 (327)
T 3a62_A 270 DAGEVQA 276 (327)
T ss_dssp THHHHHH
T ss_pred CHHHHHc
Confidence 6677665
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=3.3e-26 Score=232.84 Aligned_cols=150 Identities=19% Similarity=0.288 Sum_probs=123.7
Q ss_pred HHHHHHHHHHHHHHHHh-CCCeeecCCCCCCEEEcCCccEEEeccCCcccccCCCcccccccccCCccccCCccccCCCC
Q psy1840 25 SISVNTTASVGMIHLHD-SEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKAPELLRQPHL 103 (423)
Q Consensus 25 ~l~i~~qi~~gL~yLH~-~~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~ 103 (423)
...++.||+.||+|||+ .|++ ||||||+|||++.++.+||+|||+++...... .......||+.|+|||++.+..+
T Consensus 250 ~~~~~~qi~~aL~~LH~~~gii-HrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~ 326 (446)
T 4ejn_A 250 ARFYGAEIVSALDYLHSEKNVV-YRDLKLENLMLDKDGHIKITDFGLCKEGIKDG--ATMKTFCGTPEYLAPEVLEDNDY 326 (446)
T ss_dssp HHHHHHHHHHHHHHHHHHTCCC-CCCCCGGGEEECSSSCEEECCCCCCCTTCC-------CCSSSCGGGCCHHHHHTSCC
T ss_pred HHHHHHHHHHHHHHHhhcCCEE-ECCCCHHHEEECCCCCEEEccCCCceeccCCC--cccccccCCccccCHhhcCCCCC
Confidence 57899999999999998 8998 99999999999999999999999987533222 12245679999999999987665
Q ss_pred CCCCCccchHHHHHHHHHHHhCCCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCchHHHHHHHHHhhhcCCCCCC-----
Q psy1840 104 PRGTQKGDVYSFGLVLYEVIGRQGPWGHLRMTDEEIITSVTQGSGLRPDTSSLDCAPSIIACMRTCWEEDPELRP----- 178 (423)
Q Consensus 104 ~~~s~ksDVyS~Giil~elltg~~Pf~~~~~~~~~i~~~i~~~~~~~p~~~~~~~~~~l~~Li~~C~~~dP~~RP----- 178 (423)
+.++|||||||++|||++|+.||.. ....++...+.......| ..+++++.+++.+||+.||.+||
T Consensus 327 ---~~~~DiwslG~il~ell~g~~Pf~~--~~~~~~~~~i~~~~~~~p----~~~~~~~~~li~~~L~~dP~~R~~~~~~ 397 (446)
T 4ejn_A 327 ---GRAVDWWGLGVVMYEMMCGRLPFYN--QDHEKLFELILMEEIRFP----RTLGPEAKSLLSGLLKKDPKQRLGGGSE 397 (446)
T ss_dssp ---CTHHHHHHHHHHHHHHHHSSCSSCC--SSHHHHHHHHHHCCCCCC----TTSCHHHHHHHHHHTCSSTTTSTTCSTT
T ss_pred ---CCccchhhhHHHHHHHhhCCCCCCC--CCHHHHHHHHHhCCCCCC----ccCCHHHHHHHHHHcccCHHHhCCCCCC
Confidence 8999999999999999999999974 445666777665543333 25789999999999999999999
Q ss_pred CHHHHHHH
Q psy1840 179 DLRFVHHK 186 (423)
Q Consensus 179 t~~~I~~~ 186 (423)
++.++++.
T Consensus 398 t~~ell~h 405 (446)
T 4ejn_A 398 DAKEIMQH 405 (446)
T ss_dssp THHHHHTS
T ss_pred CHHHHHhC
Confidence 99988753
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.93 E-value=3.6e-26 Score=219.74 Aligned_cols=155 Identities=19% Similarity=0.292 Sum_probs=126.5
Q ss_pred HHHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCccEEEeccCCcccccCCCcccccccccCCccccCCccccCCCC
Q psy1840 24 GSISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKAPELLRQPHL 103 (423)
Q Consensus 24 ~~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~ 103 (423)
....++.||+.||.|||++|++ ||||||+||+++.++.+||+|||++................+++.|+|||.+.+...
T Consensus 110 ~~~~~~~qi~~al~~LH~~~i~-H~dlkp~NIl~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~ 188 (305)
T 2wtk_C 110 QAHGYFCQLIDGLEYLHSQGIV-HKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSPAFQPPEIANGLDT 188 (305)
T ss_dssp HHHHHHHHHHHHHHHHHHTTEE-CSCCSGGGEEECTTCCEEECCCTTCEECCTTCSSCEECCCCSCGGGCCHHHHTCCSC
T ss_pred HHHHHHHHHHHHHHHHHHCCee-ecCCCcccEEEcCCCcEEeeccccccccCccccccccccCCCCCCCcChhhccCccc
Confidence 3678999999999999999988 999999999999999999999999876543322223345568899999999876431
Q ss_pred CCCCCccchHHHHHHHHHHHhCCCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCchHHHHHHHHHhhhcCCCCCCCHHHH
Q psy1840 104 PRGTQKGDVYSFGLVLYEVIGRQGPWGHLRMTDEEIITSVTQGSGLRPDTSSLDCAPSIIACMRTCWEEDPELRPDLRFV 183 (423)
Q Consensus 104 ~~~s~ksDVyS~Giil~elltg~~Pf~~~~~~~~~i~~~i~~~~~~~p~~~~~~~~~~l~~Li~~C~~~dP~~RPt~~~I 183 (423)
..+.++||||||+++|||++|..||.. ....++...+..+....+ ..+++.+.+++.+||+.||.+|||+.++
T Consensus 189 -~~~~~~Di~slG~il~~l~~g~~p~~~--~~~~~~~~~i~~~~~~~~----~~~~~~l~~li~~~l~~dp~~Rps~~~l 261 (305)
T 2wtk_C 189 -FSGFKVDIWSAGVTLYNITTGLYPFEG--DNIYKLFENIGKGSYAIP----GDCGPPLSDLLKGMLEYEPAKRFSIRQI 261 (305)
T ss_dssp -EESHHHHHHHHHHHHHHHHHSSCSCCC--SSHHHHHHHHHHCCCCCC----SSSCHHHHHHHHHHTCSSTTTSCCHHHH
T ss_pred -CCcchhhHHHHHHHHHHHHhCCCCCCC--chHHHHHHHHhcCCCCCC----CccCHHHHHHHHHHccCChhhCCCHHHH
Confidence 226799999999999999999999974 345666677766543222 3578999999999999999999999999
Q ss_pred HHH
Q psy1840 184 HHK 186 (423)
Q Consensus 184 ~~~ 186 (423)
++.
T Consensus 262 l~~ 264 (305)
T 2wtk_C 262 RQH 264 (305)
T ss_dssp HHS
T ss_pred hcC
Confidence 875
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=99.93 E-value=1.7e-26 Score=220.15 Aligned_cols=159 Identities=24% Similarity=0.478 Sum_probs=128.7
Q ss_pred HHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCccEEEeccCCcccccCCCcccccccccCCccccCCccccCCCCC
Q psy1840 25 SISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKAPELLRQPHLP 104 (423)
Q Consensus 25 ~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~ 104 (423)
.+.++.|++.||.|||+.|++ ||||||+||+++.++.+||+|||++........ .......+++.|+|||.+.+..+
T Consensus 113 ~~~i~~~i~~~l~~lH~~~i~-H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~- 189 (288)
T 3kfa_A 113 LLYMATQISSAMEYLEKKNFI-HRDLAARNCLVGENHLVKVADFGLSRLMTGDTY-TAHAGAKFPIKWTAPESLAYNKF- 189 (288)
T ss_dssp HHHHHHHHHHHHHHHHHHTCC-CSCCSGGGEEECGGGCEEECCCCGGGTSCSSSS-EEETTEEECGGGCCHHHHHHCCC-
T ss_pred HHHHHHHHHHHHHHHHHCCcc-CCCCCcceEEEcCCCCEEEccCccceeccCCcc-ccccCCccccCcCChhhhccCCC-
Confidence 678999999999999999998 999999999999999999999999876543322 22233456778999999987655
Q ss_pred CCCCccchHHHHHHHHHHHh-CCCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCchHHHHHHHHHhhhcCCCCCCCHHHH
Q psy1840 105 RGTQKGDVYSFGLVLYEVIG-RQGPWGHLRMTDEEIITSVTQGSGLRPDTSSLDCAPSIIACMRTCWEEDPELRPDLRFV 183 (423)
Q Consensus 105 ~~s~ksDVyS~Giil~ellt-g~~Pf~~~~~~~~~i~~~i~~~~~~~p~~~~~~~~~~l~~Li~~C~~~dP~~RPt~~~I 183 (423)
+.++||||||+++|+|++ |..||... ....+...+...... . ....+++.+.+++.+||+.||.+|||+.++
T Consensus 190 --~~~~Di~slG~il~~ll~~g~~p~~~~--~~~~~~~~~~~~~~~--~-~~~~~~~~l~~li~~~l~~dp~~Rps~~~~ 262 (288)
T 3kfa_A 190 --SIKSDVWAFGVLLWEIATYGMSPYPGI--DLSQVYELLEKDYRM--E-RPEGCPEKVYELMRACWQWNPSDRPSFAEI 262 (288)
T ss_dssp --CHHHHHHHHHHHHHHHHTTSCCSSTTC--CGGGHHHHHHTTCCC--C-CCTTCCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred --CchhhHHHHHHHHHHHHhCCCCCCCCC--CHHHHHHHHhccCCC--C-CCCCCCHHHHHHHHHHhCCChhhCcCHHHH
Confidence 899999999999999999 89999753 334455555543221 1 224678999999999999999999999999
Q ss_pred HHHHHHHhhh
Q psy1840 184 HHKLKEMNAG 193 (423)
Q Consensus 184 ~~~L~~i~~~ 193 (423)
++.|+.+...
T Consensus 263 ~~~l~~~~~~ 272 (288)
T 3kfa_A 263 HQAFETMFQE 272 (288)
T ss_dssp HHHHHHHHHH
T ss_pred HHHHHHHHHh
Confidence 9999887653
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=99.93 E-value=2e-26 Score=226.25 Aligned_cols=152 Identities=20% Similarity=0.275 Sum_probs=120.4
Q ss_pred HHHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCccEEEeccCCcccccCCCcccccccccCCccccCCccccCCCC
Q psy1840 24 GSISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKAPELLRQPHL 103 (423)
Q Consensus 24 ~~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~ 103 (423)
....++.||+.||.|||+.|++ ||||||+||+++.++.+||+|||++....... ......||+.|+|||.+.+..+
T Consensus 109 ~~~~i~~qi~~aL~~LH~~giv-H~Dlkp~NIll~~~~~~kl~DFG~s~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~ 184 (336)
T 3h4j_B 109 EGRRFFQQIICAIEYCHRHKIV-HRDLKPENLLLDDNLNVKIADFGLSNIMTDGN---FLKTSCGSPNYAAPEVINGKLY 184 (336)
T ss_dssp HHHHHHHHHHHHHHHHHHHTCC-CCCCSTTTEEECTTCCEEECCSSCTBTTTTSB---TTCCCTTSTTTSCGGGSCCSGG
T ss_pred HHHHHHHHHHHHHHHHHHCCeE-ecCCchhhEEEcCCCCEEEEEeccceeccCCc---ccccccCCcCcCCHHHHcCCCC
Confidence 3679999999999999999998 99999999999999999999999987654322 2245578999999999987653
Q ss_pred CCCCCccchHHHHHHHHHHHhCCCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCchHHHHHHHHHhhhcCCCCCCCHHHH
Q psy1840 104 PRGTQKGDVYSFGLVLYEVIGRQGPWGHLRMTDEEIITSVTQGSGLRPDTSSLDCAPSIIACMRTCWEEDPELRPDLRFV 183 (423)
Q Consensus 104 ~~~s~ksDVyS~Giil~elltg~~Pf~~~~~~~~~i~~~i~~~~~~~p~~~~~~~~~~l~~Li~~C~~~dP~~RPt~~~I 183 (423)
.+.++|||||||++|+|++|..||..... .++...+..+... .+..+++++.+++.+||+.||.+|||+.++
T Consensus 185 --~~~~~DiwslG~il~~ll~g~~Pf~~~~~--~~~~~~i~~~~~~----~p~~~s~~~~~li~~~L~~dP~~Rpt~~ei 256 (336)
T 3h4j_B 185 --AGPEVDVWSCGIVLYVMLVGRLPFDDEFI--PNLFKKVNSCVYV----MPDFLSPGAQSLIRRMIVADPMQRITIQEI 256 (336)
T ss_dssp --GCHHHHHHHHHHHHHHHHHSSCSSBCSSS--TTCBCCCCSSCCC----CCTTSCHHHHHHHHTTSCSSGGGSCCHHHH
T ss_pred --CCCccchhHHHHHHHHHHhCCCCCCCccH--HHHHHHHHcCCCC----CcccCCHHHHHHHHHHcCCChhHCcCHHHH
Confidence 26899999999999999999999975322 1111112222111 223578999999999999999999999999
Q ss_pred HHHH
Q psy1840 184 HHKL 187 (423)
Q Consensus 184 ~~~L 187 (423)
++.-
T Consensus 257 l~hp 260 (336)
T 3h4j_B 257 RRDP 260 (336)
T ss_dssp TTCH
T ss_pred HhCh
Confidence 7643
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=2.1e-26 Score=218.45 Aligned_cols=152 Identities=20% Similarity=0.295 Sum_probs=126.1
Q ss_pred HHHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEE---cCCccEEEeccCCcccccCCCcccccccccCCccccCCccccC
Q psy1840 24 GSISVNTTASVGMIHLHDSEIISHGNLRSSNCLI---DSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKAPELLRQ 100 (423)
Q Consensus 24 ~~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILl---d~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~ 100 (423)
....++.|++.||.|||++|++ ||||||+||++ +.++.+||+|||++....... ......+++.|+|||.+.+
T Consensus 107 ~~~~i~~~i~~~l~~lH~~~i~-H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~~~---~~~~~~~t~~y~aPE~~~~ 182 (277)
T 3f3z_A 107 DAARIMKDVLSAVAYCHKLNVA-HRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGK---MMRTKVGTPYYVSPQVLEG 182 (277)
T ss_dssp HHHHHHHHHHHHHHHHHHTTEE-CCCCSGGGEEESSSSTTCCEEECCCTTCEECCTTS---CBCCCCSCTTTCCHHHHTT
T ss_pred HHHHHHHHHHHHHHHHHHCCcc-CCCCCHHHEEEecCCCCCcEEEEecccceeccCcc---chhccCCCCCccChHHhcc
Confidence 3689999999999999999988 99999999999 888999999999987654322 2234568899999999876
Q ss_pred CCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCchHHHHHHHHHhhhcCCCCCCCH
Q psy1840 101 PHLPRGTQKGDVYSFGLVLYEVIGRQGPWGHLRMTDEEIITSVTQGSGLRPDTSSLDCAPSIIACMRTCWEEDPELRPDL 180 (423)
Q Consensus 101 ~~~~~~s~ksDVyS~Giil~elltg~~Pf~~~~~~~~~i~~~i~~~~~~~p~~~~~~~~~~l~~Li~~C~~~dP~~RPt~ 180 (423)
. + +.++||||||+++|+|++|..||.. ....+....+..+....|......+++.+.+++.+||+.||++||++
T Consensus 183 ~-~---~~~~Di~slG~~l~~l~~g~~p~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~ 256 (277)
T 3f3z_A 183 L-Y---GPECDEWSAGVMMYVLLCGYPPFSA--PTDSEVMLKIREGTFTFPEKDWLNVSPQAESLIRRLLTKSPKQRITS 256 (277)
T ss_dssp C-B---CTTHHHHHHHHHHHHHHHSSCSSCC--SSHHHHHHHHHHCCCCCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCH
T ss_pred c-C---CchhhehhHHHHHHHHHHCCCCCCC--CCHHHHHHHHHhCCCCCCchhhhcCCHHHHHHHHHHccCChhhCcCH
Confidence 4 3 8999999999999999999999974 45667777777665444433223578999999999999999999999
Q ss_pred HHHHH
Q psy1840 181 RFVHH 185 (423)
Q Consensus 181 ~~I~~ 185 (423)
.++++
T Consensus 257 ~~~l~ 261 (277)
T 3f3z_A 257 LQALE 261 (277)
T ss_dssp HHHTT
T ss_pred HHHhc
Confidence 99876
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=99.93 E-value=1.2e-26 Score=238.44 Aligned_cols=167 Identities=14% Similarity=0.243 Sum_probs=130.5
Q ss_pred HHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEE---cCCccEEEeccCCcccccCCCcc-----cccccccCCccccCCc
Q psy1840 25 SISVNTTASVGMIHLHDSEIISHGNLRSSNCLI---DSRWVLQIADFGLHAFKAGQDET-----GQERKLRRRKLYKAPE 96 (423)
Q Consensus 25 ~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILl---d~~~~vKL~DFGla~~~~~~~~~-----~~~~~~~gt~~y~APE 96 (423)
.+.++.||+.||.|||++|++ ||||||+|||| +.++.+||+|||+++........ .......||..|+|||
T Consensus 105 ~~~i~~qi~~aL~yLH~~gIv-HrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE 183 (483)
T 3sv0_A 105 VLMLADQMINRVEFVHSKSFL-HRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASVN 183 (483)
T ss_dssp HHHHHHHHHHHHHHHHHTTEE-CCCCCGGGEEECCGGGTTCEEECCCTTCEECBCTTTCCBCCCCCCCCCCSCTTTCCHH
T ss_pred HHHHHHHHHHHHHHHHHCCEe-ecccCcceEEEecCCCCCeEEEEeCCcceeccCCccccccccccccccCCCccccCHH
Confidence 689999999999999999988 99999999999 68899999999998865433221 1123567899999999
Q ss_pred cccCCCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCC-ChHHHHHHHhcCCCCCC-CCCCCCchHHHHHHHHHhhhcCC
Q psy1840 97 LLRQPHLPRGTQKGDVYSFGLVLYEVIGRQGPWGHLRM-TDEEIITSVTQGSGLRP-DTSSLDCAPSIIACMRTCWEEDP 174 (423)
Q Consensus 97 ~l~~~~~~~~s~ksDVyS~Giil~elltg~~Pf~~~~~-~~~~i~~~i~~~~~~~p-~~~~~~~~~~l~~Li~~C~~~dP 174 (423)
.+.+..+ +.++|||||||++|||++|+.||..... ...+.+..+.......+ ......++.++.+++.+||+.+|
T Consensus 184 ~~~~~~~---s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~~l~~li~~cl~~dP 260 (483)
T 3sv0_A 184 THLGIEQ---SRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVATSIEALCRGYPTEFASYFHYCRSLRF 260 (483)
T ss_dssp HHTTCCC---CHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHHHSCHHHHHTTSCHHHHHHHHHHHTCCT
T ss_pred HhcCCCC---ChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhccccccHHHHhcCCcHHHHHHHHHHhcCCh
Confidence 9988765 8999999999999999999999976433 23333333332110000 00113578999999999999999
Q ss_pred CCCCCHHHHHHHHHHHhhhcC
Q psy1840 175 ELRPDLRFVHHKLKEMNAGLK 195 (423)
Q Consensus 175 ~~RPt~~~I~~~L~~i~~~~~ 195 (423)
++||++.+|++.|+.+.....
T Consensus 261 ~~RPs~~el~~~L~~l~~~~~ 281 (483)
T 3sv0_A 261 DDKPDYSYLKRLFRDLFIREG 281 (483)
T ss_dssp TCCCCHHHHHHHHHHHHHHTT
T ss_pred hhCcCHHHHHHHHHHHHHHcC
Confidence 999999999999998876543
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=99.93 E-value=2.6e-26 Score=219.85 Aligned_cols=156 Identities=16% Similarity=0.113 Sum_probs=119.4
Q ss_pred HHHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCccEEEeccCCcccccCCCcccccccccCCccccCCccccCCCC
Q psy1840 24 GSISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKAPELLRQPHL 103 (423)
Q Consensus 24 ~~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~ 103 (423)
....++.|++.||.|||++|++ ||||||+||+++.++.+||+|||++....... .......+|+.|+|||.+.+..
T Consensus 102 ~~~~~~~ql~~~l~~lH~~~iv-H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~~t~~y~aPE~~~~~~- 177 (292)
T 3o0g_A 102 IVKSFLFQLLKGLGFCHSRNVL-HRDLKPQNLLINRNGELKLANFGLARAFGIPV--RCYSAEVVTLWYRPPDVLFGAK- 177 (292)
T ss_dssp HHHHHHHHHHHHHHHHHHTTEE-CCCCSGGGEEECTTSCEEECCCTTCEECCSCC--SCCCSCCSCGGGCCHHHHTTCS-
T ss_pred HHHHHHHHHHHHHHHHHhCCee-cCCCCHHHEEEcCCCCEEEeecccceecCCcc--ccccCCccccCCcChHHHcCCC-
Confidence 3678999999999999999988 99999999999999999999999987653222 1223457789999999997654
Q ss_pred CCCCCccchHHHHHHHHHHHhCCCCCCCCCCChHHHHHHHhcCCCCC--------------------C-----CCCCCCc
Q psy1840 104 PRGTQKGDVYSFGLVLYEVIGRQGPWGHLRMTDEEIITSVTQGSGLR--------------------P-----DTSSLDC 158 (423)
Q Consensus 104 ~~~s~ksDVyS~Giil~elltg~~Pf~~~~~~~~~i~~~i~~~~~~~--------------------p-----~~~~~~~ 158 (423)
.++.++|||||||++|||++|..||... ....+....+....... + ......+
T Consensus 178 -~~~~~~DiwslG~il~~l~~~~~p~~~~-~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (292)
T 3o0g_A 178 -LYSTSIDMWSAGCIFAELANAGRPLFPG-NDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKL 255 (292)
T ss_dssp -CCCTHHHHHHHHHHHHHHTTTSCCSCCC-SSHHHHHHHHHHHHCCCCTTTCTTGGGSTTCCCCCCCCTTCCCTTTSTTC
T ss_pred -CcCchHHHHHHHHHHHHHHHcCCCCcCC-CCHHHHHHHHHHHhCCCChhhhhhhcccccccccccccCCcchhhccccc
Confidence 2389999999999999999988886432 33344444433210000 0 0011246
Q ss_pred hHHHHHHHHHhhhcCCCCCCCHHHHHH
Q psy1840 159 APSIIACMRTCWEEDPELRPDLRFVHH 185 (423)
Q Consensus 159 ~~~l~~Li~~C~~~dP~~RPt~~~I~~ 185 (423)
++.+.+++.+||+.||++|||+.++++
T Consensus 256 ~~~~~~li~~~L~~dP~~R~t~~e~l~ 282 (292)
T 3o0g_A 256 NATGRDLLQNLLKCNPVQRISAEEALQ 282 (292)
T ss_dssp CHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred ChHHHHHHHHHhccChhhCCCHHHHhc
Confidence 889999999999999999999999876
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=99.93 E-value=4.4e-26 Score=216.70 Aligned_cols=150 Identities=22% Similarity=0.287 Sum_probs=122.1
Q ss_pred HHHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCccEEEeccCCcccccCCCcccccccccCCccccCCccccCCCC
Q psy1840 24 GSISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKAPELLRQPHL 103 (423)
Q Consensus 24 ~~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~ 103 (423)
....++.||+.||.|||+.|++ ||||||+||+++.++.+||+|||++....... .....+++.|+|||.+.+...
T Consensus 110 ~~~~~~~qi~~~l~~LH~~~i~-H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~ 184 (279)
T 3fdn_A 110 RTATYITELANALSYCHSKRVI-HRDIKPENLLLGSAGELKIADFGWSVHAPSSR----RTDLCGTLDYLPPEMIEGRMH 184 (279)
T ss_dssp HHHHHHHHHHHHHHHHHTTTCE-ECCCCGGGEEECTTSCEEECSCCEESCC------------CCCCTTCCHHHHTTCCC
T ss_pred HHHHHHHHHHHHHHHHHhCCEe-cccCChHhEEEcCCCCEEEEeccccccCCccc----ccccCCCCCccCHhHhccCCC
Confidence 3679999999999999999998 99999999999999999999999875433221 234568899999999987654
Q ss_pred CCCCCccchHHHHHHHHHHHhCCCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCchHHHHHHHHHhhhcCCCCCCCHHHH
Q psy1840 104 PRGTQKGDVYSFGLVLYEVIGRQGPWGHLRMTDEEIITSVTQGSGLRPDTSSLDCAPSIIACMRTCWEEDPELRPDLRFV 183 (423)
Q Consensus 104 ~~~s~ksDVyS~Giil~elltg~~Pf~~~~~~~~~i~~~i~~~~~~~p~~~~~~~~~~l~~Li~~C~~~dP~~RPt~~~I 183 (423)
+.++||||||+++|+|++|..||.. ....+....+.......| ..+++.+.+++.+||+.||.+|||+.++
T Consensus 185 ---~~~~Di~slG~il~~l~~g~~p~~~--~~~~~~~~~~~~~~~~~~----~~~~~~~~~li~~~l~~~p~~Rps~~e~ 255 (279)
T 3fdn_A 185 ---DEKVDLWSLGVLCYEFLVGKPPFEA--NTYQETYKRISRVEFTFP----DFVTEGARDLISRLLKHNPSQRPMLREV 255 (279)
T ss_dssp ---CTTHHHHHHHHHHHHHHHSSCTTCC--SSHHHHHHHHHHTCCCCC----TTSCHHHHHHHHHHCCSSGGGSCCHHHH
T ss_pred ---CccchhHhHHHHHHHHHHCCCCCCC--CcHHHHHHHHHhCCCCCC----CcCCHHHHHHHHHHhccChhhCCCHHHH
Confidence 8899999999999999999999974 445666666665443333 2478899999999999999999999999
Q ss_pred HHHH
Q psy1840 184 HHKL 187 (423)
Q Consensus 184 ~~~L 187 (423)
++.-
T Consensus 256 l~h~ 259 (279)
T 3fdn_A 256 LEHP 259 (279)
T ss_dssp HHCH
T ss_pred hhCc
Confidence 8753
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=1.6e-26 Score=224.49 Aligned_cols=154 Identities=20% Similarity=0.281 Sum_probs=118.9
Q ss_pred HHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCccEEEeccCCcccccCCCcccccccccCCccccCCccccCCCCC
Q psy1840 25 SISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKAPELLRQPHLP 104 (423)
Q Consensus 25 ~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~ 104 (423)
...++.||+.||.|||+.|++ ||||||+||+++.++.+||+|||++........ ......+|+.|+|||++.+..
T Consensus 110 ~~~~~~qi~~aL~~lH~~~iv-H~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~-- 184 (317)
T 2pmi_A 110 VKYFQWQLLQGLAFCHENKIL-HRDLKPQNLLINKRGQLKLGDFGLARAFGIPVN--TFSSEVVTLWYRAPDVLMGSR-- 184 (317)
T ss_dssp HHHHHHHHHHHHHHHHHTTEE-CCCCCGGGEEECTTCCEEECCCSSCEETTSCCC--CCCCCCSCCTTCCHHHHTTCC--
T ss_pred HHHHHHHHHHHHHHHHHCCee-eCCCChHHeEEcCCCCEEECcCccceecCCCcc--cCCCCcccccccCchHhhCCC--
Confidence 567899999999999999988 999999999999999999999999876532221 123456889999999987643
Q ss_pred CCCCccchHHHHHHHHHHHhCCCCCCCCCCChHHHHHHHhcC--CC-------------CCCC---------------CC
Q psy1840 105 RGTQKGDVYSFGLVLYEVIGRQGPWGHLRMTDEEIITSVTQG--SG-------------LRPD---------------TS 154 (423)
Q Consensus 105 ~~s~ksDVyS~Giil~elltg~~Pf~~~~~~~~~i~~~i~~~--~~-------------~~p~---------------~~ 154 (423)
.++.++|||||||++|||++|+.||.. ....+....+... .+ ..+. ..
T Consensus 185 ~~~~~~DiwslG~il~el~~g~~pf~~--~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (317)
T 2pmi_A 185 TYSTSIDIWSCGCILAEMITGKPLFPG--TNDEEQLKLIFDIMGTPNESLWPSVTKLPKYNPNIQQRPPRDLRQVLQPHT 262 (317)
T ss_dssp CCCTHHHHHHHHHHHHHHHHSSCSCCC--SSHHHHHHHHHHHHCSCCTTTCGGGGGCTTCCTTCCCCCCCCSHHHHGGGC
T ss_pred CCCcHHHHHHHHHHHHHHHhCCCCCCC--CChHHHHHHHHHHhCCCChhHhhhhhhhhhcccccccccchhHHHhhcccc
Confidence 238999999999999999999999974 3344444443221 00 0000 01
Q ss_pred CCCchHHHHHHHHHhhhcCCCCCCCHHHHHH
Q psy1840 155 SLDCAPSIIACMRTCWEEDPELRPDLRFVHH 185 (423)
Q Consensus 155 ~~~~~~~l~~Li~~C~~~dP~~RPt~~~I~~ 185 (423)
...++.++.+++.+||+.||++|||+.++++
T Consensus 263 ~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~ 293 (317)
T 2pmi_A 263 KEPLDGNLMDFLHGLLQLNPDMRLSAKQALH 293 (317)
T ss_dssp SSCCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred cccCCHHHHHHHHHHCCCCcccCCCHHHHhC
Confidence 1246789999999999999999999999875
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=2.1e-26 Score=223.16 Aligned_cols=155 Identities=20% Similarity=0.199 Sum_probs=117.0
Q ss_pred HHHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCccEEEeccCCcccccCCCcccccccccCCccccCCccccCCCC
Q psy1840 24 GSISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKAPELLRQPHL 103 (423)
Q Consensus 24 ~~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~ 103 (423)
....++.||+.||.|||+.|++ ||||||+||+++.++.+||+|||++........ ......+|+.|+|||.+.+..
T Consensus 120 ~~~~~~~qi~~~l~~LH~~~iv-H~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~- 195 (311)
T 3niz_A 120 QIKIYLYQLLRGVAHCHQHRIL-HRDLKPQNLLINSDGALKLADFGLARAFGIPVR--SYTHEVVTLWYRAPDVLMGSK- 195 (311)
T ss_dssp HHHHHHHHHHHHHHHHHHTTEE-CCCCCGGGEEECTTCCEEECCCTTCEETTSCCC-----CCCCCCTTCCHHHHTTCC-
T ss_pred HHHHHHHHHHHHHHHHHHCCcc-cCCCchHhEEECCCCCEEEccCcCceecCCCcc--cccCCcccCCcCCHHHhcCCC-
Confidence 3578999999999999999988 999999999999999999999999876532221 223456789999999987643
Q ss_pred CCCCCccchHHHHHHHHHHHhCCCCCCCCCCChHHHHHHHhc--CCCCCC-----------------CC-------CCCC
Q psy1840 104 PRGTQKGDVYSFGLVLYEVIGRQGPWGHLRMTDEEIITSVTQ--GSGLRP-----------------DT-------SSLD 157 (423)
Q Consensus 104 ~~~s~ksDVyS~Giil~elltg~~Pf~~~~~~~~~i~~~i~~--~~~~~p-----------------~~-------~~~~ 157 (423)
.++.++|||||||++|+|++|+.||...... +....+.. +.+... .. ....
T Consensus 196 -~~~~~~DiwslG~il~~ll~g~~pf~~~~~~--~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 272 (311)
T 3niz_A 196 -KYSTSVDIWSIGCIFAEMITGKPLFPGVTDD--DQLPKIFSILGTPNPREWPQVQELPLWKQRTFQVFEKKPWSSIIPG 272 (311)
T ss_dssp -SCCTHHHHHHHHHHHHHHHHSSCSCCCSSTT--THHHHHHHHHCCCCTTTSGGGTTSHHHHSCCCCCCCCCCHHHHSTT
T ss_pred -CCCchHHhHHHHHHHHHHHhCCCCCCCCChH--HHHHHHHHHHCCCChHHhhhhhccchhhhcccccccCCcHHHhCcc
Confidence 2389999999999999999999999754322 22222211 000000 00 0124
Q ss_pred chHHHHHHHHHhhhcCCCCCCCHHHHHH
Q psy1840 158 CAPSIIACMRTCWEEDPELRPDLRFVHH 185 (423)
Q Consensus 158 ~~~~l~~Li~~C~~~dP~~RPt~~~I~~ 185 (423)
+++++.+++.+||+.||++|||+.++++
T Consensus 273 ~~~~~~~li~~~L~~dP~~Rpt~~ell~ 300 (311)
T 3niz_A 273 FCQEGIDLLSNMLCFDPNKRISARDAMN 300 (311)
T ss_dssp CCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred cCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 6788999999999999999999999876
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=2.5e-26 Score=228.72 Aligned_cols=146 Identities=19% Similarity=0.235 Sum_probs=121.9
Q ss_pred HHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCccEEEeccCCcccccCCCcccccccccCCccccCCccccCCCCC
Q psy1840 25 SISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKAPELLRQPHLP 104 (423)
Q Consensus 25 ~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~ 104 (423)
...++.||+.||+|||++|++ ||||||+|||++.++.+||+|||+++...... .......||+.|+|||++.+..+
T Consensus 141 ~~~~~~qi~~aL~~LH~~giv-HrDlkp~NIll~~~g~ikL~DFG~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~- 216 (373)
T 2r5t_A 141 ARFYAAEIASALGYLHSLNIV-YRDLKPENILLDSQGHIVLTDFGLCKENIEHN--STTSTFCGTPEYLAPEVLHKQPY- 216 (373)
T ss_dssp HHHHHHHHHHHHHHHHHTTCC-CCCCCGGGEEECTTSCEEECCCCBCGGGBCCC--CCCCSBSCCCCCCCHHHHTTCCC-
T ss_pred HHHHHHHHHHHHHHHHHCCce-ecCCCHHHEEECCCCCEEEeeCccccccccCC--CccccccCCccccCHHHhCCCCC-
Confidence 467899999999999999998 99999999999999999999999987533222 12345689999999999987655
Q ss_pred CCCCccchHHHHHHHHHHHhCCCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCchHHHHHHHHHhhhcCCCCCCCHHH
Q psy1840 105 RGTQKGDVYSFGLVLYEVIGRQGPWGHLRMTDEEIITSVTQGSGLRPDTSSLDCAPSIIACMRTCWEEDPELRPDLRF 182 (423)
Q Consensus 105 ~~s~ksDVyS~Giil~elltg~~Pf~~~~~~~~~i~~~i~~~~~~~p~~~~~~~~~~l~~Li~~C~~~dP~~RPt~~~ 182 (423)
+.++|+|||||++|||++|..||.. .+..++...+.......+ ..++.++.+++.+||+.||.+||++.+
T Consensus 217 --~~~~DiwslG~il~ell~G~~Pf~~--~~~~~~~~~i~~~~~~~~----~~~~~~~~~li~~lL~~dp~~R~~~~~ 286 (373)
T 2r5t_A 217 --DRTVDWWCLGAVLYEMLYGLPPFYS--RNTAEMYDNILNKPLQLK----PNITNSARHLLEGLLQKDRTKRLGAKD 286 (373)
T ss_dssp --CTHHHHHHHHHHHHHHHHSSCTTCC--SBHHHHHHHHHHSCCCCC----SSSCHHHHHHHHHHTCSSGGGSTTTTT
T ss_pred --CchhhhHHHHHHHHHHHcCCCCCCC--CCHHHHHHHHHhcccCCC----CCCCHHHHHHHHHHcccCHHhCCCCCC
Confidence 8999999999999999999999974 455677777766543322 357899999999999999999999753
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=99.93 E-value=2.4e-26 Score=223.38 Aligned_cols=154 Identities=18% Similarity=0.213 Sum_probs=126.0
Q ss_pred HHHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCc----cEEEeccCCcccccCCCcccccccccCCccccCCcccc
Q psy1840 24 GSISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRW----VLQIADFGLHAFKAGQDETGQERKLRRRKLYKAPELLR 99 (423)
Q Consensus 24 ~~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~----~vKL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~ 99 (423)
....++.|++.||.|||+.|++ ||||||+||+++.++ .+||+|||++........ .....|++.|+|||.+.
T Consensus 116 ~~~~i~~qi~~aL~~lH~~~iv-H~dikp~NIl~~~~~~~~~~~kl~Dfg~~~~~~~~~~---~~~~~gt~~y~aPE~~~ 191 (321)
T 2a2a_A 116 EATSFIKQILDGVNYLHTKKIA-HFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVE---FKNIFGTPEFVAPEIVN 191 (321)
T ss_dssp HHHHHHHHHHHHHHHHHHTTEE-CCCCSGGGEEESCTTSSSCCEEECCCTTCEECCTTCC---CCCCCSCGGGCCHHHHT
T ss_pred HHHHHHHHHHHHHHHHHhCCee-cCCCChHHEEEecCCCCcCCEEEccCccceecCcccc---ccccCCCCCccCccccc
Confidence 3679999999999999999988 999999999999887 799999999876543221 23456889999999998
Q ss_pred CCCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCchHHHHHHHHHhhhcCCCCCCC
Q psy1840 100 QPHLPRGTQKGDVYSFGLVLYEVIGRQGPWGHLRMTDEEIITSVTQGSGLRPDTSSLDCAPSIIACMRTCWEEDPELRPD 179 (423)
Q Consensus 100 ~~~~~~~s~ksDVyS~Giil~elltg~~Pf~~~~~~~~~i~~~i~~~~~~~p~~~~~~~~~~l~~Li~~C~~~dP~~RPt 179 (423)
+..+ +.++||||||+++|+|++|..||.. ....+....+.......+......+++.+.+++.+||+.||++|||
T Consensus 192 ~~~~---~~~~Di~slG~il~~l~~g~~pf~~--~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps 266 (321)
T 2a2a_A 192 YEPL---GLEADMWSIGVITYILLSGASPFLG--DTKQETLANITSVSYDFDEEFFSHTSELAKDFIRKLLVKETRKRLT 266 (321)
T ss_dssp TCCC---CTHHHHHHHHHHHHHHHHSCCSSCC--SSHHHHHHHHHTTCCCCCHHHHTTCCHHHHHHHHTTSCSSTTTSCC
T ss_pred CCCC---CCccccHHHHHHHHHHHHCCCCCCC--CCHHHHHHHHHhcccccChhhhcccCHHHHHHHHHHcCCChhhCcC
Confidence 7655 8999999999999999999999974 4456666666665433332222457889999999999999999999
Q ss_pred HHHHHHH
Q psy1840 180 LRFVHHK 186 (423)
Q Consensus 180 ~~~I~~~ 186 (423)
+.++++.
T Consensus 267 ~~e~l~h 273 (321)
T 2a2a_A 267 IQEALRH 273 (321)
T ss_dssp HHHHHHS
T ss_pred HHHHhcC
Confidence 9999763
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.93 E-value=3.9e-27 Score=227.97 Aligned_cols=172 Identities=19% Similarity=0.245 Sum_probs=126.7
Q ss_pred HHHHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCccEEEeccCCcccccCCCcc-------cccccccCCccccCC
Q psy1840 23 IGSISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDET-------GQERKLRRRKLYKAP 95 (423)
Q Consensus 23 ~~~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~~-------~~~~~~~gt~~y~AP 95 (423)
.....++.||+.||.|||+.|++ ||||||+||+++.++.+||+|||++......... .......|++.|+||
T Consensus 134 ~~~~~i~~qi~~~L~~LH~~~iv-H~dlkp~NIl~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP 212 (317)
T 2buj_A 134 DQILWLLLGICRGLEAIHAKGYA-HRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAP 212 (317)
T ss_dssp HHHHHHHHHHHHHHHHHHHTTEE-CCCCCGGGEEECTTSCEEECCCSSCEESCEEEESHHHHHHHHHHHHHHSCGGGCCG
T ss_pred HHHHHHHHHHHHHHHHHHhCCcc-cCCCCHHHEEEcCCCCEEEEecCcchhcccccccccccccccccccccCCcccCCH
Confidence 34689999999999999999988 9999999999999999999999987654321111 001233568899999
Q ss_pred ccccCCCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCchHHHHHHHHHhhhcCCC
Q psy1840 96 ELLRQPHLPRGTQKGDVYSFGLVLYEVIGRQGPWGHLRMTDEEIITSVTQGSGLRPDTSSLDCAPSIIACMRTCWEEDPE 175 (423)
Q Consensus 96 E~l~~~~~~~~s~ksDVyS~Giil~elltg~~Pf~~~~~~~~~i~~~i~~~~~~~p~~~~~~~~~~l~~Li~~C~~~dP~ 175 (423)
|.+.+.....++.++||||||+++|||++|+.||.........+...+... ...|. ...+++.+.+++.+||+.||.
T Consensus 213 E~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~-~~~~~--~~~~~~~l~~li~~~l~~dp~ 289 (317)
T 2buj_A 213 ELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAVQNQ-LSIPQ--SPRHSSALWQLLNSMMTVDPH 289 (317)
T ss_dssp GGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSCHHHHHHCC---CCC--CTTSCHHHHHHHHHHTCSSGG
T ss_pred hHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccchhhHHhhcc-CCCCc--cccCCHHHHHHHHHHhhcChh
Confidence 998765422247899999999999999999999953111111122222221 11121 235789999999999999999
Q ss_pred CCCCHHHHHHHHHHHhhhcCCCh
Q psy1840 176 LRPDLRFVHHKLKEMNAGLKANI 198 (423)
Q Consensus 176 ~RPt~~~I~~~L~~i~~~~~~~~ 198 (423)
+||++.++++.|+.+........
T Consensus 290 ~Rps~~~ll~~L~~~~~~~~~~~ 312 (317)
T 2buj_A 290 QRPHIPLLLSQLEALQPPAPGQH 312 (317)
T ss_dssp GSCCHHHHHHHHHHTCCCCCC--
T ss_pred hCCCHHHHHHHhhhcCCCCCCCC
Confidence 99999999999998876554443
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.93 E-value=1.7e-26 Score=223.61 Aligned_cols=146 Identities=22% Similarity=0.286 Sum_probs=115.4
Q ss_pred HHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCccEEEeccCCcccccCCCcccccccccCCccccCCccccCCCCC
Q psy1840 25 SISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKAPELLRQPHLP 104 (423)
Q Consensus 25 ~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~ 104 (423)
...++.||+.||.|||+.+++ ||||||+|||++.++.+||+|||++....... ......||+.|+|||++.+ .+
T Consensus 159 ~~~i~~qi~~aL~~LH~~~iv-H~Dikp~NIll~~~~~~kl~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~-~~- 232 (311)
T 3p1a_A 159 VWGYLRDTLLALAHLHSQGLV-HLDVKPANIFLGPRGRCKLGDFGLLVELGTAG---AGEVQEGDPRYMAPELLQG-SY- 232 (311)
T ss_dssp HHHHHHHHHHHHHHHHHTTEE-CCCCSGGGEEECGGGCEEECCCTTCEECC---------CCCCCGGGCCGGGGGT-CC-
T ss_pred HHHHHHHHHHHHHHHHHCCEe-cCCCCHHHEEECCCCCEEEccceeeeecccCC---CCcccCCCccccCHhHhcC-CC-
Confidence 678999999999999999987 99999999999999999999999987653222 2234568999999999876 33
Q ss_pred CCCCccchHHHHHHHHHHHhCCCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCchHHHHHHHHHhhhcCCCCCCCHHHHH
Q psy1840 105 RGTQKGDVYSFGLVLYEVIGRQGPWGHLRMTDEEIITSVTQGSGLRPDTSSLDCAPSIIACMRTCWEEDPELRPDLRFVH 184 (423)
Q Consensus 105 ~~s~ksDVyS~Giil~elltg~~Pf~~~~~~~~~i~~~i~~~~~~~p~~~~~~~~~~l~~Li~~C~~~dP~~RPt~~~I~ 184 (423)
+.++|||||||++|||++|..|+.. ......+..+. .+......+++++.+++.+||+.||++|||+.+++
T Consensus 233 --~~~~DiwslG~il~el~~g~~~~~~-----~~~~~~~~~~~--~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell 303 (311)
T 3p1a_A 233 --GTAADVFSLGLTILEVACNMELPHG-----GEGWQQLRQGY--LPPEFTAGLSSELRSVLVMMLEPDPKLRATAEALL 303 (311)
T ss_dssp --STHHHHHHHHHHHHHHHHTCCCCSS-----HHHHHHHTTTC--CCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHH
T ss_pred --CchhhHHHHHHHHHHHHhCCCCCCC-----ccHHHHHhccC--CCcccccCCCHHHHHHHHHHcCCChhhCcCHHHHH
Confidence 8999999999999999999766542 23334444332 11112235789999999999999999999999987
Q ss_pred H
Q psy1840 185 H 185 (423)
Q Consensus 185 ~ 185 (423)
+
T Consensus 304 ~ 304 (311)
T 3p1a_A 304 A 304 (311)
T ss_dssp T
T ss_pred h
Confidence 5
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=1.9e-26 Score=225.38 Aligned_cols=169 Identities=28% Similarity=0.428 Sum_probs=129.0
Q ss_pred HHHHHHHHHHHHHHHHH--------hCCCeeecCCCCCCEEEcCCccEEEeccCCcccccCCCccc--ccccccCCcccc
Q psy1840 24 GSISVNTTASVGMIHLH--------DSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETG--QERKLRRRKLYK 93 (423)
Q Consensus 24 ~~l~i~~qi~~gL~yLH--------~~~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~~~--~~~~~~gt~~y~ 93 (423)
..+.++.|++.||.||| +.+++ ||||||+||+++.++.+||+|||++.......... ......|++.|+
T Consensus 140 ~~~~i~~~i~~~l~~lH~~~~~~~~~~~iv-H~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~ 218 (342)
T 1b6c_B 140 GMIKLALSTASGLAHLHMEIVGTQGKPAIA-HRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYM 218 (342)
T ss_dssp HHHHHHHHHHHHHHHHHCCBCSTTCBCEEE-CSCCSGGGEEECTTSCEEECCCTTCEEEETTTTEEEECCCSCCCCGGGC
T ss_pred HHHHHHHHHHHHHHHHHHHHhhhcccCCee-eCCCCHHHEEECCCCCEEEEECCCceeccccccccccccccCCcCcccC
Confidence 36899999999999999 88887 99999999999999999999999987654332211 223457889999
Q ss_pred CCccccCCCCC---CCCCccchHHHHHHHHHHHhC----------CCCCCCCC---CChHHHHHHHhcCCCCCCCCC---
Q psy1840 94 APELLRQPHLP---RGTQKGDVYSFGLVLYEVIGR----------QGPWGHLR---MTDEEIITSVTQGSGLRPDTS--- 154 (423)
Q Consensus 94 APE~l~~~~~~---~~s~ksDVyS~Giil~elltg----------~~Pf~~~~---~~~~~i~~~i~~~~~~~p~~~--- 154 (423)
|||.+.+.... ..+.++|||||||++|||++| ..||.... .....+...+... ..++..+
T Consensus 219 aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~ 297 (342)
T 1b6c_B 219 APEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQ-KLRPNIPNRW 297 (342)
T ss_dssp CHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTS-CCCCCCCGGG
T ss_pred CHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccccCccccCcCcccHHHHHHHHHHH-HhCCCCcccc
Confidence 99999865311 113689999999999999999 77886532 2234444444332 2333322
Q ss_pred -CCCchHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHhhhc
Q psy1840 155 -SLDCAPSIIACMRTCWEEDPELRPDLRFVHHKLKEMNAGL 194 (423)
Q Consensus 155 -~~~~~~~l~~Li~~C~~~dP~~RPt~~~I~~~L~~i~~~~ 194 (423)
...++..+.+++.+||+.||++|||+.+|++.|+.+..+.
T Consensus 298 ~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~L~~i~~~~ 338 (342)
T 1b6c_B 298 QSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQE 338 (342)
T ss_dssp GTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHHHHTT
T ss_pred cchhHHHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHHh
Confidence 2345678999999999999999999999999999987654
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=99.93 E-value=6.7e-27 Score=228.25 Aligned_cols=156 Identities=21% Similarity=0.325 Sum_probs=107.9
Q ss_pred HHHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCc---cEEEeccCCcccccCCCcccccccccCCccccCCccccC
Q psy1840 24 GSISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRW---VLQIADFGLHAFKAGQDETGQERKLRRRKLYKAPELLRQ 100 (423)
Q Consensus 24 ~~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~---~vKL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~ 100 (423)
....++.||+.||.|||+.|++ ||||||+||+++.++ .+||+|||+++....... ......+|+.|+|||.+.+
T Consensus 107 ~~~~i~~qi~~~l~~LH~~~iv-H~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~--~~~~~~~t~~y~aPE~~~~ 183 (325)
T 3kn6_A 107 EASYIMRKLVSAVSHMHDVGVV-HRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQ--PLKTPCFTLHYAAPELLNQ 183 (325)
T ss_dssp HHHHHHHHHHHHHHHHHHTTEE-CCCCCGGGEEEEC----CEEEECCCTTCEECCC------------------------
T ss_pred HHHHHHHHHHHHHHHHHHCCCe-ecCCCHHHEEEecCCCcccEEEeccccceecCCCCC--cccccCCCcCccCHHHhcC
Confidence 3679999999999999999988 999999999997665 899999999876433221 2234567899999999987
Q ss_pred CCCCCCCCccchHHHHHHHHHHHhCCCCCCCCC-----CChHHHHHHHhcCCCCCCCCCCCCchHHHHHHHHHhhhcCCC
Q psy1840 101 PHLPRGTQKGDVYSFGLVLYEVIGRQGPWGHLR-----MTDEEIITSVTQGSGLRPDTSSLDCAPSIIACMRTCWEEDPE 175 (423)
Q Consensus 101 ~~~~~~s~ksDVyS~Giil~elltg~~Pf~~~~-----~~~~~i~~~i~~~~~~~p~~~~~~~~~~l~~Li~~C~~~dP~ 175 (423)
..+ +.++|||||||++|+|++|..||.... ....++...+..+....+......+++++.+++.+||+.||.
T Consensus 184 ~~~---~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~ 260 (325)
T 3kn6_A 184 NGY---DESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSFEGEAWKNVSQEAKDLIQGLLTVDPN 260 (325)
T ss_dssp CCC---CHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTTCCCCCSHHHHTSCHHHHHHHHHHHCCCTT
T ss_pred CCC---CCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcCCCCCCcccccCCCHHHHHHHHHHCCCChh
Confidence 655 899999999999999999999997532 234566777776554333222235789999999999999999
Q ss_pred CCCCHHHHHH
Q psy1840 176 LRPDLRFVHH 185 (423)
Q Consensus 176 ~RPt~~~I~~ 185 (423)
+|||+.++++
T Consensus 261 ~Rpt~~ell~ 270 (325)
T 3kn6_A 261 KRLKMSGLRY 270 (325)
T ss_dssp TCCCTTTSTT
T ss_pred HCCCHHHHhc
Confidence 9999998864
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.93 E-value=3.1e-26 Score=226.66 Aligned_cols=172 Identities=14% Similarity=0.071 Sum_probs=134.8
Q ss_pred HHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcC-----------CccEEEeccCCcccccCCCcccccccccCCcccc
Q psy1840 25 SISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDS-----------RWVLQIADFGLHAFKAGQDETGQERKLRRRKLYK 93 (423)
Q Consensus 25 ~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~-----------~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~y~ 93 (423)
.+.++.||+.||+|||+.|++ ||||||+|||++. ++.+||+|||+++...............||+.|+
T Consensus 174 ~~~i~~qi~~~L~~lH~~~iv-HrDiKp~NIll~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~ 252 (365)
T 3e7e_A 174 VISFAMRMLYMIEQVHDCEII-HGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQ 252 (365)
T ss_dssp HHHHHHHHHHHHHHHHTTTEE-CCCCSGGGEEECGGGTCC------CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCC
T ss_pred HHHHHHHHHHHHHHHhhCCee-cCCCCHHHEEecccccCccccccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCC
Confidence 689999999999999999988 9999999999998 8999999999997543332333335567999999
Q ss_pred CCccccCCCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCchHHHHHHHHHhhhcC
Q psy1840 94 APELLRQPHLPRGTQKGDVYSFGLVLYEVIGRQGPWGHLRMTDEEIITSVTQGSGLRPDTSSLDCAPSIIACMRTCWEED 173 (423)
Q Consensus 94 APE~l~~~~~~~~s~ksDVyS~Giil~elltg~~Pf~~~~~~~~~i~~~i~~~~~~~p~~~~~~~~~~l~~Li~~C~~~d 173 (423)
|||++.+..+ +.++|||||||++|||++|+.||....... .. ..........++.+.+++..|++.+
T Consensus 253 aPE~~~~~~~---~~~~DiwslG~il~elltg~~pf~~~~~~~-------~~---~~~~~~~~~~~~~~~~~~~~~l~~~ 319 (365)
T 3e7e_A 253 CVEMLSNKPW---NYQIDYFGVAATVYCMLFGTYMKVKNEGGE-------CK---PEGLFRRLPHLDMWNEFFHVMLNIP 319 (365)
T ss_dssp CHHHHTTCCB---STHHHHHHHHHHHHHHHHSSCCCEEEETTE-------EE---ECSCCTTCSSHHHHHHHHHHHHCCC
T ss_pred ChHHhcCCCC---CccccHHHHHHHHHHHHhCCCccccCCCCc-------ee---echhccccCcHHHHHHHHHHHcCCC
Confidence 9999988765 899999999999999999999985321100 00 0011111234778999999999999
Q ss_pred CCCC-CCHHHHHHHHHHHhhhcCCChHHHHHHHHHHhh
Q psy1840 174 PELR-PDLRFVHHKLKEMNAGLKANIFDNMLAIMEKYA 210 (423)
Q Consensus 174 P~~R-Pt~~~I~~~L~~i~~~~~~~~~d~~~~~~e~~~ 210 (423)
|.+| |++.++.+.|+.+......+..+.+..++....
T Consensus 320 p~~r~~~~~~l~~~l~~~l~~~~~~~~~~l~~~l~~~~ 357 (365)
T 3e7e_A 320 DCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLL 357 (365)
T ss_dssp CTTCCCCHHHHHHHHHHHHHHHTTTTHHHHHHHHHHHH
T ss_pred CCCcchHHHHHHHHHHHHHHHhhhhchHHHHHHHHHHH
Confidence 9999 678999999998887766666777777666554
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=99.93 E-value=5.3e-26 Score=219.00 Aligned_cols=154 Identities=21% Similarity=0.246 Sum_probs=127.5
Q ss_pred HHHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEE---cCCccEEEeccCCcccccCCCcccccccccCCccccCCccccC
Q psy1840 24 GSISVNTTASVGMIHLHDSEIISHGNLRSSNCLI---DSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKAPELLRQ 100 (423)
Q Consensus 24 ~~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILl---d~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~ 100 (423)
....++.|++.||.|||+.|++ ||||||+||++ +.++.+||+|||++...... ......+++.|+|||.+.+
T Consensus 107 ~~~~~~~qi~~~l~~lH~~~i~-H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~----~~~~~~~~~~y~aPE~~~~ 181 (304)
T 2jam_A 107 DASLVIQQVLSAVKYLHENGIV-HRDLKPENLLYLTPEENSKIMITDFGLSKMEQNG----IMSTACGTPGYVAPEVLAQ 181 (304)
T ss_dssp HHHHHHHHHHHHHHHHHHTTCC-CCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCCB----TTHHHHSCCCBCCTTTBSS
T ss_pred HHHHHHHHHHHHHHHHHHCCcc-ccCCCHHHEEEecCCCCCCEEEccCCcceecCCC----ccccccCCCCccChHHhcc
Confidence 3678999999999999999998 99999999999 78899999999998654321 1233468899999999987
Q ss_pred CCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCchHHHHHHHHHhhhcCCCCCCCH
Q psy1840 101 PHLPRGTQKGDVYSFGLVLYEVIGRQGPWGHLRMTDEEIITSVTQGSGLRPDTSSLDCAPSIIACMRTCWEEDPELRPDL 180 (423)
Q Consensus 101 ~~~~~~s~ksDVyS~Giil~elltg~~Pf~~~~~~~~~i~~~i~~~~~~~p~~~~~~~~~~l~~Li~~C~~~dP~~RPt~ 180 (423)
..+ +.++||||||+++|+|++|..||.. ....++...+..+....+......+++.+.+++.+||+.||++||++
T Consensus 182 ~~~---~~~~Di~slG~il~~l~~g~~pf~~--~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~ 256 (304)
T 2jam_A 182 KPY---SKAVDCWSIGVITYILLCGYPPFYE--ETESKLFEKIKEGYYEFESPFWDDISESAKDFICHLLEKDPNERYTC 256 (304)
T ss_dssp CSC---CHHHHHHHHHHHHHHHHHSSCTTTT--SCHHHHHHHHHHCCCCCCTTTTTTSCHHHHHHHHHHHCSSTTTSCCH
T ss_pred CCC---CchhhHHHHHHHHHHHHHCCCCCCC--CCHHHHHHHHHcCCCCCCccccccCCHHHHHHHHHHcCCChhHCcCH
Confidence 655 8999999999999999999999974 44566777777665444433345688999999999999999999999
Q ss_pred HHHHHHH
Q psy1840 181 RFVHHKL 187 (423)
Q Consensus 181 ~~I~~~L 187 (423)
.++++.-
T Consensus 257 ~~~l~h~ 263 (304)
T 2jam_A 257 EKALSHP 263 (304)
T ss_dssp HHHHTSH
T ss_pred HHHhcCc
Confidence 9998743
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=99.93 E-value=1.3e-26 Score=224.13 Aligned_cols=162 Identities=19% Similarity=0.205 Sum_probs=119.2
Q ss_pred HHHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCcc---EEEeccCCcccccCCCc-----ccccccccCCccccCC
Q psy1840 24 GSISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWV---LQIADFGLHAFKAGQDE-----TGQERKLRRRKLYKAP 95 (423)
Q Consensus 24 ~~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~~---vKL~DFGla~~~~~~~~-----~~~~~~~~gt~~y~AP 95 (423)
....++.||+.||.|||++|++ ||||||+||+++.++. +||+|||++........ ........|++.|+||
T Consensus 112 ~~~~i~~qi~~~l~~lH~~~iv-H~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP 190 (316)
T 2ac3_A 112 EASVVVQDVASALDFLHNKGIA-HRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAP 190 (316)
T ss_dssp HHHHHHHHHHHHHHHHHHTTCC-CCCCCGGGEEESCSSSSCSEEECCTTCCC-------------------CCSGGGCCH
T ss_pred HHHHHHHHHHHHHHHHHhCCce-eCCCCHHHEEEccCCCcCceEEEEccCccccccCCccccccccccccccCCcCccCh
Confidence 3678999999999999999998 9999999999988765 99999999875432211 1112234689999999
Q ss_pred ccccCCC--CCCCCCccchHHHHHHHHHHHhCCCCCCCCCCC-------------hHHHHHHHhcCCCCCCCCCCCCchH
Q psy1840 96 ELLRQPH--LPRGTQKGDVYSFGLVLYEVIGRQGPWGHLRMT-------------DEEIITSVTQGSGLRPDTSSLDCAP 160 (423)
Q Consensus 96 E~l~~~~--~~~~s~ksDVyS~Giil~elltg~~Pf~~~~~~-------------~~~i~~~i~~~~~~~p~~~~~~~~~ 160 (423)
|++.+.. ...++.++|||||||++|||++|..||...... ...+...+..+....|......+++
T Consensus 191 E~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 270 (316)
T 2ac3_A 191 EVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISC 270 (316)
T ss_dssp HHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCHHHHHHHHHHHHHCCCCCCHHHHTTSCH
T ss_pred HHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccchhHHHHHHHHHhccCcccCchhcccCCH
Confidence 9987411 001378999999999999999999999754321 2345566665544333222235788
Q ss_pred HHHHHHHHhhhcCCCCCCCHHHHHHH
Q psy1840 161 SIIACMRTCWEEDPELRPDLRFVHHK 186 (423)
Q Consensus 161 ~l~~Li~~C~~~dP~~RPt~~~I~~~ 186 (423)
.+.+++.+||+.||.+|||+.++++.
T Consensus 271 ~~~~li~~~L~~dP~~Rps~~e~l~h 296 (316)
T 2ac3_A 271 AAKDLISKLLVRDAKQRLSAAQVLQH 296 (316)
T ss_dssp HHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred HHHHHHHHHhhCChhhCCCHHHHhcC
Confidence 99999999999999999999999763
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=6.2e-26 Score=223.44 Aligned_cols=146 Identities=18% Similarity=0.315 Sum_probs=118.2
Q ss_pred HHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCccEEEeccCCcccccCCCcccccccccCCccccCCccccCCCCC
Q psy1840 25 SISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKAPELLRQPHLP 104 (423)
Q Consensus 25 ~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~ 104 (423)
...++.||+.||.|||++|++ ||||||+|||++.++.+||+|||+++...... .......||+.|+|||++.+..+
T Consensus 112 ~~~~~~qi~~aL~~LH~~~iv-HrDlkp~NIll~~~g~~kL~DFG~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~- 187 (345)
T 3a8x_A 112 ARFYSAEISLALNYLHERGII-YRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG--DTTSTFCGTPNYIAPEILRGEDY- 187 (345)
T ss_dssp HHHHHHHHHHHHHHHHHTTCB-CCCCCGGGEEECTTSCEEECCGGGCBCSCCTT--CCBCCCCSCGGGCCHHHHTTCCB-
T ss_pred HHHHHHHHHHHHHHHHHCCce-ecCCCHHHEEECCCCCEEEEeccccccccCCC--CcccccCCCccccCccccCCCCC-
Confidence 578999999999999999998 99999999999999999999999987532221 12345679999999999987655
Q ss_pred CCCCccchHHHHHHHHHHHhCCCCCCCCC-------CChHHHHHHHhcCCCCCCCCCCCCchHHHHHHHHHhhhcCCCCC
Q psy1840 105 RGTQKGDVYSFGLVLYEVIGRQGPWGHLR-------MTDEEIITSVTQGSGLRPDTSSLDCAPSIIACMRTCWEEDPELR 177 (423)
Q Consensus 105 ~~s~ksDVyS~Giil~elltg~~Pf~~~~-------~~~~~i~~~i~~~~~~~p~~~~~~~~~~l~~Li~~C~~~dP~~R 177 (423)
+.++|||||||++|||++|..||.... .....+...+.......| ..++.++.+++.+||+.||.+|
T Consensus 188 --~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p----~~~s~~~~~li~~lL~~dP~~R 261 (345)
T 3a8x_A 188 --GFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIP----RSLSVKAASVLKSFLNKDPKER 261 (345)
T ss_dssp --CTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHCCCCCC----TTSCHHHHHHHHHHTCSSTTTS
T ss_pred --ChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcCCCCCC----CCCCHHHHHHHHHHhcCCHhHC
Confidence 899999999999999999999996422 122344455555433322 3578999999999999999999
Q ss_pred CCH
Q psy1840 178 PDL 180 (423)
Q Consensus 178 Pt~ 180 (423)
|++
T Consensus 262 ~~~ 264 (345)
T 3a8x_A 262 LGC 264 (345)
T ss_dssp TTC
T ss_pred CCC
Confidence 985
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=4.3e-26 Score=235.09 Aligned_cols=153 Identities=25% Similarity=0.388 Sum_probs=127.3
Q ss_pred HHHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcC---CccEEEeccCCcccccCCCcccccccccCCccccCCccccC
Q psy1840 24 GSISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDS---RWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKAPELLRQ 100 (423)
Q Consensus 24 ~~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~---~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~ 100 (423)
....++.||+.||.|||+.|++ ||||||+||+++. ++.+||+|||++....... ......||+.|+|||++.+
T Consensus 137 ~~~~i~~qi~~~l~~lH~~~iv-H~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~~~~---~~~~~~gt~~y~aPE~l~~ 212 (494)
T 3lij_A 137 DAAVIIKQVLSGVTYLHKHNIV-HRDLKPENLLLESKEKDALIKIVDFGLSAVFENQK---KMKERLGTAYYIAPEVLRK 212 (494)
T ss_dssp HHHHHHHHHHHHHHHHHHTTEE-CSCCSGGGEEESCSSTTCCEEECCCTTCEECBTTB---CBCCCCSCTTTCCHHHHTT
T ss_pred HHHHHHHHHHHHHHHHHHCCce-eccCChhhEEEeCCCCCCcEEEEECCCCeECCCCc---cccccCCCcCeeCHHHHcc
Confidence 3678999999999999999988 9999999999976 4569999999987654332 2234578999999999864
Q ss_pred CCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCchHHHHHHHHHhhhcCCCCCCCH
Q psy1840 101 PHLPRGTQKGDVYSFGLVLYEVIGRQGPWGHLRMTDEEIITSVTQGSGLRPDTSSLDCAPSIIACMRTCWEEDPELRPDL 180 (423)
Q Consensus 101 ~~~~~~s~ksDVyS~Giil~elltg~~Pf~~~~~~~~~i~~~i~~~~~~~p~~~~~~~~~~l~~Li~~C~~~dP~~RPt~ 180 (423)
. ++.++||||+||++|+|++|..||.. .+..++...+..+....+......+++.+.+++.+||+.||.+|||+
T Consensus 213 ~----~~~~~DiwslG~il~~ll~g~~pf~~--~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~ 286 (494)
T 3lij_A 213 K----YDEKCDVWSIGVILFILLAGYPPFGG--QTDQEILRKVEKGKYTFDSPEWKNVSEGAKDLIKQMLQFDSQRRISA 286 (494)
T ss_dssp C----BCTHHHHHHHHHHHHHHHHSSCSSCC--SSHHHHHHHHHHTCCCCCSGGGTTSCHHHHHHHHHHTCSSTTTSCCH
T ss_pred c----CCCchhHHHHHHHHHHHHhCCCCCCC--CCHHHHHHHHHhCCCCCCchhcccCCHHHHHHHHHHCCCChhhCccH
Confidence 3 38999999999999999999999974 45677888888766544443345688999999999999999999999
Q ss_pred HHHHHH
Q psy1840 181 RFVHHK 186 (423)
Q Consensus 181 ~~I~~~ 186 (423)
.++++.
T Consensus 287 ~e~l~h 292 (494)
T 3lij_A 287 QQALEH 292 (494)
T ss_dssp HHHHTC
T ss_pred HHHhcC
Confidence 999763
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=99.93 E-value=3.8e-27 Score=234.48 Aligned_cols=141 Identities=16% Similarity=0.115 Sum_probs=112.5
Q ss_pred HHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCccEEEeccCCcccccCCCcccccccccCCccccCCccccCC---
Q psy1840 25 SISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKAPELLRQP--- 101 (423)
Q Consensus 25 ~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~--- 101 (423)
++.++.||+.||+|||++|++ ||||||+|||++.++.+||+|||+++.... ......| +.|+|||++.+.
T Consensus 208 ~~~i~~qi~~aL~~LH~~~iv-HrDikp~NIll~~~~~~kL~DFG~a~~~~~-----~~~~~~g-~~y~aPE~~~~~~~~ 280 (377)
T 3byv_A 208 RLQLTLQVIRLLASLHHYGLV-HTYLRPVDIVLDQRGGVFLTGFEHLVRDGA-----RVVSSVS-RGFEPPELEARRATI 280 (377)
T ss_dssp HHHHHHHHHHHHHHHHHTTEE-CSCCCGGGEEECTTCCEEECCGGGCEETTC-----EEECCCC-TTCCCHHHHHHHTST
T ss_pred HHHHHHHHHHHHHHHHhCCee-cCCCCHHHEEEcCCCCEEEEechhheecCC-----cccCCCC-cCccChhhhcccccc
Confidence 567999999999999999988 999999999999999999999999875321 1234456 889999999876
Q ss_pred --------CCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCchHHHHHHHHHhhhcC
Q psy1840 102 --------HLPRGTQKGDVYSFGLVLYEVIGRQGPWGHLRMTDEEIITSVTQGSGLRPDTSSLDCAPSIIACMRTCWEED 173 (423)
Q Consensus 102 --------~~~~~s~ksDVyS~Giil~elltg~~Pf~~~~~~~~~i~~~i~~~~~~~p~~~~~~~~~~l~~Li~~C~~~d 173 (423)
.+ +.++|||||||++|||++|+.||..... .+....+.. ....+++++.+++.+||+.|
T Consensus 281 ~~~~~~~~~~---~~~~DvwSlG~il~elltg~~Pf~~~~~--~~~~~~~~~--------~~~~~~~~~~~li~~~L~~d 347 (377)
T 3byv_A 281 SYHRDRRTLM---TFSFDAWALGLVIYWIWCADLPITKDAA--LGGSEWIFR--------SCKNIPQPVRALLEGFLRYP 347 (377)
T ss_dssp HHHHCCEEEC---CHHHHHHHHHHHHHHHHHSSCCC--------CCSGGGGS--------SCCCCCHHHHHHHHHHTCSS
T ss_pred cccccccccC---ChhhhHHHHHHHHHHHHHCCCCCccccc--ccchhhhhh--------hccCCCHHHHHHHHHHcCCC
Confidence 44 8999999999999999999999964211 111111111 11357899999999999999
Q ss_pred CCCCCCHHHHHH
Q psy1840 174 PELRPDLRFVHH 185 (423)
Q Consensus 174 P~~RPt~~~I~~ 185 (423)
|++||++.++++
T Consensus 348 p~~Rpt~~e~l~ 359 (377)
T 3byv_A 348 KEDRLLPLQAME 359 (377)
T ss_dssp GGGCCCHHHHHT
T ss_pred chhCCCHHHHhh
Confidence 999999999986
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=2.4e-25 Score=228.90 Aligned_cols=153 Identities=22% Similarity=0.307 Sum_probs=125.8
Q ss_pred HHHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEc---CCccEEEeccCCcccccCCCcccccccccCCccccCCccccC
Q psy1840 24 GSISVNTTASVGMIHLHDSEIISHGNLRSSNCLID---SRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKAPELLRQ 100 (423)
Q Consensus 24 ~~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld---~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~ 100 (423)
....++.||+.||.|||++|++ ||||||+||+++ .++.+||+|||++....... ......||+.|+|||++.+
T Consensus 122 ~~~~i~~qi~~al~~lH~~~iv-H~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~ 197 (486)
T 3mwu_A 122 DAARIIKQVFSGITYMHKHNIV-HRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNT---KMKDRIGTAYYIAPEVLRG 197 (486)
T ss_dssp HHHHHHHHHHHHHHHHHHTTCC-CSCCSGGGEEESSSSTTCCEEECSCSCTTTBCCC-------CCTTGGGGCCGGGGGS
T ss_pred HHHHHHHHHHHHHHHHHHCCeE-eccCchHHEEEecCCCCCCEEEEECCcCeECCCCC---ccCCCcCCCCCCCHHHhCC
Confidence 3679999999999999999998 999999999995 45679999999987654322 1234578999999999976
Q ss_pred CCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCchHHHHHHHHHhhhcCCCCCCCH
Q psy1840 101 PHLPRGTQKGDVYSFGLVLYEVIGRQGPWGHLRMTDEEIITSVTQGSGLRPDTSSLDCAPSIIACMRTCWEEDPELRPDL 180 (423)
Q Consensus 101 ~~~~~~s~ksDVyS~Giil~elltg~~Pf~~~~~~~~~i~~~i~~~~~~~p~~~~~~~~~~l~~Li~~C~~~dP~~RPt~ 180 (423)
. ++.++||||+||++|+|++|..||.+ .+..+++..+..+....+......+++++.+++.+||+.||.+|||+
T Consensus 198 ~----~~~~~DiwslG~il~~ll~g~~pf~~--~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~ 271 (486)
T 3mwu_A 198 T----YDEKCDVWSAGVILYILLSGTPPFYG--KNEYDILKRVETGKYAFDLPQWRTISDDAKDLIRKMLTFHPSLRITA 271 (486)
T ss_dssp C----CCHHHHHHHHHHHHHHHHHSSCSSCC--SSHHHHHHHHHHTCCCSCSGGGGGSCHHHHHHHHHHTCSSTTTSCCH
T ss_pred C----CCchhhHHHHHHHHHHHHhCCCCCCC--CCHHHHHHHHHhCCCCCCCcccCCCCHHHHHHHHHHcCCChhhCcCH
Confidence 3 38999999999999999999999974 45677788887765443333334678999999999999999999999
Q ss_pred HHHHHH
Q psy1840 181 RFVHHK 186 (423)
Q Consensus 181 ~~I~~~ 186 (423)
.++++.
T Consensus 272 ~~~l~h 277 (486)
T 3mwu_A 272 TQCLEH 277 (486)
T ss_dssp HHHHHC
T ss_pred HHHhcC
Confidence 999875
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=99.93 E-value=3.4e-26 Score=216.61 Aligned_cols=156 Identities=22% Similarity=0.319 Sum_probs=121.8
Q ss_pred HHHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCccEEEeccCCcccccCCCcccccccccCCccccCCccccCCCC
Q psy1840 24 GSISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKAPELLRQPHL 103 (423)
Q Consensus 24 ~~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~ 103 (423)
....++.|++.||.|||+.|++ ||||||+||+++.++.+||+|||++................+++.|+|||.+.+..+
T Consensus 106 ~~~~~~~~i~~~l~~lH~~~i~-H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~ 184 (276)
T 2yex_A 106 DAQRFFHQLMAGVVYLHGIGIT-HRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREF 184 (276)
T ss_dssp HHHHHHHHHHHHHHHHHHTTEE-CSCCSGGGEEECTTCCEEECCCTTCEECEETTEECCBCCCCSCGGGCCGGGGTCSSB
T ss_pred HHHHHHHHHHHHHHHHHhCCee-ccCCChHHEEEccCCCEEEeeCCCccccCCCcchhcccCCccccCccChHHHhcCCC
Confidence 3689999999999999999988 999999999999999999999999876533322222345578899999999976542
Q ss_pred CCCCCccchHHHHHHHHHHHhCCCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCchHHHHHHHHHhhhcCCCCCCCHHHH
Q psy1840 104 PRGTQKGDVYSFGLVLYEVIGRQGPWGHLRMTDEEIITSVTQGSGLRPDTSSLDCAPSIIACMRTCWEEDPELRPDLRFV 183 (423)
Q Consensus 104 ~~~s~ksDVyS~Giil~elltg~~Pf~~~~~~~~~i~~~i~~~~~~~p~~~~~~~~~~l~~Li~~C~~~dP~~RPt~~~I 183 (423)
.+.++||||||+++|||++|..||.......... ..+.......+ ....+++.+.+++.+||+.||++|||+.++
T Consensus 185 --~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~-~~~~~~~~~~~--~~~~~~~~~~~li~~~l~~~p~~Rps~~~i 259 (276)
T 2yex_A 185 --HAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEY-SDWKEKKTYLN--PWKKIDSAPLALLHKILVENPSARITIPDI 259 (276)
T ss_dssp --CHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHH-HHHHTTCTTST--TGGGSCHHHHHHHHHHSCSSTTTSCCHHHH
T ss_pred --CCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHH-HHhhhcccccC--chhhcCHHHHHHHHHHCCCCchhCCCHHHH
Confidence 2678999999999999999999997644333333 23332222211 123578899999999999999999999998
Q ss_pred HH
Q psy1840 184 HH 185 (423)
Q Consensus 184 ~~ 185 (423)
++
T Consensus 260 l~ 261 (276)
T 2yex_A 260 KK 261 (276)
T ss_dssp TT
T ss_pred hc
Confidence 75
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=99.93 E-value=2.8e-26 Score=217.88 Aligned_cols=155 Identities=18% Similarity=0.260 Sum_probs=125.3
Q ss_pred HHHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCccEEEeccCCcccccCCCcccccccccCCccccCCccccCCCC
Q psy1840 24 GSISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKAPELLRQPHL 103 (423)
Q Consensus 24 ~~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~ 103 (423)
..+.++.||+.||.|||+.|++ ||||||+||+++.++.+||+|||++........ .....+++.|+|||.+.+..+
T Consensus 123 ~~~~i~~qi~~~l~~lH~~~i~-H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~ 198 (284)
T 2a19_B 123 LALELFEQITKGVDYIHSKKLI-NRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGK---RTRSKGTLRYMSPEQISSQDY 198 (284)
T ss_dssp HHHHHHHHHHHHHHHHHHTTEE-CSCCSGGGEEEEETTEEEECCCTTCEESSCCSC---CCCCCSCCTTSCHHHHHCSCC
T ss_pred HHHHHHHHHHHHHHHHHhCCee-eccCCHHHEEEcCCCCEEECcchhheecccccc---ccccCCcccccChhhhccCCC
Confidence 3679999999999999999988 999999999999999999999999876543321 234568899999999987654
Q ss_pred CCCCCccchHHHHHHHHHHHhCCCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCchHHHHHHHHHhhhcCCCCCCCHHHH
Q psy1840 104 PRGTQKGDVYSFGLVLYEVIGRQGPWGHLRMTDEEIITSVTQGSGLRPDTSSLDCAPSIIACMRTCWEEDPELRPDLRFV 183 (423)
Q Consensus 104 ~~~s~ksDVyS~Giil~elltg~~Pf~~~~~~~~~i~~~i~~~~~~~p~~~~~~~~~~l~~Li~~C~~~dP~~RPt~~~I 183 (423)
+.++||||||+++|||++|..|+.. .......+..+. ....++..+.+++.+||+.||.+||++.++
T Consensus 199 ---~~~~Di~slG~il~~l~~~~~~~~~----~~~~~~~~~~~~------~~~~~~~~~~~li~~~l~~dp~~Rps~~e~ 265 (284)
T 2a19_B 199 ---GKEVDLYALGLILAELLHVCDTAFE----TSKFFTDLRDGI------ISDIFDKKEKTLLQKLLSKKPEDRPNTSEI 265 (284)
T ss_dssp ---CTHHHHHHHHHHHHHHHSCCSSHHH----HHHHHHHHHTTC------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred ---cchhhhHHHHHHHHHHHhcCCcchh----HHHHHHHhhccc------ccccCCHHHHHHHHHHccCChhhCcCHHHH
Confidence 8999999999999999999988742 233334443322 123578899999999999999999999999
Q ss_pred HHHHHHHhhhcC
Q psy1840 184 HHKLKEMNAGLK 195 (423)
Q Consensus 184 ~~~L~~i~~~~~ 195 (423)
++.|..+..+..
T Consensus 266 l~~l~~~~~~~~ 277 (284)
T 2a19_B 266 LRTLTVWKKSPE 277 (284)
T ss_dssp HHHHHHHTC---
T ss_pred HHHHHHHhhCCC
Confidence 999988876543
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.93 E-value=2.7e-26 Score=222.68 Aligned_cols=162 Identities=19% Similarity=0.285 Sum_probs=123.8
Q ss_pred HHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEE----cCCccEEEeccCCcccccCCCcccccccccCCccccCCccccC
Q psy1840 25 SISVNTTASVGMIHLHDSEIISHGNLRSSNCLI----DSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKAPELLRQ 100 (423)
Q Consensus 25 ~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILl----d~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~ 100 (423)
...++.||+.||.|||+.|++ ||||||+||++ +.++.+||+|||+++....... .....|++.|+|||++..
T Consensus 114 ~~~i~~qi~~~L~~LH~~~iv-H~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~ 189 (319)
T 4euu_A 114 FLIVLRDVVGGMNHLRENGIV-HRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQ---FVSLYGTEEYLHPDMYER 189 (319)
T ss_dssp HHHHHHHHHHHHHHHHHTTEE-CSCCSGGGEEEEECTTSCEEEEECCCTTCEECCTTCC---BCCCCSCGGGCCHHHHHH
T ss_pred HHHHHHHHHHHHHHHHHCCEe-cCCCCHHHEEEeccCCCCceEEEccCCCceecCCCCc---eeecccCCCccCHHHhhh
Confidence 689999999999999999988 99999999999 8889999999999876543322 234568999999998862
Q ss_pred C-----CCCCCCCccchHHHHHHHHHHHhCCCCCCCCC--CChHHHHHHHhcCCCCC-------------------C--C
Q psy1840 101 P-----HLPRGTQKGDVYSFGLVLYEVIGRQGPWGHLR--MTDEEIITSVTQGSGLR-------------------P--D 152 (423)
Q Consensus 101 ~-----~~~~~s~ksDVyS~Giil~elltg~~Pf~~~~--~~~~~i~~~i~~~~~~~-------------------p--~ 152 (423)
. ....++.++|||||||++|||++|..||.... ....+++..+..+.+.. + .
T Consensus 190 ~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 269 (319)
T 4euu_A 190 AVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSC 269 (319)
T ss_dssp HTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHHHHHCCTTCCEEEECSTTCCEEEESSCCTTC
T ss_pred ccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHhcCCCcccchhhhcccCCccccCccCCccc
Confidence 1 01134899999999999999999999996432 22245555554432210 1 0
Q ss_pred CCCCCchHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHH
Q psy1840 153 TSSLDCAPSIIACMRTCWEEDPELRPDLRFVHHKLKEM 190 (423)
Q Consensus 153 ~~~~~~~~~l~~Li~~C~~~dP~~RPt~~~I~~~L~~i 190 (423)
.....++..+.+++.+||+.||++|||+.++++...+-
T Consensus 270 ~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d~ 307 (319)
T 4euu_A 270 SLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDI 307 (319)
T ss_dssp SSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHH
T ss_pred ccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHHH
Confidence 11124567899999999999999999999999887654
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=4e-26 Score=224.47 Aligned_cols=157 Identities=20% Similarity=0.219 Sum_probs=120.0
Q ss_pred HHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCccEEEeccCCcccccCCCc--ccccccccCCccccCCccccCCC
Q psy1840 25 SISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDE--TGQERKLRRRKLYKAPELLRQPH 102 (423)
Q Consensus 25 ~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~--~~~~~~~~gt~~y~APE~l~~~~ 102 (423)
...++.||+.||.|||+.|++ ||||||+||+++.++.+||+|||++........ ........||+.|+|||++.+..
T Consensus 126 ~~~i~~qi~~~l~~LH~~~iv-H~Dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~ 204 (351)
T 3mi9_A 126 IKRVMQMLLNGLYYIHRNKIL-HRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGER 204 (351)
T ss_dssp HHHHHHHHHHHHHHHHHTTEE-CCCCSGGGEEECTTSCEEECCCTTCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCC
T ss_pred HHHHHHHHHHHHHHHHHCCee-CCCCCHHHEEEcCCCCEEEccchhcccccccccccccccCCcccccCccCchhhcCCC
Confidence 679999999999999999988 999999999999999999999999876542221 12224456889999999987643
Q ss_pred CCCCCCccchHHHHHHHHHHHhCCCCCCCCCCChHHHHHHHhcCCCCCCCCCCCC-------------------------
Q psy1840 103 LPRGTQKGDVYSFGLVLYEVIGRQGPWGHLRMTDEEIITSVTQGSGLRPDTSSLD------------------------- 157 (423)
Q Consensus 103 ~~~~s~ksDVyS~Giil~elltg~~Pf~~~~~~~~~i~~~i~~~~~~~p~~~~~~------------------------- 157 (423)
.++.++|||||||++|||++|..||.. ....+....+.......+......
T Consensus 205 --~~~~~~DiwslG~il~ell~g~~pf~~--~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 280 (351)
T 3mi9_A 205 --DYGPPIDLWGAGCIMAEMWTRSPIMQG--NTEQHQLALISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLK 280 (351)
T ss_dssp --SCCTHHHHHHHHHHHHHHHHSSCSCCC--SSHHHHHHHHHHHHCCCCTTTSTTGGGCGGGTSSCCCSSCCCCHHHHHH
T ss_pred --CCCcHhHHHHHHHHHHHHHhCCCCCCC--CChHHHHHHHHHHhCCCChhhccccccchhhcccccccccccCHHHHhh
Confidence 238999999999999999999999974 334444444432111111110000
Q ss_pred ---chHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q psy1840 158 ---CAPSIIACMRTCWEEDPELRPDLRFVHHK 186 (423)
Q Consensus 158 ---~~~~l~~Li~~C~~~dP~~RPt~~~I~~~ 186 (423)
.++.+.+|+.+||+.||.+|||+.++++.
T Consensus 281 ~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 312 (351)
T 3mi9_A 281 AYVRDPYALDLIDKLLVLDPAQRIDSDDALNH 312 (351)
T ss_dssp HHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred hccCChHHHHHHHHHhcCChhhCCCHHHHhCC
Confidence 25679999999999999999999999875
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=2.1e-26 Score=221.12 Aligned_cols=161 Identities=24% Similarity=0.396 Sum_probs=126.2
Q ss_pred HHHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCccEEEeccCCcccccCCCcc-cccccccCCccccCCccccCCC
Q psy1840 24 GSISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDET-GQERKLRRRKLYKAPELLRQPH 102 (423)
Q Consensus 24 ~~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~~-~~~~~~~gt~~y~APE~l~~~~ 102 (423)
..+.++.|++.||.|||+.|++ ||||||+||+++.++.+||+|||++......... .......++..|+|||.+.+..
T Consensus 127 ~~~~~~~~i~~~l~~lH~~~i~-H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~ 205 (302)
T 4e5w_A 127 QQLKYAVQICKGMDYLGSRQYV-HRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRDSPVFWYAPECLMQSK 205 (302)
T ss_dssp HHHHHHHHHHHHHHHHHHTTEE-CSCCSGGGEEEEETTEEEECCCTTCEECCTTCCEEECCCCTTCCGGGCCHHHHHHCE
T ss_pred HHHHHHHHHHHHHHHhhcCCcc-cCCCchheEEEcCCCCEEECcccccccccCCCcceeccCCCCCCccccCCeeecCCC
Confidence 3689999999999999999988 9999999999999999999999998765433221 2223456778899999998765
Q ss_pred CCCCCCccchHHHHHHHHHHHhCCCCCCCC-------------CCChHHHHHHHhcCCCCCCCCCCCCchHHHHHHHHHh
Q psy1840 103 LPRGTQKGDVYSFGLVLYEVIGRQGPWGHL-------------RMTDEEIITSVTQGSGLRPDTSSLDCAPSIIACMRTC 169 (423)
Q Consensus 103 ~~~~s~ksDVyS~Giil~elltg~~Pf~~~-------------~~~~~~i~~~i~~~~~~~p~~~~~~~~~~l~~Li~~C 169 (423)
+ +.++||||||+++|+|++|..|+... ......+...+..+... . .+..+++.+.+++.+|
T Consensus 206 ~---~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~-~~~~~~~~l~~li~~~ 279 (302)
T 4e5w_A 206 F---YIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVNTLKEGKRL--P-CPPNCPDEVYQLMRKC 279 (302)
T ss_dssp E---EHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHHHHHHHHHTTCCC--C-CCTTCCHHHHHHHHHT
T ss_pred C---CcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCHHHHHHHHhccCCC--C-CCCCCCHHHHHHHHHH
Confidence 5 78999999999999999998876321 11122333344333221 1 2236789999999999
Q ss_pred hhcCCCCCCCHHHHHHHHHHHh
Q psy1840 170 WEEDPELRPDLRFVHHKLKEMN 191 (423)
Q Consensus 170 ~~~dP~~RPt~~~I~~~L~~i~ 191 (423)
|+.||.+|||+.++++.|+.+.
T Consensus 280 l~~dp~~Rps~~~ll~~L~~ll 301 (302)
T 4e5w_A 280 WEFQPSNRTSFQNLIEGFEALL 301 (302)
T ss_dssp TCSSGGGSCCHHHHHHHHHHHH
T ss_pred cCCCCCCCCCHHHHHHHHHHHh
Confidence 9999999999999999998764
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=99.93 E-value=6.8e-26 Score=216.50 Aligned_cols=150 Identities=23% Similarity=0.351 Sum_probs=116.5
Q ss_pred HHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEE---cCCccEEEeccCCcccccCCCcccccccccCCccccCCccccCC
Q psy1840 25 SISVNTTASVGMIHLHDSEIISHGNLRSSNCLI---DSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKAPELLRQP 101 (423)
Q Consensus 25 ~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILl---d~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~ 101 (423)
...++.|++.||.|||+.|++ ||||||+||++ +.++.+||+|||++....... ......+++.|+|||.+.+.
T Consensus 126 ~~~i~~qi~~~L~~LH~~~iv-H~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~~t~~y~aPE~~~~~ 201 (285)
T 3is5_A 126 VAELMKQMMNALAYFHSQHVV-HKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDE---HSTNAAGTALYMAPEVFKRD 201 (285)
T ss_dssp HHHHHHHHHHHHHHHHHTTCC-CCCCSGGGEEESSSSTTCCEEECCCCCCCC-------------CTTGGGCCHHHHTTC
T ss_pred HHHHHHHHHHHHHHHHhCCEE-ECCCCHHHEEEecCCCCCCEEEEeeecceecCCcc---cCcCcccccCcCChHHhccC
Confidence 679999999999999999998 99999999999 556889999999987653322 12345688999999998643
Q ss_pred CCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCchHHHHHHHHHhhhcCCCCCCCHH
Q psy1840 102 HLPRGTQKGDVYSFGLVLYEVIGRQGPWGHLRMTDEEIITSVTQGSGLRPDTSSLDCAPSIIACMRTCWEEDPELRPDLR 181 (423)
Q Consensus 102 ~~~~~s~ksDVyS~Giil~elltg~~Pf~~~~~~~~~i~~~i~~~~~~~p~~~~~~~~~~l~~Li~~C~~~dP~~RPt~~ 181 (423)
.+.++||||||+++|||++|..||.. ....++...........+. ....+++.+.+++.+||+.||++|||+.
T Consensus 202 ----~~~~~Di~slG~il~~ll~g~~pf~~--~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~L~~dP~~Rps~~ 274 (285)
T 3is5_A 202 ----VTFKCDIWSAGVVMYFLLTGCLPFTG--TSLEEVQQKATYKEPNYAV-ECRPLTPQAVDLLKQMLTKDPERRPSAA 274 (285)
T ss_dssp ----CCHHHHHHHHHHHHHHHHHSSCSSCC--SSHHHHHHHHHHCCCCCCC---CCCCHHHHHHHHHHTCSCTTTSCCHH
T ss_pred ----CCcccCeehHHHHHHHHHhCCCCCCC--CCHHHHHhhhccCCccccc-ccCcCCHHHHHHHHHHccCChhhCcCHH
Confidence 38999999999999999999999974 3445555555543332222 2234789999999999999999999999
Q ss_pred HHHH
Q psy1840 182 FVHH 185 (423)
Q Consensus 182 ~I~~ 185 (423)
++++
T Consensus 275 e~l~ 278 (285)
T 3is5_A 275 QVLH 278 (285)
T ss_dssp HHHT
T ss_pred HHhc
Confidence 9875
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.93 E-value=6.2e-26 Score=223.03 Aligned_cols=155 Identities=21% Similarity=0.235 Sum_probs=120.0
Q ss_pred HHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCccEEEeccCCcccccCCCcccccccccCCccccCCccccCCCCC
Q psy1840 25 SISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKAPELLRQPHLP 104 (423)
Q Consensus 25 ~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~ 104 (423)
...++.|++.||.|||+.|++ ||||||+||+++.++.+||+|||+++....... ......+|+.|+|||.+.+..
T Consensus 114 ~~~~~~qi~~~l~~lH~~~iv-H~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~-- 188 (346)
T 1ua2_A 114 IKAYMLMTLQGLEYLHQHWIL-HRDLKPNNLLLDENGVLKLADFGLAKSFGSPNR--AYTHQVVTRWYRAPELLFGAR-- 188 (346)
T ss_dssp HHHHHHHHHHHHHHHHHTTCC-CCCCCGGGEEECTTCCEEECCCGGGSTTTSCCC--CCCCSCCCCTTCCHHHHTTCS--
T ss_pred HHHHHHHHHHHHHHHHHCCEE-CCCCCHHHEEEcCCCCEEEEecccceeccCCcc--cCCcccccccccCchHhhCCC--
Confidence 689999999999999999998 999999999999999999999999876543221 223457889999999987643
Q ss_pred CCCCccchHHHHHHHHHHHhCCCCCCCCCCChHHHHHHHhcC--CC---CCCC---------------CC----CCCchH
Q psy1840 105 RGTQKGDVYSFGLVLYEVIGRQGPWGHLRMTDEEIITSVTQG--SG---LRPD---------------TS----SLDCAP 160 (423)
Q Consensus 105 ~~s~ksDVyS~Giil~elltg~~Pf~~~~~~~~~i~~~i~~~--~~---~~p~---------------~~----~~~~~~ 160 (423)
.++.++|||||||++|||++|..||.+. +..+.+..+... .+ ..+. .+ ...++.
T Consensus 189 ~~~~~~DiwslG~il~ell~g~~~~~~~--~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (346)
T 1ua2_A 189 MYGVGVDMWAVGCILAELLLRVPFLPGD--SDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGD 266 (346)
T ss_dssp CCCHHHHHHHHHHHHHHHHHSSCSSCCS--SHHHHHHHHHHHHCCCCTTTSSSTTSSTTCCCCCCCCCCCHHHHCTTCCH
T ss_pred CCCchhhhHhHHHHHHHHHHCCCCCCCC--CHHHHHHHHHHHcCCCChhhhhhhccCcccccccccCCCChHHhhccCCH
Confidence 2388999999999999999999998743 334444443321 00 0000 00 134578
Q ss_pred HHHHHHHHhhhcCCCCCCCHHHHHHH
Q psy1840 161 SIIACMRTCWEEDPELRPDLRFVHHK 186 (423)
Q Consensus 161 ~l~~Li~~C~~~dP~~RPt~~~I~~~ 186 (423)
++.+++.+||+.||++|||+.++++.
T Consensus 267 ~~~~li~~~L~~dP~~Rpt~~ell~h 292 (346)
T 1ua2_A 267 DLLDLIQGLFLFNPCARITATQALKM 292 (346)
T ss_dssp HHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred HHHHHHHHHhccChhhCCCHHHHhcC
Confidence 99999999999999999999998764
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=2.4e-26 Score=235.23 Aligned_cols=153 Identities=22% Similarity=0.251 Sum_probs=112.9
Q ss_pred HHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCccEEEeccCCcccccCCCcccccccccCCccccCCccccCCCCC
Q psy1840 25 SISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKAPELLRQPHLP 104 (423)
Q Consensus 25 ~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~ 104 (423)
...++.||+.||+|||+.|++ ||||||+|||++.++.+||+|||+++...... ......||+.|+|||++.+..+
T Consensus 166 ~~~~~~qil~aL~~lH~~~ii-HrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~- 240 (464)
T 3ttj_A 166 MSYLLYQMLCGIKHLHSAGII-HRDLKPSNIVVKSDCTLKILDFGLARTAGTSF---MMTPYVVTRYYRAPEVILGMGY- 240 (464)
T ss_dssp HHHHHHHHHHHHHHHHHTTCC-CCCCCGGGEEECTTSCEEECCCCCC-----CC---CC----CCCTTCCHHHHTTCCC-
T ss_pred HHHHHHHHHHHHHHHHHCCcc-cCCCChHhEEEeCCCCEEEEEEEeeeecCCCc---ccCCCcccccccCHHHHcCCCC-
Confidence 568999999999999999998 99999999999999999999999987653221 2245678999999999988655
Q ss_pred CCCCccchHHHHHHHHHHHhCCCCCCCCCCChHHHHHHHhcC--CC-----------------CCCCCCCC---------
Q psy1840 105 RGTQKGDVYSFGLVLYEVIGRQGPWGHLRMTDEEIITSVTQG--SG-----------------LRPDTSSL--------- 156 (423)
Q Consensus 105 ~~s~ksDVyS~Giil~elltg~~Pf~~~~~~~~~i~~~i~~~--~~-----------------~~p~~~~~--------- 156 (423)
+.++|||||||++|||++|+.||.+. +..+.+..+... .+ ..|.....
T Consensus 241 --~~~~DiwSlG~il~ell~g~~pF~g~--~~~~~~~~i~~~lg~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 316 (464)
T 3ttj_A 241 --KENVDIWSVGCIMGEMVRHKILFPGR--DYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDS 316 (464)
T ss_dssp --CTTHHHHHHHHHHHHHHHSSCSSCCS--SHHHHHHHHHHHHCSCCHHHHTTSCHHHHHHHTTSCCCCCCCHHHHSCGG
T ss_pred --CHHHHHHHHHHHHHHHHhCCCCCCCC--CHHHHHHHHHHhcCCCCHHHHHHcchhhhhHhhcccccCCCChHHhCccc
Confidence 89999999999999999999999753 222222222210 00 00000000
Q ss_pred ----------CchHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q psy1840 157 ----------DCAPSIIACMRTCWEEDPELRPDLRFVHHK 186 (423)
Q Consensus 157 ----------~~~~~l~~Li~~C~~~dP~~RPt~~~I~~~ 186 (423)
..++++.+|+.+||+.||++|||+.++++.
T Consensus 317 ~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H 356 (464)
T 3ttj_A 317 LFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH 356 (464)
T ss_dssp GSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred ccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 015679999999999999999999998764
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=5.6e-26 Score=219.73 Aligned_cols=160 Identities=17% Similarity=0.240 Sum_probs=115.3
Q ss_pred HHHHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCccEEEeccCCcccccCCCcccccccccCCccccCCccccCCC
Q psy1840 23 IGSISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKAPELLRQPH 102 (423)
Q Consensus 23 ~~~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~ 102 (423)
.....++.|++.||.|||+.|++ ||||||+||++++ +.+||+|||++................|++.|+|||.+.+..
T Consensus 127 ~~~~~i~~qi~~aL~~LH~~~iv-H~dlkp~NIl~~~-~~~kL~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~ 204 (313)
T 3cek_A 127 WERKSYWKNMLEAVHTIHQHGIV-HSDLKPANFLIVD-GMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMS 204 (313)
T ss_dssp HHHHHHHHHHHHHHHHHHHTTCC-CCCCCGGGEEEET-TEEEECCCSSSCC--------------CCGGGCCHHHHTTCC
T ss_pred HHHHHHHHHHHHHHHHHHHCCce-ecCCCcccEEEEC-CeEEEeeccccccccCccccccccCCCCCCCcCCHHHHhhcc
Confidence 34689999999999999999998 9999999999975 899999999987654333222223456899999999987521
Q ss_pred --------CCCCCCccchHHHHHHHHHHHhCCCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCchHHHHHHHHHhhhcCC
Q psy1840 103 --------LPRGTQKGDVYSFGLVLYEVIGRQGPWGHLRMTDEEIITSVTQGSGLRPDTSSLDCAPSIIACMRTCWEEDP 174 (423)
Q Consensus 103 --------~~~~s~ksDVyS~Giil~elltg~~Pf~~~~~~~~~i~~~i~~~~~~~p~~~~~~~~~~l~~Li~~C~~~dP 174 (423)
....+.++||||||+++|||++|..||...... ......+..... ... ....++.++.+++.+||+.||
T Consensus 205 ~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~-~~~~~~~~~~~~-~~~-~~~~~~~~l~~li~~~l~~dp 281 (313)
T 3cek_A 205 SSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ-ISKLHAIIDPNH-EIE-FPDIPEKDLQDVLKCCLKRDP 281 (313)
T ss_dssp ----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSH-HHHHHHHHCTTS-CCC-CCCCSCHHHHHHHHHHTCSST
T ss_pred cccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHH-HHHHHHHHhccc-ccC-CcccchHHHHHHHHHHccCCc
Confidence 113488999999999999999999999754322 222333332211 111 123467899999999999999
Q ss_pred CCCCCHHHHHHHH
Q psy1840 175 ELRPDLRFVHHKL 187 (423)
Q Consensus 175 ~~RPt~~~I~~~L 187 (423)
.+||++.++++..
T Consensus 282 ~~Rps~~ell~h~ 294 (313)
T 3cek_A 282 KQRISIPELLAHP 294 (313)
T ss_dssp TTSCCHHHHHTSH
T ss_pred ccCcCHHHHhcCc
Confidence 9999999998753
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=99.93 E-value=4.8e-26 Score=225.79 Aligned_cols=156 Identities=20% Similarity=0.328 Sum_probs=124.8
Q ss_pred HHHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCccEEEeccCCcccccCCCcccccccccCCccccCCccccCCC-
Q psy1840 24 GSISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKAPELLRQPH- 102 (423)
Q Consensus 24 ~~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~- 102 (423)
....++.||+.||.|||+.|++ ||||||+||+++.++.+||+|||++....... ......||+.|+|||++.+..
T Consensus 201 ~~~~i~~qi~~~L~~LH~~gi~-H~Dlkp~NIl~~~~~~ikl~DfG~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~ 276 (365)
T 2y7j_A 201 ETRSIMRSLLEAVSFLHANNIV-HRDLKPENILLDDNMQIRLSDFGFSCHLEPGE---KLRELCGTPGYLAPEILKCSMD 276 (365)
T ss_dssp HHHHHHHHHHHHHHHHHHTTEE-CSCCSGGGEEECTTCCEEECCCTTCEECCTTC---CBCCCCSCGGGCCHHHHHHTTC
T ss_pred HHHHHHHHHHHHHHHHHhCCee-cCCCCHHHEEECCCCCEEEEecCcccccCCCc---ccccCCCCCCccChhhcccccc
Confidence 3679999999999999999988 99999999999999999999999987654322 123467899999999986431
Q ss_pred --CCCCCCccchHHHHHHHHHHHhCCCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCchHHHHHHHHHhhhcCCCCCCCH
Q psy1840 103 --LPRGTQKGDVYSFGLVLYEVIGRQGPWGHLRMTDEEIITSVTQGSGLRPDTSSLDCAPSIIACMRTCWEEDPELRPDL 180 (423)
Q Consensus 103 --~~~~s~ksDVyS~Giil~elltg~~Pf~~~~~~~~~i~~~i~~~~~~~p~~~~~~~~~~l~~Li~~C~~~dP~~RPt~ 180 (423)
...++.++|||||||++|||++|..||.. .........+..+....+......++..+.+++.+||+.||++|||+
T Consensus 277 ~~~~~~~~~~Di~slG~il~ell~g~~pf~~--~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~ 354 (365)
T 2y7j_A 277 ETHPGYGKEVDLWACGVILFTLLAGSPPFWH--RRQILMLRMIMEGQYQFSSPEWDDRSSTVKDLISRLLQVDPEARLTA 354 (365)
T ss_dssp TTSCCBCTTHHHHHHHHHHHHHHHSSCSSCC--SSHHHHHHHHHHTCCCCCHHHHSSSCHHHHHHHHHHSCSSTTTSCCH
T ss_pred ccCcCCCchhhHHhHHHHHHHHHHCCCCCCC--CCHHHHHHHHHhCCCCCCCcccccCCHHHHHHHHHHcCCChhHCcCH
Confidence 11348899999999999999999999974 34555666666554332221223578899999999999999999999
Q ss_pred HHHHH
Q psy1840 181 RFVHH 185 (423)
Q Consensus 181 ~~I~~ 185 (423)
.++++
T Consensus 355 ~ell~ 359 (365)
T 2y7j_A 355 EQALQ 359 (365)
T ss_dssp HHHHH
T ss_pred HHHhc
Confidence 99876
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=5.5e-26 Score=220.91 Aligned_cols=161 Identities=22% Similarity=0.336 Sum_probs=121.4
Q ss_pred HHHHHHHHHHHHHHHHhC---CCeeecCCCCCCEEEcCCccEEEeccCCcccccCCCcccccccccCCccccCCccccCC
Q psy1840 25 SISVNTTASVGMIHLHDS---EIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKAPELLRQP 101 (423)
Q Consensus 25 ~l~i~~qi~~gL~yLH~~---~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~ 101 (423)
...++.|++.||.|||+. |++ ||||||+||+++.++.+||+|||++........ .......||+.|+|||.+.+.
T Consensus 133 ~~~i~~~i~~~l~~lH~~~~~~iv-H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~ 210 (326)
T 3uim_A 133 RQRIALGSARGLAYLHDHCDPKII-HRDVKAANILLDEEFEAVVGDFGLAKLMDYKDT-HVTTAVRGTIGHIAPEYLSTG 210 (326)
T ss_dssp HHHHHHHHHHHHHHHHHSSSSCEE-CCCCSGGGEEECTTCCEEECCCSSCEECCSSSS-CEECCCCSCGGGCCHHHHHHS
T ss_pred HHHHHHHHHHHHHHHHhCCCCCeE-eCCCchhhEEECCCCCEEeccCccccccCcccc-cccccccCCcCccCHHHhccC
Confidence 689999999999999999 988 999999999999999999999999876543322 222345689999999999776
Q ss_pred CCCCCCCccchHHHHHHHHHHHhCCCCCCCC------CCChHHHHHHHhcCCCC----C---CCCCCCCchHHHHHHHHH
Q psy1840 102 HLPRGTQKGDVYSFGLVLYEVIGRQGPWGHL------RMTDEEIITSVTQGSGL----R---PDTSSLDCAPSIIACMRT 168 (423)
Q Consensus 102 ~~~~~s~ksDVyS~Giil~elltg~~Pf~~~------~~~~~~i~~~i~~~~~~----~---p~~~~~~~~~~l~~Li~~ 168 (423)
.+ +.++||||||+++|||++|..||... .....+........... . +.......+..+.+++.+
T Consensus 211 ~~---~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 287 (326)
T 3uim_A 211 KS---SEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALL 287 (326)
T ss_dssp EE---CHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTTTTSSCCSTTSSCTTCTTSCCHHHHHHHHHHHHH
T ss_pred CC---CccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHHHHhhchhhhhhcChhhccccCHHHHHHHHHHHHH
Confidence 55 89999999999999999999999521 11111111111111100 0 001112345789999999
Q ss_pred hhhcCCCCCCCHHHHHHHHHHH
Q psy1840 169 CWEEDPELRPDLRFVHHKLKEM 190 (423)
Q Consensus 169 C~~~dP~~RPt~~~I~~~L~~i 190 (423)
||+.||.+|||+.+|++.|+..
T Consensus 288 cl~~dP~~Rps~~ell~~L~~~ 309 (326)
T 3uim_A 288 CTQSSPMERPKMSEVVRMLEGD 309 (326)
T ss_dssp HTCSCGGGSCCHHHHHHHHHTS
T ss_pred HhCcCCccCCCHHHHHHHhcCc
Confidence 9999999999999999998753
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=2.6e-26 Score=223.02 Aligned_cols=163 Identities=25% Similarity=0.404 Sum_probs=126.3
Q ss_pred HHHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCccEEEeccCCcccccCCCcc-cccccccCCccccCCccccCCC
Q psy1840 24 GSISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDET-GQERKLRRRKLYKAPELLRQPH 102 (423)
Q Consensus 24 ~~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~~-~~~~~~~gt~~y~APE~l~~~~ 102 (423)
..+.++.|++.||.|||+.|++ ||||||+||+++.++.+||+|||++......... .......++..|+|||.+.+..
T Consensus 135 ~~~~i~~~l~~~l~~LH~~~iv-H~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~ 213 (318)
T 3lxp_A 135 QLLLFAQQICEGMAYLHAQHYI-HRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKEYK 213 (318)
T ss_dssp HHHHHHHHHHHHHHHHHHTTEE-CSCCSGGGEEECTTCCEEECCGGGCEECCTTCSEEEC---CCCCGGGCCHHHHHHCE
T ss_pred HHHHHHHHHHHHHHHHHhCCcc-CCCCchheEEEcCCCCEEECCccccccccccccccccccCCCCCceeeChHHhcCCC
Confidence 3689999999999999999988 9999999999999999999999998865433221 1223445778899999998765
Q ss_pred CCCCCCccchHHHHHHHHHHHhCCCCCCCCCC-------------ChHHHHHHHhcCCCCCCCCCCCCchHHHHHHHHHh
Q psy1840 103 LPRGTQKGDVYSFGLVLYEVIGRQGPWGHLRM-------------TDEEIITSVTQGSGLRPDTSSLDCAPSIIACMRTC 169 (423)
Q Consensus 103 ~~~~s~ksDVyS~Giil~elltg~~Pf~~~~~-------------~~~~i~~~i~~~~~~~p~~~~~~~~~~l~~Li~~C 169 (423)
+ +.++||||||+++|+|++|..||..... ....+...+..+. .+. ....+++++.+++.+|
T Consensus 214 ~---~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~-~~~~~~~~l~~li~~~ 287 (318)
T 3lxp_A 214 F---YYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELLERGE--RLP-RPDKCPAEVYHLMKNC 287 (318)
T ss_dssp E---EHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHHHHHHHHHHHTTC--CCC-CCTTCCHHHHHHHHHH
T ss_pred C---CcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchhHHHHHHHHhccc--CCC-CCccccHHHHHHHHHH
Confidence 5 7899999999999999999999863210 0012222333322 111 2346889999999999
Q ss_pred hhcCCCCCCCHHHHHHHHHHHhhh
Q psy1840 170 WEEDPELRPDLRFVHHKLKEMNAG 193 (423)
Q Consensus 170 ~~~dP~~RPt~~~I~~~L~~i~~~ 193 (423)
|+.||.+|||+.++++.|+.+...
T Consensus 288 l~~dP~~Rps~~ell~~L~~l~~~ 311 (318)
T 3lxp_A 288 WETEASFRPTFENLIPILKTVHEK 311 (318)
T ss_dssp TCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred cCCCcccCcCHHHHHHHHHHHHHh
Confidence 999999999999999999887654
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=99.93 E-value=1.7e-26 Score=227.73 Aligned_cols=150 Identities=19% Similarity=0.250 Sum_probs=116.1
Q ss_pred HHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcC-------------------------CccEEEeccCCcccccCCCc
Q psy1840 25 SISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDS-------------------------RWVLQIADFGLHAFKAGQDE 79 (423)
Q Consensus 25 ~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~-------------------------~~~vKL~DFGla~~~~~~~~ 79 (423)
...++.||+.||.|||+.|++ ||||||+|||++. ++.+||+|||++......
T Consensus 139 ~~~i~~qi~~aL~~LH~~~iv-HrDlkp~NIll~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~-- 215 (360)
T 3llt_A 139 IKLYCIEILKALNYLRKMSLT-HTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDY-- 215 (360)
T ss_dssp HHHHHHHHHHHHHHHHHTTEE-CSCCSGGGEEESCTTCCEEEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTSC--
T ss_pred HHHHHHHHHHHHHHHHHCCee-eCCCCcccEEEccccccccccchhcccccccccccccCCCCEEEEeccCceecCCC--
Confidence 678999999999999999988 9999999999975 789999999998764322
Q ss_pred ccccccccCCccccCCccccCCCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCChHHHHHHHhcCCCCCC--------
Q psy1840 80 TGQERKLRRRKLYKAPELLRQPHLPRGTQKGDVYSFGLVLYEVIGRQGPWGHLRMTDEEIITSVTQGSGLRP-------- 151 (423)
Q Consensus 80 ~~~~~~~~gt~~y~APE~l~~~~~~~~s~ksDVyS~Giil~elltg~~Pf~~~~~~~~~i~~~i~~~~~~~p-------- 151 (423)
.....||+.|+|||++.+..+ +.++|||||||++|||++|+.||... ...+....+.......|
T Consensus 216 ---~~~~~gt~~y~aPE~~~~~~~---~~~~DiwslG~il~ell~g~~pf~~~--~~~~~~~~~~~~~~~~p~~~~~~~~ 287 (360)
T 3llt_A 216 ---HGSIINTRQYRAPEVILNLGW---DVSSDMWSFGCVLAELYTGSLLFRTH--EHMEHLAMMESIIQPIPKNMLYEAT 287 (360)
T ss_dssp ---CCSCCSCGGGCCHHHHTTCCC---CTTHHHHHHHHHHHHHHHSSCSCCCS--SHHHHHHHHHHHTCCCCHHHHHHHT
T ss_pred ---CcCccCcccccCcHHHcCCCC---CCccchHHHHHHHHHHHHCCCCCCCC--cHHHHHHHHHHhcCCCCHHHHhhhh
Confidence 134578899999999987665 89999999999999999999999742 33344433332111111
Q ss_pred ------------------CCC----------------CCCchHHHHHHHHHhhhcCCCCCCCHHHHHH
Q psy1840 152 ------------------DTS----------------SLDCAPSIIACMRTCWEEDPELRPDLRFVHH 185 (423)
Q Consensus 152 ------------------~~~----------------~~~~~~~l~~Li~~C~~~dP~~RPt~~~I~~ 185 (423)
... ....++.+.+++.+||+.||.+|||+.++++
T Consensus 288 ~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~ 355 (360)
T 3llt_A 288 KTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHELFCDFLYSILQIDPTLRPSPAELLK 355 (360)
T ss_dssp TSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred hccCccccCcccceecCcccccchhhhhhhhhcccccccchHHHHHHHHHHHhcCChhhCCCHHHHhc
Confidence 000 0012367889999999999999999999875
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=5.2e-26 Score=233.62 Aligned_cols=153 Identities=22% Similarity=0.316 Sum_probs=127.3
Q ss_pred HHHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEE---cCCccEEEeccCCcccccCCCcccccccccCCccccCCccccC
Q psy1840 24 GSISVNTTASVGMIHLHDSEIISHGNLRSSNCLI---DSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKAPELLRQ 100 (423)
Q Consensus 24 ~~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILl---d~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~ 100 (423)
....++.||+.||.|||++|++ ||||||+||++ +.++.+||+|||++....... ......||+.|+|||++.+
T Consensus 127 ~~~~i~~qi~~~l~~lH~~~iv-H~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~ 202 (484)
T 3nyv_A 127 DAARIIRQVLSGITYMHKNKIV-HRDLKPENLLLESKSKDANIRIIDFGLSTHFEASK---KMKDKIGTAYYIAPEVLHG 202 (484)
T ss_dssp HHHHHHHHHHHHHHHHHHTTCC-CSCCCGGGEEESSSSTTCCEEECCTTHHHHBCCCC---SHHHHTTGGGTCCHHHHHT
T ss_pred HHHHHHHHHHHHHHHHHHCCee-eCCCCHHHEEEecCCCCCcEEEEeeeeeEEccccc---ccccCCCCccccCceeecC
Confidence 3678999999999999999998 99999999999 567899999999987654332 1234568999999999976
Q ss_pred CCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCchHHHHHHHHHhhhcCCCCCCCH
Q psy1840 101 PHLPRGTQKGDVYSFGLVLYEVIGRQGPWGHLRMTDEEIITSVTQGSGLRPDTSSLDCAPSIIACMRTCWEEDPELRPDL 180 (423)
Q Consensus 101 ~~~~~~s~ksDVyS~Giil~elltg~~Pf~~~~~~~~~i~~~i~~~~~~~p~~~~~~~~~~l~~Li~~C~~~dP~~RPt~ 180 (423)
. ++.++||||+||++|+|++|..||.. .+..++...+..+....+......+++++.+++.+||+.||.+|||+
T Consensus 203 ~----~~~~~DiwslG~il~~ll~g~~pf~~--~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~ 276 (484)
T 3nyv_A 203 T----YDEKCDVWSTGVILYILLSGCPPFNG--ANEYDILKKVEKGKYTFELPQWKKVSESAKDLIRKMLTYVPSMRISA 276 (484)
T ss_dssp C----CCTHHHHHHHHHHHHHHHHSSCSSCC--SSHHHHHHHHHHCCCCCCSGGGGGSCHHHHHHHHHHTCSSGGGSCCH
T ss_pred C----CCCcceeHHHHHHHHHHHHCCCCCCC--CCHHHHHHHHHcCCCCCCCcccccCCHHHHHHHHHHCCCChhHCcCH
Confidence 3 38999999999999999999999974 45677788887765443333334678999999999999999999999
Q ss_pred HHHHHH
Q psy1840 181 RFVHHK 186 (423)
Q Consensus 181 ~~I~~~ 186 (423)
.++++.
T Consensus 277 ~e~l~h 282 (484)
T 3nyv_A 277 RDALDH 282 (484)
T ss_dssp HHHHTS
T ss_pred HHHhhC
Confidence 999874
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.93 E-value=8e-26 Score=223.28 Aligned_cols=156 Identities=20% Similarity=0.284 Sum_probs=122.6
Q ss_pred HHHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCccEEEeccCCcccccCCCcccccccccCCccccCCccccCCCC
Q psy1840 24 GSISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKAPELLRQPHL 103 (423)
Q Consensus 24 ~~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~ 103 (423)
....++.||+.||.|||+.|++ ||||||+|||++.++.+||+|||+++...... ........||+.|+|||++.+...
T Consensus 160 ~~~~~~~qi~~aL~~LH~~~iv-H~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~ 237 (355)
T 1vzo_A 160 EVQIYVGEIVLALEHLHKLGII-YRDIKLENILLDSNGHVVLTDFGLSKEFVADE-TERAYDFCGTIEYMAPDIVRGGDS 237 (355)
T ss_dssp HHHHHHHHHHHHHHHHHHTTCC-CCCCCGGGEEECTTSCEEESCSSEEEECCGGG-GGGGCGGGSCCTTCCHHHHTTCC-
T ss_pred HHHHHHHHHHHHHHHHHHCCcc-cCCCCHHHEEECCCCcEEEeeCCCCeecccCC-CCcccCcccCcCccChhhhcCCCC
Confidence 3578899999999999999998 99999999999999999999999987543221 122234578999999999986432
Q ss_pred CCCCCccchHHHHHHHHHHHhCCCCCCCC--CCChHHHHHHHhcCCCCCCCCCCCCchHHHHHHHHHhhhcCCCCCC---
Q psy1840 104 PRGTQKGDVYSFGLVLYEVIGRQGPWGHL--RMTDEEIITSVTQGSGLRPDTSSLDCAPSIIACMRTCWEEDPELRP--- 178 (423)
Q Consensus 104 ~~~s~ksDVyS~Giil~elltg~~Pf~~~--~~~~~~i~~~i~~~~~~~p~~~~~~~~~~l~~Li~~C~~~dP~~RP--- 178 (423)
..+.++|||||||++|||++|..||... ......+...+.......| ..++..+.+++.+||+.||.+||
T Consensus 238 -~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~li~~~L~~dP~~R~~~~ 312 (355)
T 1vzo_A 238 -GHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYP----QEMSALAKDLIQRLLMKDPKKRLGCG 312 (355)
T ss_dssp ---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCCCCCC----TTSCHHHHHHHHHHTCSSGGGSTTSS
T ss_pred -CCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHHHHHHHhccCCCCC----cccCHHHHHHHHHHhhhCHHHhcCCC
Confidence 3478999999999999999999999643 2334555555554432222 35788999999999999999999
Q ss_pred --CHHHHHHH
Q psy1840 179 --DLRFVHHK 186 (423)
Q Consensus 179 --t~~~I~~~ 186 (423)
++.++++.
T Consensus 313 ~~s~~ell~h 322 (355)
T 1vzo_A 313 PRDADEIKEH 322 (355)
T ss_dssp TTTHHHHHTS
T ss_pred CCCHHHHHcC
Confidence 88888764
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.93 E-value=1e-25 Score=218.74 Aligned_cols=155 Identities=18% Similarity=0.311 Sum_probs=116.3
Q ss_pred HHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCccEEEeccCCcccccCCCcccccccccCCccccCCccccCCC--
Q psy1840 25 SISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKAPELLRQPH-- 102 (423)
Q Consensus 25 ~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~-- 102 (423)
...++.||+.||.|||+.|++ ||||||+||+++.++.+||+|||++....... .......+++.|+|||.+....
T Consensus 131 ~~~i~~qi~~~l~~lH~~~iv-H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~ 207 (326)
T 2x7f_A 131 IAYICREILRGLSHLHQHKVI-HRDIKGQNVLLTENAEVKLVDFGVSAQLDRTV--GRRNTFIGTPYWMAPEVIACDENP 207 (326)
T ss_dssp HHHHHHHHHHHHHHHHHTTCC-CCCCSGGGEEECTTCCEEECCCTTTC---------------CCGGGCCHHHHC-----
T ss_pred HHHHHHHHHHHHHHHHHCCcc-ccCCcHHHEEEcCCCCEEEeeCcCceecCcCc--cccccccCCccccChhhhcccccc
Confidence 578999999999999999998 99999999999999999999999987543221 1123456889999999987321
Q ss_pred CCCCCCccchHHHHHHHHHHHhCCCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCchHHHHHHHHHhhhcCCCCCCCHHH
Q psy1840 103 LPRGTQKGDVYSFGLVLYEVIGRQGPWGHLRMTDEEIITSVTQGSGLRPDTSSLDCAPSIIACMRTCWEEDPELRPDLRF 182 (423)
Q Consensus 103 ~~~~s~ksDVyS~Giil~elltg~~Pf~~~~~~~~~i~~~i~~~~~~~p~~~~~~~~~~l~~Li~~C~~~dP~~RPt~~~ 182 (423)
...++.++|||||||++|+|++|..||.. .........+..... +......++..+.+++.+||+.||.+||++.+
T Consensus 208 ~~~~~~~~Di~slG~il~~l~~g~~p~~~--~~~~~~~~~~~~~~~--~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ 283 (326)
T 2x7f_A 208 DATYDFKSDLWSLGITAIEMAEGAPPLCD--MHPMRALFLIPRNPA--PRLKSKKWSKKFQSFIESCLVKNHSQRPATEQ 283 (326)
T ss_dssp ---CCTTHHHHHHHHHHHHHHHSSCTTTT--SCHHHHHHHHHHSCC--CCCSCSCSCHHHHHHHHHHCCSSGGGSCCHHH
T ss_pred CcCCCccchHHHHHHHHHHHHhCCCCCCC--CcHHHHHHHhhcCcc--ccCCccccCHHHHHHHHHHhccChhhCCCHHH
Confidence 11348899999999999999999999964 334444444444322 22233467899999999999999999999999
Q ss_pred HHHH
Q psy1840 183 VHHK 186 (423)
Q Consensus 183 I~~~ 186 (423)
+++.
T Consensus 284 ll~h 287 (326)
T 2x7f_A 284 LMKH 287 (326)
T ss_dssp HHTS
T ss_pred HhhC
Confidence 9874
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=3.6e-26 Score=231.62 Aligned_cols=151 Identities=19% Similarity=0.295 Sum_probs=117.3
Q ss_pred HHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCcc--EEEeccCCcccccCCCcccccccccCCccccCCccccCCC
Q psy1840 25 SISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWV--LQIADFGLHAFKAGQDETGQERKLRRRKLYKAPELLRQPH 102 (423)
Q Consensus 25 ~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~~--vKL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~ 102 (423)
...++.||+.||.|||+.|++ ||||||+|||++.++. +||+|||++...... .....+|+.|+|||++.+..
T Consensus 202 ~~~i~~qi~~aL~~LH~~~iv-HrDlKp~NILl~~~~~~~vkL~DFG~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~ 275 (429)
T 3kvw_A 202 VRKFAHSILQCLDALHKNRII-HCDLKPENILLKQQGRSGIKVIDFGSSCYEHQR-----VYTYIQSRFYRAPEVILGAR 275 (429)
T ss_dssp HHHHHHHHHHHHHHHHHHTEE-CSCCSGGGEEESSTTSCCEEECCCTTCEETTCC-----CCSSCSCGGGCCHHHHHTBC
T ss_pred HHHHHHHHHHHHHHHHHCCee-cCCCCHHHeEEccCCCcceEEeecccceecCCc-----ccccCCCCCccChHHHhCCC
Confidence 678999999999999999988 9999999999999887 999999998654322 23457889999999998876
Q ss_pred CCCCCCccchHHHHHHHHHHHhCCCCCCCCCCChHHHHHHHhcCCCC--------------------C------------
Q psy1840 103 LPRGTQKGDVYSFGLVLYEVIGRQGPWGHLRMTDEEIITSVTQGSGL--------------------R------------ 150 (423)
Q Consensus 103 ~~~~s~ksDVyS~Giil~elltg~~Pf~~~~~~~~~i~~~i~~~~~~--------------------~------------ 150 (423)
+ +.++|||||||++|||++|..||... +..+.+..+...... .
T Consensus 276 ~---~~~~DiwSlG~il~elltG~~pf~~~--~~~~~l~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 350 (429)
T 3kvw_A 276 Y---GMPIDMWSLGCILAELLTGYPLLPGE--DEGDQLACMIELLGMPSQKLLDASKRAKNFVSSKGYPRYCTVTTLSDG 350 (429)
T ss_dssp C---CTHHHHHHHHHHHHHHHHSSCSSCCS--SHHHHHHHHHHHHCCCCHHHHHTBTTHHHHBCTTSCBTTSCEECCCC-
T ss_pred C---CchHHHHhHHHHHHHHHhCCCCCCCC--CHHHHHHHHHHHcCCCCHHHHHhhhhhhhccCCCCCcccccccccccc
Confidence 5 89999999999999999999999753 333333322210000 0
Q ss_pred ----------------CCC-------CCCCchHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q psy1840 151 ----------------PDT-------SSLDCAPSIIACMRTCWEEDPELRPDLRFVHHK 186 (423)
Q Consensus 151 ----------------p~~-------~~~~~~~~l~~Li~~C~~~dP~~RPt~~~I~~~ 186 (423)
+.. .....++.+.+|+.+||+.||++|||+.++++.
T Consensus 351 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~dli~~~L~~dP~~Rpta~e~L~H 409 (429)
T 3kvw_A 351 SVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEWDPAVRMTPGQALRH 409 (429)
T ss_dssp -CEECCEECTTCCEECSTTCSCHHHHTTTCCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred cccccccccchhhccCCccchhhHhhccccchHHHHHHHHHHCCCChhhCCCHHHHhCC
Confidence 000 011236789999999999999999999999863
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=99.93 E-value=1.1e-25 Score=240.49 Aligned_cols=144 Identities=22% Similarity=0.368 Sum_probs=123.6
Q ss_pred HHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCccEEEeccCCcccccCCCcccccccccCCccccCCccccCCCCC
Q psy1840 25 SISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKAPELLRQPHLP 104 (423)
Q Consensus 25 ~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~ 104 (423)
...++.||+.||+|||+.|++ ||||||+||||+.++.+||+|||+++...... .......||+.|+|||++.+..+
T Consensus 444 ~~~~~~qi~~aL~~LH~~gIi-HrDLKp~NILl~~~g~ikL~DFGla~~~~~~~--~~~~~~~GT~~Y~APE~l~~~~~- 519 (674)
T 3pfq_A 444 AVFYAAEIAIGLFFLQSKGII-YRDLKLDNVMLDSEGHIKIADFGMCKENIWDG--VTTKTFCGTPDYIAPEIIAYQPY- 519 (674)
T ss_dssp HHHHHHHHHHHHHHHHHTSEE-CCCCCSTTEEECSSSCEEECCCTTCEECCCTT--CCBCCCCSCSSSCCHHHHTCCCB-
T ss_pred HHHHHHHHHHHHHHHHhCCeE-eccCChhhEEEcCCCcEEEeecceeeccccCC--cccccccCCCcccCHhhhcCCCC-
Confidence 578999999999999999988 99999999999999999999999987533222 22345689999999999987765
Q ss_pred CCCCccchHHHHHHHHHHHhCCCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCchHHHHHHHHHhhhcCCCCCCCH
Q psy1840 105 RGTQKGDVYSFGLVLYEVIGRQGPWGHLRMTDEEIITSVTQGSGLRPDTSSLDCAPSIIACMRTCWEEDPELRPDL 180 (423)
Q Consensus 105 ~~s~ksDVyS~Giil~elltg~~Pf~~~~~~~~~i~~~i~~~~~~~p~~~~~~~~~~l~~Li~~C~~~dP~~RPt~ 180 (423)
+.++|||||||++|||++|+.||.+ .+..++...+.......| ..+++++.+|+++||+.||.+||++
T Consensus 520 --~~~~DvwSlGvilyelltG~~Pf~~--~~~~~~~~~i~~~~~~~p----~~~s~~~~~li~~lL~~dP~~R~~~ 587 (674)
T 3pfq_A 520 --GKSVDWWAFGVLLYEMLAGQAPFEG--EDEDELFQSIMEHNVAYP----KSMSKEAVAICKGLMTKHPGKRLGC 587 (674)
T ss_dssp --STHHHHHHHHHHHHHHHHSSCSSCC--SSHHHHHHHHHSSCCCCC----TTSCHHHHHHHHHHSCSSSTTCTTC
T ss_pred --CccceEechHHHHHHHHcCCCCCCC--CCHHHHHHHHHhCCCCCC----ccCCHHHHHHHHHHccCCHHHCCCC
Confidence 8999999999999999999999974 456778888887654444 2578999999999999999999987
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.93 E-value=1.9e-26 Score=224.67 Aligned_cols=163 Identities=22% Similarity=0.353 Sum_probs=126.0
Q ss_pred HHHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCccEEEeccCCcccccCCCcc-cccccccCCccccCCccccCCC
Q psy1840 24 GSISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDET-GQERKLRRRKLYKAPELLRQPH 102 (423)
Q Consensus 24 ~~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~~-~~~~~~~gt~~y~APE~l~~~~ 102 (423)
..+.++.||+.||.|||+.|++ ||||||+||+++.++.+||+|||++......... .......++..|+|||.+.+..
T Consensus 146 ~~~~i~~qi~~aL~~LH~~~iv-H~dikp~NIli~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~ 224 (326)
T 2w1i_A 146 KLLQYTSQICKGMEYLGTKRYI-HRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLTESK 224 (326)
T ss_dssp HHHHHHHHHHHHHHHHHHTTEE-CSCCCGGGEEEEETTEEEECCCTTCEECCSSCSEEECSSCCSCCGGGCCHHHHHHCE
T ss_pred HHHHHHHHHHHHHHHHHhCCEe-ccCCCcceEEEcCCCcEEEecCcchhhccccccccccccCCCCceeEECchhhcCCC
Confidence 3678999999999999999988 9999999999999999999999998765433221 1122345677799999998765
Q ss_pred CCCCCCccchHHHHHHHHHHHhCCCCCCCCC----------CC----hHHHHHHHhcCCCCCCCCCCCCchHHHHHHHHH
Q psy1840 103 LPRGTQKGDVYSFGLVLYEVIGRQGPWGHLR----------MT----DEEIITSVTQGSGLRPDTSSLDCAPSIIACMRT 168 (423)
Q Consensus 103 ~~~~s~ksDVyS~Giil~elltg~~Pf~~~~----------~~----~~~i~~~i~~~~~~~p~~~~~~~~~~l~~Li~~ 168 (423)
+ +.++||||||+++|||++|..||.... .. ...+...+..+.. +. ....+++++.+++.+
T Consensus 225 ~---~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~-~~~~~~~~l~~li~~ 298 (326)
T 2w1i_A 225 F---SVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGR--LP-RPDGCPDEIYMIMTE 298 (326)
T ss_dssp E---EHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHHHHHHHHHHTTCC--CC-CCTTCCHHHHHHHHH
T ss_pred C---CchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhhHHHHHHHhhcCCC--CC-CCCcccHHHHHHHHH
Confidence 5 889999999999999999998875210 00 0122233333221 11 124688999999999
Q ss_pred hhhcCCCCCCCHHHHHHHHHHHhhh
Q psy1840 169 CWEEDPELRPDLRFVHHKLKEMNAG 193 (423)
Q Consensus 169 C~~~dP~~RPt~~~I~~~L~~i~~~ 193 (423)
||+.||++|||+.+|++.|+.+...
T Consensus 299 cl~~dP~~Rps~~el~~~L~~l~~~ 323 (326)
T 2w1i_A 299 CWNNNVNQRPSFRDLALRVDQIRDQ 323 (326)
T ss_dssp HSCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HcCCChhhCcCHHHHHHHHHHHHHH
Confidence 9999999999999999999888654
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=99.93 E-value=1.1e-25 Score=231.02 Aligned_cols=151 Identities=22% Similarity=0.345 Sum_probs=126.3
Q ss_pred HHHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCccEEEeccCCcccccCCCcccccccccCCccccCCccccCCCC
Q psy1840 24 GSISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKAPELLRQPHL 103 (423)
Q Consensus 24 ~~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~ 103 (423)
....++.||+.||.|||+.|++ ||||||+||+++.++.+||+|||++....... ......||+.|+|||++.+..+
T Consensus 117 ~~~~i~~qi~~aL~~LH~~giv-HrDLkp~NIll~~~~~vkL~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~ 192 (476)
T 2y94_A 117 ESRRLFQQILSGVDYCHRHMVV-HRDLKPENVLLDAHMNAKIADFGLSNMMSDGE---FLRTSCGSPNYAAPEVISGRLY 192 (476)
T ss_dssp HHHHHHHHHHHHHHHHHTTTEE-CSCCSGGGEEECTTCCEEECCCSSCEECCTTC---CBCCCCSCSTTCCHHHHTTCCB
T ss_pred HHHHHHHHHHHHHHHHHHCCCC-cccccHHHEEEecCCCeEEEeccchhhccccc---cccccCCCcCeEChhhccCCCC
Confidence 3679999999999999999988 99999999999999999999999987654322 2234578999999999987642
Q ss_pred CCCCCccchHHHHHHHHHHHhCCCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCchHHHHHHHHHhhhcCCCCCCCHHHH
Q psy1840 104 PRGTQKGDVYSFGLVLYEVIGRQGPWGHLRMTDEEIITSVTQGSGLRPDTSSLDCAPSIIACMRTCWEEDPELRPDLRFV 183 (423)
Q Consensus 104 ~~~s~ksDVyS~Giil~elltg~~Pf~~~~~~~~~i~~~i~~~~~~~p~~~~~~~~~~l~~Li~~C~~~dP~~RPt~~~I 183 (423)
.+.++|||||||++|||++|..||.+. ...++...+..+....| ..+++++.+++.+||+.||.+|||+.+|
T Consensus 193 --~~~~~DiwSlGvil~elltG~~Pf~~~--~~~~~~~~i~~~~~~~p----~~~s~~~~~Li~~~L~~dP~~Rpt~~ei 264 (476)
T 2y94_A 193 --AGPEVDIWSSGVILYALLCGTLPFDDD--HVPTLFKKICDGIFYTP----QYLNPSVISLLKHMLQVDPMKRATIKDI 264 (476)
T ss_dssp --CSHHHHHHHHHHHHHHHHHSSCSSCCS--SSHHHHHHHHTTCCCCC----TTCCHHHHHHHHHHTCSSTTTSCCHHHH
T ss_pred --CCCcceehhhHHHHHHHhhCCCCCCCC--CHHHHHHHHhcCCcCCC----ccCCHHHHHHHHHHcCCCchhCcCHHHH
Confidence 268999999999999999999999743 34667777776644333 2478899999999999999999999999
Q ss_pred HHH
Q psy1840 184 HHK 186 (423)
Q Consensus 184 ~~~ 186 (423)
++.
T Consensus 265 l~h 267 (476)
T 2y94_A 265 REH 267 (476)
T ss_dssp HTC
T ss_pred HhC
Confidence 874
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=99.93 E-value=1.1e-25 Score=223.06 Aligned_cols=157 Identities=21% Similarity=0.268 Sum_probs=115.1
Q ss_pred HHHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCcc--EEEeccCCcccccCCCcccccccccCCccccCCccccCC
Q psy1840 24 GSISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWV--LQIADFGLHAFKAGQDETGQERKLRRRKLYKAPELLRQP 101 (423)
Q Consensus 24 ~~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~~--vKL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~ 101 (423)
....++.||+.||.|||++|++ ||||||+||+++.++. +||+|||+++..... .......||+.|+|||++.+.
T Consensus 117 ~~~~i~~ql~~~L~~LH~~~iv-H~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~ 192 (361)
T 3uc3_A 117 EARFFFQQLLSGVSYCHSMQIC-HRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH---SQPKSTVGTPAYIAPEVLLRQ 192 (361)
T ss_dssp HHHHHHHHHHHHHHHHHHTTCC-SCCCCGGGEEECSSSSCCEEECCCCCC------------------CTTSCHHHHHCS
T ss_pred HHHHHHHHHHHHHHHHHHCCcc-cCCCCHHHEEEcCCCCceEEEeecCcccccccc---CCCCCCcCCCCcCChhhhcCC
Confidence 3679999999999999999998 9999999999987765 999999998743221 122345689999999999876
Q ss_pred CCCCCCCccchHHHHHHHHHHHhCCCCCCCCC--CChHHHHHHHhcCCCCCCCCCCCCchHHHHHHHHHhhhcCCCCCCC
Q psy1840 102 HLPRGTQKGDVYSFGLVLYEVIGRQGPWGHLR--MTDEEIITSVTQGSGLRPDTSSLDCAPSIIACMRTCWEEDPELRPD 179 (423)
Q Consensus 102 ~~~~~s~ksDVyS~Giil~elltg~~Pf~~~~--~~~~~i~~~i~~~~~~~p~~~~~~~~~~l~~Li~~C~~~dP~~RPt 179 (423)
.+ .+.++|||||||++|+|++|+.||.... ......+..+.......|. ...+++++.+++.+||+.||.+|||
T Consensus 193 ~~--~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~s~~~~~li~~~L~~dP~~Rps 268 (361)
T 3uc3_A 193 EY--DGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKYSIPD--DIRISPECCHLISRIFVADPATRIS 268 (361)
T ss_dssp SC--CHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHHHHHHHHTTCCCCCT--TSCCCHHHHHHHHHHSCSCTTTSCC
T ss_pred CC--CCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhcCCCCCCC--cCCCCHHHHHHHHHHccCChhHCcC
Confidence 53 2345899999999999999999997532 2334555555554433332 2357899999999999999999999
Q ss_pred HHHHHHHHH
Q psy1840 180 LRFVHHKLK 188 (423)
Q Consensus 180 ~~~I~~~L~ 188 (423)
+.++++.-.
T Consensus 269 ~~ell~hp~ 277 (361)
T 3uc3_A 269 IPEIKTHSW 277 (361)
T ss_dssp HHHHHTSHH
T ss_pred HHHHHhCcc
Confidence 999987543
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.93 E-value=4.7e-26 Score=221.84 Aligned_cols=155 Identities=18% Similarity=0.186 Sum_probs=115.0
Q ss_pred HHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCccEEEeccCCcccccCCCcccccccccCCccccCCccccCCCCC
Q psy1840 25 SISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKAPELLRQPHLP 104 (423)
Q Consensus 25 ~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~ 104 (423)
...++.||+.||.|||+.|++ ||||||+||+++.++.+||+|||++....... .......+++.|+|||.+.+..
T Consensus 102 ~~~~~~qi~~aL~~LH~~~iv-H~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~--~~~~~~~~t~~y~aPE~~~~~~-- 176 (324)
T 3mtl_A 102 VKLFLFQLLRGLAYCHRQKVL-HRDLKPQNLLINERGELKLADFGLARAKSIPT--KTYDNEVVTLWYRPPDILLGST-- 176 (324)
T ss_dssp HHHHHHHHHHHHHHHHHTTEE-ESSCCGGGEEECTTCCEEECSSSEEECC--------------CGGGCCHHHHTTCC--
T ss_pred HHHHHHHHHHHHHHHHHCCcc-CCCcCHHHEEECCCCCEEEccCcccccccCCc--cccccccCcccccChhhhcCCC--
Confidence 578999999999999999988 99999999999999999999999987543222 1223446789999999987633
Q ss_pred CCCCccchHHHHHHHHHHHhCCCCCCCCCCChHHHHHHHhcCCCCC-----CC--------------C-------CCCCc
Q psy1840 105 RGTQKGDVYSFGLVLYEVIGRQGPWGHLRMTDEEIITSVTQGSGLR-----PD--------------T-------SSLDC 158 (423)
Q Consensus 105 ~~s~ksDVyS~Giil~elltg~~Pf~~~~~~~~~i~~~i~~~~~~~-----p~--------------~-------~~~~~ 158 (423)
.++.++|||||||++|+|++|..||.+. +..+....+....... +. . ....+
T Consensus 177 ~~~~~~DiwslG~il~~l~~g~~pf~~~--~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (324)
T 3mtl_A 177 DYSTQIDMWGVGCIFYEMATGRPLFPGS--TVEEQLHFIFRILGTPTEETWPGILSNEEFKTYNYPKYRAEALLSHAPRL 254 (324)
T ss_dssp CCCTHHHHHHHHHHHHHHHHSSCSCCCS--SHHHHHHHHHHHHCCCCTTTSTTGGGCHHHHHTCCCCCCCCCHHHHCTTS
T ss_pred CCCcHHHHHHHHHHHHHHHhCCCCCCCC--CHHHHHHHHHHHhCCCChHhchhhhcchhhcccccccccchhhhhhcCCC
Confidence 2489999999999999999999999743 3444444433210000 00 0 01246
Q ss_pred hHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q psy1840 159 APSIIACMRTCWEEDPELRPDLRFVHHK 186 (423)
Q Consensus 159 ~~~l~~Li~~C~~~dP~~RPt~~~I~~~ 186 (423)
++++.+++.+||+.||.+|||+.++++.
T Consensus 255 ~~~~~~li~~~L~~dP~~R~t~~e~l~h 282 (324)
T 3mtl_A 255 DSDGADLLTKLLQFEGRNRISAEDAMKH 282 (324)
T ss_dssp CHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred CHHHHHHHHHHcCcCcccCCCHHHHhcC
Confidence 7889999999999999999999999763
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=3e-26 Score=230.85 Aligned_cols=156 Identities=17% Similarity=0.185 Sum_probs=124.7
Q ss_pred HHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCccEEEeccCCcccccCCCcccccccccCCccccCCccccCCCC-
Q psy1840 25 SISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKAPELLRQPHL- 103 (423)
Q Consensus 25 ~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~- 103 (423)
...++.||+.||.|||+.|++ ||||||+|||++.++.+||+|||+++...... ........||+.|+|||++.+...
T Consensus 170 ~~~~~~qi~~aL~~LH~~giv-HrDLKp~NILl~~~g~ikL~DFG~a~~~~~~~-~~~~~~~~gt~~Y~APE~l~~~~~~ 247 (410)
T 3v8s_A 170 ARFYTAEVVLALDAIHSMGFI-HRDVKPDNMLLDKSGHLKLADFGTCMKMNKEG-MVRCDTAVGTPDYISPEVLKSQGGD 247 (410)
T ss_dssp HHHHHHHHHHHHHHHHHTTEE-CCCCSGGGEEECTTSCEEECCCTTCEECCTTS-EEECCSCCSCGGGCCHHHHHTTTTT
T ss_pred HHHHHHHHHHHHHHHHHCCeE-eccCCHHHeeECCCCCEEEeccceeEeeccCC-cccccCCcCCccccCHHHhhccCCC
Confidence 568899999999999999988 99999999999999999999999987654322 112345689999999999986541
Q ss_pred CCCCCccchHHHHHHHHHHHhCCCCCCCCCCChHHHHHHHhcCC--CCCCCCCCCCchHHHHHHHHHhhhcCCCC--CCC
Q psy1840 104 PRGTQKGDVYSFGLVLYEVIGRQGPWGHLRMTDEEIITSVTQGS--GLRPDTSSLDCAPSIIACMRTCWEEDPEL--RPD 179 (423)
Q Consensus 104 ~~~s~ksDVyS~Giil~elltg~~Pf~~~~~~~~~i~~~i~~~~--~~~p~~~~~~~~~~l~~Li~~C~~~dP~~--RPt 179 (423)
..++.++|||||||++|||++|+.||.. .+..+....+..+. ...|. ...+++++.+|+.+||..+|.+ ||+
T Consensus 248 ~~~~~~~DiwSlGvilyell~G~~Pf~~--~~~~~~~~~i~~~~~~~~~p~--~~~~s~~~~~li~~lL~~~~~rlgR~~ 323 (410)
T 3v8s_A 248 GYYGRECDWWSVGVFLYEMLVGDTPFYA--DSLVGTYSKIMNHKNSLTFPD--DNDISKEAKNLICAFLTDREVRLGRNG 323 (410)
T ss_dssp CEEETHHHHHHHHHHHHHHHHSSCTTCC--SSHHHHHHHHHTHHHHCCCCT--TCCCCHHHHHHHHHHSSCGGGCTTSSC
T ss_pred cCCCCcceEecchHHHHHHHhCCCCCCC--CChhhHHHHHHhccccccCCC--cccccHHHHHHHHHHccChhhhCCCCC
Confidence 1137899999999999999999999974 44566666665432 12222 2357899999999999988888 999
Q ss_pred HHHHHHH
Q psy1840 180 LRFVHHK 186 (423)
Q Consensus 180 ~~~I~~~ 186 (423)
+.+|+++
T Consensus 324 ~~ei~~H 330 (410)
T 3v8s_A 324 VEEIKRH 330 (410)
T ss_dssp HHHHHTS
T ss_pred HHHHhcC
Confidence 9998764
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=1.9e-26 Score=224.55 Aligned_cols=164 Identities=23% Similarity=0.368 Sum_probs=126.2
Q ss_pred HHHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCccEEEeccCCcccccCCCcc-cccccccCCccccCCccccCCC
Q psy1840 24 GSISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDET-GQERKLRRRKLYKAPELLRQPH 102 (423)
Q Consensus 24 ~~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~~-~~~~~~~gt~~y~APE~l~~~~ 102 (423)
..+.++.|++.||.|||+.|++ ||||||+||+++.++.+||+|||++......... .......++..|+|||.+.+..
T Consensus 128 ~~~~i~~qi~~al~~lH~~~iv-H~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~ 206 (327)
T 3lxl_A 128 RLLLYSSQICKGMEYLGSRRCV-HRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNI 206 (327)
T ss_dssp HHHHHHHHHHHHHHHHHHTTEE-CSCCSGGGEEEEETTEEEECCGGGCEECCTTCSEEECSSCCCSCGGGSCHHHHHHCE
T ss_pred HHHHHHHHHHHHHHHHHhCCcc-CCCCChhhEEECCCCCEEEcccccceecccCCccceeeccCCccccccCHHHhccCC
Confidence 3689999999999999999988 9999999999999999999999998865433221 1223446778899999998765
Q ss_pred CCCCCCccchHHHHHHHHHHHhCCCCCCCCC-------------CChHHHHHHHhcCCCCCCCCCCCCchHHHHHHHHHh
Q psy1840 103 LPRGTQKGDVYSFGLVLYEVIGRQGPWGHLR-------------MTDEEIITSVTQGSGLRPDTSSLDCAPSIIACMRTC 169 (423)
Q Consensus 103 ~~~~s~ksDVyS~Giil~elltg~~Pf~~~~-------------~~~~~i~~~i~~~~~~~p~~~~~~~~~~l~~Li~~C 169 (423)
+ +.++||||||+++|+|++|..||.... .....+...+..+.. +. ....+++.+.+++.+|
T Consensus 207 ~---~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~-~~~~~~~~l~~li~~~ 280 (327)
T 3lxl_A 207 F---SRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLLELLEEGQR--LP-APPACPAEVHELMKLC 280 (327)
T ss_dssp E---EHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CCHHHHHHHHHHTTCC--CC-CCTTCCHHHHHHHHHH
T ss_pred C---ChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccccccccHHHHHHHhhcccC--CC-CCCcccHHHHHHHHHH
Confidence 5 889999999999999999999985311 011223333333321 11 2346889999999999
Q ss_pred hhcCCCCCCCHHHHHHHHHHHhhhc
Q psy1840 170 WEEDPELRPDLRFVHHKLKEMNAGL 194 (423)
Q Consensus 170 ~~~dP~~RPt~~~I~~~L~~i~~~~ 194 (423)
|+.||++|||+.++++.|+.+..+.
T Consensus 281 l~~dP~~Rps~~ell~~L~~~~~~~ 305 (327)
T 3lxl_A 281 WAPSPQDRPSFSALGPQLDMLWSGS 305 (327)
T ss_dssp TCSSGGGSCCHHHHHHHHHHC----
T ss_pred cCCChhhCcCHHHHHHHHHHHHhhh
Confidence 9999999999999999998886644
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=6.4e-26 Score=222.14 Aligned_cols=150 Identities=21% Similarity=0.275 Sum_probs=116.1
Q ss_pred HHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEE-------------------cCCccEEEeccCCcccccCCCccccccc
Q psy1840 25 SISVNTTASVGMIHLHDSEIISHGNLRSSNCLI-------------------DSRWVLQIADFGLHAFKAGQDETGQERK 85 (423)
Q Consensus 25 ~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILl-------------------d~~~~vKL~DFGla~~~~~~~~~~~~~~ 85 (423)
...++.||+.||.|||++|++ ||||||+||++ +.++.+||+|||++...... ...
T Consensus 125 ~~~i~~qi~~~L~~lH~~~iv-H~Dlkp~NIll~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~-----~~~ 198 (355)
T 2eu9_A 125 VRHMAYQLCHALRFLHENQLT-HTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSATFDHEH-----HTT 198 (355)
T ss_dssp HHHHHHHHHHHHHHHHTTTEE-CCCCCGGGEEESCCCEEEEECCC-CCCEEEESCCCEEECCCTTCEETTSC-----CCS
T ss_pred HHHHHHHHHHHHHHHHHCCcc-cCCCCHHHEEEecccccccccccccccccccCCCcEEEeecCcccccccc-----ccC
Confidence 679999999999999999988 99999999999 67889999999998754322 134
Q ss_pred ccCCccccCCccccCCCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCChHHHHHHHhcCCCCCC--------------
Q psy1840 86 LRRRKLYKAPELLRQPHLPRGTQKGDVYSFGLVLYEVIGRQGPWGHLRMTDEEIITSVTQGSGLRP-------------- 151 (423)
Q Consensus 86 ~~gt~~y~APE~l~~~~~~~~s~ksDVyS~Giil~elltg~~Pf~~~~~~~~~i~~~i~~~~~~~p-------------- 151 (423)
..||+.|+|||++.+..+ +.++|||||||++|||++|..||... ...+....+.......|
T Consensus 199 ~~gt~~y~aPE~~~~~~~---~~~~Di~slG~il~el~~g~~pf~~~--~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~ 273 (355)
T 2eu9_A 199 IVATRHYRPPEVILELGW---AQPCDVWSIGCILFEYYRGFTLFQTH--ENREHLVMMEKILGPIPSHMIHRTRKQKYFY 273 (355)
T ss_dssp SCSCGGGCCHHHHTTCCC---CTHHHHHHHHHHHHHHHHSSCSCCCS--SHHHHHHHHHHHHCCCCHHHHHHCSCGGGEE
T ss_pred CcCCCcccCCeeeecCCC---CCccchHHHHHHHHHHHhCCCCCCCC--CHHHHHHHHHHHcCCCcHHHhhhccchhhhc
Confidence 578899999999987655 89999999999999999999999743 23333322221100000
Q ss_pred --------------------------CCCCCCchHHHHHHHHHhhhcCCCCCCCHHHHHH
Q psy1840 152 --------------------------DTSSLDCAPSIIACMRTCWEEDPELRPDLRFVHH 185 (423)
Q Consensus 152 --------------------------~~~~~~~~~~l~~Li~~C~~~dP~~RPt~~~I~~ 185 (423)
.......+.++.+++.+||+.||++|||+.++++
T Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~ 333 (355)
T 2eu9_A 274 KGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQRITLAEALL 333 (355)
T ss_dssp TTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred ccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence 0011223568999999999999999999999875
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=99.93 E-value=1.6e-25 Score=213.38 Aligned_cols=149 Identities=19% Similarity=0.239 Sum_probs=123.3
Q ss_pred HHHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCccEEEeccCCcccccCCCcccccccccCCccccCCccccCCCC
Q psy1840 24 GSISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKAPELLRQPHL 103 (423)
Q Consensus 24 ~~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~ 103 (423)
....++.|++.||.|||+.|++ ||||||+||+++.++.+||+|||++....... .....+++.|+|||.+.+..+
T Consensus 115 ~~~~~~~qi~~~l~~lH~~~i~-H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~ 189 (284)
T 2vgo_A 115 RSATFMEELADALHYCHERKVI-HRDIKPENLLMGYKGELKIADFGWSVHAPSLR----RRTMCGTLDYLPPEMIEGKTH 189 (284)
T ss_dssp HHHHHHHHHHHHHHHHHTTTEE-CCCCSGGGEEECTTCCEEECCCTTCEECSSSC----BCCCCSCGGGCCHHHHTTCCB
T ss_pred HHHHHHHHHHHHHHHHHHCCce-ecCCCHHHEEEcCCCCEEEecccccccCcccc----cccccCCCCcCCHHHhccCCC
Confidence 3679999999999999999988 99999999999999999999999986543221 234568899999999987655
Q ss_pred CCCCCccchHHHHHHHHHHHhCCCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCchHHHHHHHHHhhhcCCCCCCCHHHH
Q psy1840 104 PRGTQKGDVYSFGLVLYEVIGRQGPWGHLRMTDEEIITSVTQGSGLRPDTSSLDCAPSIIACMRTCWEEDPELRPDLRFV 183 (423)
Q Consensus 104 ~~~s~ksDVyS~Giil~elltg~~Pf~~~~~~~~~i~~~i~~~~~~~p~~~~~~~~~~l~~Li~~C~~~dP~~RPt~~~I 183 (423)
+.++||||||+++|+|++|..||.. ....+....+.......| ..++..+.+++.+||+.||.+||++.++
T Consensus 190 ---~~~~Di~slG~il~~l~~g~~pf~~--~~~~~~~~~~~~~~~~~~----~~~~~~~~~li~~~l~~~p~~Rps~~~l 260 (284)
T 2vgo_A 190 ---DEKVDLWCAGVLCYEFLVGMPPFDS--PSHTETHRRIVNVDLKFP----PFLSDGSKDLISKLLRYHPPQRLPLKGV 260 (284)
T ss_dssp ---CTTHHHHHHHHHHHHHHHSSCTTCC--SSHHHHHHHHHTTCCCCC----TTSCHHHHHHHHHHSCSSGGGSCCHHHH
T ss_pred ---CcccchhhHHHHHHHHHHCCCCCCC--CCHhHHHHHHhccccCCC----CcCCHHHHHHHHHHhhcCHhhCCCHHHH
Confidence 8899999999999999999999974 344555556655433222 3578899999999999999999999999
Q ss_pred HHH
Q psy1840 184 HHK 186 (423)
Q Consensus 184 ~~~ 186 (423)
++.
T Consensus 261 l~h 263 (284)
T 2vgo_A 261 MEH 263 (284)
T ss_dssp HTC
T ss_pred hhC
Confidence 763
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=2.9e-26 Score=218.74 Aligned_cols=155 Identities=20% Similarity=0.326 Sum_probs=118.7
Q ss_pred HHHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCcc--------EEEeccCCcccccCCCcccccccccCCccccCC
Q psy1840 24 GSISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWV--------LQIADFGLHAFKAGQDETGQERKLRRRKLYKAP 95 (423)
Q Consensus 24 ~~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~~--------vKL~DFGla~~~~~~~~~~~~~~~~gt~~y~AP 95 (423)
..+.++.||+.||.|||++|++ ||||||+||+++.++. +||+|||++...... ....++..|+||
T Consensus 114 ~~~~i~~qi~~~L~~LH~~~iv-H~Dlkp~NIll~~~~~~~~~~~~~~kl~Dfg~~~~~~~~------~~~~~~~~y~aP 186 (289)
T 4fvq_A 114 WKLEVAKQLAAAMHFLEENTLI-HGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPK------DILQERIPWVPP 186 (289)
T ss_dssp HHHHHHHHHHHHHHHHHHTTCC-CCCCCGGGEEEEECCBGGGTBCCEEEECCCCSCTTTSCH------HHHHHTTTTSCH
T ss_pred HHHHHHHHHHHHHHHHhhCCeE-CCCcCcceEEEecCCcccccccceeeeccCcccccccCc------cccCCcCcccCH
Confidence 3679999999999999999998 9999999999998887 999999998654221 233567789999
Q ss_pred ccccCCCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCchHHHHHHHHHhhhcCCC
Q psy1840 96 ELLRQPHLPRGTQKGDVYSFGLVLYEVIGRQGPWGHLRMTDEEIITSVTQGSGLRPDTSSLDCAPSIIACMRTCWEEDPE 175 (423)
Q Consensus 96 E~l~~~~~~~~s~ksDVyS~Giil~elltg~~Pf~~~~~~~~~i~~~i~~~~~~~p~~~~~~~~~~l~~Li~~C~~~dP~ 175 (423)
|.+.+.. .++.++||||||+++|||++|..|+.. ................. + ...++++.+++.+||+.||+
T Consensus 187 E~~~~~~--~~~~~~DiwslG~il~el~~g~~~~~~-~~~~~~~~~~~~~~~~~-~----~~~~~~l~~li~~~l~~dp~ 258 (289)
T 4fvq_A 187 ECIENPK--NLNLATDKWSFGTTLWEICSGGDKPLS-ALDSQRKLQFYEDRHQL-P----APKAAELANLINNCMDYEPD 258 (289)
T ss_dssp HHHHCGG--GCCHHHHHHHHHHHHHHHHTTTCCTTT-TSCHHHHHHHHHTTCCC-C----CCSSCTTHHHHHHHSCSSGG
T ss_pred HHhCCCC--CCCchhHHHHHHHHHHHHHcCCCCCcc-ccchHHHHHHhhccCCC-C----CCCCHHHHHHHHHHcCCChh
Confidence 9998622 238999999999999999996554432 22333333333332211 1 23467899999999999999
Q ss_pred CCCCHHHHHHHHHHHhhh
Q psy1840 176 LRPDLRFVHHKLKEMNAG 193 (423)
Q Consensus 176 ~RPt~~~I~~~L~~i~~~ 193 (423)
+|||+.++++.|+.+...
T Consensus 259 ~Rps~~~ll~~l~~l~~p 276 (289)
T 4fvq_A 259 HRPSFRAIIRDLNSLFTP 276 (289)
T ss_dssp GSCCHHHHHHHHHTCC--
T ss_pred HCcCHHHHHHHHHHhcCC
Confidence 999999999999887653
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=99.93 E-value=5.4e-26 Score=216.20 Aligned_cols=153 Identities=18% Similarity=0.243 Sum_probs=121.6
Q ss_pred HHHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCc----cEEEeccCCcccccCCCcccccccccCCccccCCcccc
Q psy1840 24 GSISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRW----VLQIADFGLHAFKAGQDETGQERKLRRRKLYKAPELLR 99 (423)
Q Consensus 24 ~~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~----~vKL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~ 99 (423)
....++.||+.||.|||+.|++ ||||||+||+++.++ .+||+|||++........ .....+++.|+|||.+.
T Consensus 109 ~~~~~~~~i~~~l~~lH~~~i~-H~dl~p~Nil~~~~~~~~~~~kl~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~ 184 (283)
T 3bhy_A 109 EATQFLKQILDGVHYLHSKRIA-HFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNE---FKNIFGTPEFVAPEIVN 184 (283)
T ss_dssp HHHHHHHHHHHHHHHHHHTTEE-CSCCSGGGEEESCSSSSSCCEEECCCTTCEECC-----------CCCGGGCCHHHHT
T ss_pred HHHHHHHHHHHHHHHHHhCCcc-CCCCChHHEEEecCCCCCCceEEEecccceeccCCCc---ccccCCCcCccCcceec
Confidence 3689999999999999999998 999999999998877 899999999876533221 23446888999999998
Q ss_pred CCCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCchHHHHHHHHHhhhcCCCCCCC
Q psy1840 100 QPHLPRGTQKGDVYSFGLVLYEVIGRQGPWGHLRMTDEEIITSVTQGSGLRPDTSSLDCAPSIIACMRTCWEEDPELRPD 179 (423)
Q Consensus 100 ~~~~~~~s~ksDVyS~Giil~elltg~~Pf~~~~~~~~~i~~~i~~~~~~~p~~~~~~~~~~l~~Li~~C~~~dP~~RPt 179 (423)
+..+ +.++||||||+++|+|++|..||.. ....+....+.......+......+++.+.+++.+||+.||++||+
T Consensus 185 ~~~~---~~~~Di~slG~il~~l~~g~~p~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps 259 (283)
T 3bhy_A 185 YEPL---GLEADMWSIGVITYILLSGASPFLG--ETKQETLTNISAVNYDFDEEYFSNTSELAKDFIRRLLVKDPKRRMT 259 (283)
T ss_dssp TCCC---CTHHHHHHHHHHHHHHHHSSCTTCC--SSHHHHHHHHHTTCCCCCHHHHTTCCHHHHHHHHTTSCSSGGGSCC
T ss_pred CCCC---CcchhhhhHHHHHHHHHHCCCCCCC--cchHHHHHHhHhcccCCcchhcccCCHHHHHHHHHHccCCHhHCcC
Confidence 7654 8999999999999999999999974 3455666666554333222222357889999999999999999999
Q ss_pred HHHHHH
Q psy1840 180 LRFVHH 185 (423)
Q Consensus 180 ~~~I~~ 185 (423)
+.++++
T Consensus 260 ~~~~l~ 265 (283)
T 3bhy_A 260 IAQSLE 265 (283)
T ss_dssp HHHHHH
T ss_pred HHHHHh
Confidence 999987
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=3e-26 Score=223.01 Aligned_cols=157 Identities=22% Similarity=0.368 Sum_probs=101.6
Q ss_pred HHHHHHHHHHHHHHHHhC-CCeeecCCCCCCEEEcCCccEEEeccCCcccccCCCcccccccccCCccccCCccccCCC-
Q psy1840 25 SISVNTTASVGMIHLHDS-EIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKAPELLRQPH- 102 (423)
Q Consensus 25 ~l~i~~qi~~gL~yLH~~-~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~- 102 (423)
...++.|++.||.|||+. |++ ||||||+||+++.++.+||+|||++....... ......|++.|+|||.+....
T Consensus 127 ~~~i~~~i~~~l~~lH~~~~iv-H~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~ 202 (327)
T 3aln_A 127 LGKITLATVKALNHLKENLKII-HRDIKPSNILLDRSGNIKLCDFGISGQLVDSI---AKTRDAGCRPYMAPERIDPSAS 202 (327)
T ss_dssp HHHHHHHHHHHHHHHHHHHSCC-CSCCCGGGEEEETTTEEEECCCSSSCC------------------------------
T ss_pred HHHHHHHHHHHHHHHhccCCEe-ECCCCHHHEEEcCCCCEEEccCCCceeccccc---ccccCCCCccccCceeeccccC
Confidence 679999999999999998 998 99999999999999999999999987653322 112346888999999984321
Q ss_pred CCCCCCccchHHHHHHHHHHHhCCCCCCCCCCChHHHHHHHhcCCC-CCCCCCCCCchHHHHHHHHHhhhcCCCCCCCHH
Q psy1840 103 LPRGTQKGDVYSFGLVLYEVIGRQGPWGHLRMTDEEIITSVTQGSG-LRPDTSSLDCAPSIIACMRTCWEEDPELRPDLR 181 (423)
Q Consensus 103 ~~~~s~ksDVyS~Giil~elltg~~Pf~~~~~~~~~i~~~i~~~~~-~~p~~~~~~~~~~l~~Li~~C~~~dP~~RPt~~ 181 (423)
...++.++||||||+++|+|++|+.||...... .+....+..+.. ..+......+++.+.+++.+||+.||++||++.
T Consensus 203 ~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ 281 (327)
T 3aln_A 203 RQGYDVRSDVWSLGITLYELATGRFPYPKWNSV-FDQLTQVVKGDPPQLSNSEEREFSPSFINFVNLCLTKDESKRPKYK 281 (327)
T ss_dssp ---CCSHHHHHHHHHHHHHHHHSCCCSSCC--------CCCCCSCCCCCCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHH
T ss_pred cCCCCchhhHHHHHHHHHHHHHCCCCCCCcchH-HHHHHHHhcCCCCCCCCcccccCCHHHHHHHHHHhhCChhhCcCHH
Confidence 112489999999999999999999999753211 111112222211 111112246889999999999999999999999
Q ss_pred HHHHH
Q psy1840 182 FVHHK 186 (423)
Q Consensus 182 ~I~~~ 186 (423)
+|++.
T Consensus 282 ell~h 286 (327)
T 3aln_A 282 ELLKH 286 (327)
T ss_dssp HHTTS
T ss_pred HHHhC
Confidence 99774
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=3.5e-26 Score=217.06 Aligned_cols=154 Identities=17% Similarity=0.321 Sum_probs=124.1
Q ss_pred HHHHHHHHHHHHHHHHHhCC-----CeeecCCCCCCEEEcCCccEEEeccCCcccccCCCcccccccccCCccccCCccc
Q psy1840 24 GSISVNTTASVGMIHLHDSE-----IISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKAPELL 98 (423)
Q Consensus 24 ~~l~i~~qi~~gL~yLH~~~-----ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l 98 (423)
..+.++.|++.||.|||+.+ ++ ||||||+||+++.++.+||+|||++........ ......+++.|+|||.+
T Consensus 112 ~~~~i~~~i~~~l~~lH~~~~~~~~iv-H~dl~p~NIl~~~~~~~kl~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~ 188 (279)
T 2w5a_A 112 FVLRVMTQLTLALKECHRRSDGGHTVL-HRDLKPANVFLDGKQNVKLGDFGLARILNHDTS--FAKTFVGTPYYMSPEQM 188 (279)
T ss_dssp HHHHHHHHHHHHHHHHHHHC------C-CCCCSGGGEEECSSSCEEECCCCHHHHC---CH--HHHHHHSCCTTCCHHHH
T ss_pred HHHHHHHHHHHHHHHHhcccCCCCeeE-EeccchhhEEEcCCCCEEEecCchheeeccccc--cccccCCCccccChHHh
Confidence 36899999999999999998 87 999999999999999999999999876532211 11234678899999999
Q ss_pred cCCCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCchHHHHHHHHHhhhcCCCCCC
Q psy1840 99 RQPHLPRGTQKGDVYSFGLVLYEVIGRQGPWGHLRMTDEEIITSVTQGSGLRPDTSSLDCAPSIIACMRTCWEEDPELRP 178 (423)
Q Consensus 99 ~~~~~~~~s~ksDVyS~Giil~elltg~~Pf~~~~~~~~~i~~~i~~~~~~~p~~~~~~~~~~l~~Li~~C~~~dP~~RP 178 (423)
.+..+ +.++||||||+++|+|++|..||.. ....++...+..+... . ....++.++.+++.+||+.||++||
T Consensus 189 ~~~~~---~~~~Di~slG~il~~l~~g~~p~~~--~~~~~~~~~i~~~~~~--~-~~~~~~~~l~~li~~~l~~~p~~Rp 260 (279)
T 2w5a_A 189 NRMSY---NEKSDIWSLGCLLYELCALMPPFTA--FSQKELAGKIREGKFR--R-IPYRYSDELNEIITRMLNLKDYHRP 260 (279)
T ss_dssp HCC-C---CHHHHHHHHHHHHHHHHHSSCSSCC--SSHHHHHHHHHHTCCC--C-CCTTSCHHHHHHHHHHTCSSGGGSC
T ss_pred ccCCC---CchhhHHHHHHHHHHHHHCCCCCcc--cCHHHHHHHHhhcccc--c-CCcccCHHHHHHHHHHcCCCcccCC
Confidence 87654 8999999999999999999999974 3456677777665432 1 1236789999999999999999999
Q ss_pred CHHHHHHHHH
Q psy1840 179 DLRFVHHKLK 188 (423)
Q Consensus 179 t~~~I~~~L~ 188 (423)
++.+|++.+.
T Consensus 261 s~~~ll~~~~ 270 (279)
T 2w5a_A 261 SVEEILENPL 270 (279)
T ss_dssp CHHHHHTSTT
T ss_pred CHHHHHhChh
Confidence 9999987543
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.93 E-value=1.7e-26 Score=224.09 Aligned_cols=150 Identities=22% Similarity=0.313 Sum_probs=115.6
Q ss_pred HHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCccEEEeccCCcccccCCCcc----------cccccccCCccccC
Q psy1840 25 SISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDET----------GQERKLRRRKLYKA 94 (423)
Q Consensus 25 ~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~~----------~~~~~~~gt~~y~A 94 (423)
.+.++.||+.||.|||++|++ ||||||+||+++.++.+||+|||+++........ .......||+.|+|
T Consensus 166 ~~~i~~qi~~aL~~LH~~~iv-H~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~a 244 (332)
T 3qd2_B 166 CLHIFIQIAEAVEFLHSKGLM-HRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMS 244 (332)
T ss_dssp HHHHHHHHHHHHHHHHHTTEE-CCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CGGGSC
T ss_pred HHHHHHHHHHHHHHHHhCCee-ecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCcCccC
Confidence 578999999999999999988 9999999999999999999999998765433211 11234568999999
Q ss_pred CccccCCCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCchHHHHHHHHHhhhcCC
Q psy1840 95 PELLRQPHLPRGTQKGDVYSFGLVLYEVIGRQGPWGHLRMTDEEIITSVTQGSGLRPDTSSLDCAPSIIACMRTCWEEDP 174 (423)
Q Consensus 95 PE~l~~~~~~~~s~ksDVyS~Giil~elltg~~Pf~~~~~~~~~i~~~i~~~~~~~p~~~~~~~~~~l~~Li~~C~~~dP 174 (423)
||.+.+..+ +.++|||||||++|||++|..|+. ........+.... .|. .....++.+.+++.+||+.||
T Consensus 245 PE~~~~~~~---~~~~Di~slG~il~el~~~~~~~~----~~~~~~~~~~~~~--~~~-~~~~~~~~~~~li~~~l~~~p 314 (332)
T 3qd2_B 245 PEQIHGNNY---SHKVDIFSLGLILFELLYSFSTQM----ERVRIITDVRNLK--FPL-LFTQKYPQEHMMVQDMLSPSP 314 (332)
T ss_dssp HHHHHCCCC---CTHHHHHHHHHHHHHHHSCCCCHH----HHHHHHHHHHTTC--CCH-HHHHHCHHHHHHHHHHHCSSG
T ss_pred hHHhcCCCC---cchhhHHHHHHHHHHHHHcCCChh----HHHHHHHHhhccC--CCc-ccccCChhHHHHHHHHccCCC
Confidence 999987655 899999999999999999877652 1223333333321 111 112356788999999999999
Q ss_pred CCCCCHHHHHH
Q psy1840 175 ELRPDLRFVHH 185 (423)
Q Consensus 175 ~~RPt~~~I~~ 185 (423)
++|||+.++++
T Consensus 315 ~~Rps~~~~l~ 325 (332)
T 3qd2_B 315 TERPEATDIIE 325 (332)
T ss_dssp GGSCCHHHHHH
T ss_pred CcCCCHHHHhh
Confidence 99999999876
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.93 E-value=9e-26 Score=221.24 Aligned_cols=144 Identities=17% Similarity=0.262 Sum_probs=117.2
Q ss_pred HHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCccEEEeccCCcccccCCCcccccccccCCccccCCccccCCCCC
Q psy1840 25 SISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKAPELLRQPHLP 104 (423)
Q Consensus 25 ~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~ 104 (423)
...++.||+.||.|||+.|++ ||||||+||+++.++.+||+|||++........ .....||+.|+|||.+.+..+
T Consensus 132 ~~~i~~qi~~~L~~LH~~~iv-H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~- 206 (335)
T 3dls_A 132 ASYIFRQLVSAVGYLRLKDII-HRDIKDENIVIAEDFTIKLIDFGSAAYLERGKL---FYTFCGTIEYCAPEVLMGNPY- 206 (335)
T ss_dssp HHHHHHHHHHHHHHHHHTTEE-CSCCSGGGEEECTTSCEEECCCTTCEECCTTCC---BCEECSCGGGCCHHHHTTCCB-
T ss_pred HHHHHHHHHHHHHHHHhCCeE-EeccCHHHEEEcCCCcEEEeecccceECCCCCc---eeccCCCccccChhhhcCCCC-
Confidence 678999999999999999988 999999999999999999999999876543221 234568999999999987542
Q ss_pred CCCCccchHHHHHHHHHHHhCCCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCchHHHHHHHHHhhhcCCCCCCCHHHHH
Q psy1840 105 RGTQKGDVYSFGLVLYEVIGRQGPWGHLRMTDEEIITSVTQGSGLRPDTSSLDCAPSIIACMRTCWEEDPELRPDLRFVH 184 (423)
Q Consensus 105 ~~s~ksDVyS~Giil~elltg~~Pf~~~~~~~~~i~~~i~~~~~~~p~~~~~~~~~~l~~Li~~C~~~dP~~RPt~~~I~ 184 (423)
.+.++|||||||++|||++|..||.... ....... ..+..+++++.+++.+||+.||++|||+.+++
T Consensus 207 -~~~~~DiwslG~il~el~~g~~pf~~~~--------~~~~~~~----~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell 273 (335)
T 3dls_A 207 -RGPELEMWSLGVTLYTLVFEENPFCELE--------ETVEAAI----HPPYLVSKELMSLVSGLLQPVPERRTTLEKLV 273 (335)
T ss_dssp -CSHHHHHHHHHHHHHHHHHSSCSCSSGG--------GGTTTCC----CCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred -CCCcccchhHHHHHHHHHhCCCchhhHH--------HHHhhcc----CCCcccCHHHHHHHHHHccCChhhCcCHHHHh
Confidence 3788999999999999999999996421 1111111 11234789999999999999999999999998
Q ss_pred HH
Q psy1840 185 HK 186 (423)
Q Consensus 185 ~~ 186 (423)
+.
T Consensus 274 ~h 275 (335)
T 3dls_A 274 TD 275 (335)
T ss_dssp HC
T ss_pred cC
Confidence 74
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=9.6e-26 Score=240.12 Aligned_cols=158 Identities=22% Similarity=0.454 Sum_probs=127.3
Q ss_pred HHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCccEEEeccCCcccccCCCcccccccccCCccccCCccccCCCCC
Q psy1840 25 SISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKAPELLRQPHLP 104 (423)
Q Consensus 25 ~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~ 104 (423)
.+.++.|++.||.|||++|++ ||||||+|||++.++.+||+|||+++........ ......+++.|+|||.+.+..+
T Consensus 493 ~~~i~~qi~~aL~~LH~~giv-HrDikp~NILl~~~~~vkL~DFG~a~~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~- 569 (656)
T 2j0j_A 493 LILYAYQLSTALAYLESKRFV-HRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYY-KASKGKLPIKWMAPESINFRRF- 569 (656)
T ss_dssp HHHHHHHHHHHHHHHHHTTCC-CSCCSGGGEEEEETTEEEECCCCCCCSCCC-----------CCGGGCCHHHHHHCCC-
T ss_pred HHHHHHHHHHHHHHHHhCCcc-ccccchHhEEEeCCCCEEEEecCCCeecCCCcce-eccCCCCCcceeCHHHhcCCCC-
Confidence 678999999999999999998 9999999999999999999999998765433211 1223456678999999977654
Q ss_pred CCCCccchHHHHHHHHHHHh-CCCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCchHHHHHHHHHhhhcCCCCCCCHHHH
Q psy1840 105 RGTQKGDVYSFGLVLYEVIG-RQGPWGHLRMTDEEIITSVTQGSGLRPDTSSLDCAPSIIACMRTCWEEDPELRPDLRFV 183 (423)
Q Consensus 105 ~~s~ksDVyS~Giil~ellt-g~~Pf~~~~~~~~~i~~~i~~~~~~~p~~~~~~~~~~l~~Li~~C~~~dP~~RPt~~~I 183 (423)
+.++|||||||++|||++ |..||.+ ....++...+..+.... . +..+++.+.+++.+||+.||++||++.+|
T Consensus 570 --~~~~DiwSlG~il~ellt~g~~Pf~~--~~~~~~~~~i~~~~~~~--~-~~~~~~~l~~li~~~l~~dP~~RPs~~el 642 (656)
T 2j0j_A 570 --TSASDVWMFGVCMWEILMHGVKPFQG--VKNNDVIGRIENGERLP--M-PPNCPPTLYSLMTKCWAYDPSRRPRFTEL 642 (656)
T ss_dssp --CHHHHHHHHHHHHHHHHTTSCCTTTT--CCHHHHHHHHHHTCCCC--C-CTTCCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred --CchhhHHHHHHHHHHHHHcCCCCCCC--CCHHHHHHHHHcCCCCC--C-CccccHHHHHHHHHHcCCChhHCcCHHHH
Confidence 899999999999999997 8999974 45567777776654322 1 23688999999999999999999999999
Q ss_pred HHHHHHHhh
Q psy1840 184 HHKLKEMNA 192 (423)
Q Consensus 184 ~~~L~~i~~ 192 (423)
++.|+.+..
T Consensus 643 ~~~L~~il~ 651 (656)
T 2j0j_A 643 KAQLSTILE 651 (656)
T ss_dssp HHHHHHHHH
T ss_pred HHHHHHHHH
Confidence 999988754
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=99.93 E-value=7.4e-26 Score=224.77 Aligned_cols=153 Identities=22% Similarity=0.241 Sum_probs=110.5
Q ss_pred HHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCccEEEeccCCcccccCCCcccccccccCCccccCCccccCCCCC
Q psy1840 25 SISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKAPELLRQPHLP 104 (423)
Q Consensus 25 ~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~ 104 (423)
...++.||+.||.|||++|++ ||||||+||+++.++.+||+|||+++...... ......||+.|+|||++.+..+
T Consensus 129 ~~~i~~qi~~al~~lH~~~iv-H~Dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~- 203 (371)
T 2xrw_A 129 MSYLLYQMLCGIKHLHSAGII-HRDLKPSNIVVKSDCTLKILDFGLARTAGTSF---MMTPYVVTRYYRAPEVILGMGY- 203 (371)
T ss_dssp HHHHHHHHHHHHHHHHHTTCC-CSCCCGGGEEECTTSCEEECCCCC-------------------CTTCCHHHHTTCCC-
T ss_pred HHHHHHHHHHHHHHHHHCCee-cccCCHHHEEEcCCCCEEEEEeeccccccccc---ccCCceecCCccCHHHhcCCCC-
Confidence 568999999999999999998 99999999999999999999999987543221 1234578899999999987654
Q ss_pred CCCCccchHHHHHHHHHHHhCCCCCCCCCCChHHHHHHHhcCCCC-------------------CCCCCC----------
Q psy1840 105 RGTQKGDVYSFGLVLYEVIGRQGPWGHLRMTDEEIITSVTQGSGL-------------------RPDTSS---------- 155 (423)
Q Consensus 105 ~~s~ksDVyS~Giil~elltg~~Pf~~~~~~~~~i~~~i~~~~~~-------------------~p~~~~---------- 155 (423)
+.++|||||||++|||++|..||.+. +..+....+...... .|....
T Consensus 204 --~~~~DiwslG~il~el~~g~~pf~~~--~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 279 (371)
T 2xrw_A 204 --KENVDIWSVGCIMGEMIKGGVLFPGT--DHIDQWNKVIEQLGTPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDV 279 (371)
T ss_dssp --CTTHHHHHHHHHHHHHHHSSCSSCCS--SHHHHHHHHHC-CCCCCHHHHTTSCHHHHHHHHSSCCCCCCCHHHHSCGG
T ss_pred --CchHhHHHHHHHHHHHHhCCCCCCCC--CHHHHHHHHHHHhCCCCHHHHHHhhhHHHHHHhhCccccccchhhhcccc
Confidence 89999999999999999999999743 333333333321110 010000
Q ss_pred ---------CCchHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q psy1840 156 ---------LDCAPSIIACMRTCWEEDPELRPDLRFVHHK 186 (423)
Q Consensus 156 ---------~~~~~~l~~Li~~C~~~dP~~RPt~~~I~~~ 186 (423)
...+.++.+|+.+||+.||.+|||+.++++.
T Consensus 280 ~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 319 (371)
T 2xrw_A 280 LFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH 319 (371)
T ss_dssp GSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred cCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCC
Confidence 0125689999999999999999999999874
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=99.93 E-value=1.2e-25 Score=218.12 Aligned_cols=153 Identities=21% Similarity=0.249 Sum_probs=120.4
Q ss_pred HHHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCccEEEeccCCcccccCCCcccccccccCCccccCCccccCCCC
Q psy1840 24 GSISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKAPELLRQPHL 103 (423)
Q Consensus 24 ~~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~ 103 (423)
....++.||+.||.|||+.|++ ||||||+||+++.++.+||+|||++....... ......++..|+|||.+.+..+
T Consensus 121 ~~~~~~~qi~~~l~~lH~~gi~-H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~ 196 (326)
T 1blx_A 121 TIKDMMFQLLRGLDFLHSHRVV-HRDLKPQNILVTSSGQIKLADFGLARIYSFQM---ALTSVVVTLWYRAPEVLLQSSY 196 (326)
T ss_dssp HHHHHHHHHHHHHHHHHHTTCC-CCCCCGGGEEECTTCCEEECSCCSCCCCCGGG---GGCCCCCCCTTCCHHHHTTCCC
T ss_pred HHHHHHHHHHHHHHHHHHCCce-eccCCHHHeEEcCCCCEEEecCcccccccCCC---CccccccccceeCHHHHhcCCC
Confidence 3678999999999999999998 99999999999999999999999987543221 2234568899999999987654
Q ss_pred CCCCCccchHHHHHHHHHHHhCCCCCCCCCCChHHHHHHHhcCCCC-----------------------CCCCCCCCchH
Q psy1840 104 PRGTQKGDVYSFGLVLYEVIGRQGPWGHLRMTDEEIITSVTQGSGL-----------------------RPDTSSLDCAP 160 (423)
Q Consensus 104 ~~~s~ksDVyS~Giil~elltg~~Pf~~~~~~~~~i~~~i~~~~~~-----------------------~p~~~~~~~~~ 160 (423)
+.++||||||+++|+|++|+.||... ...+.+..+...... ........++.
T Consensus 197 ---~~~~Di~slG~il~~l~~g~~pf~~~--~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 271 (326)
T 1blx_A 197 ---ATPVDLWSVGCIFAEMFRRKPLFRGS--SDVDQLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDE 271 (326)
T ss_dssp ---CTHHHHHHHHHHHHHHHHSSCSCCCS--SHHHHHHHHHHHHCCCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCH
T ss_pred ---CcchhHHHHHHHHHHHHcCCCCCCCC--CHHHHHHHHHHHcCCCCcccCccccccchhhhcccCcchhhhccccCCH
Confidence 89999999999999999999999743 333444333311000 00011235788
Q ss_pred HHHHHHHHhhhcCCCCCCCHHHHHH
Q psy1840 161 SIIACMRTCWEEDPELRPDLRFVHH 185 (423)
Q Consensus 161 ~l~~Li~~C~~~dP~~RPt~~~I~~ 185 (423)
.+.+++.+||+.||++||++.++++
T Consensus 272 ~~~~li~~~L~~dP~~Rpt~~e~l~ 296 (326)
T 1blx_A 272 LGKDLLLKCLTFNPAKRISAYSALS 296 (326)
T ss_dssp HHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred HHHHHHHHHcCCCcccCCCHHHHhc
Confidence 9999999999999999999999875
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=1.1e-25 Score=218.99 Aligned_cols=151 Identities=21% Similarity=0.243 Sum_probs=116.9
Q ss_pred HHHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcC-------------------CccEEEeccCCcccccCCCcccccc
Q psy1840 24 GSISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDS-------------------RWVLQIADFGLHAFKAGQDETGQER 84 (423)
Q Consensus 24 ~~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~-------------------~~~vKL~DFGla~~~~~~~~~~~~~ 84 (423)
....++.||+.||.|||++|++ ||||||+||+++. ++.+||+|||++...... ..
T Consensus 119 ~~~~~~~qi~~~l~~lH~~~iv-H~Dlkp~Nil~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~-----~~ 192 (339)
T 1z57_A 119 HIRKMAYQICKSVNFLHSNKLT-HTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSATYDDEH-----HS 192 (339)
T ss_dssp HHHHHHHHHHHHHHHHHHTTEE-CCCCCGGGEEESCCCEEEEEC----CEEEEESCCCEEECCCSSCEETTSC-----CC
T ss_pred HHHHHHHHHHHHHHHHHHCCCc-CCCCCHHHEEEeccccccccCCccccccccccCCCceEeeCcccccCccc-----cc
Confidence 3679999999999999999988 9999999999987 678999999998764322 13
Q ss_pred cccCCccccCCccccCCCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCChHHHHHHHhcCCCCCC-------------
Q psy1840 85 KLRRRKLYKAPELLRQPHLPRGTQKGDVYSFGLVLYEVIGRQGPWGHLRMTDEEIITSVTQGSGLRP------------- 151 (423)
Q Consensus 85 ~~~gt~~y~APE~l~~~~~~~~s~ksDVyS~Giil~elltg~~Pf~~~~~~~~~i~~~i~~~~~~~p------------- 151 (423)
...||+.|+|||++.+..+ +.++|||||||++|||++|..||... +..+....+.......|
T Consensus 193 ~~~gt~~y~aPE~~~~~~~---~~~~Di~slG~il~el~~g~~pf~~~--~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~ 267 (339)
T 1z57_A 193 TLVSTRHYRAPEVILALGW---SQPCDVWSIGCILIEYYLGFTVFPTH--DSKEHLAMMERILGPLPKHMIQKTRKRKYF 267 (339)
T ss_dssp SSCSCGGGCCHHHHTTSCC---CTHHHHHHHHHHHHHHHHSSCSCCCS--CHHHHHHHHHHHHCSCCHHHHHHCSCGGGE
T ss_pred cccCCccccChHHhhCCCC---CcchhhHHHHHHHHHHHhCCCCCCCC--ChHHHHHHHHHHhCCCCHHHHhhccchhHH
Confidence 4578899999999987655 89999999999999999999999743 33333332221100000
Q ss_pred ---------------------------CCCCCCchHHHHHHHHHhhhcCCCCCCCHHHHHH
Q psy1840 152 ---------------------------DTSSLDCAPSIIACMRTCWEEDPELRPDLRFVHH 185 (423)
Q Consensus 152 ---------------------------~~~~~~~~~~l~~Li~~C~~~dP~~RPt~~~I~~ 185 (423)
.......++++.+++.+||+.||.+|||+.++++
T Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~ 328 (339)
T 1z57_A 268 HHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKRITLREALK 328 (339)
T ss_dssp ETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred hhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCcccccCHHHHhc
Confidence 0111234678999999999999999999999875
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=99.93 E-value=5.8e-26 Score=229.42 Aligned_cols=157 Identities=20% Similarity=0.259 Sum_probs=114.8
Q ss_pred HHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCC---ccEEEeccCCcccccCCCcccccccccCCccccCCccccCC
Q psy1840 25 SISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSR---WVLQIADFGLHAFKAGQDETGQERKLRRRKLYKAPELLRQP 101 (423)
Q Consensus 25 ~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~---~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~ 101 (423)
...++.|++.||.|||++|++ ||||||+|||++.+ +.+||+|||+++..... .......||+.|+|||++.+.
T Consensus 241 ~~~i~~qi~~~l~~LH~~~iv-HrDlkp~NIll~~~~~~~~~kl~DFG~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~ 316 (419)
T 3i6u_A 241 CKLYFYQMLLAVQYLHENGII-HRDLKPENVLLSSQEEDCLIKITDFGHSKILGET---SLMRTLCGTPTYLAPEVLVSV 316 (419)
T ss_dssp HHHHHHHHHHHHHHHHHTTCC-CSCCCGGGEEESSSSSSCCEEECCSSTTTSCC--------------CTTCCTTTTC--
T ss_pred HHHHHHHHHHHHHHHHHCCcc-ccCCChHhEEEecCCCcceEEEeecccceecCCC---ccccccCCCCCccCceeeecC
Confidence 678999999999999999998 99999999999754 45999999998865422 122356789999999998653
Q ss_pred CCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCchHHHHHHHHHhhhcCCCCCCCHH
Q psy1840 102 HLPRGTQKGDVYSFGLVLYEVIGRQGPWGHLRMTDEEIITSVTQGSGLRPDTSSLDCAPSIIACMRTCWEEDPELRPDLR 181 (423)
Q Consensus 102 ~~~~~s~ksDVyS~Giil~elltg~~Pf~~~~~~~~~i~~~i~~~~~~~p~~~~~~~~~~l~~Li~~C~~~dP~~RPt~~ 181 (423)
....++.++|||||||++|+|++|..||..... ...+...+..+....+......+++.+.+++.+||+.||++||++.
T Consensus 317 ~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~-~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ 395 (419)
T 3i6u_A 317 GTAGYNRAVDCWSLGVILFICLSGYPPFSEHRT-QVSLKDQITSGKYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTE 395 (419)
T ss_dssp --CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSS-SCCHHHHHHTTCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHH
T ss_pred CCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcc-hHHHHHHHhcCCCCCCchhhcccCHHHHHHHHHHccCChhHCcCHH
Confidence 222347899999999999999999999975322 2234444444433222222245789999999999999999999999
Q ss_pred HHHHH
Q psy1840 182 FVHHK 186 (423)
Q Consensus 182 ~I~~~ 186 (423)
++++.
T Consensus 396 e~l~h 400 (419)
T 3i6u_A 396 EALRH 400 (419)
T ss_dssp HHHHS
T ss_pred HHhCC
Confidence 98764
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=99.93 E-value=1.6e-25 Score=231.40 Aligned_cols=154 Identities=22% Similarity=0.347 Sum_probs=127.9
Q ss_pred HHHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCc---cEEEeccCCcccccCCCcccccccccCCccccCCccccC
Q psy1840 24 GSISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRW---VLQIADFGLHAFKAGQDETGQERKLRRRKLYKAPELLRQ 100 (423)
Q Consensus 24 ~~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~---~vKL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~ 100 (423)
....++.||+.||.|||+.|++ ||||||+||+++.++ .+||+|||++....... ......||+.|+|||++.+
T Consensus 147 ~~~~i~~qi~~~l~~lH~~~iv-H~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~ 222 (504)
T 3q5i_A 147 DAANIMKQILSGICYLHKHNIV-HRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDY---KLRDRLGTAYYIAPEVLKK 222 (504)
T ss_dssp HHHHHHHHHHHHHHHHHHTTEE-CSCCSGGGEEESSTTCCSSEEECCCTTCEECCTTS---CBCCCCSCTTTCCHHHHTT
T ss_pred HHHHHHHHHHHHHHHHHHCCeE-eCCCcHHHEEEecCCCCccEEEEECCCCEEcCCCC---ccccccCCcCCCCHHHhcc
Confidence 3679999999999999999988 999999999998775 69999999987654322 2234578999999999875
Q ss_pred CCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCchHHHHHHHHHhhhcCCCCCCCH
Q psy1840 101 PHLPRGTQKGDVYSFGLVLYEVIGRQGPWGHLRMTDEEIITSVTQGSGLRPDTSSLDCAPSIIACMRTCWEEDPELRPDL 180 (423)
Q Consensus 101 ~~~~~~s~ksDVyS~Giil~elltg~~Pf~~~~~~~~~i~~~i~~~~~~~p~~~~~~~~~~l~~Li~~C~~~dP~~RPt~ 180 (423)
. + +.++||||+||++|+|++|..||.+ .+..+++..+..+....+......+++++.+++.+||+.||.+|||+
T Consensus 223 ~-~---~~~~DiwslG~il~~ll~g~~pf~~--~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~ 296 (504)
T 3q5i_A 223 K-Y---NEKCDVWSCGVIMYILLCGYPPFGG--QNDQDIIKKVEKGKYYFDFNDWKNISDEAKELIKLMLTYDYNKRCTA 296 (504)
T ss_dssp C-B---CTHHHHHHHHHHHHHHHHSSCSSCC--SSHHHHHHHHHHCCCCCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCH
T ss_pred C-C---CchHHHHHHHHHHHHHHhCCCCCCC--CCHHHHHHHHHcCCCCCCccccCCCCHHHHHHHHHHcCCChhHCCCH
Confidence 3 3 8999999999999999999999974 45677888888765443322234678999999999999999999999
Q ss_pred HHHHHHH
Q psy1840 181 RFVHHKL 187 (423)
Q Consensus 181 ~~I~~~L 187 (423)
.++++.-
T Consensus 297 ~e~l~h~ 303 (504)
T 3q5i_A 297 EEALNSR 303 (504)
T ss_dssp HHHHTSH
T ss_pred HHHhcCH
Confidence 9998753
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.93 E-value=1.5e-25 Score=222.45 Aligned_cols=152 Identities=19% Similarity=0.225 Sum_probs=118.1
Q ss_pred HHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCccEEEeccCCcccccCCCcccccccccCCccccCCccccCCCCC
Q psy1840 25 SISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKAPELLRQPHLP 104 (423)
Q Consensus 25 ~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~ 104 (423)
...++.||+.||.|||+.|++ ||||||+||+++.++.+||+|||+++..... .....+|+.|+|||++.+..
T Consensus 130 ~~~~~~qi~~~L~~LH~~~iv-H~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~-- 201 (367)
T 1cm8_A 130 IQFLVYQMLKGLRYIHAAGII-HRDLKPGNLAVNEDCELKILDFGLARQADSE-----MTGYVVTRWYRAPEVILNWM-- 201 (367)
T ss_dssp HHHHHHHHHHHHHHHHHTTEE-CCCCCGGGEEECTTCCEEECCCTTCEECCSS-----CCSSCSCGGGCCTHHHHTTT--
T ss_pred HHHHHHHHHHHHHHHHHCCcc-ccCcCHHHEEEcCCCCEEEEeeecccccccc-----cCcCcCCCCcCCHHHHhCCC--
Confidence 568999999999999999988 9999999999999999999999998764322 23457889999999987632
Q ss_pred CCCCccchHHHHHHHHHHHhCCCCCCCCCCChHHHHHHHhcCC-----------------------CCCCC----CCCCC
Q psy1840 105 RGTQKGDVYSFGLVLYEVIGRQGPWGHLRMTDEEIITSVTQGS-----------------------GLRPD----TSSLD 157 (423)
Q Consensus 105 ~~s~ksDVyS~Giil~elltg~~Pf~~~~~~~~~i~~~i~~~~-----------------------~~~p~----~~~~~ 157 (423)
.++.++||||+||++|||++|+.||.+. +..+.+..+.... +..+. .....
T Consensus 202 ~~~~~~DiwslG~il~ell~g~~pf~~~--~~~~~l~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 279 (367)
T 1cm8_A 202 RYTQTVDIWSVGCIMAEMITGKTLFKGS--DHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTN 279 (367)
T ss_dssp CCCTTHHHHHHHHHHHHHHHSSCSSCCS--SHHHHHHHHHHHHCCCCHHHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTT
T ss_pred CCChhhhHHHHHHHHHHHHhCCCCCCCC--CHHHHHHHHHHhcCCCCHHHHHHhhhHHHHHHHHhCCCCCCCCHHHHCCC
Confidence 2489999999999999999999999753 2222222222100 00000 01135
Q ss_pred chHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q psy1840 158 CAPSIIACMRTCWEEDPELRPDLRFVHHK 186 (423)
Q Consensus 158 ~~~~l~~Li~~C~~~dP~~RPt~~~I~~~ 186 (423)
+++.+.+|+.+||..||.+|||+.++++.
T Consensus 280 ~~~~~~~ll~~mL~~dP~~R~t~~e~l~h 308 (367)
T 1cm8_A 280 ASPLAVNLLEKMLVLDAEQRVTAGEALAH 308 (367)
T ss_dssp CCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred CCHHHHHHHHHHccCChhHCCCHHHHhcC
Confidence 68899999999999999999999998763
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=99.93 E-value=1.9e-25 Score=213.54 Aligned_cols=149 Identities=22% Similarity=0.371 Sum_probs=120.4
Q ss_pred HHHHHHHHHHHHHHHHhCC--CeeecCCCCCCEEEc-CCccEEEeccCCcccccCCCcccccccccCCccccCCccccCC
Q psy1840 25 SISVNTTASVGMIHLHDSE--IISHGNLRSSNCLID-SRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKAPELLRQP 101 (423)
Q Consensus 25 ~l~i~~qi~~gL~yLH~~~--ii~HrDLkp~NILld-~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~ 101 (423)
...++.||+.||.|||+.+ ++ ||||||+||+++ .++.+||+|||++....... .....+++.|+|||.+.+.
T Consensus 131 ~~~~~~qi~~~l~~lH~~~~~i~-H~dikp~Nil~~~~~~~~kl~Dfg~~~~~~~~~----~~~~~~t~~y~aPE~~~~~ 205 (290)
T 1t4h_A 131 LRSWCRQILKGLQFLHTRTPPII-HRDLKCDNIFITGPTGSVKIGDLGLATLKRASF----AKAVIGTPEFMAPEMYEEK 205 (290)
T ss_dssp HHHHHHHHHHHHHHHHTSSSCCC-CSCCCGGGEEESSTTSCEEECCTTGGGGCCTTS----BEESCSSCCCCCGGGGGTC
T ss_pred HHHHHHHHHHHHHHHHcCCCCEE-ECCCCHHHEEEECCCCCEEEeeCCCcccccccc----cccccCCcCcCCHHHHhcc
Confidence 6789999999999999998 88 999999999998 78999999999986543221 2345688999999988753
Q ss_pred CCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCchHHHHHHHHHhhhcCCCCCCCHH
Q psy1840 102 HLPRGTQKGDVYSFGLVLYEVIGRQGPWGHLRMTDEEIITSVTQGSGLRPDTSSLDCAPSIIACMRTCWEEDPELRPDLR 181 (423)
Q Consensus 102 ~~~~~s~ksDVyS~Giil~elltg~~Pf~~~~~~~~~i~~~i~~~~~~~p~~~~~~~~~~l~~Li~~C~~~dP~~RPt~~ 181 (423)
++.++||||||+++|+|++|..||... .....+...+..+. .+.......++++.+++.+||+.||.+|||+.
T Consensus 206 ----~~~~~Di~slG~~l~~l~~g~~pf~~~-~~~~~~~~~~~~~~--~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ 278 (290)
T 1t4h_A 206 ----YDESVDVYAFGMCMLEMATSEYPYSEC-QNAAQIYRRVTSGV--KPASFDKVAIPEVKEIIEGCIRQNKDERYSIK 278 (290)
T ss_dssp ----CCTHHHHHHHHHHHHHHHHSSCTTTTC-SSHHHHHHHHTTTC--CCGGGGGCCCHHHHHHHHHHSCSSGGGSCCHH
T ss_pred ----CCCcchHHHHHHHHHHHHhCCCCCCCc-CcHHHHHHHHhccC--CccccCCCCCHHHHHHHHHHccCChhhCCCHH
Confidence 389999999999999999999999753 33455555555432 22222335678999999999999999999999
Q ss_pred HHHH
Q psy1840 182 FVHH 185 (423)
Q Consensus 182 ~I~~ 185 (423)
++++
T Consensus 279 ell~ 282 (290)
T 1t4h_A 279 DLLN 282 (290)
T ss_dssp HHHT
T ss_pred HHhh
Confidence 9875
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=99.93 E-value=8.5e-26 Score=230.47 Aligned_cols=159 Identities=19% Similarity=0.257 Sum_probs=110.7
Q ss_pred HHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCccEEEeccCCcccccCCCcc------------------------
Q psy1840 25 SISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDET------------------------ 80 (423)
Q Consensus 25 ~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~~------------------------ 80 (423)
...++.||+.||.|||+.|++ ||||||+|||++.++.+||+|||+++........
T Consensus 158 ~~~~~~qi~~aL~~LH~~~ii-HrDlKp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (458)
T 3rp9_A 158 IKTLLYNLLVGVKYVHSAGIL-HRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDDMNLVTFPHTKNL 236 (458)
T ss_dssp HHHHHHHHHHHHHHHHHTTCB-CCCCCGGGEEECTTCCEEECCCTTCBCTTSCTTCCCCCC-------------------
T ss_pred HHHHHHHHHHHHHHHHhCCcC-CCCCChhhEEECCCCCEeecccccchhccCccccccccccCccccccccccccccccc
Confidence 578999999999999999998 9999999999999999999999999865422110
Q ss_pred -cccccccCCccccCCccccCCCCCCCCCccchHHHHHHHHHHHh-----------CCCCCCCCCCC-------------
Q psy1840 81 -GQERKLRRRKLYKAPELLRQPHLPRGTQKGDVYSFGLVLYEVIG-----------RQGPWGHLRMT------------- 135 (423)
Q Consensus 81 -~~~~~~~gt~~y~APE~l~~~~~~~~s~ksDVyS~Giil~ellt-----------g~~Pf~~~~~~------------- 135 (423)
.......||+.|+|||++.... .++.++|||||||++|||++ |+.+|.+....
T Consensus 237 ~~~~~~~~gt~~Y~aPE~~~~~~--~~~~~~DiwSlG~il~elltg~~~~~~~~~~~~p~f~g~~~~~~~~~~~~~~~~~ 314 (458)
T 3rp9_A 237 KRQLTGHVVTRWYRAPELILLQE--NYTEAIDVWSIGCIFAELLNMIKENVAYHADRGPLFPGSSCFPLSPDQKAGNDFK 314 (458)
T ss_dssp --------CCCTTCCHHHHTTCC--CCCTHHHHHHHHHHHHHHHTTSTTTCSSGGGCCCSCC------------------
T ss_pred cccccCCcccccccChHHhhCCC--CCCcHhHHHHHHHHHHHHHHhccccccccccccccCCCCcccccccccccccccc
Confidence 1123456799999999864332 24899999999999999998 56666442210
Q ss_pred -----hHHHHHHHh-----------------------cCCCCCCC----CCCCCchHHHHHHHHHhhhcCCCCCCCHHHH
Q psy1840 136 -----DEEIITSVT-----------------------QGSGLRPD----TSSLDCAPSIIACMRTCWEEDPELRPDLRFV 183 (423)
Q Consensus 136 -----~~~i~~~i~-----------------------~~~~~~p~----~~~~~~~~~l~~Li~~C~~~dP~~RPt~~~I 183 (423)
..+.+..+. ...+.... .....+++++.+|+.+||..||++|||+.++
T Consensus 315 ~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~t~~e~ 394 (458)
T 3rp9_A 315 FHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIFPKREGTDLAERFPASSADAIHLLKRMLVFNPNKRITINEC 394 (458)
T ss_dssp --CHHHHHHHHHHHHHHCCCCHHHHHTSSCHHHHHHHTTSCCCCCCCGGGGSTTSCHHHHHHHHHHSCSSTTTSCCHHHH
T ss_pred ccccCCHHHHHHHHHHcCCCCHHHHhhcCCHHHHHHHHhcCCCCCCCHHHHCCCCCHHHHHHHHHHhccCccccCCHHHH
Confidence 001111110 00000000 0113458899999999999999999999998
Q ss_pred HHH
Q psy1840 184 HHK 186 (423)
Q Consensus 184 ~~~ 186 (423)
++.
T Consensus 395 L~H 397 (458)
T 3rp9_A 395 LAH 397 (458)
T ss_dssp HHS
T ss_pred hcC
Confidence 864
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.93 E-value=5.6e-26 Score=215.70 Aligned_cols=150 Identities=21% Similarity=0.267 Sum_probs=99.6
Q ss_pred HHHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCccEEEeccCCcccccCCCcccccccccCCccccCCccccCCCC
Q psy1840 24 GSISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKAPELLRQPHL 103 (423)
Q Consensus 24 ~~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~ 103 (423)
....++.|++.||.|||+.|++ ||||||+||+++.++.+||+|||++........ ......+++.|+|||.+.+..+
T Consensus 113 ~~~~~~~qi~~~l~~lH~~~i~-H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~ 189 (278)
T 3cok_A 113 EARHFMHQIITGMLYLHSHGIL-HRDLTLSNLLLTRNMNIKIADFGLATQLKMPHE--KHYTLCGTPNYISPEIATRSAH 189 (278)
T ss_dssp HHHHHHHHHHHHHHHHHHTTEE-CSSCCGGGEEECTTCCEEECCCTTCEECC----------------------------
T ss_pred HHHHHHHHHHHHHHHHHHCCee-cCCCCHHHEEEcCCCCEEEEeecceeeccCCCC--cceeccCCCCcCCcchhcCCCC
Confidence 3689999999999999999988 999999999999999999999999876532221 1234568889999999987654
Q ss_pred CCCCCccchHHHHHHHHHHHhCCCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCchHHHHHHHHHhhhcCCCCCCCHHHH
Q psy1840 104 PRGTQKGDVYSFGLVLYEVIGRQGPWGHLRMTDEEIITSVTQGSGLRPDTSSLDCAPSIIACMRTCWEEDPELRPDLRFV 183 (423)
Q Consensus 104 ~~~s~ksDVyS~Giil~elltg~~Pf~~~~~~~~~i~~~i~~~~~~~p~~~~~~~~~~l~~Li~~C~~~dP~~RPt~~~I 183 (423)
+.++||||||+++|||++|..||..... .+....+...... .+..++.++.+++.+||+.||++||++.++
T Consensus 190 ---~~~~Di~slG~il~~l~~g~~p~~~~~~--~~~~~~~~~~~~~----~~~~~~~~~~~li~~~l~~dp~~Rps~~~~ 260 (278)
T 3cok_A 190 ---GLESDVWSLGCMFYTLLIGRPPFDTDTV--KNTLNKVVLADYE----MPSFLSIEAKDLIHQLLRRNPADRLSLSSV 260 (278)
T ss_dssp -----CTHHHHHHHHHHHHHHSSCSSCCCSC--C-----CCSSCCC----CCTTSCHHHHHHHHHHSCSSGGGSCCHHHH
T ss_pred ---CchhhHHHHHHHHHHHHhCCCCCCChhH--HHHHHHHhhcccC----CccccCHHHHHHHHHHcccCHhhCCCHHHH
Confidence 8899999999999999999999975332 2222222222111 123578899999999999999999999998
Q ss_pred HH
Q psy1840 184 HH 185 (423)
Q Consensus 184 ~~ 185 (423)
++
T Consensus 261 l~ 262 (278)
T 3cok_A 261 LD 262 (278)
T ss_dssp TT
T ss_pred hc
Confidence 76
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=1.2e-25 Score=215.32 Aligned_cols=151 Identities=21% Similarity=0.333 Sum_probs=124.0
Q ss_pred HHHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCccEEEeccCCcccccCCCcccccccccCCccccCCccccCCCC
Q psy1840 24 GSISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKAPELLRQPHL 103 (423)
Q Consensus 24 ~~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~ 103 (423)
....++.|++.||.|||+.|++ ||||||+||+++.++.+||+|||++........ ......+++.|+|||.+.+...
T Consensus 116 ~~~~i~~qi~~~l~~lH~~~i~-H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~ 192 (294)
T 2rku_A 116 EARYYLRQIVLGCQYLHRNRVI-HRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGE--RKKVLCGTPNYIAPEVLSKKGH 192 (294)
T ss_dssp HHHHHHHHHHHHHHHHHHTTEE-CCCCCGGGEEECTTCCEEECCCTTCEECCSTTC--CBCCCCSCCSSCCHHHHTTSCB
T ss_pred HHHHHHHHHHHHHHHHHHCCcc-ccCCChHhEEEcCCCCEEEEeccCceecccCcc--ccccccCCCCcCCcchhccCCC
Confidence 3689999999999999999988 999999999999999999999999876532221 1234568899999999987655
Q ss_pred CCCCCccchHHHHHHHHHHHhCCCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCchHHHHHHHHHhhhcCCCCCCCHHHH
Q psy1840 104 PRGTQKGDVYSFGLVLYEVIGRQGPWGHLRMTDEEIITSVTQGSGLRPDTSSLDCAPSIIACMRTCWEEDPELRPDLRFV 183 (423)
Q Consensus 104 ~~~s~ksDVyS~Giil~elltg~~Pf~~~~~~~~~i~~~i~~~~~~~p~~~~~~~~~~l~~Li~~C~~~dP~~RPt~~~I 183 (423)
+.++||||||+++|+|++|..||.. ....+....+.......| ..+++.+.+++.+||+.||++|||+.++
T Consensus 193 ---~~~~Di~slG~~l~~l~~g~~p~~~--~~~~~~~~~~~~~~~~~~----~~~~~~~~~li~~~l~~~p~~Rps~~~l 263 (294)
T 2rku_A 193 ---SFEVDVWSIGCIMYTLLVGKPPFET--SCLKETYLRIKKNEYSIP----KHINPVAASLIQKMLQTDPTARPTINEL 263 (294)
T ss_dssp ---CTHHHHHHHHHHHHHHHHSSCTTCC--SSHHHHHHHHHTTCCCCC----TTSCHHHHHHHHHHTCSSGGGSCCGGGG
T ss_pred ---CchhhHHHHHHHHHHHHhCCCCCCC--CCHHHHHHHHhhccCCCc----cccCHHHHHHHHHHcccChhhCcCHHHH
Confidence 8899999999999999999999974 334555555555433222 3578899999999999999999999998
Q ss_pred HHH
Q psy1840 184 HHK 186 (423)
Q Consensus 184 ~~~ 186 (423)
++.
T Consensus 264 l~~ 266 (294)
T 2rku_A 264 LND 266 (294)
T ss_dssp GGS
T ss_pred hhC
Confidence 764
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.93 E-value=2.1e-25 Score=215.50 Aligned_cols=154 Identities=16% Similarity=0.264 Sum_probs=122.6
Q ss_pred HHHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCccEEEeccCCcccccCCCcccccccccCCccccCCccccCCCC
Q psy1840 24 GSISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKAPELLRQPHL 103 (423)
Q Consensus 24 ~~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~ 103 (423)
....++.||+.||.|||+.|++ ||||||+||+++.++.+||+|||++........ ......+++.|+|||.+.+..+
T Consensus 126 ~~~~i~~~i~~~l~~lH~~~i~-H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~ 202 (314)
T 3com_A 126 EIATILQSTLKGLEYLHFMRKI-HRDIKAGNILLNTEGHAKLADFGVAGQLTDTMA--KRNTVIGTPFWMAPEVIQEIGY 202 (314)
T ss_dssp HHHHHHHHHHHHHHHHHHTTEE-CCCCSGGGEEECTTCCEEECCCTTCEECBTTBS--CBCCCCSCGGGCCHHHHSSSCB
T ss_pred HHHHHHHHHHHHHHHHHhCCCc-CCCcCHHHEEECCCCCEEEeecccchhhhhhcc--ccCccCCCCCccChhhcCCCCC
Confidence 3689999999999999999988 999999999999999999999999876543221 2234568889999999987655
Q ss_pred CCCCCccchHHHHHHHHHHHhCCCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCchHHHHHHHHHhhhcCCCCCCCHHHH
Q psy1840 104 PRGTQKGDVYSFGLVLYEVIGRQGPWGHLRMTDEEIITSVTQGSGLRPDTSSLDCAPSIIACMRTCWEEDPELRPDLRFV 183 (423)
Q Consensus 104 ~~~s~ksDVyS~Giil~elltg~~Pf~~~~~~~~~i~~~i~~~~~~~p~~~~~~~~~~l~~Li~~C~~~dP~~RPt~~~I 183 (423)
+.++||||||+++|+|++|..||... ........+......... ....++..+.+++.+||+.||.+|||+.++
T Consensus 203 ---~~~~Di~slG~il~~l~~g~~p~~~~--~~~~~~~~~~~~~~~~~~-~~~~~~~~l~~li~~~l~~dp~~Rpt~~~l 276 (314)
T 3com_A 203 ---NCVADIWSLGITAIEMAEGKPPYADI--HPMRAIFMIPTNPPPTFR-KPELWSDNFTDFVKQCLVKSPEQRATATQL 276 (314)
T ss_dssp ---CTTHHHHHHHHHHHHHHHSSCTTTTS--CHHHHHHHHHHSCCCCCS-SGGGSCHHHHHHHHHHTCSCTTTSCCHHHH
T ss_pred ---CccccHHHHHHHHHHHHhCCCCCCCC--ChHHHHHHHhcCCCcccC-CcccCCHHHHHHHHHHccCChhhCcCHHHH
Confidence 89999999999999999999999743 333444444333221111 123468899999999999999999999999
Q ss_pred HHH
Q psy1840 184 HHK 186 (423)
Q Consensus 184 ~~~ 186 (423)
++.
T Consensus 277 l~~ 279 (314)
T 3com_A 277 LQH 279 (314)
T ss_dssp TTS
T ss_pred HhC
Confidence 774
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=99.93 E-value=3e-26 Score=231.13 Aligned_cols=144 Identities=15% Similarity=0.081 Sum_probs=112.5
Q ss_pred HHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCccEEEeccCCcccccCCCcccccccccCCccccCCccccCC---
Q psy1840 25 SISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKAPELLRQP--- 101 (423)
Q Consensus 25 ~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~--- 101 (423)
++.++.||+.||+|||++|++ ||||||+|||++.++.+||+|||+++..... .....| +.|+|||++.+.
T Consensus 213 ~~~i~~qi~~aL~~LH~~~ii-HrDiKp~NILl~~~~~~kL~DFG~a~~~~~~-----~~~~~g-~~y~aPE~~~~~~~~ 285 (413)
T 3dzo_A 213 RLQLTLQVIRLLASLHHYGLV-HTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS-----AVSPIG-RGFAPPETTAERMLP 285 (413)
T ss_dssp HHHHHHHHHHHHHHHHHTTEE-CSCCCGGGEEECTTCCEEECCGGGCEETTEE-----ECCCCC-TTTCCHHHHHHHTST
T ss_pred HHHHHHHHHHHHHHHHhCCcc-cCCcccceEEEecCCeEEEEeccceeecCCc-----cccCCC-CceeCchhhhccccc
Confidence 678889999999999999988 9999999999999999999999998754322 234466 889999999311
Q ss_pred ----CCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCchHHHHHHHHHhhhcCCCCC
Q psy1840 102 ----HLPRGTQKGDVYSFGLVLYEVIGRQGPWGHLRMTDEEIITSVTQGSGLRPDTSSLDCAPSIIACMRTCWEEDPELR 177 (423)
Q Consensus 102 ----~~~~~s~ksDVyS~Giil~elltg~~Pf~~~~~~~~~i~~~i~~~~~~~p~~~~~~~~~~l~~Li~~C~~~dP~~R 177 (423)
....++.++|||||||++|||++|+.||.... ..+....+.. ....+++.+.+++.+||+.||++|
T Consensus 286 ~~~~~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~--~~~~~~~~~~--------~~~~~~~~~~~li~~~l~~dP~~R 355 (413)
T 3dzo_A 286 FGQHHPTLMTFAFDTWTLGLAIYWIWCADLPNTDDA--ALGGSEWIFR--------SCKNIPQPVRALLEGFLRYPKEDR 355 (413)
T ss_dssp TGGGCCEEECHHHHHHHHHHHHHHHHHSSCCCCTTG--GGSCSGGGGS--------SCCCCCHHHHHHHHHHTCSSGGGS
T ss_pred cccccCcCCCchhhHHHHHHHHHHHHHCCCCCCCcc--hhhhHHHHHh--------hcccCCHHHHHHHHHHccCChhhC
Confidence 11123789999999999999999999997431 1111111111 112568999999999999999999
Q ss_pred CCHHHHHH
Q psy1840 178 PDLRFVHH 185 (423)
Q Consensus 178 Pt~~~I~~ 185 (423)
|++.++++
T Consensus 356 pt~~~~l~ 363 (413)
T 3dzo_A 356 LLPLQAME 363 (413)
T ss_dssp CCHHHHTT
T ss_pred cCHHHHHh
Confidence 99988865
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.92 E-value=2.9e-25 Score=214.56 Aligned_cols=156 Identities=22% Similarity=0.361 Sum_probs=114.6
Q ss_pred HHHHHHHHHHHHHHHHhC-CCeeecCCCCCCEEEcCCccEEEeccCCcccccCCCcccccccccCCccccCCccccCCC-
Q psy1840 25 SISVNTTASVGMIHLHDS-EIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKAPELLRQPH- 102 (423)
Q Consensus 25 ~l~i~~qi~~gL~yLH~~-~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~- 102 (423)
...++.||+.||.|||++ |++ ||||||+||+++.++.+||+|||++....... ......+++.|+|||.+....
T Consensus 126 ~~~~~~~i~~~l~~lH~~~~i~-H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~ 201 (318)
T 2dyl_A 126 LGKMTVAIVKALYYLKEKHGVI-HRDVKPSNILLDERGQIKLCDFGISGRLVDDK---AKDRSAGCAAYMAPERIDPPDP 201 (318)
T ss_dssp HHHHHHHHHHHHHHHHHHHCCC-CCCCCGGGEEECTTSCEEECCCTTC-----------------CCTTCCHHHHC----
T ss_pred HHHHHHHHHHHHHHHHhhCCEE-eCCCCHHHEEECCCCCEEEEECCCchhccCCc---cccccCCCccccChhhcccccc
Confidence 679999999999999995 998 99999999999999999999999986543322 123446888999999986321
Q ss_pred -CCCCCCccchHHHHHHHHHHHhCCCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCchHHHHHHHHHhhhcCCCCCCCHH
Q psy1840 103 -LPRGTQKGDVYSFGLVLYEVIGRQGPWGHLRMTDEEIITSVTQGSGLRPDTSSLDCAPSIIACMRTCWEEDPELRPDLR 181 (423)
Q Consensus 103 -~~~~s~ksDVyS~Giil~elltg~~Pf~~~~~~~~~i~~~i~~~~~~~p~~~~~~~~~~l~~Li~~C~~~dP~~RPt~~ 181 (423)
...++.++||||||+++|||++|..||.... ...+....+..+...... ....+++++.+++.+||+.||.+||++.
T Consensus 202 ~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~-~~~~~~~~~~~~~~~~~~-~~~~~~~~l~~li~~~l~~dp~~Rps~~ 279 (318)
T 2dyl_A 202 TKPDYDIRADVWSLGISLVELATGQFPYKNCK-TDFEVLTKVLQEEPPLLP-GHMGFSGDFQSFVKDCLTKDHRKRPKYN 279 (318)
T ss_dssp ----CCTHHHHHHHHHHHHHHHHSSCTTTTCC-SHHHHHHHHHHSCCCCCC-SSSCCCHHHHHHHHHHTCSCTTTSCCHH
T ss_pred cccCCccccchhhHHHHHHHHHhCCCCCCCCC-ccHHHHHHHhccCCCCCC-ccCCCCHHHHHHHHHHccCChhHCcCHH
Confidence 1134889999999999999999999997533 344555555544322211 1235789999999999999999999999
Q ss_pred HHHHH
Q psy1840 182 FVHHK 186 (423)
Q Consensus 182 ~I~~~ 186 (423)
++++.
T Consensus 280 ~ll~h 284 (318)
T 2dyl_A 280 KLLEH 284 (318)
T ss_dssp HHTTS
T ss_pred HHhhC
Confidence 99764
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=1.4e-25 Score=214.90 Aligned_cols=156 Identities=17% Similarity=0.268 Sum_probs=124.9
Q ss_pred HHHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCccEEEeccCCcccccCCCcccccccccCCccccCCccccCC--
Q psy1840 24 GSISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKAPELLRQP-- 101 (423)
Q Consensus 24 ~~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~-- 101 (423)
....++.||+.||.|||+.|++ ||||||+||+++.++.+||+|||++....... ......+++.|+|||.+.+.
T Consensus 125 ~~~~~~~qi~~~l~~lH~~~i~-H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~ 200 (298)
T 1phk_A 125 ETRKIMRALLEVICALHKLNIV-HRDLKPENILLDDDMNIKLTDFGFSCQLDPGE---KLREVCGTPSYLAPEIIECSMN 200 (298)
T ss_dssp HHHHHHHHHHHHHHHHHHTTEE-CSCCSGGGEEECTTCCEEECCCTTCEECCTTC---CBCCCCSCGGGCCHHHHHHHHC
T ss_pred HHHHHHHHHHHHHHHHHHCCcc-cCCCCcceEEEcCCCcEEEecccchhhcCCCc---ccccccCCccccCHHHhccccc
Confidence 3689999999999999999988 99999999999999999999999987654322 12345688899999998521
Q ss_pred -CCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCchHHHHHHHHHhhhcCCCCCCCH
Q psy1840 102 -HLPRGTQKGDVYSFGLVLYEVIGRQGPWGHLRMTDEEIITSVTQGSGLRPDTSSLDCAPSIIACMRTCWEEDPELRPDL 180 (423)
Q Consensus 102 -~~~~~s~ksDVyS~Giil~elltg~~Pf~~~~~~~~~i~~~i~~~~~~~p~~~~~~~~~~l~~Li~~C~~~dP~~RPt~ 180 (423)
....++.++||||||+++|+|++|..||.. ....+....+..+....+......++..+.+++.+||+.||.+|||+
T Consensus 201 ~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~ 278 (298)
T 1phk_A 201 DNHPGYGKEVDMWSTGVIMYTLLAGSPPFWH--RKQMLMLRMIMSGNYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTA 278 (298)
T ss_dssp TTSCCBCTHHHHHHHHHHHHHHHHSSCSSCC--SSHHHHHHHHHHTCCCCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCH
T ss_pred cccccCCcccccHhHHHHHHHHHHCCCCCcC--ccHHHHHHHHhcCCcccCcccccccCHHHHHHHHHHccCCcccCCCH
Confidence 111348899999999999999999999964 34556666666654433333334678999999999999999999999
Q ss_pred HHHHH
Q psy1840 181 RFVHH 185 (423)
Q Consensus 181 ~~I~~ 185 (423)
.++++
T Consensus 279 ~~ll~ 283 (298)
T 1phk_A 279 EEALA 283 (298)
T ss_dssp HHHTT
T ss_pred HHHHh
Confidence 99875
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=99.92 E-value=2.1e-25 Score=225.33 Aligned_cols=154 Identities=21% Similarity=0.181 Sum_probs=116.8
Q ss_pred HHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCC-ccEEEeccCCcccccCCCcccccccccCCccccCCccccCCCC
Q psy1840 25 SISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSR-WVLQIADFGLHAFKAGQDETGQERKLRRRKLYKAPELLRQPHL 103 (423)
Q Consensus 25 ~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~-~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~ 103 (423)
...++.||+.||.|||+.|++ ||||||+|||++.+ +.+||+|||+++....... .....+|+.|+|||++.+..
T Consensus 158 ~~~~~~qi~~aL~~LH~~~iv-HrDlkp~NILl~~~~~~~kl~DFG~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~- 232 (420)
T 1j1b_A 158 VKLYMYQLFRSLAYIHSFGIC-HRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEP---NVSYICSRYYRAPELIFGAT- 232 (420)
T ss_dssp HHHHHHHHHHHHHHHHTTTEE-CSCCSGGGEEEETTTTEEEECCCTTCEECCTTCC---CCSCCSCTTSCCHHHHTTCS-
T ss_pred HHHHHHHHHHHHHHHHHCCcc-ccCCChhhEEEeCCCCeEEeccchhhhhcccCCC---ceeeeeCCCcCCHHHHcCCC-
Confidence 578999999999999999988 99999999999955 6789999999986533221 23457889999999987642
Q ss_pred CCCCCccchHHHHHHHHHHHhCCCCCCCCCCChHHHHHHHhc--------------C---CCCCCCC--------CCCCc
Q psy1840 104 PRGTQKGDVYSFGLVLYEVIGRQGPWGHLRMTDEEIITSVTQ--------------G---SGLRPDT--------SSLDC 158 (423)
Q Consensus 104 ~~~s~ksDVyS~Giil~elltg~~Pf~~~~~~~~~i~~~i~~--------------~---~~~~p~~--------~~~~~ 158 (423)
.++.++|||||||++|||++|+.||.+. +..+.+..+.. . ....|.. .....
T Consensus 233 -~~~~~~DiwSlG~il~ell~G~~pf~~~--~~~~~l~~i~~~lg~p~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~ 309 (420)
T 1j1b_A 233 -DYTSSIDVWSAGCVLAELLLGQPIFPGD--SGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRT 309 (420)
T ss_dssp -SCCTHHHHHHHHHHHHHHHHSSCSSCCS--SHHHHHHHHHHHHCSCCHHHHHHHCSCCCCCCCCCCCCCCHHHHSCTTS
T ss_pred -CCCchhhhHHHHHHHHHHHhCCCCCCCC--CHHHHHHHHHHHhCCCCHHHHHhhChhhhhhccCccCCCCHHHhcCCCC
Confidence 2389999999999999999999999753 22222222211 0 0011111 11246
Q ss_pred hHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q psy1840 159 APSIIACMRTCWEEDPELRPDLRFVHHK 186 (423)
Q Consensus 159 ~~~l~~Li~~C~~~dP~~RPt~~~I~~~ 186 (423)
++++.+|+.+||+.||.+||++.++++.
T Consensus 310 ~~~~~~Li~~~L~~dP~~R~t~~e~l~h 337 (420)
T 1j1b_A 310 PPEAIALCSRLLEYTPTARLTPLEACAH 337 (420)
T ss_dssp CHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred CHHHHHHHHHhccCChhHCCCHHHHhCC
Confidence 7899999999999999999999998753
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=1.2e-25 Score=219.99 Aligned_cols=151 Identities=21% Similarity=0.333 Sum_probs=124.3
Q ss_pred HHHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCccEEEeccCCcccccCCCcccccccccCCccccCCccccCCCC
Q psy1840 24 GSISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKAPELLRQPHL 103 (423)
Q Consensus 24 ~~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~ 103 (423)
....++.||+.||.|||++|++ ||||||+||+++.++.+||+|||++........ ......++..|+|||.+.+..+
T Consensus 142 ~~~~i~~qi~~aL~~LH~~~iv-H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~ 218 (335)
T 2owb_A 142 EARYYLRQIVLGCQYLHRNRVI-HRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGE--RKKVLCGTPNYIAPEVLSKKGH 218 (335)
T ss_dssp HHHHHHHHHHHHHHHHHHTTEE-CSCCCGGGEEECTTCCEEECCCTTCEECCSTTC--CBCCCCSCCSSCCHHHHHTSCB
T ss_pred HHHHHHHHHHHHHHHHHHCCCE-ecCCCchhEEEcCCCCEEEeeccCceecccCcc--cccccCCCccccCHHHhccCCC
Confidence 3689999999999999999988 999999999999999999999999876532221 1234568899999999987655
Q ss_pred CCCCCccchHHHHHHHHHHHhCCCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCchHHHHHHHHHhhhcCCCCCCCHHHH
Q psy1840 104 PRGTQKGDVYSFGLVLYEVIGRQGPWGHLRMTDEEIITSVTQGSGLRPDTSSLDCAPSIIACMRTCWEEDPELRPDLRFV 183 (423)
Q Consensus 104 ~~~s~ksDVyS~Giil~elltg~~Pf~~~~~~~~~i~~~i~~~~~~~p~~~~~~~~~~l~~Li~~C~~~dP~~RPt~~~I 183 (423)
+.++||||||+++|+|++|+.||.. ....+....+.......| ..+++.+.+++.+||+.||++||++.++
T Consensus 219 ---~~~~Di~slG~il~~l~~g~~pf~~--~~~~~~~~~~~~~~~~~~----~~~~~~~~~li~~~l~~dp~~Rps~~el 289 (335)
T 2owb_A 219 ---SFEVDVWSIGCIMYTLLVGKPPFET--SCLKETYLRIKKNEYSIP----KHINPVAASLIQKMLQTDPTARPTINEL 289 (335)
T ss_dssp ---CTHHHHHHHHHHHHHHHHSSCTTCC--SSHHHHHHHHHHTCCCCC----TTSCHHHHHHHHHHTCSSGGGSCCGGGG
T ss_pred ---CchhhHHHHHHHHHHHHHCcCCCCC--CCHHHHHHHHhcCCCCCC----ccCCHHHHHHHHHHccCChhHCcCHHHH
Confidence 8899999999999999999999974 334555555555433222 3578899999999999999999999998
Q ss_pred HHH
Q psy1840 184 HHK 186 (423)
Q Consensus 184 ~~~ 186 (423)
++.
T Consensus 290 l~~ 292 (335)
T 2owb_A 290 LND 292 (335)
T ss_dssp GGS
T ss_pred hcC
Confidence 764
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=99.92 E-value=1.8e-25 Score=232.31 Aligned_cols=146 Identities=25% Similarity=0.384 Sum_probs=121.4
Q ss_pred HHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCccEEEeccCCcccccCCCcccccccccCCccccCCccccCCCCC
Q psy1840 25 SISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKAPELLRQPHLP 104 (423)
Q Consensus 25 ~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~ 104 (423)
...++.||+.||.|||+.|++ ||||||+|||++.+|.+||+|||+++....... ......||+.|+|||++.+..+
T Consensus 291 ~~~~~~qi~~aL~~LH~~gIv-HrDLKP~NILl~~~g~vkL~DFGla~~~~~~~~--~~~~~~GT~~Y~APE~l~~~~~- 366 (543)
T 3c4z_A 291 AIFYTAQIVSGLEHLHQRNII-YRDLKPENVLLDDDGNVRISDLGLAVELKAGQT--KTKGYAGTPGFMAPELLLGEEY- 366 (543)
T ss_dssp HHHHHHHHHHHHHHHHHTTEE-CCCCCGGGEEECTTSCEEECCCTTCEECCTTCC--CBCCCCSCTTTSCHHHHTTCCB-
T ss_pred HHHHHHHHHHHHHHHHHcCCc-ccCCChHHEEEeCCCCEEEeecceeeeccCCCc--ccccccCCccccChhhhcCCCC-
Confidence 578899999999999999988 999999999999999999999999876543221 1234589999999999988655
Q ss_pred CCCCccchHHHHHHHHHHHhCCCCCCCCC--CChHHHHHHHhcCCCCCCCCCCCCchHHHHHHHHHhhhcCCCCCCCH
Q psy1840 105 RGTQKGDVYSFGLVLYEVIGRQGPWGHLR--MTDEEIITSVTQGSGLRPDTSSLDCAPSIIACMRTCWEEDPELRPDL 180 (423)
Q Consensus 105 ~~s~ksDVyS~Giil~elltg~~Pf~~~~--~~~~~i~~~i~~~~~~~p~~~~~~~~~~l~~Li~~C~~~dP~~RPt~ 180 (423)
+.++|||||||++|||++|..||.... ....++...+.......| ..+++.+.+++.+||+.||.+||++
T Consensus 367 --~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~~~~i~~~~~~~p----~~~s~~~~~li~~lL~~dP~~R~~~ 438 (543)
T 3c4z_A 367 --DFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAVTYP----DKFSPASKDFCEALLQKDPEKRLGF 438 (543)
T ss_dssp --CTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHHHHHHHHCCCCCC----TTSCHHHHHHHHHHSCSSGGGSCCC
T ss_pred --ChHHhcCcchHHHHHHHhCCCCCCCCccchhHHHHHHHHhhcccCCC----cccCHHHHHHHHHhccCCHhHCCCC
Confidence 899999999999999999999997542 244666666665443333 3578999999999999999999975
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=2.7e-25 Score=210.52 Aligned_cols=152 Identities=19% Similarity=0.291 Sum_probs=117.4
Q ss_pred HHHHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCccEEEeccCCcccccCCCcccccccccCCccccCCccccCCC
Q psy1840 23 IGSISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKAPELLRQPH 102 (423)
Q Consensus 23 ~~~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~ 102 (423)
.....++.|++.||.|||+.|++ ||||||+||+++.++.+||+|||++....... ......+++.|+|||.+.+..
T Consensus 111 ~~~~~~~~qi~~~l~~lH~~~i~-H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~ 186 (276)
T 2h6d_A 111 MEARRLFQQILSAVDYCHRHMVV-HRDLKPENVLLDAHMNAKIADFGLSNMMSDGE---FLRTSCGSPNYAAPEVISGRL 186 (276)
T ss_dssp HHHHHHHHHHHHHHHHHHHHCSS-CCCCCGGGEEECTTSCEEECCCCGGGCCCC----------------CCTGGGTTSC
T ss_pred HHHHHHHHHHHHHHHHHHHCCCc-cCCCChhhEEECCCCCEEEeecccccccCCCc---ceecccCCccccCHHHHcCCC
Confidence 34689999999999999999998 99999999999999999999999987653321 123446788999999998754
Q ss_pred CCCCCCccchHHHHHHHHHHHhCCCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCchHHHHHHHHHhhhcCCCCCCCHHH
Q psy1840 103 LPRGTQKGDVYSFGLVLYEVIGRQGPWGHLRMTDEEIITSVTQGSGLRPDTSSLDCAPSIIACMRTCWEEDPELRPDLRF 182 (423)
Q Consensus 103 ~~~~s~ksDVyS~Giil~elltg~~Pf~~~~~~~~~i~~~i~~~~~~~p~~~~~~~~~~l~~Li~~C~~~dP~~RPt~~~ 182 (423)
. .+.++||||||+++|+|++|..||.. ....++...+..+....| ..++..+.+++.+||+.||++|||+.+
T Consensus 187 ~--~~~~~Di~slG~~l~~l~~g~~p~~~--~~~~~~~~~~~~~~~~~~----~~~~~~l~~li~~~l~~~p~~Rps~~~ 258 (276)
T 2h6d_A 187 Y--AGPEVDIWSCGVILYALLCGTLPFDD--EHVPTLFKKIRGGVFYIP----EYLNRSVATLLMHMLQVDPLKRATIKD 258 (276)
T ss_dssp C--CHHHHHHHHHHHHHHHHHHSSCSSCC--SSHHHHHHHHHHCCCCCC----TTSCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred C--CCccchHHHHHHHHHHHHhCCCCCCC--CcHHHHHHHhhcCcccCc----hhcCHHHHHHHHHHccCChhhCCCHHH
Confidence 2 25799999999999999999999974 345566666665543332 356889999999999999999999999
Q ss_pred HHHH
Q psy1840 183 VHHK 186 (423)
Q Consensus 183 I~~~ 186 (423)
+++.
T Consensus 259 ~l~h 262 (276)
T 2h6d_A 259 IREH 262 (276)
T ss_dssp HHHS
T ss_pred HHhC
Confidence 9874
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.92 E-value=9.9e-26 Score=226.38 Aligned_cols=159 Identities=18% Similarity=0.227 Sum_probs=111.6
Q ss_pred HHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEE----cCCccEEEeccCCcccccCCCc-ccccccccCCccccCCcccc
Q psy1840 25 SISVNTTASVGMIHLHDSEIISHGNLRSSNCLI----DSRWVLQIADFGLHAFKAGQDE-TGQERKLRRRKLYKAPELLR 99 (423)
Q Consensus 25 ~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILl----d~~~~vKL~DFGla~~~~~~~~-~~~~~~~~gt~~y~APE~l~ 99 (423)
...++.||+.||.|||+.|++ ||||||+|||+ +.++.+||+|||+++....... ........||+.|+|||++.
T Consensus 130 ~~~i~~qi~~al~~LH~~~iv-H~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~ 208 (405)
T 3rgf_A 130 VKSLLYQILDGIHYLHANWVL-HRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLL 208 (405)
T ss_dssp HHHHHHHHHHHHHHHHHTTCC-CCCCCGGGEEECCSSTTTTCEEECCTTCCC----------------CCCTTCCHHHHT
T ss_pred HHHHHHHHHHHHHHHHhCCEe-CCCcCHHHeEEecCCCCCCcEEEEECCCceecCCCCcccccCCCceecCcccCchhhc
Confidence 578999999999999999998 99999999999 7789999999999876543221 12224567899999999998
Q ss_pred CCCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCC-------hHHHHHHHhcCCCCCCCCC------------------
Q psy1840 100 QPHLPRGTQKGDVYSFGLVLYEVIGRQGPWGHLRMT-------DEEIITSVTQGSGLRPDTS------------------ 154 (423)
Q Consensus 100 ~~~~~~~s~ksDVyS~Giil~elltg~~Pf~~~~~~-------~~~i~~~i~~~~~~~p~~~------------------ 154 (423)
+.. .++.++|||||||++|||++|..||...... ..+.+..+.......+...
T Consensus 209 ~~~--~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~ 286 (405)
T 3rgf_A 209 GAR--HYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFR 286 (405)
T ss_dssp TCC--SCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCCHHHHHHHHHHHCCCCTTTCGGGGGSTTHHHHHHHCC
T ss_pred CCC--cccchhhhHHHHHHHHHHHhCCCCCCCccccccccccchHHHHHHHHHhhCCCChhhcchhhcCcchhhhhhhcc
Confidence 743 2489999999999999999999999643221 1122222221100000000
Q ss_pred ----------------CCCchHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q psy1840 155 ----------------SLDCAPSIIACMRTCWEEDPELRPDLRFVHHK 186 (423)
Q Consensus 155 ----------------~~~~~~~l~~Li~~C~~~dP~~RPt~~~I~~~ 186 (423)
....++.+.+|+.+||+.||.+|||+.++++.
T Consensus 287 ~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e~L~h 334 (405)
T 3rgf_A 287 RNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQD 334 (405)
T ss_dssp GGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred ccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 01125688999999999999999999998864
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=1.2e-25 Score=219.32 Aligned_cols=154 Identities=19% Similarity=0.179 Sum_probs=111.4
Q ss_pred HHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEE-----cCCccEEEeccCCcccccCCCcccccccccCCccccCCcccc
Q psy1840 25 SISVNTTASVGMIHLHDSEIISHGNLRSSNCLI-----DSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKAPELLR 99 (423)
Q Consensus 25 ~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILl-----d~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~ 99 (423)
...++.||+.||.|||+.|++ ||||||+||++ +.++.+||+|||++........ ......+|+.|+|||++.
T Consensus 134 ~~~i~~ql~~~l~~LH~~~iv-H~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~~~~~~~~--~~~~~~~t~~y~aPE~~~ 210 (329)
T 3gbz_A 134 IKSFLYQLINGVNFCHSRRCL-HRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIR--QFTHEIITLWYRPPEILL 210 (329)
T ss_dssp HHHHHHHHHHHHHHHHHTTCC-CSCCCGGGEEEEC-----CCEEEECCTTHHHHHC-------------CCTTCCHHHHT
T ss_pred HHHHHHHHHHHHHHHHhCCEE-CCCCCHHHEEEecCCCCccceEEECcCCCccccCCccc--ccCCCcCCccccCHHHhc
Confidence 578999999999999999998 99999999999 4556699999999876532211 123446788999999997
Q ss_pred CCCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCChHHHHHHHhcCCCCCCCC------------------C-------
Q psy1840 100 QPHLPRGTQKGDVYSFGLVLYEVIGRQGPWGHLRMTDEEIITSVTQGSGLRPDT------------------S------- 154 (423)
Q Consensus 100 ~~~~~~~s~ksDVyS~Giil~elltg~~Pf~~~~~~~~~i~~~i~~~~~~~p~~------------------~------- 154 (423)
+.. .++.++|||||||++|||++|..||... ...+.+..+.......+.. .
T Consensus 211 ~~~--~~~~~~DiwslG~il~ell~g~~pf~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 286 (329)
T 3gbz_A 211 GSR--HYSTSVDIWSIACIWAEMLMKTPLFPGD--SEIDQLFKIFEVLGLPDDTTWPGVTALPDWKQSFPKFRGKTLKRV 286 (329)
T ss_dssp TCC--CCCTHHHHHHHHHHHHHHHHSSCSSCCS--SHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTCCCCCCCCHHHH
T ss_pred CCC--CCCcHHHHHHHHHHHHHHHHCCCCcCCC--CHHHHHHHHHHHhCCCchhhhhhhhhhhhhhhhhhhhccccHhhh
Confidence 643 2489999999999999999999999743 3334443333211000000 0
Q ss_pred -CCCchHHHHHHHHHhhhcCCCCCCCHHHHHH
Q psy1840 155 -SLDCAPSIIACMRTCWEEDPELRPDLRFVHH 185 (423)
Q Consensus 155 -~~~~~~~l~~Li~~C~~~dP~~RPt~~~I~~ 185 (423)
...+++++.+++.+||+.||++|||+.++++
T Consensus 287 ~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 318 (329)
T 3gbz_A 287 LGALLDDEGLDLLTAMLEMDPVKRISAKNALE 318 (329)
T ss_dssp HGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred cccccCHHHHHHHHHHccCChhhCCCHHHHhC
Confidence 0115688999999999999999999999876
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=7.1e-26 Score=229.80 Aligned_cols=157 Identities=24% Similarity=0.357 Sum_probs=113.1
Q ss_pred HHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCC-------------ccEEEeccCCcccccCCCcc--cccccccCC
Q psy1840 25 SISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSR-------------WVLQIADFGLHAFKAGQDET--GQERKLRRR 89 (423)
Q Consensus 25 ~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~-------------~~vKL~DFGla~~~~~~~~~--~~~~~~~gt 89 (423)
.+.++.||+.||.|||+.|++ ||||||+|||++.+ +.+||+|||+++........ .......||
T Consensus 117 ~~~i~~qi~~aL~~LH~~~iv-HrDLkp~NILl~~~~~~~~~~~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~gt 195 (434)
T 2rio_A 117 PISLLRQIASGVAHLHSLKII-HRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNLNNPSGT 195 (434)
T ss_dssp HHHHHHHHHHHHHHHHHTTEE-CCCCSGGGEEEECCHHHHSCCTTCCCSCEEEECCCTTCEECCC--------------C
T ss_pred HHHHHHHHHHHHHHHHHCCcc-ccCCChHhEEEecCcccccccccCCCceEEEEcccccceecCCCCccceeeecCCCCC
Confidence 478999999999999999988 99999999999754 48999999998865433221 112345789
Q ss_pred ccccCCccccCCC----CCCCCCccchHHHHHHHHHHHh-CCCCCCCCCCChHHHHHHHhcCCCCCCC---CCCCCchHH
Q psy1840 90 KLYKAPELLRQPH----LPRGTQKGDVYSFGLVLYEVIG-RQGPWGHLRMTDEEIITSVTQGSGLRPD---TSSLDCAPS 161 (423)
Q Consensus 90 ~~y~APE~l~~~~----~~~~s~ksDVyS~Giil~ellt-g~~Pf~~~~~~~~~i~~~i~~~~~~~p~---~~~~~~~~~ 161 (423)
+.|+|||++.+.. ....+.++|||||||++|||++ |..||........ .+..+....+. .....++++
T Consensus 196 ~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~----~i~~~~~~~~~~~~~~~~~~~~~ 271 (434)
T 2rio_A 196 SGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRES----NIIRGIFSLDEMKCLHDRSLIAE 271 (434)
T ss_dssp CTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTHHH----HHHHTCCCCCCCTTCCCHHHHHH
T ss_pred CCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchhhHH----HHhcCCCCcccccccccccchHH
Confidence 9999999997621 1235899999999999999998 8999975332222 22222211111 112245688
Q ss_pred HHHHHHHhhhcCCCCCCCHHHHHHH
Q psy1840 162 IIACMRTCWEEDPELRPDLRFVHHK 186 (423)
Q Consensus 162 l~~Li~~C~~~dP~~RPt~~~I~~~ 186 (423)
+.+++.+||+.||.+|||+.+|++.
T Consensus 272 ~~~li~~~L~~dP~~Rps~~eil~h 296 (434)
T 2rio_A 272 ATDLISQMIDHDPLKRPTAMKVLRH 296 (434)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred HHHHHHHHhhCChhhCCCHHHHHhC
Confidence 9999999999999999999998763
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=2e-25 Score=218.72 Aligned_cols=156 Identities=18% Similarity=0.259 Sum_probs=100.4
Q ss_pred HHHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcC---CccEEEeccCCcccccCCCcccccccccCCccccCCccccC
Q psy1840 24 GSISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDS---RWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKAPELLRQ 100 (423)
Q Consensus 24 ~~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~---~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~ 100 (423)
....++.||+.||.|||+.|++ ||||||+||+++. ++.+||+|||++...... ......+++.|+|||.+.+
T Consensus 129 ~~~~i~~ql~~~l~~LH~~~iv-H~dlkp~NIll~~~~~~~~~kl~Dfg~~~~~~~~----~~~~~~~t~~y~aPE~~~~ 203 (336)
T 3fhr_A 129 EAAEIMRDIGTAIQFLHSHNIA-HRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQN----ALQTPCYTPYYVAPEVLGP 203 (336)
T ss_dssp HHHHHHHHHHHHHHHHHHTTEE-CSCCSGGGEEESCSSTTCCEEECCCTTCEEC--------------------------
T ss_pred HHHHHHHHHHHHHHHHHhCCee-cCCCCHHHEEEEecCCCceEEEeccccceecccc----ccccCCCCcCccChhhhCC
Confidence 3689999999999999999988 9999999999976 456999999998754322 1234567889999999976
Q ss_pred CCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCh--HHHHHHHhcCCCCCCCCCCCCchHHHHHHHHHhhhcCCCCCC
Q psy1840 101 PHLPRGTQKGDVYSFGLVLYEVIGRQGPWGHLRMTD--EEIITSVTQGSGLRPDTSSLDCAPSIIACMRTCWEEDPELRP 178 (423)
Q Consensus 101 ~~~~~~s~ksDVyS~Giil~elltg~~Pf~~~~~~~--~~i~~~i~~~~~~~p~~~~~~~~~~l~~Li~~C~~~dP~~RP 178 (423)
..+ +.++||||||+++|+|++|..||....... ......+..+....+......+++++.+++.+||+.||.+||
T Consensus 204 ~~~---~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp 280 (336)
T 3fhr_A 204 EKY---DKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQYGFPNPEWSEVSEDAKQLIRLLLKTDPTERL 280 (336)
T ss_dssp CHH---HHHHHHHHHHHHHHHHHHSSCCC---------------------CCCTTTSTTCCHHHHHHHHHHSCSSGGGSC
T ss_pred CCC---CchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhHHHhhhccccccCchhhccCCHHHHHHHHHHCCCChhHCc
Confidence 655 889999999999999999999996432111 111222222222223333346899999999999999999999
Q ss_pred CHHHHHHHH
Q psy1840 179 DLRFVHHKL 187 (423)
Q Consensus 179 t~~~I~~~L 187 (423)
|+.++++.-
T Consensus 281 t~~ell~hp 289 (336)
T 3fhr_A 281 TITQFMNHP 289 (336)
T ss_dssp CHHHHHHSH
T ss_pred CHHHHhcCc
Confidence 999998743
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=2.9e-25 Score=225.09 Aligned_cols=159 Identities=20% Similarity=0.285 Sum_probs=111.5
Q ss_pred HHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCccEEEeccCCcccccCCCcc--------------------cccc
Q psy1840 25 SISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDET--------------------GQER 84 (423)
Q Consensus 25 ~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~~--------------------~~~~ 84 (423)
...++.||+.||.|||+.|++ ||||||+|||++.++.+||+|||+++........ ....
T Consensus 131 ~~~i~~qil~aL~~LH~~giv-HrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 209 (432)
T 3n9x_A 131 IKTILYNLLLGENFIHESGII-HRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLT 209 (432)
T ss_dssp HHHHHHHHHHHHHHHHHTTEE-CCCCCGGGEEECTTCCEEECCCTTCEEC------------------------------
T ss_pred HHHHHHHHHHHHHHHHHCCCC-CCCCCHHHeEECCCCCEEEccCCCcccccccccccccccccccccccccccchhcccc
Confidence 678999999999999999988 9999999999999999999999999865432211 1124
Q ss_pred cccCCccccCCccccCCCCCCCCCccchHHHHHHHHHHHhCCCCC-----------CCCCC-------------------
Q psy1840 85 KLRRRKLYKAPELLRQPHLPRGTQKGDVYSFGLVLYEVIGRQGPW-----------GHLRM------------------- 134 (423)
Q Consensus 85 ~~~gt~~y~APE~l~~~~~~~~s~ksDVyS~Giil~elltg~~Pf-----------~~~~~------------------- 134 (423)
...||+.|+|||++.... .++.++|||||||++|||++|..|| .+...
T Consensus 210 ~~~gt~~Y~APE~~~~~~--~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~ 287 (432)
T 3n9x_A 210 SHVVTRWYRAPELILLQE--NYTKSIDIWSTGCIFAELLNMLQSHINDPTNRFPLFPGSSCFPLSPDRNSKKVHEKSNRD 287 (432)
T ss_dssp -CCCCCTTCCHHHHTTCS--CCCTHHHHHHHHHHHHHHHTTCTTTCSSGGGCCCSCCCSCSCC----------CHHHHHH
T ss_pred CCCCCccccCHHHHhcCC--CCCcccccchHHHHHHHHHhcccccccccccccccCCCccccccCcccccccccccchHH
Confidence 567899999999864432 2489999999999999999854443 22110
Q ss_pred --------------------ChHHHHHHHhcCCCCCCCC---CCCCchHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q psy1840 135 --------------------TDEEIITSVTQGSGLRPDT---SSLDCAPSIIACMRTCWEEDPELRPDLRFVHHK 186 (423)
Q Consensus 135 --------------------~~~~i~~~i~~~~~~~p~~---~~~~~~~~l~~Li~~C~~~dP~~RPt~~~I~~~ 186 (423)
........+.......+.. ....+++++.+|+.+||+.||.+|||+.++++.
T Consensus 288 ql~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H 362 (432)
T 3n9x_A 288 QLNIIFNIIGTPTEDDLKNINKPEVIKYIKLFPHRKPINLKQKYPSISDDGINLLESMLKFNPNKRITIDQALDH 362 (432)
T ss_dssp HHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTC
T ss_pred HHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 0011111111111111100 013578999999999999999999999998763
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=1.1e-25 Score=224.41 Aligned_cols=150 Identities=17% Similarity=0.276 Sum_probs=114.0
Q ss_pred HHHHHHHHHHHHHHHHh--CCCeeecCCCCCCEEEc--CCccEEEeccCCcccccCCCcccccccccCCccccCCccccC
Q psy1840 25 SISVNTTASVGMIHLHD--SEIISHGNLRSSNCLID--SRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKAPELLRQ 100 (423)
Q Consensus 25 ~l~i~~qi~~gL~yLH~--~~ii~HrDLkp~NILld--~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~ 100 (423)
...++.|++.||.|||+ .|++ ||||||+|||++ .++.+||+|||++...... .....+|+.|+|||++.+
T Consensus 159 ~~~i~~qi~~al~~lH~~~~~iv-HrDlkp~NIll~~~~~~~~kL~DFG~a~~~~~~-----~~~~~~t~~y~aPE~~~~ 232 (382)
T 2vx3_A 159 TRKFAQQMCTALLFLATPELSII-HCDLKPENILLCNPKRSAIKIVDFGSSCQLGQR-----IYQYIQSRFYRSPEVLLG 232 (382)
T ss_dssp HHHHHHHHHHHHHHHTSTTTCEE-CCCCSGGGEEESSTTSCCEEECCCTTCEETTCC-----CCSSCSCGGGCCHHHHTT
T ss_pred HHHHHHHHHHHHHHhccCCCCEE-cCCCCcccEEEecCCCCcEEEEeccCceecccc-----cccccCCccccChHHHcC
Confidence 67999999999999994 5777 999999999994 5788999999998765322 234578899999999988
Q ss_pred CCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCChHHHHHHHhcCCCCC------------------------------
Q psy1840 101 PHLPRGTQKGDVYSFGLVLYEVIGRQGPWGHLRMTDEEIITSVTQGSGLR------------------------------ 150 (423)
Q Consensus 101 ~~~~~~s~ksDVyS~Giil~elltg~~Pf~~~~~~~~~i~~~i~~~~~~~------------------------------ 150 (423)
..+ +.++|||||||++|||++|+.||... +..+.+..+.......
T Consensus 233 ~~~---~~~~DiwSlG~il~elltg~~pf~~~--~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 307 (382)
T 2vx3_A 233 MPY---DLAIDMWSLGCILVEMHTGEPLFSGA--NEVDQMNKIVEVLGIPPAHILDQAPKARKFFEKLPDGTWNLKKTKD 307 (382)
T ss_dssp CCC---CTHHHHHHHHHHHHHHHHSSCSSCCS--SHHHHHHHHHHHHCSCCHHHHTTCTTHHHHEEECTTSCEEECCCCT
T ss_pred CCC---CcHHHHHHHHHHHHHHHhCCCCCCCC--CHHHHHHHHHHHhCCCCHHHHHhhHHHHHHHHhccccccccccccc
Confidence 655 89999999999999999999999743 3334443333210000
Q ss_pred ------CCCCC------------------------CCchHHHHHHHHHhhhcCCCCCCCHHHHHH
Q psy1840 151 ------PDTSS------------------------LDCAPSIIACMRTCWEEDPELRPDLRFVHH 185 (423)
Q Consensus 151 ------p~~~~------------------------~~~~~~l~~Li~~C~~~dP~~RPt~~~I~~ 185 (423)
+.... ....+++.+|+.+||+.||++|||+.++++
T Consensus 308 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~Rpta~e~L~ 372 (382)
T 2vx3_A 308 GKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKDLILRMLDYDPKTRIQPYYALQ 372 (382)
T ss_dssp TCCCSCCTTCSCHHHHHTTTTTSGGGTTTTCTTCCHHHHHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred cccccCCcchhhHHHHhhccccCCCccccccccccchhhHHHHHHHHHhcCCChhhCCCHHHHhc
Confidence 00000 001147899999999999999999999875
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.92 E-value=4e-25 Score=213.24 Aligned_cols=155 Identities=20% Similarity=0.315 Sum_probs=113.7
Q ss_pred HHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCccEEEeccCCcccccCCCcccccccccCCccccCCccccCCCCC
Q psy1840 25 SISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKAPELLRQPHLP 104 (423)
Q Consensus 25 ~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~ 104 (423)
...++.|++.||.|||+.|++ ||||||+||+++.++.+||+|||++........ ......++..|+|||.+.+..
T Consensus 104 ~~~i~~~l~~~l~~lH~~~iv-H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~-- 178 (311)
T 4agu_A 104 VKSITWQTLQAVNFCHKHNCI-HRDVKPENILITKHSVIKLCDFGFARLLTGPSD--YYDDEVATRWYRSPELLVGDT-- 178 (311)
T ss_dssp HHHHHHHHHHHHHHHHHTTEE-CCCCSGGGEEECTTSCEEECCCTTCEECC--------------GGGCCHHHHHTCS--
T ss_pred HHHHHHHHHHHHHHHHHCCCc-CCCCChhhEEEcCCCCEEEeeCCCchhccCccc--ccCCCcCCccccChHHHhcCC--
Confidence 678999999999999999988 999999999999999999999999876543222 123456888999999987633
Q ss_pred CCCCccchHHHHHHHHHHHhCCCCCCCCCCChHHHHHHHhcC-------------------CCCCCCCC--------CCC
Q psy1840 105 RGTQKGDVYSFGLVLYEVIGRQGPWGHLRMTDEEIITSVTQG-------------------SGLRPDTS--------SLD 157 (423)
Q Consensus 105 ~~s~ksDVyS~Giil~elltg~~Pf~~~~~~~~~i~~~i~~~-------------------~~~~p~~~--------~~~ 157 (423)
.++.++||||||+++|+|++|..||.+. ...+....+... ....+... ...
T Consensus 179 ~~~~~~Di~slG~il~~l~~g~~p~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (311)
T 4agu_A 179 QYGPPVDVWAIGCVFAELLSGVPLWPGK--SDVDQLYLIRKTLGDLIPRHQQVFSTNQYFSGVKIPDPEDMEPLELKFPN 256 (311)
T ss_dssp CCCTHHHHHHHHHHHHHHHHSSCSCCCS--SHHHHHHHHHHHHCSCCHHHHHHHHTCGGGTTCCCCCCSSCCCHHHHCTT
T ss_pred CCCcchhhHHHHHHHHHHHhCCCCCCCC--CHHHHHHHHHHHhcccccccccccccccccccCcCCCccccchhhhhccc
Confidence 2389999999999999999999999753 233333222210 00001000 135
Q ss_pred chHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q psy1840 158 CAPSIIACMRTCWEEDPELRPDLRFVHHK 186 (423)
Q Consensus 158 ~~~~l~~Li~~C~~~dP~~RPt~~~I~~~ 186 (423)
++..+.+++.+||+.||++|||+.++++.
T Consensus 257 ~~~~~~~li~~~L~~dP~~Rpt~~ell~h 285 (311)
T 4agu_A 257 ISYPALGLLKGCLHMDPTERLTCEQLLHH 285 (311)
T ss_dssp CCHHHHHHHHHHCCSSTTTSCCHHHHHTS
T ss_pred ccHHHHHHHHHHccCChhhcCCHHHHhcC
Confidence 78889999999999999999999999763
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=99.92 E-value=3.1e-25 Score=218.42 Aligned_cols=154 Identities=17% Similarity=0.163 Sum_probs=118.3
Q ss_pred HHHHHHHHHHHHHHHH--hCCCeeecCCCCCCEEEcC-CccEEEeccCCcccccCCCcccccccccCCccccCCccccCC
Q psy1840 25 SISVNTTASVGMIHLH--DSEIISHGNLRSSNCLIDS-RWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKAPELLRQP 101 (423)
Q Consensus 25 ~l~i~~qi~~gL~yLH--~~~ii~HrDLkp~NILld~-~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~ 101 (423)
...++.|++.||.||| +.|++ ||||||+||+++. ++.+||+|||++........ .....+|+.|+|||.+.+.
T Consensus 131 ~~~~~~qi~~al~~lH~~~~~iv-H~Dlkp~NIll~~~~~~~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~ 206 (360)
T 3e3p_A 131 IKVFLFQLIRSIGCLHLPSVNVC-HRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEP---NVAYICSRYYRAPELIFGN 206 (360)
T ss_dssp HHHHHHHHHHHHHHHTSTTTCCB-CSCCCGGGEEEETTTTEEEECCCTTCBCCCTTSC---CCSTTSCGGGCCHHHHTTC
T ss_pred HHHHHHHHHHHHHHHhCCCCCee-cCcCCHHHEEEeCCCCcEEEeeCCCceecCCCCC---cccccCCcceeCHHHHcCC
Confidence 5689999999999999 99998 9999999999996 89999999999876543322 2345678999999998654
Q ss_pred CCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCChHHHHHHHhcCCCCC----------------------------CCC
Q psy1840 102 HLPRGTQKGDVYSFGLVLYEVIGRQGPWGHLRMTDEEIITSVTQGSGLR----------------------------PDT 153 (423)
Q Consensus 102 ~~~~~s~ksDVyS~Giil~elltg~~Pf~~~~~~~~~i~~~i~~~~~~~----------------------------p~~ 153 (423)
. .++.++|||||||++|||++|+.||... ...+.+..+....... ...
T Consensus 207 ~--~~~~~~Di~slG~il~ell~g~~pf~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 282 (360)
T 3e3p_A 207 Q--HYTTAVDIWSVGCIFAEMMLGEPIFRGD--NSAGQLHEIVRVLGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSD 282 (360)
T ss_dssp S--SCCTHHHHHHHHHHHHHHHHSSCSSCCS--SHHHHHHHHHHHHCCCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTT
T ss_pred C--CCCcHHHHHHHHHHHHHHHhCCCCcCCC--ChHHHHHHHHHHcCCCCHHHHHhcccchhhccccccccCCcccccch
Confidence 3 2489999999999999999999999753 3333333332110000 000
Q ss_pred CCCCchHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q psy1840 154 SSLDCAPSIIACMRTCWEEDPELRPDLRFVHHK 186 (423)
Q Consensus 154 ~~~~~~~~l~~Li~~C~~~dP~~RPt~~~I~~~ 186 (423)
.....++++.+++.+||+.||.+|||+.++++.
T Consensus 283 ~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 315 (360)
T 3e3p_A 283 HSLKDAKEAYDLLSALLQYLPEERMKPYEALCH 315 (360)
T ss_dssp CCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred hhccccHHHHHHHHHHhccCccccCCHHHHhcC
Confidence 112367899999999999999999999998753
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=99.92 E-value=1.8e-25 Score=222.85 Aligned_cols=153 Identities=18% Similarity=0.172 Sum_probs=118.1
Q ss_pred HHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEc-CCccEEEeccCCcccccCCCcccccccccCCccccCCccccCCCC
Q psy1840 25 SISVNTTASVGMIHLHDSEIISHGNLRSSNCLID-SRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKAPELLRQPHL 103 (423)
Q Consensus 25 ~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld-~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~ 103 (423)
...++.||+.||.|||+.|++ ||||||+||+++ .++.+||+|||+++....... .....+++.|+|||.+.+..
T Consensus 143 ~~~i~~qi~~aL~~LH~~gi~-H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~- 217 (383)
T 3eb0_A 143 ISIYIYQLFRAVGFIHSLGIC-HRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEP---SVAYICSRFYRAPELMLGAT- 217 (383)
T ss_dssp HHHHHHHHHHHHHHHHTTTEE-CSCCCGGGEEEETTTTEEEECCCTTCEECCTTSC---CCCCCCCSSCCCHHHHTTCS-
T ss_pred HHHHHHHHHHHHHHHHHCcCc-cCccCHHHEEEcCCCCcEEEEECCCCcccCCCCC---CcCcccCCCccCHHHhcCCC-
Confidence 578999999999999999988 999999999998 689999999999876543322 23456788999999987643
Q ss_pred CCCCCccchHHHHHHHHHHHhCCCCCCCCCCChHHHHHHHhcC-----------------CCCCCCC--------CCCCc
Q psy1840 104 PRGTQKGDVYSFGLVLYEVIGRQGPWGHLRMTDEEIITSVTQG-----------------SGLRPDT--------SSLDC 158 (423)
Q Consensus 104 ~~~s~ksDVyS~Giil~elltg~~Pf~~~~~~~~~i~~~i~~~-----------------~~~~p~~--------~~~~~ 158 (423)
.++.++||||+||++|||++|+.||.+. +..+.+..+... ....|.. ....+
T Consensus 218 -~~~~~~DiwslG~il~ell~g~~pf~~~--~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 294 (383)
T 3eb0_A 218 -EYTPSIDLWSIGCVFGELILGKPLFSGE--TSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGT 294 (383)
T ss_dssp -SCCTHHHHHHHHHHHHHHHHSSCSSCCS--SHHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTC
T ss_pred -CCCcchhhhhHHHHHHHHHhCCCCCCCC--ChHHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCC
Confidence 2389999999999999999999999743 333333332210 0001111 12346
Q ss_pred hHHHHHHHHHhhhcCCCCCCCHHHHHH
Q psy1840 159 APSIIACMRTCWEEDPELRPDLRFVHH 185 (423)
Q Consensus 159 ~~~l~~Li~~C~~~dP~~RPt~~~I~~ 185 (423)
++++.+|+.+||+.||.+|||+.++++
T Consensus 295 ~~~~~~li~~~L~~dP~~R~t~~e~l~ 321 (383)
T 3eb0_A 295 PSLAIDLLEQILRYEPDLRINPYEAMA 321 (383)
T ss_dssp CHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred CHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 889999999999999999999999875
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=99.92 E-value=1.5e-25 Score=222.58 Aligned_cols=153 Identities=18% Similarity=0.242 Sum_probs=109.6
Q ss_pred HHHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCccEEEeccCCcccccCCCcccccccccCCccccCCccccCCCC
Q psy1840 24 GSISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKAPELLRQPHL 103 (423)
Q Consensus 24 ~~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~ 103 (423)
....++.||+.||.|||+.|++ ||||||+||+++.++.+||+|||+++..... .....+|+.|+|||++.+..
T Consensus 133 ~~~~i~~qi~~aL~~LH~~giv-H~Dlkp~NIll~~~~~~kL~DFG~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~- 205 (367)
T 2fst_X 133 HVQFLIYQILRGLKYIHSADII-HRDLKPSNLAVNEDCELKILDFGLARHTADE-----MTGYVATRWYRAPEIMLNWM- 205 (367)
T ss_dssp HHHHHHHHHHHHHHHHHHTTCC-CCCCCGGGEEECTTCCEEECC--------------------CCCTTCCHHHHTTCC-
T ss_pred HHHHHHHHHHHHHHHHHHCCee-eCCCCHhhEEECCCCCEEEeecccccccccc-----CCCcCcCcCccChHHHcCCc-
Confidence 3678999999999999999998 9999999999999999999999998764322 23457889999999987632
Q ss_pred CCCCCccchHHHHHHHHHHHhCCCCCCCCCCChHHHHHHHhcC-----------------------CCCCCCCC----CC
Q psy1840 104 PRGTQKGDVYSFGLVLYEVIGRQGPWGHLRMTDEEIITSVTQG-----------------------SGLRPDTS----SL 156 (423)
Q Consensus 104 ~~~s~ksDVyS~Giil~elltg~~Pf~~~~~~~~~i~~~i~~~-----------------------~~~~p~~~----~~ 156 (423)
.++.++|||||||++|||++|+.||.+. +..+.+..+... ....+... ..
T Consensus 206 -~~~~~~DiwslG~il~ell~g~~pf~~~--~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 282 (367)
T 2fst_X 206 -HYNQTVDIWSVGCIMAELLTGRTLFPGT--DHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFI 282 (367)
T ss_dssp -SCCTTHHHHHHHHHHHHHHHSSCSCCCS--SHHHHHHHHHHHHCSCCHHHHTTCCCHHHHHHHHTSCCCCCCCHHHHTT
T ss_pred -CCCchhhHHHHHHHHHHHHhCCCCCCCC--CHHHHHHHHHHHhCCCCHHHHHHhhhHHHHHHHhccCCCCCCCHHHHCC
Confidence 2489999999999999999999999753 223333222210 00011110 12
Q ss_pred CchHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q psy1840 157 DCAPSIIACMRTCWEEDPELRPDLRFVHHK 186 (423)
Q Consensus 157 ~~~~~l~~Li~~C~~~dP~~RPt~~~I~~~ 186 (423)
.+++.+.+|+.+||+.||.+|||+.+++..
T Consensus 283 ~~~~~~~dLl~~mL~~dP~~R~t~~e~L~h 312 (367)
T 2fst_X 283 GANPLAVDLLEKMLVLDSDKRITAAQALAH 312 (367)
T ss_dssp TCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred CCCHHHHHHHHHhCCCCcccCcCHHHHhcC
Confidence 467889999999999999999999998763
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=99.92 E-value=1.2e-25 Score=224.33 Aligned_cols=158 Identities=15% Similarity=0.227 Sum_probs=115.0
Q ss_pred HHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCccEEEeccCCcccccCCCc-----ccccccccCCccccCCcccc
Q psy1840 25 SISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDE-----TGQERKLRRRKLYKAPELLR 99 (423)
Q Consensus 25 ~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~-----~~~~~~~~gt~~y~APE~l~ 99 (423)
...++.||+.||.|||++|++ ||||||+|||++.++.+||+|||.+........ ........|++.|+|||++.
T Consensus 130 ~~~~~~qi~~~l~~LH~~~iv-HrDlkp~NIll~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~ 208 (389)
T 3gni_B 130 IAYILQGVLKALDYIHHMGYV-HRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQ 208 (389)
T ss_dssp HHHHHHHHHHHHHHHHHTTEE-CCCCSGGGEEECTTCCEEECCGGGCEECEETTEECSCBCCCCTTCTTTGGGSCHHHHS
T ss_pred HHHHHHHHHHHHHHHHhCCee-cCCCCHHHEEEcCCCCEEEcccccceeeccccccccccccccccccccccccCHHHHh
Confidence 678999999999999999988 999999999999999999999998754322111 11122346888899999998
Q ss_pred CCCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCChHHHHHHHhcCCC-------------------------------
Q psy1840 100 QPHLPRGTQKGDVYSFGLVLYEVIGRQGPWGHLRMTDEEIITSVTQGSG------------------------------- 148 (423)
Q Consensus 100 ~~~~~~~s~ksDVyS~Giil~elltg~~Pf~~~~~~~~~i~~~i~~~~~------------------------------- 148 (423)
+... .++.++|||||||++|||++|+.||.+..... ....+..+..
T Consensus 209 ~~~~-~~~~~~DiwslG~il~el~~g~~pf~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 285 (389)
T 3gni_B 209 QNLQ-GYDAKSDIYSVGITACELANGHVPFKDMPATQ--MLLEKLNGTVPCLLDTSTIPAEELTMSPSRSVANSGLSDSL 285 (389)
T ss_dssp TTSS-CBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTT--HHHHC------------------------------------
T ss_pred ccCC-CCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHH--HHHHHhcCCCCcccccccccccccccccccccccccccccc
Confidence 7321 24899999999999999999999997543221 1111110000
Q ss_pred -----------CCCCCCCCCchHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q psy1840 149 -----------LRPDTSSLDCAPSIIACMRTCWEEDPELRPDLRFVHHK 186 (423)
Q Consensus 149 -----------~~p~~~~~~~~~~l~~Li~~C~~~dP~~RPt~~~I~~~ 186 (423)
.........+++.+.+|+.+||+.||++|||+.++++.
T Consensus 286 ~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~h 334 (389)
T 3gni_B 286 TTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNH 334 (389)
T ss_dssp --------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred ccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhcC
Confidence 00001123467889999999999999999999998753
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.92 E-value=2.9e-25 Score=225.21 Aligned_cols=157 Identities=24% Similarity=0.313 Sum_probs=112.4
Q ss_pred HHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEc-----CCccEEEeccCCcccccCCCc-ccccccccCCccccCCccc
Q psy1840 25 SISVNTTASVGMIHLHDSEIISHGNLRSSNCLID-----SRWVLQIADFGLHAFKAGQDE-TGQERKLRRRKLYKAPELL 98 (423)
Q Consensus 25 ~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld-----~~~~vKL~DFGla~~~~~~~~-~~~~~~~~gt~~y~APE~l 98 (423)
.+.++.||+.||.|||+.|++ ||||||+||+++ ....+||+|||+++....... ........||+.|+|||++
T Consensus 120 ~~~i~~qi~~aL~~LH~~~iv-HrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~gt~~y~APE~l 198 (432)
T 3p23_A 120 PITLLQQTTSGLAHLHSLNIV-HRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEML 198 (432)
T ss_dssp HHHHHHHHHHHHHHHHHTTCC-CCCCSTTSEEECCCBTTTBCCEEECCTTEEECC------------CCSCTTSCCGGGT
T ss_pred HHHHHHHHHHHHHHHHHCcCE-eCCCCHHHEEEecCCCCCceeEEEecccceeeccCCCcceeeccccCCCcCccChhhh
Confidence 578999999999999999998 999999999994 334688999999876543221 1223456789999999999
Q ss_pred cCCCCCCCCCccchHHHHHHHHHHHh-CCCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCchHHHHHHHHHhhhcCCCCC
Q psy1840 99 RQPHLPRGTQKGDVYSFGLVLYEVIG-RQGPWGHLRMTDEEIITSVTQGSGLRPDTSSLDCAPSIIACMRTCWEEDPELR 177 (423)
Q Consensus 99 ~~~~~~~~s~ksDVyS~Giil~ellt-g~~Pf~~~~~~~~~i~~~i~~~~~~~p~~~~~~~~~~l~~Li~~C~~~dP~~R 177 (423)
.+......+.++|||||||++|||++ |..||..... .. ...+...............+..+.+++.+||+.||.+|
T Consensus 199 ~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~--~~-~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R 275 (432)
T 3p23_A 199 SEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQ--RQ-ANILLGACSLDCLHPEKHEDVIARELIEKMIAMDPQKR 275 (432)
T ss_dssp SCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTT--HH-HHHHTTCCCCTTSCTTCHHHHHHHHHHHHHSCSSGGGS
T ss_pred hcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhH--HH-HHHHhccCCccccCccccccHHHHHHHHHHHhCCHhhC
Confidence 85432244789999999999999999 8899964321 22 22222222222212223456678999999999999999
Q ss_pred CCHHHHHH
Q psy1840 178 PDLRFVHH 185 (423)
Q Consensus 178 Pt~~~I~~ 185 (423)
||+.+|++
T Consensus 276 ps~~evl~ 283 (432)
T 3p23_A 276 PSAKHVLK 283 (432)
T ss_dssp CCHHHHHT
T ss_pred CCHHHHHh
Confidence 99999975
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.92 E-value=1.9e-25 Score=213.54 Aligned_cols=154 Identities=22% Similarity=0.330 Sum_probs=117.3
Q ss_pred HHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcC-CccEEEeccCCcccccCCCcccccccccCCccccCCccccCCCC
Q psy1840 25 SISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDS-RWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKAPELLRQPHL 103 (423)
Q Consensus 25 ~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~-~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~ 103 (423)
...++.|++.||.|||+.|++ ||||||+||+++. ++.+||+|||++........ ......+++.|+|||.+.+...
T Consensus 124 ~~~~~~qi~~~l~~lH~~~i~-H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~ 200 (295)
T 2clq_A 124 IGFYTKQILEGLKYLHDNQIV-HRDIKGDNVLINTYSGVLKISDFGTSKRLAGINP--CTETFTGTLQYMAPEIIDKGPR 200 (295)
T ss_dssp HHHHHHHHHHHHHHHHHTTEE-CCCCSGGGEEEETTTCCEEECCTTTCEESCC-------CCCCCCGGGCCHHHHHHGGG
T ss_pred HHHHHHHHHHHHHHHHhCCEE-ccCCChhhEEEECCCCCEEEeecccccccCCCCC--cccccCCCccccChhhhcCCCC
Confidence 467899999999999999988 9999999999987 89999999999876543221 1234568899999999876431
Q ss_pred CCCCCccchHHHHHHHHHHHhCCCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCchHHHHHHHHHhhhcCCCCCCCHHHH
Q psy1840 104 PRGTQKGDVYSFGLVLYEVIGRQGPWGHLRMTDEEIITSVTQGSGLRPDTSSLDCAPSIIACMRTCWEEDPELRPDLRFV 183 (423)
Q Consensus 104 ~~~s~ksDVyS~Giil~elltg~~Pf~~~~~~~~~i~~~i~~~~~~~p~~~~~~~~~~l~~Li~~C~~~dP~~RPt~~~I 183 (423)
..+.++||||||+++|+|++|..||................. ..+.. +..+++++.+++.+||+.||++||++.++
T Consensus 201 -~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~--~~~~~-~~~~~~~~~~li~~~l~~dp~~Rps~~~l 276 (295)
T 2clq_A 201 -GYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFK--VHPEI-PESMSAEAKAFILKCFEPDPDKRACANDL 276 (295)
T ss_dssp -GCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHHHHHHHHC--CCCCC-CTTSCHHHHHHHHHTTCSSTTTSCCHHHH
T ss_pred -CCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHHHhhcccc--ccccc-cccCCHHHHHHHHHHccCChhhCCCHHHH
Confidence 237899999999999999999999964332222222221111 12222 23678999999999999999999999998
Q ss_pred HH
Q psy1840 184 HH 185 (423)
Q Consensus 184 ~~ 185 (423)
++
T Consensus 277 l~ 278 (295)
T 2clq_A 277 LV 278 (295)
T ss_dssp HT
T ss_pred hc
Confidence 75
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=99.92 E-value=2.9e-25 Score=212.41 Aligned_cols=156 Identities=22% Similarity=0.290 Sum_probs=116.4
Q ss_pred HHHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCccEEEeccCCcccccCCCc------------ccccccccCCcc
Q psy1840 24 GSISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDE------------TGQERKLRRRKL 91 (423)
Q Consensus 24 ~~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~------------~~~~~~~~gt~~ 91 (423)
....++.|++.||.|||++|++ ||||||+||+++.++.+||+|||++........ ........+++.
T Consensus 117 ~~~~i~~qi~~~l~~LH~~~i~-H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (303)
T 1zy4_A 117 EYWRLFRQILEALSYIHSQGII-HRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAM 195 (303)
T ss_dssp HHHHHHHHHHHHHHHHHHTTCC-CSCCCGGGEEECTTSCEEECCCCCCSCTTC-------------------------CT
T ss_pred HHHHHHHHHHHHHHHHHhCCee-cccCCHHhEEEcCCCCEEEeeCcchhhcccccchhccccccccccccccccCCCccc
Confidence 3578999999999999999998 999999999999999999999999876432210 111234568889
Q ss_pred ccCCccccCCCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCchHHHHHHHHHhhh
Q psy1840 92 YKAPELLRQPHLPRGTQKGDVYSFGLVLYEVIGRQGPWGHLRMTDEEIITSVTQGSGLRPDTSSLDCAPSIIACMRTCWE 171 (423)
Q Consensus 92 y~APE~l~~~~~~~~s~ksDVyS~Giil~elltg~~Pf~~~~~~~~~i~~~i~~~~~~~p~~~~~~~~~~l~~Li~~C~~ 171 (423)
|+|||.+.+.. .++.++|||||||++|||++ ||.. .....++...+.......|.......+..+.+++.+||+
T Consensus 196 y~aPE~~~~~~--~~~~~~Di~slG~il~~l~~---p~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~ 269 (303)
T 1zy4_A 196 YVATEVLDGTG--HYNEKIDMYSLGIIFFEMIY---PFST-GMERVNILKKLRSVSIEFPPDFDDNKMKVEKKIIRLLID 269 (303)
T ss_dssp TSCHHHHTSCS--CCCTHHHHHHHHHHHHHHHS---CCSS-HHHHHHHHHHHHSTTCCCCTTCCTTTSHHHHHHHHHHTC
T ss_pred ccCcccccCCC--CCcchhhHHHHHHHHHHHHh---ccCC-chhHHHHHHhccccccccCccccccchHHHHHHHHHHHh
Confidence 99999987642 24899999999999999998 5532 122344555555544444444445678899999999999
Q ss_pred cCCCCCCCHHHHHHH
Q psy1840 172 EDPELRPDLRFVHHK 186 (423)
Q Consensus 172 ~dP~~RPt~~~I~~~ 186 (423)
.||.+|||+.++++.
T Consensus 270 ~dp~~Rps~~~ll~h 284 (303)
T 1zy4_A 270 HDPNKRPGARTLLNS 284 (303)
T ss_dssp SSGGGSCCHHHHHHS
T ss_pred cCcccCcCHHHHhCC
Confidence 999999999999863
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=99.92 E-value=2e-25 Score=217.20 Aligned_cols=157 Identities=18% Similarity=0.200 Sum_probs=117.4
Q ss_pred HHHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCc-cEEEeccCCcccccCCCcccccccccCCccccCCccccCCC
Q psy1840 24 GSISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRW-VLQIADFGLHAFKAGQDETGQERKLRRRKLYKAPELLRQPH 102 (423)
Q Consensus 24 ~~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~-~vKL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~ 102 (423)
....++.||+.||.|||+.|++ ||||||+||+++.++ .+||+|||+++....... .....++..|+|||.+.+..
T Consensus 131 ~~~~~~~qi~~~l~~lH~~~iv-H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~---~~~~~~~~~y~aPE~~~~~~ 206 (330)
T 3nsz_A 131 DIRFYMYEILKALDYCHSMGIM-HRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQE---YNVRVASRYFKGPELLVDYQ 206 (330)
T ss_dssp HHHHHHHHHHHHHHHHHHTTEE-CCCCSGGGEEEETTTTEEEECCCTTCEECCTTCC---CCSCCSCGGGCCHHHHTTCC
T ss_pred HHHHHHHHHHHHHHHHHhCCee-eCCCCHHHEEEcCCCCEEEEEeCCCceEcCCCCc---cccccccccccChhhhcCCC
Confidence 3678999999999999999988 999999999999776 899999999876543322 23456888999999987633
Q ss_pred CCCCCCccchHHHHHHHHHHHhCCCCCCCCCCChHHHH------------HHHhcCCCC--------------------C
Q psy1840 103 LPRGTQKGDVYSFGLVLYEVIGRQGPWGHLRMTDEEII------------TSVTQGSGL--------------------R 150 (423)
Q Consensus 103 ~~~~s~ksDVyS~Giil~elltg~~Pf~~~~~~~~~i~------------~~i~~~~~~--------------------~ 150 (423)
.++.++|||||||++|||++|..||.........+. ..+...... .
T Consensus 207 --~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 284 (330)
T 3nsz_A 207 --MYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFV 284 (330)
T ss_dssp --CCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCCCCTHHHHHHCCCCCCCGGGGC
T ss_pred --cCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchhhhHHHHhccccccchhhhhhhccccchhhhc
Confidence 248999999999999999999999954322222111 111111100 0
Q ss_pred CCCCCCCchHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q psy1840 151 PDTSSLDCAPSIIACMRTCWEEDPELRPDLRFVHHK 186 (423)
Q Consensus 151 p~~~~~~~~~~l~~Li~~C~~~dP~~RPt~~~I~~~ 186 (423)
+......+++++.+++.+||+.||.+|||+.++++.
T Consensus 285 ~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~h 320 (330)
T 3nsz_A 285 HSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEH 320 (330)
T ss_dssp CTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred cccccccCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 011112368899999999999999999999999763
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=8.8e-26 Score=224.75 Aligned_cols=152 Identities=19% Similarity=0.205 Sum_probs=115.3
Q ss_pred HHHHHHHHHHHHHHHHhC-CCeeecCCCCCCEEEcCCc------------------------------------------
Q psy1840 25 SISVNTTASVGMIHLHDS-EIISHGNLRSSNCLIDSRW------------------------------------------ 61 (423)
Q Consensus 25 ~l~i~~qi~~gL~yLH~~-~ii~HrDLkp~NILld~~~------------------------------------------ 61 (423)
...++.||+.||.|||++ |++ ||||||+|||++.++
T Consensus 148 ~~~i~~qi~~aL~~lH~~~giv-HrDikp~NIll~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (397)
T 1wak_A 148 VKKIIQQVLQGLDYLHTKCRII-HTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLE 226 (397)
T ss_dssp HHHHHHHHHHHHHHHHHTTCEE-CCCCSGGGEEECCCHHHHHHHHHHHC---------------------CCTTSCCTTS
T ss_pred HHHHHHHHHHHHHHHHHhCCEe-cCCCCHHHeeEeccchhhhhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccc
Confidence 679999999999999998 888 999999999999775
Q ss_pred -------cEEEeccCCcccccCCCcccccccccCCccccCCccccCCCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCC
Q psy1840 62 -------VLQIADFGLHAFKAGQDETGQERKLRRRKLYKAPELLRQPHLPRGTQKGDVYSFGLVLYEVIGRQGPWGHLRM 134 (423)
Q Consensus 62 -------~vKL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~s~ksDVyS~Giil~elltg~~Pf~~~~~ 134 (423)
.+||+|||++...... .....||+.|+|||++.+..+ +.++|||||||++|||++|..||.....
T Consensus 227 ~~~~~~~~~kl~DfG~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~---~~~~DiwslG~il~elltg~~pf~~~~~ 298 (397)
T 1wak_A 227 PKNAEKLKVKIADLGNACWVHKH-----FTEDIQTRQYRSLEVLIGSGY---NTPADIWSTACMAFELATGDYLFEPHSG 298 (397)
T ss_dssp GGGGGGCCEEECCGGGCEETTBC-----SCSCCSCGGGCCHHHHHTSCC---CTHHHHHHHHHHHHHHHHSSCSCCCCCC
T ss_pred cccccccceEecccccccccccc-----CccCCCCCcccCChhhcCCCC---CcHHHHHHHHHHHHHHhhCCCCCCCCcc
Confidence 7999999998765322 234568999999999988665 8999999999999999999999965322
Q ss_pred C----hHHHHHHHhcCCCCCC------------------------C--------------CCCCCchHHHHHHHHHhhhc
Q psy1840 135 T----DEEIITSVTQGSGLRP------------------------D--------------TSSLDCAPSIIACMRTCWEE 172 (423)
Q Consensus 135 ~----~~~i~~~i~~~~~~~p------------------------~--------------~~~~~~~~~l~~Li~~C~~~ 172 (423)
. ....+..+.......| . ......+..+.+|+.+||+.
T Consensus 299 ~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~ 378 (397)
T 1wak_A 299 EEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLEL 378 (397)
T ss_dssp SSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCCCCCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCS
T ss_pred cccCchHHHHHHHHHhcCCCChHHhhcccccccccCCccccccccccCCcchhHhhhhhcccchhhHHHHHHHHHHHhcc
Confidence 1 1122222111000000 0 00123456789999999999
Q ss_pred CCCCCCCHHHHHH
Q psy1840 173 DPELRPDLRFVHH 185 (423)
Q Consensus 173 dP~~RPt~~~I~~ 185 (423)
||++|||+.++++
T Consensus 379 dP~~Rpt~~e~l~ 391 (397)
T 1wak_A 379 IPEKRATAAECLR 391 (397)
T ss_dssp SGGGSCCHHHHHT
T ss_pred ChhhcCCHHHHhh
Confidence 9999999999875
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=99.92 E-value=1.8e-25 Score=221.22 Aligned_cols=158 Identities=16% Similarity=0.241 Sum_probs=119.0
Q ss_pred HHHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCccEEEeccCCcccccCCCcc-cccccccCCccccCCccccCCC
Q psy1840 24 GSISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDET-GQERKLRRRKLYKAPELLRQPH 102 (423)
Q Consensus 24 ~~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~~-~~~~~~~gt~~y~APE~l~~~~ 102 (423)
....++.||+.||.|||+.|++ ||||||+||+++.++.+||+|||++......... .......||+.|+|||++.+..
T Consensus 129 ~~~~i~~qi~~aL~~LH~~~iv-H~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~ 207 (364)
T 3qyz_A 129 HICYFLYQILRGLKYIHSANVL-HRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSK 207 (364)
T ss_dssp HHHHHHHHHHHHHHHHHHTTEE-CCCCCGGGEEECTTCCEEECCCTTCEECCGGGCBCCTTCCCCSCGGGCCHHHHHTBC
T ss_pred HHHHHHHHHHHHHHHHHHCCee-cCCCChHhEEECCCCCEEEEeCcceEecCCCCCccccccccccccCCCCCHHhcCCC
Confidence 3678999999999999999988 9999999999999999999999998765432211 1124457899999999876543
Q ss_pred CCCCCCccchHHHHHHHHHHHhCCCCCCCCCCChHHHHHHHhcC-----------------------CCCCCCC----CC
Q psy1840 103 LPRGTQKGDVYSFGLVLYEVIGRQGPWGHLRMTDEEIITSVTQG-----------------------SGLRPDT----SS 155 (423)
Q Consensus 103 ~~~~s~ksDVyS~Giil~elltg~~Pf~~~~~~~~~i~~~i~~~-----------------------~~~~p~~----~~ 155 (423)
.++.++|||||||++|||++|+.||.... ..+.+..+... .+..... ..
T Consensus 208 --~~~~~~DiwslG~il~ell~g~~pf~~~~--~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 283 (364)
T 3qyz_A 208 --GYTKSIDIWSVGCILAEMLSNRPIFPGKH--YLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLF 283 (364)
T ss_dssp --SCSTHHHHHHHHHHHHHHHHSSCSSCCSS--GGGHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHC
T ss_pred --CCCcchhHHHHHHHHHHHHHCCCCCCCCC--hHHHHHHHHHHhCCCCHHHHHHhhhhhHHHHHHhcCCccCCCHHHhC
Confidence 23899999999999999999999997532 22222222110 0000000 01
Q ss_pred CCchHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q psy1840 156 LDCAPSIIACMRTCWEEDPELRPDLRFVHHK 186 (423)
Q Consensus 156 ~~~~~~l~~Li~~C~~~dP~~RPt~~~I~~~ 186 (423)
..+++++.+++.+||+.||++|||+.++++.
T Consensus 284 ~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 314 (364)
T 3qyz_A 284 PNADSKALDLLDKMLTFNPHKRIEVEQALAH 314 (364)
T ss_dssp TTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred CCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 3567899999999999999999999998763
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=1.1e-25 Score=216.02 Aligned_cols=157 Identities=18% Similarity=0.271 Sum_probs=118.2
Q ss_pred HHHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCccEEEeccCCcccccCCCcccccccccCCccccCCccccCC--
Q psy1840 24 GSISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKAPELLRQP-- 101 (423)
Q Consensus 24 ~~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~-- 101 (423)
....++.||+.||.|||+.|++ ||||||+||+++.++.+||+|||++...... ........+++.|+|||.+...
T Consensus 118 ~~~~~~~~i~~~l~~lH~~~i~-H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~ 194 (302)
T 2j7t_A 118 QIQVVCRQMLEALNFLHSKRII-HRDLKAGNVLMTLEGDIRLADFGVSAKNLKT--LQKRDSFIGTPYWMAPEVVMCETM 194 (302)
T ss_dssp HHHHHHHHHHHHHHHHHHTTCC-CCCCSGGGEEECTTSCEEECCCHHHHHHHHH--HHC-----CCGGGCCHHHHHHHHT
T ss_pred HHHHHHHHHHHHHHHHhcCCcc-cCCCCHHHEEECCCCCEEEEECCCCcccccc--ccccccccCChhhcCCeeeccccC
Confidence 3679999999999999999998 9999999999999999999999986532111 1111345688899999998411
Q ss_pred CCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCchHHHHHHHHHhhhcCCCCCCCHH
Q psy1840 102 HLPRGTQKGDVYSFGLVLYEVIGRQGPWGHLRMTDEEIITSVTQGSGLRPDTSSLDCAPSIIACMRTCWEEDPELRPDLR 181 (423)
Q Consensus 102 ~~~~~s~ksDVyS~Giil~elltg~~Pf~~~~~~~~~i~~~i~~~~~~~p~~~~~~~~~~l~~Li~~C~~~dP~~RPt~~ 181 (423)
.....+.++||||||+++|+|++|..||.. .........+........ .....++..+.+++.+||+.||++|||+.
T Consensus 195 ~~~~~~~~~Di~slG~il~~l~~g~~p~~~--~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~~l~~dp~~Rps~~ 271 (302)
T 2j7t_A 195 KDTPYDYKADIWSLGITLIEMAQIEPPHHE--LNPMRVLLKIAKSDPPTL-LTPSKWSVEFRDFLKIALDKNPETRPSAA 271 (302)
T ss_dssp TSTTTTTHHHHHHHHHHHHHHHHSSCTTTT--SCHHHHHHHHHHSCCCCC-SSGGGSCHHHHHHHHHHSCSCTTTSCCHH
T ss_pred CCCCCchhhhHHHHHHHHHHHhcCCCCCcc--CCHHHHHHHHhccCCccc-CCccccCHHHHHHHHHHcccChhhCCCHH
Confidence 011238899999999999999999999974 344455555544332211 12345788999999999999999999999
Q ss_pred HHHHH
Q psy1840 182 FVHHK 186 (423)
Q Consensus 182 ~I~~~ 186 (423)
++++.
T Consensus 272 ~ll~h 276 (302)
T 2j7t_A 272 QLLEH 276 (302)
T ss_dssp HHTTS
T ss_pred HHhcC
Confidence 98763
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.92 E-value=1.3e-25 Score=226.38 Aligned_cols=155 Identities=15% Similarity=0.134 Sum_probs=119.3
Q ss_pred HHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCccEEEeccCCcccccCCCcccccccccCCccccCCccccCC---
Q psy1840 25 SISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKAPELLRQP--- 101 (423)
Q Consensus 25 ~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~--- 101 (423)
...++.||+.||+|||+.|++ ||||||+|||++.++.+||+|||+++....... .......||+.|+|||++...
T Consensus 164 ~~~~~~qi~~aL~~LH~~gii-HrDLKp~NILld~~g~vkL~DFGla~~~~~~~~-~~~~~~~Gt~~Y~APE~l~~~~~~ 241 (412)
T 2vd5_A 164 ARFYLAEIVMAIDSVHRLGYV-HRDIKPDNILLDRCGHIRLADFGSCLKLRADGT-VRSLVAVGTPDYLSPEILQAVGGG 241 (412)
T ss_dssp HHHHHHHHHHHHHHHHHTTEE-CCCCSGGGEEECTTSCEEECCCTTCEECCTTSC-EECSSCCSCGGGCCHHHHHHHHTC
T ss_pred HHHHHHHHHHHHHHHHHCCee-ecccCHHHeeecCCCCEEEeechhheeccCCCc-cccceeccccCcCCHHHHhhcccC
Confidence 567899999999999999988 999999999999999999999999876543221 122346799999999999731
Q ss_pred -CCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCChHHHHHHHhcCC--CCCCCCCCCCchHHHHHHHHHhhhcCCCCC-
Q psy1840 102 -HLPRGTQKGDVYSFGLVLYEVIGRQGPWGHLRMTDEEIITSVTQGS--GLRPDTSSLDCAPSIIACMRTCWEEDPELR- 177 (423)
Q Consensus 102 -~~~~~s~ksDVyS~Giil~elltg~~Pf~~~~~~~~~i~~~i~~~~--~~~p~~~~~~~~~~l~~Li~~C~~~dP~~R- 177 (423)
....++.++|||||||++|||++|+.||.. .+..+....+.... ...|. ....+++++.++|++||. +|.+|
T Consensus 242 ~~~~~~~~~~DiwSlGvilyelltG~~Pf~~--~~~~~~~~~i~~~~~~~~~p~-~~~~~s~~~~dli~~lL~-~p~~Rl 317 (412)
T 2vd5_A 242 PGTGSYGPECDWWALGVFAYEMFYGQTPFYA--DSTAETYGKIVHYKEHLSLPL-VDEGVPEEARDFIQRLLC-PPETRL 317 (412)
T ss_dssp TTCSEECTHHHHHHHHHHHHHHHHSSCTTCC--SSHHHHHHHHHTHHHHCCCC-----CCCHHHHHHHHTTSS-CGGGCT
T ss_pred cCCCCCChHHhhhHHhHHHHHHHhCCCCCCC--CCHHHHHHHHHhcccCcCCCc-cccCCCHHHHHHHHHHcC-ChhhcC
Confidence 011238999999999999999999999974 44556666655321 11222 123688999999999999 99998
Q ss_pred --CCHHHHHH
Q psy1840 178 --PDLRFVHH 185 (423)
Q Consensus 178 --Pt~~~I~~ 185 (423)
|++.+|++
T Consensus 318 gr~~~~ei~~ 327 (412)
T 2vd5_A 318 GRGGAGDFRT 327 (412)
T ss_dssp TTTTHHHHHT
T ss_pred CCCCHHHHhc
Confidence 58888764
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=99.92 E-value=4.3e-25 Score=216.34 Aligned_cols=155 Identities=16% Similarity=0.215 Sum_probs=124.0
Q ss_pred HHHHHHHHHHHHHHHHHh-CCCeeecCCCCCCEEEcCCccEEEeccCCcccccCCCcccccccccCCccccCCccccCCC
Q psy1840 24 GSISVNTTASVGMIHLHD-SEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKAPELLRQPH 102 (423)
Q Consensus 24 ~~l~i~~qi~~gL~yLH~-~~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~ 102 (423)
....++.||+.||.|||+ .|++ ||||||+||+++.++.+||+|||++...... ......++..|+|||.+.+..
T Consensus 152 ~~~~i~~qi~~~l~~lH~~~~i~-H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~ 226 (348)
T 2pml_X 152 VIKCIIKSVLNSFSYIHNEKNIC-HRDVKPSNILMDKNGRVKLSDFGESEYMVDK----KIKGSRGTYEFMPPEFFSNES 226 (348)
T ss_dssp HHHHHHHHHHHHHHHHHHTSCEE-CCCCCGGGEEECTTSCEEECCCTTCEECBTT----EECSSCSCGGGCCGGGGSSCC
T ss_pred HHHHHHHHHHHHHHHHhccCCEe-ecCCChHhEEEcCCCcEEEeccccccccccc----cccCCCCCcCccCchhhcCCC
Confidence 368999999999999999 8988 9999999999999999999999998765332 223457889999999998752
Q ss_pred CCCCCC-ccchHHHHHHHHHHHhCCCCCCCCCCChHHHHHHHhcCCCCCCCCC---------------CCCchHHHHHHH
Q psy1840 103 LPRGTQ-KGDVYSFGLVLYEVIGRQGPWGHLRMTDEEIITSVTQGSGLRPDTS---------------SLDCAPSIIACM 166 (423)
Q Consensus 103 ~~~~s~-ksDVyS~Giil~elltg~~Pf~~~~~~~~~i~~~i~~~~~~~p~~~---------------~~~~~~~l~~Li 166 (423)
.++. ++||||||+++|||++|..||.... ...++...+..+....|... ...++.++.+++
T Consensus 227 --~~~~~~~Di~slG~il~~l~~g~~pf~~~~-~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 303 (348)
T 2pml_X 227 --SYNGAKVDIWSLGICLYVMFYNVVPFSLKI-SLVELFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFL 303 (348)
T ss_dssp --CEEHHHHHHHHHHHHHHHHHHSSCSSCCSS-CSHHHHHHHTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHH
T ss_pred --CCCcchhhHHHHHHHHHHHHhCCCCCCCCC-cHHHHHHHHhccCcCCccchhhhhccccccccccchhhcCHHHHHHH
Confidence 1144 9999999999999999999997532 22566777766543333110 145789999999
Q ss_pred HHhhhcCCCCCCCHHHHHHH
Q psy1840 167 RTCWEEDPELRPDLRFVHHK 186 (423)
Q Consensus 167 ~~C~~~dP~~RPt~~~I~~~ 186 (423)
.+||+.||.+||++.++++.
T Consensus 304 ~~~L~~dP~~Rps~~e~l~h 323 (348)
T 2pml_X 304 KLFLRKNPAERITSEDALKH 323 (348)
T ss_dssp HHHCCSSGGGSCCHHHHHTS
T ss_pred HHHccCChhhCCCHHHHhcC
Confidence 99999999999999999763
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=7.6e-26 Score=219.82 Aligned_cols=157 Identities=20% Similarity=0.242 Sum_probs=119.0
Q ss_pred HHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCcc---EEEeccCCcccccCCCcccccccccCCccccCCccccCC
Q psy1840 25 SISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWV---LQIADFGLHAFKAGQDETGQERKLRRRKLYKAPELLRQP 101 (423)
Q Consensus 25 ~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~~---vKL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~ 101 (423)
...++.||+.||.|||++|++ ||||||+||+++.++. +||+|||++....... ......|++.|+|||.+.+.
T Consensus 116 ~~~~~~qi~~~l~~lH~~~iv-H~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~ 191 (322)
T 2ycf_A 116 CKLYFYQMLLAVQYLHENGII-HRDLKPENVLLSSQEEDCLIKITDFGHSKILGETS---LMRTLCGTPTYLAPEVLVSV 191 (322)
T ss_dssp HHHHHHHHHHHHHHHHHTTEE-CCCCSGGGEEESSSSSSCCEEECCCTTCEECCCCH---HHHHHHSCCTTCCHHHHHHT
T ss_pred HHHHHHHHHHHHHHHHHCCee-ccCCCHHHEEEecCCCCCeEEEccCccceeccccc---ccccccCCcCccCchhhccC
Confidence 578999999999999999988 9999999999987654 9999999987653221 12345688999999997532
Q ss_pred CCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCchHHHHHHHHHhhhcCCCCCCCHH
Q psy1840 102 HLPRGTQKGDVYSFGLVLYEVIGRQGPWGHLRMTDEEIITSVTQGSGLRPDTSSLDCAPSIIACMRTCWEEDPELRPDLR 181 (423)
Q Consensus 102 ~~~~~s~ksDVyS~Giil~elltg~~Pf~~~~~~~~~i~~~i~~~~~~~p~~~~~~~~~~l~~Li~~C~~~dP~~RPt~~ 181 (423)
....++.++|||||||++|+|++|..||...... ..+...+..+....+......++..+.+++.+||+.||++||++.
T Consensus 192 ~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ 270 (322)
T 2ycf_A 192 GTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQ-VSLKDQITSGKYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTE 270 (322)
T ss_dssp TTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCS-SCHHHHHHHTCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHH
T ss_pred CCCCCCchhhHHHHHHHHHHHHhCCCCCcccchH-HHHHHHHHhCccccCchhhhhcCHHHHHHHHHHcccCHhhCCCHH
Confidence 1123488999999999999999999999753221 223344444332222111235788999999999999999999999
Q ss_pred HHHHH
Q psy1840 182 FVHHK 186 (423)
Q Consensus 182 ~I~~~ 186 (423)
++++.
T Consensus 271 ~~l~h 275 (322)
T 2ycf_A 271 EALRH 275 (322)
T ss_dssp HHHTS
T ss_pred HHhhC
Confidence 98763
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.92 E-value=7.4e-25 Score=215.66 Aligned_cols=152 Identities=17% Similarity=0.205 Sum_probs=115.2
Q ss_pred HHHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCccEEEeccCCcccccCCCcccccccccCCccccCCccccCCCC
Q psy1840 24 GSISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKAPELLRQPHL 103 (423)
Q Consensus 24 ~~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~ 103 (423)
....++.||+.||.|||++|++ ||||||+||+++.++.+||+|||++...... .....+++.|+|||.+.+..
T Consensus 127 ~~~~i~~qi~~al~~LH~~~iv-H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~-----~~~~~~t~~y~aPE~~~~~~- 199 (353)
T 3coi_A 127 KIQYLVYQMLKGLKYIHSAGVV-HRDLKPGNLAVNEDCELKILDFGLARHADAE-----MTGYVVTRWYRAPEVILSWM- 199 (353)
T ss_dssp HHHHHHHHHHHHHHHHHHTTCC-CSSCCGGGEEECTTCCEEECSTTCTTC-------------CCSBCCSCHHHHSCCS-
T ss_pred HHHHHHHHHHHHHHHHHHCCcc-cCCCCHHHEeECCCCcEEEeecccccCCCCC-----ccccccCcCcCCHHHHhCcC-
Confidence 3678999999999999999998 9999999999999999999999998754322 23456788999999987632
Q ss_pred CCCCCccchHHHHHHHHHHHhCCCCCCCCCCChHHHHHHHhcC-----------------------CC--CCC--CCCCC
Q psy1840 104 PRGTQKGDVYSFGLVLYEVIGRQGPWGHLRMTDEEIITSVTQG-----------------------SG--LRP--DTSSL 156 (423)
Q Consensus 104 ~~~s~ksDVyS~Giil~elltg~~Pf~~~~~~~~~i~~~i~~~-----------------------~~--~~p--~~~~~ 156 (423)
.++.++|||||||++|+|++|..||... +..+.+..+... .+ .++ .....
T Consensus 200 -~~~~~~Di~slG~il~el~~g~~pf~~~--~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 276 (353)
T 3coi_A 200 -HYNQTVDIWSVGCIMAEMLTGKTLFKGK--DYLDQLTQILKVTGVPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFP 276 (353)
T ss_dssp -CCCTTHHHHHHHHHHHHHHHSSCSSBSS--CHHHHHHHHHHHHCBCCHHHHTTCSCHHHHHHHHTSCBCSSCCTTTTCT
T ss_pred -CCCchhhHHHHHHHHHHHHhCCCCCCCC--CHHHHHHHHHHHhCCCCHHHHHHHhhHHHHHHHHhCcCCCCccHHHhcC
Confidence 2489999999999999999999999753 222322222110 00 011 11123
Q ss_pred CchHHHHHHHHHhhhcCCCCCCCHHHHHH
Q psy1840 157 DCAPSIIACMRTCWEEDPELRPDLRFVHH 185 (423)
Q Consensus 157 ~~~~~l~~Li~~C~~~dP~~RPt~~~I~~ 185 (423)
.+++.+.+++.+||+.||++|||+.++++
T Consensus 277 ~~~~~~~~li~~~L~~dp~~Rpt~~e~l~ 305 (353)
T 3coi_A 277 RASPQAADLLEKMLELDVDKRLTAAQALT 305 (353)
T ss_dssp TSCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred CcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 57899999999999999999999999875
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=3.5e-25 Score=211.47 Aligned_cols=154 Identities=22% Similarity=0.310 Sum_probs=123.6
Q ss_pred HHHHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCC---ccEEEeccCCcccccCCCcccccccccCCccccCCcccc
Q psy1840 23 IGSISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSR---WVLQIADFGLHAFKAGQDETGQERKLRRRKLYKAPELLR 99 (423)
Q Consensus 23 ~~~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~---~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~ 99 (423)
.....++.||+.||.|||+.|++ ||||||+||+++.+ +.+||+|||++........ .....+++.|+|||.+.
T Consensus 121 ~~~~~i~~qi~~~l~~LH~~~i~-H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~ 196 (287)
T 2wei_A 121 HDAARIIKQVFSGITYMHKHNIV-HRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTK---MKDRIGTAYYIAPEVLR 196 (287)
T ss_dssp HHHHHHHHHHHHHHHHHHHTTCC-CSCCCGGGEEESCSSTTCCEEECSTTGGGTBCCCSS---CSCHHHHHTTCCHHHHT
T ss_pred HHHHHHHHHHHHHHHHHHHCCee-ccCCChhhEEEecCCCcccEEEeccCcceeecCCCc---cccccCcccccChHHhc
Confidence 34689999999999999999998 99999999999754 4799999999876533221 12335778899999987
Q ss_pred CCCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCchHHHHHHHHHhhhcCCCCCCC
Q psy1840 100 QPHLPRGTQKGDVYSFGLVLYEVIGRQGPWGHLRMTDEEIITSVTQGSGLRPDTSSLDCAPSIIACMRTCWEEDPELRPD 179 (423)
Q Consensus 100 ~~~~~~~s~ksDVyS~Giil~elltg~~Pf~~~~~~~~~i~~~i~~~~~~~p~~~~~~~~~~l~~Li~~C~~~dP~~RPt 179 (423)
+. .+.++||||||+++|+|++|..||.. ....++...+..+....+......+++++.+++.+||+.||++|||
T Consensus 197 ~~----~~~~~Di~slG~~l~~l~~g~~p~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps 270 (287)
T 2wei_A 197 GT----YDEKCDVWSAGVILYILLSGTPPFYG--KNEYDILKRVETGKYAFDLPQWRTISDDAKDLIRKMLTFHPSLRIT 270 (287)
T ss_dssp TC----CCTHHHHHHHHHHHHHHHHSSCSSCC--SSHHHHHHHHHHCCCCCCSGGGTTSCHHHHHHHHHHTCSSGGGSCC
T ss_pred CC----CCCchhhHhHHHHHHHHHhCCCCCCC--CCHHHHHHHHHcCCCCCCchhhhhcCHHHHHHHHHHcccChhhCcC
Confidence 64 38999999999999999999999974 4456677777665433322222467899999999999999999999
Q ss_pred HHHHHHH
Q psy1840 180 LRFVHHK 186 (423)
Q Consensus 180 ~~~I~~~ 186 (423)
+.++++.
T Consensus 271 ~~ell~h 277 (287)
T 2wei_A 271 ATQCLEH 277 (287)
T ss_dssp HHHHHHS
T ss_pred HHHHhcC
Confidence 9999873
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=99.92 E-value=2.5e-25 Score=221.01 Aligned_cols=153 Identities=17% Similarity=0.221 Sum_probs=115.2
Q ss_pred HHHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCccEEEeccCCcccccCCCcccccccccCCccccCCccccCCCC
Q psy1840 24 GSISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKAPELLRQPHL 103 (423)
Q Consensus 24 ~~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~ 103 (423)
....++.||+.||.|||+.|++ ||||||+||+++.++.+||+|||+++..... .....+|+.|+|||.+.+..
T Consensus 145 ~~~~i~~qi~~aL~~LH~~~iv-H~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~- 217 (371)
T 4exu_A 145 KIQYLVYQMLKGLKYIHSAGVV-HRDLKPGNLAVNEDCELKILDFGLARHADAE-----MTGYVVTRWYRAPEVILSWM- 217 (371)
T ss_dssp HHHHHHHHHHHHHHHHHHTTCC-CSCCCGGGEEECTTCCEEECSTTCC-------------CTTCCCTTSCHHHHSCCS-
T ss_pred HHHHHHHHHHHHHHHHHHCCCc-CCCcCHHHeEECCCCCEEEEecCcccccccC-----cCCcccCccccCHHHhcCCC-
Confidence 3678999999999999999998 9999999999999999999999998754322 23456789999999987632
Q ss_pred CCCCCccchHHHHHHHHHHHhCCCCCCCCCCChHHHHHHHhcCC-----------------------CCCCCC----CCC
Q psy1840 104 PRGTQKGDVYSFGLVLYEVIGRQGPWGHLRMTDEEIITSVTQGS-----------------------GLRPDT----SSL 156 (423)
Q Consensus 104 ~~~s~ksDVyS~Giil~elltg~~Pf~~~~~~~~~i~~~i~~~~-----------------------~~~p~~----~~~ 156 (423)
.++.++|||||||++|+|++|..||... ...+.+..+.... ...+.. ...
T Consensus 218 -~~~~~~DiwslG~il~el~~g~~pf~~~--~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 294 (371)
T 4exu_A 218 -HYNQTVDIWSVGCIMAEMLTGKTLFKGK--DYLDQLTQILKVTGVPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFP 294 (371)
T ss_dssp -CCCTTHHHHHHHHHHHHHHHSSCSCCCS--SHHHHHHHHHHHHCCCCHHHHTTCSCHHHHHHHHHSCCCCCCCHHHHST
T ss_pred -CCCcHHhHHHHHHHHHHHHhCCCCCCCC--ChHHHHHHHHHHhCCCcHHHHHHhhhhhhhhhhhccCCCcchhHHHhcc
Confidence 2489999999999999999999999743 2333333322100 000000 012
Q ss_pred CchHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q psy1840 157 DCAPSIIACMRTCWEEDPELRPDLRFVHHK 186 (423)
Q Consensus 157 ~~~~~l~~Li~~C~~~dP~~RPt~~~I~~~ 186 (423)
.+++.+.+++.+||+.||++|||+.++++.
T Consensus 295 ~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 324 (371)
T 4exu_A 295 RASPQAADLLEKMLELDVDKRLTAAQALTH 324 (371)
T ss_dssp TSCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred ccChHHHHHHHHHCCCChhhcCCHHHHhcC
Confidence 468899999999999999999999998753
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=2.7e-25 Score=231.98 Aligned_cols=150 Identities=23% Similarity=0.325 Sum_probs=123.3
Q ss_pred HHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCccEEEeccCCcccccCCCcccccccccCCccccCCccccCCCCC
Q psy1840 25 SISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKAPELLRQPHLP 104 (423)
Q Consensus 25 ~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~ 104 (423)
...++.||+.||.|||++|++ ||||||+|||++.++.+||+|||+++...... ......||+.|+|||++.+..+
T Consensus 288 ~~~i~~qIl~aL~yLH~~gIv-HrDLKPeNILld~~g~vKL~DFGla~~~~~~~---~~~~~~GT~~Y~APEvl~~~~~- 362 (576)
T 2acx_A 288 AVFYAAEICCGLEDLHRERIV-YRDLKPENILLDDHGHIRISDLGLAVHVPEGQ---TIKGRVGTVGYMAPEVVKNERY- 362 (576)
T ss_dssp HHHHHHHHHHHHHHHHHTTEE-CCCCCGGGEEECTTSCEEECCCTTCEECCTTC---CEECCCSCGGGCCHHHHTTCEE-
T ss_pred HHHHHHHHHHHHHHHHHCCEe-ccCCchheEEEeCCCCeEEEecccceecccCc---cccccCCCccccCHHHHcCCCC-
Confidence 578999999999999999988 99999999999999999999999987654322 1234579999999999987655
Q ss_pred CCCCccchHHHHHHHHHHHhCCCCCCCCC--CChHHHHHHHhcCCCCCCCCCCCCchHHHHHHHHHhhhcCCCCCC----
Q psy1840 105 RGTQKGDVYSFGLVLYEVIGRQGPWGHLR--MTDEEIITSVTQGSGLRPDTSSLDCAPSIIACMRTCWEEDPELRP---- 178 (423)
Q Consensus 105 ~~s~ksDVyS~Giil~elltg~~Pf~~~~--~~~~~i~~~i~~~~~~~p~~~~~~~~~~l~~Li~~C~~~dP~~RP---- 178 (423)
+.++|||||||++|||++|..||.... ....++...+.......| ..+++++.+++.+||+.||.+||
T Consensus 363 --~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~i~~~~~~~p----~~~s~~~~dLI~~lL~~dP~~R~g~~~ 436 (576)
T 2acx_A 363 --TFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVPEEYS----ERFSPQARSLCSQLLCKDPAERLGCRG 436 (576)
T ss_dssp --SSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHHHHHCCCCCC----TTSCHHHHHHHHHHTCSSGGGSTTCSS
T ss_pred --CccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHHHhhcccccCC----ccCCHHHHHHHHHhccCCHHHcCCCCC
Confidence 899999999999999999999997542 234556666655433222 35789999999999999999999
Q ss_pred -CHHHHHH
Q psy1840 179 -DLRFVHH 185 (423)
Q Consensus 179 -t~~~I~~ 185 (423)
++.+|++
T Consensus 437 ~sa~eil~ 444 (576)
T 2acx_A 437 GSAREVKE 444 (576)
T ss_dssp SHHHHHHT
T ss_pred CCHHHHHh
Confidence 6777765
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.92 E-value=1.3e-25 Score=224.91 Aligned_cols=164 Identities=19% Similarity=0.271 Sum_probs=125.7
Q ss_pred HHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEE----cCCccEEEeccCCcccccCCCcccccccccCCccccCCccccC
Q psy1840 25 SISVNTTASVGMIHLHDSEIISHGNLRSSNCLI----DSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKAPELLRQ 100 (423)
Q Consensus 25 ~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILl----d~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~ 100 (423)
...++.||+.||.|||+.|++ ||||||+||++ +.++.+||+|||+++...... ......|++.|+|||++.+
T Consensus 114 ~~~i~~qi~~aL~~LH~~~iv-H~Dlkp~NIll~~~~~~~~~~kL~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~ 189 (396)
T 4eut_A 114 FLIVLRDVVGGMNHLRENGIV-HRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDE---QFVSLYGTEEYLHPDMYER 189 (396)
T ss_dssp HHHHHHHHHHHHHHHHHTTEE-CCCCCGGGEEEEECTTSCEEEEECCGGGCEECCCGG---GSSCSSSCCTTCCHHHHHH
T ss_pred HHHHHHHHHHHHHHHHHCCEE-ECCcCHHHEEEeecCCCceeEEEecCCCceEccCCC---ccccccCCccccCHHHhhc
Confidence 689999999999999999988 99999999999 888899999999987654322 2234578999999999864
Q ss_pred CCC-----CCCCCccchHHHHHHHHHHHhCCCCCCCCC--CChHHHHHHHhcCCCCC-------------------CC--
Q psy1840 101 PHL-----PRGTQKGDVYSFGLVLYEVIGRQGPWGHLR--MTDEEIITSVTQGSGLR-------------------PD-- 152 (423)
Q Consensus 101 ~~~-----~~~s~ksDVyS~Giil~elltg~~Pf~~~~--~~~~~i~~~i~~~~~~~-------------------p~-- 152 (423)
... ..++.++|||||||++|||++|+.||.... ....+++..+..+.+.. |.
T Consensus 190 ~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 269 (396)
T 4eut_A 190 AVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSC 269 (396)
T ss_dssp HCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHHHHHHSCCTTCCEEEECSTTCCEEEESSCCTTC
T ss_pred cccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHHHHhcCCCcccchhheeccCCCcccCccCCccc
Confidence 210 022789999999999999999999996432 23355566655443211 00
Q ss_pred CCCCCchHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHhh
Q psy1840 153 TSSLDCAPSIIACMRTCWEEDPELRPDLRFVHHKLKEMNA 192 (423)
Q Consensus 153 ~~~~~~~~~l~~Li~~C~~~dP~~RPt~~~I~~~L~~i~~ 192 (423)
.....++..+.+++.+||+.||++||++.++++.+..+..
T Consensus 270 ~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~il~ 309 (396)
T 4eut_A 270 SLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILH 309 (396)
T ss_dssp SSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHHT
T ss_pred ccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHHhh
Confidence 0112356788999999999999999999999888877654
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=1.6e-25 Score=214.63 Aligned_cols=158 Identities=22% Similarity=0.331 Sum_probs=116.2
Q ss_pred HHHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCccEEEeccCCcccccCCCc---ccccccccCCccccCCccccC
Q psy1840 24 GSISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDE---TGQERKLRRRKLYKAPELLRQ 100 (423)
Q Consensus 24 ~~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~---~~~~~~~~gt~~y~APE~l~~ 100 (423)
....++.||+.||.|||+.|++ ||||||+||+++.++.+||+|||++........ ........+++.|+|||.+.+
T Consensus 122 ~~~~i~~qi~~~l~~lH~~~i~-H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 200 (303)
T 2vwi_A 122 TIATILREVLEGLEYLHKNGQI-HRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQ 200 (303)
T ss_dssp HHHHHHHHHHHHHHHHHHTTCC-CCCCSGGGEEECTTCCEEECCCHHHHHCC---------------CCCTTCCHHHHHH
T ss_pred HHHHHHHHHHHHHHHHHhCCCC-CCCCChhhEEEcCCCCEEEEeccchheeccCCCccchhhhcccCCCccccCHHHhcc
Confidence 3689999999999999999998 999999999999999999999999875432211 111234568899999999865
Q ss_pred CCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCChHHHHHHHhcCCCCC-C-----CCCCCCchHHHHHHHHHhhhcCC
Q psy1840 101 PHLPRGTQKGDVYSFGLVLYEVIGRQGPWGHLRMTDEEIITSVTQGSGLR-P-----DTSSLDCAPSIIACMRTCWEEDP 174 (423)
Q Consensus 101 ~~~~~~s~ksDVyS~Giil~elltg~~Pf~~~~~~~~~i~~~i~~~~~~~-p-----~~~~~~~~~~l~~Li~~C~~~dP 174 (423)
.. ..+.++||||||+++|||++|..||..... .............. + ......++.++.+++.+||+.||
T Consensus 201 ~~--~~~~~~Di~slG~il~~l~~g~~pf~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp 276 (303)
T 2vwi_A 201 VR--GYDFKADIWSFGITAIELATGAAPYHKYPP--MKVLMLTLQNDPPSLETGVQDKEMLKKYGKSFRKMISLCLQKDP 276 (303)
T ss_dssp HH--CCCTHHHHHHHHHHHHHHHHSSCTTTTSCG--GGHHHHHHTSSCCCTTC-----CCCCCCCHHHHHHHHHHCCSSG
T ss_pred cc--CCCchhhHHHHHHHHHHHHhCCCCCccCch--hhHHHHHhccCCCccccccccchhhhhhhHHHHHHHHHHccCCh
Confidence 22 238899999999999999999999975432 22222222221111 1 11124678899999999999999
Q ss_pred CCCCCHHHHHHH
Q psy1840 175 ELRPDLRFVHHK 186 (423)
Q Consensus 175 ~~RPt~~~I~~~ 186 (423)
.+||++.++++.
T Consensus 277 ~~Rps~~~ll~h 288 (303)
T 2vwi_A 277 EKRPTAAELLRH 288 (303)
T ss_dssp GGSCCHHHHHTS
T ss_pred hhCcCHHHHhhC
Confidence 999999999763
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=5.8e-26 Score=221.63 Aligned_cols=155 Identities=21% Similarity=0.270 Sum_probs=114.6
Q ss_pred HHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCccEEEeccCCcccccCCCcccccccccCCccccCCccccCCCCC
Q psy1840 25 SISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKAPELLRQPHLP 104 (423)
Q Consensus 25 ~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~ 104 (423)
...++.||+.||.|||+.|++ ||||||+||+++.++.+||+|||++........ ......+++.|+|||.+.+..
T Consensus 126 ~~~~~~qi~~~l~~LH~~~iv-H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~-- 200 (331)
T 4aaa_A 126 VQKYLFQIINGIGFCHSHNII-HRDIKPENILVSQSGVVKLCDFGFARTLAAPGE--VYDDEVATRWYRAPELLVGDV-- 200 (331)
T ss_dssp HHHHHHHHHHHHHHHHHTTCC-CCCCCGGGEEECTTSCEEECCCTTC--------------CCCCCTTCCHHHHTTCT--
T ss_pred HHHHHHHHHHHHHHHHHCCEE-ccCcChheEEEcCCCcEEEEeCCCceeecCCcc--ccCCCcCCccccCcccccCCC--
Confidence 678999999999999999998 999999999999999999999999875433221 123456888999999997652
Q ss_pred CCCCccchHHHHHHHHHHHhCCCCCCCCCCChHHHHHHHhcC-------------------CCCCCCCC--------CCC
Q psy1840 105 RGTQKGDVYSFGLVLYEVIGRQGPWGHLRMTDEEIITSVTQG-------------------SGLRPDTS--------SLD 157 (423)
Q Consensus 105 ~~s~ksDVyS~Giil~elltg~~Pf~~~~~~~~~i~~~i~~~-------------------~~~~p~~~--------~~~ 157 (423)
.++.++|||||||++|+|++|..||... ...+....+... ....+... ...
T Consensus 201 ~~~~~~Di~slG~il~~l~~g~~pf~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 278 (331)
T 4aaa_A 201 KYGKAVDVWAIGCLVTEMFMGEPLFPGD--SDIDQLYHIMMCLGNLIPRHQELFNKNPVFAGVRLPEIKEREPLERRYPK 278 (331)
T ss_dssp TCCTHHHHHHHHHHHHHHHHSSCSCCCS--SHHHHHHHHHHHHCSCCHHHHHHHHHCGGGTTCCCCCCSSCCCHHHHSTT
T ss_pred CcchHHHHHHHHHHHHHHHhCCCCCCCC--CcHHHHHHHHHHhCCCChhhhhHhhhccccccccCccccccchhhhcccc
Confidence 2388999999999999999999999743 223322222110 00011100 125
Q ss_pred chHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q psy1840 158 CAPSIIACMRTCWEEDPELRPDLRFVHHK 186 (423)
Q Consensus 158 ~~~~l~~Li~~C~~~dP~~RPt~~~I~~~ 186 (423)
+++.+.+++.+||+.||++|||+.++++.
T Consensus 279 ~~~~l~~li~~~L~~dP~~Rpt~~ell~h 307 (331)
T 4aaa_A 279 LSEVVIDLAKKCLHIDPDKRPFCAELLHH 307 (331)
T ss_dssp SCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred hhHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 68899999999999999999999998764
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=1.4e-25 Score=227.77 Aligned_cols=157 Identities=16% Similarity=0.168 Sum_probs=122.0
Q ss_pred HHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCccEEEeccCCcccccCCCcccccccccCCccccCCccccCC--C
Q psy1840 25 SISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKAPELLRQP--H 102 (423)
Q Consensus 25 ~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~--~ 102 (423)
...++.||+.||.|||+.|++ ||||||+|||++.++.+||+|||+++....... .......||+.|+|||++... .
T Consensus 177 ~~~~~~qi~~aL~~LH~~gii-HrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~-~~~~~~~GT~~Y~APE~l~~~~~~ 254 (437)
T 4aw2_A 177 ARFYLAEMVIAIDSVHQLHYV-HRDIKPDNILMDMNGHIRLADFGSCLKLMEDGT-VQSSVAVGTPDYISPEILQAMEGG 254 (437)
T ss_dssp HHHHHHHHHHHHHHHHHTTEE-CCCCSGGGEEECTTSCEEECCCTTCEECCTTSC-EECCSCCSCGGGCCHHHHHHHHTS
T ss_pred HHHHHHHHHHHHHHHHhCCeE-ecccCHHHeeEcCCCCEEEcchhhhhhcccCCC-cccccccCCcCeeChHHHhhcccC
Confidence 568899999999999999988 999999999999999999999999876543222 222346799999999998721 0
Q ss_pred CCCCCCccchHHHHHHHHHHHhCCCCCCCCCCChHHHHHHHhcCC--CCCCCCCCCCchHHHHHHHHHhhhcCCCC--CC
Q psy1840 103 LPRGTQKGDVYSFGLVLYEVIGRQGPWGHLRMTDEEIITSVTQGS--GLRPDTSSLDCAPSIIACMRTCWEEDPEL--RP 178 (423)
Q Consensus 103 ~~~~s~ksDVyS~Giil~elltg~~Pf~~~~~~~~~i~~~i~~~~--~~~p~~~~~~~~~~l~~Li~~C~~~dP~~--RP 178 (423)
...++.++|||||||++|||++|+.||.. .+..+....+.... ...|.. ...+++++.+||++||..+|+. ||
T Consensus 255 ~~~~~~~~DvwSlGvil~elltG~~Pf~~--~~~~~~~~~i~~~~~~~~~p~~-~~~~s~~~~dLi~~lL~~~~~r~~r~ 331 (437)
T 4aw2_A 255 KGRYGPECDWWSLGVCMYEMLYGETPFYA--ESLVETYGKIMNHKERFQFPTQ-VTDVSENAKDLIRRLICSREHRLGQN 331 (437)
T ss_dssp CCEECTHHHHHHHHHHHHHHHHSSCTTCC--SSHHHHHHHHHTHHHHCCCCSS-CCCSCHHHHHHHHTTSSCGGGCTTTT
T ss_pred CCCCCCcCeeHHHHHHHHHHHhCCCCCCC--CChhHHHHhhhhccccccCCcc-cccCCHHHHHHHHHHhcccccccCCC
Confidence 11238999999999999999999999974 44556666664321 122222 2357899999999999888877 99
Q ss_pred CHHHHHHH
Q psy1840 179 DLRFVHHK 186 (423)
Q Consensus 179 t~~~I~~~ 186 (423)
++.++++.
T Consensus 332 ~~~eil~H 339 (437)
T 4aw2_A 332 GIEDFKKH 339 (437)
T ss_dssp TTHHHHTS
T ss_pred CHHHHhCC
Confidence 99988753
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=3.2e-25 Score=217.69 Aligned_cols=157 Identities=22% Similarity=0.261 Sum_probs=116.5
Q ss_pred HHHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCccEEEeccCCcccccCCCccc--------ccccccCCccccCC
Q psy1840 24 GSISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETG--------QERKLRRRKLYKAP 95 (423)
Q Consensus 24 ~~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~~~--------~~~~~~gt~~y~AP 95 (423)
....++.|++.||.|||+.|++ ||||||+||+++.++.+||+|||++.......... ......||+.|+||
T Consensus 113 ~~~~~~~qi~~~L~~LH~~~iv-H~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP 191 (353)
T 2b9h_A 113 HIQYFIYQTLRAVKVLHGSNVI-HRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEFVATRWYRAP 191 (353)
T ss_dssp HHHHHHHHHHHHHHHHHHTTEE-CSCCCGGGEEECTTCCEEECCCTTCEECC----------------CCCCCCGGGCCH
T ss_pred HHHHHHHHHHHHHHHHHHCCee-cCCCCHHHeEEcCCCcEEEEecccccccccccccccCccccccchhhccccccccCC
Confidence 3678999999999999999988 99999999999999999999999987654222110 11234688999999
Q ss_pred ccccCCCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCChHHHHHHHhc--CC----------------------CCCC
Q psy1840 96 ELLRQPHLPRGTQKGDVYSFGLVLYEVIGRQGPWGHLRMTDEEIITSVTQ--GS----------------------GLRP 151 (423)
Q Consensus 96 E~l~~~~~~~~s~ksDVyS~Giil~elltg~~Pf~~~~~~~~~i~~~i~~--~~----------------------~~~p 151 (423)
|.+.+.. .++.++|||||||++|+|++|..||.+.. ..+....+.. +. ...+
T Consensus 192 E~~~~~~--~~~~~~Di~slG~il~~l~~g~~pf~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 267 (353)
T 2b9h_A 192 EVMLTSA--KYSRAMDVWSCGCILAELFLRRPIFPGRD--YRHQLLLIFGIIGTPHSDNDLRCIESPRAREYIKSLPMYP 267 (353)
T ss_dssp HHHHSCC--CCCHHHHHHHHHHHHHHHHHSSCSCCCSS--HHHHHHHHHHHHCCCCSTTTTTTCCCHHHHHHHHTSCCCC
T ss_pred eeeccCC--CccchhhHHHHHHHHHHHHhCCCCCCCCC--cHHHHHHHHHHhCCCchhccccccccchhhHHhhcccCCC
Confidence 9876532 23899999999999999999999997532 2222222211 00 0000
Q ss_pred CCC----CCCchHHHHHHHHHhhhcCCCCCCCHHHHHH
Q psy1840 152 DTS----SLDCAPSIIACMRTCWEEDPELRPDLRFVHH 185 (423)
Q Consensus 152 ~~~----~~~~~~~l~~Li~~C~~~dP~~RPt~~~I~~ 185 (423)
... ...+++++.+++.+||+.||++|||+.++++
T Consensus 268 ~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 305 (353)
T 2b9h_A 268 AAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALE 305 (353)
T ss_dssp CCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred CcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence 000 1357889999999999999999999999876
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=99.92 E-value=5.3e-25 Score=217.14 Aligned_cols=153 Identities=22% Similarity=0.343 Sum_probs=117.9
Q ss_pred HHHHHHHHHHHHHHHHhC-CCeeecCCCCCCEEEcCCccEEEeccCCcccccCCCcccccccccCCccccCCccccCCCC
Q psy1840 25 SISVNTTASVGMIHLHDS-EIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKAPELLRQPHL 103 (423)
Q Consensus 25 ~l~i~~qi~~gL~yLH~~-~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~ 103 (423)
...++.|++.||.|||+. |++ ||||||+||+++.++.+||+|||++...... ......|++.|+|||.+.+..+
T Consensus 133 ~~~i~~~i~~~l~~lh~~~~i~-H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~ 207 (360)
T 3eqc_A 133 LGKVSIAVIKGLTYLREKHKIM-HRDVKPSNILVNSRGEIKLCDFGVSGQLIDS----MANSFVGTRSYMSPERLQGTHY 207 (360)
T ss_dssp HHHHHHHHHHHHHHHHHHHCCC-CSCCSGGGEEECTTCCEEECCCCCCHHHHHH----C----CCCCTTCCHHHHTTCCC
T ss_pred HHHHHHHHHHHHHHHHHhCCEE-cCCccHHHEEECCCCCEEEEECCCCcccccc----cccCCCCCCCeECHHHHcCCCC
Confidence 578999999999999996 888 9999999999999999999999998654221 1234578899999999987655
Q ss_pred CCCCCccchHHHHHHHHHHHhCCCCCCCCCCCh----------------------------------------HHHHHHH
Q psy1840 104 PRGTQKGDVYSFGLVLYEVIGRQGPWGHLRMTD----------------------------------------EEIITSV 143 (423)
Q Consensus 104 ~~~s~ksDVyS~Giil~elltg~~Pf~~~~~~~----------------------------------------~~i~~~i 143 (423)
+.++|||||||++|+|++|..||....... .+....+
T Consensus 208 ---~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 284 (360)
T 3eqc_A 208 ---SVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLNKFGMDSRPPMAIFELLDYI 284 (360)
T ss_dssp ---SHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC------------------------------CCCHHHHHHHH
T ss_pred ---CchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCcccCCCcccccccCCCCcccchhhhhHH
Confidence 899999999999999999999996432110 1112222
Q ss_pred hcCCCCCCCCCCCCchHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q psy1840 144 TQGSGLRPDTSSLDCAPSIIACMRTCWEEDPELRPDLRFVHHKL 187 (423)
Q Consensus 144 ~~~~~~~p~~~~~~~~~~l~~Li~~C~~~dP~~RPt~~~I~~~L 187 (423)
.... .+......++.++.+++.+||+.||++|||+.++++.-
T Consensus 285 ~~~~--~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp 326 (360)
T 3eqc_A 285 VNEP--PPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHA 326 (360)
T ss_dssp HHSC--CCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSH
T ss_pred hccC--CCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhhCh
Confidence 2221 22223345788999999999999999999999998753
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=99.92 E-value=1.8e-25 Score=221.03 Aligned_cols=154 Identities=20% Similarity=0.267 Sum_probs=113.6
Q ss_pred HHHHHHHHHHHHHHHHHhC-CCeeecCCCCCCEEEc------CCccEEEeccCCcccccCCCcccccccccCCccccCCc
Q psy1840 24 GSISVNTTASVGMIHLHDS-EIISHGNLRSSNCLID------SRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKAPE 96 (423)
Q Consensus 24 ~~l~i~~qi~~gL~yLH~~-~ii~HrDLkp~NILld------~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE 96 (423)
....++.||+.||.|||++ |++ ||||||+||+++ ..+.+||+|||++...... .....+|+.|+|||
T Consensus 132 ~~~~i~~qi~~aL~~lH~~~~iv-H~Dikp~NIll~~~~~~~~~~~~kl~Dfg~a~~~~~~-----~~~~~~t~~y~aPE 205 (373)
T 1q8y_A 132 YVKQISKQLLLGLDYMHRRCGII-HTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEH-----YTNSIQTREYRSPE 205 (373)
T ss_dssp HHHHHHHHHHHHHHHHHHTTCEE-CSCCSGGGEEEEEEETTTTEEEEEECCCTTCEETTBC-----CCSCCSCGGGCCHH
T ss_pred HHHHHHHHHHHHHHHHHhcCCEE-ecCCChHHeEEeccCCCcCcceEEEcccccccccCCC-----CCCCCCCccccCcH
Confidence 3679999999999999998 988 999999999994 4458999999998765322 13346889999999
Q ss_pred cccCCCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCC----ChHHHHHHHhcCCCCCC---------------------
Q psy1840 97 LLRQPHLPRGTQKGDVYSFGLVLYEVIGRQGPWGHLRM----TDEEIITSVTQGSGLRP--------------------- 151 (423)
Q Consensus 97 ~l~~~~~~~~s~ksDVyS~Giil~elltg~~Pf~~~~~----~~~~i~~~i~~~~~~~p--------------------- 151 (423)
++.+..+ +.++|||||||++|||++|..||..... ...+.+..+.......|
T Consensus 206 ~~~~~~~---~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~ 282 (373)
T 1q8y_A 206 VLLGAPW---GCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLR 282 (373)
T ss_dssp HHHTCCC---CTHHHHHHHHHHHHHHHHSSCCC---------CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBS
T ss_pred HHhCCCC---CchHhHHHHHHHHHHHHhCCCCCCCCcccccCChHHHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhc
Confidence 9987655 8999999999999999999999974321 11222222211000000
Q ss_pred -----------------CCCCCCchHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q psy1840 152 -----------------DTSSLDCAPSIIACMRTCWEEDPELRPDLRFVHHK 186 (423)
Q Consensus 152 -----------------~~~~~~~~~~l~~Li~~C~~~dP~~RPt~~~I~~~ 186 (423)
......++.++.+|+.+||+.||++|||+.++++.
T Consensus 283 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 334 (373)
T 1q8y_A 283 NISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLVNH 334 (373)
T ss_dssp SCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHHHTC
T ss_pred ccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccccCCHHHHhhC
Confidence 00112356789999999999999999999999763
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=4.6e-25 Score=209.38 Aligned_cols=146 Identities=16% Similarity=0.241 Sum_probs=114.8
Q ss_pred HHHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcC-------------------CccEEEeccCCcccccCCCcccccc
Q psy1840 24 GSISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDS-------------------RWVLQIADFGLHAFKAGQDETGQER 84 (423)
Q Consensus 24 ~~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~-------------------~~~vKL~DFGla~~~~~~~~~~~~~ 84 (423)
....++.||+.||.|||++|++ ||||||+||+++. .+.+||+|||.+...... .
T Consensus 116 ~~~~i~~qi~~al~~lH~~~iv-H~Dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~------~ 188 (289)
T 1x8b_A 116 ELKDLLLQVGRGLRYIHSMSLV-HMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISSP------Q 188 (289)
T ss_dssp HHHHHHHHHHHHHHHHHHTTEE-CSCCSGGGEEEC--------------------CCCEEECCCTTCEETTCS------C
T ss_pred HHHHHHHHHHHHHHHHHhCCEe-ecCCCHHHEEEcCCCCCcccccccccccccCCceEEEEcccccccccCCc------c
Confidence 3689999999999999999988 9999999999984 448999999998765322 2
Q ss_pred cccCCccccCCccccCCCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCchHHHHH
Q psy1840 85 KLRRRKLYKAPELLRQPHLPRGTQKGDVYSFGLVLYEVIGRQGPWGHLRMTDEEIITSVTQGSGLRPDTSSLDCAPSIIA 164 (423)
Q Consensus 85 ~~~gt~~y~APE~l~~~~~~~~s~ksDVyS~Giil~elltg~~Pf~~~~~~~~~i~~~i~~~~~~~p~~~~~~~~~~l~~ 164 (423)
...+++.|+|||.+.+.. ..+.++|||||||++|+|++|..|+.. ......+..+.. +.. +..+++++.+
T Consensus 189 ~~~gt~~y~aPE~~~~~~--~~~~~~Di~slG~il~~l~~~~~~~~~-----~~~~~~~~~~~~--~~~-~~~~~~~~~~ 258 (289)
T 1x8b_A 189 VEEGDSRFLANEVLQENY--THLPKADIFALALTVVCAAGAEPLPRN-----GDQWHEIRQGRL--PRI-PQVLSQEFTE 258 (289)
T ss_dssp CCCCCGGGCCHHHHTTCC--TTHHHHHHHHHHHHHHHHTTCCCCCSS-----SHHHHHHHTTCC--CCC-SSCCCHHHHH
T ss_pred ccCCCccccChhHhcCCC--CCCchhhHHHHHHHHHHHhcCCCCCcc-----hhHHHHHHcCCC--CCC-CcccCHHHHH
Confidence 335888999999997653 236799999999999999999877642 122334444322 222 2367899999
Q ss_pred HHHHhhhcCCCCCCCHHHHHHH
Q psy1840 165 CMRTCWEEDPELRPDLRFVHHK 186 (423)
Q Consensus 165 Li~~C~~~dP~~RPt~~~I~~~ 186 (423)
++.+||+.||++|||+.++++.
T Consensus 259 li~~~l~~dp~~Rps~~~ll~h 280 (289)
T 1x8b_A 259 LLKVMIHPDPERRPSAMALVKH 280 (289)
T ss_dssp HHHHHTCSSGGGSCCHHHHHTC
T ss_pred HHHHHhCCCcccCCCHHHHhhC
Confidence 9999999999999999998763
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=1.1e-24 Score=215.03 Aligned_cols=155 Identities=19% Similarity=0.248 Sum_probs=111.9
Q ss_pred HHHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCccEEEeccCCcccccCCCcccccccccCCccccCCccccCCCC
Q psy1840 24 GSISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKAPELLRQPHL 103 (423)
Q Consensus 24 ~~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~ 103 (423)
....++.||+.||.|||+.|++ ||||||+||+++.++.+||+|||++....... ......+++.|+|||.+.+..
T Consensus 135 ~~~~~~~qi~~~l~~lH~~~iv-H~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~---~~~~~~~t~~y~aPE~~~~~~- 209 (362)
T 3pg1_A 135 HIQYFMYHILLGLHVLHEAGVV-HRDLHPGNILLADNNDITICDFNLAREDTADA---NKTHYVTHRWYRAPELVMQFK- 209 (362)
T ss_dssp HHHHHHHHHHHHHHHHHHTTCC-CCCCCGGGEEECTTCCEEECCTTC------------------CGGGCCHHHHTTCT-
T ss_pred HHHHHHHHHHHHHHHHHHCcCE-ecCCChHHEEEcCCCCEEEEecCccccccccc---ccceecccceecCcHHhcCCC-
Confidence 3678999999999999999998 99999999999999999999999987433221 223456888999999987632
Q ss_pred CCCCCccchHHHHHHHHHHHhCCCCCCCCCCChHHHHHHHhc------------------------CCCCCCCC----CC
Q psy1840 104 PRGTQKGDVYSFGLVLYEVIGRQGPWGHLRMTDEEIITSVTQ------------------------GSGLRPDT----SS 155 (423)
Q Consensus 104 ~~~s~ksDVyS~Giil~elltg~~Pf~~~~~~~~~i~~~i~~------------------------~~~~~p~~----~~ 155 (423)
..+.++|||||||++|+|++|+.||... ...+....+.. .....+.. ..
T Consensus 210 -~~~~~~DiwslG~il~~l~~g~~pf~~~--~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 286 (362)
T 3pg1_A 210 -GFTKLVDMWSAGCVMAEMFNRKALFRGS--TFYNQLNKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVV 286 (362)
T ss_dssp -TCCTHHHHHHHHHHHHHHHHSSCSCCCS--SHHHHHHHHHHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHS
T ss_pred -CCCcHhHHHhHHHHHHHHHhCCCCCCCC--CHHHHHHHHHHHcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhC
Confidence 2389999999999999999999999753 23333333221 00000100 01
Q ss_pred CCchHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q psy1840 156 LDCAPSIIACMRTCWEEDPELRPDLRFVHHK 186 (423)
Q Consensus 156 ~~~~~~l~~Li~~C~~~dP~~RPt~~~I~~~ 186 (423)
..+++.+.+++.+||+.||++|||+.++++.
T Consensus 287 ~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 317 (362)
T 3pg1_A 287 PTADPVALDLIAKMLEFNPQRRISTEQALRH 317 (362)
T ss_dssp TTSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred CCCCHHHHHHHHHHhcCChhhCCCHHHHHcC
Confidence 3467889999999999999999999998763
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.91 E-value=3.4e-25 Score=213.84 Aligned_cols=158 Identities=18% Similarity=0.252 Sum_probs=117.2
Q ss_pred HHHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEc-CCccEEEeccCCcccccCCCc-ccccccccCCccccCCccccCC
Q psy1840 24 GSISVNTTASVGMIHLHDSEIISHGNLRSSNCLID-SRWVLQIADFGLHAFKAGQDE-TGQERKLRRRKLYKAPELLRQP 101 (423)
Q Consensus 24 ~~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld-~~~~vKL~DFGla~~~~~~~~-~~~~~~~~gt~~y~APE~l~~~ 101 (423)
....++.||+.||.|||+.|++ ||||||+||+++ .++.+||+|||++........ ........++..|+|||.+.+.
T Consensus 121 ~~~~~~~qi~~~l~~lH~~~i~-H~dlkp~Nil~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~ 199 (320)
T 2i6l_A 121 HARLFMYQLLRGLKYIHSANVL-HRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSP 199 (320)
T ss_dssp HHHHHHHHHHHHHHHHHHTTCB-CCCCSGGGEEEETTTTEEEECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCT
T ss_pred HHHHHHHHHHHHHHHHHhCCEe-cCCCCHHHEEEcCCCCeEEEccCccccccCCCcccccccccccccccccCcHHhcCc
Confidence 3678999999999999999998 999999999997 567999999999876532211 1122344578889999988653
Q ss_pred CCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCChHHHHHHHhcCCCC----------------------CCCC----CC
Q psy1840 102 HLPRGTQKGDVYSFGLVLYEVIGRQGPWGHLRMTDEEIITSVTQGSGL----------------------RPDT----SS 155 (423)
Q Consensus 102 ~~~~~s~ksDVyS~Giil~elltg~~Pf~~~~~~~~~i~~~i~~~~~~----------------------~p~~----~~ 155 (423)
. ..+.++||||||+++|||++|+.||... ...+....+....+. .+.. ..
T Consensus 200 ~--~~~~~~Di~slG~il~el~~g~~pf~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 275 (320)
T 2i6l_A 200 N--NYTKAIDMWAAGCIFAEMLTGKTLFAGA--HELEQMQLILESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLL 275 (320)
T ss_dssp T--CCCHHHHHHHHHHHHHHHHHSSCSSCCS--SHHHHHHHHHHHSCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHS
T ss_pred c--cCCchhhhHhHHHHHHHHHhCCCCCCCC--CHHHHHHHHHHhcCCCchhhhhhhhhcCcccccccccCCCCChhHhc
Confidence 2 2389999999999999999999999743 333333333221110 0100 01
Q ss_pred CCchHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q psy1840 156 LDCAPSIIACMRTCWEEDPELRPDLRFVHHK 186 (423)
Q Consensus 156 ~~~~~~l~~Li~~C~~~dP~~RPt~~~I~~~ 186 (423)
..++.++.+++.+||+.||++|||+.++++.
T Consensus 276 ~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 306 (320)
T 2i6l_A 276 PGISREAVDFLEQILTFSPMDRLTAEEALSH 306 (320)
T ss_dssp TTCCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred chhhHHHHHHHHHHcCCCccccCCHHHHhCC
Confidence 3578999999999999999999999999763
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=99.91 E-value=5.1e-25 Score=214.11 Aligned_cols=143 Identities=24% Similarity=0.411 Sum_probs=115.8
Q ss_pred HHHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEc-CCccEEEeccCCcccccCCCcccccccccCCccccCCccccCCC
Q psy1840 24 GSISVNTTASVGMIHLHDSEIISHGNLRSSNCLID-SRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKAPELLRQPH 102 (423)
Q Consensus 24 ~~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld-~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~ 102 (423)
....++.||+.||.|||+.|++ ||||||+||+++ .++.+||+|||++....... .....|++.|+|||.+.+..
T Consensus 150 ~~~~i~~qi~~~L~~LH~~~iv-H~Dlkp~NIll~~~~~~~kL~Dfg~~~~~~~~~----~~~~~gt~~y~aPE~~~~~~ 224 (320)
T 3a99_A 150 LARSFFWQVLEAVRHCHNCGVL-HRDIKDENILIDLNRGELKLIDFGSGALLKDTV----YTDFDGTRVYSPPEWIRYHR 224 (320)
T ss_dssp HHHHHHHHHHHHHHHHHHTTEE-CCCCSGGGEEEETTTTEEEECCCTTCEECCSSC----BCCCCSCGGGSCHHHHHHSC
T ss_pred HHHHHHHHHHHHHHHHHHCCcE-eCCCCHHHEEEeCCCCCEEEeeCcccccccccc----ccCCCCCccCCChHHhccCC
Confidence 3678999999999999999988 999999999999 78999999999987654321 23456889999999987654
Q ss_pred CCCCCCccchHHHHHHHHHHHhCCCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCchHHHHHHHHHhhhcCCCCCCCHHH
Q psy1840 103 LPRGTQKGDVYSFGLVLYEVIGRQGPWGHLRMTDEEIITSVTQGSGLRPDTSSLDCAPSIIACMRTCWEEDPELRPDLRF 182 (423)
Q Consensus 103 ~~~~s~ksDVyS~Giil~elltg~~Pf~~~~~~~~~i~~~i~~~~~~~p~~~~~~~~~~l~~Li~~C~~~dP~~RPt~~~ 182 (423)
. .+.++||||||+++|||++|+.||.. ..+ +..+... ....+++++.+++.+||+.||++|||+.+
T Consensus 225 ~--~~~~~Di~slG~il~el~~g~~pf~~----~~~----~~~~~~~----~~~~~~~~~~~li~~~l~~dp~~Rps~~~ 290 (320)
T 3a99_A 225 Y--HGRSAAVWSLGILLYDMVCGDIPFEH----DEE----IIRGQVF----FRQRVSSECQHLIRWCLALRPSDRPTFEE 290 (320)
T ss_dssp B--CHHHHHHHHHHHHHHHHHHSSCSCCS----HHH----HHHCCCC----CSSCCCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred C--CCccchHHhHHHHHHHHHHCCCCCCC----hhh----hhccccc----ccccCCHHHHHHHHHHccCChhhCcCHHH
Confidence 2 26789999999999999999999963 122 1222211 12357899999999999999999999999
Q ss_pred HHH
Q psy1840 183 VHH 185 (423)
Q Consensus 183 I~~ 185 (423)
|++
T Consensus 291 ll~ 293 (320)
T 3a99_A 291 IQN 293 (320)
T ss_dssp HHT
T ss_pred Hhc
Confidence 876
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.90 E-value=5.2e-24 Score=205.61 Aligned_cols=143 Identities=23% Similarity=0.431 Sum_probs=115.8
Q ss_pred HHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEc-CCccEEEeccCCcccccCCCcccccccccCCccccCCccccCCCC
Q psy1840 25 SISVNTTASVGMIHLHDSEIISHGNLRSSNCLID-SRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKAPELLRQPHL 103 (423)
Q Consensus 25 ~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld-~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~ 103 (423)
...++.||+.||.|||+.|++ ||||||+||+++ .++.+||+|||++....... .....++..|+|||.+.+...
T Consensus 141 ~~~~~~qi~~~l~~lH~~~i~-H~dlkp~Nil~~~~~~~~kl~dfg~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~ 215 (312)
T 2iwi_A 141 SRCFFGQVVAAIQHCHSRGVV-HRDIKDENILIDLRRGCAKLIDFGSGALLHDEP----YTDFDGTRVYSPPEWISRHQY 215 (312)
T ss_dssp HHHHHHHHHHHHHHHHHHTEE-CCCCSGGGEEEETTTTEEEECCCSSCEECCSSC----BCCCCSCTTTSCHHHHHHSCB
T ss_pred HHHHHHHHHHHHHHHHHCCee-ecCCChhhEEEeCCCCeEEEEEcchhhhcccCc----ccccCCcccccCceeeecCCC
Confidence 678999999999999999988 999999999999 88999999999987654322 234568889999999876543
Q ss_pred CCCCCccchHHHHHHHHHHHhCCCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCchHHHHHHHHHhhhcCCCCCCCHHHH
Q psy1840 104 PRGTQKGDVYSFGLVLYEVIGRQGPWGHLRMTDEEIITSVTQGSGLRPDTSSLDCAPSIIACMRTCWEEDPELRPDLRFV 183 (423)
Q Consensus 104 ~~~s~ksDVyS~Giil~elltg~~Pf~~~~~~~~~i~~~i~~~~~~~p~~~~~~~~~~l~~Li~~C~~~dP~~RPt~~~I 183 (423)
.+.++||||||+++|||++|+.||.. ..++. ...... ...++..+.+++.+||+.||++||++.++
T Consensus 216 --~~~~~Di~slG~il~~l~~g~~pf~~----~~~~~----~~~~~~----~~~~~~~~~~li~~~l~~~p~~Rps~~e~ 281 (312)
T 2iwi_A 216 --HALPATVWSLGILLYDMVCGDIPFER----DQEIL----EAELHF----PAHVSPDCCALIRRCLAPKPSSRPSLEEI 281 (312)
T ss_dssp --CHHHHHHHHHHHHHHHHHHSSCSCCS----HHHHH----HTCCCC----CTTSCHHHHHHHHHHTCSSTTTSCCHHHH
T ss_pred --CCccchHHHHHHHHHHHHHCCCCCCC----hHHHh----hhccCC----cccCCHHHHHHHHHHccCChhhCcCHHHH
Confidence 24589999999999999999999963 12222 221111 23578999999999999999999999999
Q ss_pred HHH
Q psy1840 184 HHK 186 (423)
Q Consensus 184 ~~~ 186 (423)
++.
T Consensus 282 l~~ 284 (312)
T 2iwi_A 282 LLD 284 (312)
T ss_dssp HHS
T ss_pred hcC
Confidence 763
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=99.89 E-value=2.7e-23 Score=199.79 Aligned_cols=136 Identities=17% Similarity=0.258 Sum_probs=101.4
Q ss_pred HHHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcC---CccEEEeccCCcccccCCCcccccccccCCccccCCccccC
Q psy1840 24 GSISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDS---RWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKAPELLRQ 100 (423)
Q Consensus 24 ~~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~---~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~ 100 (423)
....++.|++.||.|||+.|++ ||||||+||+++. ++.+||+|||++.....
T Consensus 118 ~~~~i~~qi~~~l~~lH~~~i~-H~dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~------------------------ 172 (299)
T 3m2w_A 118 EASEIMKSIGEAIQYLHSINIA-HRDVKPENLLYTSKRPNAILKLTDFGFAKETTG------------------------ 172 (299)
T ss_dssp HHHHHHHHHHHHHHHHHHTTEE-CCCCSGGGEEESSSSTTCCEEECCCTTCEECTT------------------------
T ss_pred HHHHHHHHHHHHHHHHHhCCcc-cCCCCHHHEEEecCCCCCcEEEecccccccccc------------------------
Confidence 3689999999999999999988 9999999999998 78999999999754321
Q ss_pred CCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCChHHHHHHHhc----CCCCCCCCCCCCchHHHHHHHHHhhhcCCCC
Q psy1840 101 PHLPRGTQKGDVYSFGLVLYEVIGRQGPWGHLRMTDEEIITSVTQ----GSGLRPDTSSLDCAPSIIACMRTCWEEDPEL 176 (423)
Q Consensus 101 ~~~~~~s~ksDVyS~Giil~elltg~~Pf~~~~~~~~~i~~~i~~----~~~~~p~~~~~~~~~~l~~Li~~C~~~dP~~ 176 (423)
.. ++.++|||||||++|||++|..||..... ......+.. +....+......+++++.+++.+||+.||++
T Consensus 173 ~~---~~~~~DiwslG~il~el~tg~~pf~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~ 247 (299)
T 3m2w_A 173 EK---YDKSCDMWSLGVIMYILLCGYPPFYSNHG--LAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQ 247 (299)
T ss_dssp CG---GGGHHHHHHHHHHHHHHHHSSCSCCC---------CCSCCSSCTTCCSSCHHHHTTSCHHHHHHHHHHTCSSTTT
T ss_pred cc---CCchhhHHHHHHHHHHHHHCCCCCCCCcc--hhhhHHHHHHHhhccccCCchhcccCCHHHHHHHHHHcccChhh
Confidence 11 27899999999999999999999964321 111111111 1111111111457899999999999999999
Q ss_pred CCCHHHHHHHHHH
Q psy1840 177 RPDLRFVHHKLKE 189 (423)
Q Consensus 177 RPt~~~I~~~L~~ 189 (423)
|||+.++++....
T Consensus 248 Rps~~e~l~hp~~ 260 (299)
T 3m2w_A 248 RMTITEFMNHPWI 260 (299)
T ss_dssp SCCHHHHHTSHHH
T ss_pred CCCHHHHhcChhh
Confidence 9999999875433
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=99.88 E-value=9.6e-24 Score=223.00 Aligned_cols=152 Identities=20% Similarity=0.179 Sum_probs=111.3
Q ss_pred HHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCcc---EEEeccCCcccccCCCcccccccccCCccccCCccccCC
Q psy1840 25 SISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWV---LQIADFGLHAFKAGQDETGQERKLRRRKLYKAPELLRQP 101 (423)
Q Consensus 25 ~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~~---vKL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~ 101 (423)
...++.|++.||.|||+.|++ ||||||+||+++.++. +||+|||++....... ......|++.|+|||.+.+.
T Consensus 123 i~~I~~QLl~aL~yLHs~gIV-HrDLKP~NILl~~~g~~~~vKL~DFG~a~~~~~~~---~~~~~~gt~~Y~APE~l~~~ 198 (676)
T 3qa8_A 123 IRTLLSDISSALRYLHENRII-HRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGE---LCTEFVGTLQYLAPELLEQK 198 (676)
T ss_dssp HHHHHHHHHHHHHHHHHTTBC-CCCCCSTTEEEECCSSSCEEEECSCCCCCBTTSCC---CCCCCCSCCTTCSSCSSCCS
T ss_pred HHHHHHHHHHHHHHHHHCCCc-cCCCCHHHeEeecCCCceeEEEccccccccccccc---ccccccCCcccCChHHhccC
Confidence 689999999999999999988 9999999999996654 9999999987654332 12345788999999999876
Q ss_pred CCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCChHHHH--------HHHh-----cCCC------CCCCCCCCCchHHH
Q psy1840 102 HLPRGTQKGDVYSFGLVLYEVIGRQGPWGHLRMTDEEII--------TSVT-----QGSG------LRPDTSSLDCAPSI 162 (423)
Q Consensus 102 ~~~~~s~ksDVyS~Giil~elltg~~Pf~~~~~~~~~i~--------~~i~-----~~~~------~~p~~~~~~~~~~l 162 (423)
.+ +.++|||||||++|+|++|..||.... ....+. .... .+.. ..|......+++.+
T Consensus 199 ~~---s~ksDIwSLGviLyeLltG~~Pf~~~~-~~~~~~~~i~~~~~~~~~~~~~l~g~~~~~~~lp~p~~l~~~ls~~L 274 (676)
T 3qa8_A 199 KY---TVTVDYWSFGTLAFECITGFRPFLPNW-QPVQWHGKVREKSNEHIVVYDDLTGAVKFSSVLPTPNHLSGILAGKL 274 (676)
T ss_dssp CC---STTHHHHHHHHHHHHHHSSCSSCCSSC-HHHHSSTTCC------CCSCCCCSSSCCCCSSSCCSCCCCGGGHHHH
T ss_pred CC---CchhHHHHHHHHHHHHHHCCCCCCccc-chhhhhhhhhcccchhhhhhhhhccccccccccCCchhhchhhhHHH
Confidence 55 899999999999999999999996421 011000 0000 0000 11111223478899
Q ss_pred HHHHHHhhhcCCCCCCCHHHHH
Q psy1840 163 IACMRTCWEEDPELRPDLRFVH 184 (423)
Q Consensus 163 ~~Li~~C~~~dP~~RPt~~~I~ 184 (423)
.+++.+||..||++|||+.+++
T Consensus 275 ~dLI~~mL~~DP~kRPTa~elL 296 (676)
T 3qa8_A 275 ERWLQCMLMWHQRQRGTDPQNP 296 (676)
T ss_dssp HHHHHHHSCSSCC---CCTTCC
T ss_pred HHHHHHHccCCHhhCcCHHHHh
Confidence 9999999999999999987753
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=99.86 E-value=1.8e-22 Score=215.92 Aligned_cols=143 Identities=20% Similarity=0.228 Sum_probs=111.7
Q ss_pred HHHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCccEEEeccCCcccccCCCcccccccccCCccccCCccccCCCC
Q psy1840 24 GSISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKAPELLRQPHL 103 (423)
Q Consensus 24 ~~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~ 103 (423)
..+.++.||+.||.|||++|++ ||||||+||+++.+ .+||+|||+++..... ....||+.|+|||++.+..
T Consensus 183 ~~~~~~~qi~~aL~~lH~~gii-HrDlkp~NIll~~~-~~kl~DFG~a~~~~~~------~~~~gt~~y~aPE~~~~~~- 253 (681)
T 2pzi_A 183 EAIAYLLEILPALSYLHSIGLV-YNDLKPENIMLTEE-QLKLIDLGAVSRINSF------GYLYGTPGFQAPEIVRTGP- 253 (681)
T ss_dssp HHHHHHHHHHHHHHHHHHTTEE-CCCCSGGGEEECSS-CEEECCCTTCEETTCC------SCCCCCTTTSCTTHHHHCS-
T ss_pred HHHHHHHHHHHHHHHHHHCCCe-ecccChHHeEEeCC-cEEEEecccchhcccC------CccCCCccccCHHHHcCCC-
Confidence 3689999999999999999988 99999999999985 8999999998765322 3456899999999987643
Q ss_pred CCCCCccchHHHHHHHHHHHhCCCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCchHHHHHHHHHhhhcCCCCCCC-HHH
Q psy1840 104 PRGTQKGDVYSFGLVLYEVIGRQGPWGHLRMTDEEIITSVTQGSGLRPDTSSLDCAPSIIACMRTCWEEDPELRPD-LRF 182 (423)
Q Consensus 104 ~~~s~ksDVyS~Giil~elltg~~Pf~~~~~~~~~i~~~i~~~~~~~p~~~~~~~~~~l~~Li~~C~~~dP~~RPt-~~~ 182 (423)
+.++|||||||++|+|++|..||...... . ..........++.+.+++.+||+.||++||+ ..+
T Consensus 254 ---~~~sDi~slG~~l~~l~~g~~~~~~~~~~----------~--~~~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~ 318 (681)
T 2pzi_A 254 ---TVATDIYTVGRTLAALTLDLPTRNGRYVD----------G--LPEDDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEE 318 (681)
T ss_dssp ---CHHHHHHHHHHHHHHHHSCCCEETTEECS----------S--CCTTCHHHHHCHHHHHHHHHHTCSSGGGSCSSHHH
T ss_pred ---CCceehhhhHHHHHHHHhCCCCCcccccc----------c--ccccccccccCHHHHHHHhhhccCChhhCCCHHHH
Confidence 78999999999999999999888632110 0 0011111124578999999999999999995 566
Q ss_pred HHHHHHHH
Q psy1840 183 VHHKLKEM 190 (423)
Q Consensus 183 I~~~L~~i 190 (423)
+.+.+..+
T Consensus 319 l~~~l~~~ 326 (681)
T 2pzi_A 319 MSAQLTGV 326 (681)
T ss_dssp HHHHHHHH
T ss_pred HHHHHHHH
Confidence 66655544
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=99.85 E-value=4.1e-22 Score=190.93 Aligned_cols=137 Identities=15% Similarity=0.154 Sum_probs=104.2
Q ss_pred hHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCccEEEeccCCcccccCCCcccccccccCCccccCCccccCC
Q psy1840 22 PIGSISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKAPELLRQP 101 (423)
Q Consensus 22 p~~~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~ 101 (423)
+...+.++.|++.||.|||++|++ ||||||+||+++.++.+||+++| |++|
T Consensus 128 ~~~~~~i~~ql~~aL~~lH~~giv-H~Dikp~NIll~~~g~~kl~~~~----------------------~~~~------ 178 (286)
T 3uqc_A 128 PVGAIRAMQSLAAAADAAHRAGVA-LSIDHPSRVRVSIDGDVVLAYPA----------------------TMPD------ 178 (286)
T ss_dssp HHHHHHHHHHHHHHHHHHHHTTCC-CCCCSGGGEEEETTSCEEECSCC----------------------CCTT------
T ss_pred hHHHHHHHHHHHHHHHHHHHCCCc-cCCCCcccEEEcCCCCEEEEecc----------------------ccCC------
Confidence 455789999999999999999998 99999999999999999998543 3332
Q ss_pred CCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCChHHH--HHHHhcCCCCCCCCCCCCchHHHHHHHHHhhhcCCCCCCC
Q psy1840 102 HLPRGTQKGDVYSFGLVLYEVIGRQGPWGHLRMTDEEI--ITSVTQGSGLRPDTSSLDCAPSIIACMRTCWEEDPELRPD 179 (423)
Q Consensus 102 ~~~~~s~ksDVyS~Giil~elltg~~Pf~~~~~~~~~i--~~~i~~~~~~~p~~~~~~~~~~l~~Li~~C~~~dP~~RPt 179 (423)
.+.++|||||||++|||++|+.||....... .+ ......+....+......+++++.+++.+||+.||++| |
T Consensus 179 ----~~~~~Di~slG~il~elltg~~Pf~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~R-s 252 (286)
T 3uqc_A 179 ----ANPQDDIRGIGASLYALLVNRWPLPEAGVRS-GLAPAERDTAGQPIEPADIDRDIPFQISAVAARSVQGDGGIR-S 252 (286)
T ss_dssp ----CCHHHHHHHHHHHHHHHHHSEECSCCCSBCC-CSEECCBCTTSCBCCHHHHCTTSCHHHHHHHHHHHCTTSSCC-C
T ss_pred ----CCchhHHHHHHHHHHHHHHCCCCCCcCCcch-hhHHHHHHhccCCCChhhcccCCCHHHHHHHHHHcccCCccC-C
Confidence 2889999999999999999999997532110 00 00000111111111124678999999999999999999 9
Q ss_pred HHHHHHHHHHHhhh
Q psy1840 180 LRFVHHKLKEMNAG 193 (423)
Q Consensus 180 ~~~I~~~L~~i~~~ 193 (423)
+.++++.|+.+...
T Consensus 253 ~~el~~~L~~~~~~ 266 (286)
T 3uqc_A 253 ASTLLNLMQQATAV 266 (286)
T ss_dssp HHHHHHHHHHHHC-
T ss_pred HHHHHHHHHHHhcc
Confidence 99999999887653
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=99.82 E-value=1e-20 Score=184.79 Aligned_cols=143 Identities=11% Similarity=0.073 Sum_probs=106.6
Q ss_pred HHHHHHHHHHHHHHHHH-hCCCeeecCCCCCCEEEcCCc--------------------cEEEeccCCcccccCCCcccc
Q psy1840 24 GSISVNTTASVGMIHLH-DSEIISHGNLRSSNCLIDSRW--------------------VLQIADFGLHAFKAGQDETGQ 82 (423)
Q Consensus 24 ~~l~i~~qi~~gL~yLH-~~~ii~HrDLkp~NILld~~~--------------------~vKL~DFGla~~~~~~~~~~~ 82 (423)
....++.||+.||.||| +.|++ ||||||+|||++.++ .+||+|||+++.....
T Consensus 162 ~~~~i~~qi~~aL~~lH~~~~iv-HrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~----- 235 (336)
T 2vuw_A 162 TAKSILHQLTASLAVAEASLRFE-HRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG----- 235 (336)
T ss_dssp HHHHHHHHHHHHHHHHHHHHCCB-CSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT-----
T ss_pred HHHHHHHHHHHHHHHHHHhCCEe-ECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC-----
Confidence 36799999999999999 89998 999999999999887 9999999999865422
Q ss_pred cccccCCccccCCccccCCCCCCCCCccchHHHHHH-HHHHHhCCCCCCCCCCChHHHHHHHhcCCCCCCCC---CCCCc
Q psy1840 83 ERKLRRRKLYKAPELLRQPHLPRGTQKGDVYSFGLV-LYEVIGRQGPWGHLRMTDEEIITSVTQGSGLRPDT---SSLDC 158 (423)
Q Consensus 83 ~~~~~gt~~y~APE~l~~~~~~~~s~ksDVyS~Gii-l~elltg~~Pf~~~~~~~~~i~~~i~~~~~~~p~~---~~~~~ 158 (423)
...||+.|+|||++.+.. +.++||||+|++ .+++++|..||.... ....+...+.......... ....+
T Consensus 236 --~~~gt~~y~aPE~~~g~~----~~~~Diwsl~~~~~~~~~~g~~p~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~ 308 (336)
T 2vuw_A 236 --IVVFCDVSMDEDLFTGDG----DYQFDIYRLMKKENNNRWGEYHPYSNVL-WLHYLTDKMLKQMTFKTKCNTPAMKQI 308 (336)
T ss_dssp --EEECCCCTTCSGGGCCCS----SHHHHHHHHHHHHHTTCTTSCCTHHHHH-HHHHHHHHHHHTCCCSSCCCSHHHHHH
T ss_pred --cEEEeecccChhhhcCCC----ccceehhhhhCCCCcccccccCCCcchh-hhhHHHHhhhhhhccCcccchhhhhhc
Confidence 347899999999998653 789999998776 777888999984210 0012233333221111111 11247
Q ss_pred hHHHHHHHHHhhhcCCCCCCCHHHHH
Q psy1840 159 APSIIACMRTCWEEDPELRPDLRFVH 184 (423)
Q Consensus 159 ~~~l~~Li~~C~~~dP~~RPt~~~I~ 184 (423)
++++.+|+.+||+.| |+.+++
T Consensus 309 s~~~~dli~~~L~~d-----sa~e~l 329 (336)
T 2vuw_A 309 KRKIQEFHRTMLNFS-----SATDLL 329 (336)
T ss_dssp HHHHHHHHHHGGGSS-----SHHHHH
T ss_pred CHHHHHHHHHHhccC-----CHHHHH
Confidence 889999999999976 888776
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.71 E-value=6.1e-19 Score=184.59 Aligned_cols=94 Identities=15% Similarity=0.127 Sum_probs=63.8
Q ss_pred HHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCccEEEeccCCcccccCCCcccccccccCCccccCCccccCCCCCC
Q psy1840 26 ISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKAPELLRQPHLPR 105 (423)
Q Consensus 26 l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~ 105 (423)
-+|+.||+.||+|+|++||| ||||||+|||++.+|.+||+|||+++...... .......||+.|+|||++.+..
T Consensus 342 ~~I~~QIl~AL~ylH~~GII-HRDIKPeNILL~~dg~vKL~DFGlAr~~~~~~--~~~~t~vGTp~YmAPE~l~g~~--- 415 (569)
T 4azs_A 342 EKILGSLLRSLAALEKQGFW-HDDVRPWNVMVDARQHARLIDFGSIVTTPQDC--SWPTNLVQSFFVFVNELFAENK--- 415 (569)
T ss_dssp HHHHHHHHHHHHHHHHTTCE-ESCCCGGGEEECTTSCEEECCCTTEESCC-----CCSHHHHHHHHHHHHHHC-------
T ss_pred HHHHHHHHHHHHHHHHCCce-eccCchHhEEECCCCCEEEeecccCeeCCCCC--ccccCceechhhccHHHhCCCC---
Confidence 46899999999999999998 99999999999999999999999988654322 2224567999999999998753
Q ss_pred CCCccchHHHHHHHHHHHhCC
Q psy1840 106 GTQKGDVYSFGLVLYEVIGRQ 126 (423)
Q Consensus 106 ~s~ksDVyS~Giil~elltg~ 126 (423)
..++|+||+|++++++.++.
T Consensus 416 -~~~~d~~s~g~~~~~l~~~~ 435 (569)
T 4azs_A 416 -SWNGFWRSAPVHPFNLPQPW 435 (569)
T ss_dssp --------------CCCCTTH
T ss_pred -CCcccccccccchhhhcccc
Confidence 67899999999888765543
|
| >1y10_A Hypothetical protein RV1264/MT1302; adenylyl cyclase fold, lyase; HET: 1PE; 2.30A {Mycobacterium tuberculosis} PDB: 1y11_A* | Back alignment and structure |
|---|
Probab=99.64 E-value=1.2e-16 Score=158.99 Aligned_cols=89 Identities=19% Similarity=0.121 Sum_probs=80.5
Q ss_pred HHHHHHHHHHHHHhhCc-------HHHHHHHhCCCCC------------CCccccceeEEEeeccccccccccCCHhHHH
Q psy1840 305 LTQEKKKTDALLHRMLP-------RSVSESLKRGDFV------------EPESFDSVTIYFSDIVGFTQLSAESTETGRV 365 (423)
Q Consensus 305 l~~e~~~~~~ll~~~lp-------~~ia~~l~~g~~~------------~~~~~~~vtv~f~di~gft~~~~~~~p~~~v 365 (423)
..++++|+++||++||| +.|+++|++|... .+..|.+|||+||||+|||.+++.++|.+++
T Consensus 160 ~~ee~~kse~LL~~iLP~L~~~l~~~va~~L~~~~~~~~v~~~~r~~~~~~~~~~~vTVlFaDIvgFT~ls~~~~p~evv 239 (407)
T 1y10_A 160 ELDIAKGSQALVSQIVPLLGPMIQDMLFMQLRHMMETEAVNAGERAAGKPLPGARQVTVAFADLVGFTQLGEVVSAEELG 239 (407)
T ss_dssp HHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCCTTCEEEEEEEEEECSBCTTSCBCCHHHHH
T ss_pred cHhHHHHHHHHHHHhcccccccchHHHHHHHHhcccchhhhhhhhcccccccceeeEEEEEEEccCchHHHhhCCHHHHH
Confidence 35778999999999999 9999999988542 2346899999999999999999999999999
Q ss_pred Hhhhccch-hhhhccCCCceEEEeecccCC
Q psy1840 366 TTRDSRRT-PDLKVGGSNPRQVITGTDMLR 394 (423)
Q Consensus 366 ~~ln~~~~-fd~~~~~~~~~~v~~~~~~~~ 394 (423)
.+||++|+ ||.+++ +++|+++|+||.||
T Consensus 240 ~lLn~~~~~~~~i~~-~~g~~iKtiGDa~m 268 (407)
T 1y10_A 240 HLAGRLAGLARDLTA-PPVWFIKTIGDAVM 268 (407)
T ss_dssp HHHHHHHHHHHHHCC-TTCEEEEEETTEEE
T ss_pred HHHHHHHHHHHHHHH-cCcEEEEEecceEE
Confidence 99999999 998887 79999999999999
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.38 E-value=3.7e-14 Score=147.43 Aligned_cols=101 Identities=20% Similarity=0.240 Sum_probs=81.3
Q ss_pred HHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCccEEEeccCCcccccCCCccc-----ccccccCCccccCCccccC
Q psy1840 26 ISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETG-----QERKLRRRKLYKAPELLRQ 100 (423)
Q Consensus 26 l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~~~-----~~~~~~gt~~y~APE~l~~ 100 (423)
+.++.|++.||.|||+++++ ||||||+|||++. .+||+|||+++......... ......||+.|+|||++..
T Consensus 434 ~~i~~qi~~aL~~LH~~gIi-HrDiKp~NILl~~--~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~GT~~y~APEv~~~ 510 (540)
T 3en9_A 434 LDIAYKIGEIVGKLHKNDVI-HNDLTTSNFIFDK--DLYIIDFGLGKISNLDEDKAVDLIVFKKAVLSTHHEKFDEIWER 510 (540)
T ss_dssp THHHHHHHHHHHHHHHTTEE-CTTCCTTSEEESS--SEEECCCTTCEECCCHHHHHHHHHHHHHHHHHHCGGGHHHHHHH
T ss_pred HHHHHHHHHHHHHHHHCcCc-cCCCCHHHEEECC--eEEEEECccCEECCCccccccchhhhhhhhcCCCCcCCHHHHHH
Confidence 58999999999999999988 9999999999999 99999999998764322111 1235678999999999976
Q ss_pred CCCCCCCCccchHHHHHHHHHHHhCCCCCC
Q psy1840 101 PHLPRGTQKGDVYSFGLVLYEVIGRQGPWG 130 (423)
Q Consensus 101 ~~~~~~s~ksDVyS~Giil~elltg~~Pf~ 130 (423)
... .++..+|+||.++-..+-+.++.+|.
T Consensus 511 ~~~-~Y~~~~d~ws~vl~~l~~v~~r~rY~ 539 (540)
T 3en9_A 511 FLE-GYKSVYDRWEIILELMKDVERRARYV 539 (540)
T ss_dssp HHH-HHHHHCTTHHHHHHHHHHHHTCSCCC
T ss_pred HHH-HHHHHHhHHHHHHHHHHHHHhccccC
Confidence 211 12677899999999888888887774
|
| >3uvj_A Guanylate cyclase soluble subunit alpha-3; nitric oxide, structural genomics, structural genomics conso SGC, CGMP biosynthesis; 2.08A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.35 E-value=1e-13 Score=127.83 Aligned_cols=84 Identities=27% Similarity=0.404 Sum_probs=70.0
Q ss_pred hCCCCCCCccccceeEEEeeccccccccccCCHhHHHHhhhccch-hhhhccCCCceEEEeecccCC--------CcchH
Q psy1840 329 KRGDFVEPESFDSVTIYFSDIVGFTQLSAESTETGRVTTRDSRRT-PDLKVGGSNPRQVITGTDMLR--------HRPHE 399 (423)
Q Consensus 329 ~~g~~~~~~~~~~vtv~f~di~gft~~~~~~~p~~~v~~ln~~~~-fd~~~~~~~~~~v~~~~~~~~--------~~~~~ 399 (423)
++|+.+.++++++|||+|+||+|||.+++.++|.+++.+||++|+ ||..|..++.|+++|+||.|| +..|+
T Consensus 2 ~~g~~~~~~~~~~vtvlF~Di~gfT~l~~~~~~~~~~~~ln~~~~~~~~~i~~~~g~v~k~~GD~~ma~fg~p~~~~~~a 81 (225)
T 3uvj_A 2 MQGQVVQAKKFSNVTMLFSDIVGFTAICSQCSPLQVITMLNALYTRFDQQCGELDVYKVETIGDAYCVAGGLHKESDTHA 81 (225)
T ss_dssp ---CEEEEEEEEEEEEEEEEETTHHHHHHHSCHHHHHHHHHHHHHHHHHHHHHHTCEEECCSTTCEEEEESSSSCCTTHH
T ss_pred CCCCccCCcccceEEEEEEEccChHHHHhcCCHHHHHHHHHHHHHHHHHHHHhcCeEEEEeeCcEEEEEECCCCCchHHH
Confidence 468889999999999999999999999999999999999999999 999999999999999999988 34555
Q ss_pred HHH-hhhhhhchHh
Q psy1840 400 SKV-SLALSSLSIA 412 (423)
Q Consensus 400 ~~~-~~~~~~~~~~ 412 (423)
..+ ..|++++...
T Consensus 82 ~~a~~~al~~~~~~ 95 (225)
T 3uvj_A 82 VQIALMALKMMELS 95 (225)
T ss_dssp HHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHH
Confidence 555 4456555544
|
| >2wz1_A Guanylate cyclase soluble subunit beta-1; lyase, GUCY1, metal-binding, CGMP biosynthesis, nucleotide-B cyclase, GUCY1B3, GTP-binding; 1.63A {Homo sapiens} PDB: 3uvj_B | Back alignment and structure |
|---|
Probab=99.33 E-value=5.2e-13 Score=122.62 Aligned_cols=65 Identities=26% Similarity=0.241 Sum_probs=58.9
Q ss_pred CCCCCCCccccceeEEEeeccccccccccCC----HhHHHHhhhccch-hhhhcc---CCCceEEEeecccCC
Q psy1840 330 RGDFVEPESFDSVTIYFSDIVGFTQLSAEST----ETGRVTTRDSRRT-PDLKVG---GSNPRQVITGTDMLR 394 (423)
Q Consensus 330 ~g~~~~~~~~~~vtv~f~di~gft~~~~~~~----p~~~v~~ln~~~~-fd~~~~---~~~~~~v~~~~~~~~ 394 (423)
+|+.+.|+++.+|||+|+||+|||.+++..+ |.+++.+||++|+ ||.+|. .|++++++|.||.+|
T Consensus 1 ~G~~~~~~~~~~vtvlF~DI~gfT~l~e~~~~~~~~~~~~~~Ln~~~~~~~~~i~~~~~~~g~~~k~~GD~~m 73 (219)
T 2wz1_A 1 HKRPVPAKRYDNVTILFSGIVGFNAFCSKHASGEGAMKIVNLLNDLYTRFDTLTDSRKNPFVYKVETVGDKYM 73 (219)
T ss_dssp ----CCCEEEEEEEEEEEEETTHHHHHHHSCCC--HHHHHHHHHHHHHHHHHHHCTTTCTTCEEECCCTTCEE
T ss_pred CCCccCccceeeEEEEEEEccCcHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHhhccCCEEEEeecCCEEE
Confidence 4889999999999999999999999999999 9999999999999 999999 789999999999999
|
| >1ab8_A Adenylyl cyclase; lyase, complex (transferase-inhibitor); HET: FOK; 2.20A {Rattus norvegicus} SCOP: d.58.29.1 PDB: 1azs_B* 1cjk_B* 1cjt_B* 1cju_B* 1cjv_B* 1cs4_B* 1tl7_B* 1u0h_B* 2gvd_B* 2gvz_B* 3c14_B* 3c15_B* 3c16_B* 3e8a_B* 3g82_B* 3maa_B* 1cul_B* | Back alignment and structure |
|---|
Probab=99.30 E-value=1.1e-12 Score=120.57 Aligned_cols=66 Identities=15% Similarity=0.142 Sum_probs=57.1
Q ss_pred hCCCCCCCccccceeEEEeeccccccccccCC----HhHHHHhhhccch-hhhhccCC---CceEEEeecccCC
Q psy1840 329 KRGDFVEPESFDSVTIYFSDIVGFTQLSAEST----ETGRVTTRDSRRT-PDLKVGGS---NPRQVITGTDMLR 394 (423)
Q Consensus 329 ~~g~~~~~~~~~~vtv~f~di~gft~~~~~~~----p~~~v~~ln~~~~-fd~~~~~~---~~~~v~~~~~~~~ 394 (423)
++|+.+.+++|++|||+|+||+|||.+++.++ |.+++.+||++|+ ||.+|.++ ++|+++|.||.||
T Consensus 2 ~~~~~~~~~~~~~vtvlF~DI~gfT~l~~~l~~~~~p~~~~~~Ln~~~~~~~~~i~~~~~~g~~~ik~iGD~~m 75 (220)
T 1ab8_A 2 LKNEELYHQSYDCVCVMFASIPDFKEFYTESDVNKEGLECLRLLNEIIADFDDLLSKPKFSGVEKIKTIGSTYM 75 (220)
T ss_dssp -----CCEEEEEEEEEEEEECTTHHHHCCCSTTTTTTHHHHHHHHHHHHHHHGGGGSGGGTTEEEEEEETTEEE
T ss_pred CCCCcccccccCcEEEEEEEccchHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHhhccCCeEEEEEeCceEE
Confidence 56788899999999999999999999998874 8999999999999 99999985 8999999999998
|
| >1azs_A VC1; complex (lyase/hydrolase), hydrolase, signal transducing protein, cyclase, effector enzyme; HET: GSP FKP; 2.30A {Canis lupus familiaris} SCOP: d.58.29.1 PDB: 1cs4_A* 1u0h_A* 2gvd_A* 2gvz_A* 3c14_A* 3c15_A* 3c16_A* 3e8a_A* 3g82_A* 3maa_A* 1cul_A* 1cjk_A* 1cju_A* 1cjv_A* 1cjt_A* 1tl7_A* | Back alignment and structure |
|---|
Probab=99.23 E-value=2e-12 Score=118.69 Aligned_cols=74 Identities=20% Similarity=0.152 Sum_probs=61.4
Q ss_pred cHHHHHHHhCC-CCCCCccccceeEEEeeccccccccccCCHhHHHHhhhccch-hhhhccCCCceEEEeecccCC
Q psy1840 321 PRSVSESLKRG-DFVEPESFDSVTIYFSDIVGFTQLSAESTETGRVTTRDSRRT-PDLKVGGSNPRQVITGTDMLR 394 (423)
Q Consensus 321 p~~ia~~l~~g-~~~~~~~~~~vtv~f~di~gft~~~~~~~p~~~v~~ln~~~~-fd~~~~~~~~~~v~~~~~~~~ 394 (423)
-+..|.|..+. ....++.+.+|||+|+||+|||.+++..+|.+++.+||++|+ ||.+|..++.+++++.||.|+
T Consensus 13 ~~~~~~~~~~~~~~l~~~~~~~vtvlF~DI~gfT~l~e~~~~~~~~~~Ln~~~~~~~~~i~~~gG~v~k~iGD~~m 88 (220)
T 1azs_A 13 ADINAKQEDMMFHKIYIQKHDNVSILFADIEGFTSLASQCTAQELVMTLNELFARFDKLAAENHCLRIKILGDCYY 88 (220)
T ss_dssp --------CCSSCCCEEEEEEEEEEEEEEEETHHHHHHHSCHHHHHHHHHHHHHHHHHHHHHHTEEEEEEETTEEE
T ss_pred ccccccccccccccccccccccEEEEEEEccChHHHHhhCCHHHHHHHHHHHHHHHHHHHHHcCcEEEEEeCCeEE
Confidence 34567777666 567788999999999999999999999999999999999999 999999999999999999888
|
| >3et6_A Soluble guanylyl cyclase beta; guanylate cyclase, dimethylarsenic, lyase, membrane, transmembrane; 2.55A {Chlamydomonas reinhardtii} PDB: 3et6_B | Back alignment and structure |
|---|
Probab=99.20 E-value=1e-11 Score=111.27 Aligned_cols=78 Identities=23% Similarity=0.230 Sum_probs=66.0
Q ss_pred CCCccccceeEEEeeccccccccccCCHhHHHHhhhccch-hhhhccCC-CceEEEeecccCC--------CcchHHHH-
Q psy1840 334 VEPESFDSVTIYFSDIVGFTQLSAESTETGRVTTRDSRRT-PDLKVGGS-NPRQVITGTDMLR--------HRPHESKV- 402 (423)
Q Consensus 334 ~~~~~~~~vtv~f~di~gft~~~~~~~p~~~v~~ln~~~~-fd~~~~~~-~~~~v~~~~~~~~--------~~~~~~~~- 402 (423)
.+|+++.+|||+|+||+|||.+++..+|.+++.+||++|+ +|.+|.++ +.+++++.||.++ +..|+..+
T Consensus 2 ~~~~e~~~vtvlf~Di~gft~l~~~~~~~~~~~~l~~~~~~~~~~i~~~~g~~~vk~~GD~~~a~fg~~~~~~~~~~~a~ 81 (190)
T 3et6_A 2 APAQEHPEATVLFSDIVGFTEIASRSSPLEVXSLLDELYQRFDAAIEEYPQLYKVETIGDAYMVVCNVTVPCDDHADVLL 81 (190)
T ss_dssp CCCEEEEEEEEEEEEETTHHHHTTTSCHHHHHHHHHHHHHHHHHHGGGCTTEEEEECTTSCEEEEESSSSCCSTHHHHHH
T ss_pred CCccccceEEEEEeEecChhHhHhhCCHHHHHHHHHHHHHHHHHHHHHcCCEEEEEEeCCEEEEEECCCCCchhHHHHHH
Confidence 4678899999999999999999999999999999999999 99999997 9999999999998 34455444
Q ss_pred hhhhhhchH
Q psy1840 403 SLALSSLSI 411 (423)
Q Consensus 403 ~~~~~~~~~ 411 (423)
..|+++...
T Consensus 82 ~~al~~~~~ 90 (190)
T 3et6_A 82 EFALRMHEE 90 (190)
T ss_dssp HHHHHHHHH
T ss_pred HHHHHHHHH
Confidence 345554443
|
| >1yk9_A Adenylate cyclase; beta-alpha-beta sandwich, structural genomics, PSI, protein structure initiative; 2.70A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=99.19 E-value=5.2e-12 Score=114.64 Aligned_cols=62 Identities=21% Similarity=0.291 Sum_probs=56.2
Q ss_pred CCCCccccceeEEEeeccccccccccCCHhHHHHhhhccch-hhhhccCCCceEEEeecccCC
Q psy1840 333 FVEPESFDSVTIYFSDIVGFTQLSAESTETGRVTTRDSRRT-PDLKVGGSNPRQVITGTDMLR 394 (423)
Q Consensus 333 ~~~~~~~~~vtv~f~di~gft~~~~~~~p~~~v~~ln~~~~-fd~~~~~~~~~~v~~~~~~~~ 394 (423)
.+.|+.+.+|||+|+||+|||.+++.++|.+++.+||++|+ +|.+|..++.+++++.||.+|
T Consensus 2 ~~~~~~~~~vtvlf~DI~gfT~l~~~~~~~~~~~~ln~~~~~~~~~i~~~gG~v~k~~GD~~m 64 (204)
T 1yk9_A 2 NIIADKYDEASVLFADIVGFTERASSTAPADLVRFLDRLYSAFDELVDQHGLEKIEVSGDSYM 64 (204)
T ss_dssp ----CCCSCEEEEEEEESCSSCSSCCCCSSSTTTHHHHHHTTTTGGGTTSSCEECCCSSSCEE
T ss_pred CCCccccCcEEEEEEEccChHHHHhcCCHHHHHHHHHHHHHHHHHHHHHcCCEEEEEeCCeEE
Confidence 46789999999999999999999999999999999999999 999999999999999999988
|
| >1fx2_A Receptor-type adenylate cyclase gresag 4.1; CAMP, trypanosomes, adenylyl cyclases, monomer-dimer, catalysis, lyase; 1.46A {Trypanosoma brucei} SCOP: d.58.29.1 PDB: 1fx4_A | Back alignment and structure |
|---|
Probab=99.11 E-value=1.5e-11 Score=113.89 Aligned_cols=63 Identities=22% Similarity=0.132 Sum_probs=60.3
Q ss_pred CCCCCCccccceeEEEeeccccccccccCCHhHHHHhhhccch-hhhhccCCCceEEEeecccCC
Q psy1840 331 GDFVEPESFDSVTIYFSDIVGFTQLSAESTETGRVTTRDSRRT-PDLKVGGSNPRQVITGTDMLR 394 (423)
Q Consensus 331 g~~~~~~~~~~vtv~f~di~gft~~~~~~~p~~~v~~ln~~~~-fd~~~~~~~~~~v~~~~~~~~ 394 (423)
|+.++|+.+++|||+|+||+|||.+++.. |.+++.+||++|+ +|.+|.+|+.|+++|.||.||
T Consensus 2 ~~~~~~~~~~~vtvlF~DI~gfT~l~~~~-~~~~~~~l~~~~~~~~~~i~~~~G~v~k~~GD~~m 65 (235)
T 1fx2_A 2 NNRAPKEPTDPVTLIFTDIESSTALWAAH-PDLMPDAVAAHHRMVRSLIGRYKCYEVKTVGDSFM 65 (235)
T ss_dssp GGGSCCCTTSCEEEEEEEETTHHHHHHHC-TTTHHHHHHHHHHHHHHHHHHTTCEEEEEETTEEE
T ss_pred CCcCCCCCCCcEEEEEEeccChHHHHHHC-HHHHHHHHHHHHHHHHHHHHHcCCEEEEEcCCeEE
Confidence 56788999999999999999999999986 9999999999999 999999999999999999999
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.04 E-value=7.1e-11 Score=112.49 Aligned_cols=58 Identities=21% Similarity=0.143 Sum_probs=50.6
Q ss_pred HHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCccEEEeccCCcccccCCCcccccccccCCccccCCcccc
Q psy1840 25 SISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKAPELLR 99 (423)
Q Consensus 25 ~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~ 99 (423)
...++.|++.||.|||+.|++ ||||||+|||++ ++.+||+|||++... ..+.|||.+.
T Consensus 195 ~~~i~~qi~~~l~~lH~~gii-HrDlkp~NILl~-~~~vkl~DFG~a~~~---------------~~~~a~e~l~ 252 (282)
T 1zar_A 195 PDEVLDMILEEVAKFYHRGIV-HGDLSQYNVLVS-EEGIWIIDFPQSVEV---------------GEEGWREILE 252 (282)
T ss_dssp HHHHHHHHHHHHHHHHHTTEE-CSCCSTTSEEEE-TTEEEECCCTTCEET---------------TSTTHHHHHH
T ss_pred HHHHHHHHHHHHHHHHHCCCE-eCCCCHHHEEEE-CCcEEEEECCCCeEC---------------CCCCHHHHHH
Confidence 457999999999999999998 999999999999 999999999997532 2367888774
|
| >1ybt_A Hydrolase, alpha/beta hydrolase fold family; cyclase homology domain, CHD, RV1900C; 2.31A {Mycobacterium tuberculosis} PDB: 1ybu_A* | Back alignment and structure |
|---|
Probab=99.00 E-value=4.4e-11 Score=106.64 Aligned_cols=75 Identities=21% Similarity=0.112 Sum_probs=61.6
Q ss_pred CCCCCccccceeEEEeeccccccccccCCHhHHHHhhhccch-hhhhccCCCceEEEeecccCC----CcchHHHHhhhh
Q psy1840 332 DFVEPESFDSVTIYFSDIVGFTQLSAESTETGRVTTRDSRRT-PDLKVGGSNPRQVITGTDMLR----HRPHESKVSLAL 406 (423)
Q Consensus 332 ~~~~~~~~~~vtv~f~di~gft~~~~~~~p~~~v~~ln~~~~-fd~~~~~~~~~~v~~~~~~~~----~~~~~~~~~~~~ 406 (423)
....+..+.+|||+|+||+|||.+++..+|.+++.+||++|+ ++..|..++.|++++.||.++ ...++...|+++
T Consensus 8 ~~~~~~~~~~~tvlf~Di~gft~l~~~~~~~~~~~~l~~~~~~~~~~i~~~gG~v~k~~GD~~ma~f~~p~~A~~~Al~~ 87 (184)
T 1ybt_A 8 HHHGSAERMLATIMFTDIVGSTQHAAALGDDRWRDLLDNHDTIVCHEIQRFGGREVNTAGDGFVATFTSPSAAIACADDI 87 (184)
T ss_dssp -----CEEEEEEEEEEEETTHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHTTCEECCCSSSSEEEEESCHHHHHHHHHHH
T ss_pred CCCCCCceEEEEEEEEECcCcHHHHHhCCHHHHHHHHHHHHHHHHHHHHHcCCEEEeEeCCEEEEEeCCHHHHHHHHHHH
Confidence 344567789999999999999999999999999999999999 999999999999999999999 333444444444
|
| >2w01_A Adenylate cyclase; guanylyl cyclase, class III nucleotidyl cyclase, lyase; 2.31A {Synechocystis SP} | Back alignment and structure |
|---|
Probab=98.98 E-value=2.8e-10 Score=103.41 Aligned_cols=58 Identities=17% Similarity=-0.016 Sum_probs=54.9
Q ss_pred ccccceeEEEeeccccccccccCCHhHHHHhhhccch-hhhhccCCCceEEEeecccCC
Q psy1840 337 ESFDSVTIYFSDIVGFTQLSAESTETGRVTTRDSRRT-PDLKVGGSNPRQVITGTDMLR 394 (423)
Q Consensus 337 ~~~~~vtv~f~di~gft~~~~~~~p~~~v~~ln~~~~-fd~~~~~~~~~~v~~~~~~~~ 394 (423)
.+..+|||+|+||+|||.+++..+|.+++.+||++|+ ++..|.+++.+++++.||.++
T Consensus 10 ~e~~~vtvlf~Di~gfT~l~~~~~~~~~~~~l~~~~~~~~~~i~~~~G~v~k~~GD~~~ 68 (208)
T 2w01_A 10 GDRRPITILTSDLRGFTSTSEGLNPEEVVKVLNIYFGKMADVITHHGGTIDEFMGDGIL 68 (208)
T ss_dssp CEEEEEEEEEEECTTHHHHGGGSCHHHHHHHHHHHHHHHHHHHHHTTCEEEEEETTEEE
T ss_pred CeEEEEEEEEEEecChHHHHhhCCHHHHHHHHHHHHHHHHHHHHHcCCEEEEEEcCEEE
Confidence 4578999999999999999999999999999999999 999999999999999999988
|
| >3r5g_A CYAB; adenylyl cyclase, lyase; 1.50A {Pseudomonas aeruginosa} SCOP: d.58.29.0 | Back alignment and structure |
|---|
Probab=98.86 E-value=6.4e-10 Score=100.06 Aligned_cols=58 Identities=21% Similarity=0.124 Sum_probs=53.6
Q ss_pred ccccceeEEEeeccccccccccCCHhHHHHhhhccch-hhhhccCCCceEEEeecccCC
Q psy1840 337 ESFDSVTIYFSDIVGFTQLSAESTETGRVTTRDSRRT-PDLKVGGSNPRQVITGTDMLR 394 (423)
Q Consensus 337 ~~~~~vtv~f~di~gft~~~~~~~p~~~v~~ln~~~~-fd~~~~~~~~~~v~~~~~~~~ 394 (423)
.+..+|||+|+||+|||.+++.++|.+++.+||++|+ ++..|..++.+.+++.||.++
T Consensus 5 ~e~~~vtvlf~Di~gft~l~~~~~~~~~~~~l~~~~~~~~~~i~~~~G~v~k~~GD~~~ 63 (198)
T 3r5g_A 5 TQRKKLTVFFSDIRGFTELSEELEAEALTDLLNNYLNEMSKIALKYGGTIDKFVGDCVM 63 (198)
T ss_dssp CEEEEEEEEEEEEETHHHHHTTSCHHHHHHHHHHHHHHHHHHHHHHTCEEEEEETTEEE
T ss_pred ceEEEEEEEEEEccccchhhhhCCHHHHHHHHHHHHHHHHHHHHHcCCEEEeeeCCEEE
Confidence 3457999999999999999999999999999999999 999999988888888888888
|
| >1wc3_A Adenylate cyclase; soluble adenylyl cyclase, CAMP signaling, lyase; HET: APC; 1.9A {Spirulina platensis} SCOP: d.58.29.1 PDB: 1wc0_A* 1wc4_A* 1wc5_A* 2bw7_A* 1wc1_A* 1wc6_A* | Back alignment and structure |
|---|
Probab=98.85 E-value=8.9e-10 Score=100.92 Aligned_cols=58 Identities=24% Similarity=0.159 Sum_probs=53.5
Q ss_pred ccccceeEEEeeccccccccccCCHhHHHHhhhccch-hhhhccCCCceEEEeecccCC
Q psy1840 337 ESFDSVTIYFSDIVGFTQLSAESTETGRVTTRDSRRT-PDLKVGGSNPRQVITGTDMLR 394 (423)
Q Consensus 337 ~~~~~vtv~f~di~gft~~~~~~~p~~~v~~ln~~~~-fd~~~~~~~~~~v~~~~~~~~ 394 (423)
.+..+|||+|+||+|||.+++..+|.+++.+||++|+ ++.+|.+++.+.+++.||.+|
T Consensus 23 ~e~~~vtvlF~DI~gfT~l~~~~~~~~~~~~Ln~~~~~~~~~i~~~gG~v~k~iGD~~m 81 (219)
T 1wc3_A 23 PEPRLITILFSDIVGFTRMSNALQSQGVAELLNEYLGEMTRAVFENQGTVDKFVGDAIM 81 (219)
T ss_dssp CEEEEEEEEEEEEESHHHHHHTSCHHHHHHHHHHHHHHHHHHHHHTTCEEEEEETTEEE
T ss_pred CceeEEEEEEEEecChHHHHhhCCHHHHHHHHHHHHHHHHHHHHHcCCEEEEEEcCeEE
Confidence 4458999999999999999999999999999999999 999999888888888888888
|
| >3hls_A Guanylate cyclase soluble subunit beta-1; coiled-coil domain, signaling helix, S-helix, CGMP biosynthesis, cytoplasm, GTP-binding, heme, iron; 2.15A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=98.78 E-value=6.6e-09 Score=75.59 Aligned_cols=36 Identities=42% Similarity=0.518 Sum_probs=33.6
Q ss_pred hhHHHHHHHHHHHHHHHHHHHHhhCcHHHHHHHhCC
Q psy1840 296 GLVQERTNQLTQEKKKTDALLHRMLPRSVSESLKRG 331 (423)
Q Consensus 296 ~~v~~~~~~l~~e~~~~~~ll~~~lp~~ia~~l~~g 331 (423)
+.+++++++|+.||+|+|+|||+|||++||++|+.|
T Consensus 31 ~~Lee~t~~L~~EK~ktd~LL~~mLP~~VA~~Lk~G 66 (66)
T 3hls_A 31 DRLQLTLRALEDEKKKTDTLLYSVLPPSVANELRHK 66 (66)
T ss_dssp HHHHHHHHHHHHHHHHHHHHHHHTSCHHHHHHHHC-
T ss_pred HHHHHHHHHHHHHHHHHHHHHHHcCCHHHHHHHhCc
Confidence 478899999999999999999999999999999987
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=98.74 E-value=7.6e-09 Score=96.91 Aligned_cols=47 Identities=15% Similarity=0.195 Sum_probs=43.3
Q ss_pred HHHHHHHHHHHHHHHH-hCCCeeecCCCCCCEEEcCCccEEEeccCCcccc
Q psy1840 25 SISVNTTASVGMIHLH-DSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFK 74 (423)
Q Consensus 25 ~l~i~~qi~~gL~yLH-~~~ii~HrDLkp~NILld~~~~vKL~DFGla~~~ 74 (423)
...++.|++.||.||| +.|++ ||||||.|||++. .++|+|||++...
T Consensus 172 ~~~i~~qi~~~l~~lH~~~giv-HrDlkp~NILl~~--~~~liDFG~a~~~ 219 (258)
T 1zth_A 172 VEGIFNDVVENVKRLYQEAELV-HADLSEYNIMYID--KVYFIDMGQAVTL 219 (258)
T ss_dssp HHHHHHHHHHHHHHHHHTSCEE-CSSCSTTSEEESS--SEEECCCTTCEET
T ss_pred HHHHHHHHHHHHHHHHHHCCEE-eCCCCHHHEEEcC--cEEEEECcccccC
Confidence 5789999999999999 89988 9999999999998 8999999998643
|
| >3mr7_A Adenylate/guanylate cyclase/hydrolase, alpha/beta family; alpha-beta fold, structural genomics, PSI-2, protein structu initiative; 2.60A {Ruegeria pomeroyi} | Back alignment and structure |
|---|
Probab=98.68 E-value=1.3e-08 Score=90.92 Aligned_cols=70 Identities=14% Similarity=0.153 Sum_probs=57.5
Q ss_pred CccccceeEEEeeccccccccccCCHhHHHHhhhccch--hhhhccCCCceEEEeecccCC----CcchHHHHhhhh
Q psy1840 336 PESFDSVTIYFSDIVGFTQLSAESTETGRVTTRDSRRT--PDLKVGGSNPRQVITGTDMLR----HRPHESKVSLAL 406 (423)
Q Consensus 336 ~~~~~~vtv~f~di~gft~~~~~~~p~~~v~~ln~~~~--fd~~~~~~~~~~v~~~~~~~~----~~~~~~~~~~~~ 406 (423)
+.+..+|||+|+||+|||.+++..+|.++ ..||++|. ++..|..++.+++++.||.++ +..++...++++
T Consensus 2 ~~e~r~vtvlf~Di~gft~l~~~~~~~~~-~~l~~~~~~~~~~~i~~~~G~v~k~~GD~~~a~f~~~~~A~~~Al~i 77 (189)
T 3mr7_A 2 NAERRLCAILAADMAGYSRLMERNETDVL-NRQKLYRRELIDPAIAQAGGQIVKTTGDGMLARFDTAQAALRCALEI 77 (189)
T ss_dssp CCEEEEEEEEEEEECCCCGGGCCCCHHHH-HHHHHHHHHTHHHHHHHTTCEEEEEETTEEEEEESSHHHHHHHHHHH
T ss_pred CCcEEEEEEEEEEchhhHHHHhhCCHHHH-HHHHHHHHHHHHHHHHHcCCEEEEEeCCEEEEEeCCHHHHHHHHHHH
Confidence 34567899999999999999999888665 77888775 999999999999999999999 555555555444
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=98.08 E-value=1.8e-06 Score=85.42 Aligned_cols=47 Identities=21% Similarity=0.250 Sum_probs=41.3
Q ss_pred HHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCc----------cEEEeccCCcc
Q psy1840 25 SISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRW----------VLQIADFGLHA 72 (423)
Q Consensus 25 ~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~----------~vKL~DFGla~ 72 (423)
...+..||+.+|.|||+.|+| ||||||.|||++.++ .+.|+||+-+-
T Consensus 207 ~~~l~~qll~~l~~lH~~gIV-HrDLKp~NILl~~dgd~~d~~~~~~~~~iID~~Q~V 263 (397)
T 4gyi_A 207 PASLYADLIALILRLAKHGLI-HGDFNEFNILIREEKDAEDPSSITLTPIIIXFPQMV 263 (397)
T ss_dssp HHHHHHHHHHHHHHHHHTTEE-CSCCSTTSEEEEEEECSSCTTSEEEEEEECCCTTCE
T ss_pred HHHHHHHHHHHHHHHHHCCCc-CCCCCHHHEEEeCCCCcccccccccceEEEEeCCcc
Confidence 357889999999999999987 999999999998776 48899998654
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=96.85 E-value=0.00016 Score=68.60 Aligned_cols=80 Identities=23% Similarity=0.308 Sum_probs=47.4
Q ss_pred eeecCCCCCCEEEcC--CccEEEeccCCcccccCCCcccccccc---cCCc-------cc--cC-CccccCCCCCCCCCc
Q psy1840 45 ISHGNLRSSNCLIDS--RWVLQIADFGLHAFKAGQDETGQERKL---RRRK-------LY--KA-PELLRQPHLPRGTQK 109 (423)
Q Consensus 45 i~HrDLkp~NILld~--~~~vKL~DFGla~~~~~~~~~~~~~~~---~gt~-------~y--~A-PE~l~~~~~~~~s~k 109 (423)
++|||++|.||+++. ...+.|+||+.+............... .+.. .| .. |+..... ...
T Consensus 193 ~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl~~~~~~~~~~~~~~~~~~l~~Y~~~~~~~~~~r~-----~~~ 267 (304)
T 3sg8_A 193 LIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFISLMEDDEEYGMEFVSKILNHYKHKDIPTVLEKY-----RMK 267 (304)
T ss_dssp EECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHHHTTCCTTTSCCHHHHHHHHHHHTCSCHHHHHHHH-----HHH
T ss_pred eEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHHHHHHhhccccCHHHHHHHHHHcCCCCcHHHHHHH-----HHH
Confidence 459999999999998 567899999987653221110000000 0000 01 11 1111100 122
Q ss_pred cchHHHHHHHHHHHhCCCCC
Q psy1840 110 GDVYSFGLVLYEVIGRQGPW 129 (423)
Q Consensus 110 sDVyS~Giil~elltg~~Pf 129 (423)
.+.|++|.++|.+.+|..+|
T Consensus 268 ~~~~~l~~~~~~~~~g~~~~ 287 (304)
T 3sg8_A 268 EKYWSFEKIIYGKEYGYMDW 287 (304)
T ss_dssp HHHHHHHHHHHHHHTTCHHH
T ss_pred HHHHHHHHHHHHHHcCCHHH
Confidence 68999999999999998776
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=96.77 E-value=0.00086 Score=61.30 Aligned_cols=28 Identities=18% Similarity=0.335 Sum_probs=24.4
Q ss_pred eeecCCCCCCEEEcCCccEEEeccCCcc
Q psy1840 45 ISHGNLRSSNCLIDSRWVLQIADFGLHA 72 (423)
Q Consensus 45 i~HrDLkp~NILld~~~~vKL~DFGla~ 72 (423)
++|||++|.||+++.++.++|+|||.+.
T Consensus 186 l~HgDl~~~Nil~~~~~~~~liD~~~a~ 213 (264)
T 1nd4_A 186 VTHGDACLPNIMVENGRFSGFIDCGRLG 213 (264)
T ss_dssp EECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred EECCCCCCCcEEEECCcEEEEEcchhcc
Confidence 5599999999999887777899999854
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=96.59 E-value=0.0016 Score=59.94 Aligned_cols=28 Identities=32% Similarity=0.476 Sum_probs=23.8
Q ss_pred eeecCCCCCCEEEcCCccEEEeccCCcc
Q psy1840 45 ISHGNLRSSNCLIDSRWVLQIADFGLHA 72 (423)
Q Consensus 45 i~HrDLkp~NILld~~~~vKL~DFGla~ 72 (423)
++|||++|.||+++....+.|+||+.+.
T Consensus 185 l~HgDl~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T 3tm0_A 185 FSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp EECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred EECCCCCcCcEEEECCcEEEEEEchhcc
Confidence 4599999999999887677899998753
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=96.13 E-value=0.0042 Score=60.12 Aligned_cols=30 Identities=30% Similarity=0.495 Sum_probs=24.7
Q ss_pred CeeecCCCCCCEEEcCCc--cEEEeccCCccc
Q psy1840 44 IISHGNLRSSNCLIDSRW--VLQIADFGLHAF 73 (423)
Q Consensus 44 ii~HrDLkp~NILld~~~--~vKL~DFGla~~ 73 (423)
.++|||+++.||+++.++ .+.|.||+.+..
T Consensus 217 ~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 217 SIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL 248 (359)
T ss_dssp EEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred eEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence 355999999999998765 368999998754
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=95.50 E-value=0.1 Score=46.91 Aligned_cols=124 Identities=9% Similarity=-0.015 Sum_probs=72.9
Q ss_pred HHHHHHHHHHHHHHHHHHh-CCCeeecCCCCCCEEEcCCccEEEeccCCcccccCCCcccccccccCCccccCCccccCC
Q psy1840 23 IGSISVNTTASVGMIHLHD-SEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKAPELLRQP 101 (423)
Q Consensus 23 ~~~l~i~~qi~~gL~yLH~-~~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~ 101 (423)
++.-.++.|.+.+|.-+-. ..-. .+=+.|..|++..+|.|.+.+ +.+. .....+.|||....
T Consensus 49 EqaWALc~Qc~~~L~~~~~~~~~~-~~i~~~~~i~l~~dG~V~f~~-~~s~--------------~~~~~~~~pe~~~~- 111 (229)
T 2yle_A 49 EQAWAVCYQCCGSLRAAARRRQPR-HRVRSAAQIRVWRDGAVTLAP-AADD--------------AGEPPPVAGKLGYS- 111 (229)
T ss_dssp HHHHHHHHHHHHHHHHHHHTTCCC-CCCCSGGGEEEETTSCEEECC-C--------------------------CCSSS-
T ss_pred HHHHHHHHHHHHHHHhhhhcccCC-ceecCCcceEEecCCceeccc-cccc--------------ccccCCCChhhccc-
Confidence 3356899999999877621 1111 222457889999999988764 2110 11123678887642
Q ss_pred CCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCchHHHHHHHHHhhhc---------
Q psy1840 102 HLPRGTQKGDVYSFGLVLYEVIGRQGPWGHLRMTDEEIITSVTQGSGLRPDTSSLDCAPSIIACMRTCWEE--------- 172 (423)
Q Consensus 102 ~~~~~s~ksDVyS~Giil~elltg~~Pf~~~~~~~~~i~~~i~~~~~~~p~~~~~~~~~~l~~Li~~C~~~--------- 172 (423)
..+.+.=|||+|+++|.-+--..|=. .....++.|.+||..|...
T Consensus 112 ---~~te~~~IysLG~tLY~ALDygL~e~-----------------------eE~eLS~~LE~LL~~Mt~~~~d~~~~De 165 (229)
T 2yle_A 112 ---QCMETEVIESLGIIIYKALDYGLKEN-----------------------EERELSPPLEQLIDHMANTVEADGSNDE 165 (229)
T ss_dssp ---SSCHHHHHHHHHHHHHHHHTTTCCTT-----------------------EEECCCHHHHHHHHHHTTCCC-------
T ss_pred ---cchHHHHHHHHHHHHHHHhhcCCCcc-----------------------cchhhCHHHHHHHHHHHhcccccccccc
Confidence 22688899999999999884222211 1124567777777777644
Q ss_pred ----------------CCCCCCCHHHHHHHHHH
Q psy1840 173 ----------------DPELRPDLRFVHHKLKE 189 (423)
Q Consensus 173 ----------------dP~~RPt~~~I~~~L~~ 189 (423)
.+..|+++.+|++.-..
T Consensus 166 G~~~~~eg~~d~~~~~~~~~~~sl~~Vi~~C~~ 198 (229)
T 2yle_A 166 GYEAAEEGLGDEDEKRKISAIRSYRDVMKLCAA 198 (229)
T ss_dssp -------------CCSCCCCCCSHHHHHHHHHT
T ss_pred cccccccccccccccccccCcCCHHHHHHHHHh
Confidence 34678888888765443
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=93.98 E-value=0.059 Score=51.04 Aligned_cols=30 Identities=13% Similarity=0.220 Sum_probs=25.5
Q ss_pred CCeeecCCCCCCEEEcCCccEEEeccCCcc
Q psy1840 43 EIISHGNLRSSNCLIDSRWVLQIADFGLHA 72 (423)
Q Consensus 43 ~ii~HrDLkp~NILld~~~~vKL~DFGla~ 72 (423)
..++|||+++.||+++.++.+.|+||+.+.
T Consensus 222 ~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~ 251 (346)
T 2q83_A 222 PNLCHQDYGTGNTLLGENEQIWVIDLDTVS 251 (346)
T ss_dssp CCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred CceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence 445599999999999888899999998753
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=90.21 E-value=0.29 Score=46.06 Aligned_cols=29 Identities=31% Similarity=0.442 Sum_probs=23.4
Q ss_pred eeecCCCCCCEEEcC---Ccc-EEEeccCCccc
Q psy1840 45 ISHGNLRSSNCLIDS---RWV-LQIADFGLHAF 73 (423)
Q Consensus 45 i~HrDLkp~NILld~---~~~-vKL~DFGla~~ 73 (423)
++|||+++.||+++. ++. +.|.||+.+..
T Consensus 192 ~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~ 224 (306)
T 3tdw_A 192 LIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI 224 (306)
T ss_dssp EECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred eEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence 359999999999987 344 58999997643
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=89.46 E-value=0.2 Score=49.49 Aligned_cols=30 Identities=17% Similarity=0.390 Sum_probs=25.0
Q ss_pred CCeeecCCCCCCEEEcCCccEEEeccCCccc
Q psy1840 43 EIISHGNLRSSNCLIDSRWVLQIADFGLHAF 73 (423)
Q Consensus 43 ~ii~HrDLkp~NILld~~~~vKL~DFGla~~ 73 (423)
..++|||+++.||+++.++ +++.||+.+..
T Consensus 232 ~~liHGDl~~~Nil~~~~~-~~lID~e~a~~ 261 (420)
T 2pyw_A 232 QALIHGDLHTGSVMVTQDS-TQVIDPEFSFY 261 (420)
T ss_dssp CEEECSCCSGGGEEECSSC-EEECCCTTCEE
T ss_pred CeEEecCCCCCcEEEeCCC-CEEEeCccccc
Confidence 3344999999999998876 99999998654
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=87.05 E-value=0.33 Score=44.29 Aligned_cols=28 Identities=21% Similarity=0.424 Sum_probs=24.5
Q ss_pred eeecCCCCCCEEEcCCccEEEeccCCcc
Q psy1840 45 ISHGNLRSSNCLIDSRWVLQIADFGLHA 72 (423)
Q Consensus 45 i~HrDLkp~NILld~~~~vKL~DFGla~ 72 (423)
++|||+.+.||+++..+.+-|.||+.+.
T Consensus 195 l~HGDl~~~Nil~~~~~~~~viDwe~a~ 222 (272)
T 4gkh_A 195 VTHGDFSLDNLIFDEGKLIGCIDVGRVG 222 (272)
T ss_dssp EECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred EEcCCCCCCeEEEECCeEEEEEECcccc
Confidence 4599999999999988878899998764
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=83.02 E-value=0.47 Score=44.49 Aligned_cols=28 Identities=18% Similarity=0.242 Sum_probs=23.8
Q ss_pred eeecCCCCCCEEEcCCccEEEeccCCcc
Q psy1840 45 ISHGNLRSSNCLIDSRWVLQIADFGLHA 72 (423)
Q Consensus 45 i~HrDLkp~NILld~~~~vKL~DFGla~ 72 (423)
++|||+.+.||+++.+..+.|+||+.+.
T Consensus 189 liHgDl~~~Nil~~~~~~~~lIDf~~a~ 216 (322)
T 2ppq_A 189 VIHADLFQDNVFFLGDELSGLIDFYFAC 216 (322)
T ss_dssp EECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred cCCCCCCccCEEEeCCceEEEecchhcc
Confidence 4499999999999987767899998754
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=82.51 E-value=0.77 Score=43.12 Aligned_cols=27 Identities=19% Similarity=0.174 Sum_probs=22.8
Q ss_pred CeeecCCCCCCEEEcCCccEEEeccCCcc
Q psy1840 44 IISHGNLRSSNCLIDSRWVLQIADFGLHA 72 (423)
Q Consensus 44 ii~HrDLkp~NILld~~~~vKL~DFGla~ 72 (423)
.++|||+++.||+++ + .+.|.||+.+.
T Consensus 196 ~l~HgD~~~~Nil~~-~-~~~lIDfe~a~ 222 (328)
T 1zyl_A 196 LRLHGDCHAGNILWR-D-GPMFVDLDDAR 222 (328)
T ss_dssp EECCSSCSGGGEEES-S-SEEECCCTTCC
T ss_pred eeeeCCCCcccEeEc-C-CCEEEECCCCC
Confidence 345999999999999 4 89999998754
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=81.08 E-value=0.54 Score=44.83 Aligned_cols=29 Identities=21% Similarity=0.329 Sum_probs=24.0
Q ss_pred CeeecCCCCCCEEEcCCccEEEeccCCcc
Q psy1840 44 IISHGNLRSSNCLIDSRWVLQIADFGLHA 72 (423)
Q Consensus 44 ii~HrDLkp~NILld~~~~vKL~DFGla~ 72 (423)
.++|||+.+.||++++...+.|.||+.+.
T Consensus 223 ~l~HgDl~~~Nil~~~~~~~~vIDwe~a~ 251 (357)
T 3ats_A 223 VLLWGDARVGNVLYRDFQPVAVLDWEMVA 251 (357)
T ss_dssp EEECSSCSGGGEEEETTEEEEECCGGGCE
T ss_pred eEEeCCCCCCeEEEeCCcEEEEEcccccc
Confidence 45599999999999965567899998754
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=80.06 E-value=0.75 Score=43.44 Aligned_cols=30 Identities=17% Similarity=0.229 Sum_probs=25.0
Q ss_pred CeeecCCCCCCEEEcCC----ccEEEeccCCccc
Q psy1840 44 IISHGNLRSSNCLIDSR----WVLQIADFGLHAF 73 (423)
Q Consensus 44 ii~HrDLkp~NILld~~----~~vKL~DFGla~~ 73 (423)
.++|||+.+.||+++.+ +.+.|.||+.+..
T Consensus 184 ~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~ 217 (333)
T 3csv_A 184 VFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKL 217 (333)
T ss_dssp EEECSCCSGGGEEECTTSCGGGGEEECCCTTCEE
T ss_pred eeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCc
Confidence 45599999999999874 7899999997653
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST 
Original result of RPS-BLAST against SCOP70(version1.75) database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() |
| 423 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 7e-29 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 8e-24 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 3e-23 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 2e-22 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 3e-22 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 2e-21 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 8e-21 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 1e-20 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 2e-20 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 3e-20 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 3e-20 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 4e-20 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 6e-20 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 8e-20 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 1e-19 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 4e-19 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 5e-19 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 6e-19 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 7e-19 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 1e-18 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 2e-18 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 3e-18 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 4e-18 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 5e-18 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 9e-18 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 4e-17 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 6e-17 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 9e-17 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 1e-16 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 6e-16 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 1e-15 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 2e-15 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 6e-15 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 8e-15 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 9e-15 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 1e-14 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 4e-14 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 8e-14 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 3e-13 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 3e-13 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 9e-13 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 1e-12 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 7e-12 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 7e-12 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 2e-11 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 3e-11 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 1e-10 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 7e-10 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 1e-09 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 4e-09 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 2e-08 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 3e-08 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 3e-08 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 7e-08 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 1e-07 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 2e-06 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 4e-06 | |
| d1azsb_ | 199 | d.58.29.1 (B:) Adenylyl cyclase IIC1, domain C2a { | 4e-06 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 5e-05 | |
| d1azsa_ | 190 | d.58.29.1 (A:) Adenylyl cyclase VC1, domain C1a {D | 7e-05 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 1e-04 | |
| d1fx2a_ | 235 | d.58.29.1 (A:) Receptor-type monomeric adenylyl cy | 1e-04 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 0.001 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 111 bits (280), Expect = 7e-29
Identities = 45/162 (27%), Positives = 81/162 (50%), Gaps = 5/162 (3%)
Query: 35 GMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKA 94
GM +LH II H +L+S+N + ++I DFGL K+ + Q +L L+ A
Sbjct: 116 GMDYLHAKSII-HRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMA 174
Query: 95 PELLRQPHLPRGTQKGDVYSFGLVLYEVIGRQGPWGHLRMTDEEIITSVTQGSGLRPDTS 154
PE++R + + DVY+FG+VLYE++ Q P+ + + + + I + L PD S
Sbjct: 175 PEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSN--INNRDQIIFMVGRGYLSPDLS 232
Query: 155 SL--DCAPSIIACMRTCWEEDPELRPDLRFVHHKLKEMNAGL 194
+ +C ++ M C ++ + RP + ++ + L
Sbjct: 233 KVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARSL 274
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 98.7 bits (245), Expect = 8e-24
Identities = 42/182 (23%), Positives = 80/182 (43%), Gaps = 14/182 (7%)
Query: 35 GMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRR--KLY 92
GM L + + H +L + NC++D ++ +++ADFGL ++ K + +
Sbjct: 142 GMKFLASKKFV-HRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKW 200
Query: 93 KAPELLRQPHLPRGTQKGDVYSFGLVLYEVIGRQGPWGHLRMTDEEIITSVTQGSGLRPD 152
A E L+ + T K DV+SFG++L+E++ R P + +I + QG R
Sbjct: 201 MALESLQT---QKFTTKSDVWSFGVLLWELMTRGAPPYP-DVNTFDITVYLLQG---RRL 253
Query: 153 TSSLDCAPSIIACMRTCWEEDPELRPDLRFVHHKLKEMNAGLKANIFDNMLAIMEKYAFN 212
C + M CW E+RP + ++ + I ++ + + Y N
Sbjct: 254 LQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAI---FSTFIGEHYVHVNATYV-N 309
Query: 213 LE 214
++
Sbjct: 310 VK 311
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 96.8 bits (240), Expect = 3e-23
Identities = 43/156 (27%), Positives = 70/156 (44%), Gaps = 8/156 (5%)
Query: 35 GMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKA 94
GM +L + + + H +L + NCL+ V++IADFGL D + +
Sbjct: 152 GMAYLSERKFV-HRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMP 210
Query: 95 PELLRQPHLPRGTQKGDVYSFGLVLYEVIGRQGPWGHLRMTDEEIITSVTQGSGLRPDTS 154
PE + T + DV+++G+VL+E+ + M EE+I V G+ L
Sbjct: 211 PESIFYNRY---TTESDVWAYGVVLWEIFSYGLQPYY-GMAHEEVIYYVRDGNILACPE- 265
Query: 155 SLDCAPSIIACMRTCWEEDPELRPDLRFVHHKLKEM 190
+C + MR CW + P RP +H L+ M
Sbjct: 266 --NCPLELYNLMRLCWSKLPADRPSFCSIHRILQRM 299
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 94.4 bits (234), Expect = 2e-22
Identities = 42/160 (26%), Positives = 78/160 (48%), Gaps = 13/160 (8%)
Query: 35 GMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKA 94
GM +L D + H +L + N L++S V +++DFGL F ++ + K
Sbjct: 140 GMKYLADMNYV-HRDLAARNILVNSNLVCKVSDFGLSRF---LEDDTSDPTYTSALGGKI 195
Query: 95 PELLRQPHLPRGTQ---KGDVYSFGLVLYEVIGR-QGPWGHLRMTDEEIITSVTQGSGLR 150
P P + + DV+S+G+V++EV+ + P+ MT++++I ++ Q L
Sbjct: 196 PIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWD--MTNQDVINAIEQDYRLP 253
Query: 151 PDTSSLDCAPSIIACMRTCWEEDPELRPDLRFVHHKLKEM 190
P +DC ++ M CW++D RP + + L +M
Sbjct: 254 PP---MDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKM 290
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 93.8 bits (232), Expect = 3e-22
Identities = 43/184 (23%), Positives = 66/184 (35%), Gaps = 28/184 (15%)
Query: 35 GMIHLHDSEI-------ISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLR 87
G+ HLH + I+H +L+S N L+ IAD GL +T
Sbjct: 112 GLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNH 171
Query: 88 RR--KLYKAPELLRQPHLPRG---TQKGDVYSFGLVLYEVIGRQGPWG------------ 130
R K Y APE+L + ++ D+Y+ GLV +E+ R G
Sbjct: 172 RVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDL 231
Query: 131 HLRMTDEEIITSVTQGSGLRPD----TSSLDCAPSIIACMRTCWEEDPELRPDLRFVHHK 186
E + V LRP+ S + + MR CW + R +
Sbjct: 232 VPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKT 291
Query: 187 LKEM 190
L ++
Sbjct: 292 LSQL 295
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 90.9 bits (225), Expect = 2e-21
Identities = 38/156 (24%), Positives = 73/156 (46%), Gaps = 9/156 (5%)
Query: 35 GMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKA 94
GM +L ++ +I H +L + NCL+ V++++DFG+ F D+ + + +
Sbjct: 113 GMAYLEEACVI-HRDLAARNCLVGENQVIKVSDFGMTRF-VLDDQYTSSTGTKFPVKWAS 170
Query: 95 PELLRQPHLPRGTQKGDVYSFGLVLYEVIGRQGPWGHLRMTDEEIITSVTQGSGLRPDTS 154
PE+ + K DV+SFG++++EV ++ E++ ++ G L
Sbjct: 171 PEVFSFSRY---SSKSDVWSFGVLMWEVFSEGKIPYE-NRSNSEVVEDISTGFRLYKPR- 225
Query: 155 SLDCAPSIIACMRTCWEEDPELRPDLRFVHHKLKEM 190
+ + M CW+E PE RP + +L E+
Sbjct: 226 --LASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEI 259
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 89.8 bits (222), Expect = 8e-21
Identities = 41/155 (26%), Positives = 71/155 (45%), Gaps = 9/155 (5%)
Query: 36 MIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKAP 95
M ++ + H +LR++N L+ V ++ADFGL A +E + + + AP
Sbjct: 126 MAYVERMNYV-HRDLRAANILVGENLVCKVADFGL-ARLIEDNEYTARQGAKFPIKWTAP 183
Query: 96 ELLRQPHLPRGTQKGDVYSFGLVLYEVIGRQGPWGHLRMTDEEIITSVTQGSGLRPDTSS 155
E T K DV+SFG++L E+ + M + E++ V + G R
Sbjct: 184 EAALYGRF---TIKSDVWSFGILLTELTTKGRVPYP-GMVNREVLDQVER--GYRMPCPP 237
Query: 156 LDCAPSIIACMRTCWEEDPELRPDLRFVHHKLKEM 190
+C S+ M CW ++PE RP ++ L++
Sbjct: 238 -ECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY 271
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 89.5 bits (221), Expect = 1e-20
Identities = 49/178 (27%), Positives = 76/178 (42%), Gaps = 14/178 (7%)
Query: 35 GMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKA 94
GM +L + I H +L + N L+ +V +IADFGL + + R R + A
Sbjct: 139 GMDYLSQKQFI-HRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLPVR---WMA 194
Query: 95 PELLRQPHLPRGTQKGDVYSFGLVLYEVIGRQGPWGHLRMTDEEIITSVTQGSGLRPDTS 154
E L T DV+S+G++L+E++ G + MT E+ + QG L
Sbjct: 195 IESLNYSV---YTTNSDVWSYGVLLWEIVSLGGTP-YCGMTCAELYEKLPQGYRLEK--- 247
Query: 155 SLDCAPSIIACMRTCWEEDPELRPDLRFVHHKLKEMNAGLKANIFDNMLAIMEKYAFN 212
L+C + MR CW E P RP + L M K + + EK+ +
Sbjct: 248 PLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERKTYVNTTL---YEKFTYA 302
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 88.6 bits (219), Expect = 2e-20
Identities = 47/157 (29%), Positives = 76/157 (48%), Gaps = 11/157 (7%)
Query: 35 GMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKA 94
GM + + I H +LR++N L+ +IADFGL A +E + + A
Sbjct: 121 GMAFIEERNYI-HRDLRAANILVSDTLSCKIADFGL-ARLIEDNEYTAREGAKFPIKWTA 178
Query: 95 PELLRQPHLPRGTQKGDVYSFGLVLYEVIGRQGPWGHLRMTDEEIITSVTQGSGL-RPDT 153
PE + T K DV+SFG++L E++ MT+ E+I ++ +G + RPD
Sbjct: 179 PEAINYGT---FTIKSDVWSFGILLTEIVTHGRIPYP-GMTNPEVIQNLERGYRMVRPD- 233
Query: 154 SSLDCAPSIIACMRTCWEEDPELRPDLRFVHHKLKEM 190
+C + MR CW+E PE RP ++ L++
Sbjct: 234 ---NCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDF 267
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 87.8 bits (217), Expect = 3e-20
Identities = 39/156 (25%), Positives = 75/156 (48%), Gaps = 13/156 (8%)
Query: 35 GMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKA 94
M +L + + H +L + N L+ V +++DFGL + +TG+ + A
Sbjct: 115 AMEYLEGNNFV-HRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGK-----LPVKWTA 168
Query: 95 PELLRQPHLPRGTQKGDVYSFGLVLYEVIGRQGPWGHLRMTDEEIITSVTQGSGLRPDTS 154
PE LR+ + K DV+SFG++L+E+ + R+ ++++ V +G + D
Sbjct: 169 PEALREKKF---STKSDVWSFGILLWEIYSFGRVP-YPRIPLKDVVPRVEKG--YKMDAP 222
Query: 155 SLDCAPSIIACMRTCWEEDPELRPDLRFVHHKLKEM 190
C P++ M+ CW D +RP + +L+ +
Sbjct: 223 D-GCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHI 257
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 88.0 bits (217), Expect = 3e-20
Identities = 35/156 (22%), Positives = 68/156 (43%), Gaps = 8/156 (5%)
Query: 36 MIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHA-FKAGQDETGQERKLRRRKLYKA 94
+ + H +L + N L++S V +++DFGL + + T + + A
Sbjct: 122 GMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTA 181
Query: 95 PELLRQPHLPRGTQKGDVYSFGLVLYEVIGRQGPWGHLRMTDEEIITSVTQGSGLRPDTS 154
PE + DV+SFG+V++EV+ +++ E++ ++ G R T
Sbjct: 182 PEAISYRKFT---SASDVWSFGIVMWEVMTYGERPYW-ELSNHEVMKAIND--GFRLPTP 235
Query: 155 SLDCAPSIIACMRTCWEEDPELRPDLRFVHHKLKEM 190
DC +I M CW+++ RP + L ++
Sbjct: 236 M-DCPSAIYQLMMQCWQQERARRPKFADIVSILDKL 270
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 87.7 bits (217), Expect = 4e-20
Identities = 29/146 (19%), Positives = 60/146 (41%), Gaps = 8/146 (5%)
Query: 35 GMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKA 94
+ +LHD++II H +L++ N L +++ADFG+ A + + A
Sbjct: 122 ALNYLHDNKII-HRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPY--WMA 178
Query: 95 PELLRQPHLPRG--TQKGDVYSFGLVLYEVIGRQGPWGHLRMTDEEIITSVTQGSGLRPD 152
PE++ K DV+S G+ L E+ + P + ++ + +
Sbjct: 179 PEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHE--LNPMRVLLKIAKSEPPTLA 236
Query: 153 TSSLDCAPSIIACMRTCWEEDPELRP 178
S + + ++ C E++ + R
Sbjct: 237 QPS-RWSSNFKDFLKKCLEKNVDARW 261
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 87.9 bits (217), Expect = 6e-20
Identities = 37/156 (23%), Positives = 56/156 (35%), Gaps = 7/156 (4%)
Query: 35 GMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKA 94
GM L + H +L + N L+ V++I DFGL R + A
Sbjct: 176 GMEFLEFKSCV-HRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMA 234
Query: 95 PELLRQPHLPRGTQKGDVYSFGLVLYEVIGRQGPWGHLRMTDEEIITSVTQGSGLRPDTS 154
PE L + T K DV+S+G++L+E+ D + G + D
Sbjct: 235 PESLFEGIY---TIKSDVWSYGILLWEIFSLGVNPYPGIPVDANFYKLIQN--GFKMDQP 289
Query: 155 SLDCAPSIIACMRTCWEEDPELRPDLRFVHHKLKEM 190
I M++CW D RP + L
Sbjct: 290 F-YATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQ 324
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 86.7 bits (214), Expect = 8e-20
Identities = 34/156 (21%), Positives = 64/156 (41%), Gaps = 9/156 (5%)
Query: 35 GMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKA 94
M +L I H +L + NCL+ ++++ADFG + D + + A
Sbjct: 127 AMEYLEKKNFI-HRDLAARNCLVGENHLVKVADFG-LSRLMTGDTYTAHAGAKFPIKWTA 184
Query: 95 PELLRQPHLPRGTQKGDVYSFGLVLYEVIGRQGPWGHLRMTDEEIITSVTQGSGLRPDTS 154
PE L + K DV++FG++L+E+ + + ++ + + +
Sbjct: 185 PESLAYNKF---SIKSDVWAFGVLLWEIATYGMSP-YPGIDLSQVYELLEKDYRMERPE- 239
Query: 155 SLDCAPSIIACMRTCWEEDPELRPDLRFVHHKLKEM 190
C + MR CW+ +P RP +H + M
Sbjct: 240 --GCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM 273
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 86.7 bits (214), Expect = 1e-19
Identities = 42/158 (26%), Positives = 72/158 (45%), Gaps = 11/158 (6%)
Query: 35 GMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKL-YK 93
GM +L + + H +L + N L+ +R +I+DFGL D R + L +
Sbjct: 121 GMKYLEEKNFV-HRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWY 179
Query: 94 APELLRQPHLPRGTQKGDVYSFGLVLYEVI-GRQGPWGHLRMTDEEIITSVTQGSGLRPD 152
APE + + + DV+S+G+ ++E + Q P+ M E++ + QG R +
Sbjct: 180 APECINFRKF---SSRSDVWSYGVTMWEALSYGQKPYKK--MKGPEVMAFIEQG--KRME 232
Query: 153 TSSLDCAPSIIACMRTCWEEDPELRPDLRFVHHKLKEM 190
+C P + A M CW E RPD V +++
Sbjct: 233 CPP-ECPPELYALMSDCWIYKWEDRPDFLTVEQRMRAC 269
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 85.2 bits (210), Expect = 4e-19
Identities = 34/156 (21%), Positives = 66/156 (42%), Gaps = 8/156 (5%)
Query: 35 GMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKA 94
GM +L D ++ H +L + N L+ + ++I DFGL +++ + + A
Sbjct: 123 GMNYLEDRRLV-HRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMA 181
Query: 95 PELLRQPHLPRGTQKGDVYSFGLVLYEVIGRQGPWGHLRMTDEEIITSVTQGSGLRPDTS 154
E + T + DV+S+G+ ++E++ + EI + + +G L
Sbjct: 182 LESILHRIY---THQSDVWSYGVTVWELMTFGSKPYD-GIPASEISSILEKGERLPQPP- 236
Query: 155 SLDCAPSIIACMRTCWEEDPELRPDLRFVHHKLKEM 190
C + M CW D + RP R + + +M
Sbjct: 237 --ICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKM 270
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 84.0 bits (207), Expect = 5e-19
Identities = 35/156 (22%), Positives = 72/156 (46%), Gaps = 9/156 (5%)
Query: 35 GMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKA 94
M +L + + H +L + NCL++ + V++++DFGL + DE + +
Sbjct: 112 AMEYLESKQFL-HRDLAARNCLVNDQGVVKVSDFGL-SRYVLDDEYTSSVGSKFPVRWSP 169
Query: 95 PELLRQPHLPRGTQKGDVYSFGLVLYEVIGRQGPWGHLRMTDEEIITSVTQGSGLRPDTS 154
PE+L + K D+++FG++++E+ G + R T+ E + QG L
Sbjct: 170 PEVLMYSKF---SSKSDIWAFGVLMWEIYSL-GKMPYERFTNSETAEHIAQGLRLYRPH- 224
Query: 155 SLDCAPSIIACMRTCWEEDPELRPDLRFVHHKLKEM 190
+ + M +CW E + RP + + + ++
Sbjct: 225 --LASEKVYTIMYSCWHEKADERPTFKILLSNILDV 258
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 84.0 bits (207), Expect = 6e-19
Identities = 41/158 (25%), Positives = 72/158 (45%), Gaps = 11/158 (6%)
Query: 35 GMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGL-HAFKAGQDETGQERKLRRRKLYK 93
GM +L +S + H +L + N L+ ++ +I+DFGL A +A ++ + + +
Sbjct: 119 GMKYLEESNFV-HRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWY 177
Query: 94 APELLRQPHLPRGTQKGDVYSFGLVLYEVI-GRQGPWGHLRMTDEEIITSVTQGSGLRPD 152
APE + + K DV+SFG++++E Q P+ M E+ + +G R
Sbjct: 178 APECINYYKF---SSKSDVWSFGVLMWEAFSYGQKPYRG--MKGSEVTAMLEKG--ERMG 230
Query: 153 TSSLDCAPSIIACMRTCWEEDPELRPDLRFVHHKLKEM 190
+ C + M CW D E RP V +L+
Sbjct: 231 CPA-GCPREMYDLMNLCWTYDVENRPGFAAVELRLRNY 267
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 83.9 bits (207), Expect = 7e-19
Identities = 26/151 (17%), Positives = 57/151 (37%), Gaps = 14/151 (9%)
Query: 35 GMIHLHD----SEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRK 90
+ H + H +L+ +N +D + +++ DFGL + +T +
Sbjct: 121 ALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLA--RILNHDTSFAKAFVGTP 178
Query: 91 LYKAPELLRQPHLPRGTQKGDVYSFGLVLYEVIGRQGPWGHLRMTDEEIITSVTQGSGLR 150
Y +PE + + +K D++S G +LYE+ P+ + +E+ + +G R
Sbjct: 179 YYMSPEQMNRMSY---NEKSDIWSLGCLLYELCALMPPFTA--FSQKELAGKIREGKFRR 233
Query: 151 PDTSSLDCAPSIIACMRTCWEEDPELRPDLR 181
+ + + RP +
Sbjct: 234 IPY---RYSDELNEIITRMLNLKDYHRPSVE 261
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 83.5 bits (206), Expect = 1e-18
Identities = 29/144 (20%), Positives = 59/144 (40%), Gaps = 11/144 (7%)
Query: 35 GMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKA 94
G+ +LH +I H ++++ N L+ ++++ DFG + + A
Sbjct: 127 GLAYLHSHNMI-HRDVKAGNILLSEPGLVKLGDFGSASI------MAPANSFVGTPYWMA 179
Query: 95 PELLRQPHLPRGTQKGDVYSFGLVLYEVIGRQGPWGHLRMTDEEIITSVTQGSGLRPDTS 154
PE++ + K DV+S G+ E+ R+ P + M + + Q P
Sbjct: 180 PEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFN--MNAMSALYHIAQNE--SPALQ 235
Query: 155 SLDCAPSIIACMRTCWEEDPELRP 178
S + + +C ++ P+ RP
Sbjct: 236 SGHWSEYFRNFVDSCLQKIPQDRP 259
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 82.3 bits (203), Expect = 2e-18
Identities = 31/149 (20%), Positives = 61/149 (40%), Gaps = 13/149 (8%)
Query: 35 GMIHLHD-SEIISHGNLRSSNCLIDSR-WVLQIADFGLHAFKAGQDETGQERKLRRRKLY 92
G+ LH + I H +L+ N I ++I D GL A + + +
Sbjct: 124 GLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGL----ATLKRASFAKAVIGTPEF 179
Query: 93 KAPELLRQPHLPRGTQKGDVYSFGLVLYEVIGRQGPWGHLRMTDEEIITSVTQGSGLRPD 152
APE+ + + + DVY+FG+ + E+ + P+ +I VT G++P
Sbjct: 180 MAPEMYEEKY----DESVDVYAFGMCMLEMATSEYPYSE-CQNAAQIYRRVTS--GVKPA 232
Query: 153 TSSLDCAPSIIACMRTCWEEDPELRPDLR 181
+ P + + C ++ + R ++
Sbjct: 233 SFDKVAIPEVKEIIEGCIRQNKDERYSIK 261
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 81.9 bits (202), Expect = 3e-18
Identities = 32/147 (21%), Positives = 60/147 (40%), Gaps = 14/147 (9%)
Query: 35 GMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKA 94
+ + H +I H +++ N L+ S L+IADFG + + + L Y
Sbjct: 118 ALSYCHSKRVI-HRDIKPENLLLGSAGELKIADFGW----SVHAPSSRRTTLCGTLDYLP 172
Query: 95 PELLRQPHLPRGTQKGDVYSFGLVLYEVIGRQGPWGHLRMTDEEIITSVTQGSGLRPDTS 154
PE++ +K D++S G++ YE + + P+ T +E +++ PD
Sbjct: 173 PEMIEGRMH---DEKVDLWSLGVLCYEFLVGKPPFEA--NTYQETYKRISRVEFTFPD-- 225
Query: 155 SLDCAPSIIACMRTCWEEDPELRPDLR 181
+ + +P RP LR
Sbjct: 226 --FVTEGARDLISRLLKHNPSQRPMLR 250
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 82.2 bits (202), Expect = 4e-18
Identities = 42/158 (26%), Positives = 81/158 (51%), Gaps = 12/158 (7%)
Query: 35 GMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKA 94
GM +L+ ++ + H +L + NC++ + ++I DFG+ D + K + +
Sbjct: 145 GMAYLNANKFV-HRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMS 203
Query: 95 PELLRQPHLPRGTQKGDVYSFGLVLYEVI-GRQGPWGHLRMTDEEIITSVTQGSGL-RPD 152
PE L+ T DV+SFG+VL+E+ + P+ +++E+++ V +G L +PD
Sbjct: 204 PESLKDGVF---TTYSDVWSFGVVLWEIATLAEQPYQG--LSNEQVLRFVMEGGLLDKPD 258
Query: 153 TSSLDCAPSIIACMRTCWEEDPELRPDLRFVHHKLKEM 190
+C + MR CW+ +P++RP + +KE
Sbjct: 259 ----NCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEE 292
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 81.3 bits (200), Expect = 5e-18
Identities = 43/157 (27%), Positives = 66/157 (42%), Gaps = 10/157 (6%)
Query: 35 GMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLH-AFKAGQDETGQERKLRRRKLYK 93
GM +L I H +L + N L+ +R +++I DFGL A D + + +
Sbjct: 123 GMGYLESKRFI-HRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWC 181
Query: 94 APELLRQPHLPRGTQKGDVYSFGLVLYEVI-GRQGPWGHLRMTDEEIITSVTQGSGLRPD 152
APE L+ + D + FG+ L+E+ Q PW + +I+ + + G R
Sbjct: 182 APESLKTRTF---SHASDTWMFGVTLWEMFTYGQEPWIG--LNGSQILHKIDKE-GERLP 235
Query: 153 TSSLDCAPSIIACMRTCWEEDPELRPDLRFVHHKLKE 189
DC I M CW PE RP + L E
Sbjct: 236 RPE-DCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLE 271
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 80.4 bits (198), Expect = 9e-18
Identities = 39/161 (24%), Positives = 69/161 (42%), Gaps = 12/161 (7%)
Query: 35 GMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKA 94
G+++LH I H +++ N L+D R L+I+DFGL + K+ Y A
Sbjct: 115 GVVYLHGIGIT-HRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVA 173
Query: 95 PELLRQPHLPRGTQKGDVYSFGLVLYEVIGRQGPWGHLRMTDEEIITSVTQGSGLRPDTS 154
PELL+ + DV+S G+VL ++ + PW + +E + + L P
Sbjct: 174 PELLK--RREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWK- 230
Query: 155 SLDCAPSIIACMRTCWEEDPELRPDLR------FVHHKLKE 189
+ +A + E+P R + + + LK+
Sbjct: 231 --KIDSAPLALLHKILVENPSARITIPDIKKDRWYNKPLKK 269
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 79.5 bits (195), Expect = 4e-17
Identities = 35/156 (22%), Positives = 60/156 (38%), Gaps = 7/156 (4%)
Query: 35 GMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKA 94
GM L I H +L + N L+ + +I DFGL + R + A
Sbjct: 157 GMAFLASKNCI-HRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMA 215
Query: 95 PELLRQPHLPRGTQKGDVYSFGLVLYEVIGRQGPWGHLRMTDEEIITSVTQGSGLRPDTS 154
PE + T + DV+S+G+ L+E+ D + + +G S
Sbjct: 216 PESIFNCV---YTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMIKEG---FRMLS 269
Query: 155 SLDCAPSIIACMRTCWEEDPELRPDLRFVHHKLKEM 190
+ M+TCW+ DP RP + + +++
Sbjct: 270 PEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQ 305
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 78.5 bits (193), Expect = 6e-17
Identities = 27/144 (18%), Positives = 55/144 (38%), Gaps = 10/144 (6%)
Query: 35 GMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKA 94
+ +LH II H +L+ N L++ +QI DFG + + + + Y +
Sbjct: 120 ALEYLHGKGII-HRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVS 178
Query: 95 PELLRQPHLPRGTQKGDVYSFGLVLYEVIGRQGPWGHLRMTDEEIITSVTQGSGLRPDTS 154
PELL + + D+++ G ++Y+++ P+ + I + + P+
Sbjct: 179 PELLTEKSA---CKSSDLWALGCIIYQLVAGLPPFRA--GNEYLIFQKIIKLEYDFPE-- 231
Query: 155 SLDCAPSIIACMRTCWEEDPELRP 178
P + D R
Sbjct: 232 --KFFPKARDLVEKLLVLDATKRL 253
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 78.0 bits (191), Expect = 9e-17
Identities = 45/156 (28%), Positives = 70/156 (44%), Gaps = 8/156 (5%)
Query: 35 GMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKA 94
GM +L + I H +L + N L+ V++IADFGL D + R + A
Sbjct: 147 GMEYLASKKCI-HRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMA 205
Query: 95 PELLRQPHLPRGTQKGDVYSFGLVLYEVIGRQGPWGHLRMTDEEIITSVTQGSGLRPDTS 154
PE L T + DV+SFG++L+E+ G + + EE+ + +G R D
Sbjct: 206 PEALFDRIY---THQSDVWSFGVLLWEIFTLGGSP-YPGVPVEELFKLLKEG--HRMDKP 259
Query: 155 SLDCAPSIIACMRTCWEEDPELRPDLRFVHHKLKEM 190
S +C + MR CW P RP + + L +
Sbjct: 260 S-NCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 294
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 77.6 bits (190), Expect = 1e-16
Identities = 42/163 (25%), Positives = 69/163 (42%), Gaps = 10/163 (6%)
Query: 35 GMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKA 94
GM L + I H +L + N L+ + V++I DFGL + ++ R + A
Sbjct: 146 GMEFLASRKCI-HRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMA 204
Query: 95 PELLRQPHLPRGTQKGDVYSFGLVLYEVIGRQGPWGHLRMTDEEIITSVTQGSGLRPDTS 154
PE + T + DV+SFG++L+E+ DEE + +G+ +R
Sbjct: 205 PETIFDRVY---TIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPD- 260
Query: 155 SLDCAPSIIACMRTCWEEDPELRPDLRFVHHKLKEMNAGLKAN 197
P + M CW +P RP + L + L+AN
Sbjct: 261 --YTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL---LQAN 298
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 75.2 bits (184), Expect = 6e-16
Identities = 28/156 (17%), Positives = 60/156 (38%), Gaps = 9/156 (5%)
Query: 35 GMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKA 94
+ +L + H ++ + N L+ S +++ DFGL + + K
Sbjct: 120 ALAYLESKRFV-HRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAP 178
Query: 95 PELLRQPHLPRGTQKGDVYSFGLVLYEVIGRQGPWGHLRMTDEEIITSVTQGSGLRPDTS 154
+ + DV+ FG+ ++E++ + + ++I + G L
Sbjct: 179 ESINFRRFTS----ASDVWMFGVCMWEILMHGVKPFQ-GVKNNDVIGRIENGERLPMPP- 232
Query: 155 SLDCAPSIIACMRTCWEEDPELRPDLRFVHHKLKEM 190
+C P++ + M CW DP RP + +L +
Sbjct: 233 --NCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTI 266
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 74.3 bits (182), Expect = 1e-15
Identities = 28/147 (19%), Positives = 60/147 (40%), Gaps = 9/147 (6%)
Query: 35 GMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKA 94
+ LH I+ H +L+ N L+D +++ DFG D + R++ Y A
Sbjct: 122 VICALHKLNIV-HRDLKPENILLDDDMNIKLTDFGFSCQL---DPGEKLREVCGTPSYLA 177
Query: 95 PELLRQPHL---PRGTQKGDVYSFGLVLYEVIGRQGPWGHLRMTDEEIITSVTQGSGLRP 151
PE++ P ++ D++S G+++Y ++ P+ H ++ + G+
Sbjct: 178 PEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWH--RKQMLMLRMIMSGNYQFG 235
Query: 152 DTSSLDCAPSIIACMRTCWEEDPELRP 178
D + ++ + P+ R
Sbjct: 236 SPEWDDYSDTVKDLVSRFLVVQPQKRY 262
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 75.1 bits (184), Expect = 2e-15
Identities = 30/146 (20%), Positives = 60/146 (41%), Gaps = 11/146 (7%)
Query: 35 GMIHLHDSEIISHGNLRSSNCLIDSRW--VLQIADFGLHAFKAGQDETGQERKLRRRKLY 92
G+ H+H++ + H +L+ N + ++ L++ DFGL A D + +
Sbjct: 136 GLCHMHENNYV-HLDLKPENIMFTTKRSNELKLIDFGLTAH---LDPKQSVKVTTGTAEF 191
Query: 93 KAPELLRQPHLPRGTQKGDVYSFGLVLYEVIGRQGPWGHLRMTDEEIITSVTQGSGLRPD 152
APE+ + D++S G++ Y ++ P+G D+E + +V D
Sbjct: 192 AAPEVAEGKPV---GYYTDMWSVGVLSYILLSGLSPFGG--ENDDETLRNVKSCDWNMDD 246
Query: 153 TSSLDCAPSIIACMRTCWEEDPELRP 178
++ + +R DP R
Sbjct: 247 SAFSGISEDGKDFIRKLLLADPNTRM 272
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 72.7 bits (178), Expect = 6e-15
Identities = 25/147 (17%), Positives = 55/147 (37%), Gaps = 9/147 (6%)
Query: 35 GMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKA 94
+ LH +++I H +++S N L+ +++ DFG A + + A
Sbjct: 128 ALEFLHSNQVI-HRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPY--WMA 184
Query: 95 PELLRQPHLPRGTQKGDVYSFGLVLYEVIGRQGPWGHLRMTDEEIITSVTQGSGLRPDTS 154
PE++ + K D++S G++ E+I + P+ + + +
Sbjct: 185 PEVVTRKAY---GPKVDIWSLGIMAIEMIEGEPPYLN--ENPLRALYLIATNGTPELQNP 239
Query: 155 SLDCAPSIIACMRTCWEEDPELRPDLR 181
+ + C + D E R +
Sbjct: 240 E-KLSAIFRDFLNRCLDMDVEKRGSAK 265
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 72.8 bits (178), Expect = 8e-15
Identities = 27/106 (25%), Positives = 52/106 (49%), Gaps = 7/106 (6%)
Query: 35 GMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKA 94
G+ +L + I H +++ SN L++SR +++ DFG+ +GQ + Y +
Sbjct: 116 GLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGV----SGQLIDSMANSFVGTRSYMS 171
Query: 95 PELLRQPHLPRGTQKGDVYSFGLVLYEVIGRQGPWGHLRMTDEEII 140
PE L+ H + + D++S GL L E+ + P + E++
Sbjct: 172 PERLQGTHY---SVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELM 214
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 72.4 bits (177), Expect = 9e-15
Identities = 31/215 (14%), Positives = 78/215 (36%), Gaps = 19/215 (8%)
Query: 35 GMIHLHDSEIISHGNLRSSNCLIDSR--WVLQIADFGLHAFKAGQDETGQERKLRRRKLY 92
+ LH I H ++R N + +R ++I +FG D Y
Sbjct: 114 ALQFLHSHNIG-HFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPE---Y 169
Query: 93 KAPELLRQPHLPRGTQKGDVYSFGLVLYEVIGRQGPWGHLRMTDEEIITSVTQGSGLRPD 152
APE+ + + + D++S G ++Y ++ P+ T+++II ++ +
Sbjct: 170 YAPEVHQHDVV---STATDMWSLGTLVYVLLSGINPFLA--ETNQQIIENIMNAEYTFDE 224
Query: 153 TSSLDCAPSIIACMRTCWEEDPELRPDLR------FVHHKLKEMNAGLKANI-FDNMLAI 205
+ + + + + ++ + R ++ K++ ++ + +
Sbjct: 225 EAFKEISIEAMDFVDRLLVKERKSRMTASEALQHPWLKQKIERVSTKVIRTLKHRRYYHT 284
Query: 206 MEKYAFNLEGEWTDWTASLRRRPKMGPCSRAASRI 240
+ K N+ + R + G S A ++
Sbjct: 285 LIKKDLNMVVSAARISCGGAIRSQKGV-SVAKVKV 318
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 71.4 bits (174), Expect = 1e-14
Identities = 25/185 (13%), Positives = 57/185 (30%), Gaps = 20/185 (10%)
Query: 35 GMIHLHDSEIISHGNLRSSNCLIDSRWV-----LQIADFGLHAFKAGQDETGQERKLRRR 89
+ +H+ ++ + +++ N LI + + DFG+ F ++
Sbjct: 113 RVQSIHEKSLV-YRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKK 171
Query: 90 KL-----YKAPELLRQPHLPRGTQKGDVYSFGLVLYEVI-GRQGPWGHLRMTDEEIITSV 143
L Y + +++ D+ + G V + G G T+++ +
Sbjct: 172 NLSGTARYMSINTHLGREQ---SRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERI 228
Query: 144 TQGSGLRPDTSSL-DCAPSIIACMRTCWEEDPELRPDLRFVHHKLKEMNAGLKAN---IF 199
+ P M + PD ++ ++ L F
Sbjct: 229 GEKKQSTPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLNTTEDENF 288
Query: 200 D-NML 203
D N+L
Sbjct: 289 DWNLL 293
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 70.9 bits (173), Expect = 4e-14
Identities = 28/146 (19%), Positives = 66/146 (45%), Gaps = 11/146 (7%)
Query: 35 GMIHLHDSEIISHGNLRSSNCLIDSR--WVLQIADFGLHAFKAGQDETGQERKLRRRKLY 92
G+ H+H+ I+ H +++ N + +++ ++I DFGL A K DE + +
Sbjct: 139 GLKHMHEHSIV-HLDIKPENIMCETKKASSVKIIDFGL-ATKLNPDEIVKVTTATAE--F 194
Query: 93 KAPELLRQPHLPRGTQKGDVYSFGLVLYEVIGRQGPWGHLRMTDEEIITSVTQGSGLRPD 152
APE++ + + D+++ G++ Y ++ P+ D E + +V + +
Sbjct: 195 AAPEIVDREPV---GFYTDMWAIGVLGYVLLSGLSPFAG--EDDLETLQNVKRCDWEFDE 249
Query: 153 TSSLDCAPSIIACMRTCWEEDPELRP 178
+ +P ++ +++P R
Sbjct: 250 DAFSSVSPEAKDFIKNLLQKEPRKRL 275
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 69.0 bits (168), Expect = 8e-14
Identities = 30/145 (20%), Positives = 59/145 (40%), Gaps = 7/145 (4%)
Query: 35 GMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHA-FKAGQDETGQERKLRRRKLYK 93
+ H + II H +++ +N +I + +++ DFG+ + Q + Y
Sbjct: 123 ALNFSHQNGII-HRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYL 181
Query: 94 APELLRQPHLPRGTQKGDVYSFGLVLYEVIGRQGPWGHLRMTDEEIITSVTQGSGLRPDT 153
+PE R + + DVYS G VLYEV+ + P+ + + + + P
Sbjct: 182 SPEQARGDSV---DARSDVYSLGCVLYEVLTGEPPFT--GDSPVSVAYQHVREDPIPPSA 236
Query: 154 SSLDCAPSIIACMRTCWEEDPELRP 178
+ + A + ++PE R
Sbjct: 237 RHEGLSADLDAVVLKALAKNPENRY 261
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 67.8 bits (165), Expect = 3e-13
Identities = 26/149 (17%), Positives = 52/149 (34%), Gaps = 6/149 (4%)
Query: 35 GMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKA 94
+ +LH I H +++ N L S+ I F Y A
Sbjct: 123 AIQYLHSINIA-HRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVA 181
Query: 95 PELLRQPHLPRGTQKGDVYSFGLVLYEVIGRQGPW--GHLRMTDEEIITSVTQGSGLRPD 152
PE+L + D++S G+++Y ++ P+ H + T + G P+
Sbjct: 182 PEVLGPEKY---DKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPN 238
Query: 153 TSSLDCAPSIIACMRTCWEEDPELRPDLR 181
+ + + +R + +P R +
Sbjct: 239 PEWSEVSEEVKMLIRNLLKTEPTQRMTIT 267
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 67.6 bits (164), Expect = 3e-13
Identities = 28/167 (16%), Positives = 52/167 (31%), Gaps = 16/167 (9%)
Query: 35 GMIHLHDSEIISHGNLRSSNCLIDSR---WVLQIADFGLHAFKAGQDETGQERKLRRRKL 91
+ ++H I H +++ N L+ ++ I DFG A K T Q R K
Sbjct: 115 RIEYIHSKNFI-HRDVKPDNFLMGLGKKGNLVYIIDFG-LAKKYRDARTHQHIPYRENKN 172
Query: 92 ------YKAPELLRQPHLPRGTQKGDVYSFGLVLYEVIGRQGPWGHLRMTDEEIITSVTQ 145
Y + +++ D+ S G VL PW L+ +
Sbjct: 173 LTGTARYASINTHLGIEQ---SRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERIS 229
Query: 146 GSGLRPDTSSL--DCAPSIIACMRTCWEEDPELRPDLRFVHHKLKEM 190
+ L + C + +PD ++ + +
Sbjct: 230 EKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNL 276
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 66.3 bits (161), Expect = 9e-13
Identities = 35/144 (24%), Positives = 59/144 (40%), Gaps = 12/144 (8%)
Query: 35 GMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKA 94
G+ LH I+ + +L+ N L+D ++IADFG+ K + Y A
Sbjct: 115 GLQFLHSKGIV-YRDLKLDNILLDKDGHIKIADFGM--CKENMLGDAKTNTFCGTPDYIA 171
Query: 95 PELLRQPHLPRGTQKGDVYSFGLVLYEVIGRQGPWGHLRMTDEEIITSVTQGSGLRPDTS 154
PE+L D +SFG++LYE++ Q P+ +EE+ S+ + P
Sbjct: 172 PEILLGQKY---NHSVDWWSFGVLLYEMLIGQSPFHG--QDEEELFHSIRMDNPFYPR-- 224
Query: 155 SLDCAPSIIACMRTCWEEDPELRP 178
+ + +PE R
Sbjct: 225 --WLEKEAKDLLVKLFVREPEKRL 246
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 65.9 bits (160), Expect = 1e-12
Identities = 28/143 (19%), Positives = 53/143 (37%), Gaps = 15/143 (10%)
Query: 36 MIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKAP 95
+ +LH +II + +L+ N L+D ++I DFG + T L Y AP
Sbjct: 117 LEYLHSKDII-YRDLKPENILLDKNGHIKITDFGFAKYVPDVTYT-----LCGTPDYIAP 170
Query: 96 ELLRQPHLPRGTQKGDVYSFGLVLYEVIGRQGPWGHLRMTDEEIITSVTQGSGLRPDTSS 155
E++ + D +SFG+++YE++ P+ + + P +
Sbjct: 171 EVVSTKPY---NKSIDWWSFGILIYEMLAGYTPFYD--SNTMKTYEKILNAELRFPPFFN 225
Query: 156 LDCAPSIIACMRTCWEEDPELRP 178
+ + D R
Sbjct: 226 ----EDVKDLLSRLITRDLSQRL 244
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 63.6 bits (154), Expect = 7e-12
Identities = 31/150 (20%), Positives = 66/150 (44%), Gaps = 12/150 (8%)
Query: 36 MIHLHDSEIISHGNLRSSNCLIDSRWV----LQIADFGLHAFKAGQDETGQERKLRRRKL 91
++ S I+H +L+ N ++ R V ++I DFGL D + + +
Sbjct: 125 GVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHK---IDFGNEFKNIFGTPE 181
Query: 92 YKAPELLRQPHLPRGTQKGDVYSFGLVLYEVIGRQGPWGHLRMTDEEIITSVTQGSGLRP 151
+ APE++ L + D++S G++ Y ++ P+ L T +E + +V+ +
Sbjct: 182 FVAPEIVNYEPL---GLEADMWSIGVITYILLSGASPF--LGDTKQETLANVSAVNYEFE 236
Query: 152 DTSSLDCAPSIIACMRTCWEEDPELRPDLR 181
D + + +R +DP+ R ++
Sbjct: 237 DEYFSNTSALAKDFIRRLLVKDPKKRMTIQ 266
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 64.0 bits (155), Expect = 7e-12
Identities = 28/144 (19%), Positives = 61/144 (42%), Gaps = 10/144 (6%)
Query: 35 GMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKA 94
G+ H+H+ ++ + +L+ +N L+D ++I+D GL A + Y A
Sbjct: 119 GLEHMHNRFVV-YRDLKPANILLDEHGHVRISDLGL----ACDFSKKKPHASVGTHGYMA 173
Query: 95 PELLRQPHLPRGTQKGDVYSFGLVLYEVIGRQGPWGHLRMTDEEIITSVTQGSGLRPDTS 154
PE+L++ D +S G +L++++ P+ + D+ I +T +
Sbjct: 174 PEVLQKGV--AYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPD- 230
Query: 155 SLDCAPSIIACMRTCWEEDPELRP 178
+P + + + + D R
Sbjct: 231 --SFSPELRSLLEGLLQRDVNRRL 252
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 62.2 bits (150), Expect = 2e-11
Identities = 29/144 (20%), Positives = 61/144 (42%), Gaps = 5/144 (3%)
Query: 35 GMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKA 94
+ HLH II + +++ N L+DS + + DFGL + + DET + Y A
Sbjct: 141 ALEHLHKLGII-YRDIKLENILLDSNGHVVLTDFGL-SKEFVADETERAYDFCGTIEYMA 198
Query: 95 PELLRQPHLPRGTQKGDVYSFGLVLYEVIGRQGPWGHLRMTDEEIITSVTQGSGLRPDTS 154
P+++R D +S G+++YE++ P+ ++ +++
Sbjct: 199 PDIVRGGDSGHDK-AVDWWSLGVLMYELLTGASPFTV--DGEKNSQAEISRRILKSEPPY 255
Query: 155 SLDCAPSIIACMRTCWEEDPELRP 178
+ + ++ +DP+ R
Sbjct: 256 PQEMSALAKDLIQRLLMKDPKKRL 279
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 61.6 bits (149), Expect = 3e-11
Identities = 35/148 (23%), Positives = 59/148 (39%), Gaps = 20/148 (13%)
Query: 35 GMIHLHDSEIISHGNLRSSNCLID-SRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYK 93
+ H H+ ++ H +++ N LID +R L++ DFG + ++Y
Sbjct: 122 AVRHCHNCGVL-HRDIKDENILIDLNRGELKLIDFGS----GALLKDTVYTDFDGTRVYS 176
Query: 94 APELLRQPHLPRGTQKGDVYSFGLVLYEVIGRQGPWGHLRMTDEEIITSVTQGSGLRPDT 153
PE +R + + V+S G++LY+++ P+ H DEEII R
Sbjct: 177 PPEWIR--YHRYHGRSAAVWSLGILLYDMVCGDIPFEH----DEEIIRGQVF---FRQRV 227
Query: 154 SSLDCAPSIIACMRTCWEEDPELRPDLR 181
S +R C P RP
Sbjct: 228 S-----SECQHLIRWCLALRPSDRPTFE 250
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 60.0 bits (145), Expect = 1e-10
Identities = 35/147 (23%), Positives = 59/147 (40%), Gaps = 12/147 (8%)
Query: 35 GMIHLHDSEIISHGNLRSSNCLI---DSRWVLQIADFGLHAFKAGQDETGQERKLRRRKL 91
+ +LHD I+ H +L+ N L D + I+DFGL +D
Sbjct: 119 AVKYLHDLGIV-HRDLKPENLLYYSLDEDSKIMISDFGLSKM---EDPGSVLSTACGTPG 174
Query: 92 YKAPELLRQPHLPRGTQKGDVYSFGLVLYEVIGRQGPWGHLRMTDEEIITSVTQGSGLRP 151
Y APE+L Q ++ D +S G++ Y ++ P+ D ++ + +
Sbjct: 175 YVAPEVLAQKPY---SKAVDCWSIGVIAYILLCGYPPFYD--ENDAKLFEQILKAEYEFD 229
Query: 152 DTSSLDCAPSIIACMRTCWEEDPELRP 178
D + S +R E+DPE R
Sbjct: 230 SPYWDDISDSAKDFIRHLMEKDPEKRF 256
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 57.9 bits (139), Expect = 7e-10
Identities = 30/144 (20%), Positives = 62/144 (43%), Gaps = 12/144 (8%)
Query: 35 GMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKA 94
+ +LH +++ + +++ N ++D ++I DFGL K G + + Y A
Sbjct: 117 ALEYLHSRDVV-YRDIKLENLMLDKDGHIKITDFGL--CKEGISDGATMKTFCGTPEYLA 173
Query: 95 PELLRQPHLPRGTQKGDVYSFGLVLYEVIGRQGPWGHLRMTDEEIITSVTQGSGLRPDTS 154
PE+L + D + G+V+YE++ + P+ + E + + P T
Sbjct: 174 PEVLEDNDY---GRAVDWWGLGVVMYEMMCGRLPFYN--QDHERLFELILMEEIRFPRTL 228
Query: 155 SLDCAPSIIACMRTCWEEDPELRP 178
S P + + ++DP+ R
Sbjct: 229 S----PEAKSLLAGLLKKDPKQRL 248
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 57.5 bits (138), Expect = 1e-09
Identities = 29/144 (20%), Positives = 55/144 (38%), Gaps = 15/144 (10%)
Query: 35 GMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKA 94
+LH ++I + +L+ N LID + +Q+ DFG G+ T L A
Sbjct: 153 TFEYLHSLDLI-YRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWT-----LCGTPEALA 206
Query: 95 PELLRQPHLPRGTQKGDVYSFGLVLYEVIGRQGPWGHLRMTDEEIITSVTQGSGLRPDTS 154
PE++ + D ++ G+++YE+ P+ +I + G P
Sbjct: 207 PEIILSKGY---NKAVDWWALGVLIYEMAAGYPPFFA--DQPIQIYEKIVSGKVRFPS-- 259
Query: 155 SLDCAPSIIACMRTCWEEDPELRP 178
+ + +R + D R
Sbjct: 260 --HFSSDLKDLLRNLLQVDLTKRF 281
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 55.6 bits (133), Expect = 4e-09
Identities = 29/170 (17%), Positives = 65/170 (38%), Gaps = 29/170 (17%)
Query: 35 GMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGL-HAFKAGQDETGQERKLRRRKLYK 93
G+ ++H + ++ H +L+ SN L+++ L+I DFGL D TG + + Y+
Sbjct: 121 GLKYIHSANVL-HRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYR 179
Query: 94 APELLRQPHLPRGTQKGDVYSFGLVLYEVIGRQGPW------------------------ 129
APE++ T+ D++S G +L E++ + +
Sbjct: 180 APEIMLNSK--GYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDL 237
Query: 130 -GHLRMTDEEIITSVTQGSGLRPDTSSLDCAPSIIACMRTCWEEDPELRP 178
+ + + S+ + + + + + + +P R
Sbjct: 238 NCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRI 287
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 53.0 bits (126), Expect = 2e-08
Identities = 32/170 (18%), Positives = 57/170 (33%), Gaps = 32/170 (18%)
Query: 35 GMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKA 94
G+ LH ++ H +L+ N L+ S +++ADFGL + Q Y+A
Sbjct: 128 GLDFLHSHRVV-HRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVTLW---YRA 183
Query: 95 PELLRQPHLPRGTQKGDVYSFGLVLYEVIGRQGPWGHLRMTDEEIITSVTQGSGL----- 149
PE+L Q D++S G + E+ R+ + +D + + + GL
Sbjct: 184 PEVLLQSSY---ATPVDLWSVGCIFAEMFRRKPLFRG--SSDVDQLGKILDVIGLPGEED 238
Query: 150 ------------------RPDTSSLDCAPSIIACMRTCWEEDPELRPDLR 181
+ D + C +P R
Sbjct: 239 WPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAY 288
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 52.6 bits (125), Expect = 3e-08
Identities = 27/169 (15%), Positives = 57/169 (33%), Gaps = 32/169 (18%)
Query: 35 GMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKA 94
G+ H ++ H +L+ N LI++ +++ADFGL T + Y+A
Sbjct: 114 GLAFCHSHRVL-HRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLW--YRA 170
Query: 95 PELLRQPHLPRGTQKGDVYSFGLVLYEVIGRQGPWGHLRMTDEEIITSVTQGSGLRPDTS 154
PE+L + D++S G + E++ R+ + ++ + + + + G +
Sbjct: 171 PEILLG--CKYYSTAVDIWSLGCIFAEMVTRRALFPG--DSEIDQLFRIFRTLGTPDEVV 226
Query: 155 SLDC-------------------------APSIIACMRTCWEEDPELRP 178
+ + DP R
Sbjct: 227 WPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRI 275
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 52.6 bits (125), Expect = 3e-08
Identities = 34/168 (20%), Positives = 63/168 (37%), Gaps = 31/168 (18%)
Query: 35 GMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKA 94
G+ +LH I H +L+ +N L+D VL++ADFGL K+ + Y+A
Sbjct: 112 GLEYLH-QHWILHRDLKPNNLLLDENGVLKLADFGLA--KSFGSPNRAYTHQVVTRWYRA 168
Query: 95 PELLRQPHLPRGTQKGDVYSFGLVLYEVIGRQGPWGHLRMTDEEIITSVTQGSGLRPDTS 154
PELL D+++ G +L E++ R +D + +T + + G +
Sbjct: 169 PELLFGAR--MYGVGVDMWAVGCILAELLLRVPFLPG--DSDLDQLTRIFETLGTPTEEQ 224
Query: 155 SLD------------------------CAPSIIACMRTCWEEDPELRP 178
D ++ ++ + +P R
Sbjct: 225 WPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARI 272
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 51.4 bits (122), Expect = 7e-08
Identities = 33/177 (18%), Positives = 64/177 (36%), Gaps = 35/177 (19%)
Query: 35 GMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRR--KLY 92
G+ ++H ++I+ H +++++N LI VL++ADFGL + + R R Y
Sbjct: 129 GLYYIHRNKIL-HRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWY 187
Query: 93 KAPELLRQPHLPRGTQKGDVYSFGLVLYEVIGRQGPWGHLRMTDEEIITSVTQGSG---- 148
+ PELL D++ G ++ E+ R T++ + ++Q G
Sbjct: 188 RPPELLLGER--DYGPPIDLWGAGCIMAEMWTRSPIMQ--GNTEQHQLALISQLCGSITP 243
Query: 149 ------------------------LRPDTSSLDCAPSIIACMRTCWEEDPELRPDLR 181
++ + P + + DP R D
Sbjct: 244 EVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSD 300
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 50.7 bits (120), Expect = 1e-07
Identities = 33/170 (19%), Positives = 63/170 (37%), Gaps = 28/170 (16%)
Query: 35 GMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKA 94
G+ + HD ++ H +L+ N LI+ L+IADFGL +A + Y+A
Sbjct: 112 GIAYCHDRRVL-HRDLKPQNLLINREGELKIADFGL--ARAFGIPVRKYTHEIVTLWYRA 168
Query: 95 PELLRQPHLPRGTQKGDVYSFGLVLYEVIGRQGPW-------------GHLRMTDEEIIT 141
P++L + + D++S G + E++ + L + +
Sbjct: 169 PDVLMGS--KKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWP 226
Query: 142 SVTQGSGLRPDTSSL----------DCAPSIIACMRTCWEEDPELRPDLR 181
+VT+ P+ + S I + + DP R +
Sbjct: 227 NVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAK 276
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 46.9 bits (110), Expect = 2e-06
Identities = 27/169 (15%), Positives = 55/169 (32%), Gaps = 31/169 (18%)
Query: 35 GMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKA 94
G+ H ++ H +L+ N LI+ L++A+FGL A G ++
Sbjct: 113 GLGFCHSRNVL-HRDLKPQNLLINRNGELKLANFGL-ARAFGIPVRCYSAEVVTLWYRPP 170
Query: 95 PELLRQPHLPRGTQKGDVYSFGLVLYEVIGRQGPWGHLRMTDEEIITSVTQGSG------ 148
L + D++S G + E+ P ++ + + + G
Sbjct: 171 DVLFGAKLY---STSIDMWSAGCIFAELANAGRPLFPGN-DVDDQLKRIFRLLGTPTEEQ 226
Query: 149 --------------LRPDTSSL-----DCAPSIIACMRTCWEEDPELRP 178
+ P T+SL + ++ + +P R
Sbjct: 227 WPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRI 275
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 45.9 bits (108), Expect = 4e-06
Identities = 26/157 (16%), Positives = 52/157 (33%), Gaps = 9/157 (5%)
Query: 35 GMIHLHDSEIISHGNLRSS-NCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYK 93
+ ++H I H +++ L VL++ DFG + Y+
Sbjct: 134 SLAYIHSFGIC-HRDIKPQNLLLDPDTAVLKLCDFGSAKQ---LVRGEPNVSYICSRYYR 189
Query: 94 APELLRQPHLPRGTQKGDVYSFGLVLYEVIGRQGPWGHLRMTDEEIITSVTQGSGLRPDT 153
APEL+ T DV+S G VL E++ Q + + + + + + G
Sbjct: 190 APELIFGAT--DYTSSIDVWSAGCVLAELLLGQPIFPG--DSGVDQLVEIIKVLGTPTRE 245
Query: 154 SSLDCAPSIIACMRTCWEEDPELRPDLRFVHHKLKEM 190
+ P+ + P + + +
Sbjct: 246 QIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIAL 282
|
| >d1azsb_ d.58.29.1 (B:) Adenylyl cyclase IIC1, domain C2a {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 199 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Ferredoxin-like superfamily: Nucleotide cyclase family: Adenylyl and guanylyl cyclase catalytic domain domain: Adenylyl cyclase IIC1, domain C2a species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 44.9 bits (105), Expect = 4e-06
Identities = 8/25 (32%), Positives = 13/25 (52%)
Query: 337 ESFDSVTIYFSDIVGFTQLSAESTE 361
+S+D V + F+ I F + ES
Sbjct: 2 QSYDCVCVMFASIPDFKEFYTESDV 26
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 42.6 bits (99), Expect = 5e-05
Identities = 30/169 (17%), Positives = 58/169 (34%), Gaps = 33/169 (19%)
Query: 35 GMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKA 94
G+ ++H S I H +L+ SN ++ L+I DFGL + + Y+A
Sbjct: 133 GLKYIH-SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYV-----ATRWYRA 186
Query: 95 PELLRQPHLPRGTQKGDVYSFGLVLYEVIGRQGPW------------------------- 129
PE++ Q D++S G ++ E++ + +
Sbjct: 187 PEIMLNWM--HYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLK 244
Query: 130 GHLRMTDEEIITSVTQGSGLRPDTSSLDCAPSIIACMRTCWEEDPELRP 178
+ I S+TQ + + P + + D + R
Sbjct: 245 KISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRI 293
|
| >d1azsa_ d.58.29.1 (A:) Adenylyl cyclase VC1, domain C1a {Dog (Canis familiaris) [TaxId: 9615]} Length = 190 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Ferredoxin-like superfamily: Nucleotide cyclase family: Adenylyl and guanylyl cyclase catalytic domain domain: Adenylyl cyclase VC1, domain C1a species: Dog (Canis familiaris) [TaxId: 9615]
Score = 41.5 bits (96), Expect = 7e-05
Identities = 11/24 (45%), Positives = 18/24 (75%)
Query: 337 ESFDSVTIYFSDIVGFTQLSAEST 360
+ D+V+I F+DI GFT L+++ T
Sbjct: 10 QKHDNVSILFADIEGFTSLASQCT 33
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 41.2 bits (95), Expect = 1e-04
Identities = 20/123 (16%), Positives = 46/123 (37%), Gaps = 8/123 (6%)
Query: 35 GMIHLHDSEIISHGNLRSSNCLIDSR-WVLQIADFGLHAFKAGQDETGQERKLRRRKLYK 93
G+ ++H I H +++ N L++ + + + + Y+
Sbjct: 137 GLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTREYR 196
Query: 94 APELLRQPHLPRGTQKGDVYSFGLVLYEVIGRQGPW----GHLRMTDEEIITSVTQGSGL 149
+PE+L D++S +++E+I + GH D++ I + + G
Sbjct: 197 SPEVLLGAPW---GCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLGE 253
Query: 150 RPD 152
P
Sbjct: 254 LPS 256
|
| >d1fx2a_ d.58.29.1 (A:) Receptor-type monomeric adenylyl cyclase {Trypanosome (Trypanosoma brucei), different isoform [TaxId: 5691]} Length = 235 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Ferredoxin-like superfamily: Nucleotide cyclase family: Adenylyl and guanylyl cyclase catalytic domain domain: Receptor-type monomeric adenylyl cyclase species: Trypanosome (Trypanosoma brucei), different isoform [TaxId: 5691]
Score = 40.7 bits (94), Expect = 1e-04
Identities = 10/28 (35%), Positives = 13/28 (46%)
Query: 334 VEPESFDSVTIYFSDIVGFTQLSAESTE 361
E D VT+ F+DI T L A +
Sbjct: 5 APKEPTDPVTLIFTDIESSTALWAAHPD 32
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 38.3 bits (88), Expect = 0.001
Identities = 34/171 (19%), Positives = 66/171 (38%), Gaps = 37/171 (21%)
Query: 35 GMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKA 94
G+ ++H + I H +L+ N ++ L+I DFGL A +A + TG + Y+A
Sbjct: 133 GLRYIH-AAGIIHRDLKPGNLAVNEDCELKILDFGL-ARQADSEMTGY----VVTRWYRA 186
Query: 95 PELLRQPHLPRGTQKGDVYSFGLVLYEVIGRQGPWGHLRMTDEEIITSVTQGSGLRPD-- 152
PE++ R TQ D++S G ++ E+I + + + + + + +G P
Sbjct: 187 PEVILNW--MRYTQTVDIWSVGCIMAEMITGKTLFKG--SDHLDQLKEIMKVTGTPPAEF 242
Query: 153 -------------------------TSSLDCAPSIIACMRTCWEEDPELRP 178
+ + +P + + D E R
Sbjct: 243 VQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRV 293
|
Homologous Domains Detected by HHsearch 
Original result of HHsearch against SCOP70(version1.75) database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Probability ![]() |
| Query | 423 | |||
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 99.98 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 99.98 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 99.98 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 99.98 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 99.98 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 99.98 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 99.98 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 99.98 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 99.97 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 99.97 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 99.97 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 99.97 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 99.97 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 99.97 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 99.97 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 99.97 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 99.97 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 99.97 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 99.97 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 99.97 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 99.97 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 99.97 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 99.97 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 99.97 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 99.97 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 99.97 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 99.97 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 99.97 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 99.96 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 99.96 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 99.96 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 99.96 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 99.96 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 99.96 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 99.96 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 99.96 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 99.96 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 99.96 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 99.96 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 99.96 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 99.96 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 99.95 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 99.95 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 99.95 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 99.95 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 99.95 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 99.94 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 99.94 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 99.94 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 99.94 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 99.93 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 99.93 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 99.92 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 99.92 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 99.89 | |
| d1azsb_ | 199 | Adenylyl cyclase IIC1, domain C2a {Rat (Rattus nor | 99.25 | |
| d1azsa_ | 190 | Adenylyl cyclase VC1, domain C1a {Dog (Canis famil | 99.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 98.95 | |
| d1wc1a_ | 197 | Adenylate cyclase CyaC {Spirulina platensis [TaxId | 98.81 | |
| d1fx2a_ | 235 | Receptor-type monomeric adenylyl cyclase {Trypanos | 98.32 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 88.92 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 85.67 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 83.62 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9e-36 Score=282.66 Aligned_cols=167 Identities=28% Similarity=0.488 Sum_probs=129.6
Q ss_pred HHHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCccEEEeccCCcccccCCCcccccccccCCccccCCccccCCCC
Q psy1840 24 GSISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKAPELLRQPHL 103 (423)
Q Consensus 24 ~~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~ 103 (423)
..+.++.||+.||+|||+++++ ||||||+|||++.++.+||+|||+++...............||+.|+|||++.+...
T Consensus 105 ~~~~i~~qi~~gl~yLH~~~iv-HrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~ 183 (276)
T d1uwha_ 105 KLIDIARQTAQGMDYLHAKSII-HRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDK 183 (276)
T ss_dssp HHHHHHHHHHHHHHHHHHTTCC-CSCCCGGGEEEETTSSEEECCCCCSCC------------CCCCGGGCCHHHHTTCSS
T ss_pred HHHHHHHHHHHHHHHHhcCCEe-ccccCHHHEEEcCCCCEEEccccceeeccccCCcccccccccCcccCCHHHHhcccC
Confidence 3789999999999999999998 999999999999999999999999987654433333456678999999999976543
Q ss_pred CCCCCccchHHHHHHHHHHHhCCCCCCCCCCChHHHHHHHhcCCCCCCC--CCCCCchHHHHHHHHHhhhcCCCCCCCHH
Q psy1840 104 PRGTQKGDVYSFGLVLYEVIGRQGPWGHLRMTDEEIITSVTQGSGLRPD--TSSLDCAPSIIACMRTCWEEDPELRPDLR 181 (423)
Q Consensus 104 ~~~s~ksDVyS~Giil~elltg~~Pf~~~~~~~~~i~~~i~~~~~~~p~--~~~~~~~~~l~~Li~~C~~~dP~~RPt~~ 181 (423)
..++.++|||||||++|||+||+.||.+.. ....+...+..+. ..|. .....+++++.++|.+||+.||++|||+.
T Consensus 184 ~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~-~~~~~~~~~~~~~-~~p~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ 261 (276)
T d1uwha_ 184 NPYSFQSDVYAFGIVLYELMTGQLPYSNIN-NRDQIIFMVGRGY-LSPDLSKVRSNCPKAMKRLMAECLKKKRDERPLFP 261 (276)
T ss_dssp CCCCHHHHHHHHHHHHHHHHHSSCTTTTCC-CHHHHHHHHHHTS-CCCCGGGSCTTCCHHHHHHHHHHTCSSGGGSCCHH
T ss_pred CCCCchhhhhhhHHHHHHHHHCCCCCCCCC-hHHHHHHHHhcCC-CCCcchhccccchHHHHHHHHHHcCCCHhHCcCHH
Confidence 345899999999999999999999997532 2334444444432 2222 22457899999999999999999999999
Q ss_pred HHHHHHHHHhhh
Q psy1840 182 FVHHKLKEMNAG 193 (423)
Q Consensus 182 ~I~~~L~~i~~~ 193 (423)
+|++.|+.+...
T Consensus 262 ~il~~Le~l~~~ 273 (276)
T d1uwha_ 262 QILASIELLARS 273 (276)
T ss_dssp HHHHHHHHHHHT
T ss_pred HHHHHHHHHHHc
Confidence 999999888654
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.1e-34 Score=271.97 Aligned_cols=160 Identities=25% Similarity=0.418 Sum_probs=126.8
Q ss_pred HHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCccEEEeccCCcccccCCCcccccccccCCccccCCccccCCCCC
Q psy1840 25 SISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKAPELLRQPHLP 104 (423)
Q Consensus 25 ~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~ 104 (423)
.+.++.||+.||.|||+++++ ||||||+||||+.++.+||+|||+++...............||+.|+|||++.+..+
T Consensus 136 ~~~~~~qi~~gl~ylH~~~iv-HrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~- 213 (299)
T d1ywna1 136 LICYSFQVAKGMEFLASRKCI-HRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVY- 213 (299)
T ss_dssp HHHHHHHHHHHHHHHHHTTCC-CSCCCGGGEEECGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCC-
T ss_pred HHHHHHHHHHHHHHHHhCCCc-CCcCCccceeECCCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCC-
Confidence 689999999999999999998 999999999999999999999999987654444444456679999999999988665
Q ss_pred CCCCccchHHHHHHHHHHHhCC-CCCCCCCCChHHHHHHHhcCCCCCCCCCCCCchHHHHHHHHHhhhcCCCCCCCHHHH
Q psy1840 105 RGTQKGDVYSFGLVLYEVIGRQ-GPWGHLRMTDEEIITSVTQGSGLRPDTSSLDCAPSIIACMRTCWEEDPELRPDLRFV 183 (423)
Q Consensus 105 ~~s~ksDVyS~Giil~elltg~-~Pf~~~~~~~~~i~~~i~~~~~~~p~~~~~~~~~~l~~Li~~C~~~dP~~RPt~~~I 183 (423)
+.++|||||||++|||++|. .||.... ....+...+..+.. +.. +..+++++.+++.+||+.||++|||+.+|
T Consensus 214 --~~~sDiwS~Gvil~ellt~~~~p~~~~~-~~~~~~~~~~~~~~--~~~-~~~~~~~l~~li~~cl~~dP~~Rpt~~ei 287 (299)
T d1ywna1 214 --TIQSDVWSFGVLLWEIFSLGASPYPGVK-IDEEFCRRLKEGTR--MRA-PDYTTPEMYQTMLDCWHGEPSQRPTFSEL 287 (299)
T ss_dssp --CHHHHHHHHHHHHHHHHTTSCCSSTTCC-CSHHHHHHHHHTCC--CCC-CTTCCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred --CcccceeehHHHHHHHHhCCCCCCCCCC-HHHHHHHHHhcCCC--CCC-CccCCHHHHHHHHHHcCCChhHCcCHHHH
Confidence 89999999999999999875 5776433 33555566665532 222 23678999999999999999999999999
Q ss_pred HHHHHHHhh
Q psy1840 184 HHKLKEMNA 192 (423)
Q Consensus 184 ~~~L~~i~~ 192 (423)
++.|+.+.+
T Consensus 288 l~~L~~ilq 296 (299)
T d1ywna1 288 VEHLGNLLQ 296 (299)
T ss_dssp HHHHHHHHH
T ss_pred HHHHHHHHh
Confidence 999987754
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.3e-33 Score=270.80 Aligned_cols=160 Identities=27% Similarity=0.524 Sum_probs=123.8
Q ss_pred HHHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCccEEEeccCCcccccCCCccc---ccccccCCccccCCccccC
Q psy1840 24 GSISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETG---QERKLRRRKLYKAPELLRQ 100 (423)
Q Consensus 24 ~~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~~~---~~~~~~gt~~y~APE~l~~ 100 (423)
.++.++.||+.||.|||+++++ ||||||+||||+.++++||+|||+++......... ......+|+.|+|||.+.+
T Consensus 129 ~~~~i~~qia~gl~yLH~~~ii-HrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~ 207 (299)
T d1jpaa_ 129 QLVGMLRGIAAGMKYLADMNYV-HRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQY 207 (299)
T ss_dssp HHHHHHHHHHHHHHHHHHTTCC-CSCCCGGGEEECTTCCEEECCC-----------------------CGGGSCHHHHHS
T ss_pred HHHHHHHHHHHHHHHHhhCCCc-cCccccceEEECCCCcEEECCcccceEccCCCCcceeeecccccCCccccCHHHHhc
Confidence 3789999999999999999998 99999999999999999999999998764332211 1123457889999999987
Q ss_pred CCCCCCCCccchHHHHHHHHHHHh-CCCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCchHHHHHHHHHhhhcCCCCCCC
Q psy1840 101 PHLPRGTQKGDVYSFGLVLYEVIG-RQGPWGHLRMTDEEIITSVTQGSGLRPDTSSLDCAPSIIACMRTCWEEDPELRPD 179 (423)
Q Consensus 101 ~~~~~~s~ksDVyS~Giil~ellt-g~~Pf~~~~~~~~~i~~~i~~~~~~~p~~~~~~~~~~l~~Li~~C~~~dP~~RPt 179 (423)
..+ +.++|||||||++|||+| |+.||.+ .+..++...+..+....+ +..+++++.+|+.+||+.||++|||
T Consensus 208 ~~~---~~~sDvwS~Gvvl~el~t~g~~Pf~~--~~~~~~~~~i~~~~~~~~---~~~~~~~l~~li~~cl~~~P~~RPs 279 (299)
T d1jpaa_ 208 RKF---TSASDVWSYGIVMWEVMSYGERPYWD--MTNQDVINAIEQDYRLPP---PMDCPSALHQLMLDCWQKDRNHRPK 279 (299)
T ss_dssp CCC---CHHHHHHHHHHHHHHHHTTSCCTTTT--CCHHHHHHHHHTTCCCCC---CTTCCHHHHHHHHHHTCSSTTTSCC
T ss_pred CCC---CcccccccchHHHHHHHhCCCCCCCC--CCHHHHHHHHHcCCCCCC---CccchHHHHHHHHHHcCCCHhHCcC
Confidence 655 899999999999999998 8999974 456788888877543222 2368999999999999999999999
Q ss_pred HHHHHHHHHHHhh
Q psy1840 180 LRFVHHKLKEMNA 192 (423)
Q Consensus 180 ~~~I~~~L~~i~~ 192 (423)
+.+|++.|+++.+
T Consensus 280 ~~ei~~~L~~~l~ 292 (299)
T d1jpaa_ 280 FGQIVNTLDKMIR 292 (299)
T ss_dssp HHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHhc
Confidence 9999999988754
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-33 Score=267.17 Aligned_cols=161 Identities=25% Similarity=0.438 Sum_probs=126.0
Q ss_pred HHHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCccEEEeccCCcccccCCCc-ccccccccCCccccCCccccCCC
Q psy1840 24 GSISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDE-TGQERKLRRRKLYKAPELLRQPH 102 (423)
Q Consensus 24 ~~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~-~~~~~~~~gt~~y~APE~l~~~~ 102 (423)
.++.++.||+.||+|||+++++ ||||||+||||+.++.+||+|||+++....... ........||+.|+|||++.++.
T Consensus 111 ~~~~i~~~i~~gl~~lH~~~ii-HrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~ 189 (283)
T d1mqba_ 111 QLVGMLRGIAAGMKYLANMNYV-HRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRK 189 (283)
T ss_dssp HHHHHHHHHHHHHHHHHHTTCC-CSCCCGGGEEECTTCCEEECCCCC-----------------CCCGGGSCHHHHHSCC
T ss_pred HHHHHHHHHHHhhhhccccccc-cCccccceEEECCCCeEEEcccchhhcccCCCccceEeccCCCCccccCHHHHccCC
Confidence 3789999999999999999998 999999999999999999999999987643322 12223456788999999998876
Q ss_pred CCCCCCccchHHHHHHHHHHHhCCCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCchHHHHHHHHHhhhcCCCCCCCHHH
Q psy1840 103 LPRGTQKGDVYSFGLVLYEVIGRQGPWGHLRMTDEEIITSVTQGSGLRPDTSSLDCAPSIIACMRTCWEEDPELRPDLRF 182 (423)
Q Consensus 103 ~~~~s~ksDVyS~Giil~elltg~~Pf~~~~~~~~~i~~~i~~~~~~~p~~~~~~~~~~l~~Li~~C~~~dP~~RPt~~~ 182 (423)
+ +.++|||||||++|||++|..|+.. ..+..++...+..+. +++. +..++.++.+|+.+||+.||++|||+.+
T Consensus 190 ~---~~~sDI~S~Gvil~el~t~~~~~~~-~~~~~~~~~~i~~~~--~~~~-~~~~~~~l~~li~~cl~~~p~~RPt~~e 262 (283)
T d1mqba_ 190 F---TSASDVWSFGIVMWEVMTYGERPYW-ELSNHEVMKAINDGF--RLPT-PMDCPSAIYQLMMQCWQQERARRPKFAD 262 (283)
T ss_dssp C---CHHHHHHHHHHHHHHHHTTSCCTTT-TCCHHHHHHHHHTTC--CCCC-CTTCBHHHHHHHHHHTCSSTTTSCCHHH
T ss_pred C---CCcccccccHHHHHHHHhCCCCccc-cCCHHHHHHHHhccC--CCCC-chhhHHHHHHHHHHHCcCCHhHCcCHHH
Confidence 5 8999999999999999997666543 456677887777653 2332 2468999999999999999999999999
Q ss_pred HHHHHHHHhh
Q psy1840 183 VHHKLKEMNA 192 (423)
Q Consensus 183 I~~~L~~i~~ 192 (423)
|++.|+.+..
T Consensus 263 il~~L~~l~~ 272 (283)
T d1mqba_ 263 IVSILDKLIR 272 (283)
T ss_dssp HHHHHHHHHH
T ss_pred HHHHHHHHhh
Confidence 9999887654
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-33 Score=264.77 Aligned_cols=159 Identities=24% Similarity=0.463 Sum_probs=122.2
Q ss_pred HHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCccEEEeccCCcccccCCCcccccccccCCccccCCccccCCCCC
Q psy1840 25 SISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKAPELLRQPHLP 104 (423)
Q Consensus 25 ~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~ 104 (423)
++.++.||+.||.|||+++++ ||||||+|||++.++.+||+|||+++........ ......||+.|+|||++.+..+
T Consensus 103 ~~~i~~qia~gl~~lH~~~ii-HrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~- 179 (263)
T d1sm2a_ 103 LLGMCLDVCEGMAYLEEACVI-HRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYT-SSTGTKFPVKWASPEVFSFSRY- 179 (263)
T ss_dssp HHHHHHHHHHHHHHHHHTTCC-CTTCSGGGEEECGGGCEEECSCC-------------------CTTSCCHHHHTTCCC-
T ss_pred HHHHHHHHHHHHHhhhcccee-ecccchhheeecCCCCeEecccchheeccCCCce-eecceecCcccCChHHhcCCCC-
Confidence 689999999999999999998 9999999999999999999999999865433222 2234568899999999988765
Q ss_pred CCCCccchHHHHHHHHHHHhCCCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCchHHHHHHHHHhhhcCCCCCCCHHHHH
Q psy1840 105 RGTQKGDVYSFGLVLYEVIGRQGPWGHLRMTDEEIITSVTQGSGLRPDTSSLDCAPSIIACMRTCWEEDPELRPDLRFVH 184 (423)
Q Consensus 105 ~~s~ksDVyS~Giil~elltg~~Pf~~~~~~~~~i~~~i~~~~~~~p~~~~~~~~~~l~~Li~~C~~~dP~~RPt~~~I~ 184 (423)
+.++|||||||++|||+|+..|+.. ..+..++...+..+.... .+..+++++.+++.+||+.||++|||+.+|+
T Consensus 180 --~~k~DVwS~Gvil~el~t~~~~~~~-~~~~~~~~~~i~~~~~~~---~p~~~~~~l~~li~~cl~~~p~~Rps~~~il 253 (263)
T d1sm2a_ 180 --SSKSDVWSFGVLMWEVFSEGKIPYE-NRSNSEVVEDISTGFRLY---KPRLASTHVYQIMNHCWKERPEDRPAFSRLL 253 (263)
T ss_dssp --CHHHHHHHHHHHHHHHHTTSCCTTC-SCCHHHHHHHHHHTCCCC---CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred --CchhhhcchHHHHHHHHHCCCCCCC-CCCHHHHHHHHHhcCCCC---CccccCHHHHHHHHHHccCCHhHCcCHHHHH
Confidence 8999999999999999996544432 345677788877753322 1236789999999999999999999999999
Q ss_pred HHHHHHhh
Q psy1840 185 HKLKEMNA 192 (423)
Q Consensus 185 ~~L~~i~~ 192 (423)
+.|+++.+
T Consensus 254 ~~L~~i~e 261 (263)
T d1sm2a_ 254 RQLAEIAE 261 (263)
T ss_dssp HHHHHHHH
T ss_pred HHHHHHHh
Confidence 99998865
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-33 Score=267.41 Aligned_cols=159 Identities=25% Similarity=0.480 Sum_probs=133.5
Q ss_pred HHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCccEEEeccCCcccccCCCcc-cccccccCCccccCCccccCCCC
Q psy1840 25 SISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDET-GQERKLRRRKLYKAPELLRQPHL 103 (423)
Q Consensus 25 ~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~~-~~~~~~~gt~~y~APE~l~~~~~ 103 (423)
++.++.||+.||+|||+++++ ||||||+||+++.++.+||+|||+++........ .......||+.|+|||++.+..+
T Consensus 111 ~~~i~~qi~~gL~ylH~~~ii-HrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~ 189 (285)
T d1u59a_ 111 VAELLHQVSMGMKYLEEKNFV-HRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKF 189 (285)
T ss_dssp HHHHHHHHHHHHHHHHHTTEE-CCCCSGGGEEEEETTEEEECCCTTCEECTTCSCEECCCCSSCCCGGGCCHHHHHHCEE
T ss_pred HHHHHHHHHHHHHHHHhCCee-cCcCchhheeeccCCceeeccchhhhcccccccccccccccccCccccChHHHhCCCC
Confidence 789999999999999999988 9999999999999999999999999876543322 22234568889999999987665
Q ss_pred CCCCCccchHHHHHHHHHHHh-CCCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCchHHHHHHHHHhhhcCCCCCCCHHH
Q psy1840 104 PRGTQKGDVYSFGLVLYEVIG-RQGPWGHLRMTDEEIITSVTQGSGLRPDTSSLDCAPSIIACMRTCWEEDPELRPDLRF 182 (423)
Q Consensus 104 ~~~s~ksDVyS~Giil~ellt-g~~Pf~~~~~~~~~i~~~i~~~~~~~p~~~~~~~~~~l~~Li~~C~~~dP~~RPt~~~ 182 (423)
+.++|||||||++|||+| |+.||.+ .+..++...+..+... .. +..+++++.+||.+||+.||++|||+.+
T Consensus 190 ---~~ksDVwS~Gv~l~E~lt~G~~Pf~~--~~~~~~~~~i~~~~~~--~~-p~~~~~~l~~li~~cl~~~p~~RPs~~~ 261 (285)
T d1u59a_ 190 ---SSRSDVWSYGVTMWEALSYGQKPYKK--MKGPEVMAFIEQGKRM--EC-PPECPPELYALMSDCWIYKWEDRPDFLT 261 (285)
T ss_dssp ---CHHHHHHHHHHHHHHHHTTSCCTTTT--CCTHHHHHHHHTTCCC--CC-CTTCCHHHHHHHHHTTCSSGGGSCCHHH
T ss_pred ---CccchhhcchHHHHHHHhCCCCCCCC--CCHHHHHHHHHcCCCC--CC-CCcCCHHHHHHHHHHcCCCHhHCcCHHH
Confidence 899999999999999998 8999975 4457788888776432 22 2368999999999999999999999999
Q ss_pred HHHHHHHHhh
Q psy1840 183 VHHKLKEMNA 192 (423)
Q Consensus 183 I~~~L~~i~~ 192 (423)
|.+.|+....
T Consensus 262 i~~~L~~~~~ 271 (285)
T d1u59a_ 262 VEQRMRACYY 271 (285)
T ss_dssp HHHHHHHHHH
T ss_pred HHHHHHHHHH
Confidence 9998876543
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-33 Score=273.35 Aligned_cols=158 Identities=24% Similarity=0.376 Sum_probs=128.9
Q ss_pred HHHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCccEEEeccCCcccccCCCcccccccccCCccccCCccccCCCC
Q psy1840 24 GSISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKAPELLRQPHL 103 (423)
Q Consensus 24 ~~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~ 103 (423)
..+.++.||+.||+|||+++++ ||||||+||+++.++.+||+|||+++...............||+.|+|||++.+..+
T Consensus 165 ~~~~i~~qi~~gl~yLH~~~Ii-HRDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~ 243 (325)
T d1rjba_ 165 DLLCFAYQVAKGMEFLEFKSCV-HRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIY 243 (325)
T ss_dssp HHHHHHHHHHHHHHHHHHTTEE-ETTCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCC
T ss_pred HHHHHHHHHHHHHHHHHhCCee-eccCchhccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCC
Confidence 3789999999999999999988 999999999999999999999999987654443333345567899999999987765
Q ss_pred CCCCCccchHHHHHHHHHHHh-CCCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCchHHHHHHHHHhhhcCCCCCCCHHH
Q psy1840 104 PRGTQKGDVYSFGLVLYEVIG-RQGPWGHLRMTDEEIITSVTQGSGLRPDTSSLDCAPSIIACMRTCWEEDPELRPDLRF 182 (423)
Q Consensus 104 ~~~s~ksDVyS~Giil~ellt-g~~Pf~~~~~~~~~i~~~i~~~~~~~p~~~~~~~~~~l~~Li~~C~~~dP~~RPt~~~ 182 (423)
+.++|||||||++|||++ |..||.+... ...+...+..+. +++. +..+++++.+||.+||+.||++|||+.+
T Consensus 244 ---~~~~DiwS~Gvil~emlt~g~~Pf~~~~~-~~~~~~~~~~~~--~~~~-p~~~~~~l~~li~~cl~~dP~~RPt~~e 316 (325)
T d1rjba_ 244 ---TIKSDVWSYGILLWEIFSLGVNPYPGIPV-DANFYKLIQNGF--KMDQ-PFYATEEIYIIMQSCWAFDSRKRPSFPN 316 (325)
T ss_dssp ---CHHHHHHHHHHHHHHHTTTSCCSSTTCCC-SHHHHHHHHTTC--CCCC-CTTCCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred ---CcceeccchhHHHHHHHhCCCCCCCCCCH-HHHHHHHHhcCC--CCCC-CCcCCHHHHHHHHHHcCCChhHCcCHHH
Confidence 899999999999999997 8999975433 233444444432 2222 2368999999999999999999999999
Q ss_pred HHHHHHH
Q psy1840 183 VHHKLKE 189 (423)
Q Consensus 183 I~~~L~~ 189 (423)
|++.|..
T Consensus 317 i~~~L~~ 323 (325)
T d1rjba_ 317 LTSFLGC 323 (325)
T ss_dssp HHHHHHH
T ss_pred HHHHHhC
Confidence 9998853
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.98 E-value=4e-33 Score=263.74 Aligned_cols=159 Identities=26% Similarity=0.467 Sum_probs=131.6
Q ss_pred HHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCccEEEeccCCcccccCCCcccccccccCCccccCCccccCCCCC
Q psy1840 25 SISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKAPELLRQPHLP 104 (423)
Q Consensus 25 ~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~ 104 (423)
+++++.||+.||.|||+++++ ||||||+||||+.++.+||+|||+++....... .......|++.|+|||++.+..+
T Consensus 111 ~~~i~~qi~~gl~~lH~~~iv-HrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~~-~~~~~~~gt~~y~APE~~~~~~~- 187 (272)
T d1qpca_ 111 LLDMAAQIAEGMAFIEERNYI-HRDLRAANILVSDTLSCKIADFGLARLIEDNEY-TAREGAKFPIKWTAPEAINYGTF- 187 (272)
T ss_dssp HHHHHHHHHHHHHHHHHTTEE-CSCCSGGGEEECTTSCEEECCCTTCEECSSSCE-ECCTTCCCCTTTSCHHHHHHCEE-
T ss_pred HHHHHHHHHHHHHHHHhCCcc-cCccchhheeeecccceeeccccceEEccCCcc-ccccccCCcccccChHHHhCCCC-
Confidence 689999999999999999988 999999999999999999999999987643322 22244578889999999987655
Q ss_pred CCCCccchHHHHHHHHHHHhCCCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCchHHHHHHHHHhhhcCCCCCCCHHHHH
Q psy1840 105 RGTQKGDVYSFGLVLYEVIGRQGPWGHLRMTDEEIITSVTQGSGLRPDTSSLDCAPSIIACMRTCWEEDPELRPDLRFVH 184 (423)
Q Consensus 105 ~~s~ksDVyS~Giil~elltg~~Pf~~~~~~~~~i~~~i~~~~~~~p~~~~~~~~~~l~~Li~~C~~~dP~~RPt~~~I~ 184 (423)
+.++|||||||++|||+||..|+.. ..+..++...+..+.. +.. +..+++++.+|+.+||+.||++|||+.+|+
T Consensus 188 --~~~sDvwS~Gvvl~ellt~~~~~~~-~~~~~~~~~~i~~~~~--~~~-p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~ 261 (272)
T d1qpca_ 188 --TIKSDVWSFGILLTEIVTHGRIPYP-GMTNPEVIQNLERGYR--MVR-PDNCPEELYQLMRLCWKERPEDRPTFDYLR 261 (272)
T ss_dssp --CHHHHHHHHHHHHHHHHTTTCCSST-TCCHHHHHHHHHTTCC--CCC-CTTCCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred --CchhhhhhhHHHHHHHHhCCCCCCC-CCCHHHHHHHHHhcCC--CCC-cccChHHHHHHHHHHcCCCHhHCcCHHHHH
Confidence 8999999999999999997665532 3456777777776532 222 246899999999999999999999999999
Q ss_pred HHHHHHhh
Q psy1840 185 HKLKEMNA 192 (423)
Q Consensus 185 ~~L~~i~~ 192 (423)
+.|+.+..
T Consensus 262 ~~L~~~ft 269 (272)
T d1qpca_ 262 SVLEDFFT 269 (272)
T ss_dssp HHHHHHHH
T ss_pred HHhhhhhh
Confidence 99887654
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.98 E-value=2.6e-33 Score=268.86 Aligned_cols=159 Identities=27% Similarity=0.481 Sum_probs=132.9
Q ss_pred HHHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCccEEEeccCCcccccCCCcccccccccCCccccCCccccCCCC
Q psy1840 24 GSISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKAPELLRQPHL 103 (423)
Q Consensus 24 ~~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~ 103 (423)
.++.++.||+.||+|||+.+++ ||||||+|||+|.++.+||+|||+++...............+++.|+|||.+.+..+
T Consensus 141 ~~~~i~~qi~~gl~ylH~~~iv-HrDlKp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~ 219 (301)
T d1lufa_ 141 EQLCIARQVAAGMAYLSERKFV-HRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRY 219 (301)
T ss_dssp HHHHHHHHHHHHHHHHHHTTCC-CSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCC
T ss_pred HHHHHHHHHHHHhhhcccCCeE-eeEEcccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCC
Confidence 3789999999999999999998 999999999999999999999999876544333333345678889999999988765
Q ss_pred CCCCCccchHHHHHHHHHHHhCC-CCCCCCCCChHHHHHHHhcCCCCCCCCCCCCchHHHHHHHHHhhhcCCCCCCCHHH
Q psy1840 104 PRGTQKGDVYSFGLVLYEVIGRQ-GPWGHLRMTDEEIITSVTQGSGLRPDTSSLDCAPSIIACMRTCWEEDPELRPDLRF 182 (423)
Q Consensus 104 ~~~s~ksDVyS~Giil~elltg~-~Pf~~~~~~~~~i~~~i~~~~~~~p~~~~~~~~~~l~~Li~~C~~~dP~~RPt~~~ 182 (423)
+.++|||||||++|||++|. .||. ..+..++...+..+.. +.. +..+++++.+|+.+||+.||++|||+.+
T Consensus 220 ---t~ksDVwS~Gvvl~ell~~~~~p~~--~~~~~e~~~~v~~~~~--~~~-p~~~~~~~~~li~~cl~~~P~~RPt~~e 291 (301)
T d1lufa_ 220 ---TTESDVWAYGVVLWEIFSYGLQPYY--GMAHEEVIYYVRDGNI--LAC-PENCPLELYNLMRLCWSKLPADRPSFCS 291 (301)
T ss_dssp ---CHHHHHHHHHHHHHHHHTTTCCTTT--TSCHHHHHHHHHTTCC--CCC-CTTCCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred ---ChhhhhccchhhHHHHHccCCCCCC--CCCHHHHHHHHHcCCC--CCC-CccchHHHHHHHHHHcCCChhHCcCHHH
Confidence 89999999999999999986 5675 4567888888887653 222 2468899999999999999999999999
Q ss_pred HHHHHHHHh
Q psy1840 183 VHHKLKEMN 191 (423)
Q Consensus 183 I~~~L~~i~ 191 (423)
|++.|+++.
T Consensus 292 v~~~L~~i~ 300 (301)
T d1lufa_ 292 IHRILQRMC 300 (301)
T ss_dssp HHHHHHHTT
T ss_pred HHHHHHHhc
Confidence 999998874
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.98 E-value=4.1e-33 Score=264.37 Aligned_cols=158 Identities=25% Similarity=0.459 Sum_probs=130.8
Q ss_pred HHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCccEEEeccCCcccccCCCcc-cccccccCCccccCCccccCCCC
Q psy1840 25 SISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDET-GQERKLRRRKLYKAPELLRQPHL 103 (423)
Q Consensus 25 ~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~~-~~~~~~~gt~~y~APE~l~~~~~ 103 (423)
.+.++.||+.||+|||+++++ ||||||+|||++.++.+||+|||+++........ .......||+.|+|||.+.+..+
T Consensus 109 ~~~i~~qi~~gl~ylH~~~ii-HrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~ 187 (277)
T d1xbba_ 109 IIELVHQVSMGMKYLEESNFV-HRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKF 187 (277)
T ss_dssp HHHHHHHHHHHHHHHHHTTEE-CSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEEC----CCCGGGCCHHHHHHCEE
T ss_pred HHHHHHHHHHHHhhHHhCCcc-cCCCcchhhcccccCcccccchhhhhhccccccccccccccCCCceecCchhhcCCCC
Confidence 789999999999999999987 9999999999999999999999999865433222 22234568889999999987665
Q ss_pred CCCCCccchHHHHHHHHHHHh-CCCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCchHHHHHHHHHhhhcCCCCCCCHHH
Q psy1840 104 PRGTQKGDVYSFGLVLYEVIG-RQGPWGHLRMTDEEIITSVTQGSGLRPDTSSLDCAPSIIACMRTCWEEDPELRPDLRF 182 (423)
Q Consensus 104 ~~~s~ksDVyS~Giil~ellt-g~~Pf~~~~~~~~~i~~~i~~~~~~~p~~~~~~~~~~l~~Li~~C~~~dP~~RPt~~~ 182 (423)
+.++|||||||++|||++ |+.||.+ .+..++...+..+.. +.. +..+++++.+||.+||+.||++|||+.+
T Consensus 188 ---~~~sDiwS~Gv~l~ellt~g~~Pf~~--~~~~~~~~~i~~~~~--~~~-p~~~~~~~~~li~~cl~~dp~~RPs~~~ 259 (277)
T d1xbba_ 188 ---SSKSDVWSFGVLMWEAFSYGQKPYRG--MKGSEVTAMLEKGER--MGC-PAGCPREMYDLMNLCWTYDVENRPGFAA 259 (277)
T ss_dssp ---EHHHHHHHHHHHHHHHHTTTCCSSTT--CCHHHHHHHHHTTCC--CCC-CTTCCHHHHHHHHHHTCSSTTTSCCHHH
T ss_pred ---CchhhhccchhhhhHHhhCCCCCCCC--CCHHHHHHHHHcCCC--CCC-CcccCHHHHHHHHHHcCCCHhHCcCHHH
Confidence 899999999999999997 8999974 456778888877542 222 2468999999999999999999999999
Q ss_pred HHHHHHHHh
Q psy1840 183 VHHKLKEMN 191 (423)
Q Consensus 183 I~~~L~~i~ 191 (423)
|.+.|+...
T Consensus 260 i~~~L~~~~ 268 (277)
T d1xbba_ 260 VELRLRNYY 268 (277)
T ss_dssp HHHHHHHHH
T ss_pred HHHHhhCHH
Confidence 988887653
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=99.98 E-value=4.7e-33 Score=265.31 Aligned_cols=159 Identities=25% Similarity=0.438 Sum_probs=130.5
Q ss_pred HHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCccEEEeccCCcccccCCCcccccccccCCccccCCccccCCCCC
Q psy1840 25 SISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKAPELLRQPHLP 104 (423)
Q Consensus 25 ~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~ 104 (423)
++.++.||+.||+|||++|++ ||||||+|||++.++.+||+|||+++........ ......|++.|+|||++.+..+
T Consensus 117 ~~~i~~qi~~gL~yLH~~~ii-HrDlKp~NILl~~~~~~Kl~DFG~a~~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~- 193 (287)
T d1opja_ 117 LLYMATQISSAMEYLEKKNFI-HRDLAARNCLVGENHLVKVADFGLSRLMTGDTYT-AHAGAKFPIKWTAPESLAYNKF- 193 (287)
T ss_dssp HHHHHHHHHHHHHHHHHTTCC-CSCCSGGGEEECGGGCEEECCCCCTTTCCSSSSE-EETTEEECGGGCCHHHHHHCCC-
T ss_pred HHHHHHHHHHHHHHHHHCCcc-cCccccCeEEECCCCcEEEccccceeecCCCCce-eeccccccccccChHHHcCCCC-
Confidence 688999999999999999998 9999999999999999999999999876443222 2234457888999999987765
Q ss_pred CCCCccchHHHHHHHHHHHhCCCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCchHHHHHHHHHhhhcCCCCCCCHHHHH
Q psy1840 105 RGTQKGDVYSFGLVLYEVIGRQGPWGHLRMTDEEIITSVTQGSGLRPDTSSLDCAPSIIACMRTCWEEDPELRPDLRFVH 184 (423)
Q Consensus 105 ~~s~ksDVyS~Giil~elltg~~Pf~~~~~~~~~i~~~i~~~~~~~p~~~~~~~~~~l~~Li~~C~~~dP~~RPt~~~I~ 184 (423)
+.++|||||||++|||++|..||.. ..+..++...+..+. ++.. +..+++++.+|+.+||+.||++|||+.+|+
T Consensus 194 --~~k~DiwS~Gv~l~ell~~~~p~~~-~~~~~~~~~~i~~~~--~~~~-~~~~~~~l~~li~~cl~~dP~~Rps~~ei~ 267 (287)
T d1opja_ 194 --SIKSDVWAFGVLLWEIATYGMSPYP-GIDLSQVYELLEKDY--RMER-PEGCPEKVYELMRACWQWNPSDRPSFAEIH 267 (287)
T ss_dssp --SHHHHHHHHHHHHHHHHTTSCCSST-TCCHHHHHHHHHTTC--CCCC-CTTCCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred --CchhhhhhHHHHHHHHHhCCCCCCC-cchHHHHHHHHhcCC--CCCC-CccchHHHHHHHHHHcCCCHhHCcCHHHHH
Confidence 8999999999999999997776543 345566666666542 2222 236899999999999999999999999999
Q ss_pred HHHHHHhh
Q psy1840 185 HKLKEMNA 192 (423)
Q Consensus 185 ~~L~~i~~ 192 (423)
+.|+.+..
T Consensus 268 ~~L~~~~~ 275 (287)
T d1opja_ 268 QAFETMFQ 275 (287)
T ss_dssp HHHHHTTS
T ss_pred HHHHHHHH
Confidence 99987754
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.98 E-value=9.9e-33 Score=259.74 Aligned_cols=149 Identities=22% Similarity=0.293 Sum_probs=128.4
Q ss_pred HHHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCccEEEeccCCcccccCCCcccccccccCCccccCCccccCCCC
Q psy1840 24 GSISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKAPELLRQPHL 103 (423)
Q Consensus 24 ~~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~ 103 (423)
....++.||+.||+|||++|++ ||||||+|||++.++.+||+|||+++...... .....||+.|+|||++.+..+
T Consensus 107 ~~~~i~~qi~~al~~lH~~~iv-HrDiKp~Nill~~~~~~kl~DFG~a~~~~~~~----~~~~~Gt~~Y~APE~~~~~~~ 181 (263)
T d2j4za1 107 RTATYITELANALSYCHSKRVI-HRDIKPENLLLGSAGELKIADFGWSVHAPSSR----RTTLCGTLDYLPPEMIEGRMH 181 (263)
T ss_dssp HHHHHHHHHHHHHHHHHHTTCC-CCCCCGGGEEECTTSCEEECCCCSCSCCCCCC----CEETTEEGGGCCHHHHTTCCC
T ss_pred HHHHHHHHHHHHHHHHHHCCee-eeeeccccceecCCCCEeecccceeeecCCCc----ccccCCCCcccCHHHHcCCCC
Confidence 3678999999999999999998 99999999999999999999999987654322 235679999999999998765
Q ss_pred CCCCCccchHHHHHHHHHHHhCCCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCchHHHHHHHHHhhhcCCCCCCCHHHH
Q psy1840 104 PRGTQKGDVYSFGLVLYEVIGRQGPWGHLRMTDEEIITSVTQGSGLRPDTSSLDCAPSIIACMRTCWEEDPELRPDLRFV 183 (423)
Q Consensus 104 ~~~s~ksDVyS~Giil~elltg~~Pf~~~~~~~~~i~~~i~~~~~~~p~~~~~~~~~~l~~Li~~C~~~dP~~RPt~~~I 183 (423)
+.++|||||||++|||++|+.||.. .+..++...+..+....| ..+++++.+++.+||+.||++|||+.++
T Consensus 182 ---~~~~DiwSlGvilyell~G~~Pf~~--~~~~~~~~~i~~~~~~~p----~~~s~~~~~li~~~L~~dp~~R~t~~ei 252 (263)
T d2j4za1 182 ---DEKVDLWSLGVLCYEFLVGKPPFEA--NTYQETYKRISRVEFTFP----DFVTEGARDLISRLLKHNPSQRPMLREV 252 (263)
T ss_dssp ---CTTHHHHHHHHHHHHHHHSSCTTCC--SSHHHHHHHHHTTCCCCC----TTSCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred ---CchhhhhhHhHHHHHHhcCCCCCCC--CCHHHHHHHHHcCCCCCC----ccCCHHHHHHHHHHccCCHhHCcCHHHH
Confidence 8999999999999999999999964 456778888877654433 3578999999999999999999999999
Q ss_pred HHH
Q psy1840 184 HHK 186 (423)
Q Consensus 184 ~~~ 186 (423)
++.
T Consensus 253 l~h 255 (263)
T d2j4za1 253 LEH 255 (263)
T ss_dssp HTC
T ss_pred HcC
Confidence 863
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.98 E-value=1.9e-32 Score=263.62 Aligned_cols=177 Identities=18% Similarity=0.257 Sum_probs=135.6
Q ss_pred HHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCccEEEeccCCcccccCCCcccccccccCCccccCCccccCCCCC
Q psy1840 25 SISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKAPELLRQPHLP 104 (423)
Q Consensus 25 ~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~ 104 (423)
...++.||+.||.|||++|++ ||||||+|||++.++.+||+|||++...... ....||+.|+|||++.+....
T Consensus 117 ~~~i~~qi~~aL~yLH~~~ii-HrDiKp~NILl~~~~~~Kl~DFG~a~~~~~~------~~~~GT~~Y~APE~~~~~~~~ 189 (309)
T d1u5ra_ 117 IAAVTHGALQGLAYLHSHNMI-HRDVKAGNILLSEPGLVKLGDFGSASIMAPA------NSFVGTPYWMAPEVILAMDEG 189 (309)
T ss_dssp HHHHHHHHHHHHHHHHHTTCB-CCCCSGGGEEEETTTEEEECCCTTCBSSSSB------CCCCSCGGGCCHHHHTTTTSC
T ss_pred HHHHHHHHHHHHHHHHhCCEe-ccCCCcceEEECCCCCEEEeecccccccCCC------CccccCccccCHHHHhccCCC
Confidence 679999999999999999998 9999999999999999999999998764321 345799999999999764433
Q ss_pred CCCCccchHHHHHHHHHHHhCCCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCchHHHHHHHHHhhhcCCCCCCCHHHHH
Q psy1840 105 RGTQKGDVYSFGLVLYEVIGRQGPWGHLRMTDEEIITSVTQGSGLRPDTSSLDCAPSIIACMRTCWEEDPELRPDLRFVH 184 (423)
Q Consensus 105 ~~s~ksDVyS~Giil~elltg~~Pf~~~~~~~~~i~~~i~~~~~~~p~~~~~~~~~~l~~Li~~C~~~dP~~RPt~~~I~ 184 (423)
.++.++|||||||++|||++|..||.+ .+..+.+..+..+... ......+++++.+|+.+||+.||++|||+.+++
T Consensus 190 ~y~~~~DiwSlGvilyel~~g~~Pf~~--~~~~~~~~~i~~~~~~--~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell 265 (309)
T d1u5ra_ 190 QYDGKVDVWSLGITCIELAERKPPLFN--MNAMSALYHIAQNESP--ALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLL 265 (309)
T ss_dssp CBCTHHHHHHHHHHHHHHHHSSCTTTT--SCHHHHHHHHHHSCCC--CCSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHT
T ss_pred CcCchhhhhhHHHHHHHHHHCCCCCCC--CCHHHHHHHHHhCCCC--CCCCCCCCHHHHHHHHHHCcCChhHCcCHHHHH
Confidence 458999999999999999999999974 3455666666654332 223346899999999999999999999999998
Q ss_pred HHHHHHhhhcCCChHHHHHHHHHHhhhcc
Q psy1840 185 HKLKEMNAGLKANIFDNMLAIMEKYAFNL 213 (423)
Q Consensus 185 ~~L~~i~~~~~~~~~d~~~~~~e~~~~~l 213 (423)
+.-. +...........+.........++
T Consensus 266 ~Hp~-~~~~~~~~~~~~~~~~~~~~~~~~ 293 (309)
T d1u5ra_ 266 KHRF-VLRERPPTVIMDLIQRTKDAVREL 293 (309)
T ss_dssp TCHH-HHSCCCTTHHHHHHHHHHHHHHHS
T ss_pred hCHH-hcCCCCchhhHHHHHHHHHHHHhh
Confidence 7422 222233334444444443333333
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.98 E-value=4.5e-33 Score=269.10 Aligned_cols=159 Identities=21% Similarity=0.390 Sum_probs=129.0
Q ss_pred HHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCccEEEeccCCcccccCCCcccccccccCCccccCCccccCCCCC
Q psy1840 25 SISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKAPELLRQPHLP 104 (423)
Q Consensus 25 ~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~ 104 (423)
++.++.||+.||.|||+++++ ||||||+|||++.++.+||+|||+++...............||+.|+|||.+.++.+
T Consensus 113 ~~~i~~qi~~gl~yLH~~~ii-HrDlKp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~- 190 (317)
T d1xkka_ 113 LLNWCVQIAKGMNYLEDRRLV-HRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIY- 190 (317)
T ss_dssp HHHHHHHHHHHHHHHHHTTCC-CSCCCGGGEEEEETTEEEECCCSHHHHTTTTCC--------CCTTTSCHHHHHHCCC-
T ss_pred HHHHHHHHHHHHHHHHHcCcc-cCcchhhcceeCCCCCeEeeccccceecccccccccccccccCccccChHHHhcCCC-
Confidence 689999999999999999998 999999999999999999999999987654433333344568999999999988765
Q ss_pred CCCCccchHHHHHHHHHHHh-CCCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCchHHHHHHHHHhhhcCCCCCCCHHHH
Q psy1840 105 RGTQKGDVYSFGLVLYEVIG-RQGPWGHLRMTDEEIITSVTQGSGLRPDTSSLDCAPSIIACMRTCWEEDPELRPDLRFV 183 (423)
Q Consensus 105 ~~s~ksDVyS~Giil~ellt-g~~Pf~~~~~~~~~i~~~i~~~~~~~p~~~~~~~~~~l~~Li~~C~~~dP~~RPt~~~I 183 (423)
+.++|||||||++|||+| |..||.+ .+..++...+..+.. +.. +..+++++.+|+.+||+.||++|||+.+|
T Consensus 191 --~~~sDvwS~Gvil~el~t~g~~p~~~--~~~~~~~~~i~~~~~--~~~-p~~~~~~~~~li~~cl~~dP~~RPs~~ei 263 (317)
T d1xkka_ 191 --THQSDVWSYGVTVWELMTFGSKPYDG--IPASEISSILEKGER--LPQ-PPICTIDVYMIMVKCWMIDADSRPKFREL 263 (317)
T ss_dssp --CHHHHHHHHHHHHHHHHTTSCCTTTT--SCGGGHHHHHHHTCC--CCC-CTTBCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred --ChhhhhhhHHHHHHHHHHCCCCCCCC--CCHHHHHHHHHcCCC--CCC-CcccCHHHHHHHHHhCCCChhhCcCHHHH
Confidence 899999999999999998 7888874 345566677766542 222 23689999999999999999999999999
Q ss_pred HHHHHHHhh
Q psy1840 184 HHKLKEMNA 192 (423)
Q Consensus 184 ~~~L~~i~~ 192 (423)
++.|..+..
T Consensus 264 l~~l~~~~~ 272 (317)
T d1xkka_ 264 IIEFSKMAR 272 (317)
T ss_dssp HHHHHHHHH
T ss_pred HHHHHHHHh
Confidence 998877643
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.98 E-value=9.7e-33 Score=259.08 Aligned_cols=155 Identities=21% Similarity=0.473 Sum_probs=131.4
Q ss_pred HHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCccEEEeccCCcccccCCCcccccccccCCccccCCccccCCCCC
Q psy1840 25 SISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKAPELLRQPHLP 104 (423)
Q Consensus 25 ~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~ 104 (423)
+++++.||++||+|||++|++ ||||||+||+++.++.+||+|||+++....... .......+|+.|+|||.+.+..+
T Consensus 102 ~~~i~~qi~~gl~~LH~~~ii-H~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~- 178 (258)
T d1k2pa_ 102 LLEMCKDVCEAMEYLESKQFL-HRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEY-TSSVGSKFPVRWSPPEVLMYSKF- 178 (258)
T ss_dssp HHHHHHHHHHHHHHHHHTTBC-CSCCSGGGEEECTTCCEEECCCSSCCBCSSSSC-CCCCCSCCCGGGCCHHHHHHCCC-
T ss_pred HHHHHHHHHHHHHHHhhcCcc-cccccceeEEEcCCCcEEECcchhheeccCCCc-eeecccCCCCCcCCcHHhcCCCC-
Confidence 689999999999999999988 999999999999999999999999976543322 22334578899999999987765
Q ss_pred CCCCccchHHHHHHHHHHHh-CCCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCchHHHHHHHHHhhhcCCCCCCCHHHH
Q psy1840 105 RGTQKGDVYSFGLVLYEVIG-RQGPWGHLRMTDEEIITSVTQGSGLRPDTSSLDCAPSIIACMRTCWEEDPELRPDLRFV 183 (423)
Q Consensus 105 ~~s~ksDVyS~Giil~ellt-g~~Pf~~~~~~~~~i~~~i~~~~~~~p~~~~~~~~~~l~~Li~~C~~~dP~~RPt~~~I 183 (423)
+.++|||||||++|||+| |+.||.. .+..++...+..+... .. +..+++++.++|.+||+.||++|||+.+|
T Consensus 179 --~~ksDiwS~G~~l~el~t~g~~Pf~~--~~~~~~~~~i~~~~~~--~~-p~~~~~~l~~li~~cl~~dP~~RPt~~ei 251 (258)
T d1k2pa_ 179 --SSKSDIWAFGVLMWEIYSLGKMPYER--FTNSETAEHIAQGLRL--YR-PHLASEKVYTIMYSCWHEKADERPTFKIL 251 (258)
T ss_dssp --CHHHHHHHHHHHHHHHHTTSCCTTTT--SCHHHHHHHHHTTCCC--CC-CTTCCHHHHHHHHHTTCSSGGGSCCHHHH
T ss_pred --CcceeecccchhhHhHHhcCCCCCCC--CCHHHHHHHHHhCCCC--CC-cccccHHHHHHHHHHccCCHhHCcCHHHH
Confidence 899999999999999998 7889974 5678888888775432 22 24688999999999999999999999999
Q ss_pred HHHHHH
Q psy1840 184 HHKLKE 189 (423)
Q Consensus 184 ~~~L~~ 189 (423)
++.|.+
T Consensus 252 l~~L~d 257 (258)
T d1k2pa_ 252 LSNILD 257 (258)
T ss_dssp HHHHHC
T ss_pred HHHhhC
Confidence 998754
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=6.8e-33 Score=261.95 Aligned_cols=155 Identities=23% Similarity=0.313 Sum_probs=124.0
Q ss_pred HHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCccEEEeccCCcccccCCCcccccccccCCccccCCccccCCCCC
Q psy1840 25 SISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKAPELLRQPHLP 104 (423)
Q Consensus 25 ~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~ 104 (423)
...++.||+.||+|||++|++ ||||||+|||++.++.+||+|||+++...............||+.|+|||++.+..+
T Consensus 105 ~~~i~~qi~~al~ylH~~~Ii-HrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~- 182 (271)
T d1nvra_ 105 AQRFFHQLMAGVVYLHGIGIT-HRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREF- 182 (271)
T ss_dssp HHHHHHHHHHHHHHHHHTTEE-CSCCCGGGEEECTTCCEEECCCTTCEECEETTEECCBCCCCSCGGGSCTHHHHCSSB-
T ss_pred HHHHHHHHHHHHHHHHHcCCc-cCcccHHHEEECCCCCEEEccchhheeeccCCccccccceeeCcCccCHhHhcCCCC-
Confidence 578999999999999999988 999999999999999999999999987654433333456789999999999987653
Q ss_pred CCCCccchHHHHHHHHHHHhCCCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCchHHHHHHHHHhhhcCCCCCCCHHHHH
Q psy1840 105 RGTQKGDVYSFGLVLYEVIGRQGPWGHLRMTDEEIITSVTQGSGLRPDTSSLDCAPSIIACMRTCWEEDPELRPDLRFVH 184 (423)
Q Consensus 105 ~~s~ksDVyS~Giil~elltg~~Pf~~~~~~~~~i~~~i~~~~~~~p~~~~~~~~~~l~~Li~~C~~~dP~~RPt~~~I~ 184 (423)
++.++||||+||++|||++|+.||........... .........+ ....+++++.+|+.+||+.||++|||+.+++
T Consensus 183 -~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~-~~~~~~~~~~--~~~~~s~~~~~li~~~L~~dP~~R~t~~eil 258 (271)
T d1nvra_ 183 -HAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYS-DWKEKKTYLN--PWKKIDSAPLALLHKILVENPSARITIPDIK 258 (271)
T ss_dssp -CHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHH-HHHTTCTTST--TGGGSCHHHHHHHHHHSCSSTTTSCCHHHHT
T ss_pred -CCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHH-HHhcCCCCCC--ccccCCHHHHHHHHHHcCCChhHCcCHHHHh
Confidence 36789999999999999999999975443333332 2222222211 1235789999999999999999999999986
Q ss_pred H
Q psy1840 185 H 185 (423)
Q Consensus 185 ~ 185 (423)
+
T Consensus 259 ~ 259 (271)
T d1nvra_ 259 K 259 (271)
T ss_dssp T
T ss_pred c
Confidence 5
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=1.1e-32 Score=260.88 Aligned_cols=159 Identities=22% Similarity=0.448 Sum_probs=122.6
Q ss_pred HHHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCccEEEeccCCcccccCCCcccccccccCCccccCCccccCCCC
Q psy1840 24 GSISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKAPELLRQPHL 103 (423)
Q Consensus 24 ~~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~ 103 (423)
..+.++.||+.||.|||+++++ ||||||+||+++.++.+||+|||+++....... .......||+.|+|||.+.+..+
T Consensus 109 ~~~~~~~qi~~gl~ylH~~~ii-HrDlKp~NIll~~~~~~Kl~DfG~a~~~~~~~~-~~~~~~~gt~~y~apE~l~~~~~ 186 (273)
T d1mp8a_ 109 SLILYAYQLSTALAYLESKRFV-HRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTY-YKASKGKLPIKWMAPESINFRRF 186 (273)
T ss_dssp HHHHHHHHHHHHHHHHHHTTCC-CSCCSGGGEEEEETTEEEECC--------------------CCGGGCCHHHHHHCCC
T ss_pred HHHHHHHHHHHHhhhhcccCee-ccccchhheeecCCCcEEEccchhheeccCCcc-eeccceecCcccchhhHhccCCC
Confidence 3689999999999999999998 999999999999999999999999986543322 22244567889999999987665
Q ss_pred CCCCCccchHHHHHHHHHHHh-CCCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCchHHHHHHHHHhhhcCCCCCCCHHH
Q psy1840 104 PRGTQKGDVYSFGLVLYEVIG-RQGPWGHLRMTDEEIITSVTQGSGLRPDTSSLDCAPSIIACMRTCWEEDPELRPDLRF 182 (423)
Q Consensus 104 ~~~s~ksDVyS~Giil~ellt-g~~Pf~~~~~~~~~i~~~i~~~~~~~p~~~~~~~~~~l~~Li~~C~~~dP~~RPt~~~ 182 (423)
+.++|||||||++|||++ |..||.. .+..++...+..+... +. +..+++++.+||.+||+.||++|||+.+
T Consensus 187 ---~~~~DiwSlGvil~e~lt~g~~P~~~--~~~~~~~~~i~~~~~~--~~-~~~~~~~~~~li~~cl~~dp~~Rps~~e 258 (273)
T d1mp8a_ 187 ---TSASDVWMFGVCMWEILMHGVKPFQG--VKNNDVIGRIENGERL--PM-PPNCPPTLYSLMTKCWAYDPSRRPRFTE 258 (273)
T ss_dssp ---SHHHHHHHHHHHHHHHHTTSCCTTTT--CCGGGHHHHHHTTCCC--CC-CTTCCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred ---CCccccccchHHHHHHHhcCCCCCCC--CCHHHHHHHHHcCCCC--CC-CCCCCHHHHHHHHHHcCCCHhHCcCHHH
Confidence 899999999999999998 7889874 4556777777765432 22 3368999999999999999999999999
Q ss_pred HHHHHHHHhh
Q psy1840 183 VHHKLKEMNA 192 (423)
Q Consensus 183 I~~~L~~i~~ 192 (423)
|++.|+.+..
T Consensus 259 i~~~L~~i~~ 268 (273)
T d1mp8a_ 259 LKAQLSTILE 268 (273)
T ss_dssp HHHHHHHHHH
T ss_pred HHHHHHHHHH
Confidence 9999987754
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=2.7e-32 Score=260.58 Aligned_cols=153 Identities=17% Similarity=0.284 Sum_probs=125.0
Q ss_pred HHHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCccEEEeccCCcccccCCCcccccccccCCccccCCccccCCCC
Q psy1840 24 GSISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKAPELLRQPHL 103 (423)
Q Consensus 24 ~~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~ 103 (423)
....++.||+.||.|||++|++ ||||||+|||++.++.+||+|||+++....... ......||+.|+|||++.+..+
T Consensus 117 ~~~~i~~qi~~aL~yLH~~~ii-HrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~~--~~~~~~gt~~Y~aPE~~~~~~~ 193 (293)
T d1yhwa1 117 QIAAVCRECLQALEFLHSNQVI-HRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS--KRSTMVGTPYWMAPEVVTRKAY 193 (293)
T ss_dssp HHHHHHHHHHHHHHHHHHTTEE-CCCCSGGGEEECTTCCEEECCCTTCEECCSTTC--CBCCCCSCGGGCCHHHHSSSCB
T ss_pred HHHHHHHHHHHHHHHHHHCCCc-ccCCcHHHeEECCCCcEeeccchhheeeccccc--cccccccCCCccChhhhcCCCC
Confidence 3678999999999999999988 999999999999999999999999987643322 2245679999999999988765
Q ss_pred CCCCCccchHHHHHHHHHHHhCCCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCchHHHHHHHHHhhhcCCCCCCCHHHH
Q psy1840 104 PRGTQKGDVYSFGLVLYEVIGRQGPWGHLRMTDEEIITSVTQGSGLRPDTSSLDCAPSIIACMRTCWEEDPELRPDLRFV 183 (423)
Q Consensus 104 ~~~s~ksDVyS~Giil~elltg~~Pf~~~~~~~~~i~~~i~~~~~~~p~~~~~~~~~~l~~Li~~C~~~dP~~RPt~~~I 183 (423)
+.++|||||||++|||++|+.||.+ .+..+.+..+......... .+..+++++.++|.+||+.||++|||+.++
T Consensus 194 ---~~~~DiwSlGvilyemltG~~Pf~~--~~~~~~~~~~~~~~~~~~~-~~~~~s~~~~~li~~~L~~dP~~R~s~~ei 267 (293)
T d1yhwa1 194 ---GPKVDIWSLGIMAIEMIEGEPPYLN--ENPLRALYLIATNGTPELQ-NPEKLSAIFRDFLNRCLDMDVEKRGSAKEL 267 (293)
T ss_dssp ---CTHHHHHHHHHHHHHHHHSSCTTTT--SCHHHHHHHHHHHCSCCCS-SGGGSCHHHHHHHHHHTCSSTTTSCCHHHH
T ss_pred ---CchhceehHhHHHHHHhhCCCCCCC--CCHHHHHHHHHhCCCCCCC-CcccCCHHHHHHHHHHccCChhHCcCHHHH
Confidence 8999999999999999999999974 3344445444433222222 224678999999999999999999999998
Q ss_pred HH
Q psy1840 184 HH 185 (423)
Q Consensus 184 ~~ 185 (423)
++
T Consensus 268 l~ 269 (293)
T d1yhwa1 268 LQ 269 (293)
T ss_dssp TT
T ss_pred hc
Confidence 75
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=2.5e-32 Score=258.32 Aligned_cols=158 Identities=26% Similarity=0.452 Sum_probs=129.3
Q ss_pred HHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCccEEEeccCCcccccCCCccc-ccccccCCccccCCccccCCCC
Q psy1840 25 SISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETG-QERKLRRRKLYKAPELLRQPHL 103 (423)
Q Consensus 25 ~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~~~-~~~~~~gt~~y~APE~l~~~~~ 103 (423)
++.++.||+.||.|||+++++ ||||||+||+++.++.+||+|||+++......... ......++..|+|||.+.+..+
T Consensus 113 ~~~~~~qi~~gl~ylH~~~ii-HrDikp~NIll~~~~~vkl~DfGl~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~ 191 (273)
T d1u46a_ 113 LSRYAVQVAEGMGYLESKRFI-HRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTF 191 (273)
T ss_dssp HHHHHHHHHHHHHHHHHTTEE-CSCCCGGGEEEEETTEEEECCCTTCEECCC-CCEEEC-----CCGGGCCHHHHHHCEE
T ss_pred HHHHHHHHHHHHHHhhhCCEe-eeeecHHHhccccccceeeccchhhhhcccCCCcceecCccccCcccCCHHHHhCCCC
Confidence 689999999999999999987 99999999999999999999999998764433222 2234457778999999988765
Q ss_pred CCCCCccchHHHHHHHHHHHh-CCCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCchHHHHHHHHHhhhcCCCCCCCHHH
Q psy1840 104 PRGTQKGDVYSFGLVLYEVIG-RQGPWGHLRMTDEEIITSVTQGSGLRPDTSSLDCAPSIIACMRTCWEEDPELRPDLRF 182 (423)
Q Consensus 104 ~~~s~ksDVyS~Giil~ellt-g~~Pf~~~~~~~~~i~~~i~~~~~~~p~~~~~~~~~~l~~Li~~C~~~dP~~RPt~~~ 182 (423)
+.++|||||||++|||++ |..||. ..+..++...+..... +++. ...+++++.+|+.+||+.||++|||+.+
T Consensus 192 ---~~~~Di~S~Gvil~emlt~G~~Pf~--~~~~~~~~~~i~~~~~-~~~~-~~~~~~~l~~li~~cl~~dp~~RPt~~e 264 (273)
T d1u46a_ 192 ---SHASDTWMFGVTLWEMFTYGQEPWI--GLNGSQILHKIDKEGE-RLPR-PEDCPQDIYNVMVQCWAHKPEDRPTFVA 264 (273)
T ss_dssp ---EHHHHHHHHHHHHHHHHTTSCCTTT--TCCHHHHHHHHHTSCC-CCCC-CTTCCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred ---CcchhhhhhHHHHHHHHhCCCCCCC--CcCHHHHHHHHHhCCC-CCCC-cccccHHHHHHHHHHcCCChhHCcCHHH
Confidence 899999999999999998 899997 4566777777765432 3322 2468899999999999999999999999
Q ss_pred HHHHHHHH
Q psy1840 183 VHHKLKEM 190 (423)
Q Consensus 183 I~~~L~~i 190 (423)
|.+.|++.
T Consensus 265 i~~~L~~~ 272 (273)
T d1u46a_ 265 LRDFLLEA 272 (273)
T ss_dssp HHHHHHHH
T ss_pred HHHHHHhc
Confidence 99988765
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=1.6e-32 Score=259.21 Aligned_cols=150 Identities=18% Similarity=0.359 Sum_probs=118.1
Q ss_pred HHHHHHHHHHHHHHHHhCC-----CeeecCCCCCCEEEcCCccEEEeccCCcccccCCCcccccccccCCccccCCcccc
Q psy1840 25 SISVNTTASVGMIHLHDSE-----IISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKAPELLR 99 (423)
Q Consensus 25 ~l~i~~qi~~gL~yLH~~~-----ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~ 99 (423)
...++.||+.||.|||+.+ ++ ||||||+|||++.++.+||+|||+++....... ......||+.|+|||++.
T Consensus 111 ~~~i~~qi~~al~ylH~~~~~~~~Ii-HrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~~--~~~~~~gt~~Y~APE~l~ 187 (269)
T d2java1 111 VLRVMTQLTLALKECHRRSDGGHTVL-HRDLKPANVFLDGKQNVKLGDFGLARILNHDTS--FAKAFVGTPYYMSPEQMN 187 (269)
T ss_dssp HHHHHHHHHHHHHHHHHHCC----------CCGGGEEECTTSCEEECCHHHHHHC-------------CCCSCCCHHHHT
T ss_pred HHHHHHHHHHHHHHHHHhcCCCCCEE-eCcCchhhcCcCCCCcEEEeeccceeecccCCC--ccccCCCCcccCCHHHHc
Confidence 6789999999999999876 66 999999999999999999999999987543221 224567899999999998
Q ss_pred CCCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCchHHHHHHHHHhhhcCCCCCCC
Q psy1840 100 QPHLPRGTQKGDVYSFGLVLYEVIGRQGPWGHLRMTDEEIITSVTQGSGLRPDTSSLDCAPSIIACMRTCWEEDPELRPD 179 (423)
Q Consensus 100 ~~~~~~~s~ksDVyS~Giil~elltg~~Pf~~~~~~~~~i~~~i~~~~~~~p~~~~~~~~~~l~~Li~~C~~~dP~~RPt 179 (423)
+..+ +.++|||||||++|||++|+.||.. .+..++...+..+.... .+..+++++.+|+.+||+.||.+|||
T Consensus 188 ~~~~---~~~~DIwSlGvilyel~tg~~Pf~~--~~~~~~~~~i~~~~~~~---~~~~~s~~l~~li~~~L~~dp~~Rps 259 (269)
T d2java1 188 RMSY---NEKSDIWSLGCLLYELCALMPPFTA--FSQKELAGKIREGKFRR---IPYRYSDELNEIITRMLNLKDYHRPS 259 (269)
T ss_dssp TCCC---CHHHHHHHHHHHHHHHHHSSCSCCC--SSHHHHHHHHHHTCCCC---CCTTSCHHHHHHHHHHTCSSGGGSCC
T ss_pred CCCC---ChHHHHHhhCHHHHHHhhCCCCCCC--CCHHHHHHHHHcCCCCC---CCcccCHHHHHHHHHHcCCChhHCcC
Confidence 7665 8999999999999999999999974 56677888887764332 22368899999999999999999999
Q ss_pred HHHHHH
Q psy1840 180 LRFVHH 185 (423)
Q Consensus 180 ~~~I~~ 185 (423)
+.++++
T Consensus 260 ~~ell~ 265 (269)
T d2java1 260 VEEILE 265 (269)
T ss_dssp HHHHHT
T ss_pred HHHHHh
Confidence 999875
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=8.8e-32 Score=257.87 Aligned_cols=160 Identities=29% Similarity=0.465 Sum_probs=135.3
Q ss_pred HHHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCccEEEeccCCcccccCCCcccccccccCCccccCCccccCCCC
Q psy1840 24 GSISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKAPELLRQPHL 103 (423)
Q Consensus 24 ~~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~ 103 (423)
..+.++.||+.||+|||+.+++ ||||||+|||++.++.+||+|||+++...............+++.|+|||.+.++.+
T Consensus 136 ~~~~~~~qi~~al~ylH~~~iv-HrDiKp~NiLl~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y 214 (299)
T d1fgka_ 136 DLVSCAYQVARGMEYLASKKCI-HRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIY 214 (299)
T ss_dssp HHHHHHHHHHHHHHHHHHTTCC-CSCCSGGGEEECTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCC
T ss_pred HHHHHHHHHHHHHHHhhhCCEE-eeeecccceeecCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCC
Confidence 4789999999999999999998 999999999999999999999999987655444444455678889999999987765
Q ss_pred CCCCCccchHHHHHHHHHHHh-CCCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCchHHHHHHHHHhhhcCCCCCCCHHH
Q psy1840 104 PRGTQKGDVYSFGLVLYEVIG-RQGPWGHLRMTDEEIITSVTQGSGLRPDTSSLDCAPSIIACMRTCWEEDPELRPDLRF 182 (423)
Q Consensus 104 ~~~s~ksDVyS~Giil~ellt-g~~Pf~~~~~~~~~i~~~i~~~~~~~p~~~~~~~~~~l~~Li~~C~~~dP~~RPt~~~ 182 (423)
+.++|||||||++|||++ |..||.+ .+..++...+..+. ++.. +..+++++.+|+.+||+.||++|||+.+
T Consensus 215 ---~~k~DiwS~Gvvl~ell~~g~~p~~~--~~~~~~~~~i~~~~--~~~~-p~~~~~~l~~li~~cl~~dP~~Rps~~e 286 (299)
T d1fgka_ 215 ---THQSDVWSFGVLLWEIFTLGGSPYPG--VPVEELFKLLKEGH--RMDK-PSNCTNELYMMMRDCWHAVPSQRPTFKQ 286 (299)
T ss_dssp ---CHHHHHHHHHHHHHHHHTTSCCSSTT--CCHHHHHHHHHTTC--CCCC-CSSCCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred ---CchhhhHHhHHHHHHhccCCCCCCCC--CCHHHHHHHHHcCC--CCCC-CccchHHHHHHHHHHccCCHhHCcCHHH
Confidence 999999999999999998 6888863 45667777777653 2322 2468899999999999999999999999
Q ss_pred HHHHHHHHhh
Q psy1840 183 VHHKLKEMNA 192 (423)
Q Consensus 183 I~~~L~~i~~ 192 (423)
|++.|+++.+
T Consensus 287 il~~L~~i~a 296 (299)
T d1fgka_ 287 LVEDLDRIVA 296 (299)
T ss_dssp HHHHHHHHHH
T ss_pred HHHHHHHHhh
Confidence 9999988754
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=1e-31 Score=253.73 Aligned_cols=149 Identities=22% Similarity=0.375 Sum_probs=122.5
Q ss_pred HHHHHHHHHHHHHHHHhCC--CeeecCCCCCCEEEc-CCccEEEeccCCcccccCCCcccccccccCCccccCCccccCC
Q psy1840 25 SISVNTTASVGMIHLHDSE--IISHGNLRSSNCLID-SRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKAPELLRQP 101 (423)
Q Consensus 25 ~l~i~~qi~~gL~yLH~~~--ii~HrDLkp~NILld-~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~ 101 (423)
...++.||+.||+|||+++ ++ ||||||+|||++ .++.+||+|||+++..... ......||+.|+|||++.+.
T Consensus 114 ~~~~~~qi~~gl~yLH~~~~~Ii-HrDiKp~NILl~~~~~~~Kl~DFGla~~~~~~----~~~~~~GT~~Y~aPE~~~~~ 188 (270)
T d1t4ha_ 114 LRSWCRQILKGLQFLHTRTPPII-HRDLKCDNIFITGPTGSVKIGDLGLATLKRAS----FAKAVIGTPEFMAPEMYEEK 188 (270)
T ss_dssp HHHHHHHHHHHHHHHHTSSSCCC-CSCCCGGGEEESSTTSCEEECCTTGGGGCCTT----SBEESCSSCCCCCGGGGGTC
T ss_pred HHHHHHHHHHHHHHHHHCCCCEE-eCCcChhhceeeCCCCCEEEeecCcceeccCC----ccCCcccCccccCHHHhCCC
Confidence 5789999999999999998 77 999999999996 5789999999999764322 22456899999999998763
Q ss_pred CCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCchHHHHHHHHHhhhcCCCCCCCHH
Q psy1840 102 HLPRGTQKGDVYSFGLVLYEVIGRQGPWGHLRMTDEEIITSVTQGSGLRPDTSSLDCAPSIIACMRTCWEEDPELRPDLR 181 (423)
Q Consensus 102 ~~~~~s~ksDVyS~Giil~elltg~~Pf~~~~~~~~~i~~~i~~~~~~~p~~~~~~~~~~l~~Li~~C~~~dP~~RPt~~ 181 (423)
++.++|||||||++|||++|+.||.+. ....++...+..+. .|......+++++.+++.+||+.||++|||+.
T Consensus 189 ----~~~~~DIwSlGvilyel~~g~~Pf~~~-~~~~~~~~~i~~~~--~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~ 261 (270)
T d1t4ha_ 189 ----YDESVDVYAFGMCMLEMATSEYPYSEC-QNAAQIYRRVTSGV--KPASFDKVAIPEVKEIIEGCIRQNKDERYSIK 261 (270)
T ss_dssp ----CCTHHHHHHHHHHHHHHHHSSCTTTTC-SSHHHHHHHHTTTC--CCGGGGGCCCHHHHHHHHHHSCSSGGGSCCHH
T ss_pred ----CCCcCchhhHHHHHHHHHHCCCCCCCc-ccHHHHHHHHHcCC--CCcccCccCCHHHHHHHHHHccCCHhHCcCHH
Confidence 389999999999999999999999743 34556666666543 23223345788999999999999999999999
Q ss_pred HHHH
Q psy1840 182 FVHH 185 (423)
Q Consensus 182 ~I~~ 185 (423)
++++
T Consensus 262 ell~ 265 (270)
T d1t4ha_ 262 DLLN 265 (270)
T ss_dssp HHHT
T ss_pred HHhC
Confidence 9875
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=3.2e-32 Score=259.53 Aligned_cols=156 Identities=19% Similarity=0.255 Sum_probs=125.5
Q ss_pred HHHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCccEEEeccCCcccccCCCcccccccccCCccccCCccccCCC-
Q psy1840 24 GSISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKAPELLRQPH- 102 (423)
Q Consensus 24 ~~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~- 102 (423)
....++.||+.||.|||++|++ ||||||+|||++.++.+||+|||+++...... .......||+.|+|||++....
T Consensus 111 ~~~~i~~qi~~gL~ylH~~~iv-HrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~--~~~~~~~Gt~~y~APE~l~~~~~ 187 (288)
T d2jfla1 111 QIQVVCKQTLDALNYLHDNKII-HRDLKAGNILFTLDGDIKLADFGVSAKNTRTI--QRRDSFIGTPYWMAPEVVMCETS 187 (288)
T ss_dssp HHHHHHHHHHHHHHHHHHTTEE-CCCCSGGGEEECTTSCEEECCCTTCEECHHHH--HHHTCCCSCCTTCCHHHHTTCST
T ss_pred HHHHHHHHHHHHHHHHHHCCEE-EeecChhheeECCCCCEEEEechhhhccCCCc--ccccccccccccCCHHHHhhccc
Confidence 3678999999999999999988 99999999999999999999999987543211 1224567999999999986432
Q ss_pred -CCCCCCccchHHHHHHHHHHHhCCCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCchHHHHHHHHHhhhcCCCCCCCHH
Q psy1840 103 -LPRGTQKGDVYSFGLVLYEVIGRQGPWGHLRMTDEEIITSVTQGSGLRPDTSSLDCAPSIIACMRTCWEEDPELRPDLR 181 (423)
Q Consensus 103 -~~~~s~ksDVyS~Giil~elltg~~Pf~~~~~~~~~i~~~i~~~~~~~p~~~~~~~~~~l~~Li~~C~~~dP~~RPt~~ 181 (423)
...++.++|||||||++|||++|+.||.+. +..++...+..+....... +..+++++.+|+.+||+.||++|||+.
T Consensus 188 ~~~~y~~k~DiwSlGvilyemltg~~Pf~~~--~~~~~~~~i~~~~~~~~~~-~~~~s~~~~~li~~~L~~dp~~R~t~~ 264 (288)
T d2jfla1 188 KDRPYDYKADVWSLGITLIEMAEIEPPHHEL--NPMRVLLKIAKSEPPTLAQ-PSRWSSNFKDFLKKCLEKNVDARWTTS 264 (288)
T ss_dssp TTSSTTTHHHHHHHHHHHHHHHHSSCTTTTS--CGGGHHHHHHHSCCCCCSS-GGGSCHHHHHHHHHHSCSSTTTSCCHH
T ss_pred CCCCCChhhhHHHHHHHHHHHhhCCCCCCCC--CHHHHHHHHHcCCCCCCCc-cccCCHHHHHHHHHHccCChhHCcCHH
Confidence 123489999999999999999999999743 4556666666654333222 236789999999999999999999999
Q ss_pred HHHH
Q psy1840 182 FVHH 185 (423)
Q Consensus 182 ~I~~ 185 (423)
++++
T Consensus 265 ell~ 268 (288)
T d2jfla1 265 QLLQ 268 (288)
T ss_dssp HHTT
T ss_pred HHhc
Confidence 9876
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=3.7e-32 Score=259.12 Aligned_cols=151 Identities=18% Similarity=0.265 Sum_probs=125.0
Q ss_pred HHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCccEEEeccCCcccccCCCcccccccccCCccccCCccccCCCCC
Q psy1840 25 SISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKAPELLRQPHLP 104 (423)
Q Consensus 25 ~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~ 104 (423)
...++.|++.||+|||+.|++ ||||||+|||++.++.+||+|||+++...............||+.|+|||++.+..+
T Consensus 110 ~~~~~~qi~~al~ylH~~~ii-HrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~- 187 (288)
T d1uu3a_ 110 TRFYTAEIVSALEYLHGKGII-HRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSA- 187 (288)
T ss_dssp HHHHHHHHHHHHHHHHHTTEE-CSCCSGGGEEECTTSCEEECCCTTCEECC----------CCCCGGGCCHHHHHTCCC-
T ss_pred HHHHHHHHHHHHHhhccccEE-cCcCCccccccCCCceEEecccccceecccCCcccccccccCCccccCceeeccCCC-
Confidence 578999999999999999998 999999999999999999999999987654433333455679999999999988765
Q ss_pred CCCCccchHHHHHHHHHHHhCCCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCchHHHHHHHHHhhhcCCCCCCCHHHHH
Q psy1840 105 RGTQKGDVYSFGLVLYEVIGRQGPWGHLRMTDEEIITSVTQGSGLRPDTSSLDCAPSIIACMRTCWEEDPELRPDLRFVH 184 (423)
Q Consensus 105 ~~s~ksDVyS~Giil~elltg~~Pf~~~~~~~~~i~~~i~~~~~~~p~~~~~~~~~~l~~Li~~C~~~dP~~RPt~~~I~ 184 (423)
+.++|||||||++|||++|+.||.. .+..++...+..+....| ..+++++.+||.+||+.||++|||+.++.
T Consensus 188 --~~~~DiwSlGvilyell~g~~Pf~~--~~~~~~~~~i~~~~~~~p----~~~s~~~~~li~~~L~~dP~~R~t~~e~~ 259 (288)
T d1uu3a_ 188 --CKSSDLWALGCIIYQLVAGLPPFRA--GNEYLIFQKIIKLEYDFP----EKFFPKARDLVEKLLVLDATKRLGCEEME 259 (288)
T ss_dssp --CHHHHHHHHHHHHHHHHHSSCSSCC--SSHHHHHHHHHTTCCCCC----TTCCHHHHHHHHTTSCSSGGGSTTSGGGT
T ss_pred --CcccceehhhHHHHHHhhCCCCCCC--cCHHHHHHHHHcCCCCCC----ccCCHHHHHHHHHHccCCHhHCcCHHHHc
Confidence 8999999999999999999999974 456777788877654333 35789999999999999999999999875
Q ss_pred H
Q psy1840 185 H 185 (423)
Q Consensus 185 ~ 185 (423)
.
T Consensus 260 ~ 260 (288)
T d1uu3a_ 260 G 260 (288)
T ss_dssp C
T ss_pred C
Confidence 4
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=9.6e-32 Score=255.84 Aligned_cols=161 Identities=25% Similarity=0.441 Sum_probs=126.5
Q ss_pred HHHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCccEEEeccCCcccccCCCcccccccccCCccccCCccccCCCC
Q psy1840 24 GSISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKAPELLRQPHL 103 (423)
Q Consensus 24 ~~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~ 103 (423)
.++.++.||+.||+|||+++++ ||||||+|||||.++++||+|||+++....... .......+|+.|+|||.+..+.+
T Consensus 114 ~~~~i~~~i~~gl~~LH~~~iv-H~DlKp~NIll~~~~~~kl~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~ 191 (285)
T d1fmka3 114 QLVDMAAQIASGMAYVERMNYV-HRDLRAANILVGENLVCKVADFGLARLIEDNEY-TARQGAKFPIKWTAPEAALYGRF 191 (285)
T ss_dssp HHHHHHHHHHHHHHHHHHTTCC-CSCCSGGGEEECGGGCEEECCCCTTC---------------CCGGGSCHHHHHHCCC
T ss_pred HHHHHHHHHHHHHHHHhhhhee-cccccceEEEECCCCcEEEcccchhhhccCCCc-eeeccccccccccChHHHhCCCC
Confidence 3789999999999999999998 999999999999999999999999986543322 22234568899999999987765
Q ss_pred CCCCCccchHHHHHHHHHHHhCCCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCchHHHHHHHHHhhhcCCCCCCCHHHH
Q psy1840 104 PRGTQKGDVYSFGLVLYEVIGRQGPWGHLRMTDEEIITSVTQGSGLRPDTSSLDCAPSIIACMRTCWEEDPELRPDLRFV 183 (423)
Q Consensus 104 ~~~s~ksDVyS~Giil~elltg~~Pf~~~~~~~~~i~~~i~~~~~~~p~~~~~~~~~~l~~Li~~C~~~dP~~RPt~~~I 183 (423)
+.++|||||||++|||++|..|+.. .....+++..+..+. +++. ...+++++.+++.+||+.||++||++.+|
T Consensus 192 ---~~ksDI~S~Giil~el~t~~~p~~~-~~~~~~~~~~i~~~~--~~~~-~~~~~~~l~~li~~cl~~dP~~Rps~~~i 264 (285)
T d1fmka3 192 ---TIKSDVWSFGILLTELTTKGRVPYP-GMVNREVLDQVERGY--RMPC-PPECPESLHDLMCQCWRKEPEERPTFEYL 264 (285)
T ss_dssp ---CHHHHHHHHHHHHHHHHTTTCCSST-TCCHHHHHHHHHTTC--CCCC-CTTSCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred ---CcHHhhhcchHHHHHHHhCCCCCCC-CCCHHHHHHHHHhcC--CCCC-CcccCHHHHHHHHHHcccCHhHCcCHHHH
Confidence 8999999999999999997766543 345677777777653 2222 34689999999999999999999999999
Q ss_pred HHHHHHHhhh
Q psy1840 184 HHKLKEMNAG 193 (423)
Q Consensus 184 ~~~L~~i~~~ 193 (423)
++.|+.....
T Consensus 265 ~~~L~~~~~~ 274 (285)
T d1fmka3 265 QAFLEDYFTS 274 (285)
T ss_dssp HHHHHTTTSC
T ss_pred HHHHhhhhcC
Confidence 9888765543
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.97 E-value=1.9e-31 Score=256.39 Aligned_cols=153 Identities=22% Similarity=0.239 Sum_probs=118.9
Q ss_pred HHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEc---CCccEEEeccCCcccccCCCcccccccccCCccccCCccccCC
Q psy1840 25 SISVNTTASVGMIHLHDSEIISHGNLRSSNCLID---SRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKAPELLRQP 101 (423)
Q Consensus 25 ~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld---~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~ 101 (423)
...++.||+.||+|||++|++ ||||||+||++. .++.+||+|||+++...... ......||+.|+|||++.+.
T Consensus 109 ~~~~~~qi~~al~ylH~~~ii-HrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~~~---~~~~~~GT~~y~APE~~~~~ 184 (307)
T d1a06a_ 109 ASRLIFQVLDAVKYLHDLGIV-HRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGS---VLSTACGTPGYVAPEVLAQK 184 (307)
T ss_dssp HHHHHHHHHHHHHHHHHTTCC-CSCCCGGGEEESSSSTTCCEEECCC---------------------CTTSCHHHHTTC
T ss_pred HHHHHHHHHHHHHhhhhceee-eEEecccceeecccCCCceEEEeccceeEEccCCC---eeeeeeeCccccCcHHHcCC
Confidence 678999999999999999998 999999999995 57899999999997653222 22456799999999999887
Q ss_pred CCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCchHHHHHHHHHhhhcCCCCCCCHH
Q psy1840 102 HLPRGTQKGDVYSFGLVLYEVIGRQGPWGHLRMTDEEIITSVTQGSGLRPDTSSLDCAPSIIACMRTCWEEDPELRPDLR 181 (423)
Q Consensus 102 ~~~~~s~ksDVyS~Giil~elltg~~Pf~~~~~~~~~i~~~i~~~~~~~p~~~~~~~~~~l~~Li~~C~~~dP~~RPt~~ 181 (423)
.+ +.++|||||||++|||++|..||.+ ....++...+..+....+......+++++.+++.+||+.||++|||+.
T Consensus 185 ~~---~~~~DiwSlGvilyell~g~~Pf~~--~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~ 259 (307)
T d1a06a_ 185 PY---SKAVDCWSIGVIAYILLCGYPPFYD--ENDAKLFEQILKAEYEFDSPYWDDISDSAKDFIRHLMEKDPEKRFTCE 259 (307)
T ss_dssp CC---CTHHHHHHHHHHHHHHHHSSCSCCC--SSHHHHHHHHHTTCCCCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHH
T ss_pred CC---CcHHHhhhhhHHHHHHHhCCCCCCC--CCHHHHHHHHhccCCCCCCccccCCCHHHHHHHHHHccCCHhHCcCHH
Confidence 65 8999999999999999999999974 456677777777665544444457899999999999999999999999
Q ss_pred HHHHH
Q psy1840 182 FVHHK 186 (423)
Q Consensus 182 ~I~~~ 186 (423)
++++.
T Consensus 260 eil~h 264 (307)
T d1a06a_ 260 QALQH 264 (307)
T ss_dssp HHHHS
T ss_pred HHhcC
Confidence 99874
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=2.7e-31 Score=255.88 Aligned_cols=162 Identities=23% Similarity=0.421 Sum_probs=130.5
Q ss_pred HHHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCccEEEeccCCcccccCCCcc--cccccccCCccccCCccccCC
Q psy1840 24 GSISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDET--GQERKLRRRKLYKAPELLRQP 101 (423)
Q Consensus 24 ~~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~~--~~~~~~~gt~~y~APE~l~~~ 101 (423)
.+++++.|++.||.|||+.+++ ||||||+|||+++++.+||+|||+++........ .......||+.|+|||.+...
T Consensus 131 ~~~~i~~qia~gL~~lH~~~ii-HrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~ 209 (311)
T d1r0pa_ 131 DLIGFGLQVAKGMKFLASKKFV-HRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQ 209 (311)
T ss_dssp HHHHHHHHHHHHHHHHHHTTCC-CSCCSGGGEEECTTCCEEECSSGGGCCTTTTTCCCTTCTTCSSCCGGGSCHHHHHHC
T ss_pred HHHHHHHHHHHhhhhhcccCcc-cCCccHHhEeECCCCCEEEecccchhhccccccccceecccccccccccChHHHhcC
Confidence 4789999999999999999998 9999999999999999999999999865433222 122345688999999999876
Q ss_pred CCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCchHHHHHHHHHhhhcCCCCCCCHH
Q psy1840 102 HLPRGTQKGDVYSFGLVLYEVIGRQGPWGHLRMTDEEIITSVTQGSGLRPDTSSLDCAPSIIACMRTCWEEDPELRPDLR 181 (423)
Q Consensus 102 ~~~~~s~ksDVyS~Giil~elltg~~Pf~~~~~~~~~i~~~i~~~~~~~p~~~~~~~~~~l~~Li~~C~~~dP~~RPt~~ 181 (423)
.+ +.++||||||+++|||++|..||... .+..++...+..+.. +.. +..+++++.+||.+||+.||++||++.
T Consensus 210 ~~---~~ksDI~SfGivl~El~t~~~p~~~~-~~~~~~~~~i~~g~~--~~~-p~~~~~~l~~li~~cl~~dP~~RPs~~ 282 (311)
T d1r0pa_ 210 KF---TTKSDVWSFGVLLWELMTRGAPPYPD-VNTFDITVYLLQGRR--LLQ-PEYCPDPLYEVMLKCWHPKAEMRPSFS 282 (311)
T ss_dssp CC---CHHHHHHHHHHHHHHHHTTSCCSCC-------CHHHHHTTCC--CCC-CTTCCHHHHHHHHHHTCSSGGGSCCHH
T ss_pred CC---CChhHhhhhHHHHHHHHHCCCCCCCC-CCHHHHHHHHHcCCC--CCC-cccCcHHHHHHHHHHcCCCHhHCcCHH
Confidence 55 99999999999999999988887642 344556666666542 322 246889999999999999999999999
Q ss_pred HHHHHHHHHhhh
Q psy1840 182 FVHHKLKEMNAG 193 (423)
Q Consensus 182 ~I~~~L~~i~~~ 193 (423)
+|++.|+.+...
T Consensus 283 ei~~~L~~i~~~ 294 (311)
T d1r0pa_ 283 ELVSRISAIFST 294 (311)
T ss_dssp HHHHHHHHHHHT
T ss_pred HHHHHHHHHHHh
Confidence 999999888754
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=99.97 E-value=2.8e-31 Score=251.43 Aligned_cols=163 Identities=21% Similarity=0.326 Sum_probs=128.2
Q ss_pred HHHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCccEEEeccCCcccccCCCc-ccccccccCCccccCCccccCCC
Q psy1840 24 GSISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDE-TGQERKLRRRKLYKAPELLRQPH 102 (423)
Q Consensus 24 ~~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~-~~~~~~~~gt~~y~APE~l~~~~ 102 (423)
....++.||+.||+|||++|++ ||||||+|||++.++..+++|||.+........ ........||+.|+|||++.+..
T Consensus 112 ~~~~i~~qi~~al~~lH~~~ii-HrDiKP~NIll~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~ 190 (277)
T d1o6ya_ 112 RAIEVIADACQALNFSHQNGII-HRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDS 190 (277)
T ss_dssp HHHHHHHHHHHHHHHHHHTTEE-CCCCSGGGEEEETTSCEEECCCTTCEECC----------------TTCCHHHHTTCC
T ss_pred HHHHHHHHHHHHHHHHHhCCcc-CccccCcccccCccccceeehhhhhhhhccccccccccccccCcccccCHHHHcCCC
Confidence 3689999999999999999998 999999999999999999999999765433222 22334567999999999998765
Q ss_pred CCCCCCccchHHHHHHHHHHHhCCCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCchHHHHHHHHHhhhcCCCCCC-CHH
Q psy1840 103 LPRGTQKGDVYSFGLVLYEVIGRQGPWGHLRMTDEEIITSVTQGSGLRPDTSSLDCAPSIIACMRTCWEEDPELRP-DLR 181 (423)
Q Consensus 103 ~~~~s~ksDVyS~Giil~elltg~~Pf~~~~~~~~~i~~~i~~~~~~~p~~~~~~~~~~l~~Li~~C~~~dP~~RP-t~~ 181 (423)
+ +.++|||||||++|||++|+.||.+ .+..++...+....+..+......+++++.+++.+||+.||++|| |+.
T Consensus 191 ~---~~~~DiwSlGvilyelltG~~Pf~~--~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~~sa~ 265 (277)
T d1o6ya_ 191 V---DARSDVYSLGCVLYEVLTGEPPFTG--DSPVSVAYQHVREDPIPPSARHEGLSADLDAVVLKALAKNPENRYQTAA 265 (277)
T ss_dssp C---CHHHHHHHHHHHHHHHHHSSCSCCC--SSHHHHHHHHHHCCCCCGGGTSSSCCHHHHHHHHHHTCSSGGGSCSSHH
T ss_pred C---CcceecccchHHHHHHHhCCCCCCC--cCHHHHHHHHHhcCCCCCchhccCCCHHHHHHHHHHccCCHhHCHhHHH
Confidence 5 8999999999999999999999974 455666666666555555444567899999999999999999999 899
Q ss_pred HHHHHHHHHhh
Q psy1840 182 FVHHKLKEMNA 192 (423)
Q Consensus 182 ~I~~~L~~i~~ 192 (423)
++.+.|.++..
T Consensus 266 ~l~~~l~r~~n 276 (277)
T d1o6ya_ 266 EMRADLVRVHN 276 (277)
T ss_dssp HHHHHHHHHHC
T ss_pred HHHHHHHHHhC
Confidence 99998887754
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=4.4e-31 Score=254.07 Aligned_cols=159 Identities=26% Similarity=0.483 Sum_probs=133.2
Q ss_pred HHHHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCccEEEeccCCcccccCCCcccccccccCCccccCCccccCCC
Q psy1840 23 IGSISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKAPELLRQPH 102 (423)
Q Consensus 23 ~~~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~ 102 (423)
..+++++.|++.||.|||+++++ ||||||+|||++.++++||+|||+++...............+++.|+|||.+.+..
T Consensus 133 ~~~~~i~~~ia~gl~~LH~~~iv-HrDlk~~NiLld~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~ 211 (308)
T d1p4oa_ 133 SKMIQMAGEIADGMAYLNANKFV-HRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGV 211 (308)
T ss_dssp HHHHHHHHHHHHHHHHHHHTTCB-CSCCSGGGEEECTTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCC
T ss_pred HHHHHHHHHHHHHHHHHhhCCee-eceEcCCceeecCCceEEEeecccceeccCCcceeeccceecccccCCHHHHccCC
Confidence 34789999999999999999998 99999999999999999999999998765444333344556889999999998876
Q ss_pred CCCCCCccchHHHHHHHHHHHhCC-CCCCCCCCChHHHHHHHhcCCCCCCCCCCCCchHHHHHHHHHhhhcCCCCCCCHH
Q psy1840 103 LPRGTQKGDVYSFGLVLYEVIGRQ-GPWGHLRMTDEEIITSVTQGSGLRPDTSSLDCAPSIIACMRTCWEEDPELRPDLR 181 (423)
Q Consensus 103 ~~~~s~ksDVyS~Giil~elltg~-~Pf~~~~~~~~~i~~~i~~~~~~~p~~~~~~~~~~l~~Li~~C~~~dP~~RPt~~ 181 (423)
+ +.++|||||||++|||+||. .||. ..+..++...+..+.. +.. +..+++.+.++|.+||+.||++|||+.
T Consensus 212 ~---~~~~Dv~S~G~il~El~t~~~~p~~--~~~~~~~~~~i~~~~~--~~~-p~~~~~~l~~li~~cl~~~P~~RPs~~ 283 (308)
T d1p4oa_ 212 F---TTYSDVWSFGVVLWEIATLAEQPYQ--GLSNEQVLRFVMEGGL--LDK-PDNCPDMLFELMRMCWQYNPKMRPSFL 283 (308)
T ss_dssp C---CHHHHHHHHHHHHHHHHHTSCCTTT--TSCHHHHHHHHHTTCC--CCC-CTTCCHHHHHHHHHHTCSSGGGSCCHH
T ss_pred C---CcccccccHHHHHHHHHhCCCCCCC--CCCHHHHHHHHHhCCC--CCC-cccchHHHHHHHHHHcCCChhHCcCHH
Confidence 5 88999999999999999985 6675 4567788888877543 222 236889999999999999999999999
Q ss_pred HHHHHHHHH
Q psy1840 182 FVHHKLKEM 190 (423)
Q Consensus 182 ~I~~~L~~i 190 (423)
+|++.|++.
T Consensus 284 ~il~~L~~~ 292 (308)
T d1p4oa_ 284 EIISSIKEE 292 (308)
T ss_dssp HHHHHHGGG
T ss_pred HHHHHHHHh
Confidence 999887654
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=4e-31 Score=248.50 Aligned_cols=154 Identities=24% Similarity=0.530 Sum_probs=124.6
Q ss_pred HHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCccEEEeccCCcccccCCCcccccccccCCccccCCccccCCCCC
Q psy1840 25 SISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKAPELLRQPHLP 104 (423)
Q Consensus 25 ~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~ 104 (423)
.++++.||+.||.|||+.+++ ||||||+||+++.++.+||+|||+++..... .....++..|+|||.+.+..+
T Consensus 105 ~~~i~~~i~~al~ylH~~~iv-H~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~-----~~~~~~~~~y~aPE~l~~~~~- 177 (262)
T d1byga_ 105 LLKFSLDVCEAMEYLEGNNFV-HRDLAARNVLVSEDNVAKVSDFGLTKEASST-----QDTGKLPVKWTAPEALREKKF- 177 (262)
T ss_dssp HHHHHHHHHHHHHHHHHTTCC-CSCCSGGGEEECTTSCEEECCCCC-----------------CCTTTSCHHHHHHCCC-
T ss_pred HHHHHHHHHhhccccccCcee-ccccchHhheecCCCCEeecccccceecCCC-----CccccccccCCChHHHhCCCC-
Confidence 789999999999999999998 9999999999999999999999998764322 133467788999999987655
Q ss_pred CCCCccchHHHHHHHHHHHh-CCCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCchHHHHHHHHHhhhcCCCCCCCHHHH
Q psy1840 105 RGTQKGDVYSFGLVLYEVIG-RQGPWGHLRMTDEEIITSVTQGSGLRPDTSSLDCAPSIIACMRTCWEEDPELRPDLRFV 183 (423)
Q Consensus 105 ~~s~ksDVyS~Giil~ellt-g~~Pf~~~~~~~~~i~~~i~~~~~~~p~~~~~~~~~~l~~Li~~C~~~dP~~RPt~~~I 183 (423)
+.++|||||||++|||++ |..||.. .+..++...+..+ .+|..+ ..+++++.+|+.+||+.||.+|||+.+|
T Consensus 178 --t~~sDIwSfG~il~el~t~~~~p~~~--~~~~~~~~~i~~~--~~~~~~-~~~~~~~~~li~~cl~~dP~~Rps~~~l 250 (262)
T d1byga_ 178 --STKSDVWSFGILLWEIYSFGRVPYPR--IPLKDVVPRVEKG--YKMDAP-DGCPPAVYEVMKNCWHLDAAMRPSFLQL 250 (262)
T ss_dssp --CHHHHHHHHHHHHHHHHTTSCCSCTT--SCGGGHHHHHTTT--CCCCCC-TTCCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred --ChHHHHHhHHHHHHHHHHCCCCCCCC--CCHHHHHHHHHcC--CCCCCC-ccCCHHHHHHHHHHcccCHhHCcCHHHH
Confidence 999999999999999998 6777763 4556777777664 333333 3678999999999999999999999999
Q ss_pred HHHHHHHhh
Q psy1840 184 HHKLKEMNA 192 (423)
Q Consensus 184 ~~~L~~i~~ 192 (423)
++.|+.+..
T Consensus 251 ~~~L~~i~~ 259 (262)
T d1byga_ 251 REQLEHIKT 259 (262)
T ss_dssp HHHHHHHHH
T ss_pred HHHHHHHHh
Confidence 999988764
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=6.3e-31 Score=253.27 Aligned_cols=162 Identities=22% Similarity=0.335 Sum_probs=130.4
Q ss_pred HHHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCccEEEeccCCcccccCCCcccccccccCCccccCCccccCCCC
Q psy1840 24 GSISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKAPELLRQPHL 103 (423)
Q Consensus 24 ~~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~ 103 (423)
.++.++.||+.||+|||+++++ ||||||+||+++.++.+|++|||+++...............||+.|+|||.+.+..+
T Consensus 146 ~~~~~~~qi~~gl~~LH~~~iv-HrDLKp~NIl~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~ 224 (311)
T d1t46a_ 146 DLLSFSYQVAKGMAFLASKNCI-HRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVY 224 (311)
T ss_dssp HHHHHHHHHHHHHHHHHHTTCC-CSCCSGGGEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCC
T ss_pred HHHHHHHHHHHHHHHHHhCCee-ecccccccccccccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCC
Confidence 3689999999999999999998 999999999999999999999999987655444444455678999999999987655
Q ss_pred CCCCCccchHHHHHHHHHHHhCCCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCchHHHHHHHHHhhhcCCCCCCCHHHH
Q psy1840 104 PRGTQKGDVYSFGLVLYEVIGRQGPWGHLRMTDEEIITSVTQGSGLRPDTSSLDCAPSIIACMRTCWEEDPELRPDLRFV 183 (423)
Q Consensus 104 ~~~s~ksDVyS~Giil~elltg~~Pf~~~~~~~~~i~~~i~~~~~~~p~~~~~~~~~~l~~Li~~C~~~dP~~RPt~~~I 183 (423)
+.++|||||||++|||+|+..|+.........+...+..+. ++.. +..+++++.+||.+||+.||++|||+.+|
T Consensus 225 ---~~~~DIwS~G~~l~ellt~g~p~~~~~~~~~~~~~~i~~~~--~~~~-~~~~~~~l~~Li~~cl~~dP~~RPs~~~i 298 (311)
T d1t46a_ 225 ---TFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMIKEGF--RMLS-PEHAPAEMYDIMKTCWDADPLKRPTFKQI 298 (311)
T ss_dssp ---CHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHHHHHHHHHTC--CCCC-CTTSCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred ---CCcccccchHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCC--CCCC-cccccHHHHHHHHHHcCCChhHCcCHHHH
Confidence 99999999999999999955444333333344444555442 2222 23578999999999999999999999999
Q ss_pred HHHHHHHhh
Q psy1840 184 HHKLKEMNA 192 (423)
Q Consensus 184 ~~~L~~i~~ 192 (423)
++.|+++..
T Consensus 299 l~~L~~~i~ 307 (311)
T d1t46a_ 299 VQLIEKQIS 307 (311)
T ss_dssp HHHHHHHHH
T ss_pred HHHHHHhhc
Confidence 999987544
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=5e-31 Score=253.73 Aligned_cols=160 Identities=29% Similarity=0.474 Sum_probs=132.0
Q ss_pred HHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCccEEEeccCCcccccCCCcccccccccCCccccCCccccCCCCC
Q psy1840 25 SISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKAPELLRQPHLP 104 (423)
Q Consensus 25 ~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~ 104 (423)
++.++.||+.||.|||+.+++ ||||||+|||++.++.+||+|||+++...... ......+|..|+|||.+.+..+
T Consensus 129 ~~~~~~qia~gl~~lH~~~ii-HrDlkp~NIL~~~~~~~kl~DfG~a~~~~~~~---~~~~~~gt~~y~aPE~l~~~~~- 203 (309)
T d1fvra_ 129 LLHFAADVARGMDYLSQKQFI-HRDLAARNILVGENYVAKIADFGLSRGQEVYV---KKTMGRLPVRWMAIESLNYSVY- 203 (309)
T ss_dssp HHHHHHHHHHHHHHHHHTTEE-CSCCSGGGEEECGGGCEEECCTTCEESSCEEC---CC----CCTTTCCHHHHHHCEE-
T ss_pred HHHHHHHHHHHHHhhhcCCcc-ccccccceEEEcCCCceEEccccccccccccc---cccceecCCcccchHHhccCCC-
Confidence 789999999999999999998 99999999999999999999999987543221 1234568889999999987765
Q ss_pred CCCCccchHHHHHHHHHHHhCCC-CCCCCCCChHHHHHHHhcCCCCCCCCCCCCchHHHHHHHHHhhhcCCCCCCCHHHH
Q psy1840 105 RGTQKGDVYSFGLVLYEVIGRQG-PWGHLRMTDEEIITSVTQGSGLRPDTSSLDCAPSIIACMRTCWEEDPELRPDLRFV 183 (423)
Q Consensus 105 ~~s~ksDVyS~Giil~elltg~~-Pf~~~~~~~~~i~~~i~~~~~~~p~~~~~~~~~~l~~Li~~C~~~dP~~RPt~~~I 183 (423)
+.++|||||||++|||++|.. ||. ..+..++...+..+. ++.. +..+++++.+||.+||+.||++|||+.+|
T Consensus 204 --~~~sDvwSfGvil~ell~~~~~p~~--~~~~~~~~~~i~~~~--~~~~-~~~~~~~~~~li~~cl~~dP~~RPs~~ei 276 (309)
T d1fvra_ 204 --TTNSDVWSYGVLLWEIVSLGGTPYC--GMTCAELYEKLPQGY--RLEK-PLNCDDEVYDLMRQCWREKPYERPSFAQI 276 (309)
T ss_dssp --CHHHHHHHHHHHHHHHHTTSCCTTT--TCCHHHHHHHGGGTC--CCCC-CTTBCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred --CccceeehhHHHHHHHHhcCCCCCC--CCCHHHHHHHHHhcC--CCCC-CccCCHHHHHHHHHHcCCChhHCcCHHHH
Confidence 899999999999999999765 665 456788888887753 2332 24689999999999999999999999999
Q ss_pred HHHHHHHhhhcCC
Q psy1840 184 HHKLKEMNAGLKA 196 (423)
Q Consensus 184 ~~~L~~i~~~~~~ 196 (423)
++.|+++....+.
T Consensus 277 l~~L~~i~~~~~~ 289 (309)
T d1fvra_ 277 LVSLNRMLEERKT 289 (309)
T ss_dssp HHHHHHHHHSSSC
T ss_pred HHHHHHHHhcCcC
Confidence 9999888765443
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=99.97 E-value=7.4e-31 Score=256.90 Aligned_cols=153 Identities=17% Similarity=0.295 Sum_probs=131.0
Q ss_pred HHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEc--CCccEEEeccCCcccccCCCcccccccccCCccccCCccccCCC
Q psy1840 25 SISVNTTASVGMIHLHDSEIISHGNLRSSNCLID--SRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKAPELLRQPH 102 (423)
Q Consensus 25 ~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld--~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~ 102 (423)
...++.||+.||.|||++|++ ||||||+|||++ .++.+||+|||+++...... ......||+.|+|||++.+..
T Consensus 129 ~~~i~~qi~~aL~ylH~~~ii-HRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~~---~~~~~~gt~~y~aPE~~~~~~ 204 (352)
T d1koba_ 129 VINYMRQACEGLKHMHEHSIV-HLDIKPENIMCETKKASSVKIIDFGLATKLNPDE---IVKVTTATAEFAAPEIVDREP 204 (352)
T ss_dssp HHHHHHHHHHHHHHHHHTTEE-CCCCCGGGEEESSTTCCCEEECCCTTCEECCTTS---CEEEECSSGGGCCHHHHTTCC
T ss_pred HHHHHHHHHHHHHHHHHCCee-ecccccccccccccCCCeEEEeecccceecCCCC---ceeeccCcccccCHHHHcCCC
Confidence 578999999999999999998 999999999998 67899999999998764332 224567899999999998876
Q ss_pred CCCCCCccchHHHHHHHHHHHhCCCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCchHHHHHHHHHhhhcCCCCCCCHHH
Q psy1840 103 LPRGTQKGDVYSFGLVLYEVIGRQGPWGHLRMTDEEIITSVTQGSGLRPDTSSLDCAPSIIACMRTCWEEDPELRPDLRF 182 (423)
Q Consensus 103 ~~~~s~ksDVyS~Giil~elltg~~Pf~~~~~~~~~i~~~i~~~~~~~p~~~~~~~~~~l~~Li~~C~~~dP~~RPt~~~ 182 (423)
+ +.++||||+||++|||++|..||.+ .+..+++..+..+....+......+++++.+||.+||+.||.+|||+.+
T Consensus 205 ~---~~~~DiwSlGvilyelltG~~Pf~~--~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e 279 (352)
T d1koba_ 205 V---GFYTDMWAIGVLGYVLLSGLSPFAG--EDDLETLQNVKRCDWEFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHD 279 (352)
T ss_dssp B---CHHHHHHHHHHHHHHHHHSCCSSCC--SSHHHHHHHHHHCCCCCCSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHH
T ss_pred C---CCccchHHHHHHHHHHHhCCCCCCC--CCHHHHHHHHHhCCCCCCcccccCCCHHHHHHHHHHccCChhHCcCHHH
Confidence 5 8999999999999999999999974 4567778888776655555445578999999999999999999999999
Q ss_pred HHHH
Q psy1840 183 VHHK 186 (423)
Q Consensus 183 I~~~ 186 (423)
+++.
T Consensus 280 il~H 283 (352)
T d1koba_ 280 ALEH 283 (352)
T ss_dssp HHTS
T ss_pred HhcC
Confidence 9763
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=99.97 E-value=7e-31 Score=256.89 Aligned_cols=153 Identities=19% Similarity=0.304 Sum_probs=129.3
Q ss_pred HHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEc--CCccEEEeccCCcccccCCCcccccccccCCccccCCccccCCC
Q psy1840 25 SISVNTTASVGMIHLHDSEIISHGNLRSSNCLID--SRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKAPELLRQPH 102 (423)
Q Consensus 25 ~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld--~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~ 102 (423)
...++.||+.||.|||++|++ ||||||+|||++ .++.+||+|||+++...... ......||+.|+|||++.+..
T Consensus 126 ~~~i~~qi~~aL~ylH~~~ii-HrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~~---~~~~~~gT~~Y~aPEv~~~~~ 201 (350)
T d1koaa2 126 AVEYMRQVCKGLCHMHENNYV-HLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ---SVKVTTGTAEFAAPEVAEGKP 201 (350)
T ss_dssp HHHHHHHHHHHHHHHHHTTEE-CCCCCGGGEEESSTTSCCEEECCCTTCEECCTTS---CEEEECSCTTTCCHHHHHTCC
T ss_pred HHHHHHHHHHHHHHHHhcCCe-eeeechhHeeeccCCCCeEEEeecchheeccccc---ccceecCcccccCHHHHcCCC
Confidence 678999999999999999998 999999999995 46889999999998654332 224567899999999998876
Q ss_pred CCCCCCccchHHHHHHHHHHHhCCCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCchHHHHHHHHHhhhcCCCCCCCHHH
Q psy1840 103 LPRGTQKGDVYSFGLVLYEVIGRQGPWGHLRMTDEEIITSVTQGSGLRPDTSSLDCAPSIIACMRTCWEEDPELRPDLRF 182 (423)
Q Consensus 103 ~~~~s~ksDVyS~Giil~elltg~~Pf~~~~~~~~~i~~~i~~~~~~~p~~~~~~~~~~l~~Li~~C~~~dP~~RPt~~~ 182 (423)
+ +.++|||||||++|||++|+.||.+ .+..++...+..+....+......+++++.+||.+||+.||++|||+.+
T Consensus 202 ~---~~~~DiwSlGvilyell~G~~Pf~~--~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e 276 (350)
T d1koaa2 202 V---GYYTDMWSVGVLSYILLSGLSPFGG--ENDDETLRNVKSCDWNMDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQ 276 (350)
T ss_dssp B---CHHHHHHHHHHHHHHHHHSSCSSCC--SSHHHHHHHHHHTCCCSCCGGGGGCCHHHHHHHHHHCCSSGGGSCCHHH
T ss_pred C---ChhHhhhhhhHHHHHHHhCCCCCCC--CCHHHHHHHHHhCCCCCCcccccCCCHHHHHHHHHHccCChhHCcCHHH
Confidence 5 8999999999999999999999973 4667788888776554444333467899999999999999999999999
Q ss_pred HHHH
Q psy1840 183 VHHK 186 (423)
Q Consensus 183 I~~~ 186 (423)
+++.
T Consensus 277 il~h 280 (350)
T d1koaa2 277 ALEH 280 (350)
T ss_dssp HHHS
T ss_pred HhcC
Confidence 9874
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=3.4e-30 Score=250.67 Aligned_cols=149 Identities=18% Similarity=0.281 Sum_probs=125.9
Q ss_pred HHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCccEEEeccCCcccccCCCcccccccccCCccccCCccccCCCCC
Q psy1840 25 SISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKAPELLRQPHLP 104 (423)
Q Consensus 25 ~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~ 104 (423)
...++.||+.||+|||++|++ ||||||+|||++.+|.+||+|||+++....... .....+||+.|+|||++.+..+
T Consensus 107 ~~~~~~qil~al~ylH~~~ii-HRDlKP~NILl~~~g~vkl~DFG~a~~~~~~~~--~~~~~~GT~~Y~aPE~~~~~~y- 182 (337)
T d1o6la_ 107 ARFYGAEIVSALEYLHSRDVV-YRDIKLENLMLDKDGHIKITDFGLCKEGISDGA--TMKTFCGTPEYLAPEVLEDNDY- 182 (337)
T ss_dssp HHHHHHHHHHHHHHHHHTTCB-CCCCCGGGEEECTTSCEEECCCTTCBCSCCTTC--CBCCCEECGGGCCGGGGSSSCB-
T ss_pred HHHHHHHHhhhhhhhhhcCcc-ccccCHHHeEecCCCCEEEeecccccccccCCc--ccccceeCHHHhhhhhccCCCC-
Confidence 457889999999999999998 999999999999999999999999986543222 2345689999999999998766
Q ss_pred CCCCccchHHHHHHHHHHHhCCCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCchHHHHHHHHHhhhcCCCCCCC-----
Q psy1840 105 RGTQKGDVYSFGLVLYEVIGRQGPWGHLRMTDEEIITSVTQGSGLRPDTSSLDCAPSIIACMRTCWEEDPELRPD----- 179 (423)
Q Consensus 105 ~~s~ksDVyS~Giil~elltg~~Pf~~~~~~~~~i~~~i~~~~~~~p~~~~~~~~~~l~~Li~~C~~~dP~~RPt----- 179 (423)
+.++||||+||++|||++|+.||.+ .+..++...+..+....| ..+++++.+||.+||+.||.+||+
T Consensus 183 --~~~~DiwSlGvilyeml~G~~pf~~--~~~~~~~~~i~~~~~~~p----~~~s~~~~dli~~~L~~dP~~R~~~~~~~ 254 (337)
T d1o6la_ 183 --GRAVDWWGLGVVMYEMMCGRLPFYN--QDHERLFELILMEEIRFP----RTLSPEAKSLLAGLLKKDPKQRLGGGPSD 254 (337)
T ss_dssp --CTTHHHHHHHHHHHHHHHSSCSSCC--SSHHHHHHHHHHCCCCCC----TTSCHHHHHHHHHHTCSSTTTSTTCSTTT
T ss_pred --ChhhcccchhhHHHHHHHCCCCCCC--cCHHHHHHHHhcCCCCCC----ccCCHHHHHHHHhhccCCchhhccccccc
Confidence 8999999999999999999999974 456777777777654333 357899999999999999999995
Q ss_pred HHHHHH
Q psy1840 180 LRFVHH 185 (423)
Q Consensus 180 ~~~I~~ 185 (423)
+.++++
T Consensus 255 ~~eil~ 260 (337)
T d1o6la_ 255 AKEVME 260 (337)
T ss_dssp HHHHHT
T ss_pred HHHHHc
Confidence 666654
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.96 E-value=9.1e-31 Score=253.35 Aligned_cols=152 Identities=22% Similarity=0.344 Sum_probs=118.2
Q ss_pred HHHHHHHHHHHHHHHHhC-CCeeecCCCCCCEEEcCCccEEEeccCCcccccCCCcccccccccCCccccCCccccCCCC
Q psy1840 25 SISVNTTASVGMIHLHDS-EIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKAPELLRQPHL 103 (423)
Q Consensus 25 ~l~i~~qi~~gL~yLH~~-~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~ 103 (423)
...++.||+.||.|||++ ||+ ||||||+|||++.++.+||+|||+|+..... ......||+.|+|||++.+..+
T Consensus 106 ~~~~~~qil~aL~yLH~~~~Ii-HRDiKP~NILl~~~~~vkl~DFGla~~~~~~----~~~~~~GT~~Y~APEvl~~~~y 180 (322)
T d1s9ja_ 106 LGKVSIAVIKGLTYLREKHKIM-HRDVKPSNILVNSRGEIKLCDFGVSGQLIDS----MANSFVGTRSYMSPERLQGTHY 180 (322)
T ss_dssp HHHHHHHHHHHHHHHHHHHCCC-CSCCSGGGEEECTTCCEEECCCCCCHHHHHH----TC---CCSSCCCCHHHHHCSCC
T ss_pred HHHHHHHHHHHHHHHHHhCCEE-ccccCHHHeeECCCCCEEEeeCCCccccCCC----ccccccCCccccCchHHcCCCC
Confidence 568999999999999974 888 9999999999999999999999998865322 2245689999999999998765
Q ss_pred CCCCCccchHHHHHHHHHHHhCCCCCCCCCCChHHH----------------------------------------HHHH
Q psy1840 104 PRGTQKGDVYSFGLVLYEVIGRQGPWGHLRMTDEEI----------------------------------------ITSV 143 (423)
Q Consensus 104 ~~~s~ksDVyS~Giil~elltg~~Pf~~~~~~~~~i----------------------------------------~~~i 143 (423)
+.++||||+||++|||++|+.||.......... ...+
T Consensus 181 ---~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (322)
T d1s9ja_ 181 ---SVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSSYGMDSRPPMAIFELLDYI 257 (322)
T ss_dssp ---CTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC------------------------------CCCCHHHHHHHH
T ss_pred ---CcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCcccccccccccccccccccchhHHHHHhhh
Confidence 899999999999999999999996533221111 1111
Q ss_pred hcCCCCCCCCCCCCchHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q psy1840 144 TQGSGLRPDTSSLDCAPSIIACMRTCWEEDPELRPDLRFVHHK 186 (423)
Q Consensus 144 ~~~~~~~p~~~~~~~~~~l~~Li~~C~~~dP~~RPt~~~I~~~ 186 (423)
.. ...|..+...++.++.+++.+||+.||.+|||+.++++.
T Consensus 258 ~~--~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~H 298 (322)
T d1s9ja_ 258 VN--EPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVH 298 (322)
T ss_dssp HT--SCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred hc--cCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhhC
Confidence 11 111222333568899999999999999999999999873
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=99.96 E-value=3.1e-30 Score=248.94 Aligned_cols=146 Identities=19% Similarity=0.268 Sum_probs=125.5
Q ss_pred HHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCccEEEeccCCcccccCCCcccccccccCCccccCCccccCCCCC
Q psy1840 25 SISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKAPELLRQPHLP 104 (423)
Q Consensus 25 ~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~ 104 (423)
...++.||+.||+|||++|++ ||||||+|||++.+|.+||+|||+++..... .....||+.|+|||++.+..+
T Consensus 106 ~~~~~~qi~~al~~lH~~~ii-HrDiKp~NILl~~~g~vkL~DFG~a~~~~~~-----~~~~~Gt~~Y~APE~l~~~~y- 178 (316)
T d1fota_ 106 AKFYAAEVCLALEYLHSKDII-YRDLKPENILLDKNGHIKITDFGFAKYVPDV-----TYTLCGTPDYIAPEVVSTKPY- 178 (316)
T ss_dssp HHHHHHHHHHHHHHHHTTTEE-CCCCCGGGEEECTTSCEEECCCSSCEECSSC-----BCCCCSCTTTCCHHHHTTCCB-
T ss_pred HHHHHHHHHHhhhhhccCcEE-ccccCchheeEcCCCCEEEecCccceEeccc-----cccccCcccccCHHHHcCCCC-
Confidence 457889999999999999988 9999999999999999999999999875432 235689999999999988765
Q ss_pred CCCCccchHHHHHHHHHHHhCCCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCchHHHHHHHHHhhhcCCCCCC-----C
Q psy1840 105 RGTQKGDVYSFGLVLYEVIGRQGPWGHLRMTDEEIITSVTQGSGLRPDTSSLDCAPSIIACMRTCWEEDPELRP-----D 179 (423)
Q Consensus 105 ~~s~ksDVyS~Giil~elltg~~Pf~~~~~~~~~i~~~i~~~~~~~p~~~~~~~~~~l~~Li~~C~~~dP~~RP-----t 179 (423)
+.++||||+||++|||++|+.||.+ .+..++...+..+....| ..+++++.+++.+||+.||.+|| |
T Consensus 179 --~~~~DiwSlGvilyemltG~~Pf~~--~~~~~~~~~i~~~~~~~p----~~~s~~~~~li~~~L~~dp~~R~~~~r~t 250 (316)
T d1fota_ 179 --NKSIDWWSFGILIYEMLAGYTPFYD--SNTMKTYEKILNAELRFP----PFFNEDVKDLLSRLITRDLSQRLGNLQNG 250 (316)
T ss_dssp --CTTHHHHHHHHHHHHHHHSSCTTCC--SSHHHHHHHHHHCCCCCC----TTSCHHHHHHHHHHTCSCTTTCTTSSTTT
T ss_pred --CchhhccccchhHHHHHhCCCCCCC--cCHHHHHHHHHcCCCCCC----CCCCHHHHHHHHHHhhhCHHhccccchhh
Confidence 8999999999999999999999974 466778888877654433 25789999999999999999996 8
Q ss_pred HHHHHH
Q psy1840 180 LRFVHH 185 (423)
Q Consensus 180 ~~~I~~ 185 (423)
+.++++
T Consensus 251 ~~~il~ 256 (316)
T d1fota_ 251 TEDVKN 256 (316)
T ss_dssp THHHHT
T ss_pred HHHHHc
Confidence 888865
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=99.96 E-value=2.2e-30 Score=253.32 Aligned_cols=146 Identities=19% Similarity=0.261 Sum_probs=125.8
Q ss_pred HHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCccEEEeccCCcccccCCCcccccccccCCccccCCccccCCCCC
Q psy1840 25 SISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKAPELLRQPHLP 104 (423)
Q Consensus 25 ~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~ 104 (423)
...++.||+.||.|||++|++ ||||||+|||++.++.+||+|||+++..... .....||+.|+|||++.+..+
T Consensus 143 ~~~i~~qi~~aL~yLH~~~ii-HRDIKP~NILl~~~g~ikL~DFG~a~~~~~~-----~~~~~Gt~~Y~APE~~~~~~~- 215 (350)
T d1rdqe_ 143 ARFYAAQIVLTFEYLHSLDLI-YRDLKPENLLIDQQGYIQVTDFGFAKRVKGR-----TWTLCGTPEALAPEIILSKGY- 215 (350)
T ss_dssp HHHHHHHHHHHHHHHHHTTEE-CCCCSGGGEEECTTSCEEECCCTTCEECSSC-----BCCCEECGGGCCHHHHTTCCB-
T ss_pred HHHHHHHHHHHHHHHHhCCEe-cCcCCHHHcccCCCCCEEeeeceeeeecccc-----cccccCccccCCHHHHcCCCC-
Confidence 578999999999999999988 9999999999999999999999999876432 234678999999999988765
Q ss_pred CCCCccchHHHHHHHHHHHhCCCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCchHHHHHHHHHhhhcCCCCCC-----C
Q psy1840 105 RGTQKGDVYSFGLVLYEVIGRQGPWGHLRMTDEEIITSVTQGSGLRPDTSSLDCAPSIIACMRTCWEEDPELRP-----D 179 (423)
Q Consensus 105 ~~s~ksDVyS~Giil~elltg~~Pf~~~~~~~~~i~~~i~~~~~~~p~~~~~~~~~~l~~Li~~C~~~dP~~RP-----t 179 (423)
+.++|||||||++|||++|+.||.+ .+...+...+..+....| ..+++++.+++++||+.||.+|+ |
T Consensus 216 --~~~~DiwSlGvilyemltG~~Pf~~--~~~~~~~~~i~~~~~~~p----~~~s~~~~~li~~~L~~dP~kR~~~~r~t 287 (350)
T d1rdqe_ 216 --NKAVDWWALGVLIYEMAAGYPPFFA--DQPIQIYEKIVSGKVRFP----SHFSSDLKDLLRNLLQVDLTKRFGNLKNG 287 (350)
T ss_dssp --CTHHHHHHHHHHHHHHHHSSCSSCC--SSHHHHHHHHHHCCCCCC----TTCCHHHHHHHHHHSCSCTTTCTTSSTTT
T ss_pred --CccccccchhHHHHHHHhCCCCCCC--cCHHHHHHHHhcCCCCCC----ccCCHHHHHHHHHHhhhCHHhcccccccc
Confidence 8999999999999999999999974 456777788877654433 35789999999999999999994 8
Q ss_pred HHHHHH
Q psy1840 180 LRFVHH 185 (423)
Q Consensus 180 ~~~I~~ 185 (423)
+.++++
T Consensus 288 ~~ell~ 293 (350)
T d1rdqe_ 288 VNDIKN 293 (350)
T ss_dssp THHHHT
T ss_pred HHHHHc
Confidence 888765
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.96 E-value=1.8e-30 Score=247.98 Aligned_cols=152 Identities=20% Similarity=0.247 Sum_probs=127.5
Q ss_pred HHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCc----cEEEeccCCcccccCCCcccccccccCCccccCCccccC
Q psy1840 25 SISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRW----VLQIADFGLHAFKAGQDETGQERKLRRRKLYKAPELLRQ 100 (423)
Q Consensus 25 ~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~----~vKL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~ 100 (423)
...++.||+.||+|||+.+++ ||||||+||+++.++ .+||+|||++....... ......+|+.|+|||++.+
T Consensus 115 ~~~~~~qi~~al~yLH~~~iv-HrDiKp~Nill~~~~~~~~~vkl~DfG~a~~~~~~~---~~~~~~~t~~y~APE~~~~ 190 (293)
T d1jksa_ 115 ATEFLKQILNGVYYLHSLQIA-HFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGN---EFKNIFGTPEFVAPEIVNY 190 (293)
T ss_dssp HHHHHHHHHHHHHHHHHTTEE-CCCCSGGGEEESCSSSSSCCEEECCCTTCEECTTSC---BCSCCCCCGGGCCHHHHTT
T ss_pred HHHHHHHHHHHHHhhhhccee-ecccccceEEEecCCCcccceEecchhhhhhcCCCc---cccccCCCCcccCHHHHcC
Confidence 578999999999999999988 999999999998776 59999999987654322 2245578899999999987
Q ss_pred CCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCchHHHHHHHHHhhhcCCCCCCCH
Q psy1840 101 PHLPRGTQKGDVYSFGLVLYEVIGRQGPWGHLRMTDEEIITSVTQGSGLRPDTSSLDCAPSIIACMRTCWEEDPELRPDL 180 (423)
Q Consensus 101 ~~~~~~s~ksDVyS~Giil~elltg~~Pf~~~~~~~~~i~~~i~~~~~~~p~~~~~~~~~~l~~Li~~C~~~dP~~RPt~ 180 (423)
..+ +.++|||||||++|||++|+.||.+ .+..+....+..+....+......+++++.+||++||+.||++|||+
T Consensus 191 ~~~---~~~~DiwSlGvilyell~g~~Pf~~--~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~ 265 (293)
T d1jksa_ 191 EPL---GLEADMWSIGVITYILLSGASPFLG--DTKQETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTI 265 (293)
T ss_dssp CCB---CTHHHHHHHHHHHHHHHHSSCSSCC--SSHHHHHHHHHTTCCCCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCH
T ss_pred CCC---CCcccchhhhHHHHHHHcCCCCCCC--CCHHHHHHHHHhcCCCCCchhcCCCCHHHHHHHHHHccCChhHCcCH
Confidence 655 8999999999999999999999974 45677777877765444333334678999999999999999999999
Q ss_pred HHHHH
Q psy1840 181 RFVHH 185 (423)
Q Consensus 181 ~~I~~ 185 (423)
.++++
T Consensus 266 ~eil~ 270 (293)
T d1jksa_ 266 QDSLQ 270 (293)
T ss_dssp HHHHH
T ss_pred HHHhc
Confidence 99876
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=99.96 E-value=3.3e-30 Score=244.15 Aligned_cols=156 Identities=17% Similarity=0.262 Sum_probs=129.0
Q ss_pred HHHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCccEEEeccCCcccccCCCcccccccccCCccccCCccccCCC-
Q psy1840 24 GSISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKAPELLRQPH- 102 (423)
Q Consensus 24 ~~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~- 102 (423)
....++.||+.||+|||++|++ ||||||+||+++.++.+||+|||+++...... ......||+.|+|||.+.+..
T Consensus 111 ~~~~~~~qi~~al~~lH~~~iv-HrDlkp~Nill~~~~~~kl~DFG~a~~~~~~~---~~~~~~gt~~y~~PE~~~~~~~ 186 (277)
T d1phka_ 111 ETRKIMRALLEVICALHKLNIV-HRDLKPENILLDDDMNIKLTDFGFSCQLDPGE---KLREVCGTPSYLAPEIIECSMN 186 (277)
T ss_dssp HHHHHHHHHHHHHHHHHHTTEE-CSCCSGGGEEECTTCCEEECCCTTCEECCTTC---CBCCCCSCGGGCCHHHHHHHHC
T ss_pred HHHHHHHHHHHHHHHHHHcCCc-ccccccceEEEcCCCCeEEccchheeEccCCC---ceeeeeccCCCCCHHHhhcccc
Confidence 3689999999999999999988 99999999999999999999999998754322 224467899999999997532
Q ss_pred --CCCCCCccchHHHHHHHHHHHhCCCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCchHHHHHHHHHhhhcCCCCCCCH
Q psy1840 103 --LPRGTQKGDVYSFGLVLYEVIGRQGPWGHLRMTDEEIITSVTQGSGLRPDTSSLDCAPSIIACMRTCWEEDPELRPDL 180 (423)
Q Consensus 103 --~~~~s~ksDVyS~Giil~elltg~~Pf~~~~~~~~~i~~~i~~~~~~~p~~~~~~~~~~l~~Li~~C~~~dP~~RPt~ 180 (423)
...++.++||||+||++|||++|+.||.+ .+..+....+..+....+......+++++.+++.+||+.||++|||+
T Consensus 187 ~~~~~~~~~~DiwslGvilyeml~g~~Pf~~--~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~~p~~R~s~ 264 (277)
T d1phka_ 187 DNHPGYGKEVDMWSTGVIMYTLLAGSPPFWH--RKQMLMLRMIMSGNYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTA 264 (277)
T ss_dssp TTSCCBCTHHHHHHHHHHHHHHHHSSCSSCC--SSHHHHHHHHHHTCCCCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCH
T ss_pred ccCCCCCchheEcccchhhhhhccCCCCCCC--CCHHHHHHHHHhCCCCCCCcccccCCHHHHHHHHHHccCChhHCcCH
Confidence 22358899999999999999999999974 45666777777665444433344789999999999999999999999
Q ss_pred HHHHH
Q psy1840 181 RFVHH 185 (423)
Q Consensus 181 ~~I~~ 185 (423)
.+|++
T Consensus 265 ~eil~ 269 (277)
T d1phka_ 265 EEALA 269 (277)
T ss_dssp HHHTT
T ss_pred HHHHc
Confidence 99865
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=99.96 E-value=8.6e-30 Score=250.44 Aligned_cols=151 Identities=19% Similarity=0.266 Sum_probs=120.3
Q ss_pred HHHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCccEEEeccCCcccccCCCcccccccccCCccccCCccccCCCC
Q psy1840 24 GSISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKAPELLRQPHL 103 (423)
Q Consensus 24 ~~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~ 103 (423)
....++.||+.||.|||++|++ ||||||+|||++.+|.+||+|||+++...... .....||+.|+|||++..+.
T Consensus 108 ~~~~~~~qi~~aL~ylH~~~ii-HrDlKP~NILl~~~g~iKl~DFGla~~~~~~~----~~~~~GT~~y~APE~~~~~~- 181 (364)
T d1omwa3 108 DMRFYAAEIILGLEHMHNRFVV-YRDLKPANILLDEHGHVRISDLGLACDFSKKK----PHASVGTHGYMAPEVLQKGV- 181 (364)
T ss_dssp HHHHHHHHHHHHHHHHHHTTEE-CCCCSGGGEEECSSSCEEECCCTTCEECSSSC----CCSCCSCGGGCCHHHHSTTC-
T ss_pred HHHHHHHHHHHHHHHHHHCCcc-ceeeccceeEEcCCCcEEEeeeceeeecCCCc----ccccccccccchhHHhhcCC-
Confidence 3578999999999999999998 99999999999999999999999988654322 24567999999999987543
Q ss_pred CCCCCccchHHHHHHHHHHHhCCCCCCCCCCCh-HHHHHHHhcCCCCCCCCCCCCchHHHHHHHHHhhhcCCCCCCC---
Q psy1840 104 PRGTQKGDVYSFGLVLYEVIGRQGPWGHLRMTD-EEIITSVTQGSGLRPDTSSLDCAPSIIACMRTCWEEDPELRPD--- 179 (423)
Q Consensus 104 ~~~s~ksDVyS~Giil~elltg~~Pf~~~~~~~-~~i~~~i~~~~~~~p~~~~~~~~~~l~~Li~~C~~~dP~~RPt--- 179 (423)
.++.++|||||||++|||++|+.||....... .++......... ..+..+++++.+||.+||+.||++|||
T Consensus 182 -~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~~~----~~~~~~s~~~~~li~~~L~~dP~~R~t~~~ 256 (364)
T d1omwa3 182 -AYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAV----ELPDSFSPELRSLLEGLLQRDVNRRLGCLG 256 (364)
T ss_dssp -CCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHHHHHSSSCCC----CCCSSSCHHHHHHHHHHTCSSTTTSTTTSS
T ss_pred -CCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCCC----CCCCCCCHHHHHHHHHHcccCHHHhCCCcc
Confidence 23899999999999999999999997644332 233333322221 123368899999999999999999999
Q ss_pred --HHHHHH
Q psy1840 180 --LRFVHH 185 (423)
Q Consensus 180 --~~~I~~ 185 (423)
+.++++
T Consensus 257 ~~a~eil~ 264 (364)
T d1omwa3 257 RGAQEVKE 264 (364)
T ss_dssp STHHHHHT
T ss_pred cCHHHHHc
Confidence 577765
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.96 E-value=9.7e-30 Score=243.78 Aligned_cols=153 Identities=20% Similarity=0.223 Sum_probs=121.9
Q ss_pred HHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCccEEEeccCCcccccCCCcccccccccCCccccCCccccCCCCC
Q psy1840 25 SISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKAPELLRQPHLP 104 (423)
Q Consensus 25 ~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~ 104 (423)
...++.|++.||+|||+++++ ||||||+|||++.++.+||+|||+++..... .......||+.|+|||++.+..+
T Consensus 118 ~~~~~~qi~~aL~yLH~~~iv-HrDiKp~NILi~~~~~~kl~dfg~~~~~~~~---~~~~~~~gT~~Y~APE~~~~~~y- 192 (305)
T d1blxa_ 118 IKDMMFQLLRGLDFLHSHRVV-HRDLKPQNILVTSSGQIKLADFGLARIYSFQ---MALTSVVVTLWYRAPEVLLQSSY- 192 (305)
T ss_dssp HHHHHHHHHHHHHHHHHTTCC-CCCCCGGGEEECTTCCEEECSCCSCCCCCGG---GGGCCCCCCCTTCCHHHHTTCCC-
T ss_pred HHHHHHHHHHHHHHHHhCCEE-ecCCCccEEEEcCCCCeeecchhhhhhhccc---ccCCCcccChhhcCcchhcCCCC-
Confidence 457999999999999999998 9999999999999999999999998754322 22346689999999999988765
Q ss_pred CCCCccchHHHHHHHHHHHhCCCCCCCCCCChHHHHHHHhcC--CC---------------------CCCCCCCCCchHH
Q psy1840 105 RGTQKGDVYSFGLVLYEVIGRQGPWGHLRMTDEEIITSVTQG--SG---------------------LRPDTSSLDCAPS 161 (423)
Q Consensus 105 ~~s~ksDVyS~Giil~elltg~~Pf~~~~~~~~~i~~~i~~~--~~---------------------~~p~~~~~~~~~~ 161 (423)
+.++||||+||++|||++|+.||.+ .+..+.+..+... .+ .........+++.
T Consensus 193 --~~~~DiwSlG~il~ell~g~~pf~~--~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~ 268 (305)
T d1blxa_ 193 --ATPVDLWSVGCIFAEMFRRKPLFRG--SSDVDQLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDEL 268 (305)
T ss_dssp --CTHHHHHHHHHHHHHHHHSSCSCCC--SSHHHHHHHHHHHHCCCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHH
T ss_pred --ChhehhhchHHHHHHHHHCCCCCCC--CCHHHHHHHHHHhhCCCchhcccccccchhhhhccccccchhhccccCCHH
Confidence 8999999999999999999999974 3444444443311 00 0000112356889
Q ss_pred HHHHHHHhhhcCCCCCCCHHHHHHH
Q psy1840 162 IIACMRTCWEEDPELRPDLRFVHHK 186 (423)
Q Consensus 162 l~~Li~~C~~~dP~~RPt~~~I~~~ 186 (423)
+.+|+.+||+.||++|||+.++++.
T Consensus 269 ~~dli~~mL~~dP~~R~sa~e~L~H 293 (305)
T d1blxa_ 269 GKDLLLKCLTFNPAKRISAYSALSH 293 (305)
T ss_dssp HHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred HHHHHHHHCcCChhHCcCHHHHhcC
Confidence 9999999999999999999998763
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.96 E-value=3.3e-30 Score=247.30 Aligned_cols=167 Identities=26% Similarity=0.384 Sum_probs=125.2
Q ss_pred HHHHHHHHHHHHHHHHh--------CCCeeecCCCCCCEEEcCCccEEEeccCCcccccCCCcc--cccccccCCccccC
Q psy1840 25 SISVNTTASVGMIHLHD--------SEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDET--GQERKLRRRKLYKA 94 (423)
Q Consensus 25 ~l~i~~qi~~gL~yLH~--------~~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~~--~~~~~~~gt~~y~A 94 (423)
+++++.|++.||.|+|+ +|++ ||||||+||||+.++.+||+|||+++........ .......||+.|+|
T Consensus 102 ~~~~~~~ia~gl~~lH~~~~~~~~~~~Iv-HrDlKp~NILl~~~~~~Kl~DFGl~~~~~~~~~~~~~~~~~~~gt~~y~a 180 (303)
T d1vjya_ 102 MIKLALSTASGLAHLHMEIVGTQGKPAIA-HRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMA 180 (303)
T ss_dssp HHHHHHHHHHHHHHHHCCBCSTTCBCEEE-CSCCCGGGEEECTTSCEEECCCTTCEEEETTTTEECC----CCSCGGGCC
T ss_pred HHHHHHHHHHHHHHHHHhhhhhccCCCee-ccccCccceEEcCCCCeEEEecCccccccCCCcceeccccceecccCcCC
Confidence 68999999999999996 4777 9999999999999999999999998866443322 12245679999999
Q ss_pred CccccCCCCC---CCCCccchHHHHHHHHHHHhCCCCCCCCC-------------CChHHHHHHHhcCCCCCCCCCC---
Q psy1840 95 PELLRQPHLP---RGTQKGDVYSFGLVLYEVIGRQGPWGHLR-------------MTDEEIITSVTQGSGLRPDTSS--- 155 (423)
Q Consensus 95 PE~l~~~~~~---~~s~ksDVyS~Giil~elltg~~Pf~~~~-------------~~~~~i~~~i~~~~~~~p~~~~--- 155 (423)
||++.+.... .++.++|||||||++|||+||..||.... .....+.. .......+|..+.
T Consensus 181 PE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~p~~~~~~~ 259 (303)
T d1vjya_ 181 PEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRK-VVCEQKLRPNIPNRWQ 259 (303)
T ss_dssp HHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCCHHHHHH-HHTTSCCCCCCCGGGG
T ss_pred hhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhcccccchHHHHHH-HHhccccCCCCCcccC
Confidence 9998764311 13678999999999999999987763211 12233333 3333334444332
Q ss_pred -CCchHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHhhh
Q psy1840 156 -LDCAPSIIACMRTCWEEDPELRPDLRFVHHKLKEMNAG 193 (423)
Q Consensus 156 -~~~~~~l~~Li~~C~~~dP~~RPt~~~I~~~L~~i~~~ 193 (423)
..+...+.+|+.+||+.||++|||+.+|++.|+++...
T Consensus 260 ~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~ 298 (303)
T d1vjya_ 260 SCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQ 298 (303)
T ss_dssp GCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHh
Confidence 23456799999999999999999999999999988754
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.96 E-value=1.1e-29 Score=242.84 Aligned_cols=154 Identities=21% Similarity=0.229 Sum_probs=120.4
Q ss_pred HHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCccEEEeccCCcccccCCCcccccccccCCccccCCccccCCCCC
Q psy1840 25 SISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKAPELLRQPHLP 104 (423)
Q Consensus 25 ~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~ 104 (423)
...++.||+.||+|||++|++ ||||||+|||++.++.+||+|||+++....... ......||+.|+|||++.+..
T Consensus 102 ~~~~~~qil~aL~~lH~~~ii-HrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~-- 176 (299)
T d1ua2a_ 102 IKAYMLMTLQGLEYLHQHWIL-HRDLKPNNLLLDENGVLKLADFGLAKSFGSPNR--AYTHQVVTRWYRAPELLFGAR-- 176 (299)
T ss_dssp HHHHHHHHHHHHHHHHHTTCC-CCCCCGGGEEECTTCCEEECCCGGGSTTTSCCC--CCCCSCCCCTTCCHHHHTTCS--
T ss_pred HHHHHHHHHHHHHHhhcccee-cccCCcceEEecCCCccccccCccccccCCCcc--cccceecChhhccHHHHccCC--
Confidence 578999999999999999998 999999999999999999999999876543322 223457899999999987543
Q ss_pred CCCCccchHHHHHHHHHHHhCCCCCCCCCCChHHHHHHHhcC--CCC------------------CCCCC----CCCchH
Q psy1840 105 RGTQKGDVYSFGLVLYEVIGRQGPWGHLRMTDEEIITSVTQG--SGL------------------RPDTS----SLDCAP 160 (423)
Q Consensus 105 ~~s~ksDVyS~Giil~elltg~~Pf~~~~~~~~~i~~~i~~~--~~~------------------~p~~~----~~~~~~ 160 (423)
.++.++|||||||++|||++|..||.. .+..+.+..+... .+. .+..+ ....++
T Consensus 177 ~~~~~~DiwSlGvil~el~~g~~pf~~--~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~ 254 (299)
T d1ua2a_ 177 MYGVGVDMWAVGCILAELLLRVPFLPG--DSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGD 254 (299)
T ss_dssp CCCHHHHHHHHHHHHHHHHHSSCSSCC--SSHHHHHHHHHHHHCCCCTTTSSSTTSSTTCCCCCCCCCCCHHHHCTTCCH
T ss_pred CCChhhhhhhcchHHHHHHhCcCCCCC--CCHHHHHHHHHHhcCCCChhhccchhccchhhhhccCCCCChHHhcccCCH
Confidence 248999999999999999999999974 3444544444321 000 00000 124578
Q ss_pred HHHHHHHHhhhcCCCCCCCHHHHHH
Q psy1840 161 SIIACMRTCWEEDPELRPDLRFVHH 185 (423)
Q Consensus 161 ~l~~Li~~C~~~dP~~RPt~~~I~~ 185 (423)
++.+|+.+||+.||++|||+.++++
T Consensus 255 ~~~dll~~~L~~dP~~R~sa~e~L~ 279 (299)
T d1ua2a_ 255 DLLDLIQGLFLFNPCARITATQALK 279 (299)
T ss_dssp HHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred HHHHHHHHHccCChhhCcCHHHHhC
Confidence 9999999999999999999999875
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.96 E-value=5.6e-30 Score=244.98 Aligned_cols=164 Identities=14% Similarity=0.236 Sum_probs=123.8
Q ss_pred HHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEc---CCccEEEeccCCcccccCCCcc-----cccccccCCccccCCc
Q psy1840 25 SISVNTTASVGMIHLHDSEIISHGNLRSSNCLID---SRWVLQIADFGLHAFKAGQDET-----GQERKLRRRKLYKAPE 96 (423)
Q Consensus 25 ~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld---~~~~vKL~DFGla~~~~~~~~~-----~~~~~~~gt~~y~APE 96 (423)
.+.++.|++.||+|||++|++ ||||||+||+++ .+..+||+|||+++........ .......||+.|+|||
T Consensus 105 ~~~~~~qi~~~l~~lH~~~ii-HrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE 183 (299)
T d1ckia_ 105 VLLLADQMISRIEYIHSKNFI-HRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASIN 183 (299)
T ss_dssp HHHHHHHHHHHHHHHHHTTEE-CSCCCGGGEEECCGGGTTCEEECCCSSCEECBCTTTCCBCCCCBCCSCCCCSSSCCHH
T ss_pred HHHHHHHHHHHHHHHHHCCee-eccCCHhhccccccCCCceeeeeccCcceeccccccccceeccccCCcCCCccccCHH
Confidence 689999999999999999988 999999999985 4567999999999876433221 1234567999999999
Q ss_pred cccCCCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCh-HHHHHHHhcCC-CCCCCCCCCCchHHHHHHHHHhhhcCC
Q psy1840 97 LLRQPHLPRGTQKGDVYSFGLVLYEVIGRQGPWGHLRMTD-EEIITSVTQGS-GLRPDTSSLDCAPSIIACMRTCWEEDP 174 (423)
Q Consensus 97 ~l~~~~~~~~s~ksDVyS~Giil~elltg~~Pf~~~~~~~-~~i~~~i~~~~-~~~p~~~~~~~~~~l~~Li~~C~~~dP 174 (423)
.+.+..+ +.++|||||||++|||++|+.||....... ........... ...+......+++++.+++.+||+.+|
T Consensus 184 ~~~~~~~---~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~li~~cl~~~p 260 (299)
T d1ckia_ 184 THLGIEQ---SRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRF 260 (299)
T ss_dssp HHTTBCC---CHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHHSCHHHHTTTSCHHHHHHHHHHHHSCT
T ss_pred HHhCCCC---CChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccCCCChhHhccCCCHHHHHHHHHHccCCh
Confidence 9988765 899999999999999999999997543221 11111111110 011111123688999999999999999
Q ss_pred CCCCCHHHHHHHHHHHhh
Q psy1840 175 ELRPDLRFVHHKLKEMNA 192 (423)
Q Consensus 175 ~~RPt~~~I~~~L~~i~~ 192 (423)
++||++.+|.+.|+.+..
T Consensus 261 ~~RP~~~~i~~~l~~~~~ 278 (299)
T d1ckia_ 261 DDKPDYSYLRQLFRNLFH 278 (299)
T ss_dssp TCCCCHHHHHHHHHHHHH
T ss_pred hHCcCHHHHHHHHHHHHH
Confidence 999999999888877643
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.96 E-value=5e-30 Score=249.39 Aligned_cols=155 Identities=17% Similarity=0.282 Sum_probs=120.4
Q ss_pred HHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcC---CccEEEeccCCcccccCCCcccccccccCCccccCCccccCC
Q psy1840 25 SISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDS---RWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKAPELLRQP 101 (423)
Q Consensus 25 ~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~---~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~ 101 (423)
...++.||+.||+|||+.|++ ||||||+|||++. .+.+||+|||+++...... ......||+.|+|||++.+.
T Consensus 113 ~~~i~~qi~~al~ylH~~~ii-HRDiKp~NIll~~~~~~~~~Kl~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~ 188 (335)
T d2ozaa1 113 ASEIMKSIGEAIQYLHSINIA-HRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHN---SLTTPCYTPYYVAPEVLGPE 188 (335)
T ss_dssp HHHHHHHHHHHHHHHHHTTEE-CCCCSGGGEEESCSSTTCCEEECCCTTCEECCCCC---CCCCCSCCCSSCCCCCCCGG
T ss_pred HHHHHHHHHHHHHHHHHcCCc-cccccccccccccccccccccccccceeeeccCCC---ccccccCCcccCCcHHHcCC
Confidence 579999999999999999998 9999999999985 5679999999998654332 22456799999999999887
Q ss_pred CCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCC--hHHHHHHHhcCCCCCCCCCCCCchHHHHHHHHHhhhcCCCCCCC
Q psy1840 102 HLPRGTQKGDVYSFGLVLYEVIGRQGPWGHLRMT--DEEIITSVTQGSGLRPDTSSLDCAPSIIACMRTCWEEDPELRPD 179 (423)
Q Consensus 102 ~~~~~s~ksDVyS~Giil~elltg~~Pf~~~~~~--~~~i~~~i~~~~~~~p~~~~~~~~~~l~~Li~~C~~~dP~~RPt 179 (423)
.+ +.++|||||||++|+|++|+.||.+.... ...+...+..+....|......+++++.+|+.+||+.||++|||
T Consensus 189 ~y---~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s 265 (335)
T d2ozaa1 189 KY---DKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMT 265 (335)
T ss_dssp GG---SHHHHHHHHHHHHHHHTTSSCSCEETTCC--------CCCSCSSSCCTTHHHHSCHHHHHHHHHHSCSSTTTSCC
T ss_pred CC---CHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCcccccCCHHHHHHHHHHccCChhHCcC
Confidence 65 89999999999999999999999643221 12222233333322232222357889999999999999999999
Q ss_pred HHHHHHH
Q psy1840 180 LRFVHHK 186 (423)
Q Consensus 180 ~~~I~~~ 186 (423)
+.++++.
T Consensus 266 ~~eil~h 272 (335)
T d2ozaa1 266 ITEFMNH 272 (335)
T ss_dssp HHHHHHS
T ss_pred HHHHHcC
Confidence 9999764
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.96 E-value=1.5e-29 Score=244.47 Aligned_cols=149 Identities=24% Similarity=0.359 Sum_probs=126.7
Q ss_pred HHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCccEEEeccCCcccccCCCcccccccccCCccccCCccccCCCCC
Q psy1840 25 SISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKAPELLRQPHLP 104 (423)
Q Consensus 25 ~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~ 104 (423)
...++.||+.||+|||+++++ ||||||+|||++.++.+||+|||+++...... .......||+.|+|||++.+..+
T Consensus 105 ~~~~~~qi~~al~ylH~~~ii-HrDikp~NiL~~~~~~~kl~DFG~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~- 180 (320)
T d1xjda_ 105 ATFYAAEIILGLQFLHSKGIV-YRDLKLDNILLDKDGHIKIADFGMCKENMLGD--AKTNTFCGTPDYIAPEILLGQKY- 180 (320)
T ss_dssp HHHHHHHHHHHHHHHHHTTCB-CCCCCGGGEEECTTSCEEECCCTTCBCCCCTT--CCBCCCCSCGGGCCHHHHTTCCB-
T ss_pred HHHHHHHHHHHHHHHHhCCee-eccCcccceeecCCCceeccccchhhhccccc--ccccccCCCCCcCCHHHHcCCCC-
Confidence 578999999999999999998 99999999999999999999999997654322 22245679999999999998766
Q ss_pred CCCCccchHHHHHHHHHHHhCCCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCchHHHHHHHHHhhhcCCCCCCCHH-HH
Q psy1840 105 RGTQKGDVYSFGLVLYEVIGRQGPWGHLRMTDEEIITSVTQGSGLRPDTSSLDCAPSIIACMRTCWEEDPELRPDLR-FV 183 (423)
Q Consensus 105 ~~s~ksDVyS~Giil~elltg~~Pf~~~~~~~~~i~~~i~~~~~~~p~~~~~~~~~~l~~Li~~C~~~dP~~RPt~~-~I 183 (423)
+.++|||||||++|||++|+.||.+ .+..++...+..+.+..| ..+++++.+|+.+||+.||++||++. ++
T Consensus 181 --~~~~DiwSlGvilyemltG~~PF~~--~~~~~~~~~i~~~~~~~p----~~~s~~~~dli~~~L~~dP~~R~s~~~~l 252 (320)
T d1xjda_ 181 --NHSVDWWSFGVLLYEMLIGQSPFHG--QDEEELFHSIRMDNPFYP----RWLEKEAKDLLVKLFVREPEKRLGVRGDI 252 (320)
T ss_dssp --CTHHHHHHHHHHHHHHHHSSCSSCC--SSHHHHHHHHHHCCCCCC----TTSCHHHHHHHHHHSCSSGGGSBTTBSCG
T ss_pred --CchhhhhhhhHHHHHHHhCCCCCCC--CCHHHHHHHHHcCCCCCC----ccCCHHHHHHHHHhcccCCCCCcCHHHHH
Confidence 8999999999999999999999974 567788888877654433 35789999999999999999999985 56
Q ss_pred HH
Q psy1840 184 HH 185 (423)
Q Consensus 184 ~~ 185 (423)
++
T Consensus 253 ~~ 254 (320)
T d1xjda_ 253 RQ 254 (320)
T ss_dssp GG
T ss_pred Hh
Confidence 43
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.96 E-value=1.2e-29 Score=239.69 Aligned_cols=142 Identities=24% Similarity=0.419 Sum_probs=116.4
Q ss_pred HHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcC-CccEEEeccCCcccccCCCcccccccccCCccccCCccccCCCC
Q psy1840 25 SISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDS-RWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKAPELLRQPHL 103 (423)
Q Consensus 25 ~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~-~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~ 103 (423)
...++.||+.||+|||++|++ ||||||+|||++. ++.+||+|||+++..... ......||+.|+|||++.+..+
T Consensus 112 ~~~~~~qi~~al~~lH~~~ii-HrDiKp~NIll~~~~~~vkl~DFG~a~~~~~~----~~~~~~GT~~y~aPE~~~~~~~ 186 (273)
T d1xwsa_ 112 ARSFFWQVLEAVRHCHNCGVL-HRDIKDENILIDLNRGELKLIDFGSGALLKDT----VYTDFDGTRVYSPPEWIRYHRY 186 (273)
T ss_dssp HHHHHHHHHHHHHHHHHTTEE-CSCCSGGGEEEETTTTEEEECCCTTCEECCSS----CBCCCCSCGGGSCHHHHHHSCB
T ss_pred HHHHHHHHHHHHHHHHHCCCc-cccCcccceEEecCCCeEEECccccceecccc----cccccccCCCcCCHHHHcCCCC
Confidence 568999999999999999998 9999999999985 579999999998764322 2235679999999999986543
Q ss_pred CCCCCccchHHHHHHHHHHHhCCCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCchHHHHHHHHHhhhcCCCCCCCHHHH
Q psy1840 104 PRGTQKGDVYSFGLVLYEVIGRQGPWGHLRMTDEEIITSVTQGSGLRPDTSSLDCAPSIIACMRTCWEEDPELRPDLRFV 183 (423)
Q Consensus 104 ~~~s~ksDVyS~Giil~elltg~~Pf~~~~~~~~~i~~~i~~~~~~~p~~~~~~~~~~l~~Li~~C~~~dP~~RPt~~~I 183 (423)
++.++||||+||++|||++|+.||.. ..+ +..+.... ...+++++.+++.+||+.||++|||+.++
T Consensus 187 --~~~~~DiwSlGvilyell~g~~Pf~~----~~~----i~~~~~~~----~~~~s~~~~~li~~~L~~dp~~R~s~~ei 252 (273)
T d1xwsa_ 187 --HGRSAAVWSLGILLYDMVCGDIPFEH----DEE----IIRGQVFF----RQRVSSECQHLIRWCLALRPSDRPTFEEI 252 (273)
T ss_dssp --CHHHHHHHHHHHHHHHHHHSSCSCCS----HHH----HHHCCCCC----SSCCCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred --CCcccccccceeeehhHhhCCCCCCC----chH----HhhcccCC----CCCCCHHHHHHHHHHccCCHhHCcCHHHH
Confidence 26789999999999999999999963 222 23332222 23578999999999999999999999998
Q ss_pred HH
Q psy1840 184 HH 185 (423)
Q Consensus 184 ~~ 185 (423)
++
T Consensus 253 l~ 254 (273)
T d1xwsa_ 253 QN 254 (273)
T ss_dssp HT
T ss_pred hc
Confidence 76
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=99.95 E-value=7.4e-29 Score=236.66 Aligned_cols=165 Identities=12% Similarity=0.209 Sum_probs=127.7
Q ss_pred HHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcC-----CccEEEeccCCcccccCCCc-----ccccccccCCccccC
Q psy1840 25 SISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDS-----RWVLQIADFGLHAFKAGQDE-----TGQERKLRRRKLYKA 94 (423)
Q Consensus 25 ~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~-----~~~vKL~DFGla~~~~~~~~-----~~~~~~~~gt~~y~A 94 (423)
.+.++.|++.||+|||+.|++ ||||||+||+++. ++.+||+|||+++....... ........||+.|+|
T Consensus 103 ~~~i~~q~~~~l~~lH~~gii-HrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~~~~~~GT~~y~a 181 (293)
T d1csna_ 103 VAMAAKQMLARVQSIHEKSLV-YRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMS 181 (293)
T ss_dssp HHHHHHHHHHHHHHHHTTTEE-CCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCC
T ss_pred HHHHHHHHHHHHHHHHHCCce-eccCCccceeecCcccccCCceEEcccceeEEcccCccccceeecccCceEEchhhcC
Confidence 679999999999999999988 9999999999974 57899999999987543221 122345679999999
Q ss_pred CccccCCCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCC-ChHHHHHHHhcCCC-CCCCCCCCCchHHHHHHHHHhhhc
Q psy1840 95 PELLRQPHLPRGTQKGDVYSFGLVLYEVIGRQGPWGHLRM-TDEEIITSVTQGSG-LRPDTSSLDCAPSIIACMRTCWEE 172 (423)
Q Consensus 95 PE~l~~~~~~~~s~ksDVyS~Giil~elltg~~Pf~~~~~-~~~~i~~~i~~~~~-~~p~~~~~~~~~~l~~Li~~C~~~ 172 (423)
||++.+..+ +.++|||||||++|||++|+.||.+... ...+....+..... ..+......+|+++.+++..||..
T Consensus 182 PE~~~~~~~---~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~~l~~ii~~~~~~ 258 (293)
T d1csna_ 182 INTHLGREQ---SRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLRELCAGFPEEFYKYMHYARNL 258 (293)
T ss_dssp HHHHTTCCC---CHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHSCHHHHTTTSCHHHHHHHHHHHHC
T ss_pred HHHhcCCCC---ChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhccCCCChHHhcCCCCHHHHHHHHHHhcC
Confidence 999988655 8999999999999999999999975433 33333333332111 111111235789999999999999
Q ss_pred CCCCCCCHHHHHHHHHHHhhh
Q psy1840 173 DPELRPDLRFVHHKLKEMNAG 193 (423)
Q Consensus 173 dP~~RPt~~~I~~~L~~i~~~ 193 (423)
+|++||+++.+.+.|+++...
T Consensus 259 ~~~~rP~y~~l~~~l~~~~~~ 279 (293)
T d1csna_ 259 AFDATPDYDYLQGLFSKVLER 279 (293)
T ss_dssp CTTCCCCHHHHHHHHHHHHHH
T ss_pred CcccCcCHHHHHHHHHHHHHH
Confidence 999999999998887776543
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.95 E-value=3.2e-29 Score=242.27 Aligned_cols=153 Identities=17% Similarity=0.226 Sum_probs=127.7
Q ss_pred HHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcC--CccEEEeccCCcccccCCCcccccccccCCccccCCccccCCC
Q psy1840 25 SISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDS--RWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKAPELLRQPH 102 (423)
Q Consensus 25 ~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~--~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~ 102 (423)
...++.||+.||.|||++|++ ||||||+|||++. .+.+||+|||+++...... ......+++.|+|||.+.+..
T Consensus 104 ~~~i~~qi~~al~yLH~~~ii-HrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~~---~~~~~~~t~~y~ape~~~~~~ 179 (321)
T d1tkia_ 104 IVSYVHQVCEALQFLHSHNIG-HFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGD---NFRLLFTAPEYYAPEVHQHDV 179 (321)
T ss_dssp HHHHHHHHHHHHHHHHHTTEE-CCCCCGGGEEESSSSCCCEEECCCTTCEECCTTC---EEEEEESCGGGSCHHHHTTCE
T ss_pred HHHHHHHHHHHHHHHHHcCCC-cccccccceeecCCCceEEEEcccchhhccccCC---cccccccccccccchhccCCC
Confidence 578999999999999999998 9999999999984 4589999999987654322 224457889999999998776
Q ss_pred CCCCCCccchHHHHHHHHHHHhCCCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCchHHHHHHHHHhhhcCCCCCCCHHH
Q psy1840 103 LPRGTQKGDVYSFGLVLYEVIGRQGPWGHLRMTDEEIITSVTQGSGLRPDTSSLDCAPSIIACMRTCWEEDPELRPDLRF 182 (423)
Q Consensus 103 ~~~~s~ksDVyS~Giil~elltg~~Pf~~~~~~~~~i~~~i~~~~~~~p~~~~~~~~~~l~~Li~~C~~~dP~~RPt~~~ 182 (423)
+ +.++||||+||++|+|++|..||.. .+..++...+..+....+......+++++.+|+.+||..||++|||+.+
T Consensus 180 ~---~~~~DiWSlGvily~ll~G~~Pf~~--~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e 254 (321)
T d1tkia_ 180 V---STATDMWSLGTLVYVLLSGINPFLA--ETNQQIIENIMNAEYTFDEEAFKEISIEAMDFVDRLLVKERKSRMTASE 254 (321)
T ss_dssp E---CHHHHHHHHHHHHHHHHHSSCTTCC--SSHHHHHHHHHHTCCCCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHH
T ss_pred C---CchhhcccHHHHHHHHHhCCCCCCC--CCHHHHHHHHHhCCCCCChhhccCCCHHHHHHHHHHccCChhHCcCHHH
Confidence 5 8999999999999999999999974 4567788888776544443333467899999999999999999999999
Q ss_pred HHHH
Q psy1840 183 VHHK 186 (423)
Q Consensus 183 I~~~ 186 (423)
+++.
T Consensus 255 il~h 258 (321)
T d1tkia_ 255 ALQH 258 (321)
T ss_dssp HHHS
T ss_pred HhcC
Confidence 9873
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.95 E-value=1.6e-28 Score=234.74 Aligned_cols=155 Identities=17% Similarity=0.219 Sum_probs=120.4
Q ss_pred HHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCccEEEeccCCcccccCCCcccccccccCCccccCCccccCCCCC
Q psy1840 25 SISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKAPELLRQPHLP 104 (423)
Q Consensus 25 ~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~ 104 (423)
...++.||+.||+|||+.|++ ||||||+|||++.++.+||+|||+++....... ......||+.|+|||.+....+
T Consensus 104 ~~~~~~qil~~L~yLH~~~Ii-HrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~~--~~~~~~gt~~y~apE~~~~~~~- 179 (298)
T d1gz8a_ 104 IKSYLFQLLQGLAFCHSHRVL-HRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--TYTHEVVTLWYRAPEILLGCKY- 179 (298)
T ss_dssp HHHHHHHHHHHHHHHHHTTCC-CSCCCGGGEEECTTSCEEECSTTHHHHHCCCSB--CTTCCBCCCTTCCHHHHTTCSS-
T ss_pred HHHHHHHHHHHHHHhhcCCEE-ccccCchheeecccCcceeccCCcceeccCCcc--cceeecccceeeehhhhccccC-
Confidence 679999999999999999998 999999999999999999999999876543322 2245578999999998876542
Q ss_pred CCCCccchHHHHHHHHHHHhCCCCCCCCCCChHHHHHHHhcC--C-------------CCC---CCCC-------CCCch
Q psy1840 105 RGTQKGDVYSFGLVLYEVIGRQGPWGHLRMTDEEIITSVTQG--S-------------GLR---PDTS-------SLDCA 159 (423)
Q Consensus 105 ~~s~ksDVyS~Giil~elltg~~Pf~~~~~~~~~i~~~i~~~--~-------------~~~---p~~~-------~~~~~ 159 (423)
.+.++||||+||++|+|++|+.||.+. +..+.+..+... . ... +... ...++
T Consensus 180 -~~~~~DiwSlGvily~m~~G~~Pf~~~--~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s 256 (298)
T d1gz8a_ 180 -YSTAVDIWSLGCIFAEMVTRRALFPGD--SEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLD 256 (298)
T ss_dssp -CCTHHHHHHHHHHHHHHHHSSCSCCCS--SHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTSCCCCCCCHHHHSTTCC
T ss_pred -CCccccccccchhhhHHhhCCCCCCCC--CHHHHHHHHHHhcCCCchhhccccccccccccccccccccchhhhccCCC
Confidence 378999999999999999999999743 334444333211 0 000 0000 12457
Q ss_pred HHHHHHHHHhhhcCCCCCCCHHHHHHH
Q psy1840 160 PSIIACMRTCWEEDPELRPDLRFVHHK 186 (423)
Q Consensus 160 ~~l~~Li~~C~~~dP~~RPt~~~I~~~ 186 (423)
+++.+|+.+||+.||++|||+.++++.
T Consensus 257 ~~~~dll~~mL~~dP~~R~t~~ell~H 283 (298)
T d1gz8a_ 257 EDGRSLLSQMLHYDPNKRISAKAALAH 283 (298)
T ss_dssp HHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred HHHHHHHHHHccCChhHCcCHHHHhCC
Confidence 889999999999999999999999764
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.95 E-value=4.2e-28 Score=233.76 Aligned_cols=157 Identities=20% Similarity=0.223 Sum_probs=117.9
Q ss_pred HHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCccEEEeccCCcccccCCCcc--cccccccCCccccCCccccCCC
Q psy1840 25 SISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDET--GQERKLRRRKLYKAPELLRQPH 102 (423)
Q Consensus 25 ~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~~--~~~~~~~gt~~y~APE~l~~~~ 102 (423)
...++.||+.||.|||+.|++ ||||||+|||++.++.+||+|||+++........ .......||+.|+|||.+.+..
T Consensus 119 ~~~i~~qil~~l~~lH~~~iv-HrDlKp~NILl~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~ 197 (318)
T d3blha1 119 IKRVMQMLLNGLYYIHRNKIL-HRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGER 197 (318)
T ss_dssp HHHHHHHHHHHHHHHHHTTEE-CCCCCGGGEEECTTSCEEECCCTTCEECCC-----CCCCCSCCSCGGGCCHHHHTTCS
T ss_pred HHHHHHHHHHHHHHhccCCEE-ecCcCchheeecCCCcEEeeecceeeecccccccccccccceecCHHHhhHHHHcCCC
Confidence 468999999999999999998 9999999999999999999999998765432221 2223457899999999987653
Q ss_pred CCCCCCccchHHHHHHHHHHHhCCCCCCCCCCChHHHHHHHhcCCCCCCCCC-------------------C--------
Q psy1840 103 LPRGTQKGDVYSFGLVLYEVIGRQGPWGHLRMTDEEIITSVTQGSGLRPDTS-------------------S-------- 155 (423)
Q Consensus 103 ~~~~s~ksDVyS~Giil~elltg~~Pf~~~~~~~~~i~~~i~~~~~~~p~~~-------------------~-------- 155 (423)
.++.++||||+||++|||++|+.||.+ .+..+....+.......+... .
T Consensus 198 --~~~~k~DiwSlGvil~el~~g~~pf~~--~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 273 (318)
T d3blha1 198 --DYGPPIDLWGAGCIMAEMWTRSPIMQG--NTEQHQLALISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLK 273 (318)
T ss_dssp --SCCTHHHHHHHHHHHHHHHHSSCSCCC--SSHHHHHHHHHHHHCCCCTTTSTTCCCC-------CCSSCCBCHHHHHH
T ss_pred --CCCcHHHcccCCceeeeHhhCCCCCCC--CCHHHHHHHHHHhcCCCChhhccccchhhhhhhhcccccccccchhhhc
Confidence 248999999999999999999999974 334444443332110000000 0
Q ss_pred -CCchHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q psy1840 156 -LDCAPSIIACMRTCWEEDPELRPDLRFVHHK 186 (423)
Q Consensus 156 -~~~~~~l~~Li~~C~~~dP~~RPt~~~I~~~ 186 (423)
...++.+.+||.+||+.||++|||+.++++.
T Consensus 274 ~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~H 305 (318)
T d3blha1 274 AYVRDPYALDLIDKLLVLDPAQRIDSDDALNH 305 (318)
T ss_dssp HHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred cccCCHHHHHHHHHHCcCChhHCcCHHHHHcC
Confidence 0125677899999999999999999999864
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=99.95 E-value=4.2e-28 Score=230.35 Aligned_cols=154 Identities=19% Similarity=0.226 Sum_probs=116.6
Q ss_pred HHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCccEEEeccCCcccccCCCcccccccccCCccccCCccccCCCCC
Q psy1840 25 SISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKAPELLRQPHLP 104 (423)
Q Consensus 25 ~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~ 104 (423)
...++.||+.||+|||+.+++ ||||||+|||++.++.+|++|||.+........ ......+++.|+|||.+.+..
T Consensus 102 ~~~i~~qi~~~L~~LH~~~Iv-HrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~~--~~~~~~~~~~y~~pE~~~~~~-- 176 (286)
T d1ob3a_ 102 AKSFLLQLLNGIAYCHDRRVL-HRDLKPQNLLINREGELKIADFGLARAFGIPVR--KYTHEIVTLWYRAPDVLMGSK-- 176 (286)
T ss_dssp HHHHHHHHHHHHHHHHHTTCC-CSCCCGGGEEECTTSCEEECCTTHHHHHCC-----------CCCTTCCHHHHTTCC--
T ss_pred hHHHHHHHHHHHHHhccCcEE-ecCCCCceeeEcCCCCEEecccccceecccCcc--ccceecccchhhhHHHHhCCC--
Confidence 578999999999999999998 999999999999999999999999876533221 223446888999999987654
Q ss_pred CCCCccchHHHHHHHHHHHhCCCCCCCCCCChHHHHHHHhcC--CC-----------------------CCCCCCCCCch
Q psy1840 105 RGTQKGDVYSFGLVLYEVIGRQGPWGHLRMTDEEIITSVTQG--SG-----------------------LRPDTSSLDCA 159 (423)
Q Consensus 105 ~~s~ksDVyS~Giil~elltg~~Pf~~~~~~~~~i~~~i~~~--~~-----------------------~~p~~~~~~~~ 159 (423)
..+.++|||||||++|||++|+.||.+ .+..+.+.++... .+ .........++
T Consensus 177 ~~~~~~DiwslGv~l~el~~G~~pf~~--~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s 254 (286)
T d1ob3a_ 177 KYSTTIDIWSVGCIFAEMVNGTPLFPG--VSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTVYEPLPWESFLKGLD 254 (286)
T ss_dssp SCCTHHHHHHHHHHHHHHHHSSCSCCC--SSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTCCCCCCCCGGGTCCSCC
T ss_pred CCCcceeehhcCcHHHHHHHCCCCCCC--CCHHHHHHHHHHhhCCCChhhccchhhhhhcccccccccCcchhhhcccCC
Confidence 248999999999999999999999974 3344444443210 00 00001123467
Q ss_pred HHHHHHHHHhhhcCCCCCCCHHHHHH
Q psy1840 160 PSIIACMRTCWEEDPELRPDLRFVHH 185 (423)
Q Consensus 160 ~~l~~Li~~C~~~dP~~RPt~~~I~~ 185 (423)
+++.+++.+||+.||++|||+.++++
T Consensus 255 ~~~~dli~~~L~~dP~~R~s~~ell~ 280 (286)
T d1ob3a_ 255 ESGIDLLSKMLKLDPNQRITAKQALE 280 (286)
T ss_dssp HHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred HHHHHHHHHHccCChhHCcCHHHHhc
Confidence 89999999999999999999999874
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.94 E-value=1.2e-27 Score=233.93 Aligned_cols=154 Identities=21% Similarity=0.187 Sum_probs=118.1
Q ss_pred HHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCc-cEEEeccCCcccccCCCcccccccccCCccccCCccccCCCC
Q psy1840 25 SISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRW-VLQIADFGLHAFKAGQDETGQERKLRRRKLYKAPELLRQPHL 103 (423)
Q Consensus 25 ~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~-~vKL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~ 103 (423)
...++.||+.||+|||++||+ ||||||+|||++.++ .+||+|||+++....... .....|+..|+|||.+.+..
T Consensus 124 ~~~i~~qil~aL~yLH~~~Ii-HrDiKp~NILl~~~~~~~kl~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~- 198 (350)
T d1q5ka_ 124 VKLYMYQLFRSLAYIHSFGIC-HRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEP---NVSYICSRYYRAPELIFGAT- 198 (350)
T ss_dssp HHHHHHHHHHHHHHHHTTTEE-CCCCCGGGEEECTTTCCEEECCCTTCEECCTTSC---CCSCCSCTTSCCHHHHTTCS-
T ss_pred HHHHHHHHHHHHHHHHhcCCc-ccCCCcceEEEecCCCceeEecccchhhccCCcc---cccccccccccChHHhhccc-
Confidence 568999999999999999998 999999999999775 899999999876543322 23457889999999887643
Q ss_pred CCCCCccchHHHHHHHHHHHhCCCCCCCCCCChHHHHHHHhc---------------C--CCCCCC--------CCCCCc
Q psy1840 104 PRGTQKGDVYSFGLVLYEVIGRQGPWGHLRMTDEEIITSVTQ---------------G--SGLRPD--------TSSLDC 158 (423)
Q Consensus 104 ~~~s~ksDVyS~Giil~elltg~~Pf~~~~~~~~~i~~~i~~---------------~--~~~~p~--------~~~~~~ 158 (423)
.++.++||||+||++|||++|..||... +..+.+..+.. . ....+. ......
T Consensus 199 -~~~~~~DIwSlG~il~el~~g~~pf~~~--~~~~~l~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 275 (350)
T d1q5ka_ 199 -DYTSSIDVWSAGCVLAELLLGQPIFPGD--SGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRT 275 (350)
T ss_dssp -SCCTHHHHHHHHHHHHHHHHTSCSSCCS--SHHHHHHHHHHHHCCCCHHHHHHHCC---CCCCCCCCCCCGGGTSCTTS
T ss_pred -CCCcceeecccceEEEehhhCCCCCCCC--CHHHHHHHHHHHhCCChHHhhhhhccchhhccccccccCchhhhcccCC
Confidence 2489999999999999999999999743 23333332211 0 000111 112346
Q ss_pred hHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q psy1840 159 APSIIACMRTCWEEDPELRPDLRFVHHK 186 (423)
Q Consensus 159 ~~~l~~Li~~C~~~dP~~RPt~~~I~~~ 186 (423)
++++.+|+.+||..||++|||+.++++.
T Consensus 276 s~~~~dLl~~mL~~dP~~R~ta~e~L~H 303 (350)
T d1q5ka_ 276 PPEAIALCSRLLEYTPTARLTPLEACAH 303 (350)
T ss_dssp CHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred CHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 8899999999999999999999998763
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.94 E-value=2.5e-28 Score=236.02 Aligned_cols=155 Identities=19% Similarity=0.251 Sum_probs=120.6
Q ss_pred HHHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCccEEEeccCCcccccCCCcccccccccCCccccCCccccCCCC
Q psy1840 24 GSISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKAPELLRQPHL 103 (423)
Q Consensus 24 ~~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~ 103 (423)
....++.||+.||+|||+.+++ ||||||+||+++.++.+||+|||+++...... ........|++.|+|||.+.+...
T Consensus 130 ~~~~~~~Qi~~al~~lH~~~iv-HrDiKp~Nill~~~~~vkL~DFG~a~~~~~~~-~~~~~~~~g~~~~~~pe~~~~~~~ 207 (322)
T d1vzoa_ 130 EVQIYVGEIVLALEHLHKLGII-YRDIKLENILLDSNGHVVLTDFGLSKEFVADE-TERAYDFCGTIEYMAPDIVRGGDS 207 (322)
T ss_dssp HHHHHHHHHHHHHHHHHHTTCC-CCCCCGGGEEECTTSCEEESCSSEEEECCGGG-GGGGCGGGSCCTTCCHHHHTTCC-
T ss_pred HHHHHHHHHHHHHHHhhcCCEE-eccCCccceeecCCCCEEEeeccchhhhcccc-cccccccccccccchhHHhhcCCc
Confidence 3567899999999999999998 99999999999999999999999987654322 222345678999999999976542
Q ss_pred CCCCCccchHHHHHHHHHHHhCCCCCCCCC--CChHHHHHHHhcCCCCCCCCCCCCchHHHHHHHHHhhhcCCCCCCC--
Q psy1840 104 PRGTQKGDVYSFGLVLYEVIGRQGPWGHLR--MTDEEIITSVTQGSGLRPDTSSLDCAPSIIACMRTCWEEDPELRPD-- 179 (423)
Q Consensus 104 ~~~s~ksDVyS~Giil~elltg~~Pf~~~~--~~~~~i~~~i~~~~~~~p~~~~~~~~~~l~~Li~~C~~~dP~~RPt-- 179 (423)
.++.++|||||||++|||++|+.||.... .....+........... +..+++++.+++.+||+.||++||+
T Consensus 208 -~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~~~~~~~~~----~~~~s~~~~~li~~~l~~dP~~R~s~~ 282 (322)
T d1vzoa_ 208 -GHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPY----PQEMSALAKDLIQRLLMKDPKKRLGCG 282 (322)
T ss_dssp ---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCCCCC----CTTSCHHHHHHHHHHTCSSGGGSTTSS
T ss_pred -CCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcccCCCCC----cccCCHHHHHHHHHHcccCHHHcCCCC
Confidence 34789999999999999999999996543 22334444433332222 2358899999999999999999994
Q ss_pred ---HHHHHH
Q psy1840 180 ---LRFVHH 185 (423)
Q Consensus 180 ---~~~I~~ 185 (423)
++++++
T Consensus 283 ~~t~~eil~ 291 (322)
T d1vzoa_ 283 PRDADEIKE 291 (322)
T ss_dssp TTTHHHHHT
T ss_pred cccHHHHHc
Confidence 677764
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.94 E-value=2.4e-27 Score=231.19 Aligned_cols=152 Identities=20% Similarity=0.236 Sum_probs=118.7
Q ss_pred HHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCccEEEeccCCcccccCCCcccccccccCCccccCCccccCCCCC
Q psy1840 25 SISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKAPELLRQPHLP 104 (423)
Q Consensus 25 ~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~ 104 (423)
...++.||+.||+|||++|++ ||||||+|||++.++.+|++|||+++..... .....+|+.|+|||.+.+..
T Consensus 123 ~~~~~~qi~~aL~~LH~~~Ii-HrDiKp~NIL~~~~~~~kl~Dfg~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~-- 194 (346)
T d1cm8a_ 123 IQFLVYQMLKGLRYIHAAGII-HRDLKPGNLAVNEDCELKILDFGLARQADSE-----MTGYVVTRWYRAPEVILNWM-- 194 (346)
T ss_dssp HHHHHHHHHHHHHHHHHTTEE-CCCCCGGGEEECTTCCEEECCCTTCEECCSS-----CCSSCSCGGGCCTHHHHTTT--
T ss_pred HHHHHHHHHHHHHHHHhCCCc-ccccCcchhhcccccccccccccceeccCCc-----cccccccccccCHHHHcCCC--
Confidence 578999999999999999998 9999999999999999999999998765322 23467889999999987643
Q ss_pred CCCCccchHHHHHHHHHHHhCCCCCCCCCCChHHHHHHHhcC------------------------CCCC---CCCCCCC
Q psy1840 105 RGTQKGDVYSFGLVLYEVIGRQGPWGHLRMTDEEIITSVTQG------------------------SGLR---PDTSSLD 157 (423)
Q Consensus 105 ~~s~ksDVyS~Giil~elltg~~Pf~~~~~~~~~i~~~i~~~------------------------~~~~---p~~~~~~ 157 (423)
..+.++||||+||++|||++|..||.+. +....+..+... .... .......
T Consensus 195 ~~~~~~DiwSlGvil~ell~g~~pf~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 272 (346)
T d1cm8a_ 195 RYTQTVDIWSVGCIMAEMITGKTLFKGS--DHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTN 272 (346)
T ss_dssp CCCTTHHHHHHHHHHHHHHHSSCSSCCS--SHHHHHHHHHHHHCCCCHHHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTT
T ss_pred CCCccchhhcchHHHHHHHHCcCCCCCC--ChHHHHHHHHhccCCCcHHHHhhhcchhhhhhhccCCcccccchHHhccC
Confidence 2389999999999999999999999753 222222221110 0000 0011235
Q ss_pred chHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q psy1840 158 CAPSIIACMRTCWEEDPELRPDLRFVHHK 186 (423)
Q Consensus 158 ~~~~l~~Li~~C~~~dP~~RPt~~~I~~~ 186 (423)
+++.+.+|+.+||..||.+|||+.++++.
T Consensus 273 ~s~~~~dli~~mL~~dP~~R~ta~eiL~H 301 (346)
T d1cm8a_ 273 ASPLAVNLLEKMLVLDAEQRVTAGEALAH 301 (346)
T ss_dssp CCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred CCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 68899999999999999999999999864
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.94 E-value=1.2e-27 Score=233.46 Aligned_cols=157 Identities=17% Similarity=0.238 Sum_probs=118.6
Q ss_pred HHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCccEEEeccCCcccccCCCcc-cccccccCCccccCCccccCCCC
Q psy1840 25 SISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDET-GQERKLRRRKLYKAPELLRQPHL 103 (423)
Q Consensus 25 ~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~~-~~~~~~~gt~~y~APE~l~~~~~ 103 (423)
...++.||+.||+|||++|++ ||||||+|||+++++.+||+|||++......... .......|++.|+|||++....
T Consensus 111 i~~i~~qil~al~yLH~~~ii-HRDIKp~NILl~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~- 188 (345)
T d1pmea_ 111 ICYFLYQILRGLKYIHSANVL-HRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSK- 188 (345)
T ss_dssp HHHHHHHHHHHHHHHHHTTEE-CCCCCGGGEEECTTCCEEECCCTTCEECCGGGCBCCTTCCCCSCGGGCCGGGTTTBC-
T ss_pred HHHHHHHHHHHHHHHHHCCCc-CCCCCcceEEECCCCCEEEcccCceeeccCCCccceeeccccccceechHHHhhcCC-
Confidence 579999999999999999998 9999999999999999999999998765433221 2234567899999999986543
Q ss_pred CCCCCccchHHHHHHHHHHHhCCCCCCCCCCChHHHHHHHhc------------------------CCCCCCC---CCCC
Q psy1840 104 PRGTQKGDVYSFGLVLYEVIGRQGPWGHLRMTDEEIITSVTQ------------------------GSGLRPD---TSSL 156 (423)
Q Consensus 104 ~~~s~ksDVyS~Giil~elltg~~Pf~~~~~~~~~i~~~i~~------------------------~~~~~p~---~~~~ 156 (423)
.++.++||||+||++|||++|+.||.... ..+....... .....+. ....
T Consensus 189 -~~~~~~DiwSlG~il~eml~g~~pf~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (345)
T d1pmea_ 189 -GYTKSIDIWSVGCILAEMLSNRPIFPGKH--YLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFP 265 (345)
T ss_dssp -SCSTHHHHHHHHHHHHHHHHSSCSCCCSS--HHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCT
T ss_pred -CCCchhhhhccCceehHHhhCCCCCCCCC--HHHHHHHHhhhccCCChhhhhhhhhhhhhcccccCCccCCCCHHHhCC
Confidence 24889999999999999999999997432 2222111110 0000000 0012
Q ss_pred CchHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q psy1840 157 DCAPSIIACMRTCWEEDPELRPDLRFVHHK 186 (423)
Q Consensus 157 ~~~~~l~~Li~~C~~~dP~~RPt~~~I~~~ 186 (423)
..++++.+|+.+||+.||.+|||+.++++.
T Consensus 266 ~~s~~~~~li~~~L~~dP~~R~ta~e~L~h 295 (345)
T d1pmea_ 266 NADSKALDLLDKMLTFNPHKRIEVEQALAH 295 (345)
T ss_dssp TSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred CCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 467889999999999999999999999763
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.93 E-value=2.1e-26 Score=218.65 Aligned_cols=155 Identities=15% Similarity=0.101 Sum_probs=118.6
Q ss_pred HHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCccEEEeccCCcccccCCCcccccccccCCccccCCccccCCCCC
Q psy1840 25 SISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKAPELLRQPHLP 104 (423)
Q Consensus 25 ~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~ 104 (423)
...++.|++.||+|||++|++ ||||||+|||++.++.+||+|||.++........ .....++..|+|||.+.+..
T Consensus 103 ~~~~~~q~~~aL~~lH~~~Iv-HrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~~~--~~~~~~~~~~~~pe~~~~~~-- 177 (292)
T d1unla_ 103 VKSFLFQLLKGLGFCHSRNVL-HRDLKPQNLLINRNGELKLANFGLARAFGIPVRC--YSAEVVTLWYRPPDVLFGAK-- 177 (292)
T ss_dssp HHHHHHHHHHHHHHHHHTTEE-CCCCSGGGEEECTTCCEEECCCTTCEECCSCCSC--CCSCCSCGGGCCHHHHTTCS--
T ss_pred HHHHHHHHHHHHHHhhcCCEe-eecccCcccccccCCceeeeecchhhcccCCCcc--ceeeccccchhhhhHhccCC--
Confidence 579999999999999999998 9999999999999999999999998865433222 23345677899999887654
Q ss_pred CCCCccchHHHHHHHHHHHhCCCCCCCCCCChHHHHHHHhcC--CC-----------------------CCCCCCCCCch
Q psy1840 105 RGTQKGDVYSFGLVLYEVIGRQGPWGHLRMTDEEIITSVTQG--SG-----------------------LRPDTSSLDCA 159 (423)
Q Consensus 105 ~~s~ksDVyS~Giil~elltg~~Pf~~~~~~~~~i~~~i~~~--~~-----------------------~~p~~~~~~~~ 159 (423)
..+.++||||+||++|||++|+.||... .+..+....+... .+ ..........+
T Consensus 178 ~~~~~~DiwSlG~il~ell~g~~p~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s 256 (292)
T d1unla_ 178 LYSTSIDMWSAGCIFAELANAGRPLFPG-NDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLN 256 (292)
T ss_dssp CCCTHHHHHHHHHHHHHHTTTSCCSCCC-SSHHHHHHHHHHHHCCCCTTTCTTGGGSTTCCCCCCCCTTCCCTTTSTTCC
T ss_pred CCCchhhccccchHHHHHhhCCCCCCCC-CCHHHHHHHHHhhcCCCChhhhhhhhhcccccccccccccchhhhccccCC
Confidence 2389999999999999999999997542 2334444443311 00 00011123567
Q ss_pred HHHHHHHHHhhhcCCCCCCCHHHHHH
Q psy1840 160 PSIIACMRTCWEEDPELRPDLRFVHH 185 (423)
Q Consensus 160 ~~l~~Li~~C~~~dP~~RPt~~~I~~ 185 (423)
+.+.+|+.+||+.||.+|||+.++++
T Consensus 257 ~~~~dll~~mL~~dP~~R~sa~e~L~ 282 (292)
T d1unla_ 257 ATGRDLLQNLLKCNPVQRISAEEALQ 282 (292)
T ss_dssp HHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred HHHHHHHHHHccCChhHCcCHHHHhc
Confidence 89999999999999999999999875
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=99.93 E-value=1.8e-26 Score=223.20 Aligned_cols=154 Identities=19% Similarity=0.205 Sum_probs=116.2
Q ss_pred HHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCc-cEEEeccCCcccccCCCcccccccccCCccccCCccccCCCC
Q psy1840 25 SISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRW-VLQIADFGLHAFKAGQDETGQERKLRRRKLYKAPELLRQPHL 103 (423)
Q Consensus 25 ~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~-~vKL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~ 103 (423)
...++.||+.||+|||++|++ ||||||+|||++.++ .+||+|||+++....... .....+|+.|+|||.+.+..
T Consensus 131 i~~i~~qil~aL~~LH~~gIv-HrDiKp~NILi~~~~~~vkl~DFG~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~- 205 (328)
T d3bqca1 131 IRFYMYEILKALDYCHSMGIM-HRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQE---YNVRVASRYFKGPELLVDYQ- 205 (328)
T ss_dssp HHHHHHHHHHHHHHHHHTTEE-CCCCSGGGEEEETTTTEEEECCGGGCEECCTTCC---CCSCCSCGGGCCHHHHTTCC-
T ss_pred HHHHHHHHHHHHHHHhhcccc-cccccccceEEcCCCCeeeecccccceeccCCCc---ccccccCccccCcccccCCC-
Confidence 568999999999999999998 999999999998655 699999999886543322 24557889999999987654
Q ss_pred CCCCCccchHHHHHHHHHHHhCCCCCCCCCCChHHHHHHHh-------------cC-CC-------------------CC
Q psy1840 104 PRGTQKGDVYSFGLVLYEVIGRQGPWGHLRMTDEEIITSVT-------------QG-SG-------------------LR 150 (423)
Q Consensus 104 ~~~s~ksDVyS~Giil~elltg~~Pf~~~~~~~~~i~~~i~-------------~~-~~-------------------~~ 150 (423)
.++.++||||+||++||+++|+.||........ ....+. .. .. ..
T Consensus 206 -~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~-~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 283 (328)
T d3bqca1 206 -MYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYD-QLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFV 283 (328)
T ss_dssp -CCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHH-HHHHHHHHHCHHHHHHHHHHTTCCCCGGGGGTCCCCCCCCGGGGC
T ss_pred -CCCcccchhhhhhhhHHhccCCCCCCCCchhHH-HHHHHHHHHCCchhhhhhhhcccccCcccchhcccccccchhhcc
Confidence 248999999999999999999999965332211 111110 00 00 00
Q ss_pred CCCCCCCchHHHHHHHHHhhhcCCCCCCCHHHHHH
Q psy1840 151 PDTSSLDCAPSIIACMRTCWEEDPELRPDLRFVHH 185 (423)
Q Consensus 151 p~~~~~~~~~~l~~Li~~C~~~dP~~RPt~~~I~~ 185 (423)
+......+++++.+||++||..||.+|||+.++++
T Consensus 284 ~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~ 318 (328)
T d3bqca1 284 HSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME 318 (328)
T ss_dssp CTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred cccccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 11111346789999999999999999999999876
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.92 E-value=3.5e-26 Score=222.82 Aligned_cols=151 Identities=18% Similarity=0.241 Sum_probs=113.6
Q ss_pred HHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCccEEEeccCCcccccCCCcccccccccCCccccCCccccCCCCC
Q psy1840 25 SISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKAPELLRQPHLP 104 (423)
Q Consensus 25 ~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~ 104 (423)
...++.||+.||+|||++|++ ||||||+|||++.++.+|++|||++..... ......|++.|+|||.+.+..
T Consensus 123 ~~~i~~qil~aL~~LH~~gii-HrDiKp~NILi~~~~~~kl~dfg~a~~~~~-----~~~~~~g~~~y~apE~~~~~~-- 194 (348)
T d2gfsa1 123 VQFLIYQILRGLKYIHSADII-HRDLKPSNLAVNEDCELKILDFGLARHTDD-----EMTGYVATRWYRAPEIMLNWM-- 194 (348)
T ss_dssp HHHHHHHHHHHHHHHHHTTCC-CCCCCGGGEEECTTCCEEECCC----CCTG-----GGSSSCHHHHTSCHHHHTTCS--
T ss_pred HHHHHHHHHHHHHHHHhCCCc-ccccCCccccccccccccccccchhcccCc-----ccccccccccccCchhhcCCc--
Confidence 568999999999999999998 999999999999999999999999865422 223456788899999877654
Q ss_pred CCCCccchHHHHHHHHHHHhCCCCCCCCCCChHHHHHHHhcC-----------------------CCCCCCCC----CCC
Q psy1840 105 RGTQKGDVYSFGLVLYEVIGRQGPWGHLRMTDEEIITSVTQG-----------------------SGLRPDTS----SLD 157 (423)
Q Consensus 105 ~~s~ksDVyS~Giil~elltg~~Pf~~~~~~~~~i~~~i~~~-----------------------~~~~p~~~----~~~ 157 (423)
..+.++||||+||++|+|++|+.||.+. +.......+... ....+... ...
T Consensus 195 ~~~~~~DiwSlGv~l~~ll~g~~pF~~~--~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 272 (348)
T d2gfsa1 195 HYNQTVDIWSVGCIMAELLTGRTLFPGT--DHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIG 272 (348)
T ss_dssp CCCTTHHHHHHHHHHHHHHHSSCSCCCS--SHHHHHHHHHHHHCCCCHHHHTTCCCHHHHHHHTTSCCCCCCCHHHHSTT
T ss_pred cCCcccchhhhhHHHHHHHhCCCCCCCC--CHHHHHHHHHHhcCCCChHHhhhccchhhhhhhhhcccCCCcchhhhcCC
Confidence 2388999999999999999999999743 222222222211 00011110 135
Q ss_pred chHHHHHHHHHhhhcCCCCCCCHHHHHH
Q psy1840 158 CAPSIIACMRTCWEEDPELRPDLRFVHH 185 (423)
Q Consensus 158 ~~~~l~~Li~~C~~~dP~~RPt~~~I~~ 185 (423)
+++++.+||.+||+.||.+|||+.++++
T Consensus 273 ~s~~~~dli~~mL~~dP~~R~ta~elL~ 300 (348)
T d2gfsa1 273 ANPLAVDLLEKMLVLDSDKRITAAQALA 300 (348)
T ss_dssp CCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred CCHHHHHHHHHHCcCChhhCcCHHHHhc
Confidence 6789999999999999999999999876
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.92 E-value=1.4e-25 Score=219.33 Aligned_cols=153 Identities=20% Similarity=0.210 Sum_probs=110.0
Q ss_pred HHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCccEEEeccCCcccccCCCcccccccccCCccccCCccccCCCCC
Q psy1840 25 SISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFKAGQDETGQERKLRRRKLYKAPELLRQPHLP 104 (423)
Q Consensus 25 ~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~ 104 (423)
...++.||+.||.|||+.|++ ||||||+|||++.++.+|++|||+++..... .......+|+.|+|||.+.+..+
T Consensus 121 i~~~~~qil~gl~~LH~~gii-HrDlKP~Nil~~~~~~~kl~df~~~~~~~~~---~~~~~~~~t~~y~aPE~l~~~~~- 195 (355)
T d2b1pa1 121 MSYLLYQMLCGIKHLHSAGII-HRDLKPSNIVVKSDCTLKILDFGLARTAGTS---FMMTPYVVTRYYRAPEVILGMGY- 195 (355)
T ss_dssp HHHHHHHHHHHHHHHHHTTCC-CSCCCGGGEEECTTCCEEECCCCC------------------CCTTCCHHHHTTCCC-
T ss_pred HHHHHHHHHHHHHHhhhcccc-cccCCccccccccccceeeechhhhhccccc---cccccccccccccChhhhcCCCC-
Confidence 568999999999999999998 9999999999999999999999997754322 22245578899999999988655
Q ss_pred CCCCccchHHHHHHHHHHHhCCCCCCCCCCChHHHHHHHh----------------------cCCCCCCCCC--------
Q psy1840 105 RGTQKGDVYSFGLVLYEVIGRQGPWGHLRMTDEEIITSVT----------------------QGSGLRPDTS-------- 154 (423)
Q Consensus 105 ~~s~ksDVyS~Giil~elltg~~Pf~~~~~~~~~i~~~i~----------------------~~~~~~p~~~-------- 154 (423)
+.++||||+||+++||++|+.||.+. +.......+. ..........
T Consensus 196 --~~~~DiwSlG~~l~ell~g~~pF~~~--~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 271 (355)
T d2b1pa1 196 --KENVDIWSVGCIMGEMVRHKILFPGR--DYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDS 271 (355)
T ss_dssp --CTTHHHHHHHHHHHHHHHSSCSSCCS--SHHHHHHHHHHHHCCCCHHHHTTSCHHHHHHHHTSCCCCCCCHHHHSCGG
T ss_pred --CCCcccccccchHHHHhhCCCCCCCC--CHHHHHHHHHHhccCCCHHHHHHhhhhHHHHhhcCccccccccccccccc
Confidence 89999999999999999999999643 2222222211 1111000000
Q ss_pred --------CCCchHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q psy1840 155 --------SLDCAPSIIACMRTCWEEDPELRPDLRFVHHK 186 (423)
Q Consensus 155 --------~~~~~~~l~~Li~~C~~~dP~~RPt~~~I~~~ 186 (423)
....++++.+|+++||..||++|||+.++++.
T Consensus 272 ~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~H 311 (355)
T d2b1pa1 272 LFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH 311 (355)
T ss_dssp GSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred cccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 01235678999999999999999999999764
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=99.89 E-value=3.6e-24 Score=209.23 Aligned_cols=152 Identities=21% Similarity=0.298 Sum_probs=110.4
Q ss_pred HHHHHHHHHHHHHHHHh-CCCeeecCCCCCCEEEcCCc------cEEEeccCCcccccCCCcccccccccCCccccCCcc
Q psy1840 25 SISVNTTASVGMIHLHD-SEIISHGNLRSSNCLIDSRW------VLQIADFGLHAFKAGQDETGQERKLRRRKLYKAPEL 97 (423)
Q Consensus 25 ~l~i~~qi~~gL~yLH~-~~ii~HrDLkp~NILld~~~------~vKL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~ 97 (423)
...++.||+.||+|||+ .|++ ||||||+|||++.++ .+|++|||.+...... .....||+.|+|||+
T Consensus 127 i~~i~~qil~al~~lh~~~~Iv-HrDlKp~NIll~~~~~~~~~~~~kl~dfg~s~~~~~~-----~~~~~gt~~y~aPE~ 200 (362)
T d1q8ya_ 127 VKQISKQLLLGLDYMHRRCGII-HTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEH-----YTNSIQTREYRSPEV 200 (362)
T ss_dssp HHHHHHHHHHHHHHHHHTTCEE-CSCCSGGGEEEEEEETTTTEEEEEECCCTTCEETTBC-----CCSCCSCGGGCCHHH
T ss_pred HHHHHHHHHHHHHHHhhhcCcc-cccCChhHeeeeccCcccccceeeEeecccccccccc-----cccccccccccChhh
Confidence 45799999999999998 7887 999999999998665 4999999998754322 234578999999999
Q ss_pred ccCCCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCC----ChHHHHHHH-h-----------cC---------CCC---
Q psy1840 98 LRQPHLPRGTQKGDVYSFGLVLYEVIGRQGPWGHLRM----TDEEIITSV-T-----------QG---------SGL--- 149 (423)
Q Consensus 98 l~~~~~~~~s~ksDVyS~Giil~elltg~~Pf~~~~~----~~~~i~~~i-~-----------~~---------~~~--- 149 (423)
+.+..+ +.++||||+||++++|++|+.||..... ......... . .. ...
T Consensus 201 ~~~~~~---~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~ 277 (362)
T d1q8ya_ 201 LLGAPW---GCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRN 277 (362)
T ss_dssp HHTCCC---CTHHHHHHHHHHHHHHHHSSCCC---------CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSS
T ss_pred ccccCC---CccccccchHHHHHHHHHCCCCCCCCccccccchhHHHHHHHHHhCCCCHHHhhcccccccccccchhhhc
Confidence 987665 8999999999999999999999963211 111111110 0 00 000
Q ss_pred CCC--------------CCCCCchHHHHHHHHHhhhcCCCCCCCHHHHHH
Q psy1840 150 RPD--------------TSSLDCAPSIIACMRTCWEEDPELRPDLRFVHH 185 (423)
Q Consensus 150 ~p~--------------~~~~~~~~~l~~Li~~C~~~dP~~RPt~~~I~~ 185 (423)
.+. ......++++.+|+.+||+.||.+|||+.++++
T Consensus 278 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~e~L~ 327 (362)
T d1q8ya_ 278 ISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLVN 327 (362)
T ss_dssp CCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHHHT
T ss_pred cccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 000 001234678999999999999999999999875
|
| >d1azsb_ d.58.29.1 (B:) Adenylyl cyclase IIC1, domain C2a {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Ferredoxin-like superfamily: Nucleotide cyclase family: Adenylyl and guanylyl cyclase catalytic domain domain: Adenylyl cyclase IIC1, domain C2a species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.25 E-value=1.3e-12 Score=115.98 Aligned_cols=58 Identities=19% Similarity=0.183 Sum_probs=53.3
Q ss_pred ccccceeEEEeeccccccccccC----CHhHHHHhhhccch-hhhhccC---CCceEEEeecccCC
Q psy1840 337 ESFDSVTIYFSDIVGFTQLSAES----TETGRVTTRDSRRT-PDLKVGG---SNPRQVITGTDMLR 394 (423)
Q Consensus 337 ~~~~~vtv~f~di~gft~~~~~~----~p~~~v~~ln~~~~-fd~~~~~---~~~~~v~~~~~~~~ 394 (423)
+.|++|||+|+||+|||.+++++ .|.+++.+||++|+ ||.+++. +++++++|.||.|+
T Consensus 2 ~~~~~vtvlF~Di~gfT~l~~~~~~~~~~~~~~~~Ln~~~~~fd~~~~~~~~~g~~~~k~iGD~~~ 67 (199)
T d1azsb_ 2 QSYDCVCVMFASIPDFKEFYTESDVNKEGLECLRLLNEIIADFDDLLSKPKFSGVEKIKTIGSTYM 67 (199)
T ss_dssp CEEEEEEEEEEECTTHHHHCCCCTTTTTTHHHHHHHHHHHHHHHGGGGSGGGTTEEEEEEETTEEE
T ss_pred CCCCcEEEEEEEcCCChHHHHhCCcccCHHHHHHHHHHHHHHHHHHHHHHhccCcEEEEEecCeEE
Confidence 68999999999999999998765 47899999999999 9999887 89999999999888
|
| >d1azsa_ d.58.29.1 (A:) Adenylyl cyclase VC1, domain C1a {Dog (Canis familiaris) [TaxId: 9615]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Ferredoxin-like superfamily: Nucleotide cyclase family: Adenylyl and guanylyl cyclase catalytic domain domain: Adenylyl cyclase VC1, domain C1a species: Dog (Canis familiaris) [TaxId: 9615]
Probab=99.00 E-value=2.7e-11 Score=106.50 Aligned_cols=62 Identities=24% Similarity=0.226 Sum_probs=57.7
Q ss_pred CCCCccccceeEEEeeccccccccccCCHhHHHHhhhccch-hhhhccCCCceEEEeecccCC
Q psy1840 333 FVEPESFDSVTIYFSDIVGFTQLSAESTETGRVTTRDSRRT-PDLKVGGSNPRQVITGTDMLR 394 (423)
Q Consensus 333 ~~~~~~~~~vtv~f~di~gft~~~~~~~p~~~v~~ln~~~~-fd~~~~~~~~~~v~~~~~~~~ 394 (423)
.+-.+.|++|||+|+||+|||.+++..+|.+++.+||.+|+ +|.++.+++.+.+++.||.++
T Consensus 6 ~~~~~~~~~Vtvlf~Di~gfT~l~~~~~~~~~~~~l~~~~~~~~~~i~~~gg~~~k~~GD~~~ 68 (190)
T d1azsa_ 6 KIYIQKHDNVSILFADIEGFTSLASQCTAQELVMTLNELFARFDKLAAENHCLRIKILGDCYY 68 (190)
T ss_dssp CCEEEEEEEEEEEEEEEETHHHHHHHSCHHHHHHHHHHHHHHHHHHHHHHTEEEEEEETTEEE
T ss_pred hhhhhcCCcEEEEEEEcCChhHHHHhCCHHHHHHHHHHHHHHHhhcccccCccccccceeEEE
Confidence 34567899999999999999999999999999999999999 999999999999999999888
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=98.95 E-value=2.7e-10 Score=99.66 Aligned_cols=48 Identities=21% Similarity=0.208 Sum_probs=43.1
Q ss_pred HHHHHHHHHHHHHHHHhCCCeeecCCCCCCEEEcCCccEEEeccCCcccc
Q psy1840 25 SISVNTTASVGMIHLHDSEIISHGNLRSSNCLIDSRWVLQIADFGLHAFK 74 (423)
Q Consensus 25 ~l~i~~qi~~gL~yLH~~~ii~HrDLkp~NILld~~~~vKL~DFGla~~~ 74 (423)
...++.|++.|+.|||+.|++ ||||||+|||++.++ ++|+|||.+...
T Consensus 105 ~~~i~~ql~~~l~~lH~~gii-HrDiKP~NILv~~~~-~~liDFG~a~~~ 152 (191)
T d1zara2 105 PDEVLDMILEEVAKFYHRGIV-HGDLSQYNVLVSEEG-IWIIDFPQSVEV 152 (191)
T ss_dssp HHHHHHHHHHHHHHHHHTTEE-CSCCSTTSEEEETTE-EEECCCTTCEET
T ss_pred HHHHHHHHHHHHHHHhhCCEE-EccCChhheeeeCCC-EEEEECCCcccC
Confidence 468999999999999999998 999999999999765 889999998654
|
| >d1wc1a_ d.58.29.1 (A:) Adenylate cyclase CyaC {Spirulina platensis [TaxId: 118562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Ferredoxin-like superfamily: Nucleotide cyclase family: Adenylyl and guanylyl cyclase catalytic domain domain: Adenylate cyclase CyaC species: Spirulina platensis [TaxId: 118562]
Probab=98.81 E-value=7e-10 Score=97.48 Aligned_cols=58 Identities=28% Similarity=0.249 Sum_probs=54.2
Q ss_pred CccccceeEEEeeccccccccccCCHhHHHHhhhccch-hhhhccCCCceEEEeecccCC
Q psy1840 336 PESFDSVTIYFSDIVGFTQLSAESTETGRVTTRDSRRT-PDLKVGGSNPRQVITGTDMLR 394 (423)
Q Consensus 336 ~~~~~~vtv~f~di~gft~~~~~~~p~~~v~~ln~~~~-fd~~~~~~~~~~v~~~~~~~~ 394 (423)
||. ..|||+|+||+|||.+++..+|.+++.+||++|+ ++..|.+++.+.+++.||.++
T Consensus 3 pe~-r~vtvlF~Di~gfT~l~~~~~~~~~~~~l~~~~~~~~~~i~~~~G~v~k~~GD~~~ 61 (197)
T d1wc1a_ 3 PEP-RLITILFSDIVGFTRMSNALQSQGVAELLNEYLGEMTRAVFENQGTVDKFVGDAIM 61 (197)
T ss_dssp CEE-EEEEEEEEEETTHHHHHHHSCHHHHHHHHHHHHHHHHHHHHHTTCEEEEEETTEEE
T ss_pred Ccc-EEEEEEEEEeCCHHHHHHhCCHHHHHHHHHHHHHHHHhhHhhhhhhceeeccceEE
Confidence 444 6899999999999999999999999999999999 999999999999999999988
|
| >d1fx2a_ d.58.29.1 (A:) Receptor-type monomeric adenylyl cyclase {Trypanosome (Trypanosoma brucei), different isoform [TaxId: 5691]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Ferredoxin-like superfamily: Nucleotide cyclase family: Adenylyl and guanylyl cyclase catalytic domain domain: Receptor-type monomeric adenylyl cyclase species: Trypanosome (Trypanosoma brucei), different isoform [TaxId: 5691]
Probab=98.32 E-value=5.6e-08 Score=87.57 Aligned_cols=57 Identities=25% Similarity=0.154 Sum_probs=52.4
Q ss_pred ccccceeEEEeeccccccccccCCHhHHHHhhhccch-hhhhccCCCceEEEeecccCC
Q psy1840 337 ESFDSVTIYFSDIVGFTQLSAESTETGRVTTRDSRRT-PDLKVGGSNPRQVITGTDMLR 394 (423)
Q Consensus 337 ~~~~~vtv~f~di~gft~~~~~~~p~~~v~~ln~~~~-fd~~~~~~~~~~v~~~~~~~~ 394 (423)
+..++|||+|+||+|||.+++. .|.+++.+||.++. ++.+|.+++.|.+++.||.++
T Consensus 8 ~~~~~vtilF~DI~gfT~l~e~-~p~~~~~~l~~~~~~~~~~i~~~~G~~~k~~GD~~l 65 (235)
T d1fx2a_ 8 EPTDPVTLIFTDIESSTALWAA-HPDLMPDAVAAHHRMVRSLIGRYKCYEVKTVGDSFM 65 (235)
T ss_dssp CTTSCEEEEEEEETTHHHHHHH-CTTTHHHHHHHHHHHHHHHHHHTTCEEEEEETTEEE
T ss_pred CCCCCEEEEEEeccChHHHHHh-CHHHHHHHHHHHHHHHHHHHHHcCCEEEEecCCcEE
Confidence 3467899999999999999875 57799999999999 999999999999999999998
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=88.92 E-value=0.058 Score=48.61 Aligned_cols=29 Identities=21% Similarity=0.291 Sum_probs=25.6
Q ss_pred CCeeecCCCCCCEEEcCCccEEEeccCCcc
Q psy1840 43 EIISHGNLRSSNCLIDSRWVLQIADFGLHA 72 (423)
Q Consensus 43 ~ii~HrDLkp~NILld~~~~vKL~DFGla~ 72 (423)
|+| |+|+.+.|++++.+...-|.||+.+.
T Consensus 184 giI-HgDl~~dNvl~~~~~v~gvIDF~~~~ 212 (316)
T d2ppqa1 184 GVI-HADLFQDNVFFLGDELSGLIDFYFAC 212 (316)
T ss_dssp EEE-CSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred ccc-cCCcchhhhhcccccceeEecccccc
Confidence 566 99999999999999888999999754
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=85.67 E-value=0.2 Score=43.32 Aligned_cols=28 Identities=32% Similarity=0.476 Sum_probs=24.1
Q ss_pred eeecCCCCCCEEEcCCccEEEeccCCcc
Q psy1840 45 ISHGNLRSSNCLIDSRWVLQIADFGLHA 72 (423)
Q Consensus 45 i~HrDLkp~NILld~~~~vKL~DFGla~ 72 (423)
++|||+.|.||+++.++.+-|.||+.+.
T Consensus 185 l~HgD~~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T d1j7la_ 185 FSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp EECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred EEEeeccCcceeecCCceEEEeechhcc
Confidence 4599999999999987777899998754
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=83.62 E-value=0.21 Score=42.89 Aligned_cols=28 Identities=18% Similarity=0.335 Sum_probs=24.1
Q ss_pred eeecCCCCCCEEEcCCccEEEeccCCcc
Q psy1840 45 ISHGNLRSSNCLIDSRWVLQIADFGLHA 72 (423)
Q Consensus 45 i~HrDLkp~NILld~~~~vKL~DFGla~ 72 (423)
++|||+.|.||+++.+..+-|+||+.+.
T Consensus 177 liHgD~~~~Nvl~~~~~~~~iID~~~~~ 204 (255)
T d1nd4a_ 177 VTHGDACLPNIMVENGRFSGFIDCGRLG 204 (255)
T ss_dssp EECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred EEeCCCCCcceEEeCCceEEEEEchhcc
Confidence 4599999999999988778899998753
|